Citrus Sinensis ID: 004979
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 721 | 2.2.26 [Sep-21-2011] | |||||||
| C0LGU7 | 695 | Probable LRR receptor-lik | yes | no | 0.865 | 0.897 | 0.430 | 1e-145 | |
| Q9SIZ4 | 489 | Inactive receptor-like se | no | no | 0.565 | 0.834 | 0.516 | 1e-119 | |
| Q9LYN6 | 499 | Probable inactive recepto | no | no | 0.560 | 0.809 | 0.530 | 1e-116 | |
| C0LGH8 | 664 | Probable LRR receptor-lik | no | no | 0.858 | 0.932 | 0.325 | 1e-90 | |
| Q9LVP0 | 1102 | Probable leucine-rich rep | no | no | 0.753 | 0.492 | 0.282 | 2e-47 | |
| Q9SYQ8 | 980 | Receptor protein kinase C | no | no | 0.742 | 0.545 | 0.264 | 3e-38 | |
| Q8VZG8 | 1045 | Probable LRR receptor-lik | no | no | 0.746 | 0.514 | 0.260 | 1e-37 | |
| C0LGF4 | 591 | LRR receptor-like serine/ | no | no | 0.739 | 0.901 | 0.251 | 5e-36 | |
| Q9SGP2 | 996 | Receptor-like protein kin | no | no | 0.712 | 0.516 | 0.255 | 7e-36 | |
| Q8VYA3 | 769 | Wall-associated receptor | no | no | 0.371 | 0.348 | 0.352 | 6e-35 |
| >sp|C0LGU7|Y5458_ARATH Probable LRR receptor-like serine/threonine-protein kinase At5g45840 OS=Arabidopsis thaliana GN=At5g45840 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 516 bits (1328), Expect = e-145, Method: Compositional matrix adjust.
Identities = 295/686 (43%), Positives = 415/686 (60%), Gaps = 62/686 (9%)
Query: 74 GMALLRFRERVVRDPFGALSKWSDNDGVGDNVNPCSWFGVECSDGKVVILNLRDLCLGGM 133
G LL+FR RV DP G L+ W+ V D+ + CSWFGV C D KV +LNL LGG
Sbjct: 34 GFVLLKFRARVDSDPHGTLANWN----VSDHDHFCSWFGVTCVDNKVQMLNLSGCSLGGT 89
Query: 134 LAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLT 193
LAPEL QLSEL+S+IL N G IP E +LE LDL NN +G P + +
Sbjct: 90 LAPELSQLSELRSLILSKNKLSGDIPNEFASFAKLEFLDLRDNNLNGVVPPELNKVLTPE 149
Query: 194 TLLLDNNQYLGGISPELHVLKVISEIQVDESWLTNAASR----------ASCNS--GLFT 241
LLL N++ G ++ + L+ + ++Q++++ ++ S C S L T
Sbjct: 150 NLLLSGNKFAGFMTVKFLRLQSLYKVQMNKNRELSSVSADVLDCVNRKLGYCVSRRSLIT 209
Query: 242 WNKVQPGDNAFRRMLQQVTNGFEAKRKAS--------EPS-SSSSIASSPEPLVSPSLSP 292
NK + AF ++ + + +R++ PS + +SI E L S
Sbjct: 210 RNKAK----AFVLRIRATSRHYMVRRESHGKNYVVNYHPSENETSIFKRRELLEETSNLA 265
Query: 293 SMSSLLSPSFSPSP-SPSESPSVSSPLIIPPAPVNIPIVSSPPH------------LHSA 339
+M P+P +PS SP + + ++ P + + P +++
Sbjct: 266 AM---------PAPDTPSPSPEIIT-IVFPRSSGSFPALTNAKKRIPPLIPPSSPPPLPT 315
Query: 340 PTSFAASTPSQVHESLHKSKHHTVLVLAGIIGGLSLILISAIGFFVCRSSKVVTVKPWVT 399
+ A+ P + E K + V+ G+ +++++I A+ FF R V ++ PW T
Sbjct: 316 NNTIASDPPRKFEEKSKGFKDVWLYVVIGVAAFVAMLIIVAVIFFF-RKRAVKSIGPWKT 374
Query: 400 GLSGQLQKAFVTGVPKLKRSELEAACEDFSNIIGSFSDGTVGTVYKGTLSSGVEIAVTST 459
GLSGQLQKAFVTGVPKL RSELE ACEDFSNII +F DG TVYKGTLSSGVEIAV ST
Sbjct: 375 GLSGQLQKAFVTGVPKLNRSELETACEDFSNIIEAF-DGY--TVYKGTLSSGVEIAVAST 431
Query: 460 SVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFE 519
++ +W++ +E +R++IDT+S+VNHKNF+NLIGYCEEDEPF RMMVFEY+PNG+LFE
Sbjct: 432 AILETREWTRAMEMTYRRRIDTMSRVNHKNFINLIGYCEEDEPFNRMMVFEYAPNGTLFE 491
Query: 520 HLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFS 579
HLH +E EHLDW R RI MG AYCL++MH+L PPI+H L SS+IYLT+DYAAK+ +
Sbjct: 492 HLHDKEMEHLDWNARTRIIMGTAYCLQYMHELNPPISHTKLVSSAIYLTDDYAAKVGEVP 551
Query: 580 FWNNTTAAKTGSAAMELLETSAVDL----ESNVYSFGTILFEMITGRISYSIENGSLENW 635
F + T +K L+ S + L E+NVYSFG ++ E+I+G++S S E GS+ W
Sbjct: 552 F-SGQTGSKPRKPMSGDLDQSLLPLPPEPETNVYSFGVLMLEIISGKLSDSEEEGSILKW 610
Query: 636 ASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITA 695
AS+YL+ + L+D++DPTL +++E LE + V ++C+ D QRP M+ + +LKE+
Sbjct: 611 ASKYLENDN-LRDMIDPTLTTYKEEELEAICDVARHCLKLDESQRPKMKYVVQQLKEVIN 669
Query: 696 MEPDGATPKLSPLWWAELEILSSEAS 721
+ + ATP+LSPLWWAELEILSSEA+
Sbjct: 670 ISQEQATPRLSPLWWAELEILSSEAT 695
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9SIZ4|Y2027_ARATH Inactive receptor-like serine/threonine-protein kinase At2g40270 OS=Arabidopsis thaliana GN=At2g40270 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 429 bits (1104), Expect = e-119, Method: Compositional matrix adjust.
Identities = 220/426 (51%), Positives = 296/426 (69%), Gaps = 18/426 (4%)
Query: 294 MSSLLSPSFSPSPSPSESPSVSSPLIIPPAPVNIPIVSSPPHLHSAPTSFAASTPSQVHE 353
+++ +PS SP P+P + +S + P + VS P SAP A++P
Sbjct: 80 VAATTTPSSSPEPAPKHVSTKASTVSEPQKRSSTQDVSPSP---SAP---LANSP----- 128
Query: 354 SLHKSKHHTVLVLAGIIGGLSLILISAIGFFVCRSSKVVTVKPWVTGLSGQLQKAFVTGV 413
+ ++ H +V ++ G +GG +L+ A G + S TV PW TGLSGQLQK FVTG+
Sbjct: 129 -IPRNSHSSVPLVVGCVGGAFFLLLVATGLYFFTSKAGKTVNPWRTGLSGQLQKVFVTGI 187
Query: 414 PKLKRSELEAACEDFSNIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLES 473
P LKRSE+EAACEDFSN+IGS +G ++KGTLSSGVEIAV S + + DW + E
Sbjct: 188 PVLKRSEIEAACEDFSNVIGS---CPIGKLFKGTLSSGVEIAVASFATTTAKDWKDSTEI 244
Query: 474 QFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAM 533
FRKKI+ LSK+NHKNF NL+GYCEE EPFTR+++FEY+PNGSLFEHLH +E+EHLDW M
Sbjct: 245 HFRKKIEMLSKINHKNFANLLGYCEEKEPFTRILIFEYAPNGSLFEHLHYKESEHLDWGM 304
Query: 534 RLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTAAKTGSAA 593
RLRIAMG+AYCL+HMHQL PPIAH NL SSS+ LTEDYA K+SDFSF ++ T +
Sbjct: 305 RLRIAMGLAYCLDHMHQLNPPIAHTNLVSSSLQLTEDYAVKVSDFSFGSSETETNINNNT 364
Query: 594 MELLETSAVDLESNVYSFGTILFEMITGRISYSIEN-GSLENWASEYLKGEQPLKDIVDP 652
+ SA++ E N+YSFG +LFEMITG++ S+ S+++ ++L+GE L +VDP
Sbjct: 365 VIDTHISALNPEDNIYSFGLLLFEMITGKLIESVNKPDSVDSSLVDFLRGET-LAKMVDP 423
Query: 653 TLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAMEPDGATPKLSPLWWAE 712
TL+S+ + E + VIK+C+ DPK+RP+M+ + L+EIT + P+ ATPKLSPLWWAE
Sbjct: 424 TLESYDAKI-ENIGEVIKSCLRTDPKERPTMQEVTGWLREITGLSPNDATPKLSPLWWAE 482
Query: 713 LEILSS 718
LE+LS+
Sbjct: 483 LEVLST 488
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9LYN6|Y3565_ARATH Probable inactive receptor-like protein kinase At3g56050 OS=Arabidopsis thaliana GN=At3g56050 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 419 bits (1076), Expect = e-116, Method: Compositional matrix adjust.
Identities = 223/420 (53%), Positives = 293/420 (69%), Gaps = 16/420 (3%)
Query: 304 PSPSPSESPSVSSPLIIPPAPVNIPIVSSPPHLH-SAPTSFAAS-TPSQVHESLHKSKHH 361
PS S S P +PP SPP H SAP F T + S S +
Sbjct: 90 PSSSVSTRPDAKRSSTLPPPQ------KSPPAQHVSAPPPFVHHVTLPSLTSSSKTSSNS 143
Query: 362 TVLVLAGIIGGLSLILISAIGFFVCRSSKVVTVKPWVTGLSGQLQKAFVTGVPKLKRSEL 421
T+ ++AG I G IL+ A G F +S +V PW TGLSGQLQK F+TGVPKLKRSE+
Sbjct: 144 TIPIVAGCIAGAVFILLLATGVFFFKSKAGKSVNPWRTGLSGQLQKVFITGVPKLKRSEI 203
Query: 422 EAACEDFSNIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDT 481
EAACEDFSN+IGS +GT++KGTLSSGVEIAV S + S +W+ N+E QFRKKI+
Sbjct: 204 EAACEDFSNVIGSCP---IGTLFKGTLSSGVEIAVASVATASAKEWTNNIEMQFRKKIEM 260
Query: 482 LSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGM 541
LSK+NHKNFVNL+GYCEE+EPFTR++VFEY+ NG++FEHLH +E+EHLDW MRLRIAMG+
Sbjct: 261 LSKINHKNFVNLLGYCEEEEPFTRILVFEYASNGTVFEHLHYKESEHLDWVMRLRIAMGI 320
Query: 542 AYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTAAKTGSAAMELLET-- 599
AYCL+HMH L PPI H NL SSS+ LTEDYA KI+DF+F ++T S+ L++T
Sbjct: 321 AYCLDHMHGLKPPIVHSNLLSSSVQLTEDYAVKIADFNFGYLKGPSETESSTNALIDTNI 380
Query: 600 SAVDLESNVYSFGTILFEMITGRISYSIENG-SLENWASEYLKGEQPLKDIVDPTLKSFQ 658
S E NV+SFG +LFE++TG++ S++ G S++ + +L+G+ L+++VDPT++SF
Sbjct: 381 SETTQEDNVHSFGLLLFELMTGKLPESVQKGDSIDTGLAVFLRGKT-LREMVDPTIESFD 439
Query: 659 ENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAMEPDGATPKLSPLWWAELEILSS 718
E + E + VIK+C+ D KQRP M+ + +L+EIT + PD PKLSPLWWAELE+LS+
Sbjct: 440 EKI-ENIGEVIKSCIRADAKQRPIMKEVTGRLREITGLSPDDTIPKLSPLWWAELEVLST 498
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|C0LGH8|Y1634_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g63430 OS=Arabidopsis thaliana GN=At1g63430 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 334 bits (857), Expect = 1e-90, Method: Compositional matrix adjust.
Identities = 229/704 (32%), Positives = 361/704 (51%), Gaps = 85/704 (12%)
Query: 50 MAALTLVMLLFLQNLSLARCLNSEGMALLRFRERVVRDPFGALSKWSDNDGVGDNVNPCS 109
+L LV+ LF +S ++E AL RF+E + DP +S W+D N +PC
Sbjct: 6 FCSLALVLGLFF--VSCDGFASNEVQALRRFKEAIYEDPLLVMSNWND-----PNSDPCD 58
Query: 110 WFGVECSDGK--VVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKE 167
W G+ CS K V+ +N+ + G LAPELGQ++ L+ +IL N GTIPKEIG LK
Sbjct: 59 WTGIYCSPSKDHVIKINISASSIKGFLAPELGQITYLQELILHGNILIGTIPKEIGNLKN 118
Query: 168 LEILDLGFNNFSGPFPSDFGNSFSLTTLLLDNNQYLGGISPELHVLKVISEIQVDESWLT 227
L+ILDLG N+ GP P++ G+ + + L +N G + EL LK + E+ +D
Sbjct: 119 LKILDLGNNHLMGPIPAEIGSLSGIMIINLQSNGLTGKLPAELGNLKYLRELHIDR---- 174
Query: 228 NAASRASCNSGLFTWNKVQPGDNAFRRMLQQVTNGFEAKRKASEPSSSSSIASSPEPLVS 287
N++Q +L +G+++K +S +SS++IA + L
Sbjct: 175 ---------------NRLQGS------LLVAGASGYQSKVYSS--NSSANIAGLCKSLKV 211
Query: 288 PSLS---------PSMSSLLSPSFSPSPSPSESPSVSSPLIIPPAPVNIPIVSSPPHLHS 338
S + +L SF + ++ S N +V + H
Sbjct: 212 ADFSYNFFVGNIPKCLENLPRTSFQGNCMQNKDLKHRSS----SQCANAQLVKT----HG 263
Query: 339 APTSFAASTPSQVHESLHKSKHHTVLVLAGIIGG--LSLILISAIGFFVCR-SSKVVTVK 395
+P++ +Q+ H++ L+ I+ G + L+L+ A+ V R +++ +
Sbjct: 264 SPSAAPKHQSAQMVAKHHRASKPKWLLALEIVTGSMVGLLLLVALFSAVHRWNNRSTLII 323
Query: 396 PWVTGLSGQ------LQKAFVTGVPKLKRSELEAACEDFSNIIGSFSDGTVGTVYKGTLS 449
PW S + + + V +L R ELE ACEDFSNIIG +D + YKGTL
Sbjct: 324 PWKKSSSEKEKFTVYVDSEMLKDVSRLTRQELEVACEDFSNIIGLSADSQI---YKGTLK 380
Query: 450 SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVF 509
G EIAV S VK DW+ LE F++++ L+++NH+N L+GYC+E PFTRM+VF
Sbjct: 381 GGSEIAVISLCVKEE-DWTGYLELYFQREVADLARLNHENTAKLLGYCKEISPFTRMLVF 439
Query: 510 EYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMH-QLTPPIAHRNLQSSSIYLT 568
EY+ NG+L+EHLH EA + WA R++I +G+A L+++H +L PP L S++IYLT
Sbjct: 440 EYASNGTLYEHLHYGEAALVSWARRMKIVIGIARGLKYLHMELDPPFTISELSSNAIYLT 499
Query: 569 EDYAAKISDFSFWNNTTA---------AKTGSAAM--ELLETSAVDLESNVYSFGTILFE 617
ED+ K+ DF W A + GS + +E+ +D+ N+Y+FG +L E
Sbjct: 500 EDFTPKLVDFECWKTILARSEKNLRNISSQGSICVLPNGMESRYLDVSGNIYAFGILLLE 559
Query: 618 MITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDP 677
+++GR Y + G L WA E+L+ + + +VDP LK F + LE + V C++ DP
Sbjct: 560 IVSGRPPYCKDKGFLIEWAKEFLEAPEAMSGLVDPELKHFNQEDLETVCEVASQCLNRDP 619
Query: 678 ------KQRPSMRGIAAKLKEITAMEPDGATPKLSPLWWAELEI 715
+PS++ + L+ ++ A + S L WAEL +
Sbjct: 620 TNNNNNHNKPSVQELCETLESRISLSIS-AELRSSSLAWAELAL 662
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LVP0|Y5639_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g63930 OS=Arabidopsis thaliana GN=At5g63930 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 191 bits (485), Expect = 2e-47, Method: Compositional matrix adjust.
Identities = 169/598 (28%), Positives = 276/598 (46%), Gaps = 55/598 (9%)
Query: 123 LNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPF 182
L L D G L E+G LS+L ++ + +N G +P EI K L+ LD+ NNFSG
Sbjct: 510 LQLADNGFTGELPREIGMLSQLGTLNISSNKLTGEVPSEIFNCKMLQRLDMCCNNFSGTL 569
Query: 183 PSDFGNSFSLTTLLLDNNQYLGGISPELHVLKVISEIQVDESWLTNAASRASCNSGLFTW 242
PS+ G+ + L L L NN G I L L ++E+Q+ + + R L +
Sbjct: 570 PSEVGSLYQLELLKLSNNNLSGTIPVALGNLSRLTELQMGGNLFNGSIPRE-----LGSL 624
Query: 243 NKVQPGDN-AFRRMLQQVTNGFEAKRKASEPSSSSSIASSPEPLVSPSLSPSMSSLLSPS 301
+Q N ++ ++ ++ + E ++ S E PS ++SSLL +
Sbjct: 625 TGLQIALNLSYNKLTGEIPPEL-SNLVMLEFLLLNNNNLSGE---IPSSFANLSSLLGYN 680
Query: 302 FS----PSPSP-----SESPSVSSPLIIPPAPVNIPIVSSPPHLHSAPTSFAASTPSQVH 352
FS P P S S + + + P P+N I + P FA S +
Sbjct: 681 FSYNSLTGPIPLLRNISMSSFIGNEGLCGP-PLNQCIQTQP---------FAPSQSTGKP 730
Query: 353 ESLHKSKHHTVLVLAGIIGGLSLILISAIGFFVCRSSKVVTVKPWVTGLSGQLQKAFVTG 412
+ SK + + A +IGG+SL+LI+ I + + R + V S +
Sbjct: 731 GGMRSSK--IIAITAAVIGGVSLMLIALIVYLMRRPVRTVASSAQDGQPSEMSLDIYFPP 788
Query: 413 VPKLKRSELEAACEDF--SNIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKN 470
+L AA ++F S ++G G GTVYK L +G +AV + + N
Sbjct: 789 KEGFTFQDLVAATDNFDESFVVGR---GACGTVYKAVLPAGYTLAVKKLASNHEGGNNNN 845
Query: 471 LESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLD 530
+++ FR +I TL + H+N V L G+C + ++++EY P GSL E LH + +LD
Sbjct: 846 VDNSFRAEILTLGNIRHRNIVKLHGFCNHQG--SNLLLYEYMPKGSLGEILH-DPSCNLD 902
Query: 531 WAMRLRIAMGMAYCLEHMHQ-LTPPIAHRNLQSSSIYLTEDYAAKISDFSFWN------- 582
W+ R +IA+G A L ++H P I HR+++S++I L + + A + DF
Sbjct: 903 WSKRFKIALGAAQGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPHS 962
Query: 583 ---NTTAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGR--ISYSIENGSLENWAS 637
+ A G A E T V +S++YS+G +L E++TG+ + + G + NW
Sbjct: 963 KSMSAIAGSYGYIAPEYAYTMKVTEKSDIYSYGVVLLELLTGKAPVQPIDQGGDVVNWVR 1022
Query: 638 EYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKN---CVHPDPKQRPSMRGIAAKLKE 692
Y++ + ++D L E ++ +L V+K C P RPSMR + L E
Sbjct: 1023 SYIRRDALSSGVLDARLTLEDERIVSHMLTVLKIALLCTSVSPVARPSMRQVVLMLIE 1080
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SYQ8|CLV1_ARATH Receptor protein kinase CLAVATA1 OS=Arabidopsis thaliana GN=CLV1 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 160 bits (405), Expect = 3e-38, Method: Compositional matrix adjust.
Identities = 171/647 (26%), Positives = 273/647 (42%), Gaps = 112/647 (17%)
Query: 117 DGKVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKEL-------- 168
+G ++ L++ D L G++ +L + +L+ +IL NN FFG IP+E+G+ K L
Sbjct: 360 NGNLIKLDVSDNHLTGLIPKDLCRGEKLEMLILSNNFFFGPIPEELGKCKSLTKIRIVKN 419
Query: 169 ------------------------------------EILD---LGFNNFSGPFPSDFGNS 189
++LD L N FSG P GN
Sbjct: 420 LLNGTVPAGLFNLPLVTIIELTDNFFSGELPVTMSGDVLDQIYLSNNWFSGEIPPAIGNF 479
Query: 190 FSLTTLLLDNNQYLGGISPELHVLKVISEIQVDESWLTNAA--SRASCNSGLFTWNKVQP 247
+L TL LD N++ G I E+ LK +S I + +T S + C++ +
Sbjct: 480 PNLQTLFLDRNRFRGNIPREIFELKHLSRINTSANNITGGIPDSISRCSTLISV------ 533
Query: 248 GDNAFRRMLQQVTNGFE-AKRKASEPSSSSSIASSPEPLVSPSLSPSMSSLLSPSFSPSP 306
D + R+ ++ G K + S + + S P+ +M+SL + S +
Sbjct: 534 -DLSRNRINGEIPKGINNVKNLGTLNISGNQLTGS-----IPTGIGNMTSLTTLDLSFND 587
Query: 307 SPSESPSVSSPLIIPPAPVNIPIVSSPPHLHSAPTSFAASTPSQVHESLHKSKHHTVLVL 366
P L+ PH S PT T H +L + V+
Sbjct: 588 LSGRVPLGGQFLVFNETSFAGNTYLCLPHRVSCPTR-PGQTSDHNHTALFSPSRIVITVI 646
Query: 367 AGIIGGLSLILISAIGFFVCRSSKVVTVKPWVTGLSGQLQKAFVTGVPKLK-RSELEAAC 425
A I G LILIS + + + K L+ +L T KL +SE C
Sbjct: 647 AAITG---LILISV-------AIRQMNKKKNQKSLAWKL-----TAFQKLDFKSEDVLEC 691
Query: 426 EDFSNIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKS--RADWSKNLESQFRKKIDTLS 483
NIIG G G VY+G++ + V++A+ + R+D F +I TL
Sbjct: 692 LKEENIIGK---GGAGIVYRGSMPNNVDVAIKRLVGRGTGRSDHG------FTAEIQTLG 742
Query: 484 KVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAY 543
++ H++ V L+GY + T ++++EY PNGSL E LH + HL W R R+A+ A
Sbjct: 743 RIRHRHIVRLLGYVANKD--TNLLLYEYMPNGSLGELLHGSKGGHLQWETRHRVAVEAAK 800
Query: 544 CLEHMHQ-LTPPIAHRNLQSSSIYLTEDYAAKISDFSFWN-----------NTTAAKTGS 591
L ++H +P I HR+++S++I L D+ A ++DF ++ A G
Sbjct: 801 GLCYLHHDCSPLILHRDVKSNNILLDSDFEAHVADFGLAKFLVDGAASECMSSIAGSYGY 860
Query: 592 AAMELLETSAVDLESNVYSFGTILFEMITGR--ISYSIENGSLENWASEYLKG-EQP--- 645
A E T VD +S+VYSFG +L E+I G+ + E + W + QP
Sbjct: 861 IAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGEGVDIVRWVRNTEEEITQPSDA 920
Query: 646 --LKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKL 690
+ IVDP L + + + + CV + RP+MR + L
Sbjct: 921 AIVVAIVDPRLTGYPLTSVIHVFKIAMMCVEEEAAARPTMREVVHML 967
|
Involved in the detection of CLV3 and CLV3-like peptides, that act as extracellular signals regulating meristem maintenance. Acts with CLV3 as a ligand-receptor pair in a signal transduction pathway coordinating growth between adjacent meristematic regions and controlling the balance between meristem cell proliferation and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8VZG8|Y4885_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g08850 OS=Arabidopsis thaliana GN=At4g08850 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 158 bits (400), Expect = 1e-37, Method: Compositional matrix adjust.
Identities = 160/615 (26%), Positives = 263/615 (42%), Gaps = 77/615 (12%)
Query: 123 LNLRDLC---LGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFS 179
LN DL G L+ Q +L + IL NNS G IP EI + +L LDL N +
Sbjct: 456 LNFIDLSNNNFHGQLSANWEQSQKLVAFILSNNSITGAIPPEIWNMTQLSQLDLSSNRIT 515
Query: 180 GPFPSDFGNSFSLTTLLLDNNQYLGGISPELHVLKVISEIQVDESWLTNAA--------- 230
G P N ++ L L+ N+ G I + +L + + + + ++
Sbjct: 516 GELPESISNINRISKLQLNGNRLSGKIPSGIRLLTNLEYLDLSSNRFSSEIPPTLNNLPR 575
Query: 231 ------SRASCNS----GLFTWNKVQPGDNAFRRMLQQVTNGFEAKRKASEPSSSSSIAS 280
SR + GL +++Q D ++ ++ ++++ F + + S + S
Sbjct: 576 LYYMNLSRNDLDQTIPEGLTKLSQLQMLDLSYNQLDGEISSQFRSLQNLERLDLSHNNLS 635
Query: 281 SPEPLVSPSLSPSMSSLLSPSFSPSPSPSESPSVSSPLIIPPAPVNIPIVSSPPHLHSAP 340
P PS +L+ + VS + P P N ++PP
Sbjct: 636 GQIP-------PSFKDMLALTHV---------DVSHNNLQGPIPDNAAFRNAPPDAFEGN 679
Query: 341 TSFAAST-------PSQVHESL--HKSKHHTVLVLAGIIGGLSLILISAIGFFVCRSSKV 391
S P + S HK ++ + +L IIG + +IL G F+C +
Sbjct: 680 KDLCGSVNTTQGLKPCSITSSKKSHKDRNLIIYILVPIIGAI-IILSVCAGIFICFRKRT 738
Query: 392 VTVKPWVTGLSGQLQKAFVTGVPKLKRSELEAACEDFS--NIIGSFSDGTVGTVYKGTLS 449
++ SG + + K++ E+ A +F +IG+ G G VYK L
Sbjct: 739 KQIEEHTDSESGGETLSIFSFDGKVRYQEIIKATGEFDPKYLIGT---GGHGKVYKAKLP 795
Query: 450 SGVEIAVTSTSVKSRADWSK-NLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508
+ + +AV + + + S + + +F +I L+++ H+N V L G+C +V
Sbjct: 796 NAI-MAVKKLNETTDSSISNPSTKQEFLNEIRALTEIRHRNVVKLFGFCSHRR--NTFLV 852
Query: 509 FEYSPNGSLFEHL-HIQEAEHLDWAMRLRIAMGMAYCLEHMHQ-LTPPIAHRNLQSSSIY 566
+EY GSL + L + EA+ LDW R+ + G+A+ L +MH +P I HR++ S +I
Sbjct: 853 YEYMERGSLRKVLENDDEAKKLDWGKRINVVKGVAHALSYMHHDRSPAIVHRDISSGNIL 912
Query: 567 LTEDYAAKISDF----------SFWNNTTAAKTGSAAMELLETSAVDLESNVYSFGTILF 616
L EDY AKISDF S W + A G A EL V + +VYSFG +
Sbjct: 913 LGEDYEAKISDFGTAKLLKPDSSNW-SAVAGTYGYVAPELAYAMKVTEKCDVYSFGVLTL 971
Query: 617 EMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKN---CV 673
E+I G + + +S LK I D L + EE+L ++K C+
Sbjct: 972 EVIKGEHPGDL----VSTLSSSPPDATLSLKSISDHRLPEPTPEIKEEVLEILKVALLCL 1027
Query: 674 HPDPKQRPSMRGIAA 688
H DP+ RP+M I+
Sbjct: 1028 HSDPQARPTMLSIST 1042
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGF4|FEI1_ARATH LRR receptor-like serine/threonine-protein kinase FEI 1 OS=Arabidopsis thaliana GN=FEI1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 153 bits (386), Expect = 5e-36, Method: Compositional matrix adjust.
Identities = 164/653 (25%), Positives = 270/653 (41%), Gaps = 120/653 (18%)
Query: 67 ARCLNSEGMALLRFRERVVR-DPFGALSKWSDNDGVGDNVNPCSWFGVECSDGKVVILNL 125
++ ++ +G ALL FR V R D F + +W D +PC+W GV C D K
Sbjct: 27 SQAISPDGEALLSFRNAVTRSDSF--IHQWRPED-----PDPCNWNGVTC-DAKT----- 73
Query: 126 RDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSD 185
K + L+L ++ GP P D
Sbjct: 74 ----------------------------------------KRVITLNLTYHKIMGPLPPD 93
Query: 186 FGNSFSLTTLLLDNNQYLGGISPELHVLKVISEIQVDESWLTNAASRASCNSGLFTWNKV 245
G L L+L NN G I L + EI + ++ T
Sbjct: 94 IGKLDHLRLLMLHNNALYGAIPTALGNCTALEEIHLQSNYFTGPI--------------- 138
Query: 246 QPGDNAFRRMLQQVTNGFEAKRKASEPSSSSSIASSPEPLVSPSLSPSMSSLLSPSFSPS 305
P + LQ++ SS+ S P P L + +S +F
Sbjct: 139 -PAEMGDLPGLQKL-------------DMSSNTLSGPIPASLGQLKKLSNFNVSNNFLVG 184
Query: 306 PSPSESPSVSSPLIIPPAPVNIPIVSSPPHLHSAPTSFAASTPSQVHESLHKSKHHTVLV 365
PS+ V S N+ + + S S+ SQ ++ K+ ++
Sbjct: 185 QIPSDG--VLSGFSKNSFIGNLNLCGKHVDVVCQDDSGNPSSHSQSGQNQKKNSGKLLIS 242
Query: 366 LAGIIGGLSLI-LISAIGFFVCRSSKVVTVKPWVTGLSGQLQKAFVTG-VPKLKRS---E 420
+ +G L L+ L+ G F+ + V +K + G G +P + +
Sbjct: 243 ASATVGALLLVALMCFWGCFLYKKLGKVEIKSLAKDVGGGASIVMFHGDLPYSSKDIIKK 302
Query: 421 LEAACEDFSNIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKID 480
LE E+ +IIG G GTVYK + G A+ K ++ + F ++++
Sbjct: 303 LEMLNEE--HIIGC---GGFGTVYKLAMDDGKVFAL-----KRILKLNEGFDRFFERELE 352
Query: 481 TLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMG 540
L + H+ VNL GYC + P +++++++Y P GSL E LH + E LDW R+ I +G
Sbjct: 353 ILGSIKHRYLVNLRGYC--NSPTSKLLLYDYLPGGSLDEALH-ERGEQLDWDSRVNIIIG 409
Query: 541 MAYCLEHMHQ-LTPPIAHRNLQSSSIYLTEDYAAKISDF----------SFWNNTTAAKT 589
A L ++H +P I HR+++SS+I L + A++SDF S A
Sbjct: 410 AAKGLSYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTF 469
Query: 590 GSAAMELLETSAVDLESNVYSFGTILFEMITGRISYS---IENG-SLENWASEYLKGEQP 645
G A E +++ +++VYSFG ++ E+++G+ IE G ++ W ++L E+
Sbjct: 470 GYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNVVGWL-KFLISEKR 528
Query: 646 LKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAMEP 698
+DIVDP + Q L+ LL + CV P P++RP+M + +L E M P
Sbjct: 529 PRDIVDPNCEGMQMESLDALLSIATQCVSPSPEERPTMHRV-VQLLESEVMTP 580
|
Involved in the signaling pathway that regulates cell wall function, including cellulose biosynthesis, likely via an 1-aminocyclopropane-1-carboxylic acid (ACC)-mediated signal (a precursor of ethylene). Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SGP2|HSL1_ARATH Receptor-like protein kinase HSL1 OS=Arabidopsis thaliana GN=HSL1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 152 bits (385), Expect = 7e-36, Method: Compositional matrix adjust.
Identities = 148/579 (25%), Positives = 250/579 (43%), Gaps = 65/579 (11%)
Query: 149 LRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLLDNNQYLGGISP 208
L NNSF G I K IG L +L L N F+G P + G+ +L L N++ G +
Sbjct: 427 LVNNSFSGEISKSIGGASNLSLLILSNNEFTGSLPEEIGSLDNLNQLSASGNKFSGSLPD 486
Query: 209 ELHVLKVISEIQVDESWLTNAASRASCNSGLFTWNKVQPGDNAFRRMLQQVTNGFEAKRK 268
L L + + + + + SG+ +W K+ + A ++ + +
Sbjct: 487 SLMSLGELGTLDLHGNQFS-----GELTSGIKSWKKLNELNLADNEFTGKIPDEIGSLSV 541
Query: 269 ASEPSSSSSIASSPEPLVSPSLSPSMSSLLSPSFSPSPSPSESPSVSSPLIIPPAPVNIP 328
+ S ++ S P+ SL + +L S PS + + I
Sbjct: 542 LNYLDLSGNMFSGKIPVSLQSLKLNQLNLSYNRLSGDLPPSLAKDMYKNSFI-------- 593
Query: 329 IVSSPPHLHSAPTSFAASTPSQVHESLHKSKHHTVLVLAGIIGGLSLILISAIGFFVCRS 388
P L S K V +L I +++L++ + +F +
Sbjct: 594 ---GNPGLCGDIKGLCGSEN-------EAKKRGYVWLLRSIFVLAAMVLLAGVAWFYFK- 642
Query: 389 SKVVTVKPWVTGLSGQLQKAFVTGVPKLKRSE---LEAACEDFSNIIGSFSDGTVGTVYK 445
+ + + + K + KL SE LE+ ED N+IG+ G G VYK
Sbjct: 643 -----YRTFKKARAMERSKWTLMSFHKLGFSEHEILESLDED--NVIGA---GASGKVYK 692
Query: 446 GTLSSGVEIAVT---STSVKSRAD------WSKNLESQ-FRKKIDTLSKVNHKNFVNLIG 495
L++G +AV + SVK D + ++ + F +++TL K+ HKN V L
Sbjct: 693 VVLTNGETVAVKRLWTGSVKETGDCDPEKGYKPGVQDEAFEAEVETLGKIRHKNIVKLWC 752
Query: 496 YCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLT-PP 554
C + +++V+EY PNGSL + LH + L W R +I + A L ++H + PP
Sbjct: 753 CCSTRD--CKLLVYEYMPNGSLGDLLHSSKGGMLGWQTRFKIILDAAEGLSYLHHDSVPP 810
Query: 555 IAHRNLQSSSIYLTEDYAAKISDFSFWN------------NTTAAKTGSAAMELLETSAV 602
I HR+++S++I + DY A+++DF + A G A E T V
Sbjct: 811 IVHRDIKSNNILIDGDYGARVADFGVAKAVDLTGKAPKSMSVIAGSCGYIAPEYAYTLRV 870
Query: 603 DLESNVYSFGTILFEMITGRISYSIENG--SLENWASEYLKGEQPLKDIVDPTLKSFQEN 660
+ +S++YSFG ++ E++T + E G L W L ++ ++ ++DP L S +
Sbjct: 871 NEKSDIYSFGVVILEIVTRKRPVDPELGEKDLVKWVCSTLD-QKGIEHVIDPKLDSCFKE 929
Query: 661 VLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAMEPD 699
+ ++L V C P P RPSMR + L+EI + D
Sbjct: 930 EISKILNVGLLCTSPLPINRPSMRRVVKMLQEIGGGDED 968
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8VYA3|WAKLJ_ARATH Wall-associated receptor kinase-like 10 OS=Arabidopsis thaliana GN=WAKL10 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 149 bits (377), Expect = 6e-35, Method: Compositional matrix adjust.
Identities = 106/301 (35%), Positives = 165/301 (54%), Gaps = 33/301 (10%)
Query: 420 ELEAACEDFS--NIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRK 477
ELE A E+FS I+G +G GTVYKG L G +AV KS+ LE +F
Sbjct: 425 ELEKATENFSLTRILG---EGGQGTVYKGMLVDGRIVAVK----KSKVVDEDKLE-EFIN 476
Query: 478 KIDTLSKVNHKNFVNLIGYC-EEDEPFTRMMVFEYSPNGSLFEHLHIQEAEH--LDWAMR 534
++ LS++NH+N V L+G C E D P ++V+E+ PNG+LFEHLH ++ W +R
Sbjct: 477 EVVILSQINHRNIVKLLGCCLETDVP---ILVYEFIPNGNLFEHLHDDSDDYTMTTWEVR 533
Query: 535 LRIAMGMAYCLEHMHQ-LTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTAAKT---- 589
LRIA+ +A L ++H + PI HR+++S++I L E + AK+SDF T T
Sbjct: 534 LRIAVDIAGALSYLHSAASSPIYHRDIKSTNIMLDEKHRAKVSDFGTSRTVTVDHTHLTT 593
Query: 590 ------GSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSI----ENGSLENWASEY 639
G E ++S +S+VYSFG +L E+ITG S S E +L + +
Sbjct: 594 VVSGTVGYMDPEYFQSSQFTDKSDVYSFGVVLAELITGEKSVSFLRSQEYRTLATYFTLA 653
Query: 640 LKGEQPLKDIVDPTLK-SFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAMEP 698
+K E L DI+D ++ + N + + + C++ ++RPSMR ++ +L++I +
Sbjct: 654 MK-ENRLSDIIDARIRDGCKLNQVTAAAKIARKCLNMKGRKRPSMRQVSMELEKIRSYSE 712
Query: 699 D 699
D
Sbjct: 713 D 713
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 721 | ||||||
| 449523573 | 657 | PREDICTED: probable LRR receptor-like se | 0.877 | 0.963 | 0.597 | 0.0 | |
| 356569509 | 699 | PREDICTED: probable LRR receptor-like se | 0.912 | 0.941 | 0.556 | 0.0 | |
| 356569292 | 644 | PREDICTED: probable LRR receptor-like se | 0.850 | 0.951 | 0.569 | 0.0 | |
| 356537999 | 638 | PREDICTED: probable LRR receptor-like se | 0.843 | 0.952 | 0.561 | 0.0 | |
| 356551890 | 692 | PREDICTED: probable LRR receptor-like se | 0.889 | 0.926 | 0.551 | 0.0 | |
| 356551399 | 643 | PREDICTED: probable LRR receptor-like se | 0.876 | 0.982 | 0.524 | 0.0 | |
| 356498966 | 686 | PREDICTED: probable LRR receptor-like se | 0.904 | 0.950 | 0.554 | 0.0 | |
| 356541803 | 629 | PREDICTED: inactive receptor-like serine | 0.821 | 0.941 | 0.571 | 0.0 | |
| 449460929 | 680 | PREDICTED: probable LRR receptor-like se | 0.911 | 0.966 | 0.512 | 0.0 | |
| 356499209 | 645 | PREDICTED: probable LRR receptor-like se | 0.866 | 0.968 | 0.532 | 0.0 |
| >gi|449523573|ref|XP_004168798.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase MRH1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 751 bits (1938), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 406/680 (59%), Positives = 496/680 (72%), Gaps = 47/680 (6%)
Query: 66 LARCLNSEGMALLRFRERVVRDPFGALSKWSDNDGVGDNVNPCSWFGVECSDGKVVILNL 125
+ C G+ALLR R+ V DPFGAL+ W+D DG D+ CSWFGVECSDGKVVILNL
Sbjct: 1 MGFCFFDAGLALLRIRDAVGSDPFGALANWNDKDGEFDH---CSWFGVECSDGKVVILNL 57
Query: 126 RDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSD 185
RDLCLGG LAPE+G+ +KSIILRNNSF G IP+EIG+L ELE+LDLGFNNFSGPFP D
Sbjct: 58 RDLCLGGTLAPEMGKFPYIKSIILRNNSFHGGIPQEIGDLLELEVLDLGFNNFSGPFPLD 117
Query: 186 FGNSFSLTTLLLDNNQYLGGISPELHVLKVISEIQVDESWLTNAASRASCNSGLFTWN-- 243
GN+ SLTTLLLD+N+++ I+PE + L ++SE +DE L++ ++SC WN
Sbjct: 118 LGNNLSLTTLLLDHNEFITSITPEAYELNLLSETLMDEEQLSSIQGKSSCTRETVRWNFG 177
Query: 244 KVQPGDNAFRRM--LQQVTNGF--------------------EAKRKASEPSSSSSIASS 281
+ Q D RR+ +Q F S S S+S
Sbjct: 178 QFQDADYQRRRLGGVQSPKRSFFSLPPSSFASSPSPLSPSAPPFSPAPSPRSPSASPTEP 237
Query: 282 PEPLVSPSLSPSMSSLLSPSFSPSPSPSESPSVSSPLIIPPAPVNIPIVSSPPHLHSAPT 341
P PL+S + +PS+ +P+ P+ +P++ +P+ V +PPH P
Sbjct: 238 PAPLLSLAPAPSLH------LNPARPPAVAPTLHAPVH----------VLTPPHSRGVPP 281
Query: 342 SFAASTPSQVHESLHKSKHHTVLVLAGIIGGLSLILISAIGFFVCRSSKVVTVKPWVTGL 401
+A +P+ + S +K+K+H VL+L GI+ G +L + +G + RSSKVVTVKPW TGL
Sbjct: 282 RSSAPSPNLIGRS-NKNKNHKVLILTGIVAGSLFLLFATVGILMFRSSKVVTVKPWATGL 340
Query: 402 SGQLQKAFVTGVPKLKRSELEAACEDFSNIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSV 461
SGQLQKAFVTGVPKLKRSELEAACEDFSNIIGSFSD TV YKGTLSSGVEIAVTST+V
Sbjct: 341 SGQLQKAFVTGVPKLKRSELEAACEDFSNIIGSFSDITV---YKGTLSSGVEIAVTSTAV 397
Query: 462 KSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHL 521
S ADWSK E QFRKKI+TLS+VNHKNFV+LIG+CEE +PFTRMMVFEY+PNG+LFEHL
Sbjct: 398 TSNADWSKTKEEQFRKKIETLSRVNHKNFVSLIGFCEEAQPFTRMMVFEYAPNGTLFEHL 457
Query: 522 HIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFW 581
HI+EAEHLDW MRLRIAMG+AYCL+HMHQL P+ HR+L SSS+YLTEDYAAK+SDFS+W
Sbjct: 458 HIKEAEHLDWEMRLRIAMGVAYCLDHMHQLDLPVVHRHLCSSSVYLTEDYAAKLSDFSYW 517
Query: 582 NNTTAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLK 641
+ TAAK GSA +ELLETS DLESNVYSFG IL EMITGR+ +S+++GSL +WAS++LK
Sbjct: 518 SEATAAKLGSATVELLETSPADLESNVYSFGVILLEMITGRLPFSVDDGSLADWASDFLK 577
Query: 642 GEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAMEPDGA 701
GEQ LKDIVDP L SF+E LE L VIK CV P+PKQRP+M IA +LKEITA+EP GA
Sbjct: 578 GEQLLKDIVDPILSSFKEEQLENLSQVIKMCVKPEPKQRPTMPEIALRLKEITALEPAGA 637
Query: 702 TPKLSPLWWAELEILSSEAS 721
TPKLSPLWWAELEILS++ +
Sbjct: 638 TPKLSPLWWAELEILSTDTN 657
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356569509|ref|XP_003552942.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At5g45840-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 741 bits (1912), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 389/699 (55%), Positives = 493/699 (70%), Gaps = 41/699 (5%)
Query: 46 LRLNMAALTLVMLLFLQNLSLARCLNSEGMALLRFRERVVRDPFGALSKWSDNDGVGDNV 105
R+ +A ++L LF+ LN+EG+AL + RERVVRDP GALS W+ +
Sbjct: 14 FRVFVAVVSL--FLFILEPIWCSTLNNEGLALQKMRERVVRDPLGALSSWNSKG----EI 67
Query: 106 NPCSWFGVECSDGKVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGEL 165
+PCSWFGVECS G VV LNL+DLCL G LA E+G+L +KSIILRNN F+G IPKEI +L
Sbjct: 68 DPCSWFGVECSHGNVVSLNLKDLCLHGTLALEIGKLVHIKSIILRNNYFYGDIPKEILQL 127
Query: 166 KELEILDLGFNNFSGPFP-SDFGNSFSLTTLLLDNNQYLGGISPELHVLKVISEIQVDES 224
++LE+LDLG+NNFSG FP D SLTTLLLDNN +L ++PE++ LK SE+ V E
Sbjct: 128 EDLEVLDLGYNNFSGQFPFHDLATYPSLTTLLLDNNDHLASLTPEVYELKTFSELHVAEE 187
Query: 225 WLTNAASRASCNSGLFTWNKVQPGDNAFRRMLQQVTNGFEAKRKASEPSSSSSIASSPEP 284
LT A +R +C W+ GD A RR L Q NG +++ + + + S + P
Sbjct: 188 QLTGATTREACVRITNNWHIGTHGDIASRRALLQEANG---EKRGDDDTETLSPSPFPST 244
Query: 285 LVSPSLSPSMSSLLSP---------------------SFSPSPSPSESPSVSSPLIIPPA 323
L S S S S + SPSPSP +P+ P + PPA
Sbjct: 245 LSPFSEPFSPSESPSDSPISSPEVSPSPSPSLSNFFFTLSPSPSPEVAPT---PDLSPPA 301
Query: 324 PVNIP-IVSSPPHLHSAPTSFAASTPSQVHESLHKSKHHTVLVLAGIIGGLSLILISAIG 382
N P +VS+PP + AS+ +Q + + K HT ++ + + G LIL+SAI
Sbjct: 302 --NPPMVVSTPPQSNWVSMPSPASSSNQGNANSSNPKQHTAIIWSTVGGFSFLILVSAIA 359
Query: 383 FFVCRSSKVVTVKPWVTGLSGQLQKAFVTGVPKLKRSELEAACEDFSNIIGSFSDGTVGT 442
F RS+KVVTVKPW TGLSGQLQKAFV+GVP LKR+ELE ACEDFSNIIGS +GT+
Sbjct: 360 FVCFRSNKVVTVKPWTTGLSGQLQKAFVSGVPSLKRTELEVACEDFSNIIGSLPEGTI-- 417
Query: 443 VYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEP 502
YKGTLSSGVEI V S++V S +WSKN+E+QFRKKI+ LS+VNHKNFVNLIGYCEE++P
Sbjct: 418 -YKGTLSSGVEIGVASSAVTSSQNWSKNMETQFRKKIEMLSRVNHKNFVNLIGYCEENKP 476
Query: 503 FTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQS 562
FTRMMVFEY+PNG+LFEHLHI+EAE LDW MR+RIAMG+AYCLEH+HQLTPPIA+RN+ S
Sbjct: 477 FTRMMVFEYAPNGTLFEHLHIREAEQLDWGMRMRIAMGIAYCLEHLHQLTPPIAYRNILS 536
Query: 563 SSIYLTEDYAAKISDFSFWNNTTAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGR 622
SSIYLTEDYAAK+SD SFW + + K GS A +LLET + +++NVYSFG +LFE+ITGR
Sbjct: 537 SSIYLTEDYAAKLSDLSFWTDIVSTKKGSEAPQLLETPSAYIKANVYSFGVLLFELITGR 596
Query: 623 ISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPS 682
I +++ENG E+WA EY+KG QPL+D+VD +L S Q N +E+ V+K+CVHPDP++RP+
Sbjct: 597 IPFAVENGLFEDWAEEYMKG-QPLRDLVDTSLNSLQANEIEKWEEVVKSCVHPDPEKRPT 655
Query: 683 MRGIAAKLKEITAMEPDGATPKLSPLWWAELEILSSEAS 721
MR + AKLKEITAM PDGATPK SPLWWAE+EI+SS+ S
Sbjct: 656 MREVTAKLKEITAMGPDGATPKASPLWWAEIEIMSSDLS 694
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356569292|ref|XP_003552837.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase MRH1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 723 bits (1867), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 379/665 (56%), Positives = 466/665 (70%), Gaps = 52/665 (7%)
Query: 62 QNLSLARCLNSEGMALLRFRERVVRDPFGALSKWSDNDGVGDNVNPCSWFGVECSDGKVV 121
QN SL LN EG ALL+F+ +V DPF ALS W ND V VNPC+WFGVECSDG+VV
Sbjct: 27 QNFSLCCSLNEEGKALLKFKHGIVNDPFDALSNWV-NDEVA--VNPCNWFGVECSDGRVV 83
Query: 122 ILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGP 181
+LNL+DLCL G L PEL L +KSIILRNNSF+G IP+ I L ELE+LDLG+NNFSGP
Sbjct: 84 VLNLKDLCLEGNLVPELANLVHIKSIILRNNSFYGIIPEGIAHLNELEVLDLGYNNFSGP 143
Query: 182 FPSDFGNSFSLTTLLLDNNQYLGGISPELHVLKVISEIQVDESWLTNAASRASCNSGLFT 241
P D GN+ SLT LLLDNN +L G SPE++ LK++SE QVDE+ L A +C +
Sbjct: 144 LPRDLGNNISLTILLLDNNDHLCGFSPEINELKMLSEYQVDENQLIRAEKVPACRRSIKQ 203
Query: 242 WNK-VQPGDNAFRRMLQQVTNGFEAKRKASEPSSSSSIASSPEPLVSPSLSPSMSSLLSP 300
++ V N +R+LQ T+ SP V P
Sbjct: 204 QSRHVGQNKNGVQRLLQTRTHE----------------GGSPFNRVFPV----------- 236
Query: 301 SFSPSPSPSESPSVSSPLIIPPAPVNIPIVSSP---PHLHSAPTSFAASTPSQVHESLHK 357
S +P PS + P++ PAPV+ +SP P SAP ++S
Sbjct: 237 SPAPFPSAPPPAPATPPVVQKPAPVDRNNSASPSPLPGPRSAPLYKSSS----------- 285
Query: 358 SKHHTVLVLAGIIGGLSLILISAIGFFVCRSSKVVTVKPWVTGLSGQLQKAFVTGVPKLK 417
SK+H V++LAG++GG +LIS IG ++C+++KV TVKPW TGLSGQLQ AFVTGVPKLK
Sbjct: 286 SKNHVVVILAGVMGGAVFLLISIIGLYLCKTNKVATVKPWATGLSGQLQNAFVTGVPKLK 345
Query: 418 RSELEAACEDFSNIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRK 477
RSELEAACEDFSN+IG+ S +GTVYKGTLSSGVEIAV S + S DWSK LE+QFR
Sbjct: 346 RSELEAACEDFSNVIGTSS---IGTVYKGTLSSGVEIAVASVAATSSKDWSKTLEAQFRN 402
Query: 478 KIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRI 537
KIDTLSKVNHKNFVNL+G+CEEDEPFTRM+VFEY+PNG+LFEHLHI+E+EHLDW RLRI
Sbjct: 403 KIDTLSKVNHKNFVNLLGHCEEDEPFTRMVVFEYAPNGTLFEHLHIKESEHLDWGTRLRI 462
Query: 538 AMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTAAKTGSAAMELL 597
AMGMAYCL+HMHQL PP+ NL SS++ LT+DYAAKISD SF N +A S A +
Sbjct: 463 AMGMAYCLQHMHQLEPPLVLSNLNSSAVQLTDDYAAKISDLSFLNEIASAVIKSPARKNT 522
Query: 598 ETSAVDLESNVYSFGTILFEMITGRISYSIEN-GSLENWASEYLKGEQPLKDIVDPTLKS 656
+ + SN+YSFG ILFEM+TGR+ YS++N GSL++WAS YL+G+QPLK++VDPTL S
Sbjct: 523 DMTPA---SNIYSFGVILFEMVTGRLPYSVDNDGSLDDWASHYLQGDQPLKEMVDPTLAS 579
Query: 657 FQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAMEPDGATPKLSPLWWAELEIL 716
FQE LE++ +IK+CVHPD KQRP+M+ + +L+EIT + PD A PKLSPLWWAELEI
Sbjct: 580 FQEEQLEQVDALIKSCVHPDQKQRPTMKEVCVRLREITKITPDAAVPKLSPLWWAELEIA 639
Query: 717 SSEAS 721
S AS
Sbjct: 640 SVNAS 644
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356537999|ref|XP_003537493.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase MRH1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 711 bits (1835), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 373/664 (56%), Positives = 469/664 (70%), Gaps = 56/664 (8%)
Query: 62 QNLSLARCLNSEGMALLRFRERVVRDPFGALSKWSDNDGVGDNVNPCSWFGVECSDGKVV 121
QN SL LN EG ALL+F++ +V DPF ALS W ND V VNPC+WFGVECSDG+VV
Sbjct: 27 QNFSLCCSLNEEGKALLKFKQGIVNDPFDALSNWV-NDEV--EVNPCNWFGVECSDGRVV 83
Query: 122 ILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGP 181
+LNL+DLCL G L PEL L +KSIILRNNSF G IP+ I L E+E+LDLG+NNFSGP
Sbjct: 84 VLNLKDLCLEGNLVPELANLVHIKSIILRNNSFHGIIPQGIAHLNEMEVLDLGYNNFSGP 143
Query: 182 FPSDFGNSFSLTTLLLDNNQYLGGISPELHVLKVISEIQVDESWLTNAASRASCNSGLFT 241
P+D GN+ LT LLLDNN +L G SPE++ LK++SE QVDE+ L++A + +
Sbjct: 144 LPTDLGNNIPLTILLLDNNDHLCGFSPEINELKMVSEYQVDENQLSSAEKVP-----IRS 198
Query: 242 WNKVQPGDNAFRRMLQQVTNGFEAKRKASEPSSSSSIASSPEPLVSPSLSPSMSSLLSPS 301
+ +N R++LQ T R+ P + + S
Sbjct: 199 IKRHAGQNNGVRKLLQVRT------REGGSP---------------------FNRVFPDS 231
Query: 302 FSPSPSPSESPSVSSPLIIPPAPVNIPIVSSP---PHLHSAPTSFAASTPSQVHESLHKS 358
+P PS + P++ PAPV+ +SP P SAP S ++S+
Sbjct: 232 PAPFPSAPSPAPATPPVVQKPAPVDRNNSASPSPLPEPRSAPLSKSSSS----------- 280
Query: 359 KHHTVLVLAGIIGGLSLILISAIGFFVCRSSKVVTVKPWVTGLSGQLQKAFVTGVPKLKR 418
K+H V++LAG++GG+ +LIS IG ++C+++KV TVKPW TGLSGQLQKAFVTGVPKLKR
Sbjct: 281 KNHLVVILAGVMGGVVFLLISIIGLYLCKTNKVATVKPWATGLSGQLQKAFVTGVPKLKR 340
Query: 419 SELEAACEDFSNIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKK 478
SELEAACEDFSN+IG+ S +GTVYKGTLSSGVEIAV S + S DWSK LE+QFR K
Sbjct: 341 SELEAACEDFSNVIGTSS---IGTVYKGTLSSGVEIAVASVAATSSKDWSKTLEAQFRNK 397
Query: 479 IDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIA 538
IDTLSKVNHKNFVNL+G+CEEDEPFTRM+VFEY+PNG+LFEHLHI+E+EHLDW RLR+A
Sbjct: 398 IDTLSKVNHKNFVNLLGHCEEDEPFTRMVVFEYAPNGTLFEHLHIKESEHLDWGTRLRVA 457
Query: 539 MGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTAAKTGSAAMELLE 598
MGMAYCL+HMHQL PP+ NL SS + LT+DYAAKISD SF N +A S A + +
Sbjct: 458 MGMAYCLQHMHQLEPPLVLSNLNSSGVQLTDDYAAKISDLSFLNEIASAVIKSPARKNTD 517
Query: 599 TSAVDLESNVYSFGTILFEMITGRISYSIEN-GSLENWASEYLKGEQPLKDIVDPTLKSF 657
+ SN+YSFG ILFEM+TGR+ YS++N GSL++WAS YL+G+QPLK++VDPTL SF
Sbjct: 518 MTPA---SNIYSFGVILFEMVTGRLPYSVDNDGSLDDWASHYLQGDQPLKEMVDPTLASF 574
Query: 658 QENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAMEPDGATPKLSPLWWAELEILS 717
QE LE++ +IK+CVHPD KQRP+M+ + +L+EIT + PD A PKLSPLWWAELEI S
Sbjct: 575 QEEQLEQVDALIKSCVHPDQKQRPTMKEVCVRLREITKITPDAAVPKLSPLWWAELEIAS 634
Query: 718 SEAS 721
+AS
Sbjct: 635 VDAS 638
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356551890|ref|XP_003544305.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At5g45840-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 700 bits (1806), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 381/691 (55%), Positives = 472/691 (68%), Gaps = 50/691 (7%)
Query: 62 QNLSLARCLNSE-GMALLRFRERVVRDPFGALSKWSDNDGVGDNVNPCSWFGVECSDGKV 120
Q SL L SE G+ALL RERVV DP G LS WS DG +V+PCSWFGVEC G V
Sbjct: 21 QKQSLCSTLKSEEGLALLALRERVVSDPQGTLSSWSGADG---DVDPCSWFGVECFHGYV 77
Query: 121 VILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSG 180
V LNL+DLCL G LAPE+G+L+ ++SIILRNNSFFG IPKEI L+ELE+LDLG+NNFSG
Sbjct: 78 VTLNLKDLCLEGTLAPEIGKLAHIRSIILRNNSFFGEIPKEILHLEELEVLDLGYNNFSG 137
Query: 181 PFPSDFGNSFSLTTLLLDNNQYLGGISPELHVLKVISEIQVDESWLTNAASR----ASCN 236
P D GN SLTTLLLDNN YL ++ EL+ LK+ SE +E LT A SR CN
Sbjct: 138 SIPFDHGNISSLTTLLLDNNYYLANLTTELYKLKMNSEFHANEEQLTGATSRELFVGRCN 197
Query: 237 SGLFTWNKVQPGDNAFRRMLQQVTNGF-------EAKRKASEPSSSSSIASSPEPLVSPS 289
+ Q GD ++RR L +V N + + + S+S S P S
Sbjct: 198 LRRIS----QHGDRSYRRQLLKVANAANTPKIQGDVNQGTLKQSASHFRFSLPPDFEPFS 253
Query: 290 LSPSMSSLLSPS------------------FSPSPSPSESPSVSSPLIIPPAPVNIPI-V 330
SPS S L SP F+PSP +P + P PVN P+ V
Sbjct: 254 SSPSESPLYSPGSAPLSYSPSPSPSPSSIFFAPSPVVLPTPDI-------PPPVNTPVTV 306
Query: 331 SSPPHLHSAPTSFAASTPSQVHESLHKSKHHTVLVLAGIIGGLSLILISAIGFFVCRSSK 390
S+PP + AP+ + S + S HH+V++ + + G LIL+SAI F +S K
Sbjct: 307 STPPEFNWAPSPSSFSNQGNTNSS--NQIHHSVIIWSAVGGFSLLILLSAIIFACFQSRK 364
Query: 391 VVTVKPWVTGLSGQLQKAFVTGVPKLKRSELEAACEDFSNIIGSFSDGTVGTVYKGTLSS 450
VV VKPW TGLSGQLQKAF+ GVP LKR E+EAA E FSNIIGS DG V YKGTLSS
Sbjct: 365 VVAVKPWSTGLSGQLQKAFIKGVPSLKRGEIEAASEYFSNIIGSLPDGIV---YKGTLSS 421
Query: 451 GVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFE 510
GVEIAV S++V + +WSK++E+QFRKKI +LS+VNHKNFVNLIGYCEE++PF+RMMVFE
Sbjct: 422 GVEIAVASSAVTTAQNWSKSMEAQFRKKIASLSRVNHKNFVNLIGYCEENKPFSRMMVFE 481
Query: 511 YSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTED 570
Y+PNG+LFEHLHI+E E L+W MR+RIAMG+AYCLE+MH+L PPIAHRNLQSS IYLTED
Sbjct: 482 YAPNGTLFEHLHIREGEELNWTMRMRIAMGIAYCLEYMHELKPPIAHRNLQSSFIYLTED 541
Query: 571 YAAKISDFSFWNNTTAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENG 630
YAAK+SD S WN+ A K GSA +LLETS+ D + NVYSFG ILFE+ITGRI + +
Sbjct: 542 YAAKVSDLSLWNDMCATKNGSATTQLLETSSADTKDNVYSFGIILFELITGRIPLAGNSE 601
Query: 631 SLENWASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKL 690
L +WA+EY++ + L+D+VD LKS QE +EE VI+NCV PDP++RP+M+ I ++L
Sbjct: 602 LLADWAAEYVRWGKSLRDVVDLRLKSLQEEEIEEWSEVIRNCVQPDPEKRPTMKEITSRL 661
Query: 691 KEITAMEPDGATPKLSPLWWAELEILSSEAS 721
KE+TAM PDGA PK SPLWWAE+ I S+++S
Sbjct: 662 KELTAMGPDGANPKASPLWWAEMAITSTDSS 692
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356551399|ref|XP_003544063.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase MRH1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 691 bits (1783), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 357/681 (52%), Positives = 470/681 (69%), Gaps = 49/681 (7%)
Query: 42 RFHRLRLNMAALTLVMLLFL-QNLSLARCLNSEGMALLRFRERVVRDPFGALSKWSDNDG 100
RF L + A V + FL +L L LN EG ALL+ R+R+V DPF ALS W D++
Sbjct: 9 RFKDLSI---AFCFVAVFFLFHHLGLCCSLNEEGNALLKLRQRIVSDPFDALSNWVDDEA 65
Query: 101 VGDNVNPCSWFGVECSDGKVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPK 160
+V+PC+WFGVECSDG+VV+LNL+DLCLGG LAPEL +L +KSIILRNNSF GTIP+
Sbjct: 66 ---SVDPCNWFGVECSDGRVVVLNLKDLCLGGTLAPELVKLVNIKSIILRNNSFSGTIPE 122
Query: 161 EIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLLDNNQYLGGISPELHVLKVISEIQ 220
+LKELE+LDLG+NNFSG P+D G++ SLT LLLDNN++L G+SPE++ L+++SE Q
Sbjct: 123 GFVQLKELEVLDLGYNNFSGHLPADLGSNISLTILLLDNNEFLVGLSPEINELRMLSECQ 182
Query: 221 VDESWLTNAASRASCNSGLFTWNKVQPGDNAFRRMLQQVTNGFEAKRKASEPSSSSSIAS 280
VDE+ LTNAA +C + A R + Q ++ + P+++ +
Sbjct: 183 VDENQLTNAAKMPACT------------ERATTRHIGQGKGTRRSQHSNTSPAANHYQFN 230
Query: 281 SPEPLVSPSLSPSMSSLLSPSFSPSPSPSESPSVSSPLIIPPAPVNIPIVSSPPHLHSAP 340
S S +S + P P + +S SSPPH S
Sbjct: 231 RVAAPPLESPSSPSASPSGSAKPPVPKLAPHRKNASD-------------SSPPHSTSGS 277
Query: 341 TSFAASTPSQVHESLHKSKHHTVLVLAGIIGGLSLILISAIGFFVCRSSKVVTVKPWVTG 400
+ + + + SK HTV +LAG+IGG ++ S+IG ++C++ KV V+PW G
Sbjct: 278 GTLSKTKSTS-------SKVHTVPILAGVIGGAVFLIFSSIGIYLCKT-KVANVRPWAMG 329
Query: 401 LSGQLQKAFVTGVPKLKRSELEAACEDFSNIIGSFSDGTVGTVYKGTLSSGVEIAVTSTS 460
LSGQLQKAFVTG KLKRS+LEAACEDFSN+IG + +G +YKGTLS GVEIAV S
Sbjct: 330 LSGQLQKAFVTGAQKLKRSDLEAACEDFSNVIG---NSPIGILYKGTLSGGVEIAVAFVS 386
Query: 461 VKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEH 520
+ S +WSK LE+QFR KID LSKVNHKNFVNLIGYCEE+EPFTRM+VFEY+PNG+LFEH
Sbjct: 387 ITSSKNWSKTLEAQFRSKIDKLSKVNHKNFVNLIGYCEEEEPFTRMLVFEYAPNGTLFEH 446
Query: 521 LHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSF 580
LHI+EAEHLDW RLR+A G+AYCL+HMHQL PP+A L SS++YLT+DYAAK+SD SF
Sbjct: 447 LHIKEAEHLDWGTRLRVATGVAYCLQHMHQLDPPMALIKLNSSAVYLTDDYAAKLSDLSF 506
Query: 581 WNNTTAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIEN-GSLENWASEY 639
N+ +A+T + ++ ESNVYS G +LFEM+TGR+ YS+E+ SLENWAS Y
Sbjct: 507 SNDIASAETRA-----MDKPLATPESNVYSLGVLLFEMVTGRLPYSVEHKDSLENWASHY 561
Query: 640 LKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAMEPD 699
L+ +QPLK+IVDP L S+QE+ LE++ +I +CVHPDP++RP+M+ ++ +L+EIT + P+
Sbjct: 562 LEVDQPLKEIVDPILVSYQEDQLEQVASLITSCVHPDPQKRPTMKDVSERLREITKITPE 621
Query: 700 GATPKLSPLWWAELEILSSEA 720
A PKLSPLWWAE+EI S+EA
Sbjct: 622 SAVPKLSPLWWAEIEIASAEA 642
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356498966|ref|XP_003518316.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At5g45840-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 689 bits (1779), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 374/675 (55%), Positives = 463/675 (68%), Gaps = 23/675 (3%)
Query: 62 QNLSLARCLNSE-GMALLRFRERVVRDPFGALSKWSDNDGVGDNVNPCSWFGVECSDGKV 120
Q SL L SE G+ALL RERVV DP GALS WS DG +++PCSWFGVEC G V
Sbjct: 20 QKQSLCSTLKSEEGLALLALRERVVSDPQGALSSWSGEDG---DIDPCSWFGVECFHGYV 76
Query: 121 VILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSG 180
V LNL+DLCL G LAPE+G+L+ +KSIILRNNSFFG IPKEI L++LE+LDLG+NNFSG
Sbjct: 77 VTLNLKDLCLEGTLAPEIGKLTHIKSIILRNNSFFGEIPKEILHLEKLEVLDLGYNNFSG 136
Query: 181 PFPSDFGNSFSLTTLLLDNNQYLGGISPELHVLKVISEIQVDESWLTNAASRASCNSGLF 240
P D G+ SLTTLLLDNN YL ++PEL+ LK+ SE +E LT A +R
Sbjct: 137 LLPFDHGSMPSLTTLLLDNNYYLTNLTPELYKLKMNSEFHANEEQLTGATTRELFVCRCH 196
Query: 241 TWNKVQPGDNAFRRMLQQVTNGFEAKR------KASEPSSSSSIASSPEPLVSPSLSPSM 294
+ Q GD ++RR L +V N R + + S+S A S P P S
Sbjct: 197 LRHIGQHGDRSYRRQLLKVANDANTPRIQGNVNRGTLKQSASHFAFSLPPDFEPFSSSPS 256
Query: 295 SSLLSPSFSPSPSPSESPSVS--------SPLIIPPAPVNIPIVSSPPHLHSAPTSFAAS 346
S + S S SP S SP+++P ++ P + PP + AP+ S
Sbjct: 257 ESPSYSPGAVPLSYSPSPLPSPSSIFFTPSPVVLPTPGISSPANTLPPEFNWAPSPSPFS 316
Query: 347 TPSQVHESLHKSKHHTVLVLAGIIGGLSLILISAIGFFVCRSSKVVTVKPWVTGLSGQLQ 406
S HH+V++ + G LIL+SAI F +S KVV VKPW TGLSGQLQ
Sbjct: 317 NQGNTDSS--NQIHHSVIIWFAVGGFSLLILVSAIIFACFQSRKVVAVKPWSTGLSGQLQ 374
Query: 407 KAFVTGVPKLKRSELEAACEDFSNIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRAD 466
KAFV GVP LKR E+EAA E FSNIIGS DGTV YKGTLSSGVEIAV S++V + +
Sbjct: 375 KAFVKGVPSLKRGEIEAASEYFSNIIGSLPDGTV---YKGTLSSGVEIAVASSAVTTAKN 431
Query: 467 WSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEA 526
WSK++E+QFRKKI TLS+VNHKNFVNLIGYCEE++PF+RMMV EY+PNG+LFEHLHI+E
Sbjct: 432 WSKSMEAQFRKKIATLSRVNHKNFVNLIGYCEENKPFSRMMVLEYAPNGTLFEHLHIREG 491
Query: 527 EHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTA 586
E L+W MR+RIAMG+AYCLE+MH+L PPIAHRNLQSS IYLTEDYAAKISD S WN+
Sbjct: 492 EELNWTMRMRIAMGIAYCLEYMHELKPPIAHRNLQSSFIYLTEDYAAKISDLSLWNDMCD 551
Query: 587 AKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPL 646
K GSA + LETS+ D + NVYSFG +LFE+ITGRI + N L +WA+EY++ + L
Sbjct: 552 TKNGSATTQFLETSSADTKDNVYSFGIVLFELITGRIPLAGNNELLADWAAEYVRWGKSL 611
Query: 647 KDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAMEPDGATPKLS 706
+D+VDP LKS QE +EE VI+NCV PDP++RP+M+ + ++LKEITAM PDGA PK S
Sbjct: 612 RDVVDPRLKSLQEEEIEEWSEVIRNCVQPDPEKRPTMKEVTSRLKEITAMGPDGANPKAS 671
Query: 707 PLWWAELEILSSEAS 721
PLWWAE+ I S+++S
Sbjct: 672 PLWWAEMAITSTDSS 686
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356541803|ref|XP_003539362.1| PREDICTED: inactive receptor-like serine/threonine-protein kinase At2g40270-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 683 bits (1763), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 356/623 (57%), Positives = 448/623 (71%), Gaps = 31/623 (4%)
Query: 120 VVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFS 179
V NL+DLCL G+LAPE+G+L +KSII RNN F+G IPKEI +L++LE+LDLGFNNFS
Sbjct: 12 VFARNLKDLCLHGILAPEIGKLVHIKSIIFRNNYFYGDIPKEILQLEDLEVLDLGFNNFS 71
Query: 180 GPFP-SDFGNSFSLTTLLLDNNQYLGGISPELHVLKVISEIQVDESWLTNAASRASCNSG 238
G FP D + SLTTLLLDNN L ++PE++ LK SE+ VDE LT A +R +C S
Sbjct: 72 GQFPFHDLASYPSLTTLLLDNNDNLASLTPEVYELKTFSELHVDEEQLTGATTREACASI 131
Query: 239 LFTWNKVQPGDNAFRRMLQQVTNGFEAKRKASEPSSSSSIASSPEPL------------- 285
W+ Q GD A RR L Q N + E S S S+ P+
Sbjct: 132 TNNWHIGQHGDIASRRKLLQAANRSKRGDDEKETLSPSPFPSTLSPVLEPFSSSESPSDS 191
Query: 286 ------VSPSLSPSMSSLLSPSFSPSPSPSESPSVSSPLIIPPAPVNIP-IVSSPPHLHS 338
+S S SPS+S+ SPSPSP +P+ P + PPA N P +V +PP +
Sbjct: 192 PISSPEISHSPSPSLSTFFF-ILSPSPSPEVAPT---PDLSPPA--NPPMVVFTPPQSNW 245
Query: 339 APTSFAASTPSQVHESLHKSKHHTVLVLAGIIGGLSLILISAIGFFVCRSSKVVTVKPWV 398
AS+ +Q + +K HTV++ + + G LIL+SAI F RS+KVVTVKPW
Sbjct: 246 GSMPSPASSSNQGNAYSSNTKQHTVIIWSTVGGFSFLILVSAIVFACFRSNKVVTVKPWA 305
Query: 399 TGLSGQLQKAFVTGVPKLKRSELEAACEDFSNIIGSFSDGTVGTVYKGTLSSGVEIAVTS 458
TGLSGQLQKAFV+GVP LKR+ELE ACEDFSNIIGS +GT+ YKGTLSSGVEIAV S
Sbjct: 306 TGLSGQLQKAFVSGVPSLKRTELEVACEDFSNIIGSLPEGTI---YKGTLSSGVEIAVAS 362
Query: 459 TSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLF 518
++V S DWSK +E+QFRKKI+ LS+VNHKNFVNLIGYCEE++PFTRMMVFEY+PNG+LF
Sbjct: 363 SAVTSSQDWSKKMETQFRKKIEMLSRVNHKNFVNLIGYCEENKPFTRMMVFEYAPNGTLF 422
Query: 519 EHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDF 578
EHLHI+EAE LDW MR+RIA+G+AYCLEH+HQLTPPIA+RN+ SSS+YLTEDYAAK+SD
Sbjct: 423 EHLHIREAEQLDWGMRMRIAVGIAYCLEHLHQLTPPIAYRNILSSSMYLTEDYAAKLSDL 482
Query: 579 SFWNNTTAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASE 638
S W + + K GS A +LLET++ +++NVYSFG +LFE+ITGRI +++ENG E+WA+E
Sbjct: 483 SLWTDIVSTKKGSEAPQLLETASAYIKANVYSFGVLLFELITGRIPFAMENGLFEDWAAE 542
Query: 639 YLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAMEP 698
Y+KG QPLKD+VD +L S Q N +E+ VI +CVH DP++RP+MR + AKLKEITAM P
Sbjct: 543 YMKG-QPLKDLVDTSLNSLQANEIEKWEEVINSCVHQDPEKRPTMREVTAKLKEITAMGP 601
Query: 699 DGATPKLSPLWWAELEILSSEAS 721
DGATPK SPLWWAE+EI+ S+ S
Sbjct: 602 DGATPKASPLWWAEIEIMPSDLS 624
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449460929|ref|XP_004148196.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase MRH1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 670 bits (1728), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 352/687 (51%), Positives = 461/687 (67%), Gaps = 30/687 (4%)
Query: 43 FHRLRLNMAALTLVML-LFLQNLSLARCLNSEGMALLRFRERVVRDPFGALSKWSDNDGV 101
FHR RL + V++ L Q+ L+ LN EG+ LL+FRERVV DPFG LS W+D+
Sbjct: 9 FHRFRLRIGVYGFVVISLLFQSFHLSWSLNEEGLTLLKFRERVVNDPFGVLSNWNDHK-- 66
Query: 102 GDNVNPCSWFGVECSDGKVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKE 161
+++NPC WFGVECSDGKVV LNL+DLCL G L PEL L +KSI LRNNSF GTIP+
Sbjct: 67 -EDINPCFWFGVECSDGKVVSLNLKDLCLEGTLTPELKNLVHIKSINLRNNSFTGTIPQG 125
Query: 162 IGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLLDNNQYLGGISPELHVLKVISEIQV 221
+G L+ELE+LDLG+NNF GP PSD G++ SL LLLDNN+ L +SPE++ L+++SE QV
Sbjct: 126 LGGLEELEVLDLGYNNFCGPLPSDLGSNLSLGILLLDNNKDLRSLSPEIYQLQLLSEFQV 185
Query: 222 DESWLTNAASRASCNSGLFTWNKVQPGDNAFRRMLQQVTNGFEAKRKASEPSSSSSIASS 281
DE+ L+N A + CN + + VQ D+ RR L+ A ++ + +A
Sbjct: 186 DENQLSNTAEGSLCNKESMSCDAVQVKDSRGRRELR-------ASASQAQLTIQGRVAEV 238
Query: 282 PEPLVSPSLSPSMSS-----------LLSPSFSPSPSPSESPSVSSPLIIPPAPVNIPIV 330
PL PS S S S P P S S+ PP P
Sbjct: 239 VVPLTPPSPSGGNSDRPPSNSPPPSPPAGAQGSQPPPPGTGISTSNNATSPPPSFKAPSE 298
Query: 331 SSPPHLHSAPTSFAASTPSQVHESLHKSKHHTVLVLAGIIGGLSLILISAIGFFVCRSSK 390
+PP +AP + PS + K+K +V+ +G ++ A+G ++ ++K
Sbjct: 299 KTPP---AAPEGLPSPQPSSKQQG-GKNKSSVGVVVGVSVGAAVFVIALAVGIYLWTNNK 354
Query: 391 VVTVKPWVTGLSGQLQKAFVTGVPKLKRSELEAACEDFSNIIGSFSDGTVGTVYKGTLSS 450
TVKPW TGLSGQLQKAFVTGVPKLKRSELE +CEDFSN+IG +G VYKGTLSS
Sbjct: 355 A-TVKPWATGLSGQLQKAFVTGVPKLKRSELEVSCEDFSNVIGY---SPIGPVYKGTLSS 410
Query: 451 GVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFE 510
GVEIAV SVKS DWS LE+QFRKKIDTLSK+NHKNFVNLIGYCEE+EPF+RMMVFE
Sbjct: 411 GVEIAVNIISVKSSKDWSMALEAQFRKKIDTLSKINHKNFVNLIGYCEEEEPFSRMMVFE 470
Query: 511 YSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTED 570
Y+PNG++FEHLH +E EHL+W MR+RI MGMAY LE++H+ + P+ H NL SS++ LTED
Sbjct: 471 YAPNGTVFEHLHDEEFEHLNWRMRMRIVMGMAYSLEYLHEQSAPLIHLNLTSSAVNLTED 530
Query: 571 YAAKISDFSFWNNTTAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENG 630
YAAKI++ S N A + + LL TS+ ES +YSFG +L E++TGRI +S +NG
Sbjct: 531 YAAKIAECSLQNKIVANERNCTSGHLLNTSSGGPESQIYSFGLVLLELMTGRIPHSAQNG 590
Query: 631 SLENWASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKL 690
+LE WA +YLK ++PLK+++DPTL SFQE LE++ ++++C+H +P+QRP+M+ I ++L
Sbjct: 591 TLEGWAIQYLKLDKPLKELIDPTLTSFQEEQLEQIGQLLRSCLHSNPEQRPTMKLITSRL 650
Query: 691 KEITAMEPDGATPKLSPLWWAELEILS 717
+ IT + PD A P+LSPLWWAELEI S
Sbjct: 651 RLITGITPDEAIPRLSPLWWAELEIAS 677
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356499209|ref|XP_003518434.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase MRH1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 664 bits (1712), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 362/680 (53%), Positives = 461/680 (67%), Gaps = 55/680 (8%)
Query: 48 LNMAALTLVMLLFLQNLSLARCLNSEGMALLRFRERVVRDPFGALSKWSDNDGVGDNVNP 107
L++A + + LQ L L LN EG ALL+ R+R+V DPFGALS W D++ +V+P
Sbjct: 13 LSIAFRFVAVFFLLQKLGLCCSLNEEGNALLKLRQRIVSDPFGALSNWIDDEV---SVDP 69
Query: 108 CSWFGVECSDGKVVI-LNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELK 166
C+WFGVECSDG+VV+ LNL+DLCLGG L PEL +L +KSIILRNNSF G IP+ EL+
Sbjct: 70 CNWFGVECSDGRVVVALNLKDLCLGGTLGPELVKLVNIKSIILRNNSFSGIIPEGFVELE 129
Query: 167 ELEILDLGFNNFSGPFPSDFGNSFSLTTLLLDNNQYLGGISPELHVLKVISEIQVDESWL 226
ELE+LDLG+N FSG P+D + SL LLLDNN +L G SPE++ L+++SE QVDE+ L
Sbjct: 130 ELEVLDLGYNYFSGHLPADLRSDISLAILLLDNNDFLVGFSPEINELRMLSECQVDENKL 189
Query: 227 TNAASRASCNSGLFTWNKVQPGDNAFRRMLQQVTNGFEAKRKASEPSSSSSIASSPEPLV 286
TNAA +C + TWN Q + R +LQQ K K + P
Sbjct: 190 TNAAKMPACTKRVTTWNIDQ--GKSTRGLLQQ-------KAKPRTNQGHFYRVADPPVKS 240
Query: 287 SPSLSPSMSSLLSPSFSPSPSPSESPSVSSPLIIPPAPVNIPIVSSPPHLHSAPTSFAAS 346
SP + S + P +P SP PPH S P S S
Sbjct: 241 SPPPPSASPSASAKPPGPKLAPHRKNGSDSP---------------PPH--STPGSGTLS 283
Query: 347 TPSQVHESLHKSKHHTVLVLAGIIGGLSLILISAIGFFVCRSSKVVTVKPWVTGLSGQLQ 406
+ K HT +L G+IGG ++ S+IG ++C++ KV V+PW TGLSGQLQ
Sbjct: 284 KTES-----NSPKVHTFPILPGVIGGAVFLIFSSIGIYLCKT-KVANVRPWATGLSGQLQ 337
Query: 407 KAFVTGVPKLKRSELEAACEDFSNIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRAD 466
KAFVTG KL+RS+LEAACEDFSN+IG+ +GT+YKGTLSSGVEIAV V S +
Sbjct: 338 KAFVTGAQKLRRSDLEAACEDFSNVIGT---SPIGTLYKGTLSSGVEIAVAFVPVTSSRN 394
Query: 467 WSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEA 526
WSK LE+QFR KIDTLSKVNHKNFVNLIGYCEE++PFTR++VFEY+PNG+LFEHLHI+EA
Sbjct: 395 WSKTLEAQFRSKIDTLSKVNHKNFVNLIGYCEEEDPFTRVLVFEYAPNGTLFEHLHIKEA 454
Query: 527 EHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTA 586
EHLDW RLR+A GMAYCL+HMHQL PP+ L SS++YLT DYAAK+SD SF N+ T+
Sbjct: 455 EHLDWGTRLRVATGMAYCLQHMHQLDPPMTLIKLNSSAVYLTNDYAAKLSDLSFSNDITS 514
Query: 587 AKTGSAAMELLETSAVDL-----ESNVYSFGTILFEMITGRISYSIEN-GSLENWASEYL 640
A E A+D+ ESNVYSFG +LFEM+TGR+ YS+E+ SLENWAS YL
Sbjct: 515 A----------EARAIDMPIATPESNVYSFGVLLFEMVTGRLPYSVEHRDSLENWASHYL 564
Query: 641 KGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAMEPDG 700
+G+QPL ++VDP L S+QE+ LE++ +I +CVHPDP+QRP+M+ ++ +L+EIT + P+
Sbjct: 565 EGDQPLIEMVDPILVSYQEDQLEQVAALITSCVHPDPQQRPTMKDVSERLREITKITPES 624
Query: 701 ATPKLSPLWWAELEILSSEA 720
A PKLSPLWWAELEI S+EA
Sbjct: 625 AVPKLSPLWWAELEIASAEA 644
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 721 | ||||||
| TAIR|locus:2124102 | 678 | MRH1 "morphogenesis of root ha | 0.463 | 0.492 | 0.577 | 3.7e-131 | |
| TAIR|locus:2182915 | 553 | AT5G07150 [Arabidopsis thalian | 0.306 | 0.399 | 0.596 | 4.5e-121 | |
| TAIR|locus:2078436 | 499 | AT3G56050 [Arabidopsis thalian | 0.456 | 0.659 | 0.581 | 3.1e-108 | |
| TAIR|locus:2063146 | 489 | AT2G40270 [Arabidopsis thalian | 0.456 | 0.672 | 0.587 | 3.6e-105 | |
| TAIR|locus:2171233 | 484 | AT5G58540 [Arabidopsis thalian | 0.441 | 0.657 | 0.561 | 3.2e-97 | |
| TAIR|locus:2163056 | 664 | AT5G41180 [Arabidopsis thalian | 0.403 | 0.438 | 0.361 | 1.1e-74 | |
| TAIR|locus:2206179 | 592 | FEI1 "FEI 1" [Arabidopsis thal | 0.366 | 0.445 | 0.322 | 5.6e-48 | |
| TAIR|locus:2160791 | 1102 | AT5G63930 [Arabidopsis thalian | 0.370 | 0.242 | 0.312 | 1.4e-46 | |
| TAIR|locus:2026097 | 628 | SERK2 "somatic embryogenesis r | 0.398 | 0.457 | 0.303 | 5.7e-45 | |
| TAIR|locus:2013021 | 625 | SERK1 "somatic embryogenesis r | 0.398 | 0.459 | 0.309 | 8.7e-45 |
| TAIR|locus:2124102 MRH1 "morphogenesis of root hair 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1045 (372.9 bits), Expect = 3.7e-131, Sum P(2) = 3.7e-131
Identities = 197/341 (57%), Positives = 261/341 (76%)
Query: 384 FVCRSSKVVTVKPWVTGLSGQLQKAFVTGVPKLKRSELEAACEDFSNIIGSFSDGTVGTV 443
F CR V ++ PW TGLSGQLQKAFVTGVPKL RSELE ACEDFSNII +F DG TV
Sbjct: 342 FFCRKRAVKSIGPWKTGLSGQLQKAFVTGVPKLNRSELETACEDFSNIIETF-DGY--TV 398
Query: 444 YKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPF 503
YKGTLSSGVEIAV ST++ +W++ +E +R+KIDTLS++NHKNFVNLIGYCEED+PF
Sbjct: 399 YKGTLSSGVEIAVASTAIAESKEWTRAMEMAYRRKIDTLSRINHKNFVNLIGYCEEDDPF 458
Query: 504 TRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSS 563
RMMVFEY+PNG+LFEHLH +E EHLDW+ R+RI MG AYCL+HMH + PP+AH + SS
Sbjct: 459 NRMMVFEYAPNGTLFEHLHDKETEHLDWSARMRIIMGTAYCLQHMHGMNPPMAHTDFNSS 518
Query: 564 SIYLTEDYAAKISDFSFWNNTTAAKTGSAAMELLETSAV---DLESNVYSFGTILFEMIT 620
IYLT+DYAAK+S+ F + +L +TS + + E+NV+SFG ++ E+I+
Sbjct: 519 EIYLTDDYAAKVSEIPFNLEARLNPKKHVSGDLEQTSLLLPPEPEANVHSFGVLMLEIIS 578
Query: 621 GRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQR 680
G++S+S E GS+E WAS+YL+ + L +++DP+LK+F+E LE + VI+ C+ + +QR
Sbjct: 579 GKLSFSDEYGSIEQWASKYLEKDD-LGEMIDPSLKTFKEEELEVICDVIRECLKTEQRQR 637
Query: 681 PSMRGIAAKLKEITAMEPDGATPKLSPLWWAELEILSSEAS 721
PSM+ +A +LK++ + P+ ATP+ SPLWWAELEILSSEA+
Sbjct: 638 PSMKDVAEQLKQVINITPEKATPRSSPLWWAELEILSSEAT 678
|
|
| TAIR|locus:2182915 AT5G07150 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 703 (252.5 bits), Expect = 4.5e-121, Sum P(3) = 4.5e-121
Identities = 145/243 (59%), Positives = 176/243 (72%)
Query: 383 FFVCRSSKVVTVKPW-VTGLSGQLQKAFVTGVPKLKRSELEAACEDFSNIIGSFSDGTVG 441
FF + KV +KPW TG SGQLQ TGVPKLK +ELE ACEDFSNIIGS S
Sbjct: 250 FFFLWNQKVKLIKPWGETGSSGQLQDVVTTGVPKLKLAELETACEDFSNIIGSTSSDA-- 307
Query: 442 TVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDE 501
T+YKGTLS+G EIAV + + S DWS++ E+QF++K LS+VNHKNF+N+IGYC EDE
Sbjct: 308 TIYKGTLSTGSEIAVLAVASGSLQDWSEDHETQFQEK--RLSQVNHKNFLNVIGYCHEDE 365
Query: 502 PFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTP-PIAHRNL 560
PF RM+VFEY+PNGSLFEHLH Q+AEHLDW MRLRI MG+AYC+EHMH L P PI+H NL
Sbjct: 366 PFNRMLVFEYAPNGSLFEHLHDQDAEHLDWPMRLRIVMGIAYCMEHMHNLNPKPISHTNL 425
Query: 561 QSSSIYLTEDYAAKISDFSFWNNTTAAKTGSAAMELLETSAVDLESNVYSFGTILFEMIT 620
SSS+YL DYAAK+SDF+F L ++ +D +NV SFG +L E+IT
Sbjct: 426 NSSSVYLATDYAAKVSDFTF----------------LSSTPLDPMTNVSSFGALLQEIIT 469
Query: 621 GRI 623
G+I
Sbjct: 470 GKI 472
|
|
| TAIR|locus:2078436 AT3G56050 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1044 (372.6 bits), Expect = 3.1e-108, Sum P(2) = 3.1e-108
Identities = 197/339 (58%), Positives = 261/339 (76%)
Query: 383 FFVCRSSKVVTVKPWVTGLSGQLQKAFVTGVPKLKRSELEAACEDFSNIIGSFSDGTVGT 442
FF ++ K +V PW TGLSGQLQK F+TGVPKLKRSE+EAACEDFSN+IGS +GT
Sbjct: 167 FFKSKAGK--SVNPWRTGLSGQLQKVFITGVPKLKRSEIEAACEDFSNVIGSCP---IGT 221
Query: 443 VYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEP 502
++KGTLSSGVEIAV S + S +W+ N+E QFRKKI+ LSK+NHKNFVNL+GYCEE+EP
Sbjct: 222 LFKGTLSSGVEIAVASVATASAKEWTNNIEMQFRKKIEMLSKINHKNFVNLLGYCEEEEP 281
Query: 503 FTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQS 562
FTR++VFEY+ NG++FEHLH +E+EHLDW MRLRIAMG+AYCL+HMH L PPI H NL S
Sbjct: 282 FTRILVFEYASNGTVFEHLHYKESEHLDWVMRLRIAMGIAYCLDHMHGLKPPIVHSNLLS 341
Query: 563 SSIYLTEDYAAKISDFSFWNNTTAAKTGSAAMELLET--SAVDLESNVYSFGTILFEMIT 620
SS+ LTEDYA KI+DF+F ++T S+ L++T S E NV+SFG +LFE++T
Sbjct: 342 SSVQLTEDYAVKIADFNFGYLKGPSETESSTNALIDTNISETTQEDNVHSFGLLLFELMT 401
Query: 621 GRISYSIENG-SLENWASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQ 679
G++ S++ G S++ + +L+G+ L+++VDPT++SF E + E + VIK+C+ D KQ
Sbjct: 402 GKLPESVQKGDSIDTGLAVFLRGKT-LREMVDPTIESFDEKI-ENIGEVIKSCIRADAKQ 459
Query: 680 RPSMRGIAAKLKEITAMEPDGATPKLSPLWWAELEILSS 718
RP M+ + +L+EIT + PD PKLSPLWWAELE+LS+
Sbjct: 460 RPIMKEVTGRLREITGLSPDDTIPKLSPLWWAELEVLST 498
|
|
| TAIR|locus:2063146 AT2G40270 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1041 (371.5 bits), Expect = 3.6e-105, P = 3.6e-105
Identities = 198/337 (58%), Positives = 255/337 (75%)
Query: 383 FFVCRSSKVVTVKPWVTGLSGQLQKAFVTGVPKLKRSELEAACEDFSNIIGSFSDGTVGT 442
FF ++ K TV PW TGLSGQLQK FVTG+P LKRSE+EAACEDFSN+IGS +G
Sbjct: 159 FFTSKAGK--TVNPWRTGLSGQLQKVFVTGIPVLKRSEIEAACEDFSNVIGSCP---IGK 213
Query: 443 VYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEP 502
++KGTLSSGVEIAV S + + DW + E FRKKI+ LSK+NHKNF NL+GYCEE EP
Sbjct: 214 LFKGTLSSGVEIAVASFATTTAKDWKDSTEIHFRKKIEMLSKINHKNFANLLGYCEEKEP 273
Query: 503 FTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQS 562
FTR+++FEY+PNGSLFEHLH +E+EHLDW MRLRIAMG+AYCL+HMHQL PPIAH NL S
Sbjct: 274 FTRILIFEYAPNGSLFEHLHYKESEHLDWGMRLRIAMGLAYCLDHMHQLNPPIAHTNLVS 333
Query: 563 SSIYLTEDYAAKISDFSFWNNTTAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGR 622
SS+ LTEDYA K+SDFSF ++ T + + SA++ E N+YSFG +LFEMITG+
Sbjct: 334 SSLQLTEDYAVKVSDFSFGSSETETNINNNTVIDTHISALNPEDNIYSFGLLLFEMITGK 393
Query: 623 ISYSIEN-GSLENWASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRP 681
+ S+ S+++ ++L+GE L +VDPTL+S+ + E + VIK+C+ DPK+RP
Sbjct: 394 LIESVNKPDSVDSSLVDFLRGET-LAKMVDPTLESYDAKI-ENIGEVIKSCLRTDPKERP 451
Query: 682 SMRGIAAKLKEITAMEPDGATPKLSPLWWAELEILSS 718
+M+ + L+EIT + P+ ATPKLSPLWWAELE+LS+
Sbjct: 452 TMQEVTGWLREITGLSPNDATPKLSPLWWAELEVLST 488
|
|
| TAIR|locus:2171233 AT5G58540 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 966 (345.1 bits), Expect = 3.2e-97, P = 3.2e-97
Identities = 187/333 (56%), Positives = 245/333 (73%)
Query: 389 SKVVTVKPWVTGLSGQLQKAFVTGVPKLKRSELEAACEDFSNIIGSFSDGTVGTVYKGTL 448
++ + +KPW SGQL+ +T VP+L+ SEL+AACEDFSN+IGSFSDGT+ YKGTL
Sbjct: 167 TRKIPIKPWTN--SGQLRDDLITDVPRLQLSELQAACEDFSNVIGSFSDGTI---YKGTL 221
Query: 449 SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508
S+G EIAV S SR+DWS +++Q +K+ LSKV+HKNF+N+IGYC E+EPF RM+V
Sbjct: 222 STGAEIAVVSIVAGSRSDWSTTMDTQLLQKMHNLSKVDHKNFLNVIGYCLEEEPFKRMLV 281
Query: 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLT 568
FEY+PNGSL EHLH Q EHLDW RLRI MG+AYCLEHMH L PPI NL SSS+YLT
Sbjct: 282 FEYAPNGSLSEHLHSQYVEHLDWPTRLRIVMGIAYCLEHMHNLNPPILLSNLDSSSVYLT 341
Query: 569 EDYAAKISDFSFWNNTTAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIE 628
ED AAK+SDFS N+ +K GS++ LLE S +D +NV++FG +LFE+I+G++ +
Sbjct: 342 EDNAAKVSDFSVINSIFPSKEGSSSKNLLEPSLLDPHTNVFNFGAVLFEIISGKLP---D 398
Query: 629 NGSLENWASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688
S+ L +P +DIVDPTLK+FQENV+E LL V++ C++P QRP+MR +
Sbjct: 399 PDSM-------LLEPKPTRDIVDPTLKTFQENVVERLLEVVRQCLNPYSDQRPTMREVVV 451
Query: 689 KLKEITAMEPDGATPKLSPLWWAELEILSSEAS 721
KL+EIT +E D A P+LSP WW ELEI+S+E +
Sbjct: 452 KLREITGIEADAAMPRLSPRWWTELEIISTEGN 484
|
|
| TAIR|locus:2163056 AT5G41180 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 533 (192.7 bits), Expect = 1.1e-74, Sum P(2) = 1.1e-74
Identities = 114/315 (36%), Positives = 178/315 (56%)
Query: 385 VCRSSKVVTVKPWVTGLSGQ------LQKAFVTGVPKLKRSELEAACEDFSNIIGSFSDG 438
+C+ + + V PW S + + + V + R ELE ACEDFSNII S ++
Sbjct: 302 LCKIKRSLIV-PWKKSASEKEKFTVYVDSEMLKDVSRYTRQELEVACEDFSNIIDSSAES 360
Query: 439 TVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCE 498
+ YKGT+ G EIAV S VK +W+ LE F++++ L+++NH+N L+GYC+
Sbjct: 361 QI---YKGTIKGGTEIAVISLCVKEE-NWTGYLELNFQREVAALARLNHENAGKLLGYCK 416
Query: 499 EDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMH-QLTPPIAH 557
E PFTRM+VFEY+ NG+L++HLH + + WA R++I +G+A L+++H +L PP
Sbjct: 417 ESTPFTRMLVFEYASNGTLYDHLHYADGSLVSWAKRMKIVIGIARGLKYLHTELHPPFTV 476
Query: 558 RNLQSSSIYLTEDYAAKISDFSFW---------NNTTAAKTGSAAM--ELLETSAVDLES 606
L S+++YLTED+ K+ DF W N G+ + +E +DL+
Sbjct: 477 SELSSTAVYLTEDFTPKLVDFECWKIIQVRSEKNLKNICNEGAICVLPNAMEHRDMDLQG 536
Query: 607 NVYSFGTILFEMITGRISYSIENGSLENWASEY-LKGEQPLKDIVDPTLKSFQENVLEEL 665
N+YSFG +L E+++GR SY + G L W E L + +VDP LK F++ LE +
Sbjct: 537 NIYSFGILLLEIVSGRPSYCQDRGCLVEWVREKNLGAPDVMASLVDPELKHFKQKELEAV 596
Query: 666 LVVIKNCVHPDPKQR 680
V C++ D ++
Sbjct: 597 CEVASQCLNLDQNEK 611
|
|
| TAIR|locus:2206179 FEI1 "FEI 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 359 (131.4 bits), Expect = 5.6e-48, Sum P(2) = 5.6e-48
Identities = 95/295 (32%), Positives = 158/295 (53%)
Query: 420 ELEAACEDFSNIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKI 479
+LE E+ +IIG G GTVYK + G A+ K ++ + F +++
Sbjct: 302 KLEMLNEE--HIIGC---GGFGTVYKLAMDDGKVFAL-----KRILKLNEGFDRFFEREL 351
Query: 480 DTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAM 539
+ L + H+ VNL GYC + P +++++++Y P GSL E LH++ E LDW R+ I +
Sbjct: 352 EILGSIKHRYLVNLRGYC--NSPTSKLLLYDYLPGGSLDEALHVERGEQLDWDSRVNIII 409
Query: 540 GMAYCLEHMHQ-LTPPIAHRNLQSSSIYLTEDYAAKISDFSFWN---------NTTAAKT 589
G A L ++H +P I HR+++SS+I L + A++SDF T A T
Sbjct: 410 GAAKGLSYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGT 469
Query: 590 -GSAAMELLETSAVDLESNVYSFGTILFEMITGR----ISYSIENG-SLENWASEYLKGE 643
G A E +++ +++VYSFG ++ E+++G+ S+ IE G ++ W ++L E
Sbjct: 470 FGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASF-IEKGLNVVGWL-KFLISE 527
Query: 644 QPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAMEP 698
+ +DIVDP + Q L+ LL + CV P P++RP+M + +L E M P
Sbjct: 528 KRPRDIVDPNCEGMQMESLDALLSIATQCVSPSPEERPTMHRVV-QLLESEVMTP 581
|
|
| TAIR|locus:2160791 AT5G63930 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 361 (132.1 bits), Expect = 1.4e-46, Sum P(2) = 1.4e-46
Identities = 91/291 (31%), Positives = 150/291 (51%)
Query: 420 ELEAACEDF--SNIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRK 477
+L AA ++F S ++G G GTVYK L +G +AV + + N+++ FR
Sbjct: 796 DLVAATDNFDESFVVGR---GACGTVYKAVLPAGYTLAVKKLASNHEGGNNNNVDNSFRA 852
Query: 478 KIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRI 537
+I TL + H+N V L G+C + ++++EY P GSL E LH +LDW+ R +I
Sbjct: 853 EILTLGNIRHRNIVKLHGFCNHQG--SNLLLYEYMPKGSLGEILHDPSC-NLDWSKRFKI 909
Query: 538 AMGMAYCLEHMHQ-LTPPIAHRNLQSSSIYLTEDYAAKISDFSF-------WNNTTAAKT 589
A+G A L ++H P I HR+++S++I L + + A + DF + + +A
Sbjct: 910 ALGAAQGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPHSKSMSAIA 969
Query: 590 GS---AAMELLETSAVDLESNVYSFGTILFEMITGR--ISYSIENGSLENWASEYLKGEQ 644
GS A E T V +S++YS+G +L E++TG+ + + G + NW Y++ +
Sbjct: 970 GSYGYIAPEYAYTMKVTEKSDIYSYGVVLLELLTGKAPVQPIDQGGDVVNWVRSYIRRDA 1029
Query: 645 PLKDIVDPTLKSFQENVLEELLVVIKN---CVHPDPKQRPSMRGIAAKLKE 692
++D L E ++ +L V+K C P RPSMR + L E
Sbjct: 1030 LSSGVLDARLTLEDERIVSHMLTVLKIALLCTSVSPVARPSMRQVVLMLIE 1080
|
|
| TAIR|locus:2026097 SERK2 "somatic embryogenesis receptor-like kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 331 (121.6 bits), Expect = 5.7e-45, Sum P(2) = 5.7e-45
Identities = 100/330 (30%), Positives = 169/330 (51%)
Query: 415 KLKR---SELEAACEDFSN--IIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSK 469
+LKR EL+ A + FSN I+G G G VYKG L+ G +AV + + + +
Sbjct: 289 QLKRFSLRELQVATDSFSNKNILGR---GGFGKVYKGRLADGTLVAVK----RLKEERTP 341
Query: 470 NLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHL 529
E QF+ +++ +S H+N + L G+C P R++V+ Y NGS+ L + L
Sbjct: 342 GGELQFQTEVEMISMAVHRNLLRLRGFCMT--PTERLLVYPYMANGSVASCLRERPPSQL 399
Query: 530 D--WAMRLRIAMGMAYCLEHMHQ-LTPPIAHRNLQSSSIYLTEDYAAKISDFSF------ 580
W++R +IA+G A L ++H P I HR++++++I L E++ A + DF
Sbjct: 400 PLAWSIRQQIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLARLMDY 459
Query: 581 --WNNTTAAK--TGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSI------ENG 630
+ TTA + G A E L T +++V+ +G +L E+ITG+ ++ + ++
Sbjct: 460 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDV 519
Query: 631 SLENWASEYLKGEQPLKDIVDPTLKS-FQENVLEELLVVIKNCVHPDPKQRPSMRGIAAK 689
L +W LK E+ L+ +VDP L+S + E +E+L+ V C P +RP M +
Sbjct: 520 MLLDWVKGLLK-EKKLEMLVDPDLQSNYTEAEVEQLIQVALLCTQSSPMERPKMSEV--- 575
Query: 690 LKEITAMEPDGATPKLSPLWWAELEILSSE 719
+ +E DG K W ++E+L E
Sbjct: 576 ---VRMLEGDGLAEKWDE--WQKVEVLRQE 600
|
|
| TAIR|locus:2013021 SERK1 "somatic embryogenesis receptor-like kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 339 (124.4 bits), Expect = 8.7e-45, Sum P(2) = 8.7e-45
Identities = 102/330 (30%), Positives = 169/330 (51%)
Query: 415 KLKR---SELEAACEDFSN--IIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSK 469
+LKR EL+ A + FSN I+G G G VYKG L+ G +AV + + + +
Sbjct: 286 QLKRFSLRELQVASDGFSNKNILGR---GGFGKVYKGRLADGTLVAVK----RLKEERTP 338
Query: 470 NLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEH- 528
E QF+ +++ +S H+N + L G+C P R++V+ Y NGS+ L +
Sbjct: 339 GGELQFQTEVEMISMAVHRNLLRLRGFCMT--PTERLLVYPYMANGSVASCLRERPPSQP 396
Query: 529 -LDWAMRLRIAMGMAYCLEHMHQ-LTPPIAHRNLQSSSIYLTEDYAAKISDFSF------ 580
LDW R RIA+G A L ++H P I HR++++++I L E++ A + DF
Sbjct: 397 PLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 456
Query: 581 --WNNTTAAK--TGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSI------ENG 630
+ TTA + G A E L T +++V+ +G +L E+ITG+ ++ + ++
Sbjct: 457 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDV 516
Query: 631 SLENWASEYLKGEQPLKDIVDPTLKS-FQENVLEELLVVIKNCVHPDPKQRPSMRGIAAK 689
L +W LK E+ L+ +VDP L++ ++E LE+++ V C P +RP M +
Sbjct: 517 MLLDWVKGLLK-EKKLEMLVDPDLQTNYEERELEQVIQVALLCTQGSPMERPKMSEV--- 572
Query: 690 LKEITAMEPDGATPKLSPLWWAELEILSSE 719
+ +E DG K W ++EIL E
Sbjct: 573 ---VRMLEGDGLAEKWDE--WQKVEILREE 597
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| C0LGU7 | Y5458_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.4300 | 0.8654 | 0.8978 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
No EC number assignment, probably not an enzyme!
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00024049001 | SubName- Full=Chromosome chr6 scaffold_3, whole genome shotgun sequence; (898 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 721 | |||
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-32 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-30 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-29 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-29 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-28 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-27 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 5e-26 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-21 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-21 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-21 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-20 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 8e-19 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-17 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 6e-17 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-16 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-16 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 7e-16 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 7e-16 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-15 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-14 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-14 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-14 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 6e-14 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 8e-14 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-13 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-13 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-13 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-13 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-13 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-13 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-13 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 9e-13 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-12 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-12 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-12 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-12 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-12 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-12 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 5e-12 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-11 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-11 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-11 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-11 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-11 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-11 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-11 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-11 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-11 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-11 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 4e-11 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 5e-11 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 5e-11 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 6e-11 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 7e-11 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 7e-11 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 7e-11 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 7e-11 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 9e-11 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-10 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-10 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-10 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-10 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-10 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-10 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 4e-10 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 4e-10 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 4e-10 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 5e-10 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 5e-10 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 8e-10 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-09 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-09 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-09 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-09 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-09 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-09 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-09 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-09 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 5e-09 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 7e-09 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 8e-09 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 9e-09 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-08 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-08 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-08 | |
| pfam08263 | 42 | pfam08263, LRRNT_2, Leucine rich repeat N-terminal | 2e-08 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 3e-08 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-08 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-08 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 3e-08 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 4e-08 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 4e-08 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 6e-08 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-07 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-07 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-07 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-07 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-07 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-07 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 4e-07 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 5e-07 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 6e-07 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 7e-07 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 7e-07 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-06 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-06 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-06 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-06 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-06 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-06 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-06 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-06 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-06 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-06 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-06 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 4e-06 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 4e-06 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-06 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 5e-06 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 6e-06 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 6e-06 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 7e-06 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 8e-06 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-05 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-05 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-05 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-05 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-05 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-05 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-05 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-05 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-05 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-05 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-05 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-05 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 4e-05 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 4e-05 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-05 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-05 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 5e-05 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 6e-05 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 8e-05 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 9e-05 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 9e-05 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-04 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-04 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-04 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-04 | |
| pfam04652 | 315 | pfam04652, DUF605, Vta1 like | 2e-04 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-04 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-04 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-04 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-04 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 4e-04 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 4e-04 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 4e-04 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 5e-04 | |
| PLN02217 | 670 | PLN02217, PLN02217, probable pectinesterase/pectin | 5e-04 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 6e-04 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 6e-04 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 7e-04 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 0.001 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 0.001 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 0.001 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 0.001 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 0.001 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 0.001 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 0.002 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 0.002 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 0.002 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 0.002 | |
| pfam05687 | 151 | pfam05687, DUF822, Plant protein of unknown functi | 0.003 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 0.003 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 0.003 | |
| pfam04652 | 315 | pfam04652, DUF605, Vta1 like | 0.004 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.004 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 0.004 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 0.004 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 0.004 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 0.004 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 3e-32
Identities = 79/281 (28%), Positives = 123/281 (43%), Gaps = 43/281 (15%)
Query: 428 FSNIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKS-RADWSKNLESQFRKKIDTLSKVN 486
+G G G VYKGTL E T +VK+ + S+ +F ++ + K++
Sbjct: 3 LGKKLGE---GAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLS 59
Query: 487 HKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLR----IAMGMA 542
H N V L+G C + EP +V EY P G L + L + E L L+ IA GM
Sbjct: 60 HPNIVRLLGVCTQGEPL--YIVTEYMPGGDLLDFLR-KHGEKLTLKDLLQMALQIAKGME 116
Query: 543 YCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFS-----FWNNTTAAKTGSA----- 592
Y LE + HR+L + + +TE+ KISDF + ++ + G
Sbjct: 117 Y-LESKN-----FVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKW 170
Query: 593 -AMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLK-GEQPLKDI 649
A E L+ +S+V+SFG +L+E+ T G Y + E L+ G + +
Sbjct: 171 MAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE---VLELLEDGYRLPR-- 225
Query: 650 VDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKL 690
P EN +EL ++ C DP+ RP+ + L
Sbjct: 226 --P------ENCPDELYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 1e-30
Identities = 81/288 (28%), Positives = 117/288 (40%), Gaps = 52/288 (18%)
Query: 430 NIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKS-RADWSKNLESQFRKKIDTLSKVNHK 488
+G G G VYKG L VK+ + D S+ F K+ + K+ H
Sbjct: 1 KKLGE---GAFGEVYKGKLKGKDGKTTEVA-VKTLKEDASEEERKDFLKEARVMKKLGHP 56
Query: 489 NFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHL-------HIQEAEHLDWAMRLR----I 537
N V L+G C E+EP +V EY G L ++L E L L I
Sbjct: 57 NVVRLLGVCTEEEPL--YLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQI 114
Query: 538 AMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDF--SFW--NNTTAAKTGSA- 592
A GM Y L HR+L + + + ED KISDF S ++ K
Sbjct: 115 AKGMEY-LASKK-----FVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGK 168
Query: 593 ------AMELLETSAVDLESNVYSFGTILFEMIT-GRISYS-IENGSLENWASEYL-KGE 643
A E L+ +S+V+SFG +L+E+ T G Y + N EYL KG
Sbjct: 169 LPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN----EEVLEYLRKGY 224
Query: 644 QPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLK 691
+ K P E +EL ++ +C DP+ RP+ + +L+
Sbjct: 225 RLPK----P------EYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 116 bits (294), Expect = 3e-29
Identities = 74/284 (26%), Positives = 117/284 (41%), Gaps = 50/284 (17%)
Query: 428 FSNIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKS-RADWSKNLESQFRKKIDTLSKVN 486
+G G G VYKG L +VK+ + D S+ +F ++ + K++
Sbjct: 3 LGKKLGE---GAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLD 59
Query: 487 HKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHL-----HIQEAEHLDWAMRLRIAMGM 541
H N V L+G C E+EP +V EY G L +L + ++ L +A L+IA GM
Sbjct: 60 HPNVVKLLGVCTEEEPL--YIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFA--LQIARGM 115
Query: 542 AYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFS---FWNNTTAAKTGSA------ 592
Y LE + HR+L + + + E+ KISDF + +
Sbjct: 116 EY-LESKN-----FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRW 169
Query: 593 -AMELLE----TSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPL 646
A E L+ TS D V+SFG +L+E+ T G Y + E+ L
Sbjct: 170 MAPESLKEGKFTSKSD----VWSFGVLLWEIFTLGEQPY------------PGMSNEEVL 213
Query: 647 KDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKL 690
+ + + N EL ++ C DP+ RP+ + L
Sbjct: 214 EYLKNGYRLPQPPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 116 bits (294), Expect = 3e-29
Identities = 77/284 (27%), Positives = 118/284 (41%), Gaps = 49/284 (17%)
Query: 428 FSNIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKS-RADWSKNLESQFRKKIDTLSKVN 486
+G G G VYKGTL + +VK+ + D S+ +F ++ + K++
Sbjct: 3 LGKKLGE---GAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLD 59
Query: 487 HKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLR----IAMGMA 542
H N V L+G C E+EP M+V EY P G L ++L + L + L IA GM
Sbjct: 60 HPNIVKLLGVCTEEEPL--MIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGME 117
Query: 543 YCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFS---FWNNTTAAKTGSA------- 592
Y LE HR+L + + + E+ KISDF + K
Sbjct: 118 Y-LESK-----NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWM 171
Query: 593 AMELLE----TSAVDLESNVYSFGTILFEMIT-GRISYS-IENGSLENWASEYLKGEQPL 646
A E L+ TS D V+SFG +L+E+ T G Y + N + + + + +P
Sbjct: 172 APESLKEGKFTSKSD----VWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPKP- 226
Query: 647 KDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKL 690
N EL ++ C DP+ RP+ + L
Sbjct: 227 ------------PNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 1e-28
Identities = 65/272 (23%), Positives = 106/272 (38%), Gaps = 78/272 (28%)
Query: 432 IGSFSDGTVGTVYKGT-LSSGVEIAVTSTSVKS-RADWSKNLESQFRKKIDTLSKVNHKN 489
+G G GTVY +G ++A+ K + + S +L + ++I+ L K+NH N
Sbjct: 1 LGE---GGFGTVYLARDKKTGKKVAI-----KIIKKEDSSSLLEELLREIEILKKLNHPN 52
Query: 490 FVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMH 549
V L G E++ +V EY GSL + L + L LRI + + LE++H
Sbjct: 53 IVKLYGVFEDENHL--YLVMEYCEGGSLKDLLK-ENEGKLSEDEILRILLQILEGLEYLH 109
Query: 550 QLTPPIAHRNLQSSSIYLTEDYA-AKISDFSFW------NNTTAAKTGS---AAMELLE- 598
I HR+L+ +I L D K++DF + G+ A E+L
Sbjct: 110 SN--GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLG 167
Query: 599 ----TSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTL 654
+ D ++S G IL+E+ LKD+
Sbjct: 168 KGYYSEKSD----IWSLGVILYEL-------------------------PELKDL----- 193
Query: 655 KSFQENVLEELLVVIKNCVHPDPKQRPSMRGI 686
I+ + DP++RPS + I
Sbjct: 194 --------------IRKMLQKDPEKRPSAKEI 211
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 60/269 (22%), Positives = 107/269 (39%), Gaps = 37/269 (13%)
Query: 430 NIIGSFSDGTVGTVYKGT-LSSGVEIAVTSTSVKS-RADWSKNLESQFRKKIDTLSKVNH 487
+G G+ G VY +G +A+ K + K + ++I L K+ H
Sbjct: 5 EKLGE---GSFGKVYLARDKKTGKLVAI-----KVIKKKKIKKDRERILREIKILKKLKH 56
Query: 488 KNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRL--RIAMGMAYCL 545
N V L E+++ +V EY G LF+ L + D A +I + Y
Sbjct: 57 PNIVRLYDVFEDEDKLY--LVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYL- 113
Query: 546 EHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDF---SFWNNTTAAKT--GS---AAMELL 597
H I HR+L+ +I L ED K++DF + T G+ A E+L
Sbjct: 114 -HSKG----IVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVL 168
Query: 598 ETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSF 657
+++S G IL+E++TG+ + ++ + K +P P
Sbjct: 169 LGKGYGKAVDIWSLGVILYELLTGKPPFPGDD----QLLELFKKIGKP-----KPPFPPP 219
Query: 658 QENVLEELLVVIKNCVHPDPKQRPSMRGI 686
+ ++ E +I+ + DP++R +
Sbjct: 220 EWDISPEAKDLIRKLLVKDPEKRLTAEEA 248
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 5e-26
Identities = 75/269 (27%), Positives = 121/269 (44%), Gaps = 37/269 (13%)
Query: 431 IIGSFSDGTVGTVYKGT-LSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKN 489
+GS G+ GTVYK +G +AV +S + R++I L +++H N
Sbjct: 6 KLGS---GSFGTVYKAKHKGTGKIVAVKILKKRSE---KSKKDQTARREIRILRRLSHPN 59
Query: 490 FVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMH 549
V LI E+ + +V EY G LF++L L +IA+ + LE++H
Sbjct: 60 IVRLIDAFEDKD--HLYLVMEYCEGGDLFDYLS--RGGPLSEDEAKKIALQILRGLEYLH 115
Query: 550 QLTPPIAHRNLQSSSIYLTEDYAAKISDF----SFWNNTTAAKT--GS---AAMELL--- 597
I HR+L+ +I L E+ KI+DF ++++ T G+ A E+L
Sbjct: 116 SN--GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGG 173
Query: 598 --ETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLK 655
VD V+S G IL+E++TG+ +S EN + + G D +
Sbjct: 174 NGYGPKVD----VWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSG 229
Query: 656 SFQENVLEELLVVIKNCVHPDPKQRPSMR 684
S EE +IK C++ DP +RP+
Sbjct: 230 S------EEAKDLIKKCLNKDPSKRPTAE 252
|
Length = 260 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 2e-21
Identities = 67/272 (24%), Positives = 118/272 (43%), Gaps = 60/272 (22%)
Query: 438 GTVGTVYKGT--LSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIG 495
G G+V KG + SG E+ V ++K + + +F ++ +++++H V LIG
Sbjct: 6 GNFGSVVKGVYLMKSGKEVEVAVKTLK--QEHIAAGKKEFLREASVMAQLDHPCIVRLIG 63
Query: 496 YCEEDEPFTRMMVFEYSPNGSLFEHL----HIQEAEHLDWAMRLRIAMGMAYCLEHMHQL 551
C+ EP M+V E +P G L ++L I ++ + A ++AMGMAY LE H
Sbjct: 64 VCKG-EPL--MLVMELAPLGPLLKYLKKRREIPVSDLKELA--HQVAMGMAY-LESKH-- 115
Query: 552 TPPIAHRNLQSSSIYLTEDYAAKISDF------SFWNNTTAAKTGSA------AMELLET 599
HR+L + ++ L + AKISDF ++ A T A E +
Sbjct: 116 ---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINY 172
Query: 600 SAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQE 659
+S+V+S+G L+E SY G +P ++ + + E
Sbjct: 173 GKFSSKSDVWSYGVTLWEA----FSY----------------GAKPYGEMKGAEVIAMLE 212
Query: 660 NVL---------EELLVVIKNCVHPDPKQRPS 682
+ +E+ ++ +C P+ RP+
Sbjct: 213 SGERLPRPEECPQEIYSIMLSCWKYRPEDRPT 244
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 2e-21
Identities = 75/284 (26%), Positives = 120/284 (42%), Gaps = 53/284 (18%)
Query: 427 DFSNIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVN 486
IG G G V G G ++AV K D S + F + ++ +
Sbjct: 9 KLGATIGK---GEFGDVMLGDYR-GQKVAV-----KCLKDDSTAAQ-AFLAEASVMTTLR 58
Query: 487 HKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHL------HIQEAEHLDWAMRLRIAMG 540
H N V L+G + P +V EY GSL ++L I A+ L +A+ + G
Sbjct: 59 HPNLVQLLGVVLQGNPL--YIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALD--VCEG 114
Query: 541 MAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTAAKTGS------AAM 594
M Y LE + HR+L + ++ ++ED AK+SDF + + A
Sbjct: 115 MEY-LEEKN-----FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWTAP 168
Query: 595 ELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPLKDIVDPT 653
E L +S+V+SFG +L+E+ + GR+ Y PLKD+V
Sbjct: 169 EALREKKFSTKSDVWSFGILLWEIYSFGRVPYP----------------RIPLKDVVPHV 212
Query: 654 LKSFQ----ENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEI 693
K ++ E E+ V+K+C DP +RP+ + + +L I
Sbjct: 213 EKGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 93.4 bits (233), Expect = 4e-21
Identities = 67/270 (24%), Positives = 112/270 (41%), Gaps = 42/270 (15%)
Query: 430 NIIGSFSDGTVGTVYKGT-LSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHK 488
++G G+ G+VY +G +AV S V+ D + LE+ ++I LS + H
Sbjct: 6 ELLGR---GSFGSVYLALDKDTGELMAVKS--VELSGDSEEELEA-LEREIRILSSLQHP 59
Query: 489 NFVNLIGYCEEDEPFTRMMVF-EYSPNGSLFEHLH----IQEAEHLDWAMRLRIAMGMAY 543
N V G E DE + +F EY GSL L + E +R +
Sbjct: 60 NIVRYYG-SERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPV-----IRKYTRQ-ILE 112
Query: 544 CLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDF----SFWNNTTAAKTGSAA-----M 594
L ++H I HR+++ ++I + D K++DF + T TGS M
Sbjct: 113 GLAYLHSNG--IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWM 170
Query: 595 --ELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDP 652
E++ ++++S G + EM TG+ +S L N + K
Sbjct: 171 APEVIRGEEYGRAADIWSLGCTVIEMATGKPPWS----ELGNPMAAL------YKIGSSG 220
Query: 653 TLKSFQENVLEELLVVIKNCVHPDPKQRPS 682
E++ EE ++ C+ DPK+RP+
Sbjct: 221 EPPEIPEHLSEEAKDFLRKCLRRDPKKRPT 250
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 1e-20
Identities = 68/296 (22%), Positives = 116/296 (39%), Gaps = 50/296 (16%)
Query: 428 FSNIIGSFSDGTVGTVYKGTL-----SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTL 482
F +G G G V ++G ++AV S + S F ++I+ L
Sbjct: 8 FIKQLGE---GHFGKVELCRYDPLGDNTGEQVAVKSL----NHSGEEQHRSDFEREIEIL 60
Query: 483 SKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLR----IA 538
++H+N V G CE+ + ++ EY P+GSL ++L + ++ L I
Sbjct: 61 RTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRH-RDQINLKRLLLFSSQIC 119
Query: 539 MGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTAAKTGSA------ 592
GM Y L HR+L + +I + + KISDF
Sbjct: 120 KGMDY-LGSQR-----YIHRDLAARNILVESEDLVKISDFGL---AKVLPEDKDYYYVKE 170
Query: 593 ---------AMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKG 642
A E L TS S+V+SFG L+E+ T G S S L +G
Sbjct: 171 PGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIA--QG 228
Query: 643 EQPLKDIVDPTLKSFQ-----ENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEI 693
+ + +++ LK + + +E+ ++K C +P+ RPS + + +
Sbjct: 229 QMIVTRLLE-LLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 86.5 bits (215), Expect = 8e-19
Identities = 73/289 (25%), Positives = 125/289 (43%), Gaps = 62/289 (21%)
Query: 427 DFSNI--IGSFSDGTVGTVYKGT-LSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLS 483
F + IG G G VYK +G E+A+ ++S+ K + +I L
Sbjct: 1 LFEILEKIGK---GGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKII-----NEIQILK 52
Query: 484 KVNHKNFVNLIG-YCEEDEPFTRMMVFEYSPNGSLFEHLH-----IQEAEHLDWAMRLRI 537
K H N V G Y ++DE +V E+ GSL + L + E++ I
Sbjct: 53 KCKHPNIVKYYGSYLKKDEL---WIVMEFCSGGSLKDLLKSTNQTLTESQ---------I 100
Query: 538 AMGMAYC------LEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSF---WNNTTAAK 588
A C LE++H I HR++++++I LT D K+ DF ++T A
Sbjct: 101 A---YVCKELLKGLEYLHSNG--IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARN 155
Query: 589 T--GS---AAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGE 643
T G+ A E++ D +++++S G E+ G+ YS E ++ A +
Sbjct: 156 TMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYS-ELPPMK--ALFKIATN 212
Query: 644 QPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKE 692
P P L++ E +E +K C+ +P++RP+ A +L +
Sbjct: 213 GP------PGLRN-PEKWSDEFKDFLKKCLQKNPEKRPT----AEQLLK 250
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 1e-17
Identities = 70/270 (25%), Positives = 114/270 (42%), Gaps = 41/270 (15%)
Query: 438 GTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYC 497
G G VYKG L E+AV + R+ +L+ +F ++ + L + +H N V LIG C
Sbjct: 6 GNFGDVYKGVLKGNTEVAVKTC----RSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 498 EEDEPFTRMMVFEYSPNGSLFEHLHIQEAE---HLDWAMRLRIAMGMAYCLEHMHQLTPP 554
+ +P +V E P GSL L ++ M L A GM Y LE + +
Sbjct: 62 VQKQPI--YIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEY-LESKNCI--- 115
Query: 555 IAHRNLQSSSIYLTEDYAAKISDFSFWNN------TTAAKTGS-----AAMELLETSAVD 603
HR+L + + + E+ KISDF T + A E L
Sbjct: 116 --HRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYT 173
Query: 604 LESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPLKDIVDPTLK-SFQENV 661
ES+V+S+G +L+E + G Y ++ Q ++ ++ + +
Sbjct: 174 SESDVWSYGILLWETFSLGDTPYP-------GMSN------QQTRERIESGYRMPAPQLC 220
Query: 662 LEELLVVIKNCVHPDPKQRPSMRGIAAKLK 691
EE+ ++ C DP+ RPS I +L+
Sbjct: 221 PEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 6e-17
Identities = 73/263 (27%), Positives = 117/263 (44%), Gaps = 45/263 (17%)
Query: 437 DGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGY 496
G G V+ GT + ++AV K+ + + E+ F ++ + K+ H V L
Sbjct: 16 AGQFGEVWMGTWNGTTKVAV-----KTLKPGTMSPEA-FLQEAQIMKKLRHDKLVQLYAV 69
Query: 497 CEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWA----MRLRIAMGMAYCLEHMHQLT 552
C E+EP +V EY GSL + L E + L M +IA GMAY LE + +
Sbjct: 70 CSEEEPI--YIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAY-LESRNYI- 125
Query: 553 PPIAHRNLQSSSIYLTEDYAAKISDFS----FWNNTTAAKTGS------AAMELLETSAV 602
HR+L + +I + E+ KI+DF ++ A+ G+ A E
Sbjct: 126 ----HRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRF 181
Query: 603 DLESNVYSFGTILFEMIT-GRISYSIENGS--LENWASEYLKGEQPLKDIVDPTLKSFQE 659
++S+V+SFG +L E++T GR+ Y LE Y + +P
Sbjct: 182 TIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGY-RMPRP-------------P 227
Query: 660 NVLEELLVVIKNCVHPDPKQRPS 682
N EEL ++ C DP++RP+
Sbjct: 228 NCPEELYDLMLQCWDKDPEERPT 250
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 1e-16
Identities = 66/289 (22%), Positives = 112/289 (38%), Gaps = 44/289 (15%)
Query: 431 IIGSFSDGTVGTVYKGTLSSGV-EIAVTSTSVKSRADWSKN-LESQFRKKIDTLSKVNHK 488
+ +G G V+ G E +VK+ + + N F ++ + L+ H+
Sbjct: 9 LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHE 68
Query: 489 NFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHM 548
N V G C E +P +MVFEY +G L + L + MG L +
Sbjct: 69 NIVKFYGVCTEGDPP--IMVFEYMEHGDLNKFLR-SHGPDAAFLKSPDSPMG-ELTLSQL 124
Query: 549 HQLTPPIA------------HRNLQSSSIYLTEDYAAKISDFSFWNN---TTAAKTGSAA 593
Q+ IA HR+L + + + D KI DF + T + G
Sbjct: 125 LQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHT 184
Query: 594 M--------ELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEY-LKGE 643
M E + ES+V+SFG +L+E+ T G+ + Y L E
Sbjct: 185 MLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPW-------------YGLSNE 231
Query: 644 QPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKE 692
+ ++ I L E+ ++ C DP+QR +++ I +L++
Sbjct: 232 EVIECITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 3e-16
Identities = 153/626 (24%), Positives = 245/626 (39%), Gaps = 112/626 (17%)
Query: 122 ILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGP 181
+L+L L G + L L +IL +NS G IPK +G + L + L N+FSG
Sbjct: 360 VLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGE 419
Query: 182 FPSDFGNSFSLTTLLLDNNQYLGGIS------PELHVLKVISEIQVDESWLTNAASRASC 235
PS+F + L + NN G I+ P L +L + +R
Sbjct: 420 LPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSL---------------ARNKF 464
Query: 236 NSGL---FTWNKVQPGDNAFRRMLQQVTNGFEA-----KRKASEPSSSSSIA---SSPEP 284
GL F +++ D + + V + + K SE S I SS +
Sbjct: 465 FGGLPDSFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKK 524
Query: 285 LVSPSLSPS-MSSLLSPSFSPSPSPSESPSVSSPLI--IPP--------APVNIPIVSSP 333
LVS LS + +S + SFS P S+ + L IP VNI S
Sbjct: 525 LVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNI----SH 580
Query: 334 PHLH-SAPTS--FAASTPSQVH-----------------ESLHKSKHHTVLVLAGIIGGL 373
HLH S P++ F A S V + + K+ + +G
Sbjct: 581 NHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRKTPSWWFYI-TCTLGAF 639
Query: 374 SLILISAIGFFVCRSSKVVTVKPWVTGLSGQLQKAFVTGVPKLKRSELEAACEDF----- 428
++ + A GF R + +K V G + F K+ +S D
Sbjct: 640 LVLALVAFGFVFIRGRNNLELKR-VENEDGTWELQFFDS--KVSKS---ITINDILSSLK 693
Query: 429 -SNIIGSFSDGTVGTVYKG-TLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVN 486
N+I S G G YKG ++ +G++ V ++ S +I + K+
Sbjct: 694 EENVI---SRGKKGASYKGKSIKNGMQFVVKEI---------NDVNSIPSSEIADMGKLQ 741
Query: 487 HKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLE 546
H N V LIG C ++ ++ EY +L E L +L W R +IA+G+A L
Sbjct: 742 HPNIVKLIGLCRSEK--GAYLIHEYIEGKNLSEVL-----RNLSWERRRKIAIGIAKALR 794
Query: 547 HMH-QLTPPIAHRNLQSSSIYLTEDYAAKI----SDFSFWNNTTAAKTGSAAMELLETSA 601
+H + +P + NL I + + + + A E ET
Sbjct: 795 FLHCRCSPAVVVGNLSPEKIIIDGKDEPHLRLSLPGLLCTDTKCFISSAYVAPETRETKD 854
Query: 602 VDLESNVYSFGTILFEMITGRISYSIE---NGSLENWASEYLKGEQPLKDIVDPTLK--- 655
+ +S++Y FG IL E++TG+ E +GS+ WA Y + L +DP+++
Sbjct: 855 ITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWA-RYCYSDCHLDMWIDPSIRGDV 913
Query: 656 SFQENVLEELLVVIKNCVHPDPKQRP 681
S +N + E++ + +C DP RP
Sbjct: 914 SVNQNEIVEVMNLALHCTATDPTARP 939
|
Length = 968 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 7e-16
Identities = 65/272 (23%), Positives = 116/272 (42%), Gaps = 43/272 (15%)
Query: 433 GSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVN 492
G F D +G Y+G ++AV + A F + ++++ H N V
Sbjct: 17 GEFGDVMLGD-YRGN-----KVAVKCIKNDATA-------QAFLAEASVMTQLRHSNLVQ 63
Query: 493 LIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLT 552
L+G E++ +V EY GSL ++L + L L+ ++ + +E++
Sbjct: 64 LLGVIVEEKG-GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE--A 120
Query: 553 PPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTAAKTGS------AAMELLETSAVDLES 606
HR+L + ++ ++ED AK+SDF ++ + A E L +S
Sbjct: 121 NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKS 180
Query: 607 NVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQ----ENV 661
+V+SFG +L+E+ + GR+ Y PLKD+V K ++ +
Sbjct: 181 DVWSFGILLWEIYSFGRVPYP----------------RIPLKDVVPRVEKGYKMDAPDGC 224
Query: 662 LEELLVVIKNCVHPDPKQRPSMRGIAAKLKEI 693
+ V+K C H D RPS + +L+ I
Sbjct: 225 PPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 7e-16
Identities = 66/256 (25%), Positives = 115/256 (44%), Gaps = 33/256 (12%)
Query: 460 SVKS-RADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLF 518
+VK+ + + + S ++K+I+ L + H+N V G C E ++ EY P GSL
Sbjct: 37 AVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLR 96
Query: 519 EHL---HIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKI 575
++L + A+ L +A +I GMAY L H + HR+L + ++ L D KI
Sbjct: 97 DYLPKHKLNLAQLLLFAQ--QICEGMAY-LHSQHYI-----HRDLAARNVLLDNDRLVKI 148
Query: 576 SDFSFWNNTTAAKTGSA---------------AMELLETSAVDLESNVYSFGTILFEMIT 620
DF A G A+E L+ + S+V+SFG L+E++T
Sbjct: 149 GDFGL---AKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLT 205
Query: 621 GRISYSIENGSLENW--ASEYLKGEQPLKDIVDPTLK-SFQENVLEELLVVIKNCVHPDP 677
S E + L ++++ ++ +N +E+ +++KNC +
Sbjct: 206 HCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEA 265
Query: 678 KQRPSMRGIAAKLKEI 693
K RP+ R + LKE+
Sbjct: 266 KFRPTFRSLIPILKEM 281
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 79.4 bits (194), Expect = 1e-15
Identities = 61/275 (22%), Positives = 108/275 (39%), Gaps = 29/275 (10%)
Query: 430 NIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNH-K 488
I+ +G+ G VY V + V + ++S +F ++I L+ +NH
Sbjct: 3 RILRKLGEGSFGEVYLARDRKLVALKVLAKKLES----KSKEVERFLREIQILASLNHPP 58
Query: 489 NFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEH-LDWAMRLRIAMGMAYCLEH 547
N V L + +++ +V EY GSL + L + L + L I + LE+
Sbjct: 59 NIVKLYDFFQDEGSL--YLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEY 116
Query: 548 MHQLTPPIAHRNLQSSSIYLTEDY-AAKISDF------------SFWNNTTAAKTGSAA- 593
+H I HR+++ +I L D K+ DF S + G+
Sbjct: 117 LHSK--GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGY 174
Query: 594 -----MELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKD 648
+ L + S+++S G L+E++TG + E S + + E P
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPS 234
Query: 649 IVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSM 683
+ P S E + + ++K + DPK R S
Sbjct: 235 LASPLSPSNPELISKAASDLLKKLLAKDPKNRLSS 269
|
Length = 384 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 1e-14
Identities = 81/279 (29%), Positives = 114/279 (40%), Gaps = 49/279 (17%)
Query: 437 DGTVGTVYKGTLSS--GVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLI 494
DG+ G V +G S+ G I V +KS D ++ F K+ + ++H+N + L
Sbjct: 5 DGSFGVVRRGEWSTSGGKVIPVAVKCLKS--DKLSDIMDDFLKEAAIMHSLDHENLIRLY 62
Query: 495 GYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHL------DWAMRLRIAMGMAYCLEHM 548
G P MMV E +P GSL + L H D+A+ +IA GM Y LE
Sbjct: 63 GVVL-THPL--MMVTELAPLGSLLDRLRKDALGHFLISTLCDYAV--QIANGMRY-LESK 116
Query: 549 HQLTPPIAHRNLQSSSIYLTEDYAAKISDF----------SFWNNTTAAKTGSA--AMEL 596
HR+L + +I L D KI DF + K A A E
Sbjct: 117 R-----FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPES 171
Query: 597 LETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPLKDIVDPTLK 655
L T S+V+ FG L+EM T G E WA L G Q LK I D +
Sbjct: 172 LRTRTFSHASDVWMFGVTLWEMFTYGE----------EPWAG--LSGSQILKKI-DKEGE 218
Query: 656 SFQ--ENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKE 692
+ E +++ V+ C +P RP+ + L E
Sbjct: 219 RLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLPE 257
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 3e-14
Identities = 75/291 (25%), Positives = 119/291 (40%), Gaps = 50/291 (17%)
Query: 430 NIIGSFSDGTVGTVYKGTL------SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLS 483
N +GS G G VY+GT SG I V +++ A + + +F K+ +S
Sbjct: 1 NFLGS---GAFGEVYEGTATDILGPGSG-PIRVAVKTLRKGATDQE--KKEFLKEAHLMS 54
Query: 484 KVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLD---------WAMR 534
NH N V L+G C +EP +M E G L +L E +
Sbjct: 55 NFNHPNIVKLLGVCLLNEPQYIIM--ELMEGGDLLSYLRDARVERFGPPLLTLKELLDIC 112
Query: 535 LRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSF----WNNTTAAKTG 590
L +A G Y LE MH + +A RN S D KI DF + + K G
Sbjct: 113 LDVAKGCVY-LEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEG 171
Query: 591 SA-------AMELLETSAVDLESNVYSFGTILFEMIT-GRISY-SIENGSLENWASEYLK 641
A E L +S+V+SFG +++E++T G+ Y ++ N + + +
Sbjct: 172 EGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGR 231
Query: 642 GEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKE 692
++P EN +++ ++ NC DP +RP+ I L+
Sbjct: 232 LQKP-------------ENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 4e-14
Identities = 64/272 (23%), Positives = 113/272 (41%), Gaps = 45/272 (16%)
Query: 438 GTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYC 497
G G V++G ++ +AV + + F + + K+ H + L C
Sbjct: 17 GQFGEVWEGLWNNTTPVAVKTLKPGTMD------PKDFLAEAQIMKKLRHPKLIQLYAVC 70
Query: 498 EEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWA----MRLRIAMGMAYCLEHMHQLTP 553
+EP +V E GSL E+L L M ++A GMAY LE + +
Sbjct: 71 TLEEPI--YIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAY-LEAQNYI-- 125
Query: 554 PIAHRNLQSSSIYLTEDYAAKISDFS----FWNNTTAAKTGS------AAMELLETSAVD 603
HR+L + ++ + E+ K++DF + A+ G+ A E +
Sbjct: 126 ---HRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFS 182
Query: 604 LESNVYSFGTILFEMIT-GRISYS-IENGS-LENWASEYLKGEQPLKDIVDPTLKSFQEN 660
++S+V+SFG +L E++T GR+ Y + N L+ Y + P
Sbjct: 183 IKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGY-RMPCP-------------PG 228
Query: 661 VLEELLVVIKNCVHPDPKQRPSMRGIAAKLKE 692
+EL ++ +C DP RP+ + KL++
Sbjct: 229 CPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.8 bits (177), Expect = 6e-14
Identities = 57/215 (26%), Positives = 94/215 (43%), Gaps = 42/215 (19%)
Query: 482 LSKVNHKNFVNLIGYCEEDEPFTRM-MVFEYSPNGSLFEHLHIQEAEHLD-WAMRLRIA- 538
LS++NH V L Y + E ++ +V EY+P G LF HL + R A
Sbjct: 47 LSRINHPFIVKLH-YAFQTE--EKLYLVLEYAPGGELFSHL--SKEGRFSEERARFYAAE 101
Query: 539 MGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFW--NNTTAAKTGS----- 591
+ +A LE++H L I +R+L+ +I L D K++DF ++ ++T +
Sbjct: 102 IVLA--LEYLHSLG--IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTP 157
Query: 592 --AAMELLE----TSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQP 645
A E+L AVD +S G +L+EM+TG+ + E+ E + LK
Sbjct: 158 EYLAPEVLLGKGYGKAVDW----WSLGVLLYEMLTGKPPFYAED-RKEIYEK-ILKDPLR 211
Query: 646 LKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQR 680
+ + P + + LL DP +R
Sbjct: 212 FPEFLSPEARDL----ISGLLQK-------DPTKR 235
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 8e-14
Identities = 63/287 (21%), Positives = 115/287 (40%), Gaps = 54/287 (18%)
Query: 433 GSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVN 492
G F + + KG G E V +++ D +NL+S+FR+++D K++HKN V
Sbjct: 16 GEFGEVFLAKA-KGIEEEGGETLVLVKALQKTKD--ENLQSEFRRELDMFRKLSHKNVVR 72
Query: 493 LIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEH-------LDWAMRLRIAMGMAYCL 545
L+G C E EP M+ EY+ G L + L +++ L ++ + +A +
Sbjct: 73 LLGLCREAEPH--YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGM 130
Query: 546 EHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT----------TAAKTGSAAME 595
+H+ HR+L + + ++ K+S S + A E
Sbjct: 131 DHLSNAR--FVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPE 188
Query: 596 LLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTL- 654
++ +S+V+SFG +++E+ T +GE P + D +
Sbjct: 189 AVQEDDFSTKSDVWSFGVLMWEVFT--------------------QGELPFYGLSDEEVL 228
Query: 655 -----KSFQ----ENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKE 692
+ E L ++ C +PK RPS + + L E
Sbjct: 229 NRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 2e-13
Identities = 47/160 (29%), Positives = 78/160 (48%), Gaps = 14/160 (8%)
Query: 53 LTLVMLLFLQNLSLARCLNSEGMALLRFRERVVRDPFGALSKWSDNDGVGDNVNPCSWFG 112
+ ++ LFL L++E + LL + + DP LS W+ + V C W G
Sbjct: 13 IFMLFFLFLN----FSMLHAEELELLLSFKSSINDPLKYLSNWNSSADV------CLWQG 62
Query: 113 VECSD-GKVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGEL-KELEI 170
+ C++ +VV ++L + G ++ + +L +++I L NN G IP +I L
Sbjct: 63 ITCNNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRY 122
Query: 171 LDLGFNNFSGPFPSDFGNSFSLTTLLLDNNQYLGGISPEL 210
L+L NNF+G P G+ +L TL L NN G I ++
Sbjct: 123 LNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDI 160
|
Length = 968 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-13
Identities = 51/239 (21%), Positives = 113/239 (47%), Gaps = 33/239 (13%)
Query: 453 EIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYS 512
E+ +T S K R D + N +I LS + H N + + +D T ++ EY+
Sbjct: 32 EVNLTRLSEKERRD-ALN-------EIVILSLLQHPNIIAYYNHFMDDN--TLLIEMEYA 81
Query: 513 PNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYA 572
G+L++ + Q+ + + M L + + ++H+ I HR++++ +I+LT+
Sbjct: 82 NGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG--ILHRDIKTLNIFLTKAGL 139
Query: 573 AKISDFSFW----NNTTAAKT--GSA---AMELLETSAVDLESNVYSFGTILFEMITGRI 623
K+ DF + + A+T G+ + EL + + +S++++ G +L+E++T +
Sbjct: 140 IKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKR 199
Query: 624 SYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPS 682
++ N N + ++G +V EL+ ++ + + DP++RP+
Sbjct: 200 TFDATN--PLNLVVKIVQGNY--TPVVSVYSS--------ELISLVHSLLQQDPEKRPT 246
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 2e-13
Identities = 72/287 (25%), Positives = 114/287 (39%), Gaps = 58/287 (20%)
Query: 438 GTVGTVYKGTL----SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNL 493
G+ G VY+G E V +V A + +E F + + + N + V L
Sbjct: 17 GSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIE--FLNEASVMKEFNCHHVVRL 74
Query: 494 IGYCEEDEPFTRMMVFEYSPNGSLFEHL--HIQEAEH------------LDWAMRLRIAM 539
+G +P ++V E G L +L EAE+ + A IA
Sbjct: 75 LGVVSTGQP--TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMA--AEIAD 130
Query: 540 GMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSF----WNNTTAAKTGSAAM- 594
GMAY L HR+L + + + ED KI DF + K G +
Sbjct: 131 GMAY-LAAKK-----FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLP 184
Query: 595 ------ELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKG---EQP 645
E L+ +S+V+SFG +L+EM T A + +G E+
Sbjct: 185 VRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT--------------LAEQPYQGLSNEEV 230
Query: 646 LKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKE 692
LK ++D EN ++LL +++ C +PK RP+ I + LK+
Sbjct: 231 LKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 2e-13
Identities = 66/253 (26%), Positives = 121/253 (47%), Gaps = 47/253 (18%)
Query: 453 EIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEE-DEPFTRMMVFEY 511
EI ++ S K R + RK++ LS + H N V Y E +E +V +Y
Sbjct: 32 EINISKMSPKER--------EESRKEVAVLSNMKHPNIVQ---YQESFEENGNLYIVMDY 80
Query: 512 SPNGSLFEHLHIQ------EAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSI 565
G L++ ++ Q E + LDW +++ +A L+H+H I HR+++S +I
Sbjct: 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLA------LKHVHDRK--ILHRDIKSQNI 132
Query: 566 YLTEDYAAKISDFSF---WNNTTA-AKT--GSA---AMELLETSAVDLESNVYSFGTILF 616
+LT+D K+ DF N+T A+T G+ + E+ E + +S++++ G +L+
Sbjct: 133 FLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLY 192
Query: 617 EMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPD 676
EM T + ++ E G+++N + ++G P V N++ +L +
Sbjct: 193 EMCT--LKHAFEAGNMKNLVLKIIRGSYP---PVSSHYSYDLRNLVSQLF-------KRN 240
Query: 677 PKQRPSMRGIAAK 689
P+ RPS+ I K
Sbjct: 241 PRDRPSVNSILEK 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 3e-13
Identities = 55/214 (25%), Positives = 100/214 (46%), Gaps = 41/214 (19%)
Query: 437 DGTVGTVYKGTLSS-GVEIAVTSTSVKS-RADWSKNLESQFRKKIDTLSKVNHKNFVNLI 494
+G G VYKG L+ ++ TS ++K+ + + ++ +FR++ + +S + H N V L+
Sbjct: 15 EGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLL 74
Query: 495 GYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLD--------------WA-----MRL 535
G C +++P M+FEY +G L E L ++ + H D + +
Sbjct: 75 GVCTKEQPTC--MLFEYLAHGDLHEFL-VRNSPHSDVGAESGDETVKSSLDCSDFLHIAI 131
Query: 536 RIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTAA---KTGSA 592
+IA GM Y H HR+L + + + E KISDF + +A + S
Sbjct: 132 QIAAGMEYLSSHH------FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSK 185
Query: 593 AM--------ELLETSAVDLESNVYSFGTILFEM 618
++ E + ES+++SFG +L+E+
Sbjct: 186 SLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 3e-13
Identities = 66/281 (23%), Positives = 119/281 (42%), Gaps = 39/281 (13%)
Query: 437 DGTVGTVYKGTLSS--GVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLI 494
+G G+V +G LS G ++ V ++K +E +F + + +H N + LI
Sbjct: 9 EGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIE-EFLSEAACMKDFDHPNVMKLI 67
Query: 495 GYCEEDEPFTR----MMVFEYSPNGSLFEHL---HIQEA-EHLDWAMRLRIAMGMAYCLE 546
G C E + M++ + +G L L + E L L+ + +A +E
Sbjct: 68 GVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGME 127
Query: 547 HMHQLTPPIAHRNLQSSSIYLTEDYAAKISDF---------SFWNNTTAAKTGSA--AME 595
++ HR+L + + L ED ++DF ++ AK A+E
Sbjct: 128 YLS--NRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIE 185
Query: 596 LLETSAVDLESNVYSFGTILFEMIT-GRISYS-IENGSLENWASEYLKGEQPLKDIVDPT 653
L +S+V++FG ++E+ T G+ Y +EN + + YL+ LK
Sbjct: 186 SLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYD----YLRHGNRLKQ----- 236
Query: 654 LKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEIT 694
E+ L+EL ++ +C DPK RP+ + L+ I
Sbjct: 237 ----PEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENIL 273
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 3e-13
Identities = 55/202 (27%), Positives = 92/202 (45%), Gaps = 27/202 (13%)
Query: 438 GTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYC 497
G G V++G + V +A+ + D K + F+K++ L ++ HK+ ++L C
Sbjct: 17 GYFGEVWEGLWKNRVRVAI---KILKSDDLLKQQD--FQKEVQALKRLRHKHLISLFAVC 71
Query: 498 EEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWA----MRLRIAMGMAYCLEHMHQLTP 553
EP ++ E GSL L E + L A M ++A GMAY LE +
Sbjct: 72 SVGEPV--YIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAY-LEEQN---- 124
Query: 554 PIAHRNLQSSSIYLTEDYAAKISDFS---------FWNNTTAAKTGSAAMELLETSAVDL 604
HR+L + +I + ED K++DF + ++ A E
Sbjct: 125 -SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFST 183
Query: 605 ESNVYSFGTILFEMIT-GRISY 625
+S+V+SFG +L+EM T G++ Y
Sbjct: 184 KSDVWSFGILLYEMFTYGQVPY 205
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 68.8 bits (169), Expect = 9e-13
Identities = 76/313 (24%), Positives = 124/313 (39%), Gaps = 89/313 (28%)
Query: 427 DFSNIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQF---RKKI--- 479
F IIG G+ TV + E A+ K L+ + KK+
Sbjct: 4 KFGKIIGE---GSFSTVVLAKEKETNKEYAI------------KILDKRQLIKEKKVKYV 48
Query: 480 ----DTLSKVN-HKNFVNLIGYCEEDEPFTRM-MVFEYSPNGSLFEHLHIQEAEHLDWAM 533
+ L+++N H + L Y +DE + V EY+PNG L +++ + LD
Sbjct: 49 KIEKEVLTRLNGHPGIIKLY-YTFQDE--ENLYFVLEYAPNGELLQYIRKYGS--LDEKC 103
Query: 534 RLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDF----------SFWNN 583
A + LE++H I HR+L+ +I L +D KI+DF S +N
Sbjct: 104 TRFYAAEILLALEYLHSKG--IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESN 161
Query: 584 TTAAK----------------TGSA---AMELLETSAVDLESNVYSFGTILFEMITGRIS 624
A G+A + ELL S++++ G I+++M+TG+
Sbjct: 162 KGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
Query: 625 YSIENGSLENWASEYL------KGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPK 678
+ GS +EYL K E P K +++E+LLV+ DP+
Sbjct: 222 F---RGS-----NEYLTFQKILKLEYSFPPNFPPDAK----DLIEKLLVL-------DPQ 262
Query: 679 QRPSMRGIAAKLK 691
R + +LK
Sbjct: 263 DRLGVNEGYDELK 275
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 1e-12
Identities = 51/189 (26%), Positives = 89/189 (47%), Gaps = 33/189 (17%)
Query: 507 MVFEYSPNGSLFEHLHIQEA----EHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQS 562
+V EY+ NG L + L +Q E W ++I +G L H+H + I HR+++S
Sbjct: 76 IVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLG----LAHLH--SKKILHRDIKS 129
Query: 563 SSIYLTEDYAAKISDF----SFWNNTTAAKT--GSA---AMELLETSAVDLESNVYSFGT 613
+++L KI D +NT A T G+ + EL E + +S+V++ G
Sbjct: 130 LNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGV 189
Query: 614 ILFEMITGRISYSIEN-GSLENWASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNC 672
+L+E TG+ + N G+L + ++G P P + + ++L +I C
Sbjct: 190 VLYECCTGKHPFDANNQGAL---ILKIIRGVFP------PVSQMYS----QQLAQLIDQC 236
Query: 673 VHPDPKQRP 681
+ D +QRP
Sbjct: 237 LTKDYRQRP 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 64/274 (23%), Positives = 117/274 (42%), Gaps = 54/274 (19%)
Query: 456 VTSTSVKS-RADWSKNLESQFRKKIDTLSKV-NHKNFVNLIGYCEEDEPFTRMMVFEYSP 513
VT +VK ++D ++ S +++ + + HKN +NL+G C +D P ++ EY+
Sbjct: 50 VTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPL--YVIVEYAS 107
Query: 514 NGSLFEHLHIQEAEHLDWAMR------------------LRIAMGMAYCLEHMHQLTPPI 555
G+L E+L + +++ ++A GM Y +
Sbjct: 108 KGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYL------ASKKC 161
Query: 556 AHRNLQSSSIYLTEDYAAKISDF---------SFWNNTTAAKTGSAAM--ELLETSAVDL 604
HR+L + ++ +TED KI+DF ++ TT + M E L
Sbjct: 162 IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTH 221
Query: 605 ESNVYSFGTILFEMIT--GRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQENVL 662
+S+V+SFG +L+E+ T G + L E + ++P N
Sbjct: 222 QSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKP-------------SNCT 268
Query: 663 EELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAM 696
EL +++++C H P QRP+ + + L I A+
Sbjct: 269 NELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 67.9 bits (167), Expect = 2e-12
Identities = 67/287 (23%), Positives = 117/287 (40%), Gaps = 78/287 (27%)
Query: 433 GSFSDGTVGTVYKGT-LSSGV-----EIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVN 486
GSF G VY S G EI +++ S K R D ++ L K+N
Sbjct: 11 GSF-----GKVYLVRRKSDGKLYVLKEIDLSNMSEKERED--------ALNEVKILKKLN 57
Query: 487 HKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHL--------HIQEAEHLDWAMRLRIA 538
H N + EE +V EY+ G L + + E + LDW +++
Sbjct: 58 HPNIIKYYESFEEKGKL--CIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWF--VQLC 113
Query: 539 MGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSF---WNNTTA-AKT--GSA 592
+ L+++H I HR+++ +I+LT + K+ DF ++T AKT G+
Sbjct: 114 LA----LKYLHSRK--ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTP 167
Query: 593 ---AMELLETSAVDLESNVYSFGTILFEMITGR----------ISYSIENGSLENWASEY 639
+ EL + + +S+++S G +L+E+ T + ++ I G S+Y
Sbjct: 168 YYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQY 227
Query: 640 LKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGI 686
L+++V L+ DP++RPS+ I
Sbjct: 228 ---SSELRNLVSSLLQ-------------------KDPEERPSIAQI 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 2e-12
Identities = 54/234 (23%), Positives = 101/234 (43%), Gaps = 33/234 (14%)
Query: 468 SKNLESQFRKKIDTLSKVNHKNFVNLIGYCE---EDEPFTRMMVFEYSPNGSLFEHLHIQ 524
+K+ + + L ++H N +I Y E ED+ M+V EY+P G+L E++ +
Sbjct: 39 TKDERLAAQNECQVLKLLSHPN---IIEYYENFLEDKAL--MIVMEYAPGGTLAEYIQKR 93
Query: 525 EAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTE-DYAAKISDFSFWNN 583
LD L + + L H+H I HR+L++ +I L + KI DF
Sbjct: 94 CNSLLDEDTILHFFVQILLALHHVHTKL--ILHRDLKTQNILLDKHKMVVKIGDFGISKI 151
Query: 584 TTAAKTGSAAM--------ELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENW 635
++ + EL E + +S++++ G +L+E+ + + ++ N L
Sbjct: 152 LSSKSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAAN--LPAL 209
Query: 636 ASEYLKGEQ-PLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688
+ + G P+ D P L+ ++L + DP +RP + I A
Sbjct: 210 VLKIMSGTFAPISDRYSPDLRQLILSML-----------NLDPSKRPQLSQIMA 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 2e-12
Identities = 71/271 (26%), Positives = 112/271 (41%), Gaps = 44/271 (16%)
Query: 438 GTVGTVYKGTLSSGVEIAVTSTSVKS-RADWSKNLESQFRKKIDTLSKVNHKNFVNLIGY 496
G G V+ G L + T +VKS R +L+++F ++ L + +H N V LIG
Sbjct: 6 GNFGEVFSGRLRADN----TPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 497 CEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRI----AMGMAYCLEHMHQLT 552
C + +P +V E G L E L +++ A GM Y LE H +
Sbjct: 62 CTQKQPI--YIVMELVQGGDFLTFLR-TEGPRLKVKELIQMVENAAAGMEY-LESKHCI- 116
Query: 553 PPIAHRNLQSSSIYLTEDYAAKISDFSFWN---NTTAAKTGS--------AAMELLETSA 601
HR+L + + +TE KISDF + A TG A E L
Sbjct: 117 ----HRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGR 172
Query: 602 VDLESNVYSFGTILFEMIT-GRISY-SIENGSLENWASEYLKGEQPLKDIVDPTLKSFQE 659
ES+V+SFG +L+E + G + Y ++ N + ++ P E
Sbjct: 173 YSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCP-------------E 219
Query: 660 NVLEELLVVIKNCVHPDPKQRPSMRGIAAKL 690
+ + +++ C DP QRPS + +L
Sbjct: 220 LCPDAVYRLMERCWEYDPGQRPSFSTVHQEL 250
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 2e-12
Identities = 68/269 (25%), Positives = 120/269 (44%), Gaps = 43/269 (15%)
Query: 428 FSNIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNH 487
IGS G G V+ G ++A+ + + + E F ++ + K++H
Sbjct: 8 LVQEIGS---GQFGLVWLGYWLEKRKVAIKTIREGAMS------EEDFIEEAQVMMKLSH 58
Query: 488 KNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQE---AEHLDWAMRLRIAMGMAYC 544
V L G C E P +VFE+ +G L ++L Q ++ M L + GMAY
Sbjct: 59 PKLVQLYGVCTERSPIC--LVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAY- 115
Query: 545 LEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSF----WNNTTAAKTGS------AAM 594
LE + + HR+L + + + E+ K+SDF ++ + TG+ ++
Sbjct: 116 LESSN-----VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSP 170
Query: 595 ELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPLKDIVDPT 653
E+ S +S+V+SFG +++E+ + G+ Y EN S G + K P
Sbjct: 171 EVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPY--ENRSNSEVVETINAGFRLYK----PR 224
Query: 654 LKSFQENVLEELLVVIKNCVHPDPKQRPS 682
L S ++V E ++++C P+ RPS
Sbjct: 225 LAS--QSVYE----LMQHCWKERPEDRPS 247
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 5e-12
Identities = 71/294 (24%), Positives = 118/294 (40%), Gaps = 56/294 (19%)
Query: 434 SFSDGTVGTVYKGTLSSGVEIAVTSTSVKS-RADWSKNLESQFRKKIDTLSKVNHKNFVN 492
+DG K + A +VK R D S N F K++ LS+++ N
Sbjct: 24 CEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83
Query: 493 LIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWA-------------MRLRIAM 539
L+G C D P M+ EY NG L + L AE A M +IA
Sbjct: 84 LLGVCTVDPPL--CMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIAS 141
Query: 540 GMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTAAK----TGSAAME 595
GM Y LE ++ HR+L + + + ++Y KI+DF N ++ G A +
Sbjct: 142 GMRY-LESLN-----FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLP 195
Query: 596 L--LETSAVDL-----ESNVYSFGTILFEMIT--GRISYS-------IENGSLENWASEY 639
+ + +V L +S+V++FG L+E++T Y IEN + +
Sbjct: 196 IRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIEN-------AGH 248
Query: 640 LKGEQPLKDIVD-PTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKE 692
+ + + P N +++ ++ C D + RP+ R I L+
Sbjct: 249 FFRDDGRQIYLPRPP------NCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 61/262 (23%), Positives = 112/262 (42%), Gaps = 51/262 (19%)
Query: 460 SVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSL-- 517
+VK+ + S++ F+++ + L+ + H++ V G C E P +MVFEY +G L
Sbjct: 39 AVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPL--LMVFEYMRHGDLNR 96
Query: 518 FEHLHIQEAEHLD---------------WAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQS 562
F H +A+ L A+ +IA GM Y L +H HR+L +
Sbjct: 97 FLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVY-LASLH-----FVHRDLAT 150
Query: 563 SSIYLTEDYAAKISDFSFWNN---TTAAKTGSAAM--------ELLETSAVDLESNVYSF 611
+ + + KI DF + T + G M E + ES+++SF
Sbjct: 151 RNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSF 210
Query: 612 GTILFEMIT-GRIS-YSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVI 669
G +L+E+ T G+ Y + N ++ + E+P E+ ++
Sbjct: 211 GVVLWEIFTYGKQPWYQLSNTEAIECITQGRELERP-------------RTCPPEVYAIM 257
Query: 670 KNCVHPDPKQRPSMRGIAAKLK 691
+ C +P+QR ++ I ++L+
Sbjct: 258 QGCWQREPQQRMVIKDIHSRLQ 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 53/197 (26%), Positives = 87/197 (44%), Gaps = 27/197 (13%)
Query: 438 GTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYC 497
G G V+KGTL +AV + + D + L+ +F + L + +H N V LIG C
Sbjct: 6 GNFGEVFKGTLKDKTPVAVKTC----KEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 498 EEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAM----GMAYCLEHMHQLTP 553
+ +P +V E P G L ++ + L ++ A+ GMAY LE + +
Sbjct: 62 TQRQPI--YIVMELVPGGDFLSFLR-KKKDELKTKQLVKFALDAAAGMAY-LESKNCI-- 115
Query: 554 PIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTAAKTGSAAM----------ELLETSAVD 603
HR+L + + + E+ KISDF S+ + E L
Sbjct: 116 ---HRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYS 172
Query: 604 LESNVYSFGTILFEMIT 620
ES+V+S+G +L+E +
Sbjct: 173 SESDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 1e-11
Identities = 75/296 (25%), Positives = 125/296 (42%), Gaps = 69/296 (23%)
Query: 430 NIIGSFSDGTVGTVYKGTL--SSGVEIAVTSTSVKSRADWSKNLE--SQFRKKIDTLSKV 485
+IG G G VY GTL S G +I S+ D LE QF K+ +
Sbjct: 1 RVIGK---GHFGCVYHGTLIDSDGQKIHCAVKSLNRITD----LEEVEQFLKEGIIMKDF 53
Query: 486 NHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMR------LRIAM 539
+H N ++L+G C E + ++V Y +G L + +E + ++ L++A
Sbjct: 54 SHPNVLSLLGICLPSEG-SPLVVLPYMKHGDL---RNFIRSETHNPTVKDLIGFGLQVAK 109
Query: 540 GMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFW-----------NNTTAAK 588
GM Y HR+L + + L E + K++DF +N T AK
Sbjct: 110 GMEYLASK------KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAK 163
Query: 589 --TGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPL 646
A+E L+T +S+V+SFG +L+E++T +G P
Sbjct: 164 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT--------------------RGAPPY 203
Query: 647 KDI--VDPTLKSFQENVLEE-------LLVVIKNCVHPDPKQRPSMRGIAAKLKEI 693
D+ D T+ Q L + L V+ +C HP P+ RP+ + +++++I
Sbjct: 204 PDVDSFDITVYLLQGRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 59/248 (23%), Positives = 100/248 (40%), Gaps = 66/248 (26%)
Query: 487 HKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAM------------- 533
HKN +NL+G C +D P ++ EY+ G+L E+L + +D++
Sbjct: 77 HKNIINLLGACTQDGPL--YVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFK 134
Query: 534 -----RLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDF---------S 579
++A GM Y + HR+L + ++ +TED KI+DF
Sbjct: 135 DLVSCAYQVARGMEYLA------SQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNID 188
Query: 580 FWNNTTAAKTGSAAM--ELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWAS 637
++ TT + M E L +S+V+SFG +L+E+ T
Sbjct: 189 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT----------------- 231
Query: 638 EYLKGEQPLKDI-VDPTLKSFQE--------NVLEELLVVIKNCVHPDPKQRPSMRGIAA 688
G P I V+ K +E N EL ++++ C H P QRP+ + +
Sbjct: 232 ---LGGSPYPGIPVEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVE 288
Query: 689 KLKEITAM 696
L + +
Sbjct: 289 DLDRVLTV 296
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 57/225 (25%), Positives = 98/225 (43%), Gaps = 42/225 (18%)
Query: 416 LKRSELEAACEDFSNIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQF 475
LK +EL ++GS G GTV+KG + ++K+ D S F
Sbjct: 4 LKETELRKL-----KLLGS---GVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSG--RQTF 53
Query: 476 RKKID---TLSKVNHKNFVNLIGYCEEDEPFTRM-MVFEYSPNGSLFEHLH-----IQEA 526
++ D + ++H V L+G C P + +V + SP GSL +H+ +
Sbjct: 54 QEITDHMLAMGSLDHAYIVRLLGIC----PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQ 109
Query: 527 EHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDF-------- 578
L+W ++IA GM Y EH + HRNL + +I L D +I+DF
Sbjct: 110 RLLNWC--VQIAKGMYYLEEHR------MVHRNLAARNILLKSDSIVQIADFGVADLLYP 161
Query: 579 ---SFWNNTTAAKTGSAAMELLETSAVDLESNVYSFGTILFEMIT 620
++ + A+E + +S+V+S+G ++EM++
Sbjct: 162 DDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 2e-11
Identities = 41/89 (46%), Positives = 50/89 (56%), Gaps = 1/89 (1%)
Query: 130 LGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNS 189
L G + ELGQ+ LK I L N+ G IP EIG L L LDL +NN +GP PS GN
Sbjct: 200 LVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNL 259
Query: 190 FSLTTLLLDNNQYLGGISPELHVL-KVIS 217
+L L L N+ G I P + L K+IS
Sbjct: 260 KNLQYLFLYQNKLSGPIPPSIFSLQKLIS 288
|
Length = 968 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 2e-11
Identities = 43/118 (36%), Positives = 59/118 (50%), Gaps = 12/118 (10%)
Query: 102 GDNVNPCS-----WFGVEC----SDGKVVI--LNLRDLCLGGMLAPELGQLSELKSIILR 150
G N +PC W G +C + GK I L L + L G + ++ +L L+SI L
Sbjct: 391 GWNGDPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLS 450
Query: 151 NNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLLDNNQYLGGISP 208
NS G IP +G + LE+LDL +N+F+G P G SL L L+ N L G P
Sbjct: 451 GNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGN-SLSGRVP 507
|
Length = 623 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 61/264 (23%), Positives = 123/264 (46%), Gaps = 49/264 (18%)
Query: 438 GTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYC 497
G G V+ G ++ ++AV K+ + ++++ F ++ + + + H V L
Sbjct: 17 GQFGEVWMGYYNNSTKVAV-----KTLKPGTMSVQA-FLEEANLMKTLQHDKLVRLYAVV 70
Query: 498 EEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRL----RIAMGMAYCLEHMHQLTP 553
++EP ++ EY GSL + L E + + +IA GMAY +E + +
Sbjct: 71 TKEEPI--YIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAY-IERKNYI-- 125
Query: 554 PIAHRNLQSSSIYLTEDYAAKISDFSFW----NNTTAAKTGS------AAMELLETSAVD 603
HR+L+++++ ++E KI+DF +N A+ G+ A E + +
Sbjct: 126 ---HRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFT 182
Query: 604 LESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQ---- 658
++S+V+SFG +L+E++T G+I Y + S D++ + ++
Sbjct: 183 IKSDVWSFGILLYEIVTYGKIPYPGMSNS----------------DVMSALQRGYRMPRM 226
Query: 659 ENVLEELLVVIKNCVHPDPKQRPS 682
EN +EL ++K C ++RP+
Sbjct: 227 ENCPDELYDIMKTCWKEKAEERPT 250
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 55/243 (22%), Positives = 101/243 (41%), Gaps = 44/243 (18%)
Query: 468 SKNLESQFRKKIDTLSKVNHKNFVNLIGY-CEEDEPFTRM-MVFEYSPNGSLFEHLHIQE 525
K L +I L +++ N + + G+ + + R+ ++ EY G L E L ++
Sbjct: 58 HKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEK 117
Query: 526 AEHLDWAMRLRIAMGMAYCLEHMHQLT--PPIAHRNLQSSSIYLTEDYAAKI-------- 575
L + +L +A+ L ++++ T P ++NL S S +TE+Y KI
Sbjct: 118 --DLSFKTKLDMAIDCCKGLYNLYKYTNKP---YKNLTSVSFLVTENYKLKIICHGLEKI 172
Query: 576 -SDFSFWN-NTTAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISY------SI 627
S F N N S M S ++ ++YS G +L+E+ TG+I + I
Sbjct: 173 LSSPPFKNVNFMVYF--SYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEI 230
Query: 628 ENGSLENWASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIA 687
+ + S L + PL E+ +++ C D +RP+++ I
Sbjct: 231 YDLIINKNNSLKLPLDCPL-----------------EIKCIVEACTSHDSIKRPNIKEIL 273
Query: 688 AKL 690
L
Sbjct: 274 YNL 276
|
Length = 283 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 3e-11
Identities = 59/268 (22%), Positives = 118/268 (44%), Gaps = 42/268 (15%)
Query: 437 DGTVGTVYKGT-LSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIG 495
+G G V +G V + V ++A F ++ ++K++HKN V L+G
Sbjct: 16 EGEFGAVLQGEYTGQKVAVKNIKCDVTAQA---------FLEETAVMTKLHHKNLVRLLG 66
Query: 496 YCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPI 555
+ + +V E G+L L + + L+ ++ +A +E++ + +
Sbjct: 67 VILHNGLY---IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE--SKKL 121
Query: 556 AHRNLQSSSIYLTEDYAAKISDFSFWN------NTTAAKTGSAAMELLETSAVDLESNVY 609
HR+L + +I ++ED AK+SDF + + A E L+ +S+V+
Sbjct: 122 VHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWTAPEALKHKKFSSKSDVW 181
Query: 610 SFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQENVLEE---- 664
S+G +L+E+ + GR Y + LK++ + K ++ E
Sbjct: 182 SYGVLLWEVFSYGRAPYP----------------KMSLKEVKECVEKGYRMEPPEGCPAD 225
Query: 665 LLVVIKNCVHPDPKQRPSMRGIAAKLKE 692
+ V++ +C +PK+RPS + KL++
Sbjct: 226 VYVLMTSCWETEPKKRPSFHKLREKLEK 253
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 3e-11
Identities = 40/161 (24%), Positives = 79/161 (49%), Gaps = 22/161 (13%)
Query: 474 QFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWA- 532
+F K+ + ++ H N V L+G C + PF ++ E+ G+L ++L + ++
Sbjct: 48 EFLKEAAVMKEIKHPNLVQLLGVCTREPPF--YIITEFMTYGNLLDYLRECNRQEVNAVV 105
Query: 533 ---MRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSF----WNNTT 585
M +I+ M Y LE + + HR+L + + + E++ K++DF +T
Sbjct: 106 LLYMATQISSAMEY-LEKKNFI-----HRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 159
Query: 586 AAKTGS------AAMELLETSAVDLESNVYSFGTILFEMIT 620
A G+ A E L + ++S+V++FG +L+E+ T
Sbjct: 160 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 4e-11
Identities = 65/298 (21%), Positives = 118/298 (39%), Gaps = 68/298 (22%)
Query: 432 IGSFSDGTVGTVYK----GTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNH 487
+ G G V++ G L V +K A S ++++ F+++ +++ +H
Sbjct: 10 VRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDH 67
Query: 488 KNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLH------------------------- 522
N V L+G C +P ++FEY G L E L
Sbjct: 68 PNIVKLLGVCAVGKPMC--LLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPL 125
Query: 523 -IQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFW 581
+ E L + ++A GMAY E HR+L + + + E+ KI+DF
Sbjct: 126 PLSCTEQL--CIAKQVAAGMAYLSERKF------VHRDLATRNCLVGENMVVKIADFGLS 177
Query: 582 NNTTAAK----TGSAAM-------ELLETSAVDLESNVYSFGTILFEMITGRISYSIENG 630
N +A + + A+ E + + ES+V+++G +L+E+ SY ++
Sbjct: 178 RNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI----FSYGMQ-- 231
Query: 631 SLENWASEY--LKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGI 686
Y + E+ + + D + S +N EL +++ C P RPS I
Sbjct: 232 -------PYYGMAHEEVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASI 282
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 63.8 bits (156), Expect = 5e-11
Identities = 67/276 (24%), Positives = 111/276 (40%), Gaps = 71/276 (25%)
Query: 437 DGTVGTVYKGT-LSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIG 495
+G G VYK T ++G E+A+ ++ +N E +I + H N V+
Sbjct: 29 EGASGEVYKATDRATGKEVAIKKMRLRK-----QNKELII-NEILIMKDCKHPNIVDYYD 82
Query: 496 -YCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAY-C------LEH 547
Y DE + +V EY GSL + + M +AY C LE+
Sbjct: 83 SYLVGDELW---VVMEYMDGGSLTDII-----TQNFVRMNEPQ---IAYVCREVLQGLEY 131
Query: 548 MHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTAAKT------GSA---AMELLE 598
+H + HR+++S +I L++D + K++DF F T K+ G+ A E+++
Sbjct: 132 LHSQ--NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIK 189
Query: 599 TSAVDLESNVYSFGTILFEMITG----------RISYSIENGSLENWASEYLKGEQPLKD 648
+ +++S G + EM G R + I KG PLK+
Sbjct: 190 RKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITT-----------KGIPPLKN 238
Query: 649 I--VDPTLKSFQENVLEELLVVIKNCVHPDPKQRPS 682
P K F + C+ DP++RPS
Sbjct: 239 PEKWSPEFKDF-----------LNKCLVKDPEKRPS 263
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 5e-11
Identities = 66/260 (25%), Positives = 117/260 (45%), Gaps = 42/260 (16%)
Query: 438 GTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYC 497
G G V+ G + ++A+ S S + F + + + ++ H V L
Sbjct: 17 GQFGEVWMGYYNGHTKVAIKSLKQGSMS------PEAFLAEANLMKQLQHPRLVRLYAVV 70
Query: 498 EEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWA----MRLRIAMGMAYCLEHMHQLTP 553
+ EP ++ EY NGSL + L E L M +IA GMA+ +E + +
Sbjct: 71 TQ-EPI--YIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAF-IERKNYI-- 124
Query: 554 PIAHRNLQSSSIYLTEDYAAKISDFSFW----NNTTAAKTGS------AAMELLETSAVD 603
HR+L++++I ++E KI+DF +N A+ G+ A E +
Sbjct: 125 ---HRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFT 181
Query: 604 LESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQENVL 662
++S+V+SFG +L E++T GRI Y + N E ++ + + P +N
Sbjct: 182 IKSDVWSFGILLTEIVTYGRIPYP----GMTN--PEVIQNLERGYRMPRP------DNCP 229
Query: 663 EELLVVIKNCVHPDPKQRPS 682
EEL +++ C P++RP+
Sbjct: 230 EELYELMRLCWKEKPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 6e-11
Identities = 68/292 (23%), Positives = 126/292 (43%), Gaps = 48/292 (16%)
Query: 428 FSNIIGSFSDGTVGTVYKGTLSS-GVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKV- 485
F ++IG +G G V + + G+++ +K A S+N F +++ L K+
Sbjct: 6 FEDVIG---EGNFGQVIRAMIKKDGLKMNAAIKMLKEFA--SENDHRDFAGELEVLCKLG 60
Query: 486 NHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMR----------- 534
+H N +NL+G CE + EY+P G+L + L D A
Sbjct: 61 HHPNIINLLGACENRGYL--YIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTS 118
Query: 535 ---LRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDF--SFWNNTTAAKT 589
L+ A +A ++++ + HR+L + ++ + E+ A+KI+DF S KT
Sbjct: 119 QQLLQFASDVATGMQYLSE--KQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKT 176
Query: 590 GS------AAMELLETSAVDLESNVYSFGTILFEMIT-GRISY-SIENGSLENWASEYLK 641
A+E L S +S+V+SFG +L+E+++ G Y + L + +
Sbjct: 177 MGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR 236
Query: 642 GEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEI 693
E+P N +E+ +++ C P +RP I+ +L +
Sbjct: 237 MEKP-------------RNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRM 275
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 7e-11
Identities = 69/286 (24%), Positives = 126/286 (44%), Gaps = 54/286 (18%)
Query: 433 GSFSDGTVGTVYKGT-LSSGVEIAVTSTSV------KSRADWSKNLESQFRKKIDTLSKV 485
G FS VYK L G +A+ + K+R D K +ID L ++
Sbjct: 13 GQFS-----VVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLK--------EIDLLKQL 59
Query: 486 NHKNFVN-LIGYCEEDEPFTRMMVFEYSPNGSL---FEHLHIQE---AEHLDWAMRLRIA 538
+H N + L + E +E +V E + G L +H Q+ E W +++
Sbjct: 60 DHPNVIKYLASFIENNE---LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLC 116
Query: 539 MGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFS----FWNNTTAA--KTGS- 591
LEHMH I HR+++ +++++T K+ D F + TTAA G+
Sbjct: 117 SA----LEHMHSKR--IMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTP 170
Query: 592 --AAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDI 649
+ E + + + +S+++S G +L+EM + + + +L + + K + P
Sbjct: 171 YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYP---- 226
Query: 650 VDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITA 695
P ++ EEL ++ C++PDP++RP + + KE+ A
Sbjct: 227 --PLPA---DHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMHA 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 7e-11
Identities = 52/191 (27%), Positives = 87/191 (45%), Gaps = 35/191 (18%)
Query: 450 SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVF 509
+G ++AV S +S + +L +K+I+ L + H+N V G C ED ++
Sbjct: 32 TGEQVAVKSLKPESGGNHIADL----KKEIEILRNLYHENIVKYKGICTEDGGNGIKLIM 87
Query: 510 EYSPNGSLFEHL-----HIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSS 564
E+ P+GSL E+L I + L +A ++I GM Y + HR+L + +
Sbjct: 88 EFLPSGSLKEYLPRNKNKINLKQQLKYA--VQICKGMDYLGSRQY------VHRDLAARN 139
Query: 565 IYLTEDYAAKISDFSFWNNTTAAKTGSA---------------AMELLETSAVDLESNVY 609
+ + ++ KI DF T A +T A E L S + S+V+
Sbjct: 140 VLVESEHQVKIGDFGL---TKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVW 196
Query: 610 SFGTILFEMIT 620
SFG L+E++T
Sbjct: 197 SFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.0 bits (154), Expect = 7e-11
Identities = 70/279 (25%), Positives = 113/279 (40%), Gaps = 50/279 (17%)
Query: 428 FSNIIGSFSDGTVGTVYKG-TLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVN 486
++IG G G VYKG L +G +A+ S++ + L+S ++ID L +
Sbjct: 4 LGDLIGR---GAFGVVYKGLNLETGDFVAIKQISLEK--IKEEALKS-IMQEIDLLKNLK 57
Query: 487 HKNFVNLIGYCEEDEPFTRMMVFEYSPNGSL------FEHLHIQEAEHLDWAMRLRIAMG 540
H N V IG E + ++ EY+ NGSL F E L ++ G
Sbjct: 58 HPNIVKYIGSIETSDSL--YIILEYAENGSLRQIIKKFGPF----PESLVAVYVYQVLQG 111
Query: 541 MAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTAAKTGSA-------- 592
+AY +H+ + HR++++++I T+D K++DF A
Sbjct: 112 LAY----LHE--QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYW 165
Query: 593 -AMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVD 651
A E++E S S+++S G + E++TG Y L L IV
Sbjct: 166 MAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYY------------DLNPMAALFRIVQ 213
Query: 652 PTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKL 690
E + EL + C DP RP+ A +L
Sbjct: 214 DDHPPLPEGISPELKDFLMQCFQKDPNLRPT----AKQL 248
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 7e-11
Identities = 65/293 (22%), Positives = 108/293 (36%), Gaps = 72/293 (24%)
Query: 434 SFSDGTVGTVYKGTL---------SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSK 484
GT +YKG L G E++V + S F + +S+
Sbjct: 2 HLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGS----DHRDSLAFFETASLMSQ 57
Query: 485 VNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYC 544
++HK+ V L G C DE +MV EY G L LH ++ ++ +L +A +A
Sbjct: 58 LSHKHLVKLYGVCVRDE---NIMVEEYVKFGPLDVFLHREKN-NVSLHWKLDVAKQLASA 113
Query: 545 LEHMHQLTPPIAHRNLQSSSIYLTEDYA-------AKISDFSFWNNTTAAKTGSAAMELL 597
L ++ + H N+ +I + K+SD T + E +
Sbjct: 114 LHYLEDKK--LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI------PITVLSREERV 165
Query: 598 E-------------TSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQ 644
E +++ + ++ +SFGT L E+ + GE+
Sbjct: 166 ERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSN--------------------GEE 205
Query: 645 PLKDIVDPTLKSFQE--NVL-----EELLVVIKNCVHPDPKQRPSMRGIAAKL 690
PL + + F + + L EL +I C DP +RPS R I L
Sbjct: 206 PLSTLSSSEKERFYQDQHRLPMPDCAELANLINQCWTYDPTKRPSFRAILRDL 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 9e-11
Identities = 75/279 (26%), Positives = 121/279 (43%), Gaps = 46/279 (16%)
Query: 431 IIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNF 490
+I +G G V+ GT + ++AV + + + S E+Q KK+ H
Sbjct: 10 LIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKL------RHDKL 63
Query: 491 VNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWA----MRLRIAMGMAYCLE 546
V L E EP +V EY GSL + L E L M ++A GMAY +E
Sbjct: 64 VQLYAVVSE-EPI--YIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAY-IE 119
Query: 547 HMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFW----NNTTAAKTGS------AAMEL 596
M+ + HR+L+S++I + + KI+DF +N A+ G+ A E
Sbjct: 120 RMNYI-----HRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEA 174
Query: 597 LETSAVDLESNVYSFGTILFEMIT-GRISYSIENGS--LENWASEYLKGEQPLKDIVDPT 653
++S+V+SFG +L E++T GR+ Y N LE Y P +
Sbjct: 175 ALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGY---RMPCPQDCPIS 231
Query: 654 LKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKE 692
L EL++ C DP++RP+ + + L++
Sbjct: 232 --------LHELML---QCWKKDPEERPTFEYLQSFLED 259
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 73/296 (24%), Positives = 121/296 (40%), Gaps = 56/296 (18%)
Query: 428 FSNIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVN 486
F ++IG +G G V K + G+ + +K A SK+ F +++ L K+
Sbjct: 11 FQDVIG---EGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLG 65
Query: 487 -HKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLR--------- 536
H N +NL+G CE + EY+P+G+L + L D A +
Sbjct: 66 HHPNIINLLGACEHRGYL--YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 123
Query: 537 ---------IAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDF--SFWNNTT 585
+A GM Y + HR+L + +I + E+Y AKI+DF S
Sbjct: 124 QQLLHFAADVARGMDYLSQKQ------FIHRDLAARNILVGENYVAKIADFGLSRGQEVY 177
Query: 586 AAKTGS------AAMELLETSAVDLESNVYSFGTILFEMIT-GRISY-SIENGSLENWAS 637
KT A+E L S S+V+S+G +L+E+++ G Y + L
Sbjct: 178 VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 237
Query: 638 EYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEI 693
+ + E+PL N +E+ +++ C P +RPS I L +
Sbjct: 238 QGYRLEKPL-------------NCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 280
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 55/241 (22%), Positives = 100/241 (41%), Gaps = 52/241 (21%)
Query: 487 HKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRL----------- 535
HKN +NL+G C +D P ++ EY+ G+L E+L + ++++ +
Sbjct: 80 HKNIINLLGACTQDGPL--YVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFK 137
Query: 536 -------RIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDF---------S 579
++A GM Y HR+L + ++ +TE+ KI+DF
Sbjct: 138 DLVSCTYQVARGMEYLASQ------KCIHRDLAARNVLVTENNVMKIADFGLARDVNNID 191
Query: 580 FWNNTTAAKTGSAAM--ELLETSAVDLESNVYSFGTILFEMIT--GRISYSIENGSLENW 635
++ TT + M E L +S+V+SFG +++E+ T G I L
Sbjct: 192 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 251
Query: 636 ASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITA 695
E + ++P N EL +++++C H P RP+ + + L I
Sbjct: 252 LKEGHRMDKP-------------ANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT 298
Query: 696 M 696
+
Sbjct: 299 L 299
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 1e-10
Identities = 63/273 (23%), Positives = 115/273 (42%), Gaps = 39/273 (14%)
Query: 431 IIGSFSDGTVGTVYK-GTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKN 489
++ G+ G+VYK LS A+ + S S+ +I L+ VNH N
Sbjct: 4 VLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSM---SQKEREDAVNEIRILASVNHPN 60
Query: 490 FVNLIGYCEEDEPFTRM-MVFEYSPNGSLFEHLHIQEA------EHLDWAMRLRIAMGMA 542
+I Y E ++ +V EY+P G L + + ++ E W + +++ G
Sbjct: 61 ---IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRG-- 115
Query: 543 YCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFW----NNTTAAKTGS---AAME 595
L+ +H+ I HR+L+S++I L + KI D N + G+ A E
Sbjct: 116 --LQALHEQK--ILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQIGTPHYMAPE 171
Query: 596 LLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLK 655
+ + +S+++S G +L+EM T E S+++ + +G+ P
Sbjct: 172 VWKGRPYSYKSDIWSLGCLLYEMATFA--PPFEARSMQDLRYKVQRGKYP---------- 219
Query: 656 SFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688
++L I++ + PK RP+ I A
Sbjct: 220 PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 1e-10
Identities = 54/228 (23%), Positives = 94/228 (41%), Gaps = 36/228 (15%)
Query: 472 ESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHL----HIQEAE 527
E F ++ + K++H N V L G C + P +V EY NG L +L E
Sbjct: 43 EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPI--FIVTEYMANGCLLNYLRERKGKLGTE 100
Query: 528 HLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSF----WNN 583
L M + M Y + HR+L + + + ED K+SDF ++
Sbjct: 101 WL-LDMCSDVCEAMEYLESNG------FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDD 153
Query: 584 TTAAKTGS------AAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWA 636
+ G+ A E+ + S +S+V+SFG +++E+ + G++ Y E S
Sbjct: 154 QYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPY--ERFSNSEVV 211
Query: 637 SEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMR 684
G + + P L E+ ++ +C H P+ RP+ +
Sbjct: 212 ESVSAGYRLYR----PKLAP------TEVYTIMYSCWHEKPEDRPAFK 249
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 58/240 (24%), Positives = 101/240 (42%), Gaps = 52/240 (21%)
Query: 487 HKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRL----------- 535
HKN +NL+G C ++ P ++ EY+ G+L E L + D+ +
Sbjct: 77 HKNIINLLGVCTQEGPL--YVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFK 134
Query: 536 -------RIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDF---------S 579
++A GM Y LE + HR+L + ++ +TED KI+DF
Sbjct: 135 DLVSCAYQVARGMEY-LESRRCI-----HRDLAARNVLVTEDNVMKIADFGLARGVHDID 188
Query: 580 FWNNTTAAKTGSAAM--ELLETSAVDLESNVYSFGTILFEMIT--GRISYSIENGSLENW 635
++ T+ + M E L +S+V+SFG +++E+ T G I L
Sbjct: 189 YYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKL 248
Query: 636 ASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITA 695
E + ++P N EL ++++ C H P QRP+ + + L ++ A
Sbjct: 249 LREGHRMDKP-------------SNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 3e-10
Identities = 55/203 (27%), Positives = 95/203 (46%), Gaps = 30/203 (14%)
Query: 438 GTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYC 497
G G V+ GT + +A+ + + + F ++ + K+ H+ V L
Sbjct: 17 GCFGEVWMGTWNGTTRVAIKTLKPGTMS------PEAFLQEAQVMKKLRHEKLVQLYAVV 70
Query: 498 EEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWA----MRLRIAMGMAYCLEHMHQLTP 553
E EP +V EY GSL + L + ++L M +IA GMAY +E M+ +
Sbjct: 71 SE-EPI--YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAY-VERMNYV-- 124
Query: 554 PIAHRNLQSSSIYLTEDYAAKISDFSFW----NNTTAAKTGS------AAMELLETSAVD 603
HR+L++++I + E+ K++DF +N A+ G+ A E
Sbjct: 125 ---HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 181
Query: 604 LESNVYSFGTILFEMIT-GRISY 625
++S+V+SFG +L E+ T GR+ Y
Sbjct: 182 IKSDVWSFGILLTELTTKGRVPY 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 4e-10
Identities = 70/270 (25%), Positives = 124/270 (45%), Gaps = 42/270 (15%)
Query: 438 GTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYC 497
G G V+ GT + ++A+ + + + F ++ + K+ H V L
Sbjct: 17 GCFGEVWMGTWNGTTKVAIKTLKPGTM------MPEAFLQEAQIMKKLRHDKLVPLYAVV 70
Query: 498 EEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWA----MRLRIAMGMAYCLEHMHQLTP 553
E EP +V E+ GSL + L + ++L M +IA GMAY +E M+ +
Sbjct: 71 SE-EPI--YIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAY-IERMNYI-- 124
Query: 554 PIAHRNLQSSSIYLTEDYAAKISDFSFW----NNTTAAKTGS------AAMELLETSAVD 603
HR+L++++I + ++ KI+DF +N A+ G+ A E
Sbjct: 125 ---HRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 181
Query: 604 LESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQENVL 662
++S+V+SFG +L E++T GR+ Y + N E L EQ + P + E++
Sbjct: 182 IKSDVWSFGILLTELVTKGRVPYP----GMVN--REVL--EQVERGYRMPCPQGCPESLH 233
Query: 663 EELLVVIKNCVHPDPKQRPSMRGIAAKLKE 692
E ++K C DP +RP+ I + L++
Sbjct: 234 E----LMKLCWKKDPDERPTFEYIQSFLED 259
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 4e-10
Identities = 49/178 (27%), Positives = 81/178 (45%), Gaps = 25/178 (14%)
Query: 464 RADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHI 523
RAD +K + F K+I +S++ + N + L+G C D+P M+ EY NG L + L
Sbjct: 53 RADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLC--MITEYMENGDLNQFLSQ 110
Query: 524 QEAEH----------LDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAA 573
+E E + A L +A+ +A ++++ L HR+L + + + Y
Sbjct: 111 REIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN--FVHRDLATRNCLVGNHYTI 168
Query: 574 KISDFSFWNNTTAAK----TGSA-------AMELLETSAVDLESNVYSFGTILFEMIT 620
KI+DF N + G A A E + S+V++FG L+EM T
Sbjct: 169 KIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.9 bits (147), Expect = 4e-10
Identities = 69/280 (24%), Positives = 117/280 (41%), Gaps = 45/280 (16%)
Query: 437 DGTVGTVYKGTLSS-GVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKV-NHKNFVNLI 494
+G G V K + G+ + +K A SK+ F +++ L K+ +H N +NL+
Sbjct: 5 EGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 495 GYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMR--------------LRIAMG 540
G CE + EY+P+G+L + L D A L A
Sbjct: 63 GACEHRGYL--YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 541 MAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDF--SFWNNTTAAKTGS------A 592
+A ++++ Q HR+L + +I + E+Y AKI+DF S KT
Sbjct: 121 VARGMDYLSQ--KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWM 178
Query: 593 AMELLETSAVDLESNVYSFGTILFEMIT-GRISY-SIENGSLENWASEYLKGEQPLKDIV 650
A+E L S S+V+S+G +L+E+++ G Y + L + + E+P
Sbjct: 179 AIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKP----- 233
Query: 651 DPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKL 690
N +E+ +++ C P +RPS I L
Sbjct: 234 --------LNCDDEVYDLMRQCWREKPYERPSFAQILVSL 265
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 5e-10
Identities = 66/284 (23%), Positives = 107/284 (37%), Gaps = 64/284 (22%)
Query: 429 SNIIGSFSDGTVGTVYKG-TLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNH 487
N IG GT G VY L +G +AV ++ D + ++ L + H
Sbjct: 5 GNKIGG---GTFGKVYTAVNLDTGELMAVKEIRIQ---DNDPKTIKEIADEMKVLELLKH 58
Query: 488 KNFVNLIGYCEEDEPFTRMMVF-EYSPNGSLFEHLH--IQEAEHLDWAMRLRIAMGMAYC 544
N V G E ++ +F EY G+L E L EH+ L++ G+AY
Sbjct: 59 PNLVKYYGVEVHRE---KVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYL 115
Query: 545 LEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFS----FWNNTTAAKTGSAAME----- 595
H I HR+++ ++I+L + K+ DF NNTT ++
Sbjct: 116 HSHG------IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAY 169
Query: 596 ------LLETS-----AVDLESNVYSFGTILFEMITGRISYS-IENGSLENWASEYLKGE 643
A D ++S G ++ EM TG+ +S ++N + + G
Sbjct: 170 MAPEVITGGKGKGHGRAAD----IWSLGCVVLEMATGKRPWSELDN----EFQIMFHVGA 221
Query: 644 Q-----PLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPS 682
P + P K F + C+ DPK+RP+
Sbjct: 222 GHKPPIPDSLQLSPEGKDF-----------LDRCLESDPKKRPT 254
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 60.9 bits (147), Expect = 5e-10
Identities = 62/269 (23%), Positives = 112/269 (41%), Gaps = 53/269 (19%)
Query: 460 SVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFE 519
+VK+ D S N F ++ + L+ + H++ V G C E +P +MVFEY +G L +
Sbjct: 39 AVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL--IMVFEYMKHGDLNK 96
Query: 520 HL-----------------HIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQS 562
L + +++ L A +IA GM Y L H HR+L +
Sbjct: 97 FLRAHGPDAVLMAEGNRPAELTQSQMLHIAQ--QIAAGMVY-LASQH-----FVHRDLAT 148
Query: 563 SSIYLTEDYAAKISDFSFWNN---TTAAKTGSAAM--------ELLETSAVDLESNVYSF 611
+ + E+ KI DF + T + G M E + ES+V+S
Sbjct: 149 RNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSL 208
Query: 612 GTILFEMIT-GRIS-YSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVI 669
G +L+E+ T G+ Y + N + ++ ++P ++ + V + +L
Sbjct: 209 GVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQRP---------RTCPKEVYDLML--- 256
Query: 670 KNCVHPDPKQRPSMRGIAAKLKEITAMEP 698
C +P R +++ I + L+ + P
Sbjct: 257 -GCWQREPHMRLNIKEIHSLLQNLAKASP 284
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 8e-10
Identities = 67/283 (23%), Positives = 118/283 (41%), Gaps = 50/283 (17%)
Query: 438 GTVGTVYKGTLSSGV-----EIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVN 492
G+ G VY+G ++ GV E V +V A + +E F + + + N + V
Sbjct: 17 GSFGMVYEG-IAKGVVKDEPETRVAIKTVNEAASMRERIE--FLNEASVMKEFNCHHVVR 73
Query: 493 LIGYCEEDEPFTRMMVFEYSPNGSLFEHLH----------IQEAEHLDWAMRL--RIAMG 540
L+G + +P +++ E G L +L +Q L +++ IA G
Sbjct: 74 LLGVVSQGQP--TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADG 131
Query: 541 MAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNN---TTAAKTGSAAM--- 594
MAY + HR+L + + + ED+ KI DF + T + G +
Sbjct: 132 MAYLNAN------KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 185
Query: 595 -----ELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDI 649
E L+ S+V+SFG +L+E+ T L + + EQ L+ +
Sbjct: 186 RWMSPESLKDGVFTTYSDVWSFGVVLWEIAT-----------LAEQPYQGMSNEQVLRFV 234
Query: 650 VDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKE 692
++ L +N + L +++ C +PK RPS I + +KE
Sbjct: 235 MEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 1e-09
Identities = 69/303 (22%), Positives = 117/303 (38%), Gaps = 74/303 (24%)
Query: 421 LEAACEDFSNIIGSFSDGTVGTVYKGTLS--SGVEIAVTSTSVKSRADWSKNLESQFRKK 478
++ + +IG G G V +G L EI V ++K+ + S F +
Sbjct: 1 IDPSYVTIEKVIGG---GEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTE 55
Query: 479 IDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDW----AMR 534
+ + +H N + L G + P M++ EY NGSL + L + + M
Sbjct: 56 ASIMGQFDHPNIIRLEGVVTKSRPV--MIITEYMENGSLDKFLRENDGK-FTVGQLVGML 112
Query: 535 LRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSF------WNNTTAAK 588
IA GM Y E + HR+L + +I + + K+SDF T K
Sbjct: 113 RGIASGMKYLSEMNY------VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTK 166
Query: 589 TGS-----AAMELLE----TSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEY 639
G A E + TSA S+V+SFG +++E+ +SY
Sbjct: 167 GGKIPIRWTAPEAIAYRKFTSA----SDVWSFGIVMWEV----MSY-------------- 204
Query: 640 LKGEQPL-----KDIVDPTLKSFQ-------ENVLEELLVVIKNCVHPDPKQRPSMRGIA 687
GE+P +D++ ++ + L +L+ +C D +RP+ I
Sbjct: 205 --GERPYWDMSNQDVIKAVEDGYRLPPPMDCPSALYQLM---LDCWQKDRNERPTFSQIV 259
Query: 688 AKL 690
+ L
Sbjct: 260 STL 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 1e-09
Identities = 71/269 (26%), Positives = 122/269 (45%), Gaps = 49/269 (18%)
Query: 438 GTVGTVYKGT-LSSGVEIAVTSTSV------KSRADWSKNLESQFRKKIDTLSKVNHKNF 490
G VY+ T L GV +A+ + K+RAD K +ID L ++NH N
Sbjct: 13 GQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIK--------EIDLLKQLNHPNV 64
Query: 491 VNLIGYCEEDEPFTRMMVFEYSPNGSL---FEHLHIQE---AEHLDWAMRLRIAMGMAYC 544
+ ED +V E + G L +H Q+ E W +++
Sbjct: 65 IKYYASFIEDNELN--IVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSA---- 118
Query: 545 LEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFS----FWNNTTAAKT--GSA---AME 595
LEHMH + + HR+++ +++++T K+ D F + TTAA + G+ + E
Sbjct: 119 LEHMH--SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 176
Query: 596 LLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVD-PTL 654
+ + + +S+++S G +L+EM + + G N S K EQ D P L
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQSPFY---GDKMNLYSLCKKIEQ-----CDYPPL 228
Query: 655 KSFQENVLEELLVVIKNCVHPDPKQRPSM 683
S ++ EEL ++ C++PDP++RP +
Sbjct: 229 PS--DHYSEELRQLVNMCINPDPEKRPDI 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 1e-09
Identities = 60/240 (25%), Positives = 100/240 (41%), Gaps = 52/240 (21%)
Query: 487 HKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLH----IQEAEHLDW----------- 531
HKN +NL+G C ++ P +V EY+ +G+L + L E D
Sbjct: 75 HKNIINLLGVCTQEGPL--YVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQK 132
Query: 532 ---AMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSF----WNNT 584
+ ++A GM + L + HR+L + ++ +TED+ KI+DF +
Sbjct: 133 DLVSFAYQVARGMEF-LA-----SKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHID 186
Query: 585 TAAKTGSA-------AMELLETSAVDLESNVYSFGTILFEMIT-GRISY-SIENGSLENW 635
KT + A E L +S+V+SFG +L+E+ T G Y I L
Sbjct: 187 YYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL 246
Query: 636 ASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITA 695
E + E+P N +EL ++++C H P QRP+ + + L +
Sbjct: 247 LKEGYRMEKPQ-------------NCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRMLT 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 46/184 (25%), Positives = 84/184 (45%), Gaps = 32/184 (17%)
Query: 464 RADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHL-- 521
R D +KN + F K++ LS++ N + L+G C +++P M+ EY NG L + L
Sbjct: 55 RPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLC--MITEYMENGDLNQFLSS 112
Query: 522 -HIQEAEH--------------LDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIY 566
H+ + E + ++ L +A+ +A ++++ L HR+L + +
Sbjct: 113 HHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN--FVHRDLATRNCL 170
Query: 567 LTEDYAAKISDFSFWNNTTAAK----TGSA-------AMELLETSAVDLESNVYSFGTIL 615
+ E+ KI+DF N A G A A E + S+V++FG L
Sbjct: 171 VGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTL 230
Query: 616 FEMI 619
+E++
Sbjct: 231 WEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 68/301 (22%), Positives = 118/301 (39%), Gaps = 68/301 (22%)
Query: 437 DGTVGTVYKGTLSSGVEIA----VTSTSVKSRADWSKNLE-SQFRKKIDTLSKVNHKNFV 491
+G G V K T + T+ +VK + + + E + + L +VNH + +
Sbjct: 10 EGEFGKVVKAT---AFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVI 66
Query: 492 NLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQ----------------------EAEHL 529
L G C +D P +++ EY+ GSL L + L
Sbjct: 67 KLYGACSQDGPL--LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERAL 124
Query: 530 DWAMRL----RIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSF----W 581
+ +I+ GM Y E + HR+L + ++ + E KISDF +
Sbjct: 125 TMGDLISFAWQISRGMQYLAEM------KLVHRDLAARNVLVAEGRKMKISDFGLSRDVY 178
Query: 582 NNTTAAKTGSA-------AMELLETSAVDLESNVYSFGTILFEMIT-GRISY-SIENGSL 632
+ K A+E L +S+V+SFG +L+E++T G Y I L
Sbjct: 179 EEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERL 238
Query: 633 ENWASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKE 692
N + E+P EN EE+ ++ C +P +RP+ I+ +L++
Sbjct: 239 FNLLKTGYRMERP-------------ENCSEEMYNLMLTCWKQEPDKRPTFADISKELEK 285
Query: 693 I 693
+
Sbjct: 286 M 286
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 2e-09
Identities = 51/206 (24%), Positives = 86/206 (41%), Gaps = 28/206 (13%)
Query: 437 DGTVGTVYKGTLSSGVEIAVTSTSVKS-RADWSKNLESQFRKKIDTLSKVNHKNFVNLIG 495
+G G V G G ++ VK RA + + + F +++ ++NH N + +G
Sbjct: 5 NGWFGKVLLGEAHRG--MSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 496 YCEEDEPFTRMMVFEYSPNGSLFEHL---HIQEAEHLDWAMRLRIAMGMAYCLEHMHQLT 552
C E P+ ++V E+ P G L +L A+ + R+A +A L +HQ
Sbjct: 63 QCIESIPY--LLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD 120
Query: 553 PPIAHRNLQSSSIYLTEDYAAKISDFSF-----------WNNTTAAKTGSAAMELLETSA 601
H +L + LT D + KI D+ + A A EL+E
Sbjct: 121 --FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRG 178
Query: 602 VDL-------ESNVYSFGTILFEMIT 620
DL +SN++S G ++E+ T
Sbjct: 179 QDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 2e-09
Identities = 65/281 (23%), Positives = 123/281 (43%), Gaps = 43/281 (15%)
Query: 438 GTVGTVYKGTL----SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNL 493
G G+V + L S ++AV +K+ S ++E +F ++ + + +H N + L
Sbjct: 10 GEFGSVREAQLKSEDGSFQKVAVKM--LKADIFSSSDIE-EFLREAACMKEFDHPNVIKL 66
Query: 494 IGYCEEDEPFTR----MMVFEYSPNGSLFEHLHI----QEAEHLDWAMRLRIAMGMAYCL 545
IG R M++ + +G L L + +E L +R + +A +
Sbjct: 67 IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGM 126
Query: 546 EHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTAA---KTGSA--------AM 594
E++ + HR+L + + L E+ ++DF + + G A A+
Sbjct: 127 EYLS--SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLAL 184
Query: 595 ELLETSAVDLESNVYSFGTILFEMIT-GRISYS-IENGSLENWASEYLKGEQPLKDIVDP 652
E L + S+V++FG ++E++T G+ Y+ +EN + N YL LK D
Sbjct: 185 ESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYN----YLIKGNRLKQPPD- 239
Query: 653 TLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEI 693
LE++ ++ C P+PK RPS + + +L+ I
Sbjct: 240 --------CLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 2e-09
Identities = 63/253 (24%), Positives = 101/253 (39%), Gaps = 55/253 (21%)
Query: 475 FRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMR 534
F ++I+ L + H N V G C +V EY P GSL ++L + E LD
Sbjct: 52 FEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYL-QKHRERLDHRKL 110
Query: 535 L----RIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFS----------- 579
L +I GM Y + HR+L + +I + + KI DF
Sbjct: 111 LLYASQICKGMEYLGSKRY------VHRDLATRNILVESENRVKIGDFGLTKVLPQDKEY 164
Query: 580 -----------FWNNTTAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIE 628
FW A E L S + S+V+SFG +L+E+ T YS +
Sbjct: 165 YKVREPGESPIFW----------YAPESLTESKFSVASDVWSFGVVLYELFT----YSDK 210
Query: 629 NGSLENWASEYLKGEQPLKDIVDPTLKSFQEN--------VLEELLVVIKNCVHPDPKQR 680
+ S + ++ + IV ++ + N E+ ++K C + DP QR
Sbjct: 211 SCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQR 270
Query: 681 PSMRGIAAKLKEI 693
PS +A +++ I
Sbjct: 271 PSFSELALQVEAI 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 5e-09
Identities = 71/291 (24%), Positives = 115/291 (39%), Gaps = 55/291 (18%)
Query: 428 FSNIIGSFSDGTV--GTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKV 485
F +G+ + G V T Y G S + V +K A S+ KI +S +
Sbjct: 39 FGKTLGAGAFGKVVEATAY-GLSKSDAVMKVAVKMLKPTAHSSEREALMSELKI--MSHL 95
Query: 486 -NHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRL----RIAMG 540
NH+N VNL+G C P +++ EY G L L + L L ++A G
Sbjct: 96 GNHENIVNLLGACTIGGPI--LVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKG 153
Query: 541 MAY-----CLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSF----WNNTTAAKTGS 591
MA+ C+ HR+L + ++ LT KI DF N++ G+
Sbjct: 154 MAFLASKNCI-----------HRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGN 202
Query: 592 A-------AMELLETSAVDLESNVYSFGTILFEMIT-GRISYS--IENGSLENWASEYLK 641
A A E + ES+V+S+G +L+E+ + G Y + E +
Sbjct: 203 ARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYR 262
Query: 642 GEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKE 692
QP E+ E+ ++K C DP +RP+ + I + +
Sbjct: 263 MAQP-------------EHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK 300
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 7e-09
Identities = 64/262 (24%), Positives = 106/262 (40%), Gaps = 53/262 (20%)
Query: 464 RADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHI 523
R D +KN + F K+I +S++ N + L+ C +P M+ EY NG L + L
Sbjct: 55 REDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLC--MITEYMENGDLNQFLSR 112
Query: 524 QEAEHLDWA-------------MRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTED 570
E + M +IA GM Y L ++ HR+L + + + ++
Sbjct: 113 HEPQEAAEKADVVTISYSTLIFMATQIASGMKY-LSSLN-----FVHRDLATRNCLVGKN 166
Query: 571 YAAKISDFSFWNNTTAAK----TGSAAM-------ELLETSAVDLESNVYSFGTILFEMI 619
Y KI+DF N + G A + E + S+V++FG L+E++
Sbjct: 167 YTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEIL 226
Query: 620 T--GRISYS-------IENGSLENWASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIK 670
T YS IEN E+ + + + P L + L ++
Sbjct: 227 TLCKEQPYSQLSDEQVIEN------TGEFFRDQGRQVYLPKPAL------CPDSLYKLML 274
Query: 671 NCVHPDPKQRPSMRGIAAKLKE 692
+C + K+RPS + I A L E
Sbjct: 275 SCWRRNAKERPSFQEIHATLLE 296
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 8e-09
Identities = 35/96 (36%), Positives = 50/96 (52%), Gaps = 5/96 (5%)
Query: 124 NLRDLCLGG-----MLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNF 178
+L+ L LGG + L L+ L+ + L +N G IP+E+G++K L+ + LG+NN
Sbjct: 165 SLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNL 224
Query: 179 SGPFPSDFGNSFSLTTLLLDNNQYLGGISPELHVLK 214
SG P + G SL L L N G I L LK
Sbjct: 225 SGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLK 260
|
Length = 968 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 9e-09
Identities = 64/275 (23%), Positives = 116/275 (42%), Gaps = 47/275 (17%)
Query: 430 NIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNL--ESQFRK---KIDTLSK 484
++G G GTVY G + G IAV + D S L E ++ K ++D L
Sbjct: 6 EVLGK---GAYGTVYCGLTNQGQLIAVKQVEL----DTSNVLAAEKEYEKLQEEVDLLKS 58
Query: 485 VNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEA--EHLDWAMRLRIAMGMA 542
+ H N V +G C +D + M E+ P GS+ L+ E + +I G+A
Sbjct: 59 LKHVNIVQYLGTCLDDNTISIFM--EFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVA 116
Query: 543 YCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFS-----FWNNTTAAKT-------G 590
Y + + HR+++ +++ L + K+ DF W + G
Sbjct: 117 YLHNNC------VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHG 170
Query: 591 SA---AMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLK 647
+ A E++ S +S+++S G +FEM TG+ + S++ A+ + G +
Sbjct: 171 TPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLA----SMDRLAAMFYIGAH--R 224
Query: 648 DIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPS 682
++ SF ++ + +C+ D +RPS
Sbjct: 225 GLMPRLPDSFSAAAID----FVTSCLTRDQHERPS 255
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 1e-08
Identities = 58/229 (25%), Positives = 105/229 (45%), Gaps = 38/229 (16%)
Query: 472 ESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHL-----HIQEA 526
E +F ++ + K++H+ V L G C + P +V EY NG L +L Q +
Sbjct: 43 EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPI--YIVTEYMSNGCLLNYLREHGKRFQPS 100
Query: 527 EHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSF----WN 582
+ L+ M + GMAY LE Q HR+L + + + + K+SDF +
Sbjct: 101 QLLE--MCKDVCEGMAY-LES-KQFI----HRDLAARNCLVDDQGCVKVSDFGLSRYVLD 152
Query: 583 NTTAAKTGS------AAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENW 635
+ + GS + E+L S +S+V++FG +++E+ + G++ Y N S
Sbjct: 153 DEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS---- 208
Query: 636 ASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMR 684
K Q L+ + P L S E++ ++ +C H ++RP+ +
Sbjct: 209 -ETVEKVSQGLR-LYRPHLAS------EKVYAIMYSCWHEKAEERPTFQ 249
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 57/230 (24%), Positives = 97/230 (42%), Gaps = 41/230 (17%)
Query: 416 LKRSELEAACEDFSNIIGSFSDGTVGTVYKGT---LSSGVEIAVTSTSVKSRADWSKNLE 472
LK +ELE ++GS G GTVYKG V+I V ++ N E
Sbjct: 4 LKETELE-----KIKVLGS---GAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKE 55
Query: 473 SQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLH-----IQEAE 527
+ ++ V+H + V L+G C ++ + P G L +++ I
Sbjct: 56 --ILDEAYVMASVDHPHVVRLLGICLSS---QVQLITQLMPLGCLLDYVRNHKDNIGSQY 110
Query: 528 HLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFW------ 581
L+W ++IA GM+Y LE + HR+L + ++ + KI+DF
Sbjct: 111 LLNWC--VQIAKGMSY-LEEKR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD 162
Query: 582 NNTTAAKTGSA-----AMELLETSAVDLESNVYSFGTILFEMIT-GRISY 625
A+ G A+E + +S+V+S+G ++E++T G Y
Sbjct: 163 EKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPY 212
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 2e-08
Identities = 60/268 (22%), Positives = 108/268 (40%), Gaps = 36/268 (13%)
Query: 438 GTVGTVYKG-TLSSGVEIAVTSTSVKSRA-----DWSKNLESQFRKKIDTLSKVNHKNFV 491
GT G VY +++G +AV + + K++ R +I+TL ++H N V
Sbjct: 12 GTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIV 71
Query: 492 NLIGYCEEDEPFTRMMVFEYSPNGSLFEHL--HIQEAEHLDWAMRLRIAMGMAYCLEHMH 549
+G+ E + EY P GS+ L + + E L ++ G+AY +H
Sbjct: 72 QYLGF--ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAY----LH 125
Query: 550 QLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTAAKTGSAAMELLET------SAVD 603
+ I HR+L++ ++ + D KISDF + M + + +
Sbjct: 126 --SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIH 183
Query: 604 LES-------NVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKS 656
S +++S G ++ EM GR +S E A+ + G + + P +
Sbjct: 184 SYSQGYSAKVDIWSLGCVVLEMFAGRRPWS----DEEAIAAMFKLGNKRSAPPIPPDVSM 239
Query: 657 FQENVLEELLVVIKNCVHPDPKQRPSMR 684
N+ L + C +P RP+ R
Sbjct: 240 ---NLSPVALDFLNACFTINPDNRPTAR 264
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 2e-08
Identities = 20/47 (42%), Positives = 26/47 (55%), Gaps = 5/47 (10%)
Query: 70 LNSEGMALLRFRERVVRDPFGALSKWSDNDGVGDNVNPCSWFGVECS 116
LN + ALL F+ + DP GALS W+ + +PCSW GV C
Sbjct: 1 LNDDRDALLAFKSSLNGDPSGALSSWNPSSS-----DPCSWTGVTCD 42
|
Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 3e-08
Identities = 65/294 (22%), Positives = 110/294 (37%), Gaps = 56/294 (19%)
Query: 430 NIIGSFSDGTVGTVYKGT----LSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKV 485
++ G+ G VY+G + E V +V A + +E F + +
Sbjct: 9 TLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE--FLNEASVMKGF 66
Query: 486 NHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHL----------------HIQEAEHL 529
+ V L+G + +P ++V E +G L +L +QE
Sbjct: 67 TCHHVVRLLGVVSKGQP--TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQ- 123
Query: 530 DWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNN---TTA 586
M IA GMAY HR+L + + + D+ KI DF + T
Sbjct: 124 ---MAAEIADGMAYLN------AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDY 174
Query: 587 AKTGSAAM--------ELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASE 638
+ G + E L+ S+++SFG +L+E+ SL +
Sbjct: 175 YRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI-----------TSLAEQPYQ 223
Query: 639 YLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKE 692
L EQ LK ++D +N E + +++ C +PK RP+ I LK+
Sbjct: 224 GLSNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 3e-08
Identities = 55/226 (24%), Positives = 102/226 (45%), Gaps = 31/226 (13%)
Query: 476 RKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRL 535
RK+ L+K+ H N V E D +V EY G L + + +Q + L
Sbjct: 46 RKEAVLLAKMKHPNIVAFKESFEADGHL--YIVMEYCDGGDLMQKIKLQRGKLFPEDTIL 103
Query: 536 RIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTAAKTGSAAM- 594
+ + M ++H+H+ + HR+++S +I+LT++ K+ DF + G+ A
Sbjct: 104 QWFVQMCLGVQHIHE--KRVLHRDIKSKNIFLTQNGKVKLGDFG--SARLLTSPGAYACT 159
Query: 595 ----------ELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGE- 643
E+ E + +S+++S G IL+E+ T + + + S +N + +G
Sbjct: 160 YVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCT--LKHPFQANSWKNLILKVCQGSY 217
Query: 644 QPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAK 689
+PL P+ S+ EL +IK +P+ RPS I ++
Sbjct: 218 KPL-----PSHYSY------ELRSLIKQMFKRNPRSRPSATTILSR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 3e-08
Identities = 64/265 (24%), Positives = 108/265 (40%), Gaps = 38/265 (14%)
Query: 432 IGSFSDGTVGTVYKG-TLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNF 490
+GS G+ G+VY+G L G AV S+ + Q ++I LSK+ H N
Sbjct: 8 LGS---GSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNI 64
Query: 491 VNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDW---AMRLR-IAMGMAYCLE 546
V +G E++ + E P GSL +++ + R I +G+ Y
Sbjct: 65 VQYLGTEREEDNLYIFL--ELVPGGSL--AKLLKKYGSFPEPVIRLYTRQILLGLEY--- 117
Query: 547 HMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTA---AKT--GSA---AME-LL 597
+H HR+++ ++I + + K++DF AK+ GS A E +
Sbjct: 118 -LH--DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIA 174
Query: 598 ETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSF 657
+ L ++++S G + EM TG+ +S G + K P+ D + K F
Sbjct: 175 QQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDF 234
Query: 658 QENVLEELLVVIKNCVHPDPKQRPS 682
I C+ DP RP+
Sbjct: 235 -----------ILKCLQRDPSLRPT 248
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 3e-08
Identities = 60/279 (21%), Positives = 109/279 (39%), Gaps = 53/279 (18%)
Query: 434 SFSDGTVGTVYKGT---LSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNF 490
S GT ++KG + E+ T +K +N F + +S+++HK+
Sbjct: 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHL 61
Query: 491 VNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAM-RLRIAMGMAYCLEHMH 549
V G C + +MV EY GSL ++++ ++L +L +A +A+ L +
Sbjct: 62 VLNYGVCVCGD--ESIMVQEYVKFGSL--DTYLKKNKNLINISWKLEVAKQLAWALHFLE 117
Query: 550 QLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWN-NTTAAKTGSAAMELL----------- 597
+ H N+ + ++ L + K + F + E+L
Sbjct: 118 DKG--LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWVPPEC 175
Query: 598 --ETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLK 655
+ L ++ +SFGT L+E+ +G G++PL +D K
Sbjct: 176 IENPQNLSLAADKWSFGTTLWEIFSG--------------------GDKPL-SALDSQKK 214
Query: 656 S-FQENVLE-------ELLVVIKNCVHPDPKQRPSMRGI 686
F E+ + EL +I C+ +P RPS R I
Sbjct: 215 LQFYEDRHQLPAPKWTELANLINQCMDYEPDFRPSFRAI 253
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.9 bits (133), Expect = 4e-08
Identities = 75/308 (24%), Positives = 115/308 (37%), Gaps = 90/308 (29%)
Query: 430 NIIGSFSDGTVGTVYKG-TLSSGVEIAVTSTSVKSRADWSKNLESQFRK---------KI 479
IG GT G VYK +G +A+ K + + K +I
Sbjct: 5 AQIGE---GTYGQVYKARNKKTGELVAL------------KKIRMENEKEGFPITAIREI 49
Query: 480 DTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPN--GSLFEHLHIQEAE-HLDWAMRLR 536
L K+ H N V L + MVFEY + L + ++ E + M+ +
Sbjct: 50 KLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMK-Q 108
Query: 537 IAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTAAKTGSAAM-- 594
+ G+ Y H + I HR+++ S+I + D K++DF T K SA
Sbjct: 109 LLEGLQYL--HSNG----ILHRDIKGSNILINNDGVLKLADFGLARPYT--KRNSADYTN 160
Query: 595 ----------ELL--ETS---AVDLESNVYSFGTILFEMITGRISY--SIENGSL----- 632
ELL T VD ++S G IL E+ G+ + S E L
Sbjct: 161 RVITLWYRPPELLLGATRYGPEVD----MWSVGCILAELFLGKPIFQGSTELEQLEKIFE 216
Query: 633 -------ENWAS-------EYLKGEQPLKDIVDPTLKSFQE----NVLEELLVVIKNCVH 674
ENW E LK ++P K + K + ++L++LL +
Sbjct: 217 LCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTL------ 270
Query: 675 PDPKQRPS 682
DPK+R S
Sbjct: 271 -DPKKRIS 277
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 4e-08
Identities = 48/214 (22%), Positives = 94/214 (43%), Gaps = 45/214 (21%)
Query: 441 GTVYKGTL---SSGVEI-AVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGY 496
G VYKG L + G + AV ++K +A+ L +F+ + S++ H N V L+G
Sbjct: 19 GKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGP--LREEFKHEAMMRSRLQHPNIVCLLGV 76
Query: 497 CEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLD-------------------WAMRLRI 537
+++P + M+F Y + L E L + + H D + +I
Sbjct: 77 VTKEQPLS--MIFSYCSHSDLHEFL-VMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQI 133
Query: 538 AMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTAAK----TGSAA 593
A GM + H + H++L + ++ + + KISD + AA G++
Sbjct: 134 AAGMEFLSSHH------VVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSL 187
Query: 594 M-------ELLETSAVDLESNVYSFGTILFEMIT 620
+ E + ++S+++S+G +L+E+ +
Sbjct: 188 LPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 6e-08
Identities = 51/223 (22%), Positives = 103/223 (46%), Gaps = 34/223 (15%)
Query: 477 KKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRL- 535
K+ID L ++NH N + + ED +V E + G L Q ++ RL
Sbjct: 51 KEIDLLKQLNHPNVIKYLDSFIEDNELN--IVLELADAGDL-----SQMIKYFKKQKRLI 103
Query: 536 ------RIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFS----FWNNTT 585
+ + + +EHMH + + HR+++ +++++T K+ D F + TT
Sbjct: 104 PERTVWKYFVQLCSAVEHMH--SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161
Query: 586 AAKT--GSA---AMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYL 640
AA + G+ + E + + + +S+++S G +L+EM + + + +L + +
Sbjct: 162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIE 221
Query: 641 KGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSM 683
+ + P P E+ E+L ++ C++PDP QRP +
Sbjct: 222 QCDYP------PLPT---EHYSEKLRELVSMCIYPDPDQRPDI 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 1e-07
Identities = 52/225 (23%), Positives = 92/225 (40%), Gaps = 38/225 (16%)
Query: 433 GSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVN 492
G G GTV KG + + + L+ + ++ + + ++++ V
Sbjct: 1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVR 60
Query: 493 LIGYCEEDEPFTRMMVFEYSPNGSLFEHL----HIQEAEHLDWAMRLRIAMGMAYCLEHM 548
+IG CE + + M+V E + G L + L H+ E + + +++MGM Y E
Sbjct: 61 MIGICEAE---SWMLVMELAELGPLNKFLQKNKHVTEKNITE--LVHQVSMGMKYLEET- 114
Query: 549 HQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTA------AKTGSA------AMEL 596
HR+L + ++ L + AKISDF A AKT A E
Sbjct: 115 -----NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPEC 169
Query: 597 LETSAVDLESNVYSFGTILFE-----------MITGRISYSIENG 630
+ +S+V+SFG +++E M ++ IE+G
Sbjct: 170 MNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESG 214
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 52/218 (23%), Positives = 96/218 (44%), Gaps = 30/218 (13%)
Query: 420 ELEAACEDFSNIIGSFSDGTVGTVYKGTL--SSGVEIAVTSTSVKSRADWSKNLESQFRK 477
E+ + +IG+ G G V++G L E+AV ++K +++ F
Sbjct: 1 EIHPSHITKQKVIGA---GEFGEVFRGILKMPGRKEVAVAIKTLK--PGYTEKQRQDFLS 55
Query: 478 KIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDW---AMR 534
+ + + +H N + L G + +P M++ EY NG+L ++L + E + M
Sbjct: 56 EASIMGQFSHHNIIRLEGVVTKFKPA--MIITEYMENGALDKYLRDHDGEFSSYQLVGML 113
Query: 535 LRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWN------NTTAAK 588
IA GM Y L M+ + HR+L + +I + + K+SDF T
Sbjct: 114 RGIAAGMKY-LSDMNYV-----HRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTT 167
Query: 589 TGS------AAMELLETSAVDLESNVYSFGTILFEMIT 620
+G A E + S+V+SFG +++E+++
Sbjct: 168 SGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 3e-07
Identities = 38/114 (33%), Positives = 57/114 (50%), Gaps = 8/114 (7%)
Query: 107 PCSWFGVECSDGKVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELK 166
P S F ++ K++ L+L D L G + + QL L+ + L +N+F G IP + L
Sbjct: 277 PPSIFSLQ----KLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLP 332
Query: 167 ELEILDLGFNNFSGPFPSDFGNSFSLTTLLLDNNQYLGGISPEL----HVLKVI 216
L++L L N FSG P + G +LT L L N G I L ++ K+I
Sbjct: 333 RLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLI 386
|
Length = 968 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 3e-07
Identities = 69/308 (22%), Positives = 127/308 (41%), Gaps = 64/308 (20%)
Query: 416 LKRSELEAACEDFSNIIGSFSDGTVGTVYKG-------TLSSGVEIAVTSTSVKSRADWS 468
LK +EL+ ++GS G GTVYKG T+ V I + + + +A+
Sbjct: 4 LKETELKRV-----KVLGS---GAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKAN-- 53
Query: 469 KNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLH-----I 523
+F + ++ ++H + V L+G C T +V + P+G L +++H I
Sbjct: 54 ----VEFMDEALIMASMDHPHLVRLLGVCLSP---TIQLVTQLMPHGCLLDYVHEHKDNI 106
Query: 524 QEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWN- 582
L+W ++IA GM Y E + HR+L + ++ + KI+DF
Sbjct: 107 GSQLLLNWC--VQIAKGMMYLEERR------LVHRDLAARNVLVKSPNHVKITDFGLARL 158
Query: 583 --------NTTAAKTGSA--AMELLETSAVDLESNVYSFGTILFEMIT--GRISYSIENG 630
N K A+E + +S+V+S+G ++E++T G+ I
Sbjct: 159 LEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR 218
Query: 631 SLENWASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKL 690
+ + + + QP +D + +V+ C D RP + +AA+
Sbjct: 219 EIPDLLEKGERLPQPPICTID-------------VYMVMVKCWMIDADSRPKFKELAAEF 265
Query: 691 KEITAMEP 698
+ A +P
Sbjct: 266 SRM-ARDP 272
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 52.2 bits (126), Expect = 3e-07
Identities = 56/260 (21%), Positives = 97/260 (37%), Gaps = 37/260 (14%)
Query: 438 GTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIG- 495
G+ G VYK +G A+ V + Q +++ TL V G
Sbjct: 12 GSSGVVYKVRHKPTGKIYALKKIHVDGD----EEFRKQLLRELKTLRSCESPYVVKCYGA 67
Query: 496 YCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPI 555
+ +E E +V EY GSL +++ + + IA + L+++H I
Sbjct: 68 FYKEGEIS---IVLEYMDGGSL--ADLLKKVGKIPEPVLAYIARQILKGLDYLHT-KRHI 121
Query: 556 AHRNLQSSSIYLTEDYAAKISDF---SFWNNTTAAKT---GSAA-M--ELLETSAVDLES 606
HR+++ S++ + KI+DF NT G+ M E ++ + +
Sbjct: 122 IHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSYAA 181
Query: 607 NVYSFGTILFEMITGRISYSIENGSLENWA--SEYLKGEQPL--KDIVDPTLKSFQENVL 662
+++S G L E G+ + G + G P + P + F
Sbjct: 182 DIWSLGLTLLECALGKFPFL-PPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDF----- 235
Query: 663 EELLVVIKNCVHPDPKQRPS 682
I C+ DPK+RPS
Sbjct: 236 ------ISACLQKDPKKRPS 249
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 3e-07
Identities = 41/161 (25%), Positives = 76/161 (47%), Gaps = 27/161 (16%)
Query: 536 RIAMGMAYCLEHMH-QLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT--AAKTGSA 592
+IA+ + LE++H +L+ + HR+++ S++ + + K+ DF AKT A
Sbjct: 107 KIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDA 164
Query: 593 ------AMEL----LETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKG 642
A E L D++S+V+S G + E+ TGR Y ++W + +
Sbjct: 165 GCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPY-------DSWKTPF--- 214
Query: 643 EQPLKDIV-DPTLKSFQENVLEELLVVIKNCVHPDPKQRPS 682
Q LK +V +P+ + E E + C+ + K+RP+
Sbjct: 215 -QQLKQVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPN 254
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 4e-07
Identities = 64/282 (22%), Positives = 121/282 (42%), Gaps = 52/282 (18%)
Query: 430 NIIGSFSDGTVGTVY--KGTLSSG----VEIAVTSTSVKSRADWSKNLESQFRKKIDTLS 483
II +G+ G +Y K S EI +T VK + +K++ L+
Sbjct: 3 EIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEK--------EASKKEVILLA 54
Query: 484 KVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQ------EAEHLDWAMRLRI 537
K+ H N V +E+ +V EY G L + ++ Q E + L W ++I
Sbjct: 55 KMKHPNIVTFFASFQENGRL--FIVMEYCDGGDLMKRINRQRGVLFSEDQILSWF--VQI 110
Query: 538 AMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTED-YAAKISDFSF---WNNTTA-AKTGSA 592
++G L+H+H I HR+++S +I+L+++ AK+ DF N++ A T
Sbjct: 111 SLG----LKHIHDRK--ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVG 164
Query: 593 -----AMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLK 647
+ E+ + + +++++S G +L+E+ T + + E +L + +G
Sbjct: 165 TPYYLSPEICQNRPYNNKTDIWSLGCVLYELCT--LKHPFEGNNLHQLVLKICQGY---- 218
Query: 648 DIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAK 689
P +F +L +I P+ RPS+ I +
Sbjct: 219 --FAPISPNFS----RDLRSLISQLFKVSPRDRPSITSILKR 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 5e-07
Identities = 64/276 (23%), Positives = 106/276 (38%), Gaps = 55/276 (19%)
Query: 426 EDFSNI--IGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKK----- 478
N IG S G V S+G ++AV +L Q R++
Sbjct: 19 SYLDNFVKIGEGSTGIVCIATD--KSTGRQVAVKKM----------DLRKQQRRELLFNE 66
Query: 479 IDTLSKVNHKNFVNLIG-YCEEDEPFTRMMVFEYSPNGSLFE---HLHIQEAEHLDWAMR 534
+ + H N V + Y DE + +V E+ G+L + H + E +
Sbjct: 67 VVIMRDYQHPNIVEMYSSYLVGDELW---VVMEFLEGGALTDIVTHTRMNEEQ------- 116
Query: 535 LRIAMGMAYCLEHMHQL-TPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTA------A 587
IA L+ + L + HR+++S SI LT D K+SDF F + +
Sbjct: 117 --IATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKS 174
Query: 588 KTGS---AAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQ 644
G+ A E++ E +++S G ++ EM+ G Y E L+ +
Sbjct: 175 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNE---------PPLQAMK 225
Query: 645 PLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQR 680
++D + P LK+ V L + + DP QR
Sbjct: 226 RIRDNLPPKLKN-LHKVSPRLRSFLDRMLVRDPAQR 260
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 6e-07
Identities = 39/159 (24%), Positives = 67/159 (42%), Gaps = 24/159 (15%)
Query: 545 LEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTAAKT--------GSAAMEL 596
LEH+HQ I +R+L+ ++ L + +ISD K G A E+
Sbjct: 108 LEHLHQRR--IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEV 165
Query: 597 LETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLK--DIVDPTL 654
L+ D + ++ G L+EMI GR + +E + E ++ D P
Sbjct: 166 LQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEA 225
Query: 655 KSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA-KLKE 692
K E +L++ DP++R RG +A +++E
Sbjct: 226 KDLCEALLQK-----------DPEKRLGCRGGSADEVRE 253
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 7e-07
Identities = 56/217 (25%), Positives = 97/217 (44%), Gaps = 30/217 (13%)
Query: 421 LEAACEDFSNIIGSFSDGTVGTVYKGTLS--SGVEIAVTSTSVKSRADWSKNLESQFRKK 478
++A+C +IG+ G G V G L EI V ++K A +++ F +
Sbjct: 1 IDASCIKIEKVIGA---GEFGEVCSGRLKLPGKREIPVAIKTLK--AGYTEKQRRDFLSE 55
Query: 479 IDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEH--LDWAMRLR 536
+ + +H N ++L G + +P M+V EY NGSL L + + + LR
Sbjct: 56 ASIMGQFDHPNIIHLEGVVTKSKPV--MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLR 113
Query: 537 -IAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFW----NNTTAAKTGS 591
IA GM Y L M + HR+L + +I + + K+SDF ++ AA T
Sbjct: 114 GIASGMKY-LSDMGYV-----HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTR 167
Query: 592 A--------AMELLETSAVDLESNVYSFGTILFEMIT 620
A E + S+V+S+G +++E+++
Sbjct: 168 GGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 7e-07
Identities = 48/190 (25%), Positives = 79/190 (41%), Gaps = 37/190 (19%)
Query: 460 SVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFE 519
+VK+ D + F+++ + L+ + H++ V G C + +P +MVFEY +G L +
Sbjct: 39 AVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPL--IMVFEYMKHGDLNK 96
Query: 520 HLH--------------IQEAEHLDWAMRL----RIAMGMAYCLEHMHQLTPPIAHRNLQ 561
L Q L + L +IA GM Y L H HR+L
Sbjct: 97 FLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVY-LASQH-----FVHRDLA 150
Query: 562 SSSIYLTEDYAAKISDFSFWNNTTAA---KTGSAAM--------ELLETSAVDLESNVYS 610
+ + + + KI DF + + + G M E + ES+V+S
Sbjct: 151 TRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWS 210
Query: 611 FGTILFEMIT 620
FG IL+E+ T
Sbjct: 211 FGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 1e-06
Identities = 56/214 (26%), Positives = 92/214 (42%), Gaps = 29/214 (13%)
Query: 426 EDFSNIIGSFSDGTVGTVYKG-TLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSK 484
D IIG DG G VYK +G+ A ++S + LE F +ID LS+
Sbjct: 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES----EEELED-FMVEIDILSE 58
Query: 485 VNHKNFVNLI-GYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEH-LDWAMRLRIAMGMA 542
H N V L Y E++ + ++ E+ G+L + + + E E L + M
Sbjct: 59 CKHPNIVGLYEAYFYENKLW---ILIEFCDGGAL-DSI-MLELERGLTEPQIRYVCRQML 113
Query: 543 YCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDF--SFWNNTTAAKTGS--------- 591
L +H + HR+L++ +I LT D K++DF S N +T K +
Sbjct: 114 EALNFLHS--HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMA 171
Query: 592 ---AAMELLETSAVDLESNVYSFGTILFEMITGR 622
A E + + D +++++S G L E+
Sbjct: 172 PEVVACETFKDNPYDYKADIWSLGITLIELAQME 205
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 1e-06
Identities = 58/273 (21%), Positives = 116/273 (42%), Gaps = 40/273 (14%)
Query: 438 GTVGTVYK--GTLSSGVEIAVTSTSVKSRAD--WSKNLESQFRKKIDTLS----KVNHKN 489
G G VYK + +A+ +V + A + + + ++ ++ H N
Sbjct: 11 GAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPN 70
Query: 490 FVNLI-GYCEEDEPFTRMMVFEYSPNGSLFEHL---HIQEAEHLDWAMRLRIAMGMAYCL 545
V + E D + M + E +P G F L + E W + +++ + + Y
Sbjct: 71 IVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRY-- 128
Query: 546 EHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFW-----NNTTAAKTGS---AAMELL 597
+H+ I HR+L ++I L ED I+DF + + G+ + E++
Sbjct: 129 --LHK-EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILYSCPEIV 185
Query: 598 ETSAVDLESNVYSFGTILFEMITGR-ISYSIENGSLENWASEYLKGE-QPLKDIVDPTLK 655
+ +++V++FG IL++M T + YS SL A++ ++ +PL + +
Sbjct: 186 KNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSL---ATKIVEAVYEPLPEGMYSEDV 242
Query: 656 SFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688
+ VI +C+ PD + RP + ++A
Sbjct: 243 TD----------VITSCLTPDAEARPDIIQVSA 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 1e-06
Identities = 71/291 (24%), Positives = 123/291 (42%), Gaps = 58/291 (19%)
Query: 431 IIGSFSDGTVGTVYKGTLSS--GVEIAVTSTSVKS-RADWSKNLESQFRKKIDTLSKVNH 487
IG +G G VY+G S +IAV +VK+ + S ++ +F ++ + + +H
Sbjct: 13 CIG---EGQFGDVYQGVYMSPENEKIAV---AVKTCKNCTSPSVREKFLQEAYIMRQFDH 66
Query: 488 KNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAM----RLRIAMGMAY 543
+ V LIG E+ + +V E +P G L +L LD A +++ +AY
Sbjct: 67 PHIVKLIGVITENPVW---IVMELAPLGELRSYLQ-VNKYSLDLASLILYSYQLSTALAY 122
Query: 544 CLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDF--SFWNNTTA---AKTGSAAMELLE 598
LE + IA RN+ SS K+ DF S + + A G ++ +
Sbjct: 123 -LESKRFVHRDIAARNVLVSSP-----DCVKLGDFGLSRYLEDESYYKASKGKLPIKWMA 176
Query: 599 TSAVDLE-----SNVYSFGTILFEMITGRIS--YSIEN----GSLENWASEYLKGEQ-PL 646
+++ S+V+ FG ++E++ + ++N G +EN GE+ P+
Sbjct: 177 PESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIEN-------GERLPM 229
Query: 647 KDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAME 697
PTL S + C DP +RP + A+L +I E
Sbjct: 230 PPNCPPTLYSL-----------MTKCWAYDPSKRPRFTELKAQLSDILQEE 269
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 61/286 (21%), Positives = 117/286 (40%), Gaps = 58/286 (20%)
Query: 441 GTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLE-SQFRKKIDTLSKVNHKNFVNLIGYCE 498
G +YKG L G++ A ++K+ D + + +F+++ +++++H N V L+G
Sbjct: 19 GKIYKGHLYLPGMDHA-QLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVT 77
Query: 499 EDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWA--------------------MRLRIA 538
+++P M+FEY G L E L I + H D + ++IA
Sbjct: 78 QEQPVC--MLFEYLNQGDLHEFL-IMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIA 134
Query: 539 MGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTAA---KTGSAAM- 594
GM Y H H++L + +I + E KISD +A + ++
Sbjct: 135 AGMEYLSSHF------FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188
Query: 595 -------ELLETSAVDLESNVYSFGTILFEMITGRIS--YSIENGSLENWASEYLKGEQP 645
E + +S+++SFG +L+E+ + + Y N + E ++ Q
Sbjct: 189 PIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEV----IEMVRKRQ- 243
Query: 646 LKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLK 691
L E+ + ++ C P +RP + I +L+
Sbjct: 244 --------LLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLR 281
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 1e-06
Identities = 62/238 (26%), Positives = 100/238 (42%), Gaps = 53/238 (22%)
Query: 412 GVPKLKRSELEAACEDFSNIIGSFSDGTVGTVYKGT-LSSGVEIAVTSTSVKSRADWSKN 470
G PK K + E IG G GTVY +++G E+A+ N
Sbjct: 15 GDPKKKYTRFEK--------IGQ---GASGTVYTAIDVATGQEVAIKQM----------N 53
Query: 471 LESQFRKK-----IDTLSKVNHKNFVN-LIGYCEEDEPFTRMMVFEYSPNGSLFE---HL 521
L+ Q +K+ I + + H N VN L Y DE + +V EY GSL +
Sbjct: 54 LQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELW---VVMEYLAGGSLTDVVTET 110
Query: 522 HIQEAEHLDWAMRLRIAMGMAYCLEHMHQL-TPPIAHRNLQSSSIYLTEDYAAKISDFSF 580
+ E + IA CL+ + L + + HR+++S +I L D + K++DF F
Sbjct: 111 CMDEGQ---------IAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGF 161
Query: 581 WNNTTAAKTGSAAM---------ELLETSAVDLESNVYSFGTILFEMITGRISYSIEN 629
T ++ + M E++ A + +++S G + EM+ G Y EN
Sbjct: 162 CAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN 219
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 2e-06
Identities = 54/298 (18%), Positives = 113/298 (37%), Gaps = 73/298 (24%)
Query: 431 IIGSFSDGTVGTVYKG-TLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKN 489
+G +GT G VYK +G +A+ ++ ++ ++I L ++NH N
Sbjct: 3 KLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPK---TALREIKLLKELNHPN 59
Query: 490 FVNLIGYCEEDEPFTR----MMVFEYSPNGSLFEHLHIQE---AEHLDWAMRLRIAMGMA 542
+ L+ + F +VFE+ + L++ + ++ E L + ++ G+A
Sbjct: 60 IIKLL------DVFRHKGDLYLVFEFM-DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLA 112
Query: 543 YCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTAAKTGSA---------- 592
+C H H I HR+L+ ++ + + K++DF A++ +
Sbjct: 113 FC--HSHG----ILHRDLKPENLLINTEGVLKLADFGL------ARSFGSPVRPYTHYVV 160
Query: 593 -----AMELL-----ETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENW------- 635
A ELL ++ VD ++S G I E+++ R + ++ ++
Sbjct: 161 TRWYRAPELLLGDKGYSTPVD----IWSVGCIFAELLSRRPLFPGKS-EIDQLFKIFRTL 215
Query: 636 ---ASEYLKGEQPLKDIVDPTLKSFQE--------NVLEELLVVIKNCVHPDPKQRPS 682
E L + N + L ++ +H DP +R +
Sbjct: 216 GTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRIT 273
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 2e-06
Identities = 38/149 (25%), Positives = 67/149 (44%), Gaps = 14/149 (9%)
Query: 433 GSFSDGTVGTVYKGTLSSGVEIAVTSTSVKS-RADWSKNLESQFRKKIDTLSKVNHKNFV 491
G F + +Y T V VK +A+ S +++F ++ D + H N +
Sbjct: 6 GWFGKVLLSEIYTDT-------GVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNIL 58
Query: 492 NLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRL--RIAMGMAYCLEHMH 549
+G C E P+ ++VFEY G L +L ++ + + L R+A +A + HMH
Sbjct: 59 QCLGQCVEAIPY--LLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH 116
Query: 550 QLTPPIAHRNLQSSSIYLTEDYAAKISDF 578
+ H +L + +LT D K+ D+
Sbjct: 117 KHN--FLHSDLALRNCFLTSDLTVKVGDY 143
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 51/205 (24%), Positives = 94/205 (45%), Gaps = 34/205 (16%)
Query: 438 GTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYC 497
G G V+ T + ++AV + S + F + + + + H V L
Sbjct: 17 GQFGEVWMATYNKHTKVAVKTMKPGSMS------VEAFLAEANVMKTLQHDKLVKLHAVV 70
Query: 498 EEDEPFTRMMVFEYSPNGSLFEHLHIQEAEH------LDWAMRLRIAMGMAYCLEHMHQL 551
+ EP ++ E+ GSL + L E +D++ + IA GMA+ +E + +
Sbjct: 71 TK-EPI--YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQ--IAEGMAF-IEQRNYI 124
Query: 552 TPPIAHRNLQSSSIYLTEDYAAKISDFSFW----NNTTAAKTGS------AAMELLETSA 601
HR+L++++I ++ KI+DF +N A+ G+ A E + +
Sbjct: 125 -----HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGS 179
Query: 602 VDLESNVYSFGTILFEMIT-GRISY 625
++S+V+SFG +L E++T GRI Y
Sbjct: 180 FTIKSDVWSFGILLMEIVTYGRIPY 204
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 3e-06
Identities = 34/95 (35%), Positives = 50/95 (52%), Gaps = 12/95 (12%)
Query: 123 LNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPF 182
+NL + G + P LG ++ L+ + L NSF G+IP+ +G+L L IL+L N+ SG
Sbjct: 447 INLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRV 506
Query: 183 PSDFGN------SFSLTTLLLDNNQYLGGISPELH 211
P+ G SF+ T +N L GI P L
Sbjct: 507 PAALGGRLLHRASFNFT-----DNAGLCGI-PGLR 535
|
Length = 623 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 49.2 bits (118), Expect = 3e-06
Identities = 51/224 (22%), Positives = 95/224 (42%), Gaps = 44/224 (19%)
Query: 482 LSKVNHKNFVNLIGYCEE--DEPFTRM-MVFEYSPNGSL--------FEHLHIQEAEHLD 530
L ++ H N V Y + D + +V EY G L E +I E
Sbjct: 53 LRELKHPNIV---RYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYI--EEEFI 107
Query: 531 WAMRLRIAMGMAYCLEHMHQLTPP---IAHRNLQSSSIYLTEDYAAKISDF----SFWNN 583
W + ++ + + C H + P + HR+L+ ++I+L + K+ DF ++
Sbjct: 108 WRILTQLLLALYEC----HNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHD 163
Query: 584 TTAAKT--GSAA-M--ELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASE 638
++ AKT G+ M E L + D +S+++S G +++E+ ++ A
Sbjct: 164 SSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFT---------ARN 214
Query: 639 YLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPS 682
L+ +K+ + EL VIK+ ++ DP +RPS
Sbjct: 215 QLQLASKIKEGKFRRIPYRYS---SELNEVIKSMLNVDPDKRPS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 4e-06
Identities = 31/111 (27%), Positives = 52/111 (46%)
Query: 122 ILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGP 181
IL+L G + L L L+ + L +N F G IPK +G+ L +LDL NN +G
Sbjct: 312 ILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGE 371
Query: 182 FPSDFGNSFSLTTLLLDNNQYLGGISPELHVLKVISEIQVDESWLTNAASR 232
P +S +L L+L +N G I L + + +++ ++ +
Sbjct: 372 IPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPS 422
|
Length = 968 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 4e-06
Identities = 65/272 (23%), Positives = 106/272 (38%), Gaps = 59/272 (21%)
Query: 438 GTVGTVYKG-TLSSGVEIAVTSTSVK-SRADWSKNLESQ-FRKKIDTLSKVNHKNFVNLI 494
GT G VY LS+ V IA+ + SR Q ++I S + H+N V +
Sbjct: 19 GTYGIVYAARDLSTQVRIAIKEIPERDSR-------YVQPLHEEIALHSYLKHRNIVQYL 71
Query: 495 GYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYC-------LEH 547
G E+ F M E P GSL L + W + + L++
Sbjct: 72 GSDSENGFFKIFM--EQVPGGSLSALLRSK------WGPLKDNEQTIIFYTKQILEGLKY 123
Query: 548 MHQLTPPIAHRNLQSSSIYLTEDYAA--KISDF------SFWNNTTAAKTGSAAMELLET 599
+H I HR+++ ++ L Y+ KISDF + N T TG+ ++ +
Sbjct: 124 LHDNQ--IVHRDIKGDNV-LVNTYSGVVKISDFGTSKRLAGINPCTETFTGT--LQYMAP 178
Query: 600 SAVD-------LESNVYSFGTILFEMITGRISYSIENGSLEN--WASEYLKGEQPLKDIV 650
+D ++++S G + EM TG+ + IE G + + K + + +
Sbjct: 179 EVIDKGPRGYGAPADIWSLGCTIVEMATGKPPF-IELGEPQAAMFKVGMFKIHPEIPESL 237
Query: 651 DPTLKSFQENVLEELLVVIKNCVHPDPKQRPS 682
K+F I C PDP +R S
Sbjct: 238 SAEAKNF-----------ILRCFEPDPDKRAS 258
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 4e-06
Identities = 64/223 (28%), Positives = 87/223 (39%), Gaps = 52/223 (23%)
Query: 438 GTVGTVYKGTLS----SGVEIAV---TSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNF 490
G G VY+G VE+ V T S D ES F + +SK NH+N
Sbjct: 17 GAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQD-----ESDFLMEALIMSKFNHQNI 71
Query: 491 VNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLD----WAMR--LRIAMGMA-- 542
V LIG E P R ++ E G L L + + M+ L A +A
Sbjct: 72 VRLIGVSFERLP--RFILLELMAGGDLKSFLR-ENRPRPERPSSLTMKDLLFCARDVAKG 128
Query: 543 -YCLEHMHQLTPPIAHRNLQSSSIYLT---EDYAAKISDFSFWNNTTAA----KTGSAAM 594
LE H + IA RN LT AKI+DF + A K G A +
Sbjct: 129 CKYLEENHFIHRDIAARN-----CLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAML 183
Query: 595 EL--------LE---TSAVDLESNVYSFGTILFEMIT-GRISY 625
+ L+ TS D V+SFG +L+E+ + G + Y
Sbjct: 184 PIKWMPPEAFLDGIFTSKTD----VWSFGVLLWEIFSLGYMPY 222
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 4e-06
Identities = 44/193 (22%), Positives = 83/193 (43%), Gaps = 39/193 (20%)
Query: 507 MVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMG-MAYCLEHMHQLTPPIAHRNLQSSSI 565
++ +Y G LF HL+ + EH + +R+ + + L+H+HQL I +R+++ +I
Sbjct: 82 LILDYVNGGELFTHLY--QREHFTES-EVRVYIAEIVLALDHLHQLG--IIYRDIKLENI 136
Query: 566 YLTEDYAAKISDFSFWNNTTAAKTGSA----------AMELLET------SAVDLESNVY 609
L + ++DF A + A A E++ AVD +
Sbjct: 137 LLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDW----W 192
Query: 610 SFGTILFEMITGRISYSIENG--SLENWASEYLKGEQPLKDIVDPTLKSFQENVLEELLV 667
S G + FE++TG ++++ S + LK + P + + F + +LE+
Sbjct: 193 SLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEARDFIQKLLEK--- 249
Query: 668 VIKNCVHPDPKQR 680
DPK+R
Sbjct: 250 --------DPKKR 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 5e-06
Identities = 53/203 (26%), Positives = 88/203 (43%), Gaps = 25/203 (12%)
Query: 431 IIGSFSDGTVGTVYKG-TLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKN 489
IIG DG G VYK +G A KS + LE + +I+ L+ NH
Sbjct: 16 IIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEE----LED-YMVEIEILATCNHPY 70
Query: 490 FVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMH 549
V L+G D M+ E+ P G++ + + ++ L I M L+++H
Sbjct: 71 IVKLLGAFYWDGKLWIMI--EFCPGGAV-DAIMLELDRGLTEPQIQVICRQMLEALQYLH 127
Query: 550 QLTPPIAHRNLQSSSIYLTEDYAAKISDF--SFWNNTTAAKTGS------------AAME 595
+ I HR+L++ ++ LT D K++DF S N T + S E
Sbjct: 128 SMK--IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCE 185
Query: 596 LLETSAVDLESNVYSFGTILFEM 618
++ + D +++++S G L EM
Sbjct: 186 TMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 6e-06
Identities = 58/256 (22%), Positives = 114/256 (44%), Gaps = 34/256 (13%)
Query: 438 GTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYC 497
G G V+ G + +++A+ + + + + E F ++ + K++H V L G C
Sbjct: 15 GQFGVVHLGKWRAQIKVAIKAINEGAMS------EEDFIEEAKVMMKLSHPKLVQLYGVC 68
Query: 498 EEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAH 557
+ +P +V E+ NG L +L Q L M L + + +E++ + + H
Sbjct: 69 TQQKPL--YIVTEFMENGCLLNYLR-QRQGKLSKDMLLSMCQDVCEGMEYLERNS--FIH 123
Query: 558 RNLQSSSIYLTEDYAAKISDFSF--------WNNTTAAK--TGSAAMELLETSAVDLESN 607
R+L + + ++ K+SDF + +++ AK + E+ S +S+
Sbjct: 124 RDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSD 183
Query: 608 VYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQENVLEELL 666
V+SFG +++E+ T G++ + E S +G + + P L S V E
Sbjct: 184 VWSFGVLMWEVFTEGKMPF--EKKSNYEVVEMISRGFR----LYRPKLASMT--VYE--- 232
Query: 667 VVIKNCVHPDPKQRPS 682
V+ +C H P+ RP+
Sbjct: 233 -VMYSCWHEKPEGRPT 247
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 6e-06
Identities = 56/255 (21%), Positives = 88/255 (34%), Gaps = 74/255 (29%)
Query: 477 KKIDTLSKVNHKNFVNLIGYCEEDEPFTR----MMVFEY-----------SPNGSLFEHL 521
+++ L ++ H+N VNL E F R +VFEY SP G L
Sbjct: 49 REVKVLRQLRHENIVNLK------EAFRRKGRLYLVFEYVERTLLELLEASPGG-----L 97
Query: 522 HIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFW 581
W ++ +AYC H H I HR+++ +I ++E K+ DF F
Sbjct: 98 PPDAVRSYIW----QLLQAIAYC--HSHN----IIHRDIKPENILVSESGVLKLCDFGFA 147
Query: 582 NNTTAAKTGS----------AAMELLETS-----AVDLESNVYSFGTILFEMITGRI--- 623
A A ELL VD V++ G I+ E++ G
Sbjct: 148 RALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVD----VWAIGCIMAELLDGEPLFP 203
Query: 624 -------SYSIEN---------GSLENWASEYLKGEQPLKDIVDPTLKSFQENVLEELLV 667
Y I+ L + + P + + + V L
Sbjct: 204 GDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALD 263
Query: 668 VIKNCVHPDPKQRPS 682
+K C+ DPK+R +
Sbjct: 264 FLKACLRMDPKERLT 278
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 47.6 bits (114), Expect = 7e-06
Identities = 64/282 (22%), Positives = 113/282 (40%), Gaps = 60/282 (21%)
Query: 425 CEDFSNIIGSFSDGTVGTVYKGT-LSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLS 483
E+ +I+ +G+ G+VYK +G +A+ V+ + + K+I L
Sbjct: 1 PEEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED---LQEII----KEISILK 53
Query: 484 KVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHI-----QEAEHLDWAMRLRIA 538
+ + V G ++ +V EY GS+ + + I E E IA
Sbjct: 54 QCDSPYIVKYYGSYFKNT--DLWIVMEYCGAGSVSDIMKITNKTLTEEE---------IA 102
Query: 539 MGMAYC---LEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDF--SFWNNTTAAKTGSA- 592
+ LE++H HR++++ +I L E+ AK++DF S T AK +
Sbjct: 103 AILYQTLKGLEYLHSNK--KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVI 160
Query: 593 ------AMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPL 646
A E+++ + +++++S G EM G+ YS P+
Sbjct: 161 GTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYS---------------DIHPM 205
Query: 647 KDIV------DPTLKSFQENVLEELLVVIKNCVHPDPKQRPS 682
+ I PTL E E +K C+ DP++RPS
Sbjct: 206 RAIFMIPNKPPPTLSD-PEKWSPEFNDFVKKCLVKDPEERPS 246
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.9 bits (115), Expect = 8e-06
Identities = 55/221 (24%), Positives = 85/221 (38%), Gaps = 70/221 (31%)
Query: 438 GTVGTVYKGT-LSSGVEIA------------VTSTSVKSRADWSKNLESQFRKKIDTLSK 484
GT G VYK +G +A + ST+++ +I L +
Sbjct: 10 GTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALR---------------EISLLKE 54
Query: 485 VNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIA----MG 540
+ H N V L+ + +VFEY L ++L + L + I G
Sbjct: 55 LKHPNIVKLLDVIHTERKLY--LVFEYCDM-DLKKYLD-KRPGPLSPNLIKSIMYQLLRG 110
Query: 541 MAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTAAKTGSA-------- 592
+AYC H H+ I HR+L+ +I + D K++DF A G
Sbjct: 111 LAYC--HSHR----ILHRDLKPQNILINRDGVLKLADFGL-----ARAFGIPLRTYTHEV 159
Query: 593 ------AMELL-----ETSAVDLESNVYSFGTILFEMITGR 622
A E+L ++AVD ++S G I EMITG+
Sbjct: 160 VTLWYRAPEILLGSKHYSTAVD----IWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 1e-05
Identities = 35/109 (32%), Positives = 55/109 (50%)
Query: 130 LGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNS 189
L G + P + L +L S+ L +NS G IP+ + +L+ LEIL L NNF+G P +
Sbjct: 272 LSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSL 331
Query: 190 FSLTTLLLDNNQYLGGISPELHVLKVISEIQVDESWLTNAASRASCNSG 238
L L L +N++ G I L ++ + + + LT C+SG
Sbjct: 332 PRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSG 380
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 1e-05
Identities = 31/92 (33%), Positives = 45/92 (48%)
Query: 115 CSDGKVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLG 174
CS G + L L L G + LG L+ + L++NSF G +P E +L + LD+
Sbjct: 377 CSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDIS 436
Query: 175 FNNFSGPFPSDFGNSFSLTTLLLDNNQYLGGI 206
NN G S + SL L L N++ GG+
Sbjct: 437 NNNLQGRINSRKWDMPSLQMLSLARNKFFGGL 468
|
Length = 968 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 54/222 (24%), Positives = 99/222 (44%), Gaps = 40/222 (18%)
Query: 482 LSKVNHKNFVNLIGYCE--EDEPFTRMMVFEYSPNGSLFEHLHIQEAEHL------DWAM 533
LS++ H N V Y E E E +V + G L+ L Q+ + L +W
Sbjct: 53 LSQLKHPNIV---AYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWF- 108
Query: 534 RLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFS----FWNNTTAAKT 589
++IAM + Y L H I HR+L++ +++LT K+ D N A T
Sbjct: 109 -VQIAMALQY-LHEKH-----ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST 161
Query: 590 --GSA---AMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQ 644
G+ + EL + +S+V++ G ++EM T + +++ ++ + + ++G+
Sbjct: 162 LIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD--MNSLVYRIIEGKL 219
Query: 645 PLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGI 686
P P K + EL +I + P++RPS++ I
Sbjct: 220 P------PMPKDYS----PELGELIATMLSKRPEKRPSVKSI 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 1e-05
Identities = 50/208 (24%), Positives = 91/208 (43%), Gaps = 34/208 (16%)
Query: 438 GTVGTVYKGT-LSSGVEIAVTSTSVKSRADWSKNLESQFRKK-----IDTLSKVNHKNFV 491
G GTV+ +++G E+A+ NL+ Q +K+ I + ++ + N V
Sbjct: 30 GASGTVFTAIDVATGQEVAIKQI----------NLQKQPKKELIINEILVMKELKNPNIV 79
Query: 492 NLI-GYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQ 550
N + + DE F +V EY GSL + + +D A + LE +H
Sbjct: 80 NFLDSFLVGDELF---VVMEYLAGGSLTD---VVTETCMDEAQIAAVCRECLQALEFLH- 132
Query: 551 LTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTAAKTGSAAM---------ELLETSA 601
+ HR+++S ++ L D + K++DF F T ++ + M E++ A
Sbjct: 133 -ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA 191
Query: 602 VDLESNVYSFGTILFEMITGRISYSIEN 629
+ +++S G + EM+ G Y EN
Sbjct: 192 YGPKVDIWSLGIMAIEMVEGEPPYLNEN 219
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 1e-05
Identities = 50/219 (22%), Positives = 100/219 (45%), Gaps = 32/219 (14%)
Query: 421 LEAACEDFSNIIGSFSDGTVGTVYKGTLS--SGVEIAVTSTSVKSRADWSKNLESQFRKK 478
++ +C +IG+ G G V +G L EI V ++K + +++ F +
Sbjct: 1 IDVSCVKIEEVIGA---GEFGEVCRGRLKLPGKREIFVAIKTLK--SGYTEKQRRDFLSE 55
Query: 479 IDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEH--LDWAMRLR 536
+ + +H N ++L G + P M++ E+ NG+L L + + + LR
Sbjct: 56 ASIMGQFDHPNIIHLEGVVTKSRPV--MIITEFMENGALDSFLRQNDGQFTVIQLVGMLR 113
Query: 537 -IAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFS---FWNNTTAAKTGSA 592
IA GM Y L M+ + HR+L + +I + + K+SDF F + T+ T ++
Sbjct: 114 GIAAGMKY-LSEMNYV-----HRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTS 167
Query: 593 AM-----------ELLETSAVDLESNVYSFGTILFEMIT 620
++ E + S+V+S+G +++E+++
Sbjct: 168 SLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 2e-05
Identities = 37/109 (33%), Positives = 49/109 (44%), Gaps = 9/109 (8%)
Query: 118 GKVVILNLRDLC---LGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLG 174
G + LN DL L G + LG L L+ + L N G IP I L++L LDL
Sbjct: 233 GGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLS 292
Query: 175 FNNFSGPFPSDFGNSFSLTTLLLDNNQYLGGIS------PELHVLKVIS 217
N+ SG P +L L L +N + G I P L VL++ S
Sbjct: 293 DNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWS 341
|
Length = 968 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 2e-05
Identities = 59/242 (24%), Positives = 99/242 (40%), Gaps = 45/242 (18%)
Query: 404 QLQKAFVTGVPKLKRSELEAACEDFSNIIGSFSDGTVGTVYKGT-LSSGVEIAVTSTSVK 462
+L+ G PK K + E G GTVY +++G E+A+
Sbjct: 8 KLRSIVSVGDPKKKYTRFE-----------KIGQGASGTVYTAMDVATGQEVAIRQM--- 53
Query: 463 SRADWSKNLESQFRKK-----IDTLSKVNHKNFVN-LIGYCEEDEPFTRMMVFEYSPNGS 516
NL+ Q +K+ I + + + N VN L Y DE + +V EY GS
Sbjct: 54 -------NLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELW---VVMEYLAGGS 103
Query: 517 LFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKIS 576
L + + +D + LE +H + + HR+++S +I L D + K++
Sbjct: 104 LTD---VVTETCMDEGQIAAVCRECLQALEFLH--SNQVIHRDIKSDNILLGMDGSVKLT 158
Query: 577 DFSFWNNTTAAKTGSAAM---------ELLETSAVDLESNVYSFGTILFEMITGRISYSI 627
DF F T ++ + M E++ A + +++S G + EMI G Y
Sbjct: 159 DFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN 218
Query: 628 EN 629
EN
Sbjct: 219 EN 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 2e-05
Identities = 63/285 (22%), Positives = 118/285 (41%), Gaps = 44/285 (15%)
Query: 434 SFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNL 493
+ +G G+V +G L+ I + A +++ F + + + +H N + L
Sbjct: 6 TLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRL 65
Query: 494 IGYC---EEDEPF-TRMMVFEYSPNGSLFEHLHIQ----EAEHLDWAMRLR----IAMGM 541
IG C E E + + +++ + +G L L ++L M ++ IA GM
Sbjct: 66 IGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGM 125
Query: 542 AYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDF---------SFWNNTTAAKTGSA 592
Y + HR+L + + L E+ ++DF ++ AK
Sbjct: 126 EYLS------SKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVK 179
Query: 593 --AMELLETSAVDLESNVYSFGTILFEMIT-GRISY-SIENGSLENWASEYLKGEQPLKD 648
A+E L +S+V+SFG ++E+ T G+ Y +EN + +YL+ LK
Sbjct: 180 WIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEI----YDYLRQGNRLKQ 235
Query: 649 IVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEI 693
D L+ L ++ +C +PK RPS + +L++
Sbjct: 236 PPD---------CLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 46.5 bits (111), Expect = 2e-05
Identities = 48/209 (22%), Positives = 80/209 (38%), Gaps = 31/209 (14%)
Query: 431 IIGSFSDGTVGTVYKGT-LSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKN 489
I+G +G G V+K +G +A+ +++ + +Q ++I L H
Sbjct: 4 ILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGG---IPNQALREIKALQACQHPY 60
Query: 490 FVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEH-LDWAMRLRIAMGMAYCLEHM 548
V L+ F +V EY P L E L + E L A + + +M
Sbjct: 61 VVKLLDVFPHGSGFV--LVMEYMP-SDLSEVLR--DEERPLPEAQVKSYMRMLLKGVAYM 115
Query: 549 HQLTPPIAHRNLQSSSIYLTEDYAAKISDF----SFWNNTTAAKTGSA------AMELL- 597
H I HR+L+ +++ ++ D KI+DF F + A ELL
Sbjct: 116 HANG--IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLY 173
Query: 598 ----ETSAVDLESNVYSFGTILFEMITGR 622
VDL ++ G I E++ G
Sbjct: 174 GARKYDPGVDL----WAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 2e-05
Identities = 35/148 (23%), Positives = 68/148 (45%), Gaps = 16/148 (10%)
Query: 482 LSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGM 541
L +V+H + L + E + M+ EY P G LF +L + + + L A +
Sbjct: 55 LKEVSHPFIIRL--FWTEHDQRFLYMLMEYVPGGELFSYL--RNSGRFSNSTGLFYASEI 110
Query: 542 AYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSF--------WNNTTAAKTGSAA 593
LE++H I +R+L+ +I L ++ K++DF F W T A
Sbjct: 111 VCALEYLHSKE--IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTW--TLCGTPEYLA 166
Query: 594 MELLETSAVDLESNVYSFGTILFEMITG 621
E++++ + + ++ G +++EM+ G
Sbjct: 167 PEVIQSKGHNKAVDWWALGILIYEMLVG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 3e-05
Identities = 33/83 (39%), Positives = 43/83 (51%), Gaps = 5/83 (6%)
Query: 130 LGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNS 189
L G + E+G L+ L + L N+ G IP +G LK L+ L L N SGP P
Sbjct: 224 LSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSI--- 280
Query: 190 FSLTTLL-LD-NNQYLGGISPEL 210
FSL L+ LD ++ L G PEL
Sbjct: 281 FSLQKLISLDLSDNSLSGEIPEL 303
|
Length = 968 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 3e-05
Identities = 66/287 (22%), Positives = 120/287 (41%), Gaps = 58/287 (20%)
Query: 437 DGTVGTVYKGTLSS---GVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNL 493
+GT G ++ G L G E V +VK A S+ + ++ L ++H+N + +
Sbjct: 16 EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA--SEIQVTLLLQESCLLYGLSHQNILPI 73
Query: 494 IGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWA------------MRLRIAMGM 541
+ C ED +++ Y G+L L +Q+ + M ++IA GM
Sbjct: 74 LHVCIED-GEPPFVLYPYMNWGNL--KLFLQQCRLGEANNPQALSTQQLVHMAIQIACGM 130
Query: 542 AYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTAAKTGS---------- 591
+ ++H+ + H+++ + + + E+ KI+D + +
Sbjct: 131 S----YLHKRG--VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVK 184
Query: 592 -AAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKG----EQP 645
A+E L S+V+SFG +L+E++T G+ Y +E E A YLK QP
Sbjct: 185 WMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPY-VEIDPFEMAA--YLKDGYRLAQP 241
Query: 646 LKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKE 692
+ N +EL V+ C DP++RPS + L +
Sbjct: 242 I-------------NCPDELFAVMACCWALDPEERPSFSQLVQCLTD 275
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 4e-05
Identities = 55/245 (22%), Positives = 100/245 (40%), Gaps = 61/245 (24%)
Query: 438 GTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGY 496
G G V KG +I V +K+ + K++ + ++ + + ++++ V +IG
Sbjct: 6 GNFGCVKKGVYKMRKKQIDVAIKVLKNENE--KSVRDEMMREAEIMHQLDNPYIVRMIGV 63
Query: 497 CEEDEPFTRMMVFEYSPNGSLFEHL----------HIQEAEHLDWAMRLRIAMGMAYCLE 546
CE + M+V E + G L + L ++ E H +++MGM Y LE
Sbjct: 64 CEAE---ALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMH-------QVSMGMKY-LE 112
Query: 547 HMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFW------NNTTAAKTGSA------AM 594
+ HR+L + ++ L + AKISDF ++ A++ A
Sbjct: 113 GKN-----FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAP 167
Query: 595 ELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTL 654
E + S+V+S+G ++E SY G++P K + P +
Sbjct: 168 ECINFRKFSSRSDVWSYGITMWEA----FSY----------------GQKPYKKMKGPEV 207
Query: 655 KSFQE 659
SF E
Sbjct: 208 MSFIE 212
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 4e-05
Identities = 47/182 (25%), Positives = 70/182 (38%), Gaps = 34/182 (18%)
Query: 545 LEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSF-------WNNTT--AAKTGSAAME 595
LEH+HQ I +R+L+ ++ L D +ISD + T A G A E
Sbjct: 110 LEHLHQRR--IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPE 167
Query: 596 LLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLK--DIVDPT 653
LL+ D + ++ G L+EMI R + +EN + + D P
Sbjct: 168 LLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPA 227
Query: 654 LKSFQENVLEELLVVIKNCVHPDPKQRPSMR-GIAAKLKEITAMEPDGATPKLSPLWWAE 712
KSF E +L + DP++R R G L+ P L W +
Sbjct: 228 SKSFCEALLAK-----------DPEKRLGFRDGNCDGLR---------THPLFRDLNWRQ 267
Query: 713 LE 714
LE
Sbjct: 268 LE 269
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 5e-05
Identities = 32/91 (35%), Positives = 42/91 (46%), Gaps = 1/91 (1%)
Query: 120 VVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFS 179
V L++ + L G + + L+ + L N FFG +P G K LE LDL N FS
Sbjct: 430 VYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGS-KRLENLDLSRNQFS 488
Query: 180 GPFPSDFGNSFSLTTLLLDNNQYLGGISPEL 210
G P G+ L L L N+ G I EL
Sbjct: 489 GAVPRKLGSLSELMQLKLSENKLSGEIPDEL 519
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 5e-05
Identities = 29/88 (32%), Positives = 39/88 (44%)
Query: 123 LNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPF 182
L+L + L G + ++G S LK + L N G IP + L LE L L N G
Sbjct: 145 LDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQI 204
Query: 183 PSDFGNSFSLTTLLLDNNQYLGGISPEL 210
P + G SL + L N G I E+
Sbjct: 205 PRELGQMKSLKWIYLGYNNLSGEIPYEI 232
|
Length = 968 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 45.5 bits (107), Expect = 5e-05
Identities = 60/243 (24%), Positives = 102/243 (41%), Gaps = 47/243 (19%)
Query: 404 QLQKAFVTGVPKLKRSELEAACEDFSNIIGSFSDGTVGTVYKG-TLSSGVEIAVTSTSVK 462
+L+ G PK K + E G GTVY +++G E+A+
Sbjct: 7 KLRSIVSVGDPKKKYTRFE-----------KIGQGASGTVYTAIDIATGQEVAIKQM--- 52
Query: 463 SRADWSKNLESQFRKK-----IDTLSKVNHKNFVN-LIGYCEEDEPFTRMMVFEYSPNGS 516
NL+ Q +K+ I + + + N VN L Y DE + +V EY GS
Sbjct: 53 -------NLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELW---VVMEYLAGGS 102
Query: 517 LFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQL-TPPIAHRNLQSSSIYLTEDYAAKI 575
L + + +D +IA CL+ + L + + HR+++S +I L D + K+
Sbjct: 103 LTD---VVTETCMDEG---QIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKL 156
Query: 576 SDFSFWNNTTAAKTGSAAM---------ELLETSAVDLESNVYSFGTILFEMITGRISYS 626
+DF F T ++ + M E++ A + +++S G + EM+ G Y
Sbjct: 157 TDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYL 216
Query: 627 IEN 629
EN
Sbjct: 217 NEN 219
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 6e-05
Identities = 71/288 (24%), Positives = 114/288 (39%), Gaps = 43/288 (14%)
Query: 420 ELEAACEDFSNIIGSFSDGTVGTVYKGTLS--SGVEIAVTSTSVKSRADWSKNLESQFRK 477
EL+ I+G+ G G + +G L S E+ V ++ RA S F
Sbjct: 1 ELDNKSIKIERILGT---GRFGELCRGCLKLPSKRELPVAIHTL--RAGCSDKQRRGFLA 55
Query: 478 KIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLR- 536
+ TL + +H N V L G T M+V EY NG+L L E + + A +L
Sbjct: 56 EALTLGQFDHSNIVRLEGVITRGN--TMMIVTEYMSNGALDSFLRKHEGQLV--AGQLMG 111
Query: 537 ----IAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWN--------NT 584
+A GM Y E + H+ L + + + D KIS F T
Sbjct: 112 MLPGLASGMKYLSEMGY------VHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTT 165
Query: 585 TAAKTGS--AAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKG 642
+ K+ AA E ++ S+V+SFG +++E+ +SY G W + G
Sbjct: 166 MSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEV----MSY----GERPYWD---MSG 214
Query: 643 EQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKL 690
+ +K + D N L ++ +C + +RP I + L
Sbjct: 215 QDVIKAVEDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSIL 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 8e-05
Identities = 67/263 (25%), Positives = 105/263 (39%), Gaps = 54/263 (20%)
Query: 446 GTLSSG-VEIAVTSTSVKSRADWSKNLESQFRKK-----IDTLSKVNHKNFVNLI-GYCE 498
G S+G V IA +S K A +L Q R++ + + H+N V + Y
Sbjct: 29 GEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV 88
Query: 499 EDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLT----PP 554
DE + M E + H + E + IA A CL + L+
Sbjct: 89 GDELWVVMEFLEGGALTDIVTHTRMNEEQ---------IA---AVCLAVLKALSVLHAQG 136
Query: 555 IAHRNLQSSSIYLTEDYAAKISDFSFWNNTT------AAKTGSA---AMELLETSAVDLE 605
+ HR+++S SI LT D K+SDF F + + G+ A EL+ E
Sbjct: 137 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPE 196
Query: 606 SNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQ------E 659
+++S G ++ EM+ G Y E LK + ++D + P LK+ +
Sbjct: 197 VDIWSLGIMVIEMVDGEPPYFNE---------PPLKAMKMIRDNLPPKLKNLHKVSPSLK 247
Query: 660 NVLEELLVVIKNCVHPDPKQRPS 682
L+ LLV DP QR +
Sbjct: 248 GFLDRLLV-------RDPAQRAT 263
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 9e-05
Identities = 57/215 (26%), Positives = 99/215 (46%), Gaps = 35/215 (16%)
Query: 431 IIGSFSDGTVGTVYKG-TLSSGVEIAV----TSTSVKSRADWSKNLESQFRKKIDTLSKV 485
+IGS G+ G+VY G SSG +AV + S D +++ ++I L ++
Sbjct: 7 LIGS---GSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL 63
Query: 486 NHKNFVNLIGYCEEDEPFTRMMVF-EYSPNGSLFEHLHIQEA--EHLDWAMRLRIAMGMA 542
H+N V +G D + +F EY P GS+ L+ A E L +I G+
Sbjct: 64 QHENIVQYLG-SSLDA--DHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLN 120
Query: 543 YCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWN----NTTAAKTGSA------ 592
Y H I HR+++ ++I + KISDF N+ + KT A
Sbjct: 121 YL--HNRG----IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQG 174
Query: 593 -----AMELLETSAVDLESNVYSFGTILFEMITGR 622
A E+++ ++ +++++S G ++ EM+TG+
Sbjct: 175 SVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 44.6 bits (106), Expect = 9e-05
Identities = 39/157 (24%), Positives = 69/157 (43%), Gaps = 20/157 (12%)
Query: 536 RIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT--AAKT---G 590
+IA+ + L ++H+ I HR+++ S+I + K+ DF AKT
Sbjct: 104 KIAVAVLKGLTYLHE-KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFVGT 162
Query: 591 SAAM--ELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKD 648
S+ M E ++ + ++S+++S G L E+ TGR Y + L+
Sbjct: 163 SSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYP-------PENDPPDGIFELLQY 215
Query: 649 IVD---PTLKSFQENVLEELLVVIKNCVHPDPKQRPS 682
IV+ P L S + + C+ DP++RPS
Sbjct: 216 IVNEPPPRLPS--GKFSPDFQDFVNLCLIKDPRERPS 250
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.2 bits (105), Expect = 1e-04
Identities = 43/158 (27%), Positives = 72/158 (45%), Gaps = 20/158 (12%)
Query: 426 EDFSNIIGSFSDGTVGTVYKG-TLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSK 484
ED+ +I GT G VYK +++G +A+ ++ D+ +++I L +
Sbjct: 3 EDY-ELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFE-----IIQQEISMLKE 56
Query: 485 VNHKNFVNLIG-YCEEDEPFTRMMVFEYSPNGSLFEHLHIQEA--EHLDWAMRLRIAM-G 540
H N V G Y D+ + M EY GSL + + L A R + G
Sbjct: 57 CRHPNIVAYFGSYLRRDKLWIVM---EYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKG 113
Query: 541 MAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDF 578
+AY L ++ HR+++ ++I LTED K++DF
Sbjct: 114 LAY-LHETGKI-----HRDIKGANILLTEDGDVKLADF 145
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 63/287 (21%), Positives = 119/287 (41%), Gaps = 47/287 (16%)
Query: 431 IIGSFSDGTVGTVYKGT-LSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKN 489
++GS G GTVYKG + G ++ + + R S + + ++ V++ +
Sbjct: 14 VLGS---GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 70
Query: 490 FVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHL-----HIQEAEHLDWAMRLRIAMGMAYC 544
L+G C T ++ + P G L +++ +I L+W ++IA GM Y
Sbjct: 71 VCRLLGICLTS---TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC--VQIAKGMNY- 124
Query: 545 LEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTA------AKTGSA-----A 593
LE + HR+L + ++ + KI+DF A A+ G A
Sbjct: 125 LEERR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMA 179
Query: 594 MELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPLKDIVDP 652
+E + +S+V+S+G ++E++T G Y + +S KGE+ + P
Sbjct: 180 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPY--DGIPASEISSILEKGER----LPQP 233
Query: 653 TLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAMEPD 699
+ + ++ +++ C D RP R + E + M D
Sbjct: 234 PICTI------DVYMIMVKCWMIDADSRPKFRELII---EFSKMARD 271
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 44.2 bits (105), Expect = 1e-04
Identities = 63/279 (22%), Positives = 103/279 (36%), Gaps = 45/279 (16%)
Query: 435 FSDGTVGTVY---KGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFV 491
S G G V+ K + I V + R KN Q + D LS+ +V
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIR----KNQVDQVLTERDILSQAQS-PYV 55
Query: 492 NLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQL 551
+ Y + + +V EY P G L L + D A R+ IA + LE++H
Sbjct: 56 VKLYYSFQGKK-NLYLVMEYLPGGDLASLLENVGSLDEDVA-RIYIAE-IVLALEYLHSN 112
Query: 552 TPPIAHRNLQSSSIYLTEDYAAKISDF-----------SFWNNTTAAKT------GSAAM 594
I HR+L+ +I + + K++DF N+ A
Sbjct: 113 G--IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAP 170
Query: 595 ELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTL 654
E++ + +S G IL+E + G + E E L G+ + V
Sbjct: 171 EVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGET--PEEIFQNILNGKIEWPEDV---- 224
Query: 655 KSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEI 693
V +E + +I + PDP++R + I +EI
Sbjct: 225 -----EVSDEAIDLISKLLVPDPEKRLGAKSI----EEI 254
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 58/214 (27%), Positives = 89/214 (41%), Gaps = 37/214 (17%)
Query: 426 EDFSNIIGSFSDGTVGTVYKG-TLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSK 484
E+F IIG DG G VYK +GV A KS + LE + +ID L+
Sbjct: 4 EEFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEE----LED-YMVEIDILAS 58
Query: 485 VNHKNFVNLIG--YCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMA 542
+H N V L+ Y E + ++ E+ G++ +A L+ L
Sbjct: 59 CDHPNIVKLLDAFYYENN----LWILIEFCAGGAV-------DAVMLELERPLTEPQIRV 107
Query: 543 YCLEHMHQLT----PPIAHRNLQSSSIYLTEDYAAKISDF--SFWNNTTAAKTGS----- 591
C + + L I HR+L++ +I T D K++DF S N T + S
Sbjct: 108 VCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTP 167
Query: 592 ----AAMELLETSA---VDLESNVYSFGTILFEM 618
+ + ETS D +++V+S G L EM
Sbjct: 168 YWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|218191 pfam04652, DUF605, Vta1 like | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 2e-04
Identities = 28/90 (31%), Positives = 34/90 (37%), Gaps = 5/90 (5%)
Query: 268 KASEPSSSSSIASSPEPLVSPSLSPSMSSLLSPSFSPSPSPSESPSVSSPLIIPPAPVNI 327
A +++S + E S SPS SP PSP E PS S +PPAP +
Sbjct: 160 DADVATTNSDNSFPGEDADPASASPSDPPSSSPGVPSFPSPPEDPSSPSDSSLPPAPSSF 219
Query: 328 -----PIVSSPPHLHSAPTSFAASTPSQVH 352
P P S P AA P V
Sbjct: 220 QSDTPPPSPESPTNPSPPPGPAAPPPPPVQ 249
|
Vta1 (VPS20-associated protein 1) is a positive regulator of Vps4. Vps4 is an ATPase that is required in the multivesicular body (MVB) sorting pathway to dissociate the endosomal sorting complex required for transport (ESCRT). Vta1 promotes correct assembly of Vps4 and stimulates its ATPase activity through its conserved Vta1/SBP1/LIP5 region. Length = 315 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 2e-04
Identities = 60/264 (22%), Positives = 104/264 (39%), Gaps = 42/264 (15%)
Query: 438 GTVGTVYKG-TLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGY 496
G G VY + +G E+AV + +K + +I L + H+ V G
Sbjct: 13 GAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGC 72
Query: 497 CEEDEPFTRMMVFEYSPNGSLFEHLHIQEA--EHLDWAMRLRIAMGMAYCLEHMHQLTPP 554
+DE + M EY P GS+ + L A E + +I G+ Y +M
Sbjct: 73 LRDDETLSIFM--EYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNM------ 124
Query: 555 IAHRNLQSSSIYLTEDYAAKISDF-------SFWNNTTAAK--TGSA---AMELLETSAV 602
I HR+++ ++I K+ DF + ++ T K TG+ + E++
Sbjct: 125 IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGY 184
Query: 603 DLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQP----LKDIVDPTLKSFQ 658
+++V+S G + EM+T + ++ E A+ + QP L V P ++F
Sbjct: 185 GRKADVWSVGCTVVEMLTEKPPWA----EFEAMAAIFKIATQPTNPQLPSHVSPDARNFL 240
Query: 659 ENVLEELLVVIKNCVHPDPKQRPS 682
E K+RPS
Sbjct: 241 RRTFVENA-----------KKRPS 253
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 2e-04
Identities = 43/200 (21%), Positives = 89/200 (44%), Gaps = 27/200 (13%)
Query: 450 SGVEIAVTSTSV--KSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMM 507
+G +AV + + ++ + +E+ RK+I ++++NH + + ++G ED F +
Sbjct: 24 TGTLMAVKQVTYVRNTSSEQEEVVEA-LRKEIRLMARLNHPHIIRMLGATCEDSHFN--L 80
Query: 508 VFEYSPNGSLFEHLHIQEA--EHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSI 565
E+ GS+ L A E + ++ G++Y H +Q I HR+++ +++
Sbjct: 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYL--HENQ----IIHRDVKGANL 134
Query: 566 YL-TEDYAAKISDFSFWNNTTAAKTGSA-------------AMELLETSAVDLESNVYSF 611
+ + +I+DF A TG+ A E+L +V+S
Sbjct: 135 LIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSV 194
Query: 612 GTILFEMITGRISYSIENGS 631
G ++ EM T + ++ E S
Sbjct: 195 GCVIIEMATAKPPWNAEKHS 214
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 3e-04
Identities = 46/170 (27%), Positives = 75/170 (44%), Gaps = 46/170 (27%)
Query: 477 KKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEH----LDWA 532
++I L ++ H+N VNLI + +VFE+ +H + + E LD
Sbjct: 49 REIRMLKQLRHENLVNLIEVFRRKKRL--YLVFEF------VDHTVLDDLEKYPNGLDE- 99
Query: 533 MRLR-----IAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTAA 587
R+R I G+ +C H H I HR+++ +I +++ K+ DF F T A
Sbjct: 100 SRVRKYLFQILRGIEFC--HSHN----IIHRDIKPENILVSQSGVVKLCDFGF--ARTLA 151
Query: 588 KTGSA-----------AMELL--ETS---AVDLESNVYSFGTILFEMITG 621
G A ELL +T AVD +++ G ++ EM+TG
Sbjct: 152 APGEVYTDYVATRWYRAPELLVGDTKYGRAVD----IWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 3e-04
Identities = 47/210 (22%), Positives = 87/210 (41%), Gaps = 45/210 (21%)
Query: 437 DGTVGTVYKG-TLSSGVEIAVTSTSVKSRADW-SKNLESQFRKKIDTLSKVNHKNFVNLI 494
+GT G VYK +G +A+ K R D ++ + S ++I L ++NH N V L+
Sbjct: 10 EGTYGVVYKARNKLTGEVVALK----KIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 65
Query: 495 GYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAM----RLRIAMGMAYCLEHMHQ 550
+ +VFE+ + L + + + + ++ G+A+C H H+
Sbjct: 66 DVIHTENKL--YLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFC--HSHR 120
Query: 551 LTPPIAHRNLQSSSIYLTEDYAAKISDF------------------SFWNNTTAAKTGSA 592
+ HR+L+ ++ + + A K++DF + W G
Sbjct: 121 ----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 176
Query: 593 AMELLETSAVDLESNVYSFGTILFEMITGR 622
++AVD ++S G I EM+T R
Sbjct: 177 ----YYSTAVD----IWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 4e-04
Identities = 69/272 (25%), Positives = 110/272 (40%), Gaps = 43/272 (15%)
Query: 437 DGTVGTVYKGTLSSGVEIAVTSTSVKS-RADWSKNLESQFRKKIDTLSKVNHKNFVNLIG 495
+G G V G ++SG VK R S + +F ++ + H N + +G
Sbjct: 5 NGWFGKVILGEVNSG--YTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 496 YCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHL---DWAMRLRIAMGMAYCLEHMHQLT 552
C E P+ ++V E+ P G L +L L D R+A +A L H+H+
Sbjct: 63 QCTEVTPY--LLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN 120
Query: 553 PPIAHRNLQSSSIYLTEDYAAKISDFSFWNN-------TTAAKTGSA----AMELLETSA 601
H +L + LT D KI D+ +N T + A EL++
Sbjct: 121 --FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVH 178
Query: 602 VDL-------ESNVYSFGTILFEMITGRISYSIENGSLENWASE----YLKGEQPLKDIV 650
+L ESNV+S G ++E+ + + + + + E Y EQ LK +
Sbjct: 179 GNLLVVDQTKESNVWSLGVTIWEL------FELGSQPYRHLSDEQVLTYTVREQQLK-LP 231
Query: 651 DPTLKSFQENVLEELLVVIKNCVHPDPKQRPS 682
P LK + E V++ C P+QRPS
Sbjct: 232 KPRLKLPLSDRWYE---VMQFCWLQ-PEQRPS 259
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 4e-04
Identities = 41/157 (26%), Positives = 71/157 (45%), Gaps = 19/157 (12%)
Query: 537 IAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDF--SFWNNTTAAKTGSA-- 592
IA+ L ++ + I HR+++ S+I L + K+ DF S + AKT A
Sbjct: 112 IAVATVKALNYLKE-ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGC 170
Query: 593 ----AMELLETSAV---DLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQP 645
A E ++ SA D+ S+V+S G L+E+ TG+ Y N + ++ +KG+ P
Sbjct: 171 RPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQ-LTQVVKGDPP 229
Query: 646 LKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPS 682
I+ + + + I C+ D +RP
Sbjct: 230 ---ILSNSEE---REFSPSFVNFINLCLIKDESKRPK 260
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 4e-04
Identities = 56/229 (24%), Positives = 98/229 (42%), Gaps = 44/229 (19%)
Query: 470 NLESQFRKKID-------TLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLH 522
N E+Q K+D S + F + YCE + + E G
Sbjct: 50 NQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRD--LDCKLEELKHTGKTLS--- 104
Query: 523 IQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWN 582
E + +W ++L +G+ Y MHQ I HR+L++ +I+L + KI DF
Sbjct: 105 --ENQVCEWFIQL--LLGVHY----MHQRR--ILHRDLKAKNIFLKNNLL-KIGDFGVSR 153
Query: 583 ------NTTAAKTGSA---AMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLE 633
+ TG+ + E L+ D +S+++S G IL+EM ++++ E +
Sbjct: 154 LLMGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCC--LAHAFEG---Q 208
Query: 634 NWASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPS 682
N+ S L+ IV+ S E +L ++++ ++ DP RPS
Sbjct: 209 NFLSVVLR-------IVEGPTPSLPETYSRQLNSIMQSMLNKDPSLRPS 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 41.9 bits (99), Expect = 5e-04
Identities = 35/165 (21%), Positives = 70/165 (42%), Gaps = 20/165 (12%)
Query: 482 LSKVNHKNFVNL-IGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWA-MRLRIA- 538
L ++NH VNL + +E+ + +V + G L H+ + ++ I
Sbjct: 54 LQELNHPFLVNLWYSFQDEENMY---LVVDLLLGGDL--RYHLSQKVKFSEEQVKFWICE 108
Query: 539 MGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDF--------SFWNNTTAAKTG 590
+ +A LE++H + I HR+++ +I L E I+DF +T+ G
Sbjct: 109 IVLA--LEYLH--SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPG 164
Query: 591 SAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENW 635
A E+L + + +S G +E + G+ Y + ++ +
Sbjct: 165 YMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQ 209
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|215130 PLN02217, PLN02217, probable pectinesterase/pectinesterase inhibitor | Back alignment and domain information |
|---|
Score = 43.2 bits (101), Expect = 5e-04
Identities = 29/88 (32%), Positives = 43/88 (48%), Gaps = 5/88 (5%)
Query: 269 ASEPSSSSSIASSPEPLVSPSLSPSMSSLLSPSFSPSP--SPSESP---SVSSPLIIPPA 323
++ S+++ + SP +V+PS SP L SP +PS SPS SP + SP P +
Sbjct: 576 SAASSNTTFSSDSPSTVVAPSTSPPAGHLGSPPATPSKIVSPSTSPPASHLGSPSTTPSS 635
Query: 324 PVNIPIVSSPPHLHSAPTSFAASTPSQV 351
P + V+S + AST S V
Sbjct: 636 PESSIKVASTETASPESSIKVASTESSV 663
|
Length = 670 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 6e-04
Identities = 43/172 (25%), Positives = 69/172 (40%), Gaps = 30/172 (17%)
Query: 473 SQFRKKIDTLSKVNHKNFVNLI--GYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLD 530
++FR++ +++ H N V L+ G F VFEY P +L E L A
Sbjct: 23 ARFRRETALCARLYHPNIVALLDSGEAPPGLLFA---VFEYVPGRTLREVLAADGALPAG 79
Query: 531 WAMRLRIAMGMAYCLEHM-HQLTPPIAHRNLQSSSIYLTE---DYAAKISDFSF------ 580
RL M L+ + I HR+L+ +I +++ AK+ DF
Sbjct: 80 ETGRL-----MLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPG 134
Query: 581 ---WNNTTAAKTGS-------AAMELLETSAVDLESNVYSFGTILFEMITGR 622
+ T +T A E L V S++Y++G I E +TG+
Sbjct: 135 VRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 6e-04
Identities = 43/191 (22%), Positives = 81/191 (42%), Gaps = 35/191 (18%)
Query: 507 MVFEYSPNGSLFEHLHIQE--AEHLDWAMRLRIAMG-MAYCLEHMHQLTPPIAHRNLQSS 563
++ +Y G LF HL +E E ++I G + LEH+H+L I +R+++
Sbjct: 82 LILDYINGGELFTHLSQRERFKEQ-----EVQIYSGEIVLALEHLHKLG--IIYRDIKLE 134
Query: 564 SIYLTEDYAAKISDFSFWNNTTAAKTGSA-----AMELLETSAV-------DLESNVYSF 611
+I L + ++DF + A +E + V D + +S
Sbjct: 135 NILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSM 194
Query: 612 GTILFEMITGRISYSI--ENGSLENWASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVI 669
G +++E++TG +++ E S + LK E P + K ++++ LL+
Sbjct: 195 GVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAK----DIIQRLLM-- 248
Query: 670 KNCVHPDPKQR 680
DPK+R
Sbjct: 249 -----KDPKKR 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.8 bits (100), Expect = 7e-04
Identities = 59/252 (23%), Positives = 105/252 (41%), Gaps = 60/252 (23%)
Query: 472 ESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLH--------I 523
+SQ +++ + ++ HKN V I ++ E+ G L ++ I
Sbjct: 56 KSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKI 115
Query: 524 QEAEHLDWAMRLRIAMGMAYCLEHMHQLT-----PPIAHRNLQSSSIYLTEDY------- 571
+E +D +L A+ AYC H L + HR+L+ +I+L+
Sbjct: 116 EEHAIVDITRQLLHAL--AYC----HNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169
Query: 572 ----------AAKISDFSFWNNTTAAKTGSAAM--------ELL--ETSAVDLESNVYSF 611
AKI DF N + + ELL ET + D +S++++
Sbjct: 170 AQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWAL 229
Query: 612 GTILFEMITGRISYSIENGSLENWASEYLKG-EQPLKDIVDPTLKSFQENVLEELLVVIK 670
G I++E+ +G+ + N + SE +G + P+K KS +EL ++IK
Sbjct: 230 GCIIYELCSGKTPFHKAN-NFSQLISELKRGPDLPIKG------KS------KELNILIK 276
Query: 671 NCVHPDPKQRPS 682
N ++ K+RPS
Sbjct: 277 NLLNLSAKERPS 288
|
Length = 1021 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 0.001
Identities = 59/252 (23%), Positives = 102/252 (40%), Gaps = 44/252 (17%)
Query: 432 IGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFV 491
IGS + G V Y L V I S +++ + + +R+ + + VNHKN +
Sbjct: 32 IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQT----HAKRAYRELV-LMKCVNHKNII 86
Query: 492 NLIGYCEEDEPFTRMMVFEYSPNGSL--FEHLHIQEAEHLDWAMRLRIAMG-----MAYC 544
L+ ++P SL F+ ++I E +D + I M M+Y
Sbjct: 87 GLLNV--------------FTPQKSLEEFQDVYIV-MELMDANLCQVIQMELDHERMSYL 131
Query: 545 LEHM-----HQLTPPIAHRNLQSSSIYLTEDYAAKISDF--------SFWNNTTAAKTGS 591
L M H + I HR+L+ S+I + D KI DF SF
Sbjct: 132 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYY 191
Query: 592 AAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDI-- 649
A E++ +++S G I+ EMI G + + + ++ W + P +
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD-HIDQWNKVIEQLGTPCPEFMK 250
Query: 650 -VDPTLKSFQEN 660
+ PT++++ EN
Sbjct: 251 KLQPTVRTYVEN 262
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 0.001
Identities = 61/279 (21%), Positives = 117/279 (41%), Gaps = 50/279 (17%)
Query: 429 SNIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKN---LESQFRKKIDTLSKV 485
S ++GS + GTV + +S G AV ++ ++ KN E D S V
Sbjct: 37 SRVLGSGATGTV--LCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIV 94
Query: 486 N-HKNFVNLIGYCEEDEPFTRMM---VFEYSPNGSLFEHLHIQE------AEHLDWAMRL 535
H++F + P +M V +Y+ G L + + + EH + +
Sbjct: 95 KCHEDFA----KKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFI 150
Query: 536 RIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSF---WNNTTAAKTGSA 592
++ + + H+H + + HR+++S++I L + K+ DF F + T + G
Sbjct: 151 QVLLA----VHHVH--SKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRT 204
Query: 593 --------AMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGE- 643
A E+ +++++S G +L+E++T + + EN +E + L G
Sbjct: 205 FCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN--MEEVMHKTLAGRY 262
Query: 644 QPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPS 682
PL + P E+ ++ + DPK+RPS
Sbjct: 263 DPLPPSISP-----------EMQEIVTALLSSDPKRRPS 290
|
Length = 496 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.1 bits (97), Expect = 0.001
Identities = 69/296 (23%), Positives = 117/296 (39%), Gaps = 85/296 (28%)
Query: 431 IIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKV-NHK 488
+IG +GT G VYK +G +A+ + ++ E + +++ + L K NH
Sbjct: 13 VIG---EGTYGKVYKARHKKTGQLVAIKIMDII------EDEEEEIKEEYNILRKYSNHP 63
Query: 489 NFVNLIG-------YCEEDEPFTRMMVFEYSPNGS---LFEHLHIQ----EAEHLDWAMR 534
N G +D+ + +V E GS L + L + + E + + +R
Sbjct: 64 NIATFYGAFIKKNPPGNDDQLW---LVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILR 120
Query: 535 LRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDF--SFWNNTTAAKTGS- 591
G+AY H ++ + HR+++ +I LT++ K+ DF S ++T + +
Sbjct: 121 -ETLRGLAYL--HENK----VIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTF 173
Query: 592 ------------AAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEY 639
A E + S D S+V+S G IT IE
Sbjct: 174 IGTPYWMAPEVIACDEQPDAS-YDARSDVWSLG------ITA-----IELA--------- 212
Query: 640 LKGEQPLKDI------------VDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSM 683
G+ PL D+ PTLKS EN ++ I C+ + +QRP M
Sbjct: 213 -DGKPPLCDMHPMRALFKIPRNPPPTLKS-PENWSKKFNDFISECLIKNYEQRPFM 266
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.001
Identities = 58/269 (21%), Positives = 111/269 (41%), Gaps = 57/269 (21%)
Query: 438 GTVGTVYKGTLSSGVEI-AVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIG- 495
G+ G VYKG + E+ A+ ++ D ++++ ++I LS+ + G
Sbjct: 15 GSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQ----QEITVLSQCDSPYITRYYGS 70
Query: 496 YCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLR-IAMGMAYCLEHMHQLTPP 554
Y + + + ++ EY GS + L E A LR I G L+++H +
Sbjct: 71 YLKGTKLW---IIMEYLGGGSALDLLKPGPLEETYIATILREILKG----LDYLH--SER 121
Query: 555 IAHRNLQSSSIYLTEDYAAKISDF---------SFWNNTTAAKTGSAAMELLETSAVDLE 605
HR+++++++ L+E K++DF NT A E+++ SA D +
Sbjct: 122 KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFK 181
Query: 606 SNVYSFGTILFEMITG----------RISYSIENGSLENWASEYLKGEQPLKDIVDPTLK 655
++++S G E+ G R+ + I S +Y K P K+ V+
Sbjct: 182 ADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSK---PFKEFVEA--- 235
Query: 656 SFQENVLEELLVVIKNCVHPDPKQRPSMR 684
C++ DP+ RP+ +
Sbjct: 236 ----------------CLNKDPRFRPTAK 248
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.001
Identities = 37/137 (27%), Positives = 62/137 (45%), Gaps = 21/137 (15%)
Query: 557 HRNLQSSSIYLTEDYAAKISDFSF----WNNTTAAKTGSA-------AMELLETSAVDLE 605
HR+L + +I L+E+ KI DF + + + GSA A E + +
Sbjct: 197 HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQ 256
Query: 606 SNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQENVLEEL 665
S+V+SFG +L+E+ + + S G N E+ + + D T EN E+
Sbjct: 257 SDVWSFGVLLWEIFS--LGASPYPGVQIN--------EEFCQRLKDGTRMRAPENATPEI 306
Query: 666 LVVIKNCVHPDPKQRPS 682
++ C DPK+RP+
Sbjct: 307 YRIMLACWQGDPKERPT 323
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 40.9 bits (95), Expect = 0.001
Identities = 46/204 (22%), Positives = 85/204 (41%), Gaps = 26/204 (12%)
Query: 437 DGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNH-KNFVNLIG 495
+GT G VYKG ++A D + + E + +++I+ L K +H +N G
Sbjct: 16 NGTYGQVYKGRHVKTGQLAAIKV-----MDVTGDEEEEIKQEINMLKKYSHHRNIATYYG 70
Query: 496 -YCEEDEPFTR---MMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQL 551
+ +++ P +V E+ GS+ + + + L I + L H+HQ
Sbjct: 71 AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ- 129
Query: 552 TPPIAHRNLQSSSIYLTEDYAAKISDFSF---------WNNTTAAKTGSAAMELLET--- 599
+ HR+++ ++ LTE+ K+ DF NT A E++
Sbjct: 130 -HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDEN 188
Query: 600 --SAVDLESNVYSFGTILFEMITG 621
+ D +S+++S G EM G
Sbjct: 189 PDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 53/222 (23%), Positives = 94/222 (42%), Gaps = 36/222 (16%)
Query: 416 LKRSELEAACEDFSNIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKS-RADWSKNLESQ 474
LK +EL+ ++GS G GTVYKG E ++K R + S +
Sbjct: 4 LKETELKKV-----KVLGS---GAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKE 55
Query: 475 FRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLH-----IQEAEHL 529
+ ++ V L+G C T +V + P G L +++ I + L
Sbjct: 56 ILDEAYVMAGVGSPYVCRLLGICLTS---TVQLVTQLMPYGCLLDYVRENKDRIGSQDLL 112
Query: 530 DWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFW-----NNT 584
+W ++IA GM+Y LE + + HR+L + ++ + KI+DF + T
Sbjct: 113 NWC--VQIAKGMSY-LEEVR-----LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDET 164
Query: 585 TAAKTGSA------AMELLETSAVDLESNVYSFGTILFEMIT 620
G A+E + +S+V+S+G ++E++T
Sbjct: 165 EYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 33/143 (23%), Positives = 64/143 (44%), Gaps = 31/143 (21%)
Query: 555 IAHRNLQSSSIYLTEDYAAKISDFSFWNNTTA------AKTGSA---AMELLETSAVDLE 605
+ HR+++S SI LT D K+SDF F + + G+ A E++ + E
Sbjct: 138 VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTE 197
Query: 606 SNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQE------ 659
+++S G ++ EM+ G Y ++ ++ + L+D P LK+ +
Sbjct: 198 VDIWSLGIMVIEMVDGEPPY---------FSDSPVQAMKRLRDSPPPKLKNAHKISPVLR 248
Query: 660 NVLEELLVVIKNCVHPDPKQRPS 682
+ LE +L +P++R +
Sbjct: 249 DFLERMLT-------REPQERAT 264
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.002
Identities = 55/225 (24%), Positives = 93/225 (41%), Gaps = 45/225 (20%)
Query: 482 LSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGM 541
+ +V+HK+ V L G C D +MV E+ G L +H ++++ L + ++A +
Sbjct: 58 MRQVSHKHIVLLYGVCVRDV--ENIMVEEFVEFGPLDLFMH-RKSDVLTTPWKFKVAKQL 114
Query: 542 AYCLEHMHQLTPPIAHRNLQSSSIYLTEDYA-------AKISD-----FSFWNNTTAAKT 589
A L ++ + H N+ + +I L + K+SD +
Sbjct: 115 ASALSYLED--KDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVERI 172
Query: 590 GSAAMELLETSAV-DLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKD 648
A E +E S + ++ +SFGT L+E I Y+ GE PLKD
Sbjct: 173 PWIAPECVEDSKNLSIAADKWSFGTTLWE-----ICYN---------------GEIPLKD 212
Query: 649 IVDPTLKSFQENVL-------EELLVVIKNCVHPDPKQRPSMRGI 686
+ F E +EL ++ +C++ DP QRP R I
Sbjct: 213 KTLAEKERFYEGQCMLVTPSCKELADLMTHCMNYDPNQRPFFRAI 257
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 47/196 (23%), Positives = 82/196 (41%), Gaps = 24/196 (12%)
Query: 446 GTLSSG-VEIAVTSTSVKSRADWSKNLESQFRKK-----IDTLSKVNHKNFVNLI-GYCE 498
G S+G V IA + K A +L Q R++ + + +H+N V++ Y
Sbjct: 31 GEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLV 90
Query: 499 EDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHR 558
DE + M E + H + E + + + + L ++H + HR
Sbjct: 91 GDELWVVMEFLEGGALTDIVTHTRMNEEQ------IATVCLSVLRALSYLH--NQGVIHR 142
Query: 559 NLQSSSIYLTEDYAAKISDFSFWNNTT------AAKTGSA---AMELLETSAVDLESNVY 609
+++S SI LT D K+SDF F + + G+ A E++ E +++
Sbjct: 143 DIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIW 202
Query: 610 SFGTILFEMITGRISY 625
S G ++ EMI G Y
Sbjct: 203 SLGIMVIEMIDGEPPY 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|218693 pfam05687, DUF822, Plant protein of unknown function (DUF822) | Back alignment and domain information |
|---|
Score = 38.6 bits (90), Expect = 0.003
Identities = 26/88 (29%), Positives = 39/88 (44%), Gaps = 1/88 (1%)
Query: 245 VQPGDNAFRRMLQQVTNGFEAKRKASEPSSSSSIASSPEPLVSPSLSPSMSSLLSPSFSP 304
V+P +R+ + E ++ S SS SP PS PS S+ + S P
Sbjct: 62 VEPDGTTYRKG-CKPLERMEGAGSSATASPCSSYQLSPVSSAFPSPVPSYSASPASSSFP 120
Query: 305 SPSPSESPSVSSPLIIPPAPVNIPIVSS 332
SPS +S +SS + P + +VSS
Sbjct: 121 SPSSLDSIPISSAASLLPWLSVLSLVSS 148
|
This family consists of the N terminal regions of several plant proteins of unknown function. Length = 151 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.003
Identities = 51/260 (19%), Positives = 99/260 (38%), Gaps = 33/260 (12%)
Query: 438 GTVGTVYKG-TLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGY 496
G G VY +G E+AV + + + +I L + H+ V G
Sbjct: 13 GAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGC 72
Query: 497 CEEDEPFTRMMVFEYSPNGSLFEHLHIQEA--EHLDWAMRLRIAMGMAYCLEHMHQLTPP 554
+ T + E+ P GS+ + L A E++ +I G++Y +M
Sbjct: 73 LRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNM------ 126
Query: 555 IAHRNLQSSSIYLTEDYAAKISDFSFWNN-TTAAKTGSAAM-----------ELLETSAV 602
I HR+++ ++I K+ DF T +G+ E++
Sbjct: 127 IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGY 186
Query: 603 DLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQENVL 662
+++++S G + EM+T + ++ E A+ + QP ++ P + + L
Sbjct: 187 GRKADIWSVGCTVVEMLTEKPPWA----EFEAMAAIFKIATQPTNPVLPPHVSDHCRDFL 242
Query: 663 EELLVVIKNCVHPDPKQRPS 682
+ + V + K RPS
Sbjct: 243 KRIFV--------EAKLRPS 254
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.003
Identities = 39/136 (28%), Positives = 61/136 (44%), Gaps = 21/136 (15%)
Query: 507 MVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIY 566
++ EY G LF HL + D A + +A LEH+HQ I +R+L+ +I
Sbjct: 77 LILEYLSGGELFMHLEREGIFMEDTACFYLSEISLA--LEHLHQQG--IIYRDLKPENIL 132
Query: 567 LTEDYAAKISDFS------FWNNTTAAKTGS---AAMELLETS----AVDLESNVYSFGT 613
L K++DF T G+ A E+L S AVD +S G
Sbjct: 133 LDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGHGKAVDW----WSLGA 188
Query: 614 ILFEMITGRISYSIEN 629
++++M+TG ++ EN
Sbjct: 189 LMYDMLTGAPPFTAEN 204
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|218191 pfam04652, DUF605, Vta1 like | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.004
Identities = 23/104 (22%), Positives = 27/104 (25%), Gaps = 2/104 (1%)
Query: 260 TNGFEAKRKASEPSSSSSIASSPEPLVSPSLSPSMSSLLSPSFSPSPSPSESPSVSSPLI 319
+ A S+P SSS P P S S P S P
Sbjct: 175 EDADPASASPSDPPSSSP--GVPSFPSPPEDPSSPSDSSLPPAPSSFQSDTPPPSPESPT 232
Query: 320 IPPAPVNIPIVSSPPHLHSAPTSFAASTPSQVHESLHKSKHHTV 363
P P PP P S A TP + T+
Sbjct: 233 NPSPPPGPAAPPPPPVQQVPPLSTAKPTPPSASATPAPIGGITL 276
|
Vta1 (VPS20-associated protein 1) is a positive regulator of Vps4. Vps4 is an ATPase that is required in the multivesicular body (MVB) sorting pathway to dissociate the endosomal sorting complex required for transport (ESCRT). Vta1 promotes correct assembly of Vps4 and stimulates its ATPase activity through its conserved Vta1/SBP1/LIP5 region. Length = 315 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 36.0 bits (84), Expect = 0.004
Identities = 22/59 (37%), Positives = 27/59 (45%), Gaps = 2/59 (3%)
Query: 144 LKSIILRNNSFFGTIPKEI-GELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLLDNNQ 201
LKS+ L NN IP L L++LDL NN + P F SL +L L N
Sbjct: 2 LKSLDLSNNRL-TVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59
|
Length = 60 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.004
Identities = 53/249 (21%), Positives = 92/249 (36%), Gaps = 35/249 (14%)
Query: 472 ESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDW 531
ES + L KVN + VNL E + +V G L H++ +
Sbjct: 44 ESMALNEKQILEKVNSQFVVNLAYAYETKDALC--LVLTIMNGGDLKFHIYNMGNPGFEE 101
Query: 532 AMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTAAKT-- 589
L A + LE +H+ +R+L+ +I L + +ISD ++
Sbjct: 102 ERALFYAAEILCGLEDLHR--ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIR 159
Query: 590 ------GSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGE 643
G A E+L L + + G +++EMI G+ + E +K E
Sbjct: 160 GRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRK--------EKVKRE 211
Query: 644 QPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQR--------------PSMRGIAAK 689
+ + +++ T + + EE + K + DPKQR P R + K
Sbjct: 212 EVDRRVLE-TEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFK 270
Query: 690 LKEITAMEP 698
E ++P
Sbjct: 271 RLEAGMLDP 279
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.004
Identities = 41/149 (27%), Positives = 66/149 (44%), Gaps = 30/149 (20%)
Query: 489 NFVNLIGY-CEEDEPFTRMMVFEYSPNGSLFEH----LHIQEAEHLDWAMRLRIAMGMAY 543
N V L Y ED F +V +++ G L+ H L+I E WA + +A
Sbjct: 46 NMVCLHKYIVSEDSVF---LVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVA----- 97
Query: 544 CLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTAAKTGSAAMELL------ 597
L+ +H+ I R+L ++I L + +++ FS W+ + G A +
Sbjct: 98 -LDALHR--EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENMYCAPEVG 154
Query: 598 ----ETSAVDLESNVYSFGTILFEMITGR 622
ET A D +S G ILFE++TG+
Sbjct: 155 GISEETEACDW----WSLGAILFELLTGK 179
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.004
Identities = 42/186 (22%), Positives = 79/186 (42%), Gaps = 25/186 (13%)
Query: 507 MVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIY 566
+V EY G L H+Q L A + L +H+ I +R+L+ ++
Sbjct: 73 LVIEYVNGGDLM--FHMQRQRKLPEEHARFYAAEICIALNFLHE--RGIIYRDLKLDNVL 128
Query: 567 LTEDYAAKISDFSFWN------NTTAAKTGSA---AMELLETSAVDLESNVYSFGTILFE 617
L D K++D+ +TT+ G+ A E+L + ++ G ++FE
Sbjct: 129 LDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFE 188
Query: 618 MITGRISYSIENGSLENWASEYLKG---EQPLKDIVDPTLKSFQENVLEELLVVIKNCVH 674
M+ GR + I + + +YL E+P++ ++K+ V+K ++
Sbjct: 189 MMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASH---------VLKGFLN 239
Query: 675 PDPKQR 680
DPK+R
Sbjct: 240 KDPKER 245
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.004
Identities = 34/128 (26%), Positives = 58/128 (45%), Gaps = 11/128 (8%)
Query: 545 LEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTAAKT-------GSAAMELL 597
LEHMH + +R+L+ ++I L E +ISD + + K G A E+L
Sbjct: 110 LEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVL 167
Query: 598 ET-SAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEY-LKGEQPLKDIVDPTLK 655
+ +A D ++ +S G +LF+++ G + ++ L L D P LK
Sbjct: 168 QKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELK 227
Query: 656 SFQENVLE 663
S E +L+
Sbjct: 228 SLLEGLLQ 235
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 721 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.98 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.98 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.98 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.98 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.96 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.95 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.94 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.94 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.94 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.93 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.93 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.93 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.93 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.92 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.91 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.9 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.9 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.84 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.84 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.83 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.83 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.82 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.82 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.8 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.8 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.79 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.77 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.76 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.75 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.73 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.73 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.73 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.71 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.7 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.7 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.69 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.67 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.67 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.66 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.66 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.63 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.57 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.54 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.54 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.53 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.52 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.42 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.4 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.35 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.34 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.24 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.18 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.03 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 98.96 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.95 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.93 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.92 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.9 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.89 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.87 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.86 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 98.81 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.75 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.64 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 98.63 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 98.62 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.56 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.54 | |
| PF08263 | 43 | LRRNT_2: Leucine rich repeat N-terminal domain; In | 98.53 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 98.49 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 98.47 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.42 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.34 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.32 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 98.26 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 98.26 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.23 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 98.23 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.22 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 98.2 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.19 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.19 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.18 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 98.18 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 98.14 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 98.12 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 98.11 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 98.07 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 98.05 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 98.02 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.01 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 97.97 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.93 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 97.92 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.89 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 97.87 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 97.86 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 97.75 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.73 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 97.62 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.62 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 97.62 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 97.59 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.54 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.54 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.52 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 97.44 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 97.38 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 97.38 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 97.35 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.31 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-54 Score=523.63 Aligned_cols=490 Identities=22% Similarity=0.362 Sum_probs=312.8
Q ss_pred CcEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCccccCCCCCCEEEC
Q 004979 118 GKVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLL 197 (721)
Q Consensus 118 ~~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~~L~~l~l 197 (721)
..+..|+|++|.+.|.+|..+ .+++|+.|+|++|.++|.+|..+.++++|+.|+|++|+++|.+|..++++++|++|+|
T Consensus 452 ~~L~~L~L~~n~~~~~~p~~~-~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 530 (968)
T PLN00113 452 PSLQMLSLARNKFFGGLPDSF-GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDL 530 (968)
T ss_pred CCCcEEECcCceeeeecCccc-ccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEEC
Confidence 356777888888877777654 3477788888888888888877778888888888888888888877778888888888
Q ss_pred ccCCCCcCCChhccCCCCCCEEEccCCCCCCcccccccCCCCCccccccCCChhhhhhhhccccccccccccCCCCCCCc
Q 004979 198 DNNQYLGGISPELHVLKVISEIQVDESWLTNAASRASCNSGLFTWNKVQPGDNAFRRMLQQVTNGFEAKRKASEPSSSSS 277 (721)
Q Consensus 198 ~~N~~~G~iP~~~~~l~~L~~l~l~~n~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 277 (721)
++|.++|.+|..+..+++|+.|+|++|.++|.+|........+. ...+..|.+.+..|... .+
T Consensus 531 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~----------~l~ls~N~l~~~~p~~~------~~- 593 (968)
T PLN00113 531 SHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLV----------QVNISHNHLHGSLPSTG------AF- 593 (968)
T ss_pred CCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccC----------EEeccCCcceeeCCCcc------hh-
Confidence 88888888888888888888888888888877775311110000 00011111111111000 00
Q ss_pred cCCCCCCCCCCCCCCcccCCCCCCCCCCCCCCCCCCCCCCccCCCCCCCCCccCCCCCCCCCCCCCCCCCCccccccccc
Q 004979 278 IASSPEPLVSPSLSPSMSSLLSPSFSPSPSPSESPSVSSPLIIPPAPVNIPIVSSPPHLHSAPTSFAASTPSQVHESLHK 357 (721)
Q Consensus 278 ~~~~~~~l~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (721)
..+....+..++ ..+..+......+|. ...
T Consensus 594 -----------------~~~~~~~~~~n~---------------------~lc~~~~~~~~~~c~------------~~~ 623 (968)
T PLN00113 594 -----------------LAINASAVAGNI---------------------DLCGGDTTSGLPPCK------------RVR 623 (968)
T ss_pred -----------------cccChhhhcCCc---------------------cccCCccccCCCCCc------------ccc
Confidence 000000000000 000000000001110 000
Q ss_pred CccceeeeehHHHHHHHHHHHHHHHHHhhhcccccccCCCccCCchhhhhhhhc--CCCCCCHHHHHHHHhhhhhhhCcC
Q 004979 358 SKHHTVLVLAGIIGGLSLILISAIGFFVCRSSKVVTVKPWVTGLSGQLQKAFVT--GVPKLKRSELEAACEDFSNIIGSF 435 (721)
Q Consensus 358 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~~~~~~~~ii~~l 435 (721)
+......++++++++++++++++++++++|+++....+..... .+.+...... ....++.+++. ..+ +....+
T Consensus 624 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~---~~~-~~~~~i 698 (968)
T PLN00113 624 KTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENE-DGTWELQFFDSKVSKSITINDIL---SSL-KEENVI 698 (968)
T ss_pred ccceeeeehhHHHHHHHHHHHHHHHHHHHHhhhcccccccccc-cccccccccccccchhhhHHHHH---hhC-CcccEE
Confidence 1111222333333333333333333444443332211111110 0001000000 01112333332 222 334578
Q ss_pred CCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEEEecCCC
Q 004979 436 SDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPN 514 (721)
Q Consensus 436 g~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV~Ey~~~ 514 (721)
|+|+||.||+|+. .++..||||++..... ...+|++++++++|||||+++|+|.+.+ ..++||||+++
T Consensus 699 g~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~l~~l~HpnIv~~~~~~~~~~--~~~lv~Ey~~~ 767 (968)
T PLN00113 699 SRGKKGASYKGKSIKNGMQFVVKEINDVNS---------IPSSEIADMGKLQHPNIVKLIGLCRSEK--GAYLIHEYIEG 767 (968)
T ss_pred ccCCCeeEEEEEECCCCcEEEEEEccCCcc---------ccHHHHHHHhhCCCCCcceEEEEEEcCC--CCEEEEeCCCC
Confidence 8999999999996 5788999998753221 1234688999999999999999998876 56999999999
Q ss_pred CChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC-----CCCC
Q 004979 515 GSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQL-TPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT-----TAAK 588 (721)
Q Consensus 515 GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~-~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~-----~~~~ 588 (721)
|+|.++++ .++|..+.+|+.|+++||+|||.. .++|+||||||+||+++.++.+++. ||..... ..++
T Consensus 768 g~L~~~l~-----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~~~~~~t 841 (968)
T PLN00113 768 KNLSEVLR-----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFIS 841 (968)
T ss_pred CcHHHHHh-----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccCCCcccc
Confidence 99999985 389999999999999999999953 4569999999999999999988876 6654322 2234
Q ss_pred ccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCC---CCCHHHHHHHHhhcCCCCccccCCccc---cccHHHH
Q 004979 589 TGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIE---NGSLENWASEYLKGEQPLKDIVDPTLK---SFQENVL 662 (721)
Q Consensus 589 ~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~---~~~~~~~~~~~~~~~~~~~~~~d~~l~---~~~~~~~ 662 (721)
..|+|||.+.+..++.++|||||||++|||+||+.||+.. .....+|.+..... .....++|+.+. ....+..
T Consensus 842 ~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 920 (968)
T PLN00113 842 SAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSD-CHLDMWIDPSIRGDVSVNQNEI 920 (968)
T ss_pred ccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCc-cchhheeCccccCCCCccHHHH
Confidence 6899999999999999999999999999999999998643 34566676554332 233445555442 2334566
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCC
Q 004979 663 EELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAMEP 698 (721)
Q Consensus 663 ~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 698 (721)
.++.+++.+||+.||++||+|+||++.|+++.+...
T Consensus 921 ~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~ 956 (968)
T PLN00113 921 VEVMNLALHCTATDPTARPCANDVLKTLESASRSSS 956 (968)
T ss_pred HHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcccc
Confidence 788999999999999999999999999999877544
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-51 Score=439.50 Aligned_cols=277 Identities=40% Similarity=0.687 Sum_probs=236.5
Q ss_pred CCCCCCHHHHHHHHhhhhhhhCcCCCCceeEEEEEEecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccc
Q 004979 412 GVPKLKRSELEAACEDFSNIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFV 491 (721)
Q Consensus 412 ~~~~~~~~~l~~~~~~~~~ii~~lg~G~~g~Vyk~~~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv 491 (721)
....|++.|+..+|++|+.- ..+|+|+||.||+|.++++..||||++...... . .++|..|++++++++|||+|
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~-~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~----~-~~eF~~Ei~~ls~l~H~Nlv 134 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSES-NLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQ----G-EREFLNEVEILSRLRHPNLV 134 (361)
T ss_pred CcceeeHHHHHHHHhCCchh-cceecCCCeEEEEEEECCCCEEEEEEecCCCCc----c-hhHHHHHHHHHhcCCCcCcc
Confidence 34568999999999999731 245578899999999999999999976543221 1 35699999999999999999
Q ss_pred eEeEEEecCCCceEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCeEeeCCCCCCeEeCCC
Q 004979 492 NLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQ-LTPPIAHRNLQSSSIYLTED 570 (721)
Q Consensus 492 ~l~g~~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~-~~~~IvHrDLKp~NILl~~~ 570 (721)
+++|||.+.+. +.+||||||++|+|.++|+......++|.+|++||.++|+||+|||+ +.|+|||||||++|||||++
T Consensus 135 ~LlGyC~e~~~-~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~ 213 (361)
T KOG1187|consen 135 KLLGYCLEGGE-HRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDED 213 (361)
T ss_pred cEEEEEecCCc-eEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCC
Confidence 99999998763 37999999999999999986543389999999999999999999997 66699999999999999999
Q ss_pred CcEEEeccCCCCCCC----------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCC----CCCHHHHH
Q 004979 571 YAAKISDFSFWNNTT----------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIE----NGSLENWA 636 (721)
Q Consensus 571 ~~~kL~DFGla~~~~----------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~----~~~~~~~~ 636 (721)
+++||+|||+++... .++.+|++||+...+..+.|+|||||||+|+||+||+.+.+.. ...+.+|+
T Consensus 214 ~~aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~ 293 (361)
T KOG1187|consen 214 FNAKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWA 293 (361)
T ss_pred CCEEccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHH
Confidence 999999999987655 4566899999999999999999999999999999999888732 34578898
Q ss_pred HHHhhcCCCCccccCCccc--cccH-HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 004979 637 SEYLKGEQPLKDIVDPTLK--SFQE-NVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAM 696 (721)
Q Consensus 637 ~~~~~~~~~~~~~~d~~l~--~~~~-~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~ 696 (721)
...+... .+.+++|+.+. .+.. .....+..++.+|++.+|++||+|.||+++|+.+...
T Consensus 294 ~~~~~~~-~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 294 KPLLEEG-KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred HHHHHCc-chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 7777654 78999999975 3443 5777899999999999999999999999999766544
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-47 Score=403.51 Aligned_cols=249 Identities=31% Similarity=0.450 Sum_probs=207.6
Q ss_pred CcCCCCceeEEEEEEecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEEEecC
Q 004979 433 GSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYS 512 (721)
Q Consensus 433 ~~lg~G~~g~Vyk~~~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV~Ey~ 512 (721)
..+|.|+||+||+|.++....||||++........ ..++|.+|+.+|.+++|||||+++|+|.+... ..++|||||
T Consensus 47 ~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~---~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~-~~~iVtEy~ 122 (362)
T KOG0192|consen 47 EVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDE---SRKAFRREASLLSRLRHPNIVQFYGACTSPPG-SLCIVTEYM 122 (362)
T ss_pred hhcccCCceeEEEEEeCCceeEEEEEecchhcChH---HHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC-ceEEEEEeC
Confidence 34889999999999998666699999876543332 26789999999999999999999999987642 368999999
Q ss_pred CCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCC-cEEEeccCCCCCCC------
Q 004979 513 PNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDY-AAKISDFSFWNNTT------ 585 (721)
Q Consensus 513 ~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~-~~kL~DFGla~~~~------ 585 (721)
++|+|.++++......+++..+++||.|||+||.|||++++ ||||||||+|||++.++ ++||+|||+++...
T Consensus 123 ~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~-iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~~~~ 201 (362)
T KOG0192|consen 123 PGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP-IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISKTSM 201 (362)
T ss_pred CCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC-eeecccChhhEEEcCCCCEEEECCCccceeeccccccc
Confidence 99999999986556789999999999999999999999887 99999999999999997 99999999985332
Q ss_pred ---CCCccccchhhcc--cCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccHH
Q 004979 586 ---AAKTGSAAMELLE--TSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQEN 660 (721)
Q Consensus 586 ---~~~~~~~apE~~~--~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 660 (721)
.++..|||||++. ...|+.|+|||||||+||||+||+.||..... .+....+..... ...++..
T Consensus 202 ~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~--~~~~~~v~~~~~---------Rp~~p~~ 270 (362)
T KOG0192|consen 202 TSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP--VQVASAVVVGGL---------RPPIPKE 270 (362)
T ss_pred cCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH--HHHHHHHHhcCC---------CCCCCcc
Confidence 4556799999999 66999999999999999999999999964433 333333332211 1123344
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcC
Q 004979 661 VLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAME 697 (721)
Q Consensus 661 ~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 697 (721)
+...+..+|.+||..||+.||++.|++..|+.+....
T Consensus 271 ~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~ 307 (362)
T KOG0192|consen 271 CPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHI 307 (362)
T ss_pred CCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhh
Confidence 7788999999999999999999999999999887643
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-47 Score=400.56 Aligned_cols=246 Identities=28% Similarity=0.459 Sum_probs=213.4
Q ss_pred hhhCcCCCCceeEEEEEEecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVF 509 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV~ 509 (721)
+.+.+||+|.||+||.|.++....||+|.++..... .+.|.+|+++|++|+|+|||+++|+|..++ -++|||
T Consensus 209 ~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~------~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~--piyIVt 280 (468)
T KOG0197|consen 209 KLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMS------PEAFLREAQIMKKLRHEKLVKLYGVCTKQE--PIYIVT 280 (468)
T ss_pred HHHHHhcCCccceEEEEEEcCCCcccceEEeccccC------hhHHHHHHHHHHhCcccCeEEEEEEEecCC--ceEEEE
Confidence 567889999999999999998889999998865432 267999999999999999999999999877 469999
Q ss_pred ecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCCCC--
Q 004979 510 EYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTAA-- 587 (721)
Q Consensus 510 Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~~~-- 587 (721)
|||++|+|.++|+......+...+.+.++.|||+||+||++++ +|||||.++|||++++..+||+|||+++.....
T Consensus 281 E~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~--~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y 358 (468)
T KOG0197|consen 281 EYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN--YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEY 358 (468)
T ss_pred EecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC--ccchhhhhhheeeccCceEEEcccccccccCCCce
Confidence 9999999999998766778999999999999999999999988 999999999999999999999999999843321
Q ss_pred --------CccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhcCCCCccccCCcccccc
Q 004979 588 --------KTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQ 658 (721)
Q Consensus 588 --------~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 658 (721)
...|.|||.+..++++.|||||||||+||||+| |+.||. +....+.+..+-.|.+ + ..+
T Consensus 359 ~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~--~msn~ev~~~le~GyR-l---------p~P 426 (468)
T KOG0197|consen 359 TASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYP--GMSNEEVLELLERGYR-L---------PRP 426 (468)
T ss_pred eecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCC--CCCHHHHHHHHhccCc-C---------CCC
Confidence 235789999999999999999999999999999 999985 4455555555554432 1 235
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcC
Q 004979 659 ENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAME 697 (721)
Q Consensus 659 ~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 697 (721)
+.|+.+++++|..||+.+|++||||+.+...|+++....
T Consensus 427 ~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~ 465 (468)
T KOG0197|consen 427 EGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTST 465 (468)
T ss_pred CCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhcc
Confidence 678899999999999999999999999999998876543
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-45 Score=370.75 Aligned_cols=240 Identities=21% Similarity=0.319 Sum_probs=203.1
Q ss_pred hhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEEE
Q 004979 431 IIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVF 509 (721)
Q Consensus 431 ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV~ 509 (721)
.++.+|+|..|+|||++++ +++.+|.|.+... ......+++.+|++++.+.+||+||++||.|..... ...|+|
T Consensus 83 ~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~----~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~-~isI~m 157 (364)
T KOG0581|consen 83 RLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN----IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE-EISICM 157 (364)
T ss_pred hhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc----CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc-eEEeeh
Confidence 4678899999999999976 5677888888432 235567899999999999999999999999998774 489999
Q ss_pred ecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCC-----
Q 004979 510 EYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQ-LTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNN----- 583 (721)
Q Consensus 510 Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~-~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~----- 583 (721)
|||.+|||.+++.. .+.+++...-+|+.+|.+||.|||+ .+ ||||||||+|||++..|++||||||.++.
T Consensus 158 EYMDgGSLd~~~k~--~g~i~E~~L~~ia~~VL~GL~YLh~~~~--IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS~ 233 (364)
T KOG0581|consen 158 EYMDGGSLDDILKR--VGRIPEPVLGKIARAVLRGLSYLHEERK--IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNSI 233 (364)
T ss_pred hhcCCCCHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhhccC--eeeccCCHHHeeeccCCCEEeccccccHHhhhhh
Confidence 99999999999863 3568999999999999999999995 66 99999999999999999999999998753
Q ss_pred --CCCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCC---CCCHHHHHHHHhhcCCCCccccCCcccccc
Q 004979 584 --TTAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIE---NGSLENWASEYLKGEQPLKDIVDPTLKSFQ 658 (721)
Q Consensus 584 --~~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~---~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 658 (721)
...|+..|||||.+.+..|+.++||||||++++|+++|+.||... ..+..+.+..++.+.. +..+
T Consensus 234 a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~pp----------P~lP 303 (364)
T KOG0581|consen 234 ANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPP----------PRLP 303 (364)
T ss_pred cccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCC----------CCCC
Confidence 345677899999999999999999999999999999999999754 2344455555444322 2233
Q ss_pred H-HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004979 659 E-NVLEELLVVIKNCVHPDPKQRPSMRGIAAK 689 (721)
Q Consensus 659 ~-~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 689 (721)
. .+++++.+++..|+++||.+||+++|+++.
T Consensus 304 ~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 304 EGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred cccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 4 378899999999999999999999999863
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=400.96 Aligned_cols=250 Identities=26% Similarity=0.432 Sum_probs=209.4
Q ss_pred hhhCcCCCCceeEEEEEEec------CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCc
Q 004979 430 NIIGSFSDGTVGTVYKGTLS------SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPF 503 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~------~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 503 (721)
..+.++|+|+||+||+|+.. +...||||.++.+. ....+.+|.+|+++|..++|||||+++|+|.++++.
T Consensus 489 ~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a----~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~ 564 (774)
T KOG1026|consen 489 VFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA----ENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL 564 (774)
T ss_pred eehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc----cHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence 35678999999999999853 34568888876443 234678999999999999999999999999999864
Q ss_pred eEEEEEecCCCCChhhhhhhcc------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCC
Q 004979 504 TRMMVFEYSPNGSLFEHLHIQE------------AEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDY 571 (721)
Q Consensus 504 ~~~lV~Ey~~~GsL~~~l~~~~------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~ 571 (721)
|||+|||..|||.++|+... ..+|+..+.+.||.|||.||+||-++. +|||||..+|+||.++.
T Consensus 565 --~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~--FVHRDLATRNCLVge~l 640 (774)
T KOG1026|consen 565 --CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH--FVHRDLATRNCLVGENL 640 (774)
T ss_pred --EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc--ccccchhhhhceeccce
Confidence 99999999999999997432 223889999999999999999998777 99999999999999999
Q ss_pred cEEEeccCCCCCCCCCC-----------ccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHH
Q 004979 572 AAKISDFSFWNNTTAAK-----------TGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEY 639 (721)
Q Consensus 572 ~~kL~DFGla~~~~~~~-----------~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~ 639 (721)
.|||+|||+++...... ..||+||.+..++||++||||||||||||++| |+.||.+-. -.+.+..+
T Consensus 641 ~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glS--n~EVIe~i 718 (774)
T KOG1026|consen 641 VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLS--NQEVIECI 718 (774)
T ss_pred EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccc--hHHHHHHH
Confidence 99999999998654432 36899999999999999999999999999999 999996332 22322222
Q ss_pred hhcCCCCccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCCC
Q 004979 640 LKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAMEPD 699 (721)
Q Consensus 640 ~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~ 699 (721)
.. ..+...+++++.++++||..||+..|++||+++||-..|+...+..+.
T Consensus 719 ~~----------g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~~ 768 (774)
T KOG1026|consen 719 RA----------GQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASPK 768 (774)
T ss_pred Hc----------CCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCcc
Confidence 22 223346788999999999999999999999999999999998876653
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=370.22 Aligned_cols=240 Identities=20% Similarity=0.344 Sum_probs=208.9
Q ss_pred hhhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEE
Q 004979 429 SNIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMM 507 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~l 507 (721)
|+.-..+|+|+|++||+++. .+|..||+|++.++.... ....+...+||++.++|+|||||+++++|++.+ ..||
T Consensus 20 Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k--~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~--nVYi 95 (592)
T KOG0575|consen 20 YKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKK--PKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSN--NVYI 95 (592)
T ss_pred eeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcC--cchHHHHHHHHHHHHhcCCCcEEeeeeEeecCC--ceEE
Confidence 45556789999999999996 899999999998755433 344578999999999999999999999999988 7899
Q ss_pred EEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC---
Q 004979 508 VFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT--- 584 (721)
Q Consensus 508 V~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~--- 584 (721)
|.|+|++|+|..+++ .+..+++..++.+..||+.||.|||+.+ |||||||..|++|++++++||+|||+|...
T Consensus 96 vLELC~~~sL~el~K--rrk~ltEpEary~l~QIv~GlkYLH~~~--IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 96 VLELCHRGSLMELLK--RRKPLTEPEARYFLRQIVEGLKYLHSLG--IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EEEecCCccHHHHHH--hcCCCCcHHHHHHHHHHHHHHHHHHhcC--ceecccchhheeecCcCcEEecccceeeeecCc
Confidence 999999999999986 5678999999999999999999999998 999999999999999999999999998533
Q ss_pred ------CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCcccccc
Q 004979 585 ------TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQ 658 (721)
Q Consensus 585 ------~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 658 (721)
..|++.|.|||++.....+..+||||+|||||-|++|++||+ ..++.+....+...+.. ++
T Consensus 172 ~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFe--tk~vkety~~Ik~~~Y~-----------~P 238 (592)
T KOG0575|consen 172 GERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFE--TKTVKETYNKIKLNEYS-----------MP 238 (592)
T ss_pred ccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcc--cchHHHHHHHHHhcCcc-----------cc
Confidence 357788999999999999999999999999999999999995 44556666555544332 23
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004979 659 ENVLEELLVVIKNCVHPDPKQRPSMRGIAAK 689 (721)
Q Consensus 659 ~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 689 (721)
...+.++.+||.++|+.+|.+|||+++|+..
T Consensus 239 ~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 239 SHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred cccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 3566789999999999999999999999863
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=352.11 Aligned_cols=238 Identities=25% Similarity=0.393 Sum_probs=190.5
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
.+..+||.|+||+||+|+++ ++..||||.+..+.. .....+.+..|+++|+.++|||||++++++..++ ..|||
T Consensus 13 ~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l---~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~--~i~lV 87 (429)
T KOG0595|consen 13 ELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL---NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDD--FIYLV 87 (429)
T ss_pred eehhhccCcceEEEEEeEeccCCceEEeeeehhhcc---CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCC--eEEEE
Confidence 45567999999999999965 678999999876542 2345677899999999999999999999999988 78999
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCC------CcEEEeccCCCC
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTED------YAAKISDFSFWN 582 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~------~~~kL~DFGla~ 582 (721)
||||.+|+|.+|++. .+.+++...+.++.|+|.||++||+++ ||||||||.||||+.. -.+||+|||+|+
T Consensus 88 MEyC~gGDLs~yi~~--~~~l~e~t~r~Fm~QLA~alq~L~~~~--IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR 163 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIRR--RGRLPEATARHFMQQLASALQFLHENN--IIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR 163 (429)
T ss_pred EEeCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence 999999999999974 347999999999999999999999998 9999999999999864 568999999998
Q ss_pred CCC--------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCcc
Q 004979 583 NTT--------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTL 654 (721)
Q Consensus 583 ~~~--------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 654 (721)
... .|++.|||||++....|+.|+|+||.|+||||+++|+.||+.. ...+....+-++....
T Consensus 164 ~L~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~--t~~eL~~~~~k~~~~~-------- 233 (429)
T KOG0595|consen 164 FLQPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAE--TPKELLLYIKKGNEIV-------- 233 (429)
T ss_pred hCCchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcccc--CHHHHHHHHhcccccc--------
Confidence 654 4677899999999999999999999999999999999999633 3344443333332111
Q ss_pred ccccHHHHHHHHHHHHHcccCCCCCCCCHHHH
Q 004979 655 KSFQENVLEELLVVIKNCVHPDPKQRPSMRGI 686 (721)
Q Consensus 655 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev 686 (721)
+..+........+++..-++.+|.+|-++.+-
T Consensus 234 ~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~ 265 (429)
T KOG0595|consen 234 PVLPAELSNPLRELLISLLQRNPKDRISFEDF 265 (429)
T ss_pred CchhhhccCchhhhhhHHHhcCccccCchHHh
Confidence 11222333445566666666777777655543
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-43 Score=357.62 Aligned_cols=251 Identities=23% Similarity=0.362 Sum_probs=203.0
Q ss_pred HHhhhhhhhCcCCCCceeEEEEEE-ecCCcEEEEEEeeeccccchhh--HHHHHHHHHHHHHhcCCCCccceEeEEEecC
Q 004979 424 ACEDFSNIIGSFSDGTVGTVYKGT-LSSGVEIAVTSTSVKSRADWSK--NLESQFRKKIDTLSKVNHKNFVNLIGYCEED 500 (721)
Q Consensus 424 ~~~~~~~ii~~lg~G~~g~Vyk~~-~~~~~~vavk~~~~~~~~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~ 500 (721)
..+++|.+.+.+|.|+||.|-+|. -++|+.||||++..+.....+. .......+|+++|++++|||||++++++...
T Consensus 169 s~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ 248 (475)
T KOG0615|consen 169 SFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVP 248 (475)
T ss_pred hhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecC
Confidence 356778888999999999999998 5689999999998765443221 1233467999999999999999999999988
Q ss_pred CCceEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCC---CcEEEec
Q 004979 501 EPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTED---YAAKISD 577 (721)
Q Consensus 501 ~~~~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~---~~~kL~D 577 (721)
+ ..|||||||.||+|.+.+-. ...+.+..-..++.|++.|+.|||++| |+||||||+|||+..+ ..+||+|
T Consensus 249 d--s~YmVlE~v~GGeLfd~vv~--nk~l~ed~~K~~f~Qll~avkYLH~~G--I~HRDiKPeNILl~~~~e~~llKItD 322 (475)
T KOG0615|consen 249 D--SSYMVLEYVEGGELFDKVVA--NKYLREDLGKLLFKQLLTAVKYLHSQG--IIHRDIKPENILLSNDAEDCLLKITD 322 (475)
T ss_pred C--ceEEEEEEecCccHHHHHHh--ccccccchhHHHHHHHHHHHHHHHHcC--cccccCCcceEEeccCCcceEEEecc
Confidence 8 56999999999999999864 345666667889999999999999999 9999999999999755 7899999
Q ss_pred cCCCCCC--------CCCCccccchhhcccCCC---CCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCC
Q 004979 578 FSFWNNT--------TAAKTGSAAMELLETSAV---DLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPL 646 (721)
Q Consensus 578 FGla~~~--------~~~~~~~~apE~~~~~~~---s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~ 646 (721)
||+|+.. ..|++.|.|||++....+ ..++|+||+|||||-+++|..||..+..+. ....++.++...+
T Consensus 323 FGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~-sl~eQI~~G~y~f 401 (475)
T KOG0615|consen 323 FGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP-SLKEQILKGRYAF 401 (475)
T ss_pred cchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc-cHHHHHhcCcccc
Confidence 9999854 356788999999965443 358899999999999999999997554332 1233344443322
Q ss_pred ccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 647 KDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 647 ~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
.. .....++++..+||.++|..||++||++.|+++
T Consensus 402 ~p-------~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 402 GP-------LQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred cC-------hhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 21 122467889999999999999999999999986
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=351.28 Aligned_cols=260 Identities=24% Similarity=0.346 Sum_probs=215.1
Q ss_pred hhhhhhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCce
Q 004979 426 EDFSNIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFT 504 (721)
Q Consensus 426 ~~~~~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 504 (721)
++| +++..+|+|+||+||.++. ++++.+|+|+++++.... ....+....|..+|.+++||.||+++-.|++.+ .
T Consensus 25 ~dF-~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~--~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~--k 99 (357)
T KOG0598|consen 25 DDF-EILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVE--KKEVRHTKAERNILSKIKHPFIVKLIYSFQTEE--K 99 (357)
T ss_pred hhe-eeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhh--hhhHHHHHHHHHHHHhCCCCcEeeeEEecccCC--e
Confidence 345 6788999999999999984 568889999987665443 234567899999999999999999999998877 7
Q ss_pred EEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCC-
Q 004979 505 RMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNN- 583 (721)
Q Consensus 505 ~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~- 583 (721)
.|||+||+.||+|..+|. +...+++..+..++..|+.||.|||+.+ ||||||||+|||||++|+++|+|||+++.
T Consensus 100 LylVld~~~GGeLf~hL~--~eg~F~E~~arfYlaEi~lAL~~LH~~g--IiyRDlKPENILLd~~GHi~LtDFgL~k~~ 175 (357)
T KOG0598|consen 100 LYLVLDYLNGGELFYHLQ--REGRFSEDRARFYLAEIVLALGYLHSKG--IIYRDLKPENILLDEQGHIKLTDFGLCKED 175 (357)
T ss_pred EEEEEeccCCccHHHHHH--hcCCcchhHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHeeecCCCcEEEeccccchhc
Confidence 899999999999999985 3456899999999999999999999999 99999999999999999999999999862
Q ss_pred --------CCCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccc
Q 004979 584 --------TTAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLK 655 (721)
Q Consensus 584 --------~~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 655 (721)
...|+..|||||++....|+..+|.||+||++|||+||.+||.. .+..++...+..+..+
T Consensus 176 ~~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~--~~~~~~~~~I~~~k~~---------- 243 (357)
T KOG0598|consen 176 LKDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYA--EDVKKMYDKILKGKLP---------- 243 (357)
T ss_pred ccCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcC--ccHHHHHHHHhcCcCC----------
Confidence 23467789999999999999999999999999999999999964 4556666666665311
Q ss_pred cccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCChhHHHHHHh
Q 004979 656 SFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAMEPDGATPKLSPLWWAELEI 715 (721)
Q Consensus 656 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~~~~p~~~~~~~~~l~~ 715 (721)
..+.-...+..+++.+.+..||++|-... ......+.+|.+..++|+.|.-
T Consensus 244 ~~p~~ls~~ardll~~LL~rdp~~RLg~~---------~d~~~ik~HpfF~~inW~~l~~ 294 (357)
T KOG0598|consen 244 LPPGYLSEEARDLLKKLLKRDPRQRLGGP---------GDAEEIKRHPFFKGINWEKLLA 294 (357)
T ss_pred CCCccCCHHHHHHHHHHhccCHHHhcCCC---------CChHHhhcCcccccCCHHHHHh
Confidence 11222457889999999999999996411 1111145689999999999853
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=336.83 Aligned_cols=248 Identities=21% Similarity=0.331 Sum_probs=204.3
Q ss_pred hhhCcCCCCceeEEEEEE-ecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGT-LSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~-~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
+|++++|.|+||+|||+. ..+|..+|.|.+.... ...........|+.+|++|+|||||++++.-...+....+||
T Consensus 22 ~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~---md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 22 QILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGM---MDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHcCCcchheEEeeeccCcchhhhhhcchhh---ccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 677889999999999998 6789999999887433 234556789999999999999999999984333222237899
Q ss_pred EecCCCCChhhhhhh--ccCCCCCHHHHHHHHHHHHHHHHHHhcCCCC--eEeeCCCCCCeEeCCCCcEEEeccCCCCCC
Q 004979 509 FEYSPNGSLFEHLHI--QEAEHLDWAMRLRIAMGMAYCLEHMHQLTPP--IAHRNLQSSSIYLTEDYAAKISDFSFWNNT 584 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~--~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~--IvHrDLKp~NILl~~~~~~kL~DFGla~~~ 584 (721)
||||..|+|...++. +..+.+++....++..|++.||.++|..-++ |+||||||.||+|+.+|.+||+|||+++..
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 999999999998863 2456799999999999999999999985555 999999999999999999999999998743
Q ss_pred ---------CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccc
Q 004979 585 ---------TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLK 655 (721)
Q Consensus 585 ---------~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 655 (721)
..+++.||+||.+....|+.||||||+||++|||+.-+.||.+. +..+.-.++-.++. +
T Consensus 179 ~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~--n~~~L~~KI~qgd~----------~ 246 (375)
T KOG0591|consen 179 SSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD--NLLSLCKKIEQGDY----------P 246 (375)
T ss_pred cchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc--cHHHHHHHHHcCCC----------C
Confidence 34678999999999999999999999999999999999999754 55555555544422 2
Q ss_pred ccc-HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 004979 656 SFQ-ENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKE 692 (721)
Q Consensus 656 ~~~-~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 692 (721)
..+ +.++.++..||..|+..||+.||+.-.++..+..
T Consensus 247 ~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 247 PLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred CCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 233 5678899999999999999999986555555444
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=365.73 Aligned_cols=249 Identities=27% Similarity=0.478 Sum_probs=204.9
Q ss_pred hhhCcCCCCceeEEEEEEecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVF 509 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV~ 509 (721)
.+...||.|+||+||||+|. ..||||++.+... +....+.|+.|+.++++-||.||+-+.|||..+. . .||+
T Consensus 395 ~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~p---t~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~--~-AIiT 466 (678)
T KOG0193|consen 395 LLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDP---TPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP--L-AIIT 466 (678)
T ss_pred hccceeccccccceeecccc--cceEEEEEecCCC---CHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc--e-eeee
Confidence 56678999999999999986 3689999887643 3446788999999999999999999999998765 3 8999
Q ss_pred ecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC-----
Q 004979 510 EYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT----- 584 (721)
Q Consensus 510 Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~----- 584 (721)
.+|+|-+|+.+||..+ ..++..+.+.||+|||+||.|||.++ |||||||..||++.+++.|||+|||++...
T Consensus 467 qwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHAK~--IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g 543 (678)
T KOG0193|consen 467 QWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHAKN--IIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSG 543 (678)
T ss_pred hhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhhhh--hhhhhccccceEEccCCcEEEecccceeeeeeecc
Confidence 9999999999998654 66899999999999999999999998 999999999999999999999999997422
Q ss_pred ------CCCCccccchhhcc---cCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccc
Q 004979 585 ------TAAKTGSAAMELLE---TSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLK 655 (721)
Q Consensus 585 ------~~~~~~~~apE~~~---~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 655 (721)
..+..-|||||+++ ..+|+..+||||||||+|||+||..||.....+ +.+..+-.| ...+.+.
T Consensus 544 ~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~d--qIifmVGrG------~l~pd~s 615 (678)
T KOG0193|consen 544 EQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRD--QIIFMVGRG------YLMPDLS 615 (678)
T ss_pred ccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChh--heEEEeccc------ccCccch
Confidence 12334689999985 457999999999999999999999999743322 111111111 1112233
Q ss_pred cccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcC
Q 004979 656 SFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAME 697 (721)
Q Consensus 656 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 697 (721)
....++..++.+|+..||..++++||.+.+|+..|+++....
T Consensus 616 ~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~ 657 (678)
T KOG0193|consen 616 KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSL 657 (678)
T ss_pred hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcc
Confidence 344567889999999999999999999999999999887743
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=376.74 Aligned_cols=262 Identities=20% Similarity=0.361 Sum_probs=216.5
Q ss_pred CCCCCHHHHHHHHhhhh--------hhhCcCCCCceeEEEEEEecC----CcEEEEEEeeeccccchhhHHHHHHHHHHH
Q 004979 413 VPKLKRSELEAACEDFS--------NIIGSFSDGTVGTVYKGTLSS----GVEIAVTSTSVKSRADWSKNLESQFRKKID 480 (721)
Q Consensus 413 ~~~~~~~~l~~~~~~~~--------~ii~~lg~G~~g~Vyk~~~~~----~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~ 480 (721)
+..++|+|--++...|. .|-+.||.|.||+||+|+++- ...||+|.++.. .++..+.+|+.|+.
T Consensus 607 iDP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G----ytekqrrdFL~EAs 682 (996)
T KOG0196|consen 607 IDPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG----YTEKQRRDFLSEAS 682 (996)
T ss_pred cCCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccC----ccHHHHhhhhhhhh
Confidence 34567887777777775 344578999999999999752 356888877643 34556789999999
Q ss_pred HHhcCCCCccceEeEEEecCCCceEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCC
Q 004979 481 TLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNL 560 (721)
Q Consensus 481 ~l~~l~H~nIv~l~g~~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDL 560 (721)
||.+++||||++|.|+.....+ .+||+|||+||+|+.+|+.+. .++++.+...+.+|||.||.||-+.+ +|||||
T Consensus 683 IMGQFdHPNIIrLEGVVTks~P--vMIiTEyMENGsLDsFLR~~D-GqftviQLVgMLrGIAsGMkYLsdm~--YVHRDL 757 (996)
T KOG0196|consen 683 IMGQFDHPNIIRLEGVVTKSKP--VMIITEYMENGSLDSFLRQND-GQFTVIQLVGMLRGIASGMKYLSDMN--YVHRDL 757 (996)
T ss_pred hcccCCCCcEEEEEEEEecCce--eEEEhhhhhCCcHHHHHhhcC-CceEeehHHHHHHHHHHHhHHHhhcC--chhhhh
Confidence 9999999999999999998874 599999999999999998654 56999999999999999999999988 999999
Q ss_pred CCCCeEeCCCCcEEEeccCCCCCCCCCC------------ccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccC
Q 004979 561 QSSSIYLTEDYAAKISDFSFWNNTTAAK------------TGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSI 627 (721)
Q Consensus 561 Kp~NILl~~~~~~kL~DFGla~~~~~~~------------~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~ 627 (721)
.++|||++.+..+||+|||+++...... ..|.|||.+..++++.++|||||||||||.++ |.+||.
T Consensus 758 AARNILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYW- 836 (996)
T KOG0196|consen 758 AARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYW- 836 (996)
T ss_pred hhhheeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCccc-
Confidence 9999999999999999999997553221 25789999999999999999999999999988 999985
Q ss_pred CCCCHHHHHHHHhhcCCCCccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 004979 628 ENGSLENWASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITA 695 (721)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~ 695 (721)
+..-.+.++.+..+ ..+ .-+.+|+..+.+||+.||++|-.+||.|.+|+..|+++..
T Consensus 837 -dmSNQdVIkaIe~g-yRL---------PpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIr 893 (996)
T KOG0196|consen 837 -DMSNQDVIKAIEQG-YRL---------PPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIR 893 (996)
T ss_pred -ccchHHHHHHHHhc-cCC---------CCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhc
Confidence 23333444443333 222 2345688899999999999999999999999999998644
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=355.80 Aligned_cols=250 Identities=24% Similarity=0.381 Sum_probs=206.3
Q ss_pred hhhCcCCCCceeEEEEEEecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVF 509 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV~ 509 (721)
.+.++||+|.||.|..|....+..||||+++.. ..++.+++|.+|+++|.+++|||||+++|+|..+++. ++|+
T Consensus 541 ~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~----a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePi--cmI~ 614 (807)
T KOG1094|consen 541 RFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPD----ATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPL--CMIT 614 (807)
T ss_pred ehhhhhcCcccceeEEEEecCceEEEEeecCcc----cchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCch--HHHH
Confidence 466889999999999999998899999988643 3455678999999999999999999999999998854 8999
Q ss_pred ecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCCCCC-
Q 004979 510 EYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTAAK- 588 (721)
Q Consensus 510 Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~- 588 (721)
|||++|+|.+++.....+.+.-..-..|+.|||.||+||.+++ +|||||.++|||+|.++++||+|||+++....+.
T Consensus 615 EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n--fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~y 692 (807)
T KOG1094|consen 615 EYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN--FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDY 692 (807)
T ss_pred HHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc--hhhccccccceeecCcccEEecCcccccccccCCc
Confidence 9999999999997665555555667789999999999999998 9999999999999999999999999999766543
Q ss_pred ----------ccccchhhcccCCCCCCccHHHHHHHHHHHHh--CCCcccCCC-CCHHHHHHHHhhcCCCCccccCCccc
Q 004979 589 ----------TGSAAMELLETSAVDLESNVYSFGTILFEMIT--GRISYSIEN-GSLENWASEYLKGEQPLKDIVDPTLK 655 (721)
Q Consensus 589 ----------~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt--G~~P~~~~~-~~~~~~~~~~~~~~~~~~~~~d~~l~ 655 (721)
..|||+|.+..+++++++|||+|||+|||+++ ...||.... ....+-...++..... ....
T Consensus 693 y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~------~~~l 766 (807)
T KOG1094|consen 693 YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGR------QVVL 766 (807)
T ss_pred eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCc------ceec
Confidence 36899999999999999999999999999987 678886321 1222222222222111 1122
Q ss_pred cccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 004979 656 SFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEI 693 (721)
Q Consensus 656 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i 693 (721)
..+.-++.+++++|.+||..|-++||+++++...|++.
T Consensus 767 ~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 767 SRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 34556788999999999999999999999999888764
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=353.50 Aligned_cols=256 Identities=23% Similarity=0.330 Sum_probs=211.3
Q ss_pred hhhhhhhCcCCCCceeEEEEEE-ecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcC-CCCccceEeEEEecCCCc
Q 004979 426 EDFSNIIGSFSDGTVGTVYKGT-LSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKV-NHKNFVNLIGYCEEDEPF 503 (721)
Q Consensus 426 ~~~~~ii~~lg~G~~g~Vyk~~-~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~ 503 (721)
+|| ...+.+|+|+|++||+|+ ..+++++|||++.++.... +...+.+..|-++|.+| .||.||+||-.|++..
T Consensus 73 ~DF-~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iik--e~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~-- 147 (604)
T KOG0592|consen 73 NDF-KFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIK--EKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEE-- 147 (604)
T ss_pred hhc-chhheeccccceeEEEeeecCCCceeeHhhhhHHHHHh--hcccchhhHHHHHHHHhhCCCCeEEEEEEeeccc--
Confidence 344 344567899999999998 5678999999987654322 33346678888999999 8999999999999877
Q ss_pred eEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCC
Q 004979 504 TRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNN 583 (721)
Q Consensus 504 ~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~ 583 (721)
..|+|+||+++|+|.++|+ +.+.++....+.++.+|..||+|||++| ||||||||+|||||++|++||+|||-|+.
T Consensus 148 sLYFvLe~A~nGdll~~i~--K~Gsfde~caR~YAAeIldAleylH~~G--IIHRDlKPENILLd~dmhikITDFGsAK~ 223 (604)
T KOG0592|consen 148 SLYFVLEYAPNGDLLDLIK--KYGSFDETCARFYAAEILDALEYLHSNG--IIHRDLKPENILLDKDGHIKITDFGSAKI 223 (604)
T ss_pred ceEEEEEecCCCcHHHHHH--HhCcchHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeEcCCCcEEEeecccccc
Confidence 6799999999999999997 4467999999999999999999999999 99999999999999999999999997653
Q ss_pred C----------------------CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhh
Q 004979 584 T----------------------TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLK 641 (721)
Q Consensus 584 ~----------------------~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~ 641 (721)
. ..|+..|.+||++.....+..+|+|+||||||+|+.|++||.+.+.- -..++++.
T Consensus 224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney--liFqkI~~ 301 (604)
T KOG0592|consen 224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY--LIFQKIQA 301 (604)
T ss_pred CChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH--HHHHHHHH
Confidence 2 12345688999999999999999999999999999999999755432 22333333
Q ss_pred cCCCCccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCChhHHHHHHhh
Q 004979 642 GEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAMEPDGATPKLSPLWWAELEIL 716 (721)
Q Consensus 642 ~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~~~~p~~~~~~~~~l~~~ 716 (721)
-+. ++++..++.+.+|+.+.|..||.+|++..+|- ++|++..++|++|...
T Consensus 302 l~y-----------~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk-------------~HpFF~~Vdw~nlw~~ 352 (604)
T KOG0592|consen 302 LDY-----------EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIK-------------AHPFFEGVDWENLWQQ 352 (604)
T ss_pred hcc-----------cCCCCCCHHHHHHHHHHHccCccccccHHHHh-------------hCcccccCChhhhhhc
Confidence 222 24455567899999999999999999997763 4899999999997654
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=327.17 Aligned_cols=250 Identities=20% Similarity=0.317 Sum_probs=194.7
Q ss_pred hhhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEE
Q 004979 429 SNIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMM 507 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~l 507 (721)
|+.+|++|+|+||+||||+.+ +|+.||||++..... .....+-.++|+++|++++|+|+|.++++|.... ..+|
T Consensus 4 YE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esed---d~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkr--klhL 78 (396)
T KOG0593|consen 4 YEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESED---DPVVKKIALREIRMLKQLKHENLVNLIEVFRRKR--KLHL 78 (396)
T ss_pred HhhhhccccCcceEEEEeccCCcccEEEEEeeccCCc---cHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcc--eeEE
Confidence 577899999999999999965 689999999875432 2345567899999999999999999999998877 6799
Q ss_pred EEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCCC-
Q 004979 508 VFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTA- 586 (721)
Q Consensus 508 V~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~~- 586 (721)
|+|||...=|.+ |. +....++.....+++.|++.|+.|+|+++ +|||||||+||||+.++.+||||||+|+....
T Consensus 79 VFE~~dhTvL~e-Le-~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n--~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p 154 (396)
T KOG0593|consen 79 VFEYCDHTVLHE-LE-RYPNGVPSELVKKYLYQLLKAIHFCHKNN--CIHRDIKPENILITQNGVVKLCDFGFARTLSAP 154 (396)
T ss_pred EeeecchHHHHH-HH-hccCCCCHHHHHHHHHHHHHHhhhhhhcC--eecccCChhheEEecCCcEEeccchhhHhhcCC
Confidence 999998754443 32 24456888999999999999999999998 99999999999999999999999999987652
Q ss_pred --------CCccccchhhccc-CCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHH--H-----------HHhhcCC
Q 004979 587 --------AKTGSAAMELLET-SAVDLESNVYSFGTILFEMITGRISYSIENGSLENWA--S-----------EYLKGEQ 644 (721)
Q Consensus 587 --------~~~~~~apE~~~~-~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~--~-----------~~~~~~~ 644 (721)
++..|.|||.+.+ ..|+..+||||.||++.||+||.+-|.+.. ++.+.. . +++...+
T Consensus 155 gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~S-DiDQLy~I~ktLG~L~prhq~iF~~N~ 233 (396)
T KOG0593|consen 155 GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRS-DIDQLYLIRKTLGNLIPRHQSIFSSNP 233 (396)
T ss_pred cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcc-hHHHHHHHHHHHcccCHHHHHHhccCC
Confidence 2345789999866 789999999999999999999998887543 222221 1 1111111
Q ss_pred CCccccCCccc------cccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 645 PLKDIVDPTLK------SFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 645 ~~~~~~d~~l~------~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
.+..+.=|... .-.+..+.-++++++.|++.||++|++.+|++.
T Consensus 234 ~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 234 FFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred ceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 11111111111 112344567899999999999999999999875
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=344.83 Aligned_cols=254 Identities=20% Similarity=0.306 Sum_probs=201.7
Q ss_pred hhhhhhCcCCCCceeEEEEEE-ecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCC-CCccceEeEEEecCCCce
Q 004979 427 DFSNIIGSFSDGTVGTVYKGT-LSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVN-HKNFVNLIGYCEEDEPFT 504 (721)
Q Consensus 427 ~~~~ii~~lg~G~~g~Vyk~~-~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~ 504 (721)
+.|.+++++|.|+||.||+|+ ..++..||||+++.+-. .|. +-.=++|++.|++++ |||||++.+++.+.+. .
T Consensus 10 ~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~-s~e---e~~nLREvksL~kln~hpniikL~Evi~d~~~-~ 84 (538)
T KOG0661|consen 10 DRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFY-SWE---ECMNLREVKSLRKLNPHPNIIKLKEVIRDNDR-I 84 (538)
T ss_pred HHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhc-cHH---HHHHHHHHHHHHhcCCCCcchhhHHHhhccCc-e
Confidence 446899999999999999998 56788999998875532 232 223478999999998 9999999999988765 6
Q ss_pred EEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC
Q 004979 505 RMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT 584 (721)
Q Consensus 505 ~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~ 584 (721)
.++|||||+. +|+++++.+ ...+++..+..|+.||.+||+|+|.+| +.|||+||+|||+.....+||+|||+||..
T Consensus 85 L~fVfE~Md~-NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~G--fFHRDlKPENiLi~~~~~iKiaDFGLARev 160 (538)
T KOG0661|consen 85 LYFVFEFMDC-NLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHG--FFHRDLKPENILISGNDVIKIADFGLAREV 160 (538)
T ss_pred EeeeHHhhhh-hHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcC--cccccCChhheEecccceeEeccccccccc
Confidence 8999999955 999999865 788999999999999999999999999 999999999999999999999999999876
Q ss_pred CC--------CCccccchhhc-ccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCC---------
Q 004979 585 TA--------AKTGSAAMELL-ETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPL--------- 646 (721)
Q Consensus 585 ~~--------~~~~~~apE~~-~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~--------- 646 (721)
.. .+..|.|||++ +...|+.+.||||+|||++|+.+-++.|.+.+.-.+-|..-.+-|....
T Consensus 161 ~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~L 240 (538)
T KOG0661|consen 161 RSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNL 240 (538)
T ss_pred ccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHH
Confidence 44 34467899986 6788999999999999999999999888754432111111111121111
Q ss_pred --------ccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004979 647 --------KDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAK 689 (721)
Q Consensus 647 --------~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 689 (721)
.....-.+.......+.++.++|.+|+++||.+|||+.|+++.
T Consensus 241 a~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 241 ASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 1111111222334467899999999999999999999999874
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=378.39 Aligned_cols=248 Identities=27% Similarity=0.417 Sum_probs=203.2
Q ss_pred hhCcCCCCceeEEEEEEecC--Cc----EEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCce
Q 004979 431 IIGSFSDGTVGTVYKGTLSS--GV----EIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFT 504 (721)
Q Consensus 431 ii~~lg~G~~g~Vyk~~~~~--~~----~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 504 (721)
....+|+|.||.||+|.+.+ +. .||||.+... .+.....+|.+|..+|++++|||||+++|+|.+.. .
T Consensus 696 l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~----~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~--~ 769 (1025)
T KOG1095|consen 696 LLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL----SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG--P 769 (1025)
T ss_pred eeeeeccccccceEEEEEecCCCCccceEEEEEecccc----CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC--C
Confidence 45578899999999998653 32 3666665432 22455688999999999999999999999999876 4
Q ss_pred EEEEEecCCCCChhhhhhhcc-----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccC
Q 004979 505 RMMVFEYSPNGSLFEHLHIQE-----AEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFS 579 (721)
Q Consensus 505 ~~lV~Ey~~~GsL~~~l~~~~-----~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFG 579 (721)
.+|++|||++|+|..+|+..+ ...++....+.++.|||+|+.||+++. +|||||.++|+||++...+||+|||
T Consensus 770 ~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~--fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 770 PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH--FVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC--CcCcchhhhheeecccCcEEEcccc
Confidence 589999999999999997542 346888999999999999999999988 9999999999999999999999999
Q ss_pred CCCCCCCC-----------CccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhcCCCCc
Q 004979 580 FWNNTTAA-----------KTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPLK 647 (721)
Q Consensus 580 la~~~~~~-----------~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~ 647 (721)
+|+..... ...|||||.+..+.++.|+|||||||+|||++| |..||... +-.+....++.+. .+
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~--~n~~v~~~~~~gg-RL- 923 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSR--SNFEVLLDVLEGG-RL- 923 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCc--chHHHHHHHHhCC-cc-
Confidence 99843321 246899999999999999999999999999999 99999633 2233333333332 11
Q ss_pred cccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCC
Q 004979 648 DIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAMEP 698 (721)
Q Consensus 648 ~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 698 (721)
+.+..|++.++++|..||+.+|++||+|..|++++..+.....
T Consensus 924 --------~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~ 966 (1025)
T KOG1095|consen 924 --------DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAAL 966 (1025)
T ss_pred --------CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhc
Confidence 2356788999999999999999999999999999988766533
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=350.49 Aligned_cols=229 Identities=25% Similarity=0.436 Sum_probs=190.6
Q ss_pred CcCCCCceeEEEEEEecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEEEecC
Q 004979 433 GSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYS 512 (721)
Q Consensus 433 ~~lg~G~~g~Vyk~~~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV~Ey~ 512 (721)
+=+|.|+.|.||+|+++ ++.||||+++.. -..+|+.|++|+|+||+.+.|+|.... ..|||||||
T Consensus 130 eWlGSGaQGAVF~Grl~-netVAVKKV~el------------kETdIKHLRkLkH~NII~FkGVCtqsP--cyCIiMEfC 194 (904)
T KOG4721|consen 130 EWLGSGAQGAVFLGRLH-NETVAVKKVREL------------KETDIKHLRKLKHPNIITFKGVCTQSP--CYCIIMEFC 194 (904)
T ss_pred hhhccCcccceeeeecc-CceehhHHHhhh------------hhhhHHHHHhccCcceeeEeeeecCCc--eeEEeeecc
Confidence 45678999999999987 578999976421 134688999999999999999999876 669999999
Q ss_pred CCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCC--------CC
Q 004979 513 PNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWN--------NT 584 (721)
Q Consensus 513 ~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~--------~~ 584 (721)
+.|-|+.+|+ ....+.......+..|||.||.|||.+. |||||||+-||||..+..+||+|||.++ ..
T Consensus 195 a~GqL~~VLk--a~~~itp~llv~Wsk~IA~GM~YLH~hK--IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STkMS 270 (904)
T KOG4721|consen 195 AQGQLYEVLK--AGRPITPSLLVDWSKGIAGGMNYLHLHK--IIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTKMS 270 (904)
T ss_pred ccccHHHHHh--ccCccCHHHHHHHHHHhhhhhHHHHHhh--HhhhccCCCceEeeccceEEeccccchHhhhhhhhhhh
Confidence 9999999996 4456788888899999999999999988 9999999999999999999999999764 33
Q ss_pred CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCcc-ccccHHHHH
Q 004979 585 TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTL-KSFQENVLE 663 (721)
Q Consensus 585 ~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l-~~~~~~~~~ 663 (721)
..++..|||||++....+++|+||||||||||||+||..||..-+... .+..+=...+ ...+..+++
T Consensus 271 FaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA------------IIwGVGsNsL~LpvPstcP~ 338 (904)
T KOG4721|consen 271 FAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA------------IIWGVGSNSLHLPVPSTCPD 338 (904)
T ss_pred hhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe------------eEEeccCCcccccCcccCch
Confidence 456778999999999999999999999999999999999995322110 0111111111 135677888
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 004979 664 ELLVVIKNCVHPDPKQRPSMRGIAAKLKE 692 (721)
Q Consensus 664 ~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 692 (721)
.+.-|++.||+..|..||+|++|+..|+-
T Consensus 339 GfklL~Kqcw~sKpRNRPSFrqil~HldI 367 (904)
T KOG4721|consen 339 GFKLLLKQCWNSKPRNRPSFRQILLHLDI 367 (904)
T ss_pred HHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence 99999999999999999999999998864
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=355.02 Aligned_cols=251 Identities=27% Similarity=0.409 Sum_probs=205.5
Q ss_pred hhCcCCCCceeEEEEEEecCC----cE-EEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceE
Q 004979 431 IIGSFSDGTVGTVYKGTLSSG----VE-IAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTR 505 (721)
Q Consensus 431 ii~~lg~G~~g~Vyk~~~~~~----~~-vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~ 505 (721)
+.+++|+|+||.||+|++... .. ||||..+... ........+|.+|+++|++++|||||++||++....|.
T Consensus 161 l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~--~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl-- 236 (474)
T KOG0194|consen 161 LGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSS--ELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL-- 236 (474)
T ss_pred ccceeecccccEEEEEEEEecCCceeeeeEEEeecccc--cccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc--
Confidence 447899999999999996532 22 7777765422 23355678999999999999999999999999998864
Q ss_pred EEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC
Q 004979 506 MMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT 585 (721)
Q Consensus 506 ~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~ 585 (721)
++|||+|+||+|.++|+.. ...++..+++.++.+.|.||+|||+.+ +|||||.++|||++.++.+||+|||+++...
T Consensus 237 ~ivmEl~~gGsL~~~L~k~-~~~v~~~ek~~~~~~AA~Gl~YLh~k~--~IHRDIAARNcL~~~~~~vKISDFGLs~~~~ 313 (474)
T KOG0194|consen 237 MLVMELCNGGSLDDYLKKN-KKSLPTLEKLRFCYDAARGLEYLHSKN--CIHRDIAARNCLYSKKGVVKISDFGLSRAGS 313 (474)
T ss_pred EEEEEecCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHhHHHHHHHCC--CcchhHhHHHheecCCCeEEeCccccccCCc
Confidence 9999999999999999743 336999999999999999999999998 9999999999999999999999999987543
Q ss_pred C---------CCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhcCCCCccccCCccc
Q 004979 586 A---------AKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPLKDIVDPTLK 655 (721)
Q Consensus 586 ~---------~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 655 (721)
. -...|.|||.+....|+.++|||||||++||+++ |..||.+ ....+....+.....+.
T Consensus 314 ~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g--~~~~~v~~kI~~~~~r~--------- 382 (474)
T KOG0194|consen 314 QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPG--MKNYEVKAKIVKNGYRM--------- 382 (474)
T ss_pred ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCC--CCHHHHHHHHHhcCccC---------
Confidence 1 2247899999999999999999999999999999 8999963 33334444443322221
Q ss_pred cccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCCC
Q 004979 656 SFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAMEPD 699 (721)
Q Consensus 656 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~ 699 (721)
..+...+.++..++.+||..+|++||+|.++.+.|+.+......
T Consensus 383 ~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 383 PIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred CCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 12234567788899999999999999999999999998876553
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=339.00 Aligned_cols=244 Identities=20% Similarity=0.340 Sum_probs=197.4
Q ss_pred cCCCCceeEEEEEEecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEec--CCCceEEEEEec
Q 004979 434 SFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEE--DEPFTRMMVFEY 511 (721)
Q Consensus 434 ~lg~G~~g~Vyk~~~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~--~~~~~~~lV~Ey 511 (721)
.+++|++|.||+|++ +++.||||++...... .....+.|.+|+++|++++|||||+++|++.+ .+....++||||
T Consensus 27 ~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 27 LIKENDQNSIYKGIF-NNKEVIIRTFKKFHKG--HKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred EEeeCCceEEEEEEE-CCEEEEEEeccccccc--cHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 467899999999998 5789999988643221 12334678899999999999999999999876 333357899999
Q ss_pred CCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC------
Q 004979 512 SPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQL-TPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT------ 584 (721)
Q Consensus 512 ~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~-~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~------ 584 (721)
+++|+|.+++.. ...++|.....++.+++.||+|||+. + ++||||||+|||+++++.+||+|||+++..
T Consensus 104 ~~~g~L~~~l~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~--~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~~~ 179 (283)
T PHA02988 104 CTRGYLREVLDK--EKDLSFKTKLDMAIDCCKGLYNLYKYTN--KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPPFK 179 (283)
T ss_pred CCCCcHHHHHhh--CCCCChhHHHHHHHHHHHHHHHHHhcCC--CCCCcCChhhEEECCCCcEEEcccchHhhhcccccc
Confidence 999999999864 35689999999999999999999974 6 889999999999999999999999997632
Q ss_pred CCCCccccchhhccc--CCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccHHHH
Q 004979 585 TAAKTGSAAMELLET--SAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQENVL 662 (721)
Q Consensus 585 ~~~~~~~~apE~~~~--~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 662 (721)
..++..|+|||.+.. ..++.++|||||||++|||+||+.||... +..+............ ..+..++
T Consensus 180 ~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~--~~~~~~~~i~~~~~~~---------~~~~~~~ 248 (283)
T PHA02988 180 NVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENL--TTKEIYDLIINKNNSL---------KLPLDCP 248 (283)
T ss_pred ccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCC--CHHHHHHHHHhcCCCC---------CCCCcCc
Confidence 234567899999865 68999999999999999999999999633 3334443333322211 1122356
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 004979 663 EELLVVIKNCVHPDPKQRPSMRGIAAKLKEITA 695 (721)
Q Consensus 663 ~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~ 695 (721)
.++.+++.+||+.||++|||+.|+++.|+.+..
T Consensus 249 ~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 249 LEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred HHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 789999999999999999999999999998764
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=336.71 Aligned_cols=243 Identities=22% Similarity=0.327 Sum_probs=194.5
Q ss_pred hhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEEE
Q 004979 431 IIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVF 509 (721)
Q Consensus 431 ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV~ 509 (721)
..+.+|+|+||+||++... +|...|||.+...... ..+.+.+|+++|++++|||||+++|.....+....++.|
T Consensus 21 ~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~-----~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 21 KGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSP-----TSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred hhccccCccceEEEEEEecCCCcceeeeeeecccch-----hHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 4467789999999999965 4889999988754211 146789999999999999999999975444322468999
Q ss_pred ecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCC-CCcEEEeccCCCCCCC---
Q 004979 510 EYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTE-DYAAKISDFSFWNNTT--- 585 (721)
Q Consensus 510 Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~-~~~~kL~DFGla~~~~--- 585 (721)
||+++|+|.+++..... .++....+.++.||++||+|||+++ ||||||||+|||++. ++.+||+|||+++...
T Consensus 96 Ey~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g--~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKG--IVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred eccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCC--EeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 99999999999975544 7999999999999999999999988 999999999999999 7999999999876333
Q ss_pred ---------CCCccccchhhcccCC-CCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccc
Q 004979 586 ---------AAKTGSAAMELLETSA-VDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLK 655 (721)
Q Consensus 586 ---------~~~~~~~apE~~~~~~-~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 655 (721)
.++..|||||++..+. ...++||||+||++.||+||+.||... ....++...+.... ..+
T Consensus 173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-~~~~~~~~~ig~~~---------~~P 242 (313)
T KOG0198|consen 173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-FEEAEALLLIGRED---------SLP 242 (313)
T ss_pred ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-cchHHHHHHHhccC---------CCC
Confidence 2456799999998543 335999999999999999999999643 22333333332221 112
Q ss_pred cccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 004979 656 SFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLK 691 (721)
Q Consensus 656 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 691 (721)
.++...+.+..+++.+|+..||++||||.|++...-
T Consensus 243 ~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf 278 (313)
T KOG0198|consen 243 EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPF 278 (313)
T ss_pred CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChh
Confidence 344557788999999999999999999999998643
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=338.72 Aligned_cols=251 Identities=21% Similarity=0.279 Sum_probs=194.9
Q ss_pred hhhhCcCCCCceeEEEEEE-ecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEE
Q 004979 429 SNIIGSFSDGTVGTVYKGT-LSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMM 507 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~-~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~l 507 (721)
++.|++||+|+||.||||+ ..+|+.||+|++....... .......+||.+|++|+||||++|.+...+.....+||
T Consensus 119 feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~---~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 119 FEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKE---GFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred HHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCC---cchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 3667899999999999999 6789999999998765332 23356789999999999999999999998874446899
Q ss_pred EEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCCCC
Q 004979 508 VFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTAA 587 (721)
Q Consensus 508 V~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~~~ 587 (721)
|+|||++ ||.-++. ...-.++..++..++.|++.||+|+|.++ |+|||||.+|||||.+|.+||+|||+|+.....
T Consensus 196 VFeYMdh-DL~GLl~-~p~vkft~~qIKc~mkQLl~Gl~~cH~~g--vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~ 271 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLS-SPGVKFTEPQIKCYMKQLLEGLEYCHSRG--VLHRDIKGSNILIDNNGVLKIADFGLARFYTPS 271 (560)
T ss_pred EEecccc-hhhhhhc-CCCcccChHHHHHHHHHHHHHHHHHhhcC--eeeccccccceEEcCCCCEEeccccceeeccCC
Confidence 9999987 8887774 33457999999999999999999999999 999999999999999999999999999844332
Q ss_pred C----------ccccchhhcc-cCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhh--cCC----------
Q 004979 588 K----------TGSAAMELLE-TSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLK--GEQ---------- 644 (721)
Q Consensus 588 ~----------~~~~apE~~~-~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~--~~~---------- 644 (721)
. -.|.+||++. ...|+.+.|+||.||||.||++|+..|.+... .+.+..+++ |..
T Consensus 272 ~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tE--veQl~kIfklcGSP~e~~W~~~kL 349 (560)
T KOG0600|consen 272 GSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTE--VEQLHKIFKLCGSPTEDYWPVSKL 349 (560)
T ss_pred CCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccH--HHHHHHHHHHhCCCChhccccccC
Confidence 2 2578999875 46899999999999999999999998864331 111111211 111
Q ss_pred CCccccCCc------cccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 645 PLKDIVDPT------LKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 645 ~~~~~~d~~------l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
+....+.+. +.+.....+...++|+..+|..||++|.|+.++++
T Consensus 350 P~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 350 PHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred CcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 000111111 11112234567889999999999999999999876
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=347.22 Aligned_cols=248 Identities=23% Similarity=0.368 Sum_probs=196.2
Q ss_pred hhhCcCCCCceeEEEEEEe------cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcC-CCCccceEeEEEecCCC
Q 004979 430 NIIGSFSDGTVGTVYKGTL------SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKV-NHKNFVNLIGYCEEDEP 502 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~------~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~ 502 (721)
++.+.||+|+||.||+|.. .++..||||++.... .....+.+.+|++++.++ +|||||+++++|...+.
T Consensus 10 ~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 10 RLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA----TASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred eeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc----chHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 6678899999999999974 234678999875322 122346789999999999 89999999999876543
Q ss_pred ceEEEEEecCCCCChhhhhhhcc---------------------------------------------------------
Q 004979 503 FTRMMVFEYSPNGSLFEHLHIQE--------------------------------------------------------- 525 (721)
Q Consensus 503 ~~~~lV~Ey~~~GsL~~~l~~~~--------------------------------------------------------- 525 (721)
..++||||+++|+|.+++....
T Consensus 86 -~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 86 -PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred -ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 4689999999999999986421
Q ss_pred ---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCCC-----------CCccc
Q 004979 526 ---AEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTA-----------AKTGS 591 (721)
Q Consensus 526 ---~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~~-----------~~~~~ 591 (721)
...+++.....++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.... ++..|
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 134788889999999999999999988 99999999999999999999999999864321 12468
Q ss_pred cchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccHHHHHHHHHHHH
Q 004979 592 AAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIK 670 (721)
Q Consensus 592 ~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~ 670 (721)
+|||.+....++.++|||||||++|||+| |+.||...... .........+ ... ..+..++.++.+++.
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~-~~~~~~~~~~-~~~---------~~~~~~~~~l~~li~ 311 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN-EEFCQRLKDG-TRM---------RAPENATPEIYRIML 311 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc-HHHHHHHhcC-CCC---------CCCCCCCHHHHHHHH
Confidence 99999998999999999999999999997 99999643322 1222222211 110 112334567899999
Q ss_pred HcccCCCCCCCCHHHHHHHHHHhhh
Q 004979 671 NCVHPDPKQRPSMRGIAAKLKEITA 695 (721)
Q Consensus 671 ~Cl~~dP~~RPs~~evl~~L~~i~~ 695 (721)
+||+.||++||++.||++.|+++..
T Consensus 312 ~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 312 ACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHccCChhhCcCHHHHHHHHHHHHh
Confidence 9999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=328.16 Aligned_cols=250 Identities=20% Similarity=0.279 Sum_probs=202.2
Q ss_pred hhhhCcCCCCceeEEEEEE-ecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEE
Q 004979 429 SNIIGSFSDGTVGTVYKGT-LSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMM 507 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~-~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~l 507 (721)
|++...+|.|..++||+|+ ...+..||||++..... ......+.+|+..|+.++||||++++..|..+. ..|+
T Consensus 28 YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc----~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~--~LWv 101 (516)
T KOG0582|consen 28 YELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKC----NNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDS--ELWV 101 (516)
T ss_pred eeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhh----hhhHHHHHHHHHHhhhcCCCCcceEEEEEEecc--eeEE
Confidence 4667788899999999998 56789999999976432 223578999999999999999999999998877 7899
Q ss_pred EEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCC-----
Q 004979 508 VFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWN----- 582 (721)
Q Consensus 508 V~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~----- 582 (721)
||.||.+||+.++++..-...+++..+..|.+++.+||.|||++| .||||||+.||||+++|.+||+|||..-
T Consensus 102 VmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G--~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~ 179 (516)
T KOG0582|consen 102 VMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG--HIHRDVKAGNILIDSDGTVKLADFGVSASLFDS 179 (516)
T ss_pred eehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC--ceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence 999999999999998766677999999999999999999999998 9999999999999999999999998632
Q ss_pred --------CCCCCCccccchhhc--ccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCC
Q 004979 583 --------NTTAAKTGSAAMELL--ETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDP 652 (721)
Q Consensus 583 --------~~~~~~~~~~apE~~--~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 652 (721)
....++..|||||++ ....|+.|+|||||||+..||++|..||.. ....+....-+.+..+... ...
T Consensus 180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k--~pPmkvLl~tLqn~pp~~~-t~~ 256 (516)
T KOG0582|consen 180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSK--YPPMKVLLLTLQNDPPTLL-TSG 256 (516)
T ss_pred CceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCccc--CChHHHHHHHhcCCCCCcc-ccc
Confidence 233566789999995 346799999999999999999999999962 2233333344444443222 100
Q ss_pred ccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004979 653 TLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAK 689 (721)
Q Consensus 653 ~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 689 (721)
.-.+........+.+++..|+++||++|||++++++.
T Consensus 257 ~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 257 LDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred CChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 0111223455689999999999999999999999853
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=343.37 Aligned_cols=241 Identities=22% Similarity=0.382 Sum_probs=202.6
Q ss_pred hCcCCCCceeEEEEEEecC-CcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEEEe
Q 004979 432 IGSFSDGTVGTVYKGTLSS-GVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFE 510 (721)
Q Consensus 432 i~~lg~G~~g~Vyk~~~~~-~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV~E 510 (721)
-.++|-|.||.||.|.|+. .-.||||.++... ...++|++|+.+|+.++|||+|+++|+|....++ |||+|
T Consensus 272 khKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt------MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF--YIiTE 343 (1157)
T KOG4278|consen 272 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT------MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF--YIITE 343 (1157)
T ss_pred eeccCCCcccceeeeeeeccceeeehhhhhhcc------hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe--EEEEe
Confidence 4578899999999999874 5678888776432 2357899999999999999999999999987754 99999
Q ss_pred cCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCCCCC--
Q 004979 511 YSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTAAK-- 588 (721)
Q Consensus 511 y~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~-- 588 (721)
||.+|+|.+||+...+..++--..+.+|.||+.||+||..++ +|||||.++|+|+.++..+||+|||+++.+...+
T Consensus 344 fM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn--FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYT 421 (1157)
T KOG4278|consen 344 FMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYT 421 (1157)
T ss_pred cccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh--hhhhhhhhhhccccccceEEeeccchhhhhcCCcee
Confidence 999999999999877777888888999999999999998877 9999999999999999999999999998765432
Q ss_pred --------ccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccH
Q 004979 589 --------TGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQE 659 (721)
Q Consensus 589 --------~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 659 (721)
..|.|||.+....++.|+|||+|||+|||+.| |-.||.+- ++.+ +...+..... .+-++
T Consensus 422 AHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGi--dlSq-VY~LLEkgyR---------M~~Pe 489 (1157)
T KOG4278|consen 422 AHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGI--DLSQ-VYGLLEKGYR---------MDGPE 489 (1157)
T ss_pred cccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCc--cHHH-HHHHHhcccc---------ccCCC
Confidence 25789999999999999999999999999999 99999633 3322 2223322211 12457
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 004979 660 NVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEIT 694 (721)
Q Consensus 660 ~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~ 694 (721)
.|++.+++||+.||++.|.+||++.|+-+.++.+-
T Consensus 490 GCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf 524 (1157)
T KOG4278|consen 490 GCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF 524 (1157)
T ss_pred CCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence 78899999999999999999999999999887653
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=335.24 Aligned_cols=259 Identities=22% Similarity=0.317 Sum_probs=209.1
Q ss_pred hhhhhhhCcCCCCceeEEEEEE-ecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCce
Q 004979 426 EDFSNIIGSFSDGTVGTVYKGT-LSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFT 504 (721)
Q Consensus 426 ~~~~~ii~~lg~G~~g~Vyk~~-~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 504 (721)
+|| +++..||+|+||.||.|+ ..+|..+|+|++++..... ....+.++.|-.+|...++|+||++|-.|++.+ .
T Consensus 141 ~DF-e~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~--~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~--~ 215 (550)
T KOG0605|consen 141 DDF-ELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLK--KNQVEHVRAERDILAEVDSPWVVKLYYSFQDKE--Y 215 (550)
T ss_pred ccc-hhheeeccccceeEEEEEEccCCcEEeeecccHHHHHh--hhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCC--e
Confidence 455 788899999999999998 5578999999998655433 344567899999999999999999999999887 7
Q ss_pred EEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC
Q 004979 505 RMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT 584 (721)
Q Consensus 505 ~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~ 584 (721)
.||||||++||++..+|. ....|+....+.++.+++.|++.+|+.| +|||||||+|+|||..|++||+||||+...
T Consensus 216 LYLiMEylPGGD~mTLL~--~~~~L~e~~arfYiaE~vlAI~~iH~~g--yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl 291 (550)
T KOG0605|consen 216 LYLIMEYLPGGDMMTLLM--RKDTLTEDWARFYIAETVLAIESIHQLG--YIHRDIKPDNLLIDAKGHIKLSDFGLSTGL 291 (550)
T ss_pred eEEEEEecCCccHHHHHH--hcCcCchHHHHHHHHHHHHHHHHHHHcC--cccccCChhheeecCCCCEeeccccccchh
Confidence 899999999999999996 4567888889999999999999999999 999999999999999999999999986310
Q ss_pred --------------------------------------------------------CCCCccccchhhcccCCCCCCccH
Q 004979 585 --------------------------------------------------------TAAKTGSAAMELLETSAVDLESNV 608 (721)
Q Consensus 585 --------------------------------------------------------~~~~~~~~apE~~~~~~~s~ksDV 608 (721)
..|++-|+|||++.+..|+..+|+
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDw 371 (550)
T KOG0605|consen 292 DKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDW 371 (550)
T ss_pred hhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccH
Confidence 012345789999999999999999
Q ss_pred HHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccHHHHHHHHHHHHHcccCCCCCCCC---HHH
Q 004979 609 YSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPS---MRG 685 (721)
Q Consensus 609 wSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs---~~e 685 (721)
||+|||+|||+.|-+||..+. ..+..++++.-...+.. | ....+..++.+||.+|+. ||++|.. ++|
T Consensus 372 WSLG~ImyEmLvGyPPF~s~t--p~~T~rkI~nwr~~l~f---P----~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~E 441 (550)
T KOG0605|consen 372 WSLGCIMYEMLVGYPPFCSET--PQETYRKIVNWRETLKF---P----EEVDLSDEAKDLITRLLC-DPENRLGSKGAEE 441 (550)
T ss_pred HHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHHhhhccC---C----CcCcccHHHHHHHHHHhc-CHHHhcCcccHHH
Confidence 999999999999999997443 33444444332211110 1 112334889999999998 9999975 444
Q ss_pred HHHHHHHhhhcCCCCCCCCCChhHHHHHHhh
Q 004979 686 IAAKLKEITAMEPDGATPKLSPLWWAELEIL 716 (721)
Q Consensus 686 vl~~L~~i~~~~~~~~~p~~~~~~~~~l~~~ 716 (721)
| .++|++..++|+.|...
T Consensus 442 I-------------K~HPfF~~v~W~~l~~~ 459 (550)
T KOG0605|consen 442 I-------------KKHPFFKGVDWDHLREM 459 (550)
T ss_pred H-------------hcCCccccCCcchhhcC
Confidence 4 35899999999987543
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=335.61 Aligned_cols=258 Identities=19% Similarity=0.260 Sum_probs=203.5
Q ss_pred hhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
+++..+|+|+||+||+|.. .++..+|+|.+....... ......+.+|++++++++|+||+++++++.+.+ ..++|
T Consensus 3 ~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~--~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~--~~~lv 78 (285)
T cd05631 3 RHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK--RKGEAMALNEKRILEKVNSRFVVSLAYAYETKD--ALCLV 78 (285)
T ss_pred eEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhh--hhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCC--eEEEE
Confidence 4567789999999999985 578899999876443221 223356889999999999999999999998777 67999
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC---
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT--- 585 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~--- 585 (721)
|||+++|+|.+++.......+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++....
T Consensus 79 ~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 79 LTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER--IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred EEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence 99999999998876544456899999999999999999999988 9999999999999999999999999976421
Q ss_pred -----CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCH-HHHHHHHhhcCCCCccccCCccccccH
Q 004979 586 -----AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSL-ENWASEYLKGEQPLKDIVDPTLKSFQE 659 (721)
Q Consensus 586 -----~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~-~~~~~~~~~~~~~~~~~~d~~l~~~~~ 659 (721)
.++..|+|||.+.+..++.++|||||||++|||++|+.||....... .+.+...... ....++.
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~----------~~~~~~~ 226 (285)
T cd05631 157 TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKE----------DQEEYSE 226 (285)
T ss_pred eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhc----------ccccCCc
Confidence 24567999999999999999999999999999999999997443211 1111111111 0011223
Q ss_pred HHHHHHHHHHHHcccCCCCCCCC-----HHHHHHHHHHhhhcCCCCCCCCCChhHHHHHHhh
Q 004979 660 NVLEELLVVIKNCVHPDPKQRPS-----MRGIAAKLKEITAMEPDGATPKLSPLWWAELEIL 716 (721)
Q Consensus 660 ~~~~~l~~li~~Cl~~dP~~RPs-----~~evl~~L~~i~~~~~~~~~p~~~~~~~~~l~~~ 716 (721)
..+.++.+|+.+||+.||++||+ ++|+++ +|.+..++|..++--
T Consensus 227 ~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~-------------h~~~~~~~~~~~~~~ 275 (285)
T cd05631 227 KFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ-------------HPIFKNINFKRLEAN 275 (285)
T ss_pred cCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc-------------CHhhcCCCHHHHHhC
Confidence 45577899999999999999997 666654 566777777777643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=311.14 Aligned_cols=256 Identities=20% Similarity=0.302 Sum_probs=213.2
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
+.+..+|.|+||.|..++.+ +|..+|+|++.+..... -...+...+|..+|+.+.||.++++++.+.+.+ ..+||
T Consensus 47 e~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVk--lKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~--~lymv 122 (355)
T KOG0616|consen 47 ERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVK--LKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNS--NLYMV 122 (355)
T ss_pred hheeeeccCccceEEEEEEccCCceeehhhcCHHHHHH--HHHHHHHhhHHHHHhhccCceeEEEEEeeccCC--eEEEE
Confidence 56788999999999999965 57788999887554332 223456788999999999999999999998877 78999
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC----
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT---- 584 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~---- 584 (721)
|||++||.|..+++ +.+.++...++.+|.+|+.||+|||+++ |++|||||+|||||.+|.+||+|||+|+..
T Consensus 123 meyv~GGElFS~Lr--k~~rF~e~~arFYAAeivlAleylH~~~--iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~rT 198 (355)
T KOG0616|consen 123 MEYVPGGELFSYLR--KSGRFSEPHARFYAAEIVLALEYLHSLD--IIYRDLKPENLLLDQNGHIKITDFGFAKRVSGRT 198 (355)
T ss_pred EeccCCccHHHHHH--hcCCCCchhHHHHHHHHHHHHHHHHhcC--eeeccCChHHeeeccCCcEEEEeccceEEecCcE
Confidence 99999999999996 4467999999999999999999999999 999999999999999999999999999754
Q ss_pred --CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccHHHH
Q 004979 585 --TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQENVL 662 (721)
Q Consensus 585 --~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 662 (721)
.++++.|.|||.+....|..++|.|||||++|||+.|..||...+. .+...+++.+.-. ++.-..
T Consensus 199 ~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~--~~iY~KI~~~~v~-----------fP~~fs 265 (355)
T KOG0616|consen 199 WTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP--IQIYEKILEGKVK-----------FPSYFS 265 (355)
T ss_pred EEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh--HHHHHHHHhCccc-----------CCcccC
Confidence 3567889999999999999999999999999999999999975543 5555666655443 334455
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh-hcCCCCCCCCCChhHHHHHHh
Q 004979 663 EELLVVIKNCVHPDPKQRPSMRGIAAKLKEIT-AMEPDGATPKLSPLWWAELEI 715 (721)
Q Consensus 663 ~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~-~~~~~~~~p~~~~~~~~~l~~ 715 (721)
.++.+|+...++.|-.+|- -.++ -......+|.+..+.|+.+.-
T Consensus 266 ~~~kdLl~~LL~vD~t~R~---------gnlknG~~dIk~H~wF~~v~W~~i~~ 310 (355)
T KOG0616|consen 266 SDAKDLLKKLLQVDLTKRF---------GNLKNGVEDIKNHPWFKGVDWEAILQ 310 (355)
T ss_pred HHHHHHHHHHHhhhhHhhh---------cCcCCCccccccCcccccccHHHHhh
Confidence 6788999999999998882 1222 234456789999999988754
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=305.44 Aligned_cols=251 Identities=19% Similarity=0.266 Sum_probs=196.8
Q ss_pred hhhhCcCCCCceeEEEEEE-ecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEE
Q 004979 429 SNIIGSFSDGTVGTVYKGT-LSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMM 507 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~-~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~l 507 (721)
|..++.+|+|.||.||+|+ ..+|+.||+|+++.....+ .......+||+.|+.++|+||+.++++|-..+ ..-|
T Consensus 4 Y~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kd---Gi~~talREIK~Lqel~h~nIi~LiD~F~~~~--~l~l 78 (318)
T KOG0659|consen 4 YEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKD---GINRTALREIKLLQELKHPNIIELIDVFPHKS--NLSL 78 (318)
T ss_pred hhhhhhhcCcceEEEEEEEecCCCcEEEEEEeecccccc---CccHHHHHHHHHHHHccCcchhhhhhhccCCC--ceEE
Confidence 4567889999999999999 5689999999998875433 23456889999999999999999999998877 5689
Q ss_pred EEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCCC-
Q 004979 508 VFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTA- 586 (721)
Q Consensus 508 V~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~~- 586 (721)
|+|||+. +|+..++. +...++..+...++.++.+|++|||++. |+||||||.|+|++++|.+||+|||+++....
T Consensus 79 VfEfm~t-dLe~vIkd-~~i~l~pa~iK~y~~m~LkGl~y~H~~~--IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p 154 (318)
T KOG0659|consen 79 VFEFMPT-DLEVVIKD-KNIILSPADIKSYMLMTLKGLAYCHSKW--ILHRDLKPNNLLISSDGQLKIADFGLARFFGSP 154 (318)
T ss_pred EEEeccc-cHHHHhcc-cccccCHHHHHHHHHHHHHHHHHHHhhh--hhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence 9999965 89988864 4567899999999999999999999998 99999999999999999999999999985442
Q ss_pred --------CCccccchhhcc-cCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCC-CccccC-----
Q 004979 587 --------AKTGSAAMELLE-TSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQP-LKDIVD----- 651 (721)
Q Consensus 587 --------~~~~~~apE~~~-~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~-~~~~~d----- 651 (721)
.+..|.|||.+- ...|+...||||.|||+.||+-|.+-|. .+.++++...-+..-..| ..++-+
T Consensus 155 ~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fp-G~sDidQL~~If~~LGTP~~~~WP~~~~lp 233 (318)
T KOG0659|consen 155 NRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFP-GDSDIDQLSKIFRALGTPTPDQWPEMTSLP 233 (318)
T ss_pred CcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCC-CCchHHHHHHHHHHcCCCCcccCccccccc
Confidence 234678999874 5679999999999999999999876554 333444332211111111 111100
Q ss_pred ----------CccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004979 652 ----------PTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAK 689 (721)
Q Consensus 652 ----------~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 689 (721)
+........+..++.+|+..+|..+|.+|.++.|++++
T Consensus 234 dY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 234 DYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred cHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 11111223456678999999999999999999998864
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=337.88 Aligned_cols=243 Identities=22% Similarity=0.332 Sum_probs=201.3
Q ss_pred hhhhhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCC-CCccceEeEEEecCCCce
Q 004979 427 DFSNIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVN-HKNFVNLIGYCEEDEPFT 504 (721)
Q Consensus 427 ~~~~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~ 504 (721)
+.+.+...+|+|+||+||.|+. .++..||+|++..+..........+.+.+|+.++++++ ||||++++.++.... .
T Consensus 17 g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~--~ 94 (370)
T KOG0583|consen 17 GKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT--K 94 (370)
T ss_pred CceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC--e
Confidence 3456778899999999999985 56899999966543221111123456778999999998 999999999999877 6
Q ss_pred EEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCC-CcEEEeccCCCCC
Q 004979 505 RMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTED-YAAKISDFSFWNN 583 (721)
Q Consensus 505 ~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~-~~~kL~DFGla~~ 583 (721)
.++||||+.+|+|++++.. ...+.+.....++.|++.|++|||+++ |+||||||+|||+|.+ +++||+|||++..
T Consensus 95 ~~ivmEy~~gGdL~~~i~~--~g~l~E~~ar~~F~Qlisav~y~H~~g--i~HRDLK~ENilld~~~~~~Kl~DFG~s~~ 170 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVN--KGRLKEDEARKYFRQLISAVAYCHSRG--IVHRDLKPENILLDGNEGNLKLSDFGLSAI 170 (370)
T ss_pred EEEEEEecCCccHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEecCCCCCEEEeccccccc
Confidence 8999999999999999974 567888999999999999999999998 9999999999999999 9999999999874
Q ss_pred C---------CCCCccccchhhcccCC-CC-CCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCC
Q 004979 584 T---------TAAKTGSAAMELLETSA-VD-LESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDP 652 (721)
Q Consensus 584 ~---------~~~~~~~~apE~~~~~~-~s-~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 652 (721)
. ..|++.|+|||++.+.. |+ .++||||+||+||.|++|+.||+. .+.......+..+...+...++
T Consensus 171 ~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d--~~~~~l~~ki~~~~~~~p~~~~- 247 (370)
T KOG0583|consen 171 SPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD--SNVPNLYRKIRKGEFKIPSYLL- 247 (370)
T ss_pred cCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC--ccHHHHHHHHhcCCccCCCCcC-
Confidence 4 23567899999998877 86 889999999999999999999975 4444555555555443333221
Q ss_pred ccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 004979 653 TLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIA 687 (721)
Q Consensus 653 ~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl 687 (721)
+.++..|+.+|+..+|.+|+++.||+
T Consensus 248 ---------S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 248 ---------SPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred ---------CHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 67889999999999999999999998
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=338.49 Aligned_cols=238 Identities=23% Similarity=0.352 Sum_probs=198.3
Q ss_pred hhhCcCCCCceeEEEEEE-ecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGT-LSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~-~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
....++|+|+.|.||.++ ..++..||||++..+.... ++-+.+|+.+|+..+|+|||++++-|...+ +.|+|
T Consensus 276 ~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~-----keLilnEi~Vm~~~~H~NiVnfl~Sylv~d--eLWVV 348 (550)
T KOG0578|consen 276 TDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK-----KELLLNEILVMRDLHHPNIVNFLDSYLVGD--ELWVV 348 (550)
T ss_pred cchhhhccccccceeeeeeccCCceEEEEEEEeccCCc-----hhhhHHHHHHHHhccchHHHHHHHHhcccc--eeEEE
Confidence 445678899999999998 5678899999998764332 356789999999999999999999887766 78999
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCC-----
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNN----- 583 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~----- 583 (721)
||||++|+|.+.+. ...+++.++..|++++++||+|||.++ |+|||||.+|||++.++.+||+|||++..
T Consensus 349 MEym~ggsLTDvVt---~~~~~E~qIA~Icre~l~aL~fLH~~g--IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~ 423 (550)
T KOG0578|consen 349 MEYMEGGSLTDVVT---KTRMTEGQIAAICREILQGLKFLHARG--IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ 423 (550)
T ss_pred EeecCCCchhhhhh---cccccHHHHHHHHHHHHHHHHHHHhcc--eeeeccccceeEeccCCcEEEeeeeeeecccccc
Confidence 99999999999984 344899999999999999999999998 99999999999999999999999998643
Q ss_pred ----CCCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccH
Q 004979 584 ----TTAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQE 659 (721)
Q Consensus 584 ----~~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 659 (721)
...++++|||||++....|++|.||||+|++++||+-|++||-.++.....|... -.+. +.+ ..++
T Consensus 424 ~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa-~ng~--------P~l-k~~~ 493 (550)
T KOG0578|consen 424 SKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA-TNGT--------PKL-KNPE 493 (550)
T ss_pred CccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHh-hcCC--------CCc-CCcc
Confidence 3346789999999999999999999999999999999999997544322222111 1111 111 2346
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004979 660 NVLEELLVVIKNCVHPDPKQRPSMRGIAAK 689 (721)
Q Consensus 660 ~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 689 (721)
..+.++.+++.+||+.|+++|+++.|+++.
T Consensus 494 klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 494 KLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred ccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 677899999999999999999999999873
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=331.43 Aligned_cols=240 Identities=31% Similarity=0.512 Sum_probs=189.6
Q ss_pred hhCcCCCCceeEEEEEEec-----CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceE
Q 004979 431 IIGSFSDGTVGTVYKGTLS-----SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTR 505 (721)
Q Consensus 431 ii~~lg~G~~g~Vyk~~~~-----~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~ 505 (721)
+.+.||.|.||.||+|.+. .+..|+||.+... ......+.|.+|++.+++++||||++++|+|...+ ..
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~----~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~--~~ 76 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS----SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENE--PL 76 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT----SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSS--SE
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc----cccccceeeeecccccccccccccccccccccccc--cc
Confidence 4567899999999999977 3467888887432 12334678999999999999999999999999666 46
Q ss_pred EEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC
Q 004979 506 MMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT 585 (721)
Q Consensus 506 ~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~ 585 (721)
++||||+++|+|.++|+......+++..+..|+.||+.||+|||+.+ |+||||+++||++++++.+||+|||++....
T Consensus 77 ~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~--iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~ 154 (259)
T PF07714_consen 77 FLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN--IIHGNLSPSNILLDSNGQVKLSDFGLSRPIS 154 (259)
T ss_dssp EEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT--EEEST-SGGGEEEETTTEEEEESTTTGEETT
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccc--ccccccccccccccccccccccccccccccc
Confidence 99999999999999998664677999999999999999999999988 9999999999999999999999999876541
Q ss_pred -----------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhcCCCCccccCCc
Q 004979 586 -----------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPLKDIVDPT 653 (721)
Q Consensus 586 -----------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 653 (721)
.....|+|||.+....++.++||||||+++|||+| |+.||.. .+..++......+..
T Consensus 155 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~--~~~~~~~~~~~~~~~--------- 223 (259)
T PF07714_consen 155 EKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSD--YDNEEIIEKLKQGQR--------- 223 (259)
T ss_dssp TSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTT--SCHHHHHHHHHTTEE---------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccc--ccccccccccccccc---------
Confidence 12346789999988889999999999999999999 7888853 244444444432211
Q ss_pred cccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 004979 654 LKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKL 690 (721)
Q Consensus 654 l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L 690 (721)
...+..++..+.+++.+||+.+|++||+|.||++.|
T Consensus 224 -~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 224 -LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp -TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred -ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 112234567788999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=335.11 Aligned_cols=234 Identities=21% Similarity=0.266 Sum_probs=191.4
Q ss_pred cCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEEEecC
Q 004979 434 SFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYS 512 (721)
Q Consensus 434 ~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV~Ey~ 512 (721)
.+|+|+||.||+++. .+++.+|+|++...... .......+.+|++++++++||||+++++++...+ ..++||||+
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~--~~~lv~e~~ 77 (323)
T cd05571 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVII--AKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHD--RLCFVMEYA 77 (323)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh--hhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCC--EEEEEEeCC
Confidence 478999999999985 46888999988643221 1233456889999999999999999999998877 679999999
Q ss_pred CCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC--------
Q 004979 513 PNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT-------- 584 (721)
Q Consensus 513 ~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~-------- 584 (721)
++|+|.+++.. ...+++.....++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 78 ~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~--ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 153 (323)
T cd05571 78 NGGELFFHLSR--ERVFSEDRARFYGAEIVSALGYLHSCD--VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMK 153 (323)
T ss_pred CCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCccc
Confidence 99999998863 356899999999999999999999998 999999999999999999999999987642
Q ss_pred -CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccHHHHH
Q 004979 585 -TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQENVLE 663 (721)
Q Consensus 585 -~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 663 (721)
..++..|+|||.+.+..++.++|||||||++|||+||+.||... +..........+.. .++.....
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~--~~~~~~~~~~~~~~-----------~~p~~~~~ 220 (323)
T cd05571 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ--DHEKLFELILMEEI-----------RFPRTLSP 220 (323)
T ss_pred ceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCC--CHHHHHHHHHcCCC-----------CCCCCCCH
Confidence 12456799999999999999999999999999999999999643 22333333322211 12234557
Q ss_pred HHHHHHHHcccCCCCCCC-----CHHHHHH
Q 004979 664 ELLVVIKNCVHPDPKQRP-----SMRGIAA 688 (721)
Q Consensus 664 ~l~~li~~Cl~~dP~~RP-----s~~evl~ 688 (721)
++.+++.+||+.||++|| ++.|+++
T Consensus 221 ~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 221 EAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred HHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 788999999999999999 7888864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=340.95 Aligned_cols=259 Identities=18% Similarity=0.290 Sum_probs=213.7
Q ss_pred hhhhhhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcC-CCCccceEeEEEecCCCc
Q 004979 426 EDFSNIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKV-NHKNFVNLIGYCEEDEPF 503 (721)
Q Consensus 426 ~~~~~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~ 503 (721)
++| .+++.+|+|.||+|+.+..+ +++.+|||++++..... .+..+....|.+++.-. +||.++.++.+++..+
T Consensus 368 ~~F-~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~--~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~-- 442 (694)
T KOG0694|consen 368 DDF-RLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQ--RDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE-- 442 (694)
T ss_pred cce-EEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceec--cccHHHHHHHHHHHHHhccCCeEeecccccccCC--
Confidence 455 67889999999999999965 57789999987654432 34456777888887766 6999999999999888
Q ss_pred eEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCC
Q 004979 504 TRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNN 583 (721)
Q Consensus 504 ~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~ 583 (721)
+.|.||||+.||++..+. ....++...+..+|..|+.||+|||+++ ||+||||.+|||||.+|.+||+|||+++.
T Consensus 443 ~l~fvmey~~Ggdm~~~~---~~~~F~e~rarfyaAev~l~L~fLH~~~--IIYRDlKLdNiLLD~eGh~kiADFGlcKe 517 (694)
T KOG0694|consen 443 HLFFVMEYVAGGDLMHHI---HTDVFSEPRARFYAAEVVLGLQFLHENG--IIYRDLKLDNLLLDTEGHVKIADFGLCKE 517 (694)
T ss_pred eEEEEEEecCCCcEEEEE---ecccccHHHHHHHHHHHHHHHHHHHhcC--ceeeecchhheEEcccCcEEecccccccc
Confidence 889999999999954443 4567999999999999999999999999 99999999999999999999999999874
Q ss_pred C---------CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCcc
Q 004979 584 T---------TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTL 654 (721)
Q Consensus 584 ~---------~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 654 (721)
. ..|++.|+|||++.+..|+..+|.|||||+||||++|+.||.++ +-++....++..+..+
T Consensus 518 ~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gd--dEee~FdsI~~d~~~y-------- 587 (694)
T KOG0694|consen 518 GMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGD--DEEEVFDSIVNDEVRY-------- 587 (694)
T ss_pred cCCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCC--CHHHHHHHHhcCCCCC--------
Confidence 3 34677899999999999999999999999999999999999744 3445555555544332
Q ss_pred ccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCChhHHHHHHh
Q 004979 655 KSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAMEPDGATPKLSPLWWAELEI 715 (721)
Q Consensus 655 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~~~~p~~~~~~~~~l~~ 715 (721)
+..++.+..+++++.+.++|++|..+.| .......++|++-.++|++|+-
T Consensus 588 ---P~~ls~ea~~il~~ll~k~p~kRLG~~e--------~d~~~i~~hpFFr~i~w~~L~~ 637 (694)
T KOG0694|consen 588 ---PRFLSKEAIAIMRRLLRKNPEKRLGSGE--------RDAEDIKKHPFFRSIDWDDLLN 637 (694)
T ss_pred ---CCcccHHHHHHHHHHhccCcccccCCCC--------CCchhhhhCCccccCCHHHHhh
Confidence 3345678999999999999999987632 2233345689999999999974
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=330.35 Aligned_cols=249 Identities=23% Similarity=0.366 Sum_probs=191.6
Q ss_pred hhhCcCCCCceeEEEEEEecC-----------------CcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccce
Q 004979 430 NIIGSFSDGTVGTVYKGTLSS-----------------GVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVN 492 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~~-----------------~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~ 492 (721)
.+.+.+|+|+||.||+|.+++ +..||+|.+.... ......+|.+|++++.+++||||++
T Consensus 8 ~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 8 LFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA----NKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred eeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC----CHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 566789999999999998542 2368888775432 2334567999999999999999999
Q ss_pred EeEEEecCCCceEEEEEecCCCCChhhhhhhcc-----------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCe
Q 004979 493 LIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQE-----------------AEHLDWAMRLRIAMGMAYCLEHMHQLTPPI 555 (721)
Q Consensus 493 l~g~~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~-----------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~I 555 (721)
+++++.+.+ ..++||||+++|+|.+++.... ...++|....+++.||+.||+|||+.+ |
T Consensus 84 ~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i 159 (304)
T cd05096 84 LLGVCVDED--PLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN--F 159 (304)
T ss_pred EEEEEecCC--ceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC--c
Confidence 999998876 5699999999999999885321 124788899999999999999999988 9
Q ss_pred EeeCCCCCCeEeCCCCcEEEeccCCCCCCCC-----------CCccccchhhcccCCCCCCccHHHHHHHHHHHHh--CC
Q 004979 556 AHRNLQSSSIYLTEDYAAKISDFSFWNNTTA-----------AKTGSAAMELLETSAVDLESNVYSFGTILFEMIT--GR 622 (721)
Q Consensus 556 vHrDLKp~NILl~~~~~~kL~DFGla~~~~~-----------~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt--G~ 622 (721)
+||||||+|||+++++.+||+|||+++.... ....|+|||.+....++.++|||||||++|||++ +.
T Consensus 160 vH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~ 239 (304)
T cd05096 160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKE 239 (304)
T ss_pred cccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCC
Confidence 9999999999999999999999999864321 1346899999988899999999999999999997 55
Q ss_pred CcccCCC-CCHHHHHHHHhhcCCCCccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 004979 623 ISYSIEN-GSLENWASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKE 692 (721)
Q Consensus 623 ~P~~~~~-~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 692 (721)
.||.... ......+......... .. ....+..++..+.+++.+||+.||++|||+.||.+.|++
T Consensus 240 ~p~~~~~~~~~~~~~~~~~~~~~~--~~----~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 240 QPYGELTDEQVIENAGEFFRDQGR--QV----YLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCCCcCCHHHHHHHHHHHhhhccc--cc----cccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 6665322 1111222221111100 00 001122345678999999999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=329.32 Aligned_cols=238 Identities=20% Similarity=0.259 Sum_probs=194.4
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
++++.+|+|+||+||+|+.. +++.+|+|++....... ....+.+.+|++++++++||||+++++++.+.+ ..++|
T Consensus 4 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--~~~lv 79 (291)
T cd05612 4 ERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIR--LKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQR--FLYML 79 (291)
T ss_pred eeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhh--hHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCC--eEEEE
Confidence 56778999999999999965 68889999886432211 223456889999999999999999999988766 67999
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC---
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT--- 585 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~--- 585 (721)
|||+++|+|.+++.. ...+++.....++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 80 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~ 155 (291)
T cd05612 80 MEYVPGGELFSYLRN--SGRFSNSTGLFYASEIVCALEYLHSKE--IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT 155 (291)
T ss_pred EeCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCCCCEEEEecCcchhccCCc
Confidence 999999999999863 346889999999999999999999988 9999999999999999999999999976432
Q ss_pred ---CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccHHHH
Q 004979 586 ---AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQENVL 662 (721)
Q Consensus 586 ---~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 662 (721)
.++..|+|||.+.+..++.++|||||||++|||+||+.||... +..+....+..+... ++....
T Consensus 156 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~--~~~~~~~~i~~~~~~-----------~~~~~~ 222 (291)
T cd05612 156 WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDD--NPFGIYEKILAGKLE-----------FPRHLD 222 (291)
T ss_pred ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHhCCcC-----------CCccCC
Confidence 2456789999999889999999999999999999999999643 333334444333221 122335
Q ss_pred HHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 004979 663 EELLVVIKNCVHPDPKQRPS-----MRGIAA 688 (721)
Q Consensus 663 ~~l~~li~~Cl~~dP~~RPs-----~~evl~ 688 (721)
..+.+++.+||+.||.+||+ +.|+++
T Consensus 223 ~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 253 (291)
T cd05612 223 LYAKDLIKKLLVVDRTRRLGNMKNGADDVKN 253 (291)
T ss_pred HHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence 67889999999999999995 777764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=349.64 Aligned_cols=247 Identities=19% Similarity=0.352 Sum_probs=204.0
Q ss_pred hhhCcCCCCceeEEEEEEecCC-cEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCC-CCccceEeE-EEe---cCC-C
Q 004979 430 NIIGSFSDGTVGTVYKGTLSSG-VEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVN-HKNFVNLIG-YCE---EDE-P 502 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~~~-~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g-~~~---~~~-~ 502 (721)
.|...|.+|||+.||.|....+ ..+|+|++.... +...+.+.+||++|++|+ |+|||.+++ ... ... .
T Consensus 40 ~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~d-----e~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 40 TVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVND-----EEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred EEEEEEccCCcEEEEEEEecCCCceeeeeeeecCC-----HHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 4556788999999999997665 999999886543 334577899999999996 999999999 322 222 4
Q ss_pred ceEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCC
Q 004979 503 FTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWN 582 (721)
Q Consensus 503 ~~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~ 582 (721)
++.+|.||||++|.|-+++..+....|++.++++|+.|+++|+++||.+.|||||||||-+||||+.++..||||||-+.
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSat 194 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSAT 194 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccccc
Confidence 67899999999999999998665566999999999999999999999999999999999999999999999999999764
Q ss_pred CCC------------------CCCccccchhhc---ccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhh
Q 004979 583 NTT------------------AAKTGSAAMELL---ETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLK 641 (721)
Q Consensus 583 ~~~------------------~~~~~~~apE~~---~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~ 641 (721)
... ..+..|.+||.+ .+...++|+|||++||+||-|+....||+..+.
T Consensus 195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~----------- 263 (738)
T KOG1989|consen 195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK----------- 263 (738)
T ss_pred cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc-----------
Confidence 221 134578999986 577889999999999999999999999964321
Q ss_pred cCCCCccccCCccc-cccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcC
Q 004979 642 GEQPLKDIVDPTLK-SFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAME 697 (721)
Q Consensus 642 ~~~~~~~~~d~~l~-~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 697 (721)
..|++.... .-.+.++..+.+||+.||+.+|++||++-+|+..+.+++...
T Consensus 264 -----laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~ 315 (738)
T KOG1989|consen 264 -----LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP 315 (738)
T ss_pred -----eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence 122222221 112578899999999999999999999999999998887654
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=331.05 Aligned_cols=237 Identities=22% Similarity=0.328 Sum_probs=202.2
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
.+.+.+|+|+||.||||+.+ +.+.||+|.+.+..+. +...+.+.+|++++++++|||||.++++|+... +.++|
T Consensus 5 hv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~---~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~--~~~vV 79 (808)
T KOG0597|consen 5 HVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRN---EKELKNLRQEVRILRSLKHPNIVEMLESFETSA--HLWVV 79 (808)
T ss_pred hHHHHhcCCccceeeecccccceeEEEEEEehhcCCc---hHHHHHHHHHHHHHHhcCCcchhhHHHhhcccc--eEEEE
Confidence 56677889999999999855 5678899888755433 334567999999999999999999999999887 78999
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC---
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT--- 585 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~--- 585 (721)
+||+.+ +|..+|.. ...+++.....|+.++..||.|||+.+ |+|||+||.|||++..+++|+||||+|+.+.
T Consensus 80 te~a~g-~L~~il~~--d~~lpEe~v~~~a~~LVsaL~yLhs~r--ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t 154 (808)
T KOG0597|consen 80 TEYAVG-DLFTILEQ--DGKLPEEQVRAIAYDLVSALYYLHSNR--ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT 154 (808)
T ss_pred ehhhhh-hHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhcC--cccccCCcceeeecCCCceeechhhhhhhcccCc
Confidence 999976 99999964 456999999999999999999999988 9999999999999999999999999998543
Q ss_pred ------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccH
Q 004979 586 ------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQE 659 (721)
Q Consensus 586 ------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 659 (721)
.+++.|||||.+.+..|+..+|.||+|||+||+++|++||. ..++.+.++.+..+... .+.
T Consensus 155 ~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~--a~si~~Lv~~I~~d~v~-----------~p~ 221 (808)
T KOG0597|consen 155 SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFY--ARSITQLVKSILKDPVK-----------PPS 221 (808)
T ss_pred eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCch--HHHHHHHHHHHhcCCCC-----------Ccc
Confidence 35678999999999999999999999999999999999996 33455566666554322 223
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004979 660 NVLEELLVVIKNCVHPDPKQRPSMRGIAAK 689 (721)
Q Consensus 660 ~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 689 (721)
..+..+..++...+.+||..|.+-.+++..
T Consensus 222 ~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 222 TASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred cccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 566789999999999999999999998763
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=334.05 Aligned_cols=238 Identities=16% Similarity=0.256 Sum_probs=193.9
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
++++.+|+|+||.||+|+.. +++.+|+|++...... .....+.+.+|++++++++||||+++++++.+.+ ..++|
T Consensus 21 ~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--~~~lv 96 (329)
T PTZ00263 21 EMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREIL--KMKQVQHVAQEKSILMELSHPFIVNMMCSFQDEN--RVYFL 96 (329)
T ss_pred EEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHh--hhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCC--EEEEE
Confidence 67788999999999999965 6788999988643221 1223467899999999999999999999998877 67999
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC---
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT--- 585 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~--- 585 (721)
|||+++|+|.+++.. ...+++.....++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 97 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 172 (329)
T PTZ00263 97 LEFVVGGELFTHLRK--AGRFPNDVAKFYHAELVLAFEYLHSKD--IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT 172 (329)
T ss_pred EcCCCCChHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEECCCCCEEEeeccCceEcCCCc
Confidence 999999999999863 346788888999999999999999988 9999999999999999999999999986432
Q ss_pred ---CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccHHHH
Q 004979 586 ---AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQENVL 662 (721)
Q Consensus 586 ---~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 662 (721)
.++..|+|||.+.+..++.++|||||||++|||+||+.||... +..+....+..+...+ +....
T Consensus 173 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~--~~~~~~~~i~~~~~~~-----------p~~~~ 239 (329)
T PTZ00263 173 FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDD--TPFRIYEKILAGRLKF-----------PNWFD 239 (329)
T ss_pred ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCC--CHHHHHHHHhcCCcCC-----------CCCCC
Confidence 2455789999999999999999999999999999999999633 2333333333332111 12234
Q ss_pred HHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 004979 663 EELLVVIKNCVHPDPKQRPS-----MRGIAA 688 (721)
Q Consensus 663 ~~l~~li~~Cl~~dP~~RPs-----~~evl~ 688 (721)
.++.+++.+||+.||++||+ ++|++.
T Consensus 240 ~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 240 GRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred HHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 56889999999999999996 677764
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=338.03 Aligned_cols=239 Identities=22% Similarity=0.340 Sum_probs=205.9
Q ss_pred hhhCcCCCCceeEEEEEE-ecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGT-LSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~-~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
++-..+|.|+.|.|-.|+ ..+|+.+|||++...... .......+.+||-+|+-+.||||+++|+++.+.. +.|+|
T Consensus 15 kLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~--s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~--~lylv 90 (786)
T KOG0588|consen 15 KLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSEL--SSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQ--HLYLV 90 (786)
T ss_pred eccccccCCCCceehhhhcccccceeEEEeecccccc--ccccccchhhhhHHHHHhcCCCeeeeeeeeccCc--eEEEE
Confidence 445678999999999998 468999999999765322 2333456889999999999999999999999877 78999
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCC-----
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNN----- 583 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~----- 583 (721)
.||+++|.|+++|. +.+.+......+++.||..|+.|+|..+ |+||||||+|+|||.+.++||+|||+|..
T Consensus 91 lEyv~gGELFdylv--~kG~l~e~eaa~ff~QIi~gv~yCH~~~--icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk 166 (786)
T KOG0588|consen 91 LEYVPGGELFDYLV--RKGPLPEREAAHFFRQILDGVSYCHAFN--ICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK 166 (786)
T ss_pred EEecCCchhHHHHH--hhCCCCCHHHHHHHHHHHHHHHHHhhhc--ceeccCCchhhhhhcccCEeeeccceeecccCCc
Confidence 99999999999996 3467899999999999999999999988 99999999999999999999999999853
Q ss_pred ---CCCCCccccchhhcccCCCC-CCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccH
Q 004979 584 ---TTAAKTGSAAMELLETSAVD-LESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQE 659 (721)
Q Consensus 584 ---~~~~~~~~~apE~~~~~~~s-~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 659 (721)
+.+|.++|++||++.+..|+ .++||||.|||||.|+||+.||+ +.++...+.++-.|... ++.
T Consensus 167 lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFd--DdNir~LLlKV~~G~f~-----------MPs 233 (786)
T KOG0588|consen 167 LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFD--DDNIRVLLLKVQRGVFE-----------MPS 233 (786)
T ss_pred cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCC--CccHHHHHHHHHcCccc-----------CCC
Confidence 34577899999999999985 88999999999999999999997 55666666666555432 345
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004979 660 NVLEELLVVIKNCVHPDPKQRPSMRGIAAK 689 (721)
Q Consensus 660 ~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 689 (721)
.++.++.+|+.+|+..||++|.|++||.+.
T Consensus 234 ~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 234 NISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred cCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 667889999999999999999999999875
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=334.28 Aligned_cols=244 Identities=20% Similarity=0.352 Sum_probs=203.1
Q ss_pred hCcCCCCceeEEEEEEec---CCc--EEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEE
Q 004979 432 IGSFSDGTVGTVYKGTLS---SGV--EIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRM 506 (721)
Q Consensus 432 i~~lg~G~~g~Vyk~~~~---~~~--~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~ 506 (721)
-..||+|.||.||+|.+. .|. .||||..+.. .+....+.|++|..+|++++|||||+++|+|.+.. .+
T Consensus 394 ~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d----~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~P---~W 466 (974)
T KOG4257|consen 394 KRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTD----CTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQP---MW 466 (974)
T ss_pred HHhhcCCcccceeeeEecccccCcceeeeeehhccC----CChhhHHHHHHHHHHHHhCCCcchhheeeeeeccc---ee
Confidence 346789999999999864 344 3566655432 23344678999999999999999999999998753 58
Q ss_pred EEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCCC
Q 004979 507 MVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTA 586 (721)
Q Consensus 507 lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~~ 586 (721)
||||.++.|.|..+|.. +...|+......++.||+.||+|||+.. .|||||..+|||+...-.+|++|||+++....
T Consensus 467 ivmEL~~~GELr~yLq~-nk~sL~l~tL~ly~~Qi~talaYLeSkr--fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed 543 (974)
T KOG4257|consen 467 IVMELAPLGELREYLQQ-NKDSLPLRTLTLYCYQICTALAYLESKR--FVHRDIAARNILVSSPQCVKLADFGLSRYLED 543 (974)
T ss_pred EEEecccchhHHHHHHh-ccccchHHHHHHHHHHHHHHHHHHHhhc--hhhhhhhhhheeecCcceeeecccchhhhccc
Confidence 99999999999999964 4567889999999999999999999988 99999999999999999999999999875543
Q ss_pred C----------CccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhcCCCCccccCCccc
Q 004979 587 A----------KTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPLKDIVDPTLK 655 (721)
Q Consensus 587 ~----------~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 655 (721)
. ...|||||.+...+++.++|||-|||++||++. |..||.+-.. ...+..+-.....
T Consensus 544 ~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkN------------sDVI~~iEnGeRl 611 (974)
T KOG4257|consen 544 DAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKN------------SDVIGHIENGERL 611 (974)
T ss_pred cchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccc------------cceEEEecCCCCC
Confidence 2 235899999999999999999999999999998 9999964321 1223333344455
Q ss_pred cccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcC
Q 004979 656 SFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAME 697 (721)
Q Consensus 656 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 697 (721)
..++.|++.++.||.+||++||.+||.+.|+...|.++.+.+
T Consensus 612 P~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qee 653 (974)
T KOG4257|consen 612 PCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEE 653 (974)
T ss_pred CCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHh
Confidence 678899999999999999999999999999999999887743
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=316.53 Aligned_cols=238 Identities=20% Similarity=0.362 Sum_probs=194.4
Q ss_pred hhhCcCCCCceeEEEEEEecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVF 509 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV~ 509 (721)
++++.+|+|+||.||++.+.++..+++|.+..... ...+|.+|++++++++||||+++++++...+ ..++||
T Consensus 7 ~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~iv~ 78 (256)
T cd05114 7 TFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAM------SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQK--PLYIVT 78 (256)
T ss_pred EEeeEecCCcCceEEEEEeccCceEEEEecccCCc------cHHHHHHHHHHHHHCCCCCceeEEEEEccCC--CEEEEE
Confidence 56778999999999999998888899987653221 1357889999999999999999999998776 579999
Q ss_pred ecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCCC---
Q 004979 510 EYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTA--- 586 (721)
Q Consensus 510 Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~~--- 586 (721)
||+++|+|.++++... ..++|..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++....
T Consensus 79 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05114 79 EFMENGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLERNS--FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY 155 (256)
T ss_pred EcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcceEEEcCCCeEEECCCCCccccCCCce
Confidence 9999999999986432 45899999999999999999999988 99999999999999999999999998764321
Q ss_pred -------CCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhcCCCCccccCCcccccc
Q 004979 587 -------AKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQ 658 (721)
Q Consensus 587 -------~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 658 (721)
....|+|||.+....++.++||||||+++|||+| |+.||... +..+.+.....+.... . +
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~--~~~~~~~~i~~~~~~~----~------~ 223 (256)
T cd05114 156 TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKK--SNYEVVEMISRGFRLY----R------P 223 (256)
T ss_pred eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCC--CHHHHHHHHHCCCCCC----C------C
Confidence 1235899999988889999999999999999999 89998533 3333333333322111 1 1
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 004979 659 ENVLEELLVVIKNCVHPDPKQRPSMRGIAAKL 690 (721)
Q Consensus 659 ~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L 690 (721)
...+.++.+++.+||+.+|++||++.|+++.|
T Consensus 224 ~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 224 KLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 12345789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=318.91 Aligned_cols=239 Identities=21% Similarity=0.348 Sum_probs=203.4
Q ss_pred hhhhCcCCCCceeEEEEEE-ecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEE
Q 004979 429 SNIIGSFSDGTVGTVYKGT-LSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMM 507 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~-~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~l 507 (721)
+++.+.+|+|+||.|-+|. +..|+.||||.+++....+ +...-.+++||++|+.|+||||+.+|.+|...+ .+.|
T Consensus 55 yE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkd--eqDlvhIRREIeIMSsLNHPhII~IyEVFENkd--KIvi 130 (668)
T KOG0611|consen 55 YEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKD--EQDLVHIRREIEIMSSLNHPHIIQIYEVFENKD--KIVI 130 (668)
T ss_pred HHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhccc--HHHHHHHHHHHHHHhhcCCCceeehhhhhcCCc--eEEE
Confidence 4677889999999999998 5789999999987655444 334567899999999999999999999999887 7899
Q ss_pred EEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCC----
Q 004979 508 VFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNN---- 583 (721)
Q Consensus 508 V~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~---- 583 (721)
||||..+|.|++|+. +.+.|++...+.+++||..|+.|+|.++ ++|||||.+|||||.++++||+|||++..
T Consensus 131 vMEYaS~GeLYDYiS--er~~LsErEaRhfFRQIvSAVhYCHknr--VvHRDLKLENILLD~N~NiKIADFGLSNly~~~ 206 (668)
T KOG0611|consen 131 VMEYASGGELYDYIS--ERGSLSEREARHFFRQIVSAVHYCHKNR--VVHRDLKLENILLDQNNNIKIADFGLSNLYADK 206 (668)
T ss_pred EEEecCCccHHHHHH--HhccccHHHHHHHHHHHHHHHHHHhhcc--ceecccchhheeecCCCCeeeeccchhhhhccc
Confidence 999999999999996 4567999999999999999999999988 99999999999999999999999999753
Q ss_pred ----CCCCCccccchhhcccCCCC-CCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCcccccc
Q 004979 584 ----TTAAKTGSAAMELLETSAVD-LESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQ 658 (721)
Q Consensus 584 ----~~~~~~~~~apE~~~~~~~s-~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 658 (721)
+..+.+-|++||.+.+..|. +.+|-||+||+||-|+.|..||++. +....++++..+... +
T Consensus 207 kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~--Dhk~lvrQIs~GaYr--E---------- 272 (668)
T KOG0611|consen 207 KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGR--DHKRLVRQISRGAYR--E---------- 272 (668)
T ss_pred cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCc--hHHHHHHHhhccccc--C----------
Confidence 34567789999999999885 8899999999999999999999643 444555555544321 1
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004979 659 ENVLEELLVVIKNCVHPDPKQRPSMRGIAAK 689 (721)
Q Consensus 659 ~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 689 (721)
++.+....-||++|+..+|++|.|..+|...
T Consensus 273 P~~PSdA~gLIRwmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 273 PETPSDASGLIRWMLMVNPERRATIEDIASH 303 (668)
T ss_pred CCCCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence 1223456779999999999999999999864
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=330.09 Aligned_cols=234 Identities=20% Similarity=0.258 Sum_probs=191.1
Q ss_pred cCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEEEecC
Q 004979 434 SFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYS 512 (721)
Q Consensus 434 ~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV~Ey~ 512 (721)
.+|+|+||.||+++. .++..+|+|++...... .......+.+|+++++.++||||+++++++...+ ..++||||+
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--~~~lv~Ey~ 77 (328)
T cd05593 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVII--AKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKD--RLCFVMEYV 77 (328)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh--hhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCC--EEEEEEeCC
Confidence 468999999999985 46889999988643221 1233467889999999999999999999998877 679999999
Q ss_pred CCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC--------
Q 004979 513 PNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT-------- 584 (721)
Q Consensus 513 ~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~-------- 584 (721)
++|+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 78 ~~g~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~ 153 (328)
T cd05593 78 NGGELFFHLSR--ERVFSEDRTRFYGAEIVSALDYLHSGK--IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMK 153 (328)
T ss_pred CCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeEECCCCcEEEecCcCCccCCCcccccc
Confidence 99999988853 356899999999999999999999988 999999999999999999999999987642
Q ss_pred -CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccHHHHH
Q 004979 585 -TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQENVLE 663 (721)
Q Consensus 585 -~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 663 (721)
..++..|+|||.+.+..++.++|||||||++|||+||+.||... +..+.......... .++.....
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~--~~~~~~~~~~~~~~-----------~~p~~~~~ 220 (328)
T cd05593 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ--DHEKLFELILMEDI-----------KFPRTLSA 220 (328)
T ss_pred cccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCC--CHHHHHHHhccCCc-----------cCCCCCCH
Confidence 12456799999999889999999999999999999999999633 23333333322211 12234456
Q ss_pred HHHHHHHHcccCCCCCCC-----CHHHHHH
Q 004979 664 ELLVVIKNCVHPDPKQRP-----SMRGIAA 688 (721)
Q Consensus 664 ~l~~li~~Cl~~dP~~RP-----s~~evl~ 688 (721)
++.+++.+||+.||++|| ++.|+++
T Consensus 221 ~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 250 (328)
T cd05593 221 DAKSLLSGLLIKDPNKRLGGGPDDAKEIMR 250 (328)
T ss_pred HHHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence 788999999999999997 8888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=327.28 Aligned_cols=233 Identities=19% Similarity=0.254 Sum_probs=190.0
Q ss_pred CCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEEEecCC
Q 004979 435 FSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSP 513 (721)
Q Consensus 435 lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV~Ey~~ 513 (721)
+|+|+||.||+|+.. ++..+|+|++...... .......+.+|++++.+++||||+++++++.+.+ ..++||||++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e~~~ 76 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIV--SRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPE--KLYLVLAFIN 76 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhh--hhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCC--eEEEEEcCCC
Confidence 588999999999965 5788999988643211 1233467889999999999999999999998776 6799999999
Q ss_pred CCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC---------
Q 004979 514 NGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT--------- 584 (721)
Q Consensus 514 ~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~--------- 584 (721)
+|+|.+++.. ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 77 ~g~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 152 (312)
T cd05585 77 GGELFHHLQR--EGRFDLSRARFYTAELLCALENLHKFN--VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT 152 (312)
T ss_pred CCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHeEECCCCcEEEEECcccccCccCCCcccc
Confidence 9999999863 346899999999999999999999988 999999999999999999999999987632
Q ss_pred CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccHHHHHH
Q 004979 585 TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQENVLEE 664 (721)
Q Consensus 585 ~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 664 (721)
..++..|+|||.+.+..++.++|||||||++|||+||+.||... +..+........... ++.....+
T Consensus 153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~--~~~~~~~~~~~~~~~-----------~~~~~~~~ 219 (312)
T cd05585 153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDE--NVNEMYRKILQEPLR-----------FPDGFDRD 219 (312)
T ss_pred ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCC--CHHHHHHHHHcCCCC-----------CCCcCCHH
Confidence 12456799999999999999999999999999999999999643 334444444332211 22344567
Q ss_pred HHHHHHHcccCCCCCCCC---HHHHHH
Q 004979 665 LLVVIKNCVHPDPKQRPS---MRGIAA 688 (721)
Q Consensus 665 l~~li~~Cl~~dP~~RPs---~~evl~ 688 (721)
+.+++.+||+.||++||+ +.|++.
T Consensus 220 ~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 220 AKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred HHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 889999999999999975 566654
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=319.41 Aligned_cols=243 Identities=22% Similarity=0.324 Sum_probs=195.1
Q ss_pred hhhCcCCCCceeEEEEEEec----CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceE
Q 004979 430 NIIGSFSDGTVGTVYKGTLS----SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTR 505 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~----~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~ 505 (721)
++...+|+|+||.||+|.+. .+..|++|.++... .......|.+|+.++.+++||||++++|++...+ ..
T Consensus 8 ~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~ 81 (266)
T cd05064 8 KIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC----SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGN--TM 81 (266)
T ss_pred EEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC----CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCC--Cc
Confidence 56678899999999999853 34578888776432 1233467999999999999999999999998766 67
Q ss_pred EEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC
Q 004979 506 MMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT 585 (721)
Q Consensus 506 ~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~ 585 (721)
++||||+++|+|.+++... ...+++..++.++.|++.||+|||+++ ++||||||+|||++.++.+|++|||......
T Consensus 82 ~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~i~~al~~lH~~~--iiH~dikp~nili~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 82 MIVTEYMSNGALDSFLRKH-EGQLVAGQLMGMLPGLASGMKYLSEMG--YVHKGLAAHKVLVNSDLVCKISGFRRLQEDK 158 (266)
T ss_pred EEEEEeCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC--EeeccccHhhEEEcCCCcEEECCCccccccc
Confidence 9999999999999998643 346899999999999999999999988 9999999999999999999999999764321
Q ss_pred ----------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhcCCCCccccCCcc
Q 004979 586 ----------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPLKDIVDPTL 654 (721)
Q Consensus 586 ----------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 654 (721)
.+...|+|||.+....++.++|||||||++||+++ |+.||... ...+.......+ ..
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~--~~~~~~~~~~~~-~~--------- 226 (266)
T cd05064 159 SEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDM--SGQDVIKAVEDG-FR--------- 226 (266)
T ss_pred ccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcC--CHHHHHHHHHCC-CC---------
Confidence 11246899999999999999999999999999875 99999633 222223322211 11
Q ss_pred ccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 004979 655 KSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEI 693 (721)
Q Consensus 655 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i 693 (721)
...+..++..+.+++.+||+.+|++||++.||.+.|.++
T Consensus 227 ~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 227 LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 012234567789999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=329.07 Aligned_cols=234 Identities=20% Similarity=0.266 Sum_probs=190.2
Q ss_pred cCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEEEecC
Q 004979 434 SFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYS 512 (721)
Q Consensus 434 ~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV~Ey~ 512 (721)
.+|+|+||.||+++. .++..||+|++...... .......+.+|++++++++||||+++++++...+ ..++||||+
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~--~~~lv~E~~ 77 (323)
T cd05595 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVII--AKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD--RLCFVMEYA 77 (323)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh--hhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCC--EEEEEEeCC
Confidence 478999999999985 46889999988643221 1223456788999999999999999999998776 679999999
Q ss_pred CCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC--------
Q 004979 513 PNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT-------- 584 (721)
Q Consensus 513 ~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~-------- 584 (721)
++|+|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 78 ~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~ 153 (323)
T cd05595 78 NGGELFFHLSR--ERVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK 153 (323)
T ss_pred CCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccc
Confidence 99999988853 346899999999999999999999988 999999999999999999999999987532
Q ss_pred -CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccHHHHH
Q 004979 585 -TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQENVLE 663 (721)
Q Consensus 585 -~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 663 (721)
..++..|+|||.+.+..++.++|||||||++|||+||+.||... +.............. ++...+.
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~--~~~~~~~~~~~~~~~-----------~p~~~~~ 220 (323)
T cd05595 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ--DHERLFELILMEEIR-----------FPRTLSP 220 (323)
T ss_pred cccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCC--CHHHHHHHHhcCCCC-----------CCCCCCH
Confidence 12456799999999899999999999999999999999999633 222323332222111 2233456
Q ss_pred HHHHHHHHcccCCCCCCC-----CHHHHHH
Q 004979 664 ELLVVIKNCVHPDPKQRP-----SMRGIAA 688 (721)
Q Consensus 664 ~l~~li~~Cl~~dP~~RP-----s~~evl~ 688 (721)
++.+++.+||+.||++|| ++.++++
T Consensus 221 ~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 221 EAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred HHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 788999999999999998 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=333.82 Aligned_cols=247 Identities=18% Similarity=0.246 Sum_probs=197.4
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
++++.+|+|+||.||+|+.. ++..||+|++....... ....+.+.+|++++..++||||+++++++.+.+ ..++|
T Consensus 4 ~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~--~~~lv 79 (333)
T cd05600 4 QILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFK--LNEVRHVLTERDILTTTKSEWLVKLLYAFQDDE--YLYLA 79 (333)
T ss_pred EEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhh--hhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCC--EEEEE
Confidence 56788999999999999965 57899999886542211 223467889999999999999999999998877 67999
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC----
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT---- 584 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~---- 584 (721)
|||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 80 ~e~~~g~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~~~ 155 (333)
T cd05600 80 MEYVPGGDFRTLLNN--LGVLSEDHARFYMAEMFEAVDALHELG--YIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYA 155 (333)
T ss_pred EeCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCCCCEEEEeCcCCccccccc
Confidence 999999999999863 346889999999999999999999988 999999999999999999999999998643
Q ss_pred --CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccHHHH
Q 004979 585 --TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQENVL 662 (721)
Q Consensus 585 --~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 662 (721)
..++..|+|||.+.+..++.++|||||||++|||++|+.||.... ..+............. .+.........+
T Consensus 156 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~--~~~~~~~i~~~~~~~~---~~~~~~~~~~~s 230 (333)
T cd05600 156 NSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGST--PNETWENLKYWKETLQ---RPVYDDPRFNLS 230 (333)
T ss_pred CCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCC--HHHHHHHHHhcccccc---CCCCCccccccC
Confidence 235567999999998899999999999999999999999996432 2222222221111110 111111112356
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004979 663 EELLVVIKNCVHPDPKQRPSMRGIAAK 689 (721)
Q Consensus 663 ~~l~~li~~Cl~~dP~~RPs~~evl~~ 689 (721)
.++.+++.+||..+|++||++.|+++.
T Consensus 231 ~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 231 DEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred HHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 788999999999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=331.80 Aligned_cols=238 Identities=18% Similarity=0.255 Sum_probs=192.6
Q ss_pred hhhCcCCCCceeEEEEEEecC--CcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLSS--GVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMM 507 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~~--~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~l 507 (721)
++++.+|+|+||.||+|+... +..||+|++...... .....+.+.+|+++++.++|||||++++++.+.+ ..++
T Consensus 33 ~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~--~~~l 108 (340)
T PTZ00426 33 NFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKII--KQKQVDHVFSERKILNYINHPFCVNLYGSFKDES--YLYL 108 (340)
T ss_pred EEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhh--hhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCC--EEEE
Confidence 677889999999999998543 357999987643211 1223457889999999999999999999998876 6799
Q ss_pred EEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC--
Q 004979 508 VFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT-- 585 (721)
Q Consensus 508 V~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~-- 585 (721)
||||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++++||+|||+++...
T Consensus 109 v~Ey~~~g~L~~~i~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~ 184 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRR--NKRFPNDVGCFYAAQIVLIFEYLQSLN--IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR 184 (340)
T ss_pred EEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEECCCCCEEEecCCCCeecCCC
Confidence 9999999999999863 346889999999999999999999988 9999999999999999999999999986432
Q ss_pred ----CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccHHH
Q 004979 586 ----AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQENV 661 (721)
Q Consensus 586 ----~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 661 (721)
.++..|+|||.+.+..++.++|||||||++|||+||+.||...+ .......+..+... ++...
T Consensus 185 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~--~~~~~~~i~~~~~~-----------~p~~~ 251 (340)
T PTZ00426 185 TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANE--PLLIYQKILEGIIY-----------FPKFL 251 (340)
T ss_pred cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCC--HHHHHHHHhcCCCC-----------CCCCC
Confidence 24557999999998889999999999999999999999996432 22223333322211 12233
Q ss_pred HHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 004979 662 LEELLVVIKNCVHPDPKQRP-----SMRGIAA 688 (721)
Q Consensus 662 ~~~l~~li~~Cl~~dP~~RP-----s~~evl~ 688 (721)
..++.+++.+|++.||++|+ +++|+++
T Consensus 252 ~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~ 283 (340)
T PTZ00426 252 DNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE 283 (340)
T ss_pred CHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence 45678999999999999995 7888764
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=335.28 Aligned_cols=246 Identities=22% Similarity=0.358 Sum_probs=194.1
Q ss_pred hhhCcCCCCceeEEEEEEec------CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcC-CCCccceEeEEEecCCC
Q 004979 430 NIIGSFSDGTVGTVYKGTLS------SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKV-NHKNFVNLIGYCEEDEP 502 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~------~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~ 502 (721)
++.+.+|+|+||.||+|+.. ++..||+|++..... ......+.+|+++++.+ +|+|||+++++|...+
T Consensus 41 ~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~- 115 (374)
T cd05106 41 QFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH----TDEREALMSELKILSHLGQHKNIVNLLGACTHGG- 115 (374)
T ss_pred eehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC----HHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC-
Confidence 56788999999999999742 235799998864322 22346788999999999 8999999999998876
Q ss_pred ceEEEEEecCCCCChhhhhhhcc---------------------------------------------------------
Q 004979 503 FTRMMVFEYSPNGSLFEHLHIQE--------------------------------------------------------- 525 (721)
Q Consensus 503 ~~~~lV~Ey~~~GsL~~~l~~~~--------------------------------------------------------- 525 (721)
..++||||+++|+|.++++...
T Consensus 116 -~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (374)
T cd05106 116 -PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS 194 (374)
T ss_pred -CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence 6799999999999999885321
Q ss_pred -----------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCCC--------
Q 004979 526 -----------AEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTA-------- 586 (721)
Q Consensus 526 -----------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~~-------- 586 (721)
...+++....+|+.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++....
T Consensus 195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~ 272 (374)
T cd05106 195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN--CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG 272 (374)
T ss_pred ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeecc
Confidence 124788889999999999999999988 99999999999999999999999999764321
Q ss_pred ---CCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccHHHH
Q 004979 587 ---AKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQENVL 662 (721)
Q Consensus 587 ---~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 662 (721)
....|+|||.+....++.++|||||||++|||++ |+.||....... .. .......... . .+...+
T Consensus 273 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~-~~-~~~~~~~~~~------~---~~~~~~ 341 (374)
T cd05106 273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS-KF-YKMVKRGYQM------S---RPDFAP 341 (374)
T ss_pred CCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH-HH-HHHHHcccCc------c---CCCCCC
Confidence 1235899999988899999999999999999997 999996432211 11 1111111100 0 111234
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 004979 663 EELLVVIKNCVHPDPKQRPSMRGIAAKLKEIT 694 (721)
Q Consensus 663 ~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~ 694 (721)
.++.+++.+||+.||++||++.||++.|+++.
T Consensus 342 ~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 342 PEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 67899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=334.04 Aligned_cols=245 Identities=23% Similarity=0.355 Sum_probs=192.9
Q ss_pred hhhCcCCCCceeEEEEEEe------cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcC-CCCccceEeEEEecCCC
Q 004979 430 NIIGSFSDGTVGTVYKGTL------SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKV-NHKNFVNLIGYCEEDEP 502 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~------~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~ 502 (721)
++.+.+|+|+||+||+|++ .++..||||+++.... ....+.+.+|++++..+ +|||||+++++|...+
T Consensus 38 ~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~----~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~- 112 (375)
T cd05104 38 SFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH----LTEREALMSELKVLSYLGNHINIVNLLGACTVGG- 112 (375)
T ss_pred ehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC----cHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC-
Confidence 5667889999999999973 2456799998753321 22346789999999999 8999999999998877
Q ss_pred ceEEEEEecCCCCChhhhhhhcc---------------------------------------------------------
Q 004979 503 FTRMMVFEYSPNGSLFEHLHIQE--------------------------------------------------------- 525 (721)
Q Consensus 503 ~~~~lV~Ey~~~GsL~~~l~~~~--------------------------------------------------------- 525 (721)
..++||||+++|+|.++++...
T Consensus 113 -~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (375)
T cd05104 113 -PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS 191 (375)
T ss_pred -cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence 5699999999999999986321
Q ss_pred ----------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCCC---
Q 004979 526 ----------------AEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTA--- 586 (721)
Q Consensus 526 ----------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~~--- 586 (721)
...++|..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 269 (375)
T cd05104 192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN--CIHRDLAARNILLTHGRITKICDFGLARDIRNDSN 269 (375)
T ss_pred ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCchhhEEEECCCcEEEecCccceeccCccc
Confidence 124788999999999999999999988 99999999999999999999999998763321
Q ss_pred --------CCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccc
Q 004979 587 --------AKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSF 657 (721)
Q Consensus 587 --------~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 657 (721)
....|+|||.+....++.++|||||||++|||+| |+.||...... ..... .+...... ..
T Consensus 270 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~-~~~~~-~~~~~~~~---------~~ 338 (375)
T cd05104 270 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD-SKFYK-MIKEGYRM---------LS 338 (375)
T ss_pred ccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch-HHHHH-HHHhCccC---------CC
Confidence 1235899999999999999999999999999998 88888643221 12222 22211110 01
Q ss_pred cHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 004979 658 QENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEI 693 (721)
Q Consensus 658 ~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i 693 (721)
+...+.++.+|+.+||+.||++||++.||++.|++.
T Consensus 339 ~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 339 PECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred CCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 112346789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=298.83 Aligned_cols=243 Identities=20% Similarity=0.326 Sum_probs=204.3
Q ss_pred hhhhhhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCce
Q 004979 426 EDFSNIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFT 504 (721)
Q Consensus 426 ~~~~~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 504 (721)
++| ++-..+|+|.||.||.|+.+ ++..||+|++.+.... ......++.+|+++-+.|+||||.++|+++.+.. .
T Consensus 22 ~df-eigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~--~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~--r 96 (281)
T KOG0580|consen 22 DDF-EIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQIL--KTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSK--R 96 (281)
T ss_pred hhc-cccccccCCccccEeEeeeccCCcEEEEeeeeHHHHH--HhcchhhhhheeEeecccCCccHHhhhhheeccc--e
Confidence 345 66678899999999999954 6778999988755432 2345678999999999999999999999999987 7
Q ss_pred EEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCC--
Q 004979 505 RMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWN-- 582 (721)
Q Consensus 505 ~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~-- 582 (721)
.||++||.++|+++..|..+....++......+..|+|.|+.|+|.++ ||||||||+|+|++.++..||+|||.+-
T Consensus 97 iyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~--VIhRdiKpenlLlg~~~~lkiAdfGwsV~~ 174 (281)
T KOG0580|consen 97 IYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR--VIHRDIKPENLLLGSAGELKIADFGWSVHA 174 (281)
T ss_pred eEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC--cccCCCCHHHhccCCCCCeeccCCCceeec
Confidence 799999999999999998777778888888999999999999999988 9999999999999999999999999753
Q ss_pred -----CCCCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccc
Q 004979 583 -----NTTAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSF 657 (721)
Q Consensus 583 -----~~~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 657 (721)
.+..++--|.+||..++..++.++|+|++||+.||++.|.+||.... ..+..+++.+-.-. +
T Consensus 175 p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~--~~etYkrI~k~~~~-----------~ 241 (281)
T KOG0580|consen 175 PSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS--HSETYKRIRKVDLK-----------F 241 (281)
T ss_pred CCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh--hHHHHHHHHHcccc-----------C
Confidence 23345567889999999999999999999999999999999996433 44444444433211 2
Q ss_pred cHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 658 QENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 658 ~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
+..++.++.++|.+|+..+|.+|....|++.
T Consensus 242 p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~ 272 (281)
T KOG0580|consen 242 PSTISGGAADLISRLLVKNPIERLALTEVMD 272 (281)
T ss_pred CcccChhHHHHHHHHhccCccccccHHHHhh
Confidence 3456678999999999999999999999875
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=321.62 Aligned_cols=256 Identities=20% Similarity=0.259 Sum_probs=200.6
Q ss_pred CCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEEEecCC
Q 004979 435 FSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSP 513 (721)
Q Consensus 435 lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV~Ey~~ 513 (721)
+|+|+||+||+++.. +++.+++|.+..+.... ....+.+..|++++++++||||+++++++.... ..++||||++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~--~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~--~~~lv~e~~~ 76 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKK--KSGEKMALLEKEILEKVNSPFIVNLAYAFESKT--HLCLVMSLMN 76 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhc--chhhHHHHHHHHHHHhcCCCcEEEEEEEEecCC--eEEEEEecCC
Confidence 578999999999864 68899999886432211 122345667999999999999999999998766 6799999999
Q ss_pred CCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC--------C
Q 004979 514 NGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT--------T 585 (721)
Q Consensus 514 ~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~--------~ 585 (721)
+|+|.+++.......+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++... .
T Consensus 77 g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~ 154 (277)
T cd05607 77 GGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD--IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQR 154 (277)
T ss_pred CCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC--EEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeecc
Confidence 999998886555566899999999999999999999988 999999999999999999999999987532 2
Q ss_pred CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCC--CHHHHHHHHhhcCCCCccccCCccccccHHHHH
Q 004979 586 AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENG--SLENWASEYLKGEQPLKDIVDPTLKSFQENVLE 663 (721)
Q Consensus 586 ~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~--~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 663 (721)
.++..|+|||.+....++.++||||+||++|||++|+.||..... ...+......... ........+.
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~ 224 (277)
T cd05607 155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDE----------VKFEHQNFTE 224 (277)
T ss_pred CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccc----------cccccccCCH
Confidence 245578999999888899999999999999999999999964322 1122222222111 0001123456
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCChhHHHHHHh
Q 004979 664 ELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAMEPDGATPKLSPLWWAELEI 715 (721)
Q Consensus 664 ~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~~~~p~~~~~~~~~l~~ 715 (721)
++.+++.+||+.||++||++.|+++.+. .+|.+..++|+.++.
T Consensus 225 ~~~~li~~~L~~~P~~R~~~~~~~~~~~---------~h~~f~~~~~~~~~~ 267 (277)
T cd05607 225 ESKDICRLFLAKKPEDRLGSREKNDDPR---------KHEFFKTINFPRLEA 267 (277)
T ss_pred HHHHHHHHHhccCHhhCCCCccchhhhh---------cChhhcCCCHHHHhc
Confidence 7899999999999999999988764333 256666777877764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=322.02 Aligned_cols=243 Identities=24% Similarity=0.439 Sum_probs=195.9
Q ss_pred hhhCcCCCCceeEEEEEEecCC------cEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCc
Q 004979 430 NIIGSFSDGTVGTVYKGTLSSG------VEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPF 503 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~~~------~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 503 (721)
++++.+|+|+||.||+|..... ..+++|.+.... .......|.+|++++++++||||+++++++...+
T Consensus 8 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~-- 81 (283)
T cd05048 8 RFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA----EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQ-- 81 (283)
T ss_pred chhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC----CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCC--
Confidence 5678899999999999986432 468888765332 2334567999999999999999999999998766
Q ss_pred eEEEEEecCCCCChhhhhhhccC--------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCC
Q 004979 504 TRMMVFEYSPNGSLFEHLHIQEA--------------EHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTE 569 (721)
Q Consensus 504 ~~~lV~Ey~~~GsL~~~l~~~~~--------------~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~ 569 (721)
..+++|||+++|+|.+++..... ..+++.....++.|++.||+|||+.+ |+||||||+||++++
T Consensus 82 ~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nil~~~ 159 (283)
T cd05048 82 PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH--FVHRDLAARNCLVGE 159 (283)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccccceEEEcC
Confidence 56999999999999999864321 45888999999999999999999988 999999999999999
Q ss_pred CCcEEEeccCCCCCCCC-----------CCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHH
Q 004979 570 DYAAKISDFSFWNNTTA-----------AKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWAS 637 (721)
Q Consensus 570 ~~~~kL~DFGla~~~~~-----------~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~ 637 (721)
++.+||+|||+++.... .+..|+|||.+....++.++|||||||++|||+| |..||.... ..+...
T Consensus 160 ~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~--~~~~~~ 237 (283)
T cd05048 160 GLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFS--NQEVIE 237 (283)
T ss_pred CCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCC--HHHHHH
Confidence 99999999998764311 1235899999988899999999999999999998 999986432 223322
Q ss_pred HHhhcCCCCccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 004979 638 EYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKE 692 (721)
Q Consensus 638 ~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 692 (721)
.+..+. ....+..++.++.+|+.+||+.||++||++.||++.|+.
T Consensus 238 ~i~~~~----------~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 238 MIRSRQ----------LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HHHcCC----------cCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 222211 111234566889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=315.82 Aligned_cols=242 Identities=21% Similarity=0.402 Sum_probs=198.3
Q ss_pred hhhCcCCCCceeEEEEEEecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVF 509 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV~ 509 (721)
++++++|+|+||.||+|...++..+++|.+.... ...+.+.+|+.++++++|+||+++++++...+ ..++||
T Consensus 9 ~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~ 80 (261)
T cd05072 9 KLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT------MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEE--PIYIIT 80 (261)
T ss_pred EEeeecCCcCCceEEEEEecCCceEEEEEccCCc------hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC--CcEEEE
Confidence 6788999999999999998888889999765322 12367899999999999999999999988766 569999
Q ss_pred ecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCCC---
Q 004979 510 EYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTA--- 586 (721)
Q Consensus 510 Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~~--- 586 (721)
||+++|+|.++++......+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05072 81 EYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN--YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY 158 (261)
T ss_pred ecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence 9999999999997655667899999999999999999999987 99999999999999999999999999864321
Q ss_pred -------CCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhcCCCCccccCCcccccc
Q 004979 587 -------AKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQ 658 (721)
Q Consensus 587 -------~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 658 (721)
....|+|||.+....++.++|||||||++|||+| |+.||.... ..+........ ... + ..
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~--~~~~~~~~~~~-~~~-----~----~~ 226 (261)
T cd05072 159 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMS--NSDVMSALQRG-YRM-----P----RM 226 (261)
T ss_pred eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCC--HHHHHHHHHcC-CCC-----C----CC
Confidence 1235899999988889999999999999999999 999996432 22222222211 111 1 11
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 004979 659 ENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEI 693 (721)
Q Consensus 659 ~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i 693 (721)
..++.++.+++.+||..+|++||+++++.+.|+++
T Consensus 227 ~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 227 ENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred CCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 23456788999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=304.45 Aligned_cols=250 Identities=18% Similarity=0.230 Sum_probs=193.4
Q ss_pred hhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
+++.+|++|+||.||+|+. +++..||+|+++.....+. .--.-++||.+|.+++|||||.+..+....+-..+|||
T Consensus 79 e~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~G---FPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 79 EKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEG---FPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHhhcccCcceeEEEeccCCcceeEEeeecccccccCC---CcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 5667889999999999995 4678899999875443221 11245799999999999999999999987665578999
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCCCC-
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTAA- 587 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~~~- 587 (721)
||||+. +|..+++. ..+.+...+...++.|+.+|++|||... |+|||||++|+|++..|.+||+|||+|+.....
T Consensus 156 Me~~Eh-DLksl~d~-m~q~F~~~evK~L~~QlL~glk~lH~~w--ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~ 231 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMET-MKQPFLPGEVKTLMLQLLRGLKHLHDNW--ILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL 231 (419)
T ss_pred HHHHHh-hHHHHHHh-ccCCCchHHHHHHHHHHHHHHHHHhhce--eEecccchhheeeccCCcEEecccchhhhhcCCc
Confidence 999977 89988864 3467999999999999999999999998 999999999999999999999999999865543
Q ss_pred --------Cccccchhhcc-cCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccc---
Q 004979 588 --------KTGSAAMELLE-TSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLK--- 655 (721)
Q Consensus 588 --------~~~~~apE~~~-~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~--- 655 (721)
+-.|.|||.+. ...|++..|+||+|||+.||+++++-|.+.. .+.+ +..++.......+.+.|...
T Consensus 232 k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~s-E~dQ-l~~If~llGtPte~iwpg~~~lp 309 (419)
T KOG0663|consen 232 KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKS-EIDQ-LDKIFKLLGTPSEAIWPGYSELP 309 (419)
T ss_pred ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCc-hHHH-HHHHHHHhCCCccccCCCccccc
Confidence 22578999875 4679999999999999999999998886433 2222 22222211111112222111
Q ss_pred -----------------cccHH-HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 656 -----------------SFQEN-VLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 656 -----------------~~~~~-~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
.+... ..+.-++|+...+..||.+|.|+.|.++
T Consensus 310 ~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 310 AVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred hhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 01111 3477889999999999999999999876
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=314.77 Aligned_cols=242 Identities=21% Similarity=0.373 Sum_probs=197.8
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
.+.+.+|+|+||.||+|... .+..+++|...... ....++.+|++++++++|+||+++++++...+ ..++|
T Consensus 9 ~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv 80 (263)
T cd05052 9 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT------MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP--PFYII 80 (263)
T ss_pred EEeeecCCcccceEEEEEEecCCceEEEEEecCCc------hHHHHHHHHHHHHHhCCCCChhheEEEEcCCC--CcEEE
Confidence 45567899999999999965 57788998765321 12357899999999999999999999998776 56999
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCCCC-
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTAA- 587 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~~~- 587 (721)
|||+++|+|.+++.......+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++.....
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~ 158 (263)
T cd05052 81 TEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 158 (263)
T ss_pred EEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEcCCCcEEeCCCccccccccce
Confidence 99999999999987555567899999999999999999999988 999999999999999999999999987643321
Q ss_pred ---------CccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccc
Q 004979 588 ---------KTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSF 657 (721)
Q Consensus 588 ---------~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 657 (721)
...|++||.+.+..++.++|||||||++|||+| |..||... +..+.......... ...
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~--~~~~~~~~~~~~~~----------~~~ 226 (263)
T cd05052 159 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI--DLSQVYELLEKGYR----------MER 226 (263)
T ss_pred eeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC--CHHHHHHHHHCCCC----------CCC
Confidence 235899999998999999999999999999998 99998633 33333333322111 012
Q ss_pred cHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 004979 658 QENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEI 693 (721)
Q Consensus 658 ~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i 693 (721)
++.++.++.+++.+||+.+|++||++.|+++.|+.+
T Consensus 227 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 227 PEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 234557899999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=325.21 Aligned_cols=236 Identities=20% Similarity=0.304 Sum_probs=189.9
Q ss_pred CcCCCCceeEEEEEEe----cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 433 GSFSDGTVGTVYKGTL----SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 433 ~~lg~G~~g~Vyk~~~----~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
+.+|+|+||.||+++. ..++.+|+|++....... .......+.+|+++|++++||||+++++++...+ ..++|
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~--~~~lv 78 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVR-NQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGG--KLYLI 78 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHh-hhhhHHHHHHHHHHHHhCCCCchhceeeEEecCC--eEEEE
Confidence 5688999999999985 357889999886432111 1223356789999999999999999999998876 67999
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC----
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT---- 584 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~---- 584 (721)
|||+++|+|.+++.. ...+.+.....++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 79 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (323)
T cd05584 79 LEYLSGGELFMHLER--EGIFMEDTACFYLSEISLALEHLHQQG--IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG 154 (323)
T ss_pred EeCCCCchHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence 999999999999863 345788888899999999999999988 999999999999999999999999987532
Q ss_pred -----CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccH
Q 004979 585 -----TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQE 659 (721)
Q Consensus 585 -----~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 659 (721)
..++..|+|||.+....++.++|||||||++|||+||+.||... +..+.......+... .+.
T Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~--~~~~~~~~~~~~~~~-----------~~~ 221 (323)
T cd05584 155 TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAE--NRKKTIDKILKGKLN-----------LPP 221 (323)
T ss_pred CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCC--CHHHHHHHHHcCCCC-----------CCC
Confidence 12455799999998888999999999999999999999999643 233333443333221 122
Q ss_pred HHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 004979 660 NVLEELLVVIKNCVHPDPKQRP-----SMRGIAA 688 (721)
Q Consensus 660 ~~~~~l~~li~~Cl~~dP~~RP-----s~~evl~ 688 (721)
....++.+++.+||+.+|++|| ++.++++
T Consensus 222 ~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 222 YLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred CCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 3456788999999999999999 7887765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=334.94 Aligned_cols=244 Identities=20% Similarity=0.278 Sum_probs=191.3
Q ss_pred hhhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEE
Q 004979 429 SNIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMM 507 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~l 507 (721)
+++++.||+|+||+||+|+. .++..+|+|++...... .......+.+|++++.+++|+|||++++++.+.+ ..++
T Consensus 3 f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~--~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~--~~~l 78 (381)
T cd05626 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVL--NRNQVAHVKAERDILAEADNEWVVKLYYSFQDKD--NLYF 78 (381)
T ss_pred ceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhh--hhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCC--EEEE
Confidence 36778999999999999985 46788999988654321 1233467899999999999999999999998876 6899
Q ss_pred EEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC---
Q 004979 508 VFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT--- 584 (721)
Q Consensus 508 V~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~--- 584 (721)
||||+++|+|.+++.. ...+++.....++.||+.||+|||+.+ |+||||||+|||++.++++||+|||+++..
T Consensus 79 v~E~~~gg~L~~~l~~--~~~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~ 154 (381)
T cd05626 79 VMDYIPGGDMMSLLIR--MEVFPEVLARFYIAELTLAIESVHKMG--FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT 154 (381)
T ss_pred EEecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence 9999999999999863 346888889999999999999999988 999999999999999999999999986421
Q ss_pred -----------------------------------------------------CCCCccccchhhcccCCCCCCccHHHH
Q 004979 585 -----------------------------------------------------TAAKTGSAAMELLETSAVDLESNVYSF 611 (721)
Q Consensus 585 -----------------------------------------------------~~~~~~~~apE~~~~~~~s~ksDVwSf 611 (721)
..++..|+|||.+....++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (381)
T cd05626 155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV 234 (381)
T ss_pred cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence 124567999999988899999999999
Q ss_pred HHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccHHHHHHHHHHHHH--cccCCCCCCCCHHHHHHH
Q 004979 612 GTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKN--CVHPDPKQRPSMRGIAAK 689 (721)
Q Consensus 612 GvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~--Cl~~dP~~RPs~~evl~~ 689 (721)
||++|||+||+.||..... .+............. + + .....+.++.+++.+ |+..+|.+||++.|++..
T Consensus 235 G~il~elltG~~Pf~~~~~--~~~~~~i~~~~~~~~-~--~----~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~h 305 (381)
T cd05626 235 GVILFEMLVGQPPFLAPTP--TETQLKVINWENTLH-I--P----PQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAH 305 (381)
T ss_pred hhHHHHHHhCCCCCcCCCH--HHHHHHHHccccccC-C--C----CCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 9999999999999964332 222222221111100 0 0 011245677888877 666677779999999863
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=329.51 Aligned_cols=242 Identities=17% Similarity=0.245 Sum_probs=188.1
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
++++.+|+|+||+||+|+.. +++.+|+|++...... .......+.+|++++.+++|+||+++++++.+.+ ..++|
T Consensus 4 ~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~--~~~lv 79 (363)
T cd05628 4 ESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADML--EKEQVGHIRAERDILVEADSLWVVKMFYSFQDKL--NLYLI 79 (363)
T ss_pred eEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHH--HhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCC--eEEEE
Confidence 56788999999999999854 6789999988643221 1233457889999999999999999999998876 67999
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC----
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT---- 584 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~---- 584 (721)
|||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 80 ~E~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~~g--ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~ 155 (363)
T cd05628 80 MEFLPGGDMMTLLMK--KDTLTEEETQFYIAETVLAIDSIHQLG--FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH 155 (363)
T ss_pred EcCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence 999999999999863 356899999999999999999999988 999999999999999999999999987532
Q ss_pred ----------------------------------------CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCc
Q 004979 585 ----------------------------------------TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRIS 624 (721)
Q Consensus 585 ----------------------------------------~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P 624 (721)
..++..|+|||.+.+..++.++|||||||++|||++|+.|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P 235 (363)
T cd05628 156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (363)
T ss_pred cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCC
Confidence 1245678999999999999999999999999999999999
Q ss_pred ccCCCCCHHHHHHHHhhcCCCCccccCCccccccHHHHHHHHHHHHHccc--CCCCCCCCHHHHHH
Q 004979 625 YSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVH--PDPKQRPSMRGIAA 688 (721)
Q Consensus 625 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~--~dP~~RPs~~evl~ 688 (721)
|.... ..+....+......+ .+ +.. .....++.+++.+++. .++..||+++||++
T Consensus 236 f~~~~--~~~~~~~i~~~~~~~--~~-p~~----~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~ 292 (363)
T cd05628 236 FCSET--PQETYKKVMNWKETL--IF-PPE----VPISEKAKDLILRFCCEWEHRIGAPGVEEIKT 292 (363)
T ss_pred CCCCC--HHHHHHHHHcCcCcc--cC-CCc----CCCCHHHHHHHHHHcCChhhcCCCCCHHHHhC
Confidence 96432 333333333221111 01 110 1134566777776433 33445789999875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=324.04 Aligned_cols=234 Identities=16% Similarity=0.245 Sum_probs=188.5
Q ss_pred cCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcC-CCCccceEeEEEecCCCceEEEEEec
Q 004979 434 SFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKV-NHKNFVNLIGYCEEDEPFTRMMVFEY 511 (721)
Q Consensus 434 ~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~~~lV~Ey 511 (721)
.+|+|+||.||+|+.. ++..+|+|++...... .......+..|.+++..+ +||||+++++++.+.+ ..++||||
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~--~~~lv~E~ 77 (321)
T cd05591 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVIL--QDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKD--RLFFVMEY 77 (321)
T ss_pred ccccCCCeEEEEEEECCCCCEEEEEEEeHHHhh--hhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCC--eEEEEEeC
Confidence 4789999999999865 5788999988643221 122345677889998866 8999999999998877 67999999
Q ss_pred CCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC-------
Q 004979 512 SPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT------- 584 (721)
Q Consensus 512 ~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~------- 584 (721)
+++|+|..++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 78 ~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~ 153 (321)
T cd05591 78 VNGGDLMFQIQR--SRKFDEPRSRFYAAEVTLALMFLHRHG--VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTT 153 (321)
T ss_pred CCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEEeecccceecccCCccc
Confidence 999999988853 356899999999999999999999988 999999999999999999999999987532
Q ss_pred --CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccHHHH
Q 004979 585 --TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQENVL 662 (721)
Q Consensus 585 --~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 662 (721)
..++..|+|||.+....++.++|||||||++|||+||+.||... +..+....+..+.... +....
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~--~~~~~~~~i~~~~~~~-----------p~~~~ 220 (321)
T cd05591 154 TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEAD--NEDDLFESILHDDVLY-----------PVWLS 220 (321)
T ss_pred cccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCC--CHHHHHHHHHcCCCCC-----------CCCCC
Confidence 12456799999999999999999999999999999999999643 3334444444332211 12234
Q ss_pred HHHHHHHHHcccCCCCCCC-------CHHHHHH
Q 004979 663 EELLVVIKNCVHPDPKQRP-------SMRGIAA 688 (721)
Q Consensus 663 ~~l~~li~~Cl~~dP~~RP-------s~~evl~ 688 (721)
.++.+++.+||+.||++|| ++.++++
T Consensus 221 ~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 221 KEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred HHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 6788999999999999999 6676654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=313.86 Aligned_cols=243 Identities=23% Similarity=0.401 Sum_probs=199.9
Q ss_pred hhhCcCCCCceeEEEEEEecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVF 509 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV~ 509 (721)
++++.+|.|+||.||+|....+..+++|.+..... .....+.+|+++++.++|+||+++++++...+ ..++||
T Consensus 9 ~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~lv~ 81 (261)
T cd05148 9 TLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDL-----LKQQDFQKEVQALKRLRHKHLISLFAVCSVGE--PVYIIT 81 (261)
T ss_pred HHhhhhccCCCccEEEeEecCCCcEEEEeccccch-----hhHHHHHHHHHHHhcCCCcchhheeeeEecCC--CeEEEE
Confidence 67788899999999999988888999998764321 12356889999999999999999999998877 569999
Q ss_pred ecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCCC---
Q 004979 510 EYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTA--- 586 (721)
Q Consensus 510 Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~~--- 586 (721)
||+++|+|.++++......+++.++..++.|++.|++|||+.+ |+||||||+||++++++.+||+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 82 ELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN--SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred eecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 9999999999997655567899999999999999999999988 99999999999999999999999998754321
Q ss_pred ------CCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccH
Q 004979 587 ------AKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQE 659 (721)
Q Consensus 587 ------~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 659 (721)
....|++||......++.++||||||+++|||++ |+.||.... ..+.......+... ..+.
T Consensus 160 ~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~--~~~~~~~~~~~~~~----------~~~~ 227 (261)
T cd05148 160 LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN--NHEVYDQITAGYRM----------PCPA 227 (261)
T ss_pred cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC--HHHHHHHHHhCCcC----------CCCC
Confidence 1235889999988899999999999999999999 899996432 22333322221110 1123
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 004979 660 NVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEI 693 (721)
Q Consensus 660 ~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i 693 (721)
.++.++.++|.+||+.||++|||+.++++.|+.+
T Consensus 228 ~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 228 KCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 4456788999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=322.24 Aligned_cols=243 Identities=19% Similarity=0.248 Sum_probs=193.8
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
++++.+|+|+||+||++... ++..||+|++....... ......+.+|++++++++||||+++++++...+ ..++|
T Consensus 3 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~lv 78 (285)
T cd05605 3 RHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK--RKGEAMALNEKQILEKVNSRFVVSLAYAYETKD--ALCLV 78 (285)
T ss_pred eEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhh--hhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCC--eEEEE
Confidence 45678899999999999954 68899999886433221 223456788999999999999999999998776 67999
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC---
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT--- 585 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~--- 585 (721)
|||+++|+|.+++.......+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||+++...
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 79 LTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER--IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred EeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence 99999999998886544456899999999999999999999988 9999999999999999999999999876432
Q ss_pred -----CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCH-HHHHHHHhhcCCCCccccCCccccccH
Q 004979 586 -----AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSL-ENWASEYLKGEQPLKDIVDPTLKSFQE 659 (721)
Q Consensus 586 -----~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~-~~~~~~~~~~~~~~~~~~d~~l~~~~~ 659 (721)
.+...|++||.+....++.++|||||||++|||++|+.||....... .+.+...... .....+.
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~----------~~~~~~~ 226 (285)
T cd05605 157 TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKE----------DQEEYSE 226 (285)
T ss_pred ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhh----------cccccCc
Confidence 23457899999988899999999999999999999999997433211 1111111111 0111233
Q ss_pred HHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 004979 660 NVLEELLVVIKNCVHPDPKQRP-----SMRGIAA 688 (721)
Q Consensus 660 ~~~~~l~~li~~Cl~~dP~~RP-----s~~evl~ 688 (721)
..+..+.+++.+||+.||++|| +++++++
T Consensus 227 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 227 KFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred ccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 4567789999999999999999 7778754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=323.42 Aligned_cols=250 Identities=18% Similarity=0.276 Sum_probs=193.2
Q ss_pred hhhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEE
Q 004979 429 SNIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMM 507 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~l 507 (721)
++++..+|+|+||.||+++.. ++..+++|.+.... .....+.+.+|+++|++++||||+++++++...+ ..++
T Consensus 7 y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~l 80 (331)
T cd06649 7 FERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI----KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG--EISI 80 (331)
T ss_pred ceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc----CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC--EEEE
Confidence 367788999999999999965 67788888776432 1234567999999999999999999999998876 6799
Q ss_pred EEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC--
Q 004979 508 VFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT-- 585 (721)
Q Consensus 508 V~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~-- 585 (721)
||||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ .|+||||||+|||+++++.+||+|||+++...
T Consensus 81 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~-~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 81 CMEHMDGGSLDQVLKE--AKRIPEEILGKVSIAVLRGLAYLREKH-QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (331)
T ss_pred EeecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHhhcC-CEEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence 9999999999999863 345889999999999999999999742 39999999999999999999999999875432
Q ss_pred -----CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhh----cCCCCcc--------
Q 004979 586 -----AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLK----GEQPLKD-------- 648 (721)
Q Consensus 586 -----~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~----~~~~~~~-------- 648 (721)
.++..|+|||.+.+..++.++|||||||++|||+||+.||..... .+.....-. +......
T Consensus 158 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (331)
T cd06649 158 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDA--KELEAIFGRPVVDGEEGEPHSISPRPRP 235 (331)
T ss_pred ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHhcccccccccCCccccCccccc
Confidence 245578999999988999999999999999999999999963321 111111000 0000000
Q ss_pred ------------------------ccCCccccc-cHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004979 649 ------------------------IVDPTLKSF-QENVLEELLVVIKNCVHPDPKQRPSMRGIAAK 689 (721)
Q Consensus 649 ------------------------~~d~~l~~~-~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 689 (721)
+........ ......++.+|+.+||+.||++|||+.|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 236 PGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred ccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000000 11245678999999999999999999999874
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=325.90 Aligned_cols=234 Identities=21% Similarity=0.269 Sum_probs=189.7
Q ss_pred cCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEEEecC
Q 004979 434 SFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYS 512 (721)
Q Consensus 434 ~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV~Ey~ 512 (721)
.+|+|+||.||+++. .++..+|+|++...... .......+.+|++++..++||||+++++++...+ ..++||||+
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~--~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~--~~~lv~E~~ 77 (325)
T cd05594 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIV--AKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHD--RLCFVMEYA 77 (325)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh--hhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCC--EEEEEEeCC
Confidence 478999999999985 46889999988643221 1223456788999999999999999999998876 679999999
Q ss_pred CCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC-------
Q 004979 513 PNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQ-LTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT------- 584 (721)
Q Consensus 513 ~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~-~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~------- 584 (721)
++|+|..++.. ...+++..+..++.||+.||+|||+ .+ |+||||||+|||+++++.+||+|||+++..
T Consensus 78 ~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~~--ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~ 153 (325)
T cd05594 78 NGGELFFHLSR--ERVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM 153 (325)
T ss_pred CCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCccc
Confidence 99999988853 3468999999999999999999997 67 999999999999999999999999987532
Q ss_pred --CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccHHHH
Q 004979 585 --TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQENVL 662 (721)
Q Consensus 585 --~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 662 (721)
..++..|+|||.+.+..++.++|||||||++|||+||+.||... +..+........... ++....
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~--~~~~~~~~i~~~~~~-----------~p~~~~ 220 (325)
T cd05594 154 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ--DHEKLFELILMEEIR-----------FPRTLS 220 (325)
T ss_pred ccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCC--CHHHHHHHHhcCCCC-----------CCCCCC
Confidence 12456799999999999999999999999999999999999633 223333333222111 122345
Q ss_pred HHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 004979 663 EELLVVIKNCVHPDPKQRP-----SMRGIAA 688 (721)
Q Consensus 663 ~~l~~li~~Cl~~dP~~RP-----s~~evl~ 688 (721)
.++.+++.+||+.||++|+ ++.++++
T Consensus 221 ~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 221 PEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred HHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence 6788999999999999996 8999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=316.99 Aligned_cols=244 Identities=22% Similarity=0.273 Sum_probs=194.3
Q ss_pred hhhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchh----h-----HHHHHHHHHHHHHhcCCCCccceEeEEEe
Q 004979 429 SNIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWS----K-----NLESQFRKKIDTLSKVNHKNFVNLIGYCE 498 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~----~-----~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~ 498 (721)
|+++..+|.|.||.|-+|+. .+++.||+|++.++...... . ...+...+||.+|++++|||||+|+++..
T Consensus 99 y~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLD 178 (576)
T KOG0585|consen 99 YELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLD 178 (576)
T ss_pred eehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeec
Confidence 47888999999999999994 47889999999765432110 0 11257899999999999999999999999
Q ss_pred cCCCceEEEEEecCCCCChhhhhhhccCCC-CCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEec
Q 004979 499 EDEPFTRMMVFEYSPNGSLFEHLHIQEAEH-LDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISD 577 (721)
Q Consensus 499 ~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~-l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~D 577 (721)
+......|||+|||..|.+...- .... ++..++++|.+++..||+|||.++ ||||||||+|+||+++|++||+|
T Consensus 179 DP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~Qg--iiHRDIKPsNLLl~~~g~VKIsD 253 (576)
T KOG0585|consen 179 DPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQG--IIHRDIKPSNLLLSSDGTVKISD 253 (576)
T ss_pred CcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEEcCCCcEEeec
Confidence 87777899999999999886432 2233 899999999999999999999998 99999999999999999999999
Q ss_pred cCCCCCC--------------CCCCccccchhhcccC----CCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHH
Q 004979 578 FSFWNNT--------------TAAKTGSAAMELLETS----AVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEY 639 (721)
Q Consensus 578 FGla~~~--------------~~~~~~~~apE~~~~~----~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~ 639 (721)
||.+... ..+++.++|||...++ ..+.+.||||+||+||-|+.|+.||.++ ...+...++
T Consensus 254 FGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~--~~~~l~~KI 331 (576)
T KOG0585|consen 254 FGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDD--FELELFDKI 331 (576)
T ss_pred cceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccc--hHHHHHHHH
Confidence 9976522 3467789999987652 2357899999999999999999999532 233334444
Q ss_pred hhcCCCCccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 640 LKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 640 ~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
+...-.+ ...+++.+++.+||+++|.+||+.|.+..||..
T Consensus 332 vn~pL~f---------P~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~ 371 (576)
T KOG0585|consen 332 VNDPLEF---------PENPEINEDLKDLIKRLLEKDPEQRITLPDIKL 371 (576)
T ss_pred hcCcccC---------CCcccccHHHHHHHHHHhhcChhheeehhhhee
Confidence 3321111 112346778999999999999999999998864
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=311.90 Aligned_cols=250 Identities=19% Similarity=0.308 Sum_probs=202.2
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
++.+.+|+|+||.||+|+.. ++..+++|.+...... .......+.+|++++++++||||+++++++...+ ..++|
T Consensus 5 ~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~~v 80 (267)
T cd08228 5 QIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMM--DAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDN--ELNIV 80 (267)
T ss_pred eeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccC--CHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECC--eEEEE
Confidence 56678899999999999954 6889999987643222 2334567899999999999999999999998766 67999
Q ss_pred EecCCCCChhhhhhhc--cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC-
Q 004979 509 FEYSPNGSLFEHLHIQ--EAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT- 585 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~--~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~- 585 (721)
+||+++|+|.+++... ....+++.....++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999999888532 2345788899999999999999999988 9999999999999999999999999875322
Q ss_pred --------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccc
Q 004979 586 --------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSF 657 (721)
Q Consensus 586 --------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 657 (721)
.+...|+|||.+.+..++.++||||||+++|||+||+.||.....+...+......... .. ..
T Consensus 159 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~--~~-------~~ 229 (267)
T cd08228 159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDY--PP-------LP 229 (267)
T ss_pred hhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCC--CC-------CC
Confidence 23456899999988889999999999999999999999997555444444443322111 00 01
Q ss_pred cHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 004979 658 QENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEIT 694 (721)
Q Consensus 658 ~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~ 694 (721)
....+..+.+++.+||+.+|++||++.||++.+++++
T Consensus 230 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 230 TEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred hhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 2345577899999999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=324.84 Aligned_cols=237 Identities=19% Similarity=0.284 Sum_probs=194.9
Q ss_pred hhCcCCCCceeEEEEEE-ecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEEE
Q 004979 431 IIGSFSDGTVGTVYKGT-LSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVF 509 (721)
Q Consensus 431 ii~~lg~G~~g~Vyk~~-~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV~ 509 (721)
.+..+|+|+||.||||. ..+++.||+|++.+.... ...+++.+|+.+|.+++|+||.++||.+..+. ..+++|
T Consensus 17 ~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~----deIediqqei~~Ls~~~~~~it~yygsyl~g~--~LwiiM 90 (467)
T KOG0201|consen 17 KLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAE----DEIEDIQQEISVLSQCDSPNITEYYGSYLKGT--KLWIIM 90 (467)
T ss_pred cchhccccccceeeeeeeccccceEEEEEechhhcc----hhhHHHHHHHHHHHhcCcchHHhhhhheeecc--cHHHHH
Confidence 34678899999999999 457889999999875433 34567899999999999999999999998877 679999
Q ss_pred ecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCC-------
Q 004979 510 EYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWN------- 582 (721)
Q Consensus 510 Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~------- 582 (721)
|||.+|++.+.|.. ...+++....-|.+++..|+.|||..+ .+|||||+.|||+..+|.+|++|||++-
T Consensus 91 ey~~gGsv~~lL~~--~~~~~E~~i~~ilre~l~~l~ylH~~~--kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 91 EYCGGGSVLDLLKS--GNILDEFEIAVILREVLKGLDYLHSEK--KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred HHhcCcchhhhhcc--CCCCccceeeeehHHHHHHhhhhhhcc--eecccccccceeEeccCcEEEEecceeeeeechhh
Confidence 99999999999853 333467777778999999999999988 9999999999999999999999999752
Q ss_pred --CCCCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccHH
Q 004979 583 --NTTAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQEN 660 (721)
Q Consensus 583 --~~~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 660 (721)
....+++.|||||++....|+.|+||||+||+.+||++|.+|+..... . ..+..+-....+.....
T Consensus 167 rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP--m----------rvlflIpk~~PP~L~~~ 234 (467)
T KOG0201|consen 167 RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP--M----------RVLFLIPKSAPPRLDGD 234 (467)
T ss_pred ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc--c----------eEEEeccCCCCCccccc
Confidence 455678899999999999999999999999999999999999853221 0 11111111112223346
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004979 661 VLEELLVVIKNCVHPDPKQRPSMRGIAAK 689 (721)
Q Consensus 661 ~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 689 (721)
++..+.+++..|+.++|+.||+|.++++.
T Consensus 235 ~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 235 FSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred cCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 77889999999999999999999998863
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=319.93 Aligned_cols=252 Identities=18% Similarity=0.245 Sum_probs=187.0
Q ss_pred hhhhCcCCCCceeEEEEEEec--CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcC---CCCccceEeEEEecC---
Q 004979 429 SNIIGSFSDGTVGTVYKGTLS--SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKV---NHKNFVNLIGYCEED--- 500 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~--~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l---~H~nIv~l~g~~~~~--- 500 (721)
|+++..+|+|+||+||+|+.. ++..||+|++....... .....+.+|+++++++ +||||++++++|...
T Consensus 3 Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~ 79 (290)
T cd07862 3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE---GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 79 (290)
T ss_pred cceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCC---CchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence 356788999999999999863 46788999876543222 1123455677666655 799999999998632
Q ss_pred CCceEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCC
Q 004979 501 EPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSF 580 (721)
Q Consensus 501 ~~~~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGl 580 (721)
.....++||||+. ++|.+++.......+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 80 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 80 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEcCCCCEEEccccc
Confidence 2225799999996 69999987555556899999999999999999999988 99999999999999999999999998
Q ss_pred CCCCC--------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCC-CCc----
Q 004979 581 WNNTT--------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQ-PLK---- 647 (721)
Q Consensus 581 a~~~~--------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~-~~~---- 647 (721)
++... .++..|+|||.+....++.++|||||||++|||++|+.||..... .+.+..+..... +..
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~--~~~~~~i~~~~~~~~~~~~~ 234 (290)
T cd07862 157 ARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD--VDQLGKILDVIGLPGEEDWP 234 (290)
T ss_pred eEeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCH--HHHHHHHHHHhCCCChhhch
Confidence 75322 234578999999888999999999999999999999999964321 122222211100 000
Q ss_pred -------cccCCc----cccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 648 -------DIVDPT----LKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 648 -------~~~d~~----l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
....+. +..........+.+++.+||+.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 235 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 000000 00111234567889999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=323.31 Aligned_cols=230 Identities=19% Similarity=0.268 Sum_probs=185.8
Q ss_pred cCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcC-CCCccceEeEEEecCCCceEEEEEec
Q 004979 434 SFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKV-NHKNFVNLIGYCEEDEPFTRMMVFEY 511 (721)
Q Consensus 434 ~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~~~lV~Ey 511 (721)
.+|+|+||+||+|+.. ++..||+|++...... .....+.+..|..++..+ +||||+++++++...+ ..++||||
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~--~~~iv~Ey 77 (320)
T cd05590 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVIL--QDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPD--RLFFVMEF 77 (320)
T ss_pred eeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHh--hccHHHHHHHHHHHHHhccCCCchhceeeEEEcCC--EEEEEEcC
Confidence 4789999999999965 5788999988643211 122345677888888876 7999999999998876 67999999
Q ss_pred CCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC-------
Q 004979 512 SPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT------- 584 (721)
Q Consensus 512 ~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~------- 584 (721)
+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 78 ~~~g~L~~~i~~--~~~l~~~~~~~~~~ql~~~L~~lH~~~--ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~ 153 (320)
T cd05590 78 VNGGDLMFHIQK--SRRFDEARARFYAAEITSALMFLHDKG--IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTT 153 (320)
T ss_pred CCCchHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcc
Confidence 999999988863 346899999999999999999999988 999999999999999999999999987532
Q ss_pred --CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccHHHH
Q 004979 585 --TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQENVL 662 (721)
Q Consensus 585 --~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 662 (721)
..++..|+|||.+.+..++.++|||||||++|||+||+.||... +..+....+..+... .+....
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~--~~~~~~~~i~~~~~~-----------~~~~~~ 220 (320)
T cd05590 154 STFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAE--NEDDLFEAILNDEVV-----------YPTWLS 220 (320)
T ss_pred cccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCC--CHHHHHHHHhcCCCC-----------CCCCCC
Confidence 12456799999999899999999999999999999999999643 333444443332211 112245
Q ss_pred HHHHHHHHHcccCCCCCCCCHH
Q 004979 663 EELLVVIKNCVHPDPKQRPSMR 684 (721)
Q Consensus 663 ~~l~~li~~Cl~~dP~~RPs~~ 684 (721)
.++.+++.+||+.||++||++.
T Consensus 221 ~~~~~li~~~L~~dP~~R~~~~ 242 (320)
T cd05590 221 QDAVDILKAFMTKNPTMRLGSL 242 (320)
T ss_pred HHHHHHHHHHcccCHHHCCCCC
Confidence 6788999999999999999983
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=317.94 Aligned_cols=256 Identities=25% Similarity=0.368 Sum_probs=196.6
Q ss_pred hhhCcCCCCceeEEEEEEe-----cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCce
Q 004979 430 NIIGSFSDGTVGTVYKGTL-----SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFT 504 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~-----~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 504 (721)
++++.+|+|+||+||++.+ .++..+++|.+..... ......|.+|++++++++||||+++++++...+...
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG----QQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG 82 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC----hHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence 6778899999999988653 3567899998764321 223467889999999999999999999987654435
Q ss_pred EEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC
Q 004979 505 RMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT 584 (721)
Q Consensus 505 ~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~ 584 (721)
.++||||+++|+|.+++.. ..+++.++..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 83 ~~lv~e~~~~~~l~~~~~~---~~l~~~~~~~i~~~l~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLPK---HKLNLAQLLLFAQQICEGMAYLHSQH--YIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred EEEEecCCCCCCHHHHHHH---cCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccChheEEEcCCCcEEEeeccccccc
Confidence 7899999999999999853 35899999999999999999999988 999999999999999999999999997643
Q ss_pred CC------------CCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhc--CCCCcccc
Q 004979 585 TA------------AKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKG--EQPLKDIV 650 (721)
Q Consensus 585 ~~------------~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~--~~~~~~~~ 650 (721)
.. +...|++||......++.++|||||||++|||+||+.||........+........ .....+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd05080 158 PEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELL 237 (283)
T ss_pred CCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhh
Confidence 22 22347899999888899999999999999999999999853322211111000000 00000011
Q ss_pred CCcc-ccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 004979 651 DPTL-KSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEIT 694 (721)
Q Consensus 651 d~~l-~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~ 694 (721)
+... ...+..++.++.+++.+||+.+|++||++++|++.|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 238 ERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 1100 1123345678999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=316.88 Aligned_cols=237 Identities=20% Similarity=0.251 Sum_probs=187.9
Q ss_pred CCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEEEecCC
Q 004979 435 FSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSP 513 (721)
Q Consensus 435 lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV~Ey~~ 513 (721)
+|+|+||+||+++.. +++.+|+|++....... ....+.+..|++++++++|+||+++.+++.... ..++||||++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~--~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~--~~~lv~e~~~ 76 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKK--RKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKT--DLCLVMTIMN 76 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhh--hHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCC--eEEEEEeCCC
Confidence 578999999999864 67889999886432211 222356788999999999999999999988766 6799999999
Q ss_pred CCChhhhhhhc--cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC------
Q 004979 514 NGSLFEHLHIQ--EAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT------ 585 (721)
Q Consensus 514 ~GsL~~~l~~~--~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~------ 585 (721)
+|+|..++... ....+++..+..++.||+.||+|||+.+ |+||||||+||++++++.+||+|||++....
T Consensus 77 ~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 154 (280)
T cd05608 77 GGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR--IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKT 154 (280)
T ss_pred CCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEeeCccceecCCCCccc
Confidence 99998887432 2356899999999999999999999988 9999999999999999999999999875322
Q ss_pred ---CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCH--HHHHHHHhhcCCCCccccCCccccccHH
Q 004979 586 ---AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSL--ENWASEYLKGEQPLKDIVDPTLKSFQEN 660 (721)
Q Consensus 586 ---~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~--~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 660 (721)
.++..|+|||.+.+..++.++|||||||++|||+||+.||....... .......... ....+..
T Consensus 155 ~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~-----------~~~~~~~ 223 (280)
T cd05608 155 KGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILND-----------SVTYPDK 223 (280)
T ss_pred cccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhccc-----------CCCCccc
Confidence 23457899999999999999999999999999999999997433221 1111111111 0112234
Q ss_pred HHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 004979 661 VLEELLVVIKNCVHPDPKQRP-----SMRGIAA 688 (721)
Q Consensus 661 ~~~~l~~li~~Cl~~dP~~RP-----s~~evl~ 688 (721)
.+.++.+++.+||+.||++|| +++|+++
T Consensus 224 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 224 FSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 567789999999999999999 5666654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=334.38 Aligned_cols=239 Identities=25% Similarity=0.393 Sum_probs=197.4
Q ss_pred hhCcCCCCceeEEEEEEec--CC--cEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEE
Q 004979 431 IIGSFSDGTVGTVYKGTLS--SG--VEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRM 506 (721)
Q Consensus 431 ii~~lg~G~~g~Vyk~~~~--~~--~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~ 506 (721)
+.+.+|+|.||.|++|.|. .| ..||||.+...... ....+|++|+.+|.+|+|+|+++|||+..+. ...
T Consensus 114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~----~~mddflrEas~M~~L~H~hliRLyGvVl~q---p~m 186 (1039)
T KOG0199|consen 114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLN----AIMDDFLREASHMLKLQHPHLIRLYGVVLDQ---PAM 186 (1039)
T ss_pred HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccc----hhHHHHHHHHHHHHhccCcceeEEeeeeccc---hhh
Confidence 4467889999999999986 33 45788877654332 2567899999999999999999999999873 358
Q ss_pred EEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCCC
Q 004979 507 MVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTA 586 (721)
Q Consensus 507 lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~~ 586 (721)
||||.++.|+|.+.|+......|-......++.|||.||+||..++ .|||||..+|+||...-.+||+|||+.+....
T Consensus 187 MV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr--lvHRDLAARNlllasprtVKI~DFGLmRaLg~ 264 (1039)
T KOG0199|consen 187 MVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR--LVHRDLAARNLLLASPRTVKICDFGLMRALGE 264 (1039)
T ss_pred HHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh--hhhhhhhhhhheecccceeeeecccceeccCC
Confidence 9999999999999998755667888888899999999999999887 99999999999999999999999999886554
Q ss_pred CCc------------cccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhcCCCCccccCCc
Q 004979 587 AKT------------GSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPLKDIVDPT 653 (721)
Q Consensus 587 ~~~------------~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 653 (721)
+.. .|.|||.+...+++.++|||+|||++|||+| |..||.+-.. .+.++. +.+.+
T Consensus 265 ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g--~qIL~~----------iD~~e 332 (1039)
T KOG0199|consen 265 NEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG--IQILKN----------IDAGE 332 (1039)
T ss_pred CCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH--HHHHHh----------ccccc
Confidence 432 4569999999999999999999999999999 8999964332 222221 11223
Q ss_pred cccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 004979 654 LKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKL 690 (721)
Q Consensus 654 l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L 690 (721)
...-++.|+++++++|+.||..+|++||+|..|.+.+
T Consensus 333 rLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 333 RLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred cCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 3345678899999999999999999999999998554
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=321.92 Aligned_cols=245 Identities=19% Similarity=0.329 Sum_probs=194.6
Q ss_pred hhhCcCCCCceeEEEEEEec-CCc----EEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCce
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGV----EIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFT 504 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~----~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 504 (721)
+++..+|+|+||+||+|++. ++. .|++|++.... .....++|.+|+.+++.++||||++++|+|....
T Consensus 10 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~~--- 82 (316)
T cd05108 10 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT----SPKANKEILDEAYVMASVDNPHVCRLLGICLTST--- 82 (316)
T ss_pred eeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC----CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCCC---
Confidence 67788999999999999864 333 37888765321 1234467999999999999999999999998653
Q ss_pred EEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC
Q 004979 505 RMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT 584 (721)
Q Consensus 505 ~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~ 584 (721)
.++|+||+++|+|.++++.. ...+++.....++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 83 ~~~v~e~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~--iiH~dlkp~Nill~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 83 VQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEERR--LVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (316)
T ss_pred ceeeeecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEecCCCcEEEccccccccc
Confidence 47999999999999998643 346889999999999999999999988 999999999999999999999999998643
Q ss_pred CC-----------CCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhcCCCCccccCC
Q 004979 585 TA-----------AKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPLKDIVDP 652 (721)
Q Consensus 585 ~~-----------~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 652 (721)
.. ....|++||.+....++.++|||||||++|||+| |+.||... ...++.. ........
T Consensus 160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~--~~~~~~~-~~~~~~~~------ 230 (316)
T cd05108 160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI--PASEISS-ILEKGERL------ 230 (316)
T ss_pred cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCC--CHHHHHH-HHhCCCCC------
Confidence 21 1235899999999999999999999999999998 99998633 2222222 22211111
Q ss_pred ccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 004979 653 TLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAM 696 (721)
Q Consensus 653 ~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~ 696 (721)
..+..+..++.+++.+||+.+|++||++.+++..+.++...
T Consensus 231 ---~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~ 271 (316)
T cd05108 231 ---PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 271 (316)
T ss_pred ---CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence 01123445788999999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=311.95 Aligned_cols=246 Identities=22% Similarity=0.358 Sum_probs=191.0
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcE----EEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCce
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVE----IAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFT 504 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~----vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 504 (721)
++++.+|+|+||+||+|++. ++.. +++|..... .......++..|+..+++++||||+++++++... .
T Consensus 10 ~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~~---~ 82 (279)
T cd05111 10 RKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR----SGRQTFQEITDHMLAMGSLDHAYIVRLLGICPGA---S 82 (279)
T ss_pred eeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc----cchHHHHHHHHHHHHHhcCCCCCcceEEEEECCC---c
Confidence 56788999999999999964 3443 555554321 1123346788899999999999999999998643 3
Q ss_pred EEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC
Q 004979 505 RMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT 584 (721)
Q Consensus 505 ~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~ 584 (721)
.++|+||+++|+|.++++.. ...++|..+..|+.||+.||+|||+.+ ++||||||+|||+++++.+||+|||+++..
T Consensus 83 ~~~i~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~nili~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 83 LQLVTQLSPLGSLLDHVRQH-RDSLDPQRLLNWCVQIAKGMYYLEEHR--MVHRNLAARNILLKSDSIVQIADFGVADLL 159 (279)
T ss_pred cEEEEEeCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEcCCCcEEEcCCccceec
Confidence 57999999999999998643 356899999999999999999999988 999999999999999999999999988643
Q ss_pred CC-----------CCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhcCCCCccccCC
Q 004979 585 TA-----------AKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPLKDIVDP 652 (721)
Q Consensus 585 ~~-----------~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 652 (721)
.. +...|++||.+....++.++|||||||++|||+| |+.||.... ..+. ...+....... .+
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~--~~~~-~~~~~~~~~~~---~~ 233 (279)
T cd05111 160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMR--PHEV-PDLLEKGERLA---QP 233 (279)
T ss_pred cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCC--HHHH-HHHHHCCCcCC---CC
Confidence 21 2236899999988899999999999999999998 999986432 1211 11121111111 11
Q ss_pred ccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcC
Q 004979 653 TLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAME 697 (721)
Q Consensus 653 ~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 697 (721)
..+..++.+++.+||..+|++||++.|+++.|..+....
T Consensus 234 ------~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~ 272 (279)
T cd05111 234 ------QICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDP 272 (279)
T ss_pred ------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCC
Confidence 123456788999999999999999999999998877643
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=318.44 Aligned_cols=252 Identities=24% Similarity=0.352 Sum_probs=194.1
Q ss_pred hhhCcCCCCceeEEEEEEec-----CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCce
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-----SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFT 504 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-----~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 504 (721)
++++.+|+|+||.||+|..+ ++..+++|++.... ....+.|.+|++++++++||||+++++++...+...
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (284)
T cd05081 7 KFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST-----AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 81 (284)
T ss_pred eeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC-----HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCc
Confidence 56788999999999999753 57789999875432 233467899999999999999999999886544335
Q ss_pred EEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC
Q 004979 505 RMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT 584 (721)
Q Consensus 505 ~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~ 584 (721)
.++||||+++|+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++..
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~aL~~LH~~~--i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 82 LRLVMEYLPYGSLRDYLQKH-RERLDHRKLLLYASQICKGMEYLGSKR--YVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred eEEEEEecCCCCHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 78999999999999998632 346899999999999999999999988 999999999999999999999999987643
Q ss_pred CCC------------CccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCc-----
Q 004979 585 TAA------------KTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLK----- 647 (721)
Q Consensus 585 ~~~------------~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~----- 647 (721)
... ...|++||...+..++.++|||||||++|||++|..++..... .+... ........
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~---~~~~~-~~~~~~~~~~~~~ 234 (284)
T cd05081 159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPA---EFMRM-MGNDKQGQMIVYH 234 (284)
T ss_pred cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcch---hhhhh-cccccccccchHH
Confidence 221 1247899999888899999999999999999998776532211 11110 00000000
Q ss_pred --cccC-CccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 004979 648 --DIVD-PTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEI 693 (721)
Q Consensus 648 --~~~d-~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i 693 (721)
+.+. .........++.++.+++.+||..+|++|||+.||++.|+.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 235 LIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 0000 001112234557899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=310.26 Aligned_cols=239 Identities=19% Similarity=0.353 Sum_probs=193.6
Q ss_pred hhhCcCCCCceeEEEEEEecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVF 509 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV~ 509 (721)
.+++.+|+|+||+||+|++..+..+++|.+..... ....|.+|+.++.+++||||+++++++...+ ..++||
T Consensus 7 ~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~ 78 (256)
T cd05113 7 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM------SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQR--PIYIVT 78 (256)
T ss_pred EEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc------cHHHHHHHHHHHhcCCCCCeeeEEEEEccCC--CcEEEE
Confidence 56788999999999999988777899998753321 1356899999999999999999999998766 469999
Q ss_pred ecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCCC---
Q 004979 510 EYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTA--- 586 (721)
Q Consensus 510 Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~~--- 586 (721)
||+++|+|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+||++++++.+||+|||+++....
T Consensus 79 e~~~~~~l~~~i~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05113 79 EYMSNGCLLNYLREH-GKRFQPSQLLEMCKDVCEGMAYLESKQ--FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY 155 (256)
T ss_pred EcCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEcCCCCEEECCCccceecCCCce
Confidence 999999999998643 236899999999999999999999988 99999999999999999999999998763321
Q ss_pred -------CCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhcCCCCccccCCcccccc
Q 004979 587 -------AKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQ 658 (721)
Q Consensus 587 -------~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 658 (721)
+...|++||......++.++|||||||++|||+| |+.||.... ..+.......+.... .+
T Consensus 156 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~--~~~~~~~~~~~~~~~----------~~ 223 (256)
T cd05113 156 TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFN--NSETVEKVSQGLRLY----------RP 223 (256)
T ss_pred eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCC--HHHHHHHHhcCCCCC----------CC
Confidence 1235889999988889999999999999999999 999985332 222233332221110 11
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 004979 659 ENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLK 691 (721)
Q Consensus 659 ~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 691 (721)
...+.++.+++.+||+.+|++||++.+|++.|+
T Consensus 224 ~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 224 HLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 123567899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=312.02 Aligned_cols=242 Identities=21% Similarity=0.359 Sum_probs=197.5
Q ss_pred hhhCcCCCCceeEEEEEEecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVF 509 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV~ 509 (721)
++++.+|+|+||.||+|...++..|++|.+..... ..+++.+|++++++++|+||+++++++...+ ..++||
T Consensus 9 ~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~ 80 (261)
T cd05068 9 QLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM------DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEE--PIYIVT 80 (261)
T ss_pred eeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc------cHHHHHHHHHHHHHCCCCCccceeEEEecCC--Ceeeee
Confidence 56788999999999999988788899998754321 1356889999999999999999999998776 579999
Q ss_pred ecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCCC---
Q 004979 510 EYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTA--- 586 (721)
Q Consensus 510 Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~~--- 586 (721)
||+++++|.+++.......+++..+..++.|++.|+.|||+.+ |+||||||+||++++++.+||+|||+++....
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05068 81 ELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN--YIHRDLAARNVLVGENNICKVADFGLARVIKEDIY 158 (261)
T ss_pred ecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence 9999999999987544457899999999999999999999988 99999999999999999999999998753321
Q ss_pred ----C---CccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhcCCCCccccCCcccccc
Q 004979 587 ----A---KTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQ 658 (721)
Q Consensus 587 ----~---~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 658 (721)
+ ...|++||......++.++||||||+++|||+| |+.||.... ........... ... ..+
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~--~~~~~~~~~~~-~~~---------~~~ 226 (261)
T cd05068 159 EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMT--NAEVLQQVDQG-YRM---------PCP 226 (261)
T ss_pred cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCC--HHHHHHHHHcC-CCC---------CCC
Confidence 1 125899999988899999999999999999999 999986332 22222222111 111 112
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 004979 659 ENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEI 693 (721)
Q Consensus 659 ~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i 693 (721)
...+..+.+++.+||+.+|++||++.++++.|+++
T Consensus 227 ~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 227 PGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred CcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 23457789999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=324.49 Aligned_cols=232 Identities=18% Similarity=0.278 Sum_probs=184.6
Q ss_pred cCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcC-CCCccceEeEEEecCCCceEEEEEec
Q 004979 434 SFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKV-NHKNFVNLIGYCEEDEPFTRMMVFEY 511 (721)
Q Consensus 434 ~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~~~lV~Ey 511 (721)
.+|+|+||+||+|+.. +++.+|+|++....... ......+.+|+.++.++ +||||+++++++...+ ..++||||
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~--~~~lv~E~ 77 (329)
T cd05618 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVND--DEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES--RLFFVIEY 77 (329)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcc--hhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCC--EEEEEEeC
Confidence 4789999999999965 57889999886542221 22345678888888877 8999999999998876 67999999
Q ss_pred CCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC-------
Q 004979 512 SPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT------- 584 (721)
Q Consensus 512 ~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~------- 584 (721)
+++|+|..++.. ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 78 ~~~~~L~~~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~ 153 (329)
T cd05618 78 VNGGDLMFHMQR--QRKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT 153 (329)
T ss_pred CCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCcc
Confidence 999999988753 356899999999999999999999998 999999999999999999999999987632
Q ss_pred --CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCC------CCHHHHHHHHhhcCCCCccccCCcccc
Q 004979 585 --TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIEN------GSLENWASEYLKGEQPLKDIVDPTLKS 656 (721)
Q Consensus 585 --~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~------~~~~~~~~~~~~~~~~~~~~~d~~l~~ 656 (721)
..++..|+|||.+.+..++.++|||||||++|||+||+.||.... .....+......... ..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~----------~~ 223 (329)
T cd05618 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ----------IR 223 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC----------CC
Confidence 124567899999999999999999999999999999999995211 122223322222111 01
Q ss_pred ccHHHHHHHHHHHHHcccCCCCCCCCH
Q 004979 657 FQENVLEELLVVIKNCVHPDPKQRPSM 683 (721)
Q Consensus 657 ~~~~~~~~l~~li~~Cl~~dP~~RPs~ 683 (721)
++.....++.+++.+||+.||++||++
T Consensus 224 ~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 224 IPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred CCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 223445678899999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=323.52 Aligned_cols=249 Identities=22% Similarity=0.327 Sum_probs=195.8
Q ss_pred hhhhCcCCCCceeEEEEEEec------CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcC-CCCccceEeEEEecCC
Q 004979 429 SNIIGSFSDGTVGTVYKGTLS------SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKV-NHKNFVNLIGYCEEDE 501 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~------~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~ 501 (721)
+++.+.+|+|+||.||+|+.. +++.|++|++..... ....+.+.+|++++.++ +|+||++++++|...+
T Consensus 9 ~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~----~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~ 84 (337)
T cd05054 9 LKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGAT----ASEYKALMTELKILIHIGHHLNVVNLLGACTKPG 84 (337)
T ss_pred hhhhcccccCcCceEEeccccccccccccceeeeeeccCCCC----HHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence 467788999999999999632 346799998753221 22345688999999999 8999999999887654
Q ss_pred CceEEEEEecCCCCChhhhhhhcc--------------------------------------------------------
Q 004979 502 PFTRMMVFEYSPNGSLFEHLHIQE-------------------------------------------------------- 525 (721)
Q Consensus 502 ~~~~~lV~Ey~~~GsL~~~l~~~~-------------------------------------------------------- 525 (721)
. ..+++|||+++|+|.+++....
T Consensus 85 ~-~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (337)
T cd05054 85 G-PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD 163 (337)
T ss_pred C-CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence 3 5789999999999999885321
Q ss_pred ---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCCC-----------CCccc
Q 004979 526 ---AEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTA-----------AKTGS 591 (721)
Q Consensus 526 ---~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~~-----------~~~~~ 591 (721)
...++|..+.+++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.... +...|
T Consensus 164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y 241 (337)
T cd05054 164 ELYKEPLTLEDLISYSFQVARGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 241 (337)
T ss_pred HHhhcCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccc
Confidence 126899999999999999999999988 99999999999999999999999998864321 12368
Q ss_pred cchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccHHHHHHHHHHHH
Q 004979 592 AAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIK 670 (721)
Q Consensus 592 ~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~ 670 (721)
+|||.+.+..++.++|||||||++|||++ |+.||...... +............ ..+.....++.+++.
T Consensus 242 ~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~--~~~~~~~~~~~~~---------~~~~~~~~~~~~l~~ 310 (337)
T cd05054 242 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQID--EEFCRRLKEGTRM---------RAPEYATPEIYSIML 310 (337)
T ss_pred cCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCcc--HHHHHHHhccCCC---------CCCccCCHHHHHHHH
Confidence 99999999999999999999999999998 99999643221 1111111111110 112234567899999
Q ss_pred HcccCCCCCCCCHHHHHHHHHHhhh
Q 004979 671 NCVHPDPKQRPSMRGIAAKLKEITA 695 (721)
Q Consensus 671 ~Cl~~dP~~RPs~~evl~~L~~i~~ 695 (721)
+||+.+|++||++.||++.|+++.+
T Consensus 311 ~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 311 DCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHccCChhhCcCHHHHHHHHHHHHh
Confidence 9999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=322.04 Aligned_cols=236 Identities=18% Similarity=0.284 Sum_probs=188.0
Q ss_pred cCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcC-CCCccceEeEEEecCCCceEEEEEec
Q 004979 434 SFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKV-NHKNFVNLIGYCEEDEPFTRMMVFEY 511 (721)
Q Consensus 434 ~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~~~lV~Ey 511 (721)
.+|+|+||.||+|+.. ++..+|+|++....... ....+.+.+|..++.++ +||||+++++++.+.+ ..++||||
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~--~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~--~~~lv~e~ 77 (329)
T cd05588 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVND--DEDIDWVQTEKHVFETASNHPFLVGLHSCFQTES--RLFFVIEF 77 (329)
T ss_pred eEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh--hhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCC--EEEEEEeC
Confidence 4689999999999864 67889999886532211 22345688899999988 7999999999998876 67999999
Q ss_pred CCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC-------
Q 004979 512 SPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT------- 584 (721)
Q Consensus 512 ~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~------- 584 (721)
+++|+|.+++.. ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 78 ~~~g~L~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~ 153 (329)
T cd05588 78 VSGGDLMFHMQR--QRKLPEEHARFYSAEISLALNFLHERG--IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTT 153 (329)
T ss_pred CCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCCCCEEECcCccccccccCCCcc
Confidence 999999988753 356999999999999999999999998 999999999999999999999999987632
Q ss_pred --CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCC------CCHHHHHHHHhhcCCCCccccCCcccc
Q 004979 585 --TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIEN------GSLENWASEYLKGEQPLKDIVDPTLKS 656 (721)
Q Consensus 585 --~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~------~~~~~~~~~~~~~~~~~~~~~d~~l~~ 656 (721)
..++..|+|||.+.+..++.++|||||||++|||+||+.||.... ....++.......... .
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~----------~ 223 (329)
T cd05588 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI----------R 223 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC----------C
Confidence 124557899999999999999999999999999999999996321 1222333222222110 1
Q ss_pred ccHHHHHHHHHHHHHcccCCCCCCCC------HHHHH
Q 004979 657 FQENVLEELLVVIKNCVHPDPKQRPS------MRGIA 687 (721)
Q Consensus 657 ~~~~~~~~l~~li~~Cl~~dP~~RPs------~~evl 687 (721)
.+...+.++.+++.+||+.||.+||+ +.|++
T Consensus 224 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~ 260 (329)
T cd05588 224 IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIK 260 (329)
T ss_pred CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHh
Confidence 22334567899999999999999998 55665
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=327.03 Aligned_cols=236 Identities=19% Similarity=0.278 Sum_probs=185.1
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
+.++.||+|+||+||+|+.. +++.|++|++.... .....+.+.+|++++++++|+||+++++++...+ ..++|
T Consensus 77 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~lv 150 (353)
T PLN00034 77 ERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH----EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNG--EIQVL 150 (353)
T ss_pred hhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC----cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCC--eEEEE
Confidence 45678899999999999864 68899999875432 1234567899999999999999999999998776 67999
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC---
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT--- 585 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~--- 585 (721)
|||+++|+|.+.. ...+.....++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++...
T Consensus 151 ~e~~~~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~ 222 (353)
T PLN00034 151 LEFMDGGSLEGTH------IADEQFLADVARQILSGIAYLHRRH--IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM 222 (353)
T ss_pred EecCCCCcccccc------cCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCEEEcccccceeccccc
Confidence 9999999986542 3456777889999999999999988 9999999999999999999999999875322
Q ss_pred ------CCCccccchhhccc-----CCCCCCccHHHHHHHHHHHHhCCCcccCCCC-CHHHHHHHHhhcCCCCccccCCc
Q 004979 586 ------AAKTGSAAMELLET-----SAVDLESNVYSFGTILFEMITGRISYSIENG-SLENWASEYLKGEQPLKDIVDPT 653 (721)
Q Consensus 586 ------~~~~~~~apE~~~~-----~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~-~~~~~~~~~~~~~~~~~~~~d~~ 653 (721)
.++..|+|||.+.. ...+.++|||||||++|||++|+.||..... +.............
T Consensus 223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~--------- 293 (353)
T PLN00034 223 DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQP--------- 293 (353)
T ss_pred ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCC---------
Confidence 34567999998742 3345689999999999999999999963321 22222211111110
Q ss_pred cccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004979 654 LKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAK 689 (721)
Q Consensus 654 l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 689 (721)
......+..++.+|+.+||+.||++||++.|+++.
T Consensus 294 -~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 294 -PEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred -CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11123455779999999999999999999999874
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=321.31 Aligned_cols=237 Identities=16% Similarity=0.288 Sum_probs=187.8
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHH---HhcCCCCccceEeEEEecCCCceE
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDT---LSKVNHKNFVNLIGYCEEDEPFTR 505 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~---l~~l~H~nIv~l~g~~~~~~~~~~ 505 (721)
++++.+|+|+||.||+|... +++.||||++....... ....+.+.+|+++ +++++||||+++++++...+ ..
T Consensus 2 ~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~--~~ 77 (324)
T cd05589 2 RCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIA--RDEVESLMCEKRIFETANSERHPFLVNLFACFQTED--HV 77 (324)
T ss_pred eEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhh--hhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCC--EE
Confidence 45678899999999999864 68899999886432111 1223456666655 46778999999999998876 77
Q ss_pred EEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC-
Q 004979 506 MMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT- 584 (721)
Q Consensus 506 ~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~- 584 (721)
|+||||+++|+|..+++ ...+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 78 ~lv~E~~~~~~L~~~~~---~~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05589 78 CFVMEYAAGGDLMMHIH---TDVFSEPRAVFYAACVVLGLQYLHENK--IVYRDLKLDNLLLDTEGFVKIADFGLCKEGM 152 (324)
T ss_pred EEEEcCCCCCcHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence 99999999999998875 246899999999999999999999988 999999999999999999999999987532
Q ss_pred --------CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCcccc
Q 004979 585 --------TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKS 656 (721)
Q Consensus 585 --------~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 656 (721)
..++..|+|||.+.+..++.++|||||||++|||++|+.||... +..+....+..+...
T Consensus 153 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~--~~~~~~~~i~~~~~~----------- 219 (324)
T cd05589 153 GFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGD--DEEEVFDSIVNDEVR----------- 219 (324)
T ss_pred CCCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCC--CHHHHHHHHHhCCCC-----------
Confidence 12456789999999999999999999999999999999999633 333333333332211
Q ss_pred ccHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 004979 657 FQENVLEELLVVIKNCVHPDPKQRPS-----MRGIAA 688 (721)
Q Consensus 657 ~~~~~~~~l~~li~~Cl~~dP~~RPs-----~~evl~ 688 (721)
.+...+.++.+++.+||+.||++||+ +.++++
T Consensus 220 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 220 YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 12234567889999999999999994 555544
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=320.48 Aligned_cols=250 Identities=18% Similarity=0.268 Sum_probs=191.3
Q ss_pred hhhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEE
Q 004979 429 SNIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMM 507 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~l 507 (721)
+++++.+|+|+||.||++... ++..+++|.+.... .......+.+|++++++++|+|||+++++|.+.+ ..++
T Consensus 7 y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~l 80 (333)
T cd06650 7 FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI----KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG--EISI 80 (333)
T ss_pred hheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc----CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECC--EEEE
Confidence 467889999999999999966 57778888765432 1233467999999999999999999999999877 7799
Q ss_pred EEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC-
Q 004979 508 VFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQL-TPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT- 585 (721)
Q Consensus 508 V~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~-~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~- 585 (721)
||||+++|+|.+++.. ...+++.....++.|++.||+|||+. + |+||||||+|||+++++.+||+|||++....
T Consensus 81 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~~--ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~ 156 (333)
T cd06650 81 CMEHMDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (333)
T ss_pred EEecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCChhhEEEcCCCCEEEeeCCcchhhhh
Confidence 9999999999999863 34588899999999999999999974 5 9999999999999999999999999875321
Q ss_pred ------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHH-HhhcCCCCccc---------
Q 004979 586 ------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASE-YLKGEQPLKDI--------- 649 (721)
Q Consensus 586 ------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~-~~~~~~~~~~~--------- 649 (721)
.++..|+|||.+.+..++.++|||||||++|||++|+.||............. ...+.......
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (333)
T cd06650 157 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGR 236 (333)
T ss_pred hccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccc
Confidence 24557999999998899999999999999999999999996432211111000 00000000000
Q ss_pred ----cCC------------------cccccc-HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 650 ----VDP------------------TLKSFQ-ENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 650 ----~d~------------------~l~~~~-~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
..+ ...... .....++.+|+.+||+.||++||++.|++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~ 298 (333)
T cd06650 237 PLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV 298 (333)
T ss_pred hhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhh
Confidence 000 000000 113467899999999999999999999975
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=323.21 Aligned_cols=230 Identities=20% Similarity=0.264 Sum_probs=183.8
Q ss_pred cCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHH-HHhcCCCCccceEeEEEecCCCceEEEEEec
Q 004979 434 SFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKID-TLSKVNHKNFVNLIGYCEEDEPFTRMMVFEY 511 (721)
Q Consensus 434 ~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~-~l~~l~H~nIv~l~g~~~~~~~~~~~lV~Ey 511 (721)
.+|+|+||+||+|+.. +++.||+|++....... ......+..|.. +++.++||||+++++++...+ ..++||||
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~--~~~lv~e~ 77 (323)
T cd05575 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILK--KKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTAD--KLYFVLDY 77 (323)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhh--hhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCC--EEEEEEcC
Confidence 4789999999999964 68899999886432211 122234555544 567899999999999998776 67999999
Q ss_pred CCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC------
Q 004979 512 SPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT------ 585 (721)
Q Consensus 512 ~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~------ 585 (721)
+++|+|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++...
T Consensus 78 ~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~g--ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 153 (323)
T cd05575 78 VNGGELFFHLQR--ERSFPEPRARFYAAEIASALGYLHSLN--IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTT 153 (323)
T ss_pred CCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCcc
Confidence 999999998863 356889999999999999999999988 9999999999999999999999999876321
Q ss_pred ---CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccHHHH
Q 004979 586 ---AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQENVL 662 (721)
Q Consensus 586 ---~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 662 (721)
.++..|+|||.+.+..++.++|||||||++|||+||+.||... +..+....+...... .....+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~--~~~~~~~~i~~~~~~-----------~~~~~~ 220 (323)
T cd05575 154 STFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR--DTAEMYDNILNKPLR-----------LKPNIS 220 (323)
T ss_pred ccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCC--CHHHHHHHHHcCCCC-----------CCCCCC
Confidence 2455789999999999999999999999999999999999633 334444444332111 112335
Q ss_pred HHHHHHHHHcccCCCCCCCCHH
Q 004979 663 EELLVVIKNCVHPDPKQRPSMR 684 (721)
Q Consensus 663 ~~l~~li~~Cl~~dP~~RPs~~ 684 (721)
.++.+++.+||+.||++||++.
T Consensus 221 ~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 221 VSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred HHHHHHHHHHhhcCHHhCCCCC
Confidence 6788999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=329.95 Aligned_cols=247 Identities=21% Similarity=0.326 Sum_probs=194.8
Q ss_pred hhhCcCCCCceeEEEEEEec------CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCC-CCccceEeEEEecCCC
Q 004979 430 NIIGSFSDGTVGTVYKGTLS------SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVN-HKNFVNLIGYCEEDEP 502 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~------~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~ 502 (721)
.+.+.||+|+||.||+|+.. .+..||||++..... ....+.|.+|++++++++ |||||+++++|.+.+
T Consensus 40 ~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~----~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~- 114 (400)
T cd05105 40 VLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTAR----SSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG- 114 (400)
T ss_pred ehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCC----hHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC-
Confidence 56678899999999999853 134689998754321 233467999999999996 999999999998766
Q ss_pred ceEEEEEecCCCCChhhhhhhcc---------------------------------------------------------
Q 004979 503 FTRMMVFEYSPNGSLFEHLHIQE--------------------------------------------------------- 525 (721)
Q Consensus 503 ~~~~lV~Ey~~~GsL~~~l~~~~--------------------------------------------------------- 525 (721)
..++|||||++|+|.++++...
T Consensus 115 -~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (400)
T cd05105 115 -PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE 193 (400)
T ss_pred -ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence 6799999999999999886421
Q ss_pred -------------------------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeC
Q 004979 526 -------------------------------------AEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLT 568 (721)
Q Consensus 526 -------------------------------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~ 568 (721)
...+++..++.++.|++.||+|||+.+ |+||||||+|||++
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~dikp~Nill~ 271 (400)
T cd05105 194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN--CVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChHhEEEe
Confidence 124788889999999999999999988 99999999999999
Q ss_pred CCCcEEEeccCCCCCCCC-----------CCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHH
Q 004979 569 EDYAAKISDFSFWNNTTA-----------AKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWA 636 (721)
Q Consensus 569 ~~~~~kL~DFGla~~~~~-----------~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~ 636 (721)
+++.+||+|||+++.... +...|+|||.+.+..++.++|||||||++|||++ |..||.....+ ...
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~--~~~ 349 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD--STF 349 (400)
T ss_pred CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh--HHH
Confidence 999999999998763211 2235899999988899999999999999999997 99998643211 111
Q ss_pred HHHhhcCCCCccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 004979 637 SEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITA 695 (721)
Q Consensus 637 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~ 695 (721)
.......... ..+..++.++.+++.+||+.||++||++.+|.+.|+++.+
T Consensus 350 ~~~~~~~~~~---------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 350 YNKIKSGYRM---------AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred HHHHhcCCCC---------CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 1112111111 1123456788999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=321.25 Aligned_cols=233 Identities=16% Similarity=0.231 Sum_probs=187.1
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCC-ccceEeEEEecCCCceEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHK-NFVNLIGYCEEDEPFTRMM 507 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~-nIv~l~g~~~~~~~~~~~l 507 (721)
++++.+|+|+||.||+|+.. +++.+|+|++...... .....+.+..|++++..++|+ +|+++++++...+ ..|+
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~--~~~l 78 (324)
T cd05587 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVII--QDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD--RLYF 78 (324)
T ss_pred eEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhh--hhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCC--EEEE
Confidence 56788999999999999865 5678999988643221 122345688899999999765 5888888888766 6799
Q ss_pred EEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC---
Q 004979 508 VFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT--- 584 (721)
Q Consensus 508 V~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~--- 584 (721)
||||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 79 v~E~~~~g~L~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05587 79 VMEYVNGGDLMYHIQQ--VGKFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG 154 (324)
T ss_pred EEcCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence 9999999999998853 346889999999999999999999988 999999999999999999999999987532
Q ss_pred ------CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCcccccc
Q 004979 585 ------TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQ 658 (721)
Q Consensus 585 ------~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 658 (721)
..++..|+|||.+.+..++.++|||||||++|||+||+.||... +..+....+...... ++
T Consensus 155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~--~~~~~~~~i~~~~~~-----------~~ 221 (324)
T cd05587 155 GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE--DEDELFQSIMEHNVS-----------YP 221 (324)
T ss_pred CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCC--CHHHHHHHHHcCCCC-----------CC
Confidence 12456799999999999999999999999999999999999643 223333333322111 12
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCH
Q 004979 659 ENVLEELLVVIKNCVHPDPKQRPSM 683 (721)
Q Consensus 659 ~~~~~~l~~li~~Cl~~dP~~RPs~ 683 (721)
...+.++.+++.+||+.||.+|++.
T Consensus 222 ~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 222 KSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred CCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 2345678899999999999999976
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=308.50 Aligned_cols=238 Identities=19% Similarity=0.342 Sum_probs=190.7
Q ss_pred cCCCCceeEEEEEEec---CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEEEe
Q 004979 434 SFSDGTVGTVYKGTLS---SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFE 510 (721)
Q Consensus 434 ~lg~G~~g~Vyk~~~~---~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV~E 510 (721)
.+|+|+||.||+|++. .+..|++|+..... .....+.|.+|++++++++|+||+++++++... ..++|||
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~----~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~---~~~lv~e 74 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN----EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEAE---ALMLVME 74 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc----ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcCC---CeEEEEE
Confidence 4789999999999864 34568888775432 133456799999999999999999999998643 4689999
Q ss_pred cCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCCC----
Q 004979 511 YSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTA---- 586 (721)
Q Consensus 511 y~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~~---- 586 (721)
|+++|+|.+++.. ....+++..+..++.|++.||+|||+++ ++||||||+|||++.++.+||+|||+++....
T Consensus 75 ~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~ 151 (257)
T cd05115 75 MASGGPLNKFLSG-KKDEITVSNVVELMHQVSMGMKYLEGKN--FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSY 151 (257)
T ss_pred eCCCCCHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhcC--eeecccchheEEEcCCCcEEeccCCccccccCCccc
Confidence 9999999999863 2456899999999999999999999988 99999999999999999999999998753211
Q ss_pred --------CCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccc
Q 004979 587 --------AKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSF 657 (721)
Q Consensus 587 --------~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 657 (721)
....|+|||.+....++.++|||||||++||+++ |+.||... ...++......+.. ...
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~--~~~~~~~~~~~~~~----------~~~ 219 (257)
T cd05115 152 YKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKM--KGPEVMSFIEQGKR----------LDC 219 (257)
T ss_pred eeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcC--CHHHHHHHHHCCCC----------CCC
Confidence 1236899999988889999999999999999997 99999633 22233332222211 112
Q ss_pred cHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 004979 658 QENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEI 693 (721)
Q Consensus 658 ~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i 693 (721)
+..+++++.+++.+||..+|++||++.+|.+.|+.+
T Consensus 220 ~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 220 PAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 234567888999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=319.22 Aligned_cols=233 Identities=20% Similarity=0.285 Sum_probs=184.0
Q ss_pred cCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcC-CCCccceEeEEEecCCCceEEEEEec
Q 004979 434 SFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKV-NHKNFVNLIGYCEEDEPFTRMMVFEY 511 (721)
Q Consensus 434 ~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~~~lV~Ey 511 (721)
.+|+|+||+||+|+.. ++..||+|++....... ....+.+..|..++... +||||+++++++...+ ..++||||
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~--~~~lv~e~ 77 (316)
T cd05592 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLE--DDDVECTMVERRVLALAWEHPFLTHLFCTFQTKE--HLFFVMEY 77 (316)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh--hhhHHHHHHHHHHHHhccCCCCccceeeEEEcCC--EEEEEEcC
Confidence 4789999999999964 57789999886432211 12234456677777654 8999999999998776 67999999
Q ss_pred CCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC-------
Q 004979 512 SPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT------- 584 (721)
Q Consensus 512 ~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~------- 584 (721)
+++|+|..++.. ...+++.....++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 78 ~~gg~L~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~ 153 (316)
T cd05592 78 LNGGDLMFHIQS--SGRFDEARARFYAAEIICGLQFLHKKG--IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKA 153 (316)
T ss_pred CCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCcc
Confidence 999999998863 346889999999999999999999988 999999999999999999999999987532
Q ss_pred --CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccHHHH
Q 004979 585 --TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQENVL 662 (721)
Q Consensus 585 --~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 662 (721)
..++..|+|||.+.+..++.++|||||||++|||++|+.||...+ ..+....+..... .++....
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~--~~~~~~~i~~~~~-----------~~~~~~~ 220 (316)
T cd05592 154 STFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGED--EDELFDSILNDRP-----------HFPRWIS 220 (316)
T ss_pred ccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCC--HHHHHHHHHcCCC-----------CCCCCCC
Confidence 124567999999998899999999999999999999999996433 2333333322211 1122345
Q ss_pred HHHHHHHHHcccCCCCCCCCHH-HHH
Q 004979 663 EELLVVIKNCVHPDPKQRPSMR-GIA 687 (721)
Q Consensus 663 ~~l~~li~~Cl~~dP~~RPs~~-evl 687 (721)
.++.+++.+||+.||++||++. +++
T Consensus 221 ~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 221 KEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred HHHHHHHHHHccCCHHHcCCChHHHH
Confidence 6788999999999999999875 443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=308.51 Aligned_cols=237 Identities=22% Similarity=0.349 Sum_probs=191.1
Q ss_pred cCCCCceeEEEEEEec---CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEEEe
Q 004979 434 SFSDGTVGTVYKGTLS---SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFE 510 (721)
Q Consensus 434 ~lg~G~~g~Vyk~~~~---~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV~E 510 (721)
++|+|+||.||+|.++ ++..+++|++..... .....+++.+|+.++++++|+||+++++++... ..++|||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~lv~e 75 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNN---DPALKDELLREANVMQQLDNPYIVRMIGICEAE---SWMLVME 75 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCC---cHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCC---CcEEEEe
Confidence 5789999999999753 567899998754321 233457899999999999999999999998643 3589999
Q ss_pred cCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCCCC---
Q 004979 511 YSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTAA--- 587 (721)
Q Consensus 511 y~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~~~--- 587 (721)
|+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++.....
T Consensus 76 ~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~ 151 (257)
T cd05116 76 LAELGPLNKFLQK--NKHVTEKNITELVHQVSMGMKYLEETN--FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENY 151 (257)
T ss_pred cCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchhhEEEcCCCeEEECCCccccccCCCCCe
Confidence 9999999999863 346899999999999999999999988 999999999999999999999999987643211
Q ss_pred ---------CccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccc
Q 004979 588 ---------KTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSF 657 (721)
Q Consensus 588 ---------~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 657 (721)
...|+|||.+....++.++|||||||++|||+| |+.||.... ..++...+..+.. ...
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~--~~~~~~~i~~~~~----------~~~ 219 (257)
T cd05116 152 YKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMK--GNEVTQMIESGER----------MEC 219 (257)
T ss_pred eeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHHHCCCC----------CCC
Confidence 136889999988889999999999999999998 999996432 2333333222211 112
Q ss_pred cHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 004979 658 QENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKE 692 (721)
Q Consensus 658 ~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 692 (721)
+..++.++.++|.+||+.||++||++.+|.+.|++
T Consensus 220 ~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 220 PQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred CCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 23455778999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=319.18 Aligned_cols=233 Identities=19% Similarity=0.260 Sum_probs=185.3
Q ss_pred cCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcC-CCCccceEeEEEecCCCceEEEEEec
Q 004979 434 SFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKV-NHKNFVNLIGYCEEDEPFTRMMVFEY 511 (721)
Q Consensus 434 ~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~~~lV~Ey 511 (721)
.+|+|+||+||+|+.. ++..||+|++....... ......+..|..++... +||||+++++++.+.+ ..++||||
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~--~~~lv~ey 77 (316)
T cd05619 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLM--DDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKE--NLFFVMEY 77 (316)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh--cchHHHHHHHHHHHHhccCCCcCcceEEEEEeCC--EEEEEEeC
Confidence 5789999999999965 57789999886532111 12234566778888764 9999999999998877 67999999
Q ss_pred CCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC-------
Q 004979 512 SPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT------- 584 (721)
Q Consensus 512 ~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~------- 584 (721)
+++|+|.+++.. ...+++.....++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 78 ~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~LH~~~--ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 153 (316)
T cd05619 78 LNGGDLMFHIQS--CHKFDLPRATFYAAEIICGLQFLHSKG--IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKT 153 (316)
T ss_pred CCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCce
Confidence 999999999863 346889999999999999999999988 999999999999999999999999987532
Q ss_pred --CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccHHHH
Q 004979 585 --TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQENVL 662 (721)
Q Consensus 585 --~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 662 (721)
..++..|+|||.+.+..++.++|||||||++|||+||+.||... +..+........... .+....
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~--~~~~~~~~i~~~~~~-----------~~~~~~ 220 (316)
T cd05619 154 CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGH--DEEELFQSIRMDNPC-----------YPRWLT 220 (316)
T ss_pred eeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCC--CHHHHHHHHHhCCCC-----------CCccCC
Confidence 12355799999999989999999999999999999999999643 233333332222111 112244
Q ss_pred HHHHHHHHHcccCCCCCCCCHH-HHH
Q 004979 663 EELLVVIKNCVHPDPKQRPSMR-GIA 687 (721)
Q Consensus 663 ~~l~~li~~Cl~~dP~~RPs~~-evl 687 (721)
.++.+++.+||+.||++||++. ++.
T Consensus 221 ~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 221 REAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred HHHHHHHHHHhccCHhhcCCChHHHH
Confidence 6788999999999999999997 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=309.95 Aligned_cols=250 Identities=20% Similarity=0.347 Sum_probs=201.7
Q ss_pred hhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
++.+.+|.|+||.||+|+. .++..++||.+...... ......++.+|+++++.++|+||+++++++...+ ..++|
T Consensus 5 ~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~--~~~~v 80 (267)
T cd08229 5 RIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLM--DAKARADCIKEIDLLKQLNHPNVIKYYASFIEDN--ELNIV 80 (267)
T ss_pred hhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhh--hHHHHHHHHHHHHHHHHccCCchhhhhheeEeCC--eEEEE
Confidence 5667888999999999995 57889999987643322 1234467899999999999999999999998776 67999
Q ss_pred EecCCCCChhhhhhhc--cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC-
Q 004979 509 FEYSPNGSLFEHLHIQ--EAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT- 585 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~--~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~- 585 (721)
|||+++++|.+++... ....+++.....++.|++.||+|||+.+ |+|+||||+||+++.++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 9999999999988632 2356899999999999999999999988 9999999999999999999999999865321
Q ss_pred --------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccc
Q 004979 586 --------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSF 657 (721)
Q Consensus 586 --------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 657 (721)
.+...|+|||......++.++||||||+++|||++|..||.....+..+.......... +.. .
T Consensus 159 ~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-------~~~--~ 229 (267)
T cd08229 159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDY-------PPL--P 229 (267)
T ss_pred CCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCC-------CCC--C
Confidence 23456899999988889999999999999999999999997554443333333221111 101 1
Q ss_pred cHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 004979 658 QENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEIT 694 (721)
Q Consensus 658 ~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~ 694 (721)
....+.++.+++.+||+.+|++||||.+|++.++++.
T Consensus 230 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 230 SDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred cccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 1245678999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=328.59 Aligned_cols=241 Identities=18% Similarity=0.276 Sum_probs=192.8
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
++++.||+|+||+||+|+.. +++.||||++...... .......+.+|++++..++||||+++++++.+.+ ..++|
T Consensus 4 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~--~~~lv 79 (364)
T cd05599 4 ESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEML--EKEQVAHVRAERDILAEADNPWVVKLYYSFQDEN--YLYLI 79 (364)
T ss_pred eEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhh--hhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCC--eEEEE
Confidence 56788999999999999964 6889999988643211 1233456889999999999999999999998877 77999
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC---
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT--- 585 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~--- 585 (721)
|||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 80 ~E~~~~g~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 155 (364)
T cd05599 80 MEYLPGGDMMTLLMK--KDTFTEEETRFYIAETILAIDSIHKLG--YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH 155 (364)
T ss_pred ECCCCCcHHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence 999999999999864 346899999999999999999999988 9999999999999999999999999875321
Q ss_pred --------------------------------------------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhC
Q 004979 586 --------------------------------------------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITG 621 (721)
Q Consensus 586 --------------------------------------------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG 621 (721)
.++..|+|||++....++.++|||||||++|||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G 235 (364)
T cd05599 156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235 (364)
T ss_pred cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcC
Confidence 245679999999999999999999999999999999
Q ss_pred CCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccHHHHHHHHHHHHHcccCCCCCCCC---HHHHHH
Q 004979 622 RISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPS---MRGIAA 688 (721)
Q Consensus 622 ~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs---~~evl~ 688 (721)
+.||.... ..+...........+. . +. ....++++.+++.+|+. +|.+|++ +.|+++
T Consensus 236 ~~Pf~~~~--~~~~~~~i~~~~~~~~-~--~~----~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 236 YPPFCSDN--PQETYRKIINWKETLQ-F--PD----EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred CCCCCCCC--HHHHHHHHHcCCCccC-C--CC----CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 99996432 3333333332211111 0 00 01235678889999996 8999997 888876
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=316.54 Aligned_cols=243 Identities=23% Similarity=0.379 Sum_probs=196.2
Q ss_pred hhhCcCCCCceeEEEEEEecC------CcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCc
Q 004979 430 NIIGSFSDGTVGTVYKGTLSS------GVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPF 503 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~~------~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 503 (721)
++++.+|+|+||.||+|+... +..+++|.+..... ....+.|.+|++++++++|+||+++++++....
T Consensus 8 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-- 81 (280)
T cd05049 8 VLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS----NDARKDFEREAELLTNFQHENIVKFYGVCTEGD-- 81 (280)
T ss_pred hHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC----HHHHHHHHHHHHHHHhcCCCCchheeeEEecCC--
Confidence 677889999999999998643 46789988754322 224568999999999999999999999998876
Q ss_pred eEEEEEecCCCCChhhhhhhcc------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCC
Q 004979 504 TRMMVFEYSPNGSLFEHLHIQE------------AEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDY 571 (721)
Q Consensus 504 ~~~lV~Ey~~~GsL~~~l~~~~------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~ 571 (721)
..++||||+++|+|.+++.... ...+++.....++.|++.|++|||+.+ |+||||||+||+++.++
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~h~dlkp~nili~~~~ 159 (280)
T cd05049 82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH--FVHRDLATRNCLVGYDL 159 (280)
T ss_pred CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eeccccccceEEEcCCC
Confidence 6799999999999999986432 245789999999999999999999988 99999999999999999
Q ss_pred cEEEeccCCCCCCCC-----------CCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHH
Q 004979 572 AAKISDFSFWNNTTA-----------AKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEY 639 (721)
Q Consensus 572 ~~kL~DFGla~~~~~-----------~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~ 639 (721)
.+||+|||+++.... ....|+|||.+....++.++|||||||++|||++ |+.||.... ..+.....
T Consensus 160 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~--~~~~~~~~ 237 (280)
T cd05049 160 VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLS--NEEVIECI 237 (280)
T ss_pred eEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCC--HHHHHHHH
Confidence 999999998763211 1235899999999999999999999999999999 999986332 23333332
Q ss_pred hhcCCCCccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 004979 640 LKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKE 692 (721)
Q Consensus 640 ~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 692 (721)
..+.. ...+...+.++.+++.+||+.||++||++.||++.|++
T Consensus 238 ~~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 238 TQGRL----------LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred HcCCc----------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 22211 11122345778999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=293.80 Aligned_cols=252 Identities=21% Similarity=0.318 Sum_probs=200.3
Q ss_pred hhhhhCcCCCCceeEEEEEE-ecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecC---CCc
Q 004979 428 FSNIIGSFSDGTVGTVYKGT-LSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEED---EPF 503 (721)
Q Consensus 428 ~~~ii~~lg~G~~g~Vyk~~-~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~---~~~ 503 (721)
.|.+...+|+|+|.-||.++ ..++..+|+|++.... ....+..++|++..++++||||+++++++..+ ...
T Consensus 22 Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~-----~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~ 96 (302)
T KOG2345|consen 22 RYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS-----QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKH 96 (302)
T ss_pred eEEEeeeecCCCceeeeeecccCcccchhhheeeccc-----hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCce
Confidence 35678899999999999998 6778899999987543 23356789999999999999999999887532 223
Q ss_pred eEEEEEecCCCCChhhhhhhc--cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCC
Q 004979 504 TRMMVFEYSPNGSLFEHLHIQ--EAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFW 581 (721)
Q Consensus 504 ~~~lV~Ey~~~GsL~~~l~~~--~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla 581 (721)
+.||+++|...|+|.+.+... +...+++.+.+.|+.||++||++||+..|+++||||||.|||+.+.+.+++.|||.+
T Consensus 97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSA 176 (302)
T ss_pred eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCc
Confidence 589999999999999998644 345799999999999999999999999999999999999999999999999999986
Q ss_pred CCCCC------------------CCccccchhhcc---cCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHh
Q 004979 582 NNTTA------------------AKTGSAAMELLE---TSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYL 640 (721)
Q Consensus 582 ~~~~~------------------~~~~~~apE~~~---~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~ 640 (721)
+.... .+..|.|||.+. +...++++|||||||+||+|+.|..||+..-.
T Consensus 177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~---------- 246 (302)
T KOG2345|consen 177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ---------- 246 (302)
T ss_pred cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh----------
Confidence 53321 234688999874 55678999999999999999999999962110
Q ss_pred hcCCCCccccCCccc-cccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 004979 641 KGEQPLKDIVDPTLK-SFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEIT 694 (721)
Q Consensus 641 ~~~~~~~~~~d~~l~-~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~ 694 (721)
.|.--.-.+..+.+. .....+++.+.++++.|++.||.+||+..|++..++++.
T Consensus 247 ~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 247 QGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred cCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 111100111111111 111236788999999999999999999999999988754
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=309.00 Aligned_cols=243 Identities=21% Similarity=0.362 Sum_probs=195.5
Q ss_pred hhhCcCCCCceeEEEEEEecC----CcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceE
Q 004979 430 NIIGSFSDGTVGTVYKGTLSS----GVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTR 505 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~~----~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~ 505 (721)
++...+|+|+||+||+|++.. ...+++|.+.... .......|.+|+.++++++||||+++++++...+ ..
T Consensus 7 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~ 80 (266)
T cd05033 7 TIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS----SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSR--PV 80 (266)
T ss_pred eeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC----ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCC--ce
Confidence 566788999999999998742 3578888775332 2334567999999999999999999999998776 56
Q ss_pred EEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC
Q 004979 506 MMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT 585 (721)
Q Consensus 506 ~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~ 585 (721)
++||||+++|+|.+++... ...+++..+..++.|++.|++|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 81 ~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 81 MIITEYMENGSLDKFLREN-DGKFTVGQLVGMLRGIASGMKYLSEMN--YVHRDLAARNILVNSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred EEEEEcCCCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEcCCCCEEECccchhhccc
Confidence 9999999999999998643 347899999999999999999999988 9999999999999999999999999876442
Q ss_pred -----------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhcCCCCccccCCc
Q 004979 586 -----------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPLKDIVDPT 653 (721)
Q Consensus 586 -----------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 653 (721)
.....|++||.+....++.++||||||+++|||++ |..||... ...+.......+ ...
T Consensus 158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~--~~~~~~~~~~~~-~~~------- 227 (266)
T cd05033 158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDM--SNQDVIKAVEDG-YRL------- 227 (266)
T ss_pred ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCC--CHHHHHHHHHcC-CCC-------
Confidence 11235899999988899999999999999999998 99998532 222222222211 111
Q ss_pred cccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 004979 654 LKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEI 693 (721)
Q Consensus 654 l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i 693 (721)
..+..++..+.+++.+||+.+|++||++.||++.|+++
T Consensus 228 --~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 228 --PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred --CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 01123456788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=317.45 Aligned_cols=248 Identities=21% Similarity=0.345 Sum_probs=197.3
Q ss_pred hhhCcCCCCceeEEEEEEec------CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCc
Q 004979 430 NIIGSFSDGTVGTVYKGTLS------SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPF 503 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~------~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 503 (721)
.+.+.+|+|+||.||+|+.. ++..+++|...... ....+.+.+|++++++++|+||+++++++...+
T Consensus 8 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 80 (291)
T cd05094 8 VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT-----LAARKDFQREAELLTNLQHEHIVKFYGVCGDGD-- 80 (291)
T ss_pred EEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc-----HHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC--
Confidence 45678899999999999742 34457777664322 223467899999999999999999999998776
Q ss_pred eEEEEEecCCCCChhhhhhhcc--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCC
Q 004979 504 TRMMVFEYSPNGSLFEHLHIQE--------------AEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTE 569 (721)
Q Consensus 504 ~~~lV~Ey~~~GsL~~~l~~~~--------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~ 569 (721)
..++||||+++|+|.+++.... ...++|..++.++.|++.|++|||+.+ |+||||||+|||+++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~Nil~~~ 158 (291)
T cd05094 81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH--FVHRDLATRNCLVGA 158 (291)
T ss_pred ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceEEEcc
Confidence 5799999999999999986432 234899999999999999999999988 999999999999999
Q ss_pred CCcEEEeccCCCCCCCC-----------CCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHH
Q 004979 570 DYAAKISDFSFWNNTTA-----------AKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWAS 637 (721)
Q Consensus 570 ~~~~kL~DFGla~~~~~-----------~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~ 637 (721)
++.+||+|||+++.... +...|+|||.+....++.++|||||||++|||+| |+.||.... ..+...
T Consensus 159 ~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~--~~~~~~ 236 (291)
T cd05094 159 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLS--NTEVIE 236 (291)
T ss_pred CCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC--HHHHHH
Confidence 99999999999754321 1335899999998999999999999999999999 999985332 222222
Q ss_pred HHhhcCCCCccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCC
Q 004979 638 EYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAMEP 698 (721)
Q Consensus 638 ~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 698 (721)
....+.. . .....++.++.+++.+||+.+|++||++.+|++.|+++.+..+
T Consensus 237 ~~~~~~~--~--------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~~~ 287 (291)
T cd05094 237 CITQGRV--L--------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKATP 287 (291)
T ss_pred HHhCCCC--C--------CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhhcC
Confidence 2222111 1 1112345678999999999999999999999999999977543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=308.57 Aligned_cols=238 Identities=22% Similarity=0.385 Sum_probs=192.7
Q ss_pred hhhCcCCCCceeEEEEEEecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVF 509 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV~ 509 (721)
.+.+.+|+|+||.||+|.++++..+++|.+..... ....|.+|++++++++|+||+++++++...+ ..++||
T Consensus 7 ~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~lv~ 78 (256)
T cd05059 7 TFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM------SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQR--PIFIVT 78 (256)
T ss_pred chhhhhccCCCceEEEeEecCCccEEEEEeccCCC------CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC--ceEEEE
Confidence 45678889999999999988777899998753321 1246889999999999999999999998776 579999
Q ss_pred ecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCCC---
Q 004979 510 EYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTA--- 586 (721)
Q Consensus 510 Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~~--- 586 (721)
||+++++|.+++... ...+++..+..++.|++.|++|||+.+ |+||||||+||++++++.+||+|||+++....
T Consensus 79 e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~ 155 (256)
T cd05059 79 EYMANGCLLNYLRER-KGKLGTEWLLDMCSDVCEAMEYLESNG--FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY 155 (256)
T ss_pred ecCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC--cccccccHhhEEECCCCcEEECCcccceecccccc
Confidence 999999999998643 236899999999999999999999988 99999999999999999999999998764321
Q ss_pred -------CCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhcCCCCccccCCcccccc
Q 004979 587 -------AKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQ 658 (721)
Q Consensus 587 -------~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 658 (721)
....|++||.+....++.++|||||||++|||+| |+.||.... ..+.......+... ..+
T Consensus 156 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~--~~~~~~~~~~~~~~----------~~~ 223 (256)
T cd05059 156 TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFS--NSEVVESVSAGYRL----------YRP 223 (256)
T ss_pred cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCC--HHHHHHHHHcCCcC----------CCC
Confidence 1125899999988899999999999999999999 899986332 22222222211110 111
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 004979 659 ENVLEELLVVIKNCVHPDPKQRPSMRGIAAKL 690 (721)
Q Consensus 659 ~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L 690 (721)
..++.++.+++.+||..+|++||++.|+++.|
T Consensus 224 ~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 224 KLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 23456899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=322.14 Aligned_cols=231 Identities=19% Similarity=0.286 Sum_probs=187.4
Q ss_pred CcCCCCceeEEEEEEe----cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 433 GSFSDGTVGTVYKGTL----SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 433 ~~lg~G~~g~Vyk~~~----~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
+.+|+|+||.||+++. .++..+|+|++...... ......+.+|++++++++||||+++++++...+ ..|+|
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~lv 76 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK---VRDRVRTKMERDILAEVNHPFIVKLHYAFQTEG--KLYLI 76 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhh---hhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCC--EEEEE
Confidence 4678999999999874 35788999988643211 223356788999999999999999999998876 67999
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC---
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT--- 585 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~--- 585 (721)
|||+++|+|.+++.. ...+++.....++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++...
T Consensus 77 ~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 152 (318)
T cd05582 77 LDFLRGGDLFTRLSK--EVMFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE 152 (318)
T ss_pred EcCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC
Confidence 999999999999853 356899999999999999999999988 9999999999999999999999999876432
Q ss_pred ------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccH
Q 004979 586 ------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQE 659 (721)
Q Consensus 586 ------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 659 (721)
.++..|+|||.+....++.++|||||||++|||+||+.||... +..+........... .+.
T Consensus 153 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~--~~~~~~~~i~~~~~~-----------~p~ 219 (318)
T cd05582 153 KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGK--DRKETMTMILKAKLG-----------MPQ 219 (318)
T ss_pred CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCC--CHHHHHHHHHcCCCC-----------CCC
Confidence 2345789999998888999999999999999999999999643 223333333322111 223
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHH
Q 004979 660 NVLEELLVVIKNCVHPDPKQRPSMRG 685 (721)
Q Consensus 660 ~~~~~l~~li~~Cl~~dP~~RPs~~e 685 (721)
..+.++.+++.+||+.||++||++.+
T Consensus 220 ~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 220 FLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 34567889999999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=316.27 Aligned_cols=247 Identities=21% Similarity=0.351 Sum_probs=197.7
Q ss_pred hhhCcCCCCceeEEEEEEec------CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCc
Q 004979 430 NIIGSFSDGTVGTVYKGTLS------SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPF 503 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~------~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 503 (721)
.+.+.+|+|+||.||++... ++..+++|.+.... ....+.+.+|++++++++|+||+++++++...+
T Consensus 8 ~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 80 (288)
T cd05093 8 VLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-----DNARKDFHREAELLTNLQHEHIVKFYGVCVEGD-- 80 (288)
T ss_pred eeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC-----HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC--
Confidence 56678899999999999742 24557777765322 234567999999999999999999999998776
Q ss_pred eEEEEEecCCCCChhhhhhhcc-----------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCc
Q 004979 504 TRMMVFEYSPNGSLFEHLHIQE-----------AEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYA 572 (721)
Q Consensus 504 ~~~lV~Ey~~~GsL~~~l~~~~-----------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~ 572 (721)
..++||||+++|+|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~--i~H~dlkp~Nili~~~~~ 158 (288)
T cd05093 81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLVGENLL 158 (288)
T ss_pred ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceEEEccCCc
Confidence 5799999999999999986432 235899999999999999999999988 999999999999999999
Q ss_pred EEEeccCCCCCCCC-----------CCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHh
Q 004979 573 AKISDFSFWNNTTA-----------AKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYL 640 (721)
Q Consensus 573 ~kL~DFGla~~~~~-----------~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~ 640 (721)
+||+|||+++.... +...|+|||.+....++.++|||||||++|||+| |+.||.... ..+......
T Consensus 159 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~--~~~~~~~i~ 236 (288)
T cd05093 159 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS--NNEVIECIT 236 (288)
T ss_pred EEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHHH
Confidence 99999999864321 1236899999998899999999999999999999 899985332 233333333
Q ss_pred hcCCCCccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcC
Q 004979 641 KGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAME 697 (721)
Q Consensus 641 ~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 697 (721)
.+... ..+...+.++.+++.+||+.+|.+||++.|+.+.|+++....
T Consensus 237 ~~~~~----------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~~ 283 (288)
T cd05093 237 QGRVL----------QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKAS 283 (288)
T ss_pred cCCcC----------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHhc
Confidence 22111 111234467899999999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=329.02 Aligned_cols=241 Identities=18% Similarity=0.256 Sum_probs=190.6
Q ss_pred hhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
++++.+|+|+||+||+++. .+++.+|+|++...... .....+.+.+|++++.+++|||||++++++.+.+ ..|+|
T Consensus 4 ~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~--~~~lv 79 (377)
T cd05629 4 HTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMF--KKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQ--YLYLI 79 (377)
T ss_pred eEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHH--HhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCC--eeEEE
Confidence 5678899999999999985 46889999988643211 1234467889999999999999999999998877 67999
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC----
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT---- 584 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~---- 584 (721)
|||+++|+|.+++.. ...+++.....++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 80 ~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~ql~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~ 155 (377)
T cd05629 80 MEFLPGGDLMTMLIK--YDTFSEDVTRFYMAECVLAIEAVHKLG--FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH 155 (377)
T ss_pred EeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 999999999999863 356888889999999999999999998 999999999999999999999999987421
Q ss_pred ----------------------------------------------------CCCCccccchhhcccCCCCCCccHHHHH
Q 004979 585 ----------------------------------------------------TAAKTGSAAMELLETSAVDLESNVYSFG 612 (721)
Q Consensus 585 ----------------------------------------------------~~~~~~~~apE~~~~~~~s~ksDVwSfG 612 (721)
..++..|+|||.+....++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 235 (377)
T cd05629 156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLG 235 (377)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecc
Confidence 1245679999999999999999999999
Q ss_pred HHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccHHHHHHHHHHHHHcccCCCCCC---CCHHHHHH
Q 004979 613 TILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQR---PSMRGIAA 688 (721)
Q Consensus 613 vvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~R---Ps~~evl~ 688 (721)
|++|||+||+.||.... ..+....+......+. . +. ....+.++.+++.+|+. +|.+| +++.|++.
T Consensus 236 vil~elltG~~Pf~~~~--~~~~~~~i~~~~~~~~-~--p~----~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~ 304 (377)
T cd05629 236 AIMFECLIGWPPFCSEN--SHETYRKIINWRETLY-F--PD----DIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKS 304 (377)
T ss_pred hhhhhhhcCCCCCCCCC--HHHHHHHHHccCCccC-C--CC----CCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhc
Confidence 99999999999996433 2222233222111110 0 10 01235678899999997 66665 59999876
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=318.08 Aligned_cols=233 Identities=18% Similarity=0.251 Sum_probs=185.6
Q ss_pred cCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcC-CCCccceEeEEEecCCCceEEEEEec
Q 004979 434 SFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKV-NHKNFVNLIGYCEEDEPFTRMMVFEY 511 (721)
Q Consensus 434 ~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~~~lV~Ey 511 (721)
.+|+|+||.||+|+.. ++..+|+|++....... ......+..|..++... +||||+++++++.+.+ ..++||||
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~--~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~--~~~lv~E~ 77 (316)
T cd05620 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLI--DDDVECTMVEKRVLALAWENPFLTHLYCTFQTKE--HLFFVMEF 77 (316)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh--cchHHHHHHHHHHHHhccCCCCccCeeEEEEeCC--EEEEEECC
Confidence 5789999999999965 67889999886532111 12234567788888754 8999999999998877 78999999
Q ss_pred CCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC-------
Q 004979 512 SPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT------- 584 (721)
Q Consensus 512 ~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~------- 584 (721)
+++|+|..++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 78 ~~~g~L~~~i~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 153 (316)
T cd05620 78 LNGGDLMFHIQD--KGRFDLYRATFYAAEIVCGLQFLHSKG--IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRA 153 (316)
T ss_pred CCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCCCCEEeCccCCCeecccCCCce
Confidence 999999998863 346889999999999999999999988 999999999999999999999999987632
Q ss_pred --CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccHHHH
Q 004979 585 --TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQENVL 662 (721)
Q Consensus 585 --~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 662 (721)
..++..|+|||.+.+..++.++|||||||++|||++|+.||...+ ..+........... .+....
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~--~~~~~~~~~~~~~~-----------~~~~~~ 220 (316)
T cd05620 154 STFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDD--EDELFESIRVDTPH-----------YPRWIT 220 (316)
T ss_pred eccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC--HHHHHHHHHhCCCC-----------CCCCCC
Confidence 124567999999999999999999999999999999999996432 23333332222111 112245
Q ss_pred HHHHHHHHHcccCCCCCCCCHH-HHH
Q 004979 663 EELLVVIKNCVHPDPKQRPSMR-GIA 687 (721)
Q Consensus 663 ~~l~~li~~Cl~~dP~~RPs~~-evl 687 (721)
.++.+++.+||+.||++||++. ++.
T Consensus 221 ~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 221 KESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred HHHHHHHHHHccCCHHHcCCChHHHH
Confidence 6788999999999999999984 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=321.66 Aligned_cols=241 Identities=19% Similarity=0.303 Sum_probs=190.0
Q ss_pred hhhCcCCCCceeEEEEEEe----cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcC-CCCccceEeEEEecCCCce
Q 004979 430 NIIGSFSDGTVGTVYKGTL----SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKV-NHKNFVNLIGYCEEDEPFT 504 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~----~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~ 504 (721)
++++.+|+|+||+||+++. .++..+|+|++....... .....+.+.+|++++.++ +|+||+++++++...+ .
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~--~ 79 (332)
T cd05614 3 ELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQ-KAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEA--K 79 (332)
T ss_pred eEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhh-hhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCC--E
Confidence 5678899999999999875 357889999886432111 122345688999999999 5999999999988776 6
Q ss_pred EEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC
Q 004979 505 RMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT 584 (721)
Q Consensus 505 ~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~ 584 (721)
.++||||+++|+|.+++.. ...+++.....++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 80 ~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nili~~~~~~kl~DfG~~~~~ 155 (332)
T cd05614 80 LHLILDYVSGGEMFTHLYQ--RDNFSEDEVRFYSGEIILALEHLHKLG--IVYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (332)
T ss_pred EEEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence 7999999999999999863 356899999999999999999999988 999999999999999999999999987632
Q ss_pred ----------CCCCccccchhhcccC-CCCCCccHHHHHHHHHHHHhCCCcccCCCC--CHHHHHHHHhhcCCCCccccC
Q 004979 585 ----------TAAKTGSAAMELLETS-AVDLESNVYSFGTILFEMITGRISYSIENG--SLENWASEYLKGEQPLKDIVD 651 (721)
Q Consensus 585 ----------~~~~~~~~apE~~~~~-~~s~ksDVwSfGvvL~ElltG~~P~~~~~~--~~~~~~~~~~~~~~~~~~~~d 651 (721)
..++..|+|||.+.+. .++.++|||||||++|||+||+.||..... ..............+
T Consensus 156 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~------ 229 (332)
T cd05614 156 LSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPP------ 229 (332)
T ss_pred cccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCC------
Confidence 1245678999998765 478999999999999999999999964322 222222222222111
Q ss_pred CccccccHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 004979 652 PTLKSFQENVLEELLVVIKNCVHPDPKQRP-----SMRGIAA 688 (721)
Q Consensus 652 ~~l~~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~evl~ 688 (721)
.+.....++.+++.+||+.||++|| +++++++
T Consensus 230 -----~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 230 -----FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred -----CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 1223456788999999999999999 6777764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=318.08 Aligned_cols=234 Identities=18% Similarity=0.268 Sum_probs=188.8
Q ss_pred cCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcC-CCCccceEeEEEecCCCceEEEEEec
Q 004979 434 SFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKV-NHKNFVNLIGYCEEDEPFTRMMVFEY 511 (721)
Q Consensus 434 ~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~~~lV~Ey 511 (721)
.+|+|+||+||+|+.. ++..+|+|++....... ......+..|++++..+ +||||+++++++...+ ..++||||
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~--~~~lv~e~ 77 (318)
T cd05570 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQ--DDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKD--RLFFVMEY 77 (318)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhh--hhHHHHHHHHHHHHHhccCCCCccceeeEEEcCC--EEEEEEcC
Confidence 5789999999999865 57789999886432111 22345677888999888 7999999999998876 67999999
Q ss_pred CCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC-------
Q 004979 512 SPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT------- 584 (721)
Q Consensus 512 ~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~------- 584 (721)
+++|+|..++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 78 ~~~~~L~~~~~~--~~~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 153 (318)
T cd05570 78 VNGGDLMFHIQR--SGRFDEPRARFYAAEIVLGLQFLHERG--IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTT 153 (318)
T ss_pred CCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCC--eEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcc
Confidence 999999988853 346899999999999999999999988 999999999999999999999999987532
Q ss_pred --CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccHHHH
Q 004979 585 --TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQENVL 662 (721)
Q Consensus 585 --~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 662 (721)
..++..|+|||.+.+..++.++|||||||++|||+||+.||... +.............. ++...+
T Consensus 154 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~--~~~~~~~~i~~~~~~-----------~~~~~~ 220 (318)
T cd05570 154 STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGD--DEDELFQSILEDEVR-----------YPRWLS 220 (318)
T ss_pred cceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCC--CHHHHHHHHHcCCCC-----------CCCcCC
Confidence 12455789999999999999999999999999999999999633 233333333322111 122345
Q ss_pred HHHHHHHHHcccCCCCCCCCH-----HHHHH
Q 004979 663 EELLVVIKNCVHPDPKQRPSM-----RGIAA 688 (721)
Q Consensus 663 ~~l~~li~~Cl~~dP~~RPs~-----~evl~ 688 (721)
.++.+++.+||+.||++||++ .++++
T Consensus 221 ~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 221 KEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred HHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 678999999999999999999 77764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=306.77 Aligned_cols=249 Identities=20% Similarity=0.342 Sum_probs=203.2
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
++.+.+|+|+||.||+|... ++..+++|.+......+ ....+.+.+|++++++++|+||+++++++...+ ..++|
T Consensus 5 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~--~~~lv 80 (267)
T cd08224 5 KIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMD--AKARQDCLKEIDLLKQLDHPNVIKYLASFIENN--ELNIV 80 (267)
T ss_pred eeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccc--hhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCC--eEEEE
Confidence 55678899999999999976 78899999876433222 233567999999999999999999999998876 67999
Q ss_pred EecCCCCChhhhhhhc--cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC-
Q 004979 509 FEYSPNGSLFEHLHIQ--EAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT- 585 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~--~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~- 585 (721)
|||+++|+|.+++... ....+++.++..++.+++.||+|||+.+ |+||||||+||++++++.++|+|||+++...
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR--IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 9999999999988642 2355899999999999999999999988 9999999999999999999999999865322
Q ss_pred --------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccc
Q 004979 586 --------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSF 657 (721)
Q Consensus 586 --------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 657 (721)
.+...|.|||.+.+..++.++|||||||++|||++|+.||.....+..+.......+.. ...
T Consensus 159 ~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----------~~~ 228 (267)
T cd08224 159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDY----------PPL 228 (267)
T ss_pred CCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCC----------CCC
Confidence 23346889999988889999999999999999999999997555554444333322211 111
Q ss_pred c-HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 004979 658 Q-ENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEIT 694 (721)
Q Consensus 658 ~-~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~ 694 (721)
+ .....++.+++.+||..+|++||++.+|++.|+++.
T Consensus 229 ~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 229 PADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred ChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 1 245567899999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=315.94 Aligned_cols=250 Identities=17% Similarity=0.225 Sum_probs=190.3
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
++++.+|+|+||+||+|+.. ++..+++|++...... ....+.+.+|++++++++||||+++++++...+ ..++|
T Consensus 4 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~lv 78 (287)
T cd07848 4 EVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEEN---EEVKETTLRELKMLRTLKQENIVELKEAFRRRG--KLYLV 78 (287)
T ss_pred eEEEEecccCCEEEEEEEECCCCcEEEEEEEeccccc---ccchhhHHHHHHHHHhCCCccccchhhhEecCC--EEEEE
Confidence 56788999999999999975 5778999988643221 223467889999999999999999999998776 67999
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC---
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT--- 585 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~--- 585 (721)
|||++++.+..+.. ....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 79 ~e~~~~~~l~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 154 (287)
T cd07848 79 FEYVEKNMLELLEE--MPNGVPPEKVRSYIYQLIKAIHWCHKND--IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS 154 (287)
T ss_pred EecCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence 99999887765432 2356899999999999999999999988 9999999999999999999999999976432
Q ss_pred -------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHH-HHHHHhh-----------cCCCC
Q 004979 586 -------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLEN-WASEYLK-----------GEQPL 646 (721)
Q Consensus 586 -------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~-~~~~~~~-----------~~~~~ 646 (721)
.++..|+|||.+.+..++.++|||||||++|||++|+.||......... .+..... .....
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07848 155 NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRF 234 (287)
T ss_pred cccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchh
Confidence 2345689999998888999999999999999999999999743311100 0000000 00000
Q ss_pred ccccCCcc-------ccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 647 KDIVDPTL-------KSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 647 ~~~~d~~l-------~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
.....+.. .......+.++.+++.+||+.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 235 HGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred cccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000000 0011224567999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=305.97 Aligned_cols=237 Identities=25% Similarity=0.407 Sum_probs=190.1
Q ss_pred cCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEEEecC
Q 004979 434 SFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYS 512 (721)
Q Consensus 434 ~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV~Ey~ 512 (721)
.+|+|+||.||+|+.. +++.+++|...... .......|.+|++++++++||||+++++++...+ ..++||||+
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~ 75 (252)
T cd05084 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETL----PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQ--PIYIVMELV 75 (252)
T ss_pred ccCcccCccEEEEEEecCCceEEEEecCccC----CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCC--CeEEEEeec
Confidence 5789999999999964 67889998765321 2334567999999999999999999999998776 579999999
Q ss_pred CCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCCCC-----
Q 004979 513 PNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTAA----- 587 (721)
Q Consensus 513 ~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~~~----- 587 (721)
++++|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 76 ~~~~L~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 152 (252)
T cd05084 76 QGGDFLTFLRT-EGPRLKVKELIQMVENAAAGMEYLESKH--CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAST 152 (252)
T ss_pred cCCcHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEEcCCCcEEECccccCccccccccccc
Confidence 99999999863 2346899999999999999999999988 999999999999999999999999987643211
Q ss_pred ------CccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccHH
Q 004979 588 ------KTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQEN 660 (721)
Q Consensus 588 ------~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 660 (721)
...|+|||.+....++.++|||||||++|||++ |..||.... ........... ... ..+..
T Consensus 153 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~--~~~~~~~~~~~-~~~---------~~~~~ 220 (252)
T cd05084 153 GGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLS--NQQTREAIEQG-VRL---------PCPEL 220 (252)
T ss_pred CCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccC--HHHHHHHHHcC-CCC---------CCccc
Confidence 124899999988889999999999999999998 888885322 11111111111 110 11233
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 004979 661 VLEELLVVIKNCVHPDPKQRPSMRGIAAKLK 691 (721)
Q Consensus 661 ~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 691 (721)
.+.++.+++.+||+.+|++||++.|+.++|+
T Consensus 221 ~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 221 CPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 4567899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=311.96 Aligned_cols=243 Identities=20% Similarity=0.372 Sum_probs=195.3
Q ss_pred hhhCcCCCCceeEEEEEEecC------CcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCc
Q 004979 430 NIIGSFSDGTVGTVYKGTLSS------GVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPF 503 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~~------~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 503 (721)
++++.+|+|+||.||+|+... +..|++|++..... ....+.|.+|+.++++++||||+++++++...+
T Consensus 8 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~-- 81 (283)
T cd05091 8 RFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAE----GPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQ-- 81 (283)
T ss_pred HHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCC----HHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCC--
Confidence 567888999999999998532 46789988764321 233467899999999999999999999998876
Q ss_pred eEEEEEecCCCCChhhhhhhc--------------cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCC
Q 004979 504 TRMMVFEYSPNGSLFEHLHIQ--------------EAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTE 569 (721)
Q Consensus 504 ~~~lV~Ey~~~GsL~~~l~~~--------------~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~ 569 (721)
..++++||+++++|.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+|||+++
T Consensus 82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g--i~H~dlkp~Nil~~~ 159 (283)
T cd05091 82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH--VVHKDLATRNVLVFD 159 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC--ccccccchhheEecC
Confidence 569999999999999998522 1235888899999999999999999988 999999999999999
Q ss_pred CCcEEEeccCCCCCCCC-----------CCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHH
Q 004979 570 DYAAKISDFSFWNNTTA-----------AKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWAS 637 (721)
Q Consensus 570 ~~~~kL~DFGla~~~~~-----------~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~ 637 (721)
++.+||+|||+++.... ....|+|||.+....++.++|||||||++|||+| |..||... ...++..
T Consensus 160 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~--~~~~~~~ 237 (283)
T cd05091 160 KLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY--SNQDVIE 237 (283)
T ss_pred CCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCC--CHHHHHH
Confidence 99999999998764321 1236899999988889999999999999999998 88888532 3334444
Q ss_pred HHhhcCCCCccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 004979 638 EYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKE 692 (721)
Q Consensus 638 ~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 692 (721)
.+..... ...+..++..+.+++.+||+.+|++||++.||+..|+.
T Consensus 238 ~i~~~~~----------~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 238 MIRNRQV----------LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHcCCc----------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 3332211 11223456778999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=307.70 Aligned_cols=241 Identities=23% Similarity=0.382 Sum_probs=196.3
Q ss_pred hhhhCcCCCCceeEEEEEEecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 429 SNIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
+++++.+|+|+||.||+|...++..+++|.+..... ..+.|.+|++++++++|+||+++++++... ..++|
T Consensus 8 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~------~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~---~~~lv 78 (260)
T cd05070 8 LQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM------SPESFLEEAQIMKKLRHDKLVQLYAVVSEE---PIYIV 78 (260)
T ss_pred hhhhheeccccCceEEEEEecCCceeEEEEecCCCC------CHHHHHHHHHHHHhcCCCceEEEEeEECCC---CcEEE
Confidence 367889999999999999988888899998764322 124689999999999999999999988543 46899
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCCC--
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTA-- 586 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~~-- 586 (721)
|||+++|+|.++++......+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++.....
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05070 79 TEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN--YIHRDLRSANILVGDGLVCKIADFGLARLIEDNE 156 (260)
T ss_pred EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence 99999999999997555566899999999999999999999988 99999999999999999999999998753221
Q ss_pred --------CCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccc
Q 004979 587 --------AKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSF 657 (721)
Q Consensus 587 --------~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 657 (721)
+...|+|||......++.++||||||+++|||++ |+.||.... ..+......... .. ..
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~--~~~~~~~~~~~~-~~---------~~ 224 (260)
T cd05070 157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN--NREVLEQVERGY-RM---------PC 224 (260)
T ss_pred cccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCC--HHHHHHHHHcCC-CC---------CC
Confidence 1235899999988899999999999999999999 888986432 223333222211 10 11
Q ss_pred cHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 004979 658 QENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKE 692 (721)
Q Consensus 658 ~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 692 (721)
+...+.++.+++.+||..+|++|||++++.+.|++
T Consensus 225 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 225 PQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 23445679999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=333.13 Aligned_cols=244 Identities=20% Similarity=0.328 Sum_probs=197.3
Q ss_pred hhCcCCCCceeEEEEEEe-cCCc----EEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceE
Q 004979 431 IIGSFSDGTVGTVYKGTL-SSGV----EIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTR 505 (721)
Q Consensus 431 ii~~lg~G~~g~Vyk~~~-~~~~----~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~ 505 (721)
..+.+|.|+||+||||.| ..|. .||+|++.... ......+|++|+-+|.+++|||+++++|+|..+. .
T Consensus 700 k~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t----~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~---~ 772 (1177)
T KOG1025|consen 700 KDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT----SPKASIELLDEALRMASLDHPNLLRLLGVCMLST---L 772 (1177)
T ss_pred hhceeccccceeEEeeeEecCCceecceeEEEEeeccC----CchhhHHHHHHHHHHhcCCCchHHHHhhhcccch---H
Confidence 456889999999999985 4444 46666654332 2334578999999999999999999999998765 5
Q ss_pred EEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC
Q 004979 506 MMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT 585 (721)
Q Consensus 506 ~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~ 585 (721)
.||++||+.|+|.++++. .+..+.-...+.|..|||+||.|||++. +|||||..+|||+.+-..+||.|||+++...
T Consensus 773 qlvtq~mP~G~LlDyvr~-hr~~igsq~lLnw~~QIAkgM~YLe~qr--lVHrdLaaRNVLVksP~hvkitdfgla~ll~ 849 (1177)
T KOG1025|consen 773 QLVTQLMPLGCLLDYVRE-HRDNIGSQDLLNWCYQIAKGMKYLEEQR--LVHRDLAARNVLVKSPNHVKITDFGLAKLLA 849 (1177)
T ss_pred HHHHHhcccchHHHHHHH-hhccccHHHHHHHHHHHHHHHHHHHhcc--hhhhhhhhhheeecCCCeEEEEecchhhccC
Confidence 799999999999999975 4567888889999999999999999887 9999999999999999999999999987654
Q ss_pred CCC-----------ccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhcCCCCccccCCc
Q 004979 586 AAK-----------TGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPLKDIVDPT 653 (721)
Q Consensus 586 ~~~-----------~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 653 (721)
... ..|+|-|.+....|+.++|||||||++||++| |..||++- ...+. ...+....+
T Consensus 850 ~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi--~~~eI-~dlle~geR-------- 918 (1177)
T KOG1025|consen 850 PDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGI--PAEEI-PDLLEKGER-------- 918 (1177)
T ss_pred cccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCC--CHHHh-hHHHhcccc--------
Confidence 332 24567788999999999999999999999999 99999632 22222 222222111
Q ss_pred cccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 004979 654 LKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAM 696 (721)
Q Consensus 654 l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~ 696 (721)
...++.+.-+++.+|.+||..|+..||+|+++...+.++...
T Consensus 919 -LsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard 960 (1177)
T KOG1025|consen 919 -LSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD 960 (1177)
T ss_pred -CCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence 123566788999999999999999999999999988876543
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=312.12 Aligned_cols=247 Identities=23% Similarity=0.396 Sum_probs=195.8
Q ss_pred hhhCcCCCCceeEEEEEEecC----CcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCC---
Q 004979 430 NIIGSFSDGTVGTVYKGTLSS----GVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEP--- 502 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~~----~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~--- 502 (721)
++.+.+|+|+||.||+|+... +..+|+|++..... .......+.+|++.+++++|+||+++++++...+.
T Consensus 2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 78 (273)
T cd05035 2 KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIH---TYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQK 78 (273)
T ss_pred ccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcC---CHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCcccc
Confidence 345678999999999998642 36799998764322 12334679999999999999999999998876442
Q ss_pred -ceEEEEEecCCCCChhhhhhhc----cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEec
Q 004979 503 -FTRMMVFEYSPNGSLFEHLHIQ----EAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISD 577 (721)
Q Consensus 503 -~~~~lV~Ey~~~GsL~~~l~~~----~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~D 577 (721)
...++|+||+++|+|..++... ....+++.....++.|++.||+|||+.+ |+||||||+||++++++.+||+|
T Consensus 79 ~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~d 156 (273)
T cd05035 79 IPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN--FIHRDLAARNCMLREDMTVCVAD 156 (273)
T ss_pred CcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--eeccccchheEEECCCCeEEECC
Confidence 2368999999999999988543 2246899999999999999999999988 99999999999999999999999
Q ss_pred cCCCCCCCC-----------CCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhcCCC
Q 004979 578 FSFWNNTTA-----------AKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQP 645 (721)
Q Consensus 578 FGla~~~~~-----------~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~ 645 (721)
||+++.... ....|++||.+....++.++|||||||++|||++ |..||.... ..+.......+..
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~--~~~~~~~~~~~~~- 233 (273)
T cd05035 157 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVE--NHEIYDYLRHGNR- 233 (273)
T ss_pred ccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHHHcCCC-
Confidence 999864321 1235889999988899999999999999999999 888885332 2333333322211
Q ss_pred CccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 004979 646 LKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEI 693 (721)
Q Consensus 646 ~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i 693 (721)
...+..++.++.+++.+||+.||++||++.|+++.|+++
T Consensus 234 ---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 234 ---------LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred ---------CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 112234567899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=316.29 Aligned_cols=248 Identities=17% Similarity=0.228 Sum_probs=188.9
Q ss_pred hhhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEE
Q 004979 429 SNIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMM 507 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~l 507 (721)
+++++.+|.|+||+||+|+.. ++..||+|++...... .....+.+|++++++++||||+++++++...+ ..++
T Consensus 7 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~l 80 (288)
T cd07871 7 YVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE----GAPCTAIREVSLLKNLKHANIVTLHDIIHTER--CLTL 80 (288)
T ss_pred ceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC----CcchhHHHHHHHHHhCCCCCEeeEEEEEcCCC--eEEE
Confidence 366788999999999999865 6788999988643221 12346789999999999999999999998766 6799
Q ss_pred EEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC--
Q 004979 508 VFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT-- 585 (721)
Q Consensus 508 V~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~-- 585 (721)
||||++ |+|.+++... ...+++.....++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++...
T Consensus 81 v~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~ 156 (288)
T cd07871 81 VFEYLD-SDLKQYLDNC-GNLMSMHNVKIFMFQLLRGLSYCHKRK--ILHRDLKPQNLLINEKGELKLADFGLARAKSVP 156 (288)
T ss_pred EEeCCC-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEECcCcceeeccCC
Confidence 999997 5999888532 345788999999999999999999988 9999999999999999999999999875321
Q ss_pred -------CCCccccchhhccc-CCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCC-CCc---------
Q 004979 586 -------AAKTGSAAMELLET-SAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQ-PLK--------- 647 (721)
Q Consensus 586 -------~~~~~~~apE~~~~-~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~-~~~--------- 647 (721)
.++..|+|||.+.+ ..++.++||||+||++|||+||+.||.... ..+....+..... +..
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07871 157 TKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGST--VKEELHLIFRLLGTPTEETWPGITSN 234 (288)
T ss_pred CccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHHhCCCChHHhhccccc
Confidence 23456899998754 568999999999999999999999996432 2222222211100 000
Q ss_pred ----cccCCcc-----ccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 648 ----DIVDPTL-----KSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 648 ----~~~d~~l-----~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
....+.. .........++.+++.+|++.||.+|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 235 EEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred hhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0000000 0011123467889999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=307.46 Aligned_cols=241 Identities=25% Similarity=0.423 Sum_probs=195.3
Q ss_pred hhhCcCCCCceeEEEEEEecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVF 509 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV~ 509 (721)
++.+.+|+|+||.||++... +..+++|...... ..+.|.+|+.++++++|+||+++++++...+. ..++||
T Consensus 9 ~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~-------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-~~~lv~ 79 (256)
T cd05082 9 KLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-------TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG-GLYIVT 79 (256)
T ss_pred eeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc-------hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCC-ceEEEE
Confidence 56778899999999999865 6778888764321 23578999999999999999999998754432 579999
Q ss_pred ecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCCC---
Q 004979 510 EYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTA--- 586 (721)
Q Consensus 510 Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~~--- 586 (721)
||+++|+|.++++......+++.....++.|++.||+|||+++ |+||||||+||++++++.+||+|||+++....
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~ 157 (256)
T cd05082 80 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD 157 (256)
T ss_pred ECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccccchheEEEcCCCcEEecCCccceeccccCC
Confidence 9999999999987555556899999999999999999999988 99999999999999999999999998764322
Q ss_pred ---CCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccHHHH
Q 004979 587 ---AKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQENVL 662 (721)
Q Consensus 587 ---~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 662 (721)
....|+|||......++.++|||||||++|||++ |+.||... ...+.......+... .....++
T Consensus 158 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~--~~~~~~~~~~~~~~~----------~~~~~~~ 225 (256)
T cd05082 158 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI--PLKDVVPRVEKGYKM----------DAPDGCP 225 (256)
T ss_pred CCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHHhcCCCC----------CCCCCCC
Confidence 2236899999988899999999999999999998 99998532 333333333222110 1122345
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 004979 663 EELLVVIKNCVHPDPKQRPSMRGIAAKLKEI 693 (721)
Q Consensus 663 ~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i 693 (721)
..+.+++.+||+.+|++||++.++++.|+++
T Consensus 226 ~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 226 PVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred HHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 6789999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=319.47 Aligned_cols=230 Identities=19% Similarity=0.252 Sum_probs=182.6
Q ss_pred cCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHH-HHhcCCCCccceEeEEEecCCCceEEEEEec
Q 004979 434 SFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKID-TLSKVNHKNFVNLIGYCEEDEPFTRMMVFEY 511 (721)
Q Consensus 434 ~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~-~l~~l~H~nIv~l~g~~~~~~~~~~~lV~Ey 511 (721)
.+|+|+||.||+|+.. ++..+|+|++....... ......+.+|.. +++.++||||+++++++.+.+ ..++||||
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~--~~~lv~e~ 77 (321)
T cd05603 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILK--KKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAE--KLYFVLDY 77 (321)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHH--hhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCC--EEEEEEcC
Confidence 5789999999999964 57889999886432211 222344555554 678899999999999998776 67999999
Q ss_pred CCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC-------
Q 004979 512 SPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT------- 584 (721)
Q Consensus 512 ~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~------- 584 (721)
+++|+|..++.. ...+.......++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 78 ~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 153 (321)
T cd05603 78 VNGGELFFHLQR--ERCFLEPRARFYAAEVASAIGYLHSLN--IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETT 153 (321)
T ss_pred CCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCcc
Confidence 999999888753 345788888899999999999999988 999999999999999999999999987642
Q ss_pred --CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccHHHH
Q 004979 585 --TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQENVL 662 (721)
Q Consensus 585 --~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 662 (721)
..++..|+|||.+....++.++|||||||++|||++|+.||... +..+....+..... ..+....
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~--~~~~~~~~i~~~~~-----------~~~~~~~ 220 (321)
T cd05603 154 STFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSR--DVSQMYDNILHKPL-----------QLPGGKT 220 (321)
T ss_pred ccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCC--CHHHHHHHHhcCCC-----------CCCCCCC
Confidence 12345799999999889999999999999999999999999643 33344333332211 1122345
Q ss_pred HHHHHHHHHcccCCCCCCCCHH
Q 004979 663 EELLVVIKNCVHPDPKQRPSMR 684 (721)
Q Consensus 663 ~~l~~li~~Cl~~dP~~RPs~~ 684 (721)
.++.+++.+||+.||++||++.
T Consensus 221 ~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 221 VAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred HHHHHHHHHHccCCHhhcCCCC
Confidence 6788999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=319.45 Aligned_cols=233 Identities=16% Similarity=0.229 Sum_probs=187.2
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcC-CCCccceEeEEEecCCCceEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKV-NHKNFVNLIGYCEEDEPFTRMM 507 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~~~l 507 (721)
+++..+|+|+||+||+|+.. ++..+|+|++...... .....+.+..|..++..+ +|++|+++++++.+.+ ..++
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~--~~~l 78 (323)
T cd05616 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVI--QDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMD--RLYF 78 (323)
T ss_pred eEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh--hhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCC--EEEE
Confidence 45678899999999999865 5678999988643211 122334567788888877 6899999999998776 6799
Q ss_pred EEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC---
Q 004979 508 VFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT--- 584 (721)
Q Consensus 508 V~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~--- 584 (721)
||||+++|+|.+++.. ...+++..+..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++..
T Consensus 79 v~E~~~~g~L~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~ 154 (323)
T cd05616 79 VMEYVNGGDLMYQIQQ--VGRFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD 154 (323)
T ss_pred EEcCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC--EEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence 9999999999988853 346889999999999999999999988 999999999999999999999999987632
Q ss_pred ------CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCcccccc
Q 004979 585 ------TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQ 658 (721)
Q Consensus 585 ------~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 658 (721)
..++..|+|||.+....++.++|||||||++|||+||+.||...+ ..+....+...... ++
T Consensus 155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~--~~~~~~~i~~~~~~-----------~p 221 (323)
T cd05616 155 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED--EDELFQSIMEHNVA-----------YP 221 (323)
T ss_pred CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCC--HHHHHHHHHhCCCC-----------CC
Confidence 124567999999999999999999999999999999999996432 33333333322111 22
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCH
Q 004979 659 ENVLEELLVVIKNCVHPDPKQRPSM 683 (721)
Q Consensus 659 ~~~~~~l~~li~~Cl~~dP~~RPs~ 683 (721)
...+.++.+++.+|++.||++|++.
T Consensus 222 ~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 222 KSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred CcCCHHHHHHHHHHcccCHHhcCCC
Confidence 3345678999999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=321.25 Aligned_cols=234 Identities=18% Similarity=0.242 Sum_probs=185.3
Q ss_pred cCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHH-HHhcCCCCccceEeEEEecCCCceEEEEEec
Q 004979 434 SFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKID-TLSKVNHKNFVNLIGYCEEDEPFTRMMVFEY 511 (721)
Q Consensus 434 ~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~-~l~~l~H~nIv~l~g~~~~~~~~~~~lV~Ey 511 (721)
.+|+|+||+||+|+. .++..+|+|++..+.... ......+..|.. +++.++||||+++++++...+ ..++||||
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~--~~~lv~e~ 77 (325)
T cd05604 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLN--RKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTE--KLYFVLDF 77 (325)
T ss_pred ceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh--hhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCC--EEEEEEcC
Confidence 478999999999985 468899999886542211 222345555654 567899999999999998877 67999999
Q ss_pred CCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC------
Q 004979 512 SPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT------ 585 (721)
Q Consensus 512 ~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~------ 585 (721)
+++|+|..++. ....+++.....++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 78 ~~~~~L~~~l~--~~~~~~~~~~~~~~~qi~~al~~lH~~g--ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~ 153 (325)
T cd05604 78 VNGGELFFHLQ--RERSFPEPRARFYAAEIASALGYLHSIN--IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTT 153 (325)
T ss_pred CCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCc
Confidence 99999998875 3456899999999999999999999988 9999999999999999999999999876321
Q ss_pred ---CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccHHHH
Q 004979 586 ---AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQENVL 662 (721)
Q Consensus 586 ---~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 662 (721)
.++..|+|||.+.+..++.++|||||||++|||++|+.||... +..+........... ..+...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~--~~~~~~~~~~~~~~~-----------~~~~~~ 220 (325)
T cd05604 154 TTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCR--DVAEMYDNILHKPLV-----------LRPGAS 220 (325)
T ss_pred ccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCC--CHHHHHHHHHcCCcc-----------CCCCCC
Confidence 2455789999999999999999999999999999999999643 333333433332111 112244
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 663 EELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 663 ~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
.++.+++.+|++.+|.+||++++.++
T Consensus 221 ~~~~~ll~~ll~~~p~~R~~~~~~~~ 246 (325)
T cd05604 221 LTAWSILEELLEKDRQRRLGAKEDFL 246 (325)
T ss_pred HHHHHHHHHHhccCHHhcCCCCCCHH
Confidence 67889999999999999998864443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=315.20 Aligned_cols=250 Identities=24% Similarity=0.420 Sum_probs=196.9
Q ss_pred hhhCcCCCCceeEEEEEEecC-Cc--EEEEEEeeeccccchhhHHHHHHHHHHHHHhcC-CCCccceEeEEEecCCCceE
Q 004979 430 NIIGSFSDGTVGTVYKGTLSS-GV--EIAVTSTSVKSRADWSKNLESQFRKKIDTLSKV-NHKNFVNLIGYCEEDEPFTR 505 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~~-~~--~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~~ 505 (721)
++.+.+|+|+||.||+|+..+ +. .+++|.++... .....+.|.+|++++.++ +||||+++++++...+ ..
T Consensus 5 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~--~~ 78 (297)
T cd05089 5 KFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA----SENDHRDFAGELEVLCKLGHHPNIINLLGACENRG--YL 78 (297)
T ss_pred eeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC----CHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCC--cc
Confidence 566788999999999998753 32 35666654211 122346789999999999 7999999999998766 57
Q ss_pred EEEEecCCCCChhhhhhhcc--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCC
Q 004979 506 MMVFEYSPNGSLFEHLHIQE--------------AEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDY 571 (721)
Q Consensus 506 ~lV~Ey~~~GsL~~~l~~~~--------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~ 571 (721)
++||||+++|+|.++++... ...+++..+..|+.|++.||+|||+.+ |+||||||+|||+++++
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~~ 156 (297)
T cd05089 79 YIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ--FIHRDLAARNVLVGENL 156 (297)
T ss_pred eEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCcCCcceEEECCCC
Confidence 99999999999999986432 135889999999999999999999988 99999999999999999
Q ss_pred cEEEeccCCCCCCCC--------CCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhc
Q 004979 572 AAKISDFSFWNNTTA--------AKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKG 642 (721)
Q Consensus 572 ~~kL~DFGla~~~~~--------~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~ 642 (721)
.+||+|||++..... ....|++||......++.++|||||||++|||+| |+.||... ...+.......+
T Consensus 157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~--~~~~~~~~~~~~ 234 (297)
T cd05089 157 ASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGM--TCAELYEKLPQG 234 (297)
T ss_pred eEEECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCC--CHHHHHHHHhcC
Confidence 999999998753211 1235899999988889999999999999999998 99999533 223333332221
Q ss_pred CCCCccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCCC
Q 004979 643 EQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAMEPD 699 (721)
Q Consensus 643 ~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~ 699 (721)
.. ...+..++.++.+++.+||+.+|.+||++.++++.|+++......
T Consensus 235 ~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~ 281 (297)
T cd05089 235 YR----------MEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKA 281 (297)
T ss_pred CC----------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 10 011223456789999999999999999999999999998876643
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=326.87 Aligned_cols=242 Identities=21% Similarity=0.335 Sum_probs=194.5
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
++++.+|+|+||+||+|+.. +++.||+|++...... .......+.+|++++..++|+||+++++++.+.+ ..++|
T Consensus 4 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~--~~~lv 79 (350)
T cd05573 4 EVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMI--KRNQIAHVRAERDILADADSPWIVKLYYSFQDEE--HLYLV 79 (350)
T ss_pred eEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHh--hccHHHHHHHHHHHHHhcCCCCccchhhheecCC--eEEEE
Confidence 56778999999999999965 6889999988643221 1233467899999999999999999999998776 67999
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC---
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT--- 585 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~--- 585 (721)
|||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 80 ~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g--iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 155 (350)
T cd05573 80 MEYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKLG--FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK 155 (350)
T ss_pred EcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence 9999999999998643 56899999999999999999999988 9999999999999999999999999875322
Q ss_pred -----------------------------------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCC
Q 004979 586 -----------------------------------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENG 630 (721)
Q Consensus 586 -----------------------------------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~ 630 (721)
.++..|+|||.+.+..++.++|||||||++|||+||+.||....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~- 234 (350)
T cd05573 156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT- 234 (350)
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC-
Confidence 23457899999999999999999999999999999999996443
Q ss_pred CHHHHHHHHhhcCCCCccccCCccccccHHHHHHHHHHHHHcccCCCCCCCC-HHHHHHH
Q 004979 631 SLENWASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPS-MRGIAAK 689 (721)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs-~~evl~~ 689 (721)
..+....+........ -+. ....+.++.+++.+|+. ||.+||+ +.|+++.
T Consensus 235 -~~~~~~~i~~~~~~~~---~p~----~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 235 -LQETYNKIINWKESLR---FPP----DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred -HHHHHHHHhccCCccc---CCC----CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 2222333322111100 010 11145778899999997 9999999 9999863
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=315.12 Aligned_cols=243 Identities=22% Similarity=0.380 Sum_probs=193.2
Q ss_pred hhhCcCCCCceeEEEEEEe-----cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCce
Q 004979 430 NIIGSFSDGTVGTVYKGTL-----SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFT 504 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~-----~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 504 (721)
++.+.+|+|+||+||+|+. ..+..+++|.+.... .......|.+|++++++++||||+++++++...+ .
T Consensus 8 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~ 81 (283)
T cd05090 8 RFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN----NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQ--P 81 (283)
T ss_pred eeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC----CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC--c
Confidence 5668899999999999984 245678888775322 1233467899999999999999999999998776 5
Q ss_pred EEEEEecCCCCChhhhhhhcc---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCC
Q 004979 505 RMMVFEYSPNGSLFEHLHIQE---------------AEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTE 569 (721)
Q Consensus 505 ~~lV~Ey~~~GsL~~~l~~~~---------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~ 569 (721)
.++||||+++|+|.+++.... ...+++.+.+.++.|++.||+|||+++ |+||||||+|||+++
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~nili~~ 159 (283)
T cd05090 82 VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF--FVHKDLAARNILIGE 159 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC--eehhccccceEEEcC
Confidence 699999999999999985321 234788999999999999999999988 999999999999999
Q ss_pred CCcEEEeccCCCCCCCC-----------CCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHH
Q 004979 570 DYAAKISDFSFWNNTTA-----------AKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWAS 637 (721)
Q Consensus 570 ~~~~kL~DFGla~~~~~-----------~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~ 637 (721)
++.+||+|||+++.... ....|++||.+.+..++.++|||||||++|||+| |..||.... ......
T Consensus 160 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~--~~~~~~ 237 (283)
T cd05090 160 QLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFS--NQEVIE 237 (283)
T ss_pred CCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC--HHHHHH
Confidence 99999999998864321 1235899999988889999999999999999999 998985432 222222
Q ss_pred HHhhcCCCCccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 004979 638 EYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKE 692 (721)
Q Consensus 638 ~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 692 (721)
..... .. ...+..++.++.+++.+||+.||++||++.+|.+.|+.
T Consensus 238 ~~~~~-~~---------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 238 MVRKR-QL---------LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHcC-Cc---------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 22111 11 11223345678999999999999999999999988864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=322.87 Aligned_cols=258 Identities=19% Similarity=0.235 Sum_probs=190.6
Q ss_pred hhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCC---ceE
Q 004979 430 NIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEP---FTR 505 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~---~~~ 505 (721)
++.+.+|+|+||.||+|+. .++..||+|++...... ......+.+|++++++++||||+++++++..... ...
T Consensus 3 ~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 3 KIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEH---VSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred EEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhcc---chhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence 5667889999999999995 46889999987632211 1223568899999999999999999998864321 246
Q ss_pred EEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC
Q 004979 506 MMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT 585 (721)
Q Consensus 506 ~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~ 585 (721)
++||||+. ++|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 80 ~lv~e~~~-~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~ 154 (338)
T cd07859 80 YVVFELME-SDLHQVIKA--NDDLTPEHHQFFLYQLLRALKYIHTAN--VFHRDLKPKNILANADCKLKICDFGLARVAF 154 (338)
T ss_pred EEEEecCC-CCHHHHHHh--cccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCcEEEccCccccccc
Confidence 99999995 689888853 346899999999999999999999998 9999999999999999999999999976321
Q ss_pred ------------CCCccccchhhccc--CCCCCCccHHHHHHHHHHHHhCCCcccCCCCC-HHHHHHHHhhcCCCC----
Q 004979 586 ------------AAKTGSAAMELLET--SAVDLESNVYSFGTILFEMITGRISYSIENGS-LENWASEYLKGEQPL---- 646 (721)
Q Consensus 586 ------------~~~~~~~apE~~~~--~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~-~~~~~~~~~~~~~~~---- 646 (721)
.++..|+|||.+.. ..++.++|||||||++|||+||+.||...+.. ....+.... +..+.
T Consensus 155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~ 233 (338)
T cd07859 155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLL-GTPSPETIS 233 (338)
T ss_pred cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHh-CCCCHHHHH
Confidence 23456899999865 67899999999999999999999999643311 001111110 00000
Q ss_pred -----------ccccC---CccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHHhhhc
Q 004979 647 -----------KDIVD---PTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAK--LKEITAM 696 (721)
Q Consensus 647 -----------~~~~d---~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~--L~~i~~~ 696 (721)
..+.. ............++.+++.+||+.||++||+++|+++. ++.+...
T Consensus 234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~~ 299 (338)
T cd07859 234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKV 299 (338)
T ss_pred HhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCcc
Confidence 00000 00000011234568899999999999999999999874 5544443
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=307.35 Aligned_cols=241 Identities=23% Similarity=0.388 Sum_probs=196.8
Q ss_pred hhhhCcCCCCceeEEEEEEecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 429 SNIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
+++++++|+|+||.||+|..+++..+++|.+..... ...+|.+|++++++++|+||+++++++.. + ..++|
T Consensus 8 ~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~--~~~~v 78 (260)
T cd05067 8 LKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM------SPEAFLAEANLMKQLQHPRLVRLYAVVTQ-E--PIYII 78 (260)
T ss_pred ceeeeeeccCccceEEeeecCCCceEEEEEecCCCC------cHHHHHHHHHHHHhcCCcCeeeEEEEEcc-C--CcEEE
Confidence 367889999999999999988889999998764322 12578999999999999999999998754 3 46899
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC---
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT--- 585 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~--- 585 (721)
|||+++|+|.+++.......+++.++..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++....
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~--i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05067 79 TEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN--YIHRDLRAANILVSETLCCKIADFGLARLIEDNE 156 (260)
T ss_pred EEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence 99999999999987555567899999999999999999999988 9999999999999999999999999875332
Q ss_pred -------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccc
Q 004979 586 -------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSF 657 (721)
Q Consensus 586 -------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 657 (721)
.....|++||.+....++.++|||||||++|||++ |+.||.... ..+.......+. .. ..
T Consensus 157 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~--~~~~~~~~~~~~-~~---------~~ 224 (260)
T cd05067 157 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMT--NPEVIQNLERGY-RM---------PR 224 (260)
T ss_pred cccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCC--hHHHHHHHHcCC-CC---------CC
Confidence 11235899999988889999999999999999999 999996332 223222222111 10 11
Q ss_pred cHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 004979 658 QENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKE 692 (721)
Q Consensus 658 ~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 692 (721)
+...+.++.+++.+||..+|++||+++++...|+.
T Consensus 225 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 225 PDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 12345679999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=306.87 Aligned_cols=242 Identities=21% Similarity=0.347 Sum_probs=195.3
Q ss_pred hhhhCcCCCCceeEEEEEEecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 429 SNIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
+++.+++|+|+||+||+|+..++..|++|++..... ..+.|.+|++++++++|+||+++++++... ..++|
T Consensus 8 ~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~------~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~---~~~lv 78 (262)
T cd05071 8 LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM------SPEAFLQEAQVMKKLRHEKLVQLYAVVSEE---PIYIV 78 (262)
T ss_pred eeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc------CHHHHHHHHHHHHhCCCCCcceEEEEECCC---CcEEE
Confidence 467889999999999999987777899988764221 125689999999999999999999987543 35899
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCCC--
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTA-- 586 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~~-- 586 (721)
|||+++|+|.+++.......+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++....
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~ 156 (262)
T cd05071 79 TEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNE 156 (262)
T ss_pred EEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcccEEEcCCCcEEeccCCceeeccccc
Confidence 99999999999997544456899999999999999999999988 99999999999999999999999998753221
Q ss_pred --------CCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccc
Q 004979 587 --------AKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSF 657 (721)
Q Consensus 587 --------~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 657 (721)
+...|++||......++.++|||||||++|||+| |+.||.... ..+.......+. .. ..
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~--~~~~~~~~~~~~-~~---------~~ 224 (262)
T cd05071 157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV--NREVLDQVERGY-RM---------PC 224 (262)
T ss_pred cccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC--hHHHHHHHhcCC-CC---------CC
Confidence 1235899999988899999999999999999999 888885332 222222222111 10 11
Q ss_pred cHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 004979 658 QENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEI 693 (721)
Q Consensus 658 ~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i 693 (721)
....+..+.+++.+||+.+|++||++.++++.|++.
T Consensus 225 ~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 225 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred ccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 234567789999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=314.63 Aligned_cols=248 Identities=26% Similarity=0.437 Sum_probs=193.9
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcE--EEEEEeeeccccchhhHHHHHHHHHHHHHhcC-CCCccceEeEEEecCCCceE
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVE--IAVTSTSVKSRADWSKNLESQFRKKIDTLSKV-NHKNFVNLIGYCEEDEPFTR 505 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~--vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~~ 505 (721)
++.+.+|+|+||.||+|..+ ++.. +++|..... ........|.+|++++.++ +|+||+++++++...+ ..
T Consensus 10 ~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~----~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~--~~ 83 (303)
T cd05088 10 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY----ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG--YL 83 (303)
T ss_pred eeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc----CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCC--Cc
Confidence 56678899999999999964 4444 455544321 1233456789999999999 8999999999998776 57
Q ss_pred EEEEecCCCCChhhhhhhcc--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCC
Q 004979 506 MMVFEYSPNGSLFEHLHIQE--------------AEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDY 571 (721)
Q Consensus 506 ~lV~Ey~~~GsL~~~l~~~~--------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~ 571 (721)
++||||+++|+|.++++... ...+++.+++.++.|++.|++|||+.+ |+||||||+|||+++++
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dlkp~Nili~~~~ 161 (303)
T cd05088 84 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENY 161 (303)
T ss_pred eEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEecCCC
Confidence 99999999999999986432 135789999999999999999999988 99999999999999999
Q ss_pred cEEEeccCCCCCCCC--------CCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhc
Q 004979 572 AAKISDFSFWNNTTA--------AKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKG 642 (721)
Q Consensus 572 ~~kL~DFGla~~~~~--------~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~ 642 (721)
.+||+|||+++.... ....|++||.+....++.++|||||||++|||+| |..||.... ..+.......+
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~--~~~~~~~~~~~ 239 (303)
T cd05088 162 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT--CAELYEKLPQG 239 (303)
T ss_pred cEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCC--hHHHHHHHhcC
Confidence 999999999853211 1235899999988889999999999999999998 999985332 22222222111
Q ss_pred CCCCccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcC
Q 004979 643 EQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAME 697 (721)
Q Consensus 643 ~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 697 (721)
... ..+...+.++.+++.+||+.+|++||++.++++.|+++....
T Consensus 240 -~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~ 284 (303)
T cd05088 240 -YRL---------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 284 (303)
T ss_pred -CcC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 000 011224467889999999999999999999999998876543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=324.16 Aligned_cols=243 Identities=19% Similarity=0.294 Sum_probs=208.1
Q ss_pred hhhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEE
Q 004979 429 SNIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMM 507 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~l 507 (721)
|+.+..+|+|+||.++..+++ ++..+++|++...... ...++...+|+.++++++|||||.+++.+..++. ..+|
T Consensus 6 Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t---~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~-~l~I 81 (426)
T KOG0589|consen 6 YEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLT---EPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQ-LLCI 81 (426)
T ss_pred hhhhhhcCccccchhhhhhhccCCceEEEEEEeccccC---chhhHHHHHHHHHHHhccCCCeeeeccchhcCCc-eEEE
Confidence 467889999999999988865 5678899988765433 3344578899999999999999999999988773 2799
Q ss_pred EEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC--
Q 004979 508 VFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT-- 585 (721)
Q Consensus 508 V~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~-- 585 (721)
||+||+||+|.+.+..++...++..+...++.|++.|+.|||+.. |+|||||+.||++..+..+||+|||+++...
T Consensus 82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~--iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR--VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh--hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 999999999999998777778999999999999999999999877 9999999999999999999999999987543
Q ss_pred -------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCcccccc
Q 004979 586 -------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQ 658 (721)
Q Consensus 586 -------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 658 (721)
.+++.|+.||.+.+..|..|+||||+||++|||++-+.+|.. .++...+.++..+. ....+
T Consensus 160 ~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a--~~m~~Li~ki~~~~----------~~Plp 227 (426)
T KOG0589|consen 160 DSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKA--SNMSELILKINRGL----------YSPLP 227 (426)
T ss_pred hhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCc--cchHHHHHHHhhcc----------CCCCC
Confidence 356789999999999999999999999999999999999963 45555555555442 12345
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004979 659 ENVLEELLVVIKNCVHPDPKQRPSMRGIAAK 689 (721)
Q Consensus 659 ~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 689 (721)
..++.++..+|..|+..+|+.||++.+++.+
T Consensus 228 ~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 228 SMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred ccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 5677889999999999999999999999986
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=304.26 Aligned_cols=253 Identities=21% Similarity=0.292 Sum_probs=207.7
Q ss_pred hhhCcCCCCceeEEEEEEecC-CcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLSS-GVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~~-~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
+++..+|.|.-|+||.++.+. +...|+|++.+..... .....+...|-+||+.++||.++.||+.++.++ ..|+|
T Consensus 80 ~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~--rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~--~~cl~ 155 (459)
T KOG0610|consen 80 RLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLAS--RKKLKRAQTEREILSLLDHPFLPTLYASFETDK--YSCLV 155 (459)
T ss_pred HHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhh--hhHHHHHHHHHHHHHhcCCCccchhhheeeccc--eeEEE
Confidence 677889999999999999764 4789999987654432 334567788899999999999999999999887 67999
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC----
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT---- 584 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~---- 584 (721)
||||+||+|..+.+.+....++...++.++..|..||+|||-.| ||.|||||+||||.++|++-|+||-++...
T Consensus 156 meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG--ivYRDLKPENILvredGHIMLsDFDLS~~~~~~P 233 (459)
T KOG0610|consen 156 MEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG--IVYRDLKPENILVREDGHIMLSDFDLSLRCPVSP 233 (459)
T ss_pred EecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc--eeeccCCcceeEEecCCcEEeeeccccccCCCCC
Confidence 99999999999998888889999999999999999999999999 999999999999999999999999753100
Q ss_pred ---------------------------------C----------------------------CCCccccchhhcccCCCC
Q 004979 585 ---------------------------------T----------------------------AAKTGSAAMELLETSAVD 603 (721)
Q Consensus 585 ---------------------------------~----------------------------~~~~~~~apE~~~~~~~s 603 (721)
. .++..|.|||++.+...+
T Consensus 234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHg 313 (459)
T KOG0610|consen 234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHG 313 (459)
T ss_pred eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCC
Confidence 0 012246799999999999
Q ss_pred CCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccHHHHHHHHHHHHHcccCCCCCCCC-
Q 004979 604 LESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPS- 682 (721)
Q Consensus 604 ~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs- 682 (721)
.++|.|+|||++|||+.|+.||.+.+. .+....++.....+. . .+..+..+.+||++.|.+||++|..
T Consensus 314 sAVDWWtfGIflYEmLyG~TPFKG~~~--~~Tl~NIv~~~l~Fp--------~-~~~vs~~akDLIr~LLvKdP~kRlg~ 382 (459)
T KOG0610|consen 314 SAVDWWTFGIFLYEMLYGTTPFKGSNN--KETLRNIVGQPLKFP--------E-EPEVSSAAKDLIRKLLVKDPSKRLGS 382 (459)
T ss_pred chhhHHHHHHHHHHHHhCCCCcCCCCc--hhhHHHHhcCCCcCC--------C-CCcchhHHHHHHHHHhccChhhhhcc
Confidence 999999999999999999999975443 334444444322221 1 1256678999999999999999987
Q ss_pred ---HHHHHHHHHHhhhcCCCCCCCCCChhHHHH
Q 004979 683 ---MRGIAAKLKEITAMEPDGATPKLSPLWWAE 712 (721)
Q Consensus 683 ---~~evl~~L~~i~~~~~~~~~p~~~~~~~~~ 712 (721)
+.|| +.+|++..++|+=
T Consensus 383 ~rGA~eI-------------K~HpFF~gVnWaL 402 (459)
T KOG0610|consen 383 KRGAAEI-------------KRHPFFEGVNWAL 402 (459)
T ss_pred ccchHHh-------------hcCccccCCChhh
Confidence 5554 4489999999993
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=313.73 Aligned_cols=244 Identities=21% Similarity=0.336 Sum_probs=192.7
Q ss_pred hhhhCcCCCCceeEEEEEEec------CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCC
Q 004979 429 SNIIGSFSDGTVGTVYKGTLS------SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEP 502 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~------~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~ 502 (721)
+++...+|+|+||.||+|... .+..+++|++..... .....+|.+|+.+++.++|+||+++++++...+
T Consensus 8 ~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~----~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~- 82 (277)
T cd05062 8 ITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAAS----MRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ- 82 (277)
T ss_pred ceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCC----HHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC-
Confidence 366788999999999999753 245688887643211 123457899999999999999999999998766
Q ss_pred ceEEEEEecCCCCChhhhhhhcc--------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEE
Q 004979 503 FTRMMVFEYSPNGSLFEHLHIQE--------AEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAK 574 (721)
Q Consensus 503 ~~~~lV~Ey~~~GsL~~~l~~~~--------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~k 574 (721)
..++||||+++|+|.++++... ...+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+|
T Consensus 83 -~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~vH~dlkp~Nil~~~~~~~~ 159 (277)
T cd05062 83 -PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVK 159 (277)
T ss_pred -CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCcchheEEEcCCCCEE
Confidence 6799999999999999986422 124678899999999999999999987 99999999999999999999
Q ss_pred EeccCCCCCCCC-----------CCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhc
Q 004979 575 ISDFSFWNNTTA-----------AKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKG 642 (721)
Q Consensus 575 L~DFGla~~~~~-----------~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~ 642 (721)
|+|||+++.... ....|+|||.+....++.++|||||||++|||+| |..||... ...+........
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~--~~~~~~~~~~~~ 237 (277)
T cd05062 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGM--SNEQVLRFVMEG 237 (277)
T ss_pred ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCC--CHHHHHHHHHcC
Confidence 999998753211 1235899999988899999999999999999999 78888533 223333322222
Q ss_pred CCCCccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 004979 643 EQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKE 692 (721)
Q Consensus 643 ~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 692 (721)
.. ...+..++..+.+++.+||+.+|++||++.|+++.|++
T Consensus 238 ~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 238 GL----------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred Cc----------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 11 11123345678999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=318.64 Aligned_cols=251 Identities=20% Similarity=0.259 Sum_probs=193.0
Q ss_pred cCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHH-HHHhcCCCCccceEeEEEecCCCceEEEEEec
Q 004979 434 SFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKI-DTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEY 511 (721)
Q Consensus 434 ~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei-~~l~~l~H~nIv~l~g~~~~~~~~~~~lV~Ey 511 (721)
.+|+|+||+||+|+.. ++..+|+|++....... ......+..|. .+++.++|+||+++++++...+ ..++||||
T Consensus 2 ~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~--~~~lv~e~ 77 (325)
T cd05602 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILK--KKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTAD--KLYFVLDY 77 (325)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHh--hhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCC--eEEEEEeC
Confidence 5789999999999965 56789999886432211 11223444444 4568899999999999998877 67999999
Q ss_pred CCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC-------
Q 004979 512 SPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT------- 584 (721)
Q Consensus 512 ~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~------- 584 (721)
+++|+|.+++.. ...+.......++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 78 ~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~g--iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~ 153 (325)
T cd05602 78 INGGELFYHLQR--ERCFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTT 153 (325)
T ss_pred CCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCc
Confidence 999999998863 345778888889999999999999998 999999999999999999999999987632
Q ss_pred --CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccHHHH
Q 004979 585 --TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQENVL 662 (721)
Q Consensus 585 --~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 662 (721)
..++..|+|||.+.+..++.++|||||||++|||++|+.||... +..+........... ..+...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~--~~~~~~~~i~~~~~~-----------~~~~~~ 220 (325)
T cd05602 154 STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR--NTAEMYDNILNKPLQ-----------LKPNIT 220 (325)
T ss_pred ccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCC--CHHHHHHHHHhCCcC-----------CCCCCC
Confidence 12456799999999999999999999999999999999999633 333333333322111 112345
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCChhHHHHHH
Q 004979 663 EELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAMEPDGATPKLSPLWWAELE 714 (721)
Q Consensus 663 ~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~~~~p~~~~~~~~~l~ 714 (721)
.++.+++.+||+.||.+||++.+.+..+.+ ++.+.+++|+++.
T Consensus 221 ~~~~~li~~~l~~~p~~R~~~~~~~~~i~~---------~~~~~~~~~~~~~ 263 (325)
T cd05602 221 NSARHLLEGLLQKDRTKRLGAKDDFMEIKN---------HIFFSPINWDDLI 263 (325)
T ss_pred HHHHHHHHHHcccCHHHCCCCCCCHHHHhc---------CcccCCCCHHHHH
Confidence 678899999999999999998765443332 4555666676653
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=319.54 Aligned_cols=233 Identities=18% Similarity=0.261 Sum_probs=185.8
Q ss_pred cCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcC-CCCccceEeEEEecCCCceEEEEEec
Q 004979 434 SFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKV-NHKNFVNLIGYCEEDEPFTRMMVFEY 511 (721)
Q Consensus 434 ~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~~~lV~Ey 511 (721)
.+|+|+||+||+|+.. +++.+|+|++....... ....+.+.+|+.++.++ +||||+++++++...+ ..++||||
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~--~~~lv~e~ 77 (327)
T cd05617 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHD--DEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTS--RLFLVIEY 77 (327)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh--hhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCC--EEEEEEeC
Confidence 5789999999999964 57889999886532211 23345688999999888 6999999999998776 67999999
Q ss_pred CCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC-------
Q 004979 512 SPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT------- 584 (721)
Q Consensus 512 ~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~------- 584 (721)
+++|+|..++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 78 ~~~~~L~~~~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 153 (327)
T cd05617 78 VNGGDLMFHMQR--QRKLPEEHARFYAAEICIALNFLHERG--IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTT 153 (327)
T ss_pred CCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEeCCCCEEEeccccceeccCCCCce
Confidence 999999988753 346899999999999999999999988 999999999999999999999999987632
Q ss_pred --CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCC----CCHHHHHHHHhhcCCCCccccCCcccccc
Q 004979 585 --TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIEN----GSLENWASEYLKGEQPLKDIVDPTLKSFQ 658 (721)
Q Consensus 585 --~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~----~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 658 (721)
..++..|+|||.+.+..++.++|||||||++|||+||+.||.... ....++......... . ..+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~---------~~p 223 (327)
T cd05617 154 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKP-I---------RIP 223 (327)
T ss_pred ecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCC-C---------CCC
Confidence 124567899999999999999999999999999999999996321 122233333222211 0 112
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHH
Q 004979 659 ENVLEELLVVIKNCVHPDPKQRPSMR 684 (721)
Q Consensus 659 ~~~~~~l~~li~~Cl~~dP~~RPs~~ 684 (721)
...+.++.+++.+||+.||++|+++.
T Consensus 224 ~~~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 224 RFLSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred CCCCHHHHHHHHHHhccCHHHcCCCC
Confidence 23446788999999999999999854
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=306.46 Aligned_cols=241 Identities=27% Similarity=0.460 Sum_probs=189.4
Q ss_pred cCCCCceeEEEEEEecC-Cc--EEEEEEeeeccccchhhHHHHHHHHHHHHHhcC-CCCccceEeEEEecCCCceEEEEE
Q 004979 434 SFSDGTVGTVYKGTLSS-GV--EIAVTSTSVKSRADWSKNLESQFRKKIDTLSKV-NHKNFVNLIGYCEEDEPFTRMMVF 509 (721)
Q Consensus 434 ~lg~G~~g~Vyk~~~~~-~~--~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~~~lV~ 509 (721)
.+|+|+||.||+|+..+ +. .+++|...... .....+.+.+|++++.++ +||||+++++++...+ ..++||
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~--~~~lv~ 75 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA----SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG--YLYLAI 75 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccC----CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCC--CceEEE
Confidence 47889999999999754 33 35666554211 123346789999999999 8999999999998876 569999
Q ss_pred ecCCCCChhhhhhhcc--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEE
Q 004979 510 EYSPNGSLFEHLHIQE--------------AEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKI 575 (721)
Q Consensus 510 Ey~~~GsL~~~l~~~~--------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL 575 (721)
||+++|+|.++++... ...+++.++..++.|++.|++|||+.+ ++||||||+|||+++++.+||
T Consensus 76 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nili~~~~~~kl 153 (270)
T cd05047 76 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENYVAKI 153 (270)
T ss_pred EeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccccceEEEcCCCeEEE
Confidence 9999999999986432 134789999999999999999999987 999999999999999999999
Q ss_pred eccCCCCCCC--------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhcCCCC
Q 004979 576 SDFSFWNNTT--------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPL 646 (721)
Q Consensus 576 ~DFGla~~~~--------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~ 646 (721)
+|||+++... .....|+|||.+....++.++|||||||++|||+| |+.||... +..+.......+. ..
T Consensus 154 ~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~--~~~~~~~~~~~~~-~~ 230 (270)
T cd05047 154 ADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM--TCAELYEKLPQGY-RL 230 (270)
T ss_pred CCCCCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCcccc--CHHHHHHHHhCCC-CC
Confidence 9999975221 11235899999988899999999999999999997 99999532 2233333222111 10
Q ss_pred ccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 004979 647 KDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEIT 694 (721)
Q Consensus 647 ~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~ 694 (721)
+.+.....++.+++.+||+.+|.+||++.|++..|+++.
T Consensus 231 ---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 231 ---------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred ---------CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 111234467889999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=322.50 Aligned_cols=242 Identities=20% Similarity=0.287 Sum_probs=192.7
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
++++.+|+|+||+||+++.. ++..+|+|++...... .....+.+.+|+++++.++|+||+++++++.+.+ ..++|
T Consensus 4 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~--~~~lv 79 (330)
T cd05601 4 DVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLL--AQETVSFFEEERDILSISNSPWIPQLQYAFQDKD--NLYLV 79 (330)
T ss_pred eEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhh--hhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCC--eEEEE
Confidence 56778999999999999854 6888999988754321 1234567889999999999999999999998776 67999
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC---
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT--- 585 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~--- 585 (721)
|||+++|+|.+++... ...+++.....++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 80 ~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~--i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 156 (330)
T cd05601 80 MEYQPGGDLLSLLNRY-EDQFDEDMAQFYLAELVLAIHSVHQMG--YVHRDIKPENVLIDRTGHIKLADFGSAARLTANK 156 (330)
T ss_pred ECCCCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--eEcccCchHheEECCCCCEEeccCCCCeECCCCC
Confidence 9999999999998643 356899999999999999999999988 9999999999999999999999999875322
Q ss_pred -------CCCccccchhhcc------cCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCC
Q 004979 586 -------AAKTGSAAMELLE------TSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDP 652 (721)
Q Consensus 586 -------~~~~~~~apE~~~------~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 652 (721)
.++..|+|||.+. ...++.++|||||||++|||+||+.||... ...+....+....... .. +
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~--~~~~~~~~i~~~~~~~-~~--~ 231 (330)
T cd05601 157 MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEG--TSAKTYNNIMNFQRFL-KF--P 231 (330)
T ss_pred ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCC--CHHHHHHHHHcCCCcc-CC--C
Confidence 2455799999986 566789999999999999999999999633 2233333333221111 00 0
Q ss_pred ccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 653 TLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 653 ~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
.....+.++.+|+..|++ +|++||++.+++.
T Consensus 232 ----~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 232 ----EDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred ----CCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 011345678899999997 9999999999875
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=335.82 Aligned_cols=239 Identities=17% Similarity=0.272 Sum_probs=193.0
Q ss_pred hhhhCcCCCCceeEEEEEEec-C-CcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEE
Q 004979 429 SNIIGSFSDGTVGTVYKGTLS-S-GVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRM 506 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~-~-~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~ 506 (721)
+.+...+|+|+||.||+|... + +..|++|.+.... ......+.+|+++++.++|||||++++++...+ ..+
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~-----~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~--~~~ 141 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND-----ERQAAYARSELHCLAACDHFGIVKHFDDFKSDD--KLL 141 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC-----HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECC--EEE
Confidence 466778899999999999854 3 5667777654322 222356788999999999999999999998877 789
Q ss_pred EEEecCCCCChhhhhhhc--cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC
Q 004979 507 MVFEYSPNGSLFEHLHIQ--EAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT 584 (721)
Q Consensus 507 lV~Ey~~~GsL~~~l~~~--~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~ 584 (721)
+||||+++|+|.++++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 142 lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll~~~~~~kL~DFgla~~~ 219 (478)
T PTZ00267 142 LIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK--MMHRDLKSANIFLMPTGIIKLGDFGFSKQY 219 (478)
T ss_pred EEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCcCHHhEEECCCCcEEEEeCcCceec
Confidence 999999999999988642 2346889999999999999999999988 999999999999999999999999998632
Q ss_pred C-----------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCc
Q 004979 585 T-----------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPT 653 (721)
Q Consensus 585 ~-----------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 653 (721)
. .++..|+|||.+.+..++.++|||||||++|||+||+.||... +..+.......+...
T Consensus 220 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~--~~~~~~~~~~~~~~~-------- 289 (478)
T PTZ00267 220 SDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGP--SQREIMQQVLYGKYD-------- 289 (478)
T ss_pred CCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHhCCCC--------
Confidence 1 2455799999999999999999999999999999999999633 333444444333211
Q ss_pred cccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 654 LKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 654 l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
..+..++.++.+++.+||+.||++||++.+++.
T Consensus 290 --~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 290 --PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred --CCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 112234567899999999999999999999875
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=315.19 Aligned_cols=249 Identities=18% Similarity=0.250 Sum_probs=187.9
Q ss_pred hhhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEE
Q 004979 429 SNIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMM 507 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~l 507 (721)
+++++.+|+|+||+||+|+.. ++..+|+|++....... ....+.+|++++++++||||+++++++.+.+ ..++
T Consensus 7 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~l 80 (303)
T cd07869 7 YEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEG----TPFTAIREASLLKGLKHANIVLLHDIIHTKE--TLTL 80 (303)
T ss_pred ceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccc----cchhHHHHHHHHhhCCCCCcCeEEEEEecCC--eEEE
Confidence 367889999999999999965 67889999886433211 1245778999999999999999999998776 6799
Q ss_pred EEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC---
Q 004979 508 VFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT--- 584 (721)
Q Consensus 508 V~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~--- 584 (721)
||||++ ++|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 v~e~~~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 156 (303)
T cd07869 81 VFEYVH-TDLCQYMDK-HPGGLHPENVKLFLFQLLRGLSYIHQRY--ILHRDLKPQNLLISDTGELKLADFGLARAKSVP 156 (303)
T ss_pred EEECCC-cCHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEECCCCcceeccCC
Confidence 999995 688888753 3356888999999999999999999988 999999999999999999999999987532
Q ss_pred ------CCCCccccchhhccc-CCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhc-CCCCcc--------
Q 004979 585 ------TAAKTGSAAMELLET-SAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKG-EQPLKD-------- 648 (721)
Q Consensus 585 ------~~~~~~~~apE~~~~-~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~-~~~~~~-------- 648 (721)
..++..|+|||.+.+ ..++.++||||+||++|||+||+.||.... +..+........ ..+...
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T cd07869 157 SHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMK-DIQDQLERIFLVLGTPNEDTWPGVHSL 235 (303)
T ss_pred CccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCc-cHHHHHHHHHHHhCCCChhhccchhhc
Confidence 123456899998764 468899999999999999999999997432 222222221110 000000
Q ss_pred -ccCCc-cc-----cccH-----HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 649 -IVDPT-LK-----SFQE-----NVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 649 -~~d~~-l~-----~~~~-----~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
..++. .. .... ....++.+++.+|++.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 236 PHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred cccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 00000 00 0000 12356889999999999999999999975
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=327.54 Aligned_cols=242 Identities=18% Similarity=0.246 Sum_probs=190.4
Q ss_pred hhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
++++.||+|+||+||+|+. .+++.+|+|++...... .......+.+|+++|++++|+||+++++.+.+.+ ..++|
T Consensus 4 ~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~--~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~--~~~lv 79 (376)
T cd05598 4 VKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVL--MRNQAAHVKAERDILAEADNEWVVKLYYSFQDKD--NLYFV 79 (376)
T ss_pred eEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHH--hhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCC--EEEEE
Confidence 6788999999999999985 46788999987543211 1223456889999999999999999999998877 77999
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC----
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT---- 584 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~---- 584 (721)
|||+++|+|.+++.. ...++......++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 80 ~E~~~~g~L~~~i~~--~~~~~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 80 MDYIPGGDMMSLLIR--LGIFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred EeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence 999999999999863 346788888899999999999999988 999999999999999999999999986311
Q ss_pred ------------------------------------------------CCCCccccchhhcccCCCCCCccHHHHHHHHH
Q 004979 585 ------------------------------------------------TAAKTGSAAMELLETSAVDLESNVYSFGTILF 616 (721)
Q Consensus 585 ------------------------------------------------~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ 616 (721)
..++..|+|||.+....++.++|||||||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily 235 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence 13456799999999999999999999999999
Q ss_pred HHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccHHHHHHHHHHHHHcccCCCCCCC---CHHHHHHH
Q 004979 617 EMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRP---SMRGIAAK 689 (721)
Q Consensus 617 ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RP---s~~evl~~ 689 (721)
||+||+.||.... ..+....+........ .+ .....+.++.+++.+|+ .+|.+|+ ++.|+++.
T Consensus 236 ell~G~~Pf~~~~--~~~~~~~i~~~~~~~~---~~----~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 236 EMLVGQPPFLADT--PAETQLKVINWETTLH---IP----SQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred ehhhCCCCCCCCC--HHHHHHHHhccCcccc---CC----CCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 9999999996433 2222222221111100 00 01234456778888876 5999999 88988753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=306.61 Aligned_cols=246 Identities=21% Similarity=0.362 Sum_probs=191.5
Q ss_pred hhCcCCCCceeEEEEEEecCCc---EEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCC----Cc
Q 004979 431 IIGSFSDGTVGTVYKGTLSSGV---EIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDE----PF 503 (721)
Q Consensus 431 ii~~lg~G~~g~Vyk~~~~~~~---~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~----~~ 503 (721)
+...+|+|+||.||+|+..... .+++|.+..... .....+.|.+|++++++++|+||+++++++.... ..
T Consensus 3 i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 79 (272)
T cd05075 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAIC---TRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP 79 (272)
T ss_pred cccccCcccCceEEEeEEccCCCeeeEEEEecccCcC---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence 3457889999999999975432 578887654321 2233567899999999999999999999875421 12
Q ss_pred eEEEEEecCCCCChhhhhhhc----cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccC
Q 004979 504 TRMMVFEYSPNGSLFEHLHIQ----EAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFS 579 (721)
Q Consensus 504 ~~~lV~Ey~~~GsL~~~l~~~----~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFG 579 (721)
..++||||+++|+|.+++... ....+++.....++.|++.||+|||+++ |+||||||+|||+++++.+||+|||
T Consensus 80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS--FIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhheEEcCCCCEEECCCC
Confidence 468999999999999887422 2345899999999999999999999987 9999999999999999999999999
Q ss_pred CCCCCCC-----------CCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhcCCCCc
Q 004979 580 FWNNTTA-----------AKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPLK 647 (721)
Q Consensus 580 la~~~~~-----------~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~ 647 (721)
+++.... ....|++||......++.++|||||||++|||++ |+.||... ...+.......+.. .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~--~~~~~~~~~~~~~~-~- 233 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGV--ENSEIYDYLRQGNR-L- 233 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCC--CHHHHHHHHHcCCC-C-
Confidence 9764321 2235789999988899999999999999999999 88898532 22333333222211 1
Q ss_pred cccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 004979 648 DIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEI 693 (721)
Q Consensus 648 ~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i 693 (721)
.....++..+.+++.+||+.+|++||++.||++.|+++
T Consensus 234 --------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 234 --------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred --------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11223456789999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=305.54 Aligned_cols=240 Identities=23% Similarity=0.371 Sum_probs=194.2
Q ss_pred hhhCcCCCCceeEEEEEEecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVF 509 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV~ 509 (721)
++.+.+|+|+||.||+|....+..+++|.+..... ..+.+.+|++++++++|+||+++++++.. + ..++||
T Consensus 9 ~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~--~~~~v~ 79 (260)
T cd05069 9 RLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM------MPEAFLQEAQIMKKLRHDKLVPLYAVVSE-E--PIYIVT 79 (260)
T ss_pred eeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc------cHHHHHHHHHHHHhCCCCCeeeEEEEEcC-C--CcEEEE
Confidence 56778999999999999988777889887653221 23568899999999999999999998854 3 458999
Q ss_pred ecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCCC---
Q 004979 510 EYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTA--- 586 (721)
Q Consensus 510 Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~~--- 586 (721)
||+++|+|.++++......+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++....
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05069 80 EFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN--YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred EcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEcCCCeEEECCCccceEccCCcc
Confidence 9999999999997555556899999999999999999999988 99999999999999999999999998753221
Q ss_pred -------CCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhcCCCCccccCCcccccc
Q 004979 587 -------AKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQ 658 (721)
Q Consensus 587 -------~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 658 (721)
....|++||......++.++|||||||++|||+| |+.||.... ..+.......+ ... ..+
T Consensus 158 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~--~~~~~~~~~~~-~~~---------~~~ 225 (260)
T cd05069 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMV--NREVLEQVERG-YRM---------PCP 225 (260)
T ss_pred cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHHHcC-CCC---------CCC
Confidence 1235899999988899999999999999999999 899986432 22222222211 110 112
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 004979 659 ENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKE 692 (721)
Q Consensus 659 ~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 692 (721)
...+..+.+++.+||+.+|++||++++|.+.|++
T Consensus 226 ~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 226 QGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred cccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 3455778999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=310.72 Aligned_cols=255 Identities=20% Similarity=0.323 Sum_probs=198.8
Q ss_pred hhhhCcCCCCceeEEEEEEec------CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCC
Q 004979 429 SNIIGSFSDGTVGTVYKGTLS------SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEP 502 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~------~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~ 502 (721)
+++.+.+|+|+||.||+|..+ .+..|++|.+..... ......+.+|+.++++++|+||+++++++.+.+
T Consensus 8 ~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~- 82 (288)
T cd05061 8 ITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS----LRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ- 82 (288)
T ss_pred ceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCC----HHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC-
Confidence 367889999999999999753 245788887653221 222346889999999999999999999988776
Q ss_pred ceEEEEEecCCCCChhhhhhhcc--------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEE
Q 004979 503 FTRMMVFEYSPNGSLFEHLHIQE--------AEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAK 574 (721)
Q Consensus 503 ~~~~lV~Ey~~~GsL~~~l~~~~--------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~k 574 (721)
..++||||+++|+|.+++.... ....++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+|
T Consensus 83 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 83 -PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK--FVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred -CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCCChheEEEcCCCcEE
Confidence 5699999999999999996421 234577788999999999999999988 99999999999999999999
Q ss_pred EeccCCCCCCCC-----------CCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhc
Q 004979 575 ISDFSFWNNTTA-----------AKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKG 642 (721)
Q Consensus 575 L~DFGla~~~~~-----------~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~ 642 (721)
|+|||+++.... +...|++||.+....++.++|||||||++|||++ |+.||... ...+.......+
T Consensus 160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~--~~~~~~~~~~~~ 237 (288)
T cd05061 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGL--SNEQVLKFVMDG 237 (288)
T ss_pred ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHHHcC
Confidence 999998763321 1235899999988899999999999999999999 78888532 233333333222
Q ss_pred CCCCccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCChhHH
Q 004979 643 EQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAMEPDGATPKLSPLWW 710 (721)
Q Consensus 643 ~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~~~~p~~~~~~~ 710 (721)
.. ...+..++.++.+++.+||+.+|++||++.|+++.|++.. +|.+.+++|
T Consensus 238 ~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~-------~~~~~~~~~ 288 (288)
T cd05061 238 GY----------LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL-------HPSFPEVSF 288 (288)
T ss_pred CC----------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc-------CCCCCCCCC
Confidence 11 1112234568999999999999999999999999888753 445555554
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=303.39 Aligned_cols=240 Identities=20% Similarity=0.317 Sum_probs=196.3
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
++.+.+|+|++|.||+|+.. ++..+++|.+..... .......+.+|++++++++||||+++++++.+.+ ..++|
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv 77 (256)
T cd08529 3 EILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKM---NRREREEAIDEARVLAKLDSSYIIRYYESFLDKG--KLNIV 77 (256)
T ss_pred eEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhC---CHHHHHHHHHHHHHHHhcCCCCeehheeeeccCC--EEEEE
Confidence 34567889999999999964 678899998764322 2334567999999999999999999999998776 67999
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC---
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT--- 585 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~--- 585 (721)
|||+++++|.++++......+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++...
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~--i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 78 MEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK--ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred EEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence 99999999999997654567899999999999999999999987 9999999999999999999999999875332
Q ss_pred ------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccH
Q 004979 586 ------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQE 659 (721)
Q Consensus 586 ------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 659 (721)
.+...|+|||......++.++|||||||++|||+||+.||.... ..+.......+.. .....
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~~~~----------~~~~~ 223 (256)
T cd08529 156 NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN--QGALILKIIRGVF----------PPVSQ 223 (256)
T ss_pred chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHcCCC----------CCCcc
Confidence 23446899999998899999999999999999999999996433 2232333322211 11222
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 660 NVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 660 ~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
....++.+++.+||+.+|++||++.|+++
T Consensus 224 ~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 224 MYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252 (256)
T ss_pred ccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence 45577899999999999999999999976
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=325.94 Aligned_cols=241 Identities=18% Similarity=0.251 Sum_probs=188.5
Q ss_pred hhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
++++.||+|+||+||+|+. .++..+|+|++...... .......+.+|++++++++|+|||++++++.+.+ ..++|
T Consensus 4 ~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~--~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~--~~~lv 79 (382)
T cd05625 4 VKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVL--LRNQVAHVKAERDILAEADNEWVVRLYYSFQDKD--NLYFV 79 (382)
T ss_pred EEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhh--hHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCC--EEEEE
Confidence 5678899999999999985 46788999988643211 1234467889999999999999999999998876 67999
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC----
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT---- 584 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~---- 584 (721)
|||+++|+|.+++.. ...+++.....++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 80 ~E~~~gg~L~~~l~~--~~~~~e~~~~~~~~qi~~al~~lH~~~--ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 80 MDYIPGGDMMSLLIR--MGIFPEDLARFYIAELTCAVESVHKMG--FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred EeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 999999999999863 345788888999999999999999988 999999999999999999999999986311
Q ss_pred ----------------------------------------------------CCCCccccchhhcccCCCCCCccHHHHH
Q 004979 585 ----------------------------------------------------TAAKTGSAAMELLETSAVDLESNVYSFG 612 (721)
Q Consensus 585 ----------------------------------------------------~~~~~~~~apE~~~~~~~s~ksDVwSfG 612 (721)
..++..|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence 1245579999999999999999999999
Q ss_pred HHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccHHHHHHHHHHHHHcccCCCCCCCC---HHHHHH
Q 004979 613 TILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPS---MRGIAA 688 (721)
Q Consensus 613 vvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs---~~evl~ 688 (721)
|++|||+||+.||.... ..+............. .+ .....+.++.+++.+++ .+|++|++ +.|+++
T Consensus 236 vil~elltG~~Pf~~~~--~~~~~~~i~~~~~~~~---~p----~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~ 304 (382)
T cd05625 236 VILYEMLVGQPPFLAQT--PLETQMKVINWQTSLH---IP----PQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKA 304 (382)
T ss_pred HHHHHHHhCCCCCCCCC--HHHHHHHHHccCCCcC---CC----CcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhc
Confidence 99999999999996432 2222222222111110 00 01223456777777765 59999987 887765
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=309.01 Aligned_cols=250 Identities=24% Similarity=0.348 Sum_probs=196.3
Q ss_pred hhhhhhCcCCCCceeEEEEEEe-----cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCC
Q 004979 427 DFSNIIGSFSDGTVGTVYKGTL-----SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDE 501 (721)
Q Consensus 427 ~~~~ii~~lg~G~~g~Vyk~~~-----~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~ 501 (721)
.|+++++.+|+|+||.||++++ .++..+++|.+..... ......+.+|++++++++||||+++++++...+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 79 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG----GNHIADLKKEIEILRNLYHENIVKYKGICTEDG 79 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCcccc----HHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCC
Confidence 3557889999999999999984 3567899998754321 223467999999999999999999999998764
Q ss_pred CceEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCC
Q 004979 502 PFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFW 581 (721)
Q Consensus 502 ~~~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla 581 (721)
....++||||+++++|.+++... ...++|..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 80 ~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~i~~~i~~aL~~lH~~g--i~H~dlkp~Nil~~~~~~~~l~dfg~~ 156 (284)
T cd05079 80 GNGIKLIMEFLPSGSLKEYLPRN-KNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESEHQVKIGDFGLT 156 (284)
T ss_pred CCceEEEEEccCCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccchheEEEcCCCCEEECCCccc
Confidence 33579999999999999998543 346899999999999999999999988 999999999999999999999999987
Q ss_pred CCCCC------------CCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCC-------------CHHHHH
Q 004979 582 NNTTA------------AKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENG-------------SLENWA 636 (721)
Q Consensus 582 ~~~~~------------~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~-------------~~~~~~ 636 (721)
+.... +...|+|||.+.+..++.++|||||||++|||+|++.|...... ......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05079 157 KAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLV 236 (284)
T ss_pred cccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHH
Confidence 64321 22357899999888899999999999999999998766431110 011111
Q ss_pred HHHhhcCCCCccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 004979 637 SEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEI 693 (721)
Q Consensus 637 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i 693 (721)
.. ..... ....+..++.++.+++.+||+.+|++||++.|+++.|+++
T Consensus 237 ~~-~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 237 RV-LEEGK---------RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HH-HHcCc---------cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 11 11100 0111234567899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=308.01 Aligned_cols=247 Identities=22% Similarity=0.339 Sum_probs=197.9
Q ss_pred hhhCcCCCCceeEEEEEEecC-----CcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCce
Q 004979 430 NIIGSFSDGTVGTVYKGTLSS-----GVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFT 504 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~~-----~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 504 (721)
++.+.+|+|+||.||+|.... +..|++|++... ......+.+.+|+.++++++|+||+++++++...+. .
T Consensus 9 ~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~----~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~-~ 83 (280)
T cd05043 9 TLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH----ASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE-P 83 (280)
T ss_pred EEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC----CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC-C
Confidence 456778899999999999765 677888876522 123345678999999999999999999999876432 5
Q ss_pred EEEEEecCCCCChhhhhhhccC------CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEecc
Q 004979 505 RMMVFEYSPNGSLFEHLHIQEA------EHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDF 578 (721)
Q Consensus 505 ~~lV~Ey~~~GsL~~~l~~~~~------~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DF 578 (721)
.++++||+++|+|.+++..... ..+++.++..++.|++.||+|||+.+ ++||||||+||++++++.+||+||
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG--VIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCHhhEEEcCCCcEEECCC
Confidence 6899999999999999864322 46899999999999999999999988 999999999999999999999999
Q ss_pred CCCCCCCC-----------CCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhcCCCC
Q 004979 579 SFWNNTTA-----------AKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPL 646 (721)
Q Consensus 579 Gla~~~~~-----------~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~ 646 (721)
|+++.... +...|+|||.+....++.++|||||||++||+++ |+.||... +..++......+ ...
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~--~~~~~~~~~~~~-~~~ 238 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEI--DPFEMAAYLKDG-YRL 238 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcC--CHHHHHHHHHcC-CCC
Confidence 99874321 2335899999988889999999999999999999 99999643 223333322222 111
Q ss_pred ccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 004979 647 KDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITA 695 (721)
Q Consensus 647 ~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~ 695 (721)
. ....++.++.+++.+||+.+|++||++.|+++.|+++.+
T Consensus 239 ~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 239 A---------QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred C---------CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 1 112245678999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=313.41 Aligned_cols=249 Identities=25% Similarity=0.398 Sum_probs=198.6
Q ss_pred hhhhCcCCCCceeEEEEEEec--------CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcC-CCCccceEeEEEec
Q 004979 429 SNIIGSFSDGTVGTVYKGTLS--------SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKV-NHKNFVNLIGYCEE 499 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~--------~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~ 499 (721)
+.+.+.+|+|+||.||+++.. ....+++|.+.... ......++.+|++++.++ +|+||+++++++..
T Consensus 20 ~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (307)
T cd05098 20 LVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA----TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 95 (307)
T ss_pred eEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC----ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence 467789999999999999753 22468888775321 122345688999999999 89999999999988
Q ss_pred CCCceEEEEEecCCCCChhhhhhhcc--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCe
Q 004979 500 DEPFTRMMVFEYSPNGSLFEHLHIQE--------------AEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSI 565 (721)
Q Consensus 500 ~~~~~~~lV~Ey~~~GsL~~~l~~~~--------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NI 565 (721)
.+ ..++||||+++|+|.+++.... ...++|.+++.++.|++.||+|||+.+ ++||||||+||
T Consensus 96 ~~--~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~H~dlkp~Ni 171 (307)
T cd05098 96 DG--PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK--CIHRDLAARNV 171 (307)
T ss_pred CC--ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--cccccccHHhe
Confidence 76 5799999999999999997532 135899999999999999999999988 99999999999
Q ss_pred EeCCCCcEEEeccCCCCCCCC-----------CCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHH
Q 004979 566 YLTEDYAAKISDFSFWNNTTA-----------AKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLE 633 (721)
Q Consensus 566 Ll~~~~~~kL~DFGla~~~~~-----------~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~ 633 (721)
|+++++.+||+|||+++.... ....|+|||.+.+..++.++|||||||++|||++ |+.||... ...
T Consensus 172 ll~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~--~~~ 249 (307)
T cd05098 172 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV--PVE 249 (307)
T ss_pred EEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcC--CHH
Confidence 999999999999998763321 1236899999988889999999999999999998 88888532 333
Q ss_pred HHHHHHhhcCCCCccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcC
Q 004979 634 NWASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAME 697 (721)
Q Consensus 634 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 697 (721)
+........ .. ...+...+.++.+++.+||+.+|++||++.||++.|+++.+..
T Consensus 250 ~~~~~~~~~-~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~ 303 (307)
T cd05098 250 ELFKLLKEG-HR---------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT 303 (307)
T ss_pred HHHHHHHcC-CC---------CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence 333322221 11 1122344578889999999999999999999999999987754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=307.90 Aligned_cols=242 Identities=23% Similarity=0.346 Sum_probs=191.7
Q ss_pred hhhCcCCCCceeEEEEEEecC------CcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCc
Q 004979 430 NIIGSFSDGTVGTVYKGTLSS------GVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPF 503 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~~------~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 503 (721)
.+++.+|+|+||.||+|.+.. +..|++|...... .......|.+|+.++++++|+||+++++++.+.+
T Consensus 9 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-- 82 (277)
T cd05036 9 TLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC----SEQDESDFLMEALIMSKFNHQNIVRLIGVSFERL-- 82 (277)
T ss_pred EeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC----CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC--
Confidence 567889999999999998753 4567777664322 1233467999999999999999999999988776
Q ss_pred eEEEEEecCCCCChhhhhhhccC-----CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCC---cEEE
Q 004979 504 TRMMVFEYSPNGSLFEHLHIQEA-----EHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDY---AAKI 575 (721)
Q Consensus 504 ~~~lV~Ey~~~GsL~~~l~~~~~-----~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~---~~kL 575 (721)
..++||||+++|+|.+++..... ..++|..++.++.||+.||+|||+.+ ++||||||+||+++.++ .+||
T Consensus 83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH--FIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchheEEEeccCCCcceEe
Confidence 45899999999999999864421 35899999999999999999999988 99999999999998654 6999
Q ss_pred eccCCCCCCCCC-----------CccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhcC
Q 004979 576 SDFSFWNNTTAA-----------KTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGE 643 (721)
Q Consensus 576 ~DFGla~~~~~~-----------~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~~ 643 (721)
+|||+++..... ...|+|||.+.+..++.++|||||||++|||+| |+.||.... ..+........
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~--~~~~~~~~~~~- 237 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRT--NQEVMEFVTGG- 237 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC--HHHHHHHHHcC-
Confidence 999998654211 135899999988899999999999999999997 999996332 22332222211
Q ss_pred CCCccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 004979 644 QPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLK 691 (721)
Q Consensus 644 ~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 691 (721)
... ..+..++.++.+++.+||+.+|++||++.||++.|+
T Consensus 238 ~~~---------~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 238 GRL---------DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred CcC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 110 112334567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=309.82 Aligned_cols=246 Identities=24% Similarity=0.378 Sum_probs=193.8
Q ss_pred hhhCcCCCCceeEEEEEEec------CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCc
Q 004979 430 NIIGSFSDGTVGTVYKGTLS------SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPF 503 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~------~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 503 (721)
++...+|+|+||.||+|+.. ....+++|.+.... ......++.+|++++++++||||+++++.+...+
T Consensus 3 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-- 76 (290)
T cd05045 3 VLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA----SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDG-- 76 (290)
T ss_pred cccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC----CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCC--
Confidence 45678899999999999853 22457777664322 1223467999999999999999999999998776
Q ss_pred eEEEEEecCCCCChhhhhhhcc----------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCC
Q 004979 504 TRMMVFEYSPNGSLFEHLHIQE----------------------AEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQ 561 (721)
Q Consensus 504 ~~~lV~Ey~~~GsL~~~l~~~~----------------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLK 561 (721)
..++|+||+.+|+|.+++.... ...+++..++.++.|++.||+|||+.+ |+|||||
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--ivH~dik 154 (290)
T cd05045 77 PLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK--LVHRDLA 154 (290)
T ss_pred CcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC--eehhhhh
Confidence 5699999999999999875321 235889999999999999999999988 9999999
Q ss_pred CCCeEeCCCCcEEEeccCCCCCCC-----------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCC
Q 004979 562 SSSIYLTEDYAAKISDFSFWNNTT-----------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIEN 629 (721)
Q Consensus 562 p~NILl~~~~~~kL~DFGla~~~~-----------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~ 629 (721)
|+|||+++++.+||+|||+++... .....|++||...+..++.++||||||+++|||+| |+.||...
T Consensus 155 p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~- 233 (290)
T cd05045 155 ARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI- 233 (290)
T ss_pred hheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCC-
Confidence 999999999999999999976421 12346899999988889999999999999999999 99998532
Q ss_pred CCHHHHHHHHhhcCCCCccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 004979 630 GSLENWASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITA 695 (721)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~ 695 (721)
...+........ ... ..+..++.++.+++.+||+.+|++||++.|+++.|+++..
T Consensus 234 -~~~~~~~~~~~~-~~~---------~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 234 -APERLFNLLKTG-YRM---------ERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred -CHHHHHHHHhCC-CCC---------CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 223322222111 100 1122345678899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=317.17 Aligned_cols=250 Identities=21% Similarity=0.344 Sum_probs=195.1
Q ss_pred hhhhCcCCCCceeEEEEEEe------cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcC-CCCccceEeEEEecCC
Q 004979 429 SNIIGSFSDGTVGTVYKGTL------SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKV-NHKNFVNLIGYCEEDE 501 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~------~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~ 501 (721)
+++.+.||+|+||+||+|+. .+++.||||++..... ......+.+|++++.++ +|+||++++++|...+
T Consensus 9 ~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (343)
T cd05103 9 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT----HSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 84 (343)
T ss_pred hcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC----hHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence 46788999999999999973 3467899998864321 22345788999999999 7899999999887654
Q ss_pred CceEEEEEecCCCCChhhhhhhcc--------------------------------------------------------
Q 004979 502 PFTRMMVFEYSPNGSLFEHLHIQE-------------------------------------------------------- 525 (721)
Q Consensus 502 ~~~~~lV~Ey~~~GsL~~~l~~~~-------------------------------------------------------- 525 (721)
. ..++||||+++|+|.++++...
T Consensus 85 ~-~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (343)
T cd05103 85 G-PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 163 (343)
T ss_pred C-ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence 3 4689999999999999986421
Q ss_pred ---------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCCC----------
Q 004979 526 ---------AEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTA---------- 586 (721)
Q Consensus 526 ---------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~~---------- 586 (721)
...++|.++..++.|++.||+|||+.+ |+||||||+|||+++++++||+|||+++....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 241 (343)
T cd05103 164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 241 (343)
T ss_pred hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence 123688889999999999999999988 99999999999999999999999998764311
Q ss_pred -CCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccHHHHHH
Q 004979 587 -AKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQENVLEE 664 (721)
Q Consensus 587 -~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 664 (721)
....|++||.+....++.++|||||||++|||++ |..||...... .........+ ... ..+.....+
T Consensus 242 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-~~~~~~~~~~-~~~---------~~~~~~~~~ 310 (343)
T cd05103 242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-EEFCRRLKEG-TRM---------RAPDYTTPE 310 (343)
T ss_pred CCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc-HHHHHHHhcc-CCC---------CCCCCCCHH
Confidence 1235899999988899999999999999999997 99998643222 1111111111 110 011123457
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 004979 665 LLVVIKNCVHPDPKQRPSMRGIAAKLKEITAM 696 (721)
Q Consensus 665 l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~ 696 (721)
+.+++.+||+.+|++||++.||++.|+.+.+.
T Consensus 311 ~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 311 MYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 88999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=303.28 Aligned_cols=238 Identities=25% Similarity=0.379 Sum_probs=191.4
Q ss_pred cCCCCceeEEEEEEecC--C--cEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEEE
Q 004979 434 SFSDGTVGTVYKGTLSS--G--VEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVF 509 (721)
Q Consensus 434 ~lg~G~~g~Vyk~~~~~--~--~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV~ 509 (721)
.+|+|+||.||+|.+.+ + ..+++|.+...... ...+.|.+|++++++++|+||+++++++.. . ..++||
T Consensus 2 ~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~--~~~~v~ 74 (257)
T cd05040 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS----DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-H--PLMMVT 74 (257)
T ss_pred cCCccCcccEEeeeEecCCCCceEEEEeecCCcccH----HHHHHHHHHHHHHhhcCCCCccceeEEEcC-C--eEEEEE
Confidence 56889999999998643 2 35788877644321 445789999999999999999999999887 4 679999
Q ss_pred ecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCCC---
Q 004979 510 EYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTA--- 586 (721)
Q Consensus 510 Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~~--- 586 (721)
||+++|+|.+++.......++|.....++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++....
T Consensus 75 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 152 (257)
T cd05040 75 ELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR--FIHRDLAARNILLASDDKVKIGDFGLMRALPQNED 152 (257)
T ss_pred EecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC--ccccccCcccEEEecCCEEEecccccccccccccc
Confidence 9999999999987543356899999999999999999999988 99999999999999999999999998764322
Q ss_pred ---------CCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhcCCCCccccCCcccc
Q 004979 587 ---------AKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKS 656 (721)
Q Consensus 587 ---------~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 656 (721)
+...|++||.+....++.++|||||||++|||+| |+.||... ...+........... . .
T Consensus 153 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~--~~~~~~~~~~~~~~~---~------~ 221 (257)
T cd05040 153 HYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGL--SGSQILKKIDKEGER---L------E 221 (257)
T ss_pred ceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHHHhcCCc---C------C
Confidence 2346899999998899999999999999999999 99998532 222333222211110 0 1
Q ss_pred ccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 004979 657 FQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLK 691 (721)
Q Consensus 657 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 691 (721)
.+...+..+.+++.+||+.+|++||++.|+++.|.
T Consensus 222 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 222 RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 12234567899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=313.42 Aligned_cols=242 Identities=20% Similarity=0.271 Sum_probs=192.5
Q ss_pred hhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEEE
Q 004979 431 IIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVF 509 (721)
Q Consensus 431 ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV~ 509 (721)
+.+.+|+|+||+||++... +++.+|+|.+....... ......+.+|+.++++++|+||+++++.+.+.+ ..++||
T Consensus 4 ~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~--~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~--~~~lv~ 79 (285)
T cd05630 4 QYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK--RKGESMALNEKQILEKVNSRFVVSLAYAYETKD--ALCLVL 79 (285)
T ss_pred eeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccc--hHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCC--EEEEEE
Confidence 4567889999999999854 67899999876443221 223356788999999999999999999998776 679999
Q ss_pred ecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC----
Q 004979 510 EYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT---- 585 (721)
Q Consensus 510 Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~---- 585 (721)
||+++|+|.+++.......+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||++....
T Consensus 80 e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05630 80 TLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER--IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 157 (285)
T ss_pred EecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence 9999999999886545556899999999999999999999988 9999999999999999999999999875322
Q ss_pred ----CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCH-HHHHHHHhhcCCCCccccCCccccccHH
Q 004979 586 ----AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSL-ENWASEYLKGEQPLKDIVDPTLKSFQEN 660 (721)
Q Consensus 586 ----~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~-~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 660 (721)
.++..|+|||.+.+..++.++|||||||++|||++|+.||....... .+......... . ......
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~---~-------~~~~~~ 227 (285)
T cd05630 158 IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV---Q-------EEYSEK 227 (285)
T ss_pred ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhh---h-------hhcCcc
Confidence 24557899999998899999999999999999999999997433211 11111111110 0 011233
Q ss_pred HHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 004979 661 VLEELLVVIKNCVHPDPKQRPS-----MRGIAA 688 (721)
Q Consensus 661 ~~~~l~~li~~Cl~~dP~~RPs-----~~evl~ 688 (721)
...++.+++.+||+.||++||+ +.|+++
T Consensus 228 ~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 228 FSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred CCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 4567889999999999999999 788875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=311.47 Aligned_cols=245 Identities=24% Similarity=0.395 Sum_probs=195.5
Q ss_pred hhhCcCCCCceeEEEEEEecC------CcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcC-CCCccceEeEEEecCCC
Q 004979 430 NIIGSFSDGTVGTVYKGTLSS------GVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKV-NHKNFVNLIGYCEEDEP 502 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~~------~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~ 502 (721)
+++..+|+|+||.||++.... ...+++|.+.... .......+.+|++++.++ +|+||+++++++...+
T Consensus 15 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~----~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~- 89 (293)
T cd05053 15 TLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA----TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG- 89 (293)
T ss_pred EEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC----CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC-
Confidence 567788999999999998642 3568888775321 122345688999999999 8999999999998776
Q ss_pred ceEEEEEecCCCCChhhhhhhc--------------cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeC
Q 004979 503 FTRMMVFEYSPNGSLFEHLHIQ--------------EAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLT 568 (721)
Q Consensus 503 ~~~~lV~Ey~~~GsL~~~l~~~--------------~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~ 568 (721)
..++||||+++|+|.++++.. ....+++..++.++.|++.||+|||+.+ |+||||||+|||++
T Consensus 90 -~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~dlkp~Nil~~ 166 (293)
T cd05053 90 -PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK--CIHRDLAARNVLVT 166 (293)
T ss_pred -CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--ccccccceeeEEEc
Confidence 569999999999999998642 2356899999999999999999999987 99999999999999
Q ss_pred CCCcEEEeccCCCCCCCC-----------CCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHH
Q 004979 569 EDYAAKISDFSFWNNTTA-----------AKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWA 636 (721)
Q Consensus 569 ~~~~~kL~DFGla~~~~~-----------~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~ 636 (721)
+++.+||+|||+++.... ....|+|||.+....++.++|||||||++|||++ |..||... ...+..
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~--~~~~~~ 244 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI--PVEELF 244 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCC--CHHHHH
Confidence 999999999998764321 1235899999988899999999999999999998 99998532 222222
Q ss_pred HHHhhcCCCCccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 004979 637 SEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEIT 694 (721)
Q Consensus 637 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~ 694 (721)
.....+. . ...+..+..++.+++.+||..+|++|||+.|+++.|+++.
T Consensus 245 ~~~~~~~-~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 245 KLLKEGY-R---------MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HHHHcCC-c---------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 2222111 1 0112334567889999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=322.99 Aligned_cols=246 Identities=20% Similarity=0.332 Sum_probs=194.3
Q ss_pred hhhCcCCCCceeEEEEEEec------CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCC-CCccceEeEEEecCCC
Q 004979 430 NIIGSFSDGTVGTVYKGTLS------SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVN-HKNFVNLIGYCEEDEP 502 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~------~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~ 502 (721)
.+.+.+|+|+||.||+|++. .+..||+|++..... ....+.+.+|+++|.++. |||||+++++|...+
T Consensus 40 ~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~----~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~- 114 (401)
T cd05107 40 VLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR----SSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG- 114 (401)
T ss_pred ehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC----hhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC-
Confidence 45678999999999999864 245799998864321 222356889999999997 999999999998876
Q ss_pred ceEEEEEecCCCCChhhhhhhcc---------------------------------------------------------
Q 004979 503 FTRMMVFEYSPNGSLFEHLHIQE--------------------------------------------------------- 525 (721)
Q Consensus 503 ~~~~lV~Ey~~~GsL~~~l~~~~--------------------------------------------------------- 525 (721)
..++||||+++|+|.++++...
T Consensus 115 -~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (401)
T cd05107 115 -PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQ 193 (401)
T ss_pred -CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchh
Confidence 5799999999999999986421
Q ss_pred ---------------------------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeE
Q 004979 526 ---------------------------------------AEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIY 566 (721)
Q Consensus 526 ---------------------------------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NIL 566 (721)
...++|...+.|+.|++.||+|||+.+ |+||||||+|||
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrdlkp~NiL 271 (401)
T cd05107 194 DMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN--CVHRDLAARNVL 271 (401)
T ss_pred cchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC--cCcccCCcceEE
Confidence 124678888999999999999999887 999999999999
Q ss_pred eCCCCcEEEeccCCCCCCC-----------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHH
Q 004979 567 LTEDYAAKISDFSFWNNTT-----------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLEN 634 (721)
Q Consensus 567 l~~~~~~kL~DFGla~~~~-----------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~ 634 (721)
+++++.+||+|||+++... .+...|++||.+....++.++|||||||++|||++ |+.||.... ..+
T Consensus 272 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~--~~~ 349 (401)
T cd05107 272 ICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELP--MNE 349 (401)
T ss_pred EeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCC--chH
Confidence 9999999999999976321 11235899999988889999999999999999998 888985332 122
Q ss_pred HHHHHhhcCCCCccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 004979 635 WASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEIT 694 (721)
Q Consensus 635 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~ 694 (721)
.....+...... ..+..++.++.+++.+||..+|++||+++||++.|+++.
T Consensus 350 ~~~~~~~~~~~~---------~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 350 QFYNAIKRGYRM---------AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred HHHHHHHcCCCC---------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 222222221111 112234578999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=300.51 Aligned_cols=237 Identities=24% Similarity=0.408 Sum_probs=191.6
Q ss_pred cCCCCceeEEEEEEecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEEEecCC
Q 004979 434 SFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSP 513 (721)
Q Consensus 434 ~lg~G~~g~Vyk~~~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV~Ey~~ 513 (721)
.+|+|+||.||+|...++..+++|.+.... .......|.+|++++++++||||+++++++...+ ..++||||++
T Consensus 2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~ 75 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDL----PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQ--PIYIVMELVP 75 (250)
T ss_pred ccCCCCCceEEEEEecCCcEEEEEecCCcC----CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCC--ccEEEEECCC
Confidence 468899999999998888889999875432 1233457899999999999999999999998776 5699999999
Q ss_pred CCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCCC-------
Q 004979 514 NGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTA------- 586 (721)
Q Consensus 514 ~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~~------- 586 (721)
+|+|.+++... ...+++..+..++.|++.||.|+|+.+ ++||||||+||++++++.+||+|||++.....
T Consensus 76 ~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~--~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~ 152 (250)
T cd05085 76 GGDFLSFLRKK-KDELKTKQLVKFALDAAAGMAYLESKN--CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSG 152 (250)
T ss_pred CCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccChheEEEcCCCeEEECCCccceeccccccccCC
Confidence 99999988643 346899999999999999999999988 99999999999999999999999998753221
Q ss_pred ---CCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccHHHH
Q 004979 587 ---AKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQENVL 662 (721)
Q Consensus 587 ---~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 662 (721)
....|+|||.+....++.++|||||||++||+++ |..||... ...........+. .. ..+..++
T Consensus 153 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~--~~~~~~~~~~~~~-~~---------~~~~~~~ 220 (250)
T cd05085 153 LKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGM--TNQQAREQVEKGY-RM---------SCPQKCP 220 (250)
T ss_pred CCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCC--CHHHHHHHHHcCC-CC---------CCCCCCC
Confidence 1235899999988899999999999999999999 99998633 2222222222111 10 1122345
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 004979 663 EELLVVIKNCVHPDPKQRPSMRGIAAKLK 691 (721)
Q Consensus 663 ~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 691 (721)
.++.+++.+||+.+|++||++.|+++.|.
T Consensus 221 ~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 221 DDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 78899999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=307.17 Aligned_cols=251 Identities=18% Similarity=0.289 Sum_probs=187.9
Q ss_pred hCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCC---ceEEE
Q 004979 432 IGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEP---FTRMM 507 (721)
Q Consensus 432 i~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~---~~~~l 507 (721)
...+|.|+||.||+|+.. ++..||||++-...+ --.+|+++|++++|||||++.-+|..... ....+
T Consensus 29 ~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r---------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl 99 (364)
T KOG0658|consen 29 VRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR---------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL 99 (364)
T ss_pred eEEEeecccceEEEEEEcCCCceeEEEEecCCCC---------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence 356778999999999964 568999998764332 12478999999999999999988865432 24578
Q ss_pred EEecCCCCChhhhhhhc--cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCC-CcEEEeccCCCCCC
Q 004979 508 VFEYSPNGSLFEHLHIQ--EAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTED-YAAKISDFSFWNNT 584 (721)
Q Consensus 508 V~Ey~~~GsL~~~l~~~--~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~-~~~kL~DFGla~~~ 584 (721)
||||||. +|+++++.. ....++...++-+..||.+||+|||+.+ |+||||||.|+|+|.+ |.+||||||.|+..
T Consensus 100 VleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~--IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 100 VLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG--ICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC--cccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 9999987 899888632 2455777777889999999999999988 9999999999999965 99999999999866
Q ss_pred CCCC--------ccccchhhcc-cCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCH-HHHHHHHhhcCCC---------
Q 004979 585 TAAK--------TGSAAMELLE-TSAVDLESNVYSFGTILFEMITGRISYSIENGSL-ENWASEYLKGEQP--------- 645 (721)
Q Consensus 585 ~~~~--------~~~~apE~~~-~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~-~~~~~~~~~~~~~--------- 645 (721)
..+. ..|.|||.+. ...|+.+.||||.|||+.||+-|+.-|.+++... ...+.+++ |...
T Consensus 177 ~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~l-G~Pt~e~I~~mn~ 255 (364)
T KOG0658|consen 177 VKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVL-GTPTREDIKSMNP 255 (364)
T ss_pred ccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHh-CCCCHHHHhhcCc
Confidence 5543 3678999875 5689999999999999999999999997644211 11111111 1111
Q ss_pred -CccccCCcccc------ccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHHhhh
Q 004979 646 -LKDIVDPTLKS------FQENVLEELLVVIKNCVHPDPKQRPSMRGIAAK--LKEITA 695 (721)
Q Consensus 646 -~~~~~d~~l~~------~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~--L~~i~~ 695 (721)
..+.-.+.+.. +......+..+|+.++++++|.+|.++.|++.. .++++.
T Consensus 256 ~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~ 314 (364)
T KOG0658|consen 256 NYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRD 314 (364)
T ss_pred ccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhC
Confidence 00111122211 233456789999999999999999999999864 444444
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=302.35 Aligned_cols=238 Identities=23% Similarity=0.375 Sum_probs=190.8
Q ss_pred cCCCCceeEEEEEEecC----CcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEEE
Q 004979 434 SFSDGTVGTVYKGTLSS----GVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVF 509 (721)
Q Consensus 434 ~lg~G~~g~Vyk~~~~~----~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV~ 509 (721)
.+|+|+||.||+|++.. +..+++|.+...... ...+++.+|++++++++|+|||++++++... ..++||
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---~~~~v~ 74 (257)
T cd05060 2 ELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA----AGKKEFLREASVMAQLDHPCIVRLIGVCKGE---PLMLVM 74 (257)
T ss_pred ccCccCceeEEEeEeeccCCCcceEEEEecccccch----HHHHHHHHHHHHHHhcCCCCeeeEEEEEcCC---ceEEEE
Confidence 57899999999998532 267888877643321 3456799999999999999999999988643 468999
Q ss_pred ecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCCCC--
Q 004979 510 EYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTAA-- 587 (721)
Q Consensus 510 Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~~~-- 587 (721)
||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||+++.....
T Consensus 75 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~ 150 (257)
T cd05060 75 ELAPLGPLLKYLKKR--REIPVSDLKELAHQVAMGMAYLESKH--FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSD 150 (257)
T ss_pred EeCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhcC--eeccCcccceEEEcCCCcEEeccccccceeecCCc
Confidence 999999999999643 36899999999999999999999988 999999999999999999999999987633211
Q ss_pred ----------CccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhcCCCCccccCCcccc
Q 004979 588 ----------KTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKS 656 (721)
Q Consensus 588 ----------~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 656 (721)
...|++||......++.++|||||||++|||++ |+.||...+ ..+........ ... .
T Consensus 151 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~--~~~~~~~~~~~-~~~---------~ 218 (257)
T cd05060 151 YYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMK--GAEVIAMLESG-ERL---------P 218 (257)
T ss_pred ccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCC--HHHHHHHHHcC-CcC---------C
Confidence 125889999998899999999999999999998 999996432 22332222222 111 1
Q ss_pred ccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 004979 657 FQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEIT 694 (721)
Q Consensus 657 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~ 694 (721)
.+..++..+.+++.+||..+|++||++.++++.|+++.
T Consensus 219 ~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 219 RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 12334567899999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=304.61 Aligned_cols=243 Identities=20% Similarity=0.326 Sum_probs=194.3
Q ss_pred hhhCcCCCCceeEEEEEEecC-C---cEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceE
Q 004979 430 NIIGSFSDGTVGTVYKGTLSS-G---VEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTR 505 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~~-~---~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~ 505 (721)
+....+|+|+||.||+|+... + ..+++|++..... ....+.+..|++++++++|+||+++++++...+ ..
T Consensus 8 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~ 81 (268)
T cd05063 8 TKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYT----EKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFK--PA 81 (268)
T ss_pred eEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCC----HHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCC--Cc
Confidence 445678899999999998652 3 2678887754321 223467899999999999999999999998776 56
Q ss_pred EEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC
Q 004979 506 MMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT 585 (721)
Q Consensus 506 ~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~ 585 (721)
++||||+++|+|.+++... ...+++.++..++.|++.|++|||+.+ |+||||||+||++++++.+||+|||++....
T Consensus 82 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 82 MIITEYMENGALDKYLRDH-DGEFSSYQLVGMLRGIAAGMKYLSDMN--YVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred EEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEEcCCCcEEECCCccceecc
Confidence 9999999999999998643 356899999999999999999999988 9999999999999999999999999875332
Q ss_pred CC------------CccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhcCCCCccccCC
Q 004979 586 AA------------KTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPLKDIVDP 652 (721)
Q Consensus 586 ~~------------~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 652 (721)
.. ...|++||.+....++.++|||||||++|||+| |+.||.... ..++...+... ...
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~--~~~~~~~i~~~-~~~------ 229 (268)
T cd05063 159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMS--NHEVMKAINDG-FRL------ 229 (268)
T ss_pred cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCC--HHHHHHHHhcC-CCC------
Confidence 11 124899999988889999999999999999998 999996332 23333333221 111
Q ss_pred ccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 004979 653 TLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEI 693 (721)
Q Consensus 653 ~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i 693 (721)
.....++.++.+++.+||+.+|++||++.+|++.|+++
T Consensus 230 ---~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 230 ---PAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred ---CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11123456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=324.07 Aligned_cols=242 Identities=20% Similarity=0.280 Sum_probs=197.3
Q ss_pred hCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEEEe
Q 004979 432 IGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFE 510 (721)
Q Consensus 432 i~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV~E 510 (721)
-..+|+|+|-+||||... +|.+||--.++...... .....++|..|+.+|+.|+|+|||++|.++.+.......+|+|
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q-~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQ-SPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhc-ChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 346779999999999854 56666643333222111 2334478999999999999999999999998876556789999
Q ss_pred cCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCC-CCcEEEeccCCCCCC-----
Q 004979 511 YSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTE-DYAAKISDFSFWNNT----- 584 (721)
Q Consensus 511 y~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~-~~~~kL~DFGla~~~----- 584 (721)
.|..|+|..|++ +.+.++......|++||.+||.|||++.|||||||||.+||+|+. .|.|||+|+|+|...
T Consensus 124 L~TSGtLr~Y~k--k~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~a 201 (632)
T KOG0584|consen 124 LFTSGTLREYRK--KHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSHA 201 (632)
T ss_pred cccCCcHHHHHH--HhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhcccc
Confidence 999999999986 445688889999999999999999999999999999999999985 599999999998533
Q ss_pred --CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccHHHH
Q 004979 585 --TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQENVL 662 (721)
Q Consensus 585 --~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 662 (721)
..|++.+||||++. ..|++.+||||||++|+||+|+..||. +-.+..+.++++..|..|-. +..--.
T Consensus 202 ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYs-EC~n~AQIYKKV~SGiKP~s---------l~kV~d 270 (632)
T KOG0584|consen 202 KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYS-ECTNPAQIYKKVTSGIKPAA---------LSKVKD 270 (632)
T ss_pred ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChh-hhCCHHHHHHHHHcCCCHHH---------hhccCC
Confidence 34678899999987 789999999999999999999999996 55677777787777654311 011113
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 663 EELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 663 ~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
+++.++|.+|+.. .++|||+.|++.
T Consensus 271 Pevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 271 PEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred HHHHHHHHHHhcC-chhccCHHHHhh
Confidence 5789999999999 999999999986
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=310.96 Aligned_cols=248 Identities=23% Similarity=0.404 Sum_probs=197.7
Q ss_pred hhhCcCCCCceeEEEEEEec--------CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcC-CCCccceEeEEEecC
Q 004979 430 NIIGSFSDGTVGTVYKGTLS--------SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKV-NHKNFVNLIGYCEED 500 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~--------~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~ 500 (721)
.+...+|+|+||.||+|+.. ++..+++|...... .....+.+.+|+.+++.+ +||||+++++++...
T Consensus 18 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 18 TLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA----TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred eecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc----chHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 56788999999999999742 23467888765321 123346789999999999 899999999999877
Q ss_pred CCceEEEEEecCCCCChhhhhhhcc--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeE
Q 004979 501 EPFTRMMVFEYSPNGSLFEHLHIQE--------------AEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIY 566 (721)
Q Consensus 501 ~~~~~~lV~Ey~~~GsL~~~l~~~~--------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NIL 566 (721)
. ..++||||+++|+|.+++.... ...++|..+..++.||+.||+|||+.+ |+||||||+|||
T Consensus 94 ~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g--ivH~dlkp~Nil 169 (304)
T cd05101 94 G--PLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK--CIHRDLAARNVL 169 (304)
T ss_pred C--ceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC--eeecccccceEE
Confidence 6 5799999999999999986532 135788999999999999999999988 999999999999
Q ss_pred eCCCCcEEEeccCCCCCCCC-----------CCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHH
Q 004979 567 LTEDYAAKISDFSFWNNTTA-----------AKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLEN 634 (721)
Q Consensus 567 l~~~~~~kL~DFGla~~~~~-----------~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~ 634 (721)
+++++.+||+|||+++.... ....|+|||.+.+..++.++|||||||++|||+| |..||... ...+
T Consensus 170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~--~~~~ 247 (304)
T cd05101 170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI--PVEE 247 (304)
T ss_pred EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC--CHHH
Confidence 99999999999998764321 1235899999988889999999999999999999 78888532 3444
Q ss_pred HHHHHhhcCCCCccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcC
Q 004979 635 WASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAME 697 (721)
Q Consensus 635 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 697 (721)
+......+. .. ..+..++.++.+++.+||+.+|++||++.|+++.|+++....
T Consensus 248 ~~~~~~~~~-~~---------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~ 300 (304)
T cd05101 248 LFKLLKEGH-RM---------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLT 300 (304)
T ss_pred HHHHHHcCC-cC---------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhh
Confidence 443332221 11 112345678899999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=310.93 Aligned_cols=250 Identities=24% Similarity=0.328 Sum_probs=190.1
Q ss_pred hhhCcCCCCceeEEEEEEecC---------------CcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEe
Q 004979 430 NIIGSFSDGTVGTVYKGTLSS---------------GVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLI 494 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~~---------------~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~ 494 (721)
++.+.+|+|+||.||+++... ...|++|.+.... .......|.+|++++++++|+||++++
T Consensus 8 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 8 RLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV----TKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred eehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC----CHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 667889999999999987542 2347888775331 223456799999999999999999999
Q ss_pred EEEecCCCceEEEEEecCCCCChhhhhhhcc----------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCC
Q 004979 495 GYCEEDEPFTRMMVFEYSPNGSLFEHLHIQE----------AEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSS 564 (721)
Q Consensus 495 g~~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~----------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~N 564 (721)
+++...+ ..++||||+++++|.+++.... ...+++..+..++.|++.||+|||+.+ ++||||||+|
T Consensus 84 ~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~N 159 (295)
T cd05097 84 GVCVSDD--PLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN--FVHRDLATRN 159 (295)
T ss_pred EEEcCCC--ccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC--eeccccChhh
Confidence 9998776 5799999999999999985421 124788999999999999999999988 9999999999
Q ss_pred eEeCCCCcEEEeccCCCCCCCC-----------CCccccchhhcccCCCCCCccHHHHHHHHHHHHh--CCCcccCCCCC
Q 004979 565 IYLTEDYAAKISDFSFWNNTTA-----------AKTGSAAMELLETSAVDLESNVYSFGTILFEMIT--GRISYSIENGS 631 (721)
Q Consensus 565 ILl~~~~~~kL~DFGla~~~~~-----------~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt--G~~P~~~~~~~ 631 (721)
|++++++.+||+|||+++.... ....|+|||......++.++|||||||++|||++ |..||....
T Consensus 160 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~-- 237 (295)
T cd05097 160 CLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS-- 237 (295)
T ss_pred EEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccC--
Confidence 9999999999999998764321 1236899999988889999999999999999998 556775322
Q ss_pred HHHHHHHHhhcCCCCccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 004979 632 LENWASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKE 692 (721)
Q Consensus 632 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 692 (721)
..+.+............ .......+..+..+.+++.+||+.+|++||++.+|++.|++
T Consensus 238 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 238 DEQVIENTGEFFRNQGR---QIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred hHHHHHHHHHhhhhccc---cccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 12222111110000000 00001112345689999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=302.55 Aligned_cols=242 Identities=19% Similarity=0.246 Sum_probs=193.7
Q ss_pred hhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
++.+.+|+|++|.||+|.. .++..+++|.+...............+.+|++++++++||||+++++++...+ ..++|
T Consensus 5 ~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~~v 82 (263)
T cd06625 5 RRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDE--TLSIF 82 (263)
T ss_pred cccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCC--eEEEE
Confidence 4567889999999999985 46889999987654322222333467899999999999999999999998877 78999
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC---
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT--- 585 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~--- 585 (721)
+||+++++|.+++.. ...+++.....++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++...
T Consensus 83 ~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~ 158 (263)
T cd06625 83 MEYMPGGSVKDQLKA--YGALTETVTRKYTRQILEGVEYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC 158 (263)
T ss_pred EEECCCCcHHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeecccceeccccc
Confidence 999999999998863 345888899999999999999999998 9999999999999999999999999875321
Q ss_pred ---------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCcccc
Q 004979 586 ---------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKS 656 (721)
Q Consensus 586 ---------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 656 (721)
.+...|+|||.+.+..++.++|||||||++|||++|+.||.... ............. ...
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~--~~~~~~~~~~~~~---------~~~ 227 (263)
T cd06625 159 SSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFE--AMAAIFKIATQPT---------NPQ 227 (263)
T ss_pred cccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccc--hHHHHHHHhccCC---------CCC
Confidence 12346899999998889999999999999999999999986332 1121112111110 111
Q ss_pred ccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 657 FQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 657 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
.+.....++.+++.+||..+|++||++.|+++
T Consensus 228 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 259 (263)
T cd06625 228 LPSHVSPDARNFLRRTFVENAKKRPSAEELLR 259 (263)
T ss_pred CCccCCHHHHHHHHHHhhcCcccCCCHHHHhh
Confidence 23345667899999999999999999999976
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=307.95 Aligned_cols=248 Identities=23% Similarity=0.351 Sum_probs=197.1
Q ss_pred hhhCcCCCCceeEEEEEEec-----CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCce
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-----SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFT 504 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-----~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 504 (721)
++++.+|+|+||.||+|++. ++..++||++...... ...+.|.+|++++++++|+||+++++++...+...
T Consensus 7 ~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~----~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~ 82 (284)
T cd05038 7 KFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE----QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS 82 (284)
T ss_pred hhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch----HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence 56788999999999999864 3678999987644321 24568999999999999999999999988744446
Q ss_pred EEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC
Q 004979 505 RMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT 584 (721)
Q Consensus 505 ~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~ 584 (721)
.++||||+++|+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++...
T Consensus 83 ~~lv~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05038 83 LRLIMEYLPSGSLRDYLQRH-RDQINLKRLLLFSSQICKGMDYLGSQR--YIHRDLAARNILVESEDLVKISDFGLAKVL 159 (284)
T ss_pred eEEEEecCCCCCHHHHHHhC-ccccCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEcCCCCEEEccccccccc
Confidence 79999999999999998643 335899999999999999999999988 999999999999999999999999987654
Q ss_pred CC------------CCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCH------------HHHHHHHh
Q 004979 585 TA------------AKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSL------------ENWASEYL 640 (721)
Q Consensus 585 ~~------------~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~------------~~~~~~~~ 640 (721)
.. ....|++||......++.++||||||+++|||+||+.|+....... .......+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05038 160 PEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELL 239 (284)
T ss_pred ccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHH
Confidence 31 1234789999988899999999999999999999999985322111 01111111
Q ss_pred hcCCCCccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 004979 641 KGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEI 693 (721)
Q Consensus 641 ~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i 693 (721)
..... ...+..++.++.+++.+||+.+|++||+|.||+++|+.+
T Consensus 240 ~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 240 KEGER---------LPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HcCCc---------CCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 11100 011233457799999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=322.09 Aligned_cols=242 Identities=18% Similarity=0.246 Sum_probs=190.9
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
++++.+|+|+||+||+++.. ++..+|+|++...... .......+.+|+++++.++||||+++++++.+.+ ..++|
T Consensus 46 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~--~~~lv 121 (370)
T cd05596 46 DVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMI--KRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDK--YLYMV 121 (370)
T ss_pred EEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh--hhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCC--EEEEE
Confidence 67788999999999999864 6788999988642211 1223345789999999999999999999998776 67999
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC---
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT--- 585 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~--- 585 (721)
|||+++|+|.+++.. ..++......++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 122 ~Ey~~gg~L~~~l~~---~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~ 196 (370)
T cd05596 122 MEYMPGGDLVNLMSN---YDIPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANG 196 (370)
T ss_pred EcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEcCCCCEEEEeccceeeccCCC
Confidence 999999999998853 34778888899999999999999988 9999999999999999999999999875321
Q ss_pred -------CCCccccchhhcccC----CCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCcc
Q 004979 586 -------AAKTGSAAMELLETS----AVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTL 654 (721)
Q Consensus 586 -------~~~~~~~apE~~~~~----~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 654 (721)
.++..|+|||.+... .++.++|||||||++|||+||+.||.... .......+......+. -+.
T Consensus 197 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~--~~~~~~~i~~~~~~~~---~~~- 270 (370)
T cd05596 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS--LVGTYSKIMDHKNSLT---FPD- 270 (370)
T ss_pred cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCC--HHHHHHHHHcCCCcCC---CCC-
Confidence 245679999998543 47899999999999999999999996433 2333333332211110 010
Q ss_pred ccccHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 004979 655 KSFQENVLEELLVVIKNCVHPDPKQ--RPSMRGIAAK 689 (721)
Q Consensus 655 ~~~~~~~~~~l~~li~~Cl~~dP~~--RPs~~evl~~ 689 (721)
....+.++.+++.+|++.+|++ |+++.|+++.
T Consensus 271 ---~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 271 ---DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred ---cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 1134578889999999999988 9999999763
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=305.45 Aligned_cols=243 Identities=23% Similarity=0.292 Sum_probs=192.8
Q ss_pred hhhhhhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCce
Q 004979 426 EDFSNIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFT 504 (721)
Q Consensus 426 ~~~~~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 504 (721)
++|+++++.+|+|+||.||+|... ++..+++|.+.... ....+.+.+|+++++.++||||+++++++...+ .
T Consensus 4 ~~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~-----~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~--~ 76 (282)
T cd06643 4 EEFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS-----EEELEDYMVEIDILASCDHPNIVKLLDAFYYEN--N 76 (282)
T ss_pred HHHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC-----HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCC--E
Confidence 567788999999999999999965 46667777764332 223467889999999999999999999998776 6
Q ss_pred EEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC
Q 004979 505 RMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT 584 (721)
Q Consensus 505 ~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~ 584 (721)
.++||||+++|+|..++.. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 77 ~~~v~e~~~~~~l~~~~~~-~~~~l~~~~~~~~~~qi~~~L~~LH~~~--i~H~dlkp~nili~~~~~~kl~dfg~~~~~ 153 (282)
T cd06643 77 LWILIEFCAGGAVDAVMLE-LERPLTEPQIRVVCKQTLEALNYLHENK--IIHRDLKAGNILFTLDGDIKLADFGVSAKN 153 (282)
T ss_pred EEEEEEecCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEEccCCCEEEccccccccc
Confidence 7999999999999988753 2356899999999999999999999988 999999999999999999999999987532
Q ss_pred C---------CCCccccchhhcc-----cCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCcccc
Q 004979 585 T---------AAKTGSAAMELLE-----TSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIV 650 (721)
Q Consensus 585 ~---------~~~~~~~apE~~~-----~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (721)
. .+...|++||.+. ...++.++|||||||++|||++|+.||.... ..+.+........+ ..
T Consensus 154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~--~~~~~~~~~~~~~~--~~- 228 (282)
T cd06643 154 TRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELN--PMRVLLKIAKSEPP--TL- 228 (282)
T ss_pred cccccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccC--HHHHHHHHhhcCCC--CC-
Confidence 1 2345789999873 4567889999999999999999999986432 22222222222111 11
Q ss_pred CCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 651 DPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 651 d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
..+..++.++.+++.+||+.+|.+||++.++++
T Consensus 229 -----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 229 -----AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred -----CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 112234567899999999999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=308.55 Aligned_cols=243 Identities=23% Similarity=0.363 Sum_probs=194.7
Q ss_pred hhhCcCCCCceeEEEEEEec------CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCc
Q 004979 430 NIIGSFSDGTVGTVYKGTLS------SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPF 503 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~------~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 503 (721)
++++.+|+|+||.||+|... ++..+++|.+.... .....+.|.+|++++++++||||+++++++...+
T Consensus 8 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~-- 81 (288)
T cd05050 8 EYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA----SADMQADFQREAALMAEFDHPNIVKLLGVCAVGK-- 81 (288)
T ss_pred eecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc----CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC--
Confidence 67789999999999999863 45678888775332 1234467999999999999999999999998776
Q ss_pred eEEEEEecCCCCChhhhhhhcc--------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCC
Q 004979 504 TRMMVFEYSPNGSLFEHLHIQE--------------------AEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSS 563 (721)
Q Consensus 504 ~~~lV~Ey~~~GsL~~~l~~~~--------------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~ 563 (721)
..++||||+++|+|.+++.... ...+++..+..++.|++.||+|||+.+ ++||||||+
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~--i~H~dl~p~ 159 (288)
T cd05050 82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK--FVHRDLATR 159 (288)
T ss_pred ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--eecccccHh
Confidence 5699999999999999986321 124788899999999999999999988 999999999
Q ss_pred CeEeCCCCcEEEeccCCCCCCCC-----------CCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCC
Q 004979 564 SIYLTEDYAAKISDFSFWNNTTA-----------AKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGS 631 (721)
Q Consensus 564 NILl~~~~~~kL~DFGla~~~~~-----------~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~ 631 (721)
||++++++.+||+|||+++.... ....|+|||.+.+..++.++|||||||++|||++ |..||.. ..
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~--~~ 237 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYG--MA 237 (288)
T ss_pred heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCC--CC
Confidence 99999999999999998753211 1235899999988899999999999999999998 8888852 23
Q ss_pred HHHHHHHHhhcCCCCccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 004979 632 LENWASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKE 692 (721)
Q Consensus 632 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 692 (721)
..+.......+.. ...++..+.++.+++.+||+.+|++||++.|+++.|++
T Consensus 238 ~~~~~~~~~~~~~----------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 238 HEEVIYYVRDGNV----------LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred HHHHHHHHhcCCC----------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 3344333322211 11223345789999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=311.75 Aligned_cols=252 Identities=23% Similarity=0.390 Sum_probs=199.3
Q ss_pred hhhCcCCCCceeEEEEEEec--------CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcC-CCCccceEeEEEecC
Q 004979 430 NIIGSFSDGTVGTVYKGTLS--------SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKV-NHKNFVNLIGYCEED 500 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~--------~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~ 500 (721)
.+...+|+|+||.||+++.. ....+++|.+.... .......+.+|+++++++ +||||+++++++...
T Consensus 15 ~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 15 VLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA----TDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred eeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC----ChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 56788999999999999742 23467888765322 122345788999999999 699999999999876
Q ss_pred CCceEEEEEecCCCCChhhhhhhcc--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeE
Q 004979 501 EPFTRMMVFEYSPNGSLFEHLHIQE--------------AEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIY 566 (721)
Q Consensus 501 ~~~~~~lV~Ey~~~GsL~~~l~~~~--------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NIL 566 (721)
+ ..++||||+++|+|.+++.... ...++|...+.++.|++.||+|||+++ |+||||||+|||
T Consensus 91 ~--~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~H~dlkp~Nil 166 (314)
T cd05099 91 G--PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR--CIHRDLAARNVL 166 (314)
T ss_pred C--ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC--eeeccccceeEE
Confidence 6 5699999999999999986432 235899999999999999999999988 999999999999
Q ss_pred eCCCCcEEEeccCCCCCCCC-----------CCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHH
Q 004979 567 LTEDYAAKISDFSFWNNTTA-----------AKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLEN 634 (721)
Q Consensus 567 l~~~~~~kL~DFGla~~~~~-----------~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~ 634 (721)
+++++.+||+|||+++.... ....|++||.+....++.++|||||||++|||++ |..||... ...+
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~--~~~~ 244 (314)
T cd05099 167 VTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGI--PVEE 244 (314)
T ss_pred EcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCC--CHHH
Confidence 99999999999999864321 1135899999988899999999999999999999 88888532 2233
Q ss_pred HHHHHhhcCCCCccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCCCCC
Q 004979 635 WASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAMEPDGA 701 (721)
Q Consensus 635 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~~~ 701 (721)
.......+ .. ...+..++.++.+++.+||..+|++||++.|+++.|+++.....+..
T Consensus 245 ~~~~~~~~-~~---------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~~~~ 301 (314)
T cd05099 245 LFKLLREG-HR---------MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVSEEY 301 (314)
T ss_pred HHHHHHcC-CC---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHhcCCc
Confidence 33222211 11 01123445678899999999999999999999999999887655544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=307.79 Aligned_cols=233 Identities=23% Similarity=0.356 Sum_probs=179.4
Q ss_pred cCCCCceeEEEEEEecC-------------------------CcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCC
Q 004979 434 SFSDGTVGTVYKGTLSS-------------------------GVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHK 488 (721)
Q Consensus 434 ~lg~G~~g~Vyk~~~~~-------------------------~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~ 488 (721)
.||+|+||.||+|++.. ...|++|++.... ......|.+|++++++++||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-----~~~~~~~~~~~~~~~~l~h~ 76 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH-----RDIALAFFETASLMSQVSHI 76 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH-----HHHHHHHHHHHHHHhcCCCC
Confidence 57899999999998521 1246666654321 22345788999999999999
Q ss_pred ccceEeEEEecCCCceEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeC
Q 004979 489 NFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLT 568 (721)
Q Consensus 489 nIv~l~g~~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~ 568 (721)
||++++++|.+.. ..++||||+++|+|..++.. ....+++..+..++.||++||+|||+.+ |+||||||+|||++
T Consensus 77 niv~~~~~~~~~~--~~~lv~ey~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~Nill~ 151 (274)
T cd05076 77 HLAFVHGVCVRGS--ENIMVEEFVEHGPLDVCLRK-EKGRVPVAWKITVAQQLASALSYLEDKN--LVHGNVCAKNILLA 151 (274)
T ss_pred CeeeEEEEEEeCC--ceEEEEecCCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHcCC--ccCCCCCcccEEEe
Confidence 9999999998776 67999999999999988853 3356889999999999999999999987 99999999999998
Q ss_pred CCC-------cEEEeccCCCCCC-----CCCCccccchhhccc-CCCCCCccHHHHHHHHHHHH-hCCCcccCCCCCHHH
Q 004979 569 EDY-------AAKISDFSFWNNT-----TAAKTGSAAMELLET-SAVDLESNVYSFGTILFEMI-TGRISYSIENGSLEN 634 (721)
Q Consensus 569 ~~~-------~~kL~DFGla~~~-----~~~~~~~~apE~~~~-~~~s~ksDVwSfGvvL~Ell-tG~~P~~~~~~~~~~ 634 (721)
+.+ .+|++|||++... ..+...|+|||.+.. ..++.++|||||||++|||+ +|+.||.........
T Consensus 152 ~~~~~~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~ 231 (274)
T cd05076 152 RLGLAEGTSPFIKLSDPGVSFTALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKE 231 (274)
T ss_pred ccCcccCccceeeecCCccccccccccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHH
Confidence 643 4899999986432 223456899998865 56899999999999999995 699998643221111
Q ss_pred HHHHHhhcCCCCccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 004979 635 WASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKL 690 (721)
Q Consensus 635 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L 690 (721)
......... ++....++.++|.+||+.+|++||+|.+|++.|
T Consensus 232 ---~~~~~~~~~-----------~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 232 ---RFYEKKHRL-----------PEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred ---HHHHhccCC-----------CCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 111111111 111234688999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=305.58 Aligned_cols=246 Identities=18% Similarity=0.318 Sum_probs=193.9
Q ss_pred hhhCcCCCCceeEEEEEEec-CCc----EEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCce
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGV----EIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFT 504 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~----~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 504 (721)
+++..+|+|+||+||+|++. ++. .||+|++.... .....+.+.+|+.++..++|+||+++++++... .
T Consensus 10 ~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~---~ 82 (279)
T cd05109 10 KKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT----SPKANKEILDEAYVMAGVGSPYVCRLLGICLTS---T 82 (279)
T ss_pred eeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC----CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC---C
Confidence 56788999999999999853 444 36777765322 233456789999999999999999999999754 3
Q ss_pred EEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC
Q 004979 505 RMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT 584 (721)
Q Consensus 505 ~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~ 584 (721)
.++++||+++|+|.++++.. ...+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 83 ~~l~~~~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~--iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 83 VQLVTQLMPYGCLLDYVREN-KDRIGSQDLLNWCVQIAKGMSYLEEVR--LVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred cEEEEEcCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccccceEEEcCCCcEEECCCCceeec
Confidence 57999999999999998642 346899999999999999999999988 999999999999999999999999987643
Q ss_pred CC-----------CCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhcCCCCccccCC
Q 004979 585 TA-----------AKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPLKDIVDP 652 (721)
Q Consensus 585 ~~-----------~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 652 (721)
.. ....|++||...+..++.++|||||||++|||+| |..||..... ..... ........
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~~-~~~~~~~~------ 230 (279)
T cd05109 160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA--REIPD-LLEKGERL------ 230 (279)
T ss_pred ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHH-HHHCCCcC------
Confidence 21 1235899999988899999999999999999999 8999853321 11111 11111111
Q ss_pred ccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcC
Q 004979 653 TLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAME 697 (721)
Q Consensus 653 ~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 697 (721)
..+..++.++.+++.+||+.||++||++.|+++.|+++....
T Consensus 231 ---~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 231 ---PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred ---CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 011234567889999999999999999999999988875543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=323.26 Aligned_cols=242 Identities=17% Similarity=0.239 Sum_probs=185.9
Q ss_pred hhhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEE
Q 004979 429 SNIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMM 507 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~l 507 (721)
|++++.+|+|+||.||+|.. .+++.||+|+.. ...+.+|++++++++|||||++++++.... ..++
T Consensus 94 y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-----------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~--~~~l 160 (391)
T PHA03212 94 FSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-----------RGGTATEAHILRAINHPSIIQLKGTFTYNK--FTCL 160 (391)
T ss_pred cEEEEEEcCCCCeEEEEEEECCCCCEEEEechh-----------hhhhHHHHHHHHhCCCCCCCCEeEEEEECC--eeEE
Confidence 47788999999999999985 467888988542 134678999999999999999999998766 6799
Q ss_pred EEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC---
Q 004979 508 VFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT--- 584 (721)
Q Consensus 508 V~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~--- 584 (721)
|+||+. ++|..++.. ...+++..++.|+.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 161 v~e~~~-~~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~ylH~~~--IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~ 235 (391)
T PHA03212 161 ILPRYK-TDLYCYLAA--KRNIAICDILAIERSVLRAIQYLHENR--IIHRDIKAENIFINHPGDVCLGDFGAACFPVDI 235 (391)
T ss_pred EEecCC-CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHhEEEcCCCCEEEEeCCcccccccc
Confidence 999995 789888753 346899999999999999999999988 999999999999999999999999998532
Q ss_pred -------CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCC-----CHHHHHHHHhhc--CCCCcc--
Q 004979 585 -------TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENG-----SLENWASEYLKG--EQPLKD-- 648 (721)
Q Consensus 585 -------~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~-----~~~~~~~~~~~~--~~~~~~-- 648 (721)
..++..|+|||.+....++.++|||||||++|||+||+.||..... +....+..+... ..+...
T Consensus 236 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~ 315 (391)
T PHA03212 236 NANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPI 315 (391)
T ss_pred cccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCc
Confidence 1245678999999988999999999999999999999988653211 111111111110 000000
Q ss_pred -----------------ccCCccc---cccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 649 -----------------IVDPTLK---SFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 649 -----------------~~d~~l~---~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
...+... ......+.++.+|+.+||+.||++|||+.|+++
T Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 316 DAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred chhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000000 001134567899999999999999999999986
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=341.29 Aligned_cols=253 Identities=19% Similarity=0.231 Sum_probs=199.0
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
++++.+|+|+||.||+|+.. +++.||+|++...... .....++|.+|++++++++|||||++++++.+.+ ..++|
T Consensus 5 eIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~--~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~--~lyLV 80 (932)
T PRK13184 5 DIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSE--NPLLKKRFLREAKIAADLIHPGIVPVYSICSDGD--PVYYT 80 (932)
T ss_pred EEEEEEecCCCEEEEEEEECCCCcEEEEEEECccccc--CHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCC--EEEEE
Confidence 67788999999999999864 5889999988643221 1334567999999999999999999999998876 67999
Q ss_pred EecCCCCChhhhhhhc---------cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccC
Q 004979 509 FEYSPNGSLFEHLHIQ---------EAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFS 579 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~---------~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFG 579 (721)
|||+++|+|.+++... ....+++...+.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G--IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG--VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchheEEEcCCCCEEEEecC
Confidence 9999999999988631 1234677888999999999999999988 9999999999999999999999999
Q ss_pred CCCCC---------------------------CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCH
Q 004979 580 FWNNT---------------------------TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSL 632 (721)
Q Consensus 580 la~~~---------------------------~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~ 632 (721)
+++.. ..++..|+|||.+.+..++.++|||||||++|||+||+.||......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~- 237 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR- 237 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh-
Confidence 87643 12456799999999999999999999999999999999999643221
Q ss_pred HHHHHHHhhcCCCCccccCCccccccHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHHHHhhhcCC
Q 004979 633 ENWASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRP-SMRGIAAKLKEITAMEP 698 (721)
Q Consensus 633 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RP-s~~evl~~L~~i~~~~~ 698 (721)
+..... .+.++.........+..+.+++.+||+.||++|| +++++.+.|+...+..+
T Consensus 238 -ki~~~~--------~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~~p 295 (932)
T PRK13184 238 -KISYRD--------VILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQGSP 295 (932)
T ss_pred -hhhhhh--------hccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcCc
Confidence 111100 0001100001123456788999999999999995 67888888888766543
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=313.67 Aligned_cols=247 Identities=17% Similarity=0.255 Sum_probs=187.5
Q ss_pred hhCcCCCC--ceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEE
Q 004979 431 IIGSFSDG--TVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMM 507 (721)
Q Consensus 431 ii~~lg~G--~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~l 507 (721)
+++.||+| +|++||+++. .++..||+|++...... ....+.+.+|+++++.++|||||++++++..++ ..++
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~--~~~l 76 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACT---NEMVTFLQGELHVSKLFNHPNIVPYRATFIADN--ELWV 76 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhcc---HHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECC--EEEE
Confidence 34566677 7899999985 57888999988643221 223456788999999999999999999998877 6799
Q ss_pred EEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC---
Q 004979 508 VFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT--- 584 (721)
Q Consensus 508 V~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~--- 584 (721)
||||+++|+|.+++.......+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.++++||+.....
T Consensus 77 v~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~ 154 (327)
T cd08227 77 VTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILISVDGKVYLSGLRSNLSMINH 154 (327)
T ss_pred EEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCChhhEEEecCCcEEEcccchhhccccc
Confidence 999999999999986544456899999999999999999999988 999999999999999999999999853211
Q ss_pred -------------CCCCccccchhhccc--CCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccc
Q 004979 585 -------------TAAKTGSAAMELLET--SAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDI 649 (721)
Q Consensus 585 -------------~~~~~~~~apE~~~~--~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (721)
..+...|+|||.+.. ..++.++|||||||++|||+||+.||..... .........+.. ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--~~~~~~~~~~~~--~~~ 230 (327)
T cd08227 155 GQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPA--TQMLLEKLNGTV--PCL 230 (327)
T ss_pred cccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcch--hHHHHHHhcCCc--ccc
Confidence 112235899999865 4689999999999999999999999963221 111111111100 000
Q ss_pred cC-------------------C------------------ccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 650 VD-------------------P------------------TLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 650 ~d-------------------~------------------~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
.+ . ...........++.+++.+||+.||++|||++|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 231 LDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred ccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 00 0 000112234568899999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=321.68 Aligned_cols=253 Identities=17% Similarity=0.277 Sum_probs=196.2
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
++++.+|+|+||+||+++.. ++..+|+|++...... .......+.+|++++.+++|+||+++++++.+.+ ..++|
T Consensus 4 ~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~--~~~lv 79 (360)
T cd05627 4 ESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADML--EKEQVAHIRAERDILVEADGAWVVKMFYSFQDKR--NLYLI 79 (360)
T ss_pred eEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHh--hhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC--EEEEE
Confidence 56788999999999999864 6788999988643211 1233467889999999999999999999998877 67999
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC----
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT---- 584 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~---- 584 (721)
|||+++|+|.+++.. ...+++.....++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 80 ~E~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~~L~~lH~~g--ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~ 155 (360)
T cd05627 80 MEFLPGGDMMTLLMK--KDTLSEEATQFYIAETVLAIDAIHQLG--FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH 155 (360)
T ss_pred EeCCCCccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence 999999999999863 356899999999999999999999988 999999999999999999999999987532
Q ss_pred ----------------------------------------CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCc
Q 004979 585 ----------------------------------------TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRIS 624 (721)
Q Consensus 585 ----------------------------------------~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P 624 (721)
..++..|+|||.+.+..++.++|||||||++|||+||+.|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~P 235 (360)
T cd05627 156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (360)
T ss_pred ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCC
Confidence 1245679999999999999999999999999999999999
Q ss_pred ccCCCCCHHHHHHHHhhcCCCCccccCCccccccHHHHHHHHHHHHHcccCCCCCCCC---HHHHHHHHHHhhhcCCCCC
Q 004979 625 YSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPS---MRGIAAKLKEITAMEPDGA 701 (721)
Q Consensus 625 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs---~~evl~~L~~i~~~~~~~~ 701 (721)
|.... ..+....+......+ .+.+. .....++.+++.+++ .+|.+|++ +.|+++
T Consensus 236 f~~~~--~~~~~~~i~~~~~~~--~~p~~-----~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~------------- 292 (360)
T cd05627 236 FCSET--PQETYRKVMNWKETL--VFPPE-----VPISEKAKDLILRFC-TDSENRIGSNGVEEIKS------------- 292 (360)
T ss_pred CCCCC--HHHHHHHHHcCCCce--ecCCC-----CCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhc-------------
Confidence 96432 233333332211110 00000 123456788888866 49999985 556543
Q ss_pred CCCCChhHHHHH
Q 004979 702 TPKLSPLWWAEL 713 (721)
Q Consensus 702 ~p~~~~~~~~~l 713 (721)
+|++..+.|+.+
T Consensus 293 hp~f~~~~~~~~ 304 (360)
T cd05627 293 HPFFEGVDWGHI 304 (360)
T ss_pred CCCCCCCCHHHH
Confidence 566666666665
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=332.21 Aligned_cols=244 Identities=18% Similarity=0.299 Sum_probs=197.5
Q ss_pred hhhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCC-----
Q 004979 429 SNIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEP----- 502 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~----- 502 (721)
|.+.+.+|+|+||+||+|+. .+++.||||++..... .......+.+|+.++..++|+||+++++.+...+.
T Consensus 34 Y~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~---~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~ 110 (496)
T PTZ00283 34 YWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM---SEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPEN 110 (496)
T ss_pred EEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC---CHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCccc
Confidence 46778899999999999984 5789999998865432 23345678899999999999999999887654321
Q ss_pred -ceEEEEEecCCCCChhhhhhhc--cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccC
Q 004979 503 -FTRMMVFEYSPNGSLFEHLHIQ--EAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFS 579 (721)
Q Consensus 503 -~~~~lV~Ey~~~GsL~~~l~~~--~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFG 579 (721)
...++||||+++|+|.++++.. ....+++.....++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 111 ~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~--IiHrDLKP~NILl~~~~~vkL~DFG 188 (496)
T PTZ00283 111 VLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH--MIHRDIKSANILLCSNGLVKLGDFG 188 (496)
T ss_pred ceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEeCCCCEEEEecc
Confidence 1368999999999999998643 2356889999999999999999999988 9999999999999999999999999
Q ss_pred CCCCCC-----------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCcc
Q 004979 580 FWNNTT-----------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKD 648 (721)
Q Consensus 580 la~~~~-----------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 648 (721)
+++... .++..|+|||.+....++.++|||||||++|||+||+.||.. .+..+.+.....+..
T Consensus 189 ls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~--~~~~~~~~~~~~~~~---- 262 (496)
T PTZ00283 189 FSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDG--ENMEEVMHKTLAGRY---- 262 (496)
T ss_pred cCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC--CCHHHHHHHHhcCCC----
Confidence 875321 245679999999999999999999999999999999999963 344444444443221
Q ss_pred ccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004979 649 IVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAK 689 (721)
Q Consensus 649 ~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 689 (721)
...+...+.++.+++.+||+.||++||++.++++.
T Consensus 263 ------~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 263 ------DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred ------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 11223456789999999999999999999999864
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=306.45 Aligned_cols=241 Identities=22% Similarity=0.373 Sum_probs=191.8
Q ss_pred hhhCcCCCCceeEEEEEEec------CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCc
Q 004979 430 NIIGSFSDGTVGTVYKGTLS------SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPF 503 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~------~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 503 (721)
.+.+++|+|+||.||++... ++..+++|...... ......|.+|++++++++|+||+++++++...+
T Consensus 8 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 80 (280)
T cd05092 8 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-----ESARQDFQREAELLTVLQHQHIVRFYGVCTEGR-- 80 (280)
T ss_pred eeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC-----HHHHHHHHHHHHHHhcCCCCCCceEEEEEecCC--
Confidence 45678999999999999742 34567777664322 234567999999999999999999999998776
Q ss_pred eEEEEEecCCCCChhhhhhhccC-------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCC
Q 004979 504 TRMMVFEYSPNGSLFEHLHIQEA-------------EHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTED 570 (721)
Q Consensus 504 ~~~lV~Ey~~~GsL~~~l~~~~~-------------~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~ 570 (721)
..++||||+++|+|.++++.... ..+++..+..++.|++.|++|||+.+ |+||||||+|||++++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~nil~~~~ 158 (280)
T cd05092 81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH--FVHRDLATRNCLVGQG 158 (280)
T ss_pred ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC--eecccccHhhEEEcCC
Confidence 56999999999999999864321 35889999999999999999999988 9999999999999999
Q ss_pred CcEEEeccCCCCCCCC-----------CCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHH
Q 004979 571 YAAKISDFSFWNNTTA-----------AKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASE 638 (721)
Q Consensus 571 ~~~kL~DFGla~~~~~-----------~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~ 638 (721)
+.+||+|||+++.... ....|++||.+.+..++.++|||||||++|||+| |+.||.... ..+....
T Consensus 159 ~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~--~~~~~~~ 236 (280)
T cd05092 159 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLS--NTEAIEC 236 (280)
T ss_pred CCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCC--HHHHHHH
Confidence 9999999998753211 1235899999988899999999999999999999 899985322 2222222
Q ss_pred HhhcCCCCccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 004979 639 YLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLK 691 (721)
Q Consensus 639 ~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 691 (721)
...+... ..+..++..+.+++.+||+.||.+||++.||.+.|+
T Consensus 237 ~~~~~~~----------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 237 ITQGREL----------ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred HHcCccC----------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 2222111 111234567889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=308.13 Aligned_cols=245 Identities=22% Similarity=0.345 Sum_probs=194.4
Q ss_pred hhhCcCCCCceeEEEEEEec------CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcC-CCCccceEeEEEecCCC
Q 004979 430 NIIGSFSDGTVGTVYKGTLS------SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKV-NHKNFVNLIGYCEEDEP 502 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~------~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~ 502 (721)
.+...+|+|+||.||+|... .+..+|+|++..... ....+.+.+|+++++++ +|+||+++++++...+
T Consensus 38 ~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~- 112 (302)
T cd05055 38 SFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH----SSEREALMSELKIMSHLGNHENIVNLLGACTIGG- 112 (302)
T ss_pred EEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC----hHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC-
Confidence 56678899999999999742 245688887653321 22346789999999999 7999999999998776
Q ss_pred ceEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCC
Q 004979 503 FTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWN 582 (721)
Q Consensus 503 ~~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~ 582 (721)
..++||||+++|+|.++++......+++.++..++.|++.||+|||+.+ |+||||||+|||+++++.+|++|||+++
T Consensus 113 -~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 113 -PILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred -ceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eehhhhccceEEEcCCCeEEECCCcccc
Confidence 5799999999999999997544445899999999999999999999988 9999999999999999999999999876
Q ss_pred CCCC-----------CCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhcCCCCcccc
Q 004979 583 NTTA-----------AKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPLKDIV 650 (721)
Q Consensus 583 ~~~~-----------~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (721)
.... ....|+|||.+....++.++|||||||++|||+| |+.||...... +............
T Consensus 190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~--~~~~~~~~~~~~~---- 263 (302)
T cd05055 190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD--SKFYKLIKEGYRM---- 263 (302)
T ss_pred cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch--HHHHHHHHcCCcC----
Confidence 4321 1235899999988889999999999999999998 99998643321 1111222111110
Q ss_pred CCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 004979 651 DPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEI 693 (721)
Q Consensus 651 d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i 693 (721)
..+...+.++.+++.+||..+|++||++.|+++.|+++
T Consensus 264 -----~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 264 -----AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred -----CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 01122346789999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=301.92 Aligned_cols=242 Identities=24% Similarity=0.363 Sum_probs=182.5
Q ss_pred cCCCCceeEEEEEEecC---CcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEEEe
Q 004979 434 SFSDGTVGTVYKGTLSS---GVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFE 510 (721)
Q Consensus 434 ~lg~G~~g~Vyk~~~~~---~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV~E 510 (721)
.+|+|+||.||+|+..+ +..+++|++..... ......|.+|+.++++++||||+++++++.+.. ..++|||
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e 75 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS----VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVT--PYLLVME 75 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCC----hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC--CcEEEEE
Confidence 57899999999998653 34678887653321 223457899999999999999999999998766 5699999
Q ss_pred cCCCCChhhhhhhcc---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCCC-
Q 004979 511 YSPNGSLFEHLHIQE---AEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTA- 586 (721)
Q Consensus 511 y~~~GsL~~~l~~~~---~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~~- 586 (721)
|+++|+|.++++... ....++..++.++.|++.|++|||+.+ ++||||||+||++++++++||+|||+++....
T Consensus 76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~ 153 (269)
T cd05087 76 FCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN--FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKE 153 (269)
T ss_pred CCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEcCCCcEEECCccccccccCc
Confidence 999999999986432 234677888899999999999999988 99999999999999999999999998753221
Q ss_pred ----------CCccccchhhcccC-------CCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhcCCCCcc
Q 004979 587 ----------AKTGSAAMELLETS-------AVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPLKD 648 (721)
Q Consensus 587 ----------~~~~~~apE~~~~~-------~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~ 648 (721)
+...|+|||.+... .++.++|||||||++|||++ |+.||..... .+......... ...
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~--~~~~~~~~~~~--~~~ 229 (269)
T cd05087 154 DYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSD--EQVLTYTVREQ--QLK 229 (269)
T ss_pred ceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCCh--HHHHHHHhhcc--cCC
Confidence 23458999987532 45789999999999999997 9999964322 11111111111 111
Q ss_pred ccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 004979 649 IVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLK 691 (721)
Q Consensus 649 ~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 691 (721)
..++... ....+++.+++..|| .+|++|||++||+..|+
T Consensus 230 ~~~~~~~---~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 230 LPKPRLK---LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCccC---CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 1122111 123456788999999 58999999999998764
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=304.01 Aligned_cols=233 Identities=23% Similarity=0.378 Sum_probs=179.9
Q ss_pred cCCCCceeEEEEEEecC-------------CcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecC
Q 004979 434 SFSDGTVGTVYKGTLSS-------------GVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEED 500 (721)
Q Consensus 434 ~lg~G~~g~Vyk~~~~~-------------~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~ 500 (721)
.+|+|+||.||+|++.. ...|++|.+.... ......|.+|+.+++.++||||+++++++...
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-----~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~ 76 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH-----RDISLAFFETASMMRQVSHKHIVLLYGVCVRD 76 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh-----hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 57899999999998542 1246666654321 22345788999999999999999999999876
Q ss_pred CCceEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCc-------E
Q 004979 501 EPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYA-------A 573 (721)
Q Consensus 501 ~~~~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~-------~ 573 (721)
. ..++||||+++|+|..+++. ....+++..+.+++.||+.||+|||+.+ |+||||||+|||++.++. +
T Consensus 77 ~--~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~~~~~~~~~~~ 151 (262)
T cd05077 77 V--ENIMVEEFVEFGPLDLFMHR-KSDVLTTPWKFKVAKQLASALSYLEDKD--LVHGNVCTKNILLAREGIDGECGPFI 151 (262)
T ss_pred C--CCEEEEecccCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHhhhCC--eECCCCCcccEEEecCCccCCCCcee
Confidence 6 56899999999999988753 2346899999999999999999999988 999999999999987664 8
Q ss_pred EEeccCCCCCCC-----CCCccccchhhcc-cCCCCCCccHHHHHHHHHHHH-hCCCcccCCCCCHHHHHHHHhhcCCCC
Q 004979 574 KISDFSFWNNTT-----AAKTGSAAMELLE-TSAVDLESNVYSFGTILFEMI-TGRISYSIENGSLENWASEYLKGEQPL 646 (721)
Q Consensus 574 kL~DFGla~~~~-----~~~~~~~apE~~~-~~~~s~ksDVwSfGvvL~Ell-tG~~P~~~~~~~~~~~~~~~~~~~~~~ 646 (721)
|++|||++.... .++..|+|||.+. ...++.++|||||||++|||+ +|+.||..... .+. .........
T Consensus 152 ~l~d~g~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~--~~~-~~~~~~~~~- 227 (262)
T cd05077 152 KLSDPGIPITVLSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTL--AEK-ERFYEGQCM- 227 (262)
T ss_pred EeCCCCCCccccCcccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcch--hHH-HHHHhcCcc-
Confidence 999999875432 2345799999886 567899999999999999998 58888753221 111 111111110
Q ss_pred ccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 004979 647 KDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKL 690 (721)
Q Consensus 647 ~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L 690 (721)
. ......++.+||.+||+.||++||++.||++.|
T Consensus 228 --~--------~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 228 --L--------VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred --C--------CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 1 111245788999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=300.76 Aligned_cols=241 Identities=24% Similarity=0.392 Sum_probs=187.6
Q ss_pred cCCCCceeEEEEEEecC----CcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEEE
Q 004979 434 SFSDGTVGTVYKGTLSS----GVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVF 509 (721)
Q Consensus 434 ~lg~G~~g~Vyk~~~~~----~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV~ 509 (721)
.+|+|+||.||+|...+ ...+++|.+.... .....+.+.+|+.+++.++||||+++++++...+. ..++||
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~~lv~ 76 (262)
T cd05058 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT----DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEG-SPLVVL 76 (262)
T ss_pred cccccCCceEEEEEEecCCCceEEEEEEecCccC----CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCC-CcEEEE
Confidence 46899999999998532 3467888764221 12234678899999999999999999998865443 468999
Q ss_pred ecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCCC---
Q 004979 510 EYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTA--- 586 (721)
Q Consensus 510 Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~~--- 586 (721)
||+++|+|.+++... ...+.+...+.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 77 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~ 153 (262)
T cd05058 77 PYMKHGDLRNFIRSE-THNPTVKDLIGFGLQVAKGMEYLASKK--FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEY 153 (262)
T ss_pred ecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEcCCCcEEECCccccccccCCcc
Confidence 999999999998643 345678888999999999999999987 99999999999999999999999998864321
Q ss_pred ----------CCccccchhhcccCCCCCCccHHHHHHHHHHHHhC-CCcccCCCCCHHHHHHHHhhcCCCCccccCCccc
Q 004979 587 ----------AKTGSAAMELLETSAVDLESNVYSFGTILFEMITG-RISYSIENGSLENWASEYLKGEQPLKDIVDPTLK 655 (721)
Q Consensus 587 ----------~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG-~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 655 (721)
....|+|||......++.++|||||||++|||+|| ..||.. .+..+.......+...
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~--~~~~~~~~~~~~~~~~---------- 221 (262)
T cd05058 154 YSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD--VDSFDITVYLLQGRRL---------- 221 (262)
T ss_pred eeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCC--CCHHHHHHHHhcCCCC----------
Confidence 12358999999888999999999999999999995 555542 2333333333322111
Q ss_pred cccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 004979 656 SFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEIT 694 (721)
Q Consensus 656 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~ 694 (721)
..+...+..+.+++.+||+.+|++||++.||++.|+++.
T Consensus 222 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 222 LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 111223467889999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=301.06 Aligned_cols=241 Identities=26% Similarity=0.439 Sum_probs=196.6
Q ss_pred hhhCcCCCCceeEEEEEEecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVF 509 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV~ 509 (721)
++...+|.|+||.||+|... ++.+++|.+..... ..+++.+|+.++++++|+||+++++++.+.+ ..++||
T Consensus 9 ~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~~v~ 79 (256)
T cd05039 9 KLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST------AAQAFLAEASVMTTLRHPNLVQLLGVVLQGN--PLYIVT 79 (256)
T ss_pred cceeeeecCCCceEEEEEec-CcEEEEEEeccchh------HHHHHHHHHHHHHhcCCcceeeeEEEEcCCC--CeEEEE
Confidence 56678899999999999876 78899998864321 3467999999999999999999999998755 579999
Q ss_pred ecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCCC---
Q 004979 510 EYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTA--- 586 (721)
Q Consensus 510 Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~~--- 586 (721)
||+++++|.+++.......+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++....
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~ 157 (256)
T cd05039 80 EYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN--FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD 157 (256)
T ss_pred EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccchhcccceEEEeCCCCEEEcccccccccccccc
Confidence 9999999999997554457999999999999999999999988 99999999999999999999999998765432
Q ss_pred ---CCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccHHHH
Q 004979 587 ---AKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQENVL 662 (721)
Q Consensus 587 ---~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 662 (721)
....|++||.+....++.++||||||+++||+++ |+.||... ...+.......+ ... ..+...+
T Consensus 158 ~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~--~~~~~~~~~~~~-~~~---------~~~~~~~ 225 (256)
T cd05039 158 SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI--PLKDVVPHVEKG-YRM---------EAPEGCP 225 (256)
T ss_pred cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCC--CHHHHHHHHhcC-CCC---------CCccCCC
Confidence 1235889999988889999999999999999997 99998533 222222222111 110 1112345
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 004979 663 EELLVVIKNCVHPDPKQRPSMRGIAAKLKEI 693 (721)
Q Consensus 663 ~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i 693 (721)
.++.+++.+||..+|++||++.|++++|+.+
T Consensus 226 ~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 226 PEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred HHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 7789999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=312.60 Aligned_cols=234 Identities=15% Similarity=0.227 Sum_probs=186.6
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCC-CCccceEeEEEecCCCceEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVN-HKNFVNLIGYCEEDEPFTRMM 507 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~~~l 507 (721)
+....+|+|+||+||+|+.. ++..||+|++...... .....+.+..|.+++..+. |++|+++++++.+.+ ..++
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~--~~~l 78 (323)
T cd05615 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVI--QDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVD--RLYF 78 (323)
T ss_pred eEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhh--hhhHHHHHHHHHHHHHhccCCCchhheeeEEecCC--EEEE
Confidence 34567889999999999854 6888999988643211 1223456788899998885 577888999888776 6799
Q ss_pred EEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC---
Q 004979 508 VFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT--- 584 (721)
Q Consensus 508 V~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~--- 584 (721)
||||+++|+|.+++.. ...+++..+..|+.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++..
T Consensus 79 v~Ey~~~g~L~~~i~~--~~~l~~~~~~~i~~qi~~al~~lH~~~--ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~ 154 (323)
T cd05615 79 VMEYVNGGDLMYHIQQ--VGKFKEPQAVFYAAEISVGLFFLHRRG--IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD 154 (323)
T ss_pred EEcCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence 9999999999998853 356899999999999999999999988 999999999999999999999999987632
Q ss_pred ------CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCcccccc
Q 004979 585 ------TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQ 658 (721)
Q Consensus 585 ------~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 658 (721)
..++..|+|||.+.+..++.++|||||||++|||+||+.||... +.......+...... .+
T Consensus 155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~--~~~~~~~~i~~~~~~-----------~p 221 (323)
T cd05615 155 GVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGE--DEDELFQSIMEHNVS-----------YP 221 (323)
T ss_pred CccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCC--CHHHHHHHHHhCCCC-----------CC
Confidence 12456799999999889999999999999999999999999643 233333333332211 12
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHH
Q 004979 659 ENVLEELLVVIKNCVHPDPKQRPSMR 684 (721)
Q Consensus 659 ~~~~~~l~~li~~Cl~~dP~~RPs~~ 684 (721)
...+.++.+++.+||+.+|++|++..
T Consensus 222 ~~~~~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05615 222 KSLSKEAVSICKGLMTKHPSKRLGCG 247 (323)
T ss_pred ccCCHHHHHHHHHHcccCHhhCCCCC
Confidence 23456788999999999999999853
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=301.35 Aligned_cols=241 Identities=24% Similarity=0.396 Sum_probs=197.4
Q ss_pred hhhCcCCCCceeEEEEEEecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVF 509 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV~ 509 (721)
.+.+.+|+|+||.||+|..+++..++||.+..... ..+++.+|++++++++|+||+++++++.... ..++||
T Consensus 9 ~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~~v~ 80 (261)
T cd05034 9 KLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM------SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEE--PIYIVT 80 (261)
T ss_pred eeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc------CHHHHHHHHHHHhhCCCCCEeeeeeeeecCC--ceEEEE
Confidence 56788899999999999988888899998764321 1357899999999999999999999988766 569999
Q ss_pred ecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCCC---
Q 004979 510 EYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTA--- 586 (721)
Q Consensus 510 Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~~--- 586 (721)
||+++++|.+++.......+++..+..++.|++.|++|||+.+ |+||||||+||++++++.+||+|||+++....
T Consensus 81 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~--i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (261)
T cd05034 81 EYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN--YIHRDLAARNILVGENLVCKIADFGLARLIEDDEY 158 (261)
T ss_pred eccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence 9999999999997655567999999999999999999999988 99999999999999999999999998764321
Q ss_pred -------CCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhcCCCCccccCCcccccc
Q 004979 587 -------AKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQ 658 (721)
Q Consensus 587 -------~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 658 (721)
....|++||.+.+..++.++|||||||++||++| |+.||... ...........+... ..+
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~--~~~~~~~~~~~~~~~----------~~~ 226 (261)
T cd05034 159 TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGM--TNREVLEQVERGYRM----------PRP 226 (261)
T ss_pred hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHHHcCCCC----------CCC
Confidence 1235889999988889999999999999999999 99999533 222333333222110 011
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 004979 659 ENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKE 692 (721)
Q Consensus 659 ~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 692 (721)
...+.++.+++.+||+.+|++||+++|+.+.|+.
T Consensus 227 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 227 PNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 2235678999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=309.43 Aligned_cols=242 Identities=24% Similarity=0.368 Sum_probs=193.2
Q ss_pred hhhCcCCCCceeEEEEEEecC------CcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCc
Q 004979 430 NIIGSFSDGTVGTVYKGTLSS------GVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPF 503 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~~------~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 503 (721)
.+.+.+|+|+||.||+|.... +..+++|...... .......+.+|++++..++|+||+++++++....
T Consensus 9 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~----~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-- 82 (277)
T cd05032 9 TLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA----SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQ-- 82 (277)
T ss_pred eEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc----CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCC--
Confidence 567889999999999998642 3678888865332 1223457889999999999999999999998776
Q ss_pred eEEEEEecCCCCChhhhhhhcc--------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEE
Q 004979 504 TRMMVFEYSPNGSLFEHLHIQE--------AEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKI 575 (721)
Q Consensus 504 ~~~lV~Ey~~~GsL~~~l~~~~--------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL 575 (721)
..++||||+++|+|.+++.... ...++|..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||
T Consensus 83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~di~p~nill~~~~~~kl 160 (277)
T cd05032 83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK--FVHRDLAARNCMVAEDLTVKI 160 (277)
T ss_pred CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccChheEEEcCCCCEEE
Confidence 5699999999999999986432 234789999999999999999999988 999999999999999999999
Q ss_pred eccCCCCCCCC-----------CCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhcC
Q 004979 576 SDFSFWNNTTA-----------AKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGE 643 (721)
Q Consensus 576 ~DFGla~~~~~-----------~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~~ 643 (721)
+|||+++.... ++..|+|||.+....++.++|||||||++||++| |+.||... +..+.......+
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~--~~~~~~~~~~~~- 237 (277)
T cd05032 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGL--SNEEVLKFVIDG- 237 (277)
T ss_pred CCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccC--CHHHHHHHHhcC-
Confidence 99998753211 1246899999988889999999999999999998 99998532 222222222211
Q ss_pred CCCccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 004979 644 QPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLK 691 (721)
Q Consensus 644 ~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 691 (721)
.. ...+..++.++.+++.+||+.+|++|||+.|+++.|+
T Consensus 238 ~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 238 GH---------LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred CC---------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 11 1122334678999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=300.15 Aligned_cols=236 Identities=24% Similarity=0.353 Sum_probs=198.8
Q ss_pred hhhhhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceE
Q 004979 427 DFSNIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTR 505 (721)
Q Consensus 427 ~~~~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~ 505 (721)
+...+++++|+|+||.|||+.++ +|..+|+|++.+.. ..+++.+|+.+|.+++.|+||++||.|.... ..
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s-------DLQEIIKEISIMQQC~S~yVVKYYGSYFK~s--DL 103 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT-------DLQEIIKEISIMQQCKSKYVVKYYGSYFKHS--DL 103 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc-------hHHHHHHHHHHHHHcCCchhhhhhhhhccCC--ce
Confidence 33478999999999999999864 78999999887643 2467899999999999999999999776554 57
Q ss_pred EEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCC---
Q 004979 506 MMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWN--- 582 (721)
Q Consensus 506 ~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~--- 582 (721)
++|||||.-|++.++++. ++..|....+..|.+..++||+|||... -||||||+.||||+-+|.+||+|||.+.
T Consensus 104 WIVMEYCGAGSiSDI~R~-R~K~L~E~EIs~iL~~TLKGL~YLH~~~--KIHRDIKAGNILLNT~G~AKLADFGVAGQLT 180 (502)
T KOG0574|consen 104 WIVMEYCGAGSISDIMRA-RRKPLSEQEISAVLRDTLKGLQYLHDLK--KIHRDIKAGNILLNTDGIAKLADFGVAGQLT 180 (502)
T ss_pred EeehhhcCCCcHHHHHHH-hcCCccHHHHHHHHHHHHhHHHHHHHHH--HHHhhcccccEEEcccchhhhhhccccchhh
Confidence 999999999999999864 4578999999999999999999999877 8999999999999999999999999864
Q ss_pred ------CCCCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCcccc---C--
Q 004979 583 ------NTTAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIV---D-- 651 (721)
Q Consensus 583 ------~~~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~---d-- 651 (721)
....+++.|||||+++.-.|+.++||||+|++..||..|++||..- .++..++ .
T Consensus 181 DTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDI---------------HPMRAIFMIPT~P 245 (502)
T KOG0574|consen 181 DTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDI---------------HPMRAIFMIPTKP 245 (502)
T ss_pred hhHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccc---------------cccceeEeccCCC
Confidence 3445778999999999999999999999999999999999999521 1111111 0
Q ss_pred CccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004979 652 PTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAK 689 (721)
Q Consensus 652 ~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 689 (721)
|..-..++..+.++-++++.|+.+.|++|-|+.++++.
T Consensus 246 PPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 246 PPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred CCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 11112356788999999999999999999999888763
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=302.25 Aligned_cols=243 Identities=20% Similarity=0.344 Sum_probs=193.5
Q ss_pred hhhCcCCCCceeEEEEEEec-C---CcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceE
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-S---GVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTR 505 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~---~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~ 505 (721)
++...+|+|+||.||+|+.. + +..+++|.+.... .....+.|.+|+.++.+++||||+++++++...+ ..
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~ 80 (267)
T cd05066 7 KIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY----TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSK--PV 80 (267)
T ss_pred EeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC----CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC--cc
Confidence 56678899999999999863 2 3367888765322 1233567899999999999999999999998776 57
Q ss_pred EEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC
Q 004979 506 MMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT 585 (721)
Q Consensus 506 ~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~ 585 (721)
++||||+++|+|.+++... ...+++.++..|+.|++.|++|||+.+ ++||||||+|||++.++.+||+|||+++...
T Consensus 81 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~h~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd05066 81 MIVTEYMENGSLDAFLRKH-DGQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 157 (267)
T ss_pred EEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC--EeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence 9999999999999998643 346899999999999999999999988 9999999999999999999999999876432
Q ss_pred CC------------CccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhcCCCCccccCC
Q 004979 586 AA------------KTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPLKDIVDP 652 (721)
Q Consensus 586 ~~------------~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 652 (721)
.. ...|++||.+.+..++.++|||||||++||+++ |+.||.... ..+.......+ ...
T Consensus 158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~--~~~~~~~~~~~-~~~------ 228 (267)
T cd05066 158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMS--NQDVIKAIEEG-YRL------ 228 (267)
T ss_pred cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCC--HHHHHHHHhCC-CcC------
Confidence 11 125789999988899999999999999999887 999985332 22222222221 110
Q ss_pred ccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 004979 653 TLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEI 693 (721)
Q Consensus 653 ~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i 693 (721)
......+..+.+++.+||+.+|++||+|.++++.|+++
T Consensus 229 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 229 ---PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred ---CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 11123456788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=301.24 Aligned_cols=240 Identities=23% Similarity=0.350 Sum_probs=195.0
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
++.+.+|+|+||.||+++.. ++..+++|.+..... ....+.+.+|+.++++++|+||+++++++.+.+ ..++|
T Consensus 3 ~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv 76 (255)
T cd08219 3 NVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS----SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADG--HLYIV 76 (255)
T ss_pred eEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc----hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECC--EEEEE
Confidence 46678999999999999864 678899998754321 223467889999999999999999999998776 77999
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC---
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT--- 585 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~--- 585 (721)
|||+++|+|.+++.......+++.....++.|++.||.|||+.+ |+|+||||+||++++++.++++|||+++...
T Consensus 77 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 154 (255)
T cd08219 77 MEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR--VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG 154 (255)
T ss_pred EeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEECCCCcEEEcccCcceeecccc
Confidence 99999999999886555566889999999999999999999988 9999999999999999999999999875332
Q ss_pred ------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccH
Q 004979 586 ------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQE 659 (721)
Q Consensus 586 ------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 659 (721)
.+...|+|||......++.++||||||+++|||++|+.||... +..........+... ..+.
T Consensus 155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~--~~~~~~~~~~~~~~~----------~~~~ 222 (255)
T cd08219 155 AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQAN--SWKNLILKVCQGSYK----------PLPS 222 (255)
T ss_pred cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCC--CHHHHHHHHhcCCCC----------CCCc
Confidence 2344689999998888999999999999999999999999643 223333332222111 1123
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004979 660 NVLEELLVVIKNCVHPDPKQRPSMRGIAAK 689 (721)
Q Consensus 660 ~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 689 (721)
..+.++.+++.+||+.||++||++.||+..
T Consensus 223 ~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 223 HYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred ccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 345678899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=307.41 Aligned_cols=241 Identities=22% Similarity=0.262 Sum_probs=190.6
Q ss_pred hhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEEE
Q 004979 431 IIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVF 509 (721)
Q Consensus 431 ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV~ 509 (721)
..+.+|+|+||+||+|+.. +++.+|+|.+....... ......+.+|++++++++|+||+++++++...+ ..++||
T Consensus 4 ~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~--~~~lv~ 79 (285)
T cd05632 4 QYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKK--RKGESMALNEKQILEKVNSQFVVNLAYAYETKD--ALCLVL 79 (285)
T ss_pred EEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhh--hhHHHHHHHHHHHHHHcCCcCceeEEEEEecCC--EEEEEE
Confidence 3456889999999999864 67889999886543221 223356788999999999999999999988776 679999
Q ss_pred ecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC-----
Q 004979 510 EYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT----- 584 (721)
Q Consensus 510 Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~----- 584 (721)
||+++|+|.+++.......+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++...
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05632 80 TIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN--TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES 157 (285)
T ss_pred EeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEECCCCCEEEecCCcceecCCCCc
Confidence 9999999998886544557999999999999999999999988 999999999999999999999999987532
Q ss_pred ---CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCH--HHHHHHHhhcCCCCccccCCccccccH
Q 004979 585 ---TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSL--ENWASEYLKGEQPLKDIVDPTLKSFQE 659 (721)
Q Consensus 585 ---~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~--~~~~~~~~~~~~~~~~~~d~~l~~~~~ 659 (721)
..++..|+|||.+.+..++.++|||||||++|||+||+.||....... ........... ..+..
T Consensus 158 ~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~-----------~~~~~ 226 (285)
T cd05632 158 IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETE-----------EVYSA 226 (285)
T ss_pred ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccc-----------cccCc
Confidence 123457899999988899999999999999999999999996432211 11111111111 01223
Q ss_pred HHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 004979 660 NVLEELLVVIKNCVHPDPKQRPS-----MRGIAA 688 (721)
Q Consensus 660 ~~~~~l~~li~~Cl~~dP~~RPs-----~~evl~ 688 (721)
....++.+|+.+||+.||++||+ +.|++.
T Consensus 227 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 227 KFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred cCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 34567889999999999999999 556654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=302.00 Aligned_cols=241 Identities=22% Similarity=0.353 Sum_probs=181.3
Q ss_pred cCCCCceeEEEEEEecCC---cEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEEEe
Q 004979 434 SFSDGTVGTVYKGTLSSG---VEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFE 510 (721)
Q Consensus 434 ~lg~G~~g~Vyk~~~~~~---~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV~E 510 (721)
.+|+|+||+||+|....+ ..+++|.+.... .......|.+|+++++.++|+||+++++++...+ ..++|||
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~--~~~lv~e 75 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASA----TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESI--PYLLVLE 75 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccC----ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCC--ceEEEEE
Confidence 578999999999975433 356666543221 2333467899999999999999999999998776 5699999
Q ss_pred cCCCCChhhhhhhcc---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCCC-
Q 004979 511 YSPNGSLFEHLHIQE---AEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTA- 586 (721)
Q Consensus 511 y~~~GsL~~~l~~~~---~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~~- 586 (721)
|+++|+|.+++.... ....++.....++.||+.|++|||+++ |+||||||+|||+++++++||+|||+++....
T Consensus 76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 153 (269)
T cd05042 76 FCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD--FIHSDLALRNCQLTADLSVKIGDYGLALEQYPE 153 (269)
T ss_pred eCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC--EecccccHhheEecCCCcEEEeccccccccccc
Confidence 999999999986532 233567888899999999999999988 99999999999999999999999998754211
Q ss_pred ----------CCccccchhhcc-------cCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhcCCCCcc
Q 004979 587 ----------AKTGSAAMELLE-------TSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPLKD 648 (721)
Q Consensus 587 ----------~~~~~~apE~~~-------~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~ 648 (721)
....|+|||... ...++.++|||||||++|||++ |..||.... ..+.......... ..
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~--~~~~~~~~~~~~~--~~ 229 (269)
T cd05042 154 DYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLS--DEQVLKQVVREQD--IK 229 (269)
T ss_pred hheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCC--HHHHHHHHhhccC--cc
Confidence 123589999864 3456889999999999999999 778885322 1222222222211 11
Q ss_pred ccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 004979 649 IVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKL 690 (721)
Q Consensus 649 ~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L 690 (721)
+.++. .......++.+++..|| .||++||+++||++.|
T Consensus 230 ~~~~~---~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 230 LPKPQ---LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred CCCCc---ccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 11111 22345567778899999 5999999999999876
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=302.60 Aligned_cols=243 Identities=19% Similarity=0.331 Sum_probs=193.6
Q ss_pred hhhCcCCCCceeEEEEEEecC-C---cEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceE
Q 004979 430 NIIGSFSDGTVGTVYKGTLSS-G---VEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTR 505 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~~-~---~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~ 505 (721)
++.+.+|+|+||.||+|+... + ..|++|.+.... .....++|..|++++++++||||+++++++.+.+ ..
T Consensus 7 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~--~~ 80 (269)
T cd05065 7 KIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY----TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSR--PV 80 (269)
T ss_pred EEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC----CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCC--ce
Confidence 456788999999999998653 2 358888875431 2334567999999999999999999999998776 56
Q ss_pred EEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC
Q 004979 506 MMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT 585 (721)
Q Consensus 506 ~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~ 585 (721)
++||||+++|+|.+++... ...+++.++..++.|++.|++|||+.+ ++||||||+||+++.++.+||+|||+++...
T Consensus 81 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~al~~lH~~g--~~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 157 (269)
T cd05065 81 MIITEFMENGALDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLSEMN--YVHRDLAARNILVNSNLVCKVSDFGLSRFLE 157 (269)
T ss_pred EEEEecCCCCcHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccChheEEEcCCCcEEECCCccccccc
Confidence 9999999999999998643 356899999999999999999999988 9999999999999999999999999875322
Q ss_pred CC--------------CccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhcCCCCcccc
Q 004979 586 AA--------------KTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPLKDIV 650 (721)
Q Consensus 586 ~~--------------~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (721)
.. ...|++||.+....++.++|||||||++||+++ |..||.... ..+....+... ...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~--~~~~~~~i~~~-~~~---- 230 (269)
T cd05065 158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS--NQDVINAIEQD-YRL---- 230 (269)
T ss_pred cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCC--HHHHHHHHHcC-CcC----
Confidence 11 124889999998999999999999999999987 999985322 22222222111 111
Q ss_pred CCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 004979 651 DPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEI 693 (721)
Q Consensus 651 d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i 693 (721)
..+.+++..+.+++.+||+.+|++||++.+|+..|+++
T Consensus 231 -----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 231 -----PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred -----CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11123456788999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=307.62 Aligned_cols=247 Identities=23% Similarity=0.364 Sum_probs=190.6
Q ss_pred hhhCcCCCCceeEEEEEEec-----------------CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccce
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-----------------SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVN 492 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-----------------~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~ 492 (721)
++.+.+|+|+||.||++... +...+++|+..... .......|.+|++++++++|+||++
T Consensus 8 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~----~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 8 TFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA----NKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred eeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC----CHHHHHHHHHHHHHHHhCCCCCcce
Confidence 67788999999999998633 23457787765321 1234567999999999999999999
Q ss_pred EeEEEecCCCceEEEEEecCCCCChhhhhhhccC---------CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCC
Q 004979 493 LIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEA---------EHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSS 563 (721)
Q Consensus 493 l~g~~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~---------~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~ 563 (721)
+++++...+ ..++||||+++|+|.+++..... ..+++.....++.|++.||+|||+++ |+||||||+
T Consensus 84 ~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dlkp~ 159 (296)
T cd05095 84 LLAVCITSD--PLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN--FVHRDLATR 159 (296)
T ss_pred EEEEEecCC--ccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--eecccCChh
Confidence 999998876 56999999999999999864321 24788899999999999999999998 999999999
Q ss_pred CeEeCCCCcEEEeccCCCCCCCCC-----------CccccchhhcccCCCCCCccHHHHHHHHHHHHh--CCCcccCCCC
Q 004979 564 SIYLTEDYAAKISDFSFWNNTTAA-----------KTGSAAMELLETSAVDLESNVYSFGTILFEMIT--GRISYSIENG 630 (721)
Q Consensus 564 NILl~~~~~~kL~DFGla~~~~~~-----------~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt--G~~P~~~~~~ 630 (721)
|||+++++.+||+|||+++..... ...|++||......++.++|||||||++|||+| |..||...
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~-- 237 (296)
T cd05095 160 NCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQL-- 237 (296)
T ss_pred eEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcccc--
Confidence 999999999999999998643211 235789998888889999999999999999998 67787532
Q ss_pred CHHHHHHHH---hhcCCCCccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 004979 631 SLENWASEY---LKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKE 692 (721)
Q Consensus 631 ~~~~~~~~~---~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 692 (721)
...+.+... ..... .... ...+..++..+.+++.+||+.||++||++.||++.|++
T Consensus 238 ~~~~~~~~~~~~~~~~~--~~~~----~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 238 SDEQVIENTGEFFRDQG--RQVY----LPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred ChHHHHHHHHHHHhhcc--cccc----CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 222222111 11100 0000 01122345778999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=318.07 Aligned_cols=243 Identities=20% Similarity=0.279 Sum_probs=198.9
Q ss_pred hhhhhhhCcCCCCceeEEEEEEecCCc-EEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCce
Q 004979 426 EDFSNIIGSFSDGTVGTVYKGTLSSGV-EIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFT 504 (721)
Q Consensus 426 ~~~~~ii~~lg~G~~g~Vyk~~~~~~~-~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 504 (721)
++|.+|||.+|.|+||.||||..+... ..|.|++..+. ....++|+-||++|..++||+||++++.|+..+ .
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetks-----eEELEDylVEIeILa~CdHP~ivkLl~ayy~en--k 103 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKS-----EEELEDYLVEIEILAECDHPVIVKLLSAYYFEN--K 103 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccc-----hhHHhhhhhhhhhhhcCCChHHHHHHHHHhccC--c
Confidence 467799999999999999999866444 34556555443 334578999999999999999999999877766 6
Q ss_pred EEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCC--
Q 004979 505 RMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWN-- 582 (721)
Q Consensus 505 ~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~-- 582 (721)
.+|..|||.||-...++-. -...|...++..+++|++.||.|||+.. |||||||+.|||+.-+|.++|+|||.+-
T Consensus 104 LwiliEFC~GGAVDaimlE-L~r~LtE~QIqvvc~q~ldALn~LHs~~--iIHRDLKAGNiL~TldGdirLADFGVSAKn 180 (1187)
T KOG0579|consen 104 LWILIEFCGGGAVDAIMLE-LGRVLTEDQIQVVCYQVLDALNWLHSQN--IIHRDLKAGNILLTLDGDIRLADFGVSAKN 180 (1187)
T ss_pred eEEEEeecCCchHhHHHHH-hccccchHHHHHHHHHHHHHHHHHhhcc--hhhhhccccceEEEecCcEeeecccccccc
Confidence 7999999999999887753 3567999999999999999999999988 9999999999999999999999999852
Q ss_pred -------CCCCCCccccchhhc-----ccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCcccc
Q 004979 583 -------NTTAAKTGSAAMELL-----ETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIV 650 (721)
Q Consensus 583 -------~~~~~~~~~~apE~~-----~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (721)
....|+++|||||+. ...+|+.++|||||||+|.||..+.+|.. ..+....+..+.+.++|. ++
T Consensus 181 ~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHh--elnpMRVllKiaKSePPT--Ll 256 (1187)
T KOG0579|consen 181 KSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHH--ELNPMRVLLKIAKSEPPT--LL 256 (1187)
T ss_pred hhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCcc--ccchHHHHHHHhhcCCCc--cc
Confidence 345678899999975 56789999999999999999999999874 334444444444433321 11
Q ss_pred CCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 651 DPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 651 d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
-+......+.+++.+|+.++|..||++.++++
T Consensus 257 ------qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 257 ------QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred ------CcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 23456778999999999999999999999875
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=319.55 Aligned_cols=243 Identities=19% Similarity=0.248 Sum_probs=189.7
Q ss_pred hhhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEE
Q 004979 429 SNIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMM 507 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~l 507 (721)
+++++.+|+|+||.||+++.. +++.+|+|++...... .......+.+|+.+++.++||||+++++++.+.+ ..++
T Consensus 45 y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~--~~~l 120 (370)
T cd05621 45 YDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMI--KRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDK--YLYM 120 (370)
T ss_pred CeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhh--hhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC--EEEE
Confidence 367788999999999999965 5778999987643211 1223456889999999999999999999998876 6799
Q ss_pred EEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC---
Q 004979 508 VFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT--- 584 (721)
Q Consensus 508 V~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~--- 584 (721)
||||+++|+|.+++.. ..+++.....++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 121 v~Ey~~gg~L~~~l~~---~~~~~~~~~~~~~qil~aL~~LH~~~--IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~ 195 (370)
T cd05621 121 VMEYMPGGDLVNLMSN---YDVPEKWAKFYTAEVVLALDAIHSMG--LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDET 195 (370)
T ss_pred EEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEECCCCCEEEEecccceecccC
Confidence 9999999999999853 34788889999999999999999988 999999999999999999999999987532
Q ss_pred -------CCCCccccchhhcccC----CCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCc
Q 004979 585 -------TAAKTGSAAMELLETS----AVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPT 653 (721)
Q Consensus 585 -------~~~~~~~~apE~~~~~----~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 653 (721)
..++..|+|||.+... .++.++||||+||++|||+||+.||... +.......+......+. . +
T Consensus 196 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~--~~~~~~~~i~~~~~~~~-~--p- 269 (370)
T cd05621 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYAD--SLVGTYSKIMDHKNSLN-F--P- 269 (370)
T ss_pred CceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCC--CHHHHHHHHHhCCcccC-C--C-
Confidence 1245679999998653 3789999999999999999999999643 23333333332211110 0 0
Q ss_pred cccccHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 004979 654 LKSFQENVLEELLVVIKNCVHPDPKQ--RPSMRGIAAK 689 (721)
Q Consensus 654 l~~~~~~~~~~l~~li~~Cl~~dP~~--RPs~~evl~~ 689 (721)
.....+..+.+++.+|+..++.+ |+++.|+++.
T Consensus 270 ---~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 270 ---EDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred ---CcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 01134567888999999865544 8899998874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=307.83 Aligned_cols=251 Identities=21% Similarity=0.257 Sum_probs=186.6
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcC---CCCccceEeEEEecCC---C
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKV---NHKNFVNLIGYCEEDE---P 502 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l---~H~nIv~l~g~~~~~~---~ 502 (721)
++++.+|+|+||+||+|+.. +++.+|+|.+......+ .....+.+|+++++++ +||||+++++++.... .
T Consensus 3 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~ 79 (288)
T cd07863 3 EPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNED---GLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE 79 (288)
T ss_pred eEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCC---CCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence 56678999999999999865 67889999886543221 1123455667666655 7999999999886431 2
Q ss_pred ceEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCC
Q 004979 503 FTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWN 582 (721)
Q Consensus 503 ~~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~ 582 (721)
...++||||++ ++|.+++.......+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 80 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 80 TKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred ceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEECccCccc
Confidence 35799999997 58988886544556899999999999999999999988 9999999999999999999999999876
Q ss_pred CCC--------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhh--cCC---CCc--
Q 004979 583 NTT--------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLK--GEQ---PLK-- 647 (721)
Q Consensus 583 ~~~--------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~--~~~---~~~-- 647 (721)
... .++..|+|||.+.+..++.++|||||||++|||++|+.||..... .+....... +.. ...
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07863 157 IYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE--ADQLGKIFDLIGLPPEDDWPRD 234 (288)
T ss_pred cccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCH--HHHHHHHHHHhCCCChhhCccc
Confidence 432 134468999999888999999999999999999999999864321 111111111 000 000
Q ss_pred -----cccCCc----cccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 648 -----DIVDPT----LKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 648 -----~~~d~~----l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
....+. .....+....++.+++.+|++.||++|||+.|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 235 VTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred ccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000000 01122345567889999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=300.45 Aligned_cols=243 Identities=17% Similarity=0.261 Sum_probs=189.2
Q ss_pred hhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
++.+.+|+|+||.||+|.. .++..+++|++...............+.+|++++++++||||+++++++.+......+++
T Consensus 5 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~ 84 (266)
T cd06651 5 RRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIF 84 (266)
T ss_pred cccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEE
Confidence 4557788999999999985 468899999876543222223344678999999999999999999999876433367899
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC---
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT--- 585 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~--- 585 (721)
+||+++++|.+++.. ...+++.....++.|++.||+|||+++ |+||||||+||++++++.+||+|||+++...
T Consensus 85 ~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~LH~~~--i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd06651 85 MEYMPGGSVKDQLKA--YGALTESVTRKYTRQILEGMSYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC 160 (266)
T ss_pred EeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCCCCEEEccCCCcccccccc
Confidence 999999999999863 345889999999999999999999988 9999999999999999999999999875321
Q ss_pred ---------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCcccc
Q 004979 586 ---------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKS 656 (721)
Q Consensus 586 ---------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 656 (721)
.+...|+|||.+.+..++.++|||||||++|||+||+.||.... ..+........ . ..+ .
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~--~~~~~~~~~~~-~-----~~~---~ 229 (266)
T cd06651 161 MSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYE--AMAAIFKIATQ-P-----TNP---Q 229 (266)
T ss_pred ccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccc--hHHHHHHHhcC-C-----CCC---C
Confidence 12346899999988889999999999999999999999996332 11212111111 0 011 2
Q ss_pred ccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 657 FQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 657 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
.+....+.+.+++ +||..+|++||+++||++
T Consensus 230 ~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 230 LPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred CchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 2233455667777 688899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=305.28 Aligned_cols=240 Identities=18% Similarity=0.293 Sum_probs=192.2
Q ss_pred hhhhhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceE
Q 004979 427 DFSNIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTR 505 (721)
Q Consensus 427 ~~~~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~ 505 (721)
+++..++.+|.|+||.||+|... ++..|++|.+..... ....+.+.+|++++++++||||+++++++...+ ..
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~ 77 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA----EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGT--KL 77 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc----hHHHHHHHHHHHHHHcCCCCccHhhhcccccCC--ce
Confidence 34456677889999999999864 567888887753321 223467899999999999999999999998766 67
Q ss_pred EEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC
Q 004979 506 MMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT 585 (721)
Q Consensus 506 ~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~ 585 (721)
++||||+++++|.+++. ...+++..+..++.|++.|+.|||+.+ ++|+||+|+||++++++.+||+|||+++...
T Consensus 78 ~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 152 (277)
T cd06642 78 WIIMEYLGGGSALDLLK---PGPLEETYIATILREILKGLDYLHSER--KIHRDIKAANVLLSEQGDVKLADFGVAGQLT 152 (277)
T ss_pred EEEEEccCCCcHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhcCC--eeccCCChheEEEeCCCCEEEcccccccccc
Confidence 99999999999999885 246889999999999999999999988 9999999999999999999999999876432
Q ss_pred C---------CCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCcccc
Q 004979 586 A---------AKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKS 656 (721)
Q Consensus 586 ~---------~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 656 (721)
. +...|++||.+.+..++.++|||||||++|||+||+.||..... .......... ....
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~--~~~~~~~~~~----------~~~~ 220 (277)
T cd06642 153 DTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHP--MRVLFLIPKN----------SPPT 220 (277)
T ss_pred CcchhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccch--hhHHhhhhcC----------CCCC
Confidence 2 34468999999888999999999999999999999999853221 1111111111 0111
Q ss_pred ccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004979 657 FQENVLEELLVVIKNCVHPDPKQRPSMRGIAAK 689 (721)
Q Consensus 657 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 689 (721)
.....+.++.+++.+||+.+|++||++.|+++.
T Consensus 221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 221 LEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred CCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 223455778999999999999999999999874
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=314.63 Aligned_cols=244 Identities=17% Similarity=0.256 Sum_probs=189.2
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
++++.+|+|+||+||+++.. +++.+|+|++...... .......+.+|+.++..++|+||+++++++.+.+ ..++|
T Consensus 4 ~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~--~~~lv 79 (332)
T cd05623 4 EILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEML--KRAETACFREERDVLVNGDNQWITTLHYAFQDEN--NLYLV 79 (332)
T ss_pred eEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHH--HhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCC--EEEEE
Confidence 56788999999999999965 4677889887542211 1223356889999999999999999999998776 67999
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC----
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT---- 584 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~---- 584 (721)
|||+++|+|.++++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 80 ~ey~~~g~L~~~l~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~--iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~ 156 (332)
T cd05623 80 MDYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 156 (332)
T ss_pred EeccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEECCCCCEEEeecchheecccCC
Confidence 9999999999999642 346899999999999999999999988 999999999999999999999999987532
Q ss_pred ------CCCCccccchhhcc-----cCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCc
Q 004979 585 ------TAAKTGSAAMELLE-----TSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPT 653 (721)
Q Consensus 585 ------~~~~~~~~apE~~~-----~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 653 (721)
..++..|+|||.+. ...++.++|||||||++|||++|+.||... +..+....+....... .
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~--~~~~~~~~i~~~~~~~------~ 228 (332)
T cd05623 157 TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAE--SLVETYGKIMNHKERF------Q 228 (332)
T ss_pred cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCC--CHHHHHHHHhCCCccc------c
Confidence 23456799999885 356889999999999999999999999643 3334444433221111 0
Q ss_pred cccccHHHHHHHHHHHHHcccCCCCC--CCCHHHHHH
Q 004979 654 LKSFQENVLEELLVVIKNCVHPDPKQ--RPSMRGIAA 688 (721)
Q Consensus 654 l~~~~~~~~~~l~~li~~Cl~~dP~~--RPs~~evl~ 688 (721)
.......++.++.+++.+|+..++++ |+++.|+++
T Consensus 229 ~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~ 265 (332)
T cd05623 229 FPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQ 265 (332)
T ss_pred CCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhC
Confidence 11112234577888999988665544 688988875
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=317.67 Aligned_cols=234 Identities=20% Similarity=0.250 Sum_probs=182.0
Q ss_pred CCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcC---CCCccceEeEEEecCCCceEEEEEe
Q 004979 435 FSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKV---NHKNFVNLIGYCEEDEPFTRMMVFE 510 (721)
Q Consensus 435 lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l---~H~nIv~l~g~~~~~~~~~~~lV~E 510 (721)
+|+|+||+||+|+.. ++..+|+|++....... ......+..|..++.+. +||||+++++++...+ ..++|||
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~--~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~--~~~lv~e 76 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVA--KKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDS--DLYLVTD 76 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhh--hhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCC--eEEEEEc
Confidence 589999999999864 68899999886432211 12233455677777665 7999999999998876 6799999
Q ss_pred cCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC------
Q 004979 511 YSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT------ 584 (721)
Q Consensus 511 y~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~------ 584 (721)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++..
T Consensus 77 ~~~~g~L~~~l~~--~~~~~~~~~~~~~~qil~al~~LH~~~--ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~ 152 (330)
T cd05586 77 YMSGGELFWHLQK--EGRFSEDRAKFYIAELVLALEHLHKYD--IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT 152 (330)
T ss_pred CCCCChHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCC
Confidence 9999999988853 356899999999999999999999988 999999999999999999999999987532
Q ss_pred ---CCCCccccchhhcccC-CCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccHH
Q 004979 585 ---TAAKTGSAAMELLETS-AVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQEN 660 (721)
Q Consensus 585 ---~~~~~~~~apE~~~~~-~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 660 (721)
..++..|+|||.+.+. .++.++|||||||++|||+||+.||... +..+.......+...+. ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~--~~~~~~~~i~~~~~~~~----------~~~ 220 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAE--DTQQMYRNIAFGKVRFP----------KNV 220 (330)
T ss_pred ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCC--CHHHHHHHHHcCCCCCC----------Ccc
Confidence 1245679999998654 5899999999999999999999999643 33333333333221111 012
Q ss_pred HHHHHHHHHHHcccCCCCCCCC----HHHHHH
Q 004979 661 VLEELLVVIKNCVHPDPKQRPS----MRGIAA 688 (721)
Q Consensus 661 ~~~~l~~li~~Cl~~dP~~RPs----~~evl~ 688 (721)
...++.+++.+||+.||++||+ +.|+++
T Consensus 221 ~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 221 LSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred CCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 3467889999999999999985 555543
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=302.58 Aligned_cols=240 Identities=21% Similarity=0.343 Sum_probs=187.5
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcC-CCCccceEeEEEecCCC----c
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKV-NHKNFVNLIGYCEEDEP----F 503 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~----~ 503 (721)
++...+|+|+||.||+|+.. +++.+++|.+..... ....+.+|+.++.++ +|+||+++++++...+. .
T Consensus 9 ~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~------~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 9 ELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD------EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred hHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc------cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 56678899999999999864 577888988754321 235688899999998 79999999999875321 2
Q ss_pred eEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCC
Q 004979 504 TRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNN 583 (721)
Q Consensus 504 ~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~ 583 (721)
..++||||+++|+|.+++.......+++..+..++.|++.|++|||+++ |+||||||+||++++++.+||+|||+++.
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~--ivh~dl~~~nili~~~~~~~l~Dfg~~~~ 160 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLTENAEVKLVDFGVSAQ 160 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHEEECCCCCEEEccCCCcee
Confidence 5789999999999999987544567899999999999999999999988 99999999999999999999999999764
Q ss_pred CC---------CCCccccchhhcc-----cCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccc
Q 004979 584 TT---------AAKTGSAAMELLE-----TSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDI 649 (721)
Q Consensus 584 ~~---------~~~~~~~apE~~~-----~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (721)
.. .+...|+|||.+. ...++.++|||||||++|||++|+.||..... ..... .... ......
T Consensus 161 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~-~~~~~-~~~~--~~~~~~ 236 (272)
T cd06637 161 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP-MRALF-LIPR--NPAPRL 236 (272)
T ss_pred cccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCH-HHHHH-HHhc--CCCCCC
Confidence 32 1344689999875 34688899999999999999999999953321 11111 1111 111111
Q ss_pred cCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 650 VDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 650 ~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
.....+.++.+++.+||..+|.+||++.|+++
T Consensus 237 -------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 237 -------KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred -------CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 11234467899999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=303.85 Aligned_cols=242 Identities=19% Similarity=0.224 Sum_probs=189.0
Q ss_pred hhhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEE
Q 004979 429 SNIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMM 507 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~l 507 (721)
++++..+|+|+||.||+|+. .++..+++|+...+... ....+.+|+.++++++||||+++++++...+ ..++
T Consensus 11 y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~-----~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~--~~~i 83 (267)
T cd06646 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGD-----DFSLIQQEIFMVKECKHCNIVAYFGSYLSRE--KLWI 83 (267)
T ss_pred cchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccc-----hHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC--EEEE
Confidence 46788999999999999995 56788999987644221 2346788999999999999999999998776 6799
Q ss_pred EEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC--
Q 004979 508 VFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT-- 585 (721)
Q Consensus 508 V~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~-- 585 (721)
||||+++|+|.++++. ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++...
T Consensus 84 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06646 84 CMEYCGGGSLQDIYHV--TGPLSELQIAYVCRETLQGLAYLHSKG--KMHRDIKGANILLTDNGDVKLADFGVAAKITAT 159 (267)
T ss_pred EEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCCCCEEECcCccceeeccc
Confidence 9999999999998863 346899999999999999999999987 9999999999999999999999999875332
Q ss_pred -------CCCccccchhhcc---cCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccc
Q 004979 586 -------AAKTGSAAMELLE---TSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLK 655 (721)
Q Consensus 586 -------~~~~~~~apE~~~---~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 655 (721)
.+...|++||.+. ...++.++|||||||++|||++|+.||...... .. ...... . ....+..
T Consensus 160 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~-~~-~~~~~~--~---~~~~~~~- 231 (267)
T cd06646 160 IAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPM-RA-LFLMSK--S---NFQPPKL- 231 (267)
T ss_pred ccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchh-hh-heeeec--C---CCCCCCC-
Confidence 1234689999874 455788999999999999999999998532211 00 000000 0 0000111
Q ss_pred cccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004979 656 SFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAK 689 (721)
Q Consensus 656 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 689 (721)
......+.++.+++.+||+.+|++||+++++++.
T Consensus 232 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 265 (267)
T cd06646 232 KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTH 265 (267)
T ss_pred ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence 1112345788999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=300.78 Aligned_cols=241 Identities=22% Similarity=0.369 Sum_probs=194.6
Q ss_pred hhhhCcCCCCceeEEEEEEecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 429 SNIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
+++.+.+|+|+||.||++....+..+++|.+.... .....|.+|++++++++|+||+++++++.+ . ..+++
T Consensus 8 ~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~--~~~~v 78 (260)
T cd05073 8 LKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS------MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-E--PIYII 78 (260)
T ss_pred eeEEeEecCccceEEEEEEecCCccEEEEecCCCh------hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-C--CeEEE
Confidence 35677899999999999998777889998765321 123578999999999999999999999876 3 46899
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCCC--
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTA-- 586 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~~-- 586 (721)
|||+++|+|.+++.......+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++.....
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 156 (260)
T cd05073 79 TEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSASLVCKIADFGLARVIEDNE 156 (260)
T ss_pred EEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence 99999999999997655567899999999999999999999987 99999999999999999999999998753221
Q ss_pred --------CCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccc
Q 004979 587 --------AKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSF 657 (721)
Q Consensus 587 --------~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 657 (721)
+...|++||.+....++.++|||||||++||++| |+.||.... ..........+ ... ..
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~--~~~~~~~~~~~-~~~---------~~ 224 (260)
T cd05073 157 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS--NPEVIRALERG-YRM---------PR 224 (260)
T ss_pred cccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCC--HHHHHHHHhCC-CCC---------CC
Confidence 1234889999988889999999999999999999 899986432 12222211111 111 11
Q ss_pred cHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 004979 658 QENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKE 692 (721)
Q Consensus 658 ~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 692 (721)
....+.++.+++.+||+.+|++||++.++.+.|+.
T Consensus 225 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 225 PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred cccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 12345678899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=299.12 Aligned_cols=231 Identities=24% Similarity=0.352 Sum_probs=180.9
Q ss_pred cCCCCceeEEEEEEecCCc-----------EEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCC
Q 004979 434 SFSDGTVGTVYKGTLSSGV-----------EIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEP 502 (721)
Q Consensus 434 ~lg~G~~g~Vyk~~~~~~~-----------~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~ 502 (721)
.+|+|+||.||+|...... .+++|...... .....|.+|+.++++++||||+++++++.. .
T Consensus 2 ~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~- 73 (259)
T cd05037 2 HLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH------RDSLAFFETASLMSQLSHKHLVKLYGVCVR-D- 73 (259)
T ss_pred cccccccceEEEEEEeccCCccccCCccceeeeeeccccch------hhHHHHHHHHHHHHcCCCcchhheeeEEec-C-
Confidence 5789999999999976433 35555543221 114679999999999999999999999987 4
Q ss_pred ceEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCC-------cEEE
Q 004979 503 FTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDY-------AAKI 575 (721)
Q Consensus 503 ~~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~-------~~kL 575 (721)
..++||||+++|+|.+++.... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++ .+||
T Consensus 74 -~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dlkp~Nill~~~~~~~~~~~~~kl 149 (259)
T cd05037 74 -ENIMVEEYVKFGPLDVFLHREK-NNVSLHWKLDVAKQLASALHYLEDKK--LVHGNVCGKNILVARYGLNEGYVPFIKL 149 (259)
T ss_pred -CcEEEEEcCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCC--eecccCccceEEEecCccccCCceeEEe
Confidence 4589999999999999986432 36899999999999999999999988 99999999999999887 7999
Q ss_pred eccCCCCCCC-----CCCccccchhhcccC--CCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhcCCCCc
Q 004979 576 SDFSFWNNTT-----AAKTGSAAMELLETS--AVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPLK 647 (721)
Q Consensus 576 ~DFGla~~~~-----~~~~~~~apE~~~~~--~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~ 647 (721)
+|||++.... .+...|++||.+... .++.++|||||||++|||++ |..||.... ..++..... ......
T Consensus 150 ~Dfg~a~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~--~~~~~~~~~-~~~~~~ 226 (259)
T cd05037 150 SDPGIPITVLSREERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLS--SSEKERFYQ-DQHRLP 226 (259)
T ss_pred CCCCcccccccccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCC--chhHHHHHh-cCCCCC
Confidence 9999987532 244578999998776 78999999999999999999 577775332 122211111 111000
Q ss_pred cccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 004979 648 DIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKL 690 (721)
Q Consensus 648 ~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L 690 (721)
......+.+++.+||..+|++||++.||++.|
T Consensus 227 -----------~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 227 -----------MPDCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred -----------CCCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 01116788999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=305.28 Aligned_cols=249 Identities=22% Similarity=0.337 Sum_probs=191.9
Q ss_pred hhhCcCCCCceeEEEEEEecC-----------------CcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccce
Q 004979 430 NIIGSFSDGTVGTVYKGTLSS-----------------GVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVN 492 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~~-----------------~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~ 492 (721)
++++.+|+|+||.||+|+... +..+++|.+..... ....+.+.+|++++++++||||++
T Consensus 8 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 8 NFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS----DNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred cccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC----HHHHHHHHHHHHHHHhcCCCCEeE
Confidence 677899999999999998542 23477877654321 234567999999999999999999
Q ss_pred EeEEEecCCCceEEEEEecCCCCChhhhhhhcc---------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCC
Q 004979 493 LIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQE---------AEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSS 563 (721)
Q Consensus 493 l~g~~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~---------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~ 563 (721)
+++++...+ ..++||||+++++|.+++.... ...+++.....++.|++.||+|||+.+ |+||||||+
T Consensus 84 ~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~--i~H~dlkp~ 159 (296)
T cd05051 84 LLGVCTVDP--PLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN--FVHRDLATR 159 (296)
T ss_pred EEEEEecCC--CcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC--ccccccchh
Confidence 999998776 5699999999999999986432 126899999999999999999999988 999999999
Q ss_pred CeEeCCCCcEEEeccCCCCCCCC-----------CCccccchhhcccCCCCCCccHHHHHHHHHHHHh--CCCcccCCCC
Q 004979 564 SIYLTEDYAAKISDFSFWNNTTA-----------AKTGSAAMELLETSAVDLESNVYSFGTILFEMIT--GRISYSIENG 630 (721)
Q Consensus 564 NILl~~~~~~kL~DFGla~~~~~-----------~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt--G~~P~~~~~~ 630 (721)
||++++++.+||+|||+++.... .+..|+|||.+....++.++|||||||++|||++ |..||....
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~- 238 (296)
T cd05051 160 NCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT- 238 (296)
T ss_pred ceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC-
Confidence 99999999999999998764321 1236899999988889999999999999999998 667774322
Q ss_pred CHHHHHHHHhhcCCCCccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 004979 631 SLENWASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLK 691 (721)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 691 (721)
..+............. .......+..++.++.+++.+||+.||++||++.||++.|+
T Consensus 239 -~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 239 -DQQVIENAGHFFRDDG---RQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred -hHHHHHHHHhcccccc---ccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 2222221111100000 00001112234578999999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=312.57 Aligned_cols=245 Identities=18% Similarity=0.270 Sum_probs=188.8
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
++++.+|+|+||+||+++.. +++.+|+|++..... ......+.+.+|+.++..++|+||+++++++.+.+ ..++|
T Consensus 4 ~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~--~~~lv 79 (331)
T cd05597 4 EILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEM--LKRAETACFREERDVLVNGDRRWITNLHYAFQDEN--NLYLV 79 (331)
T ss_pred eEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHH--hhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCC--eEEEE
Confidence 56788999999999999964 578999998864221 11223456889999999999999999999998876 78999
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC----
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT---- 584 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~---- 584 (721)
|||+++|+|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 80 ~e~~~g~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (331)
T cd05597 80 MDYYVGGDLLTLLSK-FEDRLPEDMARFYLAEMVLAIDSVHQLG--YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG 156 (331)
T ss_pred EecCCCCcHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEECCCCHHHEEECCCCCEEEEECCceeecCCCC
Confidence 999999999999853 2346889999999999999999999988 999999999999999999999999987432
Q ss_pred ------CCCCccccchhhccc-----CCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCc
Q 004979 585 ------TAAKTGSAAMELLET-----SAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPT 653 (721)
Q Consensus 585 ------~~~~~~~~apE~~~~-----~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 653 (721)
..++..|+|||.+.. ..++.++|||||||++|||++|+.||... +..+............ .
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~--~~~~~~~~i~~~~~~~-~----- 228 (331)
T cd05597 157 TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAE--SLVETYGKIMNHKEHF-Q----- 228 (331)
T ss_pred CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCC--CHHHHHHHHHcCCCcc-c-----
Confidence 124567999999853 46788999999999999999999999633 3333333333221111 0
Q ss_pred cccccHHHHHHHHHHHHHcccCCCC--CCCCHHHHHHH
Q 004979 654 LKSFQENVLEELLVVIKNCVHPDPK--QRPSMRGIAAK 689 (721)
Q Consensus 654 l~~~~~~~~~~l~~li~~Cl~~dP~--~RPs~~evl~~ 689 (721)
+.......+.++.+++.+|+..+++ .|+++.++++.
T Consensus 229 ~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 229 FPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred CCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 1111122456788888887755443 37899998763
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=297.11 Aligned_cols=238 Identities=21% Similarity=0.367 Sum_probs=192.5
Q ss_pred hhhCcCCCCceeEEEEEEecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVF 509 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV~ 509 (721)
++.+.+|.|+||.||+|.+..+..+++|.+..... ....|.+|++++++++||||+++++++.... ..++||
T Consensus 7 ~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~~v~ 78 (256)
T cd05112 7 TLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM------SEEDFIEEAQVMMKLSHPKLVQLYGVCTERS--PICLVF 78 (256)
T ss_pred EEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC------CHHHHHHHHHHHHhCCCCCeeeEEEEEccCC--ceEEEE
Confidence 45678899999999999987788899998754322 1246889999999999999999999988766 569999
Q ss_pred ecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCCC---
Q 004979 510 EYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTA--- 586 (721)
Q Consensus 510 Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~~--- 586 (721)
||+++|+|.+++... ...+++..+..++.+++.|++|||+.+ ++||||||+||+++.++.+||+|||+++....
T Consensus 79 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 155 (256)
T cd05112 79 EFMEHGCLSDYLRAQ-RGKFSQETLLGMCLDVCEGMAYLESSN--VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY 155 (256)
T ss_pred EcCCCCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccccceEEEcCCCeEEECCCcceeecccCcc
Confidence 999999999998643 345889999999999999999999988 99999999999999999999999998753211
Q ss_pred -------CCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhcCCCCccccCCcccccc
Q 004979 587 -------AKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQ 658 (721)
Q Consensus 587 -------~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 658 (721)
....|++||.+.+..++.++|||||||++|||++ |+.||... ...+.......+... ..+
T Consensus 156 ~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~--~~~~~~~~~~~~~~~----~~~------ 223 (256)
T cd05112 156 TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENR--SNSEVVETINAGFRL----YKP------ 223 (256)
T ss_pred cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcC--CHHHHHHHHhCCCCC----CCC------
Confidence 1236899999988899999999999999999998 99998532 223333333222111 111
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 004979 659 ENVLEELLVVIKNCVHPDPKQRPSMRGIAAKL 690 (721)
Q Consensus 659 ~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L 690 (721)
...+.++.+++.+||+.+|++||++.|+++.|
T Consensus 224 ~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 224 RLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred CCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 11346789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=301.05 Aligned_cols=245 Identities=20% Similarity=0.342 Sum_probs=195.7
Q ss_pred hhhCcCCCCceeEEEEEEecC-Cc----EEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCce
Q 004979 430 NIIGSFSDGTVGTVYKGTLSS-GV----EIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFT 504 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~~-~~----~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 504 (721)
++++.+|+|+||+||+|.... +. .+++|...... .......+.+|++++++++|+||+++++++.. . .
T Consensus 10 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~--~ 82 (279)
T cd05057 10 EKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET----SPKANKEILDEAYVMASVDHPHVVRLLGICLS-S--Q 82 (279)
T ss_pred EEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC----CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-C--c
Confidence 567889999999999998643 32 46777654332 13345678999999999999999999999987 3 5
Q ss_pred EEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC
Q 004979 505 RMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT 584 (721)
Q Consensus 505 ~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~ 584 (721)
.++||||+++|+|.+++... ...+++.....++.|++.|++|||+++ |+||||||+||++++++.+||+|||+++..
T Consensus 83 ~~~v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~di~p~nil~~~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 83 VQLITQLMPLGCLLDYVRNH-KDNIGSQYLLNWCVQIAKGMSYLEEKR--LVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (279)
T ss_pred eEEEEecCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCC--EEecccCcceEEEcCCCeEEECCCcccccc
Confidence 68999999999999998643 345899999999999999999999987 999999999999999999999999988643
Q ss_pred CCC-----------CccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhcCCCCccccCC
Q 004979 585 TAA-----------KTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPLKDIVDP 652 (721)
Q Consensus 585 ~~~-----------~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 652 (721)
... ...|++||......++.++|||||||++||++| |+.||... ...++......+.. .
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~--~~~~~~~~~~~~~~-~------ 230 (279)
T cd05057 160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGI--PAVEIPDLLEKGER-L------ 230 (279)
T ss_pred cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCC--CHHHHHHHHhCCCC-C------
Confidence 221 235899999988899999999999999999999 99999643 33343333332211 0
Q ss_pred ccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 004979 653 TLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAM 696 (721)
Q Consensus 653 ~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~ 696 (721)
..+..+..++.+++.+||..+|++||++.++++.|+++.+.
T Consensus 231 ---~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 231 ---PQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred ---CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 11122345688999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=305.27 Aligned_cols=246 Identities=20% Similarity=0.358 Sum_probs=191.7
Q ss_pred hhhCcCCCCceeEEEEEEec-CCc----EEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCce
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGV----EIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFT 504 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~----~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 504 (721)
++++.+|+|+||.||+|+.. ++. .+++|.+.... .......+.+|+.++++++||||++++|+|....
T Consensus 10 ~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~--- 82 (303)
T cd05110 10 KRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT----GPKANVEFMDEALIMASMDHPHLVRLLGVCLSPT--- 82 (303)
T ss_pred eeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC----CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCCC---
Confidence 45678999999999999864 443 35666654321 1223456899999999999999999999997543
Q ss_pred EEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC
Q 004979 505 RMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT 584 (721)
Q Consensus 505 ~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~ 584 (721)
.++++||+++|+|.+++... ...+++..+..++.|++.||+|||+++ |+||||||+||++++++.+||+|||+++..
T Consensus 83 ~~~v~e~~~~g~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 83 IQLVTQLMPHGCLLDYVHEH-KDNIGSQLLLNWCVQIAKGMMYLEERR--LVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred ceeeehhcCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHhhcC--eeccccccceeeecCCCceEEccccccccc
Confidence 47999999999999998642 346889999999999999999999988 999999999999999999999999988643
Q ss_pred CC-----------CCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhcCCCCccccCC
Q 004979 585 TA-----------AKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPLKDIVDP 652 (721)
Q Consensus 585 ~~-----------~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 652 (721)
.. ....|++||.+.+..++.++|||||||++|||+| |+.||.... .... ...........
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~--~~~~-~~~~~~~~~~~----- 231 (303)
T cd05110 160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP--TREI-PDLLEKGERLP----- 231 (303)
T ss_pred cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC--HHHH-HHHHHCCCCCC-----
Confidence 21 1236899999998899999999999999999998 899985332 1222 12222211111
Q ss_pred ccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcC
Q 004979 653 TLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAME 697 (721)
Q Consensus 653 ~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 697 (721)
.+..+...+.+++.+||..+|++||++.|+++.|+++....
T Consensus 232 ----~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (303)
T cd05110 232 ----QPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP 272 (303)
T ss_pred ----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence 11223457889999999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=310.58 Aligned_cols=250 Identities=24% Similarity=0.405 Sum_probs=198.8
Q ss_pred hhhhCcCCCCceeEEEEEEec--------CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcC-CCCccceEeEEEec
Q 004979 429 SNIIGSFSDGTVGTVYKGTLS--------SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKV-NHKNFVNLIGYCEE 499 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~--------~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~ 499 (721)
+++...+|+|+||.||+|+.. .+..+++|.+.... .....+.+.+|+++++++ +||||++++++|..
T Consensus 14 ~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (334)
T cd05100 14 LTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA----TDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 89 (334)
T ss_pred eeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc----CHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc
Confidence 467788999999999999742 12357888765321 123346789999999999 89999999999987
Q ss_pred CCCceEEEEEecCCCCChhhhhhhcc--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCe
Q 004979 500 DEPFTRMMVFEYSPNGSLFEHLHIQE--------------AEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSI 565 (721)
Q Consensus 500 ~~~~~~~lV~Ey~~~GsL~~~l~~~~--------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NI 565 (721)
.+ ..++||||+++|+|.+++.... ...++|..++.++.|++.||+|||+.+ |+||||||+||
T Consensus 90 ~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--ivH~dlkp~Ni 165 (334)
T cd05100 90 DG--PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK--CIHRDLAARNV 165 (334)
T ss_pred CC--ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--eeccccccceE
Confidence 76 5799999999999999986432 235889999999999999999999988 99999999999
Q ss_pred EeCCCCcEEEeccCCCCCCCC-----------CCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHH
Q 004979 566 YLTEDYAAKISDFSFWNNTTA-----------AKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLE 633 (721)
Q Consensus 566 Ll~~~~~~kL~DFGla~~~~~-----------~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~ 633 (721)
|+++++.+||+|||+++.... ....|+|||.+....++.++|||||||++|||++ |..||... ...
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~--~~~ 243 (334)
T cd05100 166 LVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI--PVE 243 (334)
T ss_pred EEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCC--CHH
Confidence 999999999999998764321 1135899999998899999999999999999999 88888532 334
Q ss_pred HHHHHHhhcCCCCccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCC
Q 004979 634 NWASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAMEP 698 (721)
Q Consensus 634 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 698 (721)
++......... . ..+..++.++.+++.+||+.+|++||++.|+++.|+++.....
T Consensus 244 ~~~~~~~~~~~-~---------~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~ 298 (334)
T cd05100 244 ELFKLLKEGHR-M---------DKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTS 298 (334)
T ss_pred HHHHHHHcCCC-C---------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcC
Confidence 44433322211 0 1122345678899999999999999999999999999886443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=306.19 Aligned_cols=237 Identities=21% Similarity=0.299 Sum_probs=191.4
Q ss_pred hhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
+++..+|.|+||.||+|+. .++..+++|.+...... ..+.+.+|+.+++.++|+||+++++++.... ..++|
T Consensus 23 ~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~-----~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~--~~~lv 95 (296)
T cd06654 23 TRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-----KKELIINEILVMRENKNPNIVNYLDSYLVGD--ELWVV 95 (296)
T ss_pred eeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc-----hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCC--EEEEe
Confidence 5667889999999999985 46788999987654322 2356889999999999999999999998766 67999
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC---
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT--- 585 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~--- 585 (721)
|||+++|+|.+++.. ..+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 96 ~e~~~~~~L~~~~~~---~~~~~~~~~~i~~ql~~aL~~LH~~g--i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~ 170 (296)
T cd06654 96 MEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (296)
T ss_pred ecccCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCCCCEEECccccchhccccc
Confidence 999999999999853 35789999999999999999999988 9999999999999999999999999875321
Q ss_pred ------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccH
Q 004979 586 ------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQE 659 (721)
Q Consensus 586 ------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 659 (721)
.+...|+|||.+....++.++|||||||++|||+||+.||..... ............ ... ..+.
T Consensus 171 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~--~~~~~~~~~~~~--~~~------~~~~ 240 (296)
T cd06654 171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP--LRALYLIATNGT--PEL------QNPE 240 (296)
T ss_pred cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCH--HHhHHHHhcCCC--CCC------CCcc
Confidence 234568999999888899999999999999999999999964432 111111111111 000 1123
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 660 NVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 660 ~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
.....+.+++.+||..+|++||++.|+++
T Consensus 241 ~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 241 KLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred ccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 45567889999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=296.72 Aligned_cols=238 Identities=29% Similarity=0.445 Sum_probs=194.1
Q ss_pred cCCCCceeEEEEEEecC----CcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEEE
Q 004979 434 SFSDGTVGTVYKGTLSS----GVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVF 509 (721)
Q Consensus 434 ~lg~G~~g~Vyk~~~~~----~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV~ 509 (721)
.+|+|+||.||+|.... +..+++|.+...... ...+.+.+|++.+.+++|+||+++++++.... ..++||
T Consensus 2 ~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~----~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~--~~~lv~ 75 (262)
T cd00192 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASE----EERKDFLKEARVMKKLGHPNVVRLLGVCTEEE--PLYLVL 75 (262)
T ss_pred ccccCCceEEEEEEEecCCCCCceEEeEeeccccch----hHHHHHHHHHHHHhhcCCCChheeeeeecCCC--ceEEEE
Confidence 57899999999999654 778899987643321 13567999999999999999999999998865 679999
Q ss_pred ecCCCCChhhhhhhcc-------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCC
Q 004979 510 EYSPNGSLFEHLHIQE-------AEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWN 582 (721)
Q Consensus 510 Ey~~~GsL~~~l~~~~-------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~ 582 (721)
||+++|+|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||.+.
T Consensus 76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~nili~~~~~~~l~dfg~~~ 153 (262)
T cd00192 76 EYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK--FVHRDLAARNCLVGEDLVVKISDFGLSR 153 (262)
T ss_pred EeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC--cccCccCcceEEECCCCcEEEccccccc
Confidence 9999999999987431 367899999999999999999999988 9999999999999999999999999876
Q ss_pred CCCC-----------CCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhcCCCCcccc
Q 004979 583 NTTA-----------AKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPLKDIV 650 (721)
Q Consensus 583 ~~~~-----------~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (721)
.... ....|+|||.+....++.++||||+||++|||++ |+.||... ...+.......+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~--~~~~~~~~~~~~~------- 224 (262)
T cd00192 154 DVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGL--SNEEVLEYLRKGY------- 224 (262)
T ss_pred ccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCC--CHHHHHHHHHcCC-------
Confidence 4432 2346899999988899999999999999999999 69998643 2333333322211
Q ss_pred CCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 004979 651 DPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLK 691 (721)
Q Consensus 651 d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 691 (721)
....+..++.++.+++.+||..+|++||++.|+++.|+
T Consensus 225 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 225 ---RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ---CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 11122344678999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=318.99 Aligned_cols=236 Identities=24% Similarity=0.322 Sum_probs=190.0
Q ss_pred cCCCCceeEEEEEE-ecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEEEecC
Q 004979 434 SFSDGTVGTVYKGT-LSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYS 512 (721)
Q Consensus 434 ~lg~G~~g~Vyk~~-~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV~Ey~ 512 (721)
.+|+|+||+||-|+ ..+...+|||-+..+... ..+-+.+||..-++++|.|||+++|.|.+++ +.-|.||.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr-----~~QPLhEEIaLH~~LrHkNIVrYLGs~senG--f~kIFMEqV 654 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSR-----EVQPLHEEIALHSTLRHKNIVRYLGSVSENG--FFKIFMEQV 654 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccch-----hhccHHHHHHHHHHHhhHhHHHHhhccCCCC--eEEEEeecC
Confidence 57899999999999 456678899988765433 2345788999999999999999999998877 567899999
Q ss_pred CCCChhhhhhhccCCCC--CHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeC-CCCcEEEeccCCCCC------
Q 004979 513 PNGSLFEHLHIQEAEHL--DWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLT-EDYAAKISDFSFWNN------ 583 (721)
Q Consensus 513 ~~GsL~~~l~~~~~~~l--~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~-~~~~~kL~DFGla~~------ 583 (721)
|||+|.++|+.. -+++ .+...-.+.+||.+||.|||+.. |||||||-+|||++ -.|.+||+|||.++.
T Consensus 655 PGGSLSsLLrsk-WGPlKDNEstm~fYtkQILeGLkYLHen~--IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP 731 (1226)
T KOG4279|consen 655 PGGSLSSLLRSK-WGPLKDNESTMNFYTKQILEGLKYLHENK--IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINP 731 (1226)
T ss_pred CCCcHHHHHHhc-cCCCccchhHHHHHHHHHHHHhhhhhhcc--eeeccccCCcEEEeeccceEEecccccchhhccCCc
Confidence 999999999743 3345 66777889999999999999988 99999999999998 579999999997653
Q ss_pred ---CCCCCccccchhhccc--CCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCcccccc
Q 004979 584 ---TTAAKTGSAAMELLET--SAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQ 658 (721)
Q Consensus 584 ---~~~~~~~~~apE~~~~--~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 658 (721)
+..++-.|||||++.. ..|+.++|||||||++.||.||++||..-+.......+--+. ..-+.++
T Consensus 732 ~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmy----------KvHP~iP 801 (1226)
T KOG4279|consen 732 CTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMY----------KVHPPIP 801 (1226)
T ss_pred cccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcce----------ecCCCCc
Confidence 3345668999999964 468899999999999999999999996333221111111000 1123456
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004979 659 ENVLEELLVVIKNCVHPDPKQRPSMRGIAAK 689 (721)
Q Consensus 659 ~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 689 (721)
++.+.+...+|.+|+..||.+||++.++++.
T Consensus 802 eelsaeak~FilrcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 802 EELSAEAKNFILRCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred HHHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence 7889999999999999999999999999863
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=301.00 Aligned_cols=239 Identities=25% Similarity=0.407 Sum_probs=188.8
Q ss_pred cCCCCceeEEEEEEecC-------CcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEE
Q 004979 434 SFSDGTVGTVYKGTLSS-------GVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRM 506 (721)
Q Consensus 434 ~lg~G~~g~Vyk~~~~~-------~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~ 506 (721)
.+|+|+||.||+|+..+ +..+++|.+.... .......|.+|++++++++||||+++++++...+ ..+
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~ 75 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA----TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNE--PQY 75 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhccc----chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCC--CeE
Confidence 47899999999998642 2467887764321 1223467899999999999999999999998766 579
Q ss_pred EEEecCCCCChhhhhhhcc-----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCC-----cEEEe
Q 004979 507 MVFEYSPNGSLFEHLHIQE-----AEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDY-----AAKIS 576 (721)
Q Consensus 507 lV~Ey~~~GsL~~~l~~~~-----~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~-----~~kL~ 576 (721)
+||||+++|+|.+++.... ...+++.+++.++.|++.||+|||+.+ ++||||||+||+++.+. .+|++
T Consensus 76 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~~~~~~l~ 153 (269)
T cd05044 76 IIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH--FIHRDLAARNCLVSEKGYDADRVVKIG 153 (269)
T ss_pred EEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC--cccCCCChheEEEecCCCCCCcceEEC
Confidence 9999999999999986432 234889999999999999999999988 99999999999999877 89999
Q ss_pred ccCCCCCCCC-----------CCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhcCC
Q 004979 577 DFSFWNNTTA-----------AKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQ 644 (721)
Q Consensus 577 DFGla~~~~~-----------~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~ 644 (721)
|||+++.... ....|++||.+....++.++|||||||++|||+| |+.||.... ..+.......+ .
T Consensus 154 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~--~~~~~~~~~~~-~ 230 (269)
T cd05044 154 DFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALN--NQEVLQHVTAG-G 230 (269)
T ss_pred CcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccC--HHHHHHHHhcC-C
Confidence 9998754321 1346899999998999999999999999999998 999986332 22222221111 1
Q ss_pred CCccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 004979 645 PLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKE 692 (721)
Q Consensus 645 ~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 692 (721)
. ...+...+..+.+++.+||..+|++||++.+|++.|++
T Consensus 231 ~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 231 R---------LQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred c---------cCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 0 01123456788999999999999999999999998863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=316.41 Aligned_cols=242 Identities=18% Similarity=0.236 Sum_probs=188.7
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
++++.+|+|+||.||+++.. +++.+|+|++....... ......+.+|+.+++.++||||+++++++.+.+ ..++|
T Consensus 46 ~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~--~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~--~~~lv 121 (371)
T cd05622 46 EVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIK--RSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR--YLYMV 121 (371)
T ss_pred EEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhh--hHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC--EEEEE
Confidence 67889999999999999965 57788999876432211 223456889999999999999999999998776 67999
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC---
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT--- 585 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~--- 585 (721)
|||+++|+|.+++.. ..++...+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 122 ~Ey~~gg~L~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~ 196 (371)
T cd05622 122 MEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG 196 (371)
T ss_pred EcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCC
Confidence 999999999999853 34788888899999999999999998 9999999999999999999999999875322
Q ss_pred -------CCCccccchhhcccC----CCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCcc
Q 004979 586 -------AAKTGSAAMELLETS----AVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTL 654 (721)
Q Consensus 586 -------~~~~~~~apE~~~~~----~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 654 (721)
.++..|+|||.+... .++.++|||||||++|||++|+.||... +.......+........ ..
T Consensus 197 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~--~~~~~~~~i~~~~~~~~-~~---- 269 (371)
T cd05622 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD--SLVGTYSKIMNHKNSLT-FP---- 269 (371)
T ss_pred cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCC--CHHHHHHHHHcCCCccc-CC----
Confidence 245679999998653 3789999999999999999999999643 33333333332211111 00
Q ss_pred ccccHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 004979 655 KSFQENVLEELLVVIKNCVHPDPKQ--RPSMRGIAAK 689 (721)
Q Consensus 655 ~~~~~~~~~~l~~li~~Cl~~dP~~--RPs~~evl~~ 689 (721)
.....+.++.+++.+|+..++.+ |+++.|+++.
T Consensus 270 --~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 270 --DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred --CcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 11235567889999999844433 7889988864
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=298.63 Aligned_cols=242 Identities=22% Similarity=0.344 Sum_probs=181.0
Q ss_pred cCCCCceeEEEEEEecCCcE---EEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEEEe
Q 004979 434 SFSDGTVGTVYKGTLSSGVE---IAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFE 510 (721)
Q Consensus 434 ~lg~G~~g~Vyk~~~~~~~~---vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV~E 510 (721)
.+|+|+||+||+|+..++.. +++|.+.... .....+.|.+|+.+++.++||||++++++|.... ..++|||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~--~~~lv~e 75 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA----SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAI--PYLLVFE 75 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC----ChHHHHHHHHHHHHHhccCCcchhheEEEecCCC--ccEEEEe
Confidence 57899999999998554433 3444433221 1233568999999999999999999999998766 5699999
Q ss_pred cCCCCChhhhhhhcc--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC---
Q 004979 511 YSPNGSLFEHLHIQE--AEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT--- 585 (721)
Q Consensus 511 y~~~GsL~~~l~~~~--~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~--- 585 (721)
|+++|+|.++++... ....++.....++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~ 153 (268)
T cd05086 76 YCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN--FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKED 153 (268)
T ss_pred cCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--eeccCCccceEEEcCCccEEecccccccccCcch
Confidence 999999999987432 234677778899999999999999988 9999999999999999999999999875321
Q ss_pred --------CCCccccchhhccc-------CCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhcCCCCccc
Q 004979 586 --------AAKTGSAAMELLET-------SAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPLKDI 649 (721)
Q Consensus 586 --------~~~~~~~apE~~~~-------~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (721)
.+...|+|||.+.. ..++.++|||||||++|||++ |..||... ...+.......+.. ...
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~--~~~~~~~~~~~~~~--~~~ 229 (268)
T cd05086 154 YIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHL--SDREVLNHVIKDQQ--VKL 229 (268)
T ss_pred hhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHHHhhcc--ccc
Confidence 12346899998742 345789999999999999997 56677532 22333333333211 222
Q ss_pred cCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 004979 650 VDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLK 691 (721)
Q Consensus 650 ~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 691 (721)
.++.+. ....+.+.+++..|| .+|++||+++||++.|.
T Consensus 230 ~~~~~~---~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 230 FKPQLE---LPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCCccC---CCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 233222 224467788999999 67999999999988763
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=297.34 Aligned_cols=259 Identities=22% Similarity=0.269 Sum_probs=195.0
Q ss_pred hhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEec---CCCceEE
Q 004979 431 IIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEE---DEPFTRM 506 (721)
Q Consensus 431 ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~---~~~~~~~ 506 (721)
.++.+|+|+||.|.++.. .+|..||+|++...-. .....++-.+|+++|+.++|+||+.+++++.. ++....|
T Consensus 26 ~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~---~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvY 102 (359)
T KOG0660|consen 26 LIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFE---NQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVY 102 (359)
T ss_pred ccccccCcceeeEEEEEEcCCCCEeehhhhhhhhh---chHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeE
Confidence 367899999999999985 5789999998862111 12345678899999999999999999999865 2233579
Q ss_pred EEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCCC
Q 004979 507 MVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTA 586 (721)
Q Consensus 507 lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~~ 586 (721)
+|+|+| .-+|...++. ...|+......+..|+.+||.|+|+.+ |+||||||+|+|++.+...||+|||+|+....
T Consensus 103 iV~elM-etDL~~iik~--~~~L~d~H~q~f~YQiLrgLKyiHSAn--ViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~ 177 (359)
T KOG0660|consen 103 LVFELM-ETDLHQIIKS--QQDLTDDHAQYFLYQILRGLKYIHSAN--VIHRDLKPSNLLLNADCDLKICDFGLARYLDK 177 (359)
T ss_pred EehhHH-hhHHHHHHHc--CccccHHHHHHHHHHHHHhcchhhccc--ccccccchhheeeccCCCEEeccccceeeccc
Confidence 999999 6689988863 344888889999999999999999999 99999999999999999999999999987632
Q ss_pred -----------CCccccchhhc-ccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCC-HHHHHHHHhhcCCC--------
Q 004979 587 -----------AKTGSAAMELL-ETSAVDLESNVYSFGTILFEMITGRISYSIENGS-LENWASEYLKGEQP-------- 645 (721)
Q Consensus 587 -----------~~~~~~apE~~-~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~-~~~~~~~~~~~~~~-------- 645 (721)
.+..|.|||.+ ....|+.+.||||.|||+.||++|+.-|.+.+.- ..+.+...+ +...
T Consensus 178 ~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~l-GtP~~e~l~~i~ 256 (359)
T KOG0660|consen 178 FFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELL-GTPSEEDLQKIR 256 (359)
T ss_pred cCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhc-CCCCHHHHHHhc
Confidence 13356799986 5678999999999999999999999988743311 111111111 0000
Q ss_pred ----------CccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHHhhhcCC
Q 004979 646 ----------LKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAK--LKEITAMEP 698 (721)
Q Consensus 646 ----------~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~--L~~i~~~~~ 698 (721)
+...-........+...+++.+|+.+||..||.+|+|++|.++. |........
T Consensus 257 s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~d 321 (359)
T KOG0660|consen 257 SEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPED 321 (359)
T ss_pred cHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCcc
Confidence 00000001112223556789999999999999999999999874 555554433
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=301.68 Aligned_cols=244 Identities=18% Similarity=0.300 Sum_probs=195.1
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
++++.+|+|+||+||++... ++..+++|+...... ....+.+.+|+++++.++||||+++++++...+ ..++|
T Consensus 8 ~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~~lv 81 (284)
T cd06620 8 ETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAK----SSVRKQILRELQIMHECRSPYIVSFYGAFLNEN--NICMC 81 (284)
T ss_pred HHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCc----chHHHHHHHHHHHHHHcCCCCcceEeeeEecCC--EEEEE
Confidence 67788999999999999864 578888887754321 234567999999999999999999999998876 67999
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC---
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQ-LTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT--- 584 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~-~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~--- 584 (721)
|||+++|+|.+++.. ...+++.....++.+++.||.|||+ .+ ++||||||+||++++++.++|+|||++...
T Consensus 82 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~ 157 (284)
T cd06620 82 MEFMDCGSLDRIYKK--GGPIPVEILGKIAVAVVEGLTYLYNVHR--IMHRDIKPSNILVNSRGQIKLCDFGVSGELINS 157 (284)
T ss_pred EecCCCCCHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHhcC--eeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence 999999999998863 3468999999999999999999996 46 999999999999999999999999987532
Q ss_pred ----CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCC---------HHHHHHHHhhcCCCCccccC
Q 004979 585 ----TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGS---------LENWASEYLKGEQPLKDIVD 651 (721)
Q Consensus 585 ----~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~---------~~~~~~~~~~~~~~~~~~~d 651 (721)
..+...|++||.+.+..++.++|||||||++|||+||+.||...... ..++.........
T Consensus 158 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------- 230 (284)
T cd06620 158 IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPP------- 230 (284)
T ss_pred ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccC-------
Confidence 12455789999998889999999999999999999999999743321 1122222221111
Q ss_pred CccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 004979 652 PTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKE 692 (721)
Q Consensus 652 ~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 692 (721)
+.+. ....+.++.+++.+||+.||++||++.|+++...-
T Consensus 231 ~~~~--~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~ 269 (284)
T cd06620 231 PRLP--SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPF 269 (284)
T ss_pred CCCC--chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccc
Confidence 0010 12255678999999999999999999999986433
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=305.42 Aligned_cols=248 Identities=19% Similarity=0.282 Sum_probs=190.6
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
++...+|+|+||.||+++.. ++..+++|.+.... ......++.+|++++.+++||||+++++++...+ ..++|
T Consensus 4 ~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~lv 77 (308)
T cd06615 4 EKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI----KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDG--EISIC 77 (308)
T ss_pred eEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc----CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC--EEEEE
Confidence 56778999999999999865 56777777765432 1234467889999999999999999999998877 78999
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC--
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQ-LTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT-- 585 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~-~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~-- 585 (721)
|||+++|+|.++++.. ..+++.....++.|++.||+|||+ ++ ++||||||+|||+++++.+||+|||++....
T Consensus 78 ~ey~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (308)
T cd06615 78 MEHMDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 153 (308)
T ss_pred eeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhCC--EEECCCChHHEEEecCCcEEEccCCCccccccc
Confidence 9999999999998643 568899999999999999999997 56 9999999999999999999999999876432
Q ss_pred -----CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCcc------------
Q 004979 586 -----AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKD------------ 648 (721)
Q Consensus 586 -----~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~------------ 648 (721)
.+...|++||.+.+..++.++|||||||++|||+||+.||.... ........-........
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (308)
T cd06615 154 MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPD--AKELEAMFGRPVSEGEAKESHRPVSGHPP 231 (308)
T ss_pred ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcc--hhhHHHhhcCccccccccCCcccccCCCC
Confidence 23457899999988889999999999999999999999986332 11111111000000000
Q ss_pred --------------ccCCcccccc-HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004979 649 --------------IVDPTLKSFQ-ENVLEELLVVIKNCVHPDPKQRPSMRGIAAK 689 (721)
Q Consensus 649 --------------~~d~~l~~~~-~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 689 (721)
+........+ .....++.+++.+||..+|++||++.||++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 232 DSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred CccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000000000 1245678999999999999999999999874
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=308.01 Aligned_cols=185 Identities=19% Similarity=0.256 Sum_probs=151.7
Q ss_pred CcCCCCceeEEEEEEec---CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEEE
Q 004979 433 GSFSDGTVGTVYKGTLS---SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVF 509 (721)
Q Consensus 433 ~~lg~G~~g~Vyk~~~~---~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV~ 509 (721)
.++|+|+||+||+|+.. +++.+|+|.+..... ...+.+|++++++++||||+++++++........++||
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~ 79 (317)
T cd07868 7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-------SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF 79 (317)
T ss_pred cccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-------cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEE
Confidence 47899999999999864 457889988753321 23577899999999999999999998765444679999
Q ss_pred ecCCCCChhhhhhhc-------cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEe----CCCCcEEEecc
Q 004979 510 EYSPNGSLFEHLHIQ-------EAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYL----TEDYAAKISDF 578 (721)
Q Consensus 510 Ey~~~GsL~~~l~~~-------~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl----~~~~~~kL~DF 578 (721)
||+. ++|.+++... ....+++.....++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+||
T Consensus 80 e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivHrDlkp~Nil~~~~~~~~~~~kl~Df 156 (317)
T cd07868 80 DYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADM 156 (317)
T ss_pred eccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEecCCCCcCcEEEeec
Confidence 9995 5888876432 1235888999999999999999999988 9999999999999 46689999999
Q ss_pred CCCCCCC------------CCCccccchhhccc-CCCCCCccHHHHHHHHHHHHhCCCcccC
Q 004979 579 SFWNNTT------------AAKTGSAAMELLET-SAVDLESNVYSFGTILFEMITGRISYSI 627 (721)
Q Consensus 579 Gla~~~~------------~~~~~~~apE~~~~-~~~s~ksDVwSfGvvL~ElltG~~P~~~ 627 (721)
|+++... .++..|+|||.+.+ ..++.++||||+||++|||+||+.||..
T Consensus 157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~ 218 (317)
T cd07868 157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred CceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence 9986432 22446899999866 4689999999999999999999999964
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=296.58 Aligned_cols=240 Identities=21% Similarity=0.384 Sum_probs=197.0
Q ss_pred hhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
+++..+|.|+||.||+++. .+++.+++|.+...... ....+++.+|++++++++|+||+++++++...+ ..++|
T Consensus 3 ~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~lv 77 (256)
T cd08218 3 VKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMS---PKEREESRKEVAVLSNMKHPNIVQYQESFEENG--NLYIV 77 (256)
T ss_pred eEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCC---hHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCC--eEEEE
Confidence 4567889999999999985 46788999987643221 233467899999999999999999999998776 77999
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCCC--
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTA-- 586 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~~-- 586 (721)
|||+++++|.+++.......+++.+...++.|++.|++|||+++ ++|+||+|+||+++.++.+||+|||++.....
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 78 MDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV 155 (256)
T ss_pred EecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence 99999999999987544456899999999999999999999988 99999999999999999999999998754322
Q ss_pred -------CCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccH
Q 004979 587 -------AKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQE 659 (721)
Q Consensus 587 -------~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 659 (721)
+...|++||...+..++.++|||||||++|||+||+.||.. .+..+.+.....+..+ ..+.
T Consensus 156 ~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~--~~~~~~~~~~~~~~~~----------~~~~ 223 (256)
T cd08218 156 ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEA--GNMKNLVLKIIRGSYP----------PVSS 223 (256)
T ss_pred hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccC--CCHHHHHHHHhcCCCC----------CCcc
Confidence 33468999999888899999999999999999999999863 3344444444333211 1223
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 660 NVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 660 ~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
....++.+++.+||+.+|++||++.||++
T Consensus 224 ~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 224 HYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred cCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 44567899999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=296.35 Aligned_cols=241 Identities=19% Similarity=0.323 Sum_probs=194.9
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
++++.+|+|++|.||+++.. +++.+++|++..... .....+.+.+|++++++++|+||+++++.+...+. ..++|
T Consensus 3 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-~~~lv 78 (257)
T cd08223 3 CFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNA---SRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDG-LLYIV 78 (257)
T ss_pred eEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhc---CHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCC-EEEEE
Confidence 56778899999999999854 567899998864332 12334578899999999999999999998764432 46899
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC---
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT--- 585 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~--- 585 (721)
|||+++++|.+++.......+++.++..++.+++.|++|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 79 ~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~--i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 79 MGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH--ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred ecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 99999999999997555566899999999999999999999988 9999999999999999999999999875321
Q ss_pred ------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccH
Q 004979 586 ------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQE 659 (721)
Q Consensus 586 ------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 659 (721)
.+...|+|||......++.++|||||||++|||++|+.||... +..........+.. ...+.
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~--~~~~~~~~~~~~~~----------~~~~~ 224 (257)
T cd08223 157 DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAK--DMNSLVYRIIEGKL----------PPMPK 224 (257)
T ss_pred CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCC--CHHHHHHHHHhcCC----------CCCcc
Confidence 2345689999999889999999999999999999999998633 23333333332211 11223
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 660 NVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 660 ~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
....++.+++.+||+.+|++||++.|+++
T Consensus 225 ~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 225 DYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred ccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 45578999999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=296.28 Aligned_cols=241 Identities=17% Similarity=0.302 Sum_probs=196.7
Q ss_pred hhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
+.++.+|.|+||.||.++. .++..+++|.+...... ....+++.+|++++++++|+||+++++++.+.+ ..++|
T Consensus 3 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~--~~~~~ 77 (256)
T cd08221 3 IPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLS---EKERRDALNEIVILSLLQHPNIIAYYNHFMDDN--TLLIE 77 (256)
T ss_pred eEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccc---hhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCC--eEEEE
Confidence 4567889999999999884 46788999987654322 233467889999999999999999999998876 67999
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC---
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT--- 585 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~--- 585 (721)
|||+++|+|.+++.......+++.++..++.|++.|++|||+.+ ++||||||+||++++++.+||+|||+++...
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 78 MEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG--ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred EEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 99999999999987544566899999999999999999999988 9999999999999999999999999875321
Q ss_pred ------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccH
Q 004979 586 ------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQE 659 (721)
Q Consensus 586 ------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 659 (721)
.+...|.+||...+..++.++||||||+++|||++|+.||... ...+.......+... ....
T Consensus 156 ~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~--~~~~~~~~~~~~~~~----------~~~~ 223 (256)
T cd08221 156 SMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDAT--NPLNLVVKIVQGNYT----------PVVS 223 (256)
T ss_pred ccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCC--CHHHHHHHHHcCCCC----------CCcc
Confidence 2345688999998888999999999999999999999999632 333444444332211 1113
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004979 660 NVLEELLVVIKNCVHPDPKQRPSMRGIAAK 689 (721)
Q Consensus 660 ~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 689 (721)
..+.++.+++.+||+.+|++||++.|+++.
T Consensus 224 ~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 224 VYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred ccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 445678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=297.98 Aligned_cols=238 Identities=25% Similarity=0.426 Sum_probs=192.5
Q ss_pred hhhCcCCCCceeEEEEEEecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVF 509 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV~ 509 (721)
++...+|+|+||.||+|.. ++..+++|+..... ....+.+|+.++++++||||+++++++.... .++||
T Consensus 9 ~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~-------~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~---~~~v~ 77 (254)
T cd05083 9 TLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV-------TAQAFLEETAVMTKLHHKNLVRLLGVILHNG---LYIVM 77 (254)
T ss_pred eeeeeeccCCCCceEeccc-CCCceEEEeecCcc-------hHHHHHHHHHHHHhCCCCCcCeEEEEEcCCC---cEEEE
Confidence 5667889999999999975 56788998875321 2357889999999999999999999987643 58999
Q ss_pred ecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCCC---
Q 004979 510 EYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTA--- 586 (721)
Q Consensus 510 Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~~--- 586 (721)
||+++|+|.+++.......+++..+..++.|++.|+.|||+.+ ++||||||+||+++.++.+||+|||+++....
T Consensus 78 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~~ 155 (254)
T cd05083 78 ELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK--LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVD 155 (254)
T ss_pred ECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEcCCCcEEECCCccceeccccCC
Confidence 9999999999997555556899999999999999999999988 99999999999999999999999998764322
Q ss_pred ---CCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccHHHH
Q 004979 587 ---AKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQENVL 662 (721)
Q Consensus 587 ---~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 662 (721)
....|++||.+....++.++|||||||++|||++ |+.||... +..+.......+. .. .....++
T Consensus 156 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~--~~~~~~~~~~~~~-~~---------~~~~~~~ 223 (254)
T cd05083 156 NSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKM--SLKEVKECVEKGY-RM---------EPPEGCP 223 (254)
T ss_pred CCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccC--CHHHHHHHHhCCC-CC---------CCCCcCC
Confidence 1235889999988899999999999999999998 99998533 2333333222211 10 1112345
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 004979 663 EELLVVIKNCVHPDPKQRPSMRGIAAKLKE 692 (721)
Q Consensus 663 ~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 692 (721)
.++.+++.+||+.+|++||+++++++.|++
T Consensus 224 ~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 224 ADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 778899999999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=324.00 Aligned_cols=253 Identities=17% Similarity=0.276 Sum_probs=186.2
Q ss_pred hhhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecC------C
Q 004979 429 SNIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEED------E 501 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~------~ 501 (721)
+++.+.+|+|+||+||+|+. .++..||||++.... ....+|+.+|++++|||||++++++... .
T Consensus 68 y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~---------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~ 138 (440)
T PTZ00036 68 YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP---------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEK 138 (440)
T ss_pred EEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc---------chHHHHHHHHHhcCCCCCcceeeeEeecccccCCC
Confidence 36678899999999999986 467899999875321 1245799999999999999999876432 1
Q ss_pred CceEEEEEecCCCCChhhhhhh--ccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCC-CcEEEecc
Q 004979 502 PFTRMMVFEYSPNGSLFEHLHI--QEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTED-YAAKISDF 578 (721)
Q Consensus 502 ~~~~~lV~Ey~~~GsL~~~l~~--~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~-~~~kL~DF 578 (721)
....++||||+++ +|.+++.. .....+++.....++.||+.||+|||+.+ |+||||||+|||++.+ +.+||+||
T Consensus 139 ~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~--IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 139 NIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF--ICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred ceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCcCHHHEEEcCCCCceeeecc
Confidence 1246799999975 77777643 23456899999999999999999999988 9999999999999966 47999999
Q ss_pred CCCCCCC--------CCCccccchhhccc-CCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhh--cCCC--
Q 004979 579 SFWNNTT--------AAKTGSAAMELLET-SAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLK--GEQP-- 645 (721)
Q Consensus 579 Gla~~~~--------~~~~~~~apE~~~~-~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~--~~~~-- 645 (721)
|+++... .++..|+|||.+.+ ..++.++|||||||++|||+||+.||..... .+.+..+.. +...
T Consensus 216 Gla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~--~~~~~~i~~~~~~p~~~ 293 (440)
T PTZ00036 216 GSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSS--VDQLVRIIQVLGTPTED 293 (440)
T ss_pred ccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHHhCCCCHH
Confidence 9986432 23456899998765 4689999999999999999999999964321 111111111 0000
Q ss_pred --------Ccc-----ccCCccc-cccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHHhhh
Q 004979 646 --------LKD-----IVDPTLK-SFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAK--LKEITA 695 (721)
Q Consensus 646 --------~~~-----~~d~~l~-~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~--L~~i~~ 695 (721)
+.+ +....+. .++...+.++.+|+.+||+.||.+|||+.|+++. ++++..
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~ 359 (440)
T PTZ00036 294 QLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRD 359 (440)
T ss_pred HHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhc
Confidence 000 0000000 1222345789999999999999999999999854 555443
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=305.39 Aligned_cols=249 Identities=20% Similarity=0.259 Sum_probs=188.4
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
++++.+|+|+||.||+|+.. ++..+++|++...... ....+.+.+|+.++++++||||+++++++.+++ ..++|
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~~v 77 (285)
T cd07861 3 TKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEE---EGVPSTAIREISLLKELQHPNIVCLQDVLMQES--RLYLI 77 (285)
T ss_pred eEeeEecccCceEEEEEEECCCCcEEEEEEecccccc---CCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCC--eEEEE
Confidence 45678899999999999964 6888999987643221 122356888999999999999999999998766 67999
Q ss_pred EecCCCCChhhhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC--
Q 004979 509 FEYSPNGSLFEHLHIQE-AEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT-- 585 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~-~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~-- 585 (721)
|||++ |+|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++....
T Consensus 78 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 154 (285)
T cd07861 78 FEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR--VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP 154 (285)
T ss_pred EecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEEcCCCcEEECcccceeecCCC
Confidence 99997 68988875433 356899999999999999999999988 9999999999999999999999999875321
Q ss_pred -------CCCccccchhhccc-CCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcC-CC-----------
Q 004979 586 -------AAKTGSAAMELLET-SAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGE-QP----------- 645 (721)
Q Consensus 586 -------~~~~~~~apE~~~~-~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~-~~----------- 645 (721)
.+...|+|||.+.+ ..++.++|||||||++|||+||+.||...... .......... .+
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 232 (285)
T cd07861 155 VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEI--DQLFRIFRILGTPTEDVWPGVTSL 232 (285)
T ss_pred cccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHH--HHHHHHHHHhCCCChhhhhcchhh
Confidence 12456899998754 45789999999999999999999999643211 1111111000 00
Q ss_pred ------CccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 646 ------LKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 646 ------~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
................+.++.+++.+||+.||++|||+.||+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 233 PDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000001111111234567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=298.73 Aligned_cols=243 Identities=20% Similarity=0.303 Sum_probs=192.8
Q ss_pred hhhCcCCCCceeEEEEEEecCCcEEEEEEeeecccc-chhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRA-DWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~~~~~vavk~~~~~~~~-~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
.+.+.+|.|+||+||+|...++..+++|.+..+... .........+.+|++++++++|+||+++++++.+.+ ..++|
T Consensus 3 ~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~lv 80 (265)
T cd06631 3 TKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDN--TISIF 80 (265)
T ss_pred cccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCC--eEEEE
Confidence 345678899999999999888899999988654321 112233467899999999999999999999998876 67999
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC---
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT--- 585 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~--- 585 (721)
|||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.+||+|||++....
T Consensus 81 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 156 (265)
T cd06631 81 MEFVPGGSISSILNR--FGPLPEPVFCKYTKQILDGVAYLHNNC--VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG 156 (265)
T ss_pred EecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHhEEECCCCeEEeccchhhHhhhhcc
Confidence 999999999999863 245789999999999999999999988 9999999999999999999999999865321
Q ss_pred ------------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCc
Q 004979 586 ------------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPT 653 (721)
Q Consensus 586 ------------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 653 (721)
.+...|++||.+.+..++.++|||||||++|||+||+.||...+. .... ..........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-~~~~-~~~~~~~~~~------- 227 (265)
T cd06631 157 LHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDR-LAAM-FYIGAHRGLM------- 227 (265)
T ss_pred ccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCCh-HHHH-HHhhhccCCC-------
Confidence 133468899999888899999999999999999999999963221 1111 1111111111
Q ss_pred cccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 654 LKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 654 l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
...+.....++.+++.+||+.+|++||++.|++.
T Consensus 228 -~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 228 -PRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred -CCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1122345677899999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=299.56 Aligned_cols=236 Identities=21% Similarity=0.282 Sum_probs=184.7
Q ss_pred CcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEEEec
Q 004979 433 GSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEY 511 (721)
Q Consensus 433 ~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV~Ey 511 (721)
..+|+|+||.||+|+.. ++..+++|.+.... ....+.+.+|++++++++|+||+++++++...+ ..++|+||
T Consensus 14 ~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e~ 86 (268)
T cd06624 14 VVLGKGTYGIVYAARDLSTQVRIAIKEIPERD-----SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENG--FFKIFMEQ 86 (268)
T ss_pred EEEecCCceEEEEeEecCCCcEEEEEEecCCC-----HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCC--EEEEEEec
Confidence 46789999999999954 56789998775432 223467899999999999999999999998876 67999999
Q ss_pred CCCCChhhhhhhccCCCC--CHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCC-CCcEEEeccCCCCCCC---
Q 004979 512 SPNGSLFEHLHIQEAEHL--DWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTE-DYAAKISDFSFWNNTT--- 585 (721)
Q Consensus 512 ~~~GsL~~~l~~~~~~~l--~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~-~~~~kL~DFGla~~~~--- 585 (721)
+++++|.+++.... ..+ ++..+..++.|++.||+|||+.+ |+||||||+||+++. ++.+||+|||++....
T Consensus 87 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~ 163 (268)
T cd06624 87 VPGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN 163 (268)
T ss_pred CCCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCeEEEecchhheecccCC
Confidence 99999999986432 234 78888899999999999999988 999999999999986 6799999999875321
Q ss_pred ------CCCccccchhhcccC--CCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccc
Q 004979 586 ------AAKTGSAAMELLETS--AVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSF 657 (721)
Q Consensus 586 ------~~~~~~~apE~~~~~--~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 657 (721)
.+...|++||.+... .++.++|||||||++|||++|+.||................. .....
T Consensus 164 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~----------~~~~~ 233 (268)
T cd06624 164 PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFK----------IHPEI 233 (268)
T ss_pred CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhc----------cCCCC
Confidence 234578999998654 378999999999999999999999863322111111110000 01112
Q ss_pred cHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 658 QENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 658 ~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
+....+++.+++.+||+.+|++||++.|++.
T Consensus 234 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 234 PESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred CcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 3345577899999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=313.13 Aligned_cols=250 Identities=20% Similarity=0.295 Sum_probs=188.1
Q ss_pred hhhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCC----c
Q 004979 429 SNIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEP----F 503 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~----~ 503 (721)
+++++.+|+|+||.||+++. .++..+|+|++..... .......+.+|+.+++.++||||+++++++...+. .
T Consensus 23 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 23 YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ---NQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred eEEEEEeecCCCEEEEEEEEcCCCceeEEEEeccccc---chhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 46788999999999999985 4688999998864321 12234578899999999999999999999865432 2
Q ss_pred eEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCC
Q 004979 504 TRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNN 583 (721)
Q Consensus 504 ~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~ 583 (721)
..++||||+.+ +|.+.++ ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 100 ~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~--ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~ 172 (359)
T cd07876 100 DVYLVMELMDA-NLCQVIH----MELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLART 172 (359)
T ss_pred eeEEEEeCCCc-CHHHHHh----ccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEEecCCCccc
Confidence 46999999965 5666653 24788888999999999999999998 99999999999999999999999999864
Q ss_pred CC--------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHH-------------------
Q 004979 584 TT--------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWA------------------- 636 (721)
Q Consensus 584 ~~--------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~------------------- 636 (721)
.. .++..|+|||.+.+..++.++|||||||++|||+||+.||...+. ...|.
T Consensus 173 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 251 (359)
T cd07876 173 ACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDH-IDQWNKVIEQLGTPSAEFMNRLQP 251 (359)
T ss_pred cccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHhcCCCcHHHHHHHHH
Confidence 32 234568999999999999999999999999999999999964321 11111
Q ss_pred --HHHhhcCCCCc---------cccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004979 637 --SEYLKGEQPLK---------DIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAK 689 (721)
Q Consensus 637 --~~~~~~~~~~~---------~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 689 (721)
........... .+..+...........++.+|+.+||+.||++|||+.|+++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 252 TVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00110000000 000000001111234678999999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=298.11 Aligned_cols=245 Identities=21% Similarity=0.360 Sum_probs=194.4
Q ss_pred hhhCcCCCCceeEEEEEEecC----CcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceE
Q 004979 430 NIIGSFSDGTVGTVYKGTLSS----GVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTR 505 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~~----~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~ 505 (721)
.+...+|+|+||.||+|...+ ...+++|....... ....+.+.+|+.++++++||||+++++++.+. ..
T Consensus 9 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~----~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~---~~ 81 (270)
T cd05056 9 TLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTS----PSVREKFLQEAYIMRQFDHPHIVKLIGVITEN---PV 81 (270)
T ss_pred eeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCC----HHHHHHHHHHHHHHHhCCCCchhceeEEEcCC---Cc
Confidence 456788999999999998643 24577777653321 23446799999999999999999999998754 35
Q ss_pred EEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC
Q 004979 506 MMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT 585 (721)
Q Consensus 506 ~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~ 585 (721)
++||||+++|+|.+++... ...+++..+..++.+++.||+|||+.+ ++||||||+||+++.++.+||+|||+++...
T Consensus 82 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~--~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 82 WIVMELAPLGELRSYLQVN-KYSLDLASLILYSYQLSTALAYLESKR--FVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158 (270)
T ss_pred EEEEEcCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccChheEEEecCCCeEEccCceeeecc
Confidence 8999999999999998643 346899999999999999999999988 9999999999999999999999999875321
Q ss_pred C----------CCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhcCCCCccccCCcc
Q 004979 586 A----------AKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPLKDIVDPTL 654 (721)
Q Consensus 586 ~----------~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 654 (721)
. ....|+|||.+....++.++|||||||++||+++ |+.||..... .+.......+.. .
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~--~~~~~~~~~~~~-~-------- 227 (270)
T cd05056 159 DESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN--NDVIGRIENGER-L-------- 227 (270)
T ss_pred cccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCH--HHHHHHHHcCCc-C--------
Confidence 1 1235899999988889999999999999999996 9999964332 222222222211 1
Q ss_pred ccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 004979 655 KSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAM 696 (721)
Q Consensus 655 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~ 696 (721)
..+..++.++.+++.+||..+|++||++.|++..|+++...
T Consensus 228 -~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 228 -PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred -CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 11234456899999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=293.30 Aligned_cols=237 Identities=27% Similarity=0.426 Sum_probs=191.6
Q ss_pred cCCCCceeEEEEEEecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEEEecCC
Q 004979 434 SFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSP 513 (721)
Q Consensus 434 ~lg~G~~g~Vyk~~~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV~Ey~~ 513 (721)
.+|+|+||.||++....++.+++|....... ......+.+|++++++++|+||+++++++...+ ..++||||++
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~~v~e~~~ 75 (251)
T cd05041 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLP----PDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQ--PIYIVMELVP 75 (251)
T ss_pred ccccCCCceEEEEEEeCCCcEEEEeccccCC----HHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCC--CeEEEEEcCC
Confidence 5789999999999977789999998764322 123467999999999999999999999998776 6799999999
Q ss_pred CCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCCC-------
Q 004979 514 NGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTA------- 586 (721)
Q Consensus 514 ~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~~------- 586 (721)
+++|.+++... ...+++.....++.+++.|++|||+.+ ++||||||+||+++.++.+||+|||+++....
T Consensus 76 ~~~l~~~l~~~-~~~~~~~~~~~~~~~~~~~l~~lH~~~--i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~ 152 (251)
T cd05041 76 GGSLLTFLRKK-KNRLTVKKLLQMSLDAAAGMEYLESKN--CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSD 152 (251)
T ss_pred CCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC--EehhhcCcceEEEcCCCcEEEeeccccccccCCcceecc
Confidence 99999998643 346889999999999999999999988 99999999999999999999999998764331
Q ss_pred ----CCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccHHH
Q 004979 587 ----AKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQENV 661 (721)
Q Consensus 587 ----~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 661 (721)
....|++||.+.+..++.++|||||||++|||+| |..||.... ........... ... ..+...
T Consensus 153 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~--~~~~~~~~~~~-~~~---------~~~~~~ 220 (251)
T cd05041 153 GLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMS--NQQTRERIESG-YRM---------PAPQLC 220 (251)
T ss_pred ccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCC--HHHHHHHHhcC-CCC---------CCCccC
Confidence 0124889999988899999999999999999999 888885332 12222221111 100 112234
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 004979 662 LEELLVVIKNCVHPDPKQRPSMRGIAAKLK 691 (721)
Q Consensus 662 ~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 691 (721)
+.++.+++.+||..+|++||++.|+++.|+
T Consensus 221 ~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 221 PEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 568999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=292.45 Aligned_cols=252 Identities=19% Similarity=0.237 Sum_probs=190.1
Q ss_pred hhhCcCCCCceeEEEEEE-ecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCc-cceEeEEEecCCC----c
Q 004979 430 NIIGSFSDGTVGTVYKGT-LSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKN-FVNLIGYCEEDEP----F 503 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~-~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~n-Iv~l~g~~~~~~~----~ 503 (721)
+.++++|+|+||+||+|+ ..+|+.||+|++......+. .-....+|+.+|++++|+| ||++++++...+. .
T Consensus 14 ~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG---~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 14 EKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEG---VPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccC---CCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 455678999999999999 45788999999987654221 2245689999999999999 9999999987552 2
Q ss_pred eEEEEEecCCCCChhhhhhhccC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCC
Q 004979 504 TRMMVFEYSPNGSLFEHLHIQEA--EHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFW 581 (721)
Q Consensus 504 ~~~lV~Ey~~~GsL~~~l~~~~~--~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla 581 (721)
..++|+||+.. +|..++..... ..++-..++.++.|+..||+|||+++ |+||||||.||||+++|.+||+|||+|
T Consensus 91 ~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~--IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 91 KLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG--ILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred eEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCcceEEECCCCcEeeeccchH
Confidence 46899999954 99999875443 35777889999999999999999998 999999999999999999999999998
Q ss_pred CCCCC---------CCccccchhhcccC-CCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccC
Q 004979 582 NNTTA---------AKTGSAAMELLETS-AVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVD 651 (721)
Q Consensus 582 ~~~~~---------~~~~~~apE~~~~~-~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d 651 (721)
+.... .+-.|.|||++.+. .|+...||||+|||+.||++++.-|.+... .+....+..-.....+..-
T Consensus 168 ra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se--~~ql~~If~~lGtP~e~~W 245 (323)
T KOG0594|consen 168 RAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE--IDQLFRIFRLLGTPNEKDW 245 (323)
T ss_pred HHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH--HHHHHHHHHHcCCCCccCC
Confidence 74331 12247899998766 799999999999999999999988875432 2222222211110000000
Q ss_pred Cc----------------ccccc---HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004979 652 PT----------------LKSFQ---ENVLEELLVVIKNCVHPDPKQRPSMRGIAAK 689 (721)
Q Consensus 652 ~~----------------l~~~~---~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 689 (721)
|. ..... +.......+++.+|++.+|.+|.|++.++..
T Consensus 246 p~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 246 PGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 00 00111 1112478899999999999999999998874
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=311.94 Aligned_cols=244 Identities=18% Similarity=0.253 Sum_probs=188.7
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
++++.+|+|+||+||+++.. +++.+|+|.+...... .......+.+|+.++..++|+||+++++++.+.+ ..|+|
T Consensus 4 ~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~--~~~lv 79 (331)
T cd05624 4 EIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEML--KRAETACFREERNVLVNGDCQWITTLHYAFQDEN--YLYLV 79 (331)
T ss_pred eEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHH--hhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC--EEEEE
Confidence 56788999999999999965 5778999987642211 1223456889999999999999999999998876 67999
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC----
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT---- 584 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~---- 584 (721)
|||+++|+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 80 ~Ey~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~lH~~~--iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 156 (331)
T cd05624 80 MDYYVGGDLLTLLSKF-EDRLPEDMARFYIAEMVLAIHSIHQLH--YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG 156 (331)
T ss_pred EeCCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCchHHEEEcCCCCEEEEeccceeeccCCC
Confidence 9999999999999642 346889999999999999999999988 999999999999999999999999987532
Q ss_pred ------CCCCccccchhhccc-----CCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCc
Q 004979 585 ------TAAKTGSAAMELLET-----SAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPT 653 (721)
Q Consensus 585 ------~~~~~~~~apE~~~~-----~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 653 (721)
..++..|+|||.+.. ..++.++|||||||++|||+||+.||... +..+....+....... .
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~--~~~~~~~~i~~~~~~~------~ 228 (331)
T cd05624 157 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAE--SLVETYGKIMNHEERF------Q 228 (331)
T ss_pred ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCC--CHHHHHHHHHcCCCcc------c
Confidence 124567999998865 56889999999999999999999999643 2333333333221111 0
Q ss_pred cccccHHHHHHHHHHHHHcccCCCCC--CCCHHHHHH
Q 004979 654 LKSFQENVLEELLVVIKNCVHPDPKQ--RPSMRGIAA 688 (721)
Q Consensus 654 l~~~~~~~~~~l~~li~~Cl~~dP~~--RPs~~evl~ 688 (721)
........++++.+++.+|+..++++ |++++++++
T Consensus 229 ~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~ 265 (331)
T cd05624 229 FPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK 265 (331)
T ss_pred CCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence 11111234577889999999865544 467887764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=307.71 Aligned_cols=247 Identities=18% Similarity=0.252 Sum_probs=187.7
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
.+++.+|+|+||+||+|+.. ++..+|+|.+....... ....+.+|++++++++||||+++++++..++ ..++|
T Consensus 9 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~lv 82 (309)
T cd07872 9 IKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG----APCTAIREVSLLKDLKHANIVTLHDIVHTDK--SLTLV 82 (309)
T ss_pred EEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCC----cchhHHHHHHHHHhCCCCCcceEEEEEeeCC--eEEEE
Confidence 66788999999999999865 57789999886443211 2345778999999999999999999998776 67999
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC---
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT--- 585 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~--- 585 (721)
|||+++ +|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 83 ~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 158 (309)
T cd07872 83 FEYLDK-DLKQYMDDC-GNIMSMHNVKIFLYQILRGLAYCHRRK--VLHRDLKPQNLLINERGELKLADFGLARAKSVPT 158 (309)
T ss_pred EeCCCC-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence 999975 888887532 345889999999999999999999988 9999999999999999999999999875321
Q ss_pred ------CCCccccchhhccc-CCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCC-CCc----cc----
Q 004979 586 ------AAKTGSAAMELLET-SAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQ-PLK----DI---- 649 (721)
Q Consensus 586 ------~~~~~~~apE~~~~-~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~-~~~----~~---- 649 (721)
.++..|+|||.+.+ ..++.++|||||||++|||+||+.||...+. .+....+..... +.. .+
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
T cd07872 159 KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTV--EDELHLIFRLLGTPTEETWPGISSND 236 (309)
T ss_pred cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHHhCCCCHHHHhhhcchh
Confidence 13446899998754 5689999999999999999999999964332 111111111000 000 00
Q ss_pred --cC---Cc-----cccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 650 --VD---PT-----LKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 650 --~d---~~-----l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
.+ +. ........+.++.+++.+|++.||++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 237 EFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 00 00 00011234567889999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=300.16 Aligned_cols=252 Identities=25% Similarity=0.408 Sum_probs=190.5
Q ss_pred hhhCcCCCCceeEEEEEEecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHh--cCCCCccceEeEEEecCC--CceE
Q 004979 430 NIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLS--KVNHKNFVNLIGYCEEDE--PFTR 505 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~--~l~H~nIv~l~g~~~~~~--~~~~ 505 (721)
++++.+|+|.||.||||++.+ +.||||++.... ...|..|-++.+ .++|+||++++++-.... ..+.
T Consensus 213 ~l~eli~~Grfg~V~KaqL~~-~~VAVKifp~~~--------kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~ey 283 (534)
T KOG3653|consen 213 QLLELIGRGRFGCVWKAQLDN-RLVAVKIFPEQE--------KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEY 283 (534)
T ss_pred hhHHHhhcCccceeehhhccC-ceeEEEecCHHH--------HHHHHhHHHHHhccCccchhHHHhhchhccCCccccce
Confidence 345677899999999999874 899999987433 356777777666 458999999998765332 2356
Q ss_pred EEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhc-------CCCCeEeeCCCCCCeEeCCCCcEEEecc
Q 004979 506 MMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQ-------LTPPIAHRNLQSSSIYLTEDYAAKISDF 578 (721)
Q Consensus 506 ~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~-------~~~~IvHrDLKp~NILl~~~~~~kL~DF 578 (721)
+||+||.++|+|.+||. ...++|....+|+.-+++||+|||+ .+|+|+|||||++|||+..|+++.|+||
T Consensus 284 wLVt~fh~kGsL~dyL~---~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF 360 (534)
T KOG3653|consen 284 WLVTEFHPKGSLCDYLK---ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF 360 (534)
T ss_pred eEEeeeccCCcHHHHHH---hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence 99999999999999996 3569999999999999999999996 3468999999999999999999999999
Q ss_pred CCCCCC-----------CCCCccccchhhcccCC-C-----CCCccHHHHHHHHHHHHhCCCccc---------------
Q 004979 579 SFWNNT-----------TAAKTGSAAMELLETSA-V-----DLESNVYSFGTILFEMITGRISYS--------------- 626 (721)
Q Consensus 579 Gla~~~-----------~~~~~~~~apE~~~~~~-~-----s~ksDVwSfGvvL~ElltG~~P~~--------------- 626 (721)
|+|... ..++..|||||++++.. + -.+.||||+|.|||||+++..-++
T Consensus 361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ev 440 (534)
T KOG3653|consen 361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEV 440 (534)
T ss_pred ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHh
Confidence 998533 23566899999986532 1 146899999999999999754332
Q ss_pred CCCCCHHHHHHHHhhcCCCCccccCCccccc--cHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCCC
Q 004979 627 IENGSLENWASEYLKGEQPLKDIVDPTLKSF--QENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAMEPD 699 (721)
Q Consensus 627 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~--~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~ 699 (721)
+....+.+....++.... .|.+++. ....+..+.+.+..||..||+.|.|+.=|.+++.++....+.
T Consensus 441 G~hPt~e~mq~~VV~kK~------RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~~ 509 (534)
T KOG3653|consen 441 GNHPTLEEMQELVVRKKQ------RPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWED 509 (534)
T ss_pred cCCCCHHHHHHHHHhhcc------CCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCCc
Confidence 111222222222222111 1222211 124466788999999999999999999999999988877765
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=298.62 Aligned_cols=239 Identities=18% Similarity=0.270 Sum_probs=194.1
Q ss_pred hhhhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEE
Q 004979 428 FSNIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRM 506 (721)
Q Consensus 428 ~~~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~ 506 (721)
+++.+..+|.|+||.||+|+.. ++..+++|.+..... ......+.+|++++++++|+||+++++++.+.. ..+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~ 78 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA----EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGT--KLW 78 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc----HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC--EEE
Confidence 4567788999999999999965 578899988764321 223467999999999999999999999998876 679
Q ss_pred EEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCCC
Q 004979 507 MVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTA 586 (721)
Q Consensus 507 lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~~ 586 (721)
+||||+++|+|.+++.. ..+++.+...++.|++.|++|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 79 lv~e~~~~~~L~~~i~~---~~l~~~~~~~~~~~l~~~l~~lh~~~--ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06640 79 IIMEYLGGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLHSEK--KIHRDIKAANVLLSEQGDVKLADFGVAGQLTD 153 (277)
T ss_pred EEEecCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC--ccCcCCChhhEEEcCCCCEEEcccccceeccC
Confidence 99999999999998853 45888899999999999999999988 99999999999999999999999998753322
Q ss_pred ---------CCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccc
Q 004979 587 ---------AKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSF 657 (721)
Q Consensus 587 ---------~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 657 (721)
+...|.+||.+.+..++.++|||||||++|||+||+.||..... .......... .....
T Consensus 154 ~~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~--~~~~~~~~~~----------~~~~~ 221 (277)
T cd06640 154 TQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHP--MRVLFLIPKN----------NPPTL 221 (277)
T ss_pred CccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcCh--HhHhhhhhcC----------CCCCC
Confidence 23457899999888899999999999999999999999863321 1111111111 11123
Q ss_pred cHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004979 658 QENVLEELLVVIKNCVHPDPKQRPSMRGIAAK 689 (721)
Q Consensus 658 ~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 689 (721)
...++.++.+++.+||+.+|++||++.|++..
T Consensus 222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 222 TGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred chhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 34567889999999999999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=297.45 Aligned_cols=247 Identities=19% Similarity=0.292 Sum_probs=198.1
Q ss_pred CCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEEEecCC
Q 004979 435 FSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSP 513 (721)
Q Consensus 435 lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV~Ey~~ 513 (721)
+|.|+||.||+|+.. ++..+++|.+....... ....+.+.+|++++++++||||+++++++.+.+ ..++|+||++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~ 76 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVE--TGQQEHIFSEKEILEECNHPFIVKLYRTFKDKK--YIYMLMEYCL 76 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchh--hhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCC--ccEEEEecCC
Confidence 578999999999965 47889999886433221 234567999999999999999999999988776 6799999999
Q ss_pred CCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCCC-------
Q 004979 514 NGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTA------- 586 (721)
Q Consensus 514 ~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~~------- 586 (721)
+|+|.+++.. ...+++..+..++.|++.||+|||+++ ++|+||||+||+++.++.+||+|||+++....
T Consensus 77 ~~~L~~~l~~--~~~l~~~~~~~~~~~i~~~l~~lH~~~--~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~ 152 (262)
T cd05572 77 GGELWTILRD--RGLFDEYTARFYIACVVLAFEYLHNRG--IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTF 152 (262)
T ss_pred CCcHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccc
Confidence 9999999864 345889999999999999999999988 99999999999999999999999998764433
Q ss_pred -CCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccHHHHHHH
Q 004979 587 -AKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQENVLEEL 665 (721)
Q Consensus 587 -~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l 665 (721)
+...|++||.+....++.++||||||+++|||++|+.||.....+..+.......+... ...+.....++
T Consensus 153 ~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~ 223 (262)
T cd05572 153 CGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGK---------LEFPNYIDKAA 223 (262)
T ss_pred cCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCC---------CCCCcccCHHH
Confidence 34568999999888899999999999999999999999975544444444444322111 11222335789
Q ss_pred HHHHHHcccCCCCCCCC-----HHHHHHHHHHhhhcCCCCCCCCCChhHHH
Q 004979 666 LVVIKNCVHPDPKQRPS-----MRGIAAKLKEITAMEPDGATPKLSPLWWA 711 (721)
Q Consensus 666 ~~li~~Cl~~dP~~RPs-----~~evl~~L~~i~~~~~~~~~p~~~~~~~~ 711 (721)
.+++.+||+.+|++||+ ++|+++ +|.+.++.|+
T Consensus 224 ~~~i~~~l~~~p~~R~~~~~~~~~~l~~-------------~~~~~~~~~~ 261 (262)
T cd05572 224 KDLIKQLLRRNPEERLGNLKGGIKDIKK-------------HKWFNGFDWE 261 (262)
T ss_pred HHHHHHHccCChhhCcCCcccCHHHHhc-------------ChhhhCCCCC
Confidence 99999999999999999 666654 5666666664
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=299.84 Aligned_cols=241 Identities=24% Similarity=0.309 Sum_probs=191.2
Q ss_pred hhhhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEE
Q 004979 428 FSNIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRM 506 (721)
Q Consensus 428 ~~~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~ 506 (721)
-+++++.+|.|+||.||+|+.. ++..+++|...... ....+.+.+|++++++++|+||+++++++..++ ..+
T Consensus 13 ~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~ 85 (292)
T cd06644 13 VWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS-----EEELEDYMVEIEILATCNHPYIVKLLGAFYWDG--KLW 85 (292)
T ss_pred hhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC-----HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCC--eEE
Confidence 3478889999999999999965 47888888875432 233567889999999999999999999988766 679
Q ss_pred EEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC-
Q 004979 507 MVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT- 585 (721)
Q Consensus 507 lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~- 585 (721)
+||||+++++|..++... ...+++..+..++.|++.|++|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 86 lv~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 162 (292)
T cd06644 86 IMIEFCPGGAVDAIMLEL-DRGLTEPQIQVICRQMLEALQYLHSMK--IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK 162 (292)
T ss_pred EEEecCCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhcCC--eeecCCCcceEEEcCCCCEEEccCccceeccc
Confidence 999999999998887532 356899999999999999999999988 9999999999999999999999999865321
Q ss_pred --------CCCccccchhhcc-----cCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCC
Q 004979 586 --------AAKTGSAAMELLE-----TSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDP 652 (721)
Q Consensus 586 --------~~~~~~~apE~~~-----~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 652 (721)
.+...|++||.+. ...++.++|||||||++|||+||+.||.... ..+..........+ ..
T Consensus 163 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~--~~~~~~~~~~~~~~--~~--- 235 (292)
T cd06644 163 TLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN--PMRVLLKIAKSEPP--TL--- 235 (292)
T ss_pred cccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCcccc--HHHHHHHHhcCCCc--cC---
Confidence 1234689999874 3457889999999999999999999985432 22222222222111 00
Q ss_pred ccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 653 TLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 653 ~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
..+...+.++.+++.+||+.+|++||++.|+++
T Consensus 236 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 236 ---SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred ---CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 112344567889999999999999999999975
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=317.68 Aligned_cols=258 Identities=21% Similarity=0.250 Sum_probs=193.8
Q ss_pred hhhhCcCCCCceeEEEEEEec---CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceE
Q 004979 429 SNIIGSFSDGTVGTVYKGTLS---SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTR 505 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~---~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~ 505 (721)
++++..+|+|+||.||+|... .+..|++|.+... +.+.+|++++++++|||||++++++.... ..
T Consensus 94 y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~----------~~~~~E~~il~~l~h~~iv~~~~~~~~~~--~~ 161 (392)
T PHA03207 94 YNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG----------KTPGREIDILKTISHRAIINLIHAYRWKS--TV 161 (392)
T ss_pred eEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc----------ccHHHHHHHHHhcCCCCccceeeeEeeCC--EE
Confidence 477889999999999999753 3467788766421 23568999999999999999999998766 67
Q ss_pred EEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC
Q 004979 506 MMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT 585 (721)
Q Consensus 506 ~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~ 585 (721)
++||||+. ++|.+++. ....+++..++.|+.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 162 ~lv~e~~~-~~l~~~l~--~~~~l~~~~~~~i~~ql~~aL~~LH~~g--ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~ 236 (392)
T PHA03207 162 CMVMPKYK-CDLFTYVD--RSGPLPLEQAITIQRRLLEALAYLHGRG--IIHRDVKTENIFLDEPENAVLGDFGAACKLD 236 (392)
T ss_pred EEEehhcC-CCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEcCCCCEEEccCccccccC
Confidence 99999995 68888883 3457999999999999999999999988 9999999999999999999999999875322
Q ss_pred -----------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCC-HHHHHHHHhhcCCCCccc----
Q 004979 586 -----------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGS-LENWASEYLKGEQPLKDI---- 649 (721)
Q Consensus 586 -----------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~-~~~~~~~~~~~~~~~~~~---- 649 (721)
.++..|+|||.+....++.++|||||||++|||++|+.||...... ....+..+..........
T Consensus 237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~ 316 (392)
T PHA03207 237 AHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQN 316 (392)
T ss_pred cccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCc
Confidence 2456789999999999999999999999999999999999643321 111111111110000000
Q ss_pred ---------------cCCcc--ccc--cHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCChhHH
Q 004979 650 ---------------VDPTL--KSF--QENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAMEPDGATPKLSPLWW 710 (721)
Q Consensus 650 ---------------~d~~l--~~~--~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~~~~p~~~~~~~ 710 (721)
..+.. ... ......++.+++.+||..||++||++.|++. +|.+.-..|
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~-------------~p~f~~~~~ 383 (392)
T PHA03207 317 GSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILS-------------LPLFTKEPI 383 (392)
T ss_pred cchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhh-------------Cchhhccch
Confidence 00000 000 0122456788999999999999999999986 455555566
Q ss_pred HHHHhh
Q 004979 711 AELEIL 716 (721)
Q Consensus 711 ~~l~~~ 716 (721)
..+.+.
T Consensus 384 ~~~~~~ 389 (392)
T PHA03207 384 NLLNIT 389 (392)
T ss_pred hhhcCc
Confidence 666543
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=333.62 Aligned_cols=245 Identities=22% Similarity=0.322 Sum_probs=191.1
Q ss_pred hhhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEE
Q 004979 429 SNIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMM 507 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~l 507 (721)
++++..||.|+||+||+|+.. ++..+++|.+..... .......|..|+.++.+++|||||++++++........||
T Consensus 15 YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l---~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyI 91 (1021)
T PTZ00266 15 YEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL---KEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYI 91 (1021)
T ss_pred EEEEEEEecCCCeEEEEEEECCCCeEEEEEEEecccc---CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEE
Confidence 378889999999999999965 466778887764322 2234567899999999999999999999887654446799
Q ss_pred EEecCCCCChhhhhhhc--cCCCCCHHHHHHHHHHHHHHHHHHhcCC-----CCeEeeCCCCCCeEeCC-----------
Q 004979 508 VFEYSPNGSLFEHLHIQ--EAEHLDWAMRLRIAMGMAYCLEHMHQLT-----PPIAHRNLQSSSIYLTE----------- 569 (721)
Q Consensus 508 V~Ey~~~GsL~~~l~~~--~~~~l~~~~~~~ia~~ia~gL~yLH~~~-----~~IvHrDLKp~NILl~~----------- 569 (721)
||||+++|+|.++|... ....+++..++.|+.||+.||+|||+.+ .+||||||||+||||+.
T Consensus 92 VMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~ 171 (1021)
T PTZ00266 92 LMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQ 171 (1021)
T ss_pred EEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccccc
Confidence 99999999999998642 2356999999999999999999999854 35999999999999964
Q ss_pred ------CCcEEEeccCCCCCCC--------CCCccccchhhccc--CCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHH
Q 004979 570 ------DYAAKISDFSFWNNTT--------AAKTGSAAMELLET--SAVDLESNVYSFGTILFEMITGRISYSIENGSLE 633 (721)
Q Consensus 570 ------~~~~kL~DFGla~~~~--------~~~~~~~apE~~~~--~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~ 633 (721)
...+||+|||+++... .++..|+|||.+.. ..++.++||||||||||||+||+.||.... ...
T Consensus 172 ~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~-~~~ 250 (1021)
T PTZ00266 172 ANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN-NFS 250 (1021)
T ss_pred ccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC-cHH
Confidence 3458999999876432 34567999999853 458899999999999999999999996432 233
Q ss_pred HHHHHHhhcCCCCccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 634 NWASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 634 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
..+...... ..+ . ....+.++.+||..||..+|.+||++.|++.
T Consensus 251 qli~~lk~~-p~l--------p--i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 251 QLISELKRG-PDL--------P--IKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred HHHHHHhcC-CCC--------C--cCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 333222211 110 0 0123467889999999999999999999984
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=300.25 Aligned_cols=233 Identities=24% Similarity=0.391 Sum_probs=179.8
Q ss_pred cCCCCceeEEEEEEecC-C-------cEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceE
Q 004979 434 SFSDGTVGTVYKGTLSS-G-------VEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTR 505 (721)
Q Consensus 434 ~lg~G~~g~Vyk~~~~~-~-------~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~ 505 (721)
.+|.|+||.||+|.... + ..+++|..... .....+.+.+|+.+++.++||||+++++++...+ ..
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~-----~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~--~~ 74 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS-----HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGD--ES 74 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcch-----hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCC--Cc
Confidence 57899999999998642 1 23555554322 1233467889999999999999999999998766 56
Q ss_pred EEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCc--------EEEec
Q 004979 506 MMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYA--------AKISD 577 (721)
Q Consensus 506 ~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~--------~kL~D 577 (721)
++||||+++|+|.++++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++. +|++|
T Consensus 75 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dlkp~nili~~~~~~~~~~~~~~~l~d 151 (258)
T cd05078 75 IMVQEYVKFGSLDTYLKKN-KNLINISWKLEVAKQLAWALHFLEDKG--LTHGNVCAKNVLLIREEDRKTGNPPFIKLSD 151 (258)
T ss_pred EEEEecCCCCcHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCccceEEEecccccccCCCceEEecc
Confidence 8999999999999998643 346899999999999999999999988 999999999999987765 69999
Q ss_pred cCCCCCCC-----CCCccccchhhccc-CCCCCCccHHHHHHHHHHHHhCC-CcccCCCCCHHHHHHHHhhcCCCCcccc
Q 004979 578 FSFWNNTT-----AAKTGSAAMELLET-SAVDLESNVYSFGTILFEMITGR-ISYSIENGSLENWASEYLKGEQPLKDIV 650 (721)
Q Consensus 578 FGla~~~~-----~~~~~~~apE~~~~-~~~s~ksDVwSfGvvL~ElltG~-~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (721)
||++.... .+...|+|||.+.. ..++.++|||||||++|||++|. .||.... ..... ........
T Consensus 152 ~g~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~--~~~~~-~~~~~~~~----- 223 (258)
T cd05078 152 PGISITVLPKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALD--SQKKL-QFYEDRHQ----- 223 (258)
T ss_pred cccccccCCchhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhcc--HHHHH-HHHHcccc-----
Confidence 99875433 23457899999876 45799999999999999999985 5553221 11111 11111111
Q ss_pred CCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 004979 651 DPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKL 690 (721)
Q Consensus 651 d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L 690 (721)
.+.....++.+++.+||+.+|++||+++|+++.|
T Consensus 224 ------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 224 ------LPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred ------CCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 1122335788999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=299.99 Aligned_cols=239 Identities=19% Similarity=0.302 Sum_probs=190.5
Q ss_pred hCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccch----hhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEE
Q 004979 432 IGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADW----SKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRM 506 (721)
Q Consensus 432 i~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~----~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~ 506 (721)
...+|+|+||.||+|... ++..+++|.+........ .....+.+.+|++++++++||||+++++++.+.+ ..+
T Consensus 5 ~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~ 82 (267)
T cd06628 5 GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDAD--HLN 82 (267)
T ss_pred cceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC--ccE
Confidence 356789999999999854 578899998765432211 1223467899999999999999999999998776 679
Q ss_pred EEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC-
Q 004979 507 MVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT- 585 (721)
Q Consensus 507 lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~- 585 (721)
+||||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++...
T Consensus 83 lv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~~l~~~l~~lH~~~--ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06628 83 IFLEYVPGGSVAALLNN--YGAFEETLVRNFVRQILKGLNYLHNRG--IIHRDIKGANILVDNKGGIKISDFGISKKLEA 158 (267)
T ss_pred EEEEecCCCCHHHHHHh--ccCccHHHHHHHHHHHHHHHHHHHhcC--cccccCCHHHEEEcCCCCEEecccCCCccccc
Confidence 99999999999999863 356889999999999999999999988 9999999999999999999999999876433
Q ss_pred --------------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccC
Q 004979 586 --------------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVD 651 (721)
Q Consensus 586 --------------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d 651 (721)
.+...|++||.+....++.++|||||||++|||+||+.||..... ...+...... .
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~-------~- 228 (267)
T cd06628 159 NSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ--LQAIFKIGEN-------A- 228 (267)
T ss_pred ccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccH--HHHHHHHhcc-------C-
Confidence 123468899999888899999999999999999999999964321 1111111111 0
Q ss_pred CccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 652 PTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 652 ~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
....+...+.++.+++.+||+.||.+||++.||++
T Consensus 229 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 229 --SPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred --CCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 11122345578899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=312.51 Aligned_cols=250 Identities=18% Similarity=0.269 Sum_probs=188.0
Q ss_pred hhhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCC----c
Q 004979 429 SNIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEP----F 503 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~----~ 503 (721)
+++++.+|+|+||.||++.. ..+..+|||++..... .......+.+|+.+++.++||||+++++++..... .
T Consensus 19 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 95 (355)
T cd07874 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ---NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ 95 (355)
T ss_pred eeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCccc---ChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence 36778899999999999985 4678899998764321 12234678899999999999999999998865321 2
Q ss_pred eEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCC
Q 004979 504 TRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNN 583 (721)
Q Consensus 504 ~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~ 583 (721)
..++||||+++ +|.+.+. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 96 ~~~lv~e~~~~-~l~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDikp~Nill~~~~~~kl~Dfg~~~~ 168 (355)
T cd07874 96 DVYLVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_pred eeEEEhhhhcc-cHHHHHh----hcCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEECCCCCEEEeeCccccc
Confidence 46999999965 6766664 24788899999999999999999988 99999999999999999999999999864
Q ss_pred CC--------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHH-------------------
Q 004979 584 TT--------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWA------------------- 636 (721)
Q Consensus 584 ~~--------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~------------------- 636 (721)
.. .++..|+|||.+.+..++.++|||||||++|||++|+.||...+. ...+.
T Consensus 169 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 247 (355)
T cd07874 169 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY-IDQWNKVIEQLGTPCPEFMKKLQP 247 (355)
T ss_pred CCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCCHHHHHhhcH
Confidence 32 234578999999988999999999999999999999999964321 11111
Q ss_pred --HHHhhcCCCCccccCCc-----c----ccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004979 637 --SEYLKGEQPLKDIVDPT-----L----KSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAK 689 (721)
Q Consensus 637 --~~~~~~~~~~~~~~d~~-----l----~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 689 (721)
...............+. . .........++.+++.+||+.||++|||+.|+++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 01110000000000000 0 01112234678899999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=299.35 Aligned_cols=241 Identities=20% Similarity=0.315 Sum_probs=191.4
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
++++.+|+|+||.||+++.. ++..+++|.+.... .......+.+|++++.+++|+||+++++++...+ ..++|
T Consensus 4 ~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~----~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~--~~~lv 77 (286)
T cd06622 4 EVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL----DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEG--AVYMC 77 (286)
T ss_pred hhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc----CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCC--eEEEE
Confidence 67888999999999999975 78899999876432 1223467899999999999999999999988766 67999
Q ss_pred EecCCCCChhhhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHhc-CCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC-
Q 004979 509 FEYSPNGSLFEHLHIQE-AEHLDWAMRLRIAMGMAYCLEHMHQ-LTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT- 585 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~-~~~l~~~~~~~ia~~ia~gL~yLH~-~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~- 585 (721)
|||+++++|..++.... ...+++..+..++.+++.||.|||+ ++ |+||||||+||+++.++.+||+|||++....
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 155 (286)
T cd06622 78 MEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA 155 (286)
T ss_pred EeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC--EeeCCCCHHHEEECCCCCEEEeecCCcccccC
Confidence 99999999998886421 3468999999999999999999996 46 9999999999999999999999999875432
Q ss_pred ------CCCccccchhhcccC------CCCCCccHHHHHHHHHHHHhCCCcccCCCCC-HHHHHHHHhhcCCCCccccCC
Q 004979 586 ------AAKTGSAAMELLETS------AVDLESNVYSFGTILFEMITGRISYSIENGS-LENWASEYLKGEQPLKDIVDP 652 (721)
Q Consensus 586 ------~~~~~~~apE~~~~~------~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~-~~~~~~~~~~~~~~~~~~~d~ 652 (721)
.+...|++||.+.+. .++.++|||||||++|||+||+.||...... ..........+
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~---------- 225 (286)
T cd06622 156 SLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDG---------- 225 (286)
T ss_pred CccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhc----------
Confidence 234468999987543 3588999999999999999999999643221 11111111111
Q ss_pred ccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 653 TLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 653 ~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
.....+..+..++.+++.+||+.+|++||++.+++.
T Consensus 226 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 226 DPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred CCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 111223446678899999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=303.88 Aligned_cols=242 Identities=22% Similarity=0.300 Sum_probs=193.3
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
++.+.+|+|+||+||+|... ++..+++|.+....... ....+.+.+|++++.+++|+||+++++++.+.+ ..++|
T Consensus 4 ~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~lv 79 (316)
T cd05574 4 KKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIK--RNKVKRVLTEQEILATLDHPFLPTLYASFQTET--YLCLV 79 (316)
T ss_pred EEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccch--HHHHHHHHHHHHHHHhCCCCCchhheeeeecCC--EEEEE
Confidence 55678899999999999965 58899999886543221 234567899999999999999999999998776 67999
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC---
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT--- 585 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~--- 585 (721)
|||+.+++|.+++.......+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++....
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 80 MDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG--IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred EEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence 99999999999987555567999999999999999999999988 9999999999999999999999999864321
Q ss_pred -----------------------------------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCC
Q 004979 586 -----------------------------------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENG 630 (721)
Q Consensus 586 -----------------------------------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~ 630 (721)
.++..|++||.+.+..++.++|||||||++|||++|+.||...+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 123458999999888899999999999999999999999964332
Q ss_pred CHHHHHHHHhhcCCCCccccCCccccccHHHHHHHHHHHHHcccCCCCCCCC----HHHHHH
Q 004979 631 SLENWASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPS----MRGIAA 688 (721)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs----~~evl~ 688 (721)
.+............. .....+.++.+++.+||+.+|++||+ +.|++.
T Consensus 238 --~~~~~~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 238 --DETFSNILKKEVTFP---------GSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred --HHHHHHHhcCCccCC---------CccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 222222221111110 01125678999999999999999999 666554
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=294.88 Aligned_cols=243 Identities=17% Similarity=0.208 Sum_probs=190.1
Q ss_pred hhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
++...+|+|+||.||+|+. .++..|++|.+.............+.+.+|++++++++||||+++++++.+......++|
T Consensus 5 ~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v 84 (265)
T cd06652 5 RLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIF 84 (265)
T ss_pred eEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEE
Confidence 4556788999999999986 458899999876433222222345678999999999999999999998876543357899
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC---
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT--- 585 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~--- 585 (721)
|||+++|+|.+++... ..+++....+++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++...
T Consensus 85 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~ 160 (265)
T cd06652 85 MEHMPGGSIKDQLKSY--GALTENVTRKYTRQILEGVSYLHSNM--IVHRDIKGANILRDSVGNVKLGDFGASKRLQTIC 160 (265)
T ss_pred EEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEecCCCCEEECcCcccccccccc
Confidence 9999999999998632 45788889999999999999999988 9999999999999999999999999875321
Q ss_pred ---------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCcccc
Q 004979 586 ---------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKS 656 (721)
Q Consensus 586 ---------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 656 (721)
.+...|+|||.+....++.++|||||||++|||++|+.||.... ........... + ....
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~--~~~~~~~~~~~--~-------~~~~ 229 (265)
T cd06652 161 LSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFE--AMAAIFKIATQ--P-------TNPV 229 (265)
T ss_pred ccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccc--hHHHHHHHhcC--C-------CCCC
Confidence 13346899999988889999999999999999999999995331 11111111111 0 1112
Q ss_pred ccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 657 FQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 657 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
.+......+.+++.+||. +|++||+++||++
T Consensus 230 ~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 230 LPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred CchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 234556778889999995 8999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=299.54 Aligned_cols=250 Identities=22% Similarity=0.292 Sum_probs=189.3
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
+++..+|+|+||.||+|+.. ++..+++|++...... ....+.+.+|++++++++|+||+++++++...+ ..++|
T Consensus 4 ~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~--~~~~v 78 (286)
T cd07847 4 EKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDD---PVIKKIALREIRMLKQLKHPNLVNLIEVFRRKR--KLHLV 78 (286)
T ss_pred eeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccC---ccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCC--EEEEE
Confidence 56678899999999999975 5888999987643211 122356889999999999999999999998776 67999
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCCC--
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTA-- 586 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~~-- 586 (721)
|||++++.|..++. ....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 79 ~e~~~~~~l~~~~~--~~~~~~~~~~~~~~~ql~~~l~~LH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07847 79 FEYCDHTVLNELEK--NPRGVPEHLIKKIIWQTLQAVNFCHKHN--CIHRDVKPENILITKQGQIKLCDFGFARILTGPG 154 (286)
T ss_pred EeccCccHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence 99999998887764 3346899999999999999999999988 99999999999999999999999998764322
Q ss_pred -------CCccccchhhccc-CCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHH-HHHHHhhc-----------CCCC
Q 004979 587 -------AKTGSAAMELLET-SAVDLESNVYSFGTILFEMITGRISYSIENGSLEN-WASEYLKG-----------EQPL 646 (721)
Q Consensus 587 -------~~~~~~apE~~~~-~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~-~~~~~~~~-----------~~~~ 646 (721)
+...|++||.+.+ ..++.++|||||||++|||+||+.||......... ........ ....
T Consensus 155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07847 155 DDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFF 234 (286)
T ss_pred ccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccc
Confidence 2346789998865 56789999999999999999999999643321111 11111100 0000
Q ss_pred ccccCCcc------ccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 647 KDIVDPTL------KSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 647 ~~~~d~~l------~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
.....+.. .......+..+.+++.+||+.+|++||++.|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 235 KGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred ccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 00000000 0011234567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=300.38 Aligned_cols=253 Identities=23% Similarity=0.316 Sum_probs=194.0
Q ss_pred CCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEEEecCC
Q 004979 435 FSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSP 513 (721)
Q Consensus 435 lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV~Ey~~ 513 (721)
+|+|+||+||++... ++..+++|.+....... ......+..|++++++++||||+++++++...+ ..|+||||++
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~lv~e~~~ 76 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKK--RKGEQMALNEKKILEKVSSRFIVSLAYAFETKD--DLCLVMTLMN 76 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhh--hhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCC--eEEEEEecCC
Confidence 578999999999854 67889999876432211 223456788999999999999999999998776 6799999999
Q ss_pred CCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC--------
Q 004979 514 NGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT-------- 585 (721)
Q Consensus 514 ~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~-------- 585 (721)
+++|.+++.......+++..+..++.|++.||.|||+++ ++||||||+||++++++.+||+|||++....
T Consensus 77 ~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 154 (277)
T cd05577 77 GGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR--IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGR 154 (277)
T ss_pred CCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEEccCcchhhhccCCccccc
Confidence 999999987554457899999999999999999999988 9999999999999999999999999875332
Q ss_pred CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCC--CHHHHHHHHhhcCCCCccccCCccccccHHHHH
Q 004979 586 AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENG--SLENWASEYLKGEQPLKDIVDPTLKSFQENVLE 663 (721)
Q Consensus 586 ~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~--~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 663 (721)
.+...|++||...+..++.++|||||||++|||++|+.||..... ...+....... .....+.....
T Consensus 155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~ 223 (277)
T cd05577 155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLE-----------MAVEYPDKFSP 223 (277)
T ss_pred cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcccc-----------ccccCCccCCH
Confidence 233468999999888899999999999999999999999964332 11111111100 01112233467
Q ss_pred HHHHHHHHcccCCCCCCCCHHH-HHHHHHHhhhcCCCCCCCCCChhHHHHH
Q 004979 664 ELLVVIKNCVHPDPKQRPSMRG-IAAKLKEITAMEPDGATPKLSPLWWAEL 713 (721)
Q Consensus 664 ~l~~li~~Cl~~dP~~RPs~~e-vl~~L~~i~~~~~~~~~p~~~~~~~~~l 713 (721)
++.+++.+||+.+|++||+++| .+..|.. +|.+..++|+.+
T Consensus 224 ~~~~li~~~l~~~p~~R~~~~~~~~~~ll~---------h~~~~~~~~~~~ 265 (277)
T cd05577 224 EAKDLCEALLQKDPEKRLGCRGGSADEVRE---------HPLFKDLNWRRL 265 (277)
T ss_pred HHHHHHHHHccCChhHccCCCcccHHHHHh---------ChhhhcCChhhh
Confidence 7899999999999999995444 3332221 455555666655
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=302.48 Aligned_cols=245 Identities=19% Similarity=0.231 Sum_probs=193.0
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
++++.+|+|+||.||++... +++.|++|.+...... .......+.+|+++++.++||||+++++.+...+ ..++|
T Consensus 4 ~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~--~~~lv 79 (305)
T cd05609 4 ETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLI--LRNQIQQVFVERDILTFAENPFVVSMFCSFETKR--HLCMV 79 (305)
T ss_pred eEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhh--hHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCC--EEEEE
Confidence 56678899999999999965 5678999987643221 1223457889999999999999999999998766 67999
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC----
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT---- 584 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~---- 584 (721)
|||+++|+|.+++.. ...+++.....++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++..
T Consensus 80 ~e~~~g~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~ 155 (305)
T cd05609 80 MEYVEGGDCATLLKN--IGALPVDMARMYFAETVLALEYLHNYG--IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL 155 (305)
T ss_pred EecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence 999999999999864 346899999999999999999999988 999999999999999999999999987521
Q ss_pred --------------------CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCC
Q 004979 585 --------------------TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQ 644 (721)
Q Consensus 585 --------------------~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~ 644 (721)
..+...|+|||.+....++.++|||||||++|||+||+.||... ...++......+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~--~~~~~~~~~~~~~~ 233 (305)
T cd05609 156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD--TPEELFGQVISDDI 233 (305)
T ss_pred cccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHhccc
Confidence 11234689999998888999999999999999999999999633 33344443333211
Q ss_pred CCccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 004979 645 PLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKE 692 (721)
Q Consensus 645 ~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 692 (721)
.. +. .....+.++.+++.+||+.+|++||++.++.+.|+.
T Consensus 234 ~~-----~~---~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 234 EW-----PE---GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred CC-----CC---ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 11 11 111345678999999999999999996555554443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=314.49 Aligned_cols=250 Identities=17% Similarity=0.189 Sum_probs=187.7
Q ss_pred hhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCC---ceE
Q 004979 430 NIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEP---FTR 505 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~---~~~ 505 (721)
++++.+|+|+||+||+++. .++..||+|++..... .....+++.+|+++++.++|+||+++++++...+. ...
T Consensus 3 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 3 EPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQ---NLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred cccceeeeCCCEEEEEEEECCCCCEEEEEecccccc---chHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence 4677899999999999995 4788999998753211 12234578899999999999999999999876531 146
Q ss_pred EEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC
Q 004979 506 MMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT 585 (721)
Q Consensus 506 ~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~ 585 (721)
++||||+. ++|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 80 ~lv~e~~~-~~l~~~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~ 154 (372)
T cd07853 80 YVVTELMQ-SDLHKIIV--SPQPLSSDHVKVFLYQILRGLKYLHSAG--ILHRDIKPGNLLVNSNCVLKICDFGLARVEE 154 (372)
T ss_pred EEEeeccc-cCHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChHHEEECCCCCEEeccccceeecc
Confidence 99999996 57887774 3456899999999999999999999988 9999999999999999999999999876321
Q ss_pred ----------CCCccccchhhcccC-CCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhh--cCCCCcc----
Q 004979 586 ----------AAKTGSAAMELLETS-AVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLK--GEQPLKD---- 648 (721)
Q Consensus 586 ----------~~~~~~~apE~~~~~-~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~--~~~~~~~---- 648 (721)
.++..|+|||.+.+. .++.++|||||||++|||++|+.||...+. .+....+.. +.....+
T Consensus 155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--~~~~~~i~~~~g~~~~~~~~~~ 232 (372)
T cd07853 155 PDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSP--IQQLDLITDLLGTPSLEAMRSA 232 (372)
T ss_pred cCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCH--HHHHHHHHHHcCCCCHHHHHHh
Confidence 124468999998764 578999999999999999999999964331 111111100 0000000
Q ss_pred -----------ccC-C---ccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004979 649 -----------IVD-P---TLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAK 689 (721)
Q Consensus 649 -----------~~d-~---~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 689 (721)
... + ..........+++.+++.+||+.||++|||+.|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 233 CEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred hHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 000 0 0001112335678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=293.40 Aligned_cols=237 Identities=24% Similarity=0.321 Sum_probs=191.5
Q ss_pred hhhCcCCCCceeEEEEEEecC-CcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLSS-GVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~~-~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
++...+|+|+||.||+|+... +..+++|.+.... ..+++.+|++++++++|+||+++++++.... ..+++
T Consensus 6 ~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-------~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~--~~~l~ 76 (256)
T cd06612 6 DILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE-------DLQEIIKEISILKQCDSPYIVKYYGSYFKNT--DLWIV 76 (256)
T ss_pred hhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH-------HHHHHHHHHHHHHhCCCCcEeeeeeeeecCC--cEEEE
Confidence 566788899999999999764 7888998875321 1467999999999999999999999998876 67999
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCCC--
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTA-- 586 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~~-- 586 (721)
+||+++++|.+++.. ....+++..+..++.|++.||.|||+.+ |+||||+|+||++++++.+||+|||++.....
T Consensus 77 ~e~~~~~~L~~~l~~-~~~~l~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (256)
T cd06612 77 MEYCGAGSVSDIMKI-TNKTLTEEEIAAILYQTLKGLEYLHSNK--KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM 153 (256)
T ss_pred EecCCCCcHHHHHHh-CccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEECCCCcEEEcccccchhcccCc
Confidence 999999999999853 3456899999999999999999999988 99999999999999999999999998764322
Q ss_pred -------CCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccH
Q 004979 587 -------AKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQE 659 (721)
Q Consensus 587 -------~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 659 (721)
+...|++||.+.+..++.++|||||||++|||+||+.||...... +........ . ......+.
T Consensus 154 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~--~~~~~~~~~--~------~~~~~~~~ 223 (256)
T cd06612 154 AKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPM--RAIFMIPNK--P------PPTLSDPE 223 (256)
T ss_pred cccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchh--hhhhhhccC--C------CCCCCchh
Confidence 234689999998889999999999999999999999999633211 111110000 0 00011223
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 660 NVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 660 ~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
....++.+++.+||+.+|++||++.||++
T Consensus 224 ~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 224 KWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred hcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 45577899999999999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=295.48 Aligned_cols=250 Identities=22% Similarity=0.382 Sum_probs=189.4
Q ss_pred hhhCcCCCCceeEEEEEEecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhc--CCCCccceEeEEEecCCC--ceE
Q 004979 430 NIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSK--VNHKNFVNLIGYCEEDEP--FTR 505 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~--l~H~nIv~l~g~~~~~~~--~~~ 505 (721)
.+++.+|+|.||+||+|.|+ |..||||++.... ++.+.+|.++... |||+||..+++.-..+.. ...
T Consensus 214 ~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srd--------E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQL 284 (513)
T KOG2052|consen 214 VLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRD--------ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQL 284 (513)
T ss_pred EEEEEecCccccceeecccc-CCceEEEEecccc--------hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEE
Confidence 46788999999999999998 7899999997543 3557777887764 599999999886543322 257
Q ss_pred EEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhc------CCCCeEeeCCCCCCeEeCCCCcEEEeccC
Q 004979 506 MMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQ------LTPPIAHRNLQSSSIYLTEDYAAKISDFS 579 (721)
Q Consensus 506 ~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~------~~~~IvHrDLKp~NILl~~~~~~kL~DFG 579 (721)
+||++|.++|||+|||.. ..++....++++..+|.||+|||- ..|.|.|||||+.|||+..++.+.|+|+|
T Consensus 285 wLvTdYHe~GSL~DyL~r---~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLG 361 (513)
T KOG2052|consen 285 WLVTDYHEHGSLYDYLNR---NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 361 (513)
T ss_pred EEeeecccCCcHHHHHhh---ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeece
Confidence 999999999999999953 568999999999999999999993 35789999999999999999999999999
Q ss_pred CCC-------------CCCCCCccccchhhcccCC----C--CCCccHHHHHHHHHHHHhC----------CCcccC---
Q 004979 580 FWN-------------NTTAAKTGSAAMELLETSA----V--DLESNVYSFGTILFEMITG----------RISYSI--- 627 (721)
Q Consensus 580 la~-------------~~~~~~~~~~apE~~~~~~----~--s~ksDVwSfGvvL~ElltG----------~~P~~~--- 627 (721)
+|- ....++..|||||++...- + -..+||||||.|+||++-. +.||..
T Consensus 362 LAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp 441 (513)
T KOG2052|consen 362 LAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVP 441 (513)
T ss_pred eeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCC
Confidence 973 2234677899999984321 1 1458999999999999863 245542
Q ss_pred CCCCHHHHHHHHhhcCCCCccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 004979 628 ENGSLENWASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITA 695 (721)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~ 695 (721)
.+.+.++ +++++-. +.+...++... ...+.+..+.++|+.||..+|.-|-|+-.|-+.|.++.+
T Consensus 442 ~DPs~ee-MrkVVCv-~~~RP~ipnrW--~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 442 SDPSFEE-MRKVVCV-QKLRPNIPNRW--KSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CCCCHHH-Hhcceee-cccCCCCCccc--ccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 1222222 2222211 11111111111 234677889999999999999999999999999988875
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=309.24 Aligned_cols=238 Identities=20% Similarity=0.281 Sum_probs=195.1
Q ss_pred hCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEEEe
Q 004979 432 IGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFE 510 (721)
Q Consensus 432 i~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV~E 510 (721)
+..||.|+||.||-|+. .+...||+|++....... .....++++||..|.+++|||+|.+.|||.... ..|||||
T Consensus 31 LrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs--~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~--TaWLVME 106 (948)
T KOG0577|consen 31 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQS--NEKWQDILKEVRFLRQLRHPNTIEYKGCYLREH--TAWLVME 106 (948)
T ss_pred HHHhcCCccceeEEeeccCccceeeeeecccccccc--HHHHHHHHHHHHHHHhccCCCcccccceeeccc--hHHHHHH
Confidence 35678999999999984 567889999987654332 344578999999999999999999999998765 6799999
Q ss_pred cCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCC-----CC
Q 004979 511 YSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNN-----TT 585 (721)
Q Consensus 511 y~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~-----~~ 585 (721)
|| -|+-.+++... ..++..-.+..|+.|.+.||+|||+.+ .||||||+.||||.+.|.|||+|||.+.. ..
T Consensus 107 YC-lGSAsDlleVh-kKplqEvEIAAi~~gaL~gLaYLHS~~--~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAnsF 182 (948)
T KOG0577|consen 107 YC-LGSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHN--RIHRDIKAGNILLSEPGLVKLADFGSASIMAPANSF 182 (948)
T ss_pred HH-hccHHHHHHHH-hccchHHHHHHHHHHHHHHHHHHHHhh--HHhhhccccceEecCCCeeeeccccchhhcCchhcc
Confidence 99 56888887533 456888888999999999999999998 99999999999999999999999998754 34
Q ss_pred CCCccccchhhc---ccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccHHHH
Q 004979 586 AAKTGSAAMELL---ETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQENVL 662 (721)
Q Consensus 586 ~~~~~~~apE~~---~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 662 (721)
.|+++|||||++ ..+.|+-|+||||+||+..||.-.++|+. +.+...-+..+...+. |.+. ..+.+
T Consensus 183 vGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlF--nMNAMSALYHIAQNes-------PtLq--s~eWS 251 (948)
T KOG0577|consen 183 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF--NMNAMSALYHIAQNES-------PTLQ--SNEWS 251 (948)
T ss_pred cCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCcc--CchHHHHHHHHHhcCC-------CCCC--CchhH
Confidence 578899999997 56789999999999999999999999975 3333333333333322 2222 35678
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 663 EELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 663 ~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
..+..++..|+++-|.+|||..++++
T Consensus 252 ~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 252 DYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred HHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 88999999999999999999998875
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=299.41 Aligned_cols=237 Identities=20% Similarity=0.295 Sum_probs=187.8
Q ss_pred hhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
++++.+|+|+||.||+|+. .++..+++|.+.... .....+.|.+|++++++++||||+++++++...+ ..++|
T Consensus 4 ~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~lv 77 (279)
T cd06619 4 QYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI----TVELQKQIMSELEILYKCDSPYIIGFYGAFFVEN--RISIC 77 (279)
T ss_pred hheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC----ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECC--EEEEE
Confidence 5677889999999999985 567889999875432 1233467999999999999999999999998876 67899
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC---
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT--- 585 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~--- 585 (721)
|||+++|+|..+. .+++.....++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 78 ~e~~~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~ 149 (279)
T cd06619 78 TEFMDGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSLK--ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI 149 (279)
T ss_pred EecCCCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCCHHHEEECCCCCEEEeeCCcceeccccc
Confidence 9999999996542 3678888899999999999999988 9999999999999999999999999876422
Q ss_pred ----CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCC-----HHHHHHHHhhcCCCCccccCCcccc
Q 004979 586 ----AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGS-----LENWASEYLKGEQPLKDIVDPTLKS 656 (721)
Q Consensus 586 ----~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~-----~~~~~~~~~~~~~~~~~~~d~~l~~ 656 (721)
.++..|+|||.+....++.++|||||||++|||+||+.||...... ............. +...
T Consensus 150 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~- 221 (279)
T cd06619 150 AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDP-------PVLP- 221 (279)
T ss_pred ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCC-------CCCC-
Confidence 2345789999998889999999999999999999999999632211 1111111111100 1110
Q ss_pred ccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004979 657 FQENVLEELLVVIKNCVHPDPKQRPSMRGIAAK 689 (721)
Q Consensus 657 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 689 (721)
......++.+++.+||+.+|++||+++|+++.
T Consensus 222 -~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 222 -VGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred -CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 12244678999999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=305.67 Aligned_cols=185 Identities=19% Similarity=0.266 Sum_probs=150.7
Q ss_pred CcCCCCceeEEEEEEec---CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEEE
Q 004979 433 GSFSDGTVGTVYKGTLS---SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVF 509 (721)
Q Consensus 433 ~~lg~G~~g~Vyk~~~~---~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV~ 509 (721)
.++|+|+||+||+|+.. ++..+|+|.+.... ....+.+|++++++++||||+++++++........++||
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~ 79 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-------ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLF 79 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC-------CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEE
Confidence 36899999999999865 34678888775321 123577899999999999999999998754444679999
Q ss_pred ecCCCCChhhhhhhc-------cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEe----CCCCcEEEecc
Q 004979 510 EYSPNGSLFEHLHIQ-------EAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYL----TEDYAAKISDF 578 (721)
Q Consensus 510 Ey~~~GsL~~~l~~~-------~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl----~~~~~~kL~DF 578 (721)
||+. ++|.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+|||+ ++++.+||+||
T Consensus 80 e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~~kl~Df 156 (317)
T cd07867 80 DYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADM 156 (317)
T ss_pred eeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEccCCCCCCcEEEeec
Confidence 9986 4787776421 1235888999999999999999999988 9999999999999 56789999999
Q ss_pred CCCCCCCC------------CCccccchhhccc-CCCCCCccHHHHHHHHHHHHhCCCcccC
Q 004979 579 SFWNNTTA------------AKTGSAAMELLET-SAVDLESNVYSFGTILFEMITGRISYSI 627 (721)
Q Consensus 579 Gla~~~~~------------~~~~~~apE~~~~-~~~s~ksDVwSfGvvL~ElltG~~P~~~ 627 (721)
|+++.... ++..|+|||.+.+ ..++.++|||||||++|||+||+.||..
T Consensus 157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred cceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 99864321 2346899999865 4589999999999999999999999964
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=297.65 Aligned_cols=251 Identities=23% Similarity=0.332 Sum_probs=199.0
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
.+++.+|+|+||.||++... +++.+++|++...... .....+.+.+|++++++++||||+++++++.+.+ ..++|
T Consensus 4 ~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~~v 79 (290)
T cd05580 4 EFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIV--KLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDS--NLYLV 79 (290)
T ss_pred EEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhh--hhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCC--eEEEE
Confidence 56778899999999999965 5788999987543211 1233467899999999999999999999998876 67999
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC---
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT--- 585 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~--- 585 (721)
|||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++...
T Consensus 80 ~e~~~~~~L~~~~~~--~~~l~~~~~~~~~~qil~~l~~lH~~~--i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 155 (290)
T cd05580 80 MEYVPGGELFSHLRK--SGRFPEPVARFYAAQVVLALEYLHSLD--IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRT 155 (290)
T ss_pred EecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEECCCCCEEEeeCCCccccCCCC
Confidence 999999999999864 356899999999999999999999988 9999999999999999999999999876432
Q ss_pred ---CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccHHHH
Q 004979 586 ---AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQENVL 662 (721)
Q Consensus 586 ---~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 662 (721)
.+...|++||.+....++.++||||||+++|||+||+.||.... ..+.......+... .+....
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~~~~~-----------~~~~~~ 222 (290)
T cd05580 156 YTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN--PIQIYEKILEGKVR-----------FPSFFS 222 (290)
T ss_pred CCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHhcCCcc-----------CCccCC
Confidence 23456899999988888999999999999999999999996433 22222233222111 122235
Q ss_pred HHHHHHHHHcccCCCCCCC-----CHHHHHHHHHHhhhcCCCCCCCCCChhHHHHHH
Q 004979 663 EELLVVIKNCVHPDPKQRP-----SMRGIAAKLKEITAMEPDGATPKLSPLWWAELE 714 (721)
Q Consensus 663 ~~l~~li~~Cl~~dP~~RP-----s~~evl~~L~~i~~~~~~~~~p~~~~~~~~~l~ 714 (721)
..+.+++.+||..+|.+|+ +++|+++ +|.+..+.|..+.
T Consensus 223 ~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~-------------~~~~~~~~~~~~~ 266 (290)
T cd05580 223 PDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN-------------HPWFAGIDWIALL 266 (290)
T ss_pred HHHHHHHHHHccCCHHHccCcccCCHHHHHc-------------CcccccCCHHHHh
Confidence 6788999999999999998 6666643 4555566666554
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=316.94 Aligned_cols=242 Identities=14% Similarity=0.201 Sum_probs=183.3
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
.+.+.+|+|+||.||+|+.. .++.|+||.... ..+.+|+++|++++|+|||++++++...+ ..++|
T Consensus 172 ~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~-----------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~--~~~lv 238 (461)
T PHA03211 172 AIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY-----------ASSVHEARLLRRLSHPAVLALLDVRVVGG--LTCLV 238 (461)
T ss_pred EEEEEEccCCCeEEEEEEECCCCCEEEEecccc-----------cCHHHHHHHHHHCCCCCCCcEEEEEEECC--EEEEE
Confidence 56778999999999999965 467888885321 24678999999999999999999998776 67999
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC----
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT---- 584 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~---- 584 (721)
|||+ .|+|.+++.. ....++|.+++.|+.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 239 ~e~~-~~~L~~~l~~-~~~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 314 (461)
T PHA03211 239 LPKY-RSDLYTYLGA-RLRPLGLAQVTAVARQLLSAIDYIHGEG--IIHRDIKTENVLVNGPEDICLGDFGAACFARGSW 314 (461)
T ss_pred EEcc-CCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence 9999 5789888853 2346999999999999999999999988 999999999999999999999999987532
Q ss_pred -------CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCC-----CHHHHHHHHhhc-CCCCccc--
Q 004979 585 -------TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENG-----SLENWASEYLKG-EQPLKDI-- 649 (721)
Q Consensus 585 -------~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~-----~~~~~~~~~~~~-~~~~~~~-- 649 (721)
..++..|+|||.+.+..++.++|||||||++|||++|..|+..... .....+.+.+.. .......
T Consensus 315 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~ 394 (461)
T PHA03211 315 STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQ 394 (461)
T ss_pred ccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCC
Confidence 1245679999999999999999999999999999998766532111 111111111111 0000000
Q ss_pred -cC----------------Cccc--cc--cHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 650 -VD----------------PTLK--SF--QENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 650 -~d----------------~~l~--~~--~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
.. +... .+ ......++.+|+.+||+.||++|||+.|+++
T Consensus 395 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~ 454 (461)
T PHA03211 395 HAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLR 454 (461)
T ss_pred CcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhh
Confidence 00 0000 00 0022346889999999999999999999986
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=294.83 Aligned_cols=246 Identities=22% Similarity=0.367 Sum_probs=191.4
Q ss_pred hhCcCCCCceeEEEEEEec----CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCC----
Q 004979 431 IIGSFSDGTVGTVYKGTLS----SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEP---- 502 (721)
Q Consensus 431 ii~~lg~G~~g~Vyk~~~~----~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~---- 502 (721)
+.+.+|+|+||.||+|.+. ++..+++|.+...... ....+++.+|++++++++||||+++++++...+.
T Consensus 3 ~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 3 LGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFS---SSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred chhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCC---hHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence 4567889999999999854 3678999988643221 2234678999999999999999999998865321
Q ss_pred ceEEEEEecCCCCChhhhhhhc----cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEecc
Q 004979 503 FTRMMVFEYSPNGSLFEHLHIQ----EAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDF 578 (721)
Q Consensus 503 ~~~~lV~Ey~~~GsL~~~l~~~----~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DF 578 (721)
...++++||+++|+|.+++... ....+++....+++.|++.||+|||+.+ |+||||||+||++++++.+||+||
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN--FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccchhhEEEcCCCCEEECcc
Confidence 1247899999999999887532 1235788999999999999999999988 999999999999999999999999
Q ss_pred CCCCCCCC-----------CCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhcCCCC
Q 004979 579 SFWNNTTA-----------AKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPL 646 (721)
Q Consensus 579 Gla~~~~~-----------~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~ 646 (721)
|+++.... ....|++||.+....++.++|||||||++|||++ |+.||... +..+......... ..
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~--~~~~~~~~~~~~~-~~ 234 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGV--ENSEIYNYLIKGN-RL 234 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCC--CHHHHHHHHHcCC-cC
Confidence 98764321 1235788999988889999999999999999999 88888533 2222222222221 11
Q ss_pred ccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 004979 647 KDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEI 693 (721)
Q Consensus 647 ~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i 693 (721)
. .....+.++.+++.+||+.+|++||++.|+++.|+++
T Consensus 235 ~---------~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 235 K---------QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred C---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1 1123456799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=310.88 Aligned_cols=249 Identities=17% Similarity=0.217 Sum_probs=187.9
Q ss_pred hhhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCC----c
Q 004979 429 SNIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEP----F 503 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~----~ 503 (721)
+.+++.+|+|+||.||++... .++.+|||++...... ......+.+|+.+++.++||||+++++++...+. .
T Consensus 26 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 26 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQN---QTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred eeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccC---chhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 367788999999999999854 6788999988643211 2234568899999999999999999998764321 2
Q ss_pred eEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCC
Q 004979 504 TRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNN 583 (721)
Q Consensus 504 ~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~ 583 (721)
..|+||||+++ +|.+++. ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 103 ~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~DfG~a~~ 175 (364)
T cd07875 103 DVYIVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLART 175 (364)
T ss_pred eEEEEEeCCCC-CHHHHHH----hcCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEECCCCcEEEEeCCCccc
Confidence 46999999965 7777764 34788899999999999999999988 99999999999999999999999999864
Q ss_pred CC--------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhc-------------
Q 004979 584 TT--------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKG------------- 642 (721)
Q Consensus 584 ~~--------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~------------- 642 (721)
.. .++..|+|||.+.+..++.++|||||||++|||+||+.||...+ ..+....++..
T Consensus 176 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 253 (364)
T cd07875 176 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD--HIDQWNKVIEQLGTPCPEFMKKLQ 253 (364)
T ss_pred cCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHhcCCCCHHHHHhhh
Confidence 32 23557899999999999999999999999999999999996432 11211111110
Q ss_pred ---------CCCCcc-----ccC----CccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004979 643 ---------EQPLKD-----IVD----PTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAK 689 (721)
Q Consensus 643 ---------~~~~~~-----~~d----~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 689 (721)
...... ... +...........++.+++.+|++.||++|||+.|+++.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 254 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000000 000 00000111224578899999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=296.35 Aligned_cols=240 Identities=23% Similarity=0.312 Sum_probs=192.0
Q ss_pred hhhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEE
Q 004979 429 SNIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMM 507 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~l 507 (721)
+++++.+|.|+||.||+|+.. ++..+++|...... ....+.|.+|++++++++|+||+++++++.... ..++
T Consensus 7 ~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~l 79 (280)
T cd06611 7 WEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES-----EEELEDFMVEIDILSECKHPNIVGLYEAYFYEN--KLWI 79 (280)
T ss_pred HHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCC-----HHHHHHHHHHHHHHHhCCCCceeEEEEEEecCC--eEEE
Confidence 478889999999999999964 57889998876432 223467899999999999999999999998766 6799
Q ss_pred EEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC--
Q 004979 508 VFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT-- 585 (721)
Q Consensus 508 V~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~-- 585 (721)
||||+++|+|.+++... ...+++.....++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 80 v~e~~~~~~L~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (280)
T cd06611 80 LIEFCDGGALDSIMLEL-ERGLTEPQIRYVCRQMLEALNFLHSHK--VIHRDLKAGNILLTLDGDVKLADFGVSAKNKST 156 (280)
T ss_pred EeeccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEECCCCCEEEccCccchhhccc
Confidence 99999999999988532 346899999999999999999999988 9999999999999999999999999864321
Q ss_pred -------CCCccccchhhcc-----cCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCc
Q 004979 586 -------AAKTGSAAMELLE-----TSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPT 653 (721)
Q Consensus 586 -------~~~~~~~apE~~~-----~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 653 (721)
.++..|++||.+. ...++.++|||||||++|||++|+.||... +..+.......+..+. .
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~--~~~~~~~~~~~~~~~~--~---- 228 (280)
T cd06611 157 LQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHEL--NPMRVLLKILKSEPPT--L---- 228 (280)
T ss_pred ccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccC--CHHHHHHHHhcCCCCC--c----
Confidence 2345689999874 345788999999999999999999999633 2222222222221110 0
Q ss_pred cccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 654 LKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 654 l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
..+...+.++.+++.+||+.+|++||++.++++
T Consensus 229 --~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (280)
T cd06611 229 --DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK 261 (280)
T ss_pred --CCcccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence 112234567889999999999999999999976
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=283.58 Aligned_cols=242 Identities=22% Similarity=0.335 Sum_probs=192.6
Q ss_pred CcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccch---hhHHHHHHHHHHHHHhcC-CCCccceEeEEEecCCCceEEE
Q 004979 433 GSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADW---SKNLESQFRKKIDTLSKV-NHKNFVNLIGYCEEDEPFTRMM 507 (721)
Q Consensus 433 ~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~---~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~~~l 507 (721)
+.+|.|..++|-++.+ .++.+.++|++........ .....+.-.+|+.+|+++ .||+|+++.++|..+. ..++
T Consensus 23 eilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s--F~Fl 100 (411)
T KOG0599|consen 23 EILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA--FVFL 100 (411)
T ss_pred HHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc--hhhh
Confidence 3455677778888875 4788999999876543322 223445678899999998 7999999999999877 6799
Q ss_pred EEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC--
Q 004979 508 VFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT-- 585 (721)
Q Consensus 508 V~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~-- 585 (721)
|+|.|+.|.|+++|. ....+++....+|+.|+..|++|||..+ ||||||||+|||+|++.++||+|||++....
T Consensus 101 VFdl~prGELFDyLt--s~VtlSEK~tR~iMrqlfegVeylHa~~--IVHRDLKpENILlddn~~i~isDFGFa~~l~~G 176 (411)
T KOG0599|consen 101 VFDLMPRGELFDYLT--SKVTLSEKETRRIMRQLFEGVEYLHARN--IVHRDLKPENILLDDNMNIKISDFGFACQLEPG 176 (411)
T ss_pred hhhhcccchHHHHhh--hheeecHHHHHHHHHHHHHHHHHHHHhh--hhhcccChhheeeccccceEEeccceeeccCCc
Confidence 999999999999996 3456899999999999999999999988 9999999999999999999999999987654
Q ss_pred ------CCCccccchhhcc------cCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCc
Q 004979 586 ------AAKTGSAAMELLE------TSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPT 653 (721)
Q Consensus 586 ------~~~~~~~apE~~~------~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 653 (721)
.++++|.|||.+. ...|+...|+|+.|||||.|+.|..||..... .-.++.++.|...+ -.|.
T Consensus 177 ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ--mlMLR~ImeGkyqF---~spe 251 (411)
T KOG0599|consen 177 EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ--MLMLRMIMEGKYQF---RSPE 251 (411)
T ss_pred hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH--HHHHHHHHhccccc---CCcc
Confidence 3678999999873 34688999999999999999999999952211 11122233332211 1111
Q ss_pred cccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004979 654 LKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAK 689 (721)
Q Consensus 654 l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 689 (721)
-.+.+.++.+||.+|++.||.+|.|++|+++.
T Consensus 252 ----Wadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 252 ----WADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred ----hhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 23567789999999999999999999999874
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=292.42 Aligned_cols=240 Identities=22% Similarity=0.343 Sum_probs=194.2
Q ss_pred hhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
++++.+|+|+||.||++.. .++..+++|.+..... .....+.+.+|++++++++||||+++++.+...+ ..++|
T Consensus 3 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~--~~~lv 77 (256)
T cd08220 3 EKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQM---TKDERLAAQNECQVLKLLSHPNIIEYYENFLEDK--ALMIV 77 (256)
T ss_pred eEEEEecccCceEEEEEEEcCCCcEEEEEEEecccc---ccHHHHHHHHHHHHHhhCCCCchhheeeeEecCC--EEEEE
Confidence 4567889999999999985 4678899998865432 2234567999999999999999999999887766 67999
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCC-CcEEEeccCCCCCCC--
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTED-YAAKISDFSFWNNTT-- 585 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~-~~~kL~DFGla~~~~-- 585 (721)
|||+++++|.+++.......+++..+.+++.+++.|++|||+++ |+||||||+||+++++ +.+||+|||++....
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 78 MEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL--ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred EecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 99999999999997655566899999999999999999999988 9999999999999854 568999999876432
Q ss_pred ------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccH
Q 004979 586 ------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQE 659 (721)
Q Consensus 586 ------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 659 (721)
.+...|++||.+....++.++|||||||++|||++|+.||... +............. ...+.
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~--~~~~~~~~~~~~~~----------~~~~~ 223 (256)
T cd08220 156 SKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAA--NLPALVLKIMSGTF----------APISD 223 (256)
T ss_pred ccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccC--chHHHHHHHHhcCC----------CCCCC
Confidence 2345689999998888999999999999999999999999643 22333333322211 11122
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 660 NVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 660 ~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
..+.++.+++.+||+.+|++|||+.|+++
T Consensus 224 ~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 224 RYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred CcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 34567899999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=295.98 Aligned_cols=243 Identities=24% Similarity=0.428 Sum_probs=191.8
Q ss_pred hhhCcCCCCceeEEEEEEec------CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCc
Q 004979 430 NIIGSFSDGTVGTVYKGTLS------SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPF 503 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~------~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 503 (721)
.++..+|+|+||+||+|+.+ ....+++|....... ......+.+|++++++++|+||+++++++.+.+
T Consensus 8 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-- 81 (275)
T cd05046 8 QEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKD----ENLQSEFRRELDMFRKLSHKNVVRLLGLCREAE-- 81 (275)
T ss_pred eeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccc----hHHHHHHHHHHHHHHhcCCcceeeeEEEECCCC--
Confidence 56788999999999999864 235677776643221 224567999999999999999999999998766
Q ss_pred eEEEEEecCCCCChhhhhhhccC-------CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEe
Q 004979 504 TRMMVFEYSPNGSLFEHLHIQEA-------EHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKIS 576 (721)
Q Consensus 504 ~~~lV~Ey~~~GsL~~~l~~~~~-------~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~ 576 (721)
..++||||+++|+|.+++..... ..+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+|++
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dlkp~Nili~~~~~~~l~ 159 (275)
T cd05046 82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR--FVHRDLAARNCLVSSQREVKVS 159 (275)
T ss_pred cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC--cccCcCccceEEEeCCCcEEEc
Confidence 56999999999999999864431 26899999999999999999999988 9999999999999999999999
Q ss_pred ccCCCCCCCC----------CCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhcCCC
Q 004979 577 DFSFWNNTTA----------AKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQP 645 (721)
Q Consensus 577 DFGla~~~~~----------~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~ 645 (721)
|||+++.... .+..|++||.+....++.++|||||||++|||++ |..||... .....+.....+...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~--~~~~~~~~~~~~~~~ 237 (275)
T cd05046 160 LLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGL--SDEEVLNRLQAGKLE 237 (275)
T ss_pred ccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCcccc--chHHHHHHHHcCCcC
Confidence 9998753321 1234899999888888999999999999999999 78888532 222233322211111
Q ss_pred CccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 004979 646 LKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLK 691 (721)
Q Consensus 646 ~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 691 (721)
. .....++..+.+++.+||+.+|++||++.|++..|.
T Consensus 238 ~---------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 238 L---------PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred C---------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 0 011234567899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=291.77 Aligned_cols=242 Identities=22% Similarity=0.330 Sum_probs=195.1
Q ss_pred hhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
++++.+|.|+||.||++.. .++..+++|.+..... .....+.+.+|++++++++|+||+++++++........+++
T Consensus 3 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 3 EVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM---TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred eeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC---CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence 5667889999999999985 4678888888764322 23345678999999999999999999998876544467999
Q ss_pred EecCCCCChhhhhhhc--cCCCCCHHHHHHHHHHHHHHHHHHh-----cCCCCeEeeCCCCCCeEeCCCCcEEEeccCCC
Q 004979 509 FEYSPNGSLFEHLHIQ--EAEHLDWAMRLRIAMGMAYCLEHMH-----QLTPPIAHRNLQSSSIYLTEDYAAKISDFSFW 581 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~--~~~~l~~~~~~~ia~~ia~gL~yLH-----~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla 581 (721)
|||+++++|.+++... ....+++.....++.|++.||+||| +.+ |+||||||+||++++++.+||+|||++
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~--i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT--VLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc--ceecCCCHHHEEEecCCCEEEeccccc
Confidence 9999999999998643 2457899999999999999999999 655 999999999999999999999999987
Q ss_pred CCCC---------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCC
Q 004979 582 NNTT---------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDP 652 (721)
Q Consensus 582 ~~~~---------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 652 (721)
.... .+...|++||.+....++.++||||||+++|||++|+.||.... ..+.......+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~~~--------- 226 (265)
T cd08217 158 KILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN--QLQLASKIKEGK--------- 226 (265)
T ss_pred ccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC--HHHHHHHHhcCC---------
Confidence 6432 23446889999988889999999999999999999999996443 333333222211
Q ss_pred ccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 653 TLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 653 ~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
....+...+.++.+++.+||+.+|++||++.||++
T Consensus 227 -~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 227 -FRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred -CCCCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 11233455678999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=313.85 Aligned_cols=243 Identities=17% Similarity=0.216 Sum_probs=181.5
Q ss_pred hhhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEE
Q 004979 429 SNIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMM 507 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~l 507 (721)
+++++.+|+|+||.||+|+.. ++..|++|+... .....|+.++++++|+|||++++++...+ ..++
T Consensus 68 y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~-----------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~l 134 (357)
T PHA03209 68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK-----------GTTLIEAMLLQNVNHPSVIRMKDTLVSGA--ITCM 134 (357)
T ss_pred cEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc-----------cccHHHHHHHHhCCCCCCcChhheEEeCC--eeEE
Confidence 377889999999999999965 456788876421 12356899999999999999999998876 6799
Q ss_pred EEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC---
Q 004979 508 VFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT--- 584 (721)
Q Consensus 508 V~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~--- 584 (721)
||||+ .|+|.+++.. ....+++..+..|+.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 135 v~e~~-~~~l~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 210 (357)
T PHA03209 135 VLPHY-SSDLYTYLTK-RSRPLPIDQALIIEKQILEGLRYLHAQR--IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA 210 (357)
T ss_pred EEEcc-CCcHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEEecCccccccccC
Confidence 99999 5689888853 3456899999999999999999999988 999999999999999999999999988632
Q ss_pred -----CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcc-cCCCCCHHH-------HHHHHhhcCCCCccccC
Q 004979 585 -----TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISY-SIENGSLEN-------WASEYLKGEQPLKDIVD 651 (721)
Q Consensus 585 -----~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~-~~~~~~~~~-------~~~~~~~~~~~~~~~~d 651 (721)
..++..|+|||.+.+..++.++|||||||++|||+++..++ ......... .+...............
T Consensus 211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 290 (357)
T PHA03209 211 PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFP 290 (357)
T ss_pred cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcC
Confidence 12456789999999999999999999999999999965544 322221111 11111110000000000
Q ss_pred --Ccc--------------ccc-------cHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 652 --PTL--------------KSF-------QENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 652 --~~l--------------~~~-------~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
+.. ... ......++.++|.+||+.||++|||+.|+++
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~ 350 (357)
T PHA03209 291 RDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILN 350 (357)
T ss_pred CCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhc
Confidence 000 000 0122345677999999999999999999986
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=290.46 Aligned_cols=240 Identities=22% Similarity=0.326 Sum_probs=192.2
Q ss_pred hCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEEEe
Q 004979 432 IGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFE 510 (721)
Q Consensus 432 i~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV~E 510 (721)
...+|.|+||+||+|... ++..+++|.+.............+.+.+|++++++++|+||+++++++...+ ..++|||
T Consensus 5 ~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~--~~~lv~e 82 (258)
T cd06632 5 GELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREED--NLYIFLE 82 (258)
T ss_pred cceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCC--eEEEEEE
Confidence 356789999999999976 7889999988765433333445578999999999999999999999998776 6799999
Q ss_pred cCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC-----
Q 004979 511 YSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT----- 585 (721)
Q Consensus 511 y~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~----- 585 (721)
|+++++|.+++.. ...+++..+..++.|++.|++|||+.+ |+||||||+||++++++.+||+|||++....
T Consensus 83 ~~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~~ 158 (258)
T cd06632 83 LVPGGSLAKLLKK--YGSFPEPVIRLYTRQILLGLEYLHDRN--TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFA 158 (258)
T ss_pred ecCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEccCccceeccccccc
Confidence 9999999999863 345889999999999999999999988 9999999999999999999999999875322
Q ss_pred ---CCCccccchhhcccCC-CCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccHHH
Q 004979 586 ---AAKTGSAAMELLETSA-VDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQENV 661 (721)
Q Consensus 586 ---~~~~~~~apE~~~~~~-~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 661 (721)
.+...|++||.+.... ++.++|||||||++|||++|+.||.... ..+........ ... ...++..
T Consensus 159 ~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~--~~~~~~~~~~~-~~~--------~~~~~~~ 227 (258)
T cd06632 159 KSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE--GVAAVFKIGRS-KEL--------PPIPDHL 227 (258)
T ss_pred cccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc--HHHHHHHHHhc-ccC--------CCcCCCc
Confidence 2345688999987666 8999999999999999999999996332 12222221110 111 1122344
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 662 LEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 662 ~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
..++.+++.+||+.+|++||++.|++.
T Consensus 228 ~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 228 SDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred CHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 577889999999999999999999875
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=294.82 Aligned_cols=240 Identities=18% Similarity=0.228 Sum_probs=187.4
Q ss_pred hhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
++...+|+|+||.||+|+. .++..+++|.+..... .....+.+|+.+++.++||||+++++++...+ ..++|
T Consensus 12 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-----~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~--~~~lv 84 (267)
T cd06645 12 ELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG-----EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRD--KLWIC 84 (267)
T ss_pred HHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch-----hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC--EEEEE
Confidence 5667889999999999985 4678899988764321 12346788999999999999999999998776 67999
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC---
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT--- 585 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~--- 585 (721)
|||+++|+|.+++.. ...+++.+...++.|++.|++|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 85 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06645 85 MEFCGGGSLQDIYHV--TGPLSESQIAYVSRETLQGLYYLHSKG--KMHRDIKGANILLTDNGHVKLADFGVSAQITATI 160 (267)
T ss_pred EeccCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEECcceeeeEccCcc
Confidence 999999999999853 346899999999999999999999988 9999999999999999999999999864321
Q ss_pred ------CCCccccchhhcc---cCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCcccc
Q 004979 586 ------AAKTGSAAMELLE---TSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKS 656 (721)
Q Consensus 586 ------~~~~~~~apE~~~---~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 656 (721)
.++..|+|||.+. ...++.++|||||||++|||++|+.||....... ........... .+....
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~--~~~~~~~~~~~-----~~~~~~ 233 (267)
T cd06645 161 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR--ALFLMTKSNFQ-----PPKLKD 233 (267)
T ss_pred cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh--hHHhhhccCCC-----CCcccc
Confidence 2345789999874 4568899999999999999999999985332211 11111111100 011100
Q ss_pred ccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 657 FQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 657 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
...++..+.+++.+||+.+|++||++++|++
T Consensus 234 -~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 234 -KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred -cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 1123456889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=301.63 Aligned_cols=247 Identities=17% Similarity=0.258 Sum_probs=188.3
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
.+++.+|+|+||.||+|+.. ++..|++|.+....... ....+.+|++++++++||||+++++++...+ ..++|
T Consensus 9 ~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~--~~~lv 82 (301)
T cd07873 9 IKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEG----APCTAIREVSLLKDLKHANIVTLHDIIHTEK--SLTLV 82 (301)
T ss_pred EEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccC----chhHHHHHHHHHHhcCCCCcceEEEEEecCC--eEEEE
Confidence 67788999999999999865 57889999876433211 2245778999999999999999999998776 67999
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC---
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT--- 585 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~--- 585 (721)
|||++ ++|.+++... ...+++.....++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++....
T Consensus 83 ~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 158 (301)
T cd07873 83 FEYLD-KDLKQYLDDC-GNSINMHNVKLFLFQLLRGLNYCHRRK--VLHRDLKPQNLLINERGELKLADFGLARAKSIPT 158 (301)
T ss_pred Eeccc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHHHEEECCCCcEEECcCcchhccCCCC
Confidence 99997 6898888643 346889999999999999999999988 9999999999999999999999999875322
Q ss_pred ------CCCccccchhhccc-CCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCC-C----CccccC--
Q 004979 586 ------AAKTGSAAMELLET-SAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQ-P----LKDIVD-- 651 (721)
Q Consensus 586 ------~~~~~~~apE~~~~-~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~-~----~~~~~d-- 651 (721)
.+...|++||.+.+ ..++.++|||||||++|||+||+.||...+ ..+....+..... + ...+.+
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (301)
T cd07873 159 KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGST--VEEQLHFIFRILGTPTEETWPGILSNE 236 (301)
T ss_pred CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHHcCCCChhhchhhhccc
Confidence 12446899998754 457889999999999999999999996432 2222211111000 0 000000
Q ss_pred -------Cc-----cccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 652 -------PT-----LKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 652 -------~~-----l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
+. ........+.++.+|+.+|++.||.+|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 237 EFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred cccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00 00111234567889999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=292.63 Aligned_cols=247 Identities=20% Similarity=0.318 Sum_probs=193.2
Q ss_pred hhhCcCCCCceeEEEEEEecC--CcEEEEEEeeeccccc-----hhhHHHHHHHHHHHHHhc-CCCCccceEeEEEecCC
Q 004979 430 NIIGSFSDGTVGTVYKGTLSS--GVEIAVTSTSVKSRAD-----WSKNLESQFRKKIDTLSK-VNHKNFVNLIGYCEEDE 501 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~~--~~~vavk~~~~~~~~~-----~~~~~~~~f~~Ei~~l~~-l~H~nIv~l~g~~~~~~ 501 (721)
++.+.+|+|+||.||+|+... +..+++|.+....... .......++.+|+.++.+ ++||||+++++++.+.+
T Consensus 3 ~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 82 (269)
T cd08528 3 AVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEND 82 (269)
T ss_pred hhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCC
Confidence 456788999999999999764 6788999876432211 112334567889998875 79999999999998876
Q ss_pred CceEEEEEecCCCCChhhhhhhc--cCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCeEeeCCCCCCeEeCCCCcEEEecc
Q 004979 502 PFTRMMVFEYSPNGSLFEHLHIQ--EAEHLDWAMRLRIAMGMAYCLEHMHQ-LTPPIAHRNLQSSSIYLTEDYAAKISDF 578 (721)
Q Consensus 502 ~~~~~lV~Ey~~~GsL~~~l~~~--~~~~l~~~~~~~ia~~ia~gL~yLH~-~~~~IvHrDLKp~NILl~~~~~~kL~DF 578 (721)
..++||||+++++|.+++... ....+++..+..++.|++.||.|||+ .+ ++||||||+||+++.++.+||+||
T Consensus 83 --~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~--i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 83 --RLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred --eEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc--eeecCCCHHHEEECCCCcEEEecc
Confidence 679999999999999887532 34568999999999999999999996 55 999999999999999999999999
Q ss_pred CCCCCCC--------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCcccc
Q 004979 579 SFWNNTT--------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIV 650 (721)
Q Consensus 579 Gla~~~~--------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (721)
|++.... .+...|++||......++.++||||||+++|||++|+.||... +............. ...
T Consensus 159 g~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~--~~~~~~~~~~~~~~--~~~- 233 (269)
T cd08528 159 GLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYST--NMLSLATKIVEAVY--EPL- 233 (269)
T ss_pred cceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCccccc--CHHHHHHHHhhccC--CcC-
Confidence 9875322 2344688999998888999999999999999999999998533 22222222222111 100
Q ss_pred CCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 004979 651 DPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLK 691 (721)
Q Consensus 651 d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 691 (721)
.......++.+++.+||+.||++||++.|+..+++
T Consensus 234 ------~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 234 ------PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred ------CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 01134567889999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=283.00 Aligned_cols=242 Identities=20% Similarity=0.290 Sum_probs=196.4
Q ss_pred hhhhCcCCCCceeEEEEEE-ecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEE
Q 004979 429 SNIIGSFSDGTVGTVYKGT-LSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMM 507 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~-~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~l 507 (721)
+++-+.+|+|.|+.||++. ..+|+.+++|++..+... ....+++.+|+++.+.++|||||++.+.+.+.. ..||
T Consensus 13 y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~---~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~--~~yl 87 (355)
T KOG0033|consen 13 YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS---ARDFQKLEREARICRKLQHPNIVRLHDSIQEES--FHYL 87 (355)
T ss_pred hhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhc---cccHHHHHHHHHHHHhcCCCcEeehhhhhcccc--eeEE
Confidence 3555677899999999997 457888999888765433 234577899999999999999999999888766 6799
Q ss_pred EEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCC---CCcEEEeccCCCCCC
Q 004979 508 VFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTE---DYAAKISDFSFWNNT 584 (721)
Q Consensus 508 V~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~---~~~~kL~DFGla~~~ 584 (721)
|+|+|.||+|..-+-.+ ...++...-.+++||..||.|+|.++ |||||+||+|+|+.. .--+||+|||++...
T Consensus 88 vFe~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n~--IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l 163 (355)
T KOG0033|consen 88 VFDLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHSNG--IVHRDLKPENLLLASKAKGAAVKLADFGLAIEV 163 (355)
T ss_pred EEecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeeeeccCCCceeecccceEEEe
Confidence 99999999997666432 45777888899999999999999998 999999999999964 346899999998654
Q ss_pred C--------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCcccc
Q 004979 585 T--------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKS 656 (721)
Q Consensus 585 ~--------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 656 (721)
. .++++|++||++...+|+..+|||+.|||||-|+.|..||.++ +......++..+...+.. +
T Consensus 164 ~~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~--~~~rlye~I~~g~yd~~~---~---- 234 (355)
T KOG0033|consen 164 NDGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE--DQHRLYEQIKAGAYDYPS---P---- 234 (355)
T ss_pred CCccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCc--cHHHHHHHHhccccCCCC---c----
Confidence 3 3567899999999999999999999999999999999999753 344455555555332211 1
Q ss_pred ccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 657 FQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 657 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
.-+...++..+|+++|+..||.+|.|+.|.++
T Consensus 235 ~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 235 EWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred ccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 11345678999999999999999999988763
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=300.14 Aligned_cols=249 Identities=19% Similarity=0.288 Sum_probs=189.7
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
+++..+|.|+||.||+|+.. ++..+++|++...... ......+.+|++++++++||||+++++++.+.+ ..++|
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~~~v 77 (284)
T cd07860 3 QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET---EGVPSTAIREISLLKELNHPNIVKLLDVIHTEN--KLYLV 77 (284)
T ss_pred eeeeeecCCCceEEEEEEECCCCCEEEEEEccccccc---cccchHHHHHHHHHHhcCCCCCcchhhhcccCC--cEEEE
Confidence 45678899999999999864 6888999987643321 122357889999999999999999999998776 67999
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCCC--
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTA-- 586 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~~-- 586 (721)
|||+. ++|.+++.......+++.....++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++....
T Consensus 78 ~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~--i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~ 154 (284)
T cd07860 78 FEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 154 (284)
T ss_pred eeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence 99995 68999887555567899999999999999999999988 99999999999999999999999998753321
Q ss_pred -------CCccccchhhcccCC-CCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCC-C------------
Q 004979 587 -------AKTGSAAMELLETSA-VDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQ-P------------ 645 (721)
Q Consensus 587 -------~~~~~~apE~~~~~~-~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~-~------------ 645 (721)
+...|+|||.+.+.. ++.++|||||||++|||+||+.||..... .....+...... +
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07860 155 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE--IDQLFRIFRTLGTPDEVVWPGVTSLP 232 (284)
T ss_pred cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH--HHHHHHHHHHhCCCChhhhhhhhHHH
Confidence 234689999876544 58899999999999999999999964321 111111111100 0
Q ss_pred -----CccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 646 -----LKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 646 -----~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
..................++.+++.+||+.||++||+++|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 233 DYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 0001111111111234467889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=306.37 Aligned_cols=250 Identities=16% Similarity=0.201 Sum_probs=187.5
Q ss_pred hhhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCC----Cc
Q 004979 429 SNIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDE----PF 503 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~----~~ 503 (721)
+.+++.+|.|+||+||+|.. .++..||||++..... .....+.+.+|++++++++||||+++++++.... ..
T Consensus 17 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07878 17 YQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQ---SLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFN 93 (343)
T ss_pred hhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhh---hhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccC
Confidence 47888999999999999985 4678899998764321 1223456789999999999999999999876432 12
Q ss_pred eEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCC
Q 004979 504 TRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNN 583 (721)
Q Consensus 504 ~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~ 583 (721)
..++++|++ +++|.+++. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.
T Consensus 94 ~~~~~~~~~-~~~l~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrdikp~Nil~~~~~~~kl~Dfg~~~~ 167 (343)
T cd07878 94 EVYLVTNLM-GADLNNIVK---CQKLSDEHVQFLIYQLLRGLKYIHSAG--IIHRDLKPSNVAVNEDCELRILDFGLARQ 167 (343)
T ss_pred cEEEEeecC-CCCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC--eecccCChhhEEECCCCCEEEcCCcccee
Confidence 468999998 789988774 345899999999999999999999988 99999999999999999999999999864
Q ss_pred CC------CCCccccchhhccc-CCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcC-CCCcccc-----
Q 004979 584 TT------AAKTGSAAMELLET-SAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGE-QPLKDIV----- 650 (721)
Q Consensus 584 ~~------~~~~~~~apE~~~~-~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~-~~~~~~~----- 650 (721)
.. .++..|+|||.+.+ ..++.++|||||||++|||++|+.||...+ ..+.+....... .+..+..
T Consensus 168 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (343)
T cd07878 168 ADDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGND--YIDQLKRIMEVVGTPSPEVLKKISS 245 (343)
T ss_pred cCCCcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCC--HHHHHHHHHHHhCCCCHHHHHhcch
Confidence 32 23557899999866 578999999999999999999999996432 111111111100 0000000
Q ss_pred --------------CCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004979 651 --------------DPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAK 689 (721)
Q Consensus 651 --------------d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 689 (721)
............+.+.+++.+|++.||++|||+.|+++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 246 EHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred hhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000011123457899999999999999999999864
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=292.75 Aligned_cols=245 Identities=22% Similarity=0.349 Sum_probs=189.6
Q ss_pred hhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccc-----hhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCce
Q 004979 431 IIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRAD-----WSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFT 504 (721)
Q Consensus 431 ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~-----~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 504 (721)
+.+.+|.|+||.||+|.. .++..+++|.+....... ......+.+.+|++++++++|+||+++++++...+ .
T Consensus 5 ~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~ 82 (272)
T cd06629 5 KGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE--Y 82 (272)
T ss_pred ecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC--c
Confidence 456789999999999985 468889999875432111 11223457889999999999999999999998766 6
Q ss_pred EEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC
Q 004979 505 RMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT 584 (721)
Q Consensus 505 ~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~ 584 (721)
.++||||+++|+|.++++.. ..+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+|||+++..
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~~~nil~~~~~~~~l~d~~~~~~~ 158 (272)
T cd06629 83 LSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHSKG--ILHRDLKADNLLVDADGICKISDFGISKKS 158 (272)
T ss_pred eEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCC--eeecCCChhhEEEcCCCeEEEeeccccccc
Confidence 79999999999999998643 56899999999999999999999987 999999999999999999999999987643
Q ss_pred C-----------CCCccccchhhcccCC--CCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccC
Q 004979 585 T-----------AAKTGSAAMELLETSA--VDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVD 651 (721)
Q Consensus 585 ~-----------~~~~~~~apE~~~~~~--~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d 651 (721)
. .+...|++||.+.... ++.++||||||+++||+++|+.||.... ..... ....... ....+.
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~-~~~~~-~~~~~~~--~~~~~~ 234 (272)
T cd06629 159 DDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEE-AIAAM-FKLGNKR--SAPPIP 234 (272)
T ss_pred cccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcc-hHHHH-HHhhccc--cCCcCC
Confidence 2 1234688999986654 8899999999999999999999995322 11111 1111110 011111
Q ss_pred CccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 652 PTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 652 ~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
. .....++.++.+++.+||..+|++||+++||++
T Consensus 235 ~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 235 P---DVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred c---cccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 1 112335678999999999999999999999976
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=300.64 Aligned_cols=238 Identities=21% Similarity=0.294 Sum_probs=191.5
Q ss_pred hhhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEE
Q 004979 429 SNIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMM 507 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~l 507 (721)
+.+++.+|+|+||.||+|+. .++..|++|.+...... ..+.+.+|+.+++.++|+||+++++++...+ ..++
T Consensus 21 y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~--~~~l 93 (297)
T cd06656 21 YTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP-----KKELIINEILVMRENKNPNIVNYLDSYLVGD--ELWV 93 (297)
T ss_pred ceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc-----hHHHHHHHHHHHHhCCCCCEeeEEEEEecCC--EEEE
Confidence 36678899999999999995 57889999988643321 2356889999999999999999999998776 6799
Q ss_pred EEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC--
Q 004979 508 VFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT-- 585 (721)
Q Consensus 508 V~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~-- 585 (721)
||||+++++|.+++.. ..+++.++..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 94 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~~~--i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~ 168 (297)
T cd06656 94 VMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALDFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 168 (297)
T ss_pred eecccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEECcCccceEccCC
Confidence 9999999999999853 45789999999999999999999988 9999999999999999999999999875322
Q ss_pred -------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCcccccc
Q 004979 586 -------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQ 658 (721)
Q Consensus 586 -------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 658 (721)
.+...|++||.+.+..++.++|||||||++|||+||+.||...+.. ...........+ . ...+
T Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~--~~~~~~~~~~~~-------~-~~~~ 238 (297)
T cd06656 169 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL--RALYLIATNGTP-------E-LQNP 238 (297)
T ss_pred ccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcc--hheeeeccCCCC-------C-CCCc
Confidence 2344688999998888999999999999999999999999643321 110000000000 0 0122
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 659 ENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 659 ~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
......+.+++.+||+.+|++||++.|+++
T Consensus 239 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 239 ERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 344567889999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=289.99 Aligned_cols=240 Identities=29% Similarity=0.453 Sum_probs=193.3
Q ss_pred hhCcCCCCceeEEEEEEecC-----CcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceE
Q 004979 431 IIGSFSDGTVGTVYKGTLSS-----GVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTR 505 (721)
Q Consensus 431 ii~~lg~G~~g~Vyk~~~~~-----~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~ 505 (721)
+++.+|.|+||.||+++... +..+++|.+..... ....+.+.+|++++.+++|+||+++++++.+.+ ..
T Consensus 3 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~ 76 (258)
T smart00219 3 LGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD----EQQIEEFLREARIMRKLDHPNIVKLLGVCTEEE--PL 76 (258)
T ss_pred ccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC----hHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC--ee
Confidence 56788999999999999653 37789988754321 124568999999999999999999999998876 67
Q ss_pred EEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC
Q 004979 506 MMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT 585 (721)
Q Consensus 506 ~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~ 585 (721)
+++|||+++++|.+++.......+++.++..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++...
T Consensus 77 ~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~--~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~ 154 (258)
T smart00219 77 MIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN--FIHRDLAARNCLVGENLVVKISDFGLSRDLY 154 (258)
T ss_pred EEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC--eeecccccceEEEccCCeEEEcccCCceecc
Confidence 99999999999999987543333899999999999999999999988 9999999999999999999999999875332
Q ss_pred C----------CCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhcCCCCccccCCcc
Q 004979 586 A----------AKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPLKDIVDPTL 654 (721)
Q Consensus 586 ~----------~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 654 (721)
. ....|++||......++.++||||+|+++|||++ |+.||.. .+..........+...
T Consensus 155 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~--~~~~~~~~~~~~~~~~--------- 223 (258)
T smart00219 155 DDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPG--MSNEEVLEYLKKGYRL--------- 223 (258)
T ss_pred cccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC--CCHHHHHHHHhcCCCC---------
Confidence 1 2346899999988889999999999999999999 7888853 2333333333222111
Q ss_pred ccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 004979 655 KSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKL 690 (721)
Q Consensus 655 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L 690 (721)
..+...+.++.+++.+||..+|++|||+.|+++.|
T Consensus 224 -~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 224 -PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred -CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 11223567789999999999999999999998754
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=290.92 Aligned_cols=241 Identities=21% Similarity=0.253 Sum_probs=191.6
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
++.+.+|.|+||.||+|... ++..+++|.+..... ...+.+.+|++++++++||||+++++++...+ ..+++
T Consensus 6 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-----~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~--~~~l~ 78 (262)
T cd06613 6 ELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG-----DDFEIIQQEISMLKECRHPNIVAYFGSYLRRD--KLWIV 78 (262)
T ss_pred EEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch-----hhHHHHHHHHHHHHhCCCCChhceEEEEEeCC--EEEEE
Confidence 56678899999999999864 567888988764322 13467899999999999999999999998776 67999
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC---
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT--- 585 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~--- 585 (721)
|||+++++|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++....
T Consensus 79 ~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 155 (262)
T cd06613 79 MEYCGGGSLQDIYQVT-RGPLSELQIAYVCRETLKGLAYLHETG--KIHRDIKGANILLTEDGDVKLADFGVSAQLTATI 155 (262)
T ss_pred EeCCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCChhhEEECCCCCEEECccccchhhhhhh
Confidence 9999999999988642 356899999999999999999999988 9999999999999999999999999875322
Q ss_pred ------CCCccccchhhcccC---CCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCcccc
Q 004979 586 ------AAKTGSAAMELLETS---AVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKS 656 (721)
Q Consensus 586 ------~~~~~~~apE~~~~~---~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 656 (721)
.+...|++||.+... .++.++|||||||++|||+||+.||..... .+-......... .+....
T Consensus 156 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~--~~~~~~~~~~~~------~~~~~~ 227 (262)
T cd06613 156 AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHP--MRALFLISKSNF------PPPKLK 227 (262)
T ss_pred hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhccC------CCcccc
Confidence 223468999998766 889999999999999999999999964321 111111111100 011111
Q ss_pred ccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 657 FQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 657 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
.....+.++.+++.+||..+|.+||++.+|+.
T Consensus 228 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 228 DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred chhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 23445678999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=299.24 Aligned_cols=237 Identities=21% Similarity=0.313 Sum_probs=191.6
Q ss_pred hhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
++++.+|.|+||.||+|.. .+++.|++|.+..... ...+.+.+|+++++.++|+||+++++++...+ ..++|
T Consensus 22 ~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~lv 94 (296)
T cd06655 22 TRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ-----PKKELIINEILVMKELKNPNIVNFLDSFLVGD--ELFVV 94 (296)
T ss_pred EEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC-----chHHHHHHHHHHHHhcCCCceeeeeeeEecCc--eEEEE
Confidence 5667889999999999984 5788999998864322 12356889999999999999999999998766 67999
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC---
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT--- 585 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~--- 585 (721)
+||+++|+|.+++.. ..+++.++..++.|++.|++|||+.+ ++||||||+||+++.++.+||+|||++....
T Consensus 95 ~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~~--i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~ 169 (296)
T cd06655 95 MEYLAGGSLTDVVTE---TCMDEAQIAAVCRECLQALEFLHANQ--VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ 169 (296)
T ss_pred EEecCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEccCccchhccccc
Confidence 999999999998853 35899999999999999999999988 9999999999999999999999999865322
Q ss_pred ------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccH
Q 004979 586 ------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQE 659 (721)
Q Consensus 586 ------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 659 (721)
.+...|++||.+....++.++|||||||++|||+||+.||..... ............+ .. ..+.
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~--~~~~~~~~~~~~~--~~------~~~~ 239 (296)
T cd06655 170 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP--LRALYLIATNGTP--EL------QNPE 239 (296)
T ss_pred ccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhcCCc--cc------CCcc
Confidence 233468999999888899999999999999999999999964432 1222222111110 00 1123
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 660 NVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 660 ~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
..+..+.++|.+||..||++||++.+++.
T Consensus 240 ~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 240 KLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred cCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 34567889999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=298.77 Aligned_cols=251 Identities=19% Similarity=0.253 Sum_probs=191.1
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
+++..+|+|+||.||+|... ++..|++|++...............+..|++++++++|+||+++++++.+.+ ..++|
T Consensus 3 ~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~--~~~lv 80 (298)
T cd07841 3 EKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKS--NINLV 80 (298)
T ss_pred eeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCC--EEEEE
Confidence 45567899999999999964 6889999998755433222334456788999999999999999999998865 67999
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCCC--
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTA-- 586 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~~-- 586 (721)
|||+ +|+|.+++.... ..+++..+..++.||++||+|||+++ |+||||||+||+++.++.+||+|||+++....
T Consensus 81 ~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 156 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSNW--ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN 156 (298)
T ss_pred Eccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCChhhEEEcCCCCEEEccceeeeeccCCC
Confidence 9999 999999986432 36999999999999999999999998 99999999999999999999999998764322
Q ss_pred -------CCccccchhhccc-CCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcC-CC----------Cc
Q 004979 587 -------AKTGSAAMELLET-SAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGE-QP----------LK 647 (721)
Q Consensus 587 -------~~~~~~apE~~~~-~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~-~~----------~~ 647 (721)
....|.|||.+.+ ..++.++|||||||++|||++|..||.... ..... ....... .+ ..
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~-~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 234 (298)
T cd07841 157 RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDS-DIDQL-GKIFEALGTPTEENWPGVTSLP 234 (298)
T ss_pred ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCc-cHHHH-HHHHHHcCCCchhhhhhccccc
Confidence 1235889998754 567899999999999999999977775433 22111 1111100 00 00
Q ss_pred ccc------CCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 648 DIV------DPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 648 ~~~------d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
... .............++.+++.+||+.+|++||++.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 235 DYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred ccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 000 00011112334678899999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=298.94 Aligned_cols=251 Identities=24% Similarity=0.294 Sum_probs=192.0
Q ss_pred HHHHHHHhhhhhhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcC-CCCccceEeEE
Q 004979 419 SELEAACEDFSNIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKV-NHKNFVNLIGY 496 (721)
Q Consensus 419 ~~l~~~~~~~~~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~ 496 (721)
.++..++++| ++++.+|+|+||.||++.. .+++.+++|.+.... .....+.+|+.++.++ +||||++++++
T Consensus 15 ~~~~~~~~~y-~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~------~~~~~~~~e~~~l~~l~~h~ni~~~~~~ 87 (291)
T cd06639 15 ESLGDPTDTW-EIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS------DVDEEIEAEYNILQSLPNHPNVVKFYGM 87 (291)
T ss_pred ccCCCCCCCe-EEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc------cHHHHHHHHHHHHHHhcCCCCeEEEEEE
Confidence 3444445555 6778899999999999996 467888998875321 1235678899999999 89999999999
Q ss_pred EecCCC---ceEEEEEecCCCCChhhhhhhc--cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCC
Q 004979 497 CEEDEP---FTRMMVFEYSPNGSLFEHLHIQ--EAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDY 571 (721)
Q Consensus 497 ~~~~~~---~~~~lV~Ey~~~GsL~~~l~~~--~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~ 571 (721)
+...+. ...++||||+++|+|.++++.. ....+++..+..++.|++.||+|||+.+ |+||||||+||++++++
T Consensus 88 ~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~nili~~~~ 165 (291)
T cd06639 88 FYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR--IIHRDVKGNNILLTTEG 165 (291)
T ss_pred EEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEcCCC
Confidence 875431 2479999999999999988632 3456899999999999999999999988 99999999999999999
Q ss_pred cEEEeccCCCCCCC---------CCCccccchhhcccC-----CCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHH
Q 004979 572 AAKISDFSFWNNTT---------AAKTGSAAMELLETS-----AVDLESNVYSFGTILFEMITGRISYSIENGSLENWAS 637 (721)
Q Consensus 572 ~~kL~DFGla~~~~---------~~~~~~~apE~~~~~-----~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~ 637 (721)
.+||+|||++.... .+...|++||.+... .++.++|||||||++|||++|+.||.... ..+.+.
T Consensus 166 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~--~~~~~~ 243 (291)
T cd06639 166 GVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMH--PVKTLF 243 (291)
T ss_pred CEEEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCc--HHHHHH
Confidence 99999999875322 233468999987543 36899999999999999999999986322 112122
Q ss_pred HHhhcCCCCccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 638 EYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 638 ~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
...... ...+. .++....++.++|.+||+.+|++||++.|+++
T Consensus 244 ~~~~~~--~~~~~------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 244 KIPRNP--PPTLL------HPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred HHhcCC--CCCCC------cccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 221111 11111 12334567899999999999999999999976
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=318.16 Aligned_cols=248 Identities=16% Similarity=0.229 Sum_probs=179.6
Q ss_pred hhhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCC------CCccceEeEEEecCC
Q 004979 429 SNIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVN------HKNFVNLIGYCEEDE 501 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~------H~nIv~l~g~~~~~~ 501 (721)
+++++.||+|+||+||+|+.. ++..||||++..... ..+.+..|++++.+++ |.+|+++++++....
T Consensus 131 y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~------~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~ 204 (467)
T PTZ00284 131 FKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK------YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNET 204 (467)
T ss_pred EEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh------hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCC
Confidence 367889999999999999864 577899998853211 1234455666666554 456899999887654
Q ss_pred CceEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCeEeeCCCCCCeEeCCCC---------
Q 004979 502 PFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQ-LTPPIAHRNLQSSSIYLTEDY--------- 571 (721)
Q Consensus 502 ~~~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~-~~~~IvHrDLKp~NILl~~~~--------- 571 (721)
. +.|+|||++ +++|.+++.. ...+++..+..|+.||+.||+|||+ ++ ||||||||+|||++.++
T Consensus 205 ~-~~~iv~~~~-g~~l~~~l~~--~~~l~~~~~~~i~~qi~~aL~yLH~~~g--IiHrDlKP~NILl~~~~~~~~~~~~~ 278 (467)
T PTZ00284 205 G-HMCIVMPKY-GPCLLDWIMK--HGPFSHRHLAQIIFQTGVALDYFHTELH--LMHTDLKPENILMETSDTVVDPVTNR 278 (467)
T ss_pred c-eEEEEEecc-CCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhcCC--eecCCCCHHHEEEecCCccccccccc
Confidence 3 579999998 7789888853 3568999999999999999999997 57 99999999999998765
Q ss_pred -------cEEEeccCCCCCC------CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCC-HHHHHH
Q 004979 572 -------AAKISDFSFWNNT------TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGS-LENWAS 637 (721)
Q Consensus 572 -------~~kL~DFGla~~~------~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~-~~~~~~ 637 (721)
.+||+|||.+... ..++..|+|||++.+..|+.++|||||||++|||+||+.||...+.. ....+.
T Consensus 279 ~~~~~~~~vkl~DfG~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~ 358 (467)
T PTZ00284 279 ALPPDPCRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLME 358 (467)
T ss_pred ccCCCCceEEECCCCccccCccccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 4999999986532 23456899999999999999999999999999999999999743321 001111
Q ss_pred HHhh--------------------cCCCCccccCCcc-------cccc-HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 638 EYLK--------------------GEQPLKDIVDPTL-------KSFQ-ENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 638 ~~~~--------------------~~~~~~~~~d~~l-------~~~~-~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
..+. ....+....++.. .... ......+.+||.+||+.||++|||++|+++
T Consensus 359 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~ 437 (467)
T PTZ00284 359 KTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTT 437 (467)
T ss_pred HHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhc
Confidence 1100 0000000000000 0000 011345789999999999999999999987
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=296.01 Aligned_cols=237 Identities=21% Similarity=0.314 Sum_probs=191.1
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
+++..+|.|+||.||+|+.. ++..+++|.+..... ......+.+|++++++++|+||+++++++.+.. ..++|
T Consensus 4 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~~v 77 (274)
T cd06609 4 TLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEA----EDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGS--KLWII 77 (274)
T ss_pred hhhhhhcCCCCeEEEEEEECCCCeEEEEEEeecccc----chHHHHHHHHHHHHHHcCCCCeeeeeEEEEECC--eEEEE
Confidence 56678889999999999965 678899998764321 223456889999999999999999999988776 67999
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCCC--
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTA-- 586 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~~-- 586 (721)
+||+++++|.+++.. ..+++.....++.|++.|+.|||+.+ ++||||+|+||++++++.++|+|||+++....
T Consensus 78 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 152 (274)
T cd06609 78 MEYCGGGSCLDLLKP---GKLDETYIAFILREVLLGLEYLHEEG--KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM 152 (274)
T ss_pred EEeeCCCcHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEEcccccceeecccc
Confidence 999999999999863 27899999999999999999999988 99999999999999999999999998754322
Q ss_pred -------CCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccH
Q 004979 587 -------AKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQE 659 (721)
Q Consensus 587 -------~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 659 (721)
+...|++||.+.+..++.++|||||||++|||+||+.||.... ..+.......... +.... .
T Consensus 153 ~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~--~~~~~~~~~~~~~-------~~~~~--~ 221 (274)
T cd06609 153 SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLH--PMRVLFLIPKNNP-------PSLEG--N 221 (274)
T ss_pred cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCc--hHHHHHHhhhcCC-------CCCcc--c
Confidence 2345899999988889999999999999999999999996432 2222222211111 11110 1
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 660 NVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 660 ~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
.++.++.+++.+||..+|++||+++++++
T Consensus 222 ~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 222 KFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 14567889999999999999999999976
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=296.50 Aligned_cols=249 Identities=20% Similarity=0.286 Sum_probs=193.9
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
+.++.+|.|++|.||+|... ++..+++|.+..... .....++.+|++++++++||||++++++|........++|
T Consensus 4 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 79 (287)
T cd06621 4 VELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN----PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA 79 (287)
T ss_pred EEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc----hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEE
Confidence 45678899999999999974 577888887764321 2345678999999999999999999999876554467999
Q ss_pred EecCCCCChhhhhhhc--cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC-
Q 004979 509 FEYSPNGSLFEHLHIQ--EAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT- 585 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~--~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~- 585 (721)
|||+++++|.+++... ....+++.....++.|++.||+|||+.+ ++||||+|+||++++++.+||+|||++....
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~--i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK--IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 9999999999887532 2456888999999999999999999988 9999999999999999999999999875322
Q ss_pred ------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCC---CHHHHHHHHhhcCCCCccccCCcccc
Q 004979 586 ------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENG---SLENWASEYLKGEQPLKDIVDPTLKS 656 (721)
Q Consensus 586 ------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~---~~~~~~~~~~~~~~~~~~~~d~~l~~ 656 (721)
.+...|++||.+.+..++.++||||+||++|||+||+.||..... ...+.......... ....+. ..
T Consensus 158 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~--~~ 233 (287)
T cd06621 158 SLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPN--PELKDE--PG 233 (287)
T ss_pred cccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCc--hhhccC--CC
Confidence 234568899999888999999999999999999999999975421 22222222211111 111000 00
Q ss_pred ccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 657 FQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 657 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
.....++++.+++.+||+.+|++|||+.|+++
T Consensus 234 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 234 NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred CCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 01234577899999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=296.04 Aligned_cols=240 Identities=21% Similarity=0.319 Sum_probs=187.2
Q ss_pred hhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcC-CCCccceEeEEEecC----CCc
Q 004979 430 NIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKV-NHKNFVNLIGYCEED----EPF 503 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~----~~~ 503 (721)
++...+|.|+||.||+|+. .++..+++|...... .....+..|+.++.++ +|+||+++++++... ...
T Consensus 19 ~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~------~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 92 (282)
T cd06636 19 ELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE------DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDD 92 (282)
T ss_pred hhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh------HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCC
Confidence 6778899999999999996 467888888775432 1235688899999998 799999999998632 122
Q ss_pred eEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCC
Q 004979 504 TRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNN 583 (721)
Q Consensus 504 ~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~ 583 (721)
..++||||+++|+|.+++.......+++..+..++.|++.|++|||+.+ |+||||||+||++++++.+||+|||++..
T Consensus 93 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dl~~~nili~~~~~~~l~dfg~~~~ 170 (282)
T cd06636 93 QLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK--VIHRDIKGQNVLLTENAEVKLVDFGVSAQ 170 (282)
T ss_pred EEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEeeCcchhh
Confidence 6799999999999999987555566888889999999999999999988 99999999999999999999999998753
Q ss_pred CC---------CCCccccchhhcc-----cCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccc
Q 004979 584 TT---------AAKTGSAAMELLE-----TSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDI 649 (721)
Q Consensus 584 ~~---------~~~~~~~apE~~~-----~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (721)
.. .+...|+|||.+. ...++.++|||||||++|||+||+.||..... ... ....... ..
T Consensus 171 ~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~-~~~-~~~~~~~--~~--- 243 (282)
T cd06636 171 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHP-MRA-LFLIPRN--PP--- 243 (282)
T ss_pred hhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCH-Hhh-hhhHhhC--CC---
Confidence 22 1344689999875 35688899999999999999999999953321 111 1111100 00
Q ss_pred cCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 650 VDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 650 ~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
+. .....++.++.+++.+||+.||.+||++.|+++
T Consensus 244 --~~--~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 244 --PK--LKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred --CC--CcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 00 011235578999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=303.66 Aligned_cols=245 Identities=20% Similarity=0.292 Sum_probs=202.8
Q ss_pred hhhhhhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCC-CCccceEeEEEecCCCc
Q 004979 426 EDFSNIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVN-HKNFVNLIGYCEEDEPF 503 (721)
Q Consensus 426 ~~~~~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~ 503 (721)
.++|++...+|.|.||.||+++.+ +|..+|+|.+.++.... ......+.+|+++|+++. |||||.+++++.+..
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~--~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~-- 109 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRG--KEDREDVRREVAILQQLSGHPNIVQLKDAFEDPD-- 109 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccc--cccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCC--
Confidence 345667778999999999999966 48999999997655432 223467999999999998 999999999999887
Q ss_pred eEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCC----CcEEEeccC
Q 004979 504 TRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTED----YAAKISDFS 579 (721)
Q Consensus 504 ~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~----~~~kL~DFG 579 (721)
..++|||++.||.|.+.+... .+++.....++.|++.++.|||+.+ |+||||||+|+|+... +.+|++|||
T Consensus 110 ~~~lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~g--vvHrDlKpEN~L~~~~~~~~~~ik~~DFG 184 (382)
T KOG0032|consen 110 SVYLVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSLG--VVHRDLKPENLLLASKDEGSGRIKLIDFG 184 (382)
T ss_pred eEEEEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence 789999999999999998654 3999999999999999999999988 9999999999999743 579999999
Q ss_pred CCCCCC--------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccC
Q 004979 580 FWNNTT--------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVD 651 (721)
Q Consensus 580 la~~~~--------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d 651 (721)
++.... .++..|+|||++....|+.++||||.||++|.|++|..||..+.... ....+..+...+ .+
T Consensus 185 la~~~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~--~~~~i~~~~~~f---~~ 259 (382)
T KOG0032|consen 185 LAKFIKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFE--IFLAILRGDFDF---TS 259 (382)
T ss_pred CceEccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhH--HHHHHHcCCCCC---CC
Confidence 986443 35678999999999999999999999999999999999997655322 222444443211 11
Q ss_pred CccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 652 PTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 652 ~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
...+..+..+.+++..|+..||.+|+++.++++
T Consensus 260 ----~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 260 ----EPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred ----CCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 122456788999999999999999999999987
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=310.41 Aligned_cols=190 Identities=24% Similarity=0.312 Sum_probs=165.2
Q ss_pred hhhhCcCCCCceeEEEEEE-ecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCC-C-----CccceEeEEEecCC
Q 004979 429 SNIIGSFSDGTVGTVYKGT-LSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVN-H-----KNFVNLIGYCEEDE 501 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~-~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~-H-----~nIv~l~g~~~~~~ 501 (721)
|+|++.||+|+||.|-||. ..+++.||||+++.+. ....+-..|+.+|..++ | -|+|++++++...+
T Consensus 188 Y~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k------~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~ 261 (586)
T KOG0667|consen 188 YEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK------RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRN 261 (586)
T ss_pred EEEEEEecccccceeEEEEecCCCcEEEEEeeccCh------HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccc
Confidence 4788999999999999998 5679999999997543 23456678999999886 4 37999999999988
Q ss_pred CceEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCC--CCcEEEeccC
Q 004979 502 PFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTE--DYAAKISDFS 579 (721)
Q Consensus 502 ~~~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~--~~~~kL~DFG 579 (721)
+.|||+|.+ .-+|+++++.+....++....+.|+.||+.||.+||+.+ |||+||||+||||.+ ...+||+|||
T Consensus 262 --HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~--IIHcDLKPENILL~~~~r~~vKVIDFG 336 (586)
T KOG0667|consen 262 --HLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG--IIHCDLKPENILLKDPKRSRIKVIDFG 336 (586)
T ss_pred --ceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCChhheeeccCCcCceeEEecc
Confidence 889999999 459999999888888999999999999999999999988 999999999999974 3579999999
Q ss_pred CCCCCCC------CCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCC
Q 004979 580 FWNNTTA------AKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIEN 629 (721)
Q Consensus 580 la~~~~~------~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~ 629 (721)
.+..... .+..|.|||++.+.+|+.+.||||||||+.||+||.+.|.+++
T Consensus 337 SSc~~~q~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~n 392 (586)
T KOG0667|consen 337 SSCFESQRVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDN 392 (586)
T ss_pred cccccCCcceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCC
Confidence 9865443 2446889999999999999999999999999999987776543
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=291.14 Aligned_cols=240 Identities=22% Similarity=0.345 Sum_probs=194.8
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
++.+.+|.|+||.||++... +++.+++|.+..... ....+++.+|++++++++||||+++++++...+ ..++|
T Consensus 4 ~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~----~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~--~~~lv 77 (265)
T cd06605 4 EYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN----EAIQKQILRELDILHKCNSPYIVGFYGAFYNNG--DISIC 77 (265)
T ss_pred hHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC----hHHHHHHHHHHHHHHHCCCCchhhhheeeecCC--EEEEE
Confidence 45677889999999999976 578899988765322 234567899999999999999999999998876 67999
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC---
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQ-LTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT--- 584 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~-~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~--- 584 (721)
+||+++++|.+++.... ..+++.....++.|++.|++|||+ .+ ++||||||+||++++++.+||+|||.+...
T Consensus 78 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~--i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~ 154 (265)
T cd06605 78 MEYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHK--IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS 154 (265)
T ss_pred EEecCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCCC--eecCCCCHHHEEECCCCCEEEeecccchhhHHH
Confidence 99999999999986432 678899999999999999999998 77 999999999999999999999999987532
Q ss_pred ----CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCC---CCHHHHHHHHhhcCCCCccccCCccccc
Q 004979 585 ----TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIEN---GSLENWASEYLKGEQPLKDIVDPTLKSF 657 (721)
Q Consensus 585 ----~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~---~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 657 (721)
..+...|++||.+.+..++.++||||||+++|||++|+.||.... ....+.......... ...
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~----------~~~ 224 (265)
T cd06605 155 LAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPP----------PRL 224 (265)
T ss_pred HhhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCC----------CCC
Confidence 234457899999988899999999999999999999999996432 222333333322211 111
Q ss_pred cH-HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 658 QE-NVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 658 ~~-~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
+. ..+.++.++|.+||..+|++||++.|++.
T Consensus 225 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 225 PSGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred ChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 11 25677899999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=293.89 Aligned_cols=236 Identities=19% Similarity=0.228 Sum_probs=181.0
Q ss_pred CCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHH---HhcCCCCccceEeEEEecCCCceEEEEEe
Q 004979 435 FSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDT---LSKVNHKNFVNLIGYCEEDEPFTRMMVFE 510 (721)
Q Consensus 435 lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~---l~~l~H~nIv~l~g~~~~~~~~~~~lV~E 510 (721)
+|+|+||.||+++. .++..+|+|.+....... ......+.+|..+ +...+|+||+.+++++...+ ..++|||
T Consensus 2 lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~--~~~lv~e 77 (279)
T cd05633 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKM--KQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPD--KLCFILD 77 (279)
T ss_pred cccCCCeEEEEEEECCCCcEEEEEEEEcccccc--chHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCC--eEEEEEe
Confidence 68999999999996 467889999876443221 1112234444433 34457999999999998776 6799999
Q ss_pred cCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC------
Q 004979 511 YSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT------ 584 (721)
Q Consensus 511 y~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~------ 584 (721)
|+++|+|.+++.. ...+++.....|+.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++...
T Consensus 78 ~~~~~~L~~~i~~--~~~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 153 (279)
T cd05633 78 LMNGGDLHYHLSQ--HGVFSEKEMRFYATEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH 153 (279)
T ss_pred cCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC--cCCCCCCHHHEEECCCCCEEEccCCcceeccccCcc
Confidence 9999999998863 346999999999999999999999988 999999999999999999999999987532
Q ss_pred -CCCCccccchhhcc-cCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccHHHH
Q 004979 585 -TAAKTGSAAMELLE-TSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQENVL 662 (721)
Q Consensus 585 -~~~~~~~~apE~~~-~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 662 (721)
..++..|+|||... +..++.++|||||||++|||+||+.||................. .+ ...++..+
T Consensus 154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~-------~~---~~~~~~~~ 223 (279)
T cd05633 154 ASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT-------VN---VELPDSFS 223 (279)
T ss_pred CcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhc-------CC---cCCccccC
Confidence 12456789999886 45689999999999999999999999964433222222221111 00 11234456
Q ss_pred HHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 004979 663 EELLVVIKNCVHPDPKQRP-----SMRGIAA 688 (721)
Q Consensus 663 ~~l~~li~~Cl~~dP~~RP-----s~~evl~ 688 (721)
.++.+++.+||..||++|| +++|+++
T Consensus 224 ~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~ 254 (279)
T cd05633 224 PELKSLLEGLLQRDVSKRLGCLGRGAQEVKE 254 (279)
T ss_pred HHHHHHHHHHhcCCHHHhcCCCCCCHHHHHh
Confidence 7889999999999999999 5888865
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=295.78 Aligned_cols=241 Identities=20% Similarity=0.265 Sum_probs=189.5
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
+++..+|+|+||+||+|+.. ++..|++|++...... .....+++.+|++++++++||||++++++|.+.+ ..++|
T Consensus 18 ~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~--~~~lv 93 (307)
T cd06607 18 TDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQ--SNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREH--TAWLV 93 (307)
T ss_pred hhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccC--cHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCC--eEEEE
Confidence 56678999999999999864 6788999987543222 1233467899999999999999999999998876 67999
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC---
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT--- 585 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~--- 585 (721)
|||++ |++.+++.. ....+++..+..++.|++.||.|||+.+ |+||||+|+||++++++.+||+|||++....
T Consensus 94 ~e~~~-g~l~~~~~~-~~~~l~~~~~~~~~~ql~~~L~~LH~~~--i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~~ 169 (307)
T cd06607 94 MEYCL-GSASDILEV-HKKPLQEVEIAAICHGALQGLAYLHSHE--RIHRDIKAGNILLTEPGTVKLADFGSASLVSPAN 169 (307)
T ss_pred HHhhC-CCHHHHHHH-cccCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEECCCCCEEEeecCcceecCCCC
Confidence 99996 677777643 2346899999999999999999999988 9999999999999999999999999876432
Q ss_pred --CCCccccchhhcc---cCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccHH
Q 004979 586 --AAKTGSAAMELLE---TSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQEN 660 (721)
Q Consensus 586 --~~~~~~~apE~~~---~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 660 (721)
.+...|+|||.+. ...++.++|||||||++|||+||+.||...+ ............. +.. ....
T Consensus 170 ~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~--~~~~~~~~~~~~~-------~~~--~~~~ 238 (307)
T cd06607 170 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN--AMSALYHIAQNDS-------PTL--SSND 238 (307)
T ss_pred CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCcc--HHHHHHHHhcCCC-------CCC--Cchh
Confidence 2345789999873 4668899999999999999999999985332 2222222111111 011 1123
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004979 661 VLEELLVVIKNCVHPDPKQRPSMRGIAAK 689 (721)
Q Consensus 661 ~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 689 (721)
.+.++.+++.+||..+|++||++.+|+..
T Consensus 239 ~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 239 WSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred hCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 56679999999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=297.89 Aligned_cols=241 Identities=21% Similarity=0.335 Sum_probs=199.2
Q ss_pred hhhhhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceE
Q 004979 427 DFSNIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTR 505 (721)
Q Consensus 427 ~~~~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~ 505 (721)
+.|.+-+.+|+|-|..|-.|++ -+|..||||++.+....+. ....+.+|++.|+-++|||||++|++..... ..
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~---st~hlfqEVRCMKLVQHpNiVRLYEViDTQT--Kl 92 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTL---STGHLFQEVRCMKLVQHPNIVRLYEVIDTQT--KL 92 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchh---hhhHHHHHHHHHHHhcCcCeeeeeehhcccc--eE
Confidence 3455567889999999999984 4799999999976554432 3356889999999999999999999998766 78
Q ss_pred EEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCC-CCcEEEeccCCCCCC
Q 004979 506 MMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTE-DYAAKISDFSFWNNT 584 (721)
Q Consensus 506 ~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~-~~~~kL~DFGla~~~ 584 (721)
|||+|.-.+|+|++|+... ...+.+....+++.||..|+.|+|+.. +|||||||+||.+-+ -|-+||.|||++...
T Consensus 93 yLiLELGD~GDl~DyImKH-e~Gl~E~La~kYF~QI~~AI~YCHqLH--VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf 169 (864)
T KOG4717|consen 93 YLILELGDGGDLFDYIMKH-EEGLNEDLAKKYFAQIVHAISYCHQLH--VVHRDLKPENVVFFEKLGLVKLTDFGFSNKF 169 (864)
T ss_pred EEEEEecCCchHHHHHHhh-hccccHHHHHHHHHHHHHHHHHHhhhh--hhcccCCcceeEEeeecCceEeeeccccccC
Confidence 9999999999999999643 456889999999999999999999988 999999999998865 589999999998754
Q ss_pred CC--------CCccccchhhcccCCCC-CCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccc
Q 004979 585 TA--------AKTGSAAMELLETSAVD-LESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLK 655 (721)
Q Consensus 585 ~~--------~~~~~~apE~~~~~~~s-~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 655 (721)
.. +.-.|.|||.+.+..|+ +++||||+|||||-|+.|+.||...+.. ..+..++|-..
T Consensus 170 ~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDS------------ETLTmImDCKY- 236 (864)
T KOG4717|consen 170 QPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDS------------ETLTMIMDCKY- 236 (864)
T ss_pred CCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccch------------hhhhhhhcccc-
Confidence 44 34478899999998887 7899999999999999999999744322 12223333221
Q ss_pred cccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 656 SFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 656 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
..+...+.++.+||..|+..||++|.+.+||+.
T Consensus 237 tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 237 TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred cCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 245678899999999999999999999999976
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=295.09 Aligned_cols=239 Identities=19% Similarity=0.286 Sum_probs=193.0
Q ss_pred hhhhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEE
Q 004979 428 FSNIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRM 506 (721)
Q Consensus 428 ~~~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~ 506 (721)
++.++..+|.|+||.||+|... ++..+++|....... ....+.+.+|++++++++||||+++++++...+ ..+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~ 78 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA----EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDT--KLW 78 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc----hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCC--eEE
Confidence 3467788999999999999864 678899997653321 223467899999999999999999999998776 679
Q ss_pred EEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCCC
Q 004979 507 MVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTA 586 (721)
Q Consensus 507 lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~~ 586 (721)
+||||+++|+|.+++.. ..+++.....++.|++.|+.|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 79 lv~e~~~~~~l~~~i~~---~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06641 79 IIMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLLSEHGEVKLADFGVAGQLTD 153 (277)
T ss_pred EEEEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHccCC--eecCCCCHHhEEECCCCCEEEeecccceeccc
Confidence 99999999999998852 45899999999999999999999988 99999999999999999999999998753322
Q ss_pred ---------CCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccc
Q 004979 587 ---------AKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSF 657 (721)
Q Consensus 587 ---------~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 657 (721)
+...|++||.+....++.++|||||||++|||+||+.||.... ............ ....
T Consensus 154 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~--~~~~~~~~~~~~----------~~~~ 221 (277)
T cd06641 154 TQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELH--PMKVLFLIPKNN----------PPTL 221 (277)
T ss_pred chhhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccc--hHHHHHHHhcCC----------CCCC
Confidence 3446889999988889999999999999999999999985322 222222211111 1112
Q ss_pred cHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004979 658 QENVLEELLVVIKNCVHPDPKQRPSMRGIAAK 689 (721)
Q Consensus 658 ~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 689 (721)
...++.++.+++.+||+.+|.+||++.++++.
T Consensus 222 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 222 EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 23455778899999999999999999999884
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=290.04 Aligned_cols=244 Identities=22% Similarity=0.331 Sum_probs=192.1
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
++.+.+|.|+||+||+|... ++..+++|++...... ...+.+.+|+++++.++|+||+++++.+...+ ..++|
T Consensus 4 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~iv 77 (267)
T cd06610 4 ELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQ----TSVDELRKEVQAMSQCNHPNVVKYYTSFVVGD--ELWLV 77 (267)
T ss_pred eeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcc----hHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCC--EEEEE
Confidence 56678899999999999954 6778888887543221 13467999999999999999999999988776 67999
Q ss_pred EecCCCCChhhhhhhccC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC--
Q 004979 509 FEYSPNGSLFEHLHIQEA-EHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT-- 585 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~-~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~-- 585 (721)
|||+++++|.++++.... ..+++.....++.|++.|++|||+.+ |+||||||+||++++++.+||+|||++....
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~--i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~ 155 (267)
T cd06610 78 MPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG--QIHRDIKAGNILLGEDGSVKIADFGVSASLADG 155 (267)
T ss_pred EeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEcCCCCEEEcccchHHHhccC
Confidence 999999999999875433 56899999999999999999999988 9999999999999999999999999864221
Q ss_pred -----------CCCccccchhhcccC-CCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCc
Q 004979 586 -----------AAKTGSAAMELLETS-AVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPT 653 (721)
Q Consensus 586 -----------~~~~~~~apE~~~~~-~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 653 (721)
.+...|++||.+... .++.++|||||||++|||++|+.||..... .+..........+ .....
T Consensus 156 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~--~~~~~~~~~~~~~---~~~~~ 230 (267)
T cd06610 156 GDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPP--MKVLMLTLQNDPP---SLETG 230 (267)
T ss_pred ccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccCh--hhhHHHHhcCCCC---CcCCc
Confidence 234468899998766 789999999999999999999999964322 1222222222111 00000
Q ss_pred cccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 654 LKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 654 l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
......+.++.+++.+||+.||++||++.||++
T Consensus 231 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 231 --ADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred --cccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 001245678899999999999999999999975
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=296.53 Aligned_cols=243 Identities=26% Similarity=0.405 Sum_probs=190.1
Q ss_pred hhhCcCCCCceeEEEEEEecC-CcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLSS-GVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~~-~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
++++.||+|+||+||+++... +..+|+|++....... .......+|+.++++++||||+++++++.+.+ ..++|
T Consensus 2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~---~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~--~~~~v 76 (260)
T PF00069_consen 2 RLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEE---EEREENIREIKILRRLRHPNIVQILDVFQDDN--YLYIV 76 (260)
T ss_dssp EEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHH---HHHHHHHHHHHHHHHHTBTTBCHEEEEEEESS--EEEEE
T ss_pred EEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccc---cccchhhhhhhccccccccccccccccccccc--ccccc
Confidence 456788999999999999664 5689999887654322 22234456999999999999999999998866 67999
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCC-----
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNN----- 583 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~----- 583 (721)
|||+++++|.+++. ....+++..+..++.|+++||+|||+.+ |+||||||+||++++++.++|+|||.+..
T Consensus 77 ~~~~~~~~L~~~l~--~~~~~~~~~~~~~~~qi~~~L~~Lh~~~--i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~ 152 (260)
T PF00069_consen 77 MEYCPGGSLQDYLQ--KNKPLSEEEILKIAYQILEALAYLHSKG--IVHRDIKPENILLDENGEVKLIDFGSSVKLSENN 152 (260)
T ss_dssp EEEETTEBHHHHHH--HHSSBBHHHHHHHHHHHHHHHHHHHHTT--EEESSBSGGGEEESTTSEEEESSGTTTEESTSTT
T ss_pred cccccccccccccc--cccccccccccccccccccccccccccc--cccccccccccccccccccccccccccccccccc
Confidence 99999999999996 3456899999999999999999999988 99999999999999999999999998752
Q ss_pred ----CCCCCccccchhhcc-cCCCCCCccHHHHHHHHHHHHhCCCcccCCCC-CHHHHHHHHhhcCCCCccccCCccccc
Q 004979 584 ----TTAAKTGSAAMELLE-TSAVDLESNVYSFGTILFEMITGRISYSIENG-SLENWASEYLKGEQPLKDIVDPTLKSF 657 (721)
Q Consensus 584 ----~~~~~~~~~apE~~~-~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~-~~~~~~~~~~~~~~~~~~~~d~~l~~~ 657 (721)
...++..|+|||... ...++.++||||+|+++|||++|+.||..... +............ .... . ..
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~--~~~~----~-~~ 225 (260)
T PF00069_consen 153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRP--LPSS----S-QQ 225 (260)
T ss_dssp SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTH--HHHH----T-TS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccc--cccc----c-cc
Confidence 122345689999998 88899999999999999999999999964411 1111111111110 0000 0 00
Q ss_pred cHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 658 QENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 658 ~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
......++.+++.+||+.||++||++.|+++
T Consensus 226 ~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 226 SREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred cchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0111378999999999999999999999875
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=296.76 Aligned_cols=236 Identities=20% Similarity=0.305 Sum_probs=188.1
Q ss_pred hCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEEEe
Q 004979 432 IGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFE 510 (721)
Q Consensus 432 i~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV~E 510 (721)
...+|+|+||.||++... ++..+++|++.... ....+.+.+|+.++++++|+||+++++.+...+ ..++|||
T Consensus 27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~--~~~lv~e 99 (292)
T cd06658 27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK-----QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGD--ELWVVME 99 (292)
T ss_pred hhcccCCCCeEEEEEEECCCCCEEEEEEEecch-----HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCC--eEEEEEe
Confidence 456889999999999854 67889999875432 223456889999999999999999999988776 6799999
Q ss_pred cCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC-----
Q 004979 511 YSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT----- 585 (721)
Q Consensus 511 y~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~----- 585 (721)
|+++++|.+++.. ..+++.....++.||+.||+|||+.+ |+||||||+||++++++.+||+|||++....
T Consensus 100 ~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~ 174 (292)
T cd06658 100 FLEGGALTDIVTH---TRMNEEQIATVCLSVLRALSYLHNQG--VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK 174 (292)
T ss_pred CCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCEEEccCcchhhccccccc
Confidence 9999999998742 35889999999999999999999988 9999999999999999999999999875321
Q ss_pred ----CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccHHH
Q 004979 586 ----AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQENV 661 (721)
Q Consensus 586 ----~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 661 (721)
.+...|+|||......++.++|||||||++|||++|+.||..... .......... . .+... .....
T Consensus 175 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~--~~~~~~~~~~---~----~~~~~-~~~~~ 244 (292)
T cd06658 175 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP--LQAMRRIRDN---L----PPRVK-DSHKV 244 (292)
T ss_pred CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhc---C----CCccc-ccccc
Confidence 234468999999888899999999999999999999999964321 1111111111 0 11111 11234
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004979 662 LEELLVVIKNCVHPDPKQRPSMRGIAAK 689 (721)
Q Consensus 662 ~~~l~~li~~Cl~~dP~~RPs~~evl~~ 689 (721)
...+.+++.+||..||.+|||+.|+++.
T Consensus 245 ~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 245 SSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 4578889999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=297.19 Aligned_cols=249 Identities=20% Similarity=0.278 Sum_probs=188.4
Q ss_pred HHHHhhhhhhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcC-CCCccceEeEEEec
Q 004979 422 EAACEDFSNIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKV-NHKNFVNLIGYCEE 499 (721)
Q Consensus 422 ~~~~~~~~~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~ 499 (721)
....++| ++++.+|+|+||.||+++.. ++..+++|+..... .....+.+|+.+++++ +|+||+++++++..
T Consensus 14 ~~~~~~~-~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~------~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 14 PDPSDTW-EIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH------DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred CCcccce-eeeeeeccCCCcEEEEEEECCCCceeEEEeecccc------chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 3344444 67789999999999999864 57788888764321 1235678899999999 79999999998853
Q ss_pred C---CCceEEEEEecCCCCChhhhhhhc--cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEE
Q 004979 500 D---EPFTRMMVFEYSPNGSLFEHLHIQ--EAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAK 574 (721)
Q Consensus 500 ~---~~~~~~lV~Ey~~~GsL~~~l~~~--~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~k 574 (721)
. .....++||||+++|+|.++++.. ....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+|
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~~~~~~k 164 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK--TIHRDVKGNNILLTTEGGVK 164 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC--ccccCCCHHhEEECCCCCEE
Confidence 2 122579999999999999987532 2356889999999999999999999988 99999999999999999999
Q ss_pred EeccCCCCCCC---------CCCccccchhhcc-----cCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHh
Q 004979 575 ISDFSFWNNTT---------AAKTGSAAMELLE-----TSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYL 640 (721)
Q Consensus 575 L~DFGla~~~~---------~~~~~~~apE~~~-----~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~ 640 (721)
|+|||+++... .+...|+|||.+. ...++.++|||||||++|||+||+.||..... ... .....
T Consensus 165 l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~-~~~-~~~~~ 242 (286)
T cd06638 165 LVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP-MRA-LFKIP 242 (286)
T ss_pred EccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCch-hHH-Hhhcc
Confidence 99999875322 2345689999874 34578999999999999999999999863321 111 11111
Q ss_pred hcCCCCccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004979 641 KGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAK 689 (721)
Q Consensus 641 ~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 689 (721)
... ..... .+.....++.+++.+||+.+|++||++.||++.
T Consensus 243 ~~~--~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 243 RNP--PPTLH------QPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred ccC--CCccc------CCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 110 00111 112234578899999999999999999999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=288.04 Aligned_cols=241 Identities=21% Similarity=0.326 Sum_probs=191.1
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
++.+.+|+|+||.||+|+.. ++..+++|.+...... ....+.+.+|++++++++|+||+++++++...+ ..++|
T Consensus 3 ~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~--~~~lv 77 (264)
T cd06626 3 QRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND---PKTIKEIADEMKVLELLKHPNLVKYYGVEVHRE--KVYIF 77 (264)
T ss_pred eeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc---hHHHHHHHHHHHHHHhCCCCChhheeeeEecCC--EEEEE
Confidence 45678899999999999864 6788999987654322 335678999999999999999999999988766 67999
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC---
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT--- 585 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~--- 585 (721)
+||+++++|.+++.. ...+++..+..|+.+++.|++|||+.+ |+||||||+||++++++.+||+|||++....
T Consensus 78 ~e~~~~~~L~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~ 153 (264)
T cd06626 78 MEYCSGGTLEELLEH--GRILDEHVIRVYTLQLLEGLAYLHSHG--IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT 153 (264)
T ss_pred EecCCCCcHHHHHhh--cCCCChHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence 999999999999863 345788999999999999999999988 9999999999999999999999999875322
Q ss_pred ----------CCCccccchhhcccCC---CCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCC
Q 004979 586 ----------AAKTGSAAMELLETSA---VDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDP 652 (721)
Q Consensus 586 ----------~~~~~~~apE~~~~~~---~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 652 (721)
.+...|++||.+.... ++.++||||||+++||+++|+.||...... .........+.. +
T Consensus 154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~-------~ 225 (264)
T cd06626 154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE-FQIMFHVGAGHK-------P 225 (264)
T ss_pred CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch-HHHHHHHhcCCC-------C
Confidence 2234688999987666 889999999999999999999999643221 222221111111 1
Q ss_pred ccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 653 TLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 653 ~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
.++. ......++.+++.+||+.+|++||++.|++.
T Consensus 226 ~~~~-~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 226 PIPD-SLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred CCCc-ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 1111 1123567889999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=298.19 Aligned_cols=249 Identities=17% Similarity=0.219 Sum_probs=187.5
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
++++.+|+|+||.||+|+.. +|..+++|++...... ......+.+|++++++++|+||+++++++.+.+ ..++|
T Consensus 3 ~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~---~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~--~~~lv 77 (284)
T cd07839 3 EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD---EGVPSSALREICLLKELKHKNIVRLYDVLHSDK--KLTLV 77 (284)
T ss_pred eeEEEecccCCeEEEEEEECCCCcEEEEEEeeccccc---ccCccchhHHHHHHHhcCCCCeeeHHHHhccCC--ceEEE
Confidence 45677899999999999964 6888999988654221 122346788999999999999999999998776 67999
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC---
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT--- 585 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~--- 585 (721)
+||++ ++|.+++... ...+++.....++.||++||.|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 78 ~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 153 (284)
T cd07839 78 FEYCD-QDLKKYFDSC-NGDIDPEIVKSFMFQLLKGLAFCHSHN--VLHRDLKPQNLLINKNGELKLADFGLARAFGIPV 153 (284)
T ss_pred EecCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence 99996 5888877532 356899999999999999999999988 9999999999999999999999999876432
Q ss_pred ------CCCccccchhhcccC-CCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCC--------cccc
Q 004979 586 ------AAKTGSAAMELLETS-AVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPL--------KDIV 650 (721)
Q Consensus 586 ------~~~~~~~apE~~~~~-~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~--------~~~~ 650 (721)
.+...|+|||.+.+. .++.++|||||||++|||+||+.|+.... +..+............ ....
T Consensus 154 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07839 154 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN-DVDDQLKRIFRLLGTPTEESWPGVSKLP 232 (284)
T ss_pred CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCC-CHHHHHHHHHHHhCCCChHHhHHhhhcc
Confidence 123468999987654 47899999999999999999998864322 2222222211110000 0000
Q ss_pred C----Ccc------ccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 651 D----PTL------KSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 651 d----~~l------~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
+ +.. .......+.++.+++.+||+.||.+|||+.|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 233 DYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred cccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 0 000 0111234578899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=296.70 Aligned_cols=248 Identities=22% Similarity=0.321 Sum_probs=188.8
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
++++.+|+|+||.||+|..+ +++.+++|++...... ....+.+.+|++++++++||||+++++++...+ ..++|
T Consensus 4 ~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv 78 (286)
T cd07846 4 ENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDD---KMVKKIAMREIRMLKQLRHENLVNLIEVFRRKK--RLYLV 78 (286)
T ss_pred eEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCc---chhhHHHHHHHHHHHhcCCcchhhHHHhcccCC--eEEEE
Confidence 56788999999999999975 5788999987543221 123457889999999999999999999998766 67999
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCCC--
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTA-- 586 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~~-- 586 (721)
|||+++++|..+... ...++|..+..++.||+.||+|||+.+ |+||||+|+||++++++.+||+|||++.....
T Consensus 79 ~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07846 79 FEFVDHTVLDDLEKY--PNGLDESRVRKYLFQILRGIEFCHSHN--IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 154 (286)
T ss_pred EecCCccHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence 999999999887642 345899999999999999999999988 99999999999999999999999998754321
Q ss_pred -------CCccccchhhccc-CCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCC------------
Q 004979 587 -------AKTGSAAMELLET-SAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPL------------ 646 (721)
Q Consensus 587 -------~~~~~~apE~~~~-~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~------------ 646 (721)
+...|++||.+.+ ..++.++|||||||++|||+||+.||..... ...+ ..........
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07846 155 EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSD-IDQL-YHIIKCLGNLIPRHQEIFQKNP 232 (286)
T ss_pred cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCch-HHHH-HHHHHHhCCCchhhHHHhccch
Confidence 2346789998764 4578899999999999999999998864321 1111 1111000000
Q ss_pred --ccccCCccc------cccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 647 --KDIVDPTLK------SFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 647 --~~~~d~~l~------~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
.....+... ...+..+..+.+++.+||+.+|++||++.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 233 LFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred HhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 000000000 011234677999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=294.65 Aligned_cols=236 Identities=18% Similarity=0.282 Sum_probs=188.5
Q ss_pred hCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEEEe
Q 004979 432 IGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFE 510 (721)
Q Consensus 432 i~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV~E 510 (721)
...+|+|+||.||++... ++..+++|.+..+.. ...+.+.+|+.++..++||||+++++++...+ ..++|||
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-----~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~--~~~iv~e 98 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ-----QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGE--ELWVLME 98 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc-----chHHHHHHHHHHHHhCCCCchhhhhhheeeCC--eEEEEEe
Confidence 346889999999999864 688899998764322 12356889999999999999999999998776 6799999
Q ss_pred cCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC-----
Q 004979 511 YSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT----- 585 (721)
Q Consensus 511 y~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~----- 585 (721)
|+++++|..++.. ..+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++....
T Consensus 99 ~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~ 173 (297)
T cd06659 99 FLQGGALTDIVSQ---TRLNEEQIATVCESVLQALCYLHSQG--VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK 173 (297)
T ss_pred cCCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHeEEccCCcEEEeechhHhhccccccc
Confidence 9999999987742 45899999999999999999999988 9999999999999999999999999875321
Q ss_pred ----CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccHHH
Q 004979 586 ----AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQENV 661 (721)
Q Consensus 586 ----~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 661 (721)
.+...|+|||.+.+..++.++|||||||++|||++|+.||.... ..+........ .. .. .......
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~--~~~~~~~~~~~-~~-~~------~~~~~~~ 243 (297)
T cd06659 174 RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDS--PVQAMKRLRDS-PP-PK------LKNAHKI 243 (297)
T ss_pred ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHhcc-CC-CC------ccccCCC
Confidence 23456899999988889999999999999999999999996432 12222221111 10 00 0011233
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004979 662 LEELLVVIKNCVHPDPKQRPSMRGIAAK 689 (721)
Q Consensus 662 ~~~l~~li~~Cl~~dP~~RPs~~evl~~ 689 (721)
..++.+++.+||+.+|++||++.|+++.
T Consensus 244 ~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 244 SPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred CHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 4668899999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=292.54 Aligned_cols=240 Identities=19% Similarity=0.295 Sum_probs=184.3
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHH-HhcCCCCccceEeEEEecCCCceEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDT-LSKVNHKNFVNLIGYCEEDEPFTRMM 507 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~-l~~l~H~nIv~l~g~~~~~~~~~~~l 507 (721)
++++.+|+|+||.||+++.. ++..||+|++...... ....++..|+.. ++.++||||+++++++...+ ..++
T Consensus 4 ~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~--~~~l 77 (283)
T cd06617 4 EVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNS----QEQKRLLMDLDISMRSVDCPYTVTFYGALFREG--DVWI 77 (283)
T ss_pred eEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCc----HHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCC--cEEE
Confidence 56678899999999999965 6889999987643221 123455566665 66679999999999998766 5799
Q ss_pred EEecCCCCChhhhhhhc--cCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC
Q 004979 508 VFEYSPNGSLFEHLHIQ--EAEHLDWAMRLRIAMGMAYCLEHMHQL-TPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT 584 (721)
Q Consensus 508 V~Ey~~~GsL~~~l~~~--~~~~l~~~~~~~ia~~ia~gL~yLH~~-~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~ 584 (721)
||||++ |+|.+++... ....+++..+..++.||+.||+|||+. + ++||||||+||++++++.+||+|||+++..
T Consensus 78 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~--i~h~dlkp~nil~~~~~~~kl~dfg~~~~~ 154 (283)
T cd06617 78 CMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYL 154 (283)
T ss_pred Ehhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEECCCCCEEEeeccccccc
Confidence 999996 7888887532 235689999999999999999999985 6 999999999999999999999999987643
Q ss_pred C--------CCCccccchhhccc----CCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCC
Q 004979 585 T--------AAKTGSAAMELLET----SAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDP 652 (721)
Q Consensus 585 ~--------~~~~~~~apE~~~~----~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 652 (721)
. .+...|++||.+.+ ..++.++|||||||++|||++|+.||......... ......+.. ..
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~-~~~~~~~~~--~~---- 227 (283)
T cd06617 155 VDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQ-LKQVVEEPS--PQ---- 227 (283)
T ss_pred ccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHH-HHHHHhcCC--CC----
Confidence 2 23446899998754 45689999999999999999999999633222222 222222111 00
Q ss_pred ccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 653 TLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 653 ~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
.. ...++.++.+++.+||..+|++||++.++++
T Consensus 228 -~~--~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 228 -LP--AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred -CC--ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 1234577899999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=291.51 Aligned_cols=240 Identities=18% Similarity=0.244 Sum_probs=193.5
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
++.+.+|.|+||.||+|+.. ++..+++|.+....... ....+.+.+|++++++++||||+++++++...+ ..++|
T Consensus 3 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv 78 (258)
T cd05578 3 ELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVE--KGSVRNVLNERRILQELNHPFLVNLWYSFQDEE--NMYLV 78 (258)
T ss_pred eEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcc--hhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCC--eEEEE
Confidence 46678899999999999965 58889999886433211 234568999999999999999999999988766 67999
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCCC--
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTA-- 586 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~~-- 586 (721)
+||+++++|.+++... ..+++.....++.|++.||.|||+++ ++|+||||+||++++++.+||+|||++.....
T Consensus 79 ~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 79 VDLLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSKG--IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154 (258)
T ss_pred EeCCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence 9999999999998643 57899999999999999999999988 99999999999999999999999998754322
Q ss_pred ------CCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccHH
Q 004979 587 ------AKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQEN 660 (721)
Q Consensus 587 ------~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 660 (721)
+...|++||.+....++.++||||||+++|||++|+.||.................. ....+..
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~----------~~~~~~~ 224 (258)
T cd05578 155 LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETA----------DVLYPAT 224 (258)
T ss_pred cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccc----------cccCccc
Confidence 334678999998888999999999999999999999999755433233332222110 0112233
Q ss_pred HHHHHHHHHHHcccCCCCCCCCH--HHHH
Q 004979 661 VLEELLVVIKNCVHPDPKQRPSM--RGIA 687 (721)
Q Consensus 661 ~~~~l~~li~~Cl~~dP~~RPs~--~evl 687 (721)
.+.++.+++.+||+.||.+||++ +|++
T Consensus 225 ~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 225 WSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred CcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 45788999999999999999999 6554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=295.32 Aligned_cols=248 Identities=18% Similarity=0.245 Sum_probs=186.1
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
++++.+|+|+||.||+|+.. ++..+++|.+....... ....+.+|++++++++|+||+++++++.+.+ ..++|
T Consensus 8 ~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~~lv 81 (291)
T cd07844 8 KKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG----APFTAIREASLLKDLKHANIVTLHDIIHTKK--TLTLV 81 (291)
T ss_pred eEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC----CchhHHHHHHHHhhCCCcceeeEEEEEecCC--eEEEE
Confidence 56788999999999999965 67889999876433211 1235678999999999999999999998776 67999
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC---
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT--- 585 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~--- 585 (721)
|||++ ++|.+++... ...+++.....++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++...
T Consensus 82 ~e~~~-~~L~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 157 (291)
T cd07844 82 FEYLD-TDLKQYMDDC-GGGLSMHNVRLFLFQLLRGLAYCHQRR--VLHRDLKPQNLLISERGELKLADFGLARAKSVPS 157 (291)
T ss_pred EecCC-CCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCHHHEEEcCCCCEEECccccccccCCCC
Confidence 99997 5999988643 346889999999999999999999988 9999999999999999999999999875321
Q ss_pred ------CCCccccchhhccc-CCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCC-CCcccc-------
Q 004979 586 ------AAKTGSAAMELLET-SAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQ-PLKDIV------- 650 (721)
Q Consensus 586 ------~~~~~~~apE~~~~-~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~-~~~~~~------- 650 (721)
.....|+|||.+.+ ..++.++|||||||++|||++|+.||...... .+.+........ +..+..
T Consensus 158 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (291)
T cd07844 158 KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDV-EDQLHKIFRVLGTPTEETWPGVSSNP 236 (291)
T ss_pred ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccH-HHHHHHHHHhcCCCChhhhhhhhhcc
Confidence 12345889998764 55889999999999999999999999644321 111111111000 000000
Q ss_pred -----------CCccccccHHH--HHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 651 -----------DPTLKSFQENV--LEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 651 -----------d~~l~~~~~~~--~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
...+....... ..++.+++.+|++.+|++||++.|++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 237 EFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred ccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 00000000111 267789999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=288.71 Aligned_cols=240 Identities=20% Similarity=0.368 Sum_probs=192.1
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
++.+.+|.|+||.||+|... ++..+++|.+..... .....+.+.+|++++++++|+||+++++++...+ ..++|
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~--~~~lv 77 (257)
T cd08225 3 EIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKM---PVKEKEASKKEVILLAKMKHPNIVTFFASFQENG--RLFIV 77 (257)
T ss_pred eEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhc---cchhhHHHHHHHHHHHhCCCCChhhhhheeccCC--eEEEE
Confidence 34567889999999999965 578889988765321 1223457889999999999999999999998776 67999
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCC-cEEEeccCCCCCCC--
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDY-AAKISDFSFWNNTT-- 585 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~-~~kL~DFGla~~~~-- 585 (721)
+||+++++|.+++.......+++..+..++.|++.||+|||+.+ ++|+||||+||++++++ .+||+|||.+....
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 78 MEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK--ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred EecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 99999999999987555556899999999999999999999988 99999999999999875 56999999875332
Q ss_pred -------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCcccccc
Q 004979 586 -------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQ 658 (721)
Q Consensus 586 -------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 658 (721)
.+...|+|||......++.++|||||||++|||++|+.||... +..++......+. .. ...
T Consensus 156 ~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~--~~~~~~~~~~~~~--~~--------~~~ 223 (257)
T cd08225 156 MELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN--NLHQLVLKICQGY--FA--------PIS 223 (257)
T ss_pred cccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCc--cHHHHHHHHhccc--CC--------CCC
Confidence 2334688999998888999999999999999999999998532 3334443333221 11 111
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 659 ENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 659 ~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
.....++.+++.+||..+|++||++.|+++
T Consensus 224 ~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 224 PNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred CCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 234467889999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=293.21 Aligned_cols=242 Identities=22% Similarity=0.305 Sum_probs=185.5
Q ss_pred hhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCC-CCccceEeEEEecCCCceEEEE
Q 004979 431 IIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVN-HKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 431 ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~~~lV 508 (721)
..+.+|+|+||.||+++.. ++..+++|.+...... .....+.+|+.++.++. |+||+++++++...+ ..+++
T Consensus 8 ~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~----~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~--~~~~~ 81 (288)
T cd06616 8 DLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE----KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREG--DCWIC 81 (288)
T ss_pred HHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh----HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCC--cEEEE
Confidence 4567889999999999864 5788999987643221 33467899999999996 999999999988765 56899
Q ss_pred EecCCCCChhhhh---hhccCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC
Q 004979 509 FEYSPNGSLFEHL---HIQEAEHLDWAMRLRIAMGMAYCLEHMHQ-LTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT 584 (721)
Q Consensus 509 ~Ey~~~GsL~~~l---~~~~~~~l~~~~~~~ia~~ia~gL~yLH~-~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~ 584 (721)
|||+.. ++.++. .......+++.....++.+++.||+|||+ .+ |+||||||+||+++.++.+||+|||+++..
T Consensus 82 ~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~ 158 (288)
T cd06616 82 MELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQL 158 (288)
T ss_pred EecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC--eeccCCCHHHEEEccCCcEEEeecchhHHh
Confidence 999864 554433 22234678999999999999999999996 46 999999999999999999999999987532
Q ss_pred --------CCCCccccchhhcccC---CCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCc
Q 004979 585 --------TAAKTGSAAMELLETS---AVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPT 653 (721)
Q Consensus 585 --------~~~~~~~~apE~~~~~---~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 653 (721)
..+...|+|||.+... .++.++|||||||++|||++|+.||.... ...+.......+..+ .+ .
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-~~~~~~~~~~~~~~~--~~-~-- 232 (288)
T cd06616 159 VDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-SVFDQLTQVVKGDPP--IL-S-- 232 (288)
T ss_pred ccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-hHHHHHhhhcCCCCC--cC-C--
Confidence 1234568999998765 68999999999999999999999996433 222222222221111 00 0
Q ss_pred cccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 654 LKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 654 l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
......++.++.+++.+||+.+|++||++.||++
T Consensus 233 -~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~ 266 (288)
T cd06616 233 -NSEEREFSPSFVNFINLCLIKDESKRPKYKELLE 266 (288)
T ss_pred -CcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1112345678999999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=292.93 Aligned_cols=250 Identities=19% Similarity=0.237 Sum_probs=187.9
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
++...+|.|+||.||+|+.. ++..+++|.+...... ......+.+|++++.+++||||+++++++...+....++|
T Consensus 8 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 8 EKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK---EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc---ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 56678899999999999975 5788999988654322 2223467889999999999999999999887633378999
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCCC--
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTA-- 586 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~~-- 586 (721)
|||++ ++|.+++... ...+++.....++.|++.||+|||+++ |+||||||+||++++++.+||+|||+++....
T Consensus 85 ~e~~~-~~L~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 85 MEYVE-HDLKSLMETM-KQPFLQSEVKCLMLQLLSGVAHLHDNW--ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL 160 (293)
T ss_pred ehhcC-cCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence 99997 5998888643 346899999999999999999999988 99999999999999999999999998764322
Q ss_pred -------CCccccchhhcccC-CCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCC-C----------Cc
Q 004979 587 -------AKTGSAAMELLETS-AVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQ-P----------LK 647 (721)
Q Consensus 587 -------~~~~~~apE~~~~~-~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~-~----------~~ 647 (721)
+...|+|||.+.+. .++.++|||||||++|||++|+.||..... .+.......... + +.
T Consensus 161 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (293)
T cd07843 161 KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSE--IDQLNKIFKLLGTPTEKIWPGFSELP 238 (293)
T ss_pred cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHHhCCCchHHHHHhhccc
Confidence 23458999988654 468999999999999999999999964321 111111111000 0 00
Q ss_pred --------cccCCccc-cccHH-HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 648 --------DIVDPTLK-SFQEN-VLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 648 --------~~~d~~l~-~~~~~-~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
......+. .++.. ..+.+.+++.+||+.+|++|||+.|++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 239 GAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred hhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 00000000 11111 3567889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=286.18 Aligned_cols=243 Identities=17% Similarity=0.226 Sum_probs=191.0
Q ss_pred hhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
++.+.+|+|+||.||+|+. .++..+++|.+...............+.+|++++++++|+||+++++++.+.+....++|
T Consensus 5 ~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v 84 (264)
T cd06653 5 RLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIF 84 (264)
T ss_pred eeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEE
Confidence 4566788999999999985 468899999875432222223345679999999999999999999999876544457899
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC---
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT--- 585 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~--- 585 (721)
+||+++++|.+++.. ...+++.....++.|++.||.|||+++ |+||||||+||+++.++.++|+|||+++...
T Consensus 85 ~e~~~~~~L~~~~~~--~~~l~~~~~~~~~~~i~~al~~LH~~~--i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 160 (264)
T cd06653 85 VEYMPGGSIKDQLKA--YGALTENVTRRYTRQILQGVSYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRIQTIC 160 (264)
T ss_pred EEeCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCEEECcccccccccccc
Confidence 999999999999863 245889999999999999999999988 9999999999999999999999999876321
Q ss_pred ---------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCcccc
Q 004979 586 ---------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKS 656 (721)
Q Consensus 586 ---------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 656 (721)
.+...|++||.+.+..++.++|||||||++|||++|+.||.... ..+.+.+.... +. ...
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~~--~~-------~~~ 229 (264)
T cd06653 161 MSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYE--AMAAIFKIATQ--PT-------KPM 229 (264)
T ss_pred ccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccC--HHHHHHHHHcC--CC-------CCC
Confidence 13346899999988889999999999999999999999996321 11212221111 11 112
Q ss_pred ccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 657 FQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 657 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
.+....+++.+++.+||. +|.+||++.+++.
T Consensus 230 ~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 230 LPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred CCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 334566789999999998 5799999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=288.09 Aligned_cols=237 Identities=23% Similarity=0.298 Sum_probs=188.1
Q ss_pred CCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEEEecCC
Q 004979 435 FSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSP 513 (721)
Q Consensus 435 lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV~Ey~~ 513 (721)
+|.|+||.||+++.. ++..+++|.+...... .....+.+.+|++++.+++|+||+++++.+...+ ..++||||++
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~--~~~lv~e~~~ 76 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMI--RKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKK--NLYLVMEYLP 76 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhh--hhhHHHHHHHHHHHHHhCCCcchhHHHHheecCc--EEEEEEecCC
Confidence 478999999999976 4889999987644321 1334567899999999999999999999888766 6799999999
Q ss_pred CCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCCC-------
Q 004979 514 NGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTA------- 586 (721)
Q Consensus 514 ~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~~------- 586 (721)
+++|.+++... ..+++..+..++.||+.||+|||+.+ ++||||+|+||++++++.+||+|||++.....
T Consensus 77 ~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 152 (265)
T cd05579 77 GGDLASLLENV--GSLDEDVARIYIAEIVLALEYLHSNG--IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLN 152 (265)
T ss_pred CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcC--eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccc
Confidence 99999998643 36899999999999999999999988 99999999999999999999999998653221
Q ss_pred ----------CCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCcccc
Q 004979 587 ----------AKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKS 656 (721)
Q Consensus 587 ----------~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 656 (721)
+...|++||......++.++||||||+++|||+||+.||.... ..+.......+......
T Consensus 153 ~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~--~~~~~~~~~~~~~~~~~-------- 222 (265)
T cd05579 153 DDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGET--PEEIFQNILNGKIEWPE-------- 222 (265)
T ss_pred cccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHhcCCcCCCc--------
Confidence 2335789999988889999999999999999999999996332 33333333222111100
Q ss_pred ccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 004979 657 FQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKL 690 (721)
Q Consensus 657 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L 690 (721)
....+.++.+++.+||+.+|++||++.++.+.|
T Consensus 223 -~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l 255 (265)
T cd05579 223 -DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK 255 (265)
T ss_pred -cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence 001257789999999999999999995554443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=287.19 Aligned_cols=239 Identities=18% Similarity=0.232 Sum_probs=183.2
Q ss_pred CcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHH-HhcCCCCccceEeEEEecCCCceEEEEEe
Q 004979 433 GSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDT-LSKVNHKNFVNLIGYCEEDEPFTRMMVFE 510 (721)
Q Consensus 433 ~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~-l~~l~H~nIv~l~g~~~~~~~~~~~lV~E 510 (721)
+.+|+|+||.||+|+.. +++.+++|.+....... ......+..|..+ ....+|+||+++++++...+ ..++|+|
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~--~~~lv~e 77 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIA--KNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKD--YLYLVME 77 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhH--HHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCC--eEEEEEe
Confidence 46789999999999864 67889999875432111 1222344555544 44558999999999998776 6799999
Q ss_pred cCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC-----
Q 004979 511 YSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT----- 585 (721)
Q Consensus 511 y~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~----- 585 (721)
|+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||+|+||++++++.+||+|||+++...
T Consensus 78 ~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 153 (260)
T cd05611 78 YLNGGDCASLIKT--LGGLPEDWAKQYIAEVVLGVEDLHQRG--IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKF 153 (260)
T ss_pred ccCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCcEEEeecccceeccccccC
Confidence 9999999999863 346888899999999999999999988 9999999999999999999999999876432
Q ss_pred CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccHHHHHHH
Q 004979 586 AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQENVLEEL 665 (721)
Q Consensus 586 ~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l 665 (721)
.+...|++||.+.+..++.++||||||+++|||+||+.||.... ..+.............. .....++.++
T Consensus 154 ~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~~~~~~~~-------~~~~~~~~~~ 224 (260)
T cd05611 154 VGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAET--PDAVFDNILSRRINWPE-------EVKEFCSPEA 224 (260)
T ss_pred CCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCC--HHHHHHHHHhcccCCCC-------cccccCCHHH
Confidence 24457899999988889999999999999999999999996432 23333332222111100 1112345788
Q ss_pred HHHHHHcccCCCCCCCCHHHHHH
Q 004979 666 LVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 666 ~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
.+++.+||+.+|++||++.++.+
T Consensus 225 ~~~i~~~l~~~p~~R~~~~~~~~ 247 (260)
T cd05611 225 VDLINRLLCMDPAKRLGANGYQE 247 (260)
T ss_pred HHHHHHHccCCHHHccCCCcHHH
Confidence 99999999999999998765544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=293.17 Aligned_cols=249 Identities=19% Similarity=0.260 Sum_probs=189.7
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
++++.+|.|++|.||+|... ++..+++|++...... ....+.+.+|++++++++|+||+++++++.+.+ ..++|
T Consensus 2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~--~~~iv 76 (283)
T cd07835 2 QKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETED---EGVPSTAIREISLLKELNHPNIVRLLDVVHSEN--KLYLV 76 (283)
T ss_pred chheEecCCCCeEEEEEEEcCCCCEEEEEEeeccccc---ccchhHHHHHHHHHHhcCCCCccCHhheeccCC--eEEEE
Confidence 45678899999999999864 6889999988654321 122356888999999999999999999998776 67999
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCCC--
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTA-- 586 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~~-- 586 (721)
|||++ ++|.+++.......+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.+||+|||+++....
T Consensus 77 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~--~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~ 153 (283)
T cd07835 77 FEFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR--VLHRDLKPQNLLIDREGALKLADFGLARAFGVPV 153 (283)
T ss_pred EeccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEEcCCCcEEEeecccccccCCCc
Confidence 99994 69999986544456899999999999999999999987 99999999999999999999999998754321
Q ss_pred -------CCccccchhhccc-CCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCC-CC-----------
Q 004979 587 -------AKTGSAAMELLET-SAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQ-PL----------- 646 (721)
Q Consensus 587 -------~~~~~~apE~~~~-~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~-~~----------- 646 (721)
+...|+|||.+.+ ..++.++|||||||++|||+||+.||...+. ............ +.
T Consensus 154 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07835 154 RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSE--IDQLFRIFRTLGTPDEDVWPGVTSLP 231 (283)
T ss_pred cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHhCCCChHHhhhhhhch
Confidence 2346899998755 4578999999999999999999999964321 111111111100 00
Q ss_pred ------ccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 647 ------KDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 647 ------~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
............+..+.++.+++.+||+.+|++||+++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 232 DYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000001111122334567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=292.19 Aligned_cols=244 Identities=19% Similarity=0.253 Sum_probs=191.5
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
+.+..+|+|+||.||+++.. ++..+++|++...... .......+.+|++++++++|+|++++++++.+.+ ..++|
T Consensus 28 ~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~lv 103 (317)
T cd06635 28 TDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQ--SNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREH--TAWLV 103 (317)
T ss_pred hhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCC--chHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCC--eEEEE
Confidence 45678899999999999954 6788999987643221 2234467899999999999999999999998876 67999
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCCC--
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTA-- 586 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~~-- 586 (721)
|||++ |+|.+++.. ....++|.++..++.|++.|+.|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 104 ~e~~~-g~l~~~~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~--i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (317)
T cd06635 104 MEYCL-GSASDLLEV-HKKPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLTEPGQVKLADFGSASIASPAN 179 (317)
T ss_pred EeCCC-CCHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcccEEECCCCCEEEecCCCccccCCcc
Confidence 99996 588777653 3456899999999999999999999988 99999999999999999999999998764332
Q ss_pred ---CCccccchhhcc---cCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccHH
Q 004979 587 ---AKTGSAAMELLE---TSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQEN 660 (721)
Q Consensus 587 ---~~~~~~apE~~~---~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 660 (721)
+...|++||.+. ...++.++|||||||++|||++|+.||... +.............+. .....
T Consensus 180 ~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~--~~~~~~~~~~~~~~~~---------~~~~~ 248 (317)
T cd06635 180 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM--NAMSALYHIAQNESPT---------LQSNE 248 (317)
T ss_pred cccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCc--cHHHHHHHHHhccCCC---------CCCcc
Confidence 345689999873 457899999999999999999999998533 2222222222221110 01123
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 004979 661 VLEELLVVIKNCVHPDPKQRPSMRGIAAKLKE 692 (721)
Q Consensus 661 ~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 692 (721)
.+..+.+++.+||+.+|.+||++.||++.+-.
T Consensus 249 ~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~ 280 (317)
T cd06635 249 WSDYFRNFVDSCLQKIPQDRPTSEELLKHMFV 280 (317)
T ss_pred ccHHHHHHHHHHccCCcccCcCHHHHHhChhh
Confidence 45678999999999999999999999876544
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=288.95 Aligned_cols=242 Identities=20% Similarity=0.262 Sum_probs=189.8
Q ss_pred hhhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcC-CCCccceEeEEEecCC----C
Q 004979 429 SNIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKV-NHKNFVNLIGYCEEDE----P 502 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~----~ 502 (721)
+++++.+|.|+||.||+|+.. ++..+++|++..... ....+.+|+++++++ +|+||+++++++.... .
T Consensus 8 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~------~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 8 FELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED------EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred eeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch------hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 367889999999999999975 567888888764321 235789999999999 7999999999997643 2
Q ss_pred ceEEEEEecCCCCChhhhhhhcc--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCC
Q 004979 503 FTRMMVFEYSPNGSLFEHLHIQE--AEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSF 580 (721)
Q Consensus 503 ~~~~lV~Ey~~~GsL~~~l~~~~--~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGl 580 (721)
...++||||+++++|.+++.... ...+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.+||+|||+
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK--VIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEEccCCeEEECCCcc
Confidence 34799999999999999986433 457899999999999999999999988 99999999999999999999999998
Q ss_pred CCCCC---------CCCccccchhhccc-----CCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCC
Q 004979 581 WNNTT---------AAKTGSAAMELLET-----SAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPL 646 (721)
Q Consensus 581 a~~~~---------~~~~~~~apE~~~~-----~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~ 646 (721)
+.... .+...|+|||.+.. ..++.++|||||||++|||+||+.||.... ............ .
T Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~~~--~ 235 (275)
T cd06608 160 SAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMH--PMRALFKIPRNP--P 235 (275)
T ss_pred ceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccc--hHHHHHHhhccC--C
Confidence 75321 23446899998743 357789999999999999999999996322 112222222111 1
Q ss_pred ccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 647 KDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 647 ~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
..+ ........++.+++.+||..||++|||+.|+++
T Consensus 236 ~~~------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 236 PTL------KSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred CCC------CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 111 112335678899999999999999999999975
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=285.76 Aligned_cols=240 Identities=21% Similarity=0.317 Sum_probs=196.0
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
++.+.+|+|++|.||+|+.. ++..+++|++...... .....+.+|++.+.+++|+||+++++++...+ ..++|
T Consensus 4 ~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~lv 77 (264)
T cd06623 4 ERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE----EFRKQLLRELKTLRSCESPYVVKCYGAFYKEG--EISIV 77 (264)
T ss_pred eeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch----HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCC--eEEEE
Confidence 56678899999999999976 5889999987654321 33567999999999999999999999998876 67999
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC--
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQ-LTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT-- 585 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~-~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~-- 585 (721)
|||+++++|.+++... ..+++..+..++.|+++|++|||+ .+ ++||||+|+||+++.++.++|+|||++....
T Consensus 78 ~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~~--~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~ 153 (264)
T cd06623 78 LEYMDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKRH--IIHRDIKPSNLLINSKGEVKIADFGISKVLENT 153 (264)
T ss_pred EEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccCC--CccCCCCHHHEEECCCCCEEEccCccceecccC
Confidence 9999999999998643 568999999999999999999999 88 9999999999999999999999999875432
Q ss_pred -------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCC-CHHHHHHHHhhcCCCCccccCCccccc
Q 004979 586 -------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENG-SLENWASEYLKGEQPLKDIVDPTLKSF 657 (721)
Q Consensus 586 -------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~-~~~~~~~~~~~~~~~~~~~~d~~l~~~ 657 (721)
.+...|++||.+....++.++||||||+++|||+||+.||...+. ...+.......... ...
T Consensus 154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~----------~~~ 223 (264)
T cd06623 154 LDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPP----------PSL 223 (264)
T ss_pred CCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCC----------CCC
Confidence 123468899999888999999999999999999999999964431 23333333221111 111
Q ss_pred cHH-HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004979 658 QEN-VLEELLVVIKNCVHPDPKQRPSMRGIAAK 689 (721)
Q Consensus 658 ~~~-~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 689 (721)
... .+..+.+++.+||+.+|++||++.|+++.
T Consensus 224 ~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 224 PAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 223 56789999999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=320.89 Aligned_cols=245 Identities=24% Similarity=0.391 Sum_probs=197.5
Q ss_pred hhCcCCCCceeEEEEEEec--------CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcC-CCCccceEeEEEecCC
Q 004979 431 IIGSFSDGTVGTVYKGTLS--------SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKV-NHKNFVNLIGYCEEDE 501 (721)
Q Consensus 431 ii~~lg~G~~g~Vyk~~~~--------~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~ 501 (721)
+-..+|+|.||.|++|... ....||||..+.... ....+.+..|+++|..+ +|+|||.++|+|..++
T Consensus 300 ~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~----~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~ 375 (609)
T KOG0200|consen 300 LGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENAS----SSEKKDLMSELNVLKELGKHPNIVNLLGACTQDG 375 (609)
T ss_pred ccceeecccccceEeEEEeecccccccceEEEEEEecccccC----cHHHHHHHHHHHHHHHhcCCcchhhheeeeccCC
Confidence 3448899999999999743 135688887754322 24567899999999999 7999999999999866
Q ss_pred CceEEEEEecCCCCChhhhhhhcc------------C--CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEe
Q 004979 502 PFTRMMVFEYSPNGSLFEHLHIQE------------A--EHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYL 567 (721)
Q Consensus 502 ~~~~~lV~Ey~~~GsL~~~l~~~~------------~--~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl 567 (721)
..++|+||+..|+|.++|+..+ . ..++....+.++.|||.||+||++.. +|||||.++|||+
T Consensus 376 --~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~--~vHRDLAaRNVLi 451 (609)
T KOG0200|consen 376 --PLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP--CVHRDLAARNVLI 451 (609)
T ss_pred --ceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC--ccchhhhhhhEEe
Confidence 5699999999999999997544 0 23888899999999999999999887 9999999999999
Q ss_pred CCCCcEEEeccCCCCCCCC------------CCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHH
Q 004979 568 TEDYAAKISDFSFWNNTTA------------AKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLEN 634 (721)
Q Consensus 568 ~~~~~~kL~DFGla~~~~~------------~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~ 634 (721)
.++..+||+|||+++.... -...|||||.+....|+.|+|||||||+||||+| |..||.+-. ...+
T Consensus 452 ~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~-~~~~ 530 (609)
T KOG0200|consen 452 TKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP-PTEE 530 (609)
T ss_pred cCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC-cHHH
Confidence 9999999999999973211 1234899999999999999999999999999999 999996411 1222
Q ss_pred HHHHHhhcCCCCccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 004979 635 WASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEIT 694 (721)
Q Consensus 635 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~ 694 (721)
... .++.... ...+..+..+++++|+.||+.+|++||++.|+++.++...
T Consensus 531 l~~-~l~~G~r---------~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l 580 (609)
T KOG0200|consen 531 LLE-FLKEGNR---------MEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL 580 (609)
T ss_pred HHH-HHhcCCC---------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence 222 2222111 1234567889999999999999999999999999998853
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-33 Score=291.48 Aligned_cols=257 Identities=21% Similarity=0.333 Sum_probs=199.1
Q ss_pred hhhCcCCCCceeEEEEEEe----cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcC-CCCccceEeEEEecCCCce
Q 004979 430 NIIGSFSDGTVGTVYKGTL----SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKV-NHKNFVNLIGYCEEDEPFT 504 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~----~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~ 504 (721)
++.+.+|+|+||.||+++. .++..++||.+...... ......+.+.+|++++.++ +|+||+++++.+...+ .
T Consensus 3 ~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~-~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~--~ 79 (288)
T cd05583 3 ELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIV-QKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDT--K 79 (288)
T ss_pred eEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHH-hhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCC--E
Confidence 4567889999999999974 25678999987632211 1122345788999999999 6999999999988766 6
Q ss_pred EEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC
Q 004979 505 RMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT 584 (721)
Q Consensus 505 ~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~ 584 (721)
.++||||+++|+|.+++.. ...+++.....++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||+++..
T Consensus 80 ~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~~--~~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 155 (288)
T cd05583 80 LHLILDYVNGGELFTHLYQ--REHFTESEVRVYIAEIVLALDHLHQLG--IIYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (288)
T ss_pred EEEEEecCCCCcHHHHHhh--cCCcCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEEEECcccccc
Confidence 7999999999999999863 346889999999999999999999987 999999999999999999999999987542
Q ss_pred C----------CCCccccchhhcccCC--CCCCccHHHHHHHHHHHHhCCCcccCCCC--CHHHHHHHHhhcCCCCcccc
Q 004979 585 T----------AAKTGSAAMELLETSA--VDLESNVYSFGTILFEMITGRISYSIENG--SLENWASEYLKGEQPLKDIV 650 (721)
Q Consensus 585 ~----------~~~~~~~apE~~~~~~--~s~ksDVwSfGvvL~ElltG~~P~~~~~~--~~~~~~~~~~~~~~~~~~~~ 650 (721)
. .+...|++||...+.. .+.++||||||+++|||+||+.||...+. ...+..........+
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~----- 230 (288)
T cd05583 156 LAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPP----- 230 (288)
T ss_pred ccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCC-----
Confidence 1 1344688999986655 78899999999999999999999963321 122222222222111
Q ss_pred CCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCChhHHHHHH
Q 004979 651 DPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAMEPDGATPKLSPLWWAELE 714 (721)
Q Consensus 651 d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~~~~p~~~~~~~~~l~ 714 (721)
.+.....++.+++.+||+.+|++|||+.++.+.|+. |.+..++|++++
T Consensus 231 ------~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~----------~~~~~~~~~~~~ 278 (288)
T cd05583 231 ------FPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH----------PFFQGIDWDDLA 278 (288)
T ss_pred ------CCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC----------cccccCCHHHHh
Confidence 122344678899999999999999998887665443 677888898773
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=296.33 Aligned_cols=255 Identities=19% Similarity=0.254 Sum_probs=190.6
Q ss_pred hCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEEEe
Q 004979 432 IGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFE 510 (721)
Q Consensus 432 i~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV~E 510 (721)
||. |.|+||+||+++. .+++.||+|++...... ....+.+.+|+.+++.++||||+++++++...+ ..++|+|
T Consensus 6 ig~-g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~--~~~~v~e 79 (328)
T cd08226 6 IGR-GFCNLTSVYLARHTPTGTLVTVRITDLENCT---EEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGS--WLWVISP 79 (328)
T ss_pred hCC-cccCceeEEEEEEcCCCcEEEEEEeccccCC---HHHHHHHHHHHHHHHhCCCCCcceEeeeEecCC--ceEEEEe
Confidence 444 4669999999996 47899999987654322 223467899999999999999999999998876 6799999
Q ss_pred cCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC------
Q 004979 511 YSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT------ 584 (721)
Q Consensus 511 y~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~------ 584 (721)
|+.+|+|.+++.......+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+|++||+.+...
T Consensus 80 ~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~ 157 (328)
T cd08226 80 FMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG--YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQK 157 (328)
T ss_pred cccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcc
Confidence 999999999987544456899999999999999999999988 999999999999999999999999743110
Q ss_pred ----------CCCCccccchhhccc--CCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCc-----
Q 004979 585 ----------TAAKTGSAAMELLET--SAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLK----- 647 (721)
Q Consensus 585 ----------~~~~~~~~apE~~~~--~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~----- 647 (721)
..+...|++||.+.+ ..++.++|||||||++|||++|+.||...... ..............
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~ 235 (328)
T cd08226 158 AKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRT--QMLLQKLKGPPYSPLDITT 235 (328)
T ss_pred ccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChH--HHHHHHhcCCCCCCccccc
Confidence 012235899999865 35789999999999999999999999643211 11111111100000
Q ss_pred ------------------------------cccCCcc-ccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHHhh
Q 004979 648 ------------------------------DIVDPTL-KSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAK--LKEIT 694 (721)
Q Consensus 648 ------------------------------~~~d~~l-~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~--L~~i~ 694 (721)
...+..+ ......+..++.+|+.+||+.||++|||+.|+++. ++.+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~ 315 (328)
T cd08226 236 FPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVK 315 (328)
T ss_pred cchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHH
Confidence 0000000 01123456789999999999999999999999863 55554
Q ss_pred hc
Q 004979 695 AM 696 (721)
Q Consensus 695 ~~ 696 (721)
+.
T Consensus 316 ~~ 317 (328)
T cd08226 316 EQ 317 (328)
T ss_pred Hh
Confidence 43
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=287.72 Aligned_cols=250 Identities=19% Similarity=0.226 Sum_probs=188.3
Q ss_pred CCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHH---HHHhcCCCCccceEeEEEecCCCceEEEEEe
Q 004979 435 FSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKI---DTLSKVNHKNFVNLIGYCEEDEPFTRMMVFE 510 (721)
Q Consensus 435 lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei---~~l~~l~H~nIv~l~g~~~~~~~~~~~lV~E 510 (721)
+|+|+||.||+++. .+++.||+|.+..+..... .....+..|. +.++..+||||+++++++.+.+ ..++|||
T Consensus 2 ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~--~~~~v~e 77 (278)
T cd05606 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK--QGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD--KLSFILD 77 (278)
T ss_pred cccCCCeEEEEEEEecCCCEEEEEEeeccccccc--hhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCC--EEEEEEe
Confidence 68899999999985 4678999998865432211 1112233443 3455568999999999998776 6799999
Q ss_pred cCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC-----
Q 004979 511 YSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT----- 585 (721)
Q Consensus 511 y~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~----- 585 (721)
|+++|+|..++.. ...+++..+..++.|++.|++|||+.+ |+||||||+||++++++.+||+|||++....
T Consensus 78 ~~~g~~L~~~l~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~~ 153 (278)
T cd05606 78 LMNGGDLHYHLSQ--HGVFSEAEMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH 153 (278)
T ss_pred cCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC--EEcCCCCHHHEEECCCCCEEEccCcCccccCccCCc
Confidence 9999999988853 356999999999999999999999988 9999999999999999999999999875322
Q ss_pred --CCCccccchhhcccC-CCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccHHHH
Q 004979 586 --AAKTGSAAMELLETS-AVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQENVL 662 (721)
Q Consensus 586 --~~~~~~~apE~~~~~-~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 662 (721)
.+...|++||.+... .++.++|||||||++|||++|+.||.................. +. ..+...+
T Consensus 154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-------~~---~~~~~~s 223 (278)
T cd05606 154 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM-------AV---ELPDSFS 223 (278)
T ss_pred CcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhcc-------CC---CCCCcCC
Confidence 245578999998644 6899999999999999999999999744221111111111110 01 1222345
Q ss_pred HHHHHHHHHcccCCCCCCC-----CHHHHHHHHHHhhhcCCCCCCCCCChhHHHHHHh
Q 004979 663 EELLVVIKNCVHPDPKQRP-----SMRGIAAKLKEITAMEPDGATPKLSPLWWAELEI 715 (721)
Q Consensus 663 ~~l~~li~~Cl~~dP~~RP-----s~~evl~~L~~i~~~~~~~~~p~~~~~~~~~l~~ 715 (721)
.++.+++.+|+..+|.+|| ++.|+++ +|.+....|+....
T Consensus 224 ~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~-------------~~~~~~~~~~~~~~ 268 (278)
T cd05606 224 PELRSLLEGLLQRDVNRRLGCLGRGAQEVKE-------------HPFFRSLDWQMVFL 268 (278)
T ss_pred HHHHHHHHHHhhcCHHhccCCCCCCHHHHHh-------------CccccCCCchHhhh
Confidence 7899999999999999999 8888864 45555555665543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=286.31 Aligned_cols=243 Identities=19% Similarity=0.283 Sum_probs=191.7
Q ss_pred hhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccc-hhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 431 IIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRAD-WSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 431 ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~-~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
....+|+|+||.||+|+. .++..+++|.+....... ......+.+.+|++++++++|+||+++++++.+.+ ..++|
T Consensus 4 ~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~~v 81 (268)
T cd06630 4 KGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDS--HFNLF 81 (268)
T ss_pred ccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCC--eEEEE
Confidence 345678999999999984 578899999886433211 11224578999999999999999999999998776 67999
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCC-cEEEeccCCCCCCC--
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDY-AAKISDFSFWNNTT-- 585 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~-~~kL~DFGla~~~~-- 585 (721)
|||+++++|.+++.. ...+++.....++.|++.||+|||+++ ++||||||+||+++.++ .+||+|||++....
T Consensus 82 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~ql~~al~~LH~~~--i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~ 157 (268)
T cd06630 82 VEWMAGGSVSHLLSK--YGAFKEAVIINYTEQLLRGLSYLHENQ--IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAK 157 (268)
T ss_pred EeccCCCcHHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEEcccccccccccc
Confidence 999999999999863 346889999999999999999999998 99999999999998775 59999999875322
Q ss_pred -----------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCC-CHHHHHHHHhhcCCCCccccCCc
Q 004979 586 -----------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENG-SLENWASEYLKGEQPLKDIVDPT 653 (721)
Q Consensus 586 -----------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~-~~~~~~~~~~~~~~~~~~~~d~~ 653 (721)
.++..|++||.+....++.++||||+|+++|||++|+.||..... ............. .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---------~ 228 (268)
T cd06630 158 GTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASAT---------T 228 (268)
T ss_pred cccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccC---------C
Confidence 123468899999888899999999999999999999999964322 1112111111110 0
Q ss_pred cccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 654 LKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 654 l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
....++....++.+++.+||..+|++||++.|+++
T Consensus 229 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 229 APSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred CCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 11233456678999999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=292.17 Aligned_cols=245 Identities=19% Similarity=0.251 Sum_probs=184.4
Q ss_pred CCCCceeEEEEEEecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEEEecCCC
Q 004979 435 FSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPN 514 (721)
Q Consensus 435 lg~G~~g~Vyk~~~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV~Ey~~~ 514 (721)
.|.|+++.||+++. ++..+|||++..... .....+.+.+|++++++++|+||+++++++...+ ..+++|||+++
T Consensus 10 ~~~~~~v~~~~~~~-~~~~~avK~~~~~~~---~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~--~~~~~~e~~~~ 83 (314)
T cd08216 10 FEDLMIVHLAKHKP-TNTLVAVKKINLDSC---SKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDS--ELYVVSPLMAY 83 (314)
T ss_pred hcCCceEEEEEecC-CCCEEEEEEEecccc---chhHHHHHHHHHHHHHhcCCcchhhhhheeecCC--eEEEEEeccCC
Confidence 34566666666655 688999998865421 2234567999999999999999999999998776 67999999999
Q ss_pred CChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC---------
Q 004979 515 GSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT--------- 585 (721)
Q Consensus 515 GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~--------- 585 (721)
|+|.+++.......+++.....++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||.+....
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~--ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~ 161 (314)
T cd08216 84 GSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG--FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV 161 (314)
T ss_pred CCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence 99999997554556889999999999999999999988 9999999999999999999999999764221
Q ss_pred -------CCCccccchhhccc--CCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCC-----------
Q 004979 586 -------AAKTGSAAMELLET--SAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQP----------- 645 (721)
Q Consensus 586 -------~~~~~~~apE~~~~--~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~----------- 645 (721)
.+...|+|||.+.. ..++.++|||||||++|||++|+.||..... ....... ..+..+
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~-~~~~~~~-~~~~~~~~~~~~~~~~~ 239 (314)
T cd08216 162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPA-TQMLLEK-VRGTVPCLLDKSTYPLY 239 (314)
T ss_pred ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHH-HhccCccccccCchhhh
Confidence 12235889999865 4588999999999999999999999964321 1111111 111000
Q ss_pred ---Ccc----ccCCcc-----ccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004979 646 ---LKD----IVDPTL-----KSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAK 689 (721)
Q Consensus 646 ---~~~----~~d~~l-----~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 689 (721)
... ..++.. .........++.+++.+||+.+|++|||++|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 240 EDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred cCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 000 000000 01123445788999999999999999999999873
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-33 Score=289.57 Aligned_cols=238 Identities=19% Similarity=0.299 Sum_probs=187.7
Q ss_pred hhhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCC---CCccceEeEEEecCCCce
Q 004979 429 SNIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVN---HKNFVNLIGYCEEDEPFT 504 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~---H~nIv~l~g~~~~~~~~~ 504 (721)
++++..+|.|+||.||+|+. .++..+++|.+..... .....++.+|++++++++ ||||+++++++.... .
T Consensus 3 y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~--~ 76 (277)
T cd06917 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTP----DDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGP--R 76 (277)
T ss_pred hhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCC----chhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCC--E
Confidence 45677889999999999996 5688899998764321 223456889999999997 999999999998766 6
Q ss_pred EEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC
Q 004979 505 RMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT 584 (721)
Q Consensus 505 ~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~ 584 (721)
.++||||+++++|.+++.. ..+++.....++.|++.||.|||+.+ |+||||+|+||++++++.++|+|||++...
T Consensus 77 ~~lv~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 151 (277)
T cd06917 77 LWIIMEYAEGGSVRTLMKA---GPIAEKYISVIIREVLVALKYIHKVG--VIHRDIKAANILVTNTGNVKLCDFGVAALL 151 (277)
T ss_pred EEEEEecCCCCcHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHHEEEcCCCCEEEccCCceeec
Confidence 7999999999999998853 36899999999999999999999988 999999999999999999999999987533
Q ss_pred CC---------CCccccchhhccc-CCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCcc
Q 004979 585 TA---------AKTGSAAMELLET-SAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTL 654 (721)
Q Consensus 585 ~~---------~~~~~~apE~~~~-~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 654 (721)
.. +...|+|||.+.. ..++.++|||||||++|||++|+.||.... ........... ..+.+
T Consensus 152 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~--~~~~~~~~~~~-------~~~~~ 222 (277)
T cd06917 152 NQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVD--AFRAMMLIPKS-------KPPRL 222 (277)
T ss_pred CCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCC--hhhhhhccccC-------CCCCC
Confidence 21 3345889998764 457899999999999999999999996432 11211111000 00111
Q ss_pred ccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 655 KSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 655 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
.. ...+.++.+++.+||+.||++||++.|++.
T Consensus 223 ~~--~~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 223 ED--NGYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred Cc--ccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 10 124567899999999999999999999976
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=294.47 Aligned_cols=240 Identities=24% Similarity=0.359 Sum_probs=189.0
Q ss_pred hhhhhCcCCCCceeEEEEEEecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcC-CCCccceEeEEEecCCCceEE
Q 004979 428 FSNIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKV-NHKNFVNLIGYCEEDEPFTRM 506 (721)
Q Consensus 428 ~~~ii~~lg~G~~g~Vyk~~~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~~~ 506 (721)
-|+++++||.||.+.||++...+.+.+|+|++...... ......|..|+..|.++ .|.+||++|+|-..++ ..|
T Consensus 362 ~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D---~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~--~lY 436 (677)
T KOG0596|consen 362 EYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEAD---NQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDG--YLY 436 (677)
T ss_pred hhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcC---HHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCc--eEE
Confidence 35788999999999999999888888898887655433 34456899999999999 5999999999988877 789
Q ss_pred EEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC--
Q 004979 507 MVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT-- 584 (721)
Q Consensus 507 lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~-- 584 (721)
|||||- .-+|..+|.........| .+..+..||+.|+.++|+.+ |||.||||.|+|+-. |.+||+|||+|+..
T Consensus 437 mvmE~G-d~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~~g--IVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~ 511 (677)
T KOG0596|consen 437 MVMECG-DIDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQHG--IVHSDLKPANFLLVK-GRLKLIDFGIANAIQP 511 (677)
T ss_pred EEeecc-cccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHHhc--eeecCCCcccEEEEe-eeEEeeeechhcccCc
Confidence 999987 559999998665555556 67789999999999999998 999999999999974 78999999998643
Q ss_pred ---------CCCCccccchhhccc-----------CCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCC
Q 004979 585 ---------TAAKTGSAAMELLET-----------SAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQ 644 (721)
Q Consensus 585 ---------~~~~~~~~apE~~~~-----------~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~ 644 (721)
..|+..||+||.+.. .+++.++||||+|||||+|+.|+.||. +......
T Consensus 512 DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~----~~~n~~a------- 580 (677)
T KOG0596|consen 512 DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFG----QIINQIA------- 580 (677)
T ss_pred cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchH----HHHHHHH-------
Confidence 346678999998732 236789999999999999999999994 1111111
Q ss_pred CCccccCCccc-cccH-HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 645 PLKDIVDPTLK-SFQE-NVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 645 ~~~~~~d~~l~-~~~~-~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
.+..+.||... ++++ ....++.++|+.||+.||++||+..|+++
T Consensus 581 Kl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 581 KLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred HHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 12333444221 1111 11133899999999999999999999986
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=286.74 Aligned_cols=238 Identities=21% Similarity=0.304 Sum_probs=192.3
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
++...+|+|+||.||+|... ++..+++|++..... ..+.+.+|++++++++|+||+++++++...+ ..++|
T Consensus 22 ~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~lv 93 (286)
T cd06614 22 KNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ------NKELIINEILIMKDCKHPNIVDYYDSYLVGD--ELWVV 93 (286)
T ss_pred hHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch------hHHHHHHHHHHHHHCCCCCeeEEEEEEEECC--EEEEE
Confidence 55677889999999999976 678899998864322 3467889999999999999999999998876 67999
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC---
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT--- 585 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~--- 585 (721)
+||+++++|.+++.... ..+++..+..++.|++.||+|||+.+ |+|+||||+||+++.++.+||+|||++....
T Consensus 94 ~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~g--i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 170 (286)
T cd06614 94 MEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQN--VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK 170 (286)
T ss_pred EeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence 99999999999997432 47999999999999999999999987 9999999999999999999999999764322
Q ss_pred ------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccH
Q 004979 586 ------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQE 659 (721)
Q Consensus 586 ------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 659 (721)
.+...|++||.+....++.++|||||||++|||+||+.||..... ........... ..... ...
T Consensus 171 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~--~~~~~~~~~~~--~~~~~------~~~ 240 (286)
T cd06614 171 SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPP--LRALFLITTKG--IPPLK------NPE 240 (286)
T ss_pred hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhcC--CCCCc------chh
Confidence 133568999999888899999999999999999999999863322 22222211111 11111 112
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 660 NVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 660 ~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
.++.++.+++.+||+.+|.+||++.+++.
T Consensus 241 ~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 241 KWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred hCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 24567899999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=289.46 Aligned_cols=248 Identities=23% Similarity=0.306 Sum_probs=190.2
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
++.+.+|+|+||.||+|+.. ++..+++|++...... ......+.+|+.++++++||||+++++++...+ ..++|
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~---~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~--~~~~v 77 (286)
T cd07832 3 KILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE---GGIPNQALREIKALQACQHPYVVKLLDVFPHGS--GFVLV 77 (286)
T ss_pred eEEeecccCCCcEEEEEEECCCCceEEEEEEEccccc---chhhHHHHHHHHHHHhCCCCCCcceeeEEecCC--eeEEE
Confidence 56678899999999999964 6889999988654321 233467899999999999999999999998766 67999
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCCC--
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTA-- 586 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~~-- 586 (721)
|||+ +++|.+++... ...+++.++..++.||+.||+|||+.+ |+|+||||+||++++++.++|+|||++.....
T Consensus 78 ~e~~-~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (286)
T cd07832 78 MEYM-PSDLSEVLRDE-ERPLPEAQVKSYMRMLLKGVAYMHANG--IMHRDLKPANLLISADGVLKIADFGLARLFSEEE 153 (286)
T ss_pred eccc-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence 9999 99999998643 356899999999999999999999988 99999999999999999999999998754322
Q ss_pred --------CCccccchhhcccC-CCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCC-C-----------
Q 004979 587 --------AKTGSAAMELLETS-AVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQ-P----------- 645 (721)
Q Consensus 587 --------~~~~~~apE~~~~~-~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~-~----------- 645 (721)
+...|+|||.+.+. .++.++||||+||++|||+||+.||.... +...+ ........ +
T Consensus 154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~-~~~~~-~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07832 154 PRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEN-DIEQL-AIVFRTLGTPNEETWPGLTSL 231 (286)
T ss_pred CCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCC-HHHHH-HHHHHHcCCCChHHHhhccCc
Confidence 23468899987544 46899999999999999999987775332 11111 11111000 0
Q ss_pred --CccccCCc-----cccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 646 --LKDIVDPT-----LKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 646 --~~~~~d~~-----l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
...+..+. +....++...++.+++.+||+.+|++||++++++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 232 PDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred chhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 00000000 01111234578999999999999999999999976
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=287.72 Aligned_cols=235 Identities=21% Similarity=0.309 Sum_probs=189.1
Q ss_pred hCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEEEe
Q 004979 432 IGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFE 510 (721)
Q Consensus 432 i~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV~E 510 (721)
...+|+|++|.||++.. .++..+++|++.... ....+.+.+|+.++++++|+||+++++++...+ ..++|+|
T Consensus 24 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-----~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~--~~~~v~e 96 (285)
T cd06648 24 FVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK-----QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGD--ELWVVME 96 (285)
T ss_pred ceEeccCCCeEEEEEEECCCCCEEEEEEEeccc-----hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCC--eEEEEEe
Confidence 35778899999999985 467889999775432 122456889999999999999999999988766 6799999
Q ss_pred cCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC-----
Q 004979 511 YSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT----- 585 (721)
Q Consensus 511 y~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~----- 585 (721)
|+++++|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++....
T Consensus 97 ~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~ 171 (285)
T cd06648 97 FLEGGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQG--VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR 171 (285)
T ss_pred ccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChhhEEEcCCCcEEEcccccchhhccCCcc
Confidence 9999999999864 45889999999999999999999988 9999999999999999999999999765321
Q ss_pred ----CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccHHH
Q 004979 586 ----AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQENV 661 (721)
Q Consensus 586 ----~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 661 (721)
.+...|++||...+..++.++|||||||++|||++|+.||...+ ..+..........+ . .. .....
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~--~~~~~~~~~~~~~~--~-----~~-~~~~~ 241 (285)
T cd06648 172 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEP--PLQAMKRIRDNLPP--K-----LK-NLHKV 241 (285)
T ss_pred cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCC--HHHHHHHHHhcCCC--C-----Cc-ccccC
Confidence 23446899999988889999999999999999999999986432 23333333222111 0 00 11224
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 662 LEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 662 ~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
+.++.+++.+||+.+|++||++.|+++
T Consensus 242 ~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 242 SPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred CHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 567899999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-33 Score=289.30 Aligned_cols=250 Identities=19% Similarity=0.236 Sum_probs=185.2
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCC-CCccceEeEEEecCCCceEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVN-HKNFVNLIGYCEEDEPFTRMM 507 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~~~l 507 (721)
++++.+|+|+||.||+|+.. ++..+++|+....... .......+|+.++.++. |+||+++++++.+......++
T Consensus 2 ~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~l 77 (282)
T cd07831 2 KILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKS----LEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLAL 77 (282)
T ss_pred ceEeeccccccceEEEEEEcCCCcEEEEEEehhccCC----chhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEE
Confidence 45678899999999999854 6788999987643211 11234457889999885 999999999998763236799
Q ss_pred EEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCCC-
Q 004979 508 VFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTA- 586 (721)
Q Consensus 508 V~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~~- 586 (721)
||||++ |+|.+++... ...++|..+..++.|++.||+|||+.+ |+||||||+||+++. +.+||+|||+++....
T Consensus 78 v~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~ 152 (282)
T cd07831 78 VFELMD-MNLYELIKGR-KRPLPEKRVKSYMYQLLKSLDHMHRNG--IFHRDIKPENILIKD-DILKLADFGSCRGIYSK 152 (282)
T ss_pred EEecCC-ccHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence 999996 6888887542 356899999999999999999999988 999999999999999 9999999998764321
Q ss_pred -------CCccccchhhcc-cCCCCCCccHHHHHHHHHHHHhCCCcccCCCC-CHHHHHHHHhhcC-----------CC-
Q 004979 587 -------AKTGSAAMELLE-TSAVDLESNVYSFGTILFEMITGRISYSIENG-SLENWASEYLKGE-----------QP- 645 (721)
Q Consensus 587 -------~~~~~~apE~~~-~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~-~~~~~~~~~~~~~-----------~~- 645 (721)
+...|+|||.+. ...++.++|||||||++|||++|+.||...+. +............ ..
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
T cd07831 153 PPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHM 232 (282)
T ss_pred CCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccc
Confidence 234688999764 45678999999999999999999999964331 1111111111000 00
Q ss_pred ---CccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 646 ---LKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 646 ---~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
........+.......+.++.+++.+||+.+|++||++.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 233 NYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred cccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 0000001111122345688999999999999999999999975
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=280.79 Aligned_cols=244 Identities=23% Similarity=0.363 Sum_probs=195.5
Q ss_pred CcCCCCceeEEEEEEecC------CcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEE
Q 004979 433 GSFSDGTVGTVYKGTLSS------GVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRM 506 (721)
Q Consensus 433 ~~lg~G~~g~Vyk~~~~~------~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~ 506 (721)
..+-+|.||.||+|.|.+ .+.|.||.++. ..+......|+.|.-.+..+.|||+..+.+++.+... ..+
T Consensus 290 ~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~----~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~-~P~ 364 (563)
T KOG1024|consen 290 CLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQ----HASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYA-TPF 364 (563)
T ss_pred hhhhcCchhheeeeeecccCCcchHHHHHHHHHHh----cccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccC-cce
Confidence 345689999999997753 23455554432 2234455678999999999999999999999987543 578
Q ss_pred EEEecCCCCChhhhhhhc------cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCC
Q 004979 507 MVFEYSPNGSLFEHLHIQ------EAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSF 580 (721)
Q Consensus 507 lV~Ey~~~GsL~~~l~~~------~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGl 580 (721)
++|.|+.-|+|..+|... ..+.++-.+...++.|++.|++|||.++ |||.||..+|++||+..++||+|=.+
T Consensus 365 V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~--ViHkDiAaRNCvIdd~LqVkltDsaL 442 (563)
T KOG1024|consen 365 VLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG--VIHKDIAARNCVIDDQLQVKLTDSAL 442 (563)
T ss_pred EEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC--cccchhhhhcceehhheeEEeccchh
Confidence 999999999999999733 2345777788899999999999999998 99999999999999999999999999
Q ss_pred CCCCCCCC-----------ccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhcCCCCcc
Q 004979 581 WNNTTAAK-----------TGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPLKD 648 (721)
Q Consensus 581 a~~~~~~~-----------~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~ 648 (721)
++....+. ..||++|.+....|+.++|||||||+||||+| |+.||. +.+..+. ..++++..++.
T Consensus 443 SRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~Pya--eIDPfEm-~~ylkdGyRla- 518 (563)
T KOG1024|consen 443 SRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYA--EIDPFEM-EHYLKDGYRLA- 518 (563)
T ss_pred ccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCcc--ccCHHHH-HHHHhccceec-
Confidence 88665432 36899999999999999999999999999999 999984 2233332 22333323222
Q ss_pred ccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 004979 649 IVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITA 695 (721)
Q Consensus 649 ~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~ 695 (721)
.+-+|+++++.+|..||+.+|++||++++++..|.+...
T Consensus 519 --------QP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~ 557 (563)
T KOG1024|consen 519 --------QPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHT 557 (563)
T ss_pred --------CCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHH
Confidence 234788999999999999999999999999999988654
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=287.02 Aligned_cols=253 Identities=20% Similarity=0.337 Sum_probs=194.9
Q ss_pred hhhCcCCCCceeEEEEEEe----cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcC-CCCccceEeEEEecCCCce
Q 004979 430 NIIGSFSDGTVGTVYKGTL----SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKV-NHKNFVNLIGYCEEDEPFT 504 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~----~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~ 504 (721)
++.+.+|.|+||.||+++. .+|..+++|.+....... .....+.+.+|++++.++ +|+||+++++++..+. .
T Consensus 3 ~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~--~ 79 (290)
T cd05613 3 ELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQ-KAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDT--K 79 (290)
T ss_pred eeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhh-cchHHHHHHHHHHHHHhcccCCChhceeeEeecCC--e
Confidence 4567889999999999985 367889999876432111 122345688999999999 6999999999988766 6
Q ss_pred EEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC
Q 004979 505 RMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT 584 (721)
Q Consensus 505 ~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~ 584 (721)
.++||||+++|+|.+++.. ...+++.....++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||+++..
T Consensus 80 ~~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 155 (290)
T cd05613 80 LHLILDYINGGELFTHLSQ--RERFKEQEVQIYSGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLSKEF 155 (290)
T ss_pred EEEEEecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEECCCCCEEEeeCccceec
Confidence 7999999999999999864 346888888999999999999999988 999999999999999999999999987543
Q ss_pred CC----------CCccccchhhccc--CCCCCCccHHHHHHHHHHHHhCCCcccCCC--CCHHHHHHHHhhcCCCCcccc
Q 004979 585 TA----------AKTGSAAMELLET--SAVDLESNVYSFGTILFEMITGRISYSIEN--GSLENWASEYLKGEQPLKDIV 650 (721)
Q Consensus 585 ~~----------~~~~~~apE~~~~--~~~s~ksDVwSfGvvL~ElltG~~P~~~~~--~~~~~~~~~~~~~~~~~~~~~ 650 (721)
.. +...|++||.+.. ..++.++|||||||++|||+||+.||...+ ....++.........+
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~----- 230 (290)
T cd05613 156 HEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP----- 230 (290)
T ss_pred ccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCC-----
Confidence 22 3446899998864 346789999999999999999999996332 2233333333222221
Q ss_pred CCccccccHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHHHHHhhhcCCCCCCCCCChhHHHHH
Q 004979 651 DPTLKSFQENVLEELLVVIKNCVHPDPKQRP-----SMRGIAAKLKEITAMEPDGATPKLSPLWWAEL 713 (721)
Q Consensus 651 d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~evl~~L~~i~~~~~~~~~p~~~~~~~~~l 713 (721)
.+......+.+++.+||+.+|++|| ++.+++. +|.+....|+++
T Consensus 231 ------~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~-------------~~~~~~~~~~~~ 279 (290)
T cd05613 231 ------YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK-------------HPFFQKINWDDL 279 (290)
T ss_pred ------CCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc-------------CcccccCCHHHH
Confidence 1223456788999999999999997 5666543 566666677665
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=289.37 Aligned_cols=248 Identities=18% Similarity=0.184 Sum_probs=184.5
Q ss_pred hhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
.+++.+|+|+||.||+|.. .++..+++|.+..+.... ....+.+|++++++++|+||+++++++...+ ..++|
T Consensus 8 ~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~----~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~--~~~lv 81 (291)
T cd07870 8 LNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEG----VPFTAIREASLLKGLKHANIVLLHDIIHTKE--TLTFV 81 (291)
T ss_pred EEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCC----CcHHHHHHHHHHHhcCCCCEeEEEEEEecCC--eEEEE
Confidence 5677899999999999985 468899999886543211 1235778999999999999999999998766 67999
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC---
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT--- 585 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~--- 585 (721)
|||+. ++|.+++... ...+.+.....++.|++.||+|||+.+ |+||||||+|||++.++++||+|||+++...
T Consensus 82 ~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 157 (291)
T cd07870 82 FEYMH-TDLAQYMIQH-PGGLHPYNVRLFMFQLLRGLAYIHGQH--ILHRDLKPQNLLISYLGELKLADFGLARAKSIPS 157 (291)
T ss_pred Eeccc-CCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEEcCCCcEEEeccccccccCCCC
Confidence 99995 7887776432 345788888999999999999999988 9999999999999999999999999876421
Q ss_pred ------CCCccccchhhccc-CCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcC-CCC-----------
Q 004979 586 ------AAKTGSAAMELLET-SAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGE-QPL----------- 646 (721)
Q Consensus 586 ------~~~~~~~apE~~~~-~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~-~~~----------- 646 (721)
.+...|+|||.+.+ ..++.++|||||||++|||+||+.||....... +......... .+.
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (291)
T cd07870 158 QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVF-EQLEKIWTVLGVPTEDTWPGVSKLP 236 (291)
T ss_pred CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHH-HHHHHHHHHcCCCChhhhhhhhhcc
Confidence 12446889998865 457889999999999999999999996433211 1111111000 000
Q ss_pred ---ccccC----Ccccccc--HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 647 ---KDIVD----PTLKSFQ--ENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 647 ---~~~~d----~~l~~~~--~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
..... ....... -....++.+++.+|++.||++|||+.|++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 237 NYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred cccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 00000 0000000 011457889999999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=290.99 Aligned_cols=250 Identities=20% Similarity=0.289 Sum_probs=189.2
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
++.+.+|+|+||.||+|+.. ++..|++|++..... .....+.+.+|++++++++|+||+++++++...+ ..++|
T Consensus 4 ~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~iv 78 (288)
T cd07833 4 EVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED---DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKG--RLYLV 78 (288)
T ss_pred eEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc---cccchhHHHHHHHHHHhcCCCCeeehhheEEECC--EEEEE
Confidence 56778899999999999965 577899998764322 1223467899999999999999999999998866 67999
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCCC--
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTA-- 586 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~~-- 586 (721)
|||++++.+..+.. ....+++..+..++.||+.||+|||+.+ ++||||||+||++++++.+||+|||++.....
T Consensus 79 ~e~~~~~~l~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 154 (288)
T cd07833 79 FEYVERTLLELLEA--SPGGLPPDAVRSYIWQLLQAIAYCHSHN--IIHRDIKPENILVSESGVLKLCDFGFARALRARP 154 (288)
T ss_pred EecCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence 99999877766553 3345899999999999999999999988 99999999999999999999999998754322
Q ss_pred --------CCccccchhhcccC-CCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHH-HHHhhc-----------CCC
Q 004979 587 --------AKTGSAAMELLETS-AVDLESNVYSFGTILFEMITGRISYSIENGSLENWA-SEYLKG-----------EQP 645 (721)
Q Consensus 587 --------~~~~~~apE~~~~~-~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~-~~~~~~-----------~~~ 645 (721)
+...|+|||.+... .++.++||||||+++|||++|+.||.........+. ...... ...
T Consensus 155 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07833 155 ASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPR 234 (288)
T ss_pred cccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcc
Confidence 23458999999877 889999999999999999999999864322111110 010000 000
Q ss_pred -----CccccCCcc--ccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 646 -----LKDIVDPTL--KSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 646 -----~~~~~d~~l--~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
..+..++.. ..++..++.++.++|++||..+|++||+++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 235 FAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred ccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 000000000 0112234678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-32 Score=285.00 Aligned_cols=251 Identities=21% Similarity=0.251 Sum_probs=189.0
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcC---CCCccceEeEEEecCCC---
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKV---NHKNFVNLIGYCEEDEP--- 502 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l---~H~nIv~l~g~~~~~~~--- 502 (721)
++++.+|+|+||.||+|+.+ ++..+++|++...... ......+.+|++++.++ +|+||+++++++...+.
T Consensus 2 ~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~ 78 (287)
T cd07838 2 EELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSE---EGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRE 78 (287)
T ss_pred eEEEEecccCceEEEEEEECCCCCEEEEEEecccccc---chhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCC
Confidence 45677899999999999976 4889999988654321 12234566777776655 69999999999987552
Q ss_pred ceEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCC
Q 004979 503 FTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWN 582 (721)
Q Consensus 503 ~~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~ 582 (721)
...+++|||+. ++|.+++.......+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||++.
T Consensus 79 ~~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~--i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 79 LKLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR--IVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred ceeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhEEEccCCCEEEeccCcce
Confidence 13799999996 58998886544456999999999999999999999988 9999999999999999999999999875
Q ss_pred CCCC--------CCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCC---------
Q 004979 583 NTTA--------AKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQP--------- 645 (721)
Q Consensus 583 ~~~~--------~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~--------- 645 (721)
.... +...|++||.+.+..++.++|||||||++|||+||+.||.... ..+...++......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07838 156 IYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTS--EADQLDKIFDVIGLPSEEEWPRN 233 (287)
T ss_pred eccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCC--hHHHHHHHHHHcCCCChHhcCCC
Confidence 4321 2345889999988899999999999999999999999986432 22222222211000
Q ss_pred -------CccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 646 -------LKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 646 -------~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
..................++.+++.+||+.||++||++.|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 234 VSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred cccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 0000001111122345677889999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=292.49 Aligned_cols=250 Identities=20% Similarity=0.224 Sum_probs=188.4
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
++++.+|+|+||.||+|+.. ++..||+|++....... .....+.+|++++++++|+||+++++++.+......++|
T Consensus 10 ~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (309)
T cd07845 10 EKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD---GIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLV 86 (309)
T ss_pred eEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC---CCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEE
Confidence 66788999999999999964 68899999886543221 112346789999999999999999999876543357999
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCCC--
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTA-- 586 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~~-- 586 (721)
|||+. ++|.+++... ...+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++.....
T Consensus 87 ~e~~~-~~l~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~ 162 (309)
T cd07845 87 MEYCE-QDLASLLDNM-PTPFSESQVKCLMLQLLRGLQYLHENF--IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA 162 (309)
T ss_pred EecCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEECccceeeecCCcc
Confidence 99996 5888887532 356899999999999999999999998 99999999999999999999999998764322
Q ss_pred -------CCccccchhhccc-CCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCC-CCccc--------
Q 004979 587 -------AKTGSAAMELLET-SAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQ-PLKDI-------- 649 (721)
Q Consensus 587 -------~~~~~~apE~~~~-~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~-~~~~~-------- 649 (721)
....|+|||.+.+ ..++.++||||+||++|||++|+.||...+ ..+.+..+..... +....
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (309)
T cd07845 163 KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKS--EIEQLDLIIQLLGTPNESIWPGFSDLP 240 (309)
T ss_pred CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHhcCCCChhhchhhhccc
Confidence 1235899998864 567899999999999999999999996432 2222222221100 00000
Q ss_pred ----c--C-C---ccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 650 ----V--D-P---TLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 650 ----~--d-~---~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
. . . ...........++.++|.+|++.||++|||+.|++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 241 LVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred ccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0 0 0 000001123567889999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=289.63 Aligned_cols=249 Identities=17% Similarity=0.248 Sum_probs=186.7
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
++++.+|+|++|+||+|+.. +++.+++|++...... ....+.+.+|++++++++|+||+++++++...+ ..++|
T Consensus 5 ~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv 79 (294)
T PLN00009 5 EKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQED---EGVPSTAIREISLLKEMQHGNIVRLQDVVHSEK--RLYLV 79 (294)
T ss_pred EEEEEecCCCCEEEEEEEecCCCcEEEEEehhhcccc---ccchHHHHHHHHHHHhccCCCEeeEEEEEecCC--eEEEE
Confidence 56778899999999999965 6788999987543221 123356889999999999999999999998776 67999
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCC-CCcEEEeccCCCCCCC--
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTE-DYAAKISDFSFWNNTT-- 585 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~-~~~~kL~DFGla~~~~-- 585 (721)
|||++ ++|.+++.......+++.....++.||+.||+|||+.+ |+||||||+||++++ ++.+||+|||++....
T Consensus 80 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 80 FEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR--VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred Eeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 99995 58888875444444678888899999999999999987 999999999999985 5679999999875321
Q ss_pred -------CCCccccchhhccc-CCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhc-CCCCccc-------
Q 004979 586 -------AAKTGSAAMELLET-SAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKG-EQPLKDI------- 649 (721)
Q Consensus 586 -------~~~~~~~apE~~~~-~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~-~~~~~~~------- 649 (721)
.+...|++||.+.+ ..++.++|||||||++|||+||+.||..... ... ....... ..+....
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~-~~~-~~~~~~~~~~~~~~~~~~~~~~ 234 (294)
T PLN00009 157 VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSE-IDE-LFKIFRILGTPNEETWPGVTSL 234 (294)
T ss_pred ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-HHH-HHHHHHHhCCCChhhccccccc
Confidence 12346899998865 4578999999999999999999999964321 111 1111110 0011100
Q ss_pred ----------cCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 650 ----------VDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 650 ----------~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
.........+..+.++.+++.+|++.+|++||++.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 235 PDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred hhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 001111112334567899999999999999999999986
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=299.56 Aligned_cols=258 Identities=19% Similarity=0.250 Sum_probs=189.9
Q ss_pred hhhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCC---ce
Q 004979 429 SNIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEP---FT 504 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~---~~ 504 (721)
+++++.+|+|+||.||+|+. .++..|++|++..... ......+.+|+.++++++|+||+++++++..... ..
T Consensus 7 y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 7 YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEH----QTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred eEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccccc----chhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 36778899999999999985 4688999998753221 2234568899999999999999999998765431 24
Q ss_pred EEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC
Q 004979 505 RMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT 584 (721)
Q Consensus 505 ~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~ 584 (721)
.++|+||+. ++|.+++. ...+++.....++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 83 ~~lv~e~~~-~~l~~~~~---~~~l~~~~~~~i~~ql~~aL~~LH~~~--ivH~dlkp~Nill~~~~~~kl~dfg~~~~~ 156 (336)
T cd07849 83 VYIVQELME-TDLYKLIK---TQHLSNDHIQYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTNCDLKICDFGLARIA 156 (336)
T ss_pred EEEEehhcc-cCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEECCCCCEEECcccceeec
Confidence 799999996 58887764 346899999999999999999999988 999999999999999999999999987543
Q ss_pred C------------CCCccccchhhccc-CCCCCCccHHHHHHHHHHHHhCCCcccCCCCC-HHHHHHHHhhcCC--CCcc
Q 004979 585 T------------AAKTGSAAMELLET-SAVDLESNVYSFGTILFEMITGRISYSIENGS-LENWASEYLKGEQ--PLKD 648 (721)
Q Consensus 585 ~------------~~~~~~~apE~~~~-~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~-~~~~~~~~~~~~~--~~~~ 648 (721)
. .++..|+|||.+.. ..++.++|||||||++|||+||+.||...+.. ........+.... ....
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (336)
T cd07849 157 DPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNC 236 (336)
T ss_pred cccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHH
Confidence 2 12345899998644 56899999999999999999999999643211 0111111111000 0000
Q ss_pred ccCC-------------cc--ccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHHhhhc
Q 004979 649 IVDP-------------TL--KSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAK--LKEITAM 696 (721)
Q Consensus 649 ~~d~-------------~l--~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~--L~~i~~~ 696 (721)
+.+. .. ....+....++.+++.+||+.+|++||++.|+++. ++.....
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~ 301 (336)
T cd07849 237 IISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDP 301 (336)
T ss_pred hhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCC
Confidence 0000 00 00112235678999999999999999999999886 6655543
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=290.45 Aligned_cols=238 Identities=22% Similarity=0.313 Sum_probs=189.5
Q ss_pred hhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
++++.+|.|+||.||++.. .++..+++|.+..... ...+.+.+|+.++++++||||+++++++...+ ..++|
T Consensus 22 ~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-----~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~--~~~lv 94 (293)
T cd06647 22 TRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ-----PKKELIINEILVMRENKHPNIVNYLDSYLVGD--ELWVV 94 (293)
T ss_pred eeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccc-----hHHHHHHHHHHHHhhcCCCCeeehhheeeeCC--cEEEE
Confidence 5678899999999999985 4678899998753321 12356889999999999999999999998776 67999
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC---
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT--- 585 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~--- 585 (721)
+||+++|+|.+++.. ..+++..+..++.|++.|+.|||+.+ ++||||||+||+++.++.+||+|||++....
T Consensus 95 ~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~g--i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~ 169 (293)
T cd06647 95 MEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (293)
T ss_pred EecCCCCcHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCC--EeeccCCHHHEEEcCCCCEEEccCcceecccccc
Confidence 999999999999853 35789999999999999999999988 9999999999999999999999999864322
Q ss_pred ------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccH
Q 004979 586 ------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQE 659 (721)
Q Consensus 586 ------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 659 (721)
.+...|++||.+....++.++|||||||++||+++|+.||...... ..+........+ .. ....
T Consensus 170 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~--~~~~~~~~~~~~-------~~-~~~~ 239 (293)
T cd06647 170 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL--RALYLIATNGTP-------EL-QNPE 239 (293)
T ss_pred cccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChh--hheeehhcCCCC-------CC-CCcc
Confidence 1334589999998888999999999999999999999999643321 111111111000 00 1122
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004979 660 NVLEELLVVIKNCVHPDPKQRPSMRGIAAK 689 (721)
Q Consensus 660 ~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 689 (721)
.....+.+++.+||+.+|++||++.+++..
T Consensus 240 ~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 240 KLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 345678899999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=293.23 Aligned_cols=254 Identities=17% Similarity=0.241 Sum_probs=185.8
Q ss_pred hhhCcCCCCceeEEEEEEec---CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLS---SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRM 506 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~---~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~ 506 (721)
++++.+|+|+||.||+|+.. ++..+|+|.+...... .....+.+.+|++++++++||||+++++++.+.+....+
T Consensus 3 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 3 EIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQ--YTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred eEEEEeccCCcEEEEEEEecCCCCCCeEEEEEecccccc--ccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 46678999999999999965 4789999988753211 112235678899999999999999999999887434789
Q ss_pred EEEecCCCCChhhhhhhcc---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCC----CCcEEEeccC
Q 004979 507 MVFEYSPNGSLFEHLHIQE---AEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTE----DYAAKISDFS 579 (721)
Q Consensus 507 lV~Ey~~~GsL~~~l~~~~---~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~----~~~~kL~DFG 579 (721)
+||||+++ +|.+++.... ...++......|+.|++.||+|||+.+ |+||||||+||+++. ++.+||+|||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW--VLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 99999975 6777664321 236888899999999999999999988 999999999999999 9999999999
Q ss_pred CCCCCCC------------CCccccchhhccc-CCCCCCccHHHHHHHHHHHHhCCCcccCCCCCH-------HHHHHHH
Q 004979 580 FWNNTTA------------AKTGSAAMELLET-SAVDLESNVYSFGTILFEMITGRISYSIENGSL-------ENWASEY 639 (721)
Q Consensus 580 la~~~~~------------~~~~~~apE~~~~-~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~-------~~~~~~~ 639 (721)
+++.... ++..|+|||.+.+ ..++.++|||||||++|||++|+.||....... ..-....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERI 237 (316)
T ss_pred cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHH
Confidence 8764321 2345899998765 457899999999999999999999997443221 0000000
Q ss_pred hhc---C-----------CCCcc--------ccC-Ccccc-ccH--HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 640 LKG---E-----------QPLKD--------IVD-PTLKS-FQE--NVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 640 ~~~---~-----------~~~~~--------~~d-~~l~~-~~~--~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
+.. . ..... ... ..+.. ... ....++.+++.+||+.||++|||+.|++.
T Consensus 238 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 238 FEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000 0 00000 000 00000 000 23457899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=288.86 Aligned_cols=248 Identities=20% Similarity=0.275 Sum_probs=188.2
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
++++.+|.|++|.||+|+.. ++..+++|++...... .....+.+|++++++++|+||+++++++.+.+ ..++|
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~~lv 76 (284)
T cd07836 3 KQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE----GTPSTAIREISLMKELKHENIVRLHDVIHTEN--KLMLV 76 (284)
T ss_pred eEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc----cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCC--cEEEE
Confidence 45678899999999999975 6788999988654321 12346778999999999999999999998876 67999
Q ss_pred EecCCCCChhhhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC--
Q 004979 509 FEYSPNGSLFEHLHIQE-AEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT-- 585 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~-~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~-- 585 (721)
|||+++ +|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++...
T Consensus 77 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~ 153 (284)
T cd07836 77 FEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR--VLHRDLKPQNLLINKRGELKLADFGLARAFGIP 153 (284)
T ss_pred EecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEECCCCcEEEeecchhhhhcCC
Confidence 999984 8888875432 246899999999999999999999988 9999999999999999999999999875321
Q ss_pred -------CCCccccchhhccc-CCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcC-CC-----------
Q 004979 586 -------AAKTGSAAMELLET-SAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGE-QP----------- 645 (721)
Q Consensus 586 -------~~~~~~~apE~~~~-~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~-~~----------- 645 (721)
.++..|++||.+.+ ..++.++|||||||++|||++|+.||..... .+......... .+
T Consensus 154 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07836 154 VNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNN--EDQLLKIFRIMGTPTESTWPGISQL 231 (284)
T ss_pred ccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCc--HHHHHHHHHHhCCCChhhHHHHhcC
Confidence 12346899998755 4578999999999999999999999964331 22111111100 00
Q ss_pred --Cc----cccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 646 --LK----DIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 646 --~~----~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
.. ...+.......+..+.++.+++.+||+.||.+||++.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 232 PEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred chhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00 00000001112234567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=289.34 Aligned_cols=251 Identities=18% Similarity=0.234 Sum_probs=186.2
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCC-CCccceEeEEEecCCC---ce
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVN-HKNFVNLIGYCEEDEP---FT 504 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~---~~ 504 (721)
++...+|+|+||.||+|+.. ++..|++|+....... ......+.+|++++++++ |+||+++++++...+. ..
T Consensus 4 ~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~---~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 4 EKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDE---EGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred eEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccc---cCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 55678899999999999965 6788999987643221 112356888999999995 6999999998876542 12
Q ss_pred EEEEEecCCCCChhhhhhhcc---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCC-CCcEEEeccCC
Q 004979 505 RMMVFEYSPNGSLFEHLHIQE---AEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTE-DYAAKISDFSF 580 (721)
Q Consensus 505 ~~lV~Ey~~~GsL~~~l~~~~---~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~-~~~~kL~DFGl 580 (721)
.++||||+++ +|.+++.... ...+++..+..++.||+.||+|||+.+ |+||||||+||+++. ++.+||+|||+
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~~~nil~~~~~~~~kl~dfg~ 157 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG--VMHRDLKPQNLLVDKQKGLLKIADLGL 157 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEEecCCCeEEEeeccc
Confidence 6899999985 8988876432 246899999999999999999999988 999999999999998 89999999998
Q ss_pred CCCCC---------CCCccccchhhccc-CCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCC-CCccc
Q 004979 581 WNNTT---------AAKTGSAAMELLET-SAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQ-PLKDI 649 (721)
Q Consensus 581 a~~~~---------~~~~~~~apE~~~~-~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~-~~~~~ 649 (721)
++... .....|+|||.+.+ ..++.++|||||||++|||+||+.||.... .. +....+..... +....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~-~~-~~~~~~~~~~~~~~~~~ 235 (295)
T cd07837 158 GRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDS-EL-QQLLHIFKLLGTPTEQV 235 (295)
T ss_pred ceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC-HH-HHHHHHHHHhCCCChhh
Confidence 76322 12345899998754 557899999999999999999999996432 12 22222211100 00000
Q ss_pred c----------------CCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 650 V----------------DPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 650 ~----------------d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
. ...+....+....++.++|.+||+.+|++||++.|++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 236 WPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred CcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0 00001111235677899999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-33 Score=312.56 Aligned_cols=255 Identities=15% Similarity=0.211 Sum_probs=178.2
Q ss_pred hhhhCcCCCCceeEEEEEEecCC--cEEEEEEeee------------ccccchhhHHHHHHHHHHHHHhcCCCCccceEe
Q 004979 429 SNIIGSFSDGTVGTVYKGTLSSG--VEIAVTSTSV------------KSRADWSKNLESQFRKKIDTLSKVNHKNFVNLI 494 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~~~--~~vavk~~~~------------~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~ 494 (721)
|++++.||+|+||+||+|..+.. ...++|.+.. .............+.+|+++|++++|||||+++
T Consensus 150 Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~ 229 (501)
T PHA03210 150 FRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILKIE 229 (501)
T ss_pred cEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCcEe
Confidence 47889999999999999875422 1111110000 000011122345788999999999999999999
Q ss_pred EEEecCCCceEEEEEecCCCCChhhhhhhcc---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCC
Q 004979 495 GYCEEDEPFTRMMVFEYSPNGSLFEHLHIQE---AEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDY 571 (721)
Q Consensus 495 g~~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~---~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~ 571 (721)
+++...+ ..++|+|++. ++|.+++.... ...........|+.||+.||+|||+++ ||||||||+|||++.++
T Consensus 230 ~~~~~~~--~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g--IiHrDLKP~NILl~~~~ 304 (501)
T PHA03210 230 EILRSEA--NTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK--LIHRDIKLENIFLNCDG 304 (501)
T ss_pred EEEEECC--eeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCC
Confidence 9998877 6799999984 57777764321 122345567789999999999999988 99999999999999999
Q ss_pred cEEEeccCCCCCC----------CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCc-ccCCCCCHHHHHHHHh
Q 004979 572 AAKISDFSFWNNT----------TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRIS-YSIENGSLENWASEYL 640 (721)
Q Consensus 572 ~~kL~DFGla~~~----------~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P-~~~~~~~~~~~~~~~~ 640 (721)
.+||+|||+++.. ..++..|+|||.+.+..++.++|||||||++|||++|+.+ +..........+....
T Consensus 305 ~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~ 384 (501)
T PHA03210 305 KIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKII 384 (501)
T ss_pred CEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHH
Confidence 9999999998532 1245678999999999999999999999999999998754 4333323222222222
Q ss_pred hcCCCC-ccccCC-----------cc----cccc-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 641 KGEQPL-KDIVDP-----------TL----KSFQ-----ENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 641 ~~~~~~-~~~~d~-----------~l----~~~~-----~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
...... .+..+. .. ...+ .....++.+++.+|++.||++|||+.|++.
T Consensus 385 ~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 385 DSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred HhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 111100 000000 00 0000 012345778899999999999999999986
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=290.17 Aligned_cols=245 Identities=12% Similarity=0.136 Sum_probs=176.8
Q ss_pred hhhhCcCCCCceeEEEEEEecCC----cEEEEEEeeeccccchhhH------HHHHHHHHHHHHhcCCCCccceEeEEEe
Q 004979 429 SNIIGSFSDGTVGTVYKGTLSSG----VEIAVTSTSVKSRADWSKN------LESQFRKKIDTLSKVNHKNFVNLIGYCE 498 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~~~----~~vavk~~~~~~~~~~~~~------~~~~f~~Ei~~l~~l~H~nIv~l~g~~~ 498 (721)
+++.+.+|+|+||+||+|...++ ..+++|+..........+. .......+...+..++|+||+++++++.
T Consensus 14 y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~ 93 (294)
T PHA02882 14 WKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGCGS 93 (294)
T ss_pred eEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEeee
Confidence 46778899999999999996543 3455554332221110000 0112334455667789999999999765
Q ss_pred cCCC--ceEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEe
Q 004979 499 EDEP--FTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKIS 576 (721)
Q Consensus 499 ~~~~--~~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~ 576 (721)
.... +..++++|++. .++.+.+.. ....++.....|+.|++.||+|||+.+ |+||||||+|||++.++.+||+
T Consensus 94 ~~~~~~~~~~~~~~~~~-~~~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiHrDiKp~Nill~~~~~~~l~ 168 (294)
T PHA02882 94 FKRCRMYYRFILLEKLV-ENTKEIFKR--IKCKNKKLIKNIMKDMLTTLEYIHEHG--ISHGDIKPENIMVDGNNRGYII 168 (294)
T ss_pred EecCCceEEEEEEehhc-cCHHHHHHh--hccCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCcEEEE
Confidence 4332 24578888874 366666542 233578888999999999999999988 9999999999999999999999
Q ss_pred ccCCCCCC----------------CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHH-------
Q 004979 577 DFSFWNNT----------------TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLE------- 633 (721)
Q Consensus 577 DFGla~~~----------------~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~------- 633 (721)
|||+++.. ..++..|+|||...+..++.++|||||||++|||+||+.||........
T Consensus 169 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~ 248 (294)
T PHA02882 169 DYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKC 248 (294)
T ss_pred EcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHH
Confidence 99997532 1245678999999999999999999999999999999999975432211
Q ss_pred HHHHHHhhcCCCCccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 004979 634 NWASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKL 690 (721)
Q Consensus 634 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L 690 (721)
++......+ .. ....++.++.+++..||..+|++||++.++.+.|
T Consensus 249 ~~~~~~~~~----------~~--~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 249 DFIKRLHEG----------KI--KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHHHHhhhh----------hh--ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 111111111 00 0123457799999999999999999999998865
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=292.06 Aligned_cols=262 Identities=21% Similarity=0.286 Sum_probs=209.2
Q ss_pred hhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
..-..+|+|+||.||-++. .+|+.+|.|++.++.... ...+...+.|-++|.+++.+.||.+--.|...+ ..|+|
T Consensus 188 ~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKk--r~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd--~LClV 263 (591)
T KOG0986|consen 188 RVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKK--RKGETMALNEKQILEKVSSPFIVSLAYAFETKD--ALCLV 263 (591)
T ss_pred eeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHH--hhhhHHhhHHHHHHHHhccCcEEEEeeeecCCC--ceEEE
Confidence 3445677899999999985 478889998887654433 233456788999999999999999988888777 78999
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC----
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT---- 584 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~---- 584 (721)
+..|.||+|.-+|.......+++..++.+|.+|+.||++||... ||.|||||+|||||+.|+++|+|.|+|...
T Consensus 264 LtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~--iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~ 341 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR--IVYRDLKPENILLDDHGHVRISDLGLAVEIPEGK 341 (591)
T ss_pred EEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc--eeeccCChhheeeccCCCeEeeccceEEecCCCC
Confidence 99999999988876556678999999999999999999999988 999999999999999999999999998543
Q ss_pred ----CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHH-HHHHHHhhcCCCCccccCCccccccH
Q 004979 585 ----TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLE-NWASEYLKGEQPLKDIVDPTLKSFQE 659 (721)
Q Consensus 585 ----~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~-~~~~~~~~~~~~~~~~~d~~l~~~~~ 659 (721)
..++.+|||||++....|+...|.||+||++|||+.|+.||........ +-+.+.... .-..+++
T Consensus 342 ~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~----------~~~ey~~ 411 (591)
T KOG0986|consen 342 PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLE----------DPEEYSD 411 (591)
T ss_pred ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhc----------chhhccc
Confidence 2467799999999999999999999999999999999999963322111 111111111 1123456
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCChhHHHHHHh
Q 004979 660 NVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAMEPDGATPKLSPLWWAELEI 715 (721)
Q Consensus 660 ~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~~~~p~~~~~~~~~l~~ 715 (721)
..++++.+|....|++||++|...+.- ....-.++|++-.++|..|+.
T Consensus 412 kFS~eakslc~~LL~Kdp~~RLGcrg~--------ga~evk~HpfFk~lnw~rlea 459 (591)
T KOG0986|consen 412 KFSEEAKSLCEGLLTKDPEKRLGCRGE--------GAQEVKEHPFFKDLNWRRLEA 459 (591)
T ss_pred ccCHHHHHHHHHHHccCHHHhccCCCc--------CcchhhhCcccccCCHhHHhc
Confidence 778899999999999999999876532 223334588888899988863
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=295.63 Aligned_cols=262 Identities=16% Similarity=0.191 Sum_probs=193.7
Q ss_pred hhhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCC---ce
Q 004979 429 SNIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEP---FT 504 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~---~~ 504 (721)
+.+++.+|+|+||+||+|+. .++..|++|.+...... ......+.+|+.++++++|+||+++++++..... ..
T Consensus 7 y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 7 YVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDN---RIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred eeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccc---cchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 46677899999999999985 46889999987643211 1223567789999999999999999998864321 24
Q ss_pred EEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC
Q 004979 505 RMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT 584 (721)
Q Consensus 505 ~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~ 584 (721)
.++||||+. ++|.+++.. ...+++.....++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++..
T Consensus 84 ~~lv~e~~~-~~L~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 158 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRS--SQTLSDDHCQYFLYQLLRGLKYIHSAN--VLHRDLKPSNLLLNANCDLKICDFGLARTT 158 (337)
T ss_pred EEEEEeCCC-CCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCEEECcCcccccc
Confidence 799999995 789888753 356899999999999999999999988 999999999999999999999999987643
Q ss_pred CC---------CCccccchhhccc-CCCCCCccHHHHHHHHHHHHhCCCcccCCCCCH-HHHHHHHhhcCC--C------
Q 004979 585 TA---------AKTGSAAMELLET-SAVDLESNVYSFGTILFEMITGRISYSIENGSL-ENWASEYLKGEQ--P------ 645 (721)
Q Consensus 585 ~~---------~~~~~~apE~~~~-~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~-~~~~~~~~~~~~--~------ 645 (721)
.. ++..|+|||.+.. ..++.++|||||||++|||++|+.||...+... ............ .
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (337)
T cd07858 159 SEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRN 238 (337)
T ss_pred CCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCc
Confidence 22 2346899998754 568999999999999999999999996432110 000111000000 0
Q ss_pred ---------CccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHHhhhcCC
Q 004979 646 ---------LKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAK--LKEITAMEP 698 (721)
Q Consensus 646 ---------~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~--L~~i~~~~~ 698 (721)
.....++......+.++.++.+++.+||+.+|++||+++|+++. ++.+.....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~~ 302 (337)
T cd07858 239 EKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSD 302 (337)
T ss_pred hhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCccc
Confidence 00000111111123456788999999999999999999999986 666655443
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=287.67 Aligned_cols=248 Identities=23% Similarity=0.343 Sum_probs=187.2
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCC-CCccceEeEEEecCCCceEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVN-HKNFVNLIGYCEEDEPFTRMM 507 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~~~l 507 (721)
++.+.+|.|+||+||+|+.. +++.+++|++...... .......+|+..+++++ |+||+++++++.+.+ ..++
T Consensus 2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~--~~~l 75 (283)
T cd07830 2 KVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS----WEECMNLREVKSLRKLNEHPNIVKLKEVFREND--ELYF 75 (283)
T ss_pred eeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc----hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCC--cEEE
Confidence 35678899999999999975 4778899887543221 12234567999999999 999999999998866 6799
Q ss_pred EEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCCC-
Q 004979 508 VFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTA- 586 (721)
Q Consensus 508 V~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~~- 586 (721)
||||+ +|+|.+++.......+++..+..++.|++.+|.|||+++ ++|+||||+||++++++.+||+|||+++....
T Consensus 76 v~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~ 152 (283)
T cd07830 76 VFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG--FFHRDLKPENLLVSGPEVVKIADFGLAREIRSR 152 (283)
T ss_pred EEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEcCCCCEEEeecccceeccCC
Confidence 99999 889999987554457899999999999999999999988 99999999999999999999999998764332
Q ss_pred -------CCccccchhhcc-cCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhh--cCC------------
Q 004979 587 -------AKTGSAAMELLE-TSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLK--GEQ------------ 644 (721)
Q Consensus 587 -------~~~~~~apE~~~-~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~--~~~------------ 644 (721)
+...|+|||.+. ...++.++||||||+++|||+||+.||...... +.+..... +..
T Consensus 153 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd07830 153 PPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEI--DQLYKICSVLGTPTKQDWPEGYKLA 230 (283)
T ss_pred CCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChH--HHHHHHHHhcCCCChhhhhhHhhhh
Confidence 234688999874 456789999999999999999999998643321 11111100 000
Q ss_pred -CCc----cccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 645 -PLK----DIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 645 -~~~----~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
... ......+....+....++.+++.+||+.+|++||+++|++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 231 SKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred ccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 000 00000011111122467899999999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-32 Score=292.35 Aligned_cols=255 Identities=20% Similarity=0.274 Sum_probs=189.6
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcC-CCCccceEeEEEecCCCceEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKV-NHKNFVNLIGYCEEDEPFTRMM 507 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~~~l 507 (721)
++.+.+|.|+||.||+|... ++..+++|++...... ......+.+|+.+++++ +|+||+++++++...+....++
T Consensus 10 ~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~---~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~l 86 (337)
T cd07852 10 EILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRN---ATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYL 86 (337)
T ss_pred HHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCc---chhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEE
Confidence 66778899999999999965 5788999987532211 12234677899999999 9999999999987654446799
Q ss_pred EEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCCC-
Q 004979 508 VFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTA- 586 (721)
Q Consensus 508 V~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~~- 586 (721)
||||++ ++|..++.. ..++|..+..++.||+.||+|||+.+ |+||||||+||++++++.+||+|||+++....
T Consensus 87 v~e~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~--i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~ 160 (337)
T cd07852 87 VFEYME-TDLHAVIRA---NILEDVHKRYIMYQLLKALKYIHSGN--VIHRDLKPSNILLNSDCRVKLADFGLARSLSEL 160 (337)
T ss_pred Eecccc-cCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCcEEEeeccchhccccc
Confidence 999997 599888753 26889999999999999999999988 99999999999999999999999998753321
Q ss_pred -------------CCccccchhhccc-CCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCC-------
Q 004979 587 -------------AKTGSAAMELLET-SAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQP------- 645 (721)
Q Consensus 587 -------------~~~~~~apE~~~~-~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~------- 645 (721)
++..|++||.+.. ..++.++|||||||++|||+||+.||..... .+...........
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~ 238 (337)
T cd07852 161 EENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTST--LNQLEKIIEVIGPPSAEDIE 238 (337)
T ss_pred cccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHHhCCCCHHHHH
Confidence 2335899998754 5678999999999999999999999964321 1111111111000
Q ss_pred ----------CccccC---CccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHHhhh
Q 004979 646 ----------LKDIVD---PTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAK--LKEITA 695 (721)
Q Consensus 646 ----------~~~~~d---~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~--L~~i~~ 695 (721)
+..+.+ ..........+.++.+++.+||+.+|++||++.++++. ++.+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~ 303 (337)
T cd07852 239 SIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHN 303 (337)
T ss_pred HHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhcc
Confidence 000000 00011112246788999999999999999999999975 555433
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=286.62 Aligned_cols=250 Identities=21% Similarity=0.253 Sum_probs=188.5
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
++++.+|.|+||.||+|+.. ++..+++|++..... .......+.+|++++++++|+||+++++++........++|
T Consensus 2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 78 (287)
T cd07840 2 EKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENE---KEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMV 78 (287)
T ss_pred eeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccc---cccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEE
Confidence 45678899999999999965 578899998875431 12233568899999999999999999999987622267999
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCCC--
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTA-- 586 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~~-- 586 (721)
|||+++ +|.+++... ...+++..+..++.|+++||+|||+.+ ++|+||||+||++++++.+||+|||++.....
T Consensus 79 ~e~~~~-~l~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~~--~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 79 FEYMDH-DLTGLLDSP-EVKFTESQIKCYMKQLLEGLQYLHSNG--ILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred eccccc-cHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 999974 898887532 256899999999999999999999988 99999999999999999999999998754322
Q ss_pred --------CCccccchhhccc-CCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCC-----cccc--
Q 004979 587 --------AKTGSAAMELLET-SAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPL-----KDIV-- 650 (721)
Q Consensus 587 --------~~~~~~apE~~~~-~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~-----~~~~-- 650 (721)
....|++||.+.+ ..++.++||||||+++|||+||+.||..... .............. ....
T Consensus 155 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07840 155 SADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTE--LEQLEKIFELCGSPTDENWPGVSKL 232 (287)
T ss_pred cccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHHhCCCchhhccccccc
Confidence 1345899997654 4678999999999999999999999964432 22222221110000 0000
Q ss_pred ------------CCccccccHH-HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 651 ------------DPTLKSFQEN-VLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 651 ------------d~~l~~~~~~-~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
...+...... ++.++.+++.+||..+|++||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 233 PWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0000001111 2668899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-32 Score=286.80 Aligned_cols=242 Identities=20% Similarity=0.274 Sum_probs=188.9
Q ss_pred hhhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEE
Q 004979 429 SNIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMM 507 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~l 507 (721)
+..++.+|+|+||+||+|+.. ++..+++|++...... .......+.+|++++++++||||+++++++.+.+ ..++
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~l 98 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQ--TNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEH--TAWL 98 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccC--chHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCC--EEEE
Confidence 345577899999999999864 6788999887643322 1233457889999999999999999999998876 6799
Q ss_pred EEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC--
Q 004979 508 VFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT-- 585 (721)
Q Consensus 508 V~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~-- 585 (721)
||||+. |++.+++.. ....+++..+..++.|++.|++|||+.+ |+||||||+||++++++.+||+|||++....
T Consensus 99 v~e~~~-~~l~~~l~~-~~~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~ 174 (313)
T cd06633 99 VMEYCL-GSASDLLEV-HKKPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLTEPGQVKLADFGSASKSSPA 174 (313)
T ss_pred EEecCC-CCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChhhEEECCCCCEEEeecCCCcccCCC
Confidence 999995 678777753 3456899999999999999999999988 9999999999999999999999999875432
Q ss_pred ---CCCccccchhhcc---cCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccH
Q 004979 586 ---AAKTGSAAMELLE---TSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQE 659 (721)
Q Consensus 586 ---~~~~~~~apE~~~---~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 659 (721)
.+...|++||.+. ...++.++|||||||++|||++|+.||...+ .............+ ... ..
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~--~~~~~~~~~~~~~~--~~~-------~~ 243 (313)
T cd06633 175 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN--AMSALYHIAQNDSP--TLQ-------SN 243 (313)
T ss_pred CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHhcCCC--CCC-------cc
Confidence 2345689999874 4668899999999999999999999986432 22222222222111 111 12
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004979 660 NVLEELLVVIKNCVHPDPKQRPSMRGIAAK 689 (721)
Q Consensus 660 ~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 689 (721)
.....+.+++.+||+.+|.+||++.|++..
T Consensus 244 ~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 244 EWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 234568899999999999999999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=270.69 Aligned_cols=241 Identities=20% Similarity=0.330 Sum_probs=187.1
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCC-CCccceEeEEEecCCCceEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVN-HKNFVNLIGYCEEDEPFTRMM 507 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~~~l 507 (721)
+.++.+|.|+.|.|++++++ +|..+|||.+..... +...++++..+.++.+-+ .|.||+.+|||..+. ..++
T Consensus 95 ~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~N----kee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~--dV~I 168 (391)
T KOG0983|consen 95 ENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGN----KEENKRILMDLDVVLKSHDCPYIVQCFGYFITNT--DVFI 168 (391)
T ss_pred hhHHhhcCCCccceEEEEEcccceEEEEEeecccCC----HHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCc--hHHH
Confidence 45788999999999999965 578899998764432 344577888888877764 899999999998765 4578
Q ss_pred EEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCC----
Q 004979 508 VFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNN---- 583 (721)
Q Consensus 508 V~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~---- 583 (721)
.||.|. -.+..+++ +-.+++++...-++...+..||.||.++. .|+|||+||+|||+|+.|++|+||||++..
T Consensus 169 cMelMs-~C~ekLlk-rik~piPE~ilGk~tva~v~AL~YLKeKH-~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS 245 (391)
T KOG0983|consen 169 CMELMS-TCAEKLLK-RIKGPIPERILGKMTVAIVKALYYLKEKH-GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS 245 (391)
T ss_pred HHHHHH-HHHHHHHH-HhcCCchHHhhhhhHHHHHHHHHHHHHhc-ceeecccCccceEEccCCCEEeecccccceeecc
Confidence 899983 35555554 33456888877889999999999996532 399999999999999999999999998643
Q ss_pred ----CCCCCccccchhhcc---cCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCcccc
Q 004979 584 ----TTAAKTGSAAMELLE---TSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKS 656 (721)
Q Consensus 584 ----~~~~~~~~~apE~~~---~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 656 (721)
..++...|||||.+. ...|+.++|||||||+|+||+||+.||..-+.+..- +..++..+.+ .+++
T Consensus 246 kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~-ltkvln~ePP---~L~~---- 317 (391)
T KOG0983|consen 246 KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEV-LTKVLNEEPP---LLPG---- 317 (391)
T ss_pred cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHH-HHHHHhcCCC---CCCc----
Confidence 334566899999984 457999999999999999999999999765544332 3334433322 1111
Q ss_pred ccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 657 FQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 657 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
....+..+.+++..||++|+.+||...++++
T Consensus 318 -~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 318 -HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred -ccCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 1226678999999999999999999998876
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-32 Score=278.69 Aligned_cols=241 Identities=22% Similarity=0.287 Sum_probs=193.2
Q ss_pred hhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEEE
Q 004979 431 IIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVF 509 (721)
Q Consensus 431 ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV~ 509 (721)
+...+|+|++|.||+|... ++..+++|+....... ....+.+.+|++++++++|+||+++++++........++|+
T Consensus 4 ~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 4 RGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS---EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred eeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc---hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 3456789999999999976 6888999987654321 23457899999999999999999999999876222679999
Q ss_pred ecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC----
Q 004979 510 EYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT---- 585 (721)
Q Consensus 510 Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~---- 585 (721)
||+++++|.+++... ..+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||.+....
T Consensus 81 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~--~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 156 (260)
T cd06606 81 EYVSGGSLSSLLKKF--GKLPEPVIRKYTRQILEGLAYLHSNG--IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET 156 (260)
T ss_pred EecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEcCCCCEEEcccccEEecccccc
Confidence 999999999998643 37999999999999999999999987 9999999999999999999999999764322
Q ss_pred -------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCcccccc
Q 004979 586 -------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQ 658 (721)
Q Consensus 586 -------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 658 (721)
.+...|.+||......++.++||||||+++|||++|+.||.... +........... ......+
T Consensus 157 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-~~~~~~~~~~~~---------~~~~~~~ 226 (260)
T cd06606 157 GEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG-NPMAALYKIGSS---------GEPPEIP 226 (260)
T ss_pred cccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-chHHHHHhcccc---------CCCcCCC
Confidence 23346789999988889999999999999999999999997544 222222111110 0111223
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 659 ENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 659 ~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
...+.++.+++.+|++.+|++||++.|++.
T Consensus 227 ~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 227 EHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred cccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 344678999999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=297.73 Aligned_cols=241 Identities=22% Similarity=0.357 Sum_probs=195.6
Q ss_pred hhhhhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceE
Q 004979 427 DFSNIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTR 505 (721)
Q Consensus 427 ~~~~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~ 505 (721)
.++.+++.||+|.|++|..|++ .++..||+|.+.+.... ......+.+|+++|..++|||||+++++..... ..
T Consensus 56 g~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln---~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~--~l 130 (596)
T KOG0586|consen 56 GLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLN---PSKRQKLGREVDIMKSLNHPNIVKLFSVIETEA--TL 130 (596)
T ss_pred cceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccC---hHHHHHHHHHHHHHHhcCCcceeeeeeeeeecc--ee
Confidence 3457889999999999999985 47899999988754432 223345899999999999999999999998877 78
Q ss_pred EEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCC--
Q 004979 506 MMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNN-- 583 (721)
Q Consensus 506 ~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~-- 583 (721)
|+||||+.+|.+++++... ..........++.|+..|++|||++. |||||||++||||+.++++||+|||++..
T Consensus 131 ylV~eya~~ge~~~yl~~~--gr~~e~~ar~~F~q~vsaveYcH~k~--ivHrdLk~eNilL~~~mnikIaDfgfS~~~~ 206 (596)
T KOG0586|consen 131 YLVMEYASGGELFDYLVKH--GRMKEKEARAKFRQIVSAVEYCHSKN--IVHRDLKAENILLDENMNIKIADFGFSTFFD 206 (596)
T ss_pred EEEEEeccCchhHHHHHhc--ccchhhhhhhhhHHHHHHHHHHhhcc--eeccccchhhcccccccceeeeccccceeec
Confidence 9999999999999999743 33455778889999999999999998 99999999999999999999999998753
Q ss_pred ------CCCCCccccchhhcccCCCC-CCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCcccc
Q 004979 584 ------TTAAKTGSAAMELLETSAVD-LESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKS 656 (721)
Q Consensus 584 ------~~~~~~~~~apE~~~~~~~s-~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 656 (721)
...+...|+|||+..+..|+ +++|+||+||++|-|+.|..||++.. +.+.-.+++.+...
T Consensus 207 ~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~--lk~Lr~rvl~gk~r----------- 273 (596)
T KOG0586|consen 207 YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQN--LKELRPRVLRGKYR----------- 273 (596)
T ss_pred ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcc--cccccchheeeeec-----------
Confidence 34466789999999888875 89999999999999999999996432 22222222222111
Q ss_pred ccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004979 657 FQENVLEELLVVIKNCVHPDPKQRPSMRGIAAK 689 (721)
Q Consensus 657 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 689 (721)
.+.-...+..+++++++..+|.+|++++++.+.
T Consensus 274 Ip~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 274 IPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred ccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 122234567889999999999999999999764
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=296.03 Aligned_cols=251 Identities=18% Similarity=0.224 Sum_probs=187.7
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCC--CceEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDE--PFTRM 506 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~--~~~~~ 506 (721)
++...+|+|+||.||+|+.. ++..|++|++...... ....+.+.+|+.++++++||||+++++++.... ....+
T Consensus 8 ~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 8 KPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDV---PTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred eeeeeeecCCCeEEEEEEEcCCCCEEEEEEecccccc---ccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 56678899999999999854 6889999988643211 123456788999999999999999999876432 22579
Q ss_pred EEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC-
Q 004979 507 MVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT- 585 (721)
Q Consensus 507 lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~- 585 (721)
+||||+. |+|.+++.. ...+++.....++.||+.||+|||+.+ |+||||||+||++++++.+||+|||+++...
T Consensus 85 lv~e~~~-~~l~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 159 (334)
T cd07855 85 VVMDLME-SDLHHIIHS--DQPLTEEHIRYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLVNEDCELRIGDFGMARGLSS 159 (334)
T ss_pred EEEehhh-hhHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCcEEecccccceeecc
Confidence 9999995 689888853 345899999999999999999999988 9999999999999999999999999875321
Q ss_pred ------------CCCccccchhhccc-CCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccC-
Q 004979 586 ------------AAKTGSAAMELLET-SAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVD- 651 (721)
Q Consensus 586 ------------~~~~~~~apE~~~~-~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d- 651 (721)
.+...|++||.+.. ..++.++|||||||++|||++|+.||...+....-.......+.. .....+
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~-~~~~~~~ 238 (334)
T cd07855 160 SPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSP-SEEVLNR 238 (334)
T ss_pred cCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCC-hhHhhhh
Confidence 23346789998754 568999999999999999999999996443211100000001100 000000
Q ss_pred ------------------CccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004979 652 ------------------PTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAK 689 (721)
Q Consensus 652 ------------------~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 689 (721)
..........+.++.+++.+||+.+|++||++.|++..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 239 IGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 00011112346789999999999999999999998874
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-32 Score=286.05 Aligned_cols=241 Identities=20% Similarity=0.257 Sum_probs=187.9
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
..++.+|+|+||.||+|+.. ++..+++|.+...... .....+++.+|++++++++|+|++++++++.... ..++|
T Consensus 18 ~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv 93 (308)
T cd06634 18 SDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQ--SNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH--TAWLV 93 (308)
T ss_pred HHHHheeeCCCEEEEEEEEcCCCcEEEEEEEeccccc--ChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCC--eeEEE
Confidence 45677899999999999964 5778889887542211 1233457889999999999999999999998766 67999
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC---
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT--- 585 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~--- 585 (721)
|||+. |++.+++.. ....+++..+..++.|++.|+.|||+.+ ++||||||+||+++.++.+||+|||++....
T Consensus 94 ~e~~~-~~l~~~~~~-~~~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 169 (308)
T cd06634 94 MEYCL-GSASDLLEV-HKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN 169 (308)
T ss_pred EEccC-CCHHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHhEEECCCCcEEECCcccceeecCcc
Confidence 99996 688777653 2356899999999999999999999987 9999999999999999999999999876432
Q ss_pred --CCCccccchhhcc---cCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccHH
Q 004979 586 --AAKTGSAAMELLE---TSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQEN 660 (721)
Q Consensus 586 --~~~~~~~apE~~~---~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 660 (721)
.+...|+|||.+. ...++.++|||||||++|||++|+.||.... ..+..........+ .. ....
T Consensus 170 ~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~--~~~~~~~~~~~~~~-------~~--~~~~ 238 (308)
T cd06634 170 XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN--AMSALYHIAQNESP-------AL--QSGH 238 (308)
T ss_pred cccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCcccc--HHHHHHHHhhcCCC-------Cc--Cccc
Confidence 2345789999874 4567899999999999999999999985332 12222222211111 00 1123
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004979 661 VLEELLVVIKNCVHPDPKQRPSMRGIAAK 689 (721)
Q Consensus 661 ~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 689 (721)
....+.+++.+||+.+|++||++.+++..
T Consensus 239 ~~~~~~~li~~cl~~~P~~Rp~~~~ll~~ 267 (308)
T cd06634 239 WSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (308)
T ss_pred ccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence 55678899999999999999999999875
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=285.54 Aligned_cols=248 Identities=19% Similarity=0.307 Sum_probs=190.1
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
++++.+|.|++|.||+|+.. ++..+++|.+...... ......+.+|++++++++|+||+++++++...+ ..++|
T Consensus 2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~~v 76 (283)
T cd05118 2 QKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFES---EGIPKTALREIKLLKELNHPNIIKLLDVFRHKG--DLYLV 76 (283)
T ss_pred ccceeeecCCCceEEEEEcCCCCcEEEEEEecccccc---chhHHHHHHHHHHHHHhcCCCcchHHHhhccCC--CEEEE
Confidence 45678899999999999864 6788999987644322 123467889999999999999999999998776 67999
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCCC--
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTA-- 586 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~~-- 586 (721)
+||+++ +|.+++... ...+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.+||+|||.+.....
T Consensus 77 ~e~~~~-~l~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~ 152 (283)
T cd05118 77 FEFMDT-DLYKLIKDR-QRGLPESLIKSYLYQLLQGLAFCHSHG--ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV 152 (283)
T ss_pred EeccCC-CHHHHHHhh-cccCCHHHHHHHHHHHHHHHHHHHHCC--eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc
Confidence 999975 888887643 357899999999999999999999988 99999999999999999999999998653322
Q ss_pred -------CCccccchhhcccC-CCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhc-CCCCc----------
Q 004979 587 -------AKTGSAAMELLETS-AVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKG-EQPLK---------- 647 (721)
Q Consensus 587 -------~~~~~~apE~~~~~-~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~-~~~~~---------- 647 (721)
+...|++||.+... .++.++||||||+++|||+||+.||...+. ... ....... ..+..
T Consensus 153 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd05118 153 RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSE-IDQ-LFKIFRTLGTPDPEVWPKFTSLA 230 (283)
T ss_pred ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH-HHH-HHHHHHHcCCCchHhcccchhhh
Confidence 23357899998766 789999999999999999999999964331 111 1111110 00000
Q ss_pred --------cccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 648 --------DIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 648 --------~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
...+.......+..+.++.++|.+||+.||.+||++.|++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 231 RNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 00001111122346678999999999999999999999975
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-32 Score=287.04 Aligned_cols=241 Identities=20% Similarity=0.312 Sum_probs=185.2
Q ss_pred hhhCcCCCCceeEEEEEEecC-CcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCC-CCccceEeEEEecCCCceEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLSS-GVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVN-HKNFVNLIGYCEEDEPFTRMM 507 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~~-~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~~~l 507 (721)
++.+.+|+|+||.||+|+... +..++||.+...... ....++.+|+.++.+.+ |+||+++++++.... ..++
T Consensus 18 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~----~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~--~~~~ 91 (296)
T cd06618 18 ENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK----EENKRILMDLDVVLKSHDCPYIVKCYGYFITDS--DVFI 91 (296)
T ss_pred eeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh----HHHHHHHHHHHHHHhccCCCchHhhheeeecCC--eEEE
Confidence 567889999999999999764 888999988643221 22356777887777774 999999999998776 6799
Q ss_pred EEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCCC
Q 004979 508 VFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQ-LTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTA 586 (721)
Q Consensus 508 V~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~-~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~~ 586 (721)
||||++ ++|.+++.. ....+++..+..++.|++.||+|||+ .+ |+||||||+||++++++.+||+|||++.....
T Consensus 92 v~e~~~-~~l~~l~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~~--i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~ 167 (296)
T cd06618 92 CMELMS-TCLDKLLKR-IQGPIPEDILGKMTVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRLVD 167 (296)
T ss_pred EeeccC-cCHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhhCC--EecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence 999985 577776643 23478999999999999999999997 46 99999999999999999999999998754321
Q ss_pred --------CCccccchhhcccCC----CCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCcc
Q 004979 587 --------AKTGSAAMELLETSA----VDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTL 654 (721)
Q Consensus 587 --------~~~~~~apE~~~~~~----~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 654 (721)
+...|+|||.+.... ++.++||||||+++|||++|+.||...... .+..........+. .
T Consensus 168 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~~~~~~~~~~~~~~--~----- 239 (296)
T cd06618 168 SKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-FEVLTKILQEEPPS--L----- 239 (296)
T ss_pred CCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-HHHHHHHhcCCCCC--C-----
Confidence 234689999986554 789999999999999999999999642221 22222322221111 0
Q ss_pred ccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004979 655 KSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAK 689 (721)
Q Consensus 655 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 689 (721)
. ....+..++.+++.+||+.||++||++.++++.
T Consensus 240 ~-~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 240 P-PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred C-CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0 011245678999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-32 Score=293.18 Aligned_cols=249 Identities=19% Similarity=0.295 Sum_probs=187.6
Q ss_pred hhhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCC----c
Q 004979 429 SNIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEP----F 503 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~----~ 503 (721)
+++++.+|+|+||.||+|+. .++..+++|.+..... .......+.+|++++++++|+||+++++++..... .
T Consensus 18 y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 94 (353)
T cd07850 18 YQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQ---NVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ 94 (353)
T ss_pred eEEEEEeccCCCEEEEEEEECCCCCEEEEEecCcccc---ChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence 46778899999999999985 4788999998753221 12233567889999999999999999998864431 2
Q ss_pred eEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCC
Q 004979 504 TRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNN 583 (721)
Q Consensus 504 ~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~ 583 (721)
..++||||+. ++|.+.+.. .+++.....++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 95 ~~~lv~e~~~-~~l~~~~~~----~l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 167 (353)
T cd07850 95 DVYLVMELMD-ANLCQVIQM----DLDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLART 167 (353)
T ss_pred cEEEEEeccC-CCHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCCCCEEEccCcccee
Confidence 4699999995 588887742 2888899999999999999999988 99999999999999999999999999864
Q ss_pred CCC--------CCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhh--------------
Q 004979 584 TTA--------AKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLK-------------- 641 (721)
Q Consensus 584 ~~~--------~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~-------------- 641 (721)
... ++..|+|||.+.+..++.++|||||||++|||++|+.||...+. ...+ ..+..
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~ 245 (353)
T cd07850 168 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDH-IDQW-NKIIEQLGTPSDEFMSRLQ 245 (353)
T ss_pred CCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCH-HHHH-HHHHHhcCCCCHHHHHHhh
Confidence 322 23468999999999999999999999999999999999964321 1111 11110
Q ss_pred --------cCC-----CCccccCCccc-----cccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004979 642 --------GEQ-----PLKDIVDPTLK-----SFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAK 689 (721)
Q Consensus 642 --------~~~-----~~~~~~d~~l~-----~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 689 (721)
... ++.+....... ........++.+++.+||+.||++||++.|++..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 246 PTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred hhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000 00011100000 0011345678899999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-31 Score=275.09 Aligned_cols=239 Identities=22% Similarity=0.357 Sum_probs=191.5
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
.+...+|.|++|.||+++.. ++..+++|+...... ...+.+.+|++++++++|+||+++++++...+ ..+++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~l~ 75 (253)
T cd05122 3 EILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK-----EKKEKIINEIQILKKCKHPNIVKYYGSYLKKD--ELWIV 75 (253)
T ss_pred eeeeeeccCCceEEEEEEECCCCcEEEEEEecccch-----hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC--eEEEE
Confidence 34567889999999999975 678899998764332 23467999999999999999999999998776 67999
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCCC--
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTA-- 586 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~~-- 586 (721)
+||+++++|.+++... ...+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.+||+|||.+.....
T Consensus 76 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~--i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 152 (253)
T cd05122 76 MEFCSGGSLKDLLKST-NQTLTESQIAYVCKELLKGLEYLHSNG--IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTK 152 (253)
T ss_pred EecCCCCcHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHhhcCC--EecCCCCHHHEEEccCCeEEEeeccccccccccc
Confidence 9999999999998643 256899999999999999999999987 99999999999999999999999998754433
Q ss_pred ------CCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccHH
Q 004979 587 ------AKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQEN 660 (721)
Q Consensus 587 ------~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 660 (721)
+...|++||.+....++.++||||||+++|||++|+.||...+. .......... ....... ...
T Consensus 153 ~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~--~~~~~~~------~~~ 222 (253)
T cd05122 153 ARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPP--MKALFKIATN--GPPGLRN------PEK 222 (253)
T ss_pred cccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCch--HHHHHHHHhc--CCCCcCc------ccc
Confidence 23468899999888899999999999999999999999964321 1211111111 1111111 112
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 661 VLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 661 ~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
...++.+++.+||+.||++||++.|+++
T Consensus 223 ~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 223 WSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred cCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 3567899999999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-32 Score=278.39 Aligned_cols=240 Identities=21% Similarity=0.320 Sum_probs=194.3
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
++++.+|+|+||.||+++.. ++..+++|.+...... ......+.+|++++++++|+||+++++++.+.. ..++|
T Consensus 3 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~~v 77 (256)
T cd08530 3 KVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMS---QKEREDAVNEIRILASVNHPNIISYKEAFLDGN--KLCIV 77 (256)
T ss_pred eEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhcc---HHHHHHHHHHHHHHHhCCCCCchhhhhhhccCC--EEEEE
Confidence 46678899999999999854 6788999887643321 233457889999999999999999999988765 67999
Q ss_pred EecCCCCChhhhhhhc--cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC-
Q 004979 509 FEYSPNGSLFEHLHIQ--EAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT- 585 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~--~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~- 585 (721)
|||+++++|.+++... ....+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.+||+|||++....
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~--i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~ 155 (256)
T cd08530 78 MEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK--ILHRDLKSANILLVANDLVKIGDLGISKVLKK 155 (256)
T ss_pred ehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEEecCCcEEEeeccchhhhcc
Confidence 9999999999998642 2356899999999999999999999988 9999999999999999999999999875432
Q ss_pred ------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccH
Q 004979 586 ------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQE 659 (721)
Q Consensus 586 ------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 659 (721)
.+...|++||...+..++.++|+||||+++|||++|+.||...+ ..+.......+. ......
T Consensus 156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~--~~~~~~~~~~~~----------~~~~~~ 223 (256)
T cd08530 156 NMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARS--MQDLRYKVQRGK----------YPPIPP 223 (256)
T ss_pred CCcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHhcCC----------CCCCch
Confidence 23457889999988889999999999999999999999996432 222222222111 112223
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 660 NVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 660 ~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
....++.+++.+||+.+|++||++.|+++
T Consensus 224 ~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 224 IYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred hhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 56678999999999999999999999975
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-32 Score=287.12 Aligned_cols=252 Identities=22% Similarity=0.283 Sum_probs=186.8
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCC-------
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDE------- 501 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~------- 501 (721)
++.+.+|+|+||.||+|+.. ++..+++|++...... ......+.+|++++++++||||+++++++.+..
T Consensus 10 ~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~ 86 (302)
T cd07864 10 DIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK---EGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKK 86 (302)
T ss_pred heeeeecccCCEEEEEEEECCCCcEEEEEEEeecccc---cCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccc
Confidence 66788899999999999975 5788999988654322 122346788999999999999999999987543
Q ss_pred -CceEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCC
Q 004979 502 -PFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSF 580 (721)
Q Consensus 502 -~~~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGl 580 (721)
....++|+||+++ ++...+.. ....+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+
T Consensus 87 ~~~~~~lv~e~~~~-~l~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili~~~~~~kl~dfg~ 162 (302)
T cd07864 87 DKGAFYLVFEYMDH-DLMGLLES-GLVHFSEDHIKSFMKQLLEGLNYCHKKN--FLHRDIKCSNILLNNKGQIKLADFGL 162 (302)
T ss_pred cCCcEEEEEcccCc-cHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCcEEeCcccc
Confidence 1257999999976 77777653 2446899999999999999999999988 99999999999999999999999998
Q ss_pred CCCCCC----------CCccccchhhccc-CCCCCCccHHHHHHHHHHHHhCCCcccCCCCC-HHHHHHHHhhcCCC--C
Q 004979 581 WNNTTA----------AKTGSAAMELLET-SAVDLESNVYSFGTILFEMITGRISYSIENGS-LENWASEYLKGEQP--L 646 (721)
Q Consensus 581 a~~~~~----------~~~~~~apE~~~~-~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~-~~~~~~~~~~~~~~--~ 646 (721)
+..... ....|++||.+.. ..++.++|||||||++|||++|+.||...+.. ..+.+........+ .
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (302)
T cd07864 163 ARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVW 242 (302)
T ss_pred cccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhc
Confidence 764321 1335889998754 45789999999999999999999999643211 11111111111100 0
Q ss_pred ccc--------cCC------ccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 647 KDI--------VDP------TLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 647 ~~~--------~d~------~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
..+ .++ .........+.++.+++.+||+.+|++||++.+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 243 PDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred ccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 000 000 000111224578899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-32 Score=293.03 Aligned_cols=259 Identities=16% Similarity=0.241 Sum_probs=191.6
Q ss_pred hhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCC----ce
Q 004979 430 NIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEP----FT 504 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~----~~ 504 (721)
.++..+|+|+||.||+|+. .++..+++|++...... ......+.+|++++++++|+||+++++++..... ..
T Consensus 18 ~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 94 (342)
T cd07879 18 TSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQS---EIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD 94 (342)
T ss_pred EEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCcccc---ccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence 6678899999999999995 46889999987643211 2223568899999999999999999999875431 24
Q ss_pred EEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC
Q 004979 505 RMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT 584 (721)
Q Consensus 505 ~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~ 584 (721)
.++|+||+.. +|..++ ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 95 ~~lv~e~~~~-~l~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dlkp~NIll~~~~~~kL~dfg~~~~~ 167 (342)
T cd07879 95 FYLVMPYMQT-DLQKIM----GHPLSEDKVQYLVYQMLCGLKYIHSAG--IIHRDLKPGNLAVNEDCELKILDFGLARHA 167 (342)
T ss_pred EEEEeccccc-CHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEeeCCCCcCC
Confidence 6899999964 776654 235889999999999999999999988 999999999999999999999999998754
Q ss_pred CC------CCccccchhhccc-CCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCC-CCc---------
Q 004979 585 TA------AKTGSAAMELLET-SAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQ-PLK--------- 647 (721)
Q Consensus 585 ~~------~~~~~~apE~~~~-~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~-~~~--------- 647 (721)
.. +...|+|||.+.. ..++.++|||||||++|||++|+.||...+ ....+........ +..
T Consensus 168 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (342)
T cd07879 168 DAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD--YLDQLTQILKVTGVPGPEFVQKLEDK 245 (342)
T ss_pred CCCCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHhcCCCCHHHHHHhccc
Confidence 32 2335789998865 568899999999999999999999996432 1111111111000 000
Q ss_pred ----------cccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHHhhhcCCCC
Q 004979 648 ----------DIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAK--LKEITAMEPDG 700 (721)
Q Consensus 648 ----------~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~--L~~i~~~~~~~ 700 (721)
...........+....++.+++.+||+.||++||++.|++.. ++.++...+.+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~~~~ 310 (342)
T cd07879 246 AAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDADEET 310 (342)
T ss_pred chHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccccccC
Confidence 000000000111234578899999999999999999999954 77776654433
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=281.56 Aligned_cols=242 Identities=21% Similarity=0.256 Sum_probs=187.7
Q ss_pred hhhCcCCCCceeEEEEEEecC-CcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLSS-GVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~~-~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
.+.+.+|+|+||.||+++... +..+++|..+.....+.......++..|+.++++++||||+++++++.+.+ ..++|
T Consensus 3 ~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv 80 (260)
T cd08222 3 ILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERD--AFCII 80 (260)
T ss_pred eeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCC--ceEEE
Confidence 455788999999999998653 344555554432222222233456778999999999999999999988766 57999
Q ss_pred EecCCCCChhhhhhhc--cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC-
Q 004979 509 FEYSPNGSLFEHLHIQ--EAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT- 585 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~--~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~- 585 (721)
|||+++++|.+++... ....+++..+..++.|++.|+.|||+.+ ++|+||||+||++++ +.+||+|||+++...
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~ 157 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR--ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG 157 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC--ccccCCChhheEeec-CCEeecccCceeecCC
Confidence 9999999999988642 3456999999999999999999999988 999999999999985 569999999875332
Q ss_pred --------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccc
Q 004979 586 --------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSF 657 (721)
Q Consensus 586 --------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 657 (721)
.+...|++||......++.++||||||+++|||++|..||... ...+.......+. ....
T Consensus 158 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~--~~~~~~~~~~~~~----------~~~~ 225 (260)
T cd08222 158 SCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQ--NFLSVVLRIVEGP----------TPSL 225 (260)
T ss_pred CcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCc--cHHHHHHHHHcCC----------CCCC
Confidence 2344688999998888899999999999999999999998532 2333333332221 1112
Q ss_pred cHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 658 QENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 658 ~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
+..++.++.+++.+||..+|++||++.|+++
T Consensus 226 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 226 PETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred cchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 3455678999999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-32 Score=284.25 Aligned_cols=234 Identities=22% Similarity=0.302 Sum_probs=186.5
Q ss_pred CcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEEEec
Q 004979 433 GSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEY 511 (721)
Q Consensus 433 ~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV~Ey 511 (721)
..+|+|+||.||++.. .++..+++|++.... ......+.+|+.++++++|+||+++++++...+ ..++||||
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e~ 98 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK-----QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD--ELWVVMEF 98 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccc-----hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCC--EEEEEEec
Confidence 4578899999999986 468889999875332 123467899999999999999999999998877 67999999
Q ss_pred CCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC------
Q 004979 512 SPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT------ 585 (721)
Q Consensus 512 ~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~------ 585 (721)
+++++|.+++.. ..+++.....++.|++.|++|||+.+ ++||||||+||++++++.++|+|||++....
T Consensus 99 ~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~g--ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~ 173 (292)
T cd06657 99 LEGGALTDIVTH---TRMNEEQIAAVCLAVLKALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR 173 (292)
T ss_pred CCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEEcccccceecccccccc
Confidence 999999988742 35889999999999999999999988 9999999999999999999999999865322
Q ss_pred ---CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccHHHH
Q 004979 586 ---AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQENVL 662 (721)
Q Consensus 586 ---~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 662 (721)
.+...|++||......++.++|||||||++|||++|+.||.... ..+.......... +... ......
T Consensus 174 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~--~~~~~~~~~~~~~-------~~~~-~~~~~~ 243 (292)
T cd06657 174 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP--PLKAMKMIRDNLP-------PKLK-NLHKVS 243 (292)
T ss_pred cccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhhCC-------cccC-CcccCC
Confidence 12346899999988889999999999999999999999986332 2222221111111 0010 112334
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 663 EELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 663 ~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
.++.+++.+||+.+|.+||++.|+++
T Consensus 244 ~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 244 PSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred HHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 56788999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-31 Score=279.24 Aligned_cols=231 Identities=15% Similarity=0.232 Sum_probs=178.6
Q ss_pred hhhCc--CCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcC-CCCccceEeEEEecCCCceE
Q 004979 430 NIIGS--FSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKV-NHKNFVNLIGYCEEDEPFTR 505 (721)
Q Consensus 430 ~ii~~--lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~~ 505 (721)
+++.. +|+|+||.||+++.. ++..+++|......... . |+.....+ +|+||+++++++...+ ..
T Consensus 17 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--------~--e~~~~~~~~~h~~iv~~~~~~~~~~--~~ 84 (267)
T PHA03390 17 EIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA--------I--EPMVHQLMKDNPNFIKLYYSVTTLK--GH 84 (267)
T ss_pred ccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch--------h--hHHHHHHhhcCCCEEEEEEEEecCC--ee
Confidence 34444 499999999999854 67778888775432111 1 22222212 7999999999998877 67
Q ss_pred EEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCC-cEEEeccCCCCCC
Q 004979 506 MMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDY-AAKISDFSFWNNT 584 (721)
Q Consensus 506 ~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~-~~kL~DFGla~~~ 584 (721)
++||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++ .++|+|||+++..
T Consensus 85 ~iv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~ 160 (267)
T PHA03390 85 VLIMDYIKDGDLFDLLKKE--GKLSEAEVKKIIRQLVEALNDLHKHN--IIHNDIKLENVLYDRAKDRIYLCDYGLCKII 160 (267)
T ss_pred EEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEeCCCCeEEEecCccceec
Confidence 9999999999999998643 37999999999999999999999988 99999999999999988 9999999987543
Q ss_pred C-----CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCC---HHHHHHHHhhcCCCCccccCCcccc
Q 004979 585 T-----AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGS---LENWASEYLKGEQPLKDIVDPTLKS 656 (721)
Q Consensus 585 ~-----~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~---~~~~~~~~~~~~~~~~~~~d~~l~~ 656 (721)
. .+...|+|||.+....++.++|||||||++|||+||+.||...... ...+.... .. ...
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~-----------~~~ 228 (267)
T PHA03390 161 GTPSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-QK-----------KLP 228 (267)
T ss_pred CCCccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-cc-----------cCC
Confidence 2 2455789999999889999999999999999999999999743322 12222111 10 001
Q ss_pred ccHHHHHHHHHHHHHcccCCCCCCCC-HHHHHH
Q 004979 657 FQENVLEELLVVIKNCVHPDPKQRPS-MRGIAA 688 (721)
Q Consensus 657 ~~~~~~~~l~~li~~Cl~~dP~~RPs-~~evl~ 688 (721)
.....+..+.+++.+||+.+|.+||+ ++|+++
T Consensus 229 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 229 FIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred cccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 12245678899999999999999996 688874
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=324.67 Aligned_cols=235 Identities=21% Similarity=0.288 Sum_probs=190.8
Q ss_pred cCCCCceeEEEEEE-ecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEEEecC
Q 004979 434 SFSDGTVGTVYKGT-LSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYS 512 (721)
Q Consensus 434 ~lg~G~~g~Vyk~~-~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV~Ey~ 512 (721)
.+|.|.||.||-|. .++|.-.|||-+...... ....+...+|+.++..++|||+|++||+-.+++ ..+|.||||
T Consensus 1242 ~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~---~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRe--kv~IFMEyC 1316 (1509)
T KOG4645|consen 1242 FIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD---HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHRE--KVYIFMEYC 1316 (1509)
T ss_pred ccCCcceeeeEEeecCCccchhhhhhhhcCccc---cccCcchHHHHHHHHhccCccccccCceeecHH--HHHHHHHHh
Confidence 57899999999998 678888899987654432 333467889999999999999999999998887 678999999
Q ss_pred CCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC-------
Q 004979 513 PNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT------- 585 (721)
Q Consensus 513 ~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~------- 585 (721)
++|+|.+.+. ..+..++.....+..|++.|++|||+.+ ||||||||.||+|+.+|.+|++|||.|....
T Consensus 1317 ~~GsLa~ll~--~gri~dE~vt~vyt~qll~gla~LH~~g--IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~ 1392 (1509)
T KOG4645|consen 1317 EGGSLASLLE--HGRIEDEMVTRVYTKQLLEGLAYLHEHG--IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMP 1392 (1509)
T ss_pred ccCcHHHHHH--hcchhhhhHHHHHHHHHHHHHHHHHhcC--ceecCCCccceeeecCCcEEeecccceeEecCchhcCC
Confidence 9999999985 3344667777788999999999999999 9999999999999999999999999875332
Q ss_pred ------CCCccccchhhcccCC---CCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCcccc
Q 004979 586 ------AAKTGSAAMELLETSA---VDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKS 656 (721)
Q Consensus 586 ------~~~~~~~apE~~~~~~---~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 656 (721)
.|+..|||||++.+.. ...++||||+|||+.||+||++||..-+.+. ..+..+-.+. .+.
T Consensus 1393 ~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~-aIMy~V~~gh----------~Pq 1461 (1509)
T KOG4645|consen 1393 GELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEW-AIMYHVAAGH----------KPQ 1461 (1509)
T ss_pred HHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchh-HHHhHHhccC----------CCC
Confidence 3567899999986543 4578999999999999999999996433222 2222222232 223
Q ss_pred ccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 657 FQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 657 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
+++..+.+-.+++..|+..||++|-++.|+++
T Consensus 1462 ~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1462 IPERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred CchhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence 55668888999999999999999988887765
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-32 Score=286.79 Aligned_cols=251 Identities=18% Similarity=0.214 Sum_probs=183.1
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCC------
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEP------ 502 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~------ 502 (721)
++++.+|+|+||.||+|+.. ++..+++|++...... ......+.+|++++++++||||++++++|...+.
T Consensus 15 ~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 15 EKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEK---EGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred EEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCc---CCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 67788999999999999964 6889999987643221 1122456789999999999999999999875431
Q ss_pred ceEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCC
Q 004979 503 FTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWN 582 (721)
Q Consensus 503 ~~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~ 582 (721)
...++||||+. ++|.+++.. ....+++.....++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.
T Consensus 92 ~~~~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~ 167 (310)
T cd07865 92 GSFYLVFEFCE-HDLAGLLSN-KNVKFTLSEIKKVMKMLLNGLYYIHRNK--ILHRDMKAANILITKDGILKLADFGLAR 167 (310)
T ss_pred ceEEEEEcCCC-cCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEECCCCcEEECcCCCcc
Confidence 24599999996 588887753 2346899999999999999999999988 9999999999999999999999999875
Q ss_pred CCCC-------------CCccccchhhcccC-CCCCCccHHHHHHHHHHHHhCCCcccCCCCCH-HHHHHHHhhcCCCC-
Q 004979 583 NTTA-------------AKTGSAAMELLETS-AVDLESNVYSFGTILFEMITGRISYSIENGSL-ENWASEYLKGEQPL- 646 (721)
Q Consensus 583 ~~~~-------------~~~~~~apE~~~~~-~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~-~~~~~~~~~~~~~~- 646 (721)
.... +...|+|||.+.+. .++.++||||||+++|||+||+.||....... ...+.... +..+.
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 246 (310)
T cd07865 168 AFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLC-GSITPE 246 (310)
T ss_pred cccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh-CCCChh
Confidence 3321 22358999987554 47899999999999999999999986433211 11111111 10000
Q ss_pred --ccc-----c------CCcccccc-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 647 --KDI-----V------DPTLKSFQ-----ENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 647 --~~~-----~------d~~l~~~~-----~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
... . +....... ......+.+++.+||..||++||+++|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 247 VWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred hcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 000 0 00000000 011346778999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=275.02 Aligned_cols=242 Identities=22% Similarity=0.289 Sum_probs=188.1
Q ss_pred hCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcC-CCCccceEeEEEecCCCceEEEEE
Q 004979 432 IGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKV-NHKNFVNLIGYCEEDEPFTRMMVF 509 (721)
Q Consensus 432 i~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~~~lV~ 509 (721)
+|.+|.|+||+|+|-.++ .|+..|||++..... ....++++.|.+...+- +-||||++||.+...+ ..|+.|
T Consensus 69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~----~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EG--dcWiCM 142 (361)
T KOG1006|consen 69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI----EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEG--DCWICM 142 (361)
T ss_pred HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc----hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCC--ceeeeH
Confidence 478899999999999864 789999999976543 33457899998865554 7999999999887666 468999
Q ss_pred ecCCCCChhhhhh---hccCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCeEeeCCCCCCeEeCCCCcEEEeccCCC----
Q 004979 510 EYSPNGSLFEHLH---IQEAEHLDWAMRLRIAMGMAYCLEHMHQ-LTPPIAHRNLQSSSIYLTEDYAAKISDFSFW---- 581 (721)
Q Consensus 510 Ey~~~GsL~~~l~---~~~~~~l~~~~~~~ia~~ia~gL~yLH~-~~~~IvHrDLKp~NILl~~~~~~kL~DFGla---- 581 (721)
|.| .-||..+.+ .-....+++...-+|+.....||.||.+ .. |||||+||+|||+|..|.+||||||++
T Consensus 143 ELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lk--iIHRDvKPSNILldr~G~vKLCDFGIcGqLv 219 (361)
T KOG1006|consen 143 ELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELK--IIHRDVKPSNILLDRHGDVKLCDFGICGQLV 219 (361)
T ss_pred HHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhh--hhhccCChhheEEecCCCEeeecccchHhHH
Confidence 999 457765543 2234557777777888889999999964 45 999999999999999999999999974
Q ss_pred ----CCCCCCCccccchhhcc--cCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccc
Q 004979 582 ----NNTTAAKTGSAAMELLE--TSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLK 655 (721)
Q Consensus 582 ----~~~~~~~~~~~apE~~~--~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 655 (721)
+....+...|||||.+. ...|+.+|||||+||+|||+.||+.||..-+ +..+.+..++.++.+.- ....
T Consensus 220 ~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~-svfeql~~Vv~gdpp~l---~~~~- 294 (361)
T KOG1006|consen 220 DSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWD-SVFEQLCQVVIGDPPIL---LFDK- 294 (361)
T ss_pred HHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHH-HHHHHHHHHHcCCCCee---cCcc-
Confidence 45566778899999984 3458999999999999999999999996322 34455566666654321 1110
Q ss_pred cccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 656 SFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 656 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
..-+....+..+|..|+.+|-.+||...++.+
T Consensus 295 -~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 295 -ECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred -cccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 01235678899999999999999999998765
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-32 Score=290.99 Aligned_cols=251 Identities=18% Similarity=0.231 Sum_probs=185.8
Q ss_pred hhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhh---------HHHHHHHHHHHHHhcCCCCccceEeEEEecC
Q 004979 431 IIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSK---------NLESQFRKKIDTLSKVNHKNFVNLIGYCEED 500 (721)
Q Consensus 431 ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~---------~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~ 500 (721)
+.+.+|.|+||+||+|+.. ++..|++|++.......... .....+.+|++++++++|+||+++++++...
T Consensus 13 ~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 92 (335)
T PTZ00024 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEG 92 (335)
T ss_pred hhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecC
Confidence 3356889999999999854 68899999876433221000 0113578999999999999999999999877
Q ss_pred CCceEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCC
Q 004979 501 EPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSF 580 (721)
Q Consensus 501 ~~~~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGl 580 (721)
+ ..++||||+. |+|.+++.. ...+++.....++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 93 ~--~~~lv~e~~~-~~l~~~l~~--~~~~~~~~~~~~~~ql~~aL~~LH~~~--i~H~dl~~~nill~~~~~~kl~dfg~ 165 (335)
T PTZ00024 93 D--FINLVMDIMA-SDLKKVVDR--KIRLTESQVKCILLQILNGLNVLHKWY--FMHRDLSPANIFINSKGICKIADFGL 165 (335)
T ss_pred C--cEEEEEeccc-cCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHeEECCCCCEEECCccc
Confidence 6 6799999996 689988853 345889999999999999999999988 99999999999999999999999998
Q ss_pred CCCCC-----------------------CCCccccchhhcccC-CCCCCccHHHHHHHHHHHHhCCCcccCCCCC-HHHH
Q 004979 581 WNNTT-----------------------AAKTGSAAMELLETS-AVDLESNVYSFGTILFEMITGRISYSIENGS-LENW 635 (721)
Q Consensus 581 a~~~~-----------------------~~~~~~~apE~~~~~-~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~-~~~~ 635 (721)
++... .+...|++||.+.+. .++.++|||||||++|||+||+.||...+.. ....
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~ 245 (335)
T PTZ00024 166 ARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGR 245 (335)
T ss_pred eeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 75432 123358899988654 4689999999999999999999999644321 1111
Q ss_pred HHHHhhcCCC--Cc------------cccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 636 ASEYLKGEQP--LK------------DIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 636 ~~~~~~~~~~--~~------------~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
+......... .. ....+.........+.++.+++.+||+.+|++||+++|++.
T Consensus 246 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 246 IFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred HHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 1111110000 00 00001111111234567889999999999999999999986
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-31 Score=275.59 Aligned_cols=240 Identities=23% Similarity=0.370 Sum_probs=195.3
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
++.+.+|.|+||.||++... ++..+++|++...... ....+.+.+|++++++++|+|++++++.+...+ ..++|
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~--~~~lv 77 (258)
T cd08215 3 EIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMS---EKEREDALNEVKILKKLNHPNIIKYYESFEEKG--KLCIV 77 (258)
T ss_pred eEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCC---hHHHHHHHHHHHHHHhcCCCChhheEEEEecCC--EEEEE
Confidence 45677889999999999965 5788999988654321 234567899999999999999999999988775 67999
Q ss_pred EecCCCCChhhhhhhcc--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCCC
Q 004979 509 FEYSPNGSLFEHLHIQE--AEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTA 586 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~--~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~~ 586 (721)
+||+++++|.+++.... ...+++..+..++.+++.||+|||+.+ ++|+||+|+||++++++.+||+|||++.....
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~ 155 (258)
T cd08215 78 MEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK--ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSS 155 (258)
T ss_pred EEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHHeEEcCCCcEEECCccceeeccc
Confidence 99999999999987543 467999999999999999999999987 99999999999999999999999998754322
Q ss_pred ---------CCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccc
Q 004979 587 ---------AKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSF 657 (721)
Q Consensus 587 ---------~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 657 (721)
+...|++||......++.++||||+|+++|||++|+.||...+ ..+......... ....
T Consensus 156 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~--~~~~~~~~~~~~----------~~~~ 223 (258)
T cd08215 156 TVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN--LLELALKILKGQ----------YPPI 223 (258)
T ss_pred CcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc--HHHHHHHHhcCC----------CCCC
Confidence 2346899999988889999999999999999999999996332 333333332211 1112
Q ss_pred cHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 658 QENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 658 ~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
+.....++.+++.+||..+|++||++.|+++
T Consensus 224 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 224 PSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 2245577899999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-31 Score=274.00 Aligned_cols=238 Identities=23% Similarity=0.363 Sum_probs=192.2
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
++...+|+|++|.||+++.. ++..+++|........ ......+.+|++++++++|+||+++++++.+.+ ..++|
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~~v 77 (254)
T cd06627 3 QLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK---EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSD--SLYII 77 (254)
T ss_pred eeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC---HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCC--EEEEE
Confidence 45678899999999999865 5778999988654321 234567999999999999999999999998766 67999
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCCC--
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTA-- 586 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~~-- 586 (721)
|||+++++|.+++... ..+++..+..++.|++.|+.|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 78 ~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (254)
T cd06627 78 LEYAENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQG--VIHRDIKAANILTTKDGVVKLADFGVATKLNDVS 153 (254)
T ss_pred EecCCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence 9999999999998633 56899999999999999999999988 99999999999999999999999998764322
Q ss_pred -------CCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccH
Q 004979 587 -------AKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQE 659 (721)
Q Consensus 587 -------~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 659 (721)
+...|++||......++.++||||+|+++|||++|+.||..... .... ....... ....+.
T Consensus 154 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~-~~~~-~~~~~~~----------~~~~~~ 221 (254)
T cd06627 154 KDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP-MAAL-FRIVQDD----------HPPLPE 221 (254)
T ss_pred ccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH-HHHH-HHHhccC----------CCCCCC
Confidence 34468999998877889999999999999999999999864331 1111 1111111 011223
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 660 NVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 660 ~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
....++.+++.+||..+|++||++.|++.
T Consensus 222 ~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 222 GISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 44577889999999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=280.29 Aligned_cols=247 Identities=21% Similarity=0.269 Sum_probs=188.3
Q ss_pred hhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEEE
Q 004979 431 IIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVF 509 (721)
Q Consensus 431 ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV~ 509 (721)
+.+.+|+|.||.||+|+.. ++..+++|+...... .....+.+..|++++++++|+||+++++++.+.+ ..++||
T Consensus 3 ~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~--~~~~v~ 77 (282)
T cd07829 3 KLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNE---EEGIPSTALREISLLKELKHPNIVKLLDVIHTER--KLYLVF 77 (282)
T ss_pred eehcccccCcceEEEeeecCCCcEEEEEEeccccc---cccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCC--ceEEEe
Confidence 4567889999999999965 588999998875431 1223456788999999999999999999998776 679999
Q ss_pred ecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCCC---
Q 004979 510 EYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTA--- 586 (721)
Q Consensus 510 Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~~--- 586 (721)
||++ ++|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||+|+||++++++.+||+|||+++....
T Consensus 78 e~~~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 153 (282)
T cd07829 78 EYCD-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSHR--ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR 153 (282)
T ss_pred cCcC-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence 9997 59999986432 46899999999999999999999988 99999999999999999999999998764322
Q ss_pred ------CCccccchhhcccC-CCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcC----------------
Q 004979 587 ------AKTGSAAMELLETS-AVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGE---------------- 643 (721)
Q Consensus 587 ------~~~~~~apE~~~~~-~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~---------------- 643 (721)
....|+|||.+... .++.++|||||||++|||++|+.||..... .+.........
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
T cd07829 154 TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSE--IDQLFKIFQILGTPTEESWPGVTKLPD 231 (282)
T ss_pred ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccH--HHHHHHHHHHhCCCcHHHHHhhccccc
Confidence 12357899998666 889999999999999999999999864321 11111111100
Q ss_pred --CCCccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 644 --QPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 644 --~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
...............+....++.+++.+||..+|++||++.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 232 YKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 000000000000111223567999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.5e-31 Score=273.25 Aligned_cols=230 Identities=25% Similarity=0.340 Sum_probs=186.3
Q ss_pred CCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEEEecCC
Q 004979 435 FSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSP 513 (721)
Q Consensus 435 lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV~Ey~~ 513 (721)
+|.|+||.||+++.. ++..+++|.+....... ......+..|++++++++|+||+++++.+...+ ..++||||++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~~v~e~~~ 76 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIK--RKEVEHTLTERNILSRINHPFIVKLHYAFQTEE--KLYLVLEYAP 76 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcc--hHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCC--eeEEEEecCC
Confidence 578999999999965 57889999876543221 224567899999999999999999999988766 6799999999
Q ss_pred CCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCCC-------
Q 004979 514 NGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTA------- 586 (721)
Q Consensus 514 ~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~~------- 586 (721)
+++|.+++... ..+++.....++.|++.|+.|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 77 ~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lh~~~--~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~ 152 (250)
T cd05123 77 GGELFSHLSKE--GRFSEERARFYAAEIVLALEYLHSLG--IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT 152 (250)
T ss_pred CCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccC
Confidence 99999998633 36899999999999999999999988 99999999999999999999999998753322
Q ss_pred --CCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccHHHHHH
Q 004979 587 --AKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQENVLEE 664 (721)
Q Consensus 587 --~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 664 (721)
+...|++||...+...+.++|+||||+++||+++|+.||...+ ..+........... .+...+.+
T Consensus 153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~--~~~~~~~~~~~~~~-----------~~~~~~~~ 219 (250)
T cd05123 153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAED--RKEIYEKILKDPLR-----------FPEFLSPE 219 (250)
T ss_pred CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC--HHHHHHHHhcCCCC-----------CCCCCCHH
Confidence 3457899999988888999999999999999999999996433 23333333322111 22233567
Q ss_pred HHHHHHHcccCCCCCCCCHHH
Q 004979 665 LLVVIKNCVHPDPKQRPSMRG 685 (721)
Q Consensus 665 l~~li~~Cl~~dP~~RPs~~e 685 (721)
+.+++.+||..||++||++.+
T Consensus 220 l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 220 ARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred HHHHHHHHhcCCHhhCCCccc
Confidence 889999999999999999944
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-31 Score=288.30 Aligned_cols=257 Identities=18% Similarity=0.208 Sum_probs=188.9
Q ss_pred HHHHHhhhhhhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEec
Q 004979 421 LEAACEDFSNIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEE 499 (721)
Q Consensus 421 l~~~~~~~~~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~ 499 (721)
+....+.| .+++.+|+|+||.||+|.. .++..||+|++..... .....+.+.+|++++.+++|+||+++++++..
T Consensus 12 ~~~~~~~y-~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~ 87 (345)
T cd07877 12 IWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ---SIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 87 (345)
T ss_pred HhhccCce-EEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcch---hhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence 33344443 6778899999999999985 5688899998764221 12234568899999999999999999998864
Q ss_pred CCC----ceEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEE
Q 004979 500 DEP----FTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKI 575 (721)
Q Consensus 500 ~~~----~~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL 575 (721)
... ...++++|++ +++|.+++.. ..+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+||
T Consensus 88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~~~~kl 161 (345)
T cd07877 88 ARSLEEFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKI 161 (345)
T ss_pred cccccccccEEEEehhc-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEEcCCCCEEE
Confidence 321 1357888887 7899888742 35899999999999999999999988 999999999999999999999
Q ss_pred eccCCCCCCCC------CCccccchhhccc-CCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCC-CCc
Q 004979 576 SDFSFWNNTTA------AKTGSAAMELLET-SAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQ-PLK 647 (721)
Q Consensus 576 ~DFGla~~~~~------~~~~~~apE~~~~-~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~-~~~ 647 (721)
+|||+++.... ++..|+|||.+.+ ..++.++|||||||++|||++|+.||...+. ............ +..
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~--~~~~~~~~~~~~~~~~ 239 (345)
T cd07877 162 LDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH--IDQLKLILRLVGTPGA 239 (345)
T ss_pred ecccccccccccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHhCCCCH
Confidence 99999764432 2346889998755 5688999999999999999999999964321 111111111100 000
Q ss_pred ccc-------------------CCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004979 648 DIV-------------------DPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAK 689 (721)
Q Consensus 648 ~~~-------------------d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 689 (721)
.+. .............++.+++.+|++.||.+||++.|++..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 240 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 000 000000011234578899999999999999999999874
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-32 Score=271.57 Aligned_cols=234 Identities=21% Similarity=0.302 Sum_probs=191.0
Q ss_pred hhhhhhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCce
Q 004979 426 EDFSNIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFT 504 (721)
Q Consensus 426 ~~~~~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 504 (721)
++| +.++.+|+|.||.|-.++- .+++.+|+|++++..... +.....-+.|-++|...+||.+..+.-.++..+ .
T Consensus 168 ~dF-dfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviia--kdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~d--r 242 (516)
T KOG0690|consen 168 EDF-DFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIA--KDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQD--R 242 (516)
T ss_pred chh-hHHHHhcCCccceEEEEeecccCceeehhhhhhhheee--hHHhhhhhhHHHHHHhccCcHHHHhhhhhccCc--e
Confidence 455 4567788999999999984 478889999887554332 333445677889999999999998877777766 7
Q ss_pred EEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCC-
Q 004979 505 RMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNN- 583 (721)
Q Consensus 505 ~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~- 583 (721)
.|.||||+.||.|+-+|. +.+.++....+.+...|..||.|||+.+ ||.||||.+|.|+|.+|++||+|||+++.
T Consensus 243 lCFVMeyanGGeLf~HLs--rer~FsE~RtRFYGaEIvsAL~YLHs~~--ivYRDlKLENLlLDkDGHIKitDFGLCKE~ 318 (516)
T KOG0690|consen 243 LCFVMEYANGGELFFHLS--RERVFSEDRTRFYGAEIVSALGYLHSRN--IVYRDLKLENLLLDKDGHIKITDFGLCKEE 318 (516)
T ss_pred EEEEEEEccCceEeeehh--hhhcccchhhhhhhHHHHHHhhhhhhCC--eeeeechhhhheeccCCceEeeecccchhc
Confidence 899999999999998885 3466888888999999999999999988 99999999999999999999999999863
Q ss_pred --------CCCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccc
Q 004979 584 --------TTAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLK 655 (721)
Q Consensus 584 --------~~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 655 (721)
...+++.|.|||++....|+.+.|.|.+|||||||+.|+.||...+ -.....-++.++-
T Consensus 319 I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~d--h~kLFeLIl~ed~----------- 385 (516)
T KOG0690|consen 319 IKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKD--HEKLFELILMEDL----------- 385 (516)
T ss_pred ccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccc--hhHHHHHHHhhhc-----------
Confidence 3456778999999999999999999999999999999999997432 2222222222221
Q ss_pred cccHHHHHHHHHHHHHcccCCCCCCC
Q 004979 656 SFQENVLEELLVVIKNCVHPDPKQRP 681 (721)
Q Consensus 656 ~~~~~~~~~l~~li~~Cl~~dP~~RP 681 (721)
.++....++...|+...+.+||.+|.
T Consensus 386 kFPr~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 386 KFPRTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred cCCccCCHHHHHHHHHHhhcChHhhc
Confidence 24455667888999999999999995
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=284.54 Aligned_cols=250 Identities=21% Similarity=0.226 Sum_probs=184.1
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCC------
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEP------ 502 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~------ 502 (721)
++++.+|+|+||.||+|+.. ++..+++|++......+ .....+.+|++++++++|+||+++++++.....
T Consensus 11 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 87 (311)
T cd07866 11 EILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKD---GFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKR 87 (311)
T ss_pred EEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCC---CcchhHHHHHHHHHhcCCCCccchhhheecccccccccC
Confidence 67788999999999999965 67889999886543222 112356789999999999999999998764331
Q ss_pred ceEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCC
Q 004979 503 FTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWN 582 (721)
Q Consensus 503 ~~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~ 582 (721)
...++|+||+.+ +|...+.. ....+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+||+|||+++
T Consensus 88 ~~~~lv~~~~~~-~l~~~~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~ 163 (311)
T cd07866 88 GSVYMVTPYMDH-DLSGLLEN-PSVKLTESQIKCYMLQLLEGINYLHENH--ILHRDIKAANILIDNQGILKIADFGLAR 163 (311)
T ss_pred ceEEEEEecCCc-CHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEECcCccch
Confidence 146999999965 67776643 2346999999999999999999999988 9999999999999999999999999875
Q ss_pred CCCC--------------------CCccccchhhccc-CCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhh
Q 004979 583 NTTA--------------------AKTGSAAMELLET-SAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLK 641 (721)
Q Consensus 583 ~~~~--------------------~~~~~~apE~~~~-~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~ 641 (721)
.... +...|+|||.+.+ ..++.++|||||||++|||++|+.||..... .........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~--~~~~~~~~~ 241 (311)
T cd07866 164 PYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSD--IDQLHLIFK 241 (311)
T ss_pred hccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHH
Confidence 3321 1234889998754 4588999999999999999999999863321 111111111
Q ss_pred cCCC-----------Cccc----cC----CccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 642 GEQP-----------LKDI----VD----PTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 642 ~~~~-----------~~~~----~d----~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
.... .... .. +...........++.+++.+||+.+|++|||+.|++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 0000 0000 00 0000011123367889999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.5e-31 Score=287.38 Aligned_cols=258 Identities=19% Similarity=0.225 Sum_probs=193.0
Q ss_pred hhhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCC----c
Q 004979 429 SNIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEP----F 503 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~----~ 503 (721)
+.++..+|+|+||.||+|.. .++..||||++..... .......+.+|++++++++||||+++++++..... .
T Consensus 17 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07880 17 YRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQ---SELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFH 93 (343)
T ss_pred eEEEEEeeecCCeEEEEEEECCCCcEEEEEEeccccc---chHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccc
Confidence 46788999999999999984 4688899998753221 12234568899999999999999999999875432 1
Q ss_pred eEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCC
Q 004979 504 TRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNN 583 (721)
Q Consensus 504 ~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~ 583 (721)
..++||||+ +++|.+++. ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++..
T Consensus 94 ~~~lv~e~~-~~~l~~~~~---~~~l~~~~~~~i~~qi~~al~~LH~~g--i~H~dlkp~Nill~~~~~~kl~dfg~~~~ 167 (343)
T cd07880 94 DFYLVMPFM-GTDLGKLMK---HEKLSEDRIQFLVYQMLKGLKYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLARQ 167 (343)
T ss_pred eEEEEEecC-CCCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeecccccc
Confidence 358999999 779988874 246899999999999999999999988 99999999999999999999999998864
Q ss_pred CCC------CCccccchhhccc-CCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCC----------
Q 004979 584 TTA------AKTGSAAMELLET-SAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPL---------- 646 (721)
Q Consensus 584 ~~~------~~~~~~apE~~~~-~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~---------- 646 (721)
... +...|++||.+.. ..++.++|||||||++|||++|+.||..... ..............
T Consensus 168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 245 (343)
T cd07880 168 TDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDH--LDQLMEIMKVTGTPSKEFVQKLQS 245 (343)
T ss_pred cccCccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHhcCCCCHHHHHhhcc
Confidence 432 2346789998865 4588999999999999999999999964321 12222211111100
Q ss_pred ----------ccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHHhhhcC
Q 004979 647 ----------KDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA--KLKEITAME 697 (721)
Q Consensus 647 ----------~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~--~L~~i~~~~ 697 (721)
.......+....+....++.+++.+|++.||++|||+.+++. .++......
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~~ 308 (343)
T cd07880 246 EDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPE 308 (343)
T ss_pred hhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCcc
Confidence 000000111112234567889999999999999999999984 355554443
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=279.92 Aligned_cols=238 Identities=23% Similarity=0.319 Sum_probs=191.2
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCC-CCccceEeEEEecCCCceEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVN-HKNFVNLIGYCEEDEPFTRMM 507 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~~~l 507 (721)
++.+.+|.|+||.||+|+.. ++..+++|++...... .....+.+.+|++++.+++ |+||+++++++...+ ..++
T Consensus 4 ~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~--~~~l 79 (280)
T cd05581 4 KFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLI--KEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEE--NLYF 79 (280)
T ss_pred eEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhcc--chHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCc--eEEE
Confidence 55678899999999999965 6888999987643221 2233467889999999998 999999999988766 6799
Q ss_pred EEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCCC-
Q 004979 508 VFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTA- 586 (721)
Q Consensus 508 V~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~~- 586 (721)
||||+++++|.+++.. ...+++..+..|+.|++.||+|||+.+ ++|+||||+||+++.++.++++|||++.....
T Consensus 80 v~e~~~~~~L~~~l~~--~~~l~~~~~~~i~~ql~~~l~~Lh~~~--~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~ 155 (280)
T cd05581 80 VLEYAPNGELLQYIRK--YGSLDEKCTRFYAAEILLALEYLHSKG--IIHRDLKPENILLDKDMHIKITDFGTAKVLDPN 155 (280)
T ss_pred EEcCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence 9999999999999864 346999999999999999999999988 99999999999999999999999998653221
Q ss_pred ----------------------------CCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHH
Q 004979 587 ----------------------------AKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASE 638 (721)
Q Consensus 587 ----------------------------~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~ 638 (721)
+...|++||......++.++||||||++++|+++|+.||.... .......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~--~~~~~~~ 233 (280)
T cd05581 156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN--EYLTFQK 233 (280)
T ss_pred cccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc--HHHHHHH
Confidence 2346789999888889999999999999999999999996433 1222222
Q ss_pred HhhcCCCCccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCH----HHHHH
Q 004979 639 YLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSM----RGIAA 688 (721)
Q Consensus 639 ~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~----~evl~ 688 (721)
...... ..+...++++.+++.+||+.+|++||++ +|+++
T Consensus 234 ~~~~~~-----------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 234 ILKLEY-----------SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred HHhcCC-----------CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 221111 1223345778999999999999999999 77654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=286.98 Aligned_cols=251 Identities=18% Similarity=0.220 Sum_probs=186.6
Q ss_pred hhhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEE
Q 004979 429 SNIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMM 507 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~l 507 (721)
++++..+|.|+||.||+|... ++..+++|++...... ....+.+.+|++++.+++||||+++++++...+. ..++
T Consensus 12 y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~-~~~l 87 (328)
T cd07856 12 YVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFST---PVLAKRTYRELKLLKHLRHENIISLSDIFISPLE-DIYF 87 (328)
T ss_pred eEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccc---cchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC-cEEE
Confidence 467788999999999999854 7889999987543211 2234568899999999999999999999876432 5689
Q ss_pred EEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCCC-
Q 004979 508 VFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTA- 586 (721)
Q Consensus 508 V~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~~- 586 (721)
|+||+ +++|.++++ ...+++.....++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++....
T Consensus 88 v~e~~-~~~L~~~~~---~~~~~~~~~~~~~~ql~~aL~~LH~~~--iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~ 161 (328)
T cd07856 88 VTELL-GTDLHRLLT---SRPLEKQFIQYFLYQILRGLKYVHSAG--VVHRDLKPSNILINENCDLKICDFGLARIQDPQ 161 (328)
T ss_pred Eeehh-ccCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEeECCCCCEEeCccccccccCCC
Confidence 99998 568988875 235788888899999999999999988 99999999999999999999999998764322
Q ss_pred -----CCccccchhhccc-CCCCCCccHHHHHHHHHHHHhCCCcccCCCCC-H------------HHHHHHHhhcCC-CC
Q 004979 587 -----AKTGSAAMELLET-SAVDLESNVYSFGTILFEMITGRISYSIENGS-L------------ENWASEYLKGEQ-PL 646 (721)
Q Consensus 587 -----~~~~~~apE~~~~-~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~-~------------~~~~~~~~~~~~-~~ 646 (721)
+...|++||.+.+ ..++.++|||||||++|||+||+.||...... . .++......... .+
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (328)
T cd07856 162 MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRF 241 (328)
T ss_pred cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHH
Confidence 2346889998765 57899999999999999999999999643210 0 111111000000 00
Q ss_pred -ccccCCc---cccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004979 647 -KDIVDPT---LKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAK 689 (721)
Q Consensus 647 -~~~~d~~---l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 689 (721)
....... .....+....++.++|.+||+.+|++||++.|++..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 242 VQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000 000112245789999999999999999999999874
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=309.63 Aligned_cols=145 Identities=24% Similarity=0.340 Sum_probs=126.0
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
.++..||+|+||+||+|+.. +++.||+|++...... .......+.+|+.++..++|+||+++++++...+ ..|+|
T Consensus 7 ~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~--~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~--~~~lV 82 (669)
T cd05610 7 VIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMI--NKNMVHQVQAERDALALSKSPFIVHLYYSLQSAN--NVYLV 82 (669)
T ss_pred EEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhcc--CHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECC--EEEEE
Confidence 67788999999999999965 6889999988653322 2334467899999999999999999999988776 67999
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCC
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWN 582 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~ 582 (721)
|||+++|+|.++++. ...+++...+.|+.||+.||+|||.++ ||||||||+|||++.++.+||+|||+++
T Consensus 83 mEy~~g~~L~~li~~--~~~l~~~~~~~i~~qil~aL~yLH~~g--IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHI--YGYFDEEMAVKYISEVALALDYLHRHG--IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999999863 345888999999999999999999987 9999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=288.11 Aligned_cols=257 Identities=18% Similarity=0.215 Sum_probs=194.9
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCC---CceE
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDE---PFTR 505 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~---~~~~ 505 (721)
++.+.+|.|+||.||+|+.. ++..+++|++..... .....+.+.+|+++++.++|+||+++++++...+ ....
T Consensus 3 ~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 3 ELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFD---DLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred eeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccc---cchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence 46678899999999999965 588899998864321 1233467899999999999999999999987653 1246
Q ss_pred EEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC
Q 004979 506 MMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT 585 (721)
Q Consensus 506 ~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~ 585 (721)
++||||++ ++|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 80 ~lv~e~~~-~~l~~~l~~--~~~l~~~~~~~i~~~l~~~l~~LH~~g--i~H~dlkp~nili~~~~~~~L~dfg~~~~~~ 154 (330)
T cd07834 80 YIVTELME-TDLHKVIKS--PQPLTDDHIQYFLYQILRGLKYLHSAN--VIHRDLKPSNILVNSNCDLKICDFGLARGVD 154 (330)
T ss_pred EEEecchh-hhHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEcccCceEeec
Confidence 99999997 589888853 347999999999999999999999988 9999999999999999999999999875332
Q ss_pred C------------CCccccchhhcccC-CCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCC-CCccc--
Q 004979 586 A------------AKTGSAAMELLETS-AVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQ-PLKDI-- 649 (721)
Q Consensus 586 ~------------~~~~~~apE~~~~~-~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~-~~~~~-- 649 (721)
. +...|+|||.+.+. .++.++||||||+++|||++|+.||...+ ..+.......... +..+.
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~ 232 (330)
T cd07834 155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRD--YIDQLNLIVEVLGTPSEEDLK 232 (330)
T ss_pred ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCC--HHHHHHHHHHhcCCCChhHhh
Confidence 2 22357899998777 88999999999999999999999996433 2222222111100 00000
Q ss_pred --cCC---------------ccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHHhhhc
Q 004979 650 --VDP---------------TLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAK--LKEITAM 696 (721)
Q Consensus 650 --~d~---------------~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~--L~~i~~~ 696 (721)
... .........+.++.+++.+||+.+|++||++.+++.. ++++...
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~ 298 (330)
T cd07834 233 FITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDP 298 (330)
T ss_pred hccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccc
Confidence 000 0001112345678999999999999999999999985 6666654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-32 Score=308.23 Aligned_cols=261 Identities=20% Similarity=0.298 Sum_probs=207.3
Q ss_pred HHHHHhhhhhhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEec
Q 004979 421 LEAACEDFSNIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEE 499 (721)
Q Consensus 421 l~~~~~~~~~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~ 499 (721)
+.-..+|| +++..||+|+||.|..++++ +++.+|.|++.+-.... ......|.+|-.+|..-+.+-||.++-.|.+
T Consensus 70 lrl~~~Df-eilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlK--r~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 70 LRLKAEDF-EILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLK--RAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HhCCHHhh-HHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhh--chhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 33334566 78889999999999999975 56778888876532211 1123569999999999999999999988888
Q ss_pred CCCceEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccC
Q 004979 500 DEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFS 579 (721)
Q Consensus 500 ~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFG 579 (721)
.. +.|+|||||+||+|..+|.. ...++...++.++..|..||.-+|+.| +|||||||+|||||..|++||+|||
T Consensus 147 ~~--~LYlVMdY~pGGDlltLlSk--~~~~pE~~ArFY~aEiVlAldslH~mg--yVHRDiKPDNvLld~~GHikLADFG 220 (1317)
T KOG0612|consen 147 ER--YLYLVMDYMPGGDLLTLLSK--FDRLPEDWARFYTAEIVLALDSLHSMG--YVHRDIKPDNVLLDKSGHIKLADFG 220 (1317)
T ss_pred cc--ceEEEEecccCchHHHHHhh--cCCChHHHHHHHHHHHHHHHHHHHhcc--ceeccCCcceeEecccCcEeeccch
Confidence 77 78999999999999999963 336888999999999999999999999 9999999999999999999999999
Q ss_pred CCC----------CCCCCCccccchhhcc----c-CCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCC
Q 004979 580 FWN----------NTTAAKTGSAAMELLE----T-SAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQ 644 (721)
Q Consensus 580 la~----------~~~~~~~~~~apE~~~----~-~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~ 644 (721)
.+- ....|++-|.+||++. + +.|+..+|.||+||++|||+.|..||+.+ ++.+.+.+++....
T Consensus 221 sClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad--slveTY~KIm~hk~ 298 (1317)
T KOG0612|consen 221 SCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD--SLVETYGKIMNHKE 298 (1317)
T ss_pred hHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH--HHHHHHHHHhchhh
Confidence 642 3345788899999973 3 78999999999999999999999999633 44555544443311
Q ss_pred CCccccCCcccccc--HHHHHHHHHHHHHcccCCCCCCCC---HHHHHHHHHHhhhcCCCCCCCCCChhHHHHHHh
Q 004979 645 PLKDIVDPTLKSFQ--ENVLEELLVVIKNCVHPDPKQRPS---MRGIAAKLKEITAMEPDGATPKLSPLWWAELEI 715 (721)
Q Consensus 645 ~~~~~~d~~l~~~~--~~~~~~l~~li~~Cl~~dP~~RPs---~~evl~~L~~i~~~~~~~~~p~~~~~~~~~l~~ 715 (721)
.+ .+| ..+++++.+||.+.+. +|+.|.. .+|+ ..||++..++|+.+..
T Consensus 299 ~l---------~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedi-------------k~HpFF~g~~W~~iR~ 351 (1317)
T KOG0612|consen 299 SL---------SFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDI-------------KNHPFFEGIDWDNIRE 351 (1317)
T ss_pred hc---------CCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHH-------------HhCccccCCChhhhhh
Confidence 11 122 2367889999998875 6888877 6666 3489999999988764
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-32 Score=292.37 Aligned_cols=258 Identities=23% Similarity=0.334 Sum_probs=189.1
Q ss_pred CcCCCCceeEEEEEE-ecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCC----CceEEE
Q 004979 433 GSFSDGTVGTVYKGT-LSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDE----PFTRMM 507 (721)
Q Consensus 433 ~~lg~G~~g~Vyk~~-~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~----~~~~~l 507 (721)
+.+|+|+||.||+|+ -.+|+.||||.+..... ....+...+|+++|++++|+|||+++++-.+.. .....+
T Consensus 19 e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~----~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 19 ERLGKGAFGNVYRGRNKETGRLVAVKTFNKESS----LRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred hhhcCCccceeeeecccccccchhHHhhhhhcc----cchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 467899999999999 56899999998875431 233467889999999999999999999866544 335789
Q ss_pred EEecCCCCChhhhhhhc-cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeC--CCC--cEEEeccCCCC
Q 004979 508 VFEYSPNGSLFEHLHIQ-EAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLT--EDY--AAKISDFSFWN 582 (721)
Q Consensus 508 V~Ey~~~GsL~~~l~~~-~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~--~~~--~~kL~DFGla~ 582 (721)
|||||.+|||+..|..- ....|+....+.+..+++.||.|||+++ |+||||||.||++- ++| .-||+|||.|+
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~--IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Ar 172 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG--IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAR 172 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC--ceeccCCCCcEEEeecCCCceEEeeecccccc
Confidence 99999999999999743 2457999999999999999999999998 99999999999984 333 47999999998
Q ss_pred CCCC--------CCccccchhhcc-cCCCCCCccHHHHHHHHHHHHhCCCcccCCCCC--HHHHHHHHhhcCCC-Ccccc
Q 004979 583 NTTA--------AKTGSAAMELLE-TSAVDLESNVYSFGTILFEMITGRISYSIENGS--LENWASEYLKGEQP-LKDIV 650 (721)
Q Consensus 583 ~~~~--------~~~~~~apE~~~-~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~--~~~~~~~~~~~~~~-~~~~~ 650 (721)
.... |+..|.+||.++ ...|+..+|.|||||++||.+||..||....+. ..+........... ..-..
T Consensus 173 el~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~ 252 (732)
T KOG4250|consen 173 ELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIGA 252 (732)
T ss_pred cCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEee
Confidence 7654 455788999998 588999999999999999999999999743322 22222222222111 00000
Q ss_pred C-----Cc-----cc---cccHHHHHHHHHHHHHcccCCCCCCC--CHHHHHHHHHHhhhc
Q 004979 651 D-----PT-----LK---SFQENVLEELLVVIKNCVHPDPKQRP--SMRGIAAKLKEITAM 696 (721)
Q Consensus 651 d-----~~-----l~---~~~~~~~~~l~~li~~Cl~~dP~~RP--s~~evl~~L~~i~~~ 696 (721)
+ |. ++ .........+-.++..++..+|++|- .+.+....+.+|...
T Consensus 253 ~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~ 313 (732)
T KOG4250|consen 253 QEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNL 313 (732)
T ss_pred ecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhh
Confidence 0 00 00 01122223444556667777788887 666666666665543
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=289.64 Aligned_cols=246 Identities=17% Similarity=0.209 Sum_probs=183.1
Q ss_pred hhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCC------
Q 004979 430 NIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEP------ 502 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~------ 502 (721)
.++..+|.|+||.||+|+. .++..|++|++..+.. ...+.+.+|++++++++||||+++++++.....
T Consensus 8 ~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~-----~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (342)
T cd07854 8 MDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP-----QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDV 82 (342)
T ss_pred EEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC-----chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccc
Confidence 5677889999999999985 4688999998865432 224568899999999999999999987664321
Q ss_pred ------ceEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeC-CCCcEEE
Q 004979 503 ------FTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLT-EDYAAKI 575 (721)
Q Consensus 503 ------~~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~-~~~~~kL 575 (721)
...++||||++ ++|.+++. ...+++.....++.||+.||+|||+.+ |+||||||+||+++ +++.+|+
T Consensus 83 ~~~~~~~~~~lv~e~~~-~~L~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g--ivH~dikp~Nili~~~~~~~kl 156 (342)
T cd07854 83 GSLTELNSVYIVQEYME-TDLANVLE---QGPLSEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANVFINTEDLVLKI 156 (342)
T ss_pred ccccccceEEEEeeccc-ccHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEcCCCceEEE
Confidence 14689999997 58988874 235889999999999999999999988 99999999999998 5567899
Q ss_pred eccCCCCCCC------------CCCccccchhhcc-cCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhc
Q 004979 576 SDFSFWNNTT------------AAKTGSAAMELLE-TSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKG 642 (721)
Q Consensus 576 ~DFGla~~~~------------~~~~~~~apE~~~-~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~ 642 (721)
+|||+++... .+...|+|||.+. ...++.++|||||||++|||++|+.||..... .+........
T Consensus 157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~--~~~~~~~~~~ 234 (342)
T cd07854 157 GDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHE--LEQMQLILES 234 (342)
T ss_pred CCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHh
Confidence 9999875321 1234688999764 45688999999999999999999999963321 1111111111
Q ss_pred CCCC------------cc-------ccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 643 EQPL------------KD-------IVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 643 ~~~~------------~~-------~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
.... .. ..........+....++.+++.+||+.||++||++.|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 0000 00 0000001111234567889999999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=304.99 Aligned_cols=248 Identities=23% Similarity=0.341 Sum_probs=181.1
Q ss_pred HHHHhhhhhhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecC
Q 004979 422 EAACEDFSNIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEED 500 (721)
Q Consensus 422 ~~~~~~~~~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~ 500 (721)
.+..+|| +.+..+|+|+||.|||++.+ +|+.+|||++..+. +......+.+|+..|++|+|||||++|..+.+.
T Consensus 475 SRY~~DF-EEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~----s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs 549 (1351)
T KOG1035|consen 475 SRYLNDF-EELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA----SDKLYSKILREVKLLARLNHPNVVRYYSAWVES 549 (1351)
T ss_pred hhHhhhh-HHHHHhcCCCCceEEEEeecccchhhhhhhccCch----HHHHHHHHHHHHHHHhhcCCcceeeeehhhhcc
Confidence 4566788 56678999999999999965 79999999998764 233456788999999999999999998643211
Q ss_pred C-------------------------------------------------------------------------------
Q 004979 501 E------------------------------------------------------------------------------- 501 (721)
Q Consensus 501 ~------------------------------------------------------------------------------- 501 (721)
.
T Consensus 550 ~~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~ 629 (1351)
T KOG1035|consen 550 TAELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRN 629 (1351)
T ss_pred CCccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccc
Confidence 0
Q ss_pred --------------------------------------CceEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHH
Q 004979 502 --------------------------------------PFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAY 543 (721)
Q Consensus 502 --------------------------------------~~~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~ 543 (721)
+...||=||||+.-.|.++++.+.... .-....+++++|++
T Consensus 630 ~S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wrLFreIlE 708 (1351)
T KOG1035|consen 630 LSNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWRLFREILE 708 (1351)
T ss_pred cccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-hhHHHHHHHHHHHH
Confidence 012356678887777776665332211 23345679999999
Q ss_pred HHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC---------------------------CCCCccccchhh
Q 004979 544 CLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT---------------------------TAAKTGSAAMEL 596 (721)
Q Consensus 544 gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~---------------------------~~~~~~~~apE~ 596 (721)
||+|+|+.+ ||||||||.||+||++..+||+|||+++.. ..|+.-|+|||+
T Consensus 709 GLaYIH~~g--iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEl 786 (1351)
T KOG1035|consen 709 GLAYIHDQG--IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPEL 786 (1351)
T ss_pred HHHHHHhCc--eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHH
Confidence 999999999 999999999999999999999999997641 113446899999
Q ss_pred cccC---CCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccHHHHHHHHHHHHHcc
Q 004979 597 LETS---AVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCV 673 (721)
Q Consensus 597 ~~~~---~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl 673 (721)
+... .|+.|+|+||+|||++||+. ||.. .++-...+.....+.-+.. .++..+...+-..+|++++
T Consensus 787 l~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~T-sMERa~iL~~LR~g~iP~~-------~~f~~~~~~~e~slI~~Ll 855 (1351)
T KOG1035|consen 787 LSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGT-SMERASILTNLRKGSIPEP-------ADFFDPEHPEEASLIRWLL 855 (1351)
T ss_pred hcccccccccchhhhHHHHHHHHHHhc---cCCc-hHHHHHHHHhcccCCCCCC-------cccccccchHHHHHHHHHh
Confidence 8654 59999999999999999996 5631 1222222222222211111 2223344455677999999
Q ss_pred cCCCCCCCCHHHHHH
Q 004979 674 HPDPKQRPSMRGIAA 688 (721)
Q Consensus 674 ~~dP~~RPs~~evl~ 688 (721)
+.||.+|||+.|++.
T Consensus 856 ~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 856 SHDPSKRPTATELLN 870 (1351)
T ss_pred cCCCccCCCHHHHhh
Confidence 999999999999986
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-32 Score=265.22 Aligned_cols=238 Identities=18% Similarity=0.304 Sum_probs=186.4
Q ss_pred CcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcC-CCCccceEeEEEecC--CCceEEEE
Q 004979 433 GSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKV-NHKNFVNLIGYCEED--EPFTRMMV 508 (721)
Q Consensus 433 ~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~--~~~~~~lV 508 (721)
..+|-|-.|.|..+..+ ++..+|+|++... ...++|++.--+. .|||||.++++|... +.....+|
T Consensus 68 qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds----------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiV 137 (400)
T KOG0604|consen 68 QVLGAGINGKVVQCVHKRTQEKFALKVLLDS----------PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIV 137 (400)
T ss_pred hhhccccCCceEEEEeccchhhhHHHHHhcC----------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEee
Confidence 45667888899999854 6778888766421 3466888865555 699999999998642 22257899
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeC---CCCcEEEeccCCCCCCC
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLT---EDYAAKISDFSFWNNTT 585 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~---~~~~~kL~DFGla~~~~ 585 (721)
||+|+||.|++.+..+....+++.++-.|+.||+.|+.|||+.+ |.||||||+|+|.. .+-.+||+|||+|+...
T Consensus 138 mE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n--IAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~ 215 (400)
T KOG0604|consen 138 MECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN--IAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQ 215 (400)
T ss_pred eecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc--hhhccCChhheeeecCCCCcceEecccccccccC
Confidence 99999999999998777778999999999999999999999998 99999999999996 45679999999998655
Q ss_pred C--------CCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCC-CH-HHHHHHHhhcCCCCccccCCccc
Q 004979 586 A--------AKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENG-SL-ENWASEYLKGEQPLKDIVDPTLK 655 (721)
Q Consensus 586 ~--------~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~-~~-~~~~~~~~~~~~~~~~~~d~~l~ 655 (721)
. .++.|.|||++...+|+..+|+||+||++|-|+.|-+||....+ .+ .....++..+...+. ++
T Consensus 216 ~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP---~p--- 289 (400)
T KOG0604|consen 216 EPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFP---EP--- 289 (400)
T ss_pred CCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCC---Ch---
Confidence 2 35678999999999999999999999999999999999973221 11 111122222221111 11
Q ss_pred cccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004979 656 SFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAK 689 (721)
Q Consensus 656 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 689 (721)
.-...+++..++|+..|..+|++|.|+.|++..
T Consensus 290 -EWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 290 -EWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred -hHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 113567889999999999999999999999863
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=286.16 Aligned_cols=248 Identities=17% Similarity=0.223 Sum_probs=187.3
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCC----ce
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEP----FT 504 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~----~~ 504 (721)
+++..+|+|+||.||+|+.. ++..+++|++..... .....+.+.+|+.++++++|+||+++++++...+. ..
T Consensus 18 ~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 94 (343)
T cd07851 18 QNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQ---SAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQD 94 (343)
T ss_pred EEEEEeccCCceEEEEEEECCCCcEEEEEecccccc---hhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccccc
Confidence 67788999999999999965 577899998753211 12233567889999999999999999997765442 23
Q ss_pred EEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC
Q 004979 505 RMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT 584 (721)
Q Consensus 505 ~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~ 584 (721)
.++|+||+ +++|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++...
T Consensus 95 ~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nill~~~~~~kL~dfg~~~~~ 168 (343)
T cd07851 95 VYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSAG--IIHRDLKPSNIAVNEDCELKILDFGLARHT 168 (343)
T ss_pred EEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCCEEEccccccccc
Confidence 79999999 6799988753 46899999999999999999999988 999999999999999999999999987644
Q ss_pred CC------CCccccchhhccc-CCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCC-Ccccc------
Q 004979 585 TA------AKTGSAAMELLET-SAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQP-LKDIV------ 650 (721)
Q Consensus 585 ~~------~~~~~~apE~~~~-~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~-~~~~~------ 650 (721)
.. +...|++||.+.. ..++.++|||||||++|||+||+.||.... ..+.+......... ...+.
T Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~ 246 (343)
T cd07851 169 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSD--HIDQLKRIMNLVGTPDEELLQKISSE 246 (343)
T ss_pred cccccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHHhcCCCCHHHHhhccch
Confidence 32 2345889998754 467899999999999999999999996432 22222222211110 00000
Q ss_pred -------------CCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 651 -------------DPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 651 -------------d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
.+.........+.++.+++.+||+.+|++|||+.||++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 247 SARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred hHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 00000111123578999999999999999999999976
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.9e-31 Score=281.38 Aligned_cols=250 Identities=18% Similarity=0.196 Sum_probs=182.9
Q ss_pred hhhCcCCCCceeEEEEEEec-C--CcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcC-CCCccceEeEEEecC--CCc
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-S--GVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKV-NHKNFVNLIGYCEED--EPF 503 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~--~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~--~~~ 503 (721)
++.+.+|+|+||.||+++.. + +..+|+|++..... .....+.+.+|++++.++ +||||+++++++... ...
T Consensus 3 ~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 3 ELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFS---KKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred eEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccc---cchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence 45667889999999999965 3 67899998753221 122345688899999999 599999999875432 222
Q ss_pred eEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCC
Q 004979 504 TRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNN 583 (721)
Q Consensus 504 ~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~ 583 (721)
..++++||+. ++|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.
T Consensus 80 ~~~~~~e~~~-~~L~~~l~--~~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivH~dlkp~Nili~~~~~~kl~Dfg~a~~ 154 (332)
T cd07857 80 ELYLYEELME-ADLHQIIR--SGQPLTDAHFQSFIYQILCGLKYIHSAN--VLHRDLKPGNLLVNADCELKICDFGLARG 154 (332)
T ss_pred cEEEEEeccc-CCHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHeEEcCCCCEEeCcCCCcee
Confidence 4688899985 68988885 3456899999999999999999999988 99999999999999999999999998753
Q ss_pred CC-------------CCCccccchhhccc-CCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCC-CCc-
Q 004979 584 TT-------------AAKTGSAAMELLET-SAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQ-PLK- 647 (721)
Q Consensus 584 ~~-------------~~~~~~~apE~~~~-~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~-~~~- 647 (721)
.. .++..|+|||...+ ..++.++|||||||++|||++|+.||...+. ............ +..
T Consensus 155 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~ 232 (332)
T cd07857 155 FSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDY--VDQLNQILQVLGTPDEE 232 (332)
T ss_pred cccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCH--HHHHHHHHHHhCCCCHH
Confidence 22 13446899998755 5689999999999999999999999864321 111111111000 000
Q ss_pred ---ccc---------------CCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004979 648 ---DIV---------------DPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAK 689 (721)
Q Consensus 648 ---~~~---------------d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 689 (721)
.+. ...+....+....++.+++.+||+.||++||++.|++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 233 TLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred HHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000 000001111235678999999999999999999998763
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=264.30 Aligned_cols=254 Identities=20% Similarity=0.245 Sum_probs=186.3
Q ss_pred hhhhCcCCCCceeEEEEEEecC-----CcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCc
Q 004979 429 SNIIGSFSDGTVGTVYKGTLSS-----GVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPF 503 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~~-----~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 503 (721)
++++|.+|+|+||.||||.-.+ .+.+|+|+++..... + .......+|+..++.++|||||.+..++...+.
T Consensus 26 ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~--t-GiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~- 101 (438)
T KOG0666|consen 26 YEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDG--T-GISMSACREIALLRELKHPNVISLVKVFLSHDK- 101 (438)
T ss_pred hhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCC--C-CcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc-
Confidence 4899999999999999996332 236888887643221 1 122456799999999999999999998877332
Q ss_pred eEEEEEecCCCCChhhhhhhc---cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCC----CcEEEe
Q 004979 504 TRMMVFEYSPNGSLFEHLHIQ---EAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTED----YAAKIS 576 (721)
Q Consensus 504 ~~~lV~Ey~~~GsL~~~l~~~---~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~----~~~kL~ 576 (721)
..+|++||.+. +|.++++.. +...++-.....|.-||..|+.|||++- |+||||||.|||+..+ |.+||+
T Consensus 102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW--vlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW--VLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh--eeeccCCcceEEEeccCCccCeeEee
Confidence 78999999987 888888643 2357888899999999999999999988 9999999999999876 999999
Q ss_pred ccCCCCCCCC------------CCccccchhhccc-CCCCCCccHHHHHHHHHHHHhCCCcccCCCCC-------HHHHH
Q 004979 577 DFSFWNNTTA------------AKTGSAAMELLET-SAVDLESNVYSFGTILFEMITGRISYSIENGS-------LENWA 636 (721)
Q Consensus 577 DFGla~~~~~------------~~~~~~apE~~~~-~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~-------~~~~~ 636 (721)
|||+++.... -+..|.|||.+.+ ..||.+.||||.|||+.||+|-++-|...... ....+
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl 258 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQL 258 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHH
Confidence 9999874322 1235789998755 56899999999999999999998877643221 11222
Q ss_pred HHHhhcCCCCccccCCccccccH--------------H------------HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004979 637 SEYLKGEQPLKDIVDPTLKSFQE--------------N------------VLEELLVVIKNCVHPDPKQRPSMRGIAAK 689 (721)
Q Consensus 637 ~~~~~~~~~~~~~~d~~l~~~~~--------------~------------~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 689 (721)
.+++.-.....+-..|.+..+++ + -.+..++|+.+++.+||.+|.|+++.++.
T Consensus 259 ~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh 337 (438)
T KOG0666|consen 259 DRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH 337 (438)
T ss_pred HHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence 22222111111111121211111 0 01247889999999999999999998764
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-31 Score=269.42 Aligned_cols=215 Identities=20% Similarity=0.261 Sum_probs=170.5
Q ss_pred CceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEEEecCCCCC
Q 004979 438 GTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGS 516 (721)
Q Consensus 438 G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV~Ey~~~Gs 516 (721)
|.||.||+++. .+++.+++|++.... .+.+|...+....||||+++++++.+.+ ..++||||+++|+
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~----------~~~~~~~~~~~~~~~~i~~~~~~~~~~~--~~~lv~e~~~~~~ 71 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS----------EYSRERLTIIPHCVPNMVCLHKYIVSED--SVFLVLQHAEGGK 71 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh----------hhhhHHHHHHhcCCCceeehhhheecCC--eEEEEEecCCCCC
Confidence 88999999995 467889999875431 2334555555667999999999998776 6799999999999
Q ss_pred hhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCCC------CCcc
Q 004979 517 LFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTA------AKTG 590 (721)
Q Consensus 517 L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~~------~~~~ 590 (721)
|.+++... ..+++.....++.|++.||+|||+.+ |+||||||+||+++.++.++++|||.+..... ....
T Consensus 72 L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~ 147 (237)
T cd05576 72 LWSHISKF--LNIPEECVKRWAAEMVVALDALHREG--IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM 147 (237)
T ss_pred HHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEcCCCCEEEecccchhccccccccCCcCcc
Confidence 99998643 45899999999999999999999988 99999999999999999999999997653322 2345
Q ss_pred ccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccHHHHHHHHHHHH
Q 004979 591 SAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIK 670 (721)
Q Consensus 591 ~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~ 670 (721)
|++||......++.++||||+||++|||++|+.|+....... ..... ...+.....++.+++.
T Consensus 148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~--------------~~~~~---~~~~~~~~~~~~~li~ 210 (237)
T cd05576 148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI--------------NTHTT---LNIPEWVSEEARSLLQ 210 (237)
T ss_pred ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc--------------ccccc---cCCcccCCHHHHHHHH
Confidence 899999988889999999999999999999998874221100 00000 0122334567899999
Q ss_pred HcccCCCCCCCCHHH
Q 004979 671 NCVHPDPKQRPSMRG 685 (721)
Q Consensus 671 ~Cl~~dP~~RPs~~e 685 (721)
+||+.||++||++.+
T Consensus 211 ~~l~~dp~~R~~~~~ 225 (237)
T cd05576 211 QLLQFNPTERLGAGV 225 (237)
T ss_pred HHccCCHHHhcCCCc
Confidence 999999999999743
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=287.09 Aligned_cols=229 Identities=20% Similarity=0.306 Sum_probs=184.0
Q ss_pred hhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcC-CCCccceEeEEEecCCCceEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKV-NHKNFVNLIGYCEEDEPFTRMM 507 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~~~l 507 (721)
++...+|.|+|+.|-++.. .+++..+||++.... .+-.+|+.++... +||||+++.+.+.+.. +.|+
T Consensus 325 ~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~---------~~~~~e~~~~~~~~~h~niv~~~~v~~~~~--~~~~ 393 (612)
T KOG0603|consen 325 EFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA---------DDNQDEIPISLLVRDHPNIVKSHDVYEDGK--EIYL 393 (612)
T ss_pred ccccccCCCCccceeeeeccccccchhheeccccc---------cccccccchhhhhcCCCcceeecceecCCc--eeee
Confidence 4455689999999999984 567888999886542 1234567666665 7999999999998877 7899
Q ss_pred EEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEe-CCCCcEEEeccCCCCCCCC
Q 004979 508 VFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYL-TEDYAAKISDFSFWNNTTA 586 (721)
Q Consensus 508 V~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl-~~~~~~kL~DFGla~~~~~ 586 (721)
|||++.+|-+.+.+.... ... ..+..|+.+|+.|+.|||+++ ||||||||+|||+ ++.++++|+|||.++....
T Consensus 394 v~e~l~g~ell~ri~~~~--~~~-~e~~~w~~~lv~Av~~LH~~g--vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~ 468 (612)
T KOG0603|consen 394 VMELLDGGELLRRIRSKP--EFC-SEASQWAAELVSAVDYLHEQG--VVHRDLKPGNILLDGSAGHLRLTYFGFWSELER 468 (612)
T ss_pred eehhccccHHHHHHHhcc--hhH-HHHHHHHHHHHHHHHHHHhcC--eeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence 999999998887775322 223 667789999999999999988 9999999999999 5899999999999876544
Q ss_pred C------CccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccHH
Q 004979 587 A------KTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQEN 660 (721)
Q Consensus 587 ~------~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 660 (721)
. +..|.|||++....|++++|+||||++||||++|+.||...... .+....+-. ..+...
T Consensus 469 ~~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-~ei~~~i~~-------------~~~s~~ 534 (612)
T KOG0603|consen 469 SCDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-IEIHTRIQM-------------PKFSEC 534 (612)
T ss_pred hhcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-HHHHHhhcC-------------Cccccc
Confidence 3 34688999999999999999999999999999999999754433 222222111 112256
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 661 VLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 661 ~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
+++++.+|+..||+.||.+||+|.++..
T Consensus 535 vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 535 VSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred cCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 7789999999999999999999999865
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-31 Score=260.80 Aligned_cols=247 Identities=23% Similarity=0.354 Sum_probs=192.2
Q ss_pred HHHHHHHHhhhhhhhCcCCCCceeEEEEEE-ecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcC-CCCccceEeE
Q 004979 418 RSELEAACEDFSNIIGSFSDGTVGTVYKGT-LSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKV-NHKNFVNLIG 495 (721)
Q Consensus 418 ~~~l~~~~~~~~~ii~~lg~G~~g~Vyk~~-~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g 495 (721)
++|+-+.|. +.+|+|+|+.|--++ +.+|.++|||++.+.. ...+.+..+|++++... .|+||+.+++
T Consensus 75 F~d~YkLt~------e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~-----gHsR~RvfREVe~f~~Cqgh~nilqLie 143 (463)
T KOG0607|consen 75 FEDMYKLTS------ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP-----GHSRSRVFREVETFYQCQGHKNILQLIE 143 (463)
T ss_pred HHHHHHhHH------HHhcCccceeeeeeeeeccchhhhhhhhhcCC-----chHHHHHHHHHHHHHHhcCCccHHHHHH
Confidence 455555554 356799999999998 7899999999987542 34567889999999999 6999999999
Q ss_pred EEecCCCceEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCC---Cc
Q 004979 496 YCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTED---YA 572 (721)
Q Consensus 496 ~~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~---~~ 572 (721)
+|.++. ..|||||-|.||.|..+++. ...+++..+.++..+|+.||.|||.++ |.||||||+|||-.+. .-
T Consensus 144 fFEdd~--~FYLVfEKm~GGplLshI~~--~~~F~E~EAs~vvkdia~aLdFlH~kg--IAHRDlKPENiLC~~pn~vsP 217 (463)
T KOG0607|consen 144 FFEDDT--RFYLVFEKMRGGPLLSHIQK--RKHFNEREASRVVKDIASALDFLHTKG--IAHRDLKPENILCESPNKVSP 217 (463)
T ss_pred Hhcccc--eEEEEEecccCchHHHHHHH--hhhccHHHHHHHHHHHHHHHHHHhhcC--cccccCCccceeecCCCCcCc
Confidence 999988 56999999999999998864 456899999999999999999999999 9999999999998654 35
Q ss_pred EEEeccCCCCC----------------CCCCCccccchhhc-----ccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCC
Q 004979 573 AKISDFSFWNN----------------TTAAKTGSAAMELL-----ETSAVDLESNVYSFGTILFEMITGRISYSIENGS 631 (721)
Q Consensus 573 ~kL~DFGla~~----------------~~~~~~~~~apE~~-----~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~ 631 (721)
+||+||.+... ...+...|||||+. +...|+.++|.||+|||||-|+.|..||.+.-+.
T Consensus 218 vKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~ 297 (463)
T KOG0607|consen 218 VKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGA 297 (463)
T ss_pred eeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCC
Confidence 89999976431 12234468999986 4567899999999999999999999999743221
Q ss_pred HHHH-------------HHHHhhcCCCCccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 632 LENW-------------ASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 632 ~~~~-------------~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
--.| ...+-.+...+ -|. --..++.+..+++...+..|+.+|.++.+++.
T Consensus 298 dCGWdrGe~Cr~CQ~~LFesIQEGkYeF---Pdk----dWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 298 DCGWDRGEVCRVCQNKLFESIQEGKYEF---PDK----DWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred cCCccCCCccHHHHHHHHHHHhccCCcC---Chh----hhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 1111 11111111111 110 11346788999999999999999999998876
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=236.29 Aligned_cols=248 Identities=17% Similarity=0.228 Sum_probs=185.2
Q ss_pred hhhCcCCCCceeEEEEEE-ecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGT-LSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~-~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
+-.++||+|.||+||||+ +++++.||+|.+......+. .....++|+.+++.++|+|||+++++...++ ..-+|
T Consensus 5 dkmekigegtygtvfkarn~~t~eivalkrvrlddddeg---vpssalreicllkelkhknivrl~dvlhsdk--kltlv 79 (292)
T KOG0662|consen 5 DKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEG---VPSSALREICLLKELKHKNIVRLHDVLHSDK--KLTLV 79 (292)
T ss_pred HHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCC---CcHHHHHHHHHHHHhhhcceeehhhhhccCc--eeEEe
Confidence 345688999999999999 56788899999887654432 2346789999999999999999999998877 67899
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCCCC-
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTAA- 587 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~~~- 587 (721)
+|||.. +|..+... -...++......++.|+.+||.|+|++. +.||||||.|.||+.+|+.|++|||+++.....
T Consensus 80 fe~cdq-dlkkyfds-lng~~d~~~~rsfmlqllrgl~fchshn--vlhrdlkpqnllin~ngelkladfglarafgipv 155 (292)
T KOG0662|consen 80 FEFCDQ-DLKKYFDS-LNGDLDPEIVRSFMLQLLRGLGFCHSHN--VLHRDLKPQNLLINRNGELKLADFGLARAFGIPV 155 (292)
T ss_pred HHHhhH-HHHHHHHh-cCCcCCHHHHHHHHHHHHhhhhhhhhhh--hhhccCCcceEEeccCCcEEecccchhhhcCCce
Confidence 999954 78777643 4567899999999999999999999988 999999999999999999999999998743322
Q ss_pred --------Cccccchhhcc-cCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhcCCCCccccCCccc--
Q 004979 588 --------KTGSAAMELLE-TSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPLKDIVDPTLK-- 655 (721)
Q Consensus 588 --------~~~~~apE~~~-~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~-- 655 (721)
+-.|.+|.++. ..-|++..|+||-|||+.|+.. |++.|.+. +..+...+++.-.....+-..|.+.
T Consensus 156 rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~--dvddqlkrif~~lg~p~ed~wps~t~l 233 (292)
T KOG0662|consen 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN--DVDDQLKRIFRLLGTPTEDQWPSMTKL 233 (292)
T ss_pred EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCC--cHHHHHHHHHHHhCCCccccCCccccC
Confidence 22456777764 4568999999999999999998 66666533 3334444443221111111111110
Q ss_pred ----------------cccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 656 ----------------SFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 656 ----------------~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
...+.....-.+++++.+.-+|.+|.++++.++
T Consensus 234 pdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 234 PDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred CCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 011222334567888888889999999998764
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-31 Score=268.43 Aligned_cols=263 Identities=18% Similarity=0.254 Sum_probs=205.4
Q ss_pred hhhhhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcC-CCCccceEeEEEecCCCce
Q 004979 427 DFSNIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKV-NHKNFVNLIGYCEEDEPFT 504 (721)
Q Consensus 427 ~~~~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~ 504 (721)
|| +.+..+|+|+||.|..|..+ +...+|||++++..... ....+--..|-++|.-- +-|.+|++..+++..+ .
T Consensus 350 DF-nFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQ--dDDvectm~EKrvLAL~~kppFL~qlHScFQTmD--R 424 (683)
T KOG0696|consen 350 DF-NFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQ--DDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMD--R 424 (683)
T ss_pred cc-ceEEEeccCccceeeeecccCcchhhhhhhhccceeee--cCcccceehhhhheecCCCCchHHHHHHHhhhhh--h
Confidence 44 55677889999999999855 45678898887554322 22223334555666655 6789999999998877 6
Q ss_pred EEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCC-
Q 004979 505 RMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNN- 583 (721)
Q Consensus 505 ~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~- 583 (721)
.|.||||+.||+|.-+++ .-..+.+..+..+|..||-||-|||+++ ||.||||..|||||.+|++||+|||+++.
T Consensus 425 LyFVMEyvnGGDLMyhiQ--Q~GkFKEp~AvFYAaEiaigLFFLh~kg--IiYRDLKLDNvmLd~eGHiKi~DFGmcKEn 500 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQ--QVGKFKEPVAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 500 (683)
T ss_pred eeeEEEEecCchhhhHHH--HhcccCCchhhhhhHHHHHHhhhhhcCC--eeeeeccccceEeccCCceEeeeccccccc
Confidence 799999999999987764 3455778888999999999999999999 99999999999999999999999999763
Q ss_pred --------CCCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccc
Q 004979 584 --------TTAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLK 655 (721)
Q Consensus 584 --------~~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 655 (721)
+..+++.|+|||.+...+|+..+|.|||||+||||+.|+.||++++ ..+..+.+.....
T Consensus 501 i~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeD--E~elF~aI~ehnv----------- 567 (683)
T KOG0696|consen 501 IFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED--EDELFQAIMEHNV----------- 567 (683)
T ss_pred ccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCC--HHHHHHHHHHccC-----------
Confidence 3346778999999999999999999999999999999999997554 3444444433211
Q ss_pred cccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCChhHHHHHHhhhcc
Q 004979 656 SFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAMEPDGATPKLSPLWWAELEILSSE 719 (721)
Q Consensus 656 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~~~~p~~~~~~~~~l~~~~~~ 719 (721)
.++...+.|+.++.+..+.+.|.+|....- .......++|++--++|+.+|-.+.+
T Consensus 568 syPKslSkEAv~ickg~ltK~P~kRLGcg~--------~ge~di~~H~FFR~iDWek~E~~eiq 623 (683)
T KOG0696|consen 568 SYPKSLSKEAVAICKGLLTKHPGKRLGCGP--------EGERDIREHPFFRRIDWEKLERREIQ 623 (683)
T ss_pred cCcccccHHHHHHHHHHhhcCCccccCCCC--------ccccchhhCcchhhccHHHHhhccCC
Confidence 245667788999999999999999975431 11123456889999999999866543
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=267.16 Aligned_cols=248 Identities=21% Similarity=0.288 Sum_probs=189.0
Q ss_pred hhhhCcCCCCceeEEEEEE-ecCCcEEEEEEeeecc--ccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceE
Q 004979 429 SNIIGSFSDGTVGTVYKGT-LSSGVEIAVTSTSVKS--RADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTR 505 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~-~~~~~~vavk~~~~~~--~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~ 505 (721)
|-++..+|+|+|+.||||. +...+.||||+-.+.. +.+...+..+...+|.++-+.|+||.||++|+|+.-+.. ..
T Consensus 465 YLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd-sF 543 (775)
T KOG1151|consen 465 YLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD-SF 543 (775)
T ss_pred HHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc-cc
Confidence 4466778899999999998 5567788998765432 122223445667889999999999999999999875432 46
Q ss_pred EEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeC---CCCcEEEeccCCCC
Q 004979 506 MMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLT---EDYAAKISDFSFWN 582 (721)
Q Consensus 506 ~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~---~~~~~kL~DFGla~ 582 (721)
|-|+|||+|.+|.-+|+. ...+++..++.|+.||..||.||.+..|||||-||||.||||- ..|.+||.|||+++
T Consensus 544 CTVLEYceGNDLDFYLKQ--hklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSK 621 (775)
T KOG1151|consen 544 CTVLEYCEGNDLDFYLKQ--HKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSK 621 (775)
T ss_pred eeeeeecCCCchhHHHHh--hhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhh
Confidence 999999999999988863 4568999999999999999999999999999999999999995 45889999999986
Q ss_pred CCC----------------CCCccccchhhcc----cCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhc
Q 004979 583 NTT----------------AAKTGSAAMELLE----TSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKG 642 (721)
Q Consensus 583 ~~~----------------~~~~~~~apE~~~----~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~ 642 (721)
.+. .++..|.+||.+. ..+.+.|+||||.|||+|..+.|+.||... ....+.+. .
T Consensus 622 IMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhn-qsQQdILq----e 696 (775)
T KOG1151|consen 622 IMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHN-QSQQDILQ----E 696 (775)
T ss_pred hccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCc-hhHHHHHh----h
Confidence 432 2344567999873 346789999999999999999999999532 22222211 1
Q ss_pred CCCCccccCCcccccc--HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 643 EQPLKDIVDPTLKSFQ--ENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 643 ~~~~~~~~d~~l~~~~--~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
..++...-..++ +....+..++|++|+++.-++|....++..
T Consensus 697 ----NTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 697 ----NTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred ----hchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 111111111121 345678899999999999999988777654
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=264.81 Aligned_cols=247 Identities=19% Similarity=0.243 Sum_probs=190.2
Q ss_pred hhhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCC-C-Cc----cceEeEEEecCC
Q 004979 429 SNIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVN-H-KN----FVNLIGYCEEDE 501 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~-H-~n----Iv~l~g~~~~~~ 501 (721)
+++++.+|+|.||.|-++.. .++..||+|+++.- ....+.-+-|+++|.++. + |+ +|.+.+++...+
T Consensus 91 y~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V------~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrg 164 (415)
T KOG0671|consen 91 YEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV------DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRG 164 (415)
T ss_pred eehhhhhcCCcccceEEEeecCCCceehHHHHHHH------HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccC
Confidence 47889999999999999984 45688999887532 234456778999999993 2 22 778888888777
Q ss_pred CceEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCC------------
Q 004979 502 PFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTE------------ 569 (721)
Q Consensus 502 ~~~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~------------ 569 (721)
+.|+|+|.+ |-|++++|..+...+++...++.|+.|++++++|||+.+ ++|-||||+|||+-+
T Consensus 165 --hiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k--l~HTDLKPENILfvss~~~~~~~~k~~ 239 (415)
T KOG0671|consen 165 --HICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK--LTHTDLKPENILFVSSEYFKTYNPKKK 239 (415)
T ss_pred --ceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc--eeecCCChheEEEeccceEEEeccCCc
Confidence 789999998 669999998777788999999999999999999999998 999999999999832
Q ss_pred --------CCcEEEeccCCCCCCC------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCC-CHHH
Q 004979 570 --------DYAAKISDFSFWNNTT------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENG-SLEN 634 (721)
Q Consensus 570 --------~~~~kL~DFGla~~~~------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~-~~~~ 634 (721)
+..+||+|||-|+... ..+..|.|||++.+-.++.++||||+||||+|+.||...|...+. +-..
T Consensus 240 ~~~~r~~ks~~I~vIDFGsAtf~~e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLa 319 (415)
T KOG0671|consen 240 VCFIRPLKSTAIKVIDFGSATFDHEHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLA 319 (415)
T ss_pred cceeccCCCcceEEEecCCcceeccCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHH
Confidence 3458999999887543 345689999999999999999999999999999999999875441 1111
Q ss_pred HHHHHhhcCCCCccccCCc-----------------------------c-----ccccHHHHHHHHHHHHHcccCCCCCC
Q 004979 635 WASEYLKGEQPLKDIVDPT-----------------------------L-----KSFQENVLEELLVVIKNCVHPDPKQR 680 (721)
Q Consensus 635 ~~~~~~~~~~~~~~~~d~~-----------------------------l-----~~~~~~~~~~l~~li~~Cl~~dP~~R 680 (721)
.+..++ +..|. .++... . .........++++|+++++..||.+|
T Consensus 320 MMerIl-Gp~P~-~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~R 397 (415)
T KOG0671|consen 320 MMERIL-GPIPS-RMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARR 397 (415)
T ss_pred HHHHhh-CCCcH-HHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcccc
Confidence 222222 11111 111000 0 00112345679999999999999999
Q ss_pred CCHHHHHH
Q 004979 681 PSMRGIAA 688 (721)
Q Consensus 681 Ps~~evl~ 688 (721)
+|+.|++.
T Consensus 398 iTl~EAL~ 405 (415)
T KOG0671|consen 398 ITLREALS 405 (415)
T ss_pred ccHHHHhc
Confidence 99999875
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-29 Score=254.07 Aligned_cols=231 Identities=24% Similarity=0.340 Sum_probs=184.6
Q ss_pred ceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEEEecCCCCCh
Q 004979 439 TVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSL 517 (721)
Q Consensus 439 ~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV~Ey~~~GsL 517 (721)
+||.||+|+.. ++..+++|+......... .+.+.+|++.+++++|+||+++++++.... ..++++||+++++|
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~--~~~l~~e~~~~~~L 74 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK----RERILREISILKKLKHPNIVRLYDVFEDED--KLYLVMEYCDGGDL 74 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH----HHHHHHHHHHHHhCCCCcHHHHHhheeeCC--EEEEEEeCCCCCCH
Confidence 47899999976 488999998865433221 468999999999999999999999998766 67999999999999
Q ss_pred hhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCCC--------CCc
Q 004979 518 FEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTA--------AKT 589 (721)
Q Consensus 518 ~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~~--------~~~ 589 (721)
.+++.... .+++..+..++.+++.++.|||+.+ |+|+||+|+||++++++.++|+|||.+..... +..
T Consensus 75 ~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~ 150 (244)
T smart00220 75 FDLLKKRG--RLSEDEARFYARQILSALEYLHSNG--IIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTP 150 (244)
T ss_pred HHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHcC--eecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCc
Confidence 99986432 3889999999999999999999987 99999999999999999999999998754332 345
Q ss_pred cccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccHHHHHHHHHHH
Q 004979 590 GSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVI 669 (721)
Q Consensus 590 ~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li 669 (721)
.|++||......++.++||||||+++|||++|+.||... .+................ ........++.+++
T Consensus 151 ~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~-~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~i 221 (244)
T smart00220 151 EYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGD-DQLLELFKKIGKPKPPFP--------PPEWKISPEAKDLI 221 (244)
T ss_pred CCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CcHHHHHHHHhccCCCCc--------cccccCCHHHHHHH
Confidence 688999998888999999999999999999999999642 222222222221111100 00011456789999
Q ss_pred HHcccCCCCCCCCHHHHHH
Q 004979 670 KNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 670 ~~Cl~~dP~~RPs~~evl~ 688 (721)
.+||..+|++||++.++++
T Consensus 222 ~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 222 RKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHccCCchhccCHHHHhh
Confidence 9999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.7e-31 Score=274.00 Aligned_cols=257 Identities=18% Similarity=0.227 Sum_probs=208.1
Q ss_pred hhhCcCCCCceeEEEEEEecCCc-EEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLSSGV-EIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~~~~-~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
+++..+|-|+||.|-........ .+|+|+++++...+ ....+.+..|-.+|...+.|.||++|-.|.+.+ ..|+.
T Consensus 423 ~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVd--tkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~k--yvYmL 498 (732)
T KOG0614|consen 423 KRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVD--TKQQEHVFSERNIMMECRSDFIVRLYRTFRDSK--YVYML 498 (732)
T ss_pred hhhhhcccCccceEEEEEecccchHHHHHHHhHhhccc--hhHHHHHHhHHHHHHhcCchHHHHHHHHhccch--hhhhh
Confidence 56788999999999998866443 37888777665544 334467889999999999999999999998877 67999
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC----
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT---- 584 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~---- 584 (721)
||-|-||.|...|+ .++.++......++..+.+|++|||+++ ||.|||||+|.|||.+|.+||.|||+|+..
T Consensus 499 mEaClGGElWTiLr--dRg~Fdd~tarF~~acv~EAfeYLH~k~--iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~ 574 (732)
T KOG0614|consen 499 MEACLGGELWTILR--DRGSFDDYTARFYVACVLEAFEYLHRKG--IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR 574 (732)
T ss_pred HHhhcCchhhhhhh--hcCCcccchhhhhHHHHHHHHHHHHhcC--ceeccCChhheeeccCCceEEeehhhHHHhccCC
Confidence 99999999999996 3466888888999999999999999998 999999999999999999999999998754
Q ss_pred ----CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccHH
Q 004979 585 ----TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQEN 660 (721)
Q Consensus 585 ----~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 660 (721)
..+++.|.|||.+.....+.++|.||+||++|||+||++||. ..+.......++++... ..++..
T Consensus 575 KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs--~~dpmktYn~ILkGid~---------i~~Pr~ 643 (732)
T KOG0614|consen 575 KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFS--GVDPMKTYNLILKGIDK---------IEFPRR 643 (732)
T ss_pred ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCC--CCchHHHHHHHHhhhhh---------hhcccc
Confidence 446678999999999999999999999999999999999996 34455555566665321 234556
Q ss_pred HHHHHHHHHHHcccCCCCCCCC--HHHHHHHHHHhhhcCCCCCCCCCChhHHHHHHh
Q 004979 661 VLEELLVVIKNCVHPDPKQRPS--MRGIAAKLKEITAMEPDGATPKLSPLWWAELEI 715 (721)
Q Consensus 661 ~~~~l~~li~~Cl~~dP~~RPs--~~evl~~L~~i~~~~~~~~~p~~~~~~~~~l~~ 715 (721)
+.....+||++....+|.+|.. ...| .+ ...+..+.+++|+.|..
T Consensus 644 I~k~a~~Lik~LCr~~P~ERLG~~~~gI----~D------IkkH~Wf~gfdweglr~ 690 (732)
T KOG0614|consen 644 ITKTATDLIKKLCRDNPTERLGYQKGGI----ND------IKKHRWFEGFDWEGLRS 690 (732)
T ss_pred cchhHHHHHHHHHhcCcHhhhccccCCh----HH------HHhhhhhhcCChhhhhh
Confidence 6778889999999999999975 2211 11 12356777778877753
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=279.49 Aligned_cols=241 Identities=23% Similarity=0.319 Sum_probs=193.9
Q ss_pred hhhCcCCCCceeEEEEEE-ecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcC-CCCccceEeEEEecCC---Cce
Q 004979 430 NIIGSFSDGTVGTVYKGT-LSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKV-NHKNFVNLIGYCEEDE---PFT 504 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~-~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~---~~~ 504 (721)
+++..+|.|.+|.||+++ .++++.+|||+....... .++...|.++++.. +|||++.+||++...+ ...
T Consensus 22 ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~------deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~Dq 95 (953)
T KOG0587|consen 22 EIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE------EEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQ 95 (953)
T ss_pred EEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc------cHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCe
Confidence 677788899999999998 557888888887654332 35677888898887 7999999999986532 337
Q ss_pred EEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCC--
Q 004979 505 RMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWN-- 582 (721)
Q Consensus 505 ~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~-- 582 (721)
.|||||||.+||.-++++......+.|..+..|++.+++||.+||... ++|||||-.|||++.++.+|+.|||++.
T Consensus 96 LWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk--viHRDikG~NiLLT~e~~VKLvDFGvSaQl 173 (953)
T KOG0587|consen 96 LWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK--VIHRDIKGQNVLLTENAEVKLVDFGVSAQL 173 (953)
T ss_pred EEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc--eeeecccCceEEEeccCcEEEeeeeeeeee
Confidence 899999999999999998767788999999999999999999999887 9999999999999999999999999863
Q ss_pred -------CCCCCCccccchhhcc-----cCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCcccc
Q 004979 583 -------NTTAAKTGSAAMELLE-----TSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIV 650 (721)
Q Consensus 583 -------~~~~~~~~~~apE~~~-----~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (721)
.+..+++.|||||++. ...|+..+|+||+||+..||.-|.+|+. +......+..+-.. |
T Consensus 174 dsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~--DmHPmraLF~IpRN--P----- 244 (953)
T KOG0587|consen 174 DSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLC--DMHPMRALFLIPRN--P----- 244 (953)
T ss_pred ecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCcc--CcchhhhhccCCCC--C-----
Confidence 4455778899999983 3457789999999999999999999984 22211111111111 1
Q ss_pred CCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 651 DPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 651 d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
.|.+ .-++....++.++|..|+.+|-++||++.++++
T Consensus 245 PPkL-krp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 245 PPKL-KRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred Cccc-cchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 1111 124677889999999999999999999998874
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-30 Score=269.43 Aligned_cols=236 Identities=21% Similarity=0.319 Sum_probs=190.8
Q ss_pred CcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEEEec
Q 004979 433 GSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEY 511 (721)
Q Consensus 433 ~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV~Ey 511 (721)
+.+|.|.||+||-|++ ++|+.||||++.+.... ...+.+++.|+.+|.+++||.||.+--.|+..+ ..++|||-
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp---~kqesqlR~EVaILq~l~HPGiV~le~M~ET~e--rvFVVMEK 644 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFP---TKQESQLRNEVAILQNLHHPGIVNLECMFETPE--RVFVVMEK 644 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCC---CchHHHHHHHHHHHHhcCCCCeeEEEEeecCCc--eEEEEehh
Confidence 4678999999999995 57999999998754322 334578999999999999999999999998877 78999999
Q ss_pred CCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCC---CcEEEeccCCCCCCC---
Q 004979 512 SPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTED---YAAKISDFSFWNNTT--- 585 (721)
Q Consensus 512 ~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~---~~~kL~DFGla~~~~--- 585 (721)
+ +|+..+.+-..+...|+......+..||+.||.|||.++ |+|+||||+|||+.+. -++||||||+|+...
T Consensus 645 l-~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn--IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks 721 (888)
T KOG4236|consen 645 L-HGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN--IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS 721 (888)
T ss_pred h-cchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc--eeeccCCchheeeccCCCCCceeeccccceeecchhh
Confidence 9 556666665566778999988999999999999999998 9999999999999743 479999999997543
Q ss_pred -----CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccHH
Q 004979 586 -----AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQEN 660 (721)
Q Consensus 586 -----~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 660 (721)
.+++.|.|||+++...|...-|+||.|||+|--++|..||. ++.++.+.++...- +..+. --.+
T Consensus 722 FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFN-EdEdIndQIQNAaF-------MyPp~---PW~e 790 (888)
T KOG4236|consen 722 FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFN-EDEDINDQIQNAAF-------MYPPN---PWSE 790 (888)
T ss_pred hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCC-CccchhHHhhcccc-------ccCCC---chhh
Confidence 46788999999999999999999999999999999999995 33344333322110 01111 1135
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHH
Q 004979 661 VLEELLVVIKNCVHPDPKQRPSMRGIA 687 (721)
Q Consensus 661 ~~~~l~~li~~Cl~~dP~~RPs~~evl 687 (721)
+..+..+||...++..-++|-+.+..+
T Consensus 791 is~~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 791 ISPEAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred cCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence 667889999999999989998877654
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-29 Score=265.92 Aligned_cols=191 Identities=18% Similarity=0.304 Sum_probs=159.7
Q ss_pred hhhCcCCCCceeEEEEEE-ecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGT-LSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~-~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
-.|+.||-|+||+|..+. .++...+|.|.+.++.. ...+.......|-.||...+.+-||+||--|.+.+ ..|+|
T Consensus 632 vkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDV--l~rnQvaHVKAERDILAEADn~WVVrLyySFQDkd--nLYFV 707 (1034)
T KOG0608|consen 632 VKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADV--LMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKD--NLYFV 707 (1034)
T ss_pred EEEeeecccccceeEEEeecchhhHHHHhhhHHHHH--HhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCC--ceEEE
Confidence 356789999999999987 45555677777654432 12333456788999999999999999999999888 67999
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCC-----
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNN----- 583 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~----- 583 (721)
|||++||++..+|.. .+.+.+..++.++..+..|+++.|..| +|||||||+|||||.+|++||.||||+..
T Consensus 708 MdYIPGGDmMSLLIr--mgIFeE~LARFYIAEltcAiesVHkmG--FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTH 783 (1034)
T KOG0608|consen 708 MDYIPGGDMMSLLIR--MGIFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 783 (1034)
T ss_pred EeccCCccHHHHHHH--hccCHHHHHHHHHHHHHHHHHHHHhcc--ceecccCccceEEccCCceeeeeccccccceecc
Confidence 999999999999863 456788888889999999999999998 99999999999999999999999998530
Q ss_pred ----------------------------------------------CCCCCccccchhhcccCCCCCCccHHHHHHHHHH
Q 004979 584 ----------------------------------------------TTAAKTGSAAMELLETSAVDLESNVYSFGTILFE 617 (721)
Q Consensus 584 ----------------------------------------------~~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~E 617 (721)
...++..|+|||++....|+.-+|.||.||||||
T Consensus 784 dskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~e 863 (1034)
T KOG0608|consen 784 DSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYE 863 (1034)
T ss_pred ccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHH
Confidence 0113346889999999999999999999999999
Q ss_pred HHhCCCcccCC
Q 004979 618 MITGRISYSIE 628 (721)
Q Consensus 618 lltG~~P~~~~ 628 (721)
|+.|+.||...
T Consensus 864 m~~g~~pf~~~ 874 (1034)
T KOG0608|consen 864 MLVGQPPFLAD 874 (1034)
T ss_pred HhhCCCCccCC
Confidence 99999999644
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-29 Score=233.23 Aligned_cols=203 Identities=20% Similarity=0.237 Sum_probs=161.0
Q ss_pred hhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcC-CCCccceEeEEEecCCCceEEEE
Q 004979 431 IIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKV-NHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 431 ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
.+..+|+|+||.|-+-++ .+|...|||.+..... ....++.+.|+.+..+. ..|.+|++||.+.... ..++.
T Consensus 50 ~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn----~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~reg--dvwIc 123 (282)
T KOG0984|consen 50 GIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN----SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREG--DVWIC 123 (282)
T ss_pred hhhhhcCCccchhhheeeccCCeEEEEeeehhhcC----hHHHHHHHHhhhhhccCCCCCeEEEeehhhhccc--cEEEe
Confidence 456789999999988875 5788999999875432 33456788888876554 7999999999776655 67999
Q ss_pred EecCCCCChhhhhhh--ccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCC-----
Q 004979 509 FEYSPNGSLFEHLHI--QEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFW----- 581 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~--~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla----- 581 (721)
||.| .-||..+.+. .....+++...-+||..|.+||.|||++- .+||||+||+|||++.+|++|+||||++
T Consensus 124 ME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL-~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~d 201 (282)
T KOG0984|consen 124 MELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL-SVIHRDVKPSNILINYDGQVKICDFGISGYLVD 201 (282)
T ss_pred HHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh-hhhhccCCcceEEEccCCcEEEcccccceeehh
Confidence 9999 4588776542 24566888888899999999999999753 3999999999999999999999999975
Q ss_pred ---CCCCCCCccccchhhcc----cCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhc
Q 004979 582 ---NNTTAAKTGSAAMELLE----TSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKG 642 (721)
Q Consensus 582 ---~~~~~~~~~~~apE~~~----~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~ 642 (721)
+....+...|||||.+. ...|+.|+||||+|+++.||.+++.||+.-. ..-+.+++++..
T Consensus 202 SiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~-tpF~qLkqvVee 268 (282)
T KOG0984|consen 202 SIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG-TPFQQLKQVVEE 268 (282)
T ss_pred hhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC-CHHHHHHHHhcC
Confidence 34456677899999873 4579999999999999999999999996433 333344455443
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.4e-29 Score=283.66 Aligned_cols=245 Identities=16% Similarity=0.218 Sum_probs=155.6
Q ss_pred hhhCcCCCCceeEEEEEEec-C----CcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEE----ecC
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-S----GVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYC----EED 500 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~----~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~----~~~ 500 (721)
++...+|+|+||.||+|++. + +..||+|++...... +.+..| .+....+.+++.++..+ ...
T Consensus 135 ~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~-------e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 135 VLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV-------EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred EEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh-------HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 67788999999999999975 4 688999976532110 111111 12222233333322211 111
Q ss_pred CCceEEEEEecCCCCChhhhhhhccCC------------------CCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCC
Q 004979 501 EPFTRMMVFEYSPNGSLFEHLHIQEAE------------------HLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQS 562 (721)
Q Consensus 501 ~~~~~~lV~Ey~~~GsL~~~l~~~~~~------------------~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp 562 (721)
.....++||||+++|+|.++++..... ......+..|+.|++.||+|||+.+ |+||||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g--IiHRDLKP 283 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG--IVHRDVKP 283 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC--EEeCcCCH
Confidence 122579999999999999998643210 0112335579999999999999987 99999999
Q ss_pred CCeEeCC-CCcEEEeccCCCCCCC----------CCCccccchhhcccC----------------------CCCCCccHH
Q 004979 563 SSIYLTE-DYAAKISDFSFWNNTT----------AAKTGSAAMELLETS----------------------AVDLESNVY 609 (721)
Q Consensus 563 ~NILl~~-~~~~kL~DFGla~~~~----------~~~~~~~apE~~~~~----------------------~~s~ksDVw 609 (721)
+|||+++ ++.+||+|||+++... .++..|+|||.+... .++.++|||
T Consensus 284 ~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVw 363 (566)
T PLN03225 284 QNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY 363 (566)
T ss_pred HHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccH
Confidence 9999995 5899999999986432 234579999965321 245677999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCc---cccCCc----cc---cccHHHHHHHHHHHHHcccCCCCC
Q 004979 610 SFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLK---DIVDPT----LK---SFQENVLEELLVVIKNCVHPDPKQ 679 (721)
Q Consensus 610 SfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~---~~~d~~----l~---~~~~~~~~~l~~li~~Cl~~dP~~ 679 (721)
||||+||||+++..+++. +...+............ ....+. .. +..........+|+.+|++.||++
T Consensus 364 SlGviL~el~~~~~~~~~---~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~k 440 (566)
T PLN03225 364 SAGLIFLQMAFPNLRSDS---NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQ 440 (566)
T ss_pred HHHHHHHHHHhCcCCCch---HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCccc
Confidence 999999999998766531 12221111111100000 000000 00 000111234568999999999999
Q ss_pred CCCHHHHHH
Q 004979 680 RPSMRGIAA 688 (721)
Q Consensus 680 RPs~~evl~ 688 (721)
|||+.|+++
T Consensus 441 R~ta~e~L~ 449 (566)
T PLN03225 441 RISAKAALA 449 (566)
T ss_pred CCCHHHHhC
Confidence 999999986
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-28 Score=270.68 Aligned_cols=247 Identities=15% Similarity=0.225 Sum_probs=171.1
Q ss_pred hhhCcCCCCceeEEEEEEe-----------------cCCcEEEEEEeeeccccchh---------hHHHHHHHHHHHHHh
Q 004979 430 NIIGSFSDGTVGTVYKGTL-----------------SSGVEIAVTSTSVKSRADWS---------KNLESQFRKKIDTLS 483 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~-----------------~~~~~vavk~~~~~~~~~~~---------~~~~~~f~~Ei~~l~ 483 (721)
++..+||+|+||+||+|.. ..++.||||++......... ....+.+..|+.++.
T Consensus 148 ~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l~ 227 (507)
T PLN03224 148 QLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMCA 227 (507)
T ss_pred eEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHHH
Confidence 5678899999999999964 23467999987643211100 001123445777888
Q ss_pred cCCCCcc-----ceEeEEEecCC------CceEEEEEecCCCCChhhhhhhcc----------------------CCCCC
Q 004979 484 KVNHKNF-----VNLIGYCEEDE------PFTRMMVFEYSPNGSLFEHLHIQE----------------------AEHLD 530 (721)
Q Consensus 484 ~l~H~nI-----v~l~g~~~~~~------~~~~~lV~Ey~~~GsL~~~l~~~~----------------------~~~l~ 530 (721)
+++|.++ ++++++|.... ....+|||||+++|+|.++++... ...++
T Consensus 228 ~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~ 307 (507)
T PLN03224 228 KIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRD 307 (507)
T ss_pred HhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCC
Confidence 8877654 67788875421 125799999999999999986421 12356
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCCC----------CCccccchhhcccC
Q 004979 531 WAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTA----------AKTGSAAMELLETS 600 (721)
Q Consensus 531 ~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~~----------~~~~~~apE~~~~~ 600 (721)
|..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.... .+..|++||.+...
T Consensus 308 ~~~~~~i~~ql~~aL~~lH~~~--ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~ 385 (507)
T PLN03224 308 INVIKGVMRQVLTGLRKLHRIG--IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMP 385 (507)
T ss_pred HHHHHHHHHHHHHHHHHHHHCC--eecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhcCC
Confidence 7888999999999999999988 99999999999999999999999999854321 13568999987432
Q ss_pred C--------------------C--CCCccHHHHHHHHHHHHhCCC-cccCCC----------CCHHHHHHHHhhcCCCCc
Q 004979 601 A--------------------V--DLESNVYSFGTILFEMITGRI-SYSIEN----------GSLENWASEYLKGEQPLK 647 (721)
Q Consensus 601 ~--------------------~--s~ksDVwSfGvvL~ElltG~~-P~~~~~----------~~~~~~~~~~~~~~~~~~ 647 (721)
. | ..+.||||+||++|||++|.. |+.... .+...|.. .....
T Consensus 386 ~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~--~~~~~--- 460 (507)
T PLN03224 386 QSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRM--YKGQK--- 460 (507)
T ss_pred CCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHh--hcccC---
Confidence 2 1 235799999999999999875 664211 11111110 00000
Q ss_pred cccCCccccccHHHHHHHHHHHHHcccCCC---CCCCCHHHHHH
Q 004979 648 DIVDPTLKSFQENVLEELLVVIKNCVHPDP---KQRPSMRGIAA 688 (721)
Q Consensus 648 ~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP---~~RPs~~evl~ 688 (721)
.+ . .......+...+|+.+++..+| .+|+|+.|+++
T Consensus 461 --~~--~-~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 461 --YD--F-SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred --CC--c-ccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 00 0 1123346778999999999766 68999999985
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=244.14 Aligned_cols=253 Identities=20% Similarity=0.291 Sum_probs=182.4
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCC------C
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDE------P 502 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~------~ 502 (721)
+-+.++|+|.||.||+|+.+ +++.|++|++-...... ..-...++|+++|..++|+|++.++++|.... .
T Consensus 20 ek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKe---GfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 20 EKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKE---GFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred HHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhcccc---CCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 44567889999999999854 57778887664322111 11235679999999999999999999886421 2
Q ss_pred ceEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCC
Q 004979 503 FTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWN 582 (721)
Q Consensus 503 ~~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~ 582 (721)
...|+||++|+. +|.-+|. .....++...+.+++.++..||.|+|... |+|||+|++|+||+.++.+||+|||+++
T Consensus 97 ~t~ylVf~~ceh-DLaGlLs-n~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k--ilHRDmKaaNvLIt~dgilklADFGlar 172 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLS-NRKVRFSLSEIKKVMKGLMNGLYYIHRNK--ILHRDMKAANVLITKDGILKLADFGLAR 172 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhc-CccccccHHHHHHHHHHHHHHHHHHHHhh--HHhhcccHhhEEEcCCceEEeecccccc
Confidence 247999999977 8888875 33456889999999999999999999988 9999999999999999999999999985
Q ss_pred CCCC-------C------Cccccchhhcc-cCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCC---
Q 004979 583 NTTA-------A------KTGSAAMELLE-TSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQP--- 645 (721)
Q Consensus 583 ~~~~-------~------~~~~~apE~~~-~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~--- 645 (721)
.... . +-.|.+||.+. ...|+++.|||..|||+.||.||.+-+.+......-...+.+.+...
T Consensus 173 ~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkev 252 (376)
T KOG0669|consen 173 AFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEV 252 (376)
T ss_pred ceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCccc
Confidence 3211 1 22567999874 56799999999999999999999987754322111111122222110
Q ss_pred --------CccccC-Cccc----cccHHHH------HHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004979 646 --------LKDIVD-PTLK----SFQENVL------EELLVVIKNCVHPDPKQRPSMRGIAAK 689 (721)
Q Consensus 646 --------~~~~~d-~~l~----~~~~~~~------~~l~~li~~Cl~~dP~~RPs~~evl~~ 689 (721)
+.+-+. +.+. ...++.. ++..+|+..++..||.+|+.+++++..
T Consensus 253 WP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 253 WPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred CCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 000000 0000 0011222 378899999999999999999998764
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-28 Score=233.24 Aligned_cols=245 Identities=16% Similarity=0.251 Sum_probs=188.7
Q ss_pred hhhhCcCCCCceeEEEEEE-ecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCC-CCccceEeEEEecCCCceEE
Q 004979 429 SNIIGSFSDGTVGTVYKGT-LSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVN-HKNFVNLIGYCEEDEPFTRM 506 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~-~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~~~ 506 (721)
++++.++|+|.|++||.|. ..+...++||+++.. ..+.+.+|+.+|..++ ||||++++++..++......
T Consensus 40 Yeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV--------kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktpa 111 (338)
T KOG0668|consen 40 YEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV--------KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPS 111 (338)
T ss_pred HHHHHHHcCccHhhHhcccccCCCceEEEeeechH--------HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCch
Confidence 4788999999999999998 566778888887632 2467899999999997 99999999999887665678
Q ss_pred EEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCC-CCcEEEeccCCCCCCC
Q 004979 507 MVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTE-DYAAKISDFSFWNNTT 585 (721)
Q Consensus 507 lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~-~~~~kL~DFGla~~~~ 585 (721)
||+||+.+.+...+. +.++-..+..+..++..||.|+|+.| |.|||+||.|++||. .-..+|+|+|+|....
T Consensus 112 LiFE~v~n~Dfk~ly-----~tl~d~dIryY~~elLkALdyCHS~G--ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH 184 (338)
T KOG0668|consen 112 LIFEYVNNTDFKQLY-----PTLTDYDIRYYIYELLKALDYCHSMG--IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
T ss_pred hHhhhhccccHHHHh-----hhhchhhHHHHHHHHHHHHhHHHhcC--cccccCCcceeeechhhceeeeeecchHhhcC
Confidence 999999998876554 34677778889999999999999999 999999999999994 5679999999987544
Q ss_pred CC--------Cccccchhhc-ccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHh-hcCC-------CCcc
Q 004979 586 AA--------KTGSAAMELL-ETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYL-KGEQ-------PLKD 648 (721)
Q Consensus 586 ~~--------~~~~~apE~~-~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~-~~~~-------~~~~ 648 (721)
.+ +..+..||.+ ....|+..-|+|||||+|.+|+..+.||.....+..+.++-.- -|.. .+.-
T Consensus 185 p~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i 264 (338)
T KOG0668|consen 185 PGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQI 264 (338)
T ss_pred CCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHcc
Confidence 43 3345689987 4567899999999999999999999999755544444332110 0000 0111
Q ss_pred ccCCcccc------------c-----cHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 649 IVDPTLKS------------F-----QENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 649 ~~d~~l~~------------~-----~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
.+||...+ + ..-..+++.+++.+.+..|-.+|+|++|.+.
T Consensus 265 ~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 265 DLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred CCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 12222111 1 1113478999999999999999999999875
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-28 Score=243.95 Aligned_cols=263 Identities=19% Similarity=0.295 Sum_probs=199.4
Q ss_pred hhhhhhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcC-CCCccceEeEEEecCCCc
Q 004979 426 EDFSNIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKV-NHKNFVNLIGYCEEDEPF 503 (721)
Q Consensus 426 ~~~~~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~ 503 (721)
++| .++..||+|+|.+|..+++. +.+.+|+|++++....+ +....-...|-.+..+. +||.+|.+..++....
T Consensus 250 ~df-~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nd--dedidwvqtek~vfe~asn~pflvglhscfqtes-- 324 (593)
T KOG0695|consen 250 QDF-DLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVND--DEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTES-- 324 (593)
T ss_pred ccc-eeeeeecCcchhhhhheehcccceeeehhhHHHHhcCC--cccchhHHhhHHHHHhccCCCeEEehhhhhcccc--
Confidence 345 56778899999999999965 56778888776443222 11123344455555554 7999999999998876
Q ss_pred eEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCC
Q 004979 504 TRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNN 583 (721)
Q Consensus 504 ~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~ 583 (721)
..+.|.||+++|+|.-+++ ..+.+++..++.+...|..||.|||+.+ ||.||||..|||+|..|.+|+.|+|+++.
T Consensus 325 rlffvieyv~ggdlmfhmq--rqrklpeeharfys~ei~lal~flh~rg--iiyrdlkldnvlldaeghikltdygmcke 400 (593)
T KOG0695|consen 325 RLFFVIEYVNGGDLMFHMQ--RQRKLPEEHARFYSAEICLALNFLHERG--IIYRDLKLDNVLLDAEGHIKLTDYGMCKE 400 (593)
T ss_pred eEEEEEEEecCcceeeehh--hhhcCcHHHhhhhhHHHHHHHHHHhhcC--eeeeeccccceEEccCCceeecccchhhc
Confidence 6799999999999987775 4456889999999999999999999999 99999999999999999999999998763
Q ss_pred ---------CCCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccC-----CCCCHHHHHHHHhhcCCCCccc
Q 004979 584 ---------TTAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSI-----ENGSLENWASEYLKGEQPLKDI 649 (721)
Q Consensus 584 ---------~~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~-----~~~~~~~~~~~~~~~~~~~~~~ 649 (721)
+..+++.|.|||.+++..|....|.|++||+|+||+.|+.||+. .+.+.++++.+++...+.
T Consensus 401 ~l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqi---- 476 (593)
T KOG0695|consen 401 GLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQI---- 476 (593)
T ss_pred CCCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcc----
Confidence 33466789999999999999999999999999999999999984 234556666555443221
Q ss_pred cCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCChhHHHHHH
Q 004979 650 VDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAMEPDGATPKLSPLWWAELE 714 (721)
Q Consensus 650 ~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~~~~p~~~~~~~~~l~ 714 (721)
..+...+.....+++.-+.+||.+|....-- .-....+.++++-.++|+-+|
T Consensus 477 ------riprslsvkas~vlkgflnkdp~erlgc~~~-------~g~~dik~h~ffr~idwd~le 528 (593)
T KOG0695|consen 477 ------RIPRSLSVKASHVLKGFLNKDPKERLGCRPQ-------TGFSDIKSHAFFRSIDWDLLE 528 (593)
T ss_pred ------cccceeehhhHHHHHHhhcCCcHHhcCCCcc-------cchhhhhcchhhhhCCHHHHh
Confidence 1223344566778889999999999653210 012223446777788888765
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-28 Score=270.03 Aligned_cols=231 Identities=23% Similarity=0.373 Sum_probs=172.3
Q ss_pred hhhCcCCCCceeEEEEEEecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcC-CCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKV-NHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
+++|.+.+|+ .||+|.++ ++.||||++... ...-..+||..|..- +|||||++|+.-.++. +.||.
T Consensus 515 eilG~Gs~Gt--~Vf~G~ye-~R~VAVKrll~e--------~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~q--F~YIa 581 (903)
T KOG1027|consen 515 EILGYGSNGT--VVFRGVYE-GREVAVKRLLEE--------FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQ--FLYIA 581 (903)
T ss_pred HHcccCCCCc--EEEEEeeC-CceehHHHHhhH--------hHHHHHHHHHHHHhccCCCceEEEEeeccCCc--eEEEE
Confidence 4555544442 58999987 779999977421 223467899999988 6999999977665555 78999
Q ss_pred EecCCCCChhhhhhhc--cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCC-----CCcEEEeccCCC
Q 004979 509 FEYSPNGSLFEHLHIQ--EAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTE-----DYAAKISDFSFW 581 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~--~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~-----~~~~kL~DFGla 581 (721)
.|.| .-+|.+++... ......-...+.+..|++.||+|||+++ ||||||||.||||+. ..+++|+|||++
T Consensus 582 lELC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~--iVHRDLkPQNILI~~~~~~~~~ra~iSDfgls 658 (903)
T KOG1027|consen 582 LELC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK--IVHRDLKPQNILISVPSADGTLRAKISDFGLS 658 (903)
T ss_pred ehHh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc--cccccCCCceEEEEccCCCcceeEEecccccc
Confidence 9999 45999998652 1111111234678899999999999998 999999999999975 357999999998
Q ss_pred CCCC------------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhcCCCCcc
Q 004979 582 NNTT------------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPLKD 648 (721)
Q Consensus 582 ~~~~------------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~ 648 (721)
+... .++.+|+|||.+....-+.++||+|+|||+|..+| |+.||... .+--..++.+...+..
T Consensus 659 Kkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~----~~R~~NIl~~~~~L~~ 734 (903)
T KOG1027|consen 659 KKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDS----LERQANILTGNYTLVH 734 (903)
T ss_pred cccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCch----HHhhhhhhcCccceee
Confidence 6443 35668999999998888889999999999999999 59999522 1112233333332222
Q ss_pred ccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 649 IVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 649 ~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
+. .. +++ ++.+||.+|++.+|..||++.+|+.
T Consensus 735 L~-----~~-~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 735 LE-----PL-PDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred ec-----cC-chH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 11 11 122 8899999999999999999999974
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.5e-26 Score=225.21 Aligned_cols=202 Identities=30% Similarity=0.466 Sum_probs=173.4
Q ss_pred CCCCceeEEEEEEecC-CcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEEEecCC
Q 004979 435 FSDGTVGTVYKGTLSS-GVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSP 513 (721)
Q Consensus 435 lg~G~~g~Vyk~~~~~-~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV~Ey~~ 513 (721)
+|+|.+|.||+++... +..+++|+........ ....+.+|++.+++++|++|+++++++.... ..++++||++
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~--~~~~~~e~~~ 74 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS----LLEELLREIEILKKLNHPNIVKLYGVFEDEN--HLYLVMEYCE 74 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh----HHHHHHHHHHHHHhcCCCCeeeEeeeeecCC--eEEEEEecCC
Confidence 5789999999999764 8889999886543221 3467999999999999999999999998765 6799999999
Q ss_pred CCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCC-CCcEEEeccCCCCCCCC------
Q 004979 514 NGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTE-DYAAKISDFSFWNNTTA------ 586 (721)
Q Consensus 514 ~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~-~~~~kL~DFGla~~~~~------ 586 (721)
+++|.+++.... ..+++..+..++.+++++++|||+.+ ++|+||+|.||+++. ++.++|+|||.+.....
T Consensus 75 ~~~l~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~--~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~ 151 (215)
T cd00180 75 GGSLKDLLKENE-GKLSEDEILRILLQILEGLEYLHSNG--IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLK 151 (215)
T ss_pred CCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhh
Confidence 999999986322 46899999999999999999999987 999999999999999 89999999998753322
Q ss_pred ---CCccccchhhcccC-CCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccHHHH
Q 004979 587 ---AKTGSAAMELLETS-AVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQENVL 662 (721)
Q Consensus 587 ---~~~~~~apE~~~~~-~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 662 (721)
....|.+||..... .++.+.|+|++|++++||
T Consensus 152 ~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------------------- 187 (215)
T cd00180 152 TIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------------------- 187 (215)
T ss_pred cccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH--------------------------------------------
Confidence 34567899998777 888999999999999998
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004979 663 EELLVVIKNCVHPDPKQRPSMRGIAAK 689 (721)
Q Consensus 663 ~~l~~li~~Cl~~dP~~RPs~~evl~~ 689 (721)
.++.+++..|++.+|++||++.++++.
T Consensus 188 ~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 457789999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.7e-26 Score=237.68 Aligned_cols=132 Identities=17% Similarity=0.192 Sum_probs=110.9
Q ss_pred hhhhhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCC-----C---CccceEeEEE
Q 004979 427 DFSNIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVN-----H---KNFVNLIGYC 497 (721)
Q Consensus 427 ~~~~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~-----H---~nIv~l~g~~ 497 (721)
+.|.++.++|-|-|++||.|.. ...+.||+|+++.. ....+..+.||++|++++ | .+||+|++.|
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA------qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~F 151 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA------QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHF 151 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh------hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccc
Confidence 3357889999999999999984 45678999887532 334466789999999884 3 3599999999
Q ss_pred ecCC--CceEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCeEeeCCCCCCeEe
Q 004979 498 EEDE--PFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQ-LTPPIAHRNLQSSSIYL 567 (721)
Q Consensus 498 ~~~~--~~~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~-~~~~IvHrDLKp~NILl 567 (721)
...+ ..+.|||+|+. |-+|..+|.....+.++.....+|++||+.||.|||. |+ |||-||||+|||+
T Consensus 152 khsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecg--IIHTDlKPENvLl 221 (590)
T KOG1290|consen 152 KHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECG--IIHTDLKPENVLL 221 (590)
T ss_pred eecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcC--ccccCCCcceeee
Confidence 7643 34899999999 7799999987777889999999999999999999995 77 9999999999999
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.5e-27 Score=245.46 Aligned_cols=257 Identities=19% Similarity=0.224 Sum_probs=194.6
Q ss_pred HHHHHhhhhhhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCC------CCccceE
Q 004979 421 LEAACEDFSNIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVN------HKNFVNL 493 (721)
Q Consensus 421 l~~~~~~~~~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~------H~nIv~l 493 (721)
|.+...+.|++.+..|+|-|++|.+|.. ..|..||||++.... ...+.=++|+++|++|. --|+++|
T Consensus 426 igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE------~M~KtGl~EleiLkKL~~AD~Edk~Hclrl 499 (752)
T KOG0670|consen 426 IGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE------VMHKTGLKELEILKKLNDADPEDKFHCLRL 499 (752)
T ss_pred hhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch------HHhhhhhHHHHHHHHhhccCchhhhHHHHH
Confidence 3344566678999999999999999984 457899999997542 23355678999999994 4478999
Q ss_pred eEEEecCCCceEEEEEecCCCCChhhhhhhc-cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCC-C
Q 004979 494 IGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQ-EAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTED-Y 571 (721)
Q Consensus 494 ~g~~~~~~~~~~~lV~Ey~~~GsL~~~l~~~-~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~-~ 571 (721)
+-.|...+ +.|||+|-+ .-+|.++|+.- ....|.......++.|+..||..|..|+ |+|.||||.|||+++. .
T Consensus 500 ~r~F~hkn--HLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~--vlHaDIKPDNiLVNE~k~ 574 (752)
T KOG0670|consen 500 FRHFKHKN--HLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG--VLHADIKPDNILVNESKN 574 (752)
T ss_pred HHHhhhcc--eeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC--eeecccCccceEeccCcc
Confidence 88887777 889999987 55899998743 3456888888999999999999999999 9999999999999965 6
Q ss_pred cEEEeccCCCCCCCCC-------CccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCC
Q 004979 572 AAKISDFSFWNNTTAA-------KTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQ 644 (721)
Q Consensus 572 ~~kL~DFGla~~~~~~-------~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~ 644 (721)
.+||||||.|...... ...|.|||.+.+..|+...|+||.||+||||.||+..|.+...+..--+..-++|..
T Consensus 575 iLKLCDfGSA~~~~eneitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~ 654 (752)
T KOG0670|consen 575 ILKLCDFGSASFASENEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKF 654 (752)
T ss_pred eeeeccCccccccccccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCC
Confidence 7899999987654332 225789999999999999999999999999999999998654332211111111111
Q ss_pred C---------Ccccc--------------------------CC------------ccccccHHHHHHHHHHHHHcccCCC
Q 004979 645 P---------LKDIV--------------------------DP------------TLKSFQENVLEELLVVIKNCVHPDP 677 (721)
Q Consensus 645 ~---------~~~~~--------------------------d~------------~l~~~~~~~~~~l~~li~~Cl~~dP 677 (721)
+ ..+-+ .| .+++-......++.+|+..|+..||
T Consensus 655 p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP 734 (752)
T KOG0670|consen 655 PNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDP 734 (752)
T ss_pred cHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccCh
Confidence 1 00001 11 1111123345678999999999999
Q ss_pred CCCCCHHHHHH
Q 004979 678 KQRPSMRGIAA 688 (721)
Q Consensus 678 ~~RPs~~evl~ 688 (721)
++|.+..+.+.
T Consensus 735 ~KRit~nqAL~ 745 (752)
T KOG0670|consen 735 EKRITVNQALK 745 (752)
T ss_pred hhcCCHHHHhc
Confidence 99999998765
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-27 Score=230.97 Aligned_cols=247 Identities=23% Similarity=0.419 Sum_probs=196.9
Q ss_pred hhhCcCCCCceeEEEEEEecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVF 509 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV~ 509 (721)
+++-++.+.-.|+.|+|+|+ |..+++|++.++ +++....++|.+|.-.|+-+.||||..++|.|..+. ...++.
T Consensus 193 nl~tkl~e~hsgelwrgrwq-gndivakil~vr---~~t~risrdfneefp~lrifshpnilpvlgacnspp--nlv~is 266 (448)
T KOG0195|consen 193 NLITKLAESHSGELWRGRWQ-GNDIVAKILNVR---EVTARISRDFNEEFPALRIFSHPNILPVLGACNSPP--NLVIIS 266 (448)
T ss_pred hhhhhhccCCCccccccccc-Ccchhhhhhhhh---hcchhhcchhhhhCcceeeecCCchhhhhhhccCCC--CceEee
Confidence 45666777778899999998 556677777654 345556688999999999999999999999998865 678999
Q ss_pred ecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEe--c--cCCCCCCC
Q 004979 510 EYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKIS--D--FSFWNNTT 585 (721)
Q Consensus 510 Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~--D--FGla~~~~ 585 (721)
.||+.|+|+..||+.....++-.+..+++.+||+|++|||+..|-|..-.|.+..+++|++.++||+ | |.+-....
T Consensus 267 q~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfqe~gr 346 (448)
T KOG0195|consen 267 QYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQEVGR 346 (448)
T ss_pred eeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeeecccc
Confidence 9999999999999877777888999999999999999999988767777899999999999999986 3 44444445
Q ss_pred CCCccccchhhcccCCCC---CCccHHHHHHHHHHHHhCCCcccCCCCCHHHH-HHHHhhcCCCCccccCCccccccHHH
Q 004979 586 AAKTGSAAMELLETSAVD---LESNVYSFGTILFEMITGRISYSIENGSLENW-ASEYLKGEQPLKDIVDPTLKSFQENV 661 (721)
Q Consensus 586 ~~~~~~~apE~~~~~~~s---~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~-~~~~~~~~~~~~~~~d~~l~~~~~~~ 661 (721)
...+.|++||.++..+-+ .++|+|||.|++|||.|...||..-. ..+. .+-.+. ......++..
T Consensus 347 ~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadls--pmecgmkiale----------glrv~ippgi 414 (448)
T KOG0195|consen 347 AYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLS--PMECGMKIALE----------GLRVHIPPGI 414 (448)
T ss_pred ccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCC--chhhhhhhhhc----------cccccCCCCc
Confidence 566789999998766544 67999999999999999999995221 1111 111111 1112345667
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 004979 662 LEELLVVIKNCVHPDPKQRPSMRGIAAKLKEIT 694 (721)
Q Consensus 662 ~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~ 694 (721)
+..+.+||.-|+..||.+||.++.|+-.|+++.
T Consensus 415 s~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 415 SRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred cHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 778999999999999999999999999998864
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.4e-27 Score=228.44 Aligned_cols=250 Identities=18% Similarity=0.219 Sum_probs=180.8
Q ss_pred CcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCC---ceEEEE
Q 004979 433 GSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEP---FTRMMV 508 (721)
Q Consensus 433 ~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~---~~~~lV 508 (721)
..||.|+||.||..+. ++|+.|+.|++...- ..-...+++.+|+++|..++|.|++..+++...... .+.|+|
T Consensus 59 RPIGYGAFGVVWsVTDPRdgrrvalkK~pnvf---q~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 59 RPIGYGAFGVVWSVTDPRSGKRVALKKMPNVF---QNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CcccccceeEEEeccCCCCccchhHhhcchHH---HHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 4688999999999984 578889998775321 112234678999999999999999999988764432 146888
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCCCC-
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTAA- 587 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~~~- 587 (721)
+|.|. .+|.+++- ..+.++-....-+..||.+||.|||+.+ |.||||||.|.|++.+...||||||+++.....
T Consensus 136 TELmQ-SDLHKIIV--SPQ~Ls~DHvKVFlYQILRGLKYLHsA~--ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~ 210 (449)
T KOG0664|consen 136 TELMQ-SDLHKIIV--SPQALTPDHVKVFVYQILRGLKYLHTAN--ILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD 210 (449)
T ss_pred HHHHH-hhhhheec--cCCCCCcchhhhhHHHHHhhhHHHhhcc--hhhccCCCccEEeccCceEEecccccccccchhh
Confidence 99984 47877764 4567888888889999999999999998 999999999999999999999999999854432
Q ss_pred ---------Cccccchhhccc-CCCCCCccHHHHHHHHHHHHhCCCcccCCCCCH-HHHHHHHhh----------cCCCC
Q 004979 588 ---------KTGSAAMELLET-SAVDLESNVYSFGTILFEMITGRISYSIENGSL-ENWASEYLK----------GEQPL 646 (721)
Q Consensus 588 ---------~~~~~apE~~~~-~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~-~~~~~~~~~----------~~~~~ 646 (721)
+.+|.|||.+.+ ..|+.+.||||.|||+.||+-.+..|...+.-. .+.+...+. .+..-
T Consensus 211 ~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk 290 (449)
T KOG0664|consen 211 RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAK 290 (449)
T ss_pred hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhH
Confidence 236789998854 579999999999999999999888886433210 011111110 00000
Q ss_pred ccccC-----Cccc---c--ccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 004979 647 KDIVD-----PTLK---S--FQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKL 690 (721)
Q Consensus 647 ~~~~d-----~~l~---~--~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L 690 (721)
..++. |... . .+.....+...+...++..||++|.+..+.+..+
T Consensus 291 ~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 291 NHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred HHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 11111 1111 1 1123335667788889999999999988877643
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.6e-27 Score=250.88 Aligned_cols=241 Identities=20% Similarity=0.217 Sum_probs=189.1
Q ss_pred hhhhCcCCCCceeEEEEEE-ecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEE
Q 004979 429 SNIIGSFSDGTVGTVYKGT-LSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMM 507 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~-~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~l 507 (721)
++++..+|.|+||.|||++ ..++...|||+++.....+ .+-..+|+-+++..+|||||.++|-+...+ ..++
T Consensus 17 yellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd-----~~~iqqei~~~~dc~h~nivay~gsylr~d--klwi 89 (829)
T KOG0576|consen 17 YELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDD-----FSGIQQEIGMLRDCRHPNIVAYFGSYLRRD--KLWI 89 (829)
T ss_pred hhheeeecCCcccchhhhcccccCchhhheeeeccCCcc-----ccccccceeeeecCCCcChHHHHhhhhhhc--CcEE
Confidence 3678899999999999999 4578889999988754433 345678999999999999999999888766 5699
Q ss_pred EEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCC-----
Q 004979 508 VFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWN----- 582 (721)
Q Consensus 508 V~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~----- 582 (721)
+||||.+|+|++..+ ....++..++..+++...+|++|||+.+ -+|||||-.|||+++.+.+|++|||.+-
T Consensus 90 cMEycgggslQdiy~--~TgplselqiayvcRetl~gl~ylhs~g--k~hRdiKGanilltd~gDvklaDfgvsaqitat 165 (829)
T KOG0576|consen 90 CMEYCGGGSLQDIYH--VTGPLSELQIAYVCRETLQGLKYLHSQG--KIHRDIKGANILLTDEGDVKLADFGVSAQITAT 165 (829)
T ss_pred EEEecCCCcccceee--ecccchhHHHHHHHhhhhccchhhhcCC--cccccccccceeecccCceeecccCchhhhhhh
Confidence 999999999999876 3467899999999999999999999988 8999999999999999999999999753
Q ss_pred ----CCCCCCccccchhhc---ccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccc
Q 004979 583 ----NTTAAKTGSAAMELL---ETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLK 655 (721)
Q Consensus 583 ----~~~~~~~~~~apE~~---~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 655 (721)
....++++|||||+. +.+.|..++|||+.|+...|+.--+.|... ........-..+. ..++-..
T Consensus 166 i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfd--lhpmr~l~LmTkS------~~qpp~l 237 (829)
T KOG0576|consen 166 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFD--LHPMRALFLMTKS------GFQPPTL 237 (829)
T ss_pred hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccc--cchHHHHHHhhcc------CCCCCcc
Confidence 334578899999985 567899999999999999999887766421 1111111111111 1111111
Q ss_pred cccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 656 SFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 656 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
.-.....+-+.++++.|+.++|++||+++.++.
T Consensus 238 kDk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 238 KDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred cCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 112344567888999999999999999987653
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.1e-25 Score=221.86 Aligned_cols=203 Identities=26% Similarity=0.350 Sum_probs=165.2
Q ss_pred hhCcCCCCceeEEEEEEecC-CcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEEE
Q 004979 431 IIGSFSDGTVGTVYKGTLSS-GVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVF 509 (721)
Q Consensus 431 ii~~lg~G~~g~Vyk~~~~~-~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV~ 509 (721)
+...+|.|++|.||++.... +..+++|........ ...+.+.+|++.+.+++|+|++++++++...+ ..++++
T Consensus 3 ~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~----~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~--~~~~v~ 76 (225)
T smart00221 3 LGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE----KQREEFLREIRILKKLKHPNIVKLYGVFEDPE--PLYLVM 76 (225)
T ss_pred eeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch----HHHHHHHHHHHHHHhCCCCChhhheeeeecCC--ceEEEE
Confidence 34577899999999999764 788999988654322 23568899999999999999999999988766 579999
Q ss_pred ecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCCC---
Q 004979 510 EYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTA--- 586 (721)
Q Consensus 510 Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~~--- 586 (721)
||+++++|.+++..... .+++.....++.+++.++.|||+++ ++|+||+++||+++.++.++|+|||.+.....
T Consensus 77 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~ 153 (225)
T smart00221 77 EYCEGGDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLHSLG--IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA 153 (225)
T ss_pred eccCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc
Confidence 99999999999864322 2889999999999999999999987 99999999999999999999999998653322
Q ss_pred -------CCccccchhhc-ccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhc
Q 004979 587 -------AKTGSAAMELL-ETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKG 642 (721)
Q Consensus 587 -------~~~~~~apE~~-~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~ 642 (721)
+...|++||.. ....++.++|||+||++++||++|+.||.............+..+
T Consensus 154 ~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~ 217 (225)
T smart00221 154 ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFG 217 (225)
T ss_pred ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcC
Confidence 23457899988 677788899999999999999999999964233333444444433
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.1e-26 Score=226.70 Aligned_cols=244 Identities=19% Similarity=0.254 Sum_probs=177.9
Q ss_pred cCCCCceeEEEEEE-ecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCC----ceEEEE
Q 004979 434 SFSDGTVGTVYKGT-LSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEP----FTRMMV 508 (721)
Q Consensus 434 ~lg~G~~g~Vyk~~-~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~----~~~~lV 508 (721)
.+|.|.- .|.-+. .-.++.|++|+.... ... ....++..+|..++..+.|+||++++.++.-... ...|+|
T Consensus 24 p~~~g~~-~v~~a~D~v~~~~v~ikk~~~p-f~n--~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v 99 (369)
T KOG0665|consen 24 PIGSGAQ-IVVAAFDQVLGRPVAIKKLSRP-FQN--QTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLV 99 (369)
T ss_pred ccCCCCc-eEEecchhhccCceehhhhcCc-ccc--CccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHH
Confidence 4455655 444443 225778888887654 222 1223567899999999999999999999864321 246899
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCCCC-
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTAA- 587 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~~~- 587 (721)
|||| .++|...++ ..++-.....|..|++.|+.|||+.+ |+||||||+||++..+..+||.|||+++.....
T Consensus 100 ~e~m-~~nl~~vi~----~elDH~tis~i~yq~~~~ik~lhs~~--IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~~ 172 (369)
T KOG0665|consen 100 MELM-DANLCQVIL----MELDHETISYILYQMLCGIKHLHSAG--IIHRDLKPSNIVVNSDCTLKILDFGLARTEDTDF 172 (369)
T ss_pred HHhh-hhHHHHHHH----HhcchHHHHHHHHHHHHHHHHHHhcc--eeecccCcccceecchhheeeccchhhcccCccc
Confidence 9999 568888875 34677788899999999999999998 999999999999999999999999998754433
Q ss_pred -------CccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCC--------------
Q 004979 588 -------KTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPL-------------- 646 (721)
Q Consensus 588 -------~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~-------------- 646 (721)
+..|.|||++.+..|.+.+||||.||++.||++|+.-|.+ ...+.+|.+..-.-+.+-
T Consensus 173 ~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g-~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~y 251 (369)
T KOG0665|consen 173 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPG-KDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNY 251 (369)
T ss_pred ccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecC-chHHHHHHHHHHHhcCCCHHHHHHhhHHHHHH
Confidence 3467899999888899999999999999999999988863 223444432221111100
Q ss_pred ------------cccc-CCcc---ccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004979 647 ------------KDIV-DPTL---KSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAK 689 (721)
Q Consensus 647 ------------~~~~-d~~l---~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 689 (721)
.+.+ |... .+..+-....+.+++.+||..+|++|-+++++++.
T Consensus 252 v~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 252 VENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred hhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 0000 0000 01111234567889999999999999999999874
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.7e-26 Score=220.10 Aligned_cols=242 Identities=19% Similarity=0.329 Sum_probs=176.0
Q ss_pred hhhhhhCcCCCCceeEEEEEEecC-CcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcC-CCCccceEeEE-EecCCCc
Q 004979 427 DFSNIIGSFSDGTVGTVYKGTLSS-GVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKV-NHKNFVNLIGY-CEEDEPF 503 (721)
Q Consensus 427 ~~~~ii~~lg~G~~g~Vyk~~~~~-~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~-~~~~~~~ 503 (721)
+-++|++.+|+|.||.+..++++. ...+++|.+.... ...++|.+|...--.| .|.||+.-|++ |+..+
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~------tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d-- 95 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ------TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSD-- 95 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch------hhHHHHHHHhccceeeccchhhhHHHHHHhhcCc--
Confidence 445888999999999999999764 5567777665321 2246899998765556 69999998875 44555
Q ss_pred eEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeC--CCCcEEEeccCCC
Q 004979 504 TRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLT--EDYAAKISDFSFW 581 (721)
Q Consensus 504 ~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~--~~~~~kL~DFGla 581 (721)
..+.++||+|.|+|.+-+. ...+.+....+++.|++.|++|||+.+ +||||||.+||||- +..++||||||..
T Consensus 96 ~YvF~qE~aP~gdL~snv~---~~GigE~~~K~v~~ql~SAi~fMHskn--lVHRdlK~eNiLif~~df~rvKlcDFG~t 170 (378)
T KOG1345|consen 96 AYVFVQEFAPRGDLRSNVE---AAGIGEANTKKVFAQLLSAIEFMHSKN--LVHRDLKAENILIFDADFYRVKLCDFGLT 170 (378)
T ss_pred eEEEeeccCccchhhhhcC---cccccHHHHHHHHHHHHHHHHHhhccc--hhhcccccceEEEecCCccEEEeeecccc
Confidence 4589999999999998763 345778888999999999999999998 99999999999994 4458999999987
Q ss_pred CCCCCC------Cccccchhhccc-----CCCCCCccHHHHHHHHHHHHhCCCcccCCC---CCHHHHHHHHhhcCCCCc
Q 004979 582 NNTTAA------KTGSAAMELLET-----SAVDLESNVYSFGTILFEMITGRISYSIEN---GSLENWASEYLKGEQPLK 647 (721)
Q Consensus 582 ~~~~~~------~~~~~apE~~~~-----~~~s~ksDVwSfGvvL~ElltG~~P~~~~~---~~~~~~~~~~~~~~~~~~ 647 (721)
+..... .-.|.+||.... -...+.+|||.|||++|.++||+.||.... ....+|.+-. .+
T Consensus 171 ~k~g~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~-~r----- 244 (378)
T KOG1345|consen 171 RKVGTTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWL-KR----- 244 (378)
T ss_pred cccCceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHh-cc-----
Confidence 654332 124567876532 234678999999999999999999997332 2222222211 11
Q ss_pred cccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004979 648 DIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAK 689 (721)
Q Consensus 648 ~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 689 (721)
..+.++......++.+..+.++-+..++++|-...++.++
T Consensus 245 --k~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~ 284 (378)
T KOG1345|consen 245 --KNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKM 284 (378)
T ss_pred --cCccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHH
Confidence 0112222333455677788899999999999655555444
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.7e-25 Score=265.55 Aligned_cols=189 Identities=18% Similarity=0.194 Sum_probs=137.3
Q ss_pred hcCCC-CccceEeEEEecCC-----CceEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 004979 483 SKVNH-KNFVNLIGYCEEDE-----PFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIA 556 (721)
Q Consensus 483 ~~l~H-~nIv~l~g~~~~~~-----~~~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~Iv 556 (721)
+.++| +||++++++|.... ....+.++||+ +++|.++|.. ....+++..++.|+.||++||+|||+++ |+
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~g--Iv 102 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN-PDRSVDAFECFHVFRQIVEIVNAAHSQG--IV 102 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc-ccccccHHHHHHHHHHHHHHHHHHHhCC--ee
Confidence 34556 68888888872211 11357788987 6699999963 2356999999999999999999999988 99
Q ss_pred eeCCCCCCeEeCC-------------------CCcEEEeccCCCCCCC-------------------------CCCcccc
Q 004979 557 HRNLQSSSIYLTE-------------------DYAAKISDFSFWNNTT-------------------------AAKTGSA 592 (721)
Q Consensus 557 HrDLKp~NILl~~-------------------~~~~kL~DFGla~~~~-------------------------~~~~~~~ 592 (721)
||||||+||||+. ++.+|++|||+++... .++..|+
T Consensus 103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 182 (793)
T PLN00181 103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT 182 (793)
T ss_pred eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence 9999999999953 5567777888765311 1234599
Q ss_pred chhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccHHHHHHHHHHHHHc
Q 004979 593 AMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNC 672 (721)
Q Consensus 593 apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~C 672 (721)
|||.+.+..|+.++|||||||+||||++|..|+..... ........ ...+.. .....+...++.+|
T Consensus 183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~----~~~~~~~~------~~~~~~----~~~~~~~~~~~~~~ 248 (793)
T PLN00181 183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR----TMSSLRHR------VLPPQI----LLNWPKEASFCLWL 248 (793)
T ss_pred ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH----HHHHHHHh------hcChhh----hhcCHHHHHHHHHh
Confidence 99999999999999999999999999999888742211 11111111 011100 11123456788999
Q ss_pred ccCCCCCCCCHHHHHHH
Q 004979 673 VHPDPKQRPSMRGIAAK 689 (721)
Q Consensus 673 l~~dP~~RPs~~evl~~ 689 (721)
|+.+|.+||+|.|+++.
T Consensus 249 L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 249 LHPEPSCRPSMSELLQS 265 (793)
T ss_pred CCCChhhCcChHHHhhc
Confidence 99999999999999863
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.4e-25 Score=234.95 Aligned_cols=192 Identities=18% Similarity=0.291 Sum_probs=157.0
Q ss_pred hhhhCcCCCCceeEEEEEEecCC-cEEEEEEeeecccc--chh-hHHHHHHHHHHHHHhcCC---CCccceEeEEEecCC
Q 004979 429 SNIIGSFSDGTVGTVYKGTLSSG-VEIAVTSTSVKSRA--DWS-KNLESQFRKKIDTLSKVN---HKNFVNLIGYCEEDE 501 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~~~-~~vavk~~~~~~~~--~~~-~~~~~~f~~Ei~~l~~l~---H~nIv~l~g~~~~~~ 501 (721)
+..+..+|+|+||.|+.|.++.. ..|++|.+.+...- .|- +......-.||++|..++ |+||++++++|++++
T Consensus 563 yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd 642 (772)
T KOG1152|consen 563 YTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDD 642 (772)
T ss_pred ceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCC
Confidence 35678999999999999997654 56777766533211 111 111233567999999997 999999999999988
Q ss_pred CceEEEEEecC-CCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCC
Q 004979 502 PFTRMMVFEYS-PNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSF 580 (721)
Q Consensus 502 ~~~~~lV~Ey~-~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGl 580 (721)
..||+||-. ++-+|++++. ....+++.....|+.||+.|+++||+.+ |||||||-+||.++.+|.+||+|||.
T Consensus 643 --~yyl~te~hg~gIDLFd~IE--~kp~m~E~eAk~IFkQV~agi~hlh~~~--ivhrdikdenvivd~~g~~klidfgs 716 (772)
T KOG1152|consen 643 --YYYLETEVHGEGIDLFDFIE--FKPRMDEPEAKLIFKQVVAGIKHLHDQG--IVHRDIKDENVIVDSNGFVKLIDFGS 716 (772)
T ss_pred --eeEEEecCCCCCcchhhhhh--ccCccchHHHHHHHHHHHhccccccccC--ceecccccccEEEecCCeEEEeeccc
Confidence 559999864 4668999985 3456899999999999999999999999 99999999999999999999999998
Q ss_pred CCCC-------CCCCccccchhhcccCCCC-CCccHHHHHHHHHHHHhCCCccc
Q 004979 581 WNNT-------TAAKTGSAAMELLETSAVD-LESNVYSFGTILFEMITGRISYS 626 (721)
Q Consensus 581 a~~~-------~~~~~~~~apE~~~~~~~s-~ksDVwSfGvvL~ElltG~~P~~ 626 (721)
+... ..++..|+|||++.+.+|- ..-|||++||+||.++....||.
T Consensus 717 aa~~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 717 AAYTKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred hhhhcCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 6533 3456789999999998884 66899999999999999888874
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.8e-23 Score=203.34 Aligned_cols=165 Identities=20% Similarity=0.233 Sum_probs=125.7
Q ss_pred CChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC----CCCCcc
Q 004979 515 GSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT----TAAKTG 590 (721)
Q Consensus 515 GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~----~~~~~~ 590 (721)
|+|.++++.. ...++|.++..|+.||+.||+|||+.+ ||+|||++.++.+|+ ||+++.. ..++..
T Consensus 1 GsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~~--------kp~Nil~~~~~~~~~--fG~~~~~~~~~~~g~~~ 69 (176)
T smart00750 1 VSLADILEVR-GRPLNEEEIWAVCLQCLRALRELHRQA--------KSGNILLTWDGLLKL--DGSVAFKTPEQSRVDPY 69 (176)
T ss_pred CcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcC--------CcccEeEcCccceee--ccceEeeccccCCCccc
Confidence 7899998642 456999999999999999999999865 999999999999999 9987632 235678
Q ss_pred ccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccHHHHH--HHHHH
Q 004979 591 SAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQENVLE--ELLVV 668 (721)
Q Consensus 591 ~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~--~l~~l 668 (721)
|+|||.+.+..++.++|||||||++|||+||+.||..... ................ +........... ++.++
T Consensus 70 y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~-~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~ 144 (176)
T smart00750 70 FMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERE-LSAILEILLNGMPADD----PRDRSNLESVSAARSFADF 144 (176)
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccch-hcHHHHHHHHHhccCC----ccccccHHHHHhhhhHHHH
Confidence 9999999999999999999999999999999999964321 2222222222111110 110111223333 68999
Q ss_pred HHHcccCCCCCCCCHHHHHHHHHHhhh
Q 004979 669 IKNCVHPDPKQRPSMRGIAAKLKEITA 695 (721)
Q Consensus 669 i~~Cl~~dP~~RPs~~evl~~L~~i~~ 695 (721)
+.+||..+|++||++.|+++.+..+..
T Consensus 145 i~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 145 MRVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred HHHHHhcccccccCHHHHHHHHHHHHH
Confidence 999999999999999999998876543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.5e-23 Score=216.68 Aligned_cols=244 Identities=18% Similarity=0.280 Sum_probs=182.7
Q ss_pred hhhhCcCCCCceeEEEEEEec----CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcC-CCCccceEeEEEecCCCc
Q 004979 429 SNIIGSFSDGTVGTVYKGTLS----SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKV-NHKNFVNLIGYCEEDEPF 503 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~----~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~ 503 (721)
+.++.++|+|.|++||+++.. ....||+|.+...... .++..|+++|..+ .|.||+++.+++...+
T Consensus 38 ~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p-------~ri~~El~~L~~~gG~~ni~~~~~~~rnnd-- 108 (418)
T KOG1167|consen 38 YKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP-------SRILNELEMLYRLGGSDNIIKLNGCFRNND-- 108 (418)
T ss_pred hhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc-------hHHHHHHHHHHHhccchhhhcchhhhccCC--
Confidence 467889999999999999843 4678999988654432 4688999999999 5999999999998877
Q ss_pred eEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCC-CCcEEEeccCCCC
Q 004979 504 TRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTE-DYAAKISDFSFWN 582 (721)
Q Consensus 504 ~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~-~~~~kL~DFGla~ 582 (721)
..++|+||++.-.-.+++. .++...+..+...+.+||+|+|..| ||||||||+|+|.+. .+.-.|.|||++.
T Consensus 109 ~v~ivlp~~~H~~f~~l~~-----~l~~~~i~~Yl~~ll~Al~~~h~~G--IvHRDiKpsNFL~n~~t~rg~LvDFgLA~ 181 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYR-----SLSLAEIRWYLRNLLKALAHLHKNG--IVHRDIKPSNFLYNRRTQRGVLVDFGLAQ 181 (418)
T ss_pred eeEEEecccCccCHHHHHh-----cCCHHHHHHHHHHHHHHhhhhhccC--ccccCCCccccccccccCCceEEechhHH
Confidence 7899999999988888874 4678888999999999999999999 999999999999984 5678899999853
Q ss_pred C-----------------------------------------------------CCCCCccccchhhcc-cCCCCCCccH
Q 004979 583 N-----------------------------------------------------TTAAKTGSAAMELLE-TSAVDLESNV 608 (721)
Q Consensus 583 ~-----------------------------------------------------~~~~~~~~~apE~~~-~~~~s~ksDV 608 (721)
. ...|+.++.|||++. ...-++++||
T Consensus 182 ~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDi 261 (418)
T KOG1167|consen 182 RYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDI 261 (418)
T ss_pred HHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccce
Confidence 0 001234667899874 4566899999
Q ss_pred HHHHHHHHHHHhCCCcccCCCCCHHHHHHH-------------HhhcCCCCcc---------------ccC-----C---
Q 004979 609 YSFGTILFEMITGRISYSIENGSLENWASE-------------YLKGEQPLKD---------------IVD-----P--- 652 (721)
Q Consensus 609 wSfGvvL~ElltG~~P~~~~~~~~~~~~~~-------------~~~~~~~~~~---------------~~d-----~--- 652 (721)
||.|||++-+++++.||.....+....+.. .+.+...+.+ -++ +
T Consensus 262 ws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q 341 (418)
T KOG1167|consen 262 WSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQ 341 (418)
T ss_pred eeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccc
Confidence 999999999999999997544332221110 0111100000 000 0
Q ss_pred ---ccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 653 ---TLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 653 ---~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
......+..+..+++++.+|+..+|.+|-|++|.++
T Consensus 342 ~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk 380 (418)
T KOG1167|consen 342 PNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK 380 (418)
T ss_pred cceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence 000111223447899999999999999999999886
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.5e-19 Score=190.97 Aligned_cols=249 Identities=24% Similarity=0.341 Sum_probs=185.9
Q ss_pred hhhCcCCCCceeEEEEEEecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCC-ccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHK-NFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~-nIv~l~g~~~~~~~~~~~lV 508 (721)
++...+|.|+||.||++... ..+++|.+....... ......|.+|+.++..+.|+ +|+++++++.... ..+++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~--~~~~~ 76 (384)
T COG0515 3 RILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESK--SKEVERFLREIQILASLNHPPNIVKLYDFFQDEG--SLYLV 76 (384)
T ss_pred eeEEeecCCCCeEEEEEEec--cEEEEEeechhhccc--hhHHHHHHHHHHHHHHccCCcceeeEEEEEecCC--EEEEE
Confidence 34567789999999999977 677888776543322 12457899999999999988 7999999996655 46899
Q ss_pred EecCCCCChhhhhhhccC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCC-cEEEeccCCCCCC--
Q 004979 509 FEYSPNGSLFEHLHIQEA-EHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDY-AAKISDFSFWNNT-- 584 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~-~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~-~~kL~DFGla~~~-- 584 (721)
+||+.++++.+++..... ..+.......+..|++.+++|+|+.+ ++|||+||+||+++... .++++|||.++..
T Consensus 77 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~--~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~ 154 (384)
T COG0515 77 MEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG--IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPD 154 (384)
T ss_pred EecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeecCCCCeEEEeccCcceecCC
Confidence 999999999976643221 26888899999999999999999998 99999999999999988 7999999986522
Q ss_pred -------------CCCCccccchhhccc---CCCCCCccHHHHHHHHHHHHhCCCcccCCCCC--HHHHHHHHhhcCCC-
Q 004979 585 -------------TAAKTGSAAMELLET---SAVDLESNVYSFGTILFEMITGRISYSIENGS--LENWASEYLKGEQP- 645 (721)
Q Consensus 585 -------------~~~~~~~~apE~~~~---~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~--~~~~~~~~~~~~~~- 645 (721)
..++..|++||.+.. ..++...|+||+|++++++++|..||...... .............+
T Consensus 155 ~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 234 (384)
T COG0515 155 PGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPS 234 (384)
T ss_pred CCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcc
Confidence 223456889999877 67889999999999999999999997644321 22222222222111
Q ss_pred CccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004979 646 LKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAK 689 (721)
Q Consensus 646 ~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 689 (721)
........ ........+.+++..|+..+|..|.++.+....
T Consensus 235 ~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 235 LASPLSPS---NPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred cccccCcc---ccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 11111110 002233567889999999999999998877654
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.5e-20 Score=201.00 Aligned_cols=138 Identities=16% Similarity=0.116 Sum_probs=106.8
Q ss_pred hhhhCcCCCCceeEEEEEEec--CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccce-EeEEEecCCCceE
Q 004979 429 SNIIGSFSDGTVGTVYKGTLS--SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVN-LIGYCEEDEPFTR 505 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~--~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~-l~g~~~~~~~~~~ 505 (721)
|.+.+.+|+|+||+||+|++. ++..+|||++.............+.|.+|+++|++++|+|||. ++++ + ..
T Consensus 20 Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~--~~ 93 (365)
T PRK09188 20 FVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----G--KD 93 (365)
T ss_pred ceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----C--Cc
Confidence 467788999999999999865 4667789876422110011234567999999999999999985 4432 2 45
Q ss_pred EEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCC-CCCCeEeCCCCcEEEeccCCCCC
Q 004979 506 MMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNL-QSSSIYLTEDYAAKISDFSFWNN 583 (721)
Q Consensus 506 ~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDL-Kp~NILl~~~~~~kL~DFGla~~ 583 (721)
++||||+++++|... . ... ...++.++++||+|||+.+ |+|||| ||+|||++.++.+||+|||+++.
T Consensus 94 ~LVmE~~~G~~L~~~-~--~~~------~~~~~~~i~~aL~~lH~~g--IiHrDL~KP~NILv~~~~~ikLiDFGlA~~ 161 (365)
T PRK09188 94 GLVRGWTEGVPLHLA-R--PHG------DPAWFRSAHRALRDLHRAG--ITHNDLAKPQNWLMGPDGEAAVIDFQLASV 161 (365)
T ss_pred EEEEEccCCCCHHHh-C--ccc------hHHHHHHHHHHHHHHHHCC--CeeCCCCCcceEEEcCCCCEEEEECcccee
Confidence 899999999999632 1 111 1467889999999999988 999999 99999999999999999999863
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2e-19 Score=192.43 Aligned_cols=263 Identities=17% Similarity=0.207 Sum_probs=188.1
Q ss_pred hhhhCcCCCCceeEEEEEEecCC--cEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCC----CccceEeEEEe-cCC
Q 004979 429 SNIIGSFSDGTVGTVYKGTLSSG--VEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNH----KNFVNLIGYCE-EDE 501 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~~~--~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H----~nIv~l~g~~~-~~~ 501 (721)
+.+.+.+|+|+||.||++..... ..+|+|......... ...+..|+.++..+.+ +++.++++... ...
T Consensus 20 ~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~-----~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~ 94 (322)
T KOG1164|consen 20 YKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSK-----PSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTED 94 (322)
T ss_pred eEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCC-----CccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCc
Confidence 36788999999999999996553 367777655432111 1146778888888863 58888888874 444
Q ss_pred CceEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCC-----CcEEEe
Q 004979 502 PFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTED-----YAAKIS 576 (721)
Q Consensus 502 ~~~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~-----~~~kL~ 576 (721)
..++||+.+ |.+|.++........++..+.+.|+.|+..+|+++|+.+ ++||||||.|+++... ..+.|.
T Consensus 95 --~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G--~iHRDiKp~N~~~g~~~~~~~~~~~ll 169 (322)
T KOG1164|consen 95 --FNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG--FIHRDIKPENFVVGQSSRSEVRTLYLL 169 (322)
T ss_pred --eeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC--cccCCcCHHHeeecCCCCcccceEEEE
Confidence 569999988 889999875444578999999999999999999999999 9999999999999854 469999
Q ss_pred ccCCCC--CC-----------------CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHH-HHH
Q 004979 577 DFSFWN--NT-----------------TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLE-NWA 636 (721)
Q Consensus 577 DFGla~--~~-----------------~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~-~~~ 636 (721)
|||+++ .. ..++..|+++..-.+...+.+.|+||++-++.|+..|..||........ .-+
T Consensus 170 DfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~ 249 (322)
T KOG1164|consen 170 DFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKF 249 (322)
T ss_pred ecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHH
Confidence 999997 21 0033456677777788889999999999999999999999964332211 111
Q ss_pred HHHhhcCCCCccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCChhHHHHH
Q 004979 637 SEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAMEPDGATPKLSPLWWAEL 713 (721)
Q Consensus 637 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~~~~p~~~~~~~~~l 713 (721)
...... ..... .....+.++..+...+-..+..++|....+...+++...... .....|++|+..
T Consensus 250 ~~~~~~-----~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~~---~~~~~~~dw~~~ 314 (322)
T KOG1164|consen 250 EKDPRK-----LLTDR----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSEG---SKEDSPFDWEVK 314 (322)
T ss_pred HHHhhh-----hcccc----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhcC---CCCCCCCccccc
Confidence 111110 00000 112223455556666666899999999999999888766652 233467778754
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.1e-20 Score=201.00 Aligned_cols=208 Identities=25% Similarity=0.403 Sum_probs=162.2
Q ss_pred HhcCCCCccceEeEEEecCCCceEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCC
Q 004979 482 LSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQ 561 (721)
Q Consensus 482 l~~l~H~nIv~l~g~~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLK 561 (721)
|+.+.|.|+.+++|.+.++. ..++|.+||..|+|.+.+.. ....++|.....+.++|+.||+|+|... -..|+.++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~--~~~~i~~~c~rGsl~D~i~~-~~~~~d~~F~~s~~rdi~~Gl~ylh~s~-i~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGP--EMIVIWEYCSRGSLLDILSN-EDIKLDYFFILSFIRDISKGLAYLHNSP-IGYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCC--ceEEEEeeecCccHHhHHhc-cccCccHHHHHHHHHHHHHHHHHHhcCc-ceeeeeec
Confidence 46789999999999999885 67999999999999999964 4567999999999999999999999754 13999999
Q ss_pred CCCeEeCCCCcEEEeccCCCCCCCC-----------CCccccchhhcccC-------CCCCCccHHHHHHHHHHHHhCCC
Q 004979 562 SSSIYLTEDYAAKISDFSFWNNTTA-----------AKTGSAAMELLETS-------AVDLESNVYSFGTILFEMITGRI 623 (721)
Q Consensus 562 p~NILl~~~~~~kL~DFGla~~~~~-----------~~~~~~apE~~~~~-------~~s~ksDVwSfGvvL~ElltG~~ 623 (721)
++|+++|..+.+||+|||+...... ....|.|||.+... ..+.++||||||++++|+++.+.
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~ 156 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG 156 (484)
T ss_pred cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence 9999999999999999998655421 11246799988653 14677999999999999999999
Q ss_pred cccCCC--CCHHHHHHHHhhcCCCCccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcC
Q 004979 624 SYSIEN--GSLENWASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAME 697 (721)
Q Consensus 624 P~~~~~--~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 697 (721)
||+... .+..+.+..+..+. .....|.+.... +..+++..++.+||..+|++||++++|-..++.+....
T Consensus 157 ~~~~~~~~~~~~eii~~~~~~~---~~~~rP~i~~~~-e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~~ 228 (484)
T KOG1023|consen 157 PFDLRNLVEDPDEIILRVKKGG---SNPFRPSIELLN-ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKGG 228 (484)
T ss_pred ccccccccCChHHHHHHHHhcC---CCCcCcchhhhh-hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcccc
Confidence 998533 22234444433311 122223333222 44557899999999999999999999998888776654
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.82 E-value=7.6e-21 Score=216.35 Aligned_cols=246 Identities=18% Similarity=0.212 Sum_probs=174.5
Q ss_pred hCcCCCCceeEEEEEEec-CCcEEEEEEeeecc-ccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEEE
Q 004979 432 IGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKS-RADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVF 509 (721)
Q Consensus 432 i~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~-~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV~ 509 (721)
...+|.|++|.|+..... .....+.|....+. ..+........+..|+.+-..++|+|++..+..+.+.. ...-+|
T Consensus 323 ~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~--~~~~~m 400 (601)
T KOG0590|consen 323 GRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEID--GILQSM 400 (601)
T ss_pred cceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcc--cchhhh
Confidence 345678888877766532 22333333332110 11111222233778888889999999988877776654 234449
Q ss_pred ecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCC------
Q 004979 510 EYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNN------ 583 (721)
Q Consensus 510 Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~------ 583 (721)
|||++ +|+.++.. ...+....+..+..|+..|+.|+|+.+ |.|||+|++|+++..++.+||+|||.+..
T Consensus 401 E~~~~-Dlf~~~~~--~~~~~~~e~~c~fKqL~~Gv~y~h~~G--iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e 475 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMS--NGKLTPLEADCFFKQLLRGVKYLHSMG--LAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE 475 (601)
T ss_pred hcccH-HHHHHHhc--ccccchhhhhHHHHHHHHHHHHHHhcC--ceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence 99999 99999853 235778888999999999999999999 99999999999999999999999997531
Q ss_pred -------CCCCCccccchhhcccCCCCC-CccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccc
Q 004979 584 -------TTAAKTGSAAMELLETSAVDL-ESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLK 655 (721)
Q Consensus 584 -------~~~~~~~~~apE~~~~~~~s~-ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 655 (721)
...+...|+|||++....|++ ..||||.||++..|.+|+.||.........+.... .....-+.....
T Consensus 476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~----~~~~~~~~~~~~ 551 (601)
T KOG0590|consen 476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNN----YSDQRNIFEGPN 551 (601)
T ss_pred hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhc----cccccccccChH
Confidence 223556899999999999975 58999999999999999999974433222210000 000011111112
Q ss_pred cccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 656 SFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 656 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
......+.+...+|.++++.+|.+|-|+++|++
T Consensus 552 ~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 552 RLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred HHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 233455677889999999999999999999986
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=1e-19 Score=178.94 Aligned_cols=144 Identities=15% Similarity=0.126 Sum_probs=109.4
Q ss_pred hCcCCCCceeEEEEEEecCCcEEEEEEeeeccccchh---------------------hHHHHHHHHHHHHHhcCCCCcc
Q 004979 432 IGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWS---------------------KNLESQFRKKIDTLSKVNHKNF 490 (721)
Q Consensus 432 i~~lg~G~~g~Vyk~~~~~~~~vavk~~~~~~~~~~~---------------------~~~~~~f~~Ei~~l~~l~H~nI 490 (721)
.+.+|+|+||.||+|...+|+.||||++......... .........|++.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 5788999999999999888999999998754211100 0011233459999999988887
Q ss_pred ceEeEEEecCCCceEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHH-hcCCCCeEeeCCCCCCeEeCC
Q 004979 491 VNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHM-HQLTPPIAHRNLQSSSIYLTE 569 (721)
Q Consensus 491 v~l~g~~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yL-H~~~~~IvHrDLKp~NILl~~ 569 (721)
.....+... ..+|||||++++++..... ....+++.....++.|++.+|+|+ |+.+ |+||||||+|||++
T Consensus 82 ~~p~~~~~~----~~~iVmE~i~g~~l~~~~~--~~~~~~~~~~~~i~~qi~~~L~~l~H~~g--iiHrDlkP~NIli~- 152 (190)
T cd05147 82 PCPEPILLK----SHVLVMEFIGDDGWAAPRL--KDAPLSESKARELYLQVIQIMRILYQDCR--LVHADLSEYNLLYH- 152 (190)
T ss_pred CCCcEEEec----CCEEEEEEeCCCCCcchhh--hcCCCCHHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEE-
Confidence 544333222 2379999999887765432 234688899999999999999999 6888 99999999999998
Q ss_pred CCcEEEeccCCCCCC
Q 004979 570 DYAAKISDFSFWNNT 584 (721)
Q Consensus 570 ~~~~kL~DFGla~~~ 584 (721)
++.++|+|||++...
T Consensus 153 ~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 DGKLYIIDVSQSVEH 167 (190)
T ss_pred CCcEEEEEccccccC
Confidence 478999999998643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.7e-19 Score=175.40 Aligned_cols=145 Identities=16% Similarity=0.094 Sum_probs=111.6
Q ss_pred hCcCCCCceeEEEEEEecCCcEEEEEEeeeccccc---------------------hhhHHHHHHHHHHHHHhcCCCCcc
Q 004979 432 IGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRAD---------------------WSKNLESQFRKKIDTLSKVNHKNF 490 (721)
Q Consensus 432 i~~lg~G~~g~Vyk~~~~~~~~vavk~~~~~~~~~---------------------~~~~~~~~f~~Ei~~l~~l~H~nI 490 (721)
.+.+|+|+||.||+|+..+|+.||||+........ ........+..|.+.+.+++|++|
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 57889999999999997789999999987542110 001112335689999999999998
Q ss_pred ceEeEEEecCCCceEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCeEeeCCCCCCeEeCC
Q 004979 491 VNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQ-LTPPIAHRNLQSSSIYLTE 569 (721)
Q Consensus 491 v~l~g~~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~-~~~~IvHrDLKp~NILl~~ 569 (721)
.....+.... .+|||||++++++..... ....++......++.+++.++.++|+ .+ |+||||||+|||++
T Consensus 82 ~~p~~~~~~~----~~lVmE~~~g~~~~~~~l--~~~~~~~~~~~~i~~~l~~~l~~lH~~~g--ivHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLKK----NVLVMEFIGDDGSPAPRL--KDVPLEEEEAEELYEQVVEQMRRLYQEAG--LVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEecC----CEEEEEEecCCCchhhhh--hhccCCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCChhhEEEE-
Confidence 6555444332 379999999886543321 12356778889999999999999998 88 99999999999999
Q ss_pred CCcEEEeccCCCCCCC
Q 004979 570 DYAAKISDFSFWNNTT 585 (721)
Q Consensus 570 ~~~~kL~DFGla~~~~ 585 (721)
++.++|+|||++....
T Consensus 153 ~~~~~liDFG~a~~~~ 168 (190)
T cd05145 153 DGKPYIIDVSQAVELD 168 (190)
T ss_pred CCCEEEEEcccceecC
Confidence 8899999999987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.1e-19 Score=218.99 Aligned_cols=153 Identities=29% Similarity=0.515 Sum_probs=114.7
Q ss_pred ChHHHHHHHHHHHhcccCCCCCCCCCCCCCCCCCCCCCCceeeEEeC-CCcEEEEEeCCCCCCCcCchhhcCCCCCCEEE
Q 004979 70 LNSEGMALLRFRERVVRDPFGALSKWSDNDGVGDNVNPCSWFGVECS-DGKVVILNLRDLCLGGMLAPELGQLSELKSII 148 (721)
Q Consensus 70 ~~~~~~~ll~~k~~~~~~~~~~l~~W~~~~~~~~~~~~C~w~gv~C~-~~~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~ 148 (721)
.+.|..+|++||+.+. +|.+.+.+|+.. .+||.|.||+|+ .++|+.|+|++++++|.+++.+..+++|+.|+
T Consensus 27 ~~~~~~~l~~~~~~~~-~~~~~~~~w~~~------~~~c~w~gv~c~~~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~ 99 (968)
T PLN00113 27 HAEELELLLSFKSSIN-DPLKYLSNWNSS------ADVCLWQGITCNNSSRVVSIDLSGKNISGKISSAIFRLPYIQTIN 99 (968)
T ss_pred CHHHHHHHHHHHHhCC-CCcccCCCCCCC------CCCCcCcceecCCCCcEEEEEecCCCccccCChHHhCCCCCCEEE
Confidence 5689999999999984 677788999643 379999999997 47999999999999999999999999999999
Q ss_pred ccCCcccccCchhhc-CCCCCCEeEcccCcccccCCccccCCCCCCEEECccCCCCcCCChhccCCCCCCEEEccCCCCC
Q 004979 149 LRNNSFFGTIPKEIG-ELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLLDNNQYLGGISPELHVLKVISEIQVDESWLT 227 (721)
Q Consensus 149 L~~n~l~G~ip~~l~-~l~~L~~l~ls~N~l~G~iP~~~~~~~~L~~l~l~~N~~~G~iP~~~~~l~~L~~l~l~~n~~~ 227 (721)
|++|.++|.+|..+. .+++|++|+|++|+++|.+|. +.+++|++|+|++|.++|.+|..++++++|++|+|++|.++
T Consensus 100 Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~ 177 (968)
T PLN00113 100 LSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLV 177 (968)
T ss_pred CCCCccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCccc
Confidence 999999999998776 778888888877777766653 23444555555555555445544444444555544444444
Q ss_pred Cccc
Q 004979 228 NAAS 231 (721)
Q Consensus 228 g~~p 231 (721)
+.+|
T Consensus 178 ~~~p 181 (968)
T PLN00113 178 GKIP 181 (968)
T ss_pred ccCC
Confidence 4444
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.9e-19 Score=179.43 Aligned_cols=177 Identities=14% Similarity=0.098 Sum_probs=131.5
Q ss_pred HHhhhhhhhCcCCCCceeEEEEEEecCCcEEEEEEeeeccccchhhHHHH------HHHHHHHHHhcCCCCccceEeEEE
Q 004979 424 ACEDFSNIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLES------QFRKKIDTLSKVNHKNFVNLIGYC 497 (721)
Q Consensus 424 ~~~~~~~ii~~lg~G~~g~Vyk~~~~~~~~vavk~~~~~~~~~~~~~~~~------~f~~Ei~~l~~l~H~nIv~l~g~~ 497 (721)
..++-++++..+|.|+||.||.... ++..+++|.+....... +.... .+.+|++.+.+++|++|..+.+++
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~--~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~ 104 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRT--ERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFY 104 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCch--HHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEee
Confidence 3344457888999999999999655 56789999886543322 11112 268999999999999999999886
Q ss_pred ecCCC------ceEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCC
Q 004979 498 EEDEP------FTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDY 571 (721)
Q Consensus 498 ~~~~~------~~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~ 571 (721)
..... ...+|||||++|.+|.++.. ++. ....+++.++..+|+.+ ++|||+||+||++++++
T Consensus 105 ~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~~g--i~H~Dikp~Nili~~~g 172 (232)
T PRK10359 105 LLAERKTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQHG--MVSGDPHKGNFIVSKNG 172 (232)
T ss_pred eecccccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHHcC--CccCCCChHHEEEeCCC
Confidence 54321 14689999999999987732 222 24568999999999998 99999999999999988
Q ss_pred cEEEeccCCCCCCCCCCccccchhhcccCCCCCCccHHHHHHHHHHHH
Q 004979 572 AAKISDFSFWNNTTAAKTGSAAMELLETSAVDLESNVYSFGTILFEMI 619 (721)
Q Consensus 572 ~~kL~DFGla~~~~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ell 619 (721)
++|+|||..+...... .....+....|..++|+|+||+++.-..
T Consensus 173 -i~liDfg~~~~~~e~~---a~d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 -LRIIDLSGKRCTAQRK---AKDRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred -EEEEECCCcccccchh---hHHHHHHHhHhcccccccceeEeehHHH
Confidence 9999999865442211 1112334556778999999999987554
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.8e-19 Score=195.72 Aligned_cols=243 Identities=19% Similarity=0.285 Sum_probs=180.7
Q ss_pred CCCCceeEEEEEE----ecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCC-CCccceEeEEEecCCCceEEEEE
Q 004979 435 FSDGTVGTVYKGT----LSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVN-HKNFVNLIGYCEEDEPFTRMMVF 509 (721)
Q Consensus 435 lg~G~~g~Vyk~~----~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~~~lV~ 509 (721)
+|+|+||.|+.++ .+.+..++.|....+....... .....|..++..++ ||.+|++.-.++.+. ..++++
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~---~~t~~er~il~~~~~~~f~v~lhyafqt~~--kl~l~l 76 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDR---THTKQERIILAFVHNTPFLVKLHYAFQTDG--KLYLIL 76 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccc---cccccHHHHHhhccCCCceeeeeeeecccc--chhHhh
Confidence 5789999988654 3345566666665443322111 13456677888886 999999988887766 679999
Q ss_pred ecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC-----
Q 004979 510 EYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT----- 584 (721)
Q Consensus 510 Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~----- 584 (721)
+|..+|+|...+. ....++......+...++-+++++|+.+ |+|||+|++||+++.+|.+|+.|||+.+..
T Consensus 77 d~~rgg~lft~l~--~~~~f~~~~~~~~~aelaLald~lh~l~--iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~ 152 (612)
T KOG0603|consen 77 DFLRGGDLFTRLS--KEVMFDELDVAFYLAELALALDHLHKLG--IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI 152 (612)
T ss_pred hhcccchhhhccc--cCCchHHHHHHHHHHHHHHHHhhcchhH--HHHhcccccceeecccCccccCCchhhhHhHhhhh
Confidence 9999999988774 3445666667777888999999999998 999999999999999999999999987632
Q ss_pred CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccHHHHHH
Q 004979 585 TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQENVLEE 664 (721)
Q Consensus 585 ~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 664 (721)
..++..|||||.+. .....+|.||||++++||+||..||.. +....+++.+. .++.+...+
T Consensus 153 ~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~------~~~~~Il~~~~-----------~~p~~l~~~ 213 (612)
T KOG0603|consen 153 ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG------DTMKRILKAEL-----------EMPRELSAE 213 (612)
T ss_pred cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch------HHHHHHhhhcc-----------CCchhhhHH
Confidence 35577899999987 567889999999999999999999953 33344433222 234566777
Q ss_pred HHHHHHHcccCCCCCCCCHH-HHHHHHHHhhhcCCCCCCCCCChhHHHHHH
Q 004979 665 LLVVIKNCVHPDPKQRPSMR-GIAAKLKEITAMEPDGATPKLSPLWWAELE 714 (721)
Q Consensus 665 l~~li~~Cl~~dP~~RPs~~-evl~~L~~i~~~~~~~~~p~~~~~~~~~l~ 714 (721)
+.+++..+...+|..|--.. +.+..+ ..++++..++|.+++
T Consensus 214 a~~~~~~l~~r~p~nrLg~~~~~~~ei---------k~h~f~~~i~~~~l~ 255 (612)
T KOG0603|consen 214 ARSLFRQLFKRNPENRLGAGPDGVDEI---------KQHEFFQSIDWNELE 255 (612)
T ss_pred HHHHHHHHHhhCHHHHhccCcchhHHH---------hccchheeeeHhhHh
Confidence 88888999999999986542 222222 235666677777654
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=5.7e-18 Score=162.93 Aligned_cols=267 Identities=13% Similarity=0.188 Sum_probs=186.2
Q ss_pred hhhhhhCcCCCCceeEEEEEE-ecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCC-CccceEeEEEecCCCce
Q 004979 427 DFSNIIGSFSDGTVGTVYKGT-LSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNH-KNFVNLIGYCEEDEPFT 504 (721)
Q Consensus 427 ~~~~ii~~lg~G~~g~Vyk~~-~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H-~nIv~l~g~~~~~~~~~ 504 (721)
+-+.++.+||.|+||.+|.|. ..+|.+||+|.-..+... .++..|.++.+.++| ..|..++.|..+.. .
T Consensus 15 gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h-------pqL~yEskvY~iL~~g~GiP~i~~y~~e~~--y 85 (341)
T KOG1163|consen 15 GKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH-------PQLLYESKVYRILQGGVGIPHIRHYGTEKD--Y 85 (341)
T ss_pred cceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC-------cchhHHHHHHHHhccCCCCchhhhhccccc--c
Confidence 335789999999999999998 678999999987654332 357788888888865 45556666666655 4
Q ss_pred EEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCC---CCcEEEeccCCC
Q 004979 505 RMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTE---DYAAKISDFSFW 581 (721)
Q Consensus 505 ~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~---~~~~kL~DFGla 581 (721)
..+|||.. |.+|.++..- ..+.++..+.+-+|-|+..-++|+|.++ .|||||||+|+|..- ...+.++|||++
T Consensus 86 nvlVMdLL-GPsLEdLfnf-C~R~ftmkTvLMLaDQml~RiEyvH~r~--fiHRDIKPdNFLMGlgrh~~kl~LIDFGLa 161 (341)
T KOG1163|consen 86 NVLVMDLL-GPSLEDLFNF-CSRRFTMKTVLMLADQMLSRIEYVHLRN--FIHRDIKPDNFLMGLGRHCNKLYLIDFGLA 161 (341)
T ss_pred ceeeeecc-CccHHHHHHH-HhhhhhHHhHHHHHHHHHHHHHHHHhhc--cccccCCccceeeccccccceEEEEeccch
Confidence 58999998 8899998754 3456888999999999999999999988 999999999999973 356889999998
Q ss_pred CCCCC----------------CCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCC
Q 004979 582 NNTTA----------------AKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQP 645 (721)
Q Consensus 582 ~~~~~----------------~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~ 645 (721)
+.... ++..|++.....+..-+.+-|+-|+|-+|...--|+.||.+-.........+.+.+
T Consensus 162 Kky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~E--- 238 (341)
T KOG1163|consen 162 KKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISE--- 238 (341)
T ss_pred hhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHH---
Confidence 74322 22234433333444556788999999999999999999975443322221111111
Q ss_pred CccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCChhHHHHHH
Q 004979 646 LKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAMEPDGATPKLSPLWWAELE 714 (721)
Q Consensus 646 ~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~~~~p~~~~~~~~~l~ 714 (721)
..+...+.......+.|+...+.-|-..--++-|.-.-+.+.+.-+..-.. +..+--.+|+-|.
T Consensus 239 --kK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln---~~~d~iyDW~~lk 302 (341)
T KOG1163|consen 239 --KKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLN---HQYDYIYDWTMLK 302 (341)
T ss_pred --hhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhcc---ccCCeEeeHHHHH
Confidence 011111222334456788888888888888888887766655544433221 2233456676654
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=3.9e-17 Score=163.96 Aligned_cols=249 Identities=13% Similarity=0.190 Sum_probs=179.6
Q ss_pred hhhCcCCCCceeEEEEEE-ecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcC-CCCccceEeEEEecCCCceEEE
Q 004979 430 NIIGSFSDGTVGTVYKGT-LSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKV-NHKNFVNLIGYCEEDEPFTRMM 507 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~-~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~~~l 507 (721)
.+-.+||+|+||+++.|+ +-+++.||+|.-..++.. .++..|.+..+.| .-++|-.+|-|-.++. +..|
T Consensus 31 rVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~A-------PQLrdEYr~YKlL~g~~GIP~vYYFGqeG~--~NiL 101 (449)
T KOG1165|consen 31 RVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEA-------PQLRDEYRTYKLLGGTEGIPQVYYFGQEGK--YNIL 101 (449)
T ss_pred eeccccccCcceeeecccccccCceEEEEeccccCCc-------chHHHHHHHHHHHcCCCCCCceeeeccccc--hhhh
Confidence 456789999999999998 667899999977655433 3566777777766 4678877766655544 5689
Q ss_pred EEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCC-----CcEEEeccCCCC
Q 004979 508 VFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTED-----YAAKISDFSFWN 582 (721)
Q Consensus 508 V~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~-----~~~kL~DFGla~ 582 (721)
|+|.. |.||.++.. -..+.++..+...||.|+..-++|+|++. +|.|||||+|+||..- ..+.|.|||+|+
T Consensus 102 VidLL-GPSLEDLFD-~CgR~FSvKTV~miA~Qmi~rie~vH~k~--LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK 177 (449)
T KOG1165|consen 102 VIDLL-GPSLEDLFD-LCGRRFSVKTVAMIAKQMITRIEYVHEKD--LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAK 177 (449)
T ss_pred hhhhh-CcCHHHHHH-HhcCcccHHhHHHHHHHHHHHHHHHHhcc--eeecccCccceeecCCCCCCCceEEEEeccchh
Confidence 99998 889998875 34567999999999999999999999998 9999999999999743 458999999987
Q ss_pred CCCC----------------CCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCC
Q 004979 583 NTTA----------------AKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPL 646 (721)
Q Consensus 583 ~~~~----------------~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~ 646 (721)
.... ++..||+.-.-.+.+-+.+-|.=|+|-++...+-|..||.+-.....+...+.+.+....
T Consensus 178 ~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~ 257 (449)
T KOG1165|consen 178 EYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRS 257 (449)
T ss_pred hhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhcccccc
Confidence 4322 344566666566777888999999999999999999999854433222111111110000
Q ss_pred ccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 004979 647 KDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAM 696 (721)
Q Consensus 647 ~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~ 696 (721)
..+.+..+..+.++..-+.-.-..+-.+-|..+-+...+.++...
T Consensus 258 -----T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr 302 (449)
T KOG1165|consen 258 -----TPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDR 302 (449)
T ss_pred -----CCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHh
Confidence 112233445566666666555556777888887777666665543
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.3e-17 Score=192.68 Aligned_cols=149 Identities=29% Similarity=0.478 Sum_probs=129.7
Q ss_pred CChHHHHHHHHHHHhcccCCCCCCCCCCCCCCCCCCCCCC-----ceeeEEeCC------CcEEEEEeCCCCCCCcCchh
Q 004979 69 CLNSEGMALLRFRERVVRDPFGALSKWSDNDGVGDNVNPC-----SWFGVECSD------GKVVILNLRDLCLGGMLAPE 137 (721)
Q Consensus 69 ~~~~~~~~ll~~k~~~~~~~~~~l~~W~~~~~~~~~~~~C-----~w~gv~C~~------~~v~~l~L~~~~l~G~ip~~ 137 (721)
....|..+|+.+|+.+. ++. ..+|++ ++| .|.||.|.. .+|+.|+|++++|.|.+|+.
T Consensus 369 t~~~~~~aL~~~k~~~~-~~~--~~~W~g--------~~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~ 437 (623)
T PLN03150 369 TLLEEVSALQTLKSSLG-LPL--RFGWNG--------DPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPND 437 (623)
T ss_pred cCchHHHHHHHHHHhcC-Ccc--cCCCCC--------CCCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHH
Confidence 45678999999999874 332 247863 234 799999952 25899999999999999999
Q ss_pred hcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCccccCCCCCCEEECccCCCCcCCChhccCC-CCC
Q 004979 138 LGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLLDNNQYLGGISPELHVL-KVI 216 (721)
Q Consensus 138 l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~~L~~l~l~~N~~~G~iP~~~~~l-~~L 216 (721)
++.|++|+.|+|++|.|.|.+|..++.+++|+.|||++|+|+|.+|..++++++|++|+|++|+|+|.+|..++.+ .++
T Consensus 438 i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~ 517 (623)
T PLN03150 438 ISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHR 517 (623)
T ss_pred HhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccC
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999998764 467
Q ss_pred CEEEccCCCCCC
Q 004979 217 SEIQVDESWLTN 228 (721)
Q Consensus 217 ~~l~l~~n~~~g 228 (721)
..+++.+|....
T Consensus 518 ~~l~~~~N~~lc 529 (623)
T PLN03150 518 ASFNFTDNAGLC 529 (623)
T ss_pred ceEEecCCcccc
Confidence 788888886543
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.9e-17 Score=163.19 Aligned_cols=135 Identities=10% Similarity=0.126 Sum_probs=101.1
Q ss_pred CcCCCCceeEEEEEEecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcC-----CCCccceEeEEEecCCC--ceE
Q 004979 433 GSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKV-----NHKNFVNLIGYCEEDEP--FTR 505 (721)
Q Consensus 433 ~~lg~G~~g~Vyk~~~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l-----~H~nIv~l~g~~~~~~~--~~~ 505 (721)
..||+|+||.||+ +......+||++..... ...+.+.+|+++++++ +||||++++|++.++.. ...
T Consensus 8 ~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~-----~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~ 80 (210)
T PRK10345 8 SPLGTGRHRKCYA--HPEDAQRCIKIVYHRGD-----GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY 80 (210)
T ss_pred ceecCCCceEEEE--CCCCcCeEEEEEecccc-----chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence 4678999999996 43333346877754321 1235789999999999 57999999999987632 223
Q ss_pred EEEEec--CCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHH-HHHhcCCCCeEeeCCCCCCeEeCC----CCcEEEecc
Q 004979 506 MMVFEY--SPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCL-EHMHQLTPPIAHRNLQSSSIYLTE----DYAAKISDF 578 (721)
Q Consensus 506 ~lV~Ey--~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL-~yLH~~~~~IvHrDLKp~NILl~~----~~~~kL~DF 578 (721)
.+|+|| +++|+|.+++.. ..+++. ..++.++..++ +|||+.+ |+||||||+|||++. +..++|+||
T Consensus 81 ~~I~e~~G~~~~tL~~~l~~---~~~~e~--~~~~~~~L~~l~~yLh~~~--IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAEQ---CRYEED--VAQLRQLLKKLKRYLLDNR--IVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred EEEecCCCCcchhHHHHHHc---ccccHh--HHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 478999 668999999953 235554 35677777777 9999998 999999999999974 348999995
Q ss_pred CCC
Q 004979 579 SFW 581 (721)
Q Consensus 579 Gla 581 (721)
+.+
T Consensus 154 ~G~ 156 (210)
T PRK10345 154 IGE 156 (210)
T ss_pred CCC
Confidence 543
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.5e-18 Score=196.93 Aligned_cols=237 Identities=19% Similarity=0.237 Sum_probs=167.0
Q ss_pred hhCcCCCCceeEEEEEEecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEEEe
Q 004979 431 IIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFE 510 (721)
Q Consensus 431 ii~~lg~G~~g~Vyk~~~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV~E 510 (721)
..+.+|.+.|=+|.||+.+.|. |+||++.++.... .-...++-++|++ ...++|||.+.+.-+-.... ..|||=+
T Consensus 27 ~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~-sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~k--AAylvRq 101 (1431)
T KOG1240|consen 27 YVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTI-SLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDK--AAYLVRQ 101 (1431)
T ss_pred eecccCchhhhhhhhccCCCce-EEEEEEeccCCCC-CchHHHHHHHHHH-HHhhcCCcccchHHHHHhhH--HHHHHHH
Confidence 3467899999999999988886 8888886554211 1112233344555 55669999998876655444 3578888
Q ss_pred cCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC------
Q 004979 511 YSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT------ 584 (721)
Q Consensus 511 y~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~------ 584 (721)
|..+ +|+|.|. .+.-+...+.+=|+.|+..|+.-+|..+ |.|+|||.+||||..-.-+.|+||.-.+.+
T Consensus 102 yvkh-nLyDRlS--TRPFL~~iEKkWiaFQLL~al~qcH~~g--VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN 176 (1431)
T KOG1240|consen 102 YVKH-NLYDRLS--TRPFLVLIEKKWIAFQLLKALSQCHKLG--VCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN 176 (1431)
T ss_pred HHhh-hhhhhhc--cchHHHHHHHHHHHHHHHHHHHHHHHcC--ccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence 8855 8998885 3344667777889999999999999999 999999999999998888999999754422
Q ss_pred ----------CCCCccccchhhccc----------C-CCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhc
Q 004979 585 ----------TAAKTGSAAMELLET----------S-AVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKG 642 (721)
Q Consensus 585 ----------~~~~~~~~apE~~~~----------~-~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~ 642 (721)
....+.|.|||.+.. . ..+++-||||.|||+.||++ |+++|. +.+.... ..+
T Consensus 177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~-----LSQL~aY-r~~ 250 (1431)
T KOG1240|consen 177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT-----LSQLLAY-RSG 250 (1431)
T ss_pred cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc-----HHHHHhH-hcc
Confidence 112346789997632 1 25788999999999999999 788884 2222211 111
Q ss_pred CCCCccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004979 643 EQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAK 689 (721)
Q Consensus 643 ~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 689 (721)
.. .+++. ...+-....+..++..|++.||++|.++++.++.
T Consensus 251 ~~-----~~~e~-~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 251 NA-----DDPEQ-LLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred Cc-----cCHHH-HHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 10 01000 0000011357889999999999999999999876
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.2e-16 Score=155.86 Aligned_cols=175 Identities=13% Similarity=0.152 Sum_probs=123.4
Q ss_pred hCcCCCCceeEEEEEEecCCcEEEEEEeeeccccchh-hHHHHHHHHHHHHHhcCC-CCccceEeEEEecCCCceEEEEE
Q 004979 432 IGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWS-KNLESQFRKKIDTLSKVN-HKNFVNLIGYCEEDEPFTRMMVF 509 (721)
Q Consensus 432 i~~lg~G~~g~Vyk~~~~~~~~vavk~~~~~~~~~~~-~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~~~lV~ 509 (721)
...++.|+||+||.+.- .+..++.+.+..... +. ......|.+|+++|++++ |++|.+++++. ..+++|
T Consensus 7 ~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~--~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~------~~~lvm 77 (218)
T PRK12274 7 NEPLKSDTFGRILLVRG-GERKFVRRDLSAAPW--WLRGVAWWLARREALALRQLDGLPRTPRLLHWD------GRHLDR 77 (218)
T ss_pred ceeecCCCcceEEEeec-CCceeeecccccchh--hhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc------CEEEEE
Confidence 34677899999997765 456666555443221 11 112235889999999995 58899998862 358999
Q ss_pred ecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCC-CCCCeEeCCCCcEEEeccCCCCCCCCCC
Q 004979 510 EYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNL-QSSSIYLTEDYAAKISDFSFWNNTTAAK 588 (721)
Q Consensus 510 Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDL-Kp~NILl~~~~~~kL~DFGla~~~~~~~ 588 (721)
||+.|.+|...+.. ....++.|++.+++++|+++ |+|||| ||+|||+++++.++|+|||++.......
T Consensus 78 eyI~G~~L~~~~~~---------~~~~~~~qi~~~L~~lH~~G--IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~ 146 (218)
T PRK12274 78 SYLAGAAMYQRPPR---------GDLAYFRAARRLLQQLHRCG--VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA 146 (218)
T ss_pred eeecCccHHhhhhh---------hhHHHHHHHHHHHHHHHHCc--CccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence 99999998754321 11357789999999999998 999999 7999999999999999999987433221
Q ss_pred c-----c------------ccchhhccc------CCCC-CCccHHHHHHHHHHHHhCCCccc
Q 004979 589 T-----G------------SAAMELLET------SAVD-LESNVYSFGTILFEMITGRISYS 626 (721)
Q Consensus 589 ~-----~------------~~apE~~~~------~~~s-~ksDVwSfGvvL~ElltG~~P~~ 626 (721)
. . ..+||.+.. ...+ ...+.++-|.-+|.++|+..+..
T Consensus 147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~ 208 (218)
T PRK12274 147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW 208 (218)
T ss_pred hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence 1 0 013333211 1122 34577799999999999988764
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.70 E-value=6.1e-17 Score=166.22 Aligned_cols=225 Identities=16% Similarity=0.296 Sum_probs=144.2
Q ss_pred CcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCC----------CccceEeEEEe-cC
Q 004979 433 GSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNH----------KNFVNLIGYCE-ED 500 (721)
Q Consensus 433 ~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H----------~nIv~l~g~~~-~~ 500 (721)
+.||.|+++.||.++.. ++++++||+..... +......+++.+|.-....+.+ -.++.-++... ..
T Consensus 18 ~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~--~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~ 95 (288)
T PF14531_consen 18 RIIGKGGFSIVFEVTDVETGEEFAVKVFLLPA--DASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPG 95 (288)
T ss_dssp EEEEEETTEEEEEEEETTTTEEEEEEEEEESS--TTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETT
T ss_pred cccccCCceEEEEEEEccCCceEEEEEEeccc--ccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcC
Confidence 45678999999999965 58899999987765 3344456778888766655433 12222222221 10
Q ss_pred -------C----Cc---eEEEEEecCCCCChhhhhhh---ccC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCC
Q 004979 501 -------E----PF---TRMMVFEYSPNGSLFEHLHI---QEA--EHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQ 561 (721)
Q Consensus 501 -------~----~~---~~~lV~Ey~~~GsL~~~l~~---~~~--~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLK 561 (721)
. .+ ..+++|+-+ .+||.+++.. ... ..+....++.+..|+.+.+++||..+ +||+|||
T Consensus 96 ~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G--lVHgdi~ 172 (288)
T PF14531_consen 96 KPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG--LVHGDIK 172 (288)
T ss_dssp S-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT--EEEST-S
T ss_pred CCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc--eEecccc
Confidence 0 01 236778877 6688877542 111 12445567788899999999999999 9999999
Q ss_pred CCCeEeCCCCcEEEeccCCCCCC------CCCCccccchhhccc--------CCCCCCccHHHHHHHHHHHHhCCCcccC
Q 004979 562 SSSIYLTEDYAAKISDFSFWNNT------TAAKTGSAAMELLET--------SAVDLESNVYSFGTILFEMITGRISYSI 627 (721)
Q Consensus 562 p~NILl~~~~~~kL~DFGla~~~------~~~~~~~~apE~~~~--------~~~s~ksDVwSfGvvL~ElltG~~P~~~ 627 (721)
|+|++++++|.++|+||+..... ......+.+||.... ..++.+.|.|++|+++|.|.+|+.||..
T Consensus 173 ~~nfll~~~G~v~Lg~F~~~~r~g~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~ 252 (288)
T PF14531_consen 173 PENFLLDQDGGVFLGDFSSLVRAGTRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGL 252 (288)
T ss_dssp GGGEEE-TTS-EEE--GGGEEETTEEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCC
T ss_pred eeeEEEcCCCCEEEcChHHHeecCceeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCC
Confidence 99999999999999999854321 122345678886533 3578899999999999999999999963
Q ss_pred CCCCHHHHHHHHhhcCCCCccccC-CccccccHHHHHHHHHHHHHcccCCCCCC
Q 004979 628 ENGSLENWASEYLKGEQPLKDIVD-PTLKSFQENVLEELLVVIKNCVHPDPKQR 680 (721)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~d-~~l~~~~~~~~~~l~~li~~Cl~~dP~~R 680 (721)
... ...+ ....... +.++.+..||..+++.+|++|
T Consensus 253 ~~~-----------------~~~~~~~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 253 SSP-----------------EADPEWDFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp CGG-----------------GSTSGGGGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred CCc-----------------cccccccchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 221 0000 1233344 778899999999999999988
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.7e-16 Score=159.16 Aligned_cols=139 Identities=16% Similarity=0.229 Sum_probs=110.9
Q ss_pred CcCCCCceeEEEEEEecCCcEEEEEEeeeccccch---hhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEEE
Q 004979 433 GSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADW---SKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVF 509 (721)
Q Consensus 433 ~~lg~G~~g~Vyk~~~~~~~~vavk~~~~~~~~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV~ 509 (721)
..+|+|++|.||+|.+ .+..+++|+......... .......+.+|++++..++|++|.....++...+ ..++||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~--~~~lv~ 78 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPE--NFIIVM 78 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCC--CCEEEE
Confidence 4678999999999987 567788887653321110 1122356889999999999999887777766555 458999
Q ss_pred ecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCC
Q 004979 510 EYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNN 583 (721)
Q Consensus 510 Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~ 583 (721)
||+++++|.+++... .+ .+..++.+++.+|.++|+.+ ++|||++|+|||++ ++.++|+|||.++.
T Consensus 79 e~~~G~~L~~~~~~~-----~~-~~~~i~~~i~~~l~~lH~~~--i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 79 EYIEGEPLKDLINSN-----GM-EELELSREIGRLVGKLHSAG--IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EEeCCcCHHHHHHhc-----cH-HHHHHHHHHHHHHHHHHhCC--cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 999999999988532 12 77899999999999999988 99999999999999 78999999998654
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.69 E-value=9.6e-17 Score=164.43 Aligned_cols=170 Identities=19% Similarity=0.239 Sum_probs=121.8
Q ss_pred eEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeC--CCC--cEEEeccC
Q 004979 504 TRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLT--EDY--AAKISDFS 579 (721)
Q Consensus 504 ~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~--~~~--~~kL~DFG 579 (721)
..|+||.-++. +|..++-. ...+...+.-|..|+.+|..|||.++ |.|||+|++|||+. +|. ...|+|||
T Consensus 317 tlylvMkrY~~-tLr~yl~~---~~~s~r~~~~~laQlLEav~hL~~hg--vAhRDlKSDNiL~ElddD~~P~LVvaDFG 390 (598)
T KOG4158|consen 317 TLYLVMKRYRQ-TLREYLWT---RHRSYRTGRVILAQLLEAVTHLHKHG--VAHRDLKSDNILLELDDDEIPQLVVADFG 390 (598)
T ss_pred eEEEehhcchh-hHHHHHhc---CCCchHHHHHHHHHHHHHHHHHHHcc--chhhcccccceEEEecCCCCcEEEEcccc
Confidence 46888887754 88888743 34566677788999999999999998 99999999999984 443 46789999
Q ss_pred CCC--CC-------------CCCCccccchhhcccCC------CCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHH
Q 004979 580 FWN--NT-------------TAAKTGSAAMELLETSA------VDLESNVYSFGTILFEMITGRISYSIENGSLENWASE 638 (721)
Q Consensus 580 la~--~~-------------~~~~~~~~apE~~~~~~------~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~ 638 (721)
.+- .. ..+....||||+..... --.|+|.|+.|-+.||+++...||...+.-..+.
T Consensus 391 CcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~--- 467 (598)
T KOG4158|consen 391 CCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDT--- 467 (598)
T ss_pred eeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheech---
Confidence 642 11 11223458999874322 1268999999999999999999997533211110
Q ss_pred HhhcCCCCccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 004979 639 YLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKL 690 (721)
Q Consensus 639 ~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L 690 (721)
. ..-...++..++.++..+.+++...++.||++|++..-....|
T Consensus 468 -----r---~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 468 -----R---TYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred -----h---hhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCccHHHhHH
Confidence 0 1112334455667788899999999999999999876555443
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.67 E-value=4.9e-16 Score=158.07 Aligned_cols=147 Identities=18% Similarity=0.130 Sum_probs=109.9
Q ss_pred hhhhhCcCCCCceeEEEEEE--ecCCcEEEEEEeeeccccc-------------------hhhHHHHHHHHHHHHHhcCC
Q 004979 428 FSNIIGSFSDGTVGTVYKGT--LSSGVEIAVTSTSVKSRAD-------------------WSKNLESQFRKKIDTLSKVN 486 (721)
Q Consensus 428 ~~~ii~~lg~G~~g~Vyk~~--~~~~~~vavk~~~~~~~~~-------------------~~~~~~~~f~~Ei~~l~~l~ 486 (721)
++.+...+|+|+||.||+|+ ..+|..||+|++....... ........+..|++.+.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 35778899999999999998 5689999999887542110 01112234678999999997
Q ss_pred CCc--cceEeEEEecCCCceEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCC
Q 004979 487 HKN--FVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSS 564 (721)
Q Consensus 487 H~n--Iv~l~g~~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~N 564 (721)
|.. +.+++++ . ..++||||+++++|...... ...+.......++.|++.+++|||+.+ .|+||||||+|
T Consensus 109 ~~~i~~p~~~~~---~---~~~lV~E~~~g~~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~g-~iiH~Dikp~N 179 (237)
T smart00090 109 EAGVPVPKPIAW---R---RNVLVMEFIGGDGLPAPRLK--DVEPEEEEEFELYDDILEEMRKLYKEG-ELVHGDLSEYN 179 (237)
T ss_pred hcCCCCCeeeEe---c---CceEEEEEecCCcccccccc--cCCcchHHHHHHHHHHHHHHHHHHhcC-CEEeCCCChhh
Confidence 633 3344432 2 23799999999888765421 223555566789999999999999875 49999999999
Q ss_pred eEeCCCCcEEEeccCCCCCC
Q 004979 565 IYLTEDYAAKISDFSFWNNT 584 (721)
Q Consensus 565 ILl~~~~~~kL~DFGla~~~ 584 (721)
|+++ ++.++|+|||.+...
T Consensus 180 Ili~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 180 ILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred EEEE-CCCEEEEEChhhhcc
Confidence 9999 889999999987643
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.67 E-value=4.7e-16 Score=154.42 Aligned_cols=134 Identities=17% Similarity=0.274 Sum_probs=104.0
Q ss_pred CCCCceeEEEEEEecCCcEEEEEEeeeccccc--h-hhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEEEec
Q 004979 435 FSDGTVGTVYKGTLSSGVEIAVTSTSVKSRAD--W-SKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEY 511 (721)
Q Consensus 435 lg~G~~g~Vyk~~~~~~~~vavk~~~~~~~~~--~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV~Ey 511 (721)
+|+|+||+||+|.+ ++..+++|+...+.... . ......++.+|++++..++|+++.....++...+ ..++||||
T Consensus 2 ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~--~~~lv~e~ 78 (199)
T TIGR03724 2 IAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPD--NKTIVMEY 78 (199)
T ss_pred CCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECC--CCEEEEEE
Confidence 68999999999985 46788888765432111 0 1122366889999999999887655554554444 45899999
Q ss_pred CCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCC
Q 004979 512 SPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNN 583 (721)
Q Consensus 512 ~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~ 583 (721)
+++++|.+++.... ..++.+++.+|.++|+.+ ++|||+||+||+++ ++.+++.|||+++.
T Consensus 79 ~~g~~l~~~~~~~~---------~~~~~~i~~~l~~lH~~g--i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 79 IEGKPLKDVIEEGN---------DELLREIGRLVGKLHKAG--IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred ECCccHHHHHhhcH---------HHHHHHHHHHHHHHHHCC--eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999998874311 078999999999999988 99999999999999 88999999998754
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.66 E-value=5.2e-16 Score=177.31 Aligned_cols=137 Identities=16% Similarity=0.169 Sum_probs=107.5
Q ss_pred hhCcCCCCceeEEEEEEecCCcEEEEEEeeeccccc---hhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEE
Q 004979 431 IIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRAD---WSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMM 507 (721)
Q Consensus 431 ii~~lg~G~~g~Vyk~~~~~~~~vavk~~~~~~~~~---~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~l 507 (721)
....+|+|+||+||+|.+.... +++|+...+.... ......+++.+|++++.+++|++|+..+.++...+ ..++
T Consensus 337 ~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~--~~~l 413 (535)
T PRK09605 337 PDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE--EKTI 413 (535)
T ss_pred ccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC--CCEE
Confidence 3567899999999999876443 4444332221111 11123457899999999999999998877776655 4589
Q ss_pred EEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCC
Q 004979 508 VFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNN 583 (721)
Q Consensus 508 V~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~ 583 (721)
||||+++++|.+++. ....++.+++.+|.|||+.+ |+||||||+|||+ +++.++|+|||+++.
T Consensus 414 v~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~g--iiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 414 VMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKAG--IVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCC--CccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 999999999998874 35679999999999999988 9999999999999 678999999999765
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.66 E-value=6.7e-16 Score=153.33 Aligned_cols=141 Identities=15% Similarity=0.168 Sum_probs=107.1
Q ss_pred hhhhCcCCCCceeEEEEEEecCCcEEEEEEeeecccc-----------------chhhHHHHHHHHHHHHHhcCCCCc--
Q 004979 429 SNIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRA-----------------DWSKNLESQFRKKIDTLSKVNHKN-- 489 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~~~~~vavk~~~~~~~~-----------------~~~~~~~~~f~~Ei~~l~~l~H~n-- 489 (721)
+.+...+|+|+||.||+|...+|+.++||++...... .+.......+..|+.++.++.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 4566788999999999999888999999986543210 000111234678899999998874
Q ss_pred cceEeEEEecCCCceEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCC
Q 004979 490 FVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTE 569 (721)
Q Consensus 490 Iv~l~g~~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~ 569 (721)
+.+.++. . ..++||||+++++|...... .....++.+++.++.++|+.+ |+||||||+||++++
T Consensus 97 v~~~~~~----~--~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~g--i~H~Dl~p~Nill~~ 160 (198)
T cd05144 97 VPKPIDW----N--RHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKHG--IIHGDLSEFNILVDD 160 (198)
T ss_pred CCceeec----C--CceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHCC--CCcCCCCcccEEEcC
Confidence 4444432 2 34899999999999765420 234578899999999999987 999999999999999
Q ss_pred CCcEEEeccCCCCCCC
Q 004979 570 DYAAKISDFSFWNNTT 585 (721)
Q Consensus 570 ~~~~kL~DFGla~~~~ 585 (721)
++.++|+|||++....
T Consensus 161 ~~~~~liDfg~~~~~~ 176 (198)
T cd05144 161 DEKIYIIDWPQMVSTD 176 (198)
T ss_pred CCcEEEEECCccccCC
Confidence 9999999999875443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.63 E-value=2.2e-15 Score=174.99 Aligned_cols=179 Identities=18% Similarity=0.322 Sum_probs=138.4
Q ss_pred hhhCcCCCCceeEEEEEEecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCC---CCccceEeEEEecCCCceEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVN---HKNFVNLIGYCEEDEPFTRM 506 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~---H~nIv~l~g~~~~~~~~~~~ 506 (721)
.|-+.+|+|+||+||+|...+|+.||+|+-+... .|. |.--.+++.+|+ -+-|..+...+...+ .-+
T Consensus 701 ~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~--~WE------fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~--~S~ 770 (974)
T KOG1166|consen 701 CISKEIGEGSYGSVYVATHSNGKLVALKVEKPPN--PWE------FYICLQVMERLKPQMLPSIMHISSAHVFQN--ASV 770 (974)
T ss_pred EEEeeeccccceEEEEeecCCCcEEEEEeecCCC--cee------eeehHHHHHhhchhhhcchHHHHHHHccCC--cce
Confidence 5667899999999999998889999999765432 221 222233444444 233445544444444 348
Q ss_pred EEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCC-------CCcEEEeccC
Q 004979 507 MVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTE-------DYAAKISDFS 579 (721)
Q Consensus 507 lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~-------~~~~kL~DFG 579 (721)
||+||.+.|+|.+++. ..+.++|.....+..|+++-+++||.++ |||+||||+|+||.. ..-++|+|||
T Consensus 771 lv~ey~~~Gtlld~~N--~~~~m~e~lv~~~~~qml~ive~lH~~~--IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG 846 (974)
T KOG1166|consen 771 LVSEYSPYGTLLDLIN--TNKVMDEYLVMFFSCQMLRIVEHLHAMG--IIHGDIKPDNFLLRREICADSDSKGLYLIDFG 846 (974)
T ss_pred eeeeccccccHHHhhc--cCCCCCchhhhHHHHHHHHHHHHHHhcc--eecccCCcceeEeecccCCCCcccceEEEecc
Confidence 9999999999999986 5677999999999999999999999999 999999999999942 3458999999
Q ss_pred CCCCCC---C--------CCccccchhhcccCCCCCCccHHHHHHHHHHHHhCC
Q 004979 580 FWNNTT---A--------AKTGSAAMELLETSAVDLESNVYSFGTILFEMITGR 622 (721)
Q Consensus 580 la~~~~---~--------~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~ 622 (721)
.+-.+. . .+...-.+|...++.++.+.|.|.+.-+++-|+.|+
T Consensus 847 ~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~ 900 (974)
T KOG1166|consen 847 RSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGK 900 (974)
T ss_pred cceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHH
Confidence 764321 1 122445789999999999999999999999999997
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.57 E-value=3.7e-15 Score=169.75 Aligned_cols=196 Identities=20% Similarity=0.314 Sum_probs=134.9
Q ss_pred hhhhhhCcCCCCceeEEEEEEecC-CcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceE
Q 004979 427 DFSNIIGSFSDGTVGTVYKGTLSS-GVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTR 505 (721)
Q Consensus 427 ~~~~ii~~lg~G~~g~Vyk~~~~~-~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~ 505 (721)
|| +.|+.+..|+||.||..+++. .+.+|.| +.++. .+.+ ||..+.| ..
T Consensus 84 df-~~IklisngAygavylvrh~~trqrfa~k-iNkq~----------lilR-----------nilt~a~--------np 132 (1205)
T KOG0606|consen 84 DF-NTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQN----------LILR-----------NILTFAG--------NP 132 (1205)
T ss_pred cc-ceeEeeccCCCCceeeeeccccccchhhc-ccccc----------hhhh-----------ccccccC--------Cc
Confidence 45 677888999999999998763 3455553 22111 1111 2222211 11
Q ss_pred EEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCC--
Q 004979 506 MMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNN-- 583 (721)
Q Consensus 506 ~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~-- 583 (721)
+.| |+-...++.-. .+.. +++.+++|+|+.+ |+|||+||+|.+|..-|.+|+.|||+.+.
T Consensus 133 fvv------gDc~tllk~~g--~lPv--------dmvla~Eylh~yg--ivhrdlkpdnllIT~mGhiKlTDfgLsk~GL 194 (1205)
T KOG0606|consen 133 FVV------GDCATLLKNIG--PLPV--------DMVLAVEYLHSYG--IVHRDLKPDNLLITSMGHIKLTDFGLSKKGL 194 (1205)
T ss_pred cee------chhhhhcccCC--CCcc--------hhhHHhHhhccCC--eecCCCCCCcceeeecccccccchhhhhhhh
Confidence 233 45555554222 2221 2278899999988 99999999999999999999999997541
Q ss_pred ----------------------CCCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhh
Q 004979 584 ----------------------TTAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLK 641 (721)
Q Consensus 584 ----------------------~~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~ 641 (721)
-..+++.|.|||++....|...+|+|++|+|+||.+.|+.||.++ ..++.+..++.
T Consensus 195 ms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGd--tpeelfg~vis 272 (1205)
T KOG0606|consen 195 MSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD--TPEELFGQVIS 272 (1205)
T ss_pred hhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCC--CHHHHHhhhhh
Confidence 123566789999999999999999999999999999999999644 33444444443
Q ss_pred cCCCCccccCCccccccHHHHHHHHHHHHHcccCCCCCCC
Q 004979 642 GEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRP 681 (721)
Q Consensus 642 ~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RP 681 (721)
......+ -.+....|+.+++.+.++.+|.+|-
T Consensus 273 d~i~wpE--------~dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 273 DDIEWPE--------EDEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred hhccccc--------cCcCCCHHHHHHHHHHHHhChHhhc
Confidence 3222111 1234557889999999999999994
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.54 E-value=3.1e-14 Score=139.81 Aligned_cols=141 Identities=14% Similarity=0.104 Sum_probs=97.1
Q ss_pred hCcCCCCceeEEEEEEecCCcEEEEEEeeeccccchhhH-------------------HHHHHHHHHHHHhcCCCCc--c
Q 004979 432 IGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKN-------------------LESQFRKKIDTLSKVNHKN--F 490 (721)
Q Consensus 432 i~~lg~G~~g~Vyk~~~~~~~~vavk~~~~~~~~~~~~~-------------------~~~~f~~Ei~~l~~l~H~n--I 490 (721)
.+.+|+|+||+||+|...+++.|+||+............ .......|.+.+.++++.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 356889999999999988899999998764321110000 0011245666666665443 4
Q ss_pred ceEeEEEecCCCceEEEEEecCCCCChhhh-hhhccCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCeEeeCCCCCCeEeC
Q 004979 491 VNLIGYCEEDEPFTRMMVFEYSPNGSLFEH-LHIQEAEHLDWAMRLRIAMGMAYCLEHMHQ-LTPPIAHRNLQSSSIYLT 568 (721)
Q Consensus 491 v~l~g~~~~~~~~~~~lV~Ey~~~GsL~~~-l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~-~~~~IvHrDLKp~NILl~ 568 (721)
.+.+++. ..++||||++++.+... +.. .. .. .....++.+++.++.++|. .+ |+||||||+||+++
T Consensus 82 ~~~~~~~------~~~lv~e~~~g~~~~~~~l~~-~~--~~-~~~~~~~~~~~~~l~~lh~~~~--ivH~Dl~p~Nili~ 149 (187)
T cd05119 82 PKPIDLN------RHVLVMEFIGGDGIPAPRLKD-VR--LL-EDPEELYDQILELMRKLYREAG--LVHGDLSEYNILVD 149 (187)
T ss_pred CceEecC------CCEEEEEEeCCCCccChhhhh-hh--hc-ccHHHHHHHHHHHHHHHhhccC--cCcCCCChhhEEEE
Confidence 4444431 34899999999654321 111 00 11 4567899999999999998 77 99999999999999
Q ss_pred CCCcEEEeccCCCCCCC
Q 004979 569 EDYAAKISDFSFWNNTT 585 (721)
Q Consensus 569 ~~~~~kL~DFGla~~~~ 585 (721)
++.++++|||.+....
T Consensus 150 -~~~~~liDfg~a~~~~ 165 (187)
T cd05119 150 -DGKVYIIDVPQAVEID 165 (187)
T ss_pred -CCcEEEEECccccccc
Confidence 8999999999886443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.54 E-value=2e-15 Score=161.43 Aligned_cols=163 Identities=20% Similarity=0.292 Sum_probs=122.8
Q ss_pred eEEEEEecCCCCChhhhhhhc-cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCC
Q 004979 504 TRMMVFEYSPNGSLFEHLHIQ-EAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWN 582 (721)
Q Consensus 504 ~~~lV~Ey~~~GsL~~~l~~~-~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~ 582 (721)
..|+.|++|...+|.+||..+ .....+|...+.++.|++.|++| ++ .+|||+||.||....+..+||.|||+..
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~--~ihrdlkp~nif~~~d~q~kIgDFgl~t 404 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG--LIHRDLKPSNIFFSDDDQLKIGDFGLVT 404 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc--chhhhccccccccccchhhhhhhhhhee
Confidence 368999999999999999633 35668889999999999999999 55 9999999999999999999999999854
Q ss_pred CCC---------------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhcCCCC
Q 004979 583 NTT---------------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPL 646 (721)
Q Consensus 583 ~~~---------------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~ 646 (721)
... .++..||+||.+.+..|+.|+||||+|++|+|+++ =...+. . ...+
T Consensus 405 s~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e-----r----------~~t~ 469 (516)
T KOG1033|consen 405 SQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE-----R----------IATL 469 (516)
T ss_pred ecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH-----H----------HHhh
Confidence 221 23457899999999999999999999999999998 222221 0 0112
Q ss_pred ccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHH
Q 004979 647 KDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGI 686 (721)
Q Consensus 647 ~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev 686 (721)
.++-|..++.......++-+.|+.+++...|.+||++.++
T Consensus 470 ~d~r~g~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 470 TDIRDGIIPPEFLQDYPEEYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred hhhhcCCCChHHhhcCcHHHHHHHHhcCCCcccCchHHHH
Confidence 2222332221111112344678899999999999965554
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.53 E-value=7.9e-14 Score=142.19 Aligned_cols=138 Identities=13% Similarity=0.073 Sum_probs=101.5
Q ss_pred CCceeEEEEEEecCCcEEEEEEeeeccc--------cchhhHHHHHHHHHHHHHhcCCCCcc--ceEeEEEecCCC--ce
Q 004979 437 DGTVGTVYKGTLSSGVEIAVTSTSVKSR--------ADWSKNLESQFRKKIDTLSKVNHKNF--VNLIGYCEEDEP--FT 504 (721)
Q Consensus 437 ~G~~g~Vyk~~~~~~~~vavk~~~~~~~--------~~~~~~~~~~f~~Ei~~l~~l~H~nI--v~l~g~~~~~~~--~~ 504 (721)
.|+.|+||+.... +..++||....... ..........+.+|++++.+++|++| ++.+++...... +.
T Consensus 42 ~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~~~~~ 120 (239)
T PRK01723 42 AKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHGLFYR 120 (239)
T ss_pred CCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecCccee
Confidence 5666688888765 67788887753211 01112234578899999999998885 677776544322 13
Q ss_pred EEEEEecCCC-CChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCC
Q 004979 505 RMMVFEYSPN-GSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNN 583 (721)
Q Consensus 505 ~~lV~Ey~~~-GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~ 583 (721)
.++||||+++ .+|.+++.. ..++.. .+.+++.++.+||+.+ |+||||||+|||++.++.++|+|||.+..
T Consensus 121 ~~lV~e~l~G~~~L~~~l~~---~~l~~~----~~~~i~~~l~~lH~~G--I~HrDlkp~NILv~~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 121 ADILIERIEGARDLVALLQE---APLSEE----QWQAIGQLIARFHDAG--VYHADLNAHNILLDPDGKFWLIDFDRGEL 191 (239)
T ss_pred eeEEEEecCCCCCHHHHHhc---CCCCHH----HHHHHHHHHHHHHHCC--CCCCCCCchhEEEcCCCCEEEEECCCccc
Confidence 3699999997 689888753 234433 3578999999999998 99999999999999989999999998765
Q ss_pred C
Q 004979 584 T 584 (721)
Q Consensus 584 ~ 584 (721)
.
T Consensus 192 ~ 192 (239)
T PRK01723 192 R 192 (239)
T ss_pred C
Confidence 3
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.52 E-value=7.4e-14 Score=131.06 Aligned_cols=133 Identities=17% Similarity=0.220 Sum_probs=108.1
Q ss_pred hCcCCCCceeEEEEEEecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCC--CccceEeEEEecCCCceEEEEE
Q 004979 432 IGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNH--KNFVNLIGYCEEDEPFTRMMVF 509 (721)
Q Consensus 432 i~~lg~G~~g~Vyk~~~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H--~nIv~l~g~~~~~~~~~~~lV~ 509 (721)
+..+|+|.++.||++...+ ..+++|....... ...+.+|+..+..++| .++.+++++....+ ..+++|
T Consensus 3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~-------~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~--~~~~v~ 72 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK-------GADREREVAILQLLARKGLPVPKVLASGESDG--WSYLLM 72 (155)
T ss_pred ceecccccccceEEEEecC-CeEEEEecCCCCc-------hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCC--ccEEEE
Confidence 4568899999999999765 6788887653321 3568899999999976 58999988887654 569999
Q ss_pred ecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCC-CCeEeeCCCCCCeEeCCCCcEEEeccCCCCC
Q 004979 510 EYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLT-PPIAHRNLQSSSIYLTEDYAAKISDFSFWNN 583 (721)
Q Consensus 510 Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~-~~IvHrDLKp~NILl~~~~~~kL~DFGla~~ 583 (721)
||++++.+..+ +......++.+++.+++++|... .+++|+|+||+||++++.+.+++.|||.++.
T Consensus 73 e~~~g~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 73 EWIEGETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred EecCCeecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 99998877543 55667788999999999999742 3599999999999999989999999998653
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.42 E-value=1.8e-12 Score=143.61 Aligned_cols=169 Identities=17% Similarity=0.210 Sum_probs=110.7
Q ss_pred hcCCCCCCHHHHHHHHhh---------hhhh-hCcCCCCceeEEEEEEecCCcEEEEEEeeeccccchhh----------
Q 004979 410 VTGVPKLKRSELEAACED---------FSNI-IGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSK---------- 469 (721)
Q Consensus 410 ~~~~~~~~~~~l~~~~~~---------~~~i-i~~lg~G~~g~Vyk~~~~~~~~vavk~~~~~~~~~~~~---------- 469 (721)
...++.++.+++++..+. |..+ -..+|.|++|.||+|++.+|+.||||+...........
T Consensus 90 qd~v~p~~~~~~~~~l~~elg~~~~~~F~~fd~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~ 169 (437)
T TIGR01982 90 QDRVPPFDFKVARKVIEAALGGPLEELFAEFEEKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLAR 169 (437)
T ss_pred hcCCCCCCHHHHHHHHHHHhCcCHHHHHhhCCCcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHH
Confidence 345666666655544332 1111 13588999999999999999999999975432111000
Q ss_pred -------------------H------HHHHHHHHHHHHhcCC----CCccceEeEEEecCCCceEEEEEecCCCCChhhh
Q 004979 470 -------------------N------LESQFRKKIDTLSKVN----HKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEH 520 (721)
Q Consensus 470 -------------------~------~~~~f~~Ei~~l~~l~----H~nIv~l~g~~~~~~~~~~~lV~Ey~~~GsL~~~ 520 (721)
. .+-+|.+|++.+.+++ |.+-|.+-.++.+-.. ..+|||||++|++|.++
T Consensus 170 ~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~-~~vLvmE~i~G~~L~~~ 248 (437)
T TIGR01982 170 IVERLSPDSRRLRPTEVVKEFEKTLRRELDLRREAANASELGENFKNDPGVYVPEVYWDRTS-ERVLTMEWIDGIPLSDI 248 (437)
T ss_pred HHHHhCccccccCHHHHHHHHHHHHHHHHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcC-CceEEEEeECCcccccH
Confidence 0 0113566776666652 3333444444433211 35899999999999887
Q ss_pred hhhccCCCCCHHHHHHHHHHHHH-HHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC
Q 004979 521 LHIQEAEHLDWAMRLRIAMGMAY-CLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT 585 (721)
Q Consensus 521 l~~~~~~~l~~~~~~~ia~~ia~-gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~ 585 (721)
..... ... .+.+++..++. .+..+|..+ ++|+|+||.||++++++++++.|||++....
T Consensus 249 ~~~~~-~~~---~~~~ia~~~~~~~l~ql~~~g--~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 249 AALDE-AGL---DRKALAENLARSFLNQVLRDG--FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred HHHHh-cCC---CHHHHHHHHHHHHHHHHHhCC--ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 64321 112 23456666665 467778887 9999999999999999999999999976544
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.40 E-value=4e-13 Score=135.30 Aligned_cols=192 Identities=23% Similarity=0.317 Sum_probs=136.1
Q ss_pred HHHhcCCCCccceEeEEEecCCC---ceEEEEEecCCCCChhhhhhhcc--CCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 004979 480 DTLSKVNHKNFVNLIGYCEEDEP---FTRMMVFEYSPNGSLFEHLHIQE--AEHLDWAMRLRIAMGMAYCLEHMHQLTPP 554 (721)
Q Consensus 480 ~~l~~l~H~nIv~l~g~~~~~~~---~~~~lV~Ey~~~GsL~~~l~~~~--~~~l~~~~~~~ia~~ia~gL~yLH~~~~~ 554 (721)
.-|-.+.|.|||+++.|+.+.+. ....++.|||..|++..+|+... ...+....-.+++-||..||.|||++.|+
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Pp 198 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPP 198 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCc
Confidence 34556679999999999876432 24678999999999999997543 23455555678999999999999999999
Q ss_pred eEeeCCCCCCeEeCCCCcEEEeccCC------C-------CCCCCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhC
Q 004979 555 IAHRNLQSSSIYLTEDYAAKISDFSF------W-------NNTTAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITG 621 (721)
Q Consensus 555 IvHrDLKp~NILl~~~~~~kL~DFGl------a-------~~~~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG 621 (721)
|+|+++..+-|++..++-+|+.---- + +....+..++.+||.-.....+.++|||+||+..+||..+
T Consensus 199 iihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemail 278 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAIL 278 (458)
T ss_pred cccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHh
Confidence 99999999999999999888863211 0 1222345577888887777788899999999999999987
Q ss_pred CCccc-CCCC-CHHHHHHHHhhcCCCCccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 622 RISYS-IENG-SLENWASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 622 ~~P~~-~~~~-~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
..--. .+.. ...+-..+...+ .-+ ..=..++..|++.+|..||+|++++.
T Consensus 279 Eiq~tnseS~~~~ee~ia~~i~~------len-----------~lqr~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 279 EIQSTNSESKVEVEENIANVIIG------LEN-----------GLQRGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred eeccCCCcceeehhhhhhhheee------ccC-----------ccccCcCcccccCCCCCCcchhhhhc
Confidence 64211 1110 001111111100 000 11134678999999999999999864
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.35 E-value=9.9e-14 Score=158.38 Aligned_cols=240 Identities=20% Similarity=0.281 Sum_probs=171.6
Q ss_pred hhhCcCCCCceeEEEEEEecC--CcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCC-CCccceEeEEEecCCCceEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLSS--GVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVN-HKNFVNLIGYCEEDEPFTRM 506 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~~--~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~~~ 506 (721)
+++..+|+|+|+.|-...... ...+++|.+.... ...........|..+-..+. |+|++++++...+.+ ..+
T Consensus 23 ~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~---~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~--~~~ 97 (601)
T KOG0590|consen 23 KLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP---KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPR--SYL 97 (601)
T ss_pred cccccccccccchhhhhhhcCCCcceeeccCCCCCC---CccchhhhcCccccccccccccccccccCCccCCCc--ccc
Confidence 566778899999998776533 3445555554432 11222344555777777775 999999999988877 568
Q ss_pred EEEecCCCCChhhhh-hhccCCCCCHHHHHHHHHHHHHHHHHHh-cCCCCeEeeCCCCCCeEeCCCC-cEEEeccCCCCC
Q 004979 507 MVFEYSPNGSLFEHL-HIQEAEHLDWAMRLRIAMGMAYCLEHMH-QLTPPIAHRNLQSSSIYLTEDY-AAKISDFSFWNN 583 (721)
Q Consensus 507 lV~Ey~~~GsL~~~l-~~~~~~~l~~~~~~~ia~~ia~gL~yLH-~~~~~IvHrDLKp~NILl~~~~-~~kL~DFGla~~ 583 (721)
+++||..+|++.+.+ +.. ....+......+..|+..++.|+| ..+ +.|||+||+|.+++..+ ..|++|||++..
T Consensus 98 ~~~~~s~g~~~f~~i~~~~-~~~~~~~~~~~~~~ql~s~l~~~H~~~~--~~h~~ikP~n~~l~~s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPD-STGTSSSSASRYLPQLNSGLSYLHPENG--VTHRDIKPSNSLLDESGSALKIADFGLATA 174 (601)
T ss_pred cccCcccccccccccccCC-ccCCCCcchhhhhhhhccCccccCcccc--cccCCCCCccchhccCCCcccCCCchhhcc
Confidence 999999999999887 322 213445556678899999999999 777 99999999999999999 999999998753
Q ss_pred CC------------CC-CccccchhhcccC-CCCCCccHHHHHHHHHHHHhCCCcccCCCCCH---HHHHHHHhhcCCCC
Q 004979 584 TT------------AA-KTGSAAMELLETS-AVDLESNVYSFGTILFEMITGRISYSIENGSL---ENWASEYLKGEQPL 646 (721)
Q Consensus 584 ~~------------~~-~~~~~apE~~~~~-~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~---~~~~~~~~~~~~~~ 646 (721)
.. .+ ...|+|||...+. ......|+||.|+++.-+++|..|+....... ..|....
T Consensus 175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~------- 247 (601)
T KOG0590|consen 175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNK------- 247 (601)
T ss_pred ccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccc-------
Confidence 22 23 5578999998774 44678999999999999999999986432211 1111100
Q ss_pred ccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 647 KDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 647 ~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
+...............++..+++..+|..|.+.+++-.
T Consensus 248 ----~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 248 ----GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred ----cccccCccccCChhhhhcccccccCCchhccccccccc
Confidence 00001112234456777888899899999999887643
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.34 E-value=3.5e-12 Score=147.64 Aligned_cols=91 Identities=26% Similarity=0.420 Sum_probs=88.1
Q ss_pred CCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCccccCCCCCCEEECccCCCCcCCChhccCCCCCCEEEcc
Q 004979 143 ELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLLDNNQYLGGISPELHVLKVISEIQVD 222 (721)
Q Consensus 143 ~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~~L~~l~l~~N~~~G~iP~~~~~l~~L~~l~l~ 222 (721)
.++.|+|++|.|.|.+|..++++++|+.|+|++|+|+|.+|..++.+++|+.|+|++|+++|.+|..++++++|+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 47889999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCccccc
Q 004979 223 ESWLTNAASRA 233 (721)
Q Consensus 223 ~n~~~g~~p~~ 233 (721)
+|.|+|.+|..
T Consensus 499 ~N~l~g~iP~~ 509 (623)
T PLN03150 499 GNSLSGRVPAA 509 (623)
T ss_pred CCcccccCChH
Confidence 99999999863
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.24 E-value=1.3e-10 Score=130.44 Aligned_cols=146 Identities=12% Similarity=0.108 Sum_probs=90.9
Q ss_pred CcCCCCceeEEEEEEecC-CcEEEEEEeeeccccc-----------------------------hhhHHH------HHHH
Q 004979 433 GSFSDGTVGTVYKGTLSS-GVEIAVTSTSVKSRAD-----------------------------WSKNLE------SQFR 476 (721)
Q Consensus 433 ~~lg~G~~g~Vyk~~~~~-~~~vavk~~~~~~~~~-----------------------------~~~~~~------~~f~ 476 (721)
..+|.|++|.||+|++++ |+.||||+........ ...+.. -+|.
T Consensus 125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~ 204 (537)
T PRK04750 125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM 204 (537)
T ss_pred hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence 578999999999999887 9999999986432110 000111 2345
Q ss_pred HHHHHHhcCC----CCccceEeEEEecCCCceEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHH-HHHHhcC
Q 004979 477 KKIDTLSKVN----HKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYC-LEHMHQL 551 (721)
Q Consensus 477 ~Ei~~l~~l~----H~nIv~l~g~~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~g-L~yLH~~ 551 (721)
+|+..+.+++ +.+.+.+-.++.+-.. ..+|||||+.|+.+.++-.... ...+. ..++...+.. +.-++..
T Consensus 205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st-~~VLvmE~i~G~~l~d~~~l~~-~g~d~---~~la~~~v~~~~~Qif~~ 279 (537)
T PRK04750 205 REAANASQLRRNFEDSDMLYVPEVYWDYCS-ETVMVMERMYGIPVSDVAALRA-AGTDM---KLLAERGVEVFFTQVFRD 279 (537)
T ss_pred HHHHHHHHHHHHccCCCCeecceeecccCC-CceEEEeeecCccHHhHHHHHh-cCCCH---HHHHHHHHHHHHHHHHhC
Confidence 5555555553 4444554455543211 4589999999999987522111 11221 1222222211 2222345
Q ss_pred CCCeEeeCCCCCCeEeCCCC----cEEEeccCCCCCCC
Q 004979 552 TPPIAHRNLQSSSIYLTEDY----AAKISDFSFWNNTT 585 (721)
Q Consensus 552 ~~~IvHrDLKp~NILl~~~~----~~kL~DFGla~~~~ 585 (721)
+ ++|+|+||.||+++.++ ++++.|||+.....
T Consensus 280 G--ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 280 G--FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred C--eeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 6 99999999999999888 99999999876543
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.18 E-value=8.2e-11 Score=113.38 Aligned_cols=128 Identities=13% Similarity=0.141 Sum_probs=92.7
Q ss_pred CcCCCCceeEEEEEEecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccc-eEeEEEecCCCceEEEEEec
Q 004979 433 GSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFV-NLIGYCEEDEPFTRMMVFEY 511 (721)
Q Consensus 433 ~~lg~G~~g~Vyk~~~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv-~l~g~~~~~~~~~~~lV~Ey 511 (721)
+.++.|.++.||+++.. +..+++|....... ....+.+|++++..+.+.+++ +++.+.. + ..++||||
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~------~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~--~~~lv~e~ 72 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE------LLINRENEAENSKLAAEAGIGPKLYYFDP--E--TGVLITEF 72 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcc------cccCHHHHHHHHHHHHHhCCCCceEEEeC--C--CCeEEEEe
Confidence 45678999999999876 67788887643221 113467888999888665554 4544432 2 23799999
Q ss_pred CCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCC---CeEeeCCCCCCeEeCCCCcEEEeccCCCC
Q 004979 512 SPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTP---PIAHRNLQSSSIYLTEDYAAKISDFSFWN 582 (721)
Q Consensus 512 ~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~---~IvHrDLKp~NILl~~~~~~kL~DFGla~ 582 (721)
+++.++.+.- .....++.+++++|+.||..+. .++|+|++|.||+++ ++.+++.|||.+.
T Consensus 73 i~G~~l~~~~----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 73 IEGSELLTED----------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred cCCCcccccc----------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 9998876430 0113456789999999998752 369999999999999 6689999999764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.03 E-value=2.9e-09 Score=104.21 Aligned_cols=141 Identities=13% Similarity=0.159 Sum_probs=96.9
Q ss_pred hCcCCCCceeEEEEEEecC-------CcEEEEEEeeeccc-----cchh------------hHHHHHHH----HHHHHHh
Q 004979 432 IGSFSDGTVGTVYKGTLSS-------GVEIAVTSTSVKSR-----ADWS------------KNLESQFR----KKIDTLS 483 (721)
Q Consensus 432 i~~lg~G~~g~Vyk~~~~~-------~~~vavk~~~~~~~-----~~~~------------~~~~~~f~----~Ei~~l~ 483 (721)
.|.+|.|.=+.||.|.-.+ +..+|||+.+.... ..+. ....+.+. +|++.|.
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3677888889999998543 47899998764321 1000 11122333 8999999
Q ss_pred cCCC--CccceEeEEEecCCCceEEEEEecCCCCChhh-hhhhccCCCCCHHHHHHHHHHHHHHHHHH-hcCCCCeEeeC
Q 004979 484 KVNH--KNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFE-HLHIQEAEHLDWAMRLRIAMGMAYCLEHM-HQLTPPIAHRN 559 (721)
Q Consensus 484 ~l~H--~nIv~l~g~~~~~~~~~~~lV~Ey~~~GsL~~-~l~~~~~~~l~~~~~~~ia~~ia~gL~yL-H~~~~~IvHrD 559 (721)
+++. -++-+.+++ . ..+|||||+.++.+.. .++ ...++..+...+..+++.+|.+| |..+ |||+|
T Consensus 82 rl~~~Gv~vP~pi~~--~----~~~lvME~Ig~~~~~~~~Lk---d~~~~~~~~~~i~~~i~~~l~~l~H~~g--lVHGD 150 (197)
T cd05146 82 RMQKAGIPCPEVVVL--K----KHVLVMSFIGDDQVPAPKLK---DAKLNDEEMKNAYYQVLSMMKQLYKECN--LVHAD 150 (197)
T ss_pred HHHHcCCCCCeEEEe--c----CCEEEEEEcCCCCccchhhh---ccccCHHHHHHHHHHHHHHHHHHHHhCC--eecCC
Confidence 9853 455666654 2 2389999997654422 221 11244445567789999999999 8888 99999
Q ss_pred CCCCCeEeCCCCcEEEeccCCCCCC
Q 004979 560 LQSSSIYLTEDYAAKISDFSFWNNT 584 (721)
Q Consensus 560 LKp~NILl~~~~~~kL~DFGla~~~ 584 (721)
|++.|||++ ++.+.|+|||.+-..
T Consensus 151 Ls~~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 151 LSEYNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred CCHHHEEEE-CCcEEEEECCCceeC
Confidence 999999997 467999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.96 E-value=1.1e-10 Score=107.48 Aligned_cols=107 Identities=22% Similarity=0.406 Sum_probs=94.9
Q ss_pred CcEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCccccCCCCCCEEEC
Q 004979 118 GKVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLL 197 (721)
Q Consensus 118 ~~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~~L~~l~l 197 (721)
.+++.+.|+.|.|+ .+||.|..|.+|+.|++++|.+. .+|..++++++|++|+++-|++. .+|..+|.++.|++|||
T Consensus 33 s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldl 109 (264)
T KOG0617|consen 33 SNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDL 109 (264)
T ss_pred hhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhc
Confidence 57888999999986 58889999999999999999997 78999999999999999999998 78999999999999999
Q ss_pred ccCCCCc-CCChhccCCCCCCEEEccCCCCC
Q 004979 198 DNNQYLG-GISPELHVLKVISEIQVDESWLT 227 (721)
Q Consensus 198 ~~N~~~G-~iP~~~~~l~~L~~l~l~~n~~~ 227 (721)
.+|+++- .+|..+..+..|+.|.|+.|.|.
T Consensus 110 tynnl~e~~lpgnff~m~tlralyl~dndfe 140 (264)
T KOG0617|consen 110 TYNNLNENSLPGNFFYMTTLRALYLGDNDFE 140 (264)
T ss_pred cccccccccCCcchhHHHHHHHHHhcCCCcc
Confidence 9999974 56777777777888888888776
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.95 E-value=7.4e-09 Score=104.21 Aligned_cols=144 Identities=15% Similarity=0.202 Sum_probs=105.3
Q ss_pred CcCCCCceeEEEEEEecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCC--ccceEeEEEecCCC-ceEEEEE
Q 004979 433 GSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHK--NFVNLIGYCEEDEP-FTRMMVF 509 (721)
Q Consensus 433 ~~lg~G~~g~Vyk~~~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~--nIv~l~g~~~~~~~-~~~~lV~ 509 (721)
..++.|.++.||+++..+|..+++|........ .....+.+|++++..+++. ++.+++.+...... ...++||
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~----~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~ 79 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL----PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVM 79 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccC----cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEE
Confidence 356789999999999876678888876533211 1234688999999999763 45677777655320 1348999
Q ss_pred ecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcC--------------------------------------
Q 004979 510 EYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQL-------------------------------------- 551 (721)
Q Consensus 510 Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~-------------------------------------- 551 (721)
||++++++.+.+.. ..++..++..++.+++++|.+||+.
T Consensus 80 e~i~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (223)
T cd05154 80 ERVDGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPA 156 (223)
T ss_pred EEeCCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHH
Confidence 99999888775421 3467777778888888888888842
Q ss_pred ----------------CCCeEeeCCCCCCeEeCC--CCcEEEeccCCCCC
Q 004979 552 ----------------TPPIAHRNLQSSSIYLTE--DYAAKISDFSFWNN 583 (721)
Q Consensus 552 ----------------~~~IvHrDLKp~NILl~~--~~~~kL~DFGla~~ 583 (721)
...++|+|+++.||+++. ++.+.|.||+.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 157 MERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 134799999999999998 66789999987543
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.93 E-value=1.4e-09 Score=119.33 Aligned_cols=237 Identities=22% Similarity=0.289 Sum_probs=160.8
Q ss_pred hhhCcCCC--CceeEEEEEEe---cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcC-CCCccceEeEEEecCCCc
Q 004979 430 NIIGSFSD--GTVGTVYKGTL---SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKV-NHKNFVNLIGYCEEDEPF 503 (721)
Q Consensus 430 ~ii~~lg~--G~~g~Vyk~~~---~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~ 503 (721)
.+.+.+|. |.+|.||.+.. .++..+++|+-+...... ....+=.+|+....++ .|+|.|+.+..+...+
T Consensus 117 ~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p---~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~-- 191 (524)
T KOG0601|consen 117 PISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPP---LDSKRKLREFLSHHKIDSHENPVRDSPAWEGSG-- 191 (524)
T ss_pred ccccccccCCCCCceeecccCCcccCCcccccccccCCCCCc---cccccccchhhcccccCccccccccCcccccCC--
Confidence 45567788 99999999986 356777877633222111 1112234566666666 4999999888887776
Q ss_pred eEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHH----HHHHHhcCCCCeEeeCCCCCCeEeCCC-CcEEEecc
Q 004979 504 TRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAY----CLEHMHQLTPPIAHRNLQSSSIYLTED-YAAKISDF 578 (721)
Q Consensus 504 ~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~----gL~yLH~~~~~IvHrDLKp~NILl~~~-~~~kL~DF 578 (721)
..++-+|++ +.+|..+.+.. ...++......+..+..+ |+.++|... |+|-|+||.||++..+ ...+++||
T Consensus 192 ~lfiqtE~~-~~sl~~~~~~~-~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~--~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 192 ILFIQTELC-GESLQSYCHTP-CNFLPDNLLWNSLRDWLSRDVTALSHLHSNN--IVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred cceeeeccc-cchhHHhhhcc-cccCCchhhhhHHhhhhhcccccccccCCCc--ccccccchhheecccccceeecCCc
Confidence 568888888 57888876532 223444555566666777 999999988 9999999999999999 88999999
Q ss_pred CCCCCCC--------------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCC
Q 004979 579 SFWNNTT--------------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQ 644 (721)
Q Consensus 579 Gla~~~~--------------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~ 644 (721)
|+..... .+...|++||... ..++.++|+|++|.+..|..++......... ..|.+
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~--~~W~~------- 337 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKN--SSWSQ------- 337 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCC--CCccc-------
Confidence 9754322 3445688999875 4678899999999999999998766532210 11110
Q ss_pred CCccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 645 PLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 645 ~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
+.....+ .++......++...+..+++.+|..|++++++..
T Consensus 338 -~r~~~ip--~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 338 -LRQGYIP--LEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred -cccccCc--hhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 1111100 0122223345555888999999999999887654
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.92 E-value=2.5e-08 Score=110.44 Aligned_cols=157 Identities=15% Similarity=0.208 Sum_probs=112.4
Q ss_pred ecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEEEecCCCCChhhhhhhccCC
Q 004979 448 LSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAE 527 (721)
Q Consensus 448 ~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~ 527 (721)
..++..|.|...+.... . ......+-++.|+.+|||||++++..+...+ ..|||+|-+. -|..++....
T Consensus 34 k~~~~~vsVF~~~~~~~-~----~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~--~~ylvTErV~--Pl~~~lk~l~-- 102 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNG-E----VTELAKRAVKRLKTLRHPNILSYLDTTEEEG--TLYLVTERVR--PLETVLKELG-- 102 (690)
T ss_pred eccCCceEEEEEeCCCc-h----hhHHHHHHHHHhhhccCchhhhhhhhhcccC--ceEEEeeccc--cHHHHHHHhH--
Confidence 45677788877665432 1 1234667788999999999999999998877 7899999874 3555554322
Q ss_pred CCCHHHHHHHHHHHHHHHHHHh-cCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCCCCCc---------cccchhhc
Q 004979 528 HLDWAMRLRIAMGMAYCLEHMH-QLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTAAKT---------GSAAMELL 597 (721)
Q Consensus 528 ~l~~~~~~~ia~~ia~gL~yLH-~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~---------~~~apE~~ 597 (721)
-....-.+.||+.||.||| +++ ++|++|.-..|++++.|+-||++|-++........ .+..|+.+
T Consensus 103 ---~~~v~~Gl~qIl~AL~FL~~d~~--lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~ 177 (690)
T KOG1243|consen 103 ---KEEVCLGLFQILAALSFLNDDCN--LVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEI 177 (690)
T ss_pred ---HHHHHHHHHHHHHHHHHHhccCC--eeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhc
Confidence 2233446789999999997 566 99999999999999999999999987543222111 12233322
Q ss_pred ccCCCCCCccHHHHHHHHHHHHhCC
Q 004979 598 ETSAVDLESNVYSFGTILFEMITGR 622 (721)
Q Consensus 598 ~~~~~s~ksDVwSfGvvL~ElltG~ 622 (721)
.... ...|.|-|||+++|++.|.
T Consensus 178 ~~s~--~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 178 DPSE--WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred Cccc--cchhhhhHHHHHHHHhCcc
Confidence 1111 3469999999999999993
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.90 E-value=3.9e-10 Score=129.45 Aligned_cols=258 Identities=19% Similarity=0.208 Sum_probs=163.3
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
.+++.+..|.++.++-+.-. .|...+.+...+.... .....+....+-.++-..+||-+++..--+.... -.+||
T Consensus 807 ~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i--~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rs--P~~L~ 882 (1205)
T KOG0606|consen 807 EITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKI--RTNDYESIRSKSNILITPRSPAVVRSFPSFPCRS--PLPLV 882 (1205)
T ss_pred eecccccCCCCcccccCCccccccccchhhhccchhh--ccccccccCCccCccccCCCCceecccCCCCCCC--Ccchh
Confidence 56677888999988876532 2212222221111000 0001122223333333345666665543322333 34899
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC----
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT---- 584 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~---- 584 (721)
++|..+|+|...||... ..+..........+..+++|||... ++|||+||.|+|+..++..+++|||.....
T Consensus 883 ~~~~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s~~--r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~ 958 (1205)
T KOG0606|consen 883 GHYLNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLHSSL--RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIP 958 (1205)
T ss_pred hHHhccCCchhhhhcCC--CcccccccchhHHHHhhhhccccch--hhcccccccchhhcccCCcccCcccccccccccc
Confidence 99999999999987432 2333333445556778899999876 899999999999999999999999832100
Q ss_pred ------------------------------------CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCC
Q 004979 585 ------------------------------------TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIE 628 (721)
Q Consensus 585 ------------------------------------~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~ 628 (721)
..+++.|.+||...+......+|.|++|++++|.++|..||..+
T Consensus 959 p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~ 1038 (1205)
T KOG0606|consen 959 PTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAE 1038 (1205)
T ss_pred CcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCc
Confidence 01233567899998989999999999999999999999999643
Q ss_pred CCCHHHHHHHHhhcCCCCccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCChh
Q 004979 629 NGSLENWASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAMEPDGATPKLSPL 708 (721)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~~~~p~~~~~ 708 (721)
. ..+.+..+..+..+ ....+.....++.+++...+..+|.+|-.|. .......++++.++
T Consensus 1039 t--pq~~f~ni~~~~~~--------~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~----------~~~e~k~~~~~~~~ 1098 (1205)
T KOG0606|consen 1039 T--PQQIFENILNRDIP--------WPEGPEEGSYEAQDLINRLLTEEPTQRLGAK----------GAAEVKGHPFFQDV 1098 (1205)
T ss_pred c--hhhhhhccccCCCC--------CCCCccccChhhhhhhhhhhccCchhccCcc----------cccccccCCccCCC
Confidence 2 22222222222111 1123344556778888889999999997654 22233456888888
Q ss_pred HHHHHHh
Q 004979 709 WWAELEI 715 (721)
Q Consensus 709 ~~~~l~~ 715 (721)
.|+.|..
T Consensus 1099 ~~~~l~~ 1105 (1205)
T KOG0606|consen 1099 DWENLAL 1105 (1205)
T ss_pred Ccccccc
Confidence 8888754
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.89 E-value=1.6e-08 Score=95.13 Aligned_cols=146 Identities=15% Similarity=0.163 Sum_probs=99.2
Q ss_pred hCcCCCCceeEEEEEEecCCcEEEEEEe-eeccccc--hhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 432 IGSFSDGTVGTVYKGTLSSGVEIAVTST-SVKSRAD--WSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 432 i~~lg~G~~g~Vyk~~~~~~~~vavk~~-~~~~~~~--~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
++.+-+|+-+.|+++.+. |+...||.- .++-+.. .++-..++..+|++.|.+++--.|.--.=++.+.. .-.|+
T Consensus 12 l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~--~~~i~ 88 (229)
T KOG3087|consen 12 LELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTY--GGQIY 88 (229)
T ss_pred ceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecC--CCeEE
Confidence 455567888899999887 555555543 2222221 12234567889999999986555443333444433 34799
Q ss_pred EecCCC-CChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCC---cEEEeccCCCC
Q 004979 509 FEYSPN-GSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDY---AAKISDFSFWN 582 (721)
Q Consensus 509 ~Ey~~~-GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~---~~kL~DFGla~ 582 (721)
|||.++ -++.+++.........-.....++..|-+.+.-||..+ |+|+||..+||+|..++ .+.++|||++.
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~nd--iiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDND--IIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCC--eecccccccceEEecCCCcCceEEEeecchh
Confidence 999966 47777776443333333333678888889999999988 99999999999997554 46899999864
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.87 E-value=2.6e-08 Score=94.25 Aligned_cols=134 Identities=19% Similarity=0.247 Sum_probs=93.2
Q ss_pred CCCCceeEEEEEEecCCcEEEEEEeeeccccc--h-hhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEEEec
Q 004979 435 FSDGTVGTVYKGTLSSGVEIAVTSTSVKSRAD--W-SKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEY 511 (721)
Q Consensus 435 lg~G~~g~Vyk~~~~~~~~vavk~~~~~~~~~--~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV~Ey 511 (721)
+++|+=+.+|.+.+. |..+.+|.-..|.... . ..-...+-.+|+.++.+++--.|-.-+=+..+.+ ...|+|||
T Consensus 4 i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~--~~~I~me~ 80 (204)
T COG3642 4 IKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPD--NGLIVMEY 80 (204)
T ss_pred hhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCC--CCEEEEEE
Confidence 456777899999765 3345555433332211 1 1122356788999999886544443333444444 45799999
Q ss_pred CCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCC
Q 004979 512 SPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNN 583 (721)
Q Consensus 512 ~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~ 583 (721)
.++-.|.+.+... +..++..+-+-+.-||..+ |+|+||.++||++..+. +.++|||++..
T Consensus 81 I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~g--ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA---------RPDLLREVGRLVGKLHKAG--IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc---------chHHHHHHHHHHHHHHhcC--eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9998888888532 3567777777888899998 99999999999998765 99999999764
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.86 E-value=1.9e-09 Score=118.15 Aligned_cols=243 Identities=20% Similarity=0.220 Sum_probs=163.3
Q ss_pred HHhhhhhhhCcCCCCceeEEEEEEec--CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcC-CCCccceEeEEEecC
Q 004979 424 ACEDFSNIIGSFSDGTVGTVYKGTLS--SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKV-NHKNFVNLIGYCEED 500 (721)
Q Consensus 424 ~~~~~~~ii~~lg~G~~g~Vyk~~~~--~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~ 500 (721)
.+.+| ..+..+|.|.|+.|++...+ ++..+++|......... .....-..|+-+...+ -|.++++++..+...
T Consensus 263 ~~~df-~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~---~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~ 338 (524)
T KOG0601|consen 263 KLTDF-GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATF---ASDIFSLGEVILEAILGSHLPSVGKNSSWSQL 338 (524)
T ss_pred ecCCc-ceeEEccCCccccceeeeecCCCCceEeChhhhccccch---HhhhcchhhhhHhhHhhcccccCCCCCCcccc
Confidence 34455 44567899999999998744 56677777654332221 1111224455555555 588888877665554
Q ss_pred CCceEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCC-CcEEEeccC
Q 004979 501 EPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTED-YAAKISDFS 579 (721)
Q Consensus 501 ~~~~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~-~~~kL~DFG 579 (721)
+ ..|+=.||+.++++...+. ....++...++.+..|++.++.++|+.. ++|+|+||+||++..+ +..+++|||
T Consensus 339 r--~~~ip~e~~~~~s~~l~~~--~~~~~d~~~~~~~~~q~~~~l~~i~s~~--~~~~d~~psni~i~~~~~~~~~~~~~ 412 (524)
T KOG0601|consen 339 R--QGYIPLEFCEGGSSSLRSV--TSQMLDEDPRLRLTAQILTALNVIHSKL--FVHLDVKPSNILISNDGFFSKLGDFG 412 (524)
T ss_pred c--cccCchhhhcCcchhhhhH--HHHhcCcchhhhhHHHHHhccccccchh--hhcccccccceeeccchhhhhccccc
Confidence 4 3468899999999876552 3345777788899999999999999887 9999999999999876 888999999
Q ss_pred CCCCCC------CCCcccc--chhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccC
Q 004979 580 FWNNTT------AAKTGSA--AMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVD 651 (721)
Q Consensus 580 la~~~~------~~~~~~~--apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d 651 (721)
.+.... .....++ +++......+-.+.|++|||..+.|.+||..--. +...|. .+..
T Consensus 413 ~~t~~~~~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~----~~~~~~-----------~i~~ 477 (524)
T KOG0601|consen 413 CWTRLAFSSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSE----SGVQSL-----------TIRS 477 (524)
T ss_pred cccccceecccccccccccccchhhccccccccccccccccccccccccCcccCc----ccccce-----------eeec
Confidence 875321 1222333 4555567778899999999999999999864321 111111 1111
Q ss_pred CccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 004979 652 PTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKE 692 (721)
Q Consensus 652 ~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 692 (721)
...... .....++..+.+.+...++..||.+.++....+.
T Consensus 478 ~~~p~~-~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 478 GDTPNL-PGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred ccccCC-CchHHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 111111 1222566777888899999999999887654433
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.81 E-value=3.5e-09 Score=109.73 Aligned_cols=110 Identities=32% Similarity=0.434 Sum_probs=94.8
Q ss_pred cEEEEEeCCCCC-----------------------CCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEccc
Q 004979 119 KVVILNLRDLCL-----------------------GGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGF 175 (721)
Q Consensus 119 ~v~~l~L~~~~l-----------------------~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~ 175 (721)
-|+.++++.|.| -+.+|..++.++.|..|+|++|-|. .+|.+++.+..|+.||+|.
T Consensus 389 ~Vt~VnfskNqL~elPk~L~~lkelvT~l~lsnn~isfv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~ 467 (565)
T KOG0472|consen 389 IVTSVNFSKNQLCELPKRLVELKELVTDLVLSNNKISFVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSF 467 (565)
T ss_pred ceEEEecccchHhhhhhhhHHHHHHHHHHHhhcCccccchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccc
Confidence 388899888764 2567888999999999999999887 8999999999999999999
Q ss_pred Cccc----------------------ccCCcc-ccCCCCCCEEECccCCCCcCCChhccCCCCCCEEEccCCCCCCcccc
Q 004979 176 NNFS----------------------GPFPSD-FGNSFSLTTLLLDNNQYLGGISPELHVLKVISEIQVDESWLTNAASR 232 (721)
Q Consensus 176 N~l~----------------------G~iP~~-~~~~~~L~~l~l~~N~~~G~iP~~~~~l~~L~~l~l~~n~~~g~~p~ 232 (721)
|+|. |.+|++ +.+|.+|..|||.+|.+- .||+.++++.+|++|.|++|.|. .|+
T Consensus 468 NrFr~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr--~Pr 544 (565)
T KOG0472|consen 468 NRFRMLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR--QPR 544 (565)
T ss_pred cccccchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC--CCH
Confidence 9874 234444 788999999999988864 89999999999999999999998 565
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.75 E-value=7.8e-08 Score=93.77 Aligned_cols=129 Identities=19% Similarity=0.228 Sum_probs=82.1
Q ss_pred EEEEEEecCCcEEEEEEeeeccc---------------------cchhhHHHHHHHHHHHHHhcCCCC--ccceEeEEEe
Q 004979 442 TVYKGTLSSGVEIAVTSTSVKSR---------------------ADWSKNLESQFRKKIDTLSKVNHK--NFVNLIGYCE 498 (721)
Q Consensus 442 ~Vyk~~~~~~~~vavk~~~~~~~---------------------~~~~~~~~~~f~~Ei~~l~~l~H~--nIv~l~g~~~ 498 (721)
.||.|...++..+|||....... ..+.........+|++.|.++..- ++-+.+++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 48999988899999998764311 011222345678899999999766 455555442
Q ss_pred cCCCceEEEEEecCC--CCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHH-hcCCCCeEeeCCCCCCeEeCCCCcEEE
Q 004979 499 EDEPFTRMMVFEYSP--NGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHM-HQLTPPIAHRNLQSSSIYLTEDYAAKI 575 (721)
Q Consensus 499 ~~~~~~~~lV~Ey~~--~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yL-H~~~~~IvHrDLKp~NILl~~~~~~kL 575 (721)
. .+|||||++ +..+..+.. .. ++......++.++...+..+ |..+ |+|+||.+.|||++++ .+.|
T Consensus 80 -~----~~ivME~I~~~G~~~~~l~~-~~---~~~~~~~~~~~~il~~~~~~~~~~g--ivHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 80 -R----NVIVMEYIGEDGVPLPRLKD-VD---LSPEEPKELLEEILEEIIKMLHKAG--IVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp -T----TEEEEE--EETTEEGGCHHH-CG---GGGSTHHHHHHHHHHHHHHHHHCTT--EEESS-STTSEEEETT-CEEE
T ss_pred -C----CEEEEEecCCCccchhhHHh-cc---ccchhHHHHHHHHHHHHHHHHHhcC--ceecCCChhhEEeecc-eEEE
Confidence 2 279999998 544544322 11 11223456777777766665 7888 9999999999999988 9999
Q ss_pred eccCCCCC
Q 004979 576 SDFSFWNN 583 (721)
Q Consensus 576 ~DFGla~~ 583 (721)
+|||.+..
T Consensus 148 IDf~qav~ 155 (188)
T PF01163_consen 148 IDFGQAVD 155 (188)
T ss_dssp --GTTEEE
T ss_pred EecCccee
Confidence 99997644
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.64 E-value=3.9e-07 Score=94.24 Aligned_cols=138 Identities=13% Similarity=0.076 Sum_probs=94.1
Q ss_pred EEEEEEecCCcEEEEEEeeeccccchhh------HHHHHHHHHHHHHhcCCCCcc--ceEeEEEecC-C--CceEEEEEe
Q 004979 442 TVYKGTLSSGVEIAVTSTSVKSRADWSK------NLESQFRKKIDTLSKVNHKNF--VNLIGYCEED-E--PFTRMMVFE 510 (721)
Q Consensus 442 ~Vyk~~~~~~~~vavk~~~~~~~~~~~~------~~~~~f~~Ei~~l~~l~H~nI--v~l~g~~~~~-~--~~~~~lV~E 510 (721)
.|++..+ .|+.+.||...........+ .....+.+|.+.+.++...+| .+.+++.... + ....++|||
T Consensus 37 rvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte 115 (268)
T PRK15123 37 RTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITE 115 (268)
T ss_pred eEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEe
Confidence 4667666 46788898664322110000 001147788888888743333 3445555321 1 224689999
Q ss_pred cCCCC-ChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCC-------CCcEEEeccCCCC
Q 004979 511 YSPNG-SLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTE-------DYAAKISDFSFWN 582 (721)
Q Consensus 511 y~~~G-sL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~-------~~~~kL~DFGla~ 582 (721)
++++- +|.+++........+...+..++.+++..+.-||+.+ |+|+|++++|||++. +..+.++||+.+.
T Consensus 116 ~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~G--i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 116 DLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAG--INHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred eCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCc--CccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 99876 7888874322234456677789999999999999999 999999999999985 5789999999764
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.63 E-value=5.3e-09 Score=113.37 Aligned_cols=107 Identities=16% Similarity=0.314 Sum_probs=71.3
Q ss_pred cEEEEEeCCCCCC-CcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCccccCCCCCCEEEC
Q 004979 119 KVVILNLRDLCLG-GMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLL 197 (721)
Q Consensus 119 ~v~~l~L~~~~l~-G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~~L~~l~l 197 (721)
-|.++|+++|.++ +.+|.....+++++.|.|....|. .+|.+++.|.+|++|.+++|+|. .+-.+++.++.|+.+++
T Consensus 8 FVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~~ 85 (1255)
T KOG0444|consen 8 FVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVIV 85 (1255)
T ss_pred eeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHhh
Confidence 4667788888887 456777777777777777777665 67777777777777777777765 33344555666666666
Q ss_pred ccCCC-CcCCChhccCCCCCCEEEccCCCCC
Q 004979 198 DNNQY-LGGISPELHVLKVISEIQVDESWLT 227 (721)
Q Consensus 198 ~~N~~-~G~iP~~~~~l~~L~~l~l~~n~~~ 227 (721)
..|++ +..||+++..+.-|..|+|++|.|.
T Consensus 86 R~N~LKnsGiP~diF~l~dLt~lDLShNqL~ 116 (1255)
T KOG0444|consen 86 RDNNLKNSGIPTDIFRLKDLTILDLSHNQLR 116 (1255)
T ss_pred hccccccCCCCchhcccccceeeecchhhhh
Confidence 66655 3346666666666666666666655
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.62 E-value=4.6e-09 Score=96.93 Aligned_cols=90 Identities=21% Similarity=0.326 Sum_probs=83.1
Q ss_pred hhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCccccCCCCCCEEECccCCCCcCCChhccCCCCC
Q 004979 137 ELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLLDNNQYLGGISPELHVLKVI 216 (721)
Q Consensus 137 ~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~~L~~l~l~~N~~~G~iP~~~~~l~~L 216 (721)
.+.++++.+.|.||+|.++ .+|+.++.+.+|+.|++++|++. .+|.+++.++.|+.|+++.|.++ .+|..+|.++.|
T Consensus 28 gLf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~l 104 (264)
T KOG0617|consen 28 GLFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPAL 104 (264)
T ss_pred cccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchh
Confidence 4667888999999999998 78999999999999999999998 89999999999999999999986 679999999999
Q ss_pred CEEEccCCCCCCc
Q 004979 217 SEIQVDESWLTNA 229 (721)
Q Consensus 217 ~~l~l~~n~~~g~ 229 (721)
++|+|..|+++..
T Consensus 105 evldltynnl~e~ 117 (264)
T KOG0617|consen 105 EVLDLTYNNLNEN 117 (264)
T ss_pred hhhhccccccccc
Confidence 9999999999853
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.56 E-value=8.6e-07 Score=87.06 Aligned_cols=143 Identities=10% Similarity=0.102 Sum_probs=102.5
Q ss_pred CCCceeEEEEEEecCCcEEEEEEeeeccccchh-hHHHHHHHHHHHHHhcCCCCc--cceEeEEEe---cCCCceEEEEE
Q 004979 436 SDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWS-KNLESQFRKKIDTLSKVNHKN--FVNLIGYCE---EDEPFTRMMVF 509 (721)
Q Consensus 436 g~G~~g~Vyk~~~~~~~~vavk~~~~~~~~~~~-~~~~~~f~~Ei~~l~~l~H~n--Iv~l~g~~~---~~~~~~~~lV~ 509 (721)
|.||.+-|++-.+... .+.+|.-.......+. +..+..|.+|+..+.++...+ +.+.. ++. ....+..+||+
T Consensus 27 ~rgG~SgV~r~~~~g~-~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVERNGK-KLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEeCCc-EEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEE
Confidence 3477778998776644 6888876532222222 334578999999999885333 33333 222 23334568999
Q ss_pred ecCCC-CChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCc--EEEeccCCCC
Q 004979 510 EYSPN-GSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYA--AKISDFSFWN 582 (721)
Q Consensus 510 Ey~~~-GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~--~kL~DFGla~ 582 (721)
|-+++ -+|.+++........+...+..+..+++..++-||+.+ +.|+|+-+.||+++.++. ++++||--++
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~G--v~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVN--RQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 97753 58888875443445677788899999999999999999 999999999999986666 9999997543
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.54 E-value=1.6e-06 Score=93.48 Aligned_cols=167 Identities=17% Similarity=0.248 Sum_probs=120.7
Q ss_pred EEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecC--CCceEEEEEecCCC-CCh
Q 004979 442 TVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEED--EPFTRMMVFEYSPN-GSL 517 (721)
Q Consensus 442 ~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~~~lV~Ey~~~-GsL 517 (721)
+.||+.. .+|..++.|+++...... . .....-+++++++.|.|||++.+++... +....++||+|.|+ ++|
T Consensus 291 Ttyk~~s~~DG~~YvLkRlhg~r~~~--~---nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL 365 (655)
T KOG3741|consen 291 TTYKATSNVDGNAYVLKRLHGDRDQS--T---NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTL 365 (655)
T ss_pred eeEeeeeccCCceeeeeeeccccccC--c---ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchH
Confidence 7899984 478888888884322111 1 1123447789999999999999987632 12257999999986 677
Q ss_pred hhhhhhc-------------cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC
Q 004979 518 FEHLHIQ-------------EAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT 584 (721)
Q Consensus 518 ~~~l~~~-------------~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~ 584 (721)
.++.... .+...++.....++.|+..||.++|+.| +.-+-|.+++||++.+.+++|+..|+....
T Consensus 366 ~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG--LAck~L~~~kIlv~G~~RIriS~C~i~Dvl 443 (655)
T KOG3741|consen 366 YDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG--LACKTLDLKKILVTGKMRIRISGCGIMDVL 443 (655)
T ss_pred HHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC--ceeecccHhHeEeeCcceEEEecccceeee
Confidence 7764311 1234566778889999999999999988 777999999999999999999988876544
Q ss_pred CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCC
Q 004979 585 TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRI 623 (721)
Q Consensus 585 ~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~ 623 (721)
..... |.++. -.+-|.=.||.+++.|.||..
T Consensus 444 ~~d~~-----~~le~---~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 444 QEDPT-----EPLES---QQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred cCCCC-----cchhH---HhhhhHHHHHHHHHHHhhccc
Confidence 43320 11111 134688899999999999953
|
|
| >PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=98.53 E-value=8.2e-08 Score=69.66 Aligned_cols=42 Identities=43% Similarity=0.963 Sum_probs=30.6
Q ss_pred hHHHHHHHHHHHhcccCCCCCCCCCCCCCCCCCCCCCCceeeEEeC
Q 004979 71 NSEGMALLRFRERVVRDPFGALSKWSDNDGVGDNVNPCSWFGVECS 116 (721)
Q Consensus 71 ~~~~~~ll~~k~~~~~~~~~~l~~W~~~~~~~~~~~~C~w~gv~C~ 116 (721)
+.|..+|++||+.+..+|.+.+.+|+... ..+||+|.||+|+
T Consensus 2 ~~d~~aLl~~k~~l~~~~~~~l~~W~~~~----~~~~C~W~GV~Cd 43 (43)
T PF08263_consen 2 NQDRQALLAFKKSLNNDPSGVLSSWNPSS----DSDPCSWSGVTCD 43 (43)
T ss_dssp HHHHHHHHHHHHCTT-SC-CCCTT--TT------S-CCCSTTEEE-
T ss_pred cHHHHHHHHHHHhcccccCcccccCCCcC----CCCCeeeccEEeC
Confidence 57899999999999877778999998752 2589999999995
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A. |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.49 E-value=1.8e-08 Score=109.43 Aligned_cols=108 Identities=22% Similarity=0.353 Sum_probs=95.7
Q ss_pred CcEEEEEeCCCCCC-CcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCcc-ccCCCCCCEE
Q 004979 118 GKVVILNLRDLCLG-GMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSD-FGNSFSLTTL 195 (721)
Q Consensus 118 ~~v~~l~L~~~~l~-G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~-~~~~~~L~~l 195 (721)
.++.++.++.|+|- ..||++|..|..|+.||||+|.|. ..|..+-.-+++-+|+||+|++. +||.+ +.+++.|-+|
T Consensus 78 p~LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfL 155 (1255)
T KOG0444|consen 78 PRLRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFL 155 (1255)
T ss_pred hhhHHHhhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhhh
Confidence 45667888888885 569999999999999999999998 78999999999999999999998 78865 5689999999
Q ss_pred ECccCCCCcCCChhccCCCCCCEEEccCCCCCC
Q 004979 196 LLDNNQYLGGISPELHVLKVISEIQVDESWLTN 228 (721)
Q Consensus 196 ~l~~N~~~G~iP~~~~~l~~L~~l~l~~n~~~g 228 (721)
|||+|.+. .+||++..+.+|+.|.|++|-|..
T Consensus 156 DLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~h 187 (1255)
T KOG0444|consen 156 DLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNH 187 (1255)
T ss_pred ccccchhh-hcCHHHHHHhhhhhhhcCCChhhH
Confidence 99999975 799999999999999999998754
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=98.47 E-value=1.7e-07 Score=109.30 Aligned_cols=103 Identities=20% Similarity=0.163 Sum_probs=48.4
Q ss_pred cEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCcccc-----------
Q 004979 119 KVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFG----------- 187 (721)
Q Consensus 119 ~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~----------- 187 (721)
.+..|+|++|.|.+ +|+.. ++|+.|++++|.|++ ||.. ..+|+.|+|++|+|++ +|....
T Consensus 343 ~Lq~LdLS~N~Ls~-LP~lp---~~L~~L~Ls~N~L~~-LP~l---~~~L~~LdLs~N~Lt~-LP~l~s~L~~LdLS~N~ 413 (788)
T PRK15387 343 GLQELSVSDNQLAS-LPTLP---SELYKLWAYNNRLTS-LPAL---PSGLKELIVSGNRLTS-LPVLPSELKELMVSGNR 413 (788)
T ss_pred ccceEecCCCccCC-CCCCC---cccceehhhcccccc-Cccc---ccccceEEecCCcccC-CCCcccCCCEEEccCCc
Confidence 46667777777664 33211 233334444444432 3321 1234445555555542 332210
Q ss_pred ------CCCCCCEEECccCCCCcCCChhccCCCCCCEEEccCCCCCCccc
Q 004979 188 ------NSFSLTTLLLDNNQYLGGISPELHVLKVISEIQVDESWLTNAAS 231 (721)
Q Consensus 188 ------~~~~L~~l~l~~N~~~G~iP~~~~~l~~L~~l~l~~n~~~g~~p 231 (721)
...+|+.|+|++|+++ .||..++++.+|..|+|++|.|+|.+|
T Consensus 414 LssIP~l~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~ 462 (788)
T PRK15387 414 LTSLPMLPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTL 462 (788)
T ss_pred CCCCCcchhhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHH
Confidence 0123444555555544 455555555555566666665555444
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.42 E-value=2.4e-06 Score=85.30 Aligned_cols=107 Identities=20% Similarity=0.269 Sum_probs=81.6
Q ss_pred HHHHHHHHHHhcCCCC--ccceEeEEEecCC--CceEEEEEecCCCC-ChhhhhhhccCCCCCHHHHHHHHHHHHHHHHH
Q 004979 473 SQFRKKIDTLSKVNHK--NFVNLIGYCEEDE--PFTRMMVFEYSPNG-SLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEH 547 (721)
Q Consensus 473 ~~f~~Ei~~l~~l~H~--nIv~l~g~~~~~~--~~~~~lV~Ey~~~G-sL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~y 547 (721)
....+|...+.+++.. .+.+.+++..... ....++|+|++++- +|.+++.... ..+...+..++.+++..++-
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~--~~~~~~~~~ll~~l~~~i~~ 133 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE--QLDPSQRRELLRALARLIAK 133 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc--ccchhhHHHHHHHHHHHHHH
Confidence 4577888877777433 3456666665432 12458999999884 7988885322 25566778899999999999
Q ss_pred HhcCCCCeEeeCCCCCCeEeCCCC---cEEEeccCCCCC
Q 004979 548 MHQLTPPIAHRNLQSSSIYLTEDY---AAKISDFSFWNN 583 (721)
Q Consensus 548 LH~~~~~IvHrDLKp~NILl~~~~---~~kL~DFGla~~ 583 (721)
||+.+ |+|+|+++.|||++.+. .+.++||+-++.
T Consensus 134 lH~~g--i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 134 LHDAG--IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHCc--CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 99999 99999999999999887 899999987554
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.34 E-value=3.8e-07 Score=71.82 Aligned_cols=61 Identities=36% Similarity=0.442 Sum_probs=40.5
Q ss_pred CCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCccccCCCCCCEEECccCCC
Q 004979 142 SELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLLDNNQY 202 (721)
Q Consensus 142 ~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~~L~~l~l~~N~~ 202 (721)
++|++|+|++|.++.--+..+..+++|++|++++|.++.--|..+.++++|++|++++|++
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 3567777777777633334566677777777777777654455667777777777777753
|
... |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.32 E-value=3.7e-06 Score=84.55 Aligned_cols=134 Identities=18% Similarity=0.202 Sum_probs=90.4
Q ss_pred hCcCCCCceeEEEEEEecCCcEEEEEEeeecc-----------------ccchhhHHHHHHHHHHHHHhcCCCC--ccce
Q 004979 432 IGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKS-----------------RADWSKNLESQFRKKIDTLSKVNHK--NFVN 492 (721)
Q Consensus 432 i~~lg~G~~g~Vyk~~~~~~~~vavk~~~~~~-----------------~~~~~~~~~~~f~~Ei~~l~~l~H~--nIv~ 492 (721)
-..||.|.=+.||.|..+.|.+++||.-.... ...|....+....+|.++|.++.-. .|-+
T Consensus 96 G~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~VP~ 175 (304)
T COG0478 96 GTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKVPK 175 (304)
T ss_pred ccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCCCC
Confidence 34667888889999999999999998654321 0112222345578899999998644 4555
Q ss_pred EeEEEecCCCceEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCc
Q 004979 493 LIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYA 572 (721)
Q Consensus 493 l~g~~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~ 572 (721)
.+++- ..++||||+++-.|...- ++......|+..|..-+.-.-..+ |||+|+.+=||+++++|.
T Consensus 176 P~~~n------RHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~~~G--iVHGDlSefNIlV~~dg~ 240 (304)
T COG0478 176 PIAWN------RHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAYRRG--IVHGDLSEFNILVTEDGD 240 (304)
T ss_pred ccccc------cceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHHHcC--ccccCCchheEEEecCCC
Confidence 54432 348999999987765432 112222334444444444443556 999999999999999999
Q ss_pred EEEeccCC
Q 004979 573 AKISDFSF 580 (721)
Q Consensus 573 ~kL~DFGl 580 (721)
+.++||--
T Consensus 241 ~~vIDwPQ 248 (304)
T COG0478 241 IVVIDWPQ 248 (304)
T ss_pred EEEEeCcc
Confidence 99999954
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.26 E-value=9.5e-08 Score=103.45 Aligned_cols=116 Identities=20% Similarity=0.087 Sum_probs=96.1
Q ss_pred CcEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCccccCCCCCCEEEC
Q 004979 118 GKVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLL 197 (721)
Q Consensus 118 ~~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~~L~~l~l 197 (721)
..+..|+|.-|+++..---.+.+|+.|+.|+||.|.+..--++.+.-+++|+.||||+|+++--=+.++..+..|+.|.|
T Consensus 269 ~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnL 348 (873)
T KOG4194|consen 269 EKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNL 348 (873)
T ss_pred cccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcc
Confidence 36778999999988655567889999999999999999888899999999999999999999555567888888999999
Q ss_pred ccCCCCcCCChhccCCCCCCEEEccCCCCCCccccc
Q 004979 198 DNNQYLGGISPELHVLKVISEIQVDESWLTNAASRA 233 (721)
Q Consensus 198 ~~N~~~G~iP~~~~~l~~L~~l~l~~n~~~g~~p~~ 233 (721)
+.|.+.-----.+-.+++|+.|+|++|.+++.|-..
T Consensus 349 s~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDa 384 (873)
T KOG4194|consen 349 SHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDA 384 (873)
T ss_pred cccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecc
Confidence 999875333334566888999999999998887663
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=98.26 E-value=1.9e-06 Score=101.05 Aligned_cols=101 Identities=16% Similarity=0.312 Sum_probs=61.2
Q ss_pred eCCCcEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCccccCCCCCCE
Q 004979 115 CSDGKVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTT 194 (721)
Q Consensus 115 C~~~~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~~L~~ 194 (721)
|-....+.|+|++++|+. +|..+. +.|+.|+|++|+++ .+|..+. ++|+.|+|++|+|+ .||..+. .+|+.
T Consensus 175 Cl~~~~~~L~L~~~~Lts-LP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~ 245 (754)
T PRK15370 175 CLKNNKTELRLKILGLTT-IPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQE 245 (754)
T ss_pred hcccCceEEEeCCCCcCc-CCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccE
Confidence 333456777887777763 554443 35777777777776 4665543 46777777777766 4565443 35666
Q ss_pred EECccCCCCcCCChhccCCCCCCEEEccCCCCC
Q 004979 195 LLLDNNQYLGGISPELHVLKVISEIQVDESWLT 227 (721)
Q Consensus 195 l~l~~N~~~G~iP~~~~~l~~L~~l~l~~n~~~ 227 (721)
|+|++|++. .||..+. .+|+.|+|++|.++
T Consensus 246 L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~ 275 (754)
T PRK15370 246 MELSINRIT-ELPERLP--SALQSLDLFHNKIS 275 (754)
T ss_pred EECcCCccC-cCChhHh--CCCCEEECcCCccC
Confidence 666666655 5555543 35666666666665
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.23 E-value=8.7e-07 Score=85.13 Aligned_cols=103 Identities=26% Similarity=0.338 Sum_probs=41.7
Q ss_pred cEEEEEeCCCCCCCcCchhhc-CCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCccc-cCCCCCCEEE
Q 004979 119 KVVILNLRDLCLGGMLAPELG-QLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDF-GNSFSLTTLL 196 (721)
Q Consensus 119 ~v~~l~L~~~~l~G~ip~~l~-~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~-~~~~~L~~l~ 196 (721)
+...|+|++|.++- | ..++ .|++|+.|+|++|.+.. |+ .+..+++|+.|+|++|+++ .+...+ ..+++|+.|+
T Consensus 20 ~~~~L~L~~n~I~~-I-e~L~~~l~~L~~L~Ls~N~I~~-l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L~ 94 (175)
T PF14580_consen 20 KLRELNLRGNQIST-I-ENLGATLDKLEVLDLSNNQITK-LE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQELY 94 (175)
T ss_dssp ------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-TT--EEE
T ss_pred cccccccccccccc-c-cchhhhhcCCCEEECCCCCCcc-cc-CccChhhhhhcccCCCCCC-ccccchHHhCCcCCEEE
Confidence 46788899888753 2 3465 58899999999999984 44 5778999999999999998 465444 3689999999
Q ss_pred CccCCCCc--CCChhccCCCCCCEEEccCCCCC
Q 004979 197 LDNNQYLG--GISPELHVLKVISEIQVDESWLT 227 (721)
Q Consensus 197 l~~N~~~G--~iP~~~~~l~~L~~l~l~~n~~~ 227 (721)
|++|++.. .+ ..+..+++|++|+|.+|.++
T Consensus 95 L~~N~I~~l~~l-~~L~~l~~L~~L~L~~NPv~ 126 (175)
T PF14580_consen 95 LSNNKISDLNEL-EPLSSLPKLRVLSLEGNPVC 126 (175)
T ss_dssp -TTS---SCCCC-GGGGG-TT--EEE-TT-GGG
T ss_pred CcCCcCCChHHh-HHHHcCCCcceeeccCCccc
Confidence 99999864 33 45778999999999999765
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=98.23 E-value=6.2e-07 Score=95.62 Aligned_cols=112 Identities=25% Similarity=0.276 Sum_probs=83.6
Q ss_pred CcEEEEEeCCCCCCCcCchhhcCCCC---CCEEEccCCcccc----cCchhhcCC-CCCCEeEcccCccccc----CCcc
Q 004979 118 GKVVILNLRDLCLGGMLAPELGQLSE---LKSIILRNNSFFG----TIPKEIGEL-KELEILDLGFNNFSGP----FPSD 185 (721)
Q Consensus 118 ~~v~~l~L~~~~l~G~ip~~l~~l~~---L~~L~L~~n~l~G----~ip~~l~~l-~~L~~l~ls~N~l~G~----iP~~ 185 (721)
.+++.|+|+++.+.+..+..+..+.. |++|++++|.+++ .+...+..+ ++|+.|+|++|.+++. ++..
T Consensus 81 ~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~ 160 (319)
T cd00116 81 CGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKA 160 (319)
T ss_pred CceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHH
Confidence 47888888888888777776666665 8889998888873 344556666 8888899998888853 3345
Q ss_pred ccCCCCCCEEECccCCCCcC----CChhccCCCCCCEEEccCCCCCCc
Q 004979 186 FGNSFSLTTLLLDNNQYLGG----ISPELHVLKVISEIQVDESWLTNA 229 (721)
Q Consensus 186 ~~~~~~L~~l~l~~N~~~G~----iP~~~~~l~~L~~l~l~~n~~~g~ 229 (721)
+..+..|++|++++|.+++. ++..+..+++|+.|+|++|.+++.
T Consensus 161 ~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~ 208 (319)
T cd00116 161 LRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDE 208 (319)
T ss_pred HHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChH
Confidence 56677888889888888853 444556667888888888887743
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.22 E-value=1.4e-05 Score=89.63 Aligned_cols=169 Identities=18% Similarity=0.226 Sum_probs=102.5
Q ss_pred cCCCCCCHHHHHHHHhh---------hhhhh-CcCCCCceeEEEEEEecCCcEEEEEEeeeccccchh------------
Q 004979 411 TGVPKLKRSELEAACED---------FSNII-GSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWS------------ 468 (721)
Q Consensus 411 ~~~~~~~~~~l~~~~~~---------~~~ii-~~lg~G~~g~Vyk~~~~~~~~vavk~~~~~~~~~~~------------ 468 (721)
..+|.+..++.++..+. |.+.- ..++.++-|.||+|++++|+.||||+....-.....
T Consensus 99 D~vpp~~~~~~~~iie~eLG~~iee~F~eF~~~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~ 178 (517)
T COG0661 99 DRVPPFPFEEAERIIEEELGRPIEELFSEFEPEPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARL 178 (517)
T ss_pred cCCCCCCHHHHHHHHHHHhCCCHHHHHHHcCCCchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHH
Confidence 45677776655443321 11111 356788999999999999999999997543221110
Q ss_pred -----------------hH------HHHHHHHHHHHHhcCC----CCccceEeEEEecCCCceEEEEEecCCCCChhhhh
Q 004979 469 -----------------KN------LESQFRKKIDTLSKVN----HKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHL 521 (721)
Q Consensus 469 -----------------~~------~~~~f~~Ei~~l~~l~----H~nIv~l~g~~~~~~~~~~~lV~Ey~~~GsL~~~l 521 (721)
++ .+-++.+|...+.+++ +.-=+++=.+|++-.. ...|+|||++|-.+.+..
T Consensus 179 ~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~-~~VLtmE~i~Gi~i~d~~ 257 (517)
T COG0661 179 IKRLPPGGRRLDLVEVVDEFEKRLREELDYRREAANAERFRENFKDDPDVYVPKVYWEYTT-RRVLTMEWIDGIKISDIA 257 (517)
T ss_pred HHHcCCccccCChHHHHHHHHHHHHHHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccC-CcEEEEEeeCCEecccHH
Confidence 00 0112455655555542 2223344445543111 458999999999988874
Q ss_pred hhccCCCCCHHHHHHHHHHHHHH-HHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCCC
Q 004979 522 HIQEAEHLDWAMRLRIAMGMAYC-LEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTA 586 (721)
Q Consensus 522 ~~~~~~~l~~~~~~~ia~~ia~g-L~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~~ 586 (721)
.... ..++ +..|+..++++ +..+-..+ ++|.|..|.||+++.+++.-+-|||+......
T Consensus 258 ~l~~-~g~d---~k~ia~~~~~~f~~q~~~dg--ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 258 ALKS-AGID---RKELAELLVRAFLRQLLRDG--FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred HHHh-cCCC---HHHHHHHHHHHHHHHHHhcC--ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 3222 3344 23344433332 22222245 99999999999999999999999998654443
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.20 E-value=3.6e-07 Score=104.13 Aligned_cols=106 Identities=27% Similarity=0.328 Sum_probs=80.1
Q ss_pred cEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCch-hhcCCCCCCEeEcccCcccccCCccccCCCCCCEEEC
Q 004979 119 KVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPK-EIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLL 197 (721)
Q Consensus 119 ~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~-~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~~L~~l~l 197 (721)
.+..|.|.+|.|+...-|-|-+..+|+.|+|+.|.|. .+|+ .+.++..|+.|+||+|.|+ .||..+.++..|++|..
T Consensus 360 ~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~a 437 (1081)
T KOG0618|consen 360 ALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLN-SFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRA 437 (1081)
T ss_pred HHHHHHHhcCcccccchhhhccccceeeeeecccccc-cCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhh
Confidence 4666777788888777777778888888888888775 5664 4677788888888888887 77777777777888877
Q ss_pred ccCCCCcCCChhccCCCCCCEEEccCCCCCC
Q 004979 198 DNNQYLGGISPELHVLKVISEIQVDESWLTN 228 (721)
Q Consensus 198 ~~N~~~G~iP~~~~~l~~L~~l~l~~n~~~g 228 (721)
.+|++. .+| ++..+++|+.+||+.|+++-
T Consensus 438 hsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~ 466 (1081)
T KOG0618|consen 438 HSNQLL-SFP-ELAQLPQLKVLDLSCNNLSE 466 (1081)
T ss_pred cCCcee-ech-hhhhcCcceEEecccchhhh
Confidence 777765 455 77777888888888877764
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.19 E-value=1.1e-06 Score=69.17 Aligned_cols=61 Identities=28% Similarity=0.284 Sum_probs=53.4
Q ss_pred CCCCEeEcccCcccccCCccccCCCCCCEEECccCCCCcCCChhccCCCCCCEEEccCCCC
Q 004979 166 KELEILDLGFNNFSGPFPSDFGNSFSLTTLLLDNNQYLGGISPELHVLKVISEIQVDESWL 226 (721)
Q Consensus 166 ~~L~~l~ls~N~l~G~iP~~~~~~~~L~~l~l~~N~~~G~iP~~~~~l~~L~~l~l~~n~~ 226 (721)
++|+.|+|++|+++.--+..+.++++|++|++++|.++.--|..+..+++|++|++++|.+
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 5799999999999954446788999999999999999866666889999999999999975
|
... |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.19 E-value=6e-07 Score=100.15 Aligned_cols=139 Identities=21% Similarity=0.312 Sum_probs=97.5
Q ss_pred HHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCCCC------------------CccccchhhcccCC
Q 004979 540 GMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTAA------------------KTGSAAMELLETSA 601 (721)
Q Consensus 540 ~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~~~------------------~~~~~apE~~~~~~ 601 (721)
+++.|+.|+|.. ..+||++|.|++|.++.++..||+.|+++-..... ...|.|||.+....
T Consensus 107 ~v~dgl~flh~s-Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~ 185 (700)
T KOG2137|consen 107 NVADGLAFLHRS-AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTT 185 (700)
T ss_pred cccchhhhhccC-cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccc
Confidence 344899999964 25999999999999999999999999875322211 11356999998888
Q ss_pred CCCCccHHHHHHHHHHHH-hCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccHHHHHHHHHHHHHcccCCCCCC
Q 004979 602 VDLESNVYSFGTILFEMI-TGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQR 680 (721)
Q Consensus 602 ~s~ksDVwSfGvvL~Ell-tG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~R 680 (721)
.+.++|+||+||++|-+. .|+.-+...+..+ .+....... +.....+..+.+.++.+=+.+.+..++.-|
T Consensus 186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~-~~~~~~~~~--------~~~~~~~s~~~p~el~~~l~k~l~~~~~~r 256 (700)
T KOG2137|consen 186 NTPASDVFSLGVLIYTIYNGGKSIIAANGGLL-SYSFSRNLL--------NAGAFGYSNNLPSELRESLKKLLNGDSAVR 256 (700)
T ss_pred ccccccceeeeeEEEEEecCCcchhhccCCcc-hhhhhhccc--------ccccccccccCcHHHHHHHHHHhcCCcccC
Confidence 899999999999999998 4665554332222 111111111 111112334567788888899999999999
Q ss_pred CCHHHHHH
Q 004979 681 PSMRGIAA 688 (721)
Q Consensus 681 Ps~~evl~ 688 (721)
|++.++..
T Consensus 257 p~~~~l~~ 264 (700)
T KOG2137|consen 257 PTLDLLLS 264 (700)
T ss_pred cchhhhhc
Confidence 98777653
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.18 E-value=2.8e-05 Score=82.10 Aligned_cols=188 Identities=13% Similarity=0.212 Sum_probs=120.2
Q ss_pred EEEEEecCCCC-Chhhhhh----hccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEecc-
Q 004979 505 RMMVFEYSPNG-SLFEHLH----IQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDF- 578 (721)
Q Consensus 505 ~~lV~Ey~~~G-sL~~~l~----~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DF- 578 (721)
.-+.|..+++- -+..++. .+......|...+++++.+|.+.+-||+.| .+-+|+.++|+|+.+++.+.+.|=
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G--h~vGDVn~~~~lVsd~~~V~LVdsD 162 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG--HVVGDVNQNSFLVSDDSKVVLVDSD 162 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC--CcccccCccceeeecCceEEEEccc
Confidence 45666666543 1222222 123456899999999999999999999988 888999999999999999998863
Q ss_pred --CC-----CCCCCCCCccccchhhcc-----cCCCCCCccHHHHHHHHHHHHhC-CCcccCCC-----CCHHHHHHHHh
Q 004979 579 --SF-----WNNTTAAKTGSAAMELLE-----TSAVDLESNVYSFGTILFEMITG-RISYSIEN-----GSLENWASEYL 640 (721)
Q Consensus 579 --Gl-----a~~~~~~~~~~~apE~~~-----~~~~s~ksDVwSfGvvL~ElltG-~~P~~~~~-----~~~~~~~~~~~ 640 (721)
-+ ......+...|.+||.-. +..-+...|-|.+||++++++.| +.||.+-. ....+ ..+.
T Consensus 163 sfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E--~~Ia 240 (637)
T COG4248 163 SFQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLE--TDIA 240 (637)
T ss_pred ceeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcch--hhhh
Confidence 22 222334566788999753 34456789999999999999995 99997311 11111 0000
Q ss_pred hcCCCCccc----cCCcccccc-HHHHHHHHHHHHHcccCC--CCCCCCHHHHHHHHHHhhhc
Q 004979 641 KGEQPLKDI----VDPTLKSFQ-ENVLEELLVVIKNCVHPD--PKQRPSMRGIAAKLKEITAM 696 (721)
Q Consensus 641 ~~~~~~~~~----~d~~l~~~~-~~~~~~l~~li~~Cl~~d--P~~RPs~~evl~~L~~i~~~ 696 (721)
.+.-.+..- ..+.....+ .-.+..+..+..+|+... +.-||+++.-+..|.++.+.
T Consensus 241 ~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~ 303 (637)
T COG4248 241 HGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQ 303 (637)
T ss_pred cceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHh
Confidence 010000000 001111111 223456777788888643 45899999888887766543
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=98.18 E-value=1e-06 Score=94.04 Aligned_cols=110 Identities=25% Similarity=0.385 Sum_probs=87.8
Q ss_pred cEEEEEeCCCCCCC----cCchhhcCC-CCCCEEEccCCccccc----CchhhcCCCCCCEeEcccCccccc----CCcc
Q 004979 119 KVVILNLRDLCLGG----MLAPELGQL-SELKSIILRNNSFFGT----IPKEIGELKELEILDLGFNNFSGP----FPSD 185 (721)
Q Consensus 119 ~v~~l~L~~~~l~G----~ip~~l~~l-~~L~~L~L~~n~l~G~----ip~~l~~l~~L~~l~ls~N~l~G~----iP~~ 185 (721)
++..|+|+++.+++ .+...+..+ ++|+.|+|++|.+++. ++..+..+.+|+.|+|++|.+++. ++..
T Consensus 109 ~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~ 188 (319)
T cd00116 109 SLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEG 188 (319)
T ss_pred cccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHH
Confidence 48999999999884 344556677 8999999999999853 445567788999999999999853 4455
Q ss_pred ccCCCCCCEEECccCCCCcC----CChhccCCCCCCEEEccCCCCCC
Q 004979 186 FGNSFSLTTLLLDNNQYLGG----ISPELHVLKVISEIQVDESWLTN 228 (721)
Q Consensus 186 ~~~~~~L~~l~l~~N~~~G~----iP~~~~~l~~L~~l~l~~n~~~g 228 (721)
+..+++|++|+|++|.+++. ++..+..+++|++|++++|.+++
T Consensus 189 l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~ 235 (319)
T cd00116 189 LKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTD 235 (319)
T ss_pred HHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCch
Confidence 66678999999999998753 44556678899999999999886
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=98.14 E-value=5.8e-06 Score=97.05 Aligned_cols=102 Identities=18% Similarity=0.287 Sum_probs=86.1
Q ss_pred CcEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCccccCCCCCCEEEC
Q 004979 118 GKVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLL 197 (721)
Q Consensus 118 ~~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~~L~~l~l 197 (721)
..++.|+|++|.+. .+|..+. .+|+.|+|++|+|+ .||..+. ..|+.|+|++|++. .||..+. .+|+.|+|
T Consensus 199 ~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~L 269 (754)
T PRK15370 199 EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELSINRIT-ELPERLP--SALQSLDL 269 (754)
T ss_pred cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECcCCccC-cCChhHh--CCCCEEEC
Confidence 36889999999998 5777664 58999999999998 6787664 47999999999998 8898775 58999999
Q ss_pred ccCCCCcCCChhccCCCCCCEEEccCCCCCCcccc
Q 004979 198 DNNQYLGGISPELHVLKVISEIQVDESWLTNAASR 232 (721)
Q Consensus 198 ~~N~~~G~iP~~~~~l~~L~~l~l~~n~~~g~~p~ 232 (721)
++|+++ .||..+. .+|+.|+|++|+|++ +|.
T Consensus 270 s~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~-LP~ 300 (754)
T PRK15370 270 FHNKIS-CLPENLP--EELRYLSVYDNSIRT-LPA 300 (754)
T ss_pred cCCccC-ccccccC--CCCcEEECCCCcccc-Ccc
Confidence 999998 5887665 589999999999985 453
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.12 E-value=3.2e-07 Score=104.57 Aligned_cols=105 Identities=23% Similarity=0.277 Sum_probs=90.8
Q ss_pred CcEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCccccCCCCCCEEEC
Q 004979 118 GKVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLL 197 (721)
Q Consensus 118 ~~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~~L~~l~l 197 (721)
.++..|+|+.|.|.---...+.+|..|+.|+||+|.|+ .||..+.+|..|+.|...+|++. .+| ++..++.|+++|+
T Consensus 383 ~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDl 459 (1081)
T KOG0618|consen 383 KHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDL 459 (1081)
T ss_pred cceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEec
Confidence 46889999999986433356899999999999999998 89999999999999999999998 677 8999999999999
Q ss_pred ccCCCCcCCChhccCCCCCCEEEccCCC
Q 004979 198 DNNQYLGGISPELHVLKVISEIQVDESW 225 (721)
Q Consensus 198 ~~N~~~G~iP~~~~~l~~L~~l~l~~n~ 225 (721)
|.|+++-.+-+..-..++|++|||++|.
T Consensus 460 S~N~L~~~~l~~~~p~p~LkyLdlSGN~ 487 (1081)
T KOG0618|consen 460 SCNNLSEVTLPEALPSPNLKYLDLSGNT 487 (1081)
T ss_pred ccchhhhhhhhhhCCCcccceeeccCCc
Confidence 9999975443344445999999999996
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.11 E-value=2.4e-07 Score=96.34 Aligned_cols=94 Identities=26% Similarity=0.386 Sum_probs=66.9
Q ss_pred CcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCcccc-CCCCCCEEECccCCCCcCCChhc
Q 004979 132 GMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFG-NSFSLTTLLLDNNQYLGGISPEL 210 (721)
Q Consensus 132 G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~-~~~~L~~l~l~~N~~~G~iP~~~ 210 (721)
+++|++++.+.+|.-|+|..|.+. .+| +++.|+.|..|.++.|++. .+|+++. ++.+|.+|||..|++. ..|.++
T Consensus 196 ~tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~ 271 (565)
T KOG0472|consen 196 ETLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEI 271 (565)
T ss_pred hcCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchHH
Confidence 556666666666666666666664 444 5666666666666666665 5666655 7788888888888876 678888
Q ss_pred cCCCCCCEEEccCCCCCCc
Q 004979 211 HVLKVISEIQVDESWLTNA 229 (721)
Q Consensus 211 ~~l~~L~~l~l~~n~~~g~ 229 (721)
+.+++|++|||++|.+++-
T Consensus 272 clLrsL~rLDlSNN~is~L 290 (565)
T KOG0472|consen 272 CLLRSLERLDLSNNDISSL 290 (565)
T ss_pred HHhhhhhhhcccCCccccC
Confidence 8888888888888888864
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=98.07 E-value=8.3e-06 Score=95.36 Aligned_cols=33 Identities=21% Similarity=0.292 Sum_probs=17.0
Q ss_pred cEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCccc
Q 004979 119 KVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFF 155 (721)
Q Consensus 119 ~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~ 155 (721)
+++.|+|.+|+|+. +|. .+++|++|+|++|+|+
T Consensus 223 ~L~~L~L~~N~Lt~-LP~---lp~~Lk~LdLs~N~Lt 255 (788)
T PRK15387 223 HITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQLT 255 (788)
T ss_pred CCCEEEccCCcCCC-CCC---CCCCCcEEEecCCccC
Confidence 34455555555543 332 1345666666666665
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=98.05 E-value=9.4e-06 Score=101.28 Aligned_cols=110 Identities=20% Similarity=0.202 Sum_probs=67.0
Q ss_pred cEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCccccCCCCCCEEECc
Q 004979 119 KVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLLD 198 (721)
Q Consensus 119 ~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~~L~~l~l~ 198 (721)
.++.|+|+++.+. .++..+..+++|+.|+|++|+.-+.+| .++.+++|+.|+|++|..-..+|.+++++++|+.|+++
T Consensus 612 ~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~ 689 (1153)
T PLN03210 612 NLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMS 689 (1153)
T ss_pred CCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCC-ccccCCcccEEEecCCCCccccchhhhccCCCCEEeCC
Confidence 4455555555543 345555666666666666665555665 36666666666666666556666666666666666666
Q ss_pred cCCCCcCCChhccCCCCCCEEEccCCCCCCccc
Q 004979 199 NNQYLGGISPELHVLKVISEIQVDESWLTNAAS 231 (721)
Q Consensus 199 ~N~~~G~iP~~~~~l~~L~~l~l~~n~~~g~~p 231 (721)
+|...+.+|..+ ++++|+.|+|++|...+.+|
T Consensus 690 ~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p 721 (1153)
T PLN03210 690 RCENLEILPTGI-NLKSLYRLNLSGCSRLKSFP 721 (1153)
T ss_pred CCCCcCccCCcC-CCCCCCEEeCCCCCCccccc
Confidence 665556666544 56666666666655444444
|
syringae 6; Provisional |
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.02 E-value=5.1e-06 Score=90.41 Aligned_cols=107 Identities=23% Similarity=0.231 Sum_probs=79.6
Q ss_pred cEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCccccCCCCCCEEECc
Q 004979 119 KVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLLD 198 (721)
Q Consensus 119 ~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~~L~~l~l~ 198 (721)
.+..|+|++|.|+-.=+..+-+|++|+.++|..|.|+ .||...+....|+.|+|.+|.++.---.++.-++.|+.||||
T Consensus 79 ~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLS 157 (873)
T KOG4194|consen 79 QTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLS 157 (873)
T ss_pred ceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhh
Confidence 3567999999999888888999999999999999987 788766666678888888887764444566677777777777
Q ss_pred cCCCCcCCC-hhccCCCCCCEEEccCCCCC
Q 004979 199 NNQYLGGIS-PELHVLKVISEIQVDESWLT 227 (721)
Q Consensus 199 ~N~~~G~iP-~~~~~l~~L~~l~l~~n~~~ 227 (721)
.|.++ .|| +.+..-.++++|+|++|.++
T Consensus 158 rN~is-~i~~~sfp~~~ni~~L~La~N~It 186 (873)
T KOG4194|consen 158 RNLIS-EIPKPSFPAKVNIKKLNLASNRIT 186 (873)
T ss_pred hchhh-cccCCCCCCCCCceEEeecccccc
Confidence 77765 333 23444466777777777665
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.01 E-value=6.9e-05 Score=83.79 Aligned_cols=170 Identities=14% Similarity=0.146 Sum_probs=102.1
Q ss_pred hcCCCCCCHHHHHHHHhh---------hhhhh-CcCCCCceeEEEEEEecCCcEEEEEEeeeccccchh-----------
Q 004979 410 VTGVPKLKRSELEAACED---------FSNII-GSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWS----------- 468 (721)
Q Consensus 410 ~~~~~~~~~~~l~~~~~~---------~~~ii-~~lg~G~~g~Vyk~~~~~~~~vavk~~~~~~~~~~~----------- 468 (721)
....|.++.+|+.+..+. |.++- ..++.-+.|.||+|++++|..||||+-+..-.....
T Consensus 134 qD~~Pp~~~ee~~~i~e~ElG~~ie~if~~f~~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~ 213 (538)
T KOG1235|consen 134 QDQAPPFPWEEAFKIFEEELGAPIEDIFSEFDEEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAK 213 (538)
T ss_pred hccCCCCCHHHHHHHHHHHhCCCHHHHHHhcCcchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHH
Confidence 346788888776554332 11221 356778889999999999999999987644322100
Q ss_pred ---------------hHH------HHHHHHHHHHHhcC----CCCcc---ceEeEEEecCCCceEEEEEecCCCCChhhh
Q 004979 469 ---------------KNL------ESQFRKKIDTLSKV----NHKNF---VNLIGYCEEDEPFTRMMVFEYSPNGSLFEH 520 (721)
Q Consensus 469 ---------------~~~------~~~f~~Ei~~l~~l----~H~nI---v~l~g~~~~~~~~~~~lV~Ey~~~GsL~~~ 520 (721)
++. +-+|.+|++-..++ +|-+. |.+=.++++-.. ...|+||||+|..+.+.
T Consensus 214 ~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st-~RVLtME~~~G~~i~Dl 292 (538)
T KOG1235|consen 214 VLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAKNAERFRENFKDFSLLTYVLVPKVYWDLST-KRVLTMEYVDGIKINDL 292 (538)
T ss_pred HHHHhCcCCchhhHHHHHHhhhHhhcchHHHHHhHHHHHHHHHhcccccceeCCeehhhcCc-ceEEEEEecCCccCCCH
Confidence 001 11355565544433 45551 222234433211 46899999999888766
Q ss_pred hhhccCCCCCHHHHHHHHHHHHHHHHHH-hcCCCCeEeeCCCCCCeEeCC----CCcEEEeccCCCCCCCC
Q 004979 521 LHIQEAEHLDWAMRLRIAMGMAYCLEHM-HQLTPPIAHRNLQSSSIYLTE----DYAAKISDFSFWNNTTA 586 (721)
Q Consensus 521 l~~~~~~~l~~~~~~~ia~~ia~gL~yL-H~~~~~IvHrDLKp~NILl~~----~~~~kL~DFGla~~~~~ 586 (721)
-.. ....++... |+.-+.++...+ -..| ++|+|=.|.||+++. ++++.+-|||+......
T Consensus 293 ~~i-~~~gi~~~~---i~~~l~~~~~~qIf~~G--ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 293 DAI-DKRGISPHD---ILNKLVEAYLEQIFKTG--FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred HHH-HHcCCCHHH---HHHHHHHHHHHHHHhcC--CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 432 223344443 333333332222 1234 999999999999994 67899999999765544
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=97.97 E-value=8.3e-05 Score=75.23 Aligned_cols=137 Identities=11% Similarity=0.089 Sum_probs=79.2
Q ss_pred CcCCCCceeEEEEEEecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCc--cceEeEEEecCCCceEEEEEe
Q 004979 433 GSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKN--FVNLIGYCEEDEPFTRMMVFE 510 (721)
Q Consensus 433 ~~lg~G~~g~Vyk~~~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~n--Iv~l~g~~~~~~~~~~~lV~E 510 (721)
..+|.|..+.||+.. +..+++|...... ......+|.+++..+..-. +.+.+++....+ ...+|||
T Consensus 7 ~~i~~G~t~~~y~~~---~~~~VlR~~~~~~-------~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~--~~glv~e 74 (226)
T TIGR02172 7 TQTGEGGNGESYTHK---TGKWMLKLYNPGF-------DKETIKREFDASRKVFSLGIPTPHPFDLVEDGG--RLGLIYE 74 (226)
T ss_pred eeecCCCCcceeEec---CCCEEEEeCCCCC-------CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCC--eeeeeee
Confidence 456789999999842 4456666654221 1134678899998885443 356677776655 4578999
Q ss_pred cCCCCC-hhhh---------------------hhhccCCCCCHHHHH-HHHH----------HHH-HHHHHHh--cCCCC
Q 004979 511 YSPNGS-LFEH---------------------LHIQEAEHLDWAMRL-RIAM----------GMA-YCLEHMH--QLTPP 554 (721)
Q Consensus 511 y~~~Gs-L~~~---------------------l~~~~~~~l~~~~~~-~ia~----------~ia-~gL~yLH--~~~~~ 554 (721)
+++|.. +... +|.-.........+. .+.. .+. ...++|. ...+.
T Consensus 75 ~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~ 154 (226)
T TIGR02172 75 LIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTST 154 (226)
T ss_pred ecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCc
Confidence 998863 2111 111000111111110 0000 011 1122232 23345
Q ss_pred eEeeCCCCCCeEeCCCCcEEEeccCCCC
Q 004979 555 IAHRNLQSSSIYLTEDYAAKISDFSFWN 582 (721)
Q Consensus 555 IvHrDLKp~NILl~~~~~~kL~DFGla~ 582 (721)
++|+|+.|.||++++++ +.|.||+.+.
T Consensus 155 ~~HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 155 CLHGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred eEecCCCCCcEEEcCCC-cEEEechhcC
Confidence 79999999999999888 9999998754
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.93 E-value=3.4e-05 Score=75.55 Aligned_cols=100 Identities=21% Similarity=0.283 Sum_probs=77.7
Q ss_pred HHHHHHHhcCCC-CccceEeEEEecCCCceEEEEEecCCCCChhhhhhh-ccCCCCCHHHHHHHHHHHHHHHHHHhcC-C
Q 004979 476 RKKIDTLSKVNH-KNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHI-QEAEHLDWAMRLRIAMGMAYCLEHMHQL-T 552 (721)
Q Consensus 476 ~~Ei~~l~~l~H-~nIv~l~g~~~~~~~~~~~lV~Ey~~~GsL~~~l~~-~~~~~l~~~~~~~ia~~ia~gL~yLH~~-~ 552 (721)
..|.-+|..+.+ +++.+++|+|- .++|.||...+++...... .....-+|..|.+||.++.+.++++++. .
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG------~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~ 80 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG------RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPL 80 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC------CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCC
Confidence 357778888866 69999999993 3789999998876532100 0113468999999999999999999642 1
Q ss_pred CCeEeeCCCCCCeEeCCCCcEEEeccCCC
Q 004979 553 PPIAHRNLQSSSIYLTEDYAAKISDFSFW 581 (721)
Q Consensus 553 ~~IvHrDLKp~NILl~~~~~~kL~DFGla 581 (721)
..+.-.|++++|+-+++++++|+.|...+
T Consensus 81 ~~~~lcDv~~~nfgv~~~~~lk~iDld~v 109 (188)
T PF12260_consen 81 GFFYLCDVSPDNFGVNDDGRLKLIDLDDV 109 (188)
T ss_pred CcEEEeecchHHeEEeCCCcEEEEechhc
Confidence 23888999999999999999999999753
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=97.92 E-value=2.5e-05 Score=97.48 Aligned_cols=104 Identities=22% Similarity=0.217 Sum_probs=62.6
Q ss_pred cEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCccccCCCCCCEEECc
Q 004979 119 KVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLLD 198 (721)
Q Consensus 119 ~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~~L~~l~l~ 198 (721)
.+..|+|++|...+.+|..+++|++|+.|+|++|..-+.+|..+ ++++|+.|+|++|..-..+|.. .++|+.|+|+
T Consensus 779 sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls 854 (1153)
T PLN03210 779 SLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLS 854 (1153)
T ss_pred cchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeECC
Confidence 35556666666666666666666666666666655555566554 5666666666665544445432 2456666666
Q ss_pred cCCCCcCCChhccCCCCCCEEEccC-CCCC
Q 004979 199 NNQYLGGISPELHVLKVISEIQVDE-SWLT 227 (721)
Q Consensus 199 ~N~~~G~iP~~~~~l~~L~~l~l~~-n~~~ 227 (721)
+|.++ .+|..+..+++|+.|+|++ |++.
T Consensus 855 ~n~i~-~iP~si~~l~~L~~L~L~~C~~L~ 883 (1153)
T PLN03210 855 RTGIE-EVPWWIEKFSNLSFLDMNGCNNLQ 883 (1153)
T ss_pred CCCCc-cChHHHhcCCCCCEEECCCCCCcC
Confidence 66665 4666666666666666665 4444
|
syringae 6; Provisional |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.89 E-value=0.00012 Score=73.25 Aligned_cols=142 Identities=17% Similarity=0.185 Sum_probs=93.4
Q ss_pred hhhCcCCCCceeEEEEEEecCCcEEEEEEeeeccccchh-------------------hHHHHHHHHHHHHHhcCC--CC
Q 004979 430 NIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWS-------------------KNLESQFRKKIDTLSKVN--HK 488 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~~~~~vavk~~~~~~~~~~~-------------------~~~~~~f~~Ei~~l~~l~--H~ 488 (721)
++.|.++.|.-+.||+|.-.++..+|||+.......-.. .....-..+|+.-|.++. +-
T Consensus 51 ~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGV 130 (268)
T COG1718 51 ELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGV 130 (268)
T ss_pred eeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCC
Confidence 567888899999999999888999999998654221100 011122456777777763 33
Q ss_pred ccceEeEEEecCCCceEEEEEecCCCCC-hhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHh-cCCCCeEeeCCCCCCeE
Q 004979 489 NFVNLIGYCEEDEPFTRMMVFEYSPNGS-LFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMH-QLTPPIAHRNLQSSSIY 566 (721)
Q Consensus 489 nIv~l~g~~~~~~~~~~~lV~Ey~~~Gs-L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH-~~~~~IvHrDLKp~NIL 566 (721)
.+-+-+++. ...|||||+.... -.-.|. ...+.......+..++.+.+.-|- ..+ +||+||..=|||
T Consensus 131 rvP~Pi~~~------~nVLvMEfIg~~g~pAP~Lk---Dv~~e~~e~~~~~~~~v~~~~~l~~~a~--LVHgDLSEyNiL 199 (268)
T COG1718 131 RVPEPIAFR------NNVLVMEFIGDDGLPAPRLK---DVPLELEEAEGLYEDVVEYMRRLYKEAG--LVHGDLSEYNIL 199 (268)
T ss_pred CCCCceeec------CCeEEEEeccCCCCCCCCcc---cCCcCchhHHHHHHHHHHHHHHHHHhcC--cccccchhhheE
Confidence 333444433 2379999996541 111121 111222245567777888888784 477 999999999999
Q ss_pred eCCCCcEEEeccCCCCC
Q 004979 567 LTEDYAAKISDFSFWNN 583 (721)
Q Consensus 567 l~~~~~~kL~DFGla~~ 583 (721)
+. ++.+.|+|||-+..
T Consensus 200 ~~-~~~p~iID~~QaV~ 215 (268)
T COG1718 200 VH-DGEPYIIDVSQAVT 215 (268)
T ss_pred EE-CCeEEEEECccccc
Confidence 99 88999999996644
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=97.87 E-value=2.9e-06 Score=92.13 Aligned_cols=113 Identities=19% Similarity=0.352 Sum_probs=92.8
Q ss_pred EEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCccccCCCCCCEEECcc
Q 004979 120 VVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLLDN 199 (721)
Q Consensus 120 v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~~L~~l~l~~ 199 (721)
+..+-+++|.+ +.+|++++.+..|..||.+.|.+. .+|+.++.+.+|+.|++..|++. .+|+++..| .|..||+|.
T Consensus 145 Lkvli~sNNkl-~~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfSc 220 (722)
T KOG0532|consen 145 LKVLIVSNNKL-TSLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFSC 220 (722)
T ss_pred ceeEEEecCcc-ccCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeeccc
Confidence 44556667766 468888888888999999999987 78889999999999999999988 788888844 689999999
Q ss_pred CCCCcCCChhccCCCCCCEEEccCCCCCCcccccccCCC
Q 004979 200 NQYLGGISPELHVLKVISEIQVDESWLTNAASRASCNSG 238 (721)
Q Consensus 200 N~~~G~iP~~~~~l~~L~~l~l~~n~~~g~~p~~~~~~~ 238 (721)
|+++ .||..+.+++.|++|.|.+|-|.. -|...|..+
T Consensus 221 Nkis-~iPv~fr~m~~Lq~l~LenNPLqS-PPAqIC~kG 257 (722)
T KOG0532|consen 221 NKIS-YLPVDFRKMRHLQVLQLENNPLQS-PPAQICEKG 257 (722)
T ss_pred Ccee-ecchhhhhhhhheeeeeccCCCCC-ChHHHHhcc
Confidence 9976 799999999999999999999984 344455444
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=97.86 E-value=1.2e-06 Score=95.04 Aligned_cols=109 Identities=27% Similarity=0.351 Sum_probs=86.0
Q ss_pred CcEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCccccCCCCCCEEEC
Q 004979 118 GKVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLL 197 (721)
Q Consensus 118 ~~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~~L~~l~l 197 (721)
..++.++|+.|.++ .+|..++.|+ |+.|-+++|+++ .+|.+++.+..|..||.|.|++. .+|+.++.+.+|+.|.+
T Consensus 121 ~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~v 196 (722)
T KOG0532|consen 121 EALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNV 196 (722)
T ss_pred hHHHHhhhccchhh-cCChhhhcCc-ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHH
Confidence 45677788888776 4677777776 888888888886 77888888888888888888887 78888888888888888
Q ss_pred ccCCCCcCCChhccCCCCCCEEEccCCCCCCccccc
Q 004979 198 DNNQYLGGISPELHVLKVISEIQVDESWLTNAASRA 233 (721)
Q Consensus 198 ~~N~~~G~iP~~~~~l~~L~~l~l~~n~~~g~~p~~ 233 (721)
..|++. .+|++++ .=.|..||++.|+++ .||..
T Consensus 197 rRn~l~-~lp~El~-~LpLi~lDfScNkis-~iPv~ 229 (722)
T KOG0532|consen 197 RRNHLE-DLPEELC-SLPLIRLDFSCNKIS-YLPVD 229 (722)
T ss_pred hhhhhh-hCCHHHh-CCceeeeecccCcee-ecchh
Confidence 888875 6788888 445778888888887 46654
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=97.75 E-value=2.2e-05 Score=75.52 Aligned_cols=87 Identities=29% Similarity=0.405 Sum_probs=29.5
Q ss_pred hhcCCCCCCEEEccCCcccccCchhhc-CCCCCCEeEcccCcccccCCccccCCCCCCEEECccCCCCcCCChhc-cCCC
Q 004979 137 ELGQLSELKSIILRNNSFFGTIPKEIG-ELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLLDNNQYLGGISPEL-HVLK 214 (721)
Q Consensus 137 ~l~~l~~L~~L~L~~n~l~G~ip~~l~-~l~~L~~l~ls~N~l~G~iP~~~~~~~~L~~l~l~~N~~~G~iP~~~-~~l~ 214 (721)
.+.+...++.|+|.+|.++ .|. .++ .+.+|+.||||+|.++ .|. .+..++.|+.|++++|.++ .|.+.+ ..++
T Consensus 14 ~~~n~~~~~~L~L~~n~I~-~Ie-~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp 88 (175)
T PF14580_consen 14 QYNNPVKLRELNLRGNQIS-TIE-NLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLP 88 (175)
T ss_dssp ------------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-T
T ss_pred ccccccccccccccccccc-ccc-chhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCC-ccccchHHhCC
Confidence 4556677999999999997 343 566 5889999999999998 454 5778999999999999998 465555 3689
Q ss_pred CCCEEEccCCCCCC
Q 004979 215 VISEIQVDESWLTN 228 (721)
Q Consensus 215 ~L~~l~l~~n~~~g 228 (721)
+|+.|+|++|.+..
T Consensus 89 ~L~~L~L~~N~I~~ 102 (175)
T PF14580_consen 89 NLQELYLSNNKISD 102 (175)
T ss_dssp T--EEE-TTS---S
T ss_pred cCCEEECcCCcCCC
Confidence 99999999999874
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.73 E-value=0.00029 Score=72.13 Aligned_cols=135 Identities=13% Similarity=0.129 Sum_probs=78.2
Q ss_pred CCce-eEEEEEEecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCC-CCccceEeEEEecCCCceEEEEEecCCC
Q 004979 437 DGTV-GTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVN-HKNFVNLIGYCEEDEPFTRMMVFEYSPN 514 (721)
Q Consensus 437 ~G~~-g~Vyk~~~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~~~lV~Ey~~~ 514 (721)
.|.. ..||+.... +..+.||...... .....+|++++..+. +--+.+++++....+ ..++||||++|
T Consensus 8 ~g~~~~~v~~~~~~-~~~~~vk~~~~~~--------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~--~~~lv~e~i~G 76 (244)
T cd05150 8 EGQSGATVYRLDGK-NPGLYLKIAPSGP--------TYELEREAERLRWLAGKLPVPEVIDYGSDDG--RAWLLTSAVPG 76 (244)
T ss_pred CCCCcCeEEEEcCC-CCcEEEEecCCCc--------ccchHHHHHHHHHHHhcCCCCeEEEEEecCC--ccEEEEEeeCC
Confidence 3444 689998765 3667777654321 124667888887773 333557777766543 45899999998
Q ss_pred CChhhhh-------------------hhccCC--CCC--HHHHHHHHH--------------------HHHHHHHHHh--
Q 004979 515 GSLFEHL-------------------HIQEAE--HLD--WAMRLRIAM--------------------GMAYCLEHMH-- 549 (721)
Q Consensus 515 GsL~~~l-------------------~~~~~~--~l~--~~~~~~ia~--------------------~ia~gL~yLH-- 549 (721)
.++.... |..... .+. +..+..... .+...+..|-
T Consensus 77 ~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 156 (244)
T cd05150 77 VPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEAT 156 (244)
T ss_pred ccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhh
Confidence 8776431 111100 111 001110000 0111222221
Q ss_pred ---cCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCC
Q 004979 550 ---QLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWN 582 (721)
Q Consensus 550 ---~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~ 582 (721)
...+.++|+|+.|.|||++++..+.|+||+.+.
T Consensus 157 ~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 157 RPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred CCCcCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 123459999999999999998778999998653
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=97.62 E-value=5.6e-05 Score=54.94 Aligned_cols=36 Identities=36% Similarity=0.539 Sum_probs=18.5
Q ss_pred CCCEEEccCCcccccCchhhcCCCCCCEeEcccCccc
Q 004979 143 ELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFS 179 (721)
Q Consensus 143 ~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~ 179 (721)
+|++|+|++|.++ .||+.+++|++|+.|+|++|+++
T Consensus 2 ~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~ 37 (44)
T PF12799_consen 2 NLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS 37 (44)
T ss_dssp T-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS
T ss_pred cceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC
Confidence 4555555555555 45555555555555555555554
|
... |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.62 E-value=0.00058 Score=82.44 Aligned_cols=82 Identities=11% Similarity=0.238 Sum_probs=54.1
Q ss_pred hCcCCCCceeEEEEEEecCC---cEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCC-CCcc--ceEeEEEecCCC-ce
Q 004979 432 IGSFSDGTVGTVYKGTLSSG---VEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVN-HKNF--VNLIGYCEEDEP-FT 504 (721)
Q Consensus 432 i~~lg~G~~g~Vyk~~~~~~---~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~-H~nI--v~l~g~~~~~~~-~~ 504 (721)
+..++.|.++.+|+.....+ ..+++|+....... .....+.+|+++|+.+. |.+| .+++++|.+... ..
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~----~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~ 118 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLL----QSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGT 118 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccC----ccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCC
Confidence 45667888999999876654 35566654322111 11246889999999995 6665 788888866421 13
Q ss_pred EEEEEecCCCCCh
Q 004979 505 RMMVFEYSPNGSL 517 (721)
Q Consensus 505 ~~lV~Ey~~~GsL 517 (721)
.|+||||+++..+
T Consensus 119 ~flVME~v~G~~~ 131 (822)
T PLN02876 119 AFYIMEYLEGRIF 131 (822)
T ss_pred ceEEEEecCCccc
Confidence 5899999987643
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=97.62 E-value=0.00077 Score=66.75 Aligned_cols=66 Identities=14% Similarity=0.181 Sum_probs=51.9
Q ss_pred EEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCC
Q 004979 505 RMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNN 583 (721)
Q Consensus 505 ~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~ 583 (721)
.+|||||++|..|.+... ++. .++..+..++.-+|+.| ++|+|..|.|+++++++ +++.||+..+.
T Consensus 118 ~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~~G--~~HGD~hpgNFlv~~~~-i~iID~~~k~~ 183 (229)
T PF06176_consen 118 YVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHKHG--FYHGDPHPGNFLVSNNG-IRIIDTQGKRM 183 (229)
T ss_pred EEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHHcC--CccCCCCcCcEEEECCc-EEEEECccccc
Confidence 468999999988876532 222 25566777889999999 99999999999999654 99999986543
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=97.59 E-value=5.8e-05 Score=54.86 Aligned_cols=36 Identities=39% Similarity=0.487 Sum_probs=20.4
Q ss_pred CCCEeEcccCcccccCCccccCCCCCCEEECccCCCC
Q 004979 167 ELEILDLGFNNFSGPFPSDFGNSFSLTTLLLDNNQYL 203 (721)
Q Consensus 167 ~L~~l~ls~N~l~G~iP~~~~~~~~L~~l~l~~N~~~ 203 (721)
+|++|+|++|+++ .||+.+++|++|+.|++++|+++
T Consensus 2 ~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~ 37 (44)
T PF12799_consen 2 NLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS 37 (44)
T ss_dssp T-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS
T ss_pred cceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC
Confidence 4566666666666 45555666666666666666554
|
... |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.54 E-value=2.1e-05 Score=87.14 Aligned_cols=169 Identities=17% Similarity=0.129 Sum_probs=116.6
Q ss_pred CCceeEEEEEEecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCc-cceEeEEEecCCCceEEEEEecCCCC
Q 004979 437 DGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKN-FVNLIGYCEEDEPFTRMMVFEYSPNG 515 (721)
Q Consensus 437 ~G~~g~Vyk~~~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~n-Iv~l~g~~~~~~~~~~~lV~Ey~~~G 515 (721)
+|+++++||.+-...+...++.+... ....-++++|.+++||| .|..++-+..++ ..+++++|+..|
T Consensus 252 K~altknpKkRptaeklL~h~fvs~~----------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~--~~~i~~~i~s~~ 319 (829)
T KOG0576|consen 252 KGALTKNPKKRPTAEKLLQHPFVSQT----------LSRRLAIELLDKVNNPNPVVRYLEDYDGED--YLWIPMRICSTG 319 (829)
T ss_pred HHHhcCCCccCCChhhheeceeeccc----------hhhHHHHHHHHHccCCCCcccccccCCccc--ccchhhhhhcCC
Confidence 58888999987443444444444321 23445788999999999 666665555444 568999999887
Q ss_pred -ChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC--------CC
Q 004979 516 -SLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT--------TA 586 (721)
Q Consensus 516 -sL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~--------~~ 586 (721)
+-...... ....+...+...+.+.-.++++|+|+.. -+||| ||+..+ ...|..||+..... ..
T Consensus 320 rs~~~~~~~-se~~~~~~~~~~~~r~et~~l~~l~~~~--~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~~~~t~~ 391 (829)
T KOG0576|consen 320 RSSALEMTV-SEIALEQYQFAYPLRKETRPLAELHSSY--KVHRD----NILGSE-EEVKLLDFAVPPQLTRTMKPRTAI 391 (829)
T ss_pred ccccccCCh-hhHhhhhhhhhhhhhhhccccccccccc--ccCcc----cccccc-cccccccccCCcccCcccccccCC
Confidence 33222111 1122333444556667778999999754 58998 887766 67899999976433 23
Q ss_pred CCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcc
Q 004979 587 AKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISY 625 (721)
Q Consensus 587 ~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~ 625 (721)
++..+++||+.....+..+.|+|+.|+--.++.-|..|-
T Consensus 392 ~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 392 GTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred CCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 455678999999999999999999998777777777664
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.54 E-value=0.0021 Score=67.88 Aligned_cols=78 Identities=13% Similarity=0.086 Sum_probs=53.2
Q ss_pred hCcCCCCceeEEEEEEecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCC---CccceEeEEEecCC-CceEEE
Q 004979 432 IGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNH---KNFVNLIGYCEEDE-PFTRMM 507 (721)
Q Consensus 432 i~~lg~G~~g~Vyk~~~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H---~nIv~l~g~~~~~~-~~~~~l 507 (721)
++.+|.|..+.||+-...+++ +.+|..+... ....|..|.+.|+.+.- -.+.+++++|.... ....+|
T Consensus 19 ~~~i~~G~~~~vy~~~~~~~~-~~~k~~~~~~-------~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~L 90 (297)
T PRK10593 19 VECISEQPYAALWALYDSQGN-PMPLMARSFS-------TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVL 90 (297)
T ss_pred eeecCCccceeEEEEEcCCCC-EEEEEecccc-------cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEE
Confidence 467889999999998765553 5555532110 12468899999988843 35778888876431 114699
Q ss_pred EEecCCCCCh
Q 004979 508 VFEYSPNGSL 517 (721)
Q Consensus 508 V~Ey~~~GsL 517 (721)
|||+++++++
T Consensus 91 VmE~i~G~~~ 100 (297)
T PRK10593 91 LLERLRGVSV 100 (297)
T ss_pred EEeccCCEec
Confidence 9999998765
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.52 E-value=0.00068 Score=68.36 Aligned_cols=141 Identities=18% Similarity=0.205 Sum_probs=79.8
Q ss_pred CcCCCCceeEEEEEEecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCC--ccceEeEEEecCC-CceEEEEE
Q 004979 433 GSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHK--NFVNLIGYCEEDE-PFTRMMVF 509 (721)
Q Consensus 433 ~~lg~G~~g~Vyk~~~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~--nIv~l~g~~~~~~-~~~~~lV~ 509 (721)
..++.|..+.||+....+ ..+++|..... .....+.+|+.++..+... .+.+++.++.... ....+++|
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~-------~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~ 74 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP-------DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM 74 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSH-------HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCC-------CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence 345678888999999877 58888875422 2345677888888877433 3456666553322 12468999
Q ss_pred ecCCCCChhh----------------h---hhhc--cCCCCCHHH---------HHHH------------HHHHHH-HHH
Q 004979 510 EYSPNGSLFE----------------H---LHIQ--EAEHLDWAM---------RLRI------------AMGMAY-CLE 546 (721)
Q Consensus 510 Ey~~~GsL~~----------------~---l~~~--~~~~l~~~~---------~~~i------------a~~ia~-gL~ 546 (721)
+|+++..+.. . +|.. ......+.. .... ...+.+ .++
T Consensus 75 ~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (239)
T PF01636_consen 75 EYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQ 154 (239)
T ss_dssp EEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHH
T ss_pred EEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHH
Confidence 9999988877 1 1111 011111111 0000 111222 333
Q ss_pred HHhc-----CCCCeEeeCCCCCCeEeC-CCCcEEEeccCCC
Q 004979 547 HMHQ-----LTPPIAHRNLQSSSIYLT-EDYAAKISDFSFW 581 (721)
Q Consensus 547 yLH~-----~~~~IvHrDLKp~NILl~-~~~~~kL~DFGla 581 (721)
.+++ ....++|+|+.+.|||++ +++.+.|.||+.+
T Consensus 155 ~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a 195 (239)
T PF01636_consen 155 ELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDA 195 (239)
T ss_dssp HHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-
T ss_pred HHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccc
Confidence 3331 234599999999999999 6676789999864
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=97.44 E-value=6.5e-05 Score=82.85 Aligned_cols=101 Identities=31% Similarity=0.364 Sum_probs=50.2
Q ss_pred EEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCC-CCCEeEcccCcccccCCccccCCCCCCEEECccCC
Q 004979 123 LNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELK-ELEILDLGFNNFSGPFPSDFGNSFSLTTLLLDNNQ 201 (721)
Q Consensus 123 l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~-~L~~l~ls~N~l~G~iP~~~~~~~~L~~l~l~~N~ 201 (721)
+++.++.+...+. .+..++.++.|++.+|+++ .||+..+.+. +|+.|++++|++. .+|..++.+++|+.|++++|+
T Consensus 98 l~~~~~~~~~~~~-~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~ 174 (394)
T COG4886 98 LDLNLNRLRSNIS-ELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFND 174 (394)
T ss_pred eeccccccccCch-hhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCch
Confidence 4444444433222 2333455555555555554 4454455443 5555555555554 444445555555555555555
Q ss_pred CCcCCChhccCCCCCCEEEccCCCCC
Q 004979 202 YLGGISPELHVLKVISEIQVDESWLT 227 (721)
Q Consensus 202 ~~G~iP~~~~~l~~L~~l~l~~n~~~ 227 (721)
++ .+|+..+.+.+|..|++++|.++
T Consensus 175 l~-~l~~~~~~~~~L~~L~ls~N~i~ 199 (394)
T COG4886 175 LS-DLPKLLSNLSNLNNLDLSGNKIS 199 (394)
T ss_pred hh-hhhhhhhhhhhhhheeccCCccc
Confidence 44 34444445555555555555554
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=97.38 E-value=3.9e-05 Score=77.34 Aligned_cols=92 Identities=17% Similarity=0.114 Sum_probs=56.4
Q ss_pred CCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCccccCCCCCCEEECccCCCCcCCChhc
Q 004979 131 GGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLLDNNQYLGGISPEL 210 (721)
Q Consensus 131 ~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~~L~~l~l~~N~~~G~iP~~~ 210 (721)
.|..-..+..-..|+.||||+|.++ .|-....-++++++|+||+|.+. .+ .++..+.+|+.||||+|.++- +-..-
T Consensus 273 ~G~~~~~~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v-~nLa~L~~L~~LDLS~N~Ls~-~~Gwh 348 (490)
T KOG1259|consen 273 NGSALVSADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR-TV-QNLAELPQLQLLDLSGNLLAE-CVGWH 348 (490)
T ss_pred CCceEEecchHhhhhhccccccchh-hhhhhhhhccceeEEecccccee-ee-hhhhhcccceEeecccchhHh-hhhhH
Confidence 3444334444456777777777776 55555556677777788877775 22 236667777777877777642 22222
Q ss_pred cCCCCCCEEEccCCCC
Q 004979 211 HVLKVISEIQVDESWL 226 (721)
Q Consensus 211 ~~l~~L~~l~l~~n~~ 226 (721)
.++.+.+.|.|++|.+
T Consensus 349 ~KLGNIKtL~La~N~i 364 (490)
T KOG1259|consen 349 LKLGNIKTLKLAQNKI 364 (490)
T ss_pred hhhcCEeeeehhhhhH
Confidence 3455666677777654
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.38 E-value=2.3e-05 Score=70.45 Aligned_cols=80 Identities=20% Similarity=0.320 Sum_probs=41.3
Q ss_pred cEEEEEeCCCCCCCcCchhhc-CCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCccccCCCCCCEEEC
Q 004979 119 KVVILNLRDLCLGGMLAPELG-QLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLL 197 (721)
Q Consensus 119 ~v~~l~L~~~~l~G~ip~~l~-~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~~L~~l~l 197 (721)
+++.++|++|.|.. +|+.+. .++.++.|+|++|.++ .+|.++..++.|+.|+++.|.|. ..|.-+..+.+|..||.
T Consensus 54 el~~i~ls~N~fk~-fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Lds 130 (177)
T KOG4579|consen 54 ELTKISLSDNGFKK-FPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDMLDS 130 (177)
T ss_pred eEEEEecccchhhh-CCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHhcC
Confidence 45555666665542 333332 3345555555555554 45555555555555555555555 33444444555555555
Q ss_pred ccCC
Q 004979 198 DNNQ 201 (721)
Q Consensus 198 ~~N~ 201 (721)
.+|.
T Consensus 131 ~~na 134 (177)
T KOG4579|consen 131 PENA 134 (177)
T ss_pred CCCc
Confidence 5554
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.35 E-value=0.00011 Score=87.71 Aligned_cols=106 Identities=29% Similarity=0.298 Sum_probs=85.2
Q ss_pred cEEEEEeCCCCC-CCcCchh-hcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCccccCCCCCCEEE
Q 004979 119 KVVILNLRDLCL-GGMLAPE-LGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLL 196 (721)
Q Consensus 119 ~v~~l~L~~~~l-~G~ip~~-l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~~L~~l~ 196 (721)
.+++|-+.+|.. -..++.+ |..++.|++|||++|.=-|.+|..++.|-+|++|||+...++ .+|.+++++..|.+|+
T Consensus 546 ~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~~Ln 624 (889)
T KOG4658|consen 546 KLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLGNLKKLIYLN 624 (889)
T ss_pred ccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccchHHHHHHhhheec
Confidence 466676766652 3445544 667899999999998877889999999999999999999988 8999999999999999
Q ss_pred CccCCCCcCCChhccCCCCCCEEEccCCC
Q 004979 197 LDNNQYLGGISPELHVLKVISEIQVDESW 225 (721)
Q Consensus 197 l~~N~~~G~iP~~~~~l~~L~~l~l~~n~ 225 (721)
+..+.....+|--+..+.+|++|.|-...
T Consensus 625 l~~~~~l~~~~~i~~~L~~Lr~L~l~~s~ 653 (889)
T KOG4658|consen 625 LEVTGRLESIPGILLELQSLRVLRLPRSA 653 (889)
T ss_pred cccccccccccchhhhcccccEEEeeccc
Confidence 99888777776666668999998886654
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.31 E-value=0.0013 Score=67.00 Aligned_cols=29 Identities=14% Similarity=0.280 Sum_probs=24.8
Q ss_pred CeEeeCCCCCCeEeCCCCcEEEeccCCCC
Q 004979 554 PIAHRNLQSSSIYLTEDYAAKISDFSFWN 582 (721)
Q Consensus 554 ~IvHrDLKp~NILl~~~~~~kL~DFGla~ 582 (721)
.++|+|+.+.|||++++...-|.||+.+.
T Consensus 165 ~l~HGD~~~~Nvlv~~~~i~giIDw~~a~ 193 (235)
T cd05155 165 VWFHGDLAPGNLLVQDGRLSAVIDFGCLG 193 (235)
T ss_pred eEEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence 48999999999999977666799999753
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 721 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-28 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-28 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 7e-23 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 9e-23 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-22 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-21 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-21 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-20 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 8e-19 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 4e-18 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 6e-18 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-17 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-17 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-17 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-17 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-17 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 6e-17 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 4e-16 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 4e-16 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 4e-16 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 4e-16 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 4e-16 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 4e-16 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 5e-16 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 5e-16 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 5e-16 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 7e-16 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-14 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 4e-14 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 7e-14 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-13 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-13 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 5e-13 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 8e-13 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 8e-13 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-12 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-12 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-12 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-12 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-12 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-12 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-12 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-12 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-12 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 5e-12 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-11 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-11 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-11 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-11 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-11 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-11 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-11 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-11 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-11 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-11 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-11 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-11 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-11 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-11 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-11 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-11 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-11 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-11 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 4e-11 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 4e-11 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 5e-11 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 5e-11 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 5e-11 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 5e-11 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 5e-11 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 6e-11 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 6e-11 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 7e-11 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 7e-11 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 7e-11 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 7e-11 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 7e-11 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 7e-11 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 7e-11 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 7e-11 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 8e-11 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 8e-11 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 8e-11 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 8e-11 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 8e-11 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 9e-11 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 9e-11 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 9e-11 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-10 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-10 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-10 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-10 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-10 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-10 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-10 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-10 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-10 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-10 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-10 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-10 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-10 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-10 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-10 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-10 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-10 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-10 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-10 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-10 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-10 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-10 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-10 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-10 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-10 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-10 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-10 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-10 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-10 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-10 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-10 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-10 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-10 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 4e-10 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 4e-10 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 4e-10 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 4e-10 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 4e-10 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 4e-10 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 5e-10 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-10 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 5e-10 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 5e-10 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 5e-10 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-10 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-10 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-10 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 6e-10 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 6e-10 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 6e-10 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-10 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 6e-10 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 7e-10 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 7e-10 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-10 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 8e-10 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 9e-10 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-09 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-09 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-09 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-09 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-09 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-09 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-09 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-09 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-09 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-09 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-09 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-09 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-09 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-09 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-09 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-09 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-09 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-09 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-09 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-09 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-09 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-09 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-09 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-09 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-09 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 3e-09 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 3e-09 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-09 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-09 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 4e-09 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 5e-09 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 6e-09 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 7e-09 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 7e-09 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 8e-09 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 8e-09 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-08 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-08 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-08 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-08 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 3e-08 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-08 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-08 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-08 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-08 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 3e-08 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-08 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-08 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-08 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 4e-08 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 4e-08 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 4e-08 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 4e-08 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 4e-08 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 4e-08 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 4e-08 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 4e-08 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 4e-08 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 4e-08 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 4e-08 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 4e-08 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 4e-08 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 5e-08 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 5e-08 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 5e-08 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 5e-08 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 6e-08 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 6e-08 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 6e-08 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 7e-08 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 8e-08 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 8e-08 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 8e-08 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 8e-08 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 8e-08 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 8e-08 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 9e-08 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 9e-08 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-07 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-07 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-07 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-07 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-07 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-07 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-07 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-07 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-07 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-07 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-07 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-07 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-07 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-07 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-07 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-07 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-07 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-07 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-07 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-07 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-07 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-07 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-07 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-07 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-07 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-07 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-07 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-07 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-07 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-07 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-07 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-07 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-07 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-07 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-07 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-07 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 3e-07 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 3e-07 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 4e-07 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-07 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 4e-07 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 4e-07 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 4e-07 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 4e-07 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-07 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 5e-07 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 5e-07 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-07 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 5e-07 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 6e-07 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 6e-07 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 6e-07 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 6e-07 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-07 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-07 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-07 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 7e-07 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 8e-07 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 8e-07 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 8e-07 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 8e-07 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 8e-07 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 8e-07 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 8e-07 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 8e-07 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-06 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-06 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-06 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-06 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-06 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-06 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-06 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-06 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-06 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-06 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-06 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-06 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-06 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-06 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-06 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-06 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-06 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-06 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 4e-06 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 5e-06 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 5e-06 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 5e-06 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-06 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 5e-06 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 5e-06 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-06 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-06 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 6e-06 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 6e-06 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 6e-06 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 6e-06 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 6e-06 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 7e-06 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 7e-06 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 7e-06 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-06 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 8e-06 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-06 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 8e-06 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 9e-06 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 9e-06 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 9e-06 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 9e-06 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 9e-06 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-05 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-05 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-05 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-05 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-05 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-05 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-05 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-05 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-05 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-05 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-05 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-05 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-05 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-05 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-05 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-05 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-05 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-05 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-05 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-05 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-05 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-05 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-05 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-05 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-05 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-05 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-05 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-05 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-05 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-05 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-05 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-05 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-05 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-05 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 3e-05 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-05 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-05 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 3e-05 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-05 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 3e-05 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-05 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-05 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 3e-05 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-05 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-05 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-05 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 4e-05 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 4e-05 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-05 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-05 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-05 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 5e-05 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 5e-05 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-05 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-05 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 6e-05 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 7e-05 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 7e-05 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 7e-05 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 7e-05 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 7e-05 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 7e-05 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-05 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-05 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 8e-05 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 8e-05 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 8e-05 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 8e-05 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 8e-05 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 8e-05 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 9e-05 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 9e-05 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 9e-05 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 9e-05 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 9e-05 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 9e-05 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 9e-05 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-04 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-04 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-04 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-04 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-04 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-04 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-04 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-04 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-04 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-04 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-04 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-04 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-04 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 1e-04 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-04 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-04 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-04 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-04 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-04 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-04 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-04 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-04 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-04 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-04 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-04 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-04 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-04 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-04 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-04 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-04 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-04 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-04 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-04 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-04 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-04 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-04 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-04 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-04 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-04 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-04 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-04 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 3e-04 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-04 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-04 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-04 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-04 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 4e-04 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-04 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 4e-04 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 4e-04 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-04 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-04 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 4e-04 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 4e-04 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-04 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 5e-04 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 5e-04 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 5e-04 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 5e-04 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 6e-04 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 6e-04 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 6e-04 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 6e-04 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 6e-04 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 6e-04 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 7e-04 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 7e-04 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 7e-04 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 7e-04 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 7e-04 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 7e-04 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 7e-04 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 7e-04 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 8e-04 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 8e-04 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 8e-04 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 8e-04 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 8e-04 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 8e-04 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 8e-04 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 8e-04 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 8e-04 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 8e-04 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 9e-04 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 9e-04 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 9e-04 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 208 bits (533), Expect = 7e-62
Identities = 92/305 (30%), Positives = 143/305 (46%), Gaps = 45/305 (14%)
Query: 419 SELEAACEDFS--NIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFR 476
+LE A +F +IG G G VYKG L G ++A+ K R S +F
Sbjct: 32 VDLEEATNNFDHKFLIGH---GVFGKVYKGVLRDGAKVAL-----KRRTPESSQGIEEFE 83
Query: 477 KKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLH--IQEAEHLDWAMR 534
+I+TLS H + V+LIG+C+E +++++Y NG+L HL+ + W R
Sbjct: 84 TEIETLSFCRHPHLVSLIGFCDERN--EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQR 141
Query: 535 LRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTAAKTGSAAM 594
L I +G A L ++H T I HR+++S +I L E++ KI+DF +K G+
Sbjct: 142 LEICIGAARGLHYLH--TRAIIHRDVKSINILLDENFVPKITDFGI------SKKGTELD 193
Query: 595 ELLETSAV-------DLE----------SNVYSFGTILFEMITGR--ISYSIENG--SLE 633
+ ++ V D E S+VYSFG +LFE++ R I S+ +L
Sbjct: 194 QTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLA 253
Query: 634 NWASEYLKGEQPLKDIVDPTLKS-FQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKE 692
WA E Q L+ IVDP L + L + C+ + RPSM + KL+
Sbjct: 254 EWAVESHNNGQ-LEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEY 312
Query: 693 ITAME 697
++
Sbjct: 313 ALRLQ 317
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 204 bits (521), Expect = 3e-60
Identities = 81/304 (26%), Positives = 140/304 (46%), Gaps = 42/304 (13%)
Query: 419 SELEAACEDFS--------NIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKN 470
EL+ +F N +G +G G VYKG ++ +AV + ++
Sbjct: 18 YELKNVTNNFDERPISVGGNKMG---EGGFGVVYKGYVN-NTTVAVKKLAAMVDIT-TEE 72
Query: 471 LESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLH-IQEAEHL 529
L+ QF ++I ++K H+N V L+G+ + + +V+ Y PNGSL + L + L
Sbjct: 73 LKQQFDQEIKVMAKCQHENLVELLGFSSDGD--DLCLVYVYMPNGSLLDRLSCLDGTPPL 130
Query: 530 DWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTAAKT 589
W MR +IA G A + +H+ HR+++S++I L E + AKISDF A+
Sbjct: 131 SWHMRCKIAQGAANGINFLHE--NHHIHRDIKSANILLDEAFTAKISDFGL------ARA 182
Query: 590 GSAAMELLETSAV----------------DLESNVYSFGTILFEMITGR--ISYSIENGS 631
+ + TS + +S++YSFG +L E+ITG + E
Sbjct: 183 SEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQL 242
Query: 632 LENWASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLK 691
L + E E+ ++D +D + +E + V C+H +RP ++ + L+
Sbjct: 243 LLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQ 302
Query: 692 EITA 695
E+TA
Sbjct: 303 EMTA 306
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 200 bits (511), Expect = 1e-58
Identities = 85/293 (29%), Positives = 142/293 (48%), Gaps = 44/293 (15%)
Query: 419 SELEAACEDFS--NIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFR 476
EL+ A ++FS NI+G G G VYKG L+ G +AV + ++ E QF+
Sbjct: 23 RELQVASDNFSNKNILG---RGGFGKVYKGRLADGTLVAVKRLKEER----TQGGELQFQ 75
Query: 477 KKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLH--IQEAEHLDWAMR 534
+++ +S H+N + L G+C R++V+ Y NGS+ L + LDW R
Sbjct: 76 TEVEMISMAVHRNLLRLRGFCMTPT--ERLLVYPYMANGSVASCLRERPESQPPLDWPKR 133
Query: 535 LRIAMGMAYCLEHMH-QLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTAAKTGSA- 592
RIA+G A L ++H P I HR++++++I L E++ A + DF AK
Sbjct: 134 QRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL------AKLMDYK 187
Query: 593 ---------------AMELLETSAVDLESNVYSFGTILFEMITGR--ISYSI----ENGS 631
A E L T +++V+ +G +L E+ITG+ + ++
Sbjct: 188 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM 247
Query: 632 LENWASEYLKGEQPLKDIVDPTLKS-FQENVLEELLVVIKNCVHPDPKQRPSM 683
L +W LK E+ L+ +VD L+ +++ +E+L+ V C P +RP M
Sbjct: 248 LLDWVKGLLK-EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKM 299
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 2e-47
Identities = 60/279 (21%), Positives = 117/279 (41%), Gaps = 35/279 (12%)
Query: 427 DFSNIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVK--SRADWSKNLESQFRKKIDTLSK 484
+F + G ++KG G +I V K DWS F ++ L
Sbjct: 13 NFLTKLNE---NHSGELWKGRWQ-GNDIVV-----KVLKVRDWSTRKSRDFNEECPRLRI 63
Query: 485 VNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYC 544
+H N + ++G C+ ++ + P GSL+ LH +D + ++ A+ MA
Sbjct: 64 FSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARG 123
Query: 545 LEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDF---SFWNNTTAAKTGSAA-M--ELLE 598
+ +H L P I L S S+ + ED A+IS + + + + A + E L+
Sbjct: 124 MAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPG--RMYAPAWVAPEALQ 181
Query: 599 TSAVDLESN---VYSFGTILFEMITGRISYS-IENGSLENWASEYLKGEQPLKDIVDPTL 654
D ++SF +L+E++T + ++ + N + + L+G +P
Sbjct: 182 KKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVA--LEGLRP--------- 230
Query: 655 KSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEI 693
+ + + ++K C++ DP +RP I L+++
Sbjct: 231 -TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKM 268
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 2e-46
Identities = 60/318 (18%), Positives = 117/318 (36%), Gaps = 53/318 (16%)
Query: 419 SELEAACEDFS--NIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFR 476
L + G G V+K L +AV ++ + W Q
Sbjct: 17 ENLYFQSMPLQLLEVKAR---GRFGCVWKAQLL-NEYVAVKIFPIQDKQSW------QNE 66
Query: 477 KKIDTLSKVNHKNFVNLIGYCEEDEPFT--RMMVFEYSPNGSLFEHLHIQEAEHLDWAMR 534
++ +L + H+N + IG + ++ + GSL + L + W
Sbjct: 67 YEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV---VSWNEL 123
Query: 535 LRIAMGMAYCLEHMHQ--------LTPPIAHRNLQSSSIYLTEDYAAKISDFS----FWN 582
IA MA L ++H+ P I+HR+++S ++ L + A I+DF F
Sbjct: 124 CHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEA 183
Query: 583 NTTAAKTGSAA-----M--ELLETSA-----VDLESNVYSFGTILFEMITGRISYSIENG 630
+A T M E+LE + L ++Y+ G +L+E+ + +
Sbjct: 184 GKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVD 243
Query: 631 SLENWASEYLKGEQP----LKDIV-----DPTLKS--FQENVLEELLVVIKNCVHPDPKQ 679
E + G+ P ++++V P L+ + + L I+ C D +
Sbjct: 244 EYMLPFEEEI-GQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEA 302
Query: 680 RPSMRGIAAKLKEITAME 697
R S + ++ ++ +
Sbjct: 303 RLSAGCVGERITQMQRLT 320
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 3e-46
Identities = 74/295 (25%), Positives = 118/295 (40%), Gaps = 44/295 (14%)
Query: 427 DFSNIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQ-----FRKKIDT 481
+ ++G G G V K ++A+ K +ES+ F ++
Sbjct: 11 EVEEVVGR---GAFGVVCKAKWR-AKDVAI------------KQIESESERKAFIVELRQ 54
Query: 482 LSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQE-AEHLDWAMRLRIAMG 540
LS+VNH N V L G C P +V EY+ GSL+ LH E + A + +
Sbjct: 55 LSRVNHPNIVKLYGACLN--PV--CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQ 110
Query: 541 MAYCLEHMHQLTP-PIAHRNLQSSSIYLTEDY-AAKISDFS---FWNNTTAAKTGSAA-M 594
+ + ++H + P + HR+L+ ++ L KI DF GSAA M
Sbjct: 111 CSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGSAAWM 170
Query: 595 --ELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDP 652
E+ E S + +V+S+G IL+E+IT R + G G +P
Sbjct: 171 APEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRP------- 223
Query: 653 TLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAMEPDGATPKLSP 707
+N+ + + ++ C DP QRPSM I + + P P P
Sbjct: 224 ---PLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYP 275
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 3e-46
Identities = 76/301 (25%), Positives = 136/301 (45%), Gaps = 42/301 (13%)
Query: 411 TGVPKLKRSELEAACEDFSNIIGSFSDGTVGTVYKGTLSS-GVEIAV---TSTSVKSRAD 466
+ +P L +E+E + IG G G V+KG L +A+ + +
Sbjct: 11 SRLPTLADNEIE-----YEKQIGK---GGFGLVHKGRLVKDKSVVAIKSLILGDSEGETE 62
Query: 467 WSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEA 526
+ + +F++++ +S +NH N V L G P MV E+ P G L+ L +A
Sbjct: 63 MIEKFQ-EFQREVFIMSNLNHPNIVKLYGLMHN--PP--RMVMEFVPCGDLYHRLL-DKA 116
Query: 527 EHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTE-----DYAAKISDFS-- 579
+ W+++LR+ + +A +E+M PPI HR+L+S +I+L AK++DF
Sbjct: 117 HPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS 176
Query: 580 -FWNNTTAAKTGSAA-M--ELL--ETSAVDLESNVYSFGTILFEMITGRISYS-IENGSL 632
++ + G+ M E + E + +++ YSF IL+ ++TG + G +
Sbjct: 177 QQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI 236
Query: 633 ENWASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKE 692
+ +G +P + E+ L VI+ C DPK+RP I +L E
Sbjct: 237 KFINMIREEGLRP----------TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286
Query: 693 I 693
+
Sbjct: 287 L 287
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 4e-46
Identities = 72/289 (24%), Positives = 127/289 (43%), Gaps = 39/289 (13%)
Query: 417 KRSELEAACEDFSNIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVK--SRADWSKNLESQ 474
+L IG+ G+ GTV++ G ++AV K D+ ++
Sbjct: 35 PWCDLN-----IKEKIGA---GSFGTVHRAEWH-GSDVAV-----KILMEQDFHAERVNE 80
Query: 475 FRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEA-EHLDWAM 533
F +++ + ++ H N V +G + +V EY GSL+ LH A E LD
Sbjct: 81 FLREVAIMKRLRHPNIVLFMGAVTQPPNL--SIVTEYLSRGSLYRLLHKSGAREQLDERR 138
Query: 534 RLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDF---SFWNNTTAAKTG 590
RL +A +A + ++H PPI HRNL+S ++ + + Y K+ DF +T +
Sbjct: 139 RLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKS 198
Query: 591 SA------AMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQ 644
+A A E+L + +S+VYSFG IL+E+ T + + +L G +
Sbjct: 199 AAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWG----NLNPAQVVAAVGFK 254
Query: 645 PLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEI 693
+ + N+ ++ +I+ C +P +RPS I L+ +
Sbjct: 255 CKR----LEIP---RNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPL 296
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 8e-41
Identities = 72/293 (24%), Positives = 126/293 (43%), Gaps = 42/293 (14%)
Query: 417 KRSELEAACEDFSNIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFR 476
+EL IIG G G VY+ G E+AV + D S+ +E R
Sbjct: 5 DFAELT-----LEEIIGI---GGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIE-NVR 54
Query: 477 KKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLR 536
++ + + H N + L G C ++ +V E++ G L L + + + +
Sbjct: 55 QEAKLFAMLKHPNIIALRGVCLKEPNL--CLVMEFARGGPLNRVLS---GKRIPPDILVN 109
Query: 537 IAMGMAYCLEHMHQLTP-PIAHRNLQSSSIYLTEDYA--------AKISDF---SFWNNT 584
A+ +A + ++H PI HR+L+SS+I + + KI+DF W+ T
Sbjct: 110 WAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRT 169
Query: 585 TA-AKTGSAA-M--ELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYL 640
T + G+ A M E++ S S+V+S+G +L+E++TG + + ++ A Y
Sbjct: 170 TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFR----GIDGLAVAYG 225
Query: 641 KGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEI 693
L + E ++++C +PDP RPS I +L I
Sbjct: 226 VAMNKLA----LPI---PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 5e-40
Identities = 69/302 (22%), Positives = 123/302 (40%), Gaps = 64/302 (21%)
Query: 418 RSELEAACEDFSNIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRK 477
++ IGS G+ GTVYKG V + + + + F+
Sbjct: 23 DGQIT-----VGQRIGS---GSFGTVYKGKWHGDVAVKM-----LNVTAPTPQQLQAFKN 69
Query: 478 KIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRI 537
++ L K H N + +GY +V ++ SL+ HLH E + + I
Sbjct: 70 EVGVLRKTRHVNILLFMGYSTA-PQL--AIVTQWCEGSSLYHHLHASE-TKFEMKKLIDI 125
Query: 538 AM----GMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDF--------SFWNNTT 585
A GM Y +H I HR+L+S++I+L ED KI DF ++
Sbjct: 126 ARQTARGMDY----LHA--KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQF 179
Query: 586 AAKTGSA---AMELL---ETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEY 639
+GS A E++ +++ +S+VY+FG +L+E++TG++ Y
Sbjct: 180 EQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPY-------------- 225
Query: 640 LKGEQPLKDIVD--------PTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLK 691
I++ P L + N + + ++ C+ +RPS I A+++
Sbjct: 226 -SNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIE 284
Query: 692 EI 693
E+
Sbjct: 285 EL 286
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 143 bits (361), Expect = 8e-38
Identities = 74/342 (21%), Positives = 126/342 (36%), Gaps = 78/342 (22%)
Query: 419 SELEAACEDFS--NIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFR 476
SE ++ +IG G G VYKG+L +AV S +R ++
Sbjct: 6 SEPSLDLDNLKLLELIGR---GRYGAVYKGSLD-ERPVAVKVFSFANRQNF------INE 55
Query: 477 KKIDTLSKVNHKNFVNLIGYCEEDEPFTR---MMVFEYSPNGSLFEHLHIQEAEHLDWAM 533
K I + + H N I E R ++V EY PNGSL ++L + DW
Sbjct: 56 KNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT---SDWVS 112
Query: 534 RLRIAMGMAYCLEHMH-------QLTPPIAHRNLQSSSIYLTEDYAAKISDFSF------ 580
R+A + L ++H P I+HR+L S ++ + D ISDF
Sbjct: 113 SCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTG 172
Query: 581 --------WNNTTAAKTGSA---AMELLETS-------AVDLESNVYSFGTILFEMITGR 622
+N ++ G+ A E+LE + + + ++Y+ G I +E+ R
Sbjct: 173 NRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFM-R 231
Query: 623 ISYSIENGSLENWASEYLKGEQPLKDIV--DPTLKSFQENVLEE---------------- 664
+ S+ EY + + V PT + Q V E
Sbjct: 232 CTDLFPGESVP----EY---QMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLA 284
Query: 665 ---LLVVIKNCVHPDPKQRPSMRGIAAKLKEITAMEPDGATP 703
L I++C D + R + + ++ E+ + +
Sbjct: 285 VRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNKSV 326
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 8e-38
Identities = 50/304 (16%), Positives = 110/304 (36%), Gaps = 61/304 (20%)
Query: 417 KRSELEAACEDFSNIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFR 476
+LE +IG G G VY G E+A+ + +++ F+
Sbjct: 31 PFEQLE-----IGELIGK---GRFGQVYHGRWHG--EVAIR---LIDIERDNEDQLKAFK 77
Query: 477 KKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLR 536
+++ + H+N V +G C ++ +L+ + + LD +
Sbjct: 78 REVMAYRQTRHENVVLFMGACMSPPHL--AIITSLCKGRTLYSVVRDAK-IVLDVNKTRQ 134
Query: 537 IAM----GMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDF-----------SFW 581
IA GM Y +H I H++L+S ++ ++ I+DF
Sbjct: 135 IAQEIVKGMGY----LHA--KGILHKDLKSKNV-FYDNGKVVITDFGLFSISGVLQAGRR 187
Query: 582 NNTTAAKTGSAA-M--ELLETSAVDLESN---------VYSFGTILFEMITGRISYSIEN 629
+ + G + E++ + D E + V++ GTI +E+ +
Sbjct: 188 EDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFK--- 244
Query: 630 GSLENWASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAK 689
+ A + G ++ Q + +E+ ++ C + ++RP+ +
Sbjct: 245 -TQPAEAIIWQMGTGMKPNLS-------QIGMGKEISDILLFCWAFEQEERPTFTKLMDM 296
Query: 690 LKEI 693
L+++
Sbjct: 297 LEKL 300
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 9e-38
Identities = 63/308 (20%), Positives = 112/308 (36%), Gaps = 53/308 (17%)
Query: 428 FSNIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNH 487
IG G G V+ G G ++AV A W +I + H
Sbjct: 41 MVKQIGK---GRYGEVWMGKWR-GEKVAVKVFFTTEEASW------FRETEIYQTVLMRH 90
Query: 488 KNFVNLIGYCEEDEPFTR--MMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCL 545
+N + I + ++ +Y NGSL+++L LD L++A L
Sbjct: 91 ENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT---LDAKSMLKLAYSSVSGL 147
Query: 546 EHMH------QLTPPIAHRNLQSSSIYLTEDYAAKISDF-------SFWNNTTAAKTGSA 592
H+H Q P IAHR+L+S +I + ++ I+D S N
Sbjct: 148 CHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRV 207
Query: 593 ------AMELLETSA--VDLESN----VYSFGTILFEMITGRISYSIENGSLENWASEYL 640
E+L+ S +S +YSFG IL+E+ +S I + L
Sbjct: 208 GTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPY--HDL 265
Query: 641 KGEQP-LKDIVD--------PTL--KSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAK 689
P +D+ + P+ + + L ++ ++ C +P R + +
Sbjct: 266 VPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325
Query: 690 LKEITAME 697
L +++ +
Sbjct: 326 LAKMSESQ 333
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 1e-36
Identities = 62/304 (20%), Positives = 116/304 (38%), Gaps = 53/304 (17%)
Query: 428 FSNIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNH 487
+G G G V++G+ G +AV S + W ++ + H
Sbjct: 12 LLECVGK---GRYGEVWRGSWQ-GENVAVKIFSSRDEKSW------FRETELYNTVMLRH 61
Query: 488 KNFVNLIGYC--EEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCL 545
+N + I ++ Y GSL+++L + LD LRI + +A L
Sbjct: 62 ENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT---LDTVSCLRIVLSIASGL 118
Query: 546 EHMH------QLTPPIAHRNLQSSSIYLTEDYAAKISDF----------SFWNNTTAAKT 589
H+H Q P IAHR+L+S +I + ++ I+D + + +
Sbjct: 119 AHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV 178
Query: 590 GSA---AMELLE--TSAVDLESN----VYSFGTILFEMITGRISYSIENGSLENWASEYL 640
G+ A E+L+ +S +++FG +L+E+ +S I + +
Sbjct: 179 GTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPF--YDV 236
Query: 641 KGEQP-LKDIVD--------PTLKS--FQENVLEELLVVIKNCVHPDPKQRPSMRGIAAK 689
P +D+ P + + F + L L ++K C + +P R + I
Sbjct: 237 VPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKT 296
Query: 690 LKEI 693
L +I
Sbjct: 297 LTKI 300
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 6e-36
Identities = 62/321 (19%), Positives = 110/321 (34%), Gaps = 61/321 (19%)
Query: 416 LKRSELEAACEDFSNIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQ 474
+ S+L ++G G G K T +G + + K + + +
Sbjct: 7 FRPSDLI-----HGEVLGK---GCFGQAIKVTHRETGEVMVM-----KELIRFDEETQRT 53
Query: 475 FRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMR 534
F K++ + + H N + IG +D+ + EY G+L + + W+ R
Sbjct: 54 FLKEVKVMRCLEHPNVLKFIGVLYKDKRL--NFITEYIKGGTLRGIIKSMD-SQYPWSQR 110
Query: 535 LR----IAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDF------------ 578
+ IA GMAY L M+ I HR+L S + + E+ ++DF
Sbjct: 111 VSFAKDIASGMAY-LHSMN-----IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ 164
Query: 579 --------SFWNNTTAAKTGSA---AMELLETSAVDLESNVYSFGTILFEMITGRISYSI 627
G+ A E++ + D + +V+SFG +L E+I +
Sbjct: 165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPD 224
Query: 628 ENGSLENWASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIA 687
++ P N + C DP++RPS +
Sbjct: 225 YLPRTMDFGLNVRGFLDRYC----P------PNCPPSFFPITVRCCDLDPEKRPSFVKLE 274
Query: 688 AKLKEITAMEPDGATPKLSPL 708
L+ + M G P L
Sbjct: 275 HWLETL-RMHLAGHLPLGPQL 294
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 6e-35
Identities = 65/317 (20%), Positives = 119/317 (37%), Gaps = 71/317 (22%)
Query: 428 FSNIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNH 487
IG G G V++G G E+AV S + W +I + H
Sbjct: 46 LQESIGK---GRFGEVWRGKWR-GEEVAVKIFSSREERSW------FREAEIYQTVMLRH 95
Query: 488 KNFVNLIGYCEEDEPFTR--MMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCL 545
+N + I +D +V +Y +GSLF++L+ + +++A+ A L
Sbjct: 96 ENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN---RYTVTVEGMIKLALSTASGL 152
Query: 546 EHMH------QLTPPIAHRNLQSSSIYLTEDYAAKISDF-------SFWNNTTAAKTGSA 592
H+H Q P IAHR+L+S +I + ++ I+D S + A
Sbjct: 153 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV 212
Query: 593 ------AMELLETSAV--DLESN----VYSFGTILFEMITGRISYSIENGSLENWASEYL 640
A E+L+ S ES +Y+ G + +E+ I +Y
Sbjct: 213 GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI--------HEDY- 263
Query: 641 KGEQPLKDIV--DPTLKSFQENV------------------LEELLVVIKNCVHPDPKQR 680
+ P D+V DP+++ ++ V L + +++ C + + R
Sbjct: 264 --QLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAAR 321
Query: 681 PSMRGIAAKLKEITAME 697
+ I L +++ E
Sbjct: 322 LTALRIKKTLSQLSQQE 338
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 5e-28
Identities = 40/151 (26%), Positives = 63/151 (41%), Gaps = 14/151 (9%)
Query: 65 SLARCLNSEGMALLRFRERVVRDPFGALSKWSDNDGVGDNVNPCSWFGVECSDGKVVILN 124
S ++ L E L+ F++ + D L WS N NPC++ GV C D KV ++
Sbjct: 5 SPSQSLYREIHQLISFKDVLP-DK-NLLPDWSSNK------NPCTFDGVTCRDDKVTSID 56
Query: 125 LRDLCL---GGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGP 181
L L ++ L L+ L+S+ L N+ G++ L LDL N+ SGP
Sbjct: 57 LSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLSRNSLSGP 115
Query: 182 FPSD--FGNSFSLTTLLLDNNQYLGGISPEL 210
+ G+ L L + +N
Sbjct: 116 VTTLTSLGSCSGLKFLNVSSNTLDFPGKVSG 146
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 3e-18
Identities = 33/100 (33%), Positives = 44/100 (44%), Gaps = 5/100 (5%)
Query: 116 SDGKVVILNLRDLCLG-----GMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEI 170
+ + L++L L G + P L SEL S+ L N GTIP +G L +L
Sbjct: 387 NLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRD 446
Query: 171 LDLGFNNFSGPFPSDFGNSFSLTTLLLDNNQYLGGISPEL 210
L L N G P + +L TL+LD N G I L
Sbjct: 447 LKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGL 486
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 4e-18
Identities = 33/93 (35%), Positives = 48/93 (51%)
Query: 122 ILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGP 181
L+L L G + LG LS+L+ + L N G IP+E+ +K LE L L FN+ +G
Sbjct: 422 SLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGE 481
Query: 182 FPSDFGNSFSLTTLLLDNNQYLGGISPELHVLK 214
PS N +L + L NN+ G I + L+
Sbjct: 482 IPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLE 514
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 7e-18
Identities = 28/93 (30%), Positives = 39/93 (41%)
Query: 122 ILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGP 181
L L L G + EL + L+++IL N G IP + L + L N +G
Sbjct: 446 DLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGE 505
Query: 182 FPSDFGNSFSLTTLLLDNNQYLGGISPELHVLK 214
P G +L L L NN + G I EL +
Sbjct: 506 IPKWIGRLENLAILKLSNNSFSGNIPAELGDCR 538
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 2e-16
Identities = 28/106 (26%), Positives = 45/106 (42%), Gaps = 4/106 (3%)
Query: 121 VILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSG 180
++L + L G + +G+L L + L NNSF G IP E+G+ + L LDL N F+G
Sbjct: 493 NWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNG 552
Query: 181 PFPSDFGNSFSLTTLLLDNNQYLGGISPELHVLKVISEIQVDESWL 226
P+ + + N G + + E + L
Sbjct: 553 TIPAAMFKQ----SGKIAANFIAGKRYVYIKNDGMKKECHGAGNLL 594
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 3e-16
Identities = 29/91 (31%), Positives = 38/91 (41%), Gaps = 2/91 (2%)
Query: 122 ILNLRDLCLGGMLAPEL-GQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSG 180
L+L + G + L G L + L N F+G +P G LE L L NNFSG
Sbjct: 273 YLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSG 332
Query: 181 PFPSD-FGNSFSLTTLLLDNNQYLGGISPEL 210
P D L L L N++ G + L
Sbjct: 333 ELPMDTLLKMRGLKVLDLSFNEFSGELPESL 363
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 5e-16
Identities = 32/81 (39%), Positives = 42/81 (51%)
Query: 130 LGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNS 189
L G + L + L I L NN G IPK IG L+ L IL L N+FSG P++ G+
Sbjct: 478 LTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDC 537
Query: 190 FSLTTLLLDNNQYLGGISPEL 210
SL L L+ N + G I +
Sbjct: 538 RSLIWLDLNTNLFNGTIPAAM 558
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 5e-16
Identities = 36/94 (38%), Positives = 51/94 (54%), Gaps = 7/94 (7%)
Query: 124 NLRDLCLG-----GMLAPELGQLSELKSIILRNNSFFGTIPKE-IGELKELEILDLGFNN 177
L L L G + P G S L+S+ L +N+F G +P + + +++ L++LDL FN
Sbjct: 295 TLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNE 354
Query: 178 FSGPFPSDFGN-SFSLTTLLLDNNQYLGGISPEL 210
FSG P N S SL TL L +N + G I P L
Sbjct: 355 FSGELPESLTNLSASLLTLDLSSNNFSGPILPNL 388
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 1e-15
Identities = 25/90 (27%), Positives = 38/90 (42%), Gaps = 3/90 (3%)
Query: 121 VILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSG 180
L++ + P LG S L+ + + N G + I EL++L++ N F G
Sbjct: 203 EFLDVSSNNFSTGI-PFLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVG 261
Query: 181 PFPSDFGNSFSLTTLLLDNNQYLGGISPEL 210
P P SL L L N++ G I L
Sbjct: 262 PIPP--LPLKSLQYLSLAENKFTGEIPDFL 289
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 1e-14
Identities = 28/92 (30%), Positives = 41/92 (44%)
Query: 119 KVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNF 178
N+ GG +P + + + N G IPKEIG + L IL+LG N+
Sbjct: 609 TRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDI 668
Query: 179 SGPFPSDFGNSFSLTTLLLDNNQYLGGISPEL 210
SG P + G+ L L L +N+ G I +
Sbjct: 669 SGSIPDEVGDLRGLNILDLSSNKLDGRIPQAM 700
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 1e-14
Identities = 32/93 (34%), Positives = 43/93 (46%), Gaps = 4/93 (4%)
Query: 122 ILNLRDLCLGGMLAPE-LGQLSELKSIILRNNSFFGTIPKEIGELK-ELEILDLGFNNFS 179
L L G L + L ++ LK + L N F G +P+ + L L LDL NNFS
Sbjct: 322 SLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFS 381
Query: 180 GPFPSDFGNSF--SLTTLLLDNNQYLGGISPEL 210
GP + + +L L L NN + G I P L
Sbjct: 382 GPILPNLCQNPKNTLQELYLQNNGFTGKIPPTL 414
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 3e-14
Identities = 28/91 (30%), Positives = 41/91 (45%), Gaps = 3/91 (3%)
Query: 121 VILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSG 180
L++ L G + + +ELK + + +N F G IP LK L+ L L N F+G
Sbjct: 226 QHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLP--LKSLQYLSLAENKFTG 283
Query: 181 PFPSD-FGNSFSLTTLLLDNNQYLGGISPEL 210
P G +LT L L N + G + P
Sbjct: 284 EIPDFLSGACDTLTGLDLSGNHFYGAVPPFF 314
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 5e-14
Identities = 21/96 (21%), Positives = 35/96 (36%)
Query: 115 CSDGKVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLG 174
K L G+ + +L +LS + + + G + LD+
Sbjct: 581 DGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMS 640
Query: 175 FNNFSGPFPSDFGNSFSLTTLLLDNNQYLGGISPEL 210
+N SG P + G+ L L L +N G I E+
Sbjct: 641 YNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEV 676
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 9e-14
Identities = 23/99 (23%), Positives = 37/99 (37%), Gaps = 6/99 (6%)
Query: 119 KVVILNLRDLCLGGMLAPEL---GQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGF 175
+ +L+L + G ELK + + N G + + LE LD+
Sbjct: 152 SLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSS 209
Query: 176 NNFSGPFPSDFGNSFSLTTLLLDNNQYLGGISPELHVLK 214
NNFS P G+ +L L + N+ G S +
Sbjct: 210 NNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCT 247
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 4e-13
Identities = 26/71 (36%), Positives = 35/71 (49%)
Query: 136 PELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTL 195
E+G + L + L +N G+IP E+G+L+ L ILDL N G P LT +
Sbjct: 650 KEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEI 709
Query: 196 LLDNNQYLGGI 206
L NN G I
Sbjct: 710 DLSNNNLSGPI 720
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 56.8 bits (138), Expect = 2e-08
Identities = 14/101 (13%), Positives = 26/101 (25%), Gaps = 6/101 (5%)
Query: 121 VILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFN--NF 178
+ L+L G + + + S + N G I + N F
Sbjct: 541 IWLDLNTNLFNGTIPAAMFKQSGK----IAANFIAGKRYVYIKNDGMKKECHGAGNLLEF 596
Query: 179 SGPFPSDFGNSFSLTTLLLDNNQYLGGISPELHVLKVISEI 219
G + + + Y G SP + +
Sbjct: 597 QGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFL 637
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 51.8 bits (125), Expect = 6e-07
Identities = 23/69 (33%), Positives = 29/69 (42%), Gaps = 3/69 (4%)
Query: 136 PELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFS-LTT 194
E+G L L + L +N G IP+ + L L +DL NN SGP P F
Sbjct: 674 DEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPE--MGQFETFPP 731
Query: 195 LLLDNNQYL 203
NN L
Sbjct: 732 AKFLNNPGL 740
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 6e-27
Identities = 67/286 (23%), Positives = 111/286 (38%), Gaps = 58/286 (20%)
Query: 428 FSNIIGSFSDGTVGTVYKGT-LSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVN 486
F IG G+ TVYKG + VE+A + +K+ +F+++ + L +
Sbjct: 30 FDIEIGR---GSFKTVYKGLDTETTVEVAWCELQDR---KLTKSERQRFKEEAEMLKGLQ 83
Query: 487 HKNFVNLIGYCEEDEPFTRMMVF--EYSPNGSLFEHL----HIQEAEHLDWAMRLRIAMG 540
H N V E + +V E +G+L +L ++ W +I G
Sbjct: 84 HPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWC--RQILKG 141
Query: 541 MAYCLEHMHQLTPPIAHRNLQSSSIYLT-EDYAAKISDF--SFWNNTTAAKT--GSA--- 592
+ + +H TPPI HR+L+ +I++T + KI D + + AK G+
Sbjct: 142 LQF----LHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFM 197
Query: 593 AMELLE---TSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGE-----Q 644
A E+ E +VD VY+FG + EM T YS +N A Y +
Sbjct: 198 APEMYEEKYDESVD----VYAFGMCMLEMATSEYPYS----ECQNAAQIYRRVTSGVKPA 249
Query: 645 PLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKL 690
+ P +K I+ C+ + +R S L
Sbjct: 250 SFDKVAIPEVKEI-----------IEGCIRQNKDERYS----IKDL 280
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 67/302 (22%), Positives = 118/302 (39%), Gaps = 43/302 (14%)
Query: 416 LKRSELEAACEDFSNIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKS-RADWSKNLESQ 474
++ L+ +G G G V + +VKS + + N +
Sbjct: 18 FEKRFLK-----RIRDLGE---GHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIAD 69
Query: 475 FRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHL-----HIQEAEHL 529
+K+I+ L + H+N V G C ED ++ E+ P+GSL E+L I + L
Sbjct: 70 LKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQL 129
Query: 530 DWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDF------SFWNN 583
+A ++I GM Y L HR+L + ++ + ++ KI DF
Sbjct: 130 KYA--VQICKGMDY-LGSRQ-----YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKE 181
Query: 584 TTAAKTGSA------AMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWA 636
K A E L S + S+V+SFG L E++T S L+
Sbjct: 182 YYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIG 241
Query: 637 SEYLKGEQPLKDIVDPTLKSFQ-----ENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLK 691
+ G+ + +V+ TLK + N +E+ +++ C P R S + + +
Sbjct: 242 PTH--GQMTVTRLVN-TLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFE 298
Query: 692 EI 693
+
Sbjct: 299 AL 300
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 35/174 (20%), Positives = 60/174 (34%), Gaps = 37/174 (21%)
Query: 68 RCLNSEGMALLRFRERVVRDPFGALSKWSDNDGVGDNVNPCSWFGVECSD----GKVVIL 123
C + ALL+ ++ + LS W + +W GV C +V L
Sbjct: 2 LCNPQDKQALLQIKKDLGNPT--TLSSWLPTT----DCCNRTWLGVLCDTDTQTYRVNNL 55
Query: 124 NLRDLCLGGMLA---------------------------PELGQLSELKSIILRNNSFFG 156
+L L L P + +L++L + + + + G
Sbjct: 56 DLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSG 115
Query: 157 TIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLLDNNQYLGGISPEL 210
IP + ++K L LD +N SG P + +L + D N+ G I
Sbjct: 116 AIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSY 169
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 74.5 bits (184), Expect = 1e-14
Identities = 24/71 (33%), Positives = 35/71 (49%), Gaps = 1/71 (1%)
Query: 136 PELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTL 195
++G L + LRNN +GT+P+ + +LK L L++ FNN G P GN
Sbjct: 238 GKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVS 296
Query: 196 LLDNNQYLGGI 206
NN+ L G
Sbjct: 297 AYANNKCLCGS 307
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 73.7 bits (182), Expect = 2e-14
Identities = 21/91 (23%), Positives = 33/91 (36%), Gaps = 2/91 (2%)
Query: 120 VVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFS 179
+ + L G + P L+ L + L N G G K + + L N+ +
Sbjct: 176 FTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLA 234
Query: 180 GPFPSDFGNSFSLTTLLLDNNQYLGGISPEL 210
G S +L L L NN+ G + L
Sbjct: 235 FDLGK-VGLSKNLNGLDLRNNRIYGTLPQGL 264
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 7e-25
Identities = 70/300 (23%), Positives = 119/300 (39%), Gaps = 41/300 (13%)
Query: 416 LKRSELEAACEDFSNIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKS-RADWSKNLESQ 474
+ L+ +G G G V + +VK+ +AD S
Sbjct: 28 FHKRYLK-----KIRDLGE---GHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSG 79
Query: 475 FRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHL---HIQEAEHLDW 531
++++ID L + H++ + G CE+ + +V EY P GSL ++L I A+ L +
Sbjct: 80 WKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLF 139
Query: 532 AMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDF------SFWNNTT 585
A +I GMAY L H HR+L + ++ L D KI DF +
Sbjct: 140 A--QQICEGMAY-LHAQH-----YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYY 191
Query: 586 AAKTGSA------AMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASE 638
+ A E L+ S+V+SFG L+E++T S S LE
Sbjct: 192 RVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIA 251
Query: 639 YLKGEQPLKDIVDPTLKSFQ-----ENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEI 693
G+ + + + L+ + + E+ ++KNC + RP+ + LK +
Sbjct: 252 Q--GQMTVLRLTE-LLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTV 308
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 7e-25
Identities = 81/326 (24%), Positives = 120/326 (36%), Gaps = 68/326 (20%)
Query: 400 GLSGQLQKAFVTGVPK----LKRSELEAACEDFSNIIGSFSDGTVGTVYKGTL-SSGVEI 454
L+ + VPK L +L IG G G V+ G L + +
Sbjct: 91 PLTKKSGVVLHRAVPKDKWVLNHEDLV-----LGEQIGR---GNFGEVFSGRLRADNTLV 142
Query: 455 AVTSTSVKS-RADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSP 513
AV KS R +L+++F ++ L + +H N V LIG C + +P +V E
Sbjct: 143 AV-----KSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPI--YIVMELVQ 195
Query: 514 NGSLFEHLHIQEAEHLDWAMRLR----IAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTE 569
G L E L L+ A GM Y LE HR+L + + +TE
Sbjct: 196 GGDFLTFLR-TEGARLRVKTLLQMVGDAAAGMEY-LESKC-----CIHRDLAARNCLVTE 248
Query: 570 DYAAKISDF----SFWNNTTAAKTGSA-------AMELLETSAVDLESNVYSFGTILFEM 618
KISDF + AA G A E L ES+V+SFG +L+E
Sbjct: 249 KNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWET 308
Query: 619 IT-GRISYSIENGSLENWASEYLKGEQPLKDIVD------PTLKSFQENVLEELLVVIKN 671
+ G Y L +Q + + P E + + +++
Sbjct: 309 FSLGASPY------------PNLSNQQTREFVEKGGRLPCP------ELCPDAVFRLMEQ 350
Query: 672 CVHPDPKQRPSMRGIAAKLKEITAME 697
C +P QRPS I +L+ I
Sbjct: 351 CWAYEPGQRPSFSTIYQELQSIRKRH 376
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 7e-25
Identities = 64/308 (20%), Positives = 114/308 (37%), Gaps = 73/308 (23%)
Query: 416 LKRSELEAACEDFSNIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKS-RADWSKNLESQ 474
LK +E + ++GS G GTVYKG E ++K R S +
Sbjct: 12 LKETEFK-----KIKVLGS---GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE 63
Query: 475 FRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHL-----HIQEAEHL 529
+ ++ V++ + L+G C ++ + P G L +++ +I L
Sbjct: 64 ILDEAYVMASVDNPHVCRLLGICLTSTV---QLITQLMPFGCLLDYVREHKDNIGSQYLL 120
Query: 530 DWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDF----SFWNNTT 585
+W ++IA GM Y LE + HR+L + ++ + KI+DF
Sbjct: 121 NWC--VQIAKGMNY-LEDRR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 172
Query: 586 AAKTGSA-------AMELLE----TSAVDLESNVYSFGTILFEMIT-GRISY-SIEN--- 629
A+E + T S+V+S+G ++E++T G Y I
Sbjct: 173 EYHAEGGKVPIKWMALESILHRIYTHQ----SDVWSYGVTVWELMTFGSKPYDGIPASEI 228
Query: 630 -GSLENWASEYLKGE---QPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRG 685
LE KGE QP ++ ++++ C D RP R
Sbjct: 229 SSILE-------KGERLPQP-------------PICTIDVYMIMRKCWMIDADSRPKFRE 268
Query: 686 IAAKLKEI 693
+ + ++
Sbjct: 269 LIIEFSKM 276
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 1e-24
Identities = 65/295 (22%), Positives = 127/295 (43%), Gaps = 52/295 (17%)
Query: 416 LKRSELEAACEDFSNIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKS-RADWSKNLESQ 474
++R+++ + +G G G VY+G + V +VK+ + D + +
Sbjct: 217 MERTDIT-----MKHKLGG---GQYGEVYEGVWK-KYSLTV---AVKTLKEDTME--VEE 262
Query: 475 FRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWA-- 532
F K+ + ++ H N V L+G C + PF ++ E+ G+L ++L + +
Sbjct: 263 FLKEAAVMKEIKHPNLVQLLGVCTREPPF--YIITEFMTYGNLLDYLRECNRQEVSAVVL 320
Query: 533 --MRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDF----SFWNNTTA 586
M +I+ M Y LE + HRNL + + + E++ K++DF +T
Sbjct: 321 LYMATQISSAMEY-LEKKN-----FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYT 374
Query: 587 AKTGS------AAMELLETSAVDLESNVYSFGTILFEMIT-GRISY-SIENGSLENWASE 638
A G+ A E L + ++S+V++FG +L+E+ T G Y I+ + +
Sbjct: 375 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK 434
Query: 639 YLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEI 693
+ E+P E E++ +++ C +P RPS I + +
Sbjct: 435 DYRMERP-------------EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 476
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 60/301 (19%), Positives = 111/301 (36%), Gaps = 42/301 (13%)
Query: 416 LKRSELEAACEDFSNIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQF 475
+ L+ + + +G G G+V + +VK + + F
Sbjct: 20 FEERHLK-----YISQLGK---GNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDF 71
Query: 476 RKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHL-----HIQEAEHLD 530
+++I L ++ V G + +V EY P+G L + L + + L
Sbjct: 72 QREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLL 131
Query: 531 WAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDF------SFWNNT 584
++ +I GM Y L HR+L + +I + + KI+DF +
Sbjct: 132 YS--SQICKGMEY-LGSRR-----CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDY 183
Query: 585 TAAKTGSA------AMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWAS 637
+ A E L + +S+V+SFG +L+E+ T S S L
Sbjct: 184 YVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGC 243
Query: 638 EYLKGEQPLKDIVDPTLKSFQ-----ENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKE 692
E + L +++ L+ Q E+ ++K C P P+ RPS + +L
Sbjct: 244 E--RDVPALSRLLE-LLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDM 300
Query: 693 I 693
+
Sbjct: 301 L 301
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-23
Identities = 69/294 (23%), Positives = 123/294 (41%), Gaps = 47/294 (15%)
Query: 420 ELEAACEDFSNIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKI 479
E+ +G G G V+ GT + +A+ K+ + + E F ++
Sbjct: 180 EIPRESLRLEVKLGQ---GCFGEVWMGTWNGTTRVAI-----KTLKPGTMSPE-AFLQEA 230
Query: 480 DTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWA----MRL 535
+ K+ H+ V L E EP +V EY GSL + L + ++L M
Sbjct: 231 QVMKKLRHEKLVQLYAVVSE-EPI--YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAA 287
Query: 536 RIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDF----SFWNNTTAAKTGS 591
+IA GMAY +E M+ HR+L++++I + E+ K++DF +N A+ G+
Sbjct: 288 QIASGMAY-VERMN-----YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA 341
Query: 592 ------AAMELLETSAVDLESNVYSFGTILFEMIT-GRISY-SIENGSLENWASEYLKGE 643
A E ++S+V+SFG +L E+ T GR+ Y + N + + +
Sbjct: 342 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP 401
Query: 644 QPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAME 697
P E L ++ C +P++RP+ + A L++
Sbjct: 402 CP-------------PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 442
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 9e-23
Identities = 65/310 (20%), Positives = 117/310 (37%), Gaps = 65/310 (20%)
Query: 416 LKRSELEAACEDFSNIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKS-RADWSKNLESQ 474
K +EL ++GS G GTV+KG E +K +
Sbjct: 10 FKETELR-----KLKVLGS---GVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQA 61
Query: 475 FRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHL-----HIQEAEHL 529
+ + ++H + V L+G C +V +Y P GSL +H+ + L
Sbjct: 62 VTDHMLAIGSLDHAHIVRLLGLCPGSSL---QLVTQYLPLGSLLDHVRQHRGALGPQLLL 118
Query: 530 DWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSF-----WNNT 584
+W ++IA GM Y LE + HRNL + ++ L +++DF ++
Sbjct: 119 NWG--VQIAKGMYY-LEEHG-----MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDK 170
Query: 585 TAAKTGS------AAMELLETSAVDLESNVYSFGTILFEMIT-GRISY-SIEN----GSL 632
+ + A+E + +S+V+S+G ++E++T G Y + L
Sbjct: 171 QLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLL 230
Query: 633 ENWASEYLKGE---QPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAK 689
E KGE QP + ++ +V+ C D RP+ + +A +
Sbjct: 231 E-------KGERLAQP-------------QICTIDVYMVMVKCWMIDENIRPTFKELANE 270
Query: 690 LKEITAMEPD 699
+ P
Sbjct: 271 FTRMARDPPR 280
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-22
Identities = 74/334 (22%), Positives = 124/334 (37%), Gaps = 71/334 (21%)
Query: 385 VCRSSKVVTVKPWVTGLSGQLQKAFVTGVPKLKRSELEAACEDFSNIIGSFSDGTVGTVY 444
R K ++ V + + L EL+ IG G G V
Sbjct: 164 CTRLIKPKVMEGTVAAQDEFYRSGWA-----LNMKELK-----LLQTIGK---GEFGDVM 210
Query: 445 KGTLSSGVEIAVTSTSVKSRADWSKNL-----ESQFRKKIDTLSKVNHKNFVNLIGYCEE 499
G G ++AV K + F + ++++ H N V L+G E
Sbjct: 211 LGDYR-GNKVAV------------KCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 257
Query: 500 DEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWA----MRLRIAMGMAYCLEHMHQLTPPI 555
++ +V EY GSL ++L + L L + M Y LE +
Sbjct: 258 EKGGL-YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY-LEGNN-----F 310
Query: 556 AHRNLQSSSIYLTEDYAAKISDFSFWNNTTAAKTGS------AAMELLETSAVDLESNVY 609
HR+L + ++ ++ED AK+SDF ++ + A E L +S+V+
Sbjct: 311 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVW 370
Query: 610 SFGTILFEMIT-GRISY-SIENGSLENWASEYL-KG---EQPLKDIVDPTLKSFQENVLE 663
SFG +L+E+ + GR+ Y I + + KG + P +
Sbjct: 371 SFGILLWEIYSFGRVPYPRIPLKDV----VPRVEKGYKMDAP-------------DGCPP 413
Query: 664 ELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAME 697
+ V+KNC H D RP+ + +L+ I E
Sbjct: 414 AVYDVMKNCWHLDAATRPTFLQLREQLEHIRTHE 447
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 2e-22
Identities = 64/317 (20%), Positives = 123/317 (38%), Gaps = 81/317 (25%)
Query: 416 LKRSELEAACEDFSNIIGSFSDGTVGTVYKGTL--SSGVEIAVTSTSVKS-RADWSKNLE 472
+ R ++ + I+G G G VY+G G +I V +VK+ + D + + +
Sbjct: 9 IAREDVV-----LNRILGE---GFFGEVYEGVYTNHKGEKINV---AVKTCKKDCTLDNK 57
Query: 473 SQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHL-----HIQEAE 527
+F + + ++H + V LIG EE EP ++ E P G L +L ++
Sbjct: 58 EKFMSEAVIMKNLDHPHIVKLIGIIEE-EPT--WIIMELYPYGELGHYLERNKNSLKVLT 114
Query: 528 HLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDF----SFWNN 583
+ ++ L+I MAY LE ++ HR++ +I + K+ DF +
Sbjct: 115 LVLYS--LQICKAMAY-LESIN-----CVHRDIAVRNILVASPECVKLGDFGLSRYIEDE 166
Query: 584 TTAAKTGS------AAMELLE----TSAVDLESNVYSFGTILFEMIT-GRISY------- 625
+ + + E + T+A S+V+ F ++E+++ G+ +
Sbjct: 167 DYYKASVTRLPIKWMSPESINFRRFTTA----SDVWMFAVCMWEILSFGKQPFFWLENKD 222
Query: 626 ---SIENGSLENWASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPS 682
+E G + L +P + L ++ C DP RP
Sbjct: 223 VIGVLEKG-------DRL--PKP-------------DLCPPVLYTLMTRCWDYDPSDRPR 260
Query: 683 MRGIAAKLKEITAMEPD 699
+ L ++ ME D
Sbjct: 261 FTELVCSLSDVYQMEKD 277
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-22
Identities = 74/319 (23%), Positives = 131/319 (41%), Gaps = 52/319 (16%)
Query: 400 GLSGQLQKAFVTGVPKLKRS-----ELEAACEDFSNIIGSFSDGTVGTVYKGTLSSGVEI 454
GL +L T P+ + E+ +G G G V+ GT + +
Sbjct: 238 GLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQ---GCFGEVWMGTWNGTTRV 294
Query: 455 AVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPN 514
A+ K+ + + E F ++ + K+ H+ V L E EP +V EY
Sbjct: 295 AI-----KTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVSE-EPI--YIVTEYMSK 345
Query: 515 GSLFEHLHIQEAEHLDWA----MRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTED 570
GSL + L + ++L M +IA GMAY +E M+ HR+L++++I + E+
Sbjct: 346 GSLLDFLKGETGKYLRLPQLVDMAAQIASGMAY-VERMN-----YVHRDLRAANILVGEN 399
Query: 571 YAAKISDF----SFWNNTTAAKTGS------AAMELLETSAVDLESNVYSFGTILFEMIT 620
K++DF +N A+ G+ A E ++S+V+SFG +L E+ T
Sbjct: 400 LVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 459
Query: 621 -GRISY-SIENGSLENWASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPK 678
GR+ Y + N + + + P E L ++ C +P+
Sbjct: 460 KGRVPYPGMVNREVLDQVERGYRMPCP-------------PECPESLHDLMCQCWRKEPE 506
Query: 679 QRPSMRGIAAKLKEITAME 697
+RP+ + A L++
Sbjct: 507 ERPTFEYLQAFLEDYFTST 525
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 3e-22
Identities = 66/305 (21%), Positives = 114/305 (37%), Gaps = 49/305 (16%)
Query: 416 LKRSELEAACEDFSNIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKS-RADWSKNLESQ 474
+ L+ F +G G G+V + +VK + ++L
Sbjct: 7 FEERHLK-----FLQQLGK---GNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD- 57
Query: 475 FRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHL-----HIQEAEHL 529
F ++I+ L + H N V G C ++ EY P GSL ++L I + L
Sbjct: 58 FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLL 117
Query: 530 DWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDF----SFWNNTT 585
+ +I GM Y L HR+L + +I + + KI DF +
Sbjct: 118 QYT--SQICKGMEY-LGTKR-----YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE 169
Query: 586 AAKTGSAAM--------ELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWAS 637
K E L S + S+V+SFG +L+E+ T Y ++ S
Sbjct: 170 FFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT----YIEKSKSPPAEFM 225
Query: 638 EYLKGEQPLKDIVDPTLKSFQEN--VLE-------ELLVVIKNCVHPDPKQRPSMRGIAA 688
+ G ++ L +N L E+ +++ C + + QRPS R +A
Sbjct: 226 RMI-GNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284
Query: 689 KLKEI 693
++ +I
Sbjct: 285 RVDQI 289
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 4e-22
Identities = 68/318 (21%), Positives = 127/318 (39%), Gaps = 61/318 (19%)
Query: 414 PKLKRSELEAACEDFSNIIGSFSDGTVGTVYKGTL--SSGVEIAVTSTSVKS--RADWSK 469
KL+ ++ I+G G G+V +G L G + V +VK+ + S+
Sbjct: 24 NKLEDVVIDRNLLILGKILGE---GEFGSVMEGNLKQEDGTSLKV---AVKTMKLDNSSQ 77
Query: 470 NLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTR---MMVFEYSPNGSLFEHL----H 522
+F + + +H N + L+G C E M++ + G L +L
Sbjct: 78 REIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRL 137
Query: 523 IQEAEHLDWA----MRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDF 578
+H+ + IA+GM Y L + + HR+L + + L +D ++DF
Sbjct: 138 ETGPKHIPLQTLLKFMVDIALGMEY-LSNRN-----FLHRDLAARNCMLRDDMTVCVADF 191
Query: 579 ----SFWNNTTAAKTGSA-------AMELLETSAVDLESNVYSFGTILFEMIT-GRISYS 626
++ + A A+E L +S+V++FG ++E+ T G Y
Sbjct: 192 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPY- 250
Query: 627 IENGSLENW-ASEYLKG----EQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRP 681
++N +YL +QP E+ L+EL ++ +C DP RP
Sbjct: 251 ---PGVQNHEMYDYLLHGHRLKQP-------------EDCLDELYEIMYSCWRTDPLDRP 294
Query: 682 SMRGIAAKLKEITAMEPD 699
+ + +L+++ PD
Sbjct: 295 TFSVLRLQLEKLLESLPD 312
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 4e-22
Identities = 66/305 (21%), Positives = 114/305 (37%), Gaps = 49/305 (16%)
Query: 416 LKRSELEAACEDFSNIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKS-RADWSKNLESQ 474
+ L+ F +G G G+V + +VK + ++L
Sbjct: 38 FEERHLK-----FLQQLGK---GNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD- 88
Query: 475 FRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHL-----HIQEAEHL 529
F ++I+ L + H N V G C ++ EY P GSL ++L I + L
Sbjct: 89 FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLL 148
Query: 530 DWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDF----SFWNNTT 585
+ +I GM Y L HR+L + +I + + KI DF +
Sbjct: 149 QYT--SQICKGMEY-LGTKR-----YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE 200
Query: 586 AAKTGSAAM--------ELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWAS 637
K E L S + S+V+SFG +L+E+ T Y ++ S
Sbjct: 201 YYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT----YIEKSKSPPAEFM 256
Query: 638 EYLKGEQPLKDIVDPTLKSFQEN--VLE-------ELLVVIKNCVHPDPKQRPSMRGIAA 688
+ G ++ L +N L E+ +++ C + + QRPS R +A
Sbjct: 257 RMI-GNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315
Query: 689 KLKEI 693
++ +I
Sbjct: 316 RVDQI 320
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 5e-22
Identities = 64/292 (21%), Positives = 108/292 (36%), Gaps = 61/292 (20%)
Query: 433 GSFSDGTVGTVYKGTLSSGVEIAVTST-SVKS-RADWSKNLESQFRKKIDTLSKVNHKNF 490
GSF G VY+G V+ + ++K+ S +F + + + N +
Sbjct: 36 GSF-----GMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90
Query: 491 VNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDW------------AMRLRIA 538
V L+G + +P +++ E G L +L + M IA
Sbjct: 91 VRLLGVVSQGQPT--LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 148
Query: 539 MGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSF----WNNTTAAKTGSAAM 594
GMAY L HR+L + + + ED+ KI DF + K G +
Sbjct: 149 DGMAY-LNANK-----FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL 202
Query: 595 -------ELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENW-ASEYLKG--- 642
E L+ S+V+SFG +L+E+ T Y L N ++
Sbjct: 203 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ----GLSNEQVLRFVMEGGL 258
Query: 643 -EQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEI 693
++P +N + L +++ C +PK RPS I + +KE
Sbjct: 259 LDKP-------------DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 297
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 5e-22
Identities = 64/308 (20%), Positives = 113/308 (36%), Gaps = 73/308 (23%)
Query: 416 LKRSELEAACEDFSNIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKS-RADWSKNLESQ 474
LK +E + ++GS G GTVYKG E ++K R S +
Sbjct: 12 LKETEFK-----KIKVLGS---GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE 63
Query: 475 FRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHL-----HIQEAEHL 529
+ ++ V++ + L+G C ++ + P G L +++ +I L
Sbjct: 64 ILDEAYVMASVDNPHVCRLLGICLTSTV---QLITQLMPFGCLLDYVREHKDNIGSQYLL 120
Query: 530 DWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDF----SFWNNTT 585
+W ++IA GM Y LE + HR+L + ++ + KI+DF
Sbjct: 121 NWC--VQIAKGMNY-LEDRR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 172
Query: 586 AAKTGSA-------AMELLE----TSAVDLESNVYSFGTILFEMIT-GRISY-SIEN--- 629
A+E + T S+V+S+G ++E++T G Y I
Sbjct: 173 EYHAEGGKVPIKWMALESILHRIYTHQ----SDVWSYGVTVWELMTFGSKPYDGIPASEI 228
Query: 630 -GSLENWASEYLKGE---QPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRG 685
LE KGE QP ++ +++ C D RP R
Sbjct: 229 SSILE-------KGERLPQP-------------PICTIDVYMIMVKCWMIDADSRPKFRE 268
Query: 686 IAAKLKEI 693
+ + ++
Sbjct: 269 LIIEFSKM 276
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 5e-22
Identities = 66/322 (20%), Positives = 118/322 (36%), Gaps = 69/322 (21%)
Query: 413 VPKLKRSELEAACEDFSNIIGSFSDGTVGTVYKGTLSSGVEIAVTST-SVKSRADWSKNL 471
V +KR ++ +G G G V+ + +VK+ D +
Sbjct: 9 VQHIKRRDIV-----LKRELGE---GAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAA 60
Query: 472 ESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDW 531
F+++ + L+ + H++ V G C + +P +MVFEY +G L + L + +
Sbjct: 61 RKDFQREAELLTNLQHEHIVKFYGVCGDGDPL--IMVFEYMKHGDLNKFLRAHGPDAMIL 118
Query: 532 A------------------MRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAA 573
+ +IA GM Y L H HR+L + + + +
Sbjct: 119 VDGQPRQAKGELGLSQMLHIASQIASGMVY-LASQH-----FVHRDLATRNCLVGANLLV 172
Query: 574 KISDF----SFWNNTTAAKTGSAAM-------ELLETSAVDLESNVYSFGTILFEMIT-G 621
KI DF ++ G + E + ES+V+SFG IL+E+ T G
Sbjct: 173 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYG 232
Query: 622 RISYSIENGSLENW-ASEYLKG----EQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPD 676
+ + L N E + E+P +E+ V+ C +
Sbjct: 233 KQPWF----QLSNTEVIECITQGRVLERP-------------RVCPKEVYDVMLGCWQRE 275
Query: 677 PKQRPSMRGIAAKLKEITAMEP 698
P+QR +++ I L + P
Sbjct: 276 PQQRLNIKEIYKILHALGKATP 297
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 6e-22
Identities = 67/325 (20%), Positives = 128/325 (39%), Gaps = 65/325 (20%)
Query: 400 GLSGQLQKAFVTGVPKLKRSELEAACEDFSNIIGSFSDGTVGTVYKGTL--SSGVEIAVT 457
G+S +L+ KL+ + ++G G G+V + L G + V
Sbjct: 6 GISDELK-------EKLEDVLIPEQQFTLGRMLGK---GEFGSVREAQLKQEDGSFVKVA 55
Query: 458 STSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTR----MMVFEYSP 513
+K+ + + +F ++ + + +H + L+G R M++ +
Sbjct: 56 VKMLKADII-ASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMK 114
Query: 514 NGSLFEHL----HIQEAEHLDWA----MRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSI 565
+G L L + +L + IA GM Y L + HR+L + +
Sbjct: 115 HGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEY-LSSRN-----FIHRDLAARNC 168
Query: 566 YLTEDYAAKISDF----SFWNNTTAAKTGSA-------AMELLETSAVDLESNVYSFGTI 614
L ED ++DF ++ + ++ A+E L + + S+V++FG
Sbjct: 169 MLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVT 228
Query: 615 LFEMIT-GRISYSIENGSLENW-ASEYLKG----EQPLKDIVDPTLKSFQENVLEELLVV 668
++E++T G+ Y+ +EN YL G +QP +EE+ +
Sbjct: 229 MWEIMTRGQTPYA----GIENAEIYNYLIGGNRLKQP-------------PECMEEVYDL 271
Query: 669 IKNCVHPDPKQRPSMRGIAAKLKEI 693
+ C DPKQRPS + +L+ I
Sbjct: 272 MYQCWSADPKQRPSFTCLRMELENI 296
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 2e-21
Identities = 72/294 (24%), Positives = 118/294 (40%), Gaps = 48/294 (16%)
Query: 416 LKRSELEAACEDFSNIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQF 475
L EL+ IG G G V G G ++AV +K+ A F
Sbjct: 18 LNMKELK-----LLQTIGK---GEFGDVMLGDYR-GNKVAVKC--IKNDAT-----AQAF 61
Query: 476 RKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWA--- 532
+ ++++ H N V L+G E++ +V EY GSL ++L + L
Sbjct: 62 LAEASVMTQLRHSNLVQLLGVIVEEKGGL-YIVTEYMAKGSLVDYLRSRGRSVLGGDCLL 120
Query: 533 -MRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTAAKTGS 591
L + M Y LE + HR+L + ++ ++ED AK+SDF ++ +
Sbjct: 121 KFSLDVCEAMEY-LEGNN-----FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG 174
Query: 592 ------AAMELLETSAVDLESNVYSFGTILFEMIT-GRISY-SIENGSLENWASEYLKGE 643
A E L +S+V+SFG +L+E+ + GR+ Y I + + K +
Sbjct: 175 KLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMD 234
Query: 644 QPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAME 697
P + + V+KNC H D RPS + +L+ I E
Sbjct: 235 AP-------------DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 275
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 2e-21
Identities = 70/297 (23%), Positives = 124/297 (41%), Gaps = 48/297 (16%)
Query: 420 ELEAACEDFSNIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKI 479
E+ +G+ G G V+ T + ++AV K+ S ++E F +
Sbjct: 184 EIPRESLKLEKKLGA---GQFGEVWMATYNKHTKVAV-----KTMKPGSMSVE-AFLAEA 234
Query: 480 DTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWA----MRL 535
+ + + H V L + EP ++ E+ GSL + L E
Sbjct: 235 NVMKTLQHDKLVKLHAVVTK-EPI--YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSA 291
Query: 536 RIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDF----SFWNNTTAAKTGS 591
+IA GMA+ +E + HR+L++++I ++ KI+DF +N A+ G+
Sbjct: 292 QIAEGMAF-IEQRN-----YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGA 345
Query: 592 ------AAMELLETSAVDLESNVYSFGTILFEMIT-GRISYS-IENGSLENWASEYLKGE 643
A E + + ++S+V+SFG +L E++T GRI Y + N + +
Sbjct: 346 KFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMP 405
Query: 644 QPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEI-TAMEPD 699
+P EN EEL ++ C P++RP+ I + L + TA E
Sbjct: 406 RP-------------ENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATESQ 449
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 2e-21
Identities = 61/291 (20%), Positives = 111/291 (38%), Gaps = 55/291 (18%)
Query: 428 FSNIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKS-RADWSKNLESQFRKKIDTLSKVN 486
+IG G G VY G + ++KS F ++ + +N
Sbjct: 25 SDRVIGK---GHFGVVYHGEYIDQAQ-NRIQCAIKSLSRITEMQQVEAFLREGLLMRGLN 80
Query: 487 HKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHL-----HIQEAEHLDWAMRLRIAMGM 541
H N + LIG E ++ Y +G L + + + + + + L++A GM
Sbjct: 81 HPNVLALIGIMLPPEG-LPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFG--LQVARGM 137
Query: 542 AYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSF-----WNNTTAAKTGSAAM-- 594
Y L HR+L + + L E + K++DF + + A
Sbjct: 138 EY-LAEQK-----FVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLP 191
Query: 595 ------ELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENW-ASEYLKG---- 642
E L+T +S+V+SFG +L+E++T G Y ++ + + +L
Sbjct: 192 VKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPY----RHIDPFDLTHFLAQGRRL 247
Query: 643 EQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEI 693
QP E + L V++ C DP RP+ R + ++++I
Sbjct: 248 PQP-------------EYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQI 285
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 5e-21
Identities = 63/314 (20%), Positives = 114/314 (36%), Gaps = 74/314 (23%)
Query: 416 LKRSELEAACEDFSNIIGSFSDGTVGTVYKGTL--SSGVEIAVTSTSVKSRADWSKNLES 473
+ +L +G G+ G V +G SG ++V +K
Sbjct: 15 IGEKDLR-----LLEKLGD---GSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMD 66
Query: 474 QFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHL-----HIQEAEH 528
F ++++ + ++H+N + L G P MV E +P GSL + L H
Sbjct: 67 DFIREVNAMHSLDHRNLIRLYGVVLT-PPM--KMVTELAPLGSLLDRLRKHQGHFLLGTL 123
Query: 529 LDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDF------SFWN 582
+A +++A GM Y LE HR+L + ++ L KI DF +
Sbjct: 124 SRYA--VQVAEGMGY-LESKR-----FIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 175
Query: 583 NTTAAKTGS------AAMELLE----TSAVDLESNVYSFGTILFEMIT-GRISY-SIEN- 629
+ + A E L+ + A S+ + FG L+EM T G+ + +
Sbjct: 176 DHYVMQEHRKVPFAWCAPESLKTRTFSHA----SDTWMFGVTLWEMFTYGQEPWIGLNGS 231
Query: 630 ---GSLENWASEYLKGE---QPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSM 683
++ +GE +P E+ +++ V+ C P+ RP+
Sbjct: 232 QILHKIDK------EGERLPRP-------------EDCPQDIYNVMVQCWAHKPEDRPTF 272
Query: 684 RGIAAKLKEITAME 697
+ L E +
Sbjct: 273 VALRDFLLEAQPTD 286
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 6e-21
Identities = 68/322 (21%), Positives = 127/322 (39%), Gaps = 68/322 (21%)
Query: 413 VPKLKRSELEAACEDFSNIIGSFSDGTVGTVYKGTLSSGVEIAVTST-SVKSRADWSKNL 471
V +KR ++ +G G G V+ + + +VK+ + S++
Sbjct: 35 VHHIKRRDIV-----LKWELGE---GAFGKVFLAECHNLLPEQDKMLVAVKALKEASESA 86
Query: 472 ESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHL--HIQEAEHL 529
F+++ + L+ + H++ V G C E P +MVFEY +G L L H +A+ L
Sbjct: 87 RQDFQREAELLTMLQHQHIVRFFGVCTEGRPL--LMVFEYMRHGDLNRFLRSHGPDAKLL 144
Query: 530 DWA---------------MRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAK 574
+ ++A GM Y L +H HR+L + + + + K
Sbjct: 145 AGGEDVAPGPLGLGQLLAVASQVAAGMVY-LAGLH-----FVHRDLATRNCLVGQGLVVK 198
Query: 575 ISDFSF----WNNTTAAKTGSAAM-------ELLETSAVDLESNVYSFGTILFEMIT-GR 622
I DF ++ G + E + ES+V+SFG +L+E+ T G+
Sbjct: 199 IGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGK 258
Query: 623 ISYSIENGSLENW-ASEYLKG----EQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDP 677
+ L N A + + E+P E+ +++ C +P
Sbjct: 259 QPWY----QLSNTEAIDCITQGRELERP-------------RACPPEVYAIMRGCWQREP 301
Query: 678 KQRPSMRGIAAKLKEITAMEPD 699
+QR S++ + A+L+ + P
Sbjct: 302 QQRHSIKDVHARLQALAQAPPV 323
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 7e-21
Identities = 65/301 (21%), Positives = 120/301 (39%), Gaps = 69/301 (22%)
Query: 420 ELEAACEDFSNIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNL------ES 473
++ + F IGS G G V+ G + ++A+ K + E
Sbjct: 4 VIDPSELTFVQEIGS---GQFGLVHLGYWLNKDKVAI------------KTIREGAMSEE 48
Query: 474 QFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHL-----HIQEAEH 528
F ++ + + K++H V L G C E P +V E+ +G L ++L
Sbjct: 49 DFIEEAEVMMKLSHPKLVQLYGVCLEQAPI--CLVTEFMEHGCLSDYLRTQRGLFAAETL 106
Query: 529 LDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDF----SFWNNT 584
L L + GMAY LE + HR+L + + + E+ K+SDF ++
Sbjct: 107 LGMC--LDVCEGMAY-LEEAC-----VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 158
Query: 585 TAAKTGS------AAMELLE----TSAVDLESNVYSFGTILFEMIT-GRISY-SIENGSL 632
+ TG+ A+ E+ +S S+V+SFG +++E+ + G+I Y + N +
Sbjct: 159 YTSSTGTKFPVKWASPEVFSFSRYSSK----SDVWSFGVLMWEVFSEGKIPYENRSNSEV 214
Query: 633 ENWASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKE 692
S + +P + ++ +C P+ RP+ + +L E
Sbjct: 215 VEDISTGFRLYKP-------------RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAE 261
Query: 693 I 693
I
Sbjct: 262 I 262
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 8e-21
Identities = 72/315 (22%), Positives = 122/315 (38%), Gaps = 71/315 (22%)
Query: 414 PKLKRSELEAACEDFSNIIGSFSDGTVGTVYKGTLSS-GVEIAVTSTSVKS-RADWSKNL 471
P L ++++ F ++IG G G V K + G+ + ++K + SK+
Sbjct: 20 PVLDWNDIK-----FQDVIGE---GNFGQVLKARIKKDGLRMDA---AIKRMKEYASKDD 68
Query: 472 ESQFRKKIDTLSKV-NHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLD 530
F +++ L K+ +H N +NL+G CE + EY+P+G+L + L D
Sbjct: 69 HRDFAGELEVLCKLGHHPNIINLLGACEHRGYL--YLAIEYAPHGNLLDFLRKSRVLETD 126
Query: 531 WA------------------MRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYA 572
A +A GM Y L HR+L + +I + E+Y
Sbjct: 127 PAFAIANSTASTLSSQQLLHFAADVARGMDY-LSQKQ-----FIHRDLAARNILVGENYV 180
Query: 573 AKISDFSFWNNTTAAKTGSAAM--------ELLETSAVDLESNVYSFGTILFEMIT-GRI 623
AKI+DF + E L S S+V+S+G +L+E+++ G
Sbjct: 181 AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT 240
Query: 624 SY-SIENGSLENWASEYLKG----EQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPK 678
Y + L E L E+P N +E+ +++ C P
Sbjct: 241 PYCGMTCAEL----YEKLPQGYRLEKP-------------LNCDDEVYDLMRQCWREKPY 283
Query: 679 QRPSMRGIAAKLKEI 693
+RPS I L +
Sbjct: 284 ERPSFAQILVSLNRM 298
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 8e-21
Identities = 63/317 (19%), Positives = 122/317 (38%), Gaps = 90/317 (28%)
Query: 416 LKRSELEAACEDFSNIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNL---- 471
LKR E+ +GS G G V G ++AV K +
Sbjct: 5 LKREEIT-----LLKELGS---GQFGVVKLGKWKGQYDVAV------------KMIKEGS 44
Query: 472 --ESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHL 529
E +F ++ T+ K++H V G C ++ P +V EY NG L +L + L
Sbjct: 45 MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPI--YIVTEYISNGCLLNYLR-SHGKGL 101
Query: 530 DWA----MRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDF----SFW 581
+ + M + GMA+ LE HR+L + + + D K+SDF
Sbjct: 102 EPSQLLEMCYDVCEGMAF-LESHQ-----FIHRDLAARNCLVDRDLCVKVSDFGMTRYVL 155
Query: 582 NNTTAAKTGS------AAMELLE----TSAVDLESNVYSFGTILFEMIT-GRISY----- 625
++ + G+ +A E+ +S S+V++FG +++E+ + G++ Y
Sbjct: 156 DDQYVSSVGTKFPVKWSAPEVFHYFKYSSK----SDVWAFGILMWEVFSLGKMPYDLYTN 211
Query: 626 -----SIENGSLENWASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQR 680
+ G L +P + + ++ +C H P++R
Sbjct: 212 SEVVLKVSQG-------HRL--YRP-------------HLASDTIYQIMYSCWHELPEKR 249
Query: 681 PSMRGIAAKLKEITAME 697
P+ + + + ++ + +
Sbjct: 250 PTFQQLLSSIEPLREKD 266
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 8e-21
Identities = 74/322 (22%), Positives = 128/322 (39%), Gaps = 64/322 (19%)
Query: 399 TGLSGQLQKAFVTGVPKLKRSELEAACEDFSNIIGSFSDGTVGTVYKGTL--SSGVEIAV 456
+ L+ +L +A V + F+ +IG G G VY GTL + G +I
Sbjct: 5 SALNPELVQAVQHVVIGPSSLIVH-----FNEVIGR---GHFGCVYHGTLLDNDGKKIHC 56
Query: 457 TSTSVKS-RADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNG 515
+VKS SQF + + +H N ++L+G C E + ++V Y +G
Sbjct: 57 ---AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG-SPLVVLPYMKHG 112
Query: 516 SLFEHL-----HIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTED 570
L + + + + + L++A GM Y L HR+L + + L E
Sbjct: 113 DLRNFIRNETHNPTVKDLIGFG--LQVAKGMKY-LASKK-----FVHRDLAARNCMLDEK 164
Query: 571 YAAKISDFS-----FWNNTTAAKTGSAAM--------ELLETSAVDLESNVYSFGTILFE 617
+ K++DF + + + A E L+T +S+V+SFG +L+E
Sbjct: 165 FTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWE 224
Query: 618 MIT-GRISYSIENGSLENW-ASEYLKG----EQPLKDIVDPTLKSFQENVLEELLVVIKN 671
++T G Y + + + YL QP E + L V+
Sbjct: 225 LMTRGAPPYP----DVNTFDITVYLLQGRRLLQP-------------EYCPDPLYEVMLK 267
Query: 672 CVHPDPKQRPSMRGIAAKLKEI 693
C HP + RPS + +++ I
Sbjct: 268 CWHPKAEMRPSFSELVSRISAI 289
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 1e-20
Identities = 57/310 (18%), Positives = 117/310 (37%), Gaps = 79/310 (25%)
Query: 420 ELEAACEDFSNIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNL------ES 473
E++ F +G+ G G V G ++A+ K + E
Sbjct: 20 EIDPKDLTFLKELGT---GQFGVVKYGKWRGQYDVAI------------KMIKEGSMSED 64
Query: 474 QFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHL-----HIQEAEH 528
+F ++ + ++H+ V L G C + P ++ EY NG L +L Q +
Sbjct: 65 EFIEEAKVMMNLSHEKLVQLYGVCTKQRPI--FIITEYMANGCLLNYLREMRHRFQTQQL 122
Query: 529 LDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDF----SFWNNT 584
L+ M + M Y LE HR+L + + + + K+SDF ++
Sbjct: 123 LE--MCKDVCEAMEY-LESKQ-----FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 174
Query: 585 TAAKTGS------AAMELLE----TSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLE 633
+ GS + E+L +S S++++FG +++E+ + G++ Y
Sbjct: 175 YTSSVGSKFPVRWSPPEVLMYSKFSSK----SDIWAFGVLMWEIYSLGKMPY-------- 222
Query: 634 NWASEYLKGEQPLKDIVD------PTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIA 687
E + + I P E++ ++ +C H +RP+ + +
Sbjct: 223 ----ERFTNSETAEHIAQGLRLYRP------HLASEKVYTIMYSCWHEKADERPTFKILL 272
Query: 688 AKLKEITAME 697
+ + ++ E
Sbjct: 273 SNILDVMDEE 282
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 95.7 bits (238), Expect = 1e-20
Identities = 63/313 (20%), Positives = 117/313 (37%), Gaps = 68/313 (21%)
Query: 414 PKLKRSELEAACEDFSNIIGSFSDGTVGTVYKGTL--SSGVEIAVTSTSVKS-RADWSKN 470
P + E++ + IG G G V++G +AV ++K+ + S +
Sbjct: 380 PSTRDYEIQRERIELGRCIGE---GQFGDVHQGIYMSPENPAMAV---AIKTCKNCTSDS 433
Query: 471 LESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHL-----HIQE 525
+ +F ++ T+ + +H + V LIG E P ++ E G L L +
Sbjct: 434 VREKFLQEALTMRQFDHPHIVKLIGVITE-NPV--WIIMELCTLGELRSFLQVRKFSLDL 490
Query: 526 AEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDF----SFW 581
A + +A +++ +AY LE HR++ + ++ ++ + K+ DF
Sbjct: 491 ASLILYA--YQLSTALAY-LESKR-----FVHRDIAARNVLVSSNDCVKLGDFGLSRYME 542
Query: 582 NNTTAAKTGS------AAMELLETSAVDLESNVYSFGTILFEMIT-GRISY--------- 625
++T + A E + S+V+ FG ++E++ G +
Sbjct: 543 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI 602
Query: 626 -SIENGSLENWASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMR 684
IENG E L P N L ++ C DP +RP
Sbjct: 603 GRIENG-------ERL--PMP-------------PNCPPTLYSLMTKCWAYDPSRRPRFT 640
Query: 685 GIAAKLKEITAME 697
+ A+L I E
Sbjct: 641 ELKAQLSTILEEE 653
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 1e-20
Identities = 67/299 (22%), Positives = 127/299 (42%), Gaps = 47/299 (15%)
Query: 412 GVPKLKRSELEAACEDFSNIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKS-RADWSKN 470
G P + E+E + +G G G VY+G + V +VK+ + D +
Sbjct: 1 GSPNYDKWEMERTDITMKHKLGG---GQYGEVYEGVWK-KYSLTV---AVKTLKEDTME- 52
Query: 471 LESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLD 530
+F K+ + ++ H N V L+G C + PF ++ E+ G+L ++L + +
Sbjct: 53 -VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF--YIITEFMTYGNLLDYLRECNRQEVS 109
Query: 531 WA----MRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDF----SFWN 582
M +I+ M Y LE + HR+L + + + E++ K++DF
Sbjct: 110 AVVLLYMATQISSAMEY-LEKKN-----FIHRDLAARNCLVGENHLVKVADFGLSRLMTG 163
Query: 583 NTTAAKTGS------AAMELLETSAVDLESNVYSFGTILFEMIT-GRISY-SIENGSLEN 634
+T A G+ A E L + ++S+V++FG +L+E+ T G Y I+ +
Sbjct: 164 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 223
Query: 635 WASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEI 693
+ + E+P E E++ +++ C +P RPS I + +
Sbjct: 224 LLEKDYRMERP-------------EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 65/334 (19%), Positives = 108/334 (32%), Gaps = 107/334 (32%)
Query: 414 PKLKRSELEAACEDFSNIIGSFSDGTVGTVYKGTL---SSGVEIAVTSTSVKSRADWSKN 470
K++ +L F+ +G GT ++KG ++ T +K +N
Sbjct: 3 HKIRNEDLI-----FNESLGQ---GTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRN 54
Query: 471 LESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHL-----HIQE 525
F + +SK++HK+ V G C + ++V E+ GSL +L I
Sbjct: 55 YSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN--ILVQEFVKFGSLDTYLKKNKNCINI 112
Query: 526 AEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNL--------QSSSIYLTEDYAAKISD 577
L+ A ++A M + LE + H N+ + K+SD
Sbjct: 113 LWKLEVA--KQLAAAMHF-LEENT-----LIHGNVCAKNILLIREEDRKTGNPPFIKLSD 164
Query: 578 F----------------------SFWNN---TTAAKTGSAAMELLETSAVDLESNVYSFG 612
N A ++ +SFG
Sbjct: 165 PGISITVLPKDILQERIPWVPPECIENPKNLNLA-------------------TDKWSFG 205
Query: 613 TILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQEN--VLE-----EL 665
T L+E+ + G++PL + F E+ L EL
Sbjct: 206 TTLWEICS--------------------GGDKPLSALDSQRKLQFYEDRHQLPAPKAAEL 245
Query: 666 LVVIKNCVHPDPKQRPSMRGIAAKLKEITAMEPD 699
+I NC+ +P RPS R I L + PD
Sbjct: 246 ANLINNCMDYEPDHRPSFRAIIRDLNSL--FTPD 277
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 2e-20
Identities = 69/301 (22%), Positives = 120/301 (39%), Gaps = 59/301 (19%)
Query: 420 ELEAACEDFSNIIGSFSDGTVGTVYKGTL--SSGVEIAVTSTSVKS-RADWSKNLESQFR 476
+ F+ +IG G G VY GTL + G +I +VKS SQF
Sbjct: 85 GPSSLIVHFNEVIGR---GHFGCVYHGTLLDNDGKKIHC---AVKSLNRITDIGEVSQFL 138
Query: 477 KKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHL-----HIQEAEHLDW 531
+ + +H N ++L+G C E + ++V Y +G L + + + + +
Sbjct: 139 TEGIIMKDFSHPNVLSLLGICLRSEG-SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF 197
Query: 532 AMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFS-----FWNNTTA 586
L++A GM + L HR+L + + L E + K++DF + +
Sbjct: 198 G--LQVAKGMKF-LASKK-----FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 249
Query: 587 AKTGSAAM--------ELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENW-A 636
+ A E L+T +S+V+SFG +L+E++T G Y + +
Sbjct: 250 VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP----DVNTFDI 305
Query: 637 SEYLKG----EQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKE 692
+ YL QP E + L V+ C HP + RPS + +++
Sbjct: 306 TVYLLQGRRLLQP-------------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 352
Query: 693 I 693
I
Sbjct: 353 I 353
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 2e-20
Identities = 66/315 (20%), Positives = 119/315 (37%), Gaps = 81/315 (25%)
Query: 416 LKRSELEAACEDFSNIIGSFSDGTVGTVYKGTL--SSGVEIAVTSTSVKS-RADWSKNLE 472
++R +E IG G G V++G +AV ++K+ + S ++
Sbjct: 12 IQRERIE-----LGRCIGE---GQFGDVHQGIYMSPENPALAV---AIKTCKNCTSDSVR 60
Query: 473 SQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHL-----HIQEAE 527
+F ++ T+ + +H + V LIG E P ++ E G L L + A
Sbjct: 61 EKFLQEALTMRQFDHPHIVKLIGVITE-NPV--WIIMELCTLGELRSFLQVRKYSLDLAS 117
Query: 528 HLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDF----SFWNN 583
+ +A +++ +AY LE HR++ + ++ ++ + K+ DF ++
Sbjct: 118 LILYA--YQLSTALAY-LESKR-----FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 169
Query: 584 TTAAKTGS------AAMELLE----TSAVDLESNVYSFGTILFEMIT-GRISY------- 625
T + A E + TSA S+V+ FG ++E++ G +
Sbjct: 170 TYYKASKGKLPIKWMAPESINFRRFTSA----SDVWMFGVCMWEILMHGVKPFQGVKNND 225
Query: 626 ---SIENGSLENWASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPS 682
IENG E L P N L ++ C DP +RP
Sbjct: 226 VIGRIENG-------ERL--PMP-------------PNCPPTLYSLMTKCWAYDPSRRPR 263
Query: 683 MRGIAAKLKEITAME 697
+ A+L I E
Sbjct: 264 FTELKAQLSTILEEE 278
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 2e-20
Identities = 53/300 (17%), Positives = 102/300 (34%), Gaps = 50/300 (16%)
Query: 433 GSFSDGTVGTVYKGT-LSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFV 491
G F V L G A+ + D + +++ D NH N +
Sbjct: 40 GGF-----SYVDLVEGLHDGHFYALKRILCHEQQD-----REEAQREADMHRLFNHPNIL 89
Query: 492 NLIGYCEEDEPFTRM--MVFEYSPNGSLFEHL--HIQEAEHLDWAMRLRIAMGMAYCLEH 547
L+ YC + ++ + G+L+ + + L L + +G+ LE
Sbjct: 90 RLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEA 149
Query: 548 MHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTAAKTGSAAMELLETSA------ 601
+H AHR+L+ ++I L ++ + D N GS L+ A
Sbjct: 150 IHA--KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTI 207
Query: 602 ---------------VDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKG-EQP 645
+D ++V+S G +L+ M+ G Y + ++ A P
Sbjct: 208 SYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIP 267
Query: 646 LKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAMEPDGATPKL 705
L + + + DP QRP + + ++L+ + P T ++
Sbjct: 268 QSPRHSSALWQL-----------LNSMMTVDPHQRPHIPLLLSQLEALQPPAPGQHTTQI 316
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 3e-20
Identities = 66/307 (21%), Positives = 119/307 (38%), Gaps = 72/307 (23%)
Query: 420 ELEAACEDFSNIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKS-RADWSKNLESQFRKK 478
E+ +C +IG+ G G VYKG L + ++K+ +A +++ F +
Sbjct: 40 EIHPSCVTRQKVIGA---GEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGE 96
Query: 479 IDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHL-----HIQEAEHLDWAM 533
+ + +H N + L G + +P M++ EY NG+L + L + +
Sbjct: 97 AGIMGQFSHHNIIRLEGVISKYKPM--MIITEYMENGALDKFLREKDGEFSVLQLVGML- 153
Query: 534 RLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSF------WNNTTAA 587
IA GM Y L +M+ HR+L + +I + + K+SDF T
Sbjct: 154 -RGIAAGMKY-LANMN-----YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYT 206
Query: 588 KTGS------AAMELLE----TSAVDLESNVYSFGTILFEMIT-GRISY----------S 626
+G A E + TSA S+V+SFG +++E++T G Y +
Sbjct: 207 TSGGKIPIRWTAPEAISYRKFTSA----SDVWSFGIVMWEVMTYGERPYWELSNHEVMKA 262
Query: 627 IENGSLENWASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGI 686
I +G L P + + ++ C + +RP I
Sbjct: 263 INDG-------FRL--PTP-------------MDCPSAIYQLMMQCWQQERARRPKFADI 300
Query: 687 AAKLKEI 693
+ L ++
Sbjct: 301 VSILDKL 307
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 4e-20
Identities = 66/295 (22%), Positives = 118/295 (40%), Gaps = 73/295 (24%)
Query: 431 IIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKN 489
+GS G GTV KG V V +K+ A+ L+ + + + + ++++
Sbjct: 24 ELGS---GNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPY 79
Query: 490 FVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHL----HIQEAEHLDWAMRLRIAMGMAYCL 545
V +IG CE E + M+V E + G L ++L H+++ ++ +++MGM Y L
Sbjct: 80 IVRMIGICEA-ESW--MLVMEMAELGPLNKYLQQNRHVKDKNIIELV--HQVSMGMKY-L 133
Query: 546 EHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDF------SFWNNTTAAKTGS------AA 593
E + HR+L + ++ L + AKISDF N A+T A
Sbjct: 134 EESN-----FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYA 188
Query: 594 MELLE----TSAVDLESNVYSFGTILFEMIT-GRISY----------SIENGSLENWASE 638
E + +S S+V+SFG +++E + G+ Y +E G E
Sbjct: 189 PECINYYKFSSK----SDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG-------E 237
Query: 639 YLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEI 693
+ P E+ ++ C D + RP + +L+
Sbjct: 238 RM--GCP-------------AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 277
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 4e-20
Identities = 72/323 (22%), Positives = 120/323 (37%), Gaps = 78/323 (24%)
Query: 420 ELEAACEDFSNIIGSFSDGTVGTVYKGTL--SSGVEIAVTSTSVKS-RADWSKNLESQFR 476
E+EA+ IIGS G G V G L ++ V ++K+ +A +++ F
Sbjct: 45 EIEASRIHIEKIIGS---GDSGEVCYGRLRVPGQRDVPV---AIKALKAGYTERQRRDFL 98
Query: 477 KKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHL-----HIQEAEHLDW 531
+ + + +H N + L G M+V EY NGSL L + +
Sbjct: 99 SEASIMGQFDHPNIIRLEGVVTRGRLA--MIVTEYMENGSLDTFLRTHDGQFTIMQLVGM 156
Query: 532 AMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDF----SFWNNTTAA 587
+ GM Y L + HR+L + ++ + + K+SDF ++ AA
Sbjct: 157 L--RGVGAGMRY-LSDLG-----YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAA 208
Query: 588 KTGSAAM--------ELLE----TSAVDLESNVYSFGTILFEMIT-GRISY--------- 625
T + E + +SA S+V+SFG +++E++ G Y
Sbjct: 209 YTTTGGKIPIRWTAPEAIAFRTFSSA----SDVWSFGVVMWEVLAYGERPYWNMTNRDVI 264
Query: 626 -SIENGSLENWASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMR 684
S+E G L P L ++ +C H D QRP
Sbjct: 265 SSVEEG-------YRL--PAP-------------MGCPHALHQLMLDCWHKDRAQRPRFS 302
Query: 685 GIAAKLKEI-TAMEPDGATPKLS 706
I + L + + E AT +S
Sbjct: 303 QIVSVLDALIRSPESLRATATVS 325
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 8e-20
Identities = 57/293 (19%), Positives = 112/293 (38%), Gaps = 71/293 (24%)
Query: 432 IGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKS-RADWSKNLESQFRKKIDTLSKVNHKN 489
+G G G+V +G +I V ++K + K + ++ + ++++
Sbjct: 18 LGC---GNFGSVRQGVYRMRKKQIDV---AIKVLKQGTEKADTEEMMREAQIMHQLDNPY 71
Query: 490 FVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHL-----HIQEAEHLDWAMRLRIAMGMAYC 544
V LIG C+ E M+V E + G L + L I + + +++MGM Y
Sbjct: 72 IVRLIGVCQA-EAL--MLVMEMAGGGPLHKFLVGKREEIPVSNVAELL--HQVSMGMKY- 125
Query: 545 LEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDF------SFWNNTTAAKTGS------A 592
LE + HR+L + ++ L + AKISDF ++ A++
Sbjct: 126 LEEKN-----FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY 180
Query: 593 AMELLE----TSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKG----- 642
A E + +S S+V+S+G ++E ++ G+ Y ++ E +
Sbjct: 181 APECINFRKFSSR----SDVWSYGVTMWEALSYGQKPY----KKMKG--PEVMAFIEQGK 230
Query: 643 --EQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEI 693
E P EL ++ +C + RP + +++
Sbjct: 231 RMECP-------------PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 270
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 8e-20
Identities = 59/317 (18%), Positives = 119/317 (37%), Gaps = 70/317 (22%)
Query: 413 VPKLKRSELEAACEDFSNIIGSFSDGTVGTVYKGTLSSGVEIAVTST-SVKS-RADWSKN 470
+ ++ S + F +G G VYKG L T ++K+ +
Sbjct: 3 LKEISLSAVR-----FMEELGE---DRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGP 54
Query: 471 LESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLD 530
L +FR + +++ H N V L+G +D+P M+F Y +G L E L ++
Sbjct: 55 LREEFRHEAMLRARLQHPNVVCLLGVVTKDQPL--SMIFSYCSHGDLHEFLVMRSPHSDV 112
Query: 531 WA------------------MRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYA 572
+ + +IA GM Y L H + H++L + ++ + +
Sbjct: 113 GSTDDDRTVKSALEPPDFVHLVAQIAAGMEY-LSSHH-----VVHKDLATRNVLVYDKLN 166
Query: 573 AKISDF----SFWNNTTAAKTGSAAM-------ELLETSAVDLESNVYSFGTILFEMIT- 620
KISD + G++ + E + ++S+++S+G +L+E+ +
Sbjct: 167 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSY 226
Query: 621 GRISYSIENGSLENW-ASEYLKG----EQPLKDIVDPTLKSFQENVLEELLVVIKNCVHP 675
G Y N E ++ P ++ + ++ C +
Sbjct: 227 GLQPYC----GYSNQDVVEMIRNRQVLPCP-------------DDCPAWVYALMIECWNE 269
Query: 676 DPKQRPSMRGIAAKLKE 692
P +RP + I ++L+
Sbjct: 270 FPSRRPRFKDIHSRLRA 286
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 1e-19
Identities = 65/313 (20%), Positives = 113/313 (36%), Gaps = 64/313 (20%)
Query: 413 VPKLKRSELEAACEDFSNIIGSFSDGTVGTVYKGTLSSGV-EIAVTSTSVKS-RADWSKN 470
+ ++ R + +G G G VY+G +S + + +VK+ S+
Sbjct: 24 LKEVPRKNIT-----LIRGLGH---GAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQ 75
Query: 471 LESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHL-----HIQE 525
E F + +SK NH+N V IG + P ++ E G L L +
Sbjct: 76 DELDFLMEALIISKFNHQNIVRCIGVSLQSLPR--FILMELMAGGDLKSFLRETRPRPSQ 133
Query: 526 AEHLDW----AMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLT---EDYAAKISDF 578
L + IA G Y LE H HR++ + + LT AKI DF
Sbjct: 134 PSSLAMLDLLHVARDIACGCQY-LEENH-----FIHRDIAARNCLLTCPGPGRVAKIGDF 187
Query: 579 SF----WNNTTAAKTGSAAM-------ELLETSAVDLESNVYSFGTILFEMIT-GRISYS 626
+ + K G A + E +++ +SFG +L+E+ + G + Y
Sbjct: 188 GMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYP 247
Query: 627 IENGSLENW-ASEYLKG----EQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRP 681
S N E++ + P +N + ++ C P+ RP
Sbjct: 248 ----SKSNQEVLEFVTSGGRMDPP-------------KNCPGPVYRIMTQCWQHQPEDRP 290
Query: 682 SMRGIAAKLKEIT 694
+ I +++ T
Sbjct: 291 NFAIILERIEYCT 303
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 1e-19
Identities = 69/301 (22%), Positives = 121/301 (40%), Gaps = 70/301 (23%)
Query: 433 GSFSDGTVGTVYKGT---LSSGVEIAVTSTSVKS-RADWSKNLESQFRKKIDTLSKV-NH 487
G+F G V + + +VK + D ++ S +++ + + H
Sbjct: 46 GAF-----GQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 488 KNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHL--------------HIQEAEHLDW-- 531
KN +NL+G C +D P ++ EY+ G+L E+L + E + +
Sbjct: 101 KNIINLLGACTQDGPL--YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 532 --AMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDF----SFWNNTT 585
+ ++A GM Y L HR+L + ++ +TE+ KI+DF N
Sbjct: 159 LVSCTYQLARGMEY-LASQK-----CIHRDLAARNVLVTENNVMKIADFGLARDINNIDY 212
Query: 586 AAKTGSA-------AMELLETSAVDLESNVYSFGTILFEMIT-GRISY-SIENGSLENWA 636
KT + A E L +S+V+SFG +++E+ T G Y I L
Sbjct: 213 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL---- 268
Query: 637 SEYLKG----EQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKE 692
+ LK ++P N EL +++++C H P QRP+ + + L
Sbjct: 269 FKLLKEGHRMDKP-------------ANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 315
Query: 693 I 693
I
Sbjct: 316 I 316
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 2e-19
Identities = 70/301 (23%), Positives = 122/301 (40%), Gaps = 70/301 (23%)
Query: 433 GSFSDGTVGTVYKGT---LSSGVEIAVTSTSVKS-RADWSKNLESQFRKKIDTLSKV-NH 487
G+F G V L VT +VK ++D ++ S +++ + + H
Sbjct: 80 GAF-----GQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 134
Query: 488 KNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHL----------HIQEAEHLDWAMRLR- 536
KN +NL+G C +D P ++ EY+ G+L E+L + + + + +
Sbjct: 135 KNIINLLGACTQDGPL--YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 192
Query: 537 -------IAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSF----WNNTT 585
+A GM Y L HR+L + ++ +TED KI+DF +
Sbjct: 193 LVSCAYQVARGMEY-LASKK-----CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 246
Query: 586 AAKTGSAAM-------ELLETSAVDLESNVYSFGTILFEMIT-GRISY-SIENGSLENWA 636
KT + + E L +S+V+SFG +L+E+ T G Y + L
Sbjct: 247 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL---- 302
Query: 637 SEYLKG----EQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKE 692
+ LK ++P N EL +++++C H P QRP+ + + L
Sbjct: 303 FKLLKEGHRMDKP-------------SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 349
Query: 693 I 693
I
Sbjct: 350 I 350
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 2e-19
Identities = 71/301 (23%), Positives = 127/301 (42%), Gaps = 56/301 (18%)
Query: 420 ELEAACEDFSNIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKI 479
E+ +G+ G G V+ G + ++AV S +K + F +
Sbjct: 9 EVPRETLKLVERLGA---GQFGEVWMGYYNGHTKVAVKS--LKQGS----MSPDAFLAEA 59
Query: 480 DTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWA----MRL 535
+ + ++ H+ V L + EP ++ EY NGSL + L L M
Sbjct: 60 NLMKQLQHQRLVRLYAVVTQ-EPI--YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAA 116
Query: 536 RIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDF----SFWNNTTAAKTGS 591
+IA GMA+ +E + HR+L++++I +++ + KI+DF +N A+ G+
Sbjct: 117 QIAEGMAF-IEERN-----YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGA 170
Query: 592 ------AAMELLE----TSAVDLESNVYSFGTILFEMIT-GRISY-SIENGSLENWASEY 639
A E + T S+V+SFG +L E++T GRI Y + N +
Sbjct: 171 KFPIKWTAPEAINYGTFTIK----SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG 226
Query: 640 LKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEI-TAMEP 698
+ +P +N EEL +++ C P+ RP+ + + L++ TA E
Sbjct: 227 YRMVRP-------------DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEG 273
Query: 699 D 699
Sbjct: 274 Q 274
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 2e-19
Identities = 71/308 (23%), Positives = 118/308 (38%), Gaps = 79/308 (25%)
Query: 433 GSFSDGTVGTVYKGTLSSGVEIAVTST-SVKS-RADWSKNLESQFRKKIDTLSKVNHKNF 490
G F G V K T A +T +VK + + S + + + L +VNH +
Sbjct: 34 GEF-----GKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 491 VNLIGYCEEDEPFTRMMVFEYSPNGSLFEHL----------------------------H 522
+ L G C +D P +++ EY+ GSL L
Sbjct: 89 IKLYGACSQDGPL--LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146
Query: 523 IQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDF---- 578
+ + + +A +I+ GM Y L M + HR+L + +I + E KISDF
Sbjct: 147 LTMGDLISFA--WQISQGMQY-LAEMK-----LVHRDLAARNILVAEGRKMKISDFGLSR 198
Query: 579 SFWNNTTAAKTGSAAM-------ELLETSAVDLESNVYSFGTILFEMIT-GRISY-SIEN 629
+ + K + E L +S+V+SFG +L+E++T G Y I
Sbjct: 199 DVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP 258
Query: 630 GSLENWASEYLKG----EQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRG 685
L LK E+P +N EE+ ++ C +P +RP
Sbjct: 259 ERL----FNLLKTGHRMERP-------------DNCSEEMYRLMLQCWKQEPDKRPVFAD 301
Query: 686 IAAKLKEI 693
I+ L+++
Sbjct: 302 ISKDLEKM 309
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 2e-19
Identities = 65/310 (20%), Positives = 115/310 (37%), Gaps = 75/310 (24%)
Query: 433 GSFSDGTVGTVYKGTLSSGVEIAVTST-SVKS-RADWSKNLESQFRKKIDTLSKV-NHKN 489
G+F G V + T ++ T +VK + ++ LS + NH N
Sbjct: 34 GAF-----GKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 490 FVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHL----------------------HIQEAE 527
VNL+G C P +++ EY G L L + +
Sbjct: 89 IVNLLGACTIGGPT--LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146
Query: 528 HLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSF----WNN 583
L ++ ++A GMA+ L + HR+L + +I LT KI DF N+
Sbjct: 147 LLSFS--YQVAKGMAF-LASKN-----CIHRDLAARNILLTHGRITKICDFGLARDIKND 198
Query: 584 TTAAKTGSA-------AMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENW 635
+ G+A A E + ES+V+S+G L+E+ + G Y +
Sbjct: 199 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP----GMPVD 254
Query: 636 AS--EYLKG----EQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAK 689
+ + +K P E+ E+ ++K C DP +RP+ + I
Sbjct: 255 SKFYKMIKEGFRMLSP-------------EHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301
Query: 690 LKEITAMEPD 699
+++ + +
Sbjct: 302 IEKQISESTN 311
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 3e-19
Identities = 60/317 (18%), Positives = 118/317 (37%), Gaps = 73/317 (23%)
Query: 428 FSNIIGSFSDGTVGTVYKGTLSSGVEIAVTST-SVKS-RADWSKNLESQFRKKIDTLSKV 485
+ IG G G V++ + + +VK + + S ++++ F+++ +++
Sbjct: 51 YVRDIGE---GAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF 107
Query: 486 NHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWA------------- 532
++ N V L+G C +P ++FEY G L E L +
Sbjct: 108 DNPNIVKLLGVCAVGKPM--CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSS 165
Query: 533 -------------MRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDF- 578
+ ++A GMAY L HR+L + + + E+ KI+DF
Sbjct: 166 PGPPPLSCAEQLCIARQVAAGMAY-LSERK-----FVHRDLATRNCLVGENMVVKIADFG 219
Query: 579 ---SFWNNTTAAKTGSAAM-------ELLETSAVDLESNVYSFGTILFEMIT-GRISYSI 627
+ ++ G+ A+ E + + ES+V+++G +L+E+ + G Y
Sbjct: 220 LSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY- 278
Query: 628 ENGSLENW-ASEYLKG----EQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPS 682
+ + Y++ P EN EL +++ C P RPS
Sbjct: 279 ---GMAHEEVIYYVRDGNILACP-------------ENCPLELYNLMRLCWSKLPADRPS 322
Query: 683 MRGIAAKLKEITAMEPD 699
I L+ +
Sbjct: 323 FCSIHRILQRMCERAEG 339
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 3e-19
Identities = 46/295 (15%), Positives = 101/295 (34%), Gaps = 56/295 (18%)
Query: 426 EDFSNI--IGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLS 483
DF I +G G G V++ + ++ + +++ L+
Sbjct: 5 TDFEPIQCLGR---GGFGVVFEAKNKVDDCNYAIKRIRLPNRELAR---EKVMREVKALA 58
Query: 484 KVNHKNFVNLIGYCEEDEPFTRM----------MVFEYSPNGSLFEHLHIQE-AEHLDWA 532
K+ H V E ++ + + +L + ++ + E + +
Sbjct: 59 KLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERS 118
Query: 533 MRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDF----SFWNNTTAAK 588
+ L I + +A +E +H + HR+L+ S+I+ T D K+ DF + +
Sbjct: 119 VCLHIFLQIAEAVEFLHSKG--LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQT 176
Query: 589 TGSAAM-----------------ELLETSAVDLESNVYSFGTILFEMITGRISYSIENGS 631
+ E + ++ + +++S G ILFE++ S +E
Sbjct: 177 VLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY-PFSTQMERVR 235
Query: 632 LENWASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGI 686
L D+ + V++++ + P P +RP I
Sbjct: 236 T-------------LTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINI 277
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 4e-19
Identities = 49/283 (17%), Positives = 102/283 (36%), Gaps = 68/283 (24%)
Query: 433 GSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSK------NLESQ-FRKKIDTLSKV 485
G F G V+K K R D ++ +++ L+K+
Sbjct: 22 GGF-----GQVFK---------------AKHRIDGKTYVIKRVKYNNEKAEREVKALAKL 61
Query: 486 NHKNFVNLIGYCEEDEPFTRM--------------MVFEYSPNGSLFEHLHIQEAEHLDW 531
+H N V+ G + + + E+ G+L + + + E LD
Sbjct: 62 DHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDK 121
Query: 532 AMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDF---SFWNNTTAAK 588
+ L + + ++++H + +R+L+ S+I+L + KI DF + N
Sbjct: 122 VLALELFEQITKGVDYIHSKK--LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRT 179
Query: 589 T--GS---AAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGE 643
G+ + E + + E ++Y+ G IL E++ + + ++ G
Sbjct: 180 RSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAF----ETSKFFTDLRDG- 234
Query: 644 QPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGI 686
+ DI D K+ ++ + P+ RP+ I
Sbjct: 235 -IISDIFDKKEKTL-----------LQKLLSKKPEDRPNTSEI 265
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 7e-19
Identities = 63/306 (20%), Positives = 117/306 (38%), Gaps = 73/306 (23%)
Query: 433 GSFSDGTVGTVYKGTLSSGVEIAVTST----SVKSRADWSKNLESQFRKKIDTLSKV-NH 487
G+F G V + T + +KS A + + ++ +S + H
Sbjct: 57 GAF-----GKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQH 109
Query: 488 KNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHL------------------HIQEAEHL 529
+N VNL+G C P +++ EY G L L + L
Sbjct: 110 ENIVNLLGACTHGGPV--LVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLL 167
Query: 530 DWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSF----WNNTT 585
++ ++A GMA+ L + HR++ + ++ LT + AKI DF N++
Sbjct: 168 HFS--SQVAQGMAF-LASKN-----CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN 219
Query: 586 AAKTGSA-------AMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENW-A 636
G+A A E + ++S+V+S+G +L+E+ + G Y G L N
Sbjct: 220 YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYP---GILVNSKF 276
Query: 637 SEYLKG----EQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKE 692
+ +K QP + + +++ C +P RP+ + I + L+E
Sbjct: 277 YKLVKDGYQMAQP-------------AFAPKNIYSIMQACWALEPTHRPTFQQICSFLQE 323
Query: 693 ITAMEP 698
+
Sbjct: 324 QAQEDR 329
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 8e-19
Identities = 65/313 (20%), Positives = 112/313 (35%), Gaps = 64/313 (20%)
Query: 413 VPKLKRSELEAACEDFSNIIGSFSDGTVGTVYKGTLSSGV-EIAVTSTSVKS-RADWSKN 470
+ ++ R + +G G G VY+G +S + + +VK+ S+
Sbjct: 65 LKEVPRKNIT-----LIRGLGH---GAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQ 116
Query: 471 LESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHL-----HIQE 525
E F + +SK NH+N V IG + P ++ E G L L +
Sbjct: 117 DELDFLMEALIISKFNHQNIVRCIGVSLQSLPR--FILLELMAGGDLKSFLRETRPRPSQ 174
Query: 526 AEHLDW----AMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLT---EDYAAKISDF 578
L + IA G Y LE H HR++ + + LT AKI DF
Sbjct: 175 PSSLAMLDLLHVARDIACGCQY-LEENH-----FIHRDIAARNCLLTCPGPGRVAKIGDF 228
Query: 579 SF----WNNTTAAKTGSAAM-------ELLETSAVDLESNVYSFGTILFEMIT-GRISYS 626
+ K G A + E +++ +SFG +L+E+ + G + Y
Sbjct: 229 GMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYP 288
Query: 627 IENGSLENW-ASEYLKG----EQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRP 681
S N E++ + P +N + ++ C P+ RP
Sbjct: 289 ----SKSNQEVLEFVTSGGRMDPP-------------KNCPGPVYRIMTQCWQHQPEDRP 331
Query: 682 SMRGIAAKLKEIT 694
+ I +++ T
Sbjct: 332 NFAIILERIEYCT 344
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 8e-19
Identities = 68/307 (22%), Positives = 121/307 (39%), Gaps = 70/307 (22%)
Query: 433 GSFSDGTVGTVYKGT---LSSGVEIAVTSTSVKS-RADWSKNLESQFRKKIDTLSKV-NH 487
G F G V + + +VK + D ++ S +++ + + H
Sbjct: 92 GCF-----GQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 146
Query: 488 KNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHL--------------HIQEAEHLDWA- 532
KN +NL+G C +D P ++ EY+ G+L E+L + E + +
Sbjct: 147 KNIINLLGACTQDGPL--YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204
Query: 533 ---MRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDF----SFWNNTT 585
++A GM Y L HR+L + ++ +TE+ KI+DF N
Sbjct: 205 LVSCTYQLARGMEY-LASQK-----CIHRDLAARNVLVTENNVMKIADFGLARDINNIDY 258
Query: 586 AAKTGSAAM-------ELLETSAVDLESNVYSFGTILFEMIT-GRISY-SIENGSLENWA 636
KT + + E L +S+V+SFG +++E+ T G Y I L
Sbjct: 259 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL---- 314
Query: 637 SEYLKG----EQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKE 692
+ LK ++P N EL +++++C H P QRP+ + + L
Sbjct: 315 FKLLKEGHRMDKP-------------ANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 361
Query: 693 ITAMEPD 699
I + +
Sbjct: 362 ILTLTTN 368
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 9e-19
Identities = 60/274 (21%), Positives = 114/274 (41%), Gaps = 48/274 (17%)
Query: 433 GSFSDGTVGTVYKGT-LSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFV 491
G F VY+ L GV +A+ + D +K K+ID L ++NH N +
Sbjct: 43 GQF-----SEVYRAACLLDGVPVALKKVQIFDLMD-AKARA-DCIKEIDLLKQLNHPNVI 95
Query: 492 NLIGYCEEDEPFTRMMVFEYSPNGSLFEHL--------HIQEAEHLDWAMRLRIAMGMAY 543
ED +V E + G L + I E + ++L A
Sbjct: 96 KYYASFIEDNEL--NIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSA----- 148
Query: 544 CLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDF----SFWNNTTAAKT--GS---AAM 594
LEHMH + HR+++ +++++T K+ D F + TTAA + G+ +
Sbjct: 149 -LEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 205
Query: 595 ELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQP--LKDIVDP 652
E + + + +S+++S G +L+EM + + + +L + + + + P D
Sbjct: 206 ERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSE 265
Query: 653 TLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGI 686
L+ + C++PDP++RP + +
Sbjct: 266 ELRQL-----------VNMCINPDPEKRPDVTYV 288
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 89.6 bits (222), Expect = 9e-19
Identities = 61/315 (19%), Positives = 115/315 (36%), Gaps = 77/315 (24%)
Query: 413 VPKLKRSELEAACEDFSNIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKS-RADWSKN 470
+ K +G G G+V +G +I V ++K + K
Sbjct: 325 LKDKKLFLKRDNLLIADIELGC---GNFGSVRQGVYRMRKKQIDV---AIKVLKQGTEKA 378
Query: 471 LESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHL-----HIQE 525
+ ++ + ++++ V LIG C+ E M+V E + G L + L I
Sbjct: 379 DTEEMMREAQIMHQLDNPYIVRLIGVCQA-EAL--MLVMEMAGGGPLHKFLVGKREEIPV 435
Query: 526 AEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDF------S 579
+ + +++MGM Y LE + HRNL + ++ L + AKISDF
Sbjct: 436 SNVAELL--HQVSMGMKY-LEEKN-----FVHRNLAARNVLLVNRHYAKISDFGLSKALG 487
Query: 580 FWNNTTAAKTGS------AAMELLE----TSAVDLESNVYSFGTILFEMIT-GRISY--- 625
++ A++ A E + +S S+V+S+G ++E ++ G+ Y
Sbjct: 488 ADDSYYTARSAGKWPLKWYAPECINFRKFSSR----SDVWSYGVTMWEALSYGQKPYKKM 543
Query: 626 -------SIENGSLENWASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPK 678
IE G + + E P EL ++ +C +
Sbjct: 544 KGPEVMAFIEQG-------KRM--ECP-------------PECPPELYALMSDCWIYKWE 581
Query: 679 QRPSMRGIAAKLKEI 693
RP + +++
Sbjct: 582 DRPDFLTVEQRMRAC 596
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 1e-18
Identities = 51/288 (17%), Positives = 99/288 (34%), Gaps = 73/288 (25%)
Query: 433 GSFSDGTVGTVYKGT-LSSGV-----EIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVN 486
GS+ G K S G E+ S + + +++ L ++
Sbjct: 17 GSY-----GRCQKIRRKSDGKILVWKELDYGSMTEAEKQ--------MLVSEVNLLRELK 63
Query: 487 HKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHL--------HIQEAEHLDWAMRLRIA 538
H N V + T +V EY G L + ++ E L ++
Sbjct: 64 HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVM--TQLT 121
Query: 539 MGMAYCLEH-MHQLTPPIAHRNLQSSSIYLTEDYAAKISDF----SFWNNTTAAKT--GS 591
+ + C H + HR+L+ ++++L K+ DF ++T+ AKT G+
Sbjct: 122 LALKEC--HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGT 179
Query: 592 ---AAMELLETSAVDLESNVYSFGTILFEMITGR----------ISYSIENGSLENWASE 638
+ E + + + +S+++S G +L+E+ ++ I G
Sbjct: 180 PYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYR 239
Query: 639 YLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGI 686
Y S +EL +I ++ RPS+ I
Sbjct: 240 Y----------------S------DELNEIITRMLNLKDYHRPSVEEI 265
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 2e-18
Identities = 67/309 (21%), Positives = 118/309 (38%), Gaps = 69/309 (22%)
Query: 420 ELEAACEDFSNIIGSFSDGTVGTVYKGTL--SSGVEIAVTSTSVKS-RADWSKNLESQFR 476
EL+A ++G+ G G V G L S EI+V ++K+ + +++ F
Sbjct: 41 ELDATNISIDKVVGA---GEFGEVCSGRLKLPSKKEISV---AIKTLKVGYTEKQRRDFL 94
Query: 477 KKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEH-----LDW 531
+ + + +H N + L G + +P M+V EY NGSL L +A+ +
Sbjct: 95 GEASIMGQFDHPNIIRLEGVVTKSKPV--MIVTEYMENGSLDSFLRKHDAQFTVIQLVGM 152
Query: 532 AMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDF------SFWNNTT 585
IA GM Y L M HR+L + +I + + K+SDF
Sbjct: 153 L--RGIASGMKY-LSDMG-----YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAA 204
Query: 586 AAKTGS------AAMELLE----TSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLEN 634
G + E + TSA S+V+S+G +L+E+++ G Y
Sbjct: 205 YTTRGGKIPIRWTSPEAIAYRKFTSA----SDVWSYGIVLWEVMSYGERPY--------- 251
Query: 635 WASEYLKGEQPLKDIVD------PTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688
+ + +K + + P + L ++ +C D RP I +
Sbjct: 252 ---WEMSNQDVIKAVDEGYRLPPP------MDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302
Query: 689 KLKEITAME 697
L ++
Sbjct: 303 ILDKLIRNP 311
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 2e-18
Identities = 61/307 (19%), Positives = 118/307 (38%), Gaps = 76/307 (24%)
Query: 433 GSFSDGTVGTVYKGTLSSGVEIAVTST-SVKS-RADWSKNLESQFRKKIDTLSKV-NHKN 489
G+F G V T + V+ +VK + + ++ ++++ +H+N
Sbjct: 56 GAF-----GKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110
Query: 490 FVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHL---------------HIQEAEHLDWAMR 534
VNL+G C P ++FEY G L +L + + E +
Sbjct: 111 IVNLLGACTLSGPI--YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 168
Query: 535 LR----------IAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSF---- 580
L +A GM + LE HR+L + ++ +T KI DF
Sbjct: 169 LTFEDLLCFAYQVAKGMEF-LEFKS-----CVHRDLAARNVLVTHGKVVKICDFGLARDI 222
Query: 581 WNNTTAAKTGSA-------AMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSL 632
+++ G+A A E L ++S+V+S+G +L+E+ + G Y +
Sbjct: 223 MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP----GI 278
Query: 633 ENWAS--EYLKG----EQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGI 686
A+ + ++ +QP EE+ +++++C D ++RPS +
Sbjct: 279 PVDANFYKLIQNGFKMDQP-------------FYATEEIYIIMQSCWAFDSRKRPSFPNL 325
Query: 687 AAKLKEI 693
+ L
Sbjct: 326 TSFLGCQ 332
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 6e-18
Identities = 60/284 (21%), Positives = 105/284 (36%), Gaps = 54/284 (19%)
Query: 430 NIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVK--SRADWSKNLESQFRKKIDTLSKVNH 487
IGS G V++ A+ K + + +R +I L+K+
Sbjct: 34 KQIGS---GGSSKVFQVLNEKKQIYAI-----KYVNLEEADNQTLDSYRNEIAYLNKLQQ 85
Query: 488 KNF--VNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCL 545
+ + L Y D+ MV E N L +++ + +D R M +
Sbjct: 86 HSDKIIRLYDYEITDQYI--YMVMECG-NIDLNSW--LKKKKSIDPWERKSYWKNMLEAV 140
Query: 546 EHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDF----SFWNNTTAAKTGS-------AAM 594
+HQ I H +L+ ++ L D K+ DF +TT+ S
Sbjct: 141 HTIHQHG--IVHSDLKPANF-LIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 197
Query: 595 ELLE-----------TSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGE 643
E ++ S + +S+V+S G IL+ M G+ + +
Sbjct: 198 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK--------- 248
Query: 644 QPLKDIVDPTLK-SFQENVLEELLVVIKNCVHPDPKQRPSMRGI 686
L I+DP + F + ++L V+K C+ DPKQR S+ +
Sbjct: 249 --LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 290
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 6e-18
Identities = 59/308 (19%), Positives = 108/308 (35%), Gaps = 67/308 (21%)
Query: 427 DFSNIIGSFSDGTVGTVYKGT-LSSGVEIAVTSTSVK--SRADWSKNLESQFRKKIDTLS 483
S+I+G G V++G +G A+ K + + + ++ Q R+ + L
Sbjct: 12 LLSDILGQ---GATANVFRGRHKKTGDLFAI-----KVFNNISFLRPVDVQMRE-FEVLK 62
Query: 484 KVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLH-------IQEAEHLDWAMRL- 535
K+NHKN V L EE ++++ E+ P GSL+ L + E+E + +
Sbjct: 63 KLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESE----FLIVL 118
Query: 536 -RIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLT----EDYAAKISDFSF---WNNTTAA 587
+ GM + E+ I HRN++ +I K++DF +
Sbjct: 119 RDVVGGMNHLRENG------IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF 172
Query: 588 KT--GS---AAMELLETSAV--------DLESNVYSFGTILFEMITGR------------ 622
+ G+ ++ E + + +++S G + TG
Sbjct: 173 VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN 232
Query: 623 --ISYSIENGSLENWASEYLKGEQPLKDIVD--PTLKSFQENVLEELLVVIKNCVHPDPK 678
+ Y I G S K E D P S + L V+ N + D +
Sbjct: 233 KEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQE 292
Query: 679 QRPSMRGI 686
+
Sbjct: 293 KCWGFDQF 300
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 7e-18
Identities = 63/276 (22%), Positives = 118/276 (42%), Gaps = 58/276 (21%)
Query: 433 GSFSDGTVGTVYKGT-LSSGV-----EIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVN 486
GSF G G EI ++ S K R + R+++ L+ +
Sbjct: 35 GSF-----GKAILVKSTEDGRQYVIKEINISRMSSKEREE--------SRREVAVLANMK 81
Query: 487 HKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHL------HIQEAEHLDWAMRLRIAMG 540
H N V EE+ +V +Y G LF+ + QE + LDW +++ +A
Sbjct: 82 HPNIVQYRESFEENGSL--YIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLA-- 137
Query: 541 MAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDF----SFWNNTTAAKT--GS--- 591
L+H+H I HR+++S +I+LT+D ++ DF + A+ G+
Sbjct: 138 ----LKHVHDRK--ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYY 191
Query: 592 AAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGE-QPLKDIV 650
+ E+ E + +S++++ G +L+E+ T + ++ E GS++N + + G P+
Sbjct: 192 LSPEICENKPYNNKSDIWALGCVLYELCTLKHAF--EAGSMKNLVLKIISGSFPPVSLHY 249
Query: 651 DPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGI 686
L+S + +P+ RPS+ I
Sbjct: 250 SYDLRSL-----------VSQLFKRNPRDRPSVNSI 274
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 8e-18
Identities = 60/301 (19%), Positives = 111/301 (36%), Gaps = 70/301 (23%)
Query: 433 GSFSDGTVGTVYKGTLSSGVEIAVTST-SVKS-RADWSKNLESQFRKKIDTLSKV-NHKN 489
G+F G V + + A T +VK + + + ++ L + +H N
Sbjct: 38 GAF-----GQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 490 FVNLIGYC-EEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWA---------------- 532
VNL+G C + P M++ E+ G+L +L + E + +
Sbjct: 93 VVNLLGACTKPGGPL--MVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 533 --MRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSF----WNNTTA 586
++A GM + L HR+L + +I L+E KI DF + +
Sbjct: 151 ICYSFQVAKGMEF-LASRK-----CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 204
Query: 587 AKTGSAAM-------ELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWAS- 637
+ G A + E + ++S+V+SFG +L+E+ + G Y ++
Sbjct: 205 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP----GVKIDEEF 260
Query: 638 -EYLKG----EQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKE 692
LK P + E+ + +C H +P QRP+ + L
Sbjct: 261 CRRLKEGTRMRAP-------------DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 307
Query: 693 I 693
+
Sbjct: 308 L 308
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 2e-17
Identities = 58/284 (20%), Positives = 105/284 (36%), Gaps = 54/284 (19%)
Query: 430 NIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVK--SRADWSKNLESQFRKKIDTLSKVNH 487
IGS G V++ A+ K + + +R +I L+K+
Sbjct: 15 KQIGS---GGSSKVFQVLNEKKQIYAI-----KYVNLEEADNQTLDSYRNEIAYLNKLQQ 66
Query: 488 KNF--VNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCL 545
+ + L Y D+ MV E N L +++ + +D R M +
Sbjct: 67 HSDKIIRLYDYEITDQYI--YMVMECG-NIDLNSW--LKKKKSIDPWERKSYWKNMLEAV 121
Query: 546 EHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDF----SFWNNTTAAKTGS-------AAM 594
+HQ I H +L+ ++ + + K+ DF +TT+ S
Sbjct: 122 HTIHQHG--IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 178
Query: 595 ELLE-----------TSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGE 643
E ++ S + +S+V+S G IL+ M G+ + +
Sbjct: 179 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK--------- 229
Query: 644 QPLKDIVDPTLK-SFQENVLEELLVVIKNCVHPDPKQRPSMRGI 686
L I+DP + F + ++L V+K C+ DPKQR S+ +
Sbjct: 230 --LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 271
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 83.3 bits (206), Expect = 3e-17
Identities = 60/284 (21%), Positives = 105/284 (36%), Gaps = 54/284 (19%)
Query: 430 NIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVK--SRADWSKNLESQFRKKIDTLSKVNH 487
IGS G V++ A+ K + + +R +I L+K+
Sbjct: 62 KQIGS---GGSSKVFQVLNEKKQIYAI-----KYVNLEEADNQTLDSYRNEIAYLNKLQQ 113
Query: 488 KNF--VNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCL 545
+ + L Y D+ MV E N L +++ + +D R M +
Sbjct: 114 HSDKIIRLYDYEITDQYI--YMVMECG-NIDLNSW--LKKKKSIDPWERKSYWKNMLEAV 168
Query: 546 EHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDF----SFWNNTTAAKTGS-------AAM 594
+HQ I H +L+ ++ L D K+ DF +TT+ S
Sbjct: 169 HTIHQHG--IVHSDLKPANF-LIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPP 225
Query: 595 ELLE-----------TSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGE 643
E ++ S + +S+V+S G IL+ M G+ + +
Sbjct: 226 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK--------- 276
Query: 644 QPLKDIVDPTLK-SFQENVLEELLVVIKNCVHPDPKQRPSMRGI 686
L I+DP + F + ++L V+K C+ DPKQR S+ +
Sbjct: 277 --LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 318
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 82.6 bits (204), Expect = 5e-17
Identities = 61/318 (19%), Positives = 112/318 (35%), Gaps = 67/318 (21%)
Query: 427 DFSNIIGSFSDGTVGTVYKGT-LSSGVEIAVTSTSVK--SRADWSKNLESQFRKKIDTLS 483
S+I+G G V++G +G A+ K + + + ++ Q R+ + L
Sbjct: 12 LLSDILGQ---GATANVFRGRHKKTGDLFAI-----KVFNNISFLRPVDVQMRE-FEVLK 62
Query: 484 KVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLH-------IQEAEHLDWAMRL- 535
K+NHKN V L EE ++++ E+ P GSL+ L + E+E + +
Sbjct: 63 KLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESE----FLIVL 118
Query: 536 -RIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLT----EDYAAKISDFSF---WNNTTAA 587
+ GM + E+ I HRN++ +I K++DF +
Sbjct: 119 RDVVGGMNHLRENG------IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF 172
Query: 588 KT--GS---AAMELLETSAV--------DLESNVYSFGTILFEMITGR------------ 622
+ G+ ++ E + + +++S G + TG
Sbjct: 173 VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN 232
Query: 623 --ISYSIENGSLENWASEYLKGEQPLKDIVD--PTLKSFQENVLEELLVVIKNCVHPDPK 678
+ Y I G S K E D P S + L V+ N + D +
Sbjct: 233 KEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQE 292
Query: 679 QRPSMRGIAAKLKEITAM 696
+ A+ +I
Sbjct: 293 KCWGFDQFFAETSDILHR 310
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 1e-16
Identities = 36/261 (13%), Positives = 78/261 (29%), Gaps = 65/261 (24%)
Query: 468 SKNLESQFRKKIDTLSKVNHKNFVNLIGYCE-EDEPFTRMMVFEYSPNGSLFEHLHIQEA 526
K+ F+ ++ ++ + ++ + G DE + +++EY N S+ +
Sbjct: 83 IKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVY---IIYEYMENDSILKFDEYFFV 139
Query: 527 EHLDWAMRLR----------IAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKIS 576
++ + + +Y + I HR+++ S+I + ++ K+S
Sbjct: 140 LDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN-----ICHRDVKPSNILMDKNGRVKLS 194
Query: 577 DF--SFWNNTTAAKT--GS---AAMELLET------SAVDLESNVYSFGTILFEMITG-- 621
DF S + K G+ E + VD ++S G L+ M
Sbjct: 195 DFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVD----IWSLGICLYVMFYNVV 250
Query: 622 -------------RIS---YSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQENVLEEL 665
I K + + F L+
Sbjct: 251 PFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDF----LKLF 306
Query: 666 LVVIKNCVHPDPKQRPSMRGI 686
L +P +R +
Sbjct: 307 LRK-------NPAERITSEDA 320
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 59/286 (20%), Positives = 93/286 (32%), Gaps = 57/286 (19%)
Query: 426 EDFSNI--IGSFSDGTVGTVYKGT-LSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTL 482
+ F + +G G+ G V+K G AV S K+ + +
Sbjct: 57 QSFQRLSRLGH---GSYGEVFKVRSKEDGRLYAVKR--SMSPFRGPKDRARKLAEVGSHE 111
Query: 483 SKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHL-----HIQEAEHLDWAMRLRI 537
H V L EE + E SL +H + EA+ +
Sbjct: 112 KVGQHPCCVRLEQAWEEGGIL--YLQTELC-GPSLQQHCEAWGASLPEAQVWGYL--RDT 166
Query: 538 AMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDF---SFWNNTTAAKT--GSA 592
+ L H+H + H +++ ++I+L K+ DF A + G
Sbjct: 167 LLA----LAHLHSQG--LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDP 220
Query: 593 ---AMELLE---TSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPL 646
A ELL+ +A D V+S G + E+ E W Q L
Sbjct: 221 RYMAPELLQGSYGTAAD----VFSLGLTILEVACNMELPH----GGEGW--------QQL 264
Query: 647 KDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKE 692
+ P F + EL V+ + PDPK R + A L
Sbjct: 265 RQGYLP--PEFTAGLSSELRSVLVMMLEPDPKLRAT----AEALLA 304
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 77.4 bits (190), Expect = 3e-15
Identities = 22/322 (6%), Positives = 75/322 (23%), Gaps = 52/322 (16%)
Query: 401 LSGQLQKAFVTGVPKLKRSELEAACEDFS--NIIGSFSDGTVGTVYKGT-LSSGVEIAVT 457
+ + S L + G V+ + + A+
Sbjct: 37 VEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRV---GDRSVVFLVRDVERLEDFALK 93
Query: 458 STSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPF-------------- 503
++ + S+ + + +++ ++ P
Sbjct: 94 VFTMGAENSRSE--LERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQL 151
Query: 504 ----------TRMMVFEYSPNGSLFE-----HLHIQEAEHLDWAMRLRIAMGMAYCLEHM 548
+++ + L + + ++
Sbjct: 152 SPGQDDYAVANYLLLMPA-ASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANL 210
Query: 549 HQLTPPIAHRNLQSSSIYLTEDYAAKISDFSF---WNNTTAAKTGSAAM---ELL--ETS 600
+ H + ++++ D + D S A + E L T+
Sbjct: 211 QSK--GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGPASSVPVTYAPREFLNASTA 268
Query: 601 AVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQEN 660
N + G ++ + + + + + + + S
Sbjct: 269 TFTHALNAWQLGLSIYRVWCLFLPFGLVT---PGIKGSWKRPSLRVPGTDSLAFGS-CTP 324
Query: 661 VLEELLVVIKNCVHPDPKQRPS 682
+ + + +I ++ D ++R
Sbjct: 325 LPDFVKTLIGRFLNFDRRRRLL 346
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 3e-15
Identities = 46/225 (20%), Positives = 96/225 (42%), Gaps = 28/225 (12%)
Query: 470 NLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRM-MVFEYSPNGSLFEHLHIQEAEH 528
+E Q R++++ S + H N + L GY + TR+ ++ EY+P G+++ L Q+
Sbjct: 51 GVEHQLRREVEIQSHLRHPNILRLYGYFHDA---TRVYLILEYAPLGTVYREL--QKLSK 105
Query: 529 LDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTAAK 588
D +A L + H + HR+++ ++ L KI+DF + + +++
Sbjct: 106 FDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 163
Query: 589 T----GS---AAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLK 641
G+ E++E D + +++S G + +E + G+ + E + + +
Sbjct: 164 RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF--EANTYQETYKRISR 221
Query: 642 GEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGI 686
E D V + I + +P QRP +R +
Sbjct: 222 VEFTFPDFVTEGARDL-----------ISRLLKHNPSQRPMLREV 255
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 4e-15
Identities = 50/254 (19%), Positives = 100/254 (39%), Gaps = 40/254 (15%)
Query: 475 FRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRM--MVFEYSPNGSLFEHLHIQEAEHLDWA 532
FR++ + +NH V + E + P + +V EY +L + + +
Sbjct: 59 FRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDI--VHTEGPMTPK 116
Query: 533 MRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDF---SFWNNTTAAKT 589
+ + L HQ I HR+++ ++I ++ A K+ DF ++ + T
Sbjct: 117 RAIEVIADACQALNFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVT 174
Query: 590 GSAAM---------ELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYL 640
+AA+ E +VD S+VYS G +L+E++TG ++
Sbjct: 175 QTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT-------------- 220
Query: 641 KGEQP----LKDIVD--PTLKSFQENVLEELLVVIKNCVHPDPKQRP-SMRGIAAKLKEI 693
G+ P + + + + E + +L V+ + +P+ R + + A L +
Sbjct: 221 -GDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279
Query: 694 TAMEPDGATPKLSP 707
EP A L+
Sbjct: 280 HNGEPPEAPKVLTD 293
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 4e-15
Identities = 61/307 (19%), Positives = 109/307 (35%), Gaps = 77/307 (25%)
Query: 426 EDFSNI--IGSFSDGTVGTVYKGT-LSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTL 482
DF I +G G G V K A+ K + ++ S ++ L
Sbjct: 6 SDFEEIAVLGQ---GAFGQVVKARNALDSRYYAI-----K-KIRHTEEKLSTILSEVMLL 56
Query: 483 SKVNHKNFVNLIGYCEEDEPFTRM-----------MVFEYSPNGSLFEHL-----HIQEA 526
+ +NH+ V E F + + EY NG+L++ + + Q
Sbjct: 57 ASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRD 116
Query: 527 EHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDF----SFWN 582
E+ R +I ++Y H I HR+L+ +I++ E KI DF +
Sbjct: 117 EYWRL-FR-QILEALSYI--HSQG----IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHR 168
Query: 583 NTTAAKTGSAAM-------------------ELLETSAV-DLESNVYSFGTILFEMITGR 622
+ K S + E+L+ + + + ++YS G I FEMI
Sbjct: 169 SLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP- 227
Query: 623 ISYSIENGSLENWASEYLKGEQPLKDIVDPTLK---SFQENVLEELLVVIKNCVHPDPKQ 679
G LK + +++ F +N ++ +I+ + DP +
Sbjct: 228 ----FSTGMERV---------NILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNK 274
Query: 680 RPSMRGI 686
RP R +
Sbjct: 275 RPGARTL 281
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 5e-15
Identities = 47/225 (20%), Positives = 93/225 (41%), Gaps = 40/225 (17%)
Query: 475 FRKKIDTLSKVNHKNFVNLIGYCEEDE-PFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAM 533
F +++ S+++H+N V++I EED+ + +V EY +L E+ I+ L
Sbjct: 58 FEREVHNSSQLSHQNIVSMIDVDEEDDCYY---LVMEYIEGPTLSEY--IESHGPLSVDT 112
Query: 534 RLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDF---SFWNNTTAAKTG 590
+ + ++H H + I HR+++ +I + + KI DF + T+ +T
Sbjct: 113 AINFTNQILDGIKHAHDMR--IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTN 170
Query: 591 SA-------AMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGE 643
+ E + A D +++YS G +L+EM+ G ++ GE
Sbjct: 171 HVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFN---------------GE 215
Query: 644 QP-------LKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRP 681
++D V ++++ + L VI D R
Sbjct: 216 TAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRY 260
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 5e-15
Identities = 53/266 (19%), Positives = 98/266 (36%), Gaps = 45/266 (16%)
Query: 438 GTVGTVYKGT-LSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGY 496
G ++ + + A KS + + +I + H++ V G+
Sbjct: 26 GGFAKCFEISDADTKEVFAGKIVP-KSLLL-KPHQREKMSMEISIHRSLAHQHVVGFHGF 83
Query: 497 CEEDEPFTRM-MVFEYSPNGSLFEHL----HIQEAEHLDWAMRL--RIAMGMAYCLEHMH 549
E++ + +V E SL E + E E A +I +G Y H +
Sbjct: 84 FEDN---DFVFVVLELCRRRSLLELHKRRKALTEPE----ARYYLRQIVLGCQYL--HRN 134
Query: 550 QLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTAA----KT--GS---AAMELLETS 600
+ + HR+L+ +++L ED KI DF K G+ A E+L
Sbjct: 135 R----VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKK 190
Query: 601 AVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQEN 660
E +V+S G I++ ++ G+ + E L+ K E + ++P S
Sbjct: 191 GHSFEVDVWSIGCIMYTLLVGKPPF--ETSCLKETYLRIKKNEYSIPKHINPVAASL--- 245
Query: 661 VLEELLVVIKNCVHPDPKQRPSMRGI 686
I+ + DP RP++ +
Sbjct: 246 --------IQKMLQTDPTARPTINEL 263
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 77.0 bits (189), Expect = 8e-15
Identities = 55/297 (18%), Positives = 99/297 (33%), Gaps = 55/297 (18%)
Query: 427 DFSNIIGSFSDGTVGTVYKGT-LSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKV 485
+ +G+ G G V + +G ++A+ + KN E + I + K+
Sbjct: 17 EMKERLGT---GGFGYVLRWIHQDTGEQVAIKQ--CRQELS-PKNRERWCLE-IQIMKKL 69
Query: 486 NHKNFVNLIGYCEEDEPFTRM----MVFEYSPNGSLFEHLH-------IQEAEHLDWAMR 534
NH N V+ + + + EY G L ++L+ ++E
Sbjct: 70 NHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGP----IRT 125
Query: 535 L--RIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYL---TEDYAAKISDFSF---WNNTTA 586
L I+ + Y E+ I HR+L+ +I L + KI D + +
Sbjct: 126 LLSDISSALRYLHENR------IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL 179
Query: 587 AKT--GS---AAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLK 641
G+ A ELLE + + +SFGT+ FE ITG + W + +
Sbjct: 180 CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP-VQWHGKVRE 238
Query: 642 GEQ----PLKDIVDPTLKSFQENVLEELLVVIKNCVHP--------DPKQRPSMRGI 686
D+ S L ++ + +QR +
Sbjct: 239 KSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN 295
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 2e-14
Identities = 25/134 (18%), Positives = 47/134 (35%), Gaps = 10/134 (7%)
Query: 104 NVNPCSW---FGVEC-SDGKVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFG--- 156
N W GV S+G+V L+L G + +GQL+EL+ + L ++
Sbjct: 63 NKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNER 122
Query: 157 -TIPKEIGELKELEILDLGFNNFSGPFPSDFG--NSFSLTTLLLDNNQYLGGISPELHVL 213
PK I E ++ F + L ++++ I +
Sbjct: 123 LFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRIT 182
Query: 214 KVISEIQVDESWLT 227
++I + +T
Sbjct: 183 LKDTQIGQLSNNIT 196
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 1e-13
Identities = 17/90 (18%), Positives = 37/90 (41%), Gaps = 3/90 (3%)
Query: 122 ILNLRDLCLGGMLAPELGQLSELKSIILRNNSFF-GTIPKEIGELKELEILDLGFNNFSG 180
++ L + +++ I + N+ + + ++K+L +L+ +N G
Sbjct: 285 GISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEG 344
Query: 181 PFPSDFGNSFSLTTLLLDNNQYLGGISPEL 210
P+ FG+ L +L L NQ + I
Sbjct: 345 KLPA-FGSEIKLASLNLAYNQ-ITEIPANF 372
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 3e-13
Identities = 10/87 (11%), Positives = 26/87 (29%), Gaps = 8/87 (9%)
Query: 123 LNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNF---- 178
N + L +L + + N +P + L E++++++ N
Sbjct: 230 ENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGE 289
Query: 179 ----SGPFPSDFGNSFSLTTLLLDNNQ 201
+D + + + N
Sbjct: 290 QLKDDWQALADAPVGEKIQIIYIGYNN 316
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 6e-12
Identities = 26/137 (18%), Positives = 39/137 (28%), Gaps = 12/137 (8%)
Query: 87 DPFGALSK-WSDNDGVGDNVNPCSWFGVECSDGKVVILNLRDLCL-GGMLAPELGQLSEL 144
+ AL + W +G S G G N ++L + G L +
Sbjct: 30 KDYLALKEIWDALNG-----KNWSQQGFGTQPGANWNFN-KELDMWGAQPGVSLNSNGRV 83
Query: 145 KSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGP----FPSDFGNSFSLTTLLLDNN 200
+ L G +P IG+L ELE+L LG + P + S
Sbjct: 84 TGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRM 143
Query: 201 QYLGGISPELHVLKVIS 217
Y
Sbjct: 144 HYQKTFVDYDPREDFSD 160
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 1e-10
Identities = 13/81 (16%), Positives = 25/81 (30%), Gaps = 8/81 (9%)
Query: 137 ELGQLSELKSIILRNNSF-------FGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNS 189
+ +S + +I N F + + + ++L N S F
Sbjct: 397 DAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTG 456
Query: 190 FSLTTLLLDNNQYLGGISPEL 210
L+++ L N L I
Sbjct: 457 SPLSSINLMGNM-LTEIPKNS 476
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 2e-10
Identities = 15/75 (20%), Positives = 29/75 (38%), Gaps = 2/75 (2%)
Query: 136 PELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTL 195
L ++ +L + N G +P G +L L+L +N + + G + + L
Sbjct: 324 TSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITEIPANFCGFTEQVENL 382
Query: 196 LLDNNQYLGGISPEL 210
+N+ L I
Sbjct: 383 SFAHNK-LKYIPNIF 396
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 2e-10
Identities = 17/86 (19%), Positives = 31/86 (36%), Gaps = 8/86 (9%)
Query: 136 PELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSG-------PFPSDFGN 188
P + + SI L NN + L ++L N + +F N
Sbjct: 427 PTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKN 486
Query: 189 SFSLTTLLLDNNQYLGGISPELHVLK 214
++ LT++ L N+ L +S +
Sbjct: 487 TYLLTSIDLRFNK-LTKLSDDFRATT 511
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 2e-10
Identities = 10/85 (11%), Positives = 25/85 (29%)
Query: 124 NLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFP 183
LR +G ++ + T + LK+L +++ P
Sbjct: 207 KLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLP 266
Query: 184 SDFGNSFSLTTLLLDNNQYLGGISP 208
+ + + + N+ + G
Sbjct: 267 TFLKALPEMQLINVACNRGISGEQL 291
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 3e-09
Identities = 13/107 (12%), Positives = 27/107 (25%), Gaps = 20/107 (18%)
Query: 123 LNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGP- 181
+ + + I +N+ + K + L +L +G + F
Sbjct: 164 DCINSDPQQKSIKKSSRITLKDTQIGQLSNNI-TFVSKAVMRLTKLRQFYMGNSPFVAEN 222
Query: 182 ------------------FPSDFGNSFSLTTLLLDNNQYLGGISPEL 210
+ N LT + + N L + L
Sbjct: 223 ICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFL 269
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 3e-09
Identities = 16/95 (16%), Positives = 29/95 (30%), Gaps = 10/95 (10%)
Query: 122 ILNLRDLCLGGMLAPELGQLSELKSIILRN------NSFFGTIPKEIGELKELEILDLGF 175
++L + S LK +RN N P+ I L L +G
Sbjct: 517 GIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGS 575
Query: 176 NNFSGPFPSDFGNSFSLTTLLLDNNQYLGGISPEL 210
N+ N ++ L + +N + +
Sbjct: 576 NDIRKVNEKITPN---ISVLDIKDNPNISIDLSYV 607
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 3e-09
Identities = 20/78 (25%), Positives = 29/78 (37%), Gaps = 4/78 (5%)
Query: 130 LGGMLAPELGQLSELKSIILRNNSFFGTIPKEI--GELKELEILDLGFNNFSGPFPSDFG 187
L SI LR N + + L L +DL +N+FS FP+
Sbjct: 476 SLKDENENFKNTYLLTSIDLRFNKL-TKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPL 533
Query: 188 NSFSLTTLLLDNNQYLGG 205
NS +L + N + G
Sbjct: 534 NSSTLKGFGIRNQRDAQG 551
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 4e-09
Identities = 16/76 (21%), Positives = 29/76 (38%), Gaps = 4/76 (5%)
Query: 136 PELGQLSELKSIILRNNSFFGTIPKEI-GELKELEILDLGFNNFSG-PFPSDFGNSFSLT 193
P G +L S+ L N IP G +++E L N P D + ++
Sbjct: 347 PAFGSEIKLASLNLAYNQI-TEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMS 405
Query: 194 TLLLDNNQYLGGISPE 209
+ N+ +G + +
Sbjct: 406 AIDFSYNE-IGSVDGK 420
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 1e-08
Identities = 16/97 (16%), Positives = 24/97 (24%), Gaps = 9/97 (9%)
Query: 122 ILNLRDLCLGGMLAPELGQLSELKSIILRNNSF-------FGTIPKEIGELKELEILDLG 174
+NL + + S L SI L N + L +DL
Sbjct: 437 SINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLR 496
Query: 175 FNNFSG-PFPSDFGNSFSLTTLLLDNNQYLGGISPEL 210
FN + L + L N +
Sbjct: 497 FNKLTKLSDDFRATTLPYLVGIDLSYNS-FSKFPTQP 532
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 5e-08
Identities = 10/101 (9%), Positives = 24/101 (23%), Gaps = 3/101 (2%)
Query: 122 ILNLRDLCLGGMLAPELG--QLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFS 179
+ S+L + ++ +I K + + NN +
Sbjct: 137 QKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNIT 196
Query: 180 GPFPSDFGNSFSLTTLLLDNNQYLGGISPELHVLKVISEIQ 220
L + N+ ++ E + Q
Sbjct: 197 F-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQ 236
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 1e-07
Identities = 8/70 (11%), Positives = 21/70 (30%), Gaps = 3/70 (4%)
Query: 132 GMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFS 191
+ L + + +N + ++I + +LD+ N S
Sbjct: 556 REWPEGITLCPSLTQLQIGSNDI-RKVNEKI--TPNISVLDIKDNPNISIDLSYVCPYIE 612
Query: 192 LTTLLLDNNQ 201
+L ++
Sbjct: 613 AGMYMLFYDK 622
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 2e-14
Identities = 53/266 (19%), Positives = 98/266 (36%), Gaps = 45/266 (16%)
Query: 438 GTVGTVYKGT-LSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGY 496
G ++ + + A KS + + +I + H++ V G+
Sbjct: 52 GGFAKCFEISDADTKEVFAGKIVP-KSLLL-KPHQREKMSMEISIHRSLAHQHVVGFHGF 109
Query: 497 CEEDEPFTRM-MVFEYSPNGSLFEHL----HIQEAEHLDWAMRL--RIAMGMAYCLEHMH 549
E++ + +V E SL E + E E A +I +G Y H +
Sbjct: 110 FEDN---DFVFVVLELCRRRSLLELHKRRKALTEPE----ARYYLRQIVLGCQYL--HRN 160
Query: 550 QLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTAA----KT--GS---AAMELLETS 600
+ + HR+L+ +++L ED KI DF K G+ A E+L
Sbjct: 161 R----VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKK 216
Query: 601 AVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQEN 660
E +V+S G I++ ++ G+ + E L+ K E + ++P S
Sbjct: 217 GHSFEVDVWSIGCIMYTLLVGKPPF--ETSCLKETYLRIKKNEYSIPKHINPVAASL--- 271
Query: 661 VLEELLVVIKNCVHPDPKQRPSMRGI 686
I+ + DP RP++ +
Sbjct: 272 --------IQKMLQTDPTARPTINEL 289
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 3e-14
Identities = 32/161 (19%), Positives = 73/161 (45%), Gaps = 15/161 (9%)
Query: 470 NLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRM-MVFEYSPNGSLFEHLHIQEAEH 528
+E Q R++I+ S + H N + + Y + R+ ++ E++P G L++ L Q+
Sbjct: 56 GVEHQLRREIEIQSHLRHPNILRMYNYFHDR---KRIYLMLEFAPRGELYKEL--QKHGR 110
Query: 529 LDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTAAK 588
D +A L + H+ + HR+++ ++ + KI+DF + + + +
Sbjct: 111 FDEQRSATFMEELADALHYCHERK--VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR 168
Query: 589 T----GS---AAMELLETSAVDLESNVYSFGTILFEMITGR 622
G+ E++E D + +++ G + +E + G
Sbjct: 169 RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGM 209
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 3e-14
Identities = 47/201 (23%), Positives = 87/201 (43%), Gaps = 29/201 (14%)
Query: 438 GTVGTVYKGT-LSSGVEIAVTSTSVKSRADWSK-NLESQFRKKIDTLSKVNHKNFVNLIG 495
G+ VY+ + +G+E+A+ + + K + + + ++ ++ H + + L
Sbjct: 22 GSFAGVYRAESIHTGLEVAI---KMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 496 YCEEDEPFTRM-MVFEYSPNGSLFEHLHIQEAEHLDWAMR---LRIAMGMAYCLEHMHQL 551
Y E+ + +V E NG + +L + + R +I GM Y H H
Sbjct: 79 YFEDS---NYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYL--HSHG- 132
Query: 552 TPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTAA-----KT--GS---AAMELLETSA 601
I HR+L S++ LT + KI+DF T G+ + E+ SA
Sbjct: 133 ---ILHRDLTLSNLLLTRNMNIKIADFG-LATQLKMPHEKHYTLCGTPNYISPEIATRSA 188
Query: 602 VDLESNVYSFGTILFEMITGR 622
LES+V+S G + + ++ GR
Sbjct: 189 HGLESDVWSLGCMFYTLLIGR 209
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 73.3 bits (180), Expect = 4e-14
Identities = 57/304 (18%), Positives = 98/304 (32%), Gaps = 69/304 (22%)
Query: 433 GSFSDGTVGTVYKGT-LSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKV-NHKNF 490
G F VY+ + SG E A+ +++ + K+ H N
Sbjct: 39 GGF-----AFVYEAQDVGSGREYALKRLLSNEEEK-----NRAIIQEVCFMKKLSGHPNI 88
Query: 491 VNLIGYC-----EEDEPFTRMMVFEYSPNGSLFEHL-HIQEAEHLDWAMRLRIAMGMAYC 544
V E D ++ G L E L ++ L L+I
Sbjct: 89 VQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRA 148
Query: 545 LEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDF---SFWNNTTAAKTGSAAMELLETSA 601
++HMH+ PPI HR+L+ ++ L+ K+ DF + ++ + L+E
Sbjct: 149 VQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEI 208
Query: 602 -------------VDLESNVY--------SFGTILFEMITGR------ISYSIENGSLEN 634
+DL SN + G IL+ + + I NG
Sbjct: 209 TRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNGKYSI 268
Query: 635 WASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEIT 694
P D S I+ + +P++R S+ + +L+EI
Sbjct: 269 ----------PPHDTQYTVFHSL-----------IRAMLQVNPEERLSIAEVVHQLQEIA 307
Query: 695 AMEP 698
A
Sbjct: 308 AARN 311
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 5e-14
Identities = 61/282 (21%), Positives = 104/282 (36%), Gaps = 58/282 (20%)
Query: 427 DFSNIIGSFSDGTVGTVYKGT-LSSGVEIAVTSTSVKS--RADWSKNLESQFRKKIDTLS 483
+GS G G V + VE A+ K + S + S+ +++ L
Sbjct: 40 QRVKKLGS---GAYGEVLLCRDKVTHVERAI-----KIIRKTSVSTSSNSKLLEEVAVLK 91
Query: 484 KVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAY 543
++H N + L + E+ + +V E G LF+ I + I +
Sbjct: 92 LLDHPNIMKLYDFFEDKRNYY--LVMECYKGGELFDE--IIHRMKFNEVDAAVIIKQVLS 147
Query: 544 CLEHMHQLTPPIAHRNLQSSSIYLT---EDYAAKISDF---SFWNNTTAAKT--GSA--- 592
+ ++H+ I HR+L+ ++ L +D KI DF + + N K G+A
Sbjct: 148 GVTYLHKHN--IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYI 205
Query: 593 AMELLETSAVDLESNVYSFGTILFEMITGR----------ISYSIENGSLENWASEYLKG 642
A E+L D + +V+S G ILF ++ G I +E G + S K
Sbjct: 206 APEVLRKK-YDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKY-TFDSPEWKN 263
Query: 643 EQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMR 684
V K IK + D ++R S +
Sbjct: 264 -------VSEGAKDL-----------IKQMLQFDSQRRISAQ 287
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 72.7 bits (178), Expect = 8e-14
Identities = 46/314 (14%), Positives = 99/314 (31%), Gaps = 60/314 (19%)
Query: 413 VPKLK-RSELEAACEDFS--NIIGSFSDGTVGTVYKGTLSSGVEIAVTST----SVKSRA 465
+P +K ++E + + +++G G VY+ T + K
Sbjct: 51 LPAIKPKTEFQLGSKLVYVHHLLGE---GAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN 107
Query: 466 DWSKNLESQFRKKIDTLSKVNHKNFVNLIG-YCEEDEPFTRMMVFEYSPNGSLFEHL--- 521
W + +Q ++ L F+ + ++ +V E G+L +
Sbjct: 108 PWEFYIGTQLMER---LKPSMQHMFMKFYSAHLFQNGSV---LVGELYSYGTLLNAINLY 161
Query: 522 HIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAA-------- 573
+ + + + AM M Y +E +H I H +++ + L +
Sbjct: 162 KNTPEKVMPQGLVISFAMRMLYMIEQVHDCE--IIHGDIKPDNFILGNGFLEQDDEDDLS 219
Query: 574 ---KISDFSF--------WNNTTAAKTGS---AAMELLETSAVDLESNVYSFGTILFEMI 619
+ D AK + +E+L + + + + ++ M+
Sbjct: 220 AGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCML 279
Query: 620 TGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQ 679
G G K E + + ++ E V+ N PD
Sbjct: 280 FGTYMKVKNEGGEC-------KPEGLFR-------RLPHLDMWNEFFHVMLN--IPDCHH 323
Query: 680 RPSMRGIAAKLKEI 693
PS+ + KLK++
Sbjct: 324 LPSLDLLRQKLKKV 337
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 8e-14
Identities = 59/280 (21%), Positives = 105/280 (37%), Gaps = 53/280 (18%)
Query: 427 DFSNIIGSFSDGTVGTVYKGT-LSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKV 485
++G G+ G V +G E AV + R K + +++ L ++
Sbjct: 29 KGQRVLGK---GSFGEVILCKDKITGQECAVKV--ISKRQVKQKTDKESLLREVQLLKQL 83
Query: 486 NHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCL 545
+H N + L + E+ F +V E G LF+ I + RI + +
Sbjct: 84 DHPNIMKLYEFFEDKGYFY--LVGEVYTGGELFDE--IISRKRFSEVDAARIIRQVLSGI 139
Query: 546 EHMHQLTPPIAHRNLQSSSIYLT---EDYAAKISDF---SFWNNTTAAKT--GSA---AM 594
+MH+ I HR+L+ ++ L +D +I DF + + + K G+A A
Sbjct: 140 TYMHKNK--IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAP 197
Query: 595 ELLETSAVDLESNVYSFGTILFEMITGR----------ISYSIENGSLENWASEYLKGEQ 644
E+L + D + +V+S G IL+ +++G I +E G + K
Sbjct: 198 EVLHGT-YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKY-TFELPQWKK-- 253
Query: 645 PLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMR 684
V + K I+ + P R S R
Sbjct: 254 -----VSESAKDL-----------IRKMLTYVPSMRISAR 277
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 27/302 (8%), Positives = 76/302 (25%), Gaps = 70/302 (23%)
Query: 431 IIGSFSDGTVGTVYKGT-LSSGVEIAVTSTSVKSRADWSK-------------------- 469
++G + T +G V R +
Sbjct: 80 VLGQ---EDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQ 136
Query: 470 ---NLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFE--YSPNGSLFEHL--H 522
+ +F D + K + + + +R ++ S + E L H
Sbjct: 137 KQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSH 196
Query: 523 IQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSF-- 580
+ L RL++ + + L +H + H L+ I L + ++ F
Sbjct: 197 SSTHKSLVHHARLQLTLQVIRLLASLHHYG--LVHTYLRPVDIVLDQRGGVFLTGFEHLV 254
Query: 581 WNNTTAAKTGSAA--------------MELLETSAVDLESNVYSFGTILFEMITGRISYS 626
+ + S + + + ++ G +++ + + +
Sbjct: 255 RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPIT 314
Query: 627 IENGSLENWASEYLKGEQPLKDIVD--PTLKSFQENVLEELLVVIKNCVHPDPKQRPSMR 684
+ E + + +++ ++ + + R
Sbjct: 315 KDA--------ALGGSEWIFRSCKNIPQPVRAL-----------LEGFLRYPKEDRLLPL 355
Query: 685 GI 686
Sbjct: 356 QA 357
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 3e-13
Identities = 54/288 (18%), Positives = 96/288 (33%), Gaps = 59/288 (20%)
Query: 427 DFSNIIGSFSDGTVGTVYKGT-LSSGVEIAV--------TSTSVKSRADWSKNLESQFRK 477
+GS G G V + E A+ + +
Sbjct: 39 FKVRKLGS---GAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYN 95
Query: 478 KIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRI 537
+I L ++H N + L E+ + F +V E+ G LFE I D I
Sbjct: 96 EISLLKSLDHPNIIKLFDVFEDKKYFY--LVTEFYEGGELFEQ--IINRHKFDECDAANI 151
Query: 538 AMGMAYCLEHMHQLTPPIAHRNLQSSSIYLT---EDYAAKISDF---SFWNNTTAAKT-- 589
+ + ++H+ I HR+++ +I L KI DF SF++ +
Sbjct: 152 MKQILSGICYLHKHN--IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRL 209
Query: 590 GSA---AMELLETSAVDLESNVYSFGTILFEMITGR----------ISYSIENGSLENWA 636
G+A A E+L+ + + +V+S G I++ ++ G I +E G +
Sbjct: 210 GTAYYIAPEVLKKK-YNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKY-YFD 267
Query: 637 SEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMR 684
K + K IK + D +R +
Sbjct: 268 FNDWKN-------ISDEAKEL-----------IKLMLTYDYNKRCTAE 297
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 6e-13
Identities = 43/286 (15%), Positives = 88/286 (30%), Gaps = 67/286 (23%)
Query: 430 NIIGSFSDGTVGTVYKGT-LSSGVEIAVTSTSVKSRADWSK--NLESQFRKKIDTLSKVN 486
+G G+ G V++ +G + AV K LE +++ + ++
Sbjct: 64 PRVGR---GSFGEVHRMKDKQTGFQCAV------------KKVRLEVFRVEELVACAGLS 108
Query: 487 HKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHL--HIQEAEHLDWAMRLRIAMGMAYC 544
V L G E M E GSL + + E + G+ Y
Sbjct: 109 SPRIVPLYGAVREGPWVNIFM--ELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEY- 165
Query: 545 LEHMHQLTPPIAHRNLQSSSIYLTED-YAAKISDFSF-----WNNTTAAKTGSAAM---- 594
L H + I H ++++ ++ L+ D A + DF + + +
Sbjct: 166 L-HTRR----ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTE 220
Query: 595 -----ELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQ----- 644
E++ D + +++S ++ M+ G ++ +
Sbjct: 221 THMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWT----QYFRGPLCLKIASEPPPIR 276
Query: 645 PLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKL 690
+ P I+ + +P R S A +L
Sbjct: 277 EIPPSCAPLTAQA-----------IQEGLRKEPVHRAS----AMEL 307
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 7e-13
Identities = 66/266 (24%), Positives = 120/266 (45%), Gaps = 46/266 (17%)
Query: 438 GTVGTVYKGT-LSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGY 496
G V + +G E+A+ K++ + +L+ FR+ + + +NH N V L
Sbjct: 26 GNFAKVKLARHILTGREVAIKIID-KTQLN-PTSLQKLFRE-VRIMKILNHPNIVKLFEV 82
Query: 497 CE-EDEPFTRMMVFEYSPNGSLFEHL----HIQEAEHLDWAMRL--RIAMGMAYCLEHMH 549
E E + ++ EY+ G +F++L ++E E A +I + YC H
Sbjct: 83 IETEKTLY---LIMEYASGGEVFDYLVAHGRMKEKE----ARSKFRQIVSAVQYC--HQK 133
Query: 550 QLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTAAKT-----GS---AAMELLETSA 601
+ I HR+L++ ++ L D KI+DF F N T G+ AA EL +
Sbjct: 134 R----IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKK 189
Query: 602 VD-LESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQEN 660
D E +V+S G IL+ +++G + + +N L+ L+G+ + + EN
Sbjct: 190 YDGPEVDVWSLGVILYTLVSGSLPFDGQN--LKELRERVLRGKYRIPFYMSTDC----EN 243
Query: 661 VLEELLVVIKNCVHPDPKQRPSMRGI 686
+L+ LV+ +P +R ++ I
Sbjct: 244 LLKRFLVL-------NPIKRGTLEQI 262
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 8e-13
Identities = 48/295 (16%), Positives = 105/295 (35%), Gaps = 70/295 (23%)
Query: 426 EDFSNI--IGSFSDGTVGTVYKGT-LSSGVEIAVTSTSVK--SRADWSKNLESQFRKKID 480
+F + IGS G G+V+K G A+ K + E +++
Sbjct: 11 TEFHELEKIGS---GEFGSVFKCVKRLDGCIYAI-----KRSKKPLAGSVDEQNALREVY 62
Query: 481 TLSKV-NHKNFVNLIGYCEEDEPFTRMMVF-EYSPNGSLFEHL--HIQEAEHLD----WA 532
+ + H + V ED+ M++ EY GSL + + + + +
Sbjct: 63 AHAVLGQHSHVVRYFSAWAEDD---HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKD 119
Query: 533 MRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTED-------------------YAA 573
+ L++ G L ++H ++ + H +++ S+I+++
Sbjct: 120 LLLQVGRG----LRYIHSMS--LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMF 173
Query: 574 KISDFSFWNNTTAAKT--GSA---AMELL-ETSAVDLESNVYSFGTILFEMITGRISYSI 627
KI D ++ + G + A E+L E ++++++ +
Sbjct: 174 KIGDLGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE----- 228
Query: 628 ENGSLENWASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPS 682
+ +I L + + +E ++K +HPDP++RPS
Sbjct: 229 ----------PLPRNGDQWHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPS 273
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 56/295 (18%), Positives = 101/295 (34%), Gaps = 78/295 (26%)
Query: 427 DFSNIIGSFSDGTVGTVYKGT-LSSGVEIAVTS---TSVKSRADWSKNLESQFRKKIDTL 482
S +GS G G V + ++A+ + + +I+ L
Sbjct: 138 IMSKTLGS---GACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 194
Query: 483 SKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLF----EHLHIQEAEHLDWAMRL--R 536
K+NH + + + + ++ + +V E G LF + ++EA +
Sbjct: 195 KKLNHPCIIKIKNFFDAEDYY---IVLELMEGGELFDKVVGNKRLKEAT----CKLYFYQ 247
Query: 537 IAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLT---EDYAAKISDF---SFWNNTTAAKT- 589
+ + + Y E+ I HR+L+ ++ L+ ED KI+DF T+ +T
Sbjct: 248 MLLAVQYLHENG------IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL 301
Query: 590 -GS---AAMELLE-------TSAVDLESNVYSFGTILFEMITG-----------RISYSI 627
G+ A E+L AVD +S G ILF ++G + I
Sbjct: 302 CGTPTYLAPEVLVSVGTAGYNRAVD----CWSLGVILFICLSGYPPFSEHRTQVSLKDQI 357
Query: 628 ENGSLENWASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPS 682
+G + E V +K + DPK R +
Sbjct: 358 TSGKYN-FIPEV-------WAEVSEKALDL-----------VKKLLVVDPKARFT 393
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 3e-12
Identities = 60/282 (21%), Positives = 105/282 (37%), Gaps = 58/282 (20%)
Query: 427 DFSNIIGSFSDGTVGTVYKGT-LSSGVEIAVTSTSVKS--RADWSKNLESQFRKKIDTLS 483
+ ++G G+ G V K + E AV K +A S ++++ L
Sbjct: 25 NIVCMLGK---GSFGEVLKCKDRITQQEYAV-----KVINKASAKNKDTSTILREVELLK 76
Query: 484 KVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAY 543
K++H N + L E+ F +V E G LF+ I + + RI +
Sbjct: 77 KLDHPNIMKLFEILEDSSSFY--IVGELYTGGELFDE--IIKRKRFSEHDAARIIKQVFS 132
Query: 544 CLEHMHQLTPPIAHRNLQSSSIYLT---EDYAAKISDF---SFWNNTTAAKT--GSA--- 592
+ +MH+ I HR+L+ +I L +D KI DF + + T K G+A
Sbjct: 133 GITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYI 190
Query: 593 AMELLETSAVDLESNVYSFGTILFEMITGR----------ISYSIENGSLENWASEYLKG 642
A E+L + D + +V+S G IL+ +++G I +E G + +
Sbjct: 191 APEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKY-AFDLPQWRT 248
Query: 643 EQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMR 684
+ K I+ + P R +
Sbjct: 249 -------ISDDAKDL-----------IRKMLTFHPSLRITAT 272
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 7e-12
Identities = 54/306 (17%), Positives = 105/306 (34%), Gaps = 76/306 (24%)
Query: 427 DFSNIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKV- 485
I+G G+ GTV G +AV K + +I L++
Sbjct: 18 VSEKILGY---GSSGTVVFQGSFQGRPVAV-----KR---MLIDFCDIALMEIKLLTESD 66
Query: 486 NHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYC- 544
+H N + E + F + E N +L + ++ D ++L+
Sbjct: 67 DHPNVIRYYCS-ETTDRF-LYIALELC-NLNLQDL--VESKNVSDENLKLQKEYNPISLL 121
Query: 545 ------LEHMHQLTPPIAHRNL-------------QSSSIYLTEDYAAKISDF------- 578
+ H+H L I HR+L + E+ ISDF
Sbjct: 122 RQIASGVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLD 179
Query: 579 ---SFWNNTTAAKTGSA---AMELLE-----------TSAVDLESNVYSFGTILFEMIT- 620
S + +G++ A ELLE T ++D ++S G + + +++
Sbjct: 180 SGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSID----IFSMGCVFYYILSK 235
Query: 621 GRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQR 680
G+ + + N ++G L ++ +++ E +I + DP +R
Sbjct: 236 GKHPFGDKYSRESN----IIRGIFSLDEMKCL----HDRSLIAEATDLISQMIDHDPLKR 287
Query: 681 PSMRGI 686
P+ +
Sbjct: 288 PTAMKV 293
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 1e-11
Identities = 52/278 (18%), Positives = 91/278 (32%), Gaps = 61/278 (21%)
Query: 438 GTVGTVYKGT-LSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGY 496
G+ G V + + AV K + N E+ +K+I L ++ HKN + L+
Sbjct: 16 GSYGKVKEVLDSETLCRRAVKILK-KKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDV 74
Query: 497 CEEDEPFTRMMVFEYSPNGS--LFEHL---HIQEAEHLDWAMRL--RIAMGMAYCLEHMH 549
+E MV EY G + + + + A ++ G+ Y H
Sbjct: 75 LYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQ----AHGYFCQLIDGLEYL--HSQ 128
Query: 550 QLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTAAKTGSAAMELLETS--------- 600
I H++++ ++ LT KIS + TS
Sbjct: 129 G----IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAAD----DTCRTSQGSPAFQPP 180
Query: 601 ------------AVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKD 648
VD ++S G L+ + TG + +N + KG +
Sbjct: 181 EIANGLDTFSGFKVD----IWSAGVTLYNITTGLYPFEGDN--IYKLFENIGKGSYAIPG 234
Query: 649 IVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGI 686
P L +K + +P +R S+R I
Sbjct: 235 DCGPPLSDL-----------LKGMLEYEPAKRFSIRQI 261
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 2e-11
Identities = 16/90 (17%), Positives = 23/90 (25%), Gaps = 1/90 (1%)
Query: 120 VVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFS 179
L+L L + + EL+ + L L L L L N
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89
Query: 180 GPFPSDFGNSFSLTTLLLDNNQYLGGISPE 209
F SL L+ L +
Sbjct: 90 SLALGAFSGLSSLQKLVAVETN-LASLENF 118
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 2e-11
Identities = 16/89 (17%), Positives = 28/89 (31%), Gaps = 2/89 (2%)
Query: 122 ILNLRDLCLGGMLAPE-LGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSG 180
+L + P+ +L L + L P L L++L++ NNF
Sbjct: 449 VLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFS 508
Query: 181 PFPSDFGNSFSLTTLLLDNNQYLGGISPE 209
+ SL L N + +
Sbjct: 509 LDTFPYKCLNSLQVLDYSLNH-IMTSKKQ 536
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 2e-11
Identities = 21/89 (23%), Positives = 34/89 (38%), Gaps = 2/89 (2%)
Query: 122 ILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNF-SG 180
L L + + LS L+ ++ + IG LK L+ L++ N S
Sbjct: 80 TLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSF 139
Query: 181 PFPSDFGNSFSLTTLLLDNNQYLGGISPE 209
P F N +L L L +N+ + I
Sbjct: 140 KLPEYFSNLTNLEHLDLSSNK-IQSIYCT 167
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 4e-11
Identities = 20/89 (22%), Positives = 32/89 (35%), Gaps = 2/89 (2%)
Query: 122 ILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEI-GELKELEILDLGFNNFSG 180
L++ LS L+ + + NSF +I EL+ L LDL
Sbjct: 425 YLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQ 484
Query: 181 PFPSDFGNSFSLTTLLLDNNQYLGGISPE 209
P+ F + SL L + +N +
Sbjct: 485 LSPTAFNSLSSLQVLNMSHNN-FFSLDTF 512
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 6e-11
Identities = 18/88 (20%), Positives = 30/88 (34%)
Query: 122 ILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGP 181
+L+L + + LS L ++IL N L L+ L N +
Sbjct: 56 VLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASL 115
Query: 182 FPSDFGNSFSLTTLLLDNNQYLGGISPE 209
G+ +L L + +N PE
Sbjct: 116 ENFPIGHLKTLKELNVAHNLIQSFKLPE 143
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 7e-11
Identities = 19/87 (21%), Positives = 32/87 (36%), Gaps = 1/87 (1%)
Query: 122 ILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGP 181
L+L L + LS L+ + + +N+FF L L++LD N+
Sbjct: 474 FLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTS 533
Query: 182 FPSDFGNSF-SLTTLLLDNNQYLGGIS 207
+ + SL L L N +
Sbjct: 534 KKQELQHFPSSLAFLNLTQNDFACTCE 560
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 2e-10
Identities = 13/76 (17%), Positives = 28/76 (36%), Gaps = 1/76 (1%)
Query: 136 PELGQLSELKSIILRNNSFFGTIPKEI-GELKELEILDLGFNNFSGPFPSDFGNSFSLTT 194
L +L+ + ++++ + L+ L LD+ + F F SL
Sbjct: 390 SNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEV 449
Query: 195 LLLDNNQYLGGISPEL 210
L + N + P++
Sbjct: 450 LKMAGNSFQENFLPDI 465
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 8e-10
Identities = 21/94 (22%), Positives = 34/94 (36%), Gaps = 6/94 (6%)
Query: 122 ILNLRDLCLGGMLAPELGQLSELKSIILRNNSF-FGTIPKEIGELKELEILDLGFNNFSG 180
L + L + +G L LK + + +N +P+ L LE LDL N
Sbjct: 104 KLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQS 163
Query: 181 PFPSDFGNSFSLT----TLLLDNNQYLGGISPEL 210
+ +D + +L L N + I P
Sbjct: 164 IYCTDLRVLHQMPLLNLSLDLSLNP-MNFIQPGA 196
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 4e-09
Identities = 22/88 (25%), Positives = 30/88 (34%), Gaps = 4/88 (4%)
Query: 123 LNLRDLCLGGMLAPELGQLSELKSIILRNN--SFFGTIPKEIGELKELEILDLGFNNFSG 180
L G A L L+ + L N SF G + L+ LDL FN
Sbjct: 328 KRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT 387
Query: 181 PFPSDFGNSFSLTTLLLDNNQYLGGISP 208
S+F L L ++ L +S
Sbjct: 388 -MSSNFLGLEQLEHLDFQHSN-LKQMSE 413
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 7e-09
Identities = 13/69 (18%), Positives = 24/69 (34%), Gaps = 1/69 (1%)
Query: 142 SELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLLDNNQ 201
K++ L N EL++LDL + + L+TL+L N
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87
Query: 202 YLGGISPEL 210
+ ++
Sbjct: 88 -IQSLALGA 95
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 1e-08
Identities = 19/97 (19%), Positives = 33/97 (34%), Gaps = 11/97 (11%)
Query: 124 NLRDLCL------GGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEI----LDL 173
L++L + L L+ L+ + L +N ++ L ++ + LDL
Sbjct: 125 TLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDL 184
Query: 174 GFNNFSGPFPSDFGNSFSLTTLLLDNNQYLGGISPEL 210
N + P F L L L NN +
Sbjct: 185 SLNPMNFIQPGAFKE-IRLHKLTLRNNFDSLNVMKTC 220
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 2e-05
Identities = 26/108 (24%), Positives = 36/108 (33%), Gaps = 8/108 (7%)
Query: 123 LNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFN--NFSG 180
L L + G +L L L S G +L LE LDL N +F G
Sbjct: 309 LELVNCKFGQFPTLKLKSLKRL-----TFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKG 363
Query: 181 PFPSDFGNSFSLTTLLLDNNQYLGGISPELHVLKVISEIQVDESWLTN 228
+ SL L L N + +S L+ + + S L
Sbjct: 364 CCSQSDFGTTSLKYLDLSFNG-VITMSSNFLGLEQLEHLDFQHSNLKQ 410
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 3e-04
Identities = 12/96 (12%), Positives = 22/96 (22%), Gaps = 12/96 (12%)
Query: 122 ILNLRDLCLGG---MLAPELGQLSELKSIILRNNS------FFGTIPKEIGELKELEILD 172
+ L + + L L ++ + + I L +
Sbjct: 229 VHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFS 288
Query: 173 LGFNNFSGPFPSDFGNSFSLTTLLLDNNQYLGGISP 208
L F +F L L N + G
Sbjct: 289 LVSVTIERVKD--FSYNFGWQHLELVNCK-FGQFPT 321
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 2e-11
Identities = 57/286 (19%), Positives = 104/286 (36%), Gaps = 61/286 (21%)
Query: 427 DFSNIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVN 486
+++G G GT+ + ++AV K S +++ L + +
Sbjct: 27 CPKDVLGH---GAEGTIVYRGMFDNRDVAV-----KR---ILPECFSFADREVQLLRESD 75
Query: 487 -HKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMR--LR-IAMGMA 542
H N + E+D F + + E +L E++ ++ HL L+ G+A
Sbjct: 76 EHPNVIRYFC-TEKDRQF-QYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLA 132
Query: 543 YCLEHMHQLTPPIAHRNLQSSSIYLTEDYA-----AKISDF-----------SFWNNTTA 586
+ H L I HR+L+ +I ++ A A ISDF SF +
Sbjct: 133 HL----HSLN--IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGV 186
Query: 587 AKT-GSAAMELLE-------TSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASE 638
T G A E+L T VD ++S G + + +I+ GS
Sbjct: 187 PGTEGWIAPEMLSEDCKENPTYTVD----IFSAGCVFYYVISE--------GSHPFGK-S 233
Query: 639 YLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMR 684
+ L +++ +I+ + DP++RPS +
Sbjct: 234 LQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAK 279
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 64.9 bits (158), Expect = 2e-11
Identities = 37/250 (14%), Positives = 89/250 (35%), Gaps = 39/250 (15%)
Query: 460 SVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRM-MVFEYSPNGSLF 518
DW + S + +++ + N +G + P + + + +L
Sbjct: 90 LKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLK 149
Query: 519 EHLHIQ-EAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISD 577
+ ++ + E + + L I + +A +E +H + HR+L+ S+I+ T D K+ D
Sbjct: 150 DWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG--LMHRDLKPSNIFFTMDDVVKVGD 207
Query: 578 F----SFWNNTTAAKTGSAAM-----------------ELLETSAVDLESNVYSFGTILF 616
F + + + E + + + +++S G ILF
Sbjct: 208 FGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILF 267
Query: 617 EMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPD 676
E++ + E + + D+ + + +++++ + P
Sbjct: 268 ELLYSFSTQM-ERVRI-------------ITDVRNLKFPLLFTQKYPQEHMMVQDMLSPS 313
Query: 677 PKQRPSMRGI 686
P +RP I
Sbjct: 314 PTERPEATDI 323
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 65.5 bits (159), Expect = 2e-11
Identities = 29/299 (9%), Positives = 78/299 (26%), Gaps = 65/299 (21%)
Query: 431 IIGSFSDGTVGTVYKGT-LSSGVEIAVTSTSVKSRADWSK-------------------- 469
++G + T +G V R +
Sbjct: 85 VLGQ---EDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQ 141
Query: 470 ---NLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFE--YSPNGSLFEHL--H 522
+ +F D + K + + + +R ++ S + E L H
Sbjct: 142 KQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSH 201
Query: 523 IQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSF-- 580
+ L RL++ + + L +H + H L+ I L + ++ F
Sbjct: 202 SSTHKSLVHHARLQLTLQVIRLLASLHHYG--LVHTYLRPVDIVLDQRGGVFLTGFEHLV 259
Query: 581 -WNNTTAAKTGSA-------AMELLE-----TSAVDLESNVYSFGTILFEMITGRISYSI 627
+ + G A +L + + + ++ G ++ + + +
Sbjct: 260 RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTD 319
Query: 628 ENGSLENWASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGI 686
+ E + + + + +++ + + R
Sbjct: 320 DA--------ALGGSEWIFRSCKNIP---------QPVRALLEGFLRYPKEDRLLPLQA 361
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 2e-11
Identities = 70/284 (24%), Positives = 111/284 (39%), Gaps = 60/284 (21%)
Query: 431 IIGSFSDGTVGTVYKGT-LSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKN 489
++G GT G VY G LS+ V IA+ K + ++I + HKN
Sbjct: 29 VLGK---GTYGIVYAGRDLSNQVRIAI-----KEIPERDSRYSQPLHEEIALHKHLKHKN 80
Query: 490 FVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLH-----IQEAEHLDWAMRLRIAMGMAYC 544
V +G E+ M E P GSL L +++ E +I G+ Y
Sbjct: 81 IVQYLGSFSENGFIKIFM--EQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKY- 137
Query: 545 LEHMHQLTPPIAHRNLQSSSIYL-TEDYAAKISDF------SFWNNTTAAKTGSA---AM 594
L H +Q I HR+++ ++ + T KISDF + N T TG+ A
Sbjct: 138 L-HDNQ----IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAP 192
Query: 595 ELLETSAV--DLESNVYSFG-TILFEMITGRISYSIENGSLEN-WASEYLKGEQ----PL 646
E+++ ++++S G TI+ EM TG+ + L A+ + G +
Sbjct: 193 EIIDKGPRGYGKAADIWSLGCTII-EMATGKPPFY----ELGEPQAAMFKVGMFKVHPEI 247
Query: 647 KDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKL 690
+ + K+F I C PDP +R A L
Sbjct: 248 PESMSAEAKAF-----------ILKCFEPDPDKRAC----ANDL 276
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 65.6 bits (160), Expect = 3e-11
Identities = 47/253 (18%), Positives = 91/253 (35%), Gaps = 52/253 (20%)
Query: 475 FRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVF---EYSPNGSLFEHLHIQEAEHLDW 531
+ L++V H + V + + E + + + EY SL + L
Sbjct: 126 AMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK----GQKLPV 181
Query: 532 AMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTAAKT-- 589
A + + + L ++H + + + +L+ +I LTE+ K+ D A
Sbjct: 182 AEAIAYLLEILPALSYLHSI--GLVYNDLKPENIMLTEE-QLKLIDLG------AVSRIN 232
Query: 590 ------GSAA-M--ELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYL 640
G+ E++ T +++Y+ G L + + + Y+
Sbjct: 233 SFGYLYGTPGFQAPEIVRTGPTV-ATDIYTVGRTLAALTLDLPTRN----------GRYV 281
Query: 641 KGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPS----MRG-IAAKLKEITA 695
G DP LK++ LL + PDP+QR + M + L+E+ A
Sbjct: 282 DGLPED----DPVLKTYDS--YGRLLR---RAIDPDPRQRFTTAEEMSAQLTGVLREVVA 332
Query: 696 MEPDGATPKLSPL 708
+ P LS +
Sbjct: 333 QDTGVPRPGLSTI 345
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 3e-11
Identities = 20/104 (19%), Positives = 35/104 (33%), Gaps = 2/104 (1%)
Query: 106 NPCSWFGVECSDGKVVILNLRDLCLGGMLAPELGQL--SELKSIILRNNSFFGTIPKEIG 163
+ +E ++ + L+L + L L + L + L N+
Sbjct: 210 SLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFA 269
Query: 164 ELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLLDNNQYLGGIS 207
L +LE L +NN F F++ L L + IS
Sbjct: 270 WLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSIS 313
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 9e-11
Identities = 26/89 (29%), Positives = 39/89 (43%), Gaps = 1/89 (1%)
Query: 122 ILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGP 181
+ L G L LS L + L +N F + +L EL+I+DLG NN +
Sbjct: 516 LARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTL 575
Query: 182 FPSDFGNSFSLTTLLLDNNQYLGGISPEL 210
S F N SL +L L N + + ++
Sbjct: 576 PASVFNNQVSLKSLNLQKNL-ITSVEKKV 603
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 2e-10
Identities = 22/89 (24%), Positives = 33/89 (37%), Gaps = 1/89 (1%)
Query: 122 ILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGP 181
+LNL+ L + + L + L +NS + K L LDL N S
Sbjct: 77 VLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSST 136
Query: 182 FPSDFGNSFSLTTLLLDNNQYLGGISPEL 210
+L LLL NN+ + + E
Sbjct: 137 KLGTQVQLENLQELLLSNNK-IQALKSEE 164
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 6e-10
Identities = 23/91 (25%), Positives = 39/91 (42%), Gaps = 1/91 (1%)
Query: 120 VVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFS 179
+ +LNL L + A + S+L S+ + N+ P+ +L L++L+L N S
Sbjct: 27 ITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELS 86
Query: 180 GPFPSDFGNSFSLTTLLLDNNQYLGGISPEL 210
F +LT L L +N + I
Sbjct: 87 QLSDKTFAFCTNLTELHLMSNS-IQKIKNNP 116
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 6e-10
Identities = 18/94 (19%), Positives = 31/94 (32%)
Query: 121 VILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSG 180
L++ + + +L LK + L++N K L L L N+
Sbjct: 52 TSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQK 111
Query: 181 PFPSDFGNSFSLTTLLLDNNQYLGGISPELHVLK 214
+ F +L TL L +N L+
Sbjct: 112 IKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLE 145
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 2e-09
Identities = 24/90 (26%), Positives = 33/90 (36%), Gaps = 3/90 (3%)
Query: 122 ILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELK--ELEILDLGFNNFS 179
L+L L QL L+ ++L NN +E+ L+ L+L N
Sbjct: 125 TLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIK 184
Query: 180 GPFPSDFGNSFSLTTLLLDNNQYLGGISPE 209
P F L L L+N Q LG E
Sbjct: 185 EFSPGCFHAIGRLFGLFLNNVQ-LGPSLTE 213
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 5e-09
Identities = 19/90 (21%), Positives = 32/90 (35%), Gaps = 3/90 (3%)
Query: 122 ILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGP 181
L+L + + + L ++ L +N T +L+ L+ L L N
Sbjct: 101 ELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQAL 160
Query: 182 FPSDFGNSF--SLTTLLLDNNQYLGGISPE 209
+ SL L L +NQ + SP
Sbjct: 161 KSEELDIFANSSLKKLELSSNQ-IKEFSPG 189
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 1e-08
Identities = 18/107 (16%), Positives = 39/107 (36%), Gaps = 3/107 (2%)
Query: 96 SDNDGVGDNVNPCSWFGVECSDGKVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFF 155
S++ + ++ + S + LNL + + + L L+ + L N
Sbjct: 361 SNSFTSLRTLTNETFVSLAHSPLHI--LNLTKNKISKIESDAFSWLGHLEVLDLGLNEIG 418
Query: 156 GTIP-KEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLLDNNQ 201
+ +E L+ + + L +N + + F SL L+L
Sbjct: 419 QELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVA 465
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 2e-08
Identities = 22/92 (23%), Positives = 34/92 (36%), Gaps = 4/92 (4%)
Query: 122 ILNLRDLCLGGMLAP-ELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSG 180
+L+L +G L E L + I L N + + L+ L L
Sbjct: 409 VLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKN 468
Query: 181 --PFPSDFGNSFSLTTLLLDNNQYLGGISPEL 210
PS F +LT L L NN + I+ ++
Sbjct: 469 VDSSPSPFQPLRNLTILDLSNNN-IANINDDM 499
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 2e-08
Identities = 21/92 (22%), Positives = 36/92 (39%), Gaps = 6/92 (6%)
Query: 122 ILNLRDLCLGGMLAPELG---QLSELKSIILRNNSFFGTIPKEIGELK--ELEILDLGFN 176
L L ++ LG L +L + ++++ L N+ T LK L +LDL +N
Sbjct: 199 GLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYN 258
Query: 177 NFSGPFPSDFGNSFSLTTLLLDNNQYLGGISP 208
N + F L L+ N + +
Sbjct: 259 NLNVVGNDSFAWLPQLEYFFLEYNN-IQHLFS 289
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 5e-08
Identities = 16/70 (22%), Positives = 26/70 (37%), Gaps = 1/70 (1%)
Query: 141 LSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLLDNN 200
+ + + L +N +L LD+GFN S P L L L +N
Sbjct: 24 PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHN 83
Query: 201 QYLGGISPEL 210
+ L +S +
Sbjct: 84 E-LSQLSDKT 92
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 5e-08
Identities = 22/87 (25%), Positives = 31/87 (35%), Gaps = 1/87 (1%)
Query: 122 ILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGP 181
ILNL + L ELK I L N+ L+ L+L N +
Sbjct: 540 ILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSV 599
Query: 182 FPSDFGNSF-SLTTLLLDNNQYLGGIS 207
FG +F +LT L + N +
Sbjct: 600 EKKVFGPAFRNLTELDMRFNPFDCTCE 626
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 7e-08
Identities = 15/82 (18%), Positives = 27/82 (32%), Gaps = 6/82 (7%)
Query: 141 LSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSD-FGNSFSLTTLLLDN 199
S L + L N L LE+LDLG N + ++ + L
Sbjct: 380 HSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSY 439
Query: 200 NQYLGGISPE----LHVLKVIS 217
N+ ++ + L+ +
Sbjct: 440 NK-YLQLTRNSFALVPSLQRLM 460
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 1e-07
Identities = 17/82 (20%), Positives = 28/82 (34%), Gaps = 2/82 (2%)
Query: 122 ILNLRDLCLGGMLAPELGQLSELKSIILRNNSF--FGTIPKEIGELKELEILDLGFNNFS 179
+ L + + L+ ++LR + + P L+ L ILDL NN +
Sbjct: 434 EIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIA 493
Query: 180 GPFPSDFGNSFSLTTLLLDNNQ 201
L L L +N
Sbjct: 494 NINDDMLEGLEKLEILDLQHNN 515
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 2e-07
Identities = 16/76 (21%), Positives = 23/76 (30%), Gaps = 4/76 (5%)
Query: 137 ELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSF---SLT 193
++ S LK + L +N P + L L L S+
Sbjct: 166 DIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIR 225
Query: 194 TLLLDNNQYLGGISPE 209
L L N+Q L S
Sbjct: 226 NLSLSNSQ-LSTTSNT 240
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 2e-07
Identities = 25/99 (25%), Positives = 34/99 (34%), Gaps = 11/99 (11%)
Query: 122 ILNLRD--LCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFS 179
L LR L L L + L NN+ + L++LEILDL NN +
Sbjct: 458 RLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLA 517
Query: 180 --------GPFPSDFGNSFSLTTLLLDNNQYLGGISPEL 210
G L L L++N I E+
Sbjct: 518 RLWKHANPGGPIYFLKGLSHLHILNLESNG-FDEIPVEV 555
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 4e-07
Identities = 15/93 (16%), Positives = 29/93 (31%), Gaps = 6/93 (6%)
Query: 122 ILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGE---LKELEILDLGFNNF 178
L L + + L + L N ++ +++ + L L +
Sbjct: 175 KLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQL 234
Query: 179 SGPFPSDFGN--SFSLTTLLLDNNQYLGGISPE 209
S + F +LT L L N L + +
Sbjct: 235 STTSNTTFLGLKWTNLTMLDLSYNN-LNVVGND 266
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 5e-07
Identities = 17/92 (18%), Positives = 33/92 (35%), Gaps = 9/92 (9%)
Query: 119 KVVILNLRDLCLGGMLAPELGQLSELKSIILRNN---------SFFGTIPKEIGELKELE 169
++ L + + + L L ++ + L+ + S LK LE
Sbjct: 273 QLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLE 332
Query: 170 ILDLGFNNFSGPFPSDFGNSFSLTTLLLDNNQ 201
L++ N+ G + F +L L L N+
Sbjct: 333 HLNMEDNDIPGIKSNMFTGLINLKYLSLSNSF 364
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 7e-06
Identities = 16/92 (17%), Positives = 29/92 (31%), Gaps = 5/92 (5%)
Query: 122 ILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGP 181
++ L + L L+ + + +N G L L+ L L + S
Sbjct: 309 KQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLR 368
Query: 182 F--PSDFGNSF--SLTTLLLDNNQYLGGISPE 209
F + L L L N+ + I +
Sbjct: 369 TLTNETFVSLAHSPLHILNLTKNK-ISKIESD 399
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 6e-04
Identities = 15/79 (18%), Positives = 32/79 (40%), Gaps = 8/79 (10%)
Query: 143 ELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLLDNNQY 202
+ + +P ++ + +L+L N ++F LT+L + N
Sbjct: 5 SHEVADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNT- 60
Query: 203 LGGISPE----LHVLKVIS 217
+ + PE L +LKV++
Sbjct: 61 ISKLEPELCQKLPMLKVLN 79
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 3e-11
Identities = 63/265 (23%), Positives = 117/265 (44%), Gaps = 43/265 (16%)
Query: 438 GTVGTVYKGT-LSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGY 496
GT G V G +G ++AV + + + S ++ + +++I L H + + L Y
Sbjct: 22 GTFGKVKIGEHQLTGHKVAVKILN-RQKIR-SLDVVGKIKREIQNLKLFRHPHIIKL--Y 77
Query: 497 CEEDEPFTRMMVFEYSPNGSLFEHL----HIQEAEHLDWAMRL--RIAMGMAYCLEHMHQ 550
P MV EY G LF+++ ++E E A RL +I + YC H H
Sbjct: 78 QVISTPTDFFMVMEYVSGGELFDYICKHGRVEEME----ARRLFQQILSAVDYC--HRHM 131
Query: 551 LTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTAA---KT--GS---AAMELLETSAV 602
+ HR+L+ ++ L AKI+DF N + +T GS AA E++
Sbjct: 132 ----VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLY 187
Query: 603 D-LESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQENV 661
E +++S G IL+ ++ G + + E+ + + G + + ++ ++ +
Sbjct: 188 AGPEVDIWSCGVILYALLCGTLPFDDEH--VPTLFKKIRGGVFYIPEYLNRSVA----TL 241
Query: 662 LEELLVVIKNCVHPDPKQRPSMRGI 686
L +L V DP +R +++ I
Sbjct: 242 LMHMLQV-------DPLKRATIKDI 259
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 4e-11
Identities = 43/209 (20%), Positives = 75/209 (35%), Gaps = 47/209 (22%)
Query: 442 TVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNL---IGYCE 498
+ + + + Q ++I L K++H N V L +
Sbjct: 50 KLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPN 109
Query: 499 EDEPFTRMMVFEYSPNGSLFE---HLHIQEAEHLDWAMRL--RIAMGMAYCLEHMHQLTP 553
ED + MVFE G + E + E + A + G+ Y H +
Sbjct: 110 EDHLY---MVFELVNQGPVMEVPTLKPLSEDQ----ARFYFQDLIKGIEYL--HYQK--- 157
Query: 554 PIAHRNLQSSSIYLTEDYAAKISDFSFWN---------NTTAAKTGS---AAMELLETS- 600
I HR+++ S++ + ED KI+DF N + T G+ A E L +
Sbjct: 158 -IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTV---GTPAFMAPESLSETR 213
Query: 601 ------AVDLESNVYSFGTILFEMITGRI 623
A+D V++ G L+ + G+
Sbjct: 214 KIFSGKALD----VWAMGVTLYCFVFGQC 238
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 64.9 bits (158), Expect = 6e-11
Identities = 16/90 (17%), Positives = 32/90 (35%), Gaps = 10/90 (11%)
Query: 122 ILNLRDLCLGGMLAPELGQLSELKSIILRNNSF---------FGTIPKEIGELKELEILD 172
+ L + L L L EL+S+ + N + + + +++I
Sbjct: 495 DVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFY 554
Query: 173 LGFNNFSG-PFPSDFGNSFSLTTLLLDNNQ 201
+G+NN P + L L +N+
Sbjct: 555 MGYNNLEEFPASASLQKMVKLGLLDCVHNK 584
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 64.1 bits (156), Expect = 1e-10
Identities = 20/141 (14%), Positives = 42/141 (29%), Gaps = 20/141 (14%)
Query: 72 SEGMALLRFRERVVRDPFGALSKWSDNDGVGDN-VNPCSWFGVECSDGKVVILNLRDLCL 130
+ AL E + W G +N ++ +W ++L +
Sbjct: 269 KDYKALKAIWEAL------DGKNWRYYSGTINNTIHSLNW------------NFNKELDM 310
Query: 131 -GGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNS 189
G +L + + L G +P IG+L EL++L G ++ +
Sbjct: 311 WGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEE 370
Query: 190 FSLTTLLLDNNQYLGGISPEL 210
+ ++
Sbjct: 371 LTPDMSEERKHRIRMHYKKMF 391
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 63.7 bits (155), Expect = 1e-10
Identities = 16/122 (13%), Positives = 41/122 (33%), Gaps = 26/122 (21%)
Query: 122 ILNLRDLCLGGM------LAPELGQLSELKSIILRNNSF-------------------FG 156
++L+D +G + ++ + +L++L+ I N+ F +
Sbjct: 422 RISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYE 481
Query: 157 TIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLLDNNQYLGGISPELHVLKVI 216
LK+L ++L P + L +L + N+ + +
Sbjct: 482 NEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNR-GISAAQLKADWTRL 540
Query: 217 SE 218
++
Sbjct: 541 AD 542
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 58.7 bits (142), Expect = 5e-09
Identities = 18/79 (22%), Positives = 32/79 (40%), Gaps = 6/79 (7%)
Query: 134 LAPELGQLSELKSIILRNNSFFGTIPKE--IGELKELEILDLGFNNFSGPFPSDFGNSFS 191
LA + +++ + N+ P + ++ +L +LD N FG +
Sbjct: 540 LADDEDTGPKIQIFYMGYNNL-EEFPASASLQKMVKLGLLDCVHNKVR--HLEAFGTNVK 596
Query: 192 LTTLLLDNNQYLGGISPEL 210
LT L LD NQ + I +
Sbjct: 597 LTDLKLDYNQ-IEEIPEDF 614
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 55.7 bits (134), Expect = 4e-08
Identities = 12/77 (15%), Positives = 27/77 (35%), Gaps = 4/77 (5%)
Query: 136 PELGQLSELKSIILRNNSFFGTIPKEIGE-LKELEILDLGFNNFSG-PFPSDFGNSFSLT 193
G +L + L N IP++ ++E L N P + + + +
Sbjct: 589 EAFGTNVKLTDLKLDYNQI-EEIPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMG 647
Query: 194 TLLLDNNQYLGGISPEL 210
++ N+ +G +
Sbjct: 648 SVDFSYNK-IGSEGRNI 663
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 55.3 bits (133), Expect = 6e-08
Identities = 14/102 (13%), Positives = 24/102 (23%), Gaps = 9/102 (8%)
Query: 121 VILNLRDLCLGGMLAPELGQLSELKSIILRNNSF-------FGTIPKEIGELKELEILDL 173
+ L + S + +IIL NN L +DL
Sbjct: 676 STVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDL 735
Query: 174 GFNNFSG-PFPSDFGNSFSLTTLLLDNNQYLGGISPELHVLK 214
FN + L+ + + N +
Sbjct: 736 RFNKLTSLSDDFRATTLPYLSNMDVSYNC-FSSFPTQPLNSS 776
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 54.5 bits (131), Expect = 1e-07
Identities = 13/96 (13%), Positives = 31/96 (32%), Gaps = 8/96 (8%)
Query: 124 NLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFS---- 179
+ + + + ++ L N + + + L N +
Sbjct: 655 KIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPE 714
Query: 180 ---GPFPSDFGNSFSLTTLLLDNNQYLGGISPELHV 212
P ++ N++ LTT+ L N+ L +S +
Sbjct: 715 NSLKPKDGNYKNTYLLTTIDLRFNK-LTSLSDDFRA 749
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 53.7 bits (129), Expect = 2e-07
Identities = 17/78 (21%), Positives = 28/78 (35%), Gaps = 4/78 (5%)
Query: 130 LGGMLAPELGQLSELKSIILRNNSFFGTIPKEI--GELKELEILDLGFNNFSGPFPSDFG 187
L +I LR N ++ + L L +D+ +N FS FP+
Sbjct: 716 SLKPKDGNYKNTYLLTTIDLRFNKL-TSLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPL 773
Query: 188 NSFSLTTLLLDNNQYLGG 205
NS L + + + G
Sbjct: 774 NSSQLKAFGIRHQRDAEG 791
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 53.3 bits (128), Expect = 2e-07
Identities = 15/88 (17%), Positives = 26/88 (29%), Gaps = 13/88 (14%)
Query: 124 NLRDLCLGG----MLAPELGQLSELKSIILR------NNSFFGTIPKEIGELKELEILDL 173
L ++ + + S+LK+ +R N P I L L +
Sbjct: 754 YLSNMDVSYNCFSSFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQI 813
Query: 174 GFNNFSGPFPSDFGNSFSLTTLLLDNNQ 201
G N+ L L + +N
Sbjct: 814 GSNDIRK-VDEKLTP--QLYILDIADNP 838
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 53.3 bits (128), Expect = 2e-07
Identities = 19/115 (16%), Positives = 34/115 (29%), Gaps = 25/115 (21%)
Query: 125 LRDLCLGGMLAPELGQLSELKSIILRNNSF------FGTIPKEIGELKELEILDLGFNNF 178
L PE+ + + I L++ I K I L +L+I+ + F
Sbjct: 401 SDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPF 460
Query: 179 SGP-------------------FPSDFGNSFSLTTLLLDNNQYLGGISPELHVLK 214
+ + N LT + L N + + L+ L
Sbjct: 461 TYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLP 515
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 53.0 bits (127), Expect = 3e-07
Identities = 12/80 (15%), Positives = 25/80 (31%), Gaps = 8/80 (10%)
Query: 137 ELGQLSELKSIILRNNSFFGTIPKEIG------ELKELEILDLGFNNFSGPFPSDFGNSF 190
+ + S+ N G+ + I + + L +N F
Sbjct: 639 NAKSVYVMGSVDFSYNKI-GSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGS 697
Query: 191 SLTTLLLDNNQYLGGISPEL 210
++T++L NN + I
Sbjct: 698 PISTIILSNNL-MTSIPENS 716
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 52.6 bits (126), Expect = 4e-07
Identities = 10/66 (15%), Positives = 22/66 (33%), Gaps = 2/66 (3%)
Query: 136 PELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTL 195
L ++ +L + +N + G +L L L +N + + L
Sbjct: 567 ASLQKMVKLGLLDCVHNKV--RHLEAFGTNVKLTDLKLDYNQIEEIPEDFCAFTDQVEGL 624
Query: 196 LLDNNQ 201
+N+
Sbjct: 625 GFSHNK 630
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 64.1 bits (156), Expect = 8e-11
Identities = 49/209 (23%), Positives = 87/209 (41%), Gaps = 30/209 (14%)
Query: 427 DFSNIIGSFSDGTVGTVYKGT-LSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKV 485
D +G+ G G V++ T ++G A +D + RK+I T+S +
Sbjct: 160 DIHEELGT---GAFGVVHRVTERATGNNFAAKFVMTPHESD-----KETVRKEIQTMSVL 211
Query: 486 NHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHL---DWAMRLRIAMGMA 542
H VNL E+D M++E+ G LFE + E + + +R
Sbjct: 212 RHPTLVNLHDAFEDDNEMV--MIYEFMSGGELFEKV-ADEHNKMSEDEAVEYMRQVCK-- 266
Query: 543 YCLEHMHQLTPPIAHRNLQSSSIYLT--EDYAAKISDF---SFWNNTTAAKT--GSA--- 592
L HMH+ H +L+ +I T K+ DF + + + K G+A
Sbjct: 267 -GLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFA 323
Query: 593 AMELLETSAVDLESNVYSFGTILFEMITG 621
A E+ E V ++++S G + + +++G
Sbjct: 324 APEVAEGKPVGYYTDMWSVGVLSYILLSG 352
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 9e-11
Identities = 39/209 (18%), Positives = 87/209 (41%), Gaps = 30/209 (14%)
Query: 427 DFSNIIGSFSDGTVGTVYKGT-LSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKV 485
D +GS G G V++ ++G + D + + +I ++++
Sbjct: 54 DILEELGS---GAFGVVHRCVEKATGRVFVAKFINTPYPLD-----KYTVKNEISIMNQL 105
Query: 486 NHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHL---DWAMRLRIAMGMA 542
+H +NL E+ ++ E+ G LF+ + E + + +R A
Sbjct: 106 HHPKLINLHDAFEDKYEMV--LILEFLSGGELFDRI-AAEDYKMSEAEVINYMRQACE-- 160
Query: 543 YCLEHMHQLTPPIAHRNLQSSSIYLT--EDYAAKISDF---SFWNNTTAAKT--GSA--- 592
L+HMH+ + I H +++ +I + + KI DF + N K +A
Sbjct: 161 -GLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFA 217
Query: 593 AMELLETSAVDLESNVYSFGTILFEMITG 621
A E+++ V +++++ G + + +++G
Sbjct: 218 APEIVDREPVGFYTDMWAIGVLGYVLLSG 246
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 1e-10
Identities = 23/109 (21%), Positives = 34/109 (31%), Gaps = 4/109 (3%)
Query: 124 NLRDLCLGG----MLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFS 179
NL+ L + L P + L +L+ + LR + P G L+ L L +
Sbjct: 207 NLKSLKIRNSPLSALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNL 266
Query: 180 GPFPSDFGNSFSLTTLLLDNNQYLGGISPELHVLKVISEIQVDESWLTN 228
P D L L L L + + L I V
Sbjct: 267 LTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQ 315
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 1e-10
Identities = 22/80 (27%), Positives = 34/80 (42%)
Query: 122 ILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGP 181
L+LR P G + LK +IL++ S T+P +I L +LE LDL
Sbjct: 233 ELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSR 292
Query: 182 FPSDFGNSFSLTTLLLDNNQ 201
PS + +L+ +
Sbjct: 293 LPSLIAQLPANCIILVPPHL 312
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 1e-08
Identities = 15/91 (16%), Positives = 31/91 (34%), Gaps = 14/91 (15%)
Query: 124 NLRDLCLGG----MLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFS 179
+L+ + + L + Q + L+++ L N +P I L L L +
Sbjct: 105 HLQHMTIDAAGLMELPDTMQQFAGLETLTLARNPL-RALPASIASLNRLRELSIRACPEL 163
Query: 180 GPFPSDFGNSF---------SLTTLLLDNNQ 201
P ++ +L +L L+
Sbjct: 164 TELPEPLASTDASGEHQGLVNLQSLRLEWTG 194
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 2e-08
Identities = 20/106 (18%), Positives = 35/106 (33%), Gaps = 3/106 (2%)
Query: 114 ECSDGKVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDL 173
+ + V L LR + L + +LS L+ + + +P + + LE L L
Sbjct: 77 DATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGL-MELPDTMQQFAGLETLTL 134
Query: 174 GFNNFSGPFPSDFGNSFSLTTLLLDNNQYLGGISPELHVLKVISEI 219
N P+ + L L + L + L E
Sbjct: 135 ARNPLRA-LPASIASLNRLRELSIRACPELTELPEPLASTDASGEH 179
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 2e-07
Identities = 16/100 (16%), Positives = 28/100 (28%), Gaps = 5/100 (5%)
Query: 104 NVNPCSWFGVECSDGKVVILNLRDLCLGGMLAPELGQLSE--LKSIILRNNSFFGTIPKE 161
+ N + + I L A L ++ ++ LR+ P +
Sbjct: 42 DRNRWHSAWRQANSNNPQIETRTGRALK-ATADLLEDATQPGRVALELRSVPL-PQFPDQ 99
Query: 162 IGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLLDNNQ 201
L L+ + + P L TL L N
Sbjct: 100 AFRLSHLQHMTIDAAGLME-LPDTMQQFAGLETLTLARNP 138
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 5e-07
Identities = 16/77 (20%), Positives = 26/77 (33%), Gaps = 2/77 (2%)
Query: 134 LAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLT 193
+ E L L+S+ L ++P I L+ L+ L + + S + L
Sbjct: 175 ASGEHQGLVNLQSLRLEWTGI-RSLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLE 232
Query: 194 TLLLDNNQYLGGISPEL 210
L L L P
Sbjct: 233 ELDLRGCTALRNYPPIF 249
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 1e-10
Identities = 61/282 (21%), Positives = 96/282 (34%), Gaps = 72/282 (25%)
Query: 437 DGTVGTVYKGT-LSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKV-NHKNFVNLI 494
+G+ K S AV K SK +E+ +K+I L H N V L
Sbjct: 21 EGSFSICRKCVHKKSNQAFAV-----KI---ISKRMEANTQKEITALKLCEGHPNIVKLH 72
Query: 495 GYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPP 554
+ +V E G LFE I++ +H I + + HMH +
Sbjct: 73 EVFHDQLHTF--LVMELLNGGELFE--RIKKKKHFSETEASYIMRKLVSAVSHMHDVG-- 126
Query: 555 IAHRNLQSSSIYLT---EDYAAKISDF----SFWNNTTAAKT--GSA---AMELLETSAV 602
+ HR+L+ ++ T ++ KI DF + KT + A ELL +
Sbjct: 127 VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGY 186
Query: 603 DLESNVYSFGTILFEMITG-----------------RISYSIENGSL----ENWASEYLK 641
D +++S G IL+ M++G I I+ G E W +
Sbjct: 187 DESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKN---- 242
Query: 642 GEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSM 683
V K I+ + DP +R M
Sbjct: 243 --------VSQEAKDL-----------IQGLLTVDPNKRLKM 265
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 2e-10
Identities = 39/258 (15%), Positives = 89/258 (34%), Gaps = 32/258 (12%)
Query: 464 RADWSKNLESQ--FRKKIDTLSKVNHKNFVNLIGYCEEDE-PFTRMMVFEYSPNGSLFEH 520
S + + +++ T ++ + V + + E D + + L
Sbjct: 68 SETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLY---VDMRLINGVDLAAM 124
Query: 521 LHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDF-- 578
++ L + I + L+ H HR+++ +I ++ D A + DF
Sbjct: 125 --LRRQGPLAPPRAVAIVRQIGSALDAAHAAG--ATHRDVKPENILVSADDFAYLVDFGI 180
Query: 579 -SFWNNTTAAKTGSA-------AMELLETSAVDLESNVYSFGTILFEMITGRISYSIENG 630
S + + G+ A E S +++Y+ +L+E +TG Y +
Sbjct: 181 ASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL 240
Query: 631 SLENWASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQR-PSMRGIAAK 689
S+ ++ + P + + + VI + +P+ R + ++A
Sbjct: 241 SV---MGAHIN-QAI------PRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAA 290
Query: 690 LKE-ITAMEPDGATPKLS 706
+ + D AT L
Sbjct: 291 AHAALATADQDRATDILR 308
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 63.3 bits (153), Expect = 2e-10
Identities = 90/712 (12%), Positives = 183/712 (25%), Gaps = 280/712 (39%)
Query: 8 DSYKKTNANPTSLDPSFNSLETKAFR---LAPQTHPCR---FHRLRLNMAALTLVMLLFL 61
K P+ + + + + + + + R + +LR L
Sbjct: 96 SPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQA-----------L 144
Query: 62 QNLSLARCLNSEGMA----------LLRFRERVVRDPFGALSKWSDNDGVGDNVNPCSWF 111
L A+ + +G+ + + + F W +N
Sbjct: 145 LELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIF--W---------LN----L 189
Query: 112 GVECSDGKVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEIL 171
C+ + V+ L+ L + P S+ S I I ++ E+
Sbjct: 190 K-NCNSPETVLEMLQKLLY--QIDPNWTSRSDHSS----------NIKLRIHSIQA-ELR 235
Query: 172 DLGFNNFSGPFPSDFGNSFSLTTLLLDNNQYLGGISPELHVLKVISEIQVDESWLTNAAS 231
L + P+ + L L+L N V +
Sbjct: 236 RLLKSK---PYEN------CL--LVLLN---------------------VQNAK------ 257
Query: 232 RASCNSGLFTWNKVQPGDNAFR---RMLQQVTNGFEAKRKASEPSSSSSIASSPEPLV-- 286
W NAF ++L +T R S+ ++ L
Sbjct: 258 ---------AW-------NAFNLSCKIL--LTT-----RFKQVTDFLSAATTTHISLDHH 294
Query: 287 SPSLSPSMS-SLLSPSFSPSPS--PSESPSVSSPLIIPPAPVNIPIVSSPPHLHSAPTSF 343
S +L+P SLL P P E + +P +
Sbjct: 295 SMTLTPDEVKSLLLKYLDCRPQDLPREVLTT-NPRRL----------------------- 330
Query: 344 AASTPSQVHESLHKSKHHTVLVLAGIIGGLSLILISAIGFFVCRSSKVVTVKPWVTGLSG 403
S + ES+ + W
Sbjct: 331 -----SIIAESIRD--------------------------GLATW------DNWKHVNCD 353
Query: 404 QLQKAFVTGVPKLKRSELEAACEDFSNIIGSFSDG------TVGTVYKGTLSSGVEIAVT 457
+L + + L+ +E + S + F + ++ + S V + V
Sbjct: 354 KLTTIIESSLNVLEPAEYRKMFDRLS-V---FPPSAHIPTILLSLIWFDVIKSDVMVVVN 409
Query: 458 STSVKSRAD-WSKN-------LESQFRKKIDTLSKVNHKNFVN----LIGYCEEDEPFTR 505
S + K + + + K++ + H++ V+ + +D
Sbjct: 410 KLHKYSLVEKQPKESTISIPSIYLELKVKLENEYAL-HRSIVDHYNIPKTFDSDD--LIP 466
Query: 506 MMVFEYSPNGSLFEHL--HIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSS 563
+ +Y + H+ H++ EH R
Sbjct: 467 PYLDQY-----FYSHIGHHLKNIEH---------------------------PERMTLFR 494
Query: 564 SIYLTEDYAAKISDFSFW-----NNTTAAKTGSAAMELLETSAVDLESNVYSFGTILFEM 618
++L DF F +++TA + + L+ L+ Y
Sbjct: 495 MVFL---------DFRFLEQKIRHDSTAWNASGSILNTLQ----QLK--FYK------PY 533
Query: 619 IT------GRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQENVLEE 664
I R+ +I + L + D++ L + E + EE
Sbjct: 534 ICDNDPKYERLVNAILD-FLPKIEENLICS--KYTDLLRIALMAEDEAIFEE 582
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 56.8 bits (136), Expect = 2e-08
Identities = 63/520 (12%), Positives = 140/520 (26%), Gaps = 183/520 (35%)
Query: 215 VISEIQVDESWLTNAASRASCNSGLFTWNKVQPGDNAFRRMLQQVTN---GFEAKRKASE 271
++S+ ++D + + S LF W + + ++ +++V F +E
Sbjct: 45 ILSKEEIDH--IIMSKDAVSGTLRLF-WTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTE 101
Query: 272 PSSSSSIASSPEPLVSPSLSPSM-SSLLSPSFSPSPSPSESPSVSSPLIIPPAPVNIPIV 330
PS+ M ++ + + V+
Sbjct: 102 QRQ-------------PSMMTRMYIEQRDRLYNDNQ------------VFAKYNVSRL-- 134
Query: 331 SSPPHLHSAPTSFAASTPSQVHESLHKSKHHTVLVLAGIIG-GLSLILISAIGFFVCRSS 389
P+L ++ ++L + + +++ G++G G + + VC S
Sbjct: 135 --QPYL-------------KLRQALLELRPAKNVLIDGVLGSGKT-WVALD----VCLSY 174
Query: 390 KVVTVKP----WVTGLSGQLQKAFVTGVPKLKRSELEAACEDFSNIIGSFSDGTVGTVYK 445
KV W+ P+ L+ S SD
Sbjct: 175 KVQCKMDFKIFWLN--LKNCNS------PETVLEMLQKLLYQIDPNWTSRSDH------- 219
Query: 446 GTLSSGVEIAVTSTSVKSRADWSKN------LESQFRKKIDTLSKVNHKNFVNL--IGYC 497
S+++K R + + + L V + N + C
Sbjct: 220 ------------SSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLS-C 266
Query: 498 EEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAH 557
++++ + + + L H+ L+H
Sbjct: 267 -------KILLT--TRFKQVTDFLSAATTTHI--------------SLDHHSMT------ 297
Query: 558 RNLQSSSIYLTEDYAAKISDFSFWNNTTAAKTGSAAMELLETSAVDLESNVYSFGTILFE 617
LT D + + L+ DL V +
Sbjct: 298 ---------LTPDEVKSL--LLKY---------------LDCRPQDLPREVLTTNPRRLS 331
Query: 618 MITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQENVLEEL---LVVIKNCVH 674
+I I + +NW +++ ++ L I++ +L + ++ L V H
Sbjct: 332 IIAESI--RDGLATWDNW--KHVNCDK-LTTIIESSLNVLEPAEYRKMFDRLSVFPPSAH 386
Query: 675 PDPKQRPSMRGIAAKLKEITAMEPDGATPKLSPLWWAELE 714
I L LS +W+ ++
Sbjct: 387 -----------IPTIL--------------LSLIWFDVIK 401
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 3e-10
Identities = 38/210 (18%), Positives = 77/210 (36%), Gaps = 33/210 (15%)
Query: 427 DFSNIIGSFSDGTVGTVYKGT-LSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKV 485
+ +G G G V++ SS VK + +K+I L+
Sbjct: 8 MIAEDLGR---GEFGIVHRCVETSSKKTYMAKFVKVKGTD------QVLVKKEISILNIA 58
Query: 486 NHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHL---DWAMRLR-IAMGM 541
H+N ++L E E M+FE+ +FE + A L + + + +
Sbjct: 59 RHRNILHLHESFESMEELV--MIFEFISGLDIFERI-NTSAFELNEREIVSYVHQVCEAL 115
Query: 542 AYCLEHMHQLTPPIAHRNLQSSSIYLT--EDYAAKISDF---SFWNNTTAAKT--GSA-- 592
+ H H I H +++ +I KI +F + +
Sbjct: 116 QFL--HSHN----IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEY 169
Query: 593 -AMELLETSAVDLESNVYSFGTILFEMITG 621
A E+ + V ++++S GT+++ +++G
Sbjct: 170 YAPEVHQHDVVSTATDMWSLGTLVYVLLSG 199
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 3e-10
Identities = 58/282 (20%), Positives = 103/282 (36%), Gaps = 63/282 (22%)
Query: 426 EDFSNI--IGSFSDGTVGTVYKGT-LSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTL 482
+ IG G+ G V SG ++AV ++ + ++ +
Sbjct: 45 LLLDSYVKIGE---GSTGIVCLAREKHSGRQVAVKMMDLRKQQR-----RELLFNEVVIM 96
Query: 483 SKVNHKNFVNLIG-YCEEDEPFTRMMVFEYSPNGSL---FEHLHIQEAEHLDWAMRLRIA 538
H N V + Y +E + M E+ G+L + + E + IA
Sbjct: 97 RDYQHFNVVEMYKSYLVGEELWVLM---EFLQGGALTDIVSQVRLNEEQ---------IA 144
Query: 539 MGMAYC---LEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSF--WNNTTAAKTGSA- 592
L ++H + HR+++S SI LT D K+SDF F + K S
Sbjct: 145 TVCEAVLQALAYLHAQG--VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV 202
Query: 593 ------AMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPL 646
A E++ S E +++S G ++ EM+ G Y + P+
Sbjct: 203 GTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYF---------------SDSPV 247
Query: 647 K---DIVD---PTLKSFQENVLEELLVVIKNCVHPDPKQRPS 682
+ + D P LK+ V L ++ + DP++R +
Sbjct: 248 QAMKRLRDSPPPKLKN-SHKVSPVLRDFLERMLVRDPQERAT 288
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 5e-10
Identities = 48/213 (22%), Positives = 85/213 (39%), Gaps = 31/213 (14%)
Query: 427 DFSNIIGSFSDGTVGTVYKGT-LSSGVEIAVTSTSV-KSRADWSKNLESQFRKKIDTLSK 484
D +GS G V K S+G+E A +SRA + +++ L +
Sbjct: 15 DIGEELGS---GQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71
Query: 485 VNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHL---DWAMRLR-IAMG 540
V H N + L E ++ E G LF+ + + E L + ++ I G
Sbjct: 72 VLHHNVITLHDVYENRTDVV--LILELVSGGELFD--FLAQKESLSEEEATSFIKQILDG 127
Query: 541 MAYCLEHMHQLTPPIAHRNLQSSSIYL---TEDYAA-KISDF---SFWNNTTAAKT--GS 591
+ Y H + IAH +L+ +I L K+ DF + K G+
Sbjct: 128 VNYL--HTKK----IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGT 181
Query: 592 A---AMELLETSAVDLESNVYSFGTILFEMITG 621
A E++ + LE++++S G I + +++G
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 8e-10
Identities = 62/282 (21%), Positives = 112/282 (39%), Gaps = 63/282 (22%)
Query: 426 EDFSNI--IGSFSDGTVGTVYKGT-LSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTL 482
+ ++ IG G GTVY +++G E+A+ +++ + +I +
Sbjct: 20 KKYTRFEKIGQ---GASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL-----IINEILVM 71
Query: 483 SKVNHKNFVNLIG-YCEEDEPFTRMMVFEYSPNGSLFEHLH---IQEAEHLDWAMRLRIA 538
+ + N VN + Y DE + M EY GSL + + + E + IA
Sbjct: 72 RENKNPNIVNYLDSYLVGDELWVVM---EYLAGGSLTDVVTETCMDEGQ---------IA 119
Query: 539 MGMAYC---LEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTAAKTGSAAM- 594
C LE +H + HR+++S +I L D + K++DF F T ++ + M
Sbjct: 120 AVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV 177
Query: 595 --------ELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPL 646
E++ A + +++S G + EMI G Y EN PL
Sbjct: 178 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN---------------PL 222
Query: 647 KDIV------DPTLKSFQENVLEELLVVIKNCVHPDPKQRPS 682
+ + P L++ E + + C+ D ++R S
Sbjct: 223 RALYLIATNGTPELQN-PEKLSAIFRDFLNRCLEMDVEKRGS 263
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 9e-10
Identities = 47/213 (22%), Positives = 83/213 (38%), Gaps = 31/213 (14%)
Query: 427 DFSNIIGSFSDGTVGTVYKGT-LSSGVEIAVTSTSVKS-RADWSKNLESQFRKKIDTLSK 484
D +GS G V K S+G+E A + RA + +++ L +
Sbjct: 15 DIGEELGS---GQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQ 71
Query: 485 VNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHL---DWAMRLR-IAMG 540
V H N + L E ++ E G LF+ + + E L + ++ I G
Sbjct: 72 VLHPNIITLHDVYENRTDVV--LILELVSGGELFD--FLAQKESLSEEEATSFIKQILDG 127
Query: 541 MAYCLEHMHQLTPPIAHRNLQSSSIYLT----EDYAAKISDF---SFWNNTTAAKT--GS 591
+ Y H IAH +L+ +I L K+ DF + K G+
Sbjct: 128 VNYL----HTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGT 181
Query: 592 A---AMELLETSAVDLESNVYSFGTILFEMITG 621
A E++ + LE++++S G I + +++G
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 9e-10
Identities = 56/295 (18%), Positives = 101/295 (34%), Gaps = 78/295 (26%)
Query: 427 DFSNIIGSFSDGTVGTVYKGT-LSSGVEIAVTS---TSVKSRADWSKNLESQFRKKIDTL 482
S +GS G G V + ++A+ + + +I+ L
Sbjct: 13 IMSKTLGS---GACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 483 SKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLF----EHLHIQEAEHLDWAMRL--R 536
K+NH + + + + ++ + +V E G LF + ++EA +
Sbjct: 70 KKLNHPCIIKIKNFFDAEDYY---IVLELMEGGELFDKVVGNKRLKEAT----CKLYFYQ 122
Query: 537 IAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLT---EDYAAKISDF---SFWNNTTAAKT- 589
+ + + Y E+ I HR+L+ ++ L+ ED KI+DF T+ +T
Sbjct: 123 MLLAVQYLHENG------IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL 176
Query: 590 -GS---AAMELLE-------TSAVDLESNVYSFGTILFEMITG-----------RISYSI 627
G+ A E+L AVD +S G ILF ++G + I
Sbjct: 177 CGTPTYLAPEVLVSVGTAGYNRAVD----CWSLGVILFICLSGYPPFSEHRTQVSLKDQI 232
Query: 628 ENGSLENWASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPS 682
+G + E V +K + DPK R +
Sbjct: 233 TSGKYN-FIPEVW-------AEVSEKALDL-----------VKKLLVVDPKARFT 268
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 59.5 bits (145), Expect = 9e-10
Identities = 42/216 (19%), Positives = 79/216 (36%), Gaps = 37/216 (17%)
Query: 427 DFSNIIGSFSDGTVGTVYKGT-LSSGVEIAVTSTSV-KSRADWSKNLESQFRKKIDTLSK 484
+ +GS G V K +G E A + + + ++++ L +
Sbjct: 8 EMGEELGS---GQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 64
Query: 485 VNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHL---DWAMRLR-IAMG 540
+ H N + L E ++ E G LF+ + E E L + L+ I G
Sbjct: 65 IRHPNIITLHDIFENKTDVV--LILELVSGGELFD--FLAEKESLTEDEATQFLKQILDG 120
Query: 541 MAYCLEHMHQLTPPIAHRNL-------QSSSIYLTEDYAAKISDF---SFWNNTTAAKT- 589
+ Y H + IAH +L + + K+ DF K
Sbjct: 121 VHYL--HSKR----IAHFDLKPENIMLLDKN---VPNPRIKLIDFGIAHKIEAGNEFKNI 171
Query: 590 -GSA---AMELLETSAVDLESNVYSFGTILFEMITG 621
G+ A E++ + LE++++S G I + +++G
Sbjct: 172 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 1e-09
Identities = 62/266 (23%), Positives = 112/266 (42%), Gaps = 46/266 (17%)
Query: 438 GTVGTVYKGT-LSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGY 496
G+ G V T + ++A+ S + ++ + ++I L + H + + L
Sbjct: 20 GSFGKVKLATHYKTQQKVALKFIS-RQLLK-KSDMHMRVEREISYLKLLRHPHIIKLYDV 77
Query: 497 CE-EDEPFTRMMVFEYSPNGSLFEHL----HIQEAEHLDWAMRL--RIAMGMAYCLEHMH 549
+ MV EY+ G LF+++ + E E R +I + YC H H
Sbjct: 78 ITTPTDIV---MVIEYA-GGELFDYIVEKKRMTEDE----GRRFFQQIICAIEYC--HRH 127
Query: 550 QLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTAA---KT--GS---AAMELLETSA 601
+ I HR+L+ ++ L ++ KI+DF N T KT GS AA E++
Sbjct: 128 K----IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKL 183
Query: 602 VD-LESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQEN 660
E +V+S G +L+ M+ GR+ + E + N + + D + P +S
Sbjct: 184 YAGPEVDVWSCGIVLYVMLVGRLPFDDEF--IPNLFKKVNSCVYVMPDFLSPGAQSL--- 238
Query: 661 VLEELLVVIKNCVHPDPKQRPSMRGI 686
+ ++V DP QR +++ I
Sbjct: 239 -IRRMIVA-------DPMQRITIQEI 256
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 1e-09
Identities = 28/240 (11%), Positives = 63/240 (26%), Gaps = 40/240 (16%)
Query: 475 FRKKIDTLSKVNHKNFVNLIGYCEEDE-PFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAM 533
+ LS+++ ++ +V E+ GSL E
Sbjct: 78 TLSRTLRLSRIDKPGVARVLDVVHTRAGGL---VVAEWIRGGSLQEVA----DTSPSPVG 130
Query: 534 RLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTAAKTGSAA 593
+R +A + H+ +A S + ++ D ++ +
Sbjct: 131 AIRAMQSLAAAADAAHRA--GVALSIDHPSRVRVSIDGDVVLAYPAT------------- 175
Query: 594 MELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPT 653
+ + ++ G L+ ++ R +E QP
Sbjct: 176 -----MPDANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQP------IE 224
Query: 654 LKSFQENVLEELLVVIKNCVHPDPKQRPS------MRGIAAKLKEITAMEPDGATPKLSP 707
++ ++ V V D R + M+ A + P P +
Sbjct: 225 PADIDRDIPFQISAVAARSVQGDGGIRSASTLLNLMQQATAVADRTEVLGPIDEAPVSAA 284
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 64/266 (24%), Positives = 117/266 (43%), Gaps = 45/266 (16%)
Query: 438 GTVGTVYKGT-LSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGY 496
GT G V G +G ++AV + + + S ++ + R++I L H + + L
Sbjct: 27 GTFGKVKVGKHELTGHKVAVKILN-RQKIR-SLDVVGKIRREIQNLKLFRHPHIIKLYQV 84
Query: 497 CE-EDEPFTRMMVFEYSPNGSLFEHL----HIQEAEHLDWAMRL--RIAMGMAYCLEHMH 549
+ F MV EY G LF+++ + E E + RL +I G+ YC HM
Sbjct: 85 ISTPSDIF---MVMEYVSGGELFDYICKNGRLDEKE----SRRLFQQILSGVDYCHRHM- 136
Query: 550 QLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTAA---KT--GS---AAMELLETSA 601
+ HR+L+ ++ L AKI+DF N + +T GS AA E++
Sbjct: 137 -----VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRL 191
Query: 602 VD-LESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQEN 660
E +++S G IL+ ++ G + + ++ + + G ++P++ S
Sbjct: 192 YAGPEVDIWSSGVILYALLCGTLPFDDDH--VPTLFKKICDGIFYTPQYLNPSVISL--- 246
Query: 661 VLEELLVVIKNCVHPDPKQRPSMRGI 686
L+ +L V DP +R +++ I
Sbjct: 247 -LKHMLQV-------DPMKRATIKDI 264
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 58.8 bits (142), Expect = 2e-09
Identities = 60/353 (16%), Positives = 105/353 (29%), Gaps = 110/353 (31%)
Query: 428 FSNIIGSFSDGTVGTVYKGTL----SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLS 483
+G G G V + + V +K A + ++ L
Sbjct: 26 LGKPLGR---GAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILI 80
Query: 484 KV-NHKNFVNLIGYC-EEDEPFTRMMVFEYSPNGSLFEHLH------------------- 522
+ +H N VNL+G C + P M++ E+ G+L +L
Sbjct: 81 HIGHHLNVVNLLGACTKPGGPL--MVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQG 138
Query: 523 --IQEAEHLDWAMRL------RIAMGMAYCLEH-----------MHQLTPPIAHRNLQSS 563
A +D RL + + + E + +L
Sbjct: 139 KDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICY 198
Query: 564 SI-------YLTE------DYAA-----------KISDFSF----WNNTTAAKTGSA--- 592
S +L D AA KI DF + + + G A
Sbjct: 199 SFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258
Query: 593 ----AMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWAS--EYLKG--- 642
A E + ++S+V+SFG +L+E+ + G Y ++ LK
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP----GVKIDEEFCRRLKEGTR 314
Query: 643 -EQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEIT 694
P + E+ + +C H +P QRP+ + L +
Sbjct: 315 MRAP-------------DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 354
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 2e-09
Identities = 55/287 (19%), Positives = 99/287 (34%), Gaps = 66/287 (22%)
Query: 427 DFSNIIGSFSDGTVGTVYKGT-LSSGVEIAVTSTSV-KSRADWSKNLESQFRKKIDTLSK 484
D +GS G V K S+G++ A ++++ +++ L +
Sbjct: 14 DTGEELGS---GQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 485 VNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHL---DWAMRLR-IAMG 540
+ H N + L E ++ E G LF+ + E E L + L+ I G
Sbjct: 71 IQHPNVITLHEVYENKTDVI--LILELVAGGELFD--FLAEKESLTEEEATEFLKQILNG 126
Query: 541 MAYCLEHMHQLTPPIAHRNL-------QSSSIYLTEDYAAKISDF---SFWNNTTAAKT- 589
+ Y H Q IAH +L + KI DF + K
Sbjct: 127 VYYL--HSLQ----IAHFDLKPENIMLLDRN---VPKPRIKIIDFGLAHKIDFGNEFKNI 177
Query: 590 -GSA---AMELLETSAVDLESNVYSFGTILFEMITG----------RISYSIENGSLENW 635
G+ A E++ + LE++++S G I + +++G ++ + E +
Sbjct: 178 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE-F 236
Query: 636 ASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPS 682
EY K F I+ + DPK+R +
Sbjct: 237 EDEYFSN-------TSALAKDF-----------IRRLLVKDPKKRMT 265
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 3e-09
Identities = 56/294 (19%), Positives = 104/294 (35%), Gaps = 74/294 (25%)
Query: 427 DFSNIIGSFSDGTVGTVYKGT-LSSGVEIAV----TSTSVKSRADWSKNLESQFRKKIDT 481
+ I+G G V + + E AV + A+ + L K++D
Sbjct: 20 EPKEILGR---GVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 482 LSKVN-HKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHL---DWAMRLR- 536
L KV+ H N + L E + F +VF+ G LF++ + E L + +R
Sbjct: 77 LRKVSGHPNIIQLKDTYETNTFFF--LVFDLMKKGELFDY--LTEKVTLSEKETRKIMRA 132
Query: 537 IAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDF---SFWNNTTAAKT--GS 591
+ + H I HR+L+ +I L +D K++DF + + G+
Sbjct: 133 LLEVICAL--HKLN----IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGT 186
Query: 592 A---AMELLETSAV------DLESNVYSFGTILFEMITG----------RISYSIENGSL 632
A E++E S E +++S G I++ ++ G + I +G+
Sbjct: 187 PSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNY 246
Query: 633 ----ENWASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPS 682
W D T+K + + P++R +
Sbjct: 247 QFGSPEW------------DDYSDTVKDL-----------VSRFLVVQPQKRYT 277
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 4e-09
Identities = 60/284 (21%), Positives = 111/284 (39%), Gaps = 53/284 (18%)
Query: 437 DGTVGTVYKGT-LSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKV-NHKNFVNLI 494
+G V L + E AV K ++ S+ ++++ L + H+N + LI
Sbjct: 23 EGAHARVQTCINLITSQEYAV-----KIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77
Query: 495 GYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHL---DWAMRLR-IAMGMAYCLEHMHQ 550
+ EE++ F +VFE GS+ HI + H + ++ ++ +A + + H
Sbjct: 78 EFFEEEDRF--YLVFEKMRGGSILS--HIHKRRHFNELEASVVVQDVASALDFL--HNKG 131
Query: 551 LTPPIAHRNLQSSSI-YLTEDYAA--KISDFSF-----------WNNTTAAKT--GSA-- 592
IAHR+L+ +I + + KI DF +T T GSA
Sbjct: 132 ----IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEY 187
Query: 593 -AMELLETSAV-----DLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPL 646
A E++E + D +++S G IL+ +++G + GS W
Sbjct: 188 MAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQ- 246
Query: 647 KDIVDPTLK---SFQE----NVLEELLVVIKNCVHPDPKQRPSM 683
+ + + F + ++ +I + D KQR S
Sbjct: 247 NMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSA 290
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 57.5 bits (139), Expect = 5e-09
Identities = 22/150 (14%), Positives = 47/150 (31%), Gaps = 6/150 (4%)
Query: 427 DFSNIIGSFSDGTVGTVYKGT-LSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKV 485
IG G+ G V + A+ + + + + ++ + K+
Sbjct: 29 HLKGAIGQ---GSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL 85
Query: 486 NHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCL 545
+H N L E+++ +V E G L + L++ + + + C
Sbjct: 86 HHPNIARLYEVYEDEQYIC--LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCP 143
Query: 546 EHMHQLTPPIAHRNLQSSSIYLTEDYAAKI 575
E + H +S E + I
Sbjct: 144 ECNEEAINGSIHGFRESLDFVQREKLISNI 173
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 7e-09
Identities = 58/293 (19%), Positives = 98/293 (33%), Gaps = 81/293 (27%)
Query: 427 DFSNIIGSFSDGTVGTVYKGT-LSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSK- 484
+ IG G+ + ++ +E AV KS+ D ++I+ L +
Sbjct: 25 EVKEDIG---VGSYSVCKRCIHKATNMEFAVKIID-KSKRD--------PTEEIEILLRY 72
Query: 485 VNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHL---DWAMRLR-IAMG 540
H N + L ++ + +V E G L + I + + + L I
Sbjct: 73 GQHPNIITLKDVYDDGKYVY--VVTELMKGGELLD--KILRQKFFSEREASAVLFTITKT 128
Query: 541 MAYCLEHMHQLTPPIAHRNLQSSSI-YLTEDYAA---KISDF----SFWNNTTAAKT--G 590
+ Y H + HR+L+ S+I Y+ E +I DF T
Sbjct: 129 VEYL--HAQG----VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCY 182
Query: 591 SA---AMELLETSAVDLESNVYSFGTILFEMITG-------------RISYSIENGSL-- 632
+A A E+LE D +++S G +L+ M+TG I I +G
Sbjct: 183 TANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSL 242
Query: 633 --ENWASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSM 683
W + V T K + +H DP QR +
Sbjct: 243 SGGYW------------NSVSDTAKDL-----------VSKMLHVDPHQRLTA 272
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 8e-09
Identities = 24/120 (20%), Positives = 36/120 (30%), Gaps = 12/120 (10%)
Query: 120 VVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFS 179
V +NL+ + + S L+ + L +P + L L+ L L N F
Sbjct: 256 VESINLQKHYFFNISSNTFHCFSGLQELDLTATHL-SELPSGLVGLSTLKKLVLSANKFE 314
Query: 180 GPFPSDFGNSFSLTTLLLDNNQYLGGISPE-------LHVLKV----ISEIQVDESWLTN 228
N SLT L + N + L L + I L N
Sbjct: 315 NLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRN 374
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 1e-08
Identities = 21/89 (23%), Positives = 27/89 (30%), Gaps = 1/89 (1%)
Query: 122 ILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGP 181
L L L M L LK + + K LE L LG N+ S
Sbjct: 85 TLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSI 144
Query: 182 FPSDFGNSFSLTTLLLDNNQYLGGISPEL 210
+ L L NN + +S E
Sbjct: 145 KLPKGFPTEKLKVLDFQNNA-IHYLSKED 172
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 4e-07
Identities = 17/91 (18%), Positives = 28/91 (30%), Gaps = 6/91 (6%)
Query: 124 NLRDLCLGG----MLAPE-LGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNF 178
NL L L + + L +++L N + K L+ L
Sbjct: 58 NLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGI 117
Query: 179 SGPFPSDFGNSFSLTTLLLDNNQYLGGISPE 209
S N +L +L L +N + I
Sbjct: 118 SSIDFIPLHNQKTLESLYLGSNH-ISSIKLP 147
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 1e-06
Identities = 12/90 (13%), Positives = 20/90 (22%), Gaps = 1/90 (1%)
Query: 120 VVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFS 179
L L + +L L + L + L+ L L N
Sbjct: 35 TECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLI 94
Query: 180 GPFPSDFGNSFSLTTLLLDNNQYLGGISPE 209
+ +L L + I
Sbjct: 95 FMAETALSGPKALKHLFFIQTG-ISSIDFI 123
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 1e-06
Identities = 22/94 (23%), Positives = 37/94 (39%), Gaps = 9/94 (9%)
Query: 124 NLRDLCLGG----MLAPE-LGQLSELKSIILRNNSFFGTIPKEIG---ELKELEILDLGF 175
L+ L L + + + L L+ + L+ N F ++ L LEIL L F
Sbjct: 426 LLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSF 485
Query: 176 NNFSGPFPSDFGNSFSLTTLLLDNNQYLGGISPE 209
+ S F + + + L +N+ L S E
Sbjct: 486 CDLSSIDQHAFTSLKMMNHVDLSHNR-LTSSSIE 518
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 2e-06
Identities = 21/120 (17%), Positives = 38/120 (31%), Gaps = 3/120 (2%)
Query: 122 ILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGP 181
L + + L L+S+ L +N + ++L++LD N
Sbjct: 109 HLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYL 168
Query: 182 FPSDFGNSFSLTTLLLD--NNQYLGGISPELHVLKVISEIQVDESWLTNAASRASCNSGL 239
D + T L L+ N + GI P V + + + NS +
Sbjct: 169 SKEDMSSLQQATNLSLNLNGND-IAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTI 227
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 3e-06
Identities = 19/100 (19%), Positives = 35/100 (35%), Gaps = 1/100 (1%)
Query: 119 KVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFN-N 177
+ L L + + P+ +LK + +NN+ +++ L++ L L N N
Sbjct: 130 TLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGN 189
Query: 178 FSGPFPSDFGNSFSLTTLLLDNNQYLGGISPELHVLKVIS 217
+S +L Q L I L + S
Sbjct: 190 DIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQS 229
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 7e-06
Identities = 15/73 (20%), Positives = 25/73 (34%), Gaps = 2/73 (2%)
Query: 138 LGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLL 197
L L L+ ++L LK + +DL N + + + L L
Sbjct: 472 LQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNL 530
Query: 198 DNNQYLGGISPEL 210
+N + I P L
Sbjct: 531 ASNH-ISIILPSL 542
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 9e-06
Identities = 16/100 (16%), Positives = 35/100 (35%), Gaps = 1/100 (1%)
Query: 123 LNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEI-GELKELEILDLGFNNFSGP 181
LNL + + +L+ + L + L L++L+L +
Sbjct: 381 LNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDIS 440
Query: 182 FPSDFGNSFSLTTLLLDNNQYLGGISPELHVLKVISEIQV 221
F +L L L N + G + + L+ + +++
Sbjct: 441 SEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEI 480
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 1e-05
Identities = 16/90 (17%), Positives = 30/90 (33%), Gaps = 4/90 (4%)
Query: 123 LNLRDLCLGGMLAPE-LGQLSELKSIILRNN--SFFGTIPKEIGELKELEILDLGFNNFS 179
L+++ L L L L+ + L ++ ++ L L+ L+L +N
Sbjct: 330 LSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPL 389
Query: 180 GPFPSDFGNSFSLTTLLLDNNQYLGGISPE 209
F L L L + L +
Sbjct: 390 SLKTEAFKECPQLELLDLAFTR-LKVKDAQ 418
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 1e-05
Identities = 13/70 (18%), Positives = 20/70 (28%), Gaps = 1/70 (1%)
Query: 141 LSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLLDNN 200
+ + + N L L LDL F + L TL+L N
Sbjct: 32 PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTAN 91
Query: 201 QYLGGISPEL 210
L ++
Sbjct: 92 P-LIFMAETA 100
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 1e-05
Identities = 18/81 (22%), Positives = 29/81 (35%), Gaps = 1/81 (1%)
Query: 122 ILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGP 181
IL L L + L + + L +N + + + LK + L+L N+ S
Sbjct: 480 ILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISII 538
Query: 182 FPSDFGNSFSLTTLLLDNNQY 202
PS T+ L N
Sbjct: 539 LPSLLPILSQQRTINLRQNPL 559
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 3e-05
Identities = 19/92 (20%), Positives = 31/92 (33%), Gaps = 5/92 (5%)
Query: 122 ILNLRDLCLGGMLAPE-LGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSG 180
+L+L L A L LK + L ++ + + L L+ L+L N+F
Sbjct: 404 LLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPK 463
Query: 181 PF---PSDFGNSFSLTTLLLDNNQYLGGISPE 209
+ L L+L L I
Sbjct: 464 GNIQKTNSLQTLGRLEILVLSFCD-LSSIDQH 494
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 8e-04
Identities = 15/96 (15%), Positives = 31/96 (32%), Gaps = 6/96 (6%)
Query: 119 KVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIG--ELKELEILDLGFN 176
+ LNL + G + P + +S+ I K + ++ L +
Sbjct: 180 TNLSLNLNGNDIAG-IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDM 238
Query: 177 NFSGPFPSDFGNSF--SLTTLLLDNNQYLGGISPEL 210
+ P+ F S+ ++ L + IS
Sbjct: 239 DDEDISPAVFEGLCEMSVESINLQKHY-FFNISSNT 273
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 9e-09
Identities = 56/270 (20%), Positives = 96/270 (35%), Gaps = 49/270 (18%)
Query: 438 GTVGTVYKGT-LSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGY 496
G G V + +AV RA + +K+I +NH+N V G+
Sbjct: 18 GAYGEVQLAVNRVTEEAVAVKIVD-MKRAV---DCPENIKKEICINKMLNHENVVKFYGH 73
Query: 497 CEEDEPFTRM-MVFEYSPNGSLFEHL----HIQEAEHLDWAMRL--RIAMGMAYCLEHMH 549
E + EY G LF+ + + E + A R ++ G+ Y H
Sbjct: 74 RREG---NIQYLFLEYCSGGELFDRIEPDIGMPEPD----AQRFFHQLMAGVVYL--HGI 124
Query: 550 QLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTAAKT--------GS---AAMELLE 598
I HR+++ ++ L E KISDF G+ A ELL+
Sbjct: 125 G----ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 599 TSAVD-LESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKG-EQPLKDIVDPTLKS 656
+V+S G +L M+ G + + + S + ++ K +D +
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 240
Query: 657 FQENVLEELLVVIKNCVHPDPKQRPSMRGI 686
L ++LV +P R ++ I
Sbjct: 241 L----LHKILV-------ENPSARITIPDI 259
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 42/199 (21%), Positives = 85/199 (42%), Gaps = 29/199 (14%)
Query: 438 GTVGTVYKGT-LSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGY 496
G G V+K ++G+++A + D + + + +I +++++H N + L
Sbjct: 100 GRFGQVHKCEETATGLKLAAKIIKTRGMKD-----KEEVKNEISVMNQLDHANLIQLYDA 154
Query: 497 CEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHL---DWAMRLR-IAMGMAYCLEHMHQLT 552
E +V EY G LF+ + I E+ +L D + ++ I G+ + H
Sbjct: 155 FESKNDIV--LVMEYVDGGELFDRI-IDESYNLTELDTILFMKQICEGIRHM--HQMY-- 207
Query: 553 PPIAHRNLQSSSIYLT--EDYAAKISDF---SFWNNTTAAKT--GSA---AMELLETSAV 602
I H +L+ +I + KI DF + K G+ A E++ V
Sbjct: 208 --ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFV 265
Query: 603 DLESNVYSFGTILFEMITG 621
++++S G I + +++G
Sbjct: 266 SFPTDMWSVGVIAYMLLSG 284
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 1e-08
Identities = 56/289 (19%), Positives = 108/289 (37%), Gaps = 70/289 (24%)
Query: 426 EDFSNI--IGSFSDGTVGTVYKGT-LSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTL 482
E + + +G DG G VYK +G A KS + + +I+ L
Sbjct: 19 EVWEIVGELG---DGAFGKVYKAKNKETGALAAAKVIETKSEEELE-----DYIVEIEIL 70
Query: 483 SKVNHKNFVNLIG-YCEEDEPFTRMMVFEYSPNGSLFEHLH-----IQEAEHLDWAMRLR 536
+ +H V L+G Y + + + ++ E+ P G++ + + E +
Sbjct: 71 ATCDHPYIVKLLGAYYHDGKLW---IMIEFCPGGAVDAIMLELDRGLTEPQ--------- 118
Query: 537 IAMGMAYC---LEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDF--SFWNNTTAAKTGS 591
I + L +H I HR+L++ ++ +T + +++DF S N T K S
Sbjct: 119 IQVVCRQMLEALNFLHSKR--IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS 176
Query: 592 ------------AAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEY 639
E ++ + D +++++S G L EM + N
Sbjct: 177 FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN---------- 226
Query: 640 LKGEQPLKDIVD------PTLKSFQENVLEELLVVIKNCVHPDPKQRPS 682
P++ ++ PTL + E +K + +P+ RPS
Sbjct: 227 -----PMRVLLKIAKSDPPTLLT-PSKWSVEFRDFLKIALDKNPETRPS 269
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 2e-08
Identities = 51/225 (22%), Positives = 93/225 (41%), Gaps = 56/225 (24%)
Query: 480 DTLSKVNHKNFVNLIGYCEEDEPFTRM-MVFEYSPNGSLFEHLHIQEAEHLDWAM-RLRI 537
D +S+++H FV L + +D+ ++ Y+ NG L +++ ++ D R
Sbjct: 82 DVMSRLDHPFFVKLY-FTFQDD--EKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYT 136
Query: 538 A-MGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSF----WNNTTAAKTGS- 591
A + A LE++H I HR+L+ +I L ED +I+DF + A+ S
Sbjct: 137 AEIVSA--LEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSF 192
Query: 592 ------AAMELLE----TSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEY-- 639
+ ELL + DL ++ G I+++++ G + N EY
Sbjct: 193 VGTAQYVSPELLTEKSACKSSDL----WALGCIIYQLVAGLPPFRAGN--------EYLI 240
Query: 640 ----LKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQR 680
+K E + P + +E+LLV+ D +R
Sbjct: 241 FQKIIKLEYDFPEKFFPKARDL----VEKLLVL-------DATKR 274
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 3e-08
Identities = 18/100 (18%), Positives = 36/100 (36%), Gaps = 7/100 (7%)
Query: 124 NLRDLCLGG----MLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFS 179
N++DL + P + LS L+ + + + L L +LD+ +
Sbjct: 67 NIKDLTINNIHATNYNP-ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHD 125
Query: 180 GPFPSDFGNSFSLTTLLLDNNQYLGGISP--ELHVLKVIS 217
+ + ++ L N + I P L LK ++
Sbjct: 126 DSILTKINTLPKVNSIDLSYNGAITDIMPLKTLPELKSLN 165
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 1e-05
Identities = 16/90 (17%), Positives = 33/90 (36%), Gaps = 7/90 (7%)
Query: 124 NLRDLCLGG-----MLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNF 178
NL L + G P L L+ L + + +++ +I +I L ++ +DL +N
Sbjct: 89 NLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGA 148
Query: 179 SGPFPSDFGNSFSLTTLLLDNNQYLGGISP 208
L +L + + +
Sbjct: 149 IT-DIMPLKTLPELKSLNIQFDG-VHDYRG 176
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 3e-08
Identities = 52/276 (18%), Positives = 95/276 (34%), Gaps = 65/276 (23%)
Query: 438 GTVGTVYKGT-LSSGVEIAVTSTSVKSRADWSKNLESQFRKK--IDTLSKVNHK--NFVN 492
G G+VY G +S + +A+ K R L + R + L KV+ +
Sbjct: 54 GGFGSVYSGIRVSDNLPVAIKHVE-KDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIR 112
Query: 493 LIGYCEEDEPFTRMMVFEY-SPNGSLFEHL----HIQEAEHLDWAMRL--RIAMGMAYCL 545
L+ + E + F +++ E P LF+ + +QE A ++ + +C
Sbjct: 113 LLDWFERPDSF--VLILERPEPVQDLFDFITERGALQEEL----ARSFFWQVLEAVRHC- 165
Query: 546 EHMHQLTPPIAHRNLQSSSIYL-TEDYAAKISDFSFWNNT--TAAKT--GS---AAMELL 597
H + HR+++ +I + K+ DF T G+ + E +
Sbjct: 166 -HNCG----VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWI 220
Query: 598 ETSAVD-LESNVYSFGTILFEMITGRI----SYSIENGSLE--NWASEYLKGEQPLKDIV 650
+ V+S G +L++M+ G I I G + S
Sbjct: 221 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVS------------- 267
Query: 651 DPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGI 686
E +I+ C+ P RP+ I
Sbjct: 268 ------------SECQHLIRWCLALRPSDRPTFEEI 291
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 5e-08
Identities = 50/307 (16%), Positives = 96/307 (31%), Gaps = 69/307 (22%)
Query: 414 PKLKRSELEAACEDFSNIIGSFS------DGTVGTVYKGT-LSSGVEIAV---TSTSVKS 463
K ELE +S G G V+ E+ V V
Sbjct: 5 EPPKAVELEGLAACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLE 64
Query: 464 RADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFE-YSPNGSLFEHL- 521
+ +I LS+V H N + ++ E F +V E + LF +
Sbjct: 65 DCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFF--QLVMEKHGSGLDLFAFID 122
Query: 522 ---HIQEAEHLDWAMRL--RIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKIS 576
+ E A + ++ + Y + I HR+++ +I + ED+ K+
Sbjct: 123 RHPRLDEPL----ASYIFRQLVSAVGYL--RLKD----IIHRDIKDENIVIAEDFTIKLI 172
Query: 577 DFSFWNNTTAAKT-----GS---AAMELLETSAVD-LESNVYSFGTILFEMITGRISY-- 625
DF K G+ A E+L + E ++S G L+ ++ +
Sbjct: 173 DFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE 232
Query: 626 --SIENGSLE--NWASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRP 681
++ S +EL+ ++ + P P++R
Sbjct: 233 LEETVEAAIHPPYLVS-------------------------KELMSLVSGLLQPVPERRT 267
Query: 682 SMRGIAA 688
++ +
Sbjct: 268 TLEKLVT 274
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 6e-08
Identities = 56/270 (20%), Positives = 96/270 (35%), Gaps = 49/270 (18%)
Query: 438 GTVGTVYKGT-LSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGY 496
G G V + +AV RA + +K+I +NH+N V G+
Sbjct: 18 GAYGEVQLAVNRVTEEAVAVKIVD-MKRAV---DCPENIKKEICINKMLNHENVVKFYGH 73
Query: 497 CEEDEPFTRM-MVFEYSPNGSLFEHL----HIQEAEHLDWAMRL--RIAMGMAYCLEHMH 549
E + EY G LF+ + + E + A R ++ G+ Y H
Sbjct: 74 RREG---NIQYLFLEYCSGGELFDRIEPDIGMPEPD----AQRFFHQLMAGVVYL--HGI 124
Query: 550 QLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTAAKT--------GS---AAMELLE 598
I HR+++ ++ L E KISDF G+ A ELL+
Sbjct: 125 G----ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 599 TSAVD-LESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKG-EQPLKDIVDPTLKS 656
+V+S G +L M+ G + + + S + ++ K +D +
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 240
Query: 657 FQENVLEELLVVIKNCVHPDPKQRPSMRGI 686
L ++LV +P R ++ I
Sbjct: 241 L----LHKILV-------ENPSARITIPDI 259
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 6e-08
Identities = 58/281 (20%), Positives = 112/281 (39%), Gaps = 64/281 (22%)
Query: 432 IGSFSDGTVGTVYKGT-LSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNF 490
IG G+ G V+KG + +A+ ++ D +E +++I LS+ +
Sbjct: 30 IGK---GSFGEVFKGIDNRTQKVVAIKIIDLEEAED---EIED-IQQEITVLSQCDSPYV 82
Query: 491 VNLIG-YCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMH 549
G Y ++ + + M EY GS L + E LD I + L+++H
Sbjct: 83 TKYYGSYLKDTKLWIIM---EYLGGGSA---LDLLEPGPLDETQIATILREILKGLDYLH 136
Query: 550 QLTPPIAHRNLQSSSIYLTEDYAAKISDF--SFWNNTTAAKTGSA-------AMELLETS 600
HR+++++++ L+E K++DF + T K + A E+++ S
Sbjct: 137 SEK--KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQS 194
Query: 601 AVDLESNVYSFGTILFEMITG----------RISYSIENGSLENWASEYLKGEQP-LKDI 649
A D +++++S G E+ G ++ + I K P L+
Sbjct: 195 AYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLI------------PKNNPPTLEGN 242
Query: 650 VDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKL 690
LK F ++ C++ +P RP+ A +L
Sbjct: 243 YSKPLKEF-----------VEACLNKEPSFRPT----AKEL 268
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 6e-08
Identities = 47/272 (17%), Positives = 95/272 (34%), Gaps = 57/272 (20%)
Query: 438 GTVGTVYKGT-LSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNH-KNFVNLIG 495
G V + S+G E A + R ++ ++ +I L +NL
Sbjct: 40 GKFAVVRQCISKSTGQEYAAKFLKKRRR---GQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 496 YCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHL---DWAMRLR-IAMGMAYCLEHMHQL 551
E ++ EY+ G +F + AE + D ++ I G+ Y H +
Sbjct: 97 VYENTSEII--LILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYL--HQNN- 151
Query: 552 TPPIAHRNLQSSSIYL---TEDYAAKISDF---SFWNNTTAAKT--GSA---AMELLETS 600
I H +L+ +I L KI DF + + G+ A E+L
Sbjct: 152 ---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYD 208
Query: 601 AVDLESNVYSFGTILFEMITG----------RISYSIENGSLENWASEYLKGEQPLKDIV 650
+ +++++ G I + ++T +I +++ ++ E V
Sbjct: 209 PITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVD-YSEETF-------SSV 260
Query: 651 DPTLKSFQENVLEELLVVIKNCVHPDPKQRPS 682
F I++ + +P++RP+
Sbjct: 261 SQLATDF-----------IQSLLVKNPEKRPT 281
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 54.1 bits (131), Expect = 7e-08
Identities = 24/88 (27%), Positives = 33/88 (37%), Gaps = 7/88 (7%)
Query: 124 NLRDLCLGGML---APELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSG 180
NL L L G L L +L ++ + N T + L L L L +N S
Sbjct: 67 NLEYLNLNGNQITDISPLSNLVKLTNLYIGTNKI--TDISALQNLTNLRELYLNEDNISD 124
Query: 181 PFPSDFGNSFSLTTLLLDNNQYLGGISP 208
S N + +L L N L +SP
Sbjct: 125 --ISPLANLTKMYSLNLGANHNLSDLSP 150
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 51.0 bits (123), Expect = 7e-07
Identities = 17/66 (25%), Positives = 25/66 (37%), Gaps = 2/66 (3%)
Query: 136 PELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTL 195
L LS+L S+ L NN + IG L L L L N+ + P + + +
Sbjct: 281 SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSA 338
Query: 196 LLDNNQ 201
N
Sbjct: 339 DFANQV 344
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 46.4 bits (111), Expect = 2e-05
Identities = 15/81 (18%), Positives = 25/81 (30%), Gaps = 7/81 (8%)
Query: 124 NLRDLCLGGML---APELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSG 180
L +L + +++ + I L LE L+L N +
Sbjct: 23 EGIRAVLQKASVTDVVTQEELESITKLVVAGEKV--ASIQGIEYLTNLEYLNLNGNQITD 80
Query: 181 PFPSDFGNSFSLTTLLLDNNQ 201
S N LT L + N+
Sbjct: 81 --ISPLSNLVKLTNLYIGTNK 99
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 46.4 bits (111), Expect = 2e-05
Identities = 18/89 (20%), Positives = 34/89 (38%), Gaps = 10/89 (11%)
Query: 124 NLRDLCLGG----MLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFS 179
+L + + ++ L S+ + NN T + L +L L++G N S
Sbjct: 200 SLHYFTAYVNQITDI-TPVANMTRLNSLKIGNNKI--TDLSPLANLSQLTWLEIGTNQIS 256
Query: 180 GPFPSDFGNSFSLTTLLLDNNQYLGGISP 208
+ + L L + +NQ + IS
Sbjct: 257 D--INAVKDLTKLKMLNVGSNQ-ISDISV 282
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 45.6 bits (109), Expect = 3e-05
Identities = 16/84 (19%), Positives = 28/84 (33%), Gaps = 7/84 (8%)
Query: 136 PELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTL 195
L ++ L + + + I L +L L L +N S + SL
Sbjct: 149 SPLSNMTGLNYLTVTESKV--KDVTPIANLTDLYSLSLNYNQIED--ISPLASLTSLHYF 204
Query: 196 LLDNNQYLGGISP--ELHVLKVIS 217
NQ + I+P + L +
Sbjct: 205 TAYVNQ-ITDITPVANMTRLNSLK 227
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 7e-08
Identities = 20/92 (21%), Positives = 37/92 (40%), Gaps = 7/92 (7%)
Query: 124 NLRDLCLGG----MLAPE-LGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNF 178
+L +L L G +P L+ L++++ IG+L L+ L++ N
Sbjct: 81 HLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFI 140
Query: 179 SG-PFPSDFGNSFSLTTLLLDNNQYLGGISPE 209
P+ F N +L + L N + I+
Sbjct: 141 HSCKLPAYFSNLTNLVHVDLSYNY-IQTITVN 171
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 7e-08
Identities = 15/90 (16%), Positives = 25/90 (27%), Gaps = 2/90 (2%)
Query: 122 ILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEI-GELKELEILDLGFNNFSG 180
L++ L+ L ++ + NSF + L LDL
Sbjct: 428 YLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQ 487
Query: 181 PFPSDFGNSFSLTTLLLDNNQYLGGISPEL 210
F L L + +N L +
Sbjct: 488 ISWGVFDTLHRLQLLNMSHNN-LLFLDSSH 516
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 7e-08
Identities = 15/90 (16%), Positives = 27/90 (30%), Gaps = 2/90 (2%)
Query: 122 ILNLRDLCLGGMLAPE-LGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSG 180
L + + L + L L L++L++ NN
Sbjct: 452 TLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLF 511
Query: 181 PFPSDFGNSFSLTTLLLDNNQYLGGISPEL 210
S + +SL+TL N+ + L
Sbjct: 512 LDSSHYNQLYSLSTLDCSFNR-IETSKGIL 540
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 8e-08
Identities = 19/93 (20%), Positives = 36/93 (38%), Gaps = 5/93 (5%)
Query: 123 LNLRDLCLGG----MLAPELGQLSELKSIILRNNSFFGTIPKE-IGELKELEILDLGFNN 177
+LR L L +++ L EL+ + ++++ L++L LD+ + N
Sbjct: 376 NSLRHLDLSFNGAIIMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTN 435
Query: 178 FSGPFPSDFGNSFSLTTLLLDNNQYLGGISPEL 210
F F SL TL + N + +
Sbjct: 436 TKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNV 468
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 1e-07
Identities = 14/65 (21%), Positives = 20/65 (30%)
Query: 138 LGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLL 197
L L+ + + +N+ +L L LD FN SL L
Sbjct: 493 FDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNL 552
Query: 198 DNNQY 202
NN
Sbjct: 553 TNNSV 557
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 1e-07
Identities = 16/80 (20%), Positives = 25/80 (31%)
Query: 122 ILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGP 181
L+L + + L L ++IL N P L LE L +
Sbjct: 60 WLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASL 119
Query: 182 FPSDFGNSFSLTTLLLDNNQ 201
G +L L + +N
Sbjct: 120 ESFPIGQLITLKKLNVAHNF 139
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 4e-07
Identities = 16/73 (21%), Positives = 21/73 (28%), Gaps = 1/73 (1%)
Query: 138 LGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLL 197
SEL+ + L K L L L L N P F SL L+
Sbjct: 52 FSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVA 111
Query: 198 DNNQYLGGISPEL 210
+ L +
Sbjct: 112 VETK-LASLESFP 123
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 6e-06
Identities = 18/93 (19%), Positives = 33/93 (35%), Gaps = 6/93 (6%)
Query: 123 LNLRDLCLGGMLAPELGQLSELKSIILRNNSFFG-TIPKEIGELKELEILDLGFNNFSGP 181
L + L + + +GQL LK + + +N +P L L +DL +N
Sbjct: 109 LVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTI 168
Query: 182 FPSDFGN----SFSLTTLLLDNNQYLGGISPEL 210
+D +L + N + I +
Sbjct: 169 TVNDLQFLRENPQVNLSLDMSLNP-IDFIQDQA 200
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 1e-05
Identities = 16/69 (23%), Positives = 22/69 (31%), Gaps = 1/69 (1%)
Query: 142 SELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLLDNNQ 201
S K+I L N EL+ LDL + L+ L+L N
Sbjct: 32 SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNP 91
Query: 202 YLGGISPEL 210
+ SP
Sbjct: 92 -IQSFSPGS 99
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 7e-05
Identities = 17/97 (17%), Positives = 25/97 (25%), Gaps = 11/97 (11%)
Query: 124 NLRDLCLGG------MLAPELGQLSELKSIILRNNSFFGTIPKEIGELKEL----EILDL 173
L+ L + L L+ L + L N ++ L+E LD+
Sbjct: 129 TLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDM 188
Query: 174 GFNNFSGPFPSDFGNSFSLTTLLLDNNQYLGGISPEL 210
N L L L N I
Sbjct: 189 SLNPIDF-IQDQAFQGIKLHELTLRGNFNSSNIMKTC 224
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 8e-08
Identities = 56/289 (19%), Positives = 108/289 (37%), Gaps = 65/289 (22%)
Query: 427 DFSNIIGSFSDGTVGTVYKGT-LSSGVEIAVTS---TSVKSRADWSKNLESQFRKKIDTL 482
D ++IG G V + ++G E AV T+ + + + + R++ L
Sbjct: 97 DPKDVIGR---GVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHIL 153
Query: 483 SKV-NHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHL---DWAMRLR-I 537
+V H + + LI E +VF+ G LF++ + E L + +R +
Sbjct: 154 RQVAGHPHIITLIDSYESSSFMF--LVFDLMRKGELFDY--LTEKVALSEKETRSIMRSL 209
Query: 538 AMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDF---SFWNNTTAAKT--GSA 592
+++ H + I HR+L+ +I L ++ ++SDF + G+
Sbjct: 210 LEAVSFL--HANN----IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTP 263
Query: 593 ---AMELLETSAV------DLESNVYSFGTILFEMITG----------RISYSIENGSLE 633
A E+L+ S E ++++ G ILF ++ G + I G +
Sbjct: 264 GYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQ 323
Query: 634 NWASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPS 682
++S D T+K I + DP+ R +
Sbjct: 324 -FSSPEW-------DDRSSTVKDL-----------ISRLLQVDPEARLT 353
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 1e-07
Identities = 61/311 (19%), Positives = 121/311 (38%), Gaps = 73/311 (23%)
Query: 405 LQKAFVTGVPKLKRSELEAAC------EDFSNI--IGSFSDGTVGTVYKGT-LSSGVEIA 455
L+ + P+ + +L+ E F + +G G+ G+VYK +G +A
Sbjct: 2 LETVQLRNPPRRQLKKLDEDSLTKQPEEVFDVLEKLGE---GSYGSVYKAIHKETGQIVA 58
Query: 456 VTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIG-YCEEDEPFTRMMVFEYSPN 514
+ V+S + K+I + + + + V G Y + + + M EY
Sbjct: 59 IKQVPVESD-------LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM---EYCGA 108
Query: 515 GSLFEHLH-----IQEAEHLDWAMRLRIAMGMAYC---LEHMHQLTPPIAHRNLQSSSIY 566
GS+ + + + E E IA + LE++H + HR++++ +I
Sbjct: 109 GSVSDIIRLRNKTLTEDE---------IATILQSTLKGLEYLHFMR--KIHRDIKAGNIL 157
Query: 567 LTEDYAAKISDF--SFWNNTTAAKTGSA-------AMELLETSAVDLESNVYSFGTILFE 617
L + AK++DF + T AK + A E+++ + ++++S G E
Sbjct: 158 LNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIE 217
Query: 618 MITGRISYSIENGSLENWASEYLKGEQPLKDIVD------PTLKSFQENVLEELLVVIKN 671
M G+ Y+ + P++ I PT + E + +K
Sbjct: 218 MAEGKPPYADIH---------------PMRAIFMIPTNPPPTFRK-PELWSDNFTDFVKQ 261
Query: 672 CVHPDPKQRPS 682
C+ P+QR +
Sbjct: 262 CLVKSPEQRAT 272
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 1e-07
Identities = 52/283 (18%), Positives = 97/283 (34%), Gaps = 62/283 (21%)
Query: 427 DFSNIIGSFSDGTVGTVYKGT-LSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKV 485
+G G V + + +G E A + K S + ++ +
Sbjct: 14 QLFEELGK---GAFSVVRRCVKVLAGQEYAAMIINTKKL---SARDHQKLEREARICRLL 67
Query: 486 NHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHL---DWAMRLR-IAMGM 541
H N V L E+ ++F+ G LFE I E+ D + ++ I +
Sbjct: 68 KHPNIVRLHDSISEEGHHY--LIFDLVTGGELFE--DIVAREYYSEADASHCIQQILEAV 123
Query: 542 AYCLEHMHQLTPPIAHRNLQSSSIYLT---EDYAAKISDF----SFWNNTTAAKT--GSA 592
+C H + HRNL+ ++ L + A K++DF A G+
Sbjct: 124 LHC--HQMG----VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTP 177
Query: 593 ---AMELLETSAVDLESNVYSFGTILFEMITG----------RISYSIENGSLENWASEY 639
+ E+L ++++ G IL+ ++ G R+ I+ G+ + + S
Sbjct: 178 GYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYD-FPSPE 236
Query: 640 LKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPS 682
D V P K I + +P +R +
Sbjct: 237 W-------DTVTPEAKDL-----------INKMLTINPSKRIT 261
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 3e-07
Identities = 24/92 (26%), Positives = 35/92 (38%), Gaps = 6/92 (6%)
Query: 124 NLRDLCLGG----MLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFS 179
L+ L L + PE + + I LRNN I K + + LE DL N F
Sbjct: 192 KLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKL-VLIEKALRFSQNLEHFDLRGNGFH 250
Query: 180 -GPFPSDFGNSFSLTTLLLDNNQYLGGISPEL 210
G F + + T+ + L G + E
Sbjct: 251 CGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEE 282
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 2e-06
Identities = 16/85 (18%), Positives = 35/85 (41%), Gaps = 4/85 (4%)
Query: 138 LGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLL 197
L+ + L+ N + + ++ +L+ LDL N + +F ++ +T + L
Sbjct: 165 AASSDTLEHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISL 221
Query: 198 DNNQYLGGISPELHVLKVISEIQVD 222
NN+ L I L + + +
Sbjct: 222 RNNK-LVLIEKALRFSQNLEHFDLR 245
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 8e-06
Identities = 20/80 (25%), Positives = 31/80 (38%), Gaps = 2/80 (2%)
Query: 122 ILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGP 181
I + D L LA +K + L N ++ +LE+L+L N
Sbjct: 14 IEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE- 72
Query: 182 FPSDFGNSFSLTTLLLDNNQ 201
D + +L TL L+NN
Sbjct: 73 -TLDLESLSTLRTLDLNNNY 91
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 2e-05
Identities = 16/66 (24%), Positives = 23/66 (34%), Gaps = 1/66 (1%)
Query: 137 ELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSG-PFPSDFGNSFSLTTL 195
+ K+I L NN + G ++ LDL N F +S +L L
Sbjct: 115 SCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHL 174
Query: 196 LLDNNQ 201
L N
Sbjct: 175 NLQYNF 180
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 4e-05
Identities = 15/78 (19%), Positives = 27/78 (34%), Gaps = 3/78 (3%)
Query: 124 NLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFP 183
LR L L EL ++++ NN+ + + + + L N +
Sbjct: 81 TLRTLDLNNNYVQELLVGPSIETLHAANNNI-SRVSCSR--GQGKKNIYLANNKITMLRD 137
Query: 184 SDFGNSFSLTTLLLDNNQ 201
D G + L L N+
Sbjct: 138 LDEGCRSRVQYLDLKLNE 155
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 12/61 (19%), Positives = 21/61 (34%)
Query: 141 LSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLLDNN 200
+ K + ++S + ++ LDL N S +D L L L +N
Sbjct: 9 GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68
Query: 201 Q 201
Sbjct: 69 V 69
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 4e-07
Identities = 62/295 (21%), Positives = 121/295 (41%), Gaps = 54/295 (18%)
Query: 426 EDFSNI--IGSFSDGTVGTVYKGT-LSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTL 482
+D+ IGS G V ++A+ +++ +++ K+I +
Sbjct: 15 DDYELQEVIGS---GATAVVQAAYCAPKKEKVAIKRINLEKCQT---SMDE-LLKEIQAM 67
Query: 483 SKVNHKNFVNLIG-YCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLR---IA 538
S+ +H N V+ + +DE + M + GS+ + + A+ + L IA
Sbjct: 68 SQCHHPNIVSYYTSFVVKDELWLVM---KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIA 124
Query: 539 MGMAYC---LEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDF--SFWNNTTAAKTGSA- 592
+ LE++H+ HR++++ +I L ED + +I+DF S + T T +
Sbjct: 125 TILREVLEGLEYLHKNG--QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKV 182
Query: 593 -----------AMELLE-TSAVDLESNVYSFGTILFEMITGRISYSIENGS-----LENW 635
A E++E D +++++SFG E+ TG Y
Sbjct: 183 RKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQN 242
Query: 636 ASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKL 690
L+ K+++ KSF++ +I C+ DP++RP+ AA+L
Sbjct: 243 DPPSLETGVQDKEMLKKYGKSFRK--------MISLCLQKDPEKRPT----AAEL 285
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 51.8 bits (124), Expect = 4e-07
Identities = 60/320 (18%), Positives = 116/320 (36%), Gaps = 57/320 (17%)
Query: 406 QKAFVTGVPKLKRSELEAACEDFSNI--IGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVK 462
Q+ + K+ E +DF I +G+ G G V+K + SG+ +A K
Sbjct: 13 QRKRLEAFLTQKQKVGELKDDDFEKISELGA---GNGGVVFKVSHKPSGLVMAR-----K 64
Query: 463 S-RADWSKNLESQFRKKIDTLSKVNHKNFVNLIG-YCEEDEPFTRMMVFEYSPNGSLFEH 520
+ + +Q +++ L + N V G + + E + E+ GSL +
Sbjct: 65 LIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS---ICMEHMDGGSLDQV 121
Query: 521 LHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDF-- 578
L ++A + + ++++ + L ++ + I HR+++ S+I + K+ DF
Sbjct: 122 L--KKAGRIPEQILGKVSIAVIKGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGV 178
Query: 579 SFWNNTTAAKT--GSAA-M--ELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLE 633
S + A + G+ + M E L+ + ++S+++S G L EM GR +
Sbjct: 179 SGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEL 238
Query: 634 NWASEYLKGEQPLKDIVDPTLKSFQENVLE----------ELLVVIKN------------ 671
+ P N ELL I N
Sbjct: 239 ELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFS 298
Query: 672 ---------CVHPDPKQRPS 682
C+ +P +R
Sbjct: 299 LEFQDFVNKCLIKNPAERAD 318
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 5e-07
Identities = 48/212 (22%), Positives = 79/212 (37%), Gaps = 45/212 (21%)
Query: 432 IGSFSDGTVGTVYKGT-LSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNF 490
IGS G G + +AV R ++ +++I + H N
Sbjct: 28 IGS---GNFGVARLMRDKLTKELVAVK---YIER---GAAIDENVQREIINHRSLRHPNI 78
Query: 491 VNLIGYCEEDEPFTR---MMVFEYSPNGSLFEHL----HIQEAEHLDWAMRL--RIAMGM 541
V T ++ EY+ G L+E + E E A ++ G+
Sbjct: 79 VRFKEVIL-----TPTHLAIIMEYASGGELYERICNAGRFSEDE----ARFFFQQLLSGV 129
Query: 542 AYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAA--KISDFSFWNNTT---AAKT--GS--- 591
+YC H Q I HR+L+ + L A KI DF + ++ K+ G+
Sbjct: 130 SYC--HSMQ----ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY 183
Query: 592 AAMELLETSAVD-LESNVYSFGTILFEMITGR 622
A E+L D ++V+S G L+ M+ G
Sbjct: 184 IAPEVLLRQEYDGKIADVWSCGVTLYVMLVGA 215
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 1e-06
Identities = 25/92 (27%), Positives = 37/92 (40%), Gaps = 7/92 (7%)
Query: 124 NLRDLCLGG----MLAPE-LGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNF 178
+L L L G LA LS L+ ++ + IG LK L+ L++ N
Sbjct: 77 HLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLI 136
Query: 179 -SGPFPSDFGNSFSLTTLLLDNNQYLGGISPE 209
S P F N +L L L +N+ + I
Sbjct: 137 QSFKLPEYFSNLTNLEHLDLSSNK-IQSIYCT 167
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 6e-06
Identities = 23/84 (27%), Positives = 34/84 (40%), Gaps = 6/84 (7%)
Query: 124 NLRDLCLGG----MLAPE-LGQLSELKSIILRNNSFFGTIPKEI-GELKELEILDLGFNN 177
NL L + + LS L+ + + NSF +I EL+ L LDL
Sbjct: 422 NLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQ 481
Query: 178 FSGPFPSDFGNSFSLTTLLLDNNQ 201
P+ F + SL L + +NQ
Sbjct: 482 LEQLSPTAFNSLSSLQVLNMASNQ 505
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 4e-05
Identities = 17/83 (20%), Positives = 27/83 (32%), Gaps = 5/83 (6%)
Query: 124 NLRDLCLGG----MLAPE-LGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNF 178
L+ L L + LS L ++IL N L L+ L N
Sbjct: 53 ELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNL 112
Query: 179 SGPFPSDFGNSFSLTTLLLDNNQ 201
+ G+ +L L + +N
Sbjct: 113 ASLENFPIGHLKTLKELNVAHNL 135
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 9e-05
Identities = 14/82 (17%), Positives = 25/82 (30%), Gaps = 3/82 (3%)
Query: 122 ILNLRDLCLGGMLAPE-LGQLSELKSIILRNNSFFGTIPKEI-GELKELEILDLGFNNFS 179
+L + P+ +L L + L + L L++L++ N
Sbjct: 449 VLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQL-EQLSPTAFNSLSSLQVLNMASNQLK 507
Query: 180 GPFPSDFGNSFSLTTLLLDNNQ 201
F SL + L N
Sbjct: 508 SVPDGIFDRLTSLQKIWLHTNP 529
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 2e-04
Identities = 16/92 (17%), Positives = 35/92 (38%), Gaps = 5/92 (5%)
Query: 124 NLRDLCLGG----MLAPELGQLSELKSIILRNNSFFGTIPKEI-GELKELEILDLGFNNF 178
+L+ L L ++ L +L+ + ++++ + L+ L LD+ +
Sbjct: 374 SLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHT 433
Query: 179 SGPFPSDFGNSFSLTTLLLDNNQYLGGISPEL 210
F F SL L + N + P++
Sbjct: 434 RVAFNGIFNGLSSLEVLKMAGNSFQENFLPDI 465
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 2e-04
Identities = 12/64 (18%), Positives = 15/64 (23%)
Query: 138 LGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLL 197
EL+ + L L L L L N F SL L+
Sbjct: 48 FFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 107
Query: 198 DNNQ 201
Sbjct: 108 VETN 111
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 5e-04
Identities = 21/93 (22%), Positives = 34/93 (36%), Gaps = 6/93 (6%)
Query: 122 ILNLRDLCLGGMLAPELGQLSELKSIILRNNSF-FGTIPKEIGELKELEILDLGFNNFSG 180
L + L + +G L LK + + +N +P+ L LE LDL N
Sbjct: 104 KLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQS 163
Query: 181 PFPSDFGNSFSLT----TLLLDNNQYLGGISPE 209
+ +D + +L L N + I P
Sbjct: 164 IYCTDLRVLHQMPLLNLSLDLSLNP-MNFIQPG 195
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 1e-06
Identities = 51/220 (23%), Positives = 88/220 (40%), Gaps = 47/220 (21%)
Query: 482 LSKVNHKNFVNLIGYCEEDEPFTRM-MVFEYSPNGSLFEHLHIQEAEHLD-WAMRLRIA- 538
+ + H VNL Y +DE M MV + G L HL Q+ H ++L I
Sbjct: 69 MQGLEHPFLVNLW-YSFQDE--EDMFMVVDLLLGGDLRYHL--QQNVHFKEETVKLFICE 123
Query: 539 MGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSF-----WNNTTAAKTGSA- 592
+ MA L+++ I HR+++ +I L E I+DF+ G+
Sbjct: 124 LVMA--LDYLQNQR--IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKP 179
Query: 593 --AMELLE-------TSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGE 643
A E+ + AVD +S G +E++ GR Y +++
Sbjct: 180 YMAPEMFSSRKGAGYSFAVDW----WSLGVTAYELLRGRRPY-------------HIRSS 222
Query: 644 QPLKDIVDPTLKS---FQENVLEELLVVIKNCVHPDPKQR 680
K+IV + + +E++ ++K + P+P QR
Sbjct: 223 TSSKEIVHTFETTVVTYPSAWSQEMVSLLKKLLEPNPDQR 262
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 1e-06
Identities = 21/88 (23%), Positives = 31/88 (35%), Gaps = 8/88 (9%)
Query: 124 NLRDLCLGGML---APELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSG 180
NL + L L++L I++ NN + L L L L N +
Sbjct: 69 NLTQINFSNNQLTDITPLKNLTKLVDILMNNNQI--ADITPLANLTNLTGLTLFNNQITD 126
Query: 181 PFPSDFGNSFSLTTLLLDNNQYLGGISP 208
P N +L L L +N + IS
Sbjct: 127 IDP--LKNLTNLNRLELSSNT-ISDISA 151
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 2e-06
Identities = 25/88 (28%), Positives = 35/88 (39%), Gaps = 9/88 (10%)
Query: 124 NLRDLCLGG---MLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSG 180
NL L L L L+ L+ + N T K + L LE LD+ N S
Sbjct: 135 NLNRLELSSNTISDISALSGLTSLQQLSFGNQV---TDLKPLANLTTLERLDISSNKVSD 191
Query: 181 PFPSDFGNSFSLTTLLLDNNQYLGGISP 208
S +L +L+ NNQ + I+P
Sbjct: 192 --ISVLAKLTNLESLIATNNQ-ISDITP 216
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 4e-06
Identities = 22/73 (30%), Positives = 27/73 (36%), Gaps = 5/73 (6%)
Query: 136 PELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTL 195
LG L+ L + L N + L L LDL N S + LT L
Sbjct: 215 TPLGILTNLDELSLNGNQL--KDIGTLASLTNLTDLDLANNQISN--LAPLSGLTKLTEL 270
Query: 196 LLDNNQYLGGISP 208
L NQ + ISP
Sbjct: 271 KLGANQ-ISNISP 282
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 7e-06
Identities = 23/90 (25%), Positives = 35/90 (38%), Gaps = 7/90 (7%)
Query: 119 KVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNF 178
+V L L + + + L+ L I NN P + L +L + + N
Sbjct: 47 QVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQI 102
Query: 179 SGPFPSDFGNSFSLTTLLLDNNQYLGGISP 208
+ P N +LT L L NNQ + I P
Sbjct: 103 ADITP--LANLTNLTGLTLFNNQ-ITDIDP 129
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 1e-05
Identities = 26/88 (29%), Positives = 36/88 (40%), Gaps = 8/88 (9%)
Query: 124 NLRDLCLGG-MLA--PELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSG 180
L +L LG ++ L L+ L ++ L N P I LK L L L FNN S
Sbjct: 266 KLTELKLGANQISNISPLAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISD 323
Query: 181 PFPSDFGNSFSLTTLLLDNNQYLGGISP 208
S + L L NN+ + +S
Sbjct: 324 --ISPVSSLTKLQRLFFYNNK-VSDVSS 348
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 3e-05
Identities = 14/66 (21%), Positives = 25/66 (37%), Gaps = 4/66 (6%)
Query: 136 PELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTL 195
+ L++L+ + NN + + L + L G N S P N +T L
Sbjct: 325 SPVSSLTKLQRLFFYNNKV--SDVSSLANLTNINWLSAGHNQISDLTP--LANLTRITQL 380
Query: 196 LLDNNQ 201
L++
Sbjct: 381 GLNDQA 386
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 4e-04
Identities = 9/66 (13%), Positives = 23/66 (34%), Gaps = 3/66 (4%)
Query: 136 PELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTL 195
L L+ + + +N P + L + L L ++ P ++ + S+
Sbjct: 347 SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTN-APVNYKANVSIPNT 403
Query: 196 LLDNNQ 201
+ +
Sbjct: 404 VKNVTG 409
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 20/80 (25%), Positives = 31/80 (38%), Gaps = 2/80 (2%)
Query: 122 ILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGP 181
I + D L LA +K + L N ++ +LE+L+L N
Sbjct: 14 IEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE- 72
Query: 182 FPSDFGNSFSLTTLLLDNNQ 201
D + +L TL L+NN
Sbjct: 73 -TLDLESLSTLRTLDLNNNY 91
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 5e-06
Identities = 24/91 (26%), Positives = 35/91 (38%), Gaps = 6/91 (6%)
Query: 124 NLRDLCLGG----MLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFS 179
L+ L L + PE + + I LRNN I K + + LE DL N F
Sbjct: 192 KLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKL-VLIEKALRFSQNLEHFDLRGNGFH 250
Query: 180 -GPFPSDFGNSFSLTTLLLDNNQYLGGISPE 209
G F + + T+ + L G + E
Sbjct: 251 CGTLRDFFSKNQRVQTVAKQTVKKLTGQNEE 281
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 5e-06
Identities = 12/75 (16%), Positives = 23/75 (30%), Gaps = 2/75 (2%)
Query: 136 PELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTL 195
++LK++ L +N + E + + L N S +L
Sbjct: 185 KGQVVFAKLKTLDLSSNKL-AFMGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHF 242
Query: 196 LLDNNQYLGGISPEL 210
L N + G +
Sbjct: 243 DLRGNGFHCGTLRDF 257
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 3e-05
Identities = 16/66 (24%), Positives = 23/66 (34%), Gaps = 1/66 (1%)
Query: 137 ELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSG-PFPSDFGNSFSLTTL 195
+ K+I L NN + G ++ LDL N F +S +L L
Sbjct: 115 SCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHL 174
Query: 196 LLDNNQ 201
L N
Sbjct: 175 NLQYNF 180
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 45.2 bits (107), Expect = 5e-05
Identities = 14/67 (20%), Positives = 24/67 (35%), Gaps = 1/67 (1%)
Query: 136 PELGQ-LSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTT 194
E+ Q + K + ++S + ++ LDL N S +D L
Sbjct: 3 HEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLEL 62
Query: 195 LLLDNNQ 201
L L +N
Sbjct: 63 LNLSSNV 69
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 44.1 bits (104), Expect = 1e-04
Identities = 15/78 (19%), Positives = 27/78 (34%), Gaps = 3/78 (3%)
Query: 124 NLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFP 183
LR L L EL ++++ NN+ + + + + L N +
Sbjct: 81 TLRTLDLNNNYVQELLVGPSIETLHAANNNI-SRVSCSR--GQGKKNIYLANNKITMLRD 137
Query: 184 SDFGNSFSLTTLLLDNNQ 201
D G + L L N+
Sbjct: 138 LDEGCRSRVQYLDLKLNE 155
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 49.4 bits (118), Expect = 3e-06
Identities = 47/251 (18%), Positives = 82/251 (32%), Gaps = 64/251 (25%)
Query: 413 VPKLKRSELEAACEDFSNIIGSF-SDGTVGTVYKG---TLSSGVEIAVTSTSVKSRADWS 468
K+K S ED G GT G VYK + A+ +
Sbjct: 6 DFKVKLSSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALK----QIEGT-- 59
Query: 469 KNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEH--LHIQEA 526
+ ++I L ++ H N ++L ++F+Y EH HI +
Sbjct: 60 -GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY------AEHDLWHIIKF 112
Query: 527 EHLDWAMRLRIAM--------------GMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYA 572
A + + + G+ Y H + + HR+L+ ++I + +
Sbjct: 113 HRASKANKKPVQLPRGMVKSLLYQILDGIHYL--HANW----VLHRDLKPANILVMGEGP 166
Query: 573 A----KISDF----SFWNNTTAAKTGSA--------AMELLE-----TSAVDLESNVYSF 611
KI+D F + A ELL T A+D +++
Sbjct: 167 ERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAID----IWAI 222
Query: 612 GTILFEMITGR 622
G I E++T
Sbjct: 223 GCIFAELLTSE 233
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 3e-06
Identities = 56/272 (20%), Positives = 101/272 (37%), Gaps = 55/272 (20%)
Query: 438 GTVGTVYKGT-LSSGVEIAVTSTSVKSRADWSKNLESQFRKK--IDTLSKVN----HKNF 490
G GTV+ G L+ +++A+ ++R L + L KV H
Sbjct: 42 GGFGTVFAGHRLTDRLQVAIKVIP-RNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGV 100
Query: 491 VNLIGYCEEDEPFTRMMVFEY-SPNGSLFEHL----HIQEAEHLDWAMRL--RIAMGMAY 543
+ L+ + E E F M+V E P LF+++ + E + ++ + +
Sbjct: 101 IRLLDWFETQEGF--MLVLERPLPAQDLFDYITEKGPLGEGP----SRCFFGQVVAAIQH 154
Query: 544 CLEHMHQLTPPIAHRNLQSSSIYL-TEDYAAKISDFSFWNNT--TAAKT--GS---AAME 595
C H + HR+++ +I + AK+ DF G+ + E
Sbjct: 155 C--HSRG----VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFDGTRVYSPPE 208
Query: 596 LLETSAVD-LESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTL 654
+ L + V+S G +L++M+ G I + + E L+ E V P
Sbjct: 209 WISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ--------EILEAELHFPAHVSPDC 260
Query: 655 KSFQENVLEELLVVIKNCVHPDPKQRPSMRGI 686
+ I+ C+ P P RPS+ I
Sbjct: 261 CAL-----------IRRCLAPKPSSRPSLEEI 281
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 4e-06
Identities = 41/161 (25%), Positives = 68/161 (42%), Gaps = 33/161 (20%)
Query: 482 LSKVNHKNFVNLIGYCEEDEPFTRM-MVFEYSPNGSLFEHLHIQEAEHLDWAM-RLR--- 536
L+KV+ + V+L Y E + T + +V G + H++ + ++ + R
Sbjct: 239 LAKVHSRFIVSLA-YAFETK--TDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYT 295
Query: 537 --IAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDF------SFWNNTTAAK 588
I G LEH+HQ I +R+L+ ++ L +D +ISD T
Sbjct: 296 AQIVSG----LEHLHQRN--IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGY 349
Query: 589 TGSA---AMELLE----TSAVDLESNVYSFGTILFEMITGR 622
G+ A ELL +VD ++ G L+EMI R
Sbjct: 350 AGTPGFMAPELLLGEEYDFSVDY----FALGVTLYEMIAAR 386
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 6e-06
Identities = 61/283 (21%), Positives = 114/283 (40%), Gaps = 62/283 (21%)
Query: 432 IGSFSDGTVGTVYKGT-LSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKV-NHKN 489
+G+ GT G VYKG + +G A+ V + E + +++I+ L K +H+N
Sbjct: 32 VGN---GTYGQVYKGRHVKTGQLAAIKVMDVTG------DEEEEIKQEINMLKKYSHHRN 82
Query: 490 FVNLIG-YCEEDEPFTRM---MVFEYSPNGSLFEHLHIQEAEHL--DW-AMRLR-IAMGM 541
G + +++ P +V E+ GS+ + + + L +W A R I G
Sbjct: 83 IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRG- 141
Query: 542 AYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDF--SFWNNTTAAKTGS-------- 591
L H+HQ + HR+++ ++ LTE+ K+ DF S + T + +
Sbjct: 142 ---LSHLHQHK--VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWM 196
Query: 592 ----AAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLK 647
A + + D +S+++S G EM G P++
Sbjct: 197 APEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLC---------------DMHPMR 241
Query: 648 DIVD------PTLKSFQENVLEELLVVIKNCVHPDPKQRPSMR 684
+ P LKS + ++ I++C+ + QRP+
Sbjct: 242 ALFLIPRNPAPRLKS--KKWSKKFQSFIESCLVKNHSQRPATE 282
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 47.6 bits (113), Expect = 8e-06
Identities = 32/215 (14%), Positives = 79/215 (36%), Gaps = 40/215 (18%)
Query: 438 GTVGTVYKGT-LSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIG- 495
+ TV +G + V ++++ ++ + + + ++ NH N V
Sbjct: 38 EDLMTVNLARYKPTGEYVTVRRINLEACSN--EMVT-FLQGELHVSKLFNHPNIVPYRAT 94
Query: 496 YCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYC------LEHMH 549
+ ++E + +V + GS + + + ++ L IA L+++H
Sbjct: 95 FIADNELW---VVTSFMAYGSAKDLICTHFMDGMN---ELAIA---YILQGVLKALDYIH 145
Query: 550 QLTPPIAHRNLQSSSIYLTEDYAAKISDFSF---------WNNTTAAKTGSA-------A 593
+ HR++++S I ++ D +S + +
Sbjct: 146 HMG--YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLS 203
Query: 594 MELLETSAV--DLESNVYSFGTILFEMITGRISYS 626
E+L+ + D +S++YS G E+ G + +
Sbjct: 204 PEVLQQNLQGYDAKSDIYSVGITACELANGHVPFK 238
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 1e-05
Identities = 22/93 (23%), Positives = 36/93 (38%), Gaps = 8/93 (8%)
Query: 124 NLRDLCLGG----MLAPE-LGQLSELKSIILRNNSFFGTIPKE-IGELKELEILDLGFNN 177
NL+ L L + + L L+ + L +N ++ G L L+ L+L N
Sbjct: 51 NLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHL-SSLSSSWFGPLSSLKYLNLMGNP 109
Query: 178 FSG-PFPSDFGNSFSLTTLLLDNNQYLGGISPE 209
+ S F N +L TL + N + I
Sbjct: 110 YQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRI 142
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 3e-04
Identities = 24/84 (28%), Positives = 35/84 (41%), Gaps = 5/84 (5%)
Query: 122 ILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGE-LKELEILDLGFNNFS- 179
L++ L L+ L ++K I + N+ F +P + LK LE LDL N
Sbjct: 290 RLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVE 348
Query: 180 --GPFPSDFGNSFSLTTLLLDNNQ 201
+ G SL TL+L N
Sbjct: 349 EYLKNSACKGAWPSLQTLVLSQNH 372
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 3e-04
Identities = 30/208 (14%), Positives = 53/208 (25%), Gaps = 32/208 (15%)
Query: 13 TNANPTSLDPSFNSLETKAFRLAPQTHPCRFHRLRLN-MAALTLVMLLFLQNLSLARCLN 71
D SFN L K R + F LN + + L +
Sbjct: 229 AFRGSVLTDESFNEL-LKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVT 287
Query: 72 SEGMALLRFRERVVRDPFGALSKWSDNDGVGDNVNPCSWFGVECSDGKVVILNLRDLCLG 131
+ + +F + D V + KV + + + +
Sbjct: 288 IRRLHIPQFYL------------FYDLSTVYSLLE------------KVKRITVENSKVF 323
Query: 132 GMLAPELGQLSELKSIILRNNSFFGTIPKE---IGELKELEILDLGFNNFS--GPFPSDF 186
+ L L+ + L N K G L+ L L N+
Sbjct: 324 LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEIL 383
Query: 187 GNSFSLTTLLLDNNQYLGGISPELHVLK 214
+LT+L + N + +
Sbjct: 384 LTLKNLTSLDISRNT-FHPMPDSCQWPE 410
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 5e-04
Identities = 16/77 (20%), Positives = 27/77 (35%), Gaps = 5/77 (6%)
Query: 140 QLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLLDN 199
L L S+ + N+F +P +++ L+L L L + N
Sbjct: 385 TLKNLTSLDISRNTF-HPMPDSCQWPEKMRFLNLSSTGIRVVKTCIPQT---LEVLDVSN 440
Query: 200 NQYLGGISPELHVLKVI 216
N L S L L+ +
Sbjct: 441 NN-LDSFSLFLPRLQEL 456
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 5e-04
Identities = 23/66 (34%), Positives = 31/66 (46%), Gaps = 2/66 (3%)
Query: 138 LGQLSELKSIILRNNSFFGTIPKEI-GELKELEILDLGFNNFSGPFPSDFGNSFSLTTLL 196
L + L+ +IL+++ TI + L LE LDL N+ S S FG SL L
Sbjct: 46 LRACANLQVLILKSSRI-NTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLN 104
Query: 197 LDNNQY 202
L N Y
Sbjct: 105 LMGNPY 110
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 47.5 bits (113), Expect = 1e-05
Identities = 39/159 (24%), Positives = 65/159 (40%), Gaps = 32/159 (20%)
Query: 482 LSKVNHKNFVNLIGYCEEDEPFTRM-MVFEYSPNGSLFEHLHIQEAEHLDWAMRLR---- 536
L KVN + V+L Y E + + +V G L H++ A R
Sbjct: 238 LEKVNSRFVVSLA-YAYETK--DALCLVLTLMNGGDLKFHIYHMGQAGFPEA-RAVFYAA 293
Query: 537 -IAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDF-----SFWNNTTAAKTG 590
I G LE +H+ I +R+L+ +I L + +ISD T + G
Sbjct: 294 EICCG----LEDLHRER--IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVG 347
Query: 591 SA---AMELLE----TSAVDLESNVYSFGTILFEMITGR 622
+ A E+++ T + D ++ G +L+EMI G+
Sbjct: 348 TVGYMAPEVVKNERYTFSPDW----WALGCLLYEMIAGQ 382
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 1e-05
Identities = 23/103 (22%), Positives = 34/103 (33%), Gaps = 20/103 (19%)
Query: 114 ECSDGKVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDL 173
+C D + L L +L L L L L + NS +P+ LK L + +
Sbjct: 67 DCLDRQAHELELNNLGLS-SLPELPPHLESL---VASCNSL-TELPELPQSLKSLLVDNN 121
Query: 174 GFNNFSGPFPS---------------DFGNSFSLTTLLLDNNQ 201
S P + NS L + +DNN
Sbjct: 122 NLKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNS 164
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 3e-05
Identities = 25/99 (25%), Positives = 37/99 (37%), Gaps = 13/99 (13%)
Query: 122 ILNLRDLCLGG---MLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNF 178
L+L + G PEL L L +I NN T+P L+ L + D +
Sbjct: 214 PLSLESIVAGNNILEELPELQNLPFLTTIYADNNLL-KTLPDLPPSLEALNVRDNYLTD- 271
Query: 179 SGPFPSDFGNSFSLTTLLLDNNQY--LGGISPELHVLKV 215
P + LT L + N + L + P L+ L
Sbjct: 272 ---LPELPQS---LTFLDVSENIFSGLSELPPNLYYLNA 304
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 8e-04
Identities = 11/80 (13%), Positives = 26/80 (32%), Gaps = 4/80 (5%)
Query: 122 ILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGP 181
++ DL + LA LK + + N P +++L + P
Sbjct: 376 PESVEDLRMNSHLAEVPELPQNLKQLHVETNPL-REFPDIPESVEDL---RMNSERVVDP 431
Query: 182 FPSDFGNSFSLTTLLLDNNQ 201
+ + L + +++
Sbjct: 432 YEFAHETTDKLEDDVFEHHH 451
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 47.6 bits (113), Expect = 1e-05
Identities = 18/95 (18%), Positives = 29/95 (30%), Gaps = 16/95 (16%)
Query: 124 NLRDLCLGGM----LAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFS 179
++ L + L +L L + N ++P L EL I +
Sbjct: 62 HITTLVIPDNNLTSLPALPPELRTL---EVSGNQL-TSLPVLPPGLLELSIFSNPLTHLP 117
Query: 180 GPFPSDFGNSFSLTTLLLDNNQYLGGISPELHVLK 214
PS L L + NQ L + L+
Sbjct: 118 -ALPS------GLCKLWIFGNQ-LTSLPVLPPGLQ 144
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 8e-05
Identities = 18/82 (21%), Positives = 31/82 (37%), Gaps = 12/82 (14%)
Query: 124 NLRDLCLGG----MLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFS 179
L++L + G L +L EL ++ N ++P L L + N +
Sbjct: 222 GLKELIVSGNRLTSLPVLPSELKEL---MVSGN-RLTSLPMLPSGLLSL---SVYRNQLT 274
Query: 180 GPFPSDFGNSFSLTTLLLDNNQ 201
P + S TT+ L+ N
Sbjct: 275 R-LPESLIHLSSETTVNLEGNP 295
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 44.1 bits (104), Expect = 1e-04
Identities = 18/97 (18%), Positives = 30/97 (30%), Gaps = 16/97 (16%)
Query: 122 ILNLRDLCLGGM----LAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNN 177
L L L L EL + +N ++P EL +L + +
Sbjct: 160 PSELCKLWAYNNQLTSLPMLPSGLQEL---SVSDNQL-ASLPTLPSELYKLWAYNNRLTS 215
Query: 178 FSGPFPSDFGNSFSLTTLLLDNNQYLGGISPELHVLK 214
P+ L L++ N+ L + LK
Sbjct: 216 ----LPALPSG---LKELIVSGNR-LTSLPVLPSELK 244
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 33/163 (20%), Positives = 63/163 (38%), Gaps = 28/163 (17%)
Query: 480 DTLSKVNHKNFVNLIGYCEEDEPFTRM-MVFEYSPNGSLFEHLHIQEAE-HLDWAMRLRI 537
D L + + L + +DE + +V EY G L L + A R +
Sbjct: 113 DVLVNGDRRWITQLH-FAFQDE--NYLYLVMEYYVGGDLLTLLSKFGERIPAEMA-RFYL 168
Query: 538 A-MGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSF-----WNNTTAAKT-- 589
A + MA ++ +H+L HR+++ +I L +++DF + T +
Sbjct: 169 AEIVMA--IDSVHRLG--YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAV 224
Query: 590 GSA---AMELLETSAVDLESNVY-------SFGTILFEMITGR 622
G+ + E+L+ + Y + G +EM G+
Sbjct: 225 GTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 4e-05
Identities = 46/187 (24%), Positives = 71/187 (37%), Gaps = 32/187 (17%)
Query: 507 MVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIY 566
+ + G L HL Q + MR A + LEHMH + +R+L+ ++I
Sbjct: 269 FILDLMNGGDLHYHLS-QHGVFSEADMRFYAAE-IILGLEHMHNRF--VVYRDLKPANIL 324
Query: 567 LTEDYAAKISDF----SFWNNTTAAKTGSA---AMELLE-----TSAVDLESNVYSFGTI 614
L E +ISD F A G+ A E+L+ S+ D +S G +
Sbjct: 325 LDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADW----FSLGCM 380
Query: 615 LFEMITGRISYSIENGSLENWASEY-LKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCV 673
LF+++ G + ++ L L D P L+S LE LL
Sbjct: 381 LFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSL----LEGLL------- 429
Query: 674 HPDPKQR 680
D +R
Sbjct: 430 QRDVNRR 436
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 4e-05
Identities = 20/65 (30%), Positives = 25/65 (38%), Gaps = 1/65 (1%)
Query: 138 LGQLSELKSIILRNNSFFGTIPKEI-GELKELEILDLGFNNFSGPFPSDFGNSFSLTTLL 196
L +L+ + L + TI KE L L ILDLG + P F F L L
Sbjct: 44 FPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELR 103
Query: 197 LDNNQ 201
L
Sbjct: 104 LYFCG 108
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 45.2 bits (107), Expect = 7e-05
Identities = 14/61 (22%), Positives = 25/61 (40%)
Query: 141 LSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLLDNN 200
L +LK + L N + L L++L+L +N + S+F + + L N
Sbjct: 289 LKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKN 348
Query: 201 Q 201
Sbjct: 349 H 349
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 18/84 (21%), Positives = 31/84 (36%), Gaps = 2/84 (2%)
Query: 119 KVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEI-GELKELEILDLGFNN 177
+ +LNL + + L L+ + L N G + L ++ +DL N+
Sbjct: 291 DLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLL-GELYSSNFYGLPKVAYIDLQKNH 349
Query: 178 FSGPFPSDFGNSFSLTTLLLDNNQ 201
+ F L TL L +N
Sbjct: 350 IAIIQDQTFKFLEKLQTLDLRDNA 373
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 41.7 bits (98), Expect = 8e-04
Identities = 18/86 (20%), Positives = 31/86 (36%), Gaps = 6/86 (6%)
Query: 122 ILNLRDLCLGGMLAPEL-GQLSELKSIILRNNSFFGTIPKEIGE-----LKELEILDLGF 175
IL L + + L+ + L N E+ L L++L L
Sbjct: 430 ILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNH 489
Query: 176 NNFSGPFPSDFGNSFSLTTLLLDNNQ 201
N + P F + +L L L++N+
Sbjct: 490 NYLNSLPPGVFSHLTALRGLSLNSNR 515
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 41.7 bits (98), Expect = 9e-04
Identities = 20/85 (23%), Positives = 29/85 (34%), Gaps = 5/85 (5%)
Query: 122 ILNLRDLCLGGMLAPE-LGQLSELKSIILRNNSFFGTIPKEI-GELKELEILDLGFNNFS 179
+L L + E L L+ + L ++ + + L L L L F S
Sbjct: 52 LLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKI-YFLHPDAFQGLFHLFELRLYFCGLS 110
Query: 180 GPF--PSDFGNSFSLTTLLLDNNQY 202
F N +LT L L NQ
Sbjct: 111 DAVLKDGYFRNLKALTRLDLSKNQI 135
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 5e-05
Identities = 21/96 (21%), Positives = 32/96 (33%), Gaps = 9/96 (9%)
Query: 125 LRDLCLGGMLAPELGQLSELKSIILRNN---SFFGTIPKEIGELKELEILDLGFNNFSG- 180
L + L L P + L+ + LRN + G +L+ LDL N+
Sbjct: 186 LGERGLISALCP--LKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDA 243
Query: 181 PFPSDFGNSFSLTTLLLDNNQ---YLGGISPELHVL 213
L +L L G+ +L VL
Sbjct: 244 AGAPSCDWPSQLNSLNLSFTGLKQVPKGLPAKLSVL 279
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 42.6 bits (100), Expect = 3e-04
Identities = 22/103 (21%), Positives = 34/103 (33%), Gaps = 8/103 (7%)
Query: 107 PCSWFGVECSDGKVVILNLRDLCLGGMLA--PELGQLSE--LKSIILRNNSFFGTIPKEI 162
+E + + ILNLR++ A EL Q + LK + + +++
Sbjct: 110 TAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQV 169
Query: 163 GELKELEILDLGFNNFSGPFPSD----FGNSFSLTTLLLDNNQ 201
L LDL N G +L L L N
Sbjct: 170 RVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAG 212
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 6e-05
Identities = 22/84 (26%), Positives = 33/84 (39%), Gaps = 6/84 (7%)
Query: 124 NLRDLCLGG----MLAPE-LGQLSELKSIILRNNSFFGTIPKEI-GELKELEILDLGFNN 177
NL L + + LS L+ + + NSF +I EL+ L LDL
Sbjct: 127 NLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQ 186
Query: 178 FSGPFPSDFGNSFSLTTLLLDNNQ 201
P+ F + SL L + +N
Sbjct: 187 LEQLSPTAFNSLSSLQVLNMSHNN 210
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 3e-04
Identities = 16/92 (17%), Positives = 35/92 (38%), Gaps = 5/92 (5%)
Query: 124 NLRDLCLGG----MLAPELGQLSELKSIILRNNSFFGTIPKEI-GELKELEILDLGFNNF 178
+L+ L L ++ L +L+ + ++++ + L+ L LD+ +
Sbjct: 79 SLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHT 138
Query: 179 SGPFPSDFGNSFSLTTLLLDNNQYLGGISPEL 210
F F SL L + N + P++
Sbjct: 139 RVAFNGIFNGLSSLEVLKMAGNSFQENFLPDI 170
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 45.1 bits (106), Expect = 7e-05
Identities = 22/94 (23%), Positives = 35/94 (37%), Gaps = 5/94 (5%)
Query: 108 CSWFGVECSDGKVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKE 167
++ V +L+L L + L QL + + L +N +P + L+
Sbjct: 431 LENSVLKMEYADVRVLHLAHKDLTVL--CHLEQLLLVTHLDLSHNRLR-ALPPALAALRC 487
Query: 168 LEILDLGFNNFSGPFPSDFGNSFSLTTLLLDNNQ 201
LE+L N N L LLL NN+
Sbjct: 488 LEVLQASDNALE--NVDGVANLPRLQELLLCNNR 519
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 43.6 bits (102), Expect = 2e-04
Identities = 17/83 (20%), Positives = 26/83 (31%), Gaps = 7/83 (8%)
Query: 124 NLRDLCLGG----MLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFS 179
+ L L L P L L L+ + +N+ + + L L+ L L N
Sbjct: 464 LVTHLDLSHNRLRALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQ 521
Query: 180 G-PFPSDFGNSFSLTTLLLDNNQ 201
+ L L L N
Sbjct: 522 QSAAIQPLVSCPRLVLLNLQGNS 544
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 45.0 bits (106), Expect = 9e-05
Identities = 35/146 (23%), Positives = 53/146 (36%), Gaps = 17/146 (11%)
Query: 56 VMLLFLQNLSLARCLNSEGMALLRFRERVVRDPFGALSKWSDNDGVGDNVNPCSWFGVEC 115
+ML N SL++ ++ D F A KW G+N N EC
Sbjct: 3 IMLPINNNFSLSQNSFYNTISGTY------ADYFSAWDKWEKQALPGENRNEAVSLLKEC 56
Query: 116 SDGKVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGF 175
+ L L L L L L ++ + + N+ ++P+ L+ LD
Sbjct: 57 LINQFSELQLNRLNLSS-LPDNLPP--QITVLEITQNAL-ISLPELPASLEY---LDACD 109
Query: 176 NNFSGPFPSDFGNSFSLTTLLLDNNQ 201
N S P + L L +DNNQ
Sbjct: 110 NRLST-LPELPAS---LKHLDVDNNQ 131
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 44.6 bits (105), Expect = 9e-05
Identities = 18/153 (11%), Positives = 39/153 (25%), Gaps = 17/153 (11%)
Query: 124 NLRDLCLGG----MLAPELGQLSELKSII----LRNNSFFGTIPKEIGELKELEILDLGF 175
+L L + L + + R N IP+ I L + L
Sbjct: 181 SLEALDVSTNLLESLPAVPVRNHHSEETEIFFRCRENRI-THIPENILSLDPTCTIILED 239
Query: 176 NNFSGPFPSDFGNSFSLTTLLLDNNQYLGGISPELHVLKVISEIQVDESWLTNAASRASC 235
N S + + + + + +++ W
Sbjct: 240 NPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLHRPLADAVTA--WFPENKQSDV- 296
Query: 236 NSGLFTWNKVQ--PGDNAFRRMLQQVTNGFEAK 266
W+ + N F L ++++ A+
Sbjct: 297 ---SQIWHAFEHEEHANTFSAFLDRLSDTVSAR 326
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 9e-05
Identities = 15/80 (18%), Positives = 26/80 (32%), Gaps = 2/80 (2%)
Query: 123 LNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKE-IGELKELEILDLGFNNFSGP 181
L + + P L S+ + + + +P + L L L+L +N S
Sbjct: 205 LEISHWPYLDTMTPNCLYGLNLTSLSITHCNL-TAVPYLAVRHLVYLRFLNLSYNPISTI 263
Query: 182 FPSDFGNSFSLTTLLLDNNQ 201
S L + L Q
Sbjct: 264 EGSMLHELLRLQEIQLVGGQ 283
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 43.7 bits (104), Expect = 1e-04
Identities = 44/170 (25%), Positives = 78/170 (45%), Gaps = 37/170 (21%)
Query: 476 RKKIDT------LSKVNHKNFVNLIGYC--EEDEPFTRMMVFEYSPNGSLFEHLHIQEAE 527
R ++ T L +VNH V L Y E + + ++ ++ G LF L +
Sbjct: 68 RDRVRTKMERDILVEVNHPFIVKLH-YAFQTEGKLY---LILDFLRGGDLFTRLSKEVMF 123
Query: 528 HLDWAMRLRIA-MGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDF-----SFW 581
+ + +A + +A L+H+H L I +R+L+ +I L E+ K++DF S
Sbjct: 124 TEEDV-KFYLAELALA--LDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKESID 178
Query: 582 NNTTAAKT--GSA---AMELLE----TSAVDLESNVYSFGTILFEMITGR 622
+ A + G+ A E++ T + D +SFG ++FEM+TG
Sbjct: 179 HEKKA-YSFCGTVEYMAPEVVNRRGHTQSADW----WSFGVLMFEMLTGT 223
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 1e-04
Identities = 38/160 (23%), Positives = 72/160 (45%), Gaps = 31/160 (19%)
Query: 482 LSKVNHKNF-VNLIGYCEEDEPFTRM-MVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIA- 538
L + F V L Y + E T++ ++ +Y G LF HL +E ++ +
Sbjct: 112 LEHIRQSPFLVTLH-YAFQTE--TKLHLILDYINGGELFTHLSQRERFTEHEV-QIYVGE 167
Query: 539 MGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDF-----SFWNNTTAAKT--GS 591
+ +A LEH+H+L I +R+++ +I L + ++DF + T A G+
Sbjct: 168 IVLA--LEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGT 223
Query: 592 A---AMELLE------TSAVDLESNVYSFGTILFEMITGR 622
A +++ AVD +S G +++E++TG
Sbjct: 224 IEYMAPDIVRGGDSGHDKAVDW----WSLGVLMYELLTGA 259
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 44.1 bits (104), Expect = 2e-04
Identities = 12/89 (13%), Positives = 34/89 (38%), Gaps = 3/89 (3%)
Query: 123 LNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEI-GELKELEILDLGFNNFSGP 181
+++ E L+ K + +N++ +P + +++E+L+L
Sbjct: 32 VHIDMQTQDVYFGFEDITLNNQKIVTFKNSTM-RKLPAALLDSFRQVELLNLNDLQIEEI 90
Query: 182 FPSDFGNSFSLTTLLLDNNQYLGGISPEL 210
F + ++ L + N + + P +
Sbjct: 91 DTYAFAYAHTIQKLYMGFNA-IRYLPPHV 118
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 42.2 bits (99), Expect = 6e-04
Identities = 16/82 (19%), Positives = 26/82 (31%), Gaps = 8/82 (9%)
Query: 124 NLRDLCLGG----MLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFS 179
L L + L + LK + L +N + + + LE L L N+
Sbjct: 279 RLERLYISNNRLVALNLYGQPIPTLKVLDLSHNHL-LHVERNQPQFDRLENLYLDHNSIV 337
Query: 180 GPFPSDFGNSFSLTTLLLDNNQ 201
+L L L +N
Sbjct: 338 ---TLKLSTHHTLKNLTLSHND 356
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 2e-04
Identities = 60/301 (19%), Positives = 108/301 (35%), Gaps = 69/301 (22%)
Query: 414 PKLKRSELEAAC------EDFSNI--IGSFSDGTVGTVYKGT-LSSGVEIAVTSTSVKSR 464
LK ++ + FS++ IG G+ G VY + + +A+ S +
Sbjct: 36 GSLKDPDVAELFFKDDPEKLFSDLREIGH---GSFGAVYFARDVRNSEVVAIKKMSYSGK 92
Query: 465 ADWSKNLESQFRKKIDTLSKVNHKNFVNLIG-YCEEDEPFTRMMVFEYSPNGSLFEHLH- 522
S K++ L K+ H N + G Y E + M EY GS + L
Sbjct: 93 Q--SNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM---EYCL-GSASDLLEV 146
Query: 523 ----IQEAEHLDWAMRLRIAMGMAYC---LEHMHQLTPPIAHRNLQSSSIYLTEDYAAKI 575
+QE E IA L ++H + HR++++ +I L+E K+
Sbjct: 147 HKKPLQEVE---------IAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKL 195
Query: 576 SDFSFWNNTTAAKT--GSA---AMEL---LETSAVDLESNVYSFGTILFEMITGRISYSI 627
DF + A + G+ A E+ ++ D + +V+S G E+ +
Sbjct: 196 GDFGSASIMAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 255
Query: 628 ENGSLENWASEYLKGEQPLKDIVD------PTLKSFQENVLEELLVVIKNCVHPDPKQRP 681
N + + P L+S + E + +C+ P+ RP
Sbjct: 256 MN---------------AMSALYHIAQNESPALQS--GHWSEYFRNFVDSCLQKIPQDRP 298
Query: 682 S 682
+
Sbjct: 299 T 299
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 3e-04
Identities = 16/82 (19%), Positives = 26/82 (31%), Gaps = 8/82 (9%)
Query: 124 NLRDLCLGG----MLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFS 179
L L + L + LK + L +N + + + LE L L N+
Sbjct: 273 RLERLYISNNRLVALNLYGQPIPTLKVLDLSHNHL-LHVERNQPQFDRLENLYLDHNSIV 331
Query: 180 GPFPSDFGNSFSLTTLLLDNNQ 201
+L L L +N
Sbjct: 332 -TLK--LSTHHTLKNLTLSHND 350
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 4e-04
Identities = 17/84 (20%), Positives = 29/84 (34%), Gaps = 7/84 (8%)
Query: 124 NLRDLCLGG----MLAPE-LGQLSELKSIILRNNSFFGTIPKEI-GELKELEILDLGFNN 177
N + + L L +++ + L + I ++ L +GFN
Sbjct: 46 NQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQI-EEIDTYAFAYAHTIQKLYMGFNA 104
Query: 178 FSGPFPSDFGNSFSLTTLLLDNNQ 201
P F N LT L+L+ N
Sbjct: 105 IRYLPPHVFQNVPLLTVLVLERND 128
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 7e-04
Identities = 20/84 (23%), Positives = 35/84 (41%), Gaps = 7/84 (8%)
Query: 124 NLRDLCLGG----MLAPELGQ-LSELKSIILRNNSFFGTIPKEI-GELKELEILDLGFNN 177
++ L +G L P + Q + L ++L N ++P+ I +L L + NN
Sbjct: 94 TIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDL-SSLPRGIFHNTPKLTTLSMSNNN 152
Query: 178 FSGPFPSDFGNSFSLTTLLLDNNQ 201
F + SL L L +N+
Sbjct: 153 LERIEDDTFQATTSLQNLQLSSNR 176
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 3e-04
Identities = 43/157 (27%), Positives = 65/157 (41%), Gaps = 28/157 (17%)
Query: 482 LSKVNHKNFVNLIGYC--EEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAM 539
L H L Y D V EY+ G LF HL + D A R A
Sbjct: 202 LQNSRHPFLTALK-YSFQTHDRLC---FVMEYANGGELFFHLSRERVFSEDRA-RFYGAE 256
Query: 540 GMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDF-----SFWNNTTAAKT--GSA 592
+ L+++H + +R+L+ ++ L +D KI+DF + T KT G+
Sbjct: 257 -IVSALDYLHS-EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM-KTFCGTP 313
Query: 593 ---AMELLE----TSAVDLESNVYSFGTILFEMITGR 622
A E+LE AVD + G +++EM+ GR
Sbjct: 314 EYLAPEVLEDNDYGRAVDW----WGLGVVMYEMMCGR 346
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 42.9 bits (101), Expect = 3e-04
Identities = 33/190 (17%), Positives = 51/190 (26%), Gaps = 7/190 (3%)
Query: 18 TSLDPSFNSLETKAFRLAPQTHPCRFHRLRLNMAALT---LVMLLFLQNLSLARCLNSEG 74
N LA + L LN T + +L L + +
Sbjct: 197 IKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISN 256
Query: 75 MALLR-FRERVVRDPFGALSKWSDNDGVGDNVNPCSWFGVECSDGKVVILNLRDLCLGGM 133
+ L R +L S + V +V + + I N +
Sbjct: 257 VKLQGQLDFRDFDYSGTSLKALSIHQ-VVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMV 315
Query: 134 LAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFS--GPFPSDFGNSFS 191
++S + NN T+ + G L ELE L L N S
Sbjct: 316 HMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKS 375
Query: 192 LTTLLLDNNQ 201
L L + N
Sbjct: 376 LQQLDISQNS 385
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 41.8 bits (98), Expect = 8e-04
Identities = 19/63 (30%), Positives = 25/63 (39%), Gaps = 4/63 (6%)
Query: 140 QLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNF-SGPFPSDFGNSFSLTTLLLD 198
EL+ + L +N I L+ LDL FN F + P +FGN L L L
Sbjct: 67 FNQELEYLDLSHNKL-VKIS--CHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLS 123
Query: 199 NNQ 201
Sbjct: 124 TTH 126
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 3e-04
Identities = 43/158 (27%), Positives = 66/158 (41%), Gaps = 31/158 (19%)
Query: 482 LSKVNHKNFVNLIGYC--EEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIA- 538
L H L Y D V EY+ G LF HL + + A R A
Sbjct: 59 LQNTRHPFLTALK-YAFQTHDRLC---FVMEYANGGELFFHLSRERVFTEERA-RFYGAE 113
Query: 539 MGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDF-----SFWNNTTAAKT--GS 591
+ A LE++H + +R+++ ++ L +D KI+DF + T KT G+
Sbjct: 114 IVSA--LEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM-KTFCGT 168
Query: 592 A---AMELLE----TSAVDLESNVYSFGTILFEMITGR 622
A E+LE AVD + G +++EM+ GR
Sbjct: 169 PEYLAPEVLEDNDYGRAVDW----WGLGVVMYEMMCGR 202
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 3e-04
Identities = 64/294 (21%), Positives = 110/294 (37%), Gaps = 48/294 (16%)
Query: 411 TGVPKLKRSELEAACEDFSNI--IGSFSDGTVGTVYKGT-LSSGVEIAVTSTSVKS-RAD 466
TG + +A D N+ +GS GT G V+K +G IAV K R
Sbjct: 10 TGYLTIGGQRYQAEINDLENLGEMGS---GTCGQVWKMRFRKTGHVIAV-----KQMRRS 61
Query: 467 WSKNLESQFRKKIDTLSK-VNHKNFVNLIG-YCEEDEPFTRMMVFEYSPNGSLFEHLHIQ 524
+K + +D + K + V G + + F + E G+ E L +
Sbjct: 62 GNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVF---IAMELM--GTCAEKLKKR 116
Query: 525 EAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDF--SFWN 582
+ + ++ + + L ++ + I HR+++ S+I L E K+ DF S
Sbjct: 117 MQGPIPERILGKMTVAIVKALYYLKEKHGVI-HRDVKPSNILLDERGQIKLCDFGISGRL 175
Query: 583 NTTAAKTGSA------AMELLETSAV-----DLESNVYSFGTILFEMITGRISYSIENGS 631
AK SA A E ++ D+ ++V+S G L E+ TG+ Y
Sbjct: 176 VDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD 235
Query: 632 LENWASEYLKGEQPLKDIVD---PTLKSFQENVLEELLVVIKNCVHPDPKQRPS 682
E L ++ P L + +K+C+ D ++RP
Sbjct: 236 FEV-----------LTKVLQEEPPLLPG-HMGFSGDFQSFVKDCLTKDHRKRPK 277
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 42.6 bits (100), Expect = 5e-04
Identities = 18/63 (28%), Positives = 27/63 (42%), Gaps = 4/63 (6%)
Query: 140 QLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNF-SGPFPSDFGNSFSLTTLLLD 198
+L+ + + +N I + L LDL FN+F P +FGN LT L L
Sbjct: 98 FNQDLEYLDVSHNRL-QNIS--CCPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLS 154
Query: 199 NNQ 201
+
Sbjct: 155 AAK 157
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 5e-04
Identities = 15/80 (18%), Positives = 25/80 (31%), Gaps = 8/80 (10%)
Query: 124 NLRDLCLGGML--APELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGP 181
L L +L Q + L + +N + + L +L L+ N +
Sbjct: 65 GLTKLICTSNNITTLDLSQNTNLTYLACDSNKL-TNLD--VTPLTKLTYLNCDTNKLT-- 119
Query: 182 FPSDFGNSFSLTTLLLDNNQ 201
D + LT L N
Sbjct: 120 -KLDVSQNPLLTYLNCARNT 138
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 6e-04
Identities = 14/62 (22%), Positives = 21/62 (33%), Gaps = 1/62 (1%)
Query: 141 LSELKSIILRNNSFFGTIPKEI-GELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLLDN 199
L +L+ + + + I L L IL L +N F F +L L L
Sbjct: 53 LQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQ 112
Query: 200 NQ 201
Sbjct: 113 CN 114
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 6e-04
Identities = 38/161 (23%), Positives = 67/161 (41%), Gaps = 29/161 (18%)
Query: 480 DTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHL---HIQEAEHLDWAMRLR 536
D ++ N V L Y +D+ + MV EY P G L + + E WA R
Sbjct: 121 DIMAFANSPWVVQLF-YAFQDDRYL-YMVMEYMPGGDLVNLMSNYDVPE----KWA-RFY 173
Query: 537 IA-MGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSF---WNNTTAAKTGSA 592
A + +A L+ +H + HR+++ ++ L + K++DF N + +A
Sbjct: 174 TAEVVLA--LDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTA 229
Query: 593 -------AMELLETSAVDLESNV----YSFGTILFEMITGR 622
+ E+L++ D +S G L+EM+ G
Sbjct: 230 VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 270
|
| >3h0g_A DNA-directed RNA polymerase II subunit RPB1; transcription, multi-protein complex, DNA- binding, magnesium; 3.65A {Schizosaccharomyces pombe} Length = 1752 | Back alignment and structure |
|---|
Score = 42.4 bits (99), Expect = 6e-04
Identities = 29/87 (33%), Positives = 40/87 (45%), Gaps = 7/87 (8%)
Query: 269 ASEPSSSSSIASSPEP-LVSPSLSPSMSSLLSPSFSPSPSPSESPSVSSPLIIPPAPVNI 327
+ P+S S +SP SPS SP+ SPS+SP+ SPS SP+ S P+
Sbjct: 1619 SYSPTSPSYSPTSPSYSPTSPSYSPT-----SPSYSPT-SPSYSPTSPSYSPTSPSYSPT 1672
Query: 328 PIVSSPPHLHSAPTSFAASTPSQVHES 354
SP +PTS + S S +
Sbjct: 1673 SPSYSPTSPSYSPTSPSYSPTSPSYSP 1699
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 41.7 bits (98), Expect = 6e-04
Identities = 22/84 (26%), Positives = 35/84 (41%), Gaps = 8/84 (9%)
Query: 124 NLRDLCLGGM-----LAPE-LGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNN 177
+L L LG + ++ L LK + L + +P + L LE L++ N+
Sbjct: 172 SLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNH 229
Query: 178 FSGPFPSDFGNSFSLTTLLLDNNQ 201
F P F SL L + N+Q
Sbjct: 230 FPEIRPGSFHGLSSLKKLWVMNSQ 253
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 41.4 bits (98), Expect = 8e-04
Identities = 38/131 (29%), Positives = 59/131 (45%), Gaps = 25/131 (19%)
Query: 507 MVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIA-MGMAYCLEHMHQLTPPIAHRNLQSSSI 565
++ EY G LF L + D A +A + MA L H+HQ I +R+L+ +I
Sbjct: 98 LILEYLSGGELFMQLEREGIFMEDTA-CFYLAEISMA--LGHLHQKG--IIYRDLKPENI 152
Query: 566 YLTEDYAAKISDF-----SFWNNTTAAKT--GSA---AMELLE----TSAVDLESNVYSF 611
L K++DF S + T T G+ A E+L AVD +S
Sbjct: 153 MLNHQGHVKLTDFGLCKESIHDGTVT-HTFCGTIEYMAPEILMRSGHNRAVDW----WSL 207
Query: 612 GTILFEMITGR 622
G ++++M+TG
Sbjct: 208 GALMYDMLTGA 218
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 41.0 bits (97), Expect = 8e-04
Identities = 38/160 (23%), Positives = 71/160 (44%), Gaps = 38/160 (23%)
Query: 482 LSKVNHKNFVNLIGYCEEDEPFTRM-MVFEYSPNGSLFEHLHIQEAEHLDWAM-RLRIA- 538
LS V H + + +D ++ M+ +Y G LF L ++++ + + A
Sbjct: 60 LSIVTHPFIIRMW-GTFQDA--QQIFMIMDYIEGGELFSLL--RKSQRFPNPVAKFYAAE 114
Query: 539 MGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTAAKTGSA------ 592
+ +A LE++H I +R+L+ +I L ++ KI+DF F AK
Sbjct: 115 VCLA--LEYLHSKD--IIYRDLKPENILLDKNGHIKITDFGF------AKYVPDVTYTLC 164
Query: 593 ------AMELLETS----AVDLESNVYSFGTILFEMITGR 622
A E++ T ++D +SFG +++EM+ G
Sbjct: 165 GTPDYIAPEVVSTKPYNKSIDW----WSFGILIYEMLAGY 200
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 9e-04
Identities = 36/164 (21%), Positives = 65/164 (39%), Gaps = 38/164 (23%)
Query: 477 KKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAM-RL 535
K+I L VN V L +++ MV EY G +F HL + R
Sbjct: 92 KRI--LQAVNFPFLVKLEFSFKDNSNL--YMVMEYVAGGEMFSHL--RRIGRFSEPHARF 145
Query: 536 RIA-MGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTAAKTGSA-- 592
A + + E++H L + +R+L+ ++ + + +++DF F AK
Sbjct: 146 YAAQIVLT--FEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGF------AKRVKGRT 195
Query: 593 ----------AMELLETS----AVDLESNVYSFGTILFEMITGR 622
A E++ + AVD ++ G +++EM G
Sbjct: 196 WTLCGTPEALAPEIILSKGYNKAVDW----WALGVLIYEMAAGY 235
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 721 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.94 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.91 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.89 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.85 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.85 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.83 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.82 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.74 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.74 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.6 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.58 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.57 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.56 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.54 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.5 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.5 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.49 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.48 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.46 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.45 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.44 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.44 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.43 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.41 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.4 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.38 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.37 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.36 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.35 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.35 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.35 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.35 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.35 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.33 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.33 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.32 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.32 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.32 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.31 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.31 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.3 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.29 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.28 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.27 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.27 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.27 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.26 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.26 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.26 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.25 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.24 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.24 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.24 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.23 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.23 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.23 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.22 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.22 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.21 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.21 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.21 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.2 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.2 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.2 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.2 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.2 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.19 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.18 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.18 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.17 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.16 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.16 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.16 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.16 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.15 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.15 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.14 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.14 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.14 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.14 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.13 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.13 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.13 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.13 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.13 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.12 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.11 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.11 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.1 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.1 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.09 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.08 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.08 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.07 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.07 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.07 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.06 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.05 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.05 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.04 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.04 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.03 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.02 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.01 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.0 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.0 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.0 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 98.99 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 98.99 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 98.97 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 98.97 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 98.97 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 98.97 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 98.95 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 98.94 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 98.94 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.93 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 98.92 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 98.92 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 98.92 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 98.91 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 98.91 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 98.91 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 98.91 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 98.9 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.87 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 98.85 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 98.85 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 98.85 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 98.84 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 98.82 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 98.82 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 98.81 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 98.8 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 98.79 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 98.75 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.75 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 98.75 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 98.7 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 98.7 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.61 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 98.5 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 98.48 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.42 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 98.41 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 98.4 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.34 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 98.21 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.19 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 98.16 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.14 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.07 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.05 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.94 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.8 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 97.79 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 97.66 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 97.63 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 97.62 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.53 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.45 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 97.39 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.33 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.32 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 96.93 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 96.88 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.68 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.61 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 96.47 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 96.38 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.22 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 95.96 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 95.96 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 95.91 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 95.83 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 95.8 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 95.69 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 95.65 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 95.61 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 95.25 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 95.02 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 94.95 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 94.49 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 93.18 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 93.01 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 92.83 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 90.43 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 90.24 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 87.3 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 87.12 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 86.27 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 81.63 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-52 Score=438.36 Aligned_cols=248 Identities=22% Similarity=0.370 Sum_probs=206.6
Q ss_pred hhhCcCCCCceeEEEEEEec------CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCc
Q 004979 430 NIIGSFSDGTVGTVYKGTLS------SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPF 503 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~------~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 503 (721)
.+.++||+|+||+||+|++. ++..||||+++... ....++|.+|+++|++++|||||+++|+|.+.+
T Consensus 16 ~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-----~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~-- 88 (299)
T 4asz_A 16 VLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-----DNARKDFHREAELLTNLQHEHIVKFYGVCVEGD-- 88 (299)
T ss_dssp EEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC-----HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS--
T ss_pred EEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC-----hHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC--
Confidence 45678999999999999864 46789999886432 334578999999999999999999999999877
Q ss_pred eEEEEEecCCCCChhhhhhhc-----------cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCc
Q 004979 504 TRMMVFEYSPNGSLFEHLHIQ-----------EAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYA 572 (721)
Q Consensus 504 ~~~lV~Ey~~~GsL~~~l~~~-----------~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~ 572 (721)
..+||||||++|+|.++|+.. ....++|.+++.|+.|||.||+|||+++ ||||||||+||||++++.
T Consensus 89 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDlKp~NILl~~~~~ 166 (299)
T 4asz_A 89 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLVGENLL 166 (299)
T ss_dssp SEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGC
T ss_pred EEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCccCHhhEEECCCCc
Confidence 579999999999999999743 2357999999999999999999999988 999999999999999999
Q ss_pred EEEeccCCCCCCC-----------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHh
Q 004979 573 AKISDFSFWNNTT-----------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYL 640 (721)
Q Consensus 573 ~kL~DFGla~~~~-----------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~ 640 (721)
+||+|||+++... .++..|+|||.+.+..|+.++|||||||+||||+| |+.||.. .+..+....+.
T Consensus 167 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~--~~~~~~~~~i~ 244 (299)
T 4asz_A 167 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQ--LSNNEVIECIT 244 (299)
T ss_dssp EEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT--SCHHHHHHHHH
T ss_pred EEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCC--CCHHHHHHHHH
Confidence 9999999986321 24557999999999999999999999999999999 9999964 33445555554
Q ss_pred hcCCCCccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCC
Q 004979 641 KGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAMEP 698 (721)
Q Consensus 641 ~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 698 (721)
.+... ..+..+++++.+||.+||+.||++||||.||++.|+++.+..|
T Consensus 245 ~~~~~----------~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~p 292 (299)
T 4asz_A 245 QGRVL----------QRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKASP 292 (299)
T ss_dssp HTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSC
T ss_pred cCCCC----------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCC
Confidence 44221 1234566789999999999999999999999999999987654
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-52 Score=440.20 Aligned_cols=247 Identities=22% Similarity=0.375 Sum_probs=203.9
Q ss_pred hhhCcCCCCceeEEEEEEec------CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCc
Q 004979 430 NIIGSFSDGTVGTVYKGTLS------SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPF 503 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~------~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 503 (721)
.+.++||+|+||+||+|++. ++..||||++.... ....++|.+|+++|++++|||||+++|+|.+.+
T Consensus 44 ~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-----~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~-- 116 (329)
T 4aoj_A 44 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-----ESARQDFQREAELLTMLQHQHIVRFFGVCTEGR-- 116 (329)
T ss_dssp EEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCS-----HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS--
T ss_pred EEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCC-----HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC--
Confidence 34567899999999999864 46789999986432 334578999999999999999999999999877
Q ss_pred eEEEEEecCCCCChhhhhhhcc-------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCC
Q 004979 504 TRMMVFEYSPNGSLFEHLHIQE-------------AEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTED 570 (721)
Q Consensus 504 ~~~lV~Ey~~~GsL~~~l~~~~-------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~ 570 (721)
..+||||||++|+|.++++... ...++|.+++.|+.|||.||+|||+++ ||||||||+||||+++
T Consensus 117 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDLKp~NILl~~~ 194 (329)
T 4aoj_A 117 PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH--FVHRDLATRNCLVGQG 194 (329)
T ss_dssp SEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEETT
T ss_pred EEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHhhEEECCC
Confidence 5799999999999999997432 246999999999999999999999988 9999999999999999
Q ss_pred CcEEEeccCCCCCC-----------CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHH
Q 004979 571 YAAKISDFSFWNNT-----------TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASE 638 (721)
Q Consensus 571 ~~~kL~DFGla~~~-----------~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~ 638 (721)
+++||+|||+++.. ..++..|||||.+.+..|+.++|||||||+||||+| |+.||... +..+.+..
T Consensus 195 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~--~~~~~~~~ 272 (329)
T 4aoj_A 195 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQL--SNTEAIDC 272 (329)
T ss_dssp TEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSS--CHHHHHHH
T ss_pred CcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCC--CHHHHHHH
Confidence 99999999998743 124557999999999999999999999999999999 99999633 34444444
Q ss_pred HhhcCCCCccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcC
Q 004979 639 YLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAME 697 (721)
Q Consensus 639 ~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 697 (721)
+..+... ..+..+++++.+||.+||+.||++||||.||++.|+.+.+..
T Consensus 273 i~~g~~~----------~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~p 321 (329)
T 4aoj_A 273 ITQGREL----------ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAP 321 (329)
T ss_dssp HHHTCCC----------CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHSC
T ss_pred HHcCCCC----------CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhCC
Confidence 4444221 123445678999999999999999999999999999998754
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-51 Score=433.27 Aligned_cols=251 Identities=25% Similarity=0.449 Sum_probs=204.0
Q ss_pred hhhCcCCCCceeEEEEEEecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVF 509 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV~ 509 (721)
++.++||+|+||+||+|+++. .||||+++.... .....+.|.+|+++|++++|||||+++|+|.++ ..+|||
T Consensus 39 ~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~---~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~---~~~iVm 110 (307)
T 3omv_A 39 MLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDP---TPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKD---NLAIVT 110 (307)
T ss_dssp CEEEECCCCSSSEEEEEESSS--EEEEEECCCSSC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS---SCEEEE
T ss_pred EEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCC---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEECC---eEEEEE
Confidence 456789999999999999764 589998864322 234467899999999999999999999998654 358999
Q ss_pred ecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC-----
Q 004979 510 EYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT----- 584 (721)
Q Consensus 510 Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~----- 584 (721)
|||++|+|.++|+.. ...++|.+++.|+.|||.||+|||+++ ||||||||+||||++++++||+|||+++..
T Consensus 111 Ey~~gGsL~~~l~~~-~~~l~~~~~~~i~~qia~gL~yLH~~~--IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~ 187 (307)
T 3omv_A 111 QWCEGSSLYKHLHVQ-ETKFQMFQLIDIARQTAQGMDYLHAKN--IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG 187 (307)
T ss_dssp ECCSSCBHHHHHHTS-CCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCCSSSEEEETTEEEEECCCSSCBC------
T ss_pred EcCCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCccCHHHEEECCCCcEEEeeccCceecccCCc
Confidence 999999999999643 356999999999999999999999987 999999999999999999999999998642
Q ss_pred ------CCCCccccchhhcc---cCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccc
Q 004979 585 ------TAAKTGSAAMELLE---TSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLK 655 (721)
Q Consensus 585 ------~~~~~~~~apE~~~---~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 655 (721)
..++..|||||++. ...|+.++|||||||+||||+||+.||...+. ...+...+.... ..|.+.
T Consensus 188 ~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~--~~~~~~~~~~~~-----~~p~~~ 260 (307)
T 3omv_A 188 SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINN--RDQIIFMVGRGY-----ASPDLS 260 (307)
T ss_dssp ------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC--HHHHHHHHHTTC-----CCCCST
T ss_pred ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCCh--HHHHHHHHhcCC-----CCCCcc
Confidence 23567899999985 34699999999999999999999999964322 222222222211 122333
Q ss_pred cccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCC
Q 004979 656 SFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAMEP 698 (721)
Q Consensus 656 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 698 (721)
..+..++.++.+||.+||+.||++||||.||++.|+.++...+
T Consensus 261 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lp 303 (307)
T 3omv_A 261 KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLP 303 (307)
T ss_dssp TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCC
T ss_pred cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCC
Confidence 3445667889999999999999999999999999999876543
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-52 Score=439.82 Aligned_cols=244 Identities=20% Similarity=0.376 Sum_probs=202.7
Q ss_pred hhhCcCCCCceeEEEEEEec------CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCc
Q 004979 430 NIIGSFSDGTVGTVYKGTLS------SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPF 503 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~------~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 503 (721)
+++++||+|+||+||+|++. +++.||||++..... ....++|.+|+.+|++++|||||+++|+|.+.+
T Consensus 29 ~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~----~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~-- 102 (308)
T 4gt4_A 29 RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAE----GPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQ-- 102 (308)
T ss_dssp EEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CC----C-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS--
T ss_pred eEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccC----hHHHHHHHHHHHHHHhCCCCCCCCcceEEEECC--
Confidence 45778999999999999873 467899999864322 223468999999999999999999999999877
Q ss_pred eEEEEEecCCCCChhhhhhhcc--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCC
Q 004979 504 TRMMVFEYSPNGSLFEHLHIQE--------------AEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTE 569 (721)
Q Consensus 504 ~~~lV~Ey~~~GsL~~~l~~~~--------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~ 569 (721)
..+||||||++|+|.++|+.+. ...++|.++++|+.|||.||+|||+++ ||||||||+||||++
T Consensus 103 ~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDLK~~NILl~~ 180 (308)
T 4gt4_A 103 PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH--VVHKDLATRNVLVYD 180 (308)
T ss_dssp SCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECG
T ss_pred EEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--CCCCCccccceEECC
Confidence 5699999999999999996432 246999999999999999999999988 999999999999999
Q ss_pred CCcEEEeccCCCCCC-----------CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHH
Q 004979 570 DYAAKISDFSFWNNT-----------TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWAS 637 (721)
Q Consensus 570 ~~~~kL~DFGla~~~-----------~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~ 637 (721)
++++||+|||+++.. ..++..|+|||.+.+..|+.++|||||||+||||+| |+.||... +..+.+.
T Consensus 181 ~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~--~~~~~~~ 258 (308)
T 4gt4_A 181 KLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY--SNQDVVE 258 (308)
T ss_dssp GGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTC--CHHHHHH
T ss_pred CCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCC--CHHHHHH
Confidence 999999999998642 124457999999999999999999999999999999 89999643 3444444
Q ss_pred HHhhcCCCCccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 004979 638 EYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEI 693 (721)
Q Consensus 638 ~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i 693 (721)
.+..+.. ...++.++.++.+||.+||+.||++||||.||++.|+.+
T Consensus 259 ~i~~~~~----------~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 259 MIRNRQV----------LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HHHTTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHHcCCC----------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 4443321 122345667899999999999999999999999999865
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-50 Score=426.76 Aligned_cols=241 Identities=20% Similarity=0.373 Sum_probs=202.1
Q ss_pred hhhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEE
Q 004979 429 SNIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMM 507 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~l 507 (721)
|++++.||+|+||+||+|+. .+++.||||++...... ....+.|.+|+++|++++|||||++++++.+.+ ..||
T Consensus 26 Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~---~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~--~~yi 100 (350)
T 4b9d_A 26 YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMS---SKEREESRREVAVLANMKHPNIVQYRESFEENG--SLYI 100 (350)
T ss_dssp EEEEEEC------CEEEEEETTTCCEEEEEEEECTTSC---HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT--EEEE
T ss_pred eEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCC---HHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECC--EEEE
Confidence 47889999999999999996 46899999998754322 334578999999999999999999999999877 7899
Q ss_pred EEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC--
Q 004979 508 VFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT-- 585 (721)
Q Consensus 508 V~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~-- 585 (721)
|||||++|+|.++|..+....+++.+.+.|+.||+.||+|||+++ ||||||||+||||++++.+||+|||+++...
T Consensus 101 VmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 101 VMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST 178 (350)
T ss_dssp EEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred EEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence 999999999999997666667899999999999999999999998 9999999999999999999999999997543
Q ss_pred -------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCcccccc
Q 004979 586 -------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQ 658 (721)
Q Consensus 586 -------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 658 (721)
.++..|+|||++.+..|+.++||||+||+||||+||+.||.. .+..+.+..+..+..+ ..+
T Consensus 179 ~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~--~~~~~~~~~i~~~~~~----------~~~ 246 (350)
T 4b9d_A 179 VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEA--GSMKNLVLKIISGSFP----------PVS 246 (350)
T ss_dssp HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC--SSHHHHHHHHHHTCCC----------CCC
T ss_pred cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC--cCHHHHHHHHHcCCCC----------CCC
Confidence 267789999999999999999999999999999999999963 3455666666554322 112
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 659 ENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 659 ~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
..++.++.+||.+||+.||++|||+.|+++
T Consensus 247 ~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 247 LHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 345578899999999999999999999986
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-49 Score=412.96 Aligned_cols=243 Identities=23% Similarity=0.342 Sum_probs=196.8
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecC--CCceEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEED--EPFTRM 506 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~~~ 506 (721)
++..+||+|+||+||+|+.. ++..||+|++..... .....+.|.+|+++|++++|||||++++++.+. +....|
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~---~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 105 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL---TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEE
Confidence 44456899999999999964 688999999875432 233457899999999999999999999998652 222579
Q ss_pred EEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeC-CCCcEEEeccCCCCCC-
Q 004979 507 MVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLT-EDYAAKISDFSFWNNT- 584 (721)
Q Consensus 507 lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~-~~~~~kL~DFGla~~~- 584 (721)
||||||++|+|.++++. ...+++..+..|+.||+.||+|||+++++||||||||+||||+ +++.+||+|||+++..
T Consensus 106 lvmEy~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 106 LVTELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEEeCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 99999999999999964 3569999999999999999999999888899999999999998 4799999999998632
Q ss_pred ------CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCcccccc
Q 004979 585 ------TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQ 658 (721)
Q Consensus 585 ------~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 658 (721)
..++..|||||++.+ .|+.++|||||||+||||+||+.||... .+.......+..+..+. .++
T Consensus 184 ~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~-~~~~~~~~~i~~~~~~~---------~~~ 252 (290)
T 3fpq_A 184 ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSEC-QNAAQIYRRVTSGVKPA---------SFD 252 (290)
T ss_dssp TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTC-SSHHHHHHHHTTTCCCG---------GGG
T ss_pred CCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCC-CcHHHHHHHHHcCCCCC---------CCC
Confidence 236778999998865 6999999999999999999999999633 23334444433332111 122
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 659 ENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 659 ~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
...++++.+|+.+||+.||++|||+.|+++
T Consensus 253 ~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 253 KVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp GCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 234467899999999999999999999975
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=422.21 Aligned_cols=250 Identities=16% Similarity=0.152 Sum_probs=208.1
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
++.++||+|+||+||+|+.. +|+.||||++.... .+.+|+++|++++|||||++++++.+.+ ..|||
T Consensus 61 ~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~----------~~~~E~~il~~l~HpnIV~l~~~~~~~~--~~~iv 128 (336)
T 4g3f_A 61 THQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV----------FRVEELVACAGLSSPRIVPLYGAVREGP--WVNIF 128 (336)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT----------CCTHHHHTTTTCCCTTBCCEEEEEEETT--EEEEE
T ss_pred EeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH----------hHHHHHHHHHhCCCCCCCcEEEEEEECC--EEEEE
Confidence 56678999999999999964 68999999986432 1247999999999999999999999877 77999
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCC-cEEEeccCCCCCC---
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDY-AAKISDFSFWNNT--- 584 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~-~~kL~DFGla~~~--- 584 (721)
||||++|+|.++|+.. ..+++..+..|+.||+.||+|||+++ ||||||||+||||+.++ .+||+|||+++..
T Consensus 129 mEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~ 204 (336)
T 4g3f_A 129 MELLEGGSLGQLIKQM--GCLPEDRALYYLGQALEGLEYLHTRR--ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD 204 (336)
T ss_dssp ECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCCGGGEEECTTSCCEEECCCTTCEEC---
T ss_pred EeccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCC
Confidence 9999999999999643 46999999999999999999999998 99999999999999987 6999999998632
Q ss_pred -----------CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCc
Q 004979 585 -----------TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPT 653 (721)
Q Consensus 585 -----------~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 653 (721)
..++..|||||++.+..|+.++|||||||++|||+||+.||...... +....+..+..+.
T Consensus 205 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~--~~~~~i~~~~~~~------- 275 (336)
T 4g3f_A 205 GLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRG--PLCLKIASEPPPI------- 275 (336)
T ss_dssp ---------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCS--CCHHHHHHSCCGG-------
T ss_pred CcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH--HHHHHHHcCCCCc-------
Confidence 23677899999999999999999999999999999999999754322 1222333332211
Q ss_pred cccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCCCCCCCCC
Q 004979 654 LKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAMEPDGATPKL 705 (721)
Q Consensus 654 l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~~~~p~~ 705 (721)
...++.++.++.+++.+||+.||++|||+.|+++.|.........-.+|..
T Consensus 276 -~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~ 326 (336)
T 4g3f_A 276 -REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWK 326 (336)
T ss_dssp -GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSS
T ss_pred -hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCc
Confidence 123445677899999999999999999999999999888776665556654
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-50 Score=419.21 Aligned_cols=258 Identities=19% Similarity=0.282 Sum_probs=215.5
Q ss_pred hhhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEE
Q 004979 429 SNIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMM 507 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~l 507 (721)
|++++.||+|+||+||+|+. .+++.||||++....... ....+.+.+|+++|++++|||||++++++.+.+ ..||
T Consensus 34 y~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~--~~yi 109 (311)
T 4aw0_A 34 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK--ENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDE--KLYF 109 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHH--TTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS--EEEE
T ss_pred cEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC--EEEE
Confidence 37888999999999999995 478999999987543221 223467999999999999999999999999877 7899
Q ss_pred EEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC---
Q 004979 508 VFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT--- 584 (721)
Q Consensus 508 V~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~--- 584 (721)
|||||++|+|.+++.. ...+++.....|+.||+.||+|||+++ ||||||||+|||+++++.+||+|||+++..
T Consensus 110 vmEy~~gG~L~~~i~~--~~~l~e~~~~~~~~qi~~al~ylH~~~--IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 110 GLSYAKNGELLKYIRK--IGSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp EECCCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 9999999999999964 356999999999999999999999998 999999999999999999999999998632
Q ss_pred --------CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCcccc
Q 004979 585 --------TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKS 656 (721)
Q Consensus 585 --------~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 656 (721)
..|+..|+|||++.+..|+.++||||+||++|||+||+.||.. .+..+....+..+...+
T Consensus 186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~--~~~~~~~~~i~~~~~~~---------- 253 (311)
T 4aw0_A 186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA--GNEGLIFAKIIKLEYDF---------- 253 (311)
T ss_dssp TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCC--SSHHHHHHHHHHTCCCC----------
T ss_pred CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC--CCHHHHHHHHHcCCCCC----------
Confidence 2367789999999999999999999999999999999999964 34555566666553322
Q ss_pred ccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCChhHHHHHH
Q 004979 657 FQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAMEPDGATPKLSPLWWAELE 714 (721)
Q Consensus 657 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~~~~p~~~~~~~~~l~ 714 (721)
++..++++.+|+.+||+.||++|||++|++.. ..+ ..+|++..++|+.|+
T Consensus 254 -p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~-~~i------~~Hp~F~~idw~~l~ 303 (311)
T 4aw0_A 254 -PEKFFPKARDLVEKLLVLDATKRLGCEEMEGY-GPL------KAHPFFESVTWENLH 303 (311)
T ss_dssp -CTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCH-HHH------HTSGGGTTCCCTTGG
T ss_pred -CcccCHHHHHHHHHHccCCHhHCcChHHHcCC-HHH------HCCCCcCCCCHHHhc
Confidence 23345678999999999999999999986432 111 237899999998874
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-49 Score=426.18 Aligned_cols=251 Identities=21% Similarity=0.348 Sum_probs=203.2
Q ss_pred hhhCcCCCCceeEEEEEEecC------CcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCC-CccceEeEEEecCCC
Q 004979 430 NIIGSFSDGTVGTVYKGTLSS------GVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNH-KNFVNLIGYCEEDEP 502 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~~------~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H-~nIv~l~g~~~~~~~ 502 (721)
++.+.||+|+||+||+|++.. ++.||||++.... .....+.|.+|+++|.+++| ||||+++|+|.+.+.
T Consensus 67 ~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~----~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~ 142 (353)
T 4ase_A 67 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA----THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 142 (353)
T ss_dssp EEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTS
T ss_pred EEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc----ChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCC
Confidence 677889999999999998642 3578998876432 12345689999999999965 899999999976432
Q ss_pred ceEEEEEecCCCCChhhhhhhcc--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeC
Q 004979 503 FTRMMVFEYSPNGSLFEHLHIQE--------------AEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLT 568 (721)
Q Consensus 503 ~~~~lV~Ey~~~GsL~~~l~~~~--------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~ 568 (721)
..+||||||++|+|.++|+... ...++|..++.|+.|||.||+|||+++ ||||||||+|||++
T Consensus 143 -~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~--iiHRDLK~~NILl~ 219 (353)
T 4ase_A 143 -PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLS 219 (353)
T ss_dssp -CCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC
T ss_pred -EEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC--eecCccCccceeeC
Confidence 4689999999999999997432 245899999999999999999999988 99999999999999
Q ss_pred CCCcEEEeccCCCCCCCC-----------CCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHH
Q 004979 569 EDYAAKISDFSFWNNTTA-----------AKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWA 636 (721)
Q Consensus 569 ~~~~~kL~DFGla~~~~~-----------~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~ 636 (721)
+++.+||+|||+++.... ++..|||||.+.+..|+.++|||||||+||||+| |+.||...... ....
T Consensus 220 ~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~-~~~~ 298 (353)
T 4ase_A 220 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-EEFC 298 (353)
T ss_dssp GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS-HHHH
T ss_pred CCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHH-HHHH
Confidence 999999999999975422 2346999999999999999999999999999998 99999744322 2222
Q ss_pred HHHhhcCCCCccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCC
Q 004979 637 SEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAMEP 698 (721)
Q Consensus 637 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 698 (721)
..+..+.. . ..++.+++++.++|.+||+.||++||||.||++.|+++.+...
T Consensus 299 ~~i~~g~~-~---------~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~~ 350 (353)
T 4ase_A 299 RRLKEGTR-M---------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 350 (353)
T ss_dssp HHHHHTCC-C---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred HHHHcCCC-C---------CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHhh
Confidence 22222211 1 1233456789999999999999999999999999999876543
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-49 Score=419.18 Aligned_cols=238 Identities=21% Similarity=0.284 Sum_probs=200.5
Q ss_pred hhhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEE
Q 004979 429 SNIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMM 507 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~l 507 (721)
++++++||+|+||+||+|+.. +|+.||||++....... .+.+.+|+++|++++|||||++++++.+.+ ..||
T Consensus 76 y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~-----~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~--~~~i 148 (346)
T 4fih_A 76 LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR-----RELLFNEVVIMRDYQHENVVEMYNSYLVGD--ELWV 148 (346)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS-----GGGGHHHHHHHHHCCCTTBCCEEEEEEETT--EEEE
T ss_pred cEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH-----HHHHHHHHHHHHhCCCCCCCcEEEEEEECC--EEEE
Confidence 577889999999999999965 68999999987543222 246889999999999999999999999887 7899
Q ss_pred EEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC---
Q 004979 508 VFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT--- 584 (721)
Q Consensus 508 V~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~--- 584 (721)
|||||++|+|.+++.. ..+++..+..|+.||+.||+|||+++ ||||||||+||||+.++.+||+|||+++..
T Consensus 149 vmEy~~gg~L~~~l~~---~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 223 (346)
T 4fih_A 149 VMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE 223 (346)
T ss_dssp EECCCTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCSS
T ss_pred EEeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEECCCCCEEEecCcCceecCCC
Confidence 9999999999999863 45999999999999999999999998 999999999999999999999999998532
Q ss_pred ------CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCcccccc
Q 004979 585 ------TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQ 658 (721)
Q Consensus 585 ------~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 658 (721)
..++..|+|||++.+..|+.++||||+||++|||+||+.||... +..+....+.....+. + ...
T Consensus 224 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~--~~~~~~~~i~~~~~~~-------~-~~~ 293 (346)
T 4fih_A 224 VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE--PPLKAMKMIRDNLPPR-------L-KNL 293 (346)
T ss_dssp SCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS--CHHHHHHHHHHSSCCC-------C-SCG
T ss_pred CCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc--CHHHHHHHHHcCCCCC-------C-Ccc
Confidence 23667899999999999999999999999999999999999643 3344444443332111 1 122
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 659 ENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 659 ~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
..+++++.+|+.+||+.||++|||+.|+++
T Consensus 294 ~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 294 HKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 345678999999999999999999999876
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-49 Score=413.83 Aligned_cols=252 Identities=21% Similarity=0.314 Sum_probs=194.5
Q ss_pred hhhCcCCCCceeEEEEEEecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCC--ceEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEP--FTRMM 507 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~--~~~~l 507 (721)
.+.++||+|+||+||+|++. |+.||||++.... .....+..|+..+.+++|||||+++|+|.+++. ...||
T Consensus 6 ~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~------~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~l 78 (303)
T 3hmm_A 6 VLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE------ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp EEEEEEEECSSSEEEEEEET-TEEEEEEEECGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred EEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccc------hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEE
Confidence 34467899999999999984 8899999885432 112234456777788999999999999986542 24699
Q ss_pred EEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcC------CCCeEeeCCCCCCeEeCCCCcEEEeccCCC
Q 004979 508 VFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQL------TPPIAHRNLQSSSIYLTEDYAAKISDFSFW 581 (721)
Q Consensus 508 V~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~------~~~IvHrDLKp~NILl~~~~~~kL~DFGla 581 (721)
|||||++|+|.++|+. ..++|..+.+|+.|++.||+|||+. .++||||||||+||||++++++||+|||++
T Consensus 79 V~Ey~~~gsL~~~l~~---~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla 155 (303)
T 3hmm_A 79 VSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EecCCCCCcHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence 9999999999999964 4589999999999999999999976 346999999999999999999999999997
Q ss_pred CCC-------------CCCCccccchhhcccC------CCCCCccHHHHHHHHHHHHhCCCcccCCC-------------
Q 004979 582 NNT-------------TAAKTGSAAMELLETS------AVDLESNVYSFGTILFEMITGRISYSIEN------------- 629 (721)
Q Consensus 582 ~~~-------------~~~~~~~~apE~~~~~------~~s~ksDVwSfGvvL~ElltG~~P~~~~~------------- 629 (721)
+.. ..++..|+|||++.+. .|+.++|||||||+||||+||+.||....
T Consensus 156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~ 235 (303)
T 3hmm_A 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccccc
Confidence 522 1356789999998654 46789999999999999999987764211
Q ss_pred CCHHHHHHHHhhcCCCCccccCCccccc--cHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcC
Q 004979 630 GSLENWASEYLKGEQPLKDIVDPTLKSF--QENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAME 697 (721)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~--~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 697 (721)
............ ...+|.++.. ..+++..+.+||.+||+.||++||||.||++.|+++.+..
T Consensus 236 ~~~~~~~~~~~~------~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~ 299 (303)
T 3hmm_A 236 PSVEEMRKVVCE------QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp CCHHHHHHHHTT------SCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred chHHHHHHHHhc------ccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHc
Confidence 112222222211 1122333221 2356778999999999999999999999999999987653
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-49 Score=412.14 Aligned_cols=252 Identities=19% Similarity=0.266 Sum_probs=205.6
Q ss_pred hhhhCcCCCCceeEEEEEEec----CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCce
Q 004979 429 SNIIGSFSDGTVGTVYKGTLS----SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFT 504 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~----~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 504 (721)
|++++.||+|+||+||+|+.. +++.||+|++........ ...++.+|+++|++++|||||++++++.+++ .
T Consensus 26 Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~---~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~--~ 100 (304)
T 3ubd_A 26 FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR---DRVRTKMERDILVEVNHPFIVKLHYAFQTEG--K 100 (304)
T ss_dssp EEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEE---ECC------CCCCCCCCTTEECEEEEEEETT--E
T ss_pred cEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChH---HHHHHHHHHHHHHHCCCCCCCeEEEEEEECC--E
Confidence 478899999999999999852 467899999865432211 1236889999999999999999999999877 7
Q ss_pred EEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC
Q 004979 505 RMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT 584 (721)
Q Consensus 505 ~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~ 584 (721)
.|||||||++|+|.+++.. ...+++..+..|+.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++..
T Consensus 101 ~~ivmEy~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 176 (304)
T 3ubd_A 101 LYLILDFLRGGDLFTRLSK--EVMFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKES 176 (304)
T ss_dssp EEEEECCCTTCEEHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred EEEEEEcCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHeEEcCCCCEEecccccceec
Confidence 8999999999999999964 356999999999999999999999998 999999999999999999999999998632
Q ss_pred ---------CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccc
Q 004979 585 ---------TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLK 655 (721)
Q Consensus 585 ---------~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 655 (721)
..++..|+|||.+.+..|+.++||||+||++|||+||+.||.. .+..+....+..+....
T Consensus 177 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~--~~~~~~~~~i~~~~~~~--------- 245 (304)
T 3ubd_A 177 IDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQG--KDRKETMTMILKAKLGM--------- 245 (304)
T ss_dssp ----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCC--SSHHHHHHHHHHCCCCC---------
T ss_pred cCCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCC--cCHHHHHHHHHcCCCCC---------
Confidence 2467789999999999999999999999999999999999964 34555555555543322
Q ss_pred cccHHHHHHHHHHHHHcccCCCCCCCCH-----HHHHHHHHHhhhcCCCCCCCCCChhHHHHHHh
Q 004979 656 SFQENVLEELLVVIKNCVHPDPKQRPSM-----RGIAAKLKEITAMEPDGATPKLSPLWWAELEI 715 (721)
Q Consensus 656 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~-----~evl~~L~~i~~~~~~~~~p~~~~~~~~~l~~ 715 (721)
+..+++++.+|+.+||+.||++|||+ +|+++ +|++..++|+.++-
T Consensus 246 --p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~-------------Hp~f~~idw~~l~~ 295 (304)
T 3ubd_A 246 --PQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR-------------HSFFSTIDWNKLYR 295 (304)
T ss_dssp --CTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT-------------SGGGTTCCHHHHHT
T ss_pred --CCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc-------------CccccCCCHHHHHh
Confidence 23345778999999999999999985 45542 78889999998854
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=397.55 Aligned_cols=238 Identities=22% Similarity=0.341 Sum_probs=193.0
Q ss_pred hhhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEE
Q 004979 429 SNIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMM 507 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~l 507 (721)
|++++.||+|+||+||+|+. .+++.||+|++......+ ....+.+.+|+++|++++|||||++++++.+.+ ..|+
T Consensus 15 Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~--~~~i 90 (275)
T 3hyh_A 15 YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAK--SDMQGRIEREISYLRLLRHPHIIKLYDVIKSKD--EIIM 90 (275)
T ss_dssp CEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSS--EEEE
T ss_pred eEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCC--HHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC--EEEE
Confidence 47888999999999999995 478999999987543222 223467999999999999999999999999877 7899
Q ss_pred EEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC---
Q 004979 508 VFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT--- 584 (721)
Q Consensus 508 V~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~--- 584 (721)
||||+ +|+|.+++.. ...+++.....++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++..
T Consensus 91 vmEy~-~g~L~~~l~~--~~~l~e~~~~~~~~qi~~al~ylH~~~--IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 165 (275)
T 3hyh_A 91 VIEYA-GNELFDYIVQ--RDKMSEQEARRFFQQIISAVEYCHRHK--IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG 165 (275)
T ss_dssp EEECC-CEEHHHHHHH--SCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred EEeCC-CCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence 99999 7899999864 456999999999999999999999998 999999999999999999999999998643
Q ss_pred -----CCCCccccchhhcccCCC-CCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCcccccc
Q 004979 585 -----TAAKTGSAAMELLETSAV-DLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQ 658 (721)
Q Consensus 585 -----~~~~~~~~apE~~~~~~~-s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 658 (721)
..++..|+|||++.+..| +.++||||+||++|||+||+.||.. .+..+....+..+...+ +
T Consensus 166 ~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~--~~~~~~~~~i~~~~~~~-----------p 232 (275)
T 3hyh_A 166 NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDD--ESIPVLFKNISNGVYTL-----------P 232 (275)
T ss_dssp ---------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCC--SSHHHHHHHHHHTCCCC-----------C
T ss_pred CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCC--CCHHHHHHHHHcCCCCC-----------C
Confidence 246778999999988876 5799999999999999999999964 34555555555543322 2
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 659 ENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 659 ~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
...++++.+|+.+||+.||++|||++|+++
T Consensus 233 ~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 233 KFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 234567889999999999999999999986
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-48 Score=420.48 Aligned_cols=239 Identities=21% Similarity=0.289 Sum_probs=200.6
Q ss_pred hhhhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEE
Q 004979 428 FSNIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRM 506 (721)
Q Consensus 428 ~~~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~ 506 (721)
+|+++++||+|+||+||+|+.. +|+.||||++....... .+.+.+|+++|++++|||||++++++.+.+ ..|
T Consensus 152 ~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~-----~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~--~~~ 224 (423)
T 4fie_A 152 YLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR-----RELLFNEVVIMRDYQHENVVEMYNSYLVGD--ELW 224 (423)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS-----GGGHHHHHHHHHHCCCTTBCCEEEEEEETT--EEE
T ss_pred hcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH-----HHHHHHHHHHHHhCCCCCCCceEEEEEECC--EEE
Confidence 4578889999999999999964 68999999987543322 246889999999999999999999999877 789
Q ss_pred EEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC--
Q 004979 507 MVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT-- 584 (721)
Q Consensus 507 lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~-- 584 (721)
||||||++|+|.+++.. ..+++.++..|+.||+.||+|||+++ ||||||||+||||+.++.+||+|||+++..
T Consensus 225 iVmEy~~gG~L~~~i~~---~~l~e~~~~~~~~qil~aL~ylH~~~--IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~ 299 (423)
T 4fie_A 225 VVMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 299 (423)
T ss_dssp EEEECCTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSTTTEEECTTCCEEECCCTTCEECCS
T ss_pred EEEeCCCCCcHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEEcCCCCEEEecCccceECCC
Confidence 99999999999999853 35899999999999999999999998 999999999999999999999999998632
Q ss_pred -------CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccc
Q 004979 585 -------TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSF 657 (721)
Q Consensus 585 -------~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 657 (721)
..++..|||||++.+..|+.++|||||||++|||++|+.||... +..+....+.....+. + ..
T Consensus 300 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~--~~~~~~~~i~~~~~~~-------~-~~ 369 (423)
T 4fie_A 300 EVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE--PPLKAMKMIRDNLPPR-------L-KN 369 (423)
T ss_dssp SCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS--CHHHHHHHHHHSCCCC-------C-SC
T ss_pred CCccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc--CHHHHHHHHHcCCCCC-------C-cc
Confidence 23567899999999999999999999999999999999999643 3344444443332111 1 11
Q ss_pred cHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 658 QENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 658 ~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
...++.++.+|+.+||+.||++|||+.|+++
T Consensus 370 ~~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 370 LHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp TTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 2345578899999999999999999999876
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-47 Score=398.84 Aligned_cols=239 Identities=18% Similarity=0.299 Sum_probs=187.2
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCC------
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEP------ 502 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~------ 502 (721)
++++.||+|+||+||+|+.. +++.||||++..... ....+.+.+|+++|++++|||||++++++.+.+.
T Consensus 8 ~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~----~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 8 EPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNR----ELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp EEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSS----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred EEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCC----HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 77889999999999999964 688999999875432 2345679999999999999999999999875432
Q ss_pred ----ceEEEEEecCCCCChhhhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEec
Q 004979 503 ----FTRMMVFEYSPNGSLFEHLHIQE-AEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISD 577 (721)
Q Consensus 503 ----~~~~lV~Ey~~~GsL~~~l~~~~-~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~D 577 (721)
...|+|||||++|+|.+++.... ....++...+.|+.||+.||+|||+++ ||||||||+|||++.++.+||+|
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~--IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG--LMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECC
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc--CccccCcHHHeEECCCCcEEEcc
Confidence 13689999999999999997543 234677788899999999999999998 99999999999999999999999
Q ss_pred cCCCCCCC---------------------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHH
Q 004979 578 FSFWNNTT---------------------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWA 636 (721)
Q Consensus 578 FGla~~~~---------------------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~ 636 (721)
||+++... .|+..|||||.+.+..|+.++|||||||++|||++ ||.... +.....
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~-~~~~~~ 237 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM-ERVRTL 237 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH-HHHHHH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc-HHHHHH
Confidence 99986432 36778999999999999999999999999999997 774221 111111
Q ss_pred HHHhhcCCCCccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 637 SEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 637 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
...... ..+.......+++.+|+.+||+.||++|||+.|+++
T Consensus 238 ~~~~~~----------~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 238 TDVRNL----------KFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HHHHTT----------CCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHhcC----------CCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111111 111222344556788999999999999999999875
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-44 Score=406.39 Aligned_cols=255 Identities=19% Similarity=0.240 Sum_probs=205.4
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccch-hhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADW-SKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMM 507 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~l 507 (721)
++++.||+|+||+||+|+.. +|+.||+|++.+...... ..........++++++.++|||||++++++.+.+ ..||
T Consensus 192 ~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~--~lyl 269 (689)
T 3v5w_A 192 SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD--KLSF 269 (689)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS--EEEE
T ss_pred EEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECC--EEEE
Confidence 77889999999999999964 689999999875432211 1111223344577888899999999999999887 7899
Q ss_pred EEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCC----
Q 004979 508 VFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNN---- 583 (721)
Q Consensus 508 V~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~---- 583 (721)
|||||+||+|.++|.. ...+++..+..|+.||+.||+|||+++ ||||||||+||||+.+|.+||+|||+++.
T Consensus 270 VmEy~~GGdL~~~l~~--~~~l~E~~a~~y~~qIl~aL~yLH~~g--IiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~ 345 (689)
T 3v5w_A 270 ILDLMNGGDLHYHLSQ--HGVFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKK 345 (689)
T ss_dssp EECCCCSCBHHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred EEecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHeEEeCCCCEEecccceeeecCCC
Confidence 9999999999999964 356999999999999999999999998 99999999999999999999999999863
Q ss_pred ---CCCCCccccchhhcc-cCCCCCCccHHHHHHHHHHHHhCCCcccCCCC-CHHHHHHHHhhcCCCCccccCCcccccc
Q 004979 584 ---TTAAKTGSAAMELLE-TSAVDLESNVYSFGTILFEMITGRISYSIENG-SLENWASEYLKGEQPLKDIVDPTLKSFQ 658 (721)
Q Consensus 584 ---~~~~~~~~~apE~~~-~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~-~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 658 (721)
...|+..|+|||++. +..|+.++||||+||++|||+||+.||...+. +..+........... ++
T Consensus 346 ~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~-----------~p 414 (689)
T 3v5w_A 346 KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE-----------LP 414 (689)
T ss_dssp CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCC-----------CC
T ss_pred CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCC-----------CC
Confidence 234678899999996 45799999999999999999999999975432 333444444433222 22
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHHHHHhhhcCCCCCCCCCChhHHHHHH
Q 004979 659 ENVLEELLVVIKNCVHPDPKQRPS-----MRGIAAKLKEITAMEPDGATPKLSPLWWAELE 714 (721)
Q Consensus 659 ~~~~~~l~~li~~Cl~~dP~~RPs-----~~evl~~L~~i~~~~~~~~~p~~~~~~~~~l~ 714 (721)
...+.++.+||.+||+.||++|++ +.||.+ ||++..++|+.|.
T Consensus 415 ~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~-------------HpfF~~idW~~l~ 462 (689)
T 3v5w_A 415 DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE-------------SPFFRSLDWQMVF 462 (689)
T ss_dssp TTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT-------------SGGGTTCCHHHHH
T ss_pred ccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc-------------CccccCCCHHHHH
Confidence 345678899999999999999998 677643 6777777787774
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-44 Score=389.05 Aligned_cols=250 Identities=17% Similarity=0.215 Sum_probs=195.8
Q ss_pred hhhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCC----Cc
Q 004979 429 SNIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDE----PF 503 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~----~~ 503 (721)
|++++.||+|+||+||+|+. .+|+.||||++..... .....+.+.+|+++|++++|||||++++++.... ..
T Consensus 56 Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 56 YEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFD---VVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTS---SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred eEEEEEEecccCeEEEEEEECCCCCEEEEEEECcccc---chHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 47888999999999999996 4789999999864322 1233467899999999999999999999986432 22
Q ss_pred eEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCC
Q 004979 504 TRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNN 583 (721)
Q Consensus 504 ~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~ 583 (721)
..|||||||+ |+|.+++. ....+++..+..|+.||+.||+|||+++ ||||||||+|||++.++.+||+|||+++.
T Consensus 133 ~~~ivmE~~~-g~L~~~i~--~~~~l~~~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NIl~~~~~~~Ki~DFGla~~ 207 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIH--SSQPLTLEHVRYFLYQLLRGLKYMHSAQ--VIHRDLKPSNLLVNENCELKIGDFGMARG 207 (398)
T ss_dssp CEEEEEECCS-EEHHHHHT--SSSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEEEEeCCC-CCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCc--CcCCCcCccccccCCCCCEEEeecceeee
Confidence 6799999995 78999986 3457999999999999999999999998 99999999999999999999999999863
Q ss_pred C-------------CCCCccccchhhcccC-CCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCC-cc
Q 004979 584 T-------------TAAKTGSAAMELLETS-AVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPL-KD 648 (721)
Q Consensus 584 ~-------------~~~~~~~~apE~~~~~-~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~-~~ 648 (721)
. ..++..|+|||++.+. .|+.++||||+||++|||+||+.||.+.+ ..+.+..+....... ..
T Consensus 208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~--~~~~l~~I~~~~g~p~~~ 285 (398)
T 4b99_A 208 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKN--YVHQLQLIMMVLGTPSPA 285 (398)
T ss_dssp C-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSS--HHHHHHHHHHHHCCCCGG
T ss_pred cccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCC--HHHHHHHHHHhcCCCChH
Confidence 2 2456789999998764 56999999999999999999999996443 233333322211110 10
Q ss_pred ccC---------------C----ccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 649 IVD---------------P----TLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 649 ~~d---------------~----~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
... + .+....+..+.++.+|+.+||+.||++|||+.|+++
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 286 VIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp GTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000 0 000111234578899999999999999999999986
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=379.20 Aligned_cols=245 Identities=19% Similarity=0.327 Sum_probs=190.4
Q ss_pred hhhhhhCcCCCCceeEEEEEEec----CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcC-CCCccceEeEEEecCC
Q 004979 427 DFSNIIGSFSDGTVGTVYKGTLS----SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKV-NHKNFVNLIGYCEEDE 501 (721)
Q Consensus 427 ~~~~ii~~lg~G~~g~Vyk~~~~----~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~ 501 (721)
+.|++++.||+|+||+||+|+.+ +++.||+|++..... ..++.+|+++|.++ +|||||++++++.+.+
T Consensus 21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~-------~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~ 93 (361)
T 4f9c_A 21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH-------PIRIAAELQCLTVAGGQDNVMGVKYCFRKND 93 (361)
T ss_dssp GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC-------HHHHHHHHHHHHHTCSBTTBCCCSEEEEETT
T ss_pred CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC-------HHHHHHHHHHHHHhcCCCCCceEEEEEEECC
Confidence 44688899999999999999853 467899998754321 24678999999998 6999999999999877
Q ss_pred CceEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCC-CcEEEeccCC
Q 004979 502 PFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTED-YAAKISDFSF 580 (721)
Q Consensus 502 ~~~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~-~~~kL~DFGl 580 (721)
+.|+|||||++|+|.+++. .+++.+...++.|++.||+|||+++ |+||||||+|||++.+ +.+||+|||+
T Consensus 94 --~~~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~g--IiHRDiKPeNiLl~~~~~~~kl~DFGl 164 (361)
T 4f9c_A 94 --HVVIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQFG--IVHRDVKPSNFLYNRRLKKYALVDFGL 164 (361)
T ss_dssp --EEEEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred --EEEEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCcCCHHHeEEeCCCCeEEECcCCC
Confidence 7899999999999999983 4899999999999999999999998 9999999999999876 7999999999
Q ss_pred CCCC-------------------------------------CCCCccccchhhcccC-CCCCCccHHHHHHHHHHHHhCC
Q 004979 581 WNNT-------------------------------------TAAKTGSAAMELLETS-AVDLESNVYSFGTILFEMITGR 622 (721)
Q Consensus 581 a~~~-------------------------------------~~~~~~~~apE~~~~~-~~s~ksDVwSfGvvL~ElltG~ 622 (721)
|+.. ..++..|+|||++.+. .|+.++||||+||++|||+||+
T Consensus 165 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~ 244 (361)
T 4f9c_A 165 AQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGR 244 (361)
T ss_dssp CEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTC
T ss_pred CcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCC
Confidence 8532 1367789999998765 5899999999999999999999
Q ss_pred CcccCCCCCHHHHHHHHhh--c-------------------CCCCcc---c------cC---Ccc----------ccccH
Q 004979 623 ISYSIENGSLENWASEYLK--G-------------------EQPLKD---I------VD---PTL----------KSFQE 659 (721)
Q Consensus 623 ~P~~~~~~~~~~~~~~~~~--~-------------------~~~~~~---~------~d---~~l----------~~~~~ 659 (721)
.||.....+.... ..+.. + ..+..+ . .+ +.. .....
T Consensus 245 ~Pf~~~~~~~~~l-~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~ 323 (361)
T 4f9c_A 245 YPFYKASDDLTAL-AQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWN 323 (361)
T ss_dssp SSSSCCSSHHHHH-HHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CT
T ss_pred CCCCCCCCHHHHH-HHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccc
Confidence 9996544332211 11110 0 000000 0 00 000 00112
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 660 NVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 660 ~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
..++++.+|+.+||+.||++|||++|+++
T Consensus 324 ~is~~a~DLl~~lL~~dP~~R~ta~eaL~ 352 (361)
T 4f9c_A 324 EVPDEAYDLLDKLLDLNPASRITAEEALL 352 (361)
T ss_dssp TCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred cCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 34567899999999999999999999875
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=394.84 Aligned_cols=241 Identities=22% Similarity=0.304 Sum_probs=201.7
Q ss_pred hhhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEE
Q 004979 429 SNIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMM 507 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~l 507 (721)
|++++.||+|+||+||+|+. .+|+.||+|++..... ...+.+.+|+++|++++|||||++++++.+.+ ..||
T Consensus 159 Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~-----~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~--~~~i 231 (573)
T 3uto_A 159 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE-----SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDN--EMVM 231 (573)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH-----HHHHHHHHHHHHHHHTCCTTBCCEEEEEECSS--EEEE
T ss_pred cEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccch-----hhHHHHHHHHHHHHhCCCCCCCeEEEEEEECC--EEEE
Confidence 47888999999999999996 4789999998865432 23467899999999999999999999999877 7899
Q ss_pred EEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCC--CcEEEeccCCCCCCC
Q 004979 508 VFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTED--YAAKISDFSFWNNTT 585 (721)
Q Consensus 508 V~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~--~~~kL~DFGla~~~~ 585 (721)
|||||++|+|.+++.. ....+++..+..|+.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+++...
T Consensus 232 v~E~~~gg~L~~~i~~-~~~~l~e~~~~~~~~qi~~al~ylH~~~--iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~ 308 (573)
T 3uto_A 232 IYEFMSGGELFEKVAD-EHNKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 308 (573)
T ss_dssp EEECCCCCBHHHHHTC-TTSCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCSSCEECC
T ss_pred EEeecCCCcHHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhccccCCCCCCEEEeeccceeEcc
Confidence 9999999999999853 3356999999999999999999999998 9999999999999854 899999999987543
Q ss_pred --------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccc
Q 004979 586 --------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSF 657 (721)
Q Consensus 586 --------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 657 (721)
.++..|+|||++.+..|+.++||||+||++|||++|+.||... +..+....+......... ..
T Consensus 309 ~~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~--~~~~~~~~i~~~~~~~~~-------~~ 379 (573)
T 3uto_A 309 PKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE--NDDETLRNVKSCDWNMDD-------SA 379 (573)
T ss_dssp TTSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS--SHHHHHHHHHTTCCCCCS-------GG
T ss_pred CCCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc--CHHHHHHHHHhCCCCCCc-------cc
Confidence 3567899999999999999999999999999999999999643 444555555444322211 11
Q ss_pred cHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 658 QENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 658 ~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
...++.++.+||.+||+.||++|||+.|+++
T Consensus 380 ~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 380 FSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 2334577899999999999999999999976
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-42 Score=364.06 Aligned_cols=262 Identities=30% Similarity=0.522 Sum_probs=215.6
Q ss_pred HhhhhhhhCcCCCCceeEEEEEEecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCce
Q 004979 425 CEDFSNIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFT 504 (721)
Q Consensus 425 ~~~~~~ii~~lg~G~~g~Vyk~~~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 504 (721)
+++| ++...+|+|+||+||+|+..++..||||++..... ...+.+.+|++++++++||||+++++++.+.+ .
T Consensus 38 ~~~y-~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~ 109 (321)
T 2qkw_B 38 TNNF-DHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESS-----QGIEEFETEIETLSFCRHPHLVSLIGFCDERN--E 109 (321)
T ss_dssp CCCC-SCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCS-----SHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT--C
T ss_pred Hhcc-CccceeecCCCeeEEEEEECCCCEEEEEEecccCh-----HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC--e
Confidence 3444 66788999999999999988899999998764322 23467999999999999999999999998776 5
Q ss_pred EEEEEecCCCCChhhhhhhcc--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCC
Q 004979 505 RMMVFEYSPNGSLFEHLHIQE--AEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWN 582 (721)
Q Consensus 505 ~~lV~Ey~~~GsL~~~l~~~~--~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~ 582 (721)
.++||||+++|+|.+++.... ...++|..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 187 (321)
T 2qkw_B 110 MILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA--IIHRDVKSINILLDENFVPKITDFGISK 187 (321)
T ss_dssp CEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCSTTEEECTTCCEEECCCTTCE
T ss_pred EEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC--eecCCCCHHHEEECCCCCEEEeeccccc
Confidence 699999999999999986433 235999999999999999999999988 9999999999999999999999999875
Q ss_pred CCC-----------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCC----CCHHHHHHHHhhcCCCCc
Q 004979 583 NTT-----------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIEN----GSLENWASEYLKGEQPLK 647 (721)
Q Consensus 583 ~~~-----------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~----~~~~~~~~~~~~~~~~~~ 647 (721)
... .++..|+|||.+.+..++.++|||||||++|||+||+.||.... ....+|...... ...+.
T Consensus 188 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~ 266 (321)
T 2qkw_B 188 KGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHN-NGQLE 266 (321)
T ss_dssp ECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHT-TTCCC
T ss_pred ccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccc-cccHH
Confidence 321 13457999999988899999999999999999999999996432 233444433322 23344
Q ss_pred cccCCccc-cccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcC
Q 004979 648 DIVDPTLK-SFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAME 697 (721)
Q Consensus 648 ~~~d~~l~-~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 697 (721)
..+++... ......+.++.+++.+||+.||++||++.|+++.|+.+.+..
T Consensus 267 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~ 317 (321)
T 2qkw_B 267 QIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ 317 (321)
T ss_dssp SSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred HhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhcc
Confidence 55555443 345778899999999999999999999999999999987754
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=361.96 Aligned_cols=273 Identities=29% Similarity=0.555 Sum_probs=220.7
Q ss_pred CCCCCHHHHHHHHhhhhhhhCcCCCCceeEEEEEEecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccce
Q 004979 413 VPKLKRSELEAACEDFSNIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVN 492 (721)
Q Consensus 413 ~~~~~~~~l~~~~~~~~~ii~~lg~G~~g~Vyk~~~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~ 492 (721)
...++..++....++| ++.+.+|+|+||+||+|+..++..||||++....... ....+.+|++++++++||||++
T Consensus 17 ~~~~~~~~~~~~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~ 91 (326)
T 3uim_A 17 LKRFSLRELQVASDNF-SNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQG----GELQFQTEVEMISMAVHRNLLR 91 (326)
T ss_dssp CEECCTHHHHTTTTSS-CSTTEEECCSSSEEEEECCSSSCCEEEEECCC---------CCCHHHHHHHGGGTCCCTTBCC
T ss_pred cceecHHHHHHHhhcc-ccceeEecCCCcEEEEEEecCCCEEEEEEeccccCch----HHHHHHHHHHHHHhccCCCccc
Confidence 4567778888777666 7788899999999999998889999999986543221 1236899999999999999999
Q ss_pred EeEEEecCCCceEEEEEecCCCCChhhhhhhcc--CCCCCHHHHHHHHHHHHHHHHHHhcC-CCCeEeeCCCCCCeEeCC
Q 004979 493 LIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQE--AEHLDWAMRLRIAMGMAYCLEHMHQL-TPPIAHRNLQSSSIYLTE 569 (721)
Q Consensus 493 l~g~~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~--~~~l~~~~~~~ia~~ia~gL~yLH~~-~~~IvHrDLKp~NILl~~ 569 (721)
+++++...+ ..++||||+++|+|.++++... ...++|..+..|+.|++.||+|||+. .++|+||||||+|||+++
T Consensus 92 ~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~ 169 (326)
T 3uim_A 92 LRGFCMTPT--ERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDE 169 (326)
T ss_dssp CCEEECCSS--CCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECT
T ss_pred eEEEEecCC--ceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECC
Confidence 999998876 5699999999999999997543 34599999999999999999999987 112999999999999999
Q ss_pred CCcEEEeccCCCCCCC----------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccC------CCCCHH
Q 004979 570 DYAAKISDFSFWNNTT----------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSI------ENGSLE 633 (721)
Q Consensus 570 ~~~~kL~DFGla~~~~----------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~------~~~~~~ 633 (721)
++.+||+|||+++... .++..|+|||.+.+..++.++|||||||++|||+||+.||.. ......
T Consensus 170 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~ 249 (326)
T 3uim_A 170 EFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL 249 (326)
T ss_dssp TCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHH
T ss_pred CCCEEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHH
Confidence 9999999999985321 245679999999888899999999999999999999999951 223344
Q ss_pred HHHHHHhhcCCCCccccCCccc-cccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 004979 634 NWASEYLKGEQPLKDIVDPTLK-SFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEI 693 (721)
Q Consensus 634 ~~~~~~~~~~~~~~~~~d~~l~-~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i 693 (721)
+|+...... .....+.+.... ......+.++.+++.+||+.||++|||+.||++.|++.
T Consensus 250 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 250 DWVKGLLKE-KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp HHHTTTTSS-CCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred HHHHHHhhc-hhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 554443332 233444444332 45677889999999999999999999999999999874
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=351.79 Aligned_cols=277 Identities=29% Similarity=0.506 Sum_probs=225.4
Q ss_pred CCCCCCHHHHHHHHhhhhh-----hhCcCCCCceeEEEEEEecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCC
Q 004979 412 GVPKLKRSELEAACEDFSN-----IIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVN 486 (721)
Q Consensus 412 ~~~~~~~~~l~~~~~~~~~-----ii~~lg~G~~g~Vyk~~~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~ 486 (721)
....++..++..++++|.. ....+|+|+||+||+|+. ++..|+||++...... ......+.+.+|++++++++
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~~~E~~~l~~l~ 88 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDI-TTEELKQQFDQEIKVMAKCQ 88 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTS-CTTTHHHHHHHHHHHHHHCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCc-chHHHHHHHHHHHHHHHhcC
Confidence 3457888999999998862 126789999999999987 5788999988643221 12334577999999999999
Q ss_pred CCccceEeEEEecCCCceEEEEEecCCCCChhhhhhhc-cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCe
Q 004979 487 HKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQ-EAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSI 565 (721)
Q Consensus 487 H~nIv~l~g~~~~~~~~~~~lV~Ey~~~GsL~~~l~~~-~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NI 565 (721)
||||+++++++.+.+ ..++||||+++|+|.+++... ....+++..+..|+.|++.||+|||+.+ |+||||||+||
T Consensus 89 h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp~Ni 164 (307)
T 2nru_A 89 HENLVELLGFSSDGD--DLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH--HIHRDIKSANI 164 (307)
T ss_dssp CTTBCCEEEEECSSS--SCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGE
T ss_pred CCCeEEEEEEEecCC--ceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecCCCCHHHE
Confidence 999999999998876 569999999999999998643 2456999999999999999999999988 99999999999
Q ss_pred EeCCCCcEEEeccCCCCCC-----------CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCC--CCH
Q 004979 566 YLTEDYAAKISDFSFWNNT-----------TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIEN--GSL 632 (721)
Q Consensus 566 Ll~~~~~~kL~DFGla~~~-----------~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~--~~~ 632 (721)
|+++++.+||+|||+++.. ..++..|+|||.+.+ .++.++|||||||++|||+||+.||.... ...
T Consensus 165 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~ 243 (307)
T 2nru_A 165 LLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLL 243 (307)
T ss_dssp EECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBT
T ss_pred EEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHH
Confidence 9999999999999987532 134567999998764 58899999999999999999999997433 223
Q ss_pred HHHHHHHhhcCCCCccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 004979 633 ENWASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITA 695 (721)
Q Consensus 633 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~ 695 (721)
..+..........+...+++.+.......+.++.+++.+||+.||++||++.||++.|+++.+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 244 LDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp THHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred HHHHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 344444433344445555666666677888999999999999999999999999999998764
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=355.91 Aligned_cols=252 Identities=26% Similarity=0.395 Sum_probs=201.6
Q ss_pred hhhCcCCCCceeEEEEEEecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVF 509 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV~ 509 (721)
++.+.+|+|+||+||+|+. ++..||||++..... .....+.|.+|++++++++||||+++++++.+.+ ..++||
T Consensus 40 ~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--~~~lv~ 113 (309)
T 3p86_A 40 NIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDF---HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPP--NLSIVT 113 (309)
T ss_dssp EEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCC---SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT--CCEEEE
T ss_pred eeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCC---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC--ceEEEE
Confidence 6778899999999999987 478899998865432 2334567999999999999999999999998776 569999
Q ss_pred ecCCCCChhhhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC----
Q 004979 510 EYSPNGSLFEHLHIQE-AEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT---- 584 (721)
Q Consensus 510 Ey~~~GsL~~~l~~~~-~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~---- 584 (721)
||+++|+|.+++.... ...+++..+..++.|++.||+|||+.+++|+||||||+|||++.++.+||+|||+++..
T Consensus 114 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~ 193 (309)
T 3p86_A 114 EYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTF 193 (309)
T ss_dssp ECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC---------
T ss_pred ecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCccccccc
Confidence 9999999999986432 12489999999999999999999998878999999999999999999999999987532
Q ss_pred -----CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccH
Q 004979 585 -----TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQE 659 (721)
Q Consensus 585 -----~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 659 (721)
..++..|+|||.+.+..++.++|||||||++|||+||+.||... +..+........... ...+.
T Consensus 194 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~--~~~~~~~~~~~~~~~---------~~~~~ 262 (309)
T 3p86_A 194 LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNL--NPAQVVAAVGFKCKR---------LEIPR 262 (309)
T ss_dssp --------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTS--CHHHHHHHHHHSCCC---------CCCCT
T ss_pred cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHhcCCC---------CCCCc
Confidence 23456799999999999999999999999999999999999633 233333322211111 11223
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCC
Q 004979 660 NVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAMEP 698 (721)
Q Consensus 660 ~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 698 (721)
.++.++.+++.+||+.||++||++.|+++.|+.+.+...
T Consensus 263 ~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~ 301 (309)
T 3p86_A 263 NLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAV 301 (309)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC---
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCC
Confidence 455678999999999999999999999999999877543
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-41 Score=363.08 Aligned_cols=250 Identities=23% Similarity=0.399 Sum_probs=203.3
Q ss_pred hhhhCcCCCCceeEEEEEEec--------CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcC-CCCccceEeEEEec
Q 004979 429 SNIIGSFSDGTVGTVYKGTLS--------SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKV-NHKNFVNLIGYCEE 499 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~--------~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~ 499 (721)
+++.+.||+|+||+||+|+.. ++..||||++.... .....+.+.+|+++|+++ +|||||+++++|.+
T Consensus 83 ~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 158 (370)
T 2psq_A 83 LTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA----TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158 (370)
T ss_dssp EEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC----BHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred CEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc----CHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence 367788999999999999852 34569999886432 233456799999999999 89999999999988
Q ss_pred CCCceEEEEEecCCCCChhhhhhhcc--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCe
Q 004979 500 DEPFTRMMVFEYSPNGSLFEHLHIQE--------------AEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSI 565 (721)
Q Consensus 500 ~~~~~~~lV~Ey~~~GsL~~~l~~~~--------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NI 565 (721)
.+ ..++||||+++|+|.+++.... ...+++..+..++.||+.||+|||+++ |+||||||+||
T Consensus 159 ~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NI 234 (370)
T 2psq_A 159 DG--PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNV 234 (370)
T ss_dssp SS--SCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGE
T ss_pred CC--CEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--eeccccchhhE
Confidence 76 5699999999999999997532 235899999999999999999999998 99999999999
Q ss_pred EeCCCCcEEEeccCCCCCCC-----------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHH
Q 004979 566 YLTEDYAAKISDFSFWNNTT-----------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLE 633 (721)
Q Consensus 566 Ll~~~~~~kL~DFGla~~~~-----------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~ 633 (721)
|++.++.+||+|||+++... .++..|+|||.+.+..++.++|||||||++|||+| |+.||.... ..
T Consensus 235 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~--~~ 312 (370)
T 2psq_A 235 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP--VE 312 (370)
T ss_dssp EECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC--GG
T ss_pred EECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCC--HH
Confidence 99999999999999986321 12346999999999999999999999999999999 999996432 22
Q ss_pred HHHHHHhhcCCCCccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCC
Q 004979 634 NWASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAMEP 698 (721)
Q Consensus 634 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 698 (721)
+.......+.. ...+..++.++.+++.+||+.||++||++.|+++.|+++.....
T Consensus 313 ~~~~~~~~~~~----------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~~ 367 (370)
T 2psq_A 313 ELFKLLKEGHR----------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 367 (370)
T ss_dssp GHHHHHHTTCC----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred HHHHHHhcCCC----------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence 33332222211 11223456789999999999999999999999999999876543
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=353.21 Aligned_cols=238 Identities=20% Similarity=0.265 Sum_probs=198.2
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
++++.+|+|+||+||+|+.. +++.||+|++....... ......+.+|++++++++||||+++++++.+.+ ..++|
T Consensus 8 ~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~--~~~lv 83 (337)
T 1o6l_A 8 DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIA--KDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD--RLCFV 83 (337)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH--TTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSS--EEEEE
T ss_pred EEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhh--hhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCC--EEEEE
Confidence 67788999999999999965 68899999986432111 223457889999999999999999999999877 77999
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC---
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT--- 585 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~--- 585 (721)
|||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 159 (337)
T 1o6l_A 84 MEYANGGELFFHLSR--ERVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp EECCTTCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred EeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCCHHHEEECCCCCEEEeeccchhhcccCC
Confidence 999999999999864 346899999999999999999999998 9999999999999999999999999986421
Q ss_pred ------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccH
Q 004979 586 ------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQE 659 (721)
Q Consensus 586 ------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 659 (721)
.++..|+|||.+.+..++.++|||||||++|||+||+.||... +..+....+...... ++.
T Consensus 160 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~--~~~~~~~~i~~~~~~-----------~p~ 226 (337)
T 1o6l_A 160 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ--DHERLFELILMEEIR-----------FPR 226 (337)
T ss_dssp CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHCCCC-----------CCT
T ss_pred CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCC--CHHHHHHHHHcCCCC-----------CCC
Confidence 2456799999999999999999999999999999999999643 344444444443222 223
Q ss_pred HHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 004979 660 NVLEELLVVIKNCVHPDPKQRP-----SMRGIAA 688 (721)
Q Consensus 660 ~~~~~l~~li~~Cl~~dP~~RP-----s~~evl~ 688 (721)
..+.++.+++.+||+.||++|| ++.||++
T Consensus 227 ~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 227 TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 3456789999999999999999 8999875
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=353.74 Aligned_cols=250 Identities=21% Similarity=0.326 Sum_probs=198.2
Q ss_pred hhhCcCCCCceeEEEEEEecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCC--CceEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDE--PFTRMM 507 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~--~~~~~l 507 (721)
++++.+|+|+||+||+|+.. ++.||||++.... .....+.+|+.++++++|||||++++++.... ....++
T Consensus 27 ~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~------~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l 99 (322)
T 3soc_A 27 QLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD------KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL 99 (322)
T ss_dssp EEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred hhhheecccCceEEEEEEEC-CCEEEEEEeecCc------hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence 67788999999999999876 7899999885432 22345667999999999999999999998754 224699
Q ss_pred EEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcC----------CCCeEeeCCCCCCeEeCCCCcEEEec
Q 004979 508 VFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQL----------TPPIAHRNLQSSSIYLTEDYAAKISD 577 (721)
Q Consensus 508 V~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~----------~~~IvHrDLKp~NILl~~~~~~kL~D 577 (721)
||||+++|+|.++++. ..++|..+..|+.|++.||+|||+. + |+||||||+|||++.++.+||+|
T Consensus 100 v~e~~~~g~L~~~l~~---~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~--ivH~Dlkp~Nill~~~~~~kL~D 174 (322)
T 3soc_A 100 ITAFHEKGSLSDFLKA---NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA--ISHRDIKSKNVLLKNNLTACIAD 174 (322)
T ss_dssp EEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE--EECSCCSGGGEEECTTCCEEECC
T ss_pred EEecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC--EEeCCCChHhEEECCCCeEEEcc
Confidence 9999999999999964 3489999999999999999999998 6 99999999999999999999999
Q ss_pred cCCCCCC-----------CCCCccccchhhccc-----CCCCCCccHHHHHHHHHHHHhCCCcccCCCC-----------
Q 004979 578 FSFWNNT-----------TAAKTGSAAMELLET-----SAVDLESNVYSFGTILFEMITGRISYSIENG----------- 630 (721)
Q Consensus 578 FGla~~~-----------~~~~~~~~apE~~~~-----~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~----------- 630 (721)
||+++.. ..++..|+|||.+.+ ..++.++|||||||++|||+||+.||.....
T Consensus 175 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~ 254 (322)
T 3soc_A 175 FGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIG 254 (322)
T ss_dssp CTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHC
T ss_pred CCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhc
Confidence 9998421 234567999999876 3556788999999999999999999964321
Q ss_pred ---CHHHHHHHHhhcCCCCccccCCcccc--ccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcC
Q 004979 631 ---SLENWASEYLKGEQPLKDIVDPTLKS--FQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAME 697 (721)
Q Consensus 631 ---~~~~~~~~~~~~~~~~~~~~d~~l~~--~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 697 (721)
....+........ ..+.+.. .....+.++.+|+.+||+.||++|||+.||++.|+++.+..
T Consensus 255 ~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~~ 320 (322)
T 3soc_A 255 QHPSLEDMQEVVVHKK------KRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRLT 320 (322)
T ss_dssp SSCCHHHHHHHHTTSC------CCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred cCCchhhhhhhhhccc------CCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 1222222221111 1111111 12345678999999999999999999999999999987653
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=360.74 Aligned_cols=271 Identities=24% Similarity=0.368 Sum_probs=208.0
Q ss_pred hhhhCcCCCCceeEEEEEEec--------CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcC-CCCccceEeEEEec
Q 004979 429 SNIIGSFSDGTVGTVYKGTLS--------SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKV-NHKNFVNLIGYCEE 499 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~--------~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~ 499 (721)
+.+.+.||+|+||+||+|+.. .+..||||++.... .....+.+.+|+++++++ +|||||++++++..
T Consensus 71 y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 71 LVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA----TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp EEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred eEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc----CHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 367788999999999999852 23568999876432 233456799999999999 99999999999988
Q ss_pred CCCceEEEEEecCCCCChhhhhhhcc--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCe
Q 004979 500 DEPFTRMMVFEYSPNGSLFEHLHIQE--------------AEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSI 565 (721)
Q Consensus 500 ~~~~~~~lV~Ey~~~GsL~~~l~~~~--------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NI 565 (721)
.+ ..++||||+++|+|.+++.... ...+++..+..|+.||+.||+|||+.+ |+||||||+||
T Consensus 147 ~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NI 222 (382)
T 3tt0_A 147 DG--PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNV 222 (382)
T ss_dssp SS--SCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGE
T ss_pred CC--ceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCcceE
Confidence 77 5699999999999999997543 245999999999999999999999998 99999999999
Q ss_pred EeCCCCcEEEeccCCCCCCCC-----------CCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHH
Q 004979 566 YLTEDYAAKISDFSFWNNTTA-----------AKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLE 633 (721)
Q Consensus 566 Ll~~~~~~kL~DFGla~~~~~-----------~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~ 633 (721)
|+++++.+||+|||+++.... ++..|+|||.+.+..++.++|||||||++|||+| |+.||... ...
T Consensus 223 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~--~~~ 300 (382)
T 3tt0_A 223 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV--PVE 300 (382)
T ss_dssp EECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC--CHH
T ss_pred EEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC--CHH
Confidence 999999999999999864321 2246899999999999999999999999999999 99999633 334
Q ss_pred HHHHHHhhcCCCCccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCChhHHHHH
Q 004979 634 NWASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAMEPDGATPKLSPLWWAEL 713 (721)
Q Consensus 634 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~~~~p~~~~~~~~~l 713 (721)
+.......+... ..+..++.++.+++.+||+.||++||++.||++.|+++.............+.+|.+.
T Consensus 301 ~~~~~~~~~~~~----------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~~~~~~~~~~~~ 370 (382)
T 3tt0_A 301 ELFKLLKEGHRM----------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEMGYYHHHHHHDY 370 (382)
T ss_dssp HHHHHHHTTCCC----------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC------------
T ss_pred HHHHHHHcCCCC----------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCCCCCCCccccccC
Confidence 444333332111 1122345678999999999999999999999999999999888777777777787777
Q ss_pred Hhhhcc
Q 004979 714 EILSSE 719 (721)
Q Consensus 714 ~~~~~~ 719 (721)
++.+.|
T Consensus 371 ~~~~~~ 376 (382)
T 3tt0_A 371 DIPTTE 376 (382)
T ss_dssp ------
T ss_pred CCCCCC
Confidence 766554
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=350.44 Aligned_cols=246 Identities=20% Similarity=0.280 Sum_probs=201.5
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
.+.+.+|+|+||+||+|+.. ++..||+|++... .....+.|.+|++++++++||||+++++++.+.+ ..++|
T Consensus 13 ~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~-----~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--~~~lv 85 (310)
T 3s95_A 13 IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF-----DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDK--RLNFI 85 (310)
T ss_dssp EEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC-----CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT--EEEEE
T ss_pred eccceecCCCCEEEEEEEECCCCcEEEEEEeccC-----CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCC--eeEEE
Confidence 56678999999999999965 6888999987432 2334578999999999999999999999999877 67999
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC----
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT---- 584 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~---- 584 (721)
|||+++|+|.+++.. ....+++..+..|+.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 86 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 162 (310)
T 3s95_A 86 TEYIKGGTLRGIIKS-MDSQYPWSQRVSFAKDIASGMAYLHSMN--IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK 162 (310)
T ss_dssp EECCTTCBHHHHHHH-CCTTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred EEecCCCcHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence 999999999999964 3456999999999999999999999998 999999999999999999999999987532
Q ss_pred -------------------CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHH---HHHHHHhhc
Q 004979 585 -------------------TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLE---NWASEYLKG 642 (721)
Q Consensus 585 -------------------~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~---~~~~~~~~~ 642 (721)
..++..|+|||.+.+..++.++|||||||++|||++|..||........ ........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~- 241 (310)
T 3s95_A 163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD- 241 (310)
T ss_dssp -----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHH-
T ss_pred ccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccc-
Confidence 2355679999999999999999999999999999999998853211100 00000000
Q ss_pred CCCCccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCC
Q 004979 643 EQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAMEP 698 (721)
Q Consensus 643 ~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 698 (721)
...+..++.++.+++.+||+.||++||++.|+++.|+++.....
T Consensus 242 ------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~ 285 (310)
T 3s95_A 242 ------------RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLA 285 (310)
T ss_dssp ------------HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred ------------ccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcc
Confidence 01123344678899999999999999999999999999887643
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=352.29 Aligned_cols=250 Identities=21% Similarity=0.317 Sum_probs=204.1
Q ss_pred hhhhCcCCCCceeEEEEEEec----CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCce
Q 004979 429 SNIIGSFSDGTVGTVYKGTLS----SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFT 504 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~----~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 504 (721)
+++.+.+|+|+||+||+|+.. .+..||||++.... .....+.|.+|++++++++||||+++++++.+.+ .
T Consensus 51 y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~ 124 (325)
T 3kul_A 51 IHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY----TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGR--L 124 (325)
T ss_dssp EEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC----CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGG--C
T ss_pred eEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC----CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC--c
Confidence 367788999999999999974 34469999886432 2334578999999999999999999999998766 5
Q ss_pred EEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC
Q 004979 505 RMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT 584 (721)
Q Consensus 505 ~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~ 584 (721)
.++||||+++|+|.++++. ....+++..+..|+.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 125 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 125 AMIVTEYMENGSLDTFLRT-HDGQFTIMQLVGMLRGVGAGMRYLSDLG--YVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201 (325)
T ss_dssp CEEEEECCTTCBHHHHHHT-TTTCSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred cEEEeeCCCCCcHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEECCCCCEEECCCCccccc
Confidence 6999999999999999863 3356999999999999999999999998 999999999999999999999999998643
Q ss_pred CC------------CCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhcCCCCccccC
Q 004979 585 TA------------AKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPLKDIVD 651 (721)
Q Consensus 585 ~~------------~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d 651 (721)
.. ++..|+|||.+.+..++.++|||||||++|||++ |+.||... ...+.......+...
T Consensus 202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~--~~~~~~~~~~~~~~~------ 273 (325)
T 3kul_A 202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNM--TNRDVISSVEEGYRL------ 273 (325)
T ss_dssp C----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTS--CHHHHHHHHHTTCCC------
T ss_pred ccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccC--CHHHHHHHHHcCCCC------
Confidence 21 1235999999998899999999999999999999 99999533 333333333322111
Q ss_pred CccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCCC
Q 004979 652 PTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAMEPD 699 (721)
Q Consensus 652 ~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~ 699 (721)
..+..++.++.+++.+||+.||++||++.||++.|+.+.+....
T Consensus 274 ----~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~ 317 (325)
T 3kul_A 274 ----PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPES 317 (325)
T ss_dssp ----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC-
T ss_pred ----CCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCccc
Confidence 11234557889999999999999999999999999998876543
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=341.65 Aligned_cols=251 Identities=22% Similarity=0.363 Sum_probs=204.2
Q ss_pred hhhCcCCCCceeEEEEEEecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVF 509 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV~ 509 (721)
++.+.+|+|+||+||+|+.. +..+|||++..... .....+.|.+|++++++++||||+++++++.+.+....++||
T Consensus 13 ~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 13 NFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDW---STRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp EEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTC---CHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHHHHhcCCCcceEEEEEEC-CeeEEEEEeccccc---CHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 67788999999999999986 78899998875432 233456799999999999999999999999876333679999
Q ss_pred ecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC----C
Q 004979 510 EYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT----T 585 (721)
Q Consensus 510 Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~----~ 585 (721)
||+++|+|.+++.......+++..+..|+.|++.||+|||+.+++|+||||||+|||+++++.+||+|||+.... .
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 168 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGR 168 (271)
T ss_dssp ECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSCTTC
T ss_pred cccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeecccCc
Confidence 999999999999765555699999999999999999999998888999999999999999999999988875432 2
Q ss_pred CCCccccchhhcccCCCCC---CccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccHHHH
Q 004979 586 AAKTGSAAMELLETSAVDL---ESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQENVL 662 (721)
Q Consensus 586 ~~~~~~~apE~~~~~~~s~---ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 662 (721)
.++..|+|||.+.+..++. ++|||||||++|||+||+.||... ...+........... ...+..++
T Consensus 169 ~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~--~~~~~~~~~~~~~~~---------~~~~~~~~ 237 (271)
T 3kmu_A 169 MYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADL--SNMEIGMKVALEGLR---------PTIPPGIS 237 (271)
T ss_dssp BSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTS--CHHHHHHHHHHSCCC---------CCCCTTCC
T ss_pred cCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCcccc--ChHHHHHHHHhcCCC---------CCCCCCCC
Confidence 3466899999987665544 799999999999999999999633 233333333322111 01223445
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 004979 663 EELLVVIKNCVHPDPKQRPSMRGIAAKLKEITA 695 (721)
Q Consensus 663 ~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~ 695 (721)
.++.+++.+||+.||++|||+.|+++.|+++.+
T Consensus 238 ~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 238 PHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 678999999999999999999999999998764
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-40 Score=349.42 Aligned_cols=239 Identities=21% Similarity=0.344 Sum_probs=200.6
Q ss_pred hhhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEE
Q 004979 429 SNIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMM 507 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~l 507 (721)
+++++.+|+|+||.||+|+. .+++.||||++..... .....+.+.+|+++|++++||||+++++++...+ ..++
T Consensus 17 y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~--~~~l 91 (328)
T 3fe3_A 17 YRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL---NPTSLQKLFREVRIMKILNHPNIVKLFEVIETEK--TLYL 91 (328)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS--EEEE
T ss_pred EEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC--EEEE
Confidence 46788999999999999996 5789999999865432 2334567899999999999999999999998876 6799
Q ss_pred EEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC---
Q 004979 508 VFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT--- 584 (721)
Q Consensus 508 V~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~--- 584 (721)
||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 92 v~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 167 (328)
T 3fe3_A 92 IMEYASGGEVFDYLVAH--GRMKEKEARSKFRQIVSAVQYCHQKR--IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG 167 (328)
T ss_dssp EECCCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred EEECCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence 99999999999998643 46899999999999999999999998 999999999999999999999999998632
Q ss_pred -----CCCCccccchhhcccCCCC-CCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCcccccc
Q 004979 585 -----TAAKTGSAAMELLETSAVD-LESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQ 658 (721)
Q Consensus 585 -----~~~~~~~~apE~~~~~~~s-~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 658 (721)
..++..|+|||.+.+..++ .++||||+||++|||+||+.||.. .+..+....+..+.....
T Consensus 168 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~--~~~~~~~~~i~~~~~~~p----------- 234 (328)
T 3fe3_A 168 GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG--QNLKELRERVLRGKYRIP----------- 234 (328)
T ss_dssp CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCC--SSHHHHHHHHHHCCCCCC-----------
T ss_pred CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCC--CCHHHHHHHHHhCCCCCC-----------
Confidence 2356679999999888775 789999999999999999999963 344555555554433221
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004979 659 ENVLEELLVVIKNCVHPDPKQRPSMRGIAAK 689 (721)
Q Consensus 659 ~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 689 (721)
...+.++.+++.+||+.||++|||+.|+++.
T Consensus 235 ~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 235 FYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp TTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred CCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 2244678899999999999999999999863
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=369.48 Aligned_cols=246 Identities=22% Similarity=0.366 Sum_probs=204.5
Q ss_pred hhhCcCCCCceeEEEEEEecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVF 509 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV~ 509 (721)
++.+.+|+|+||+||+|++.++..||||++..... ..+.|.+|+++|++++|||||++++++.. + ..++||
T Consensus 191 ~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~------~~~~~~~E~~~l~~l~h~~iv~l~~~~~~-~--~~~lv~ 261 (454)
T 1qcf_A 191 KLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM------SVEAFLAEANVMKTLQHDKLVKLHAVVTK-E--PIYIIT 261 (454)
T ss_dssp EEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSB------CHHHHHHHHHHHTTCCCTTBCCEEEEECS-S--SCEEEE
T ss_pred EEEEEcccCCceEEEEEEECCccEEEEEEecCCCc------cHHHHHHHHHHHhhCCCCCEeeEEEEEeC-C--ccEEEE
Confidence 66788999999999999998888999999864321 24679999999999999999999999873 3 468999
Q ss_pred ecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCCC---
Q 004979 510 EYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTA--- 586 (721)
Q Consensus 510 Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~~--- 586 (721)
||+++|+|.++++......+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 262 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~ 339 (454)
T 1qcf_A 262 EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 339 (454)
T ss_dssp CCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHH
T ss_pred eecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCce
Confidence 9999999999997544456899999999999999999999998 99999999999999999999999999864321
Q ss_pred -------CCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhcCCCCccccCCcccccc
Q 004979 587 -------AKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQ 658 (721)
Q Consensus 587 -------~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 658 (721)
.+..|+|||.+....++.++|||||||++|||+| |+.||... ...+....+..+.. . ..+
T Consensus 340 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~--~~~~~~~~i~~~~~-~---------~~~ 407 (454)
T 1qcf_A 340 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM--SNPEVIRALERGYR-M---------PRP 407 (454)
T ss_dssp HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC--CHHHHHHHHHHTCC-C---------CCC
T ss_pred eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCC--CHHHHHHHHHcCCC-C---------CCC
Confidence 2346999999998999999999999999999999 99999633 33333333333211 1 112
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCC
Q 004979 659 ENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAMEP 698 (721)
Q Consensus 659 ~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 698 (721)
..++.++.++|.+||+.||++|||+.+|++.|+++.....
T Consensus 408 ~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~~ 447 (454)
T 1qcf_A 408 ENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATE 447 (454)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSSC
T ss_pred CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhccc
Confidence 3456789999999999999999999999999999876543
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=345.80 Aligned_cols=253 Identities=20% Similarity=0.267 Sum_probs=205.1
Q ss_pred CCCCHHHHHHHHhh---------hhhhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHh
Q 004979 414 PKLKRSELEAACED---------FSNIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLS 483 (721)
Q Consensus 414 ~~~~~~~l~~~~~~---------~~~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~ 483 (721)
+.++.+++..+++. +++....+|+|+||.||+|+.. +|+.||||++...... ..+.+.+|+.+++
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~-----~~~~~~~E~~~l~ 97 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQ-----RRELLFNEVVIMR 97 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-----SHHHHHHHHHHHT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchh-----HHHHHHHHHHHHH
Confidence 56778888887764 2344567899999999999976 7899999998654322 2356889999999
Q ss_pred cCCCCccceEeEEEecCCCceEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCC
Q 004979 484 KVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSS 563 (721)
Q Consensus 484 ~l~H~nIv~l~g~~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~ 563 (721)
+++||||+++++++...+ ..++||||+++|+|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+
T Consensus 98 ~l~h~niv~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~---~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~ 170 (321)
T 2c30_A 98 DYQHFNVVEMYKSYLVGE--ELWVLMEFLQGGALTDIVSQ---VRLNEEQIATVCEAVLQALAYLHAQG--VIHRDIKSD 170 (321)
T ss_dssp TCCCTTBCCEEEEEEETT--EEEEEECCCCSCBHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGG
T ss_pred hCCCCCcceEEEEEEECC--EEEEEEecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHH
Confidence 999999999999998877 67999999999999999852 46999999999999999999999988 999999999
Q ss_pred CeEeCCCCcEEEeccCCCCCC---------CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHH
Q 004979 564 SIYLTEDYAAKISDFSFWNNT---------TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLEN 634 (721)
Q Consensus 564 NILl~~~~~~kL~DFGla~~~---------~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~ 634 (721)
|||++.++.+||+|||+++.. ..++..|+|||.+.+..++.++|||||||++|||+||+.||... ...+
T Consensus 171 NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~--~~~~ 248 (321)
T 2c30_A 171 SILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSD--SPVQ 248 (321)
T ss_dssp GEEECTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS--CHHH
T ss_pred HEEECCCCcEEEeeeeeeeecccCccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC--CHHH
Confidence 999999999999999987532 23456799999999999999999999999999999999999643 3333
Q ss_pred HHHHHhhcCCCCccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 635 WASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 635 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
..........+. . ......+.++.+++.+||+.||++||++.|+++
T Consensus 249 ~~~~~~~~~~~~-------~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 249 AMKRLRDSPPPK-------L-KNSHKVSPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp HHHHHHHSSCCC-------C-TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHhcCCCCC-------c-CccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 333333221111 0 112234567899999999999999999999986
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=338.30 Aligned_cols=244 Identities=20% Similarity=0.356 Sum_probs=203.4
Q ss_pred hhhCcCCCCceeEEEEEEecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVF 509 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV~ 509 (721)
++++.+|+|+||+||+|+..++..||+|++...... .+++.+|++++++++||||+++++++.+.+ ..++||
T Consensus 13 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~ 84 (269)
T 4hcu_A 13 TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS------EEDFIEEAEVMMKLSHPKLVQLYGVCLEQA--PICLVF 84 (269)
T ss_dssp EEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBC------HHHHHHHHHHHHTCCCTTBCCEEEEECSSS--SEEEEE
T ss_pred eeeheecCCCccEEEEEEecCCCeEEEEEecccccC------HHHHHHHHHHHHhCCCCCEeeEEEEEecCC--ceEEEE
Confidence 677889999999999999988889999988643321 256899999999999999999999998876 579999
Q ss_pred ecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC----
Q 004979 510 EYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT---- 585 (721)
Q Consensus 510 Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~---- 585 (721)
||+++|+|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 85 e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 161 (269)
T 4hcu_A 85 EFMEHGCLSDYLRT-QRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 161 (269)
T ss_dssp ECCTTCBHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred EeCCCCcHHHHHHh-cCcccCHHHHHHHHHHHHHHHHHHHhCC--eecCCcchheEEEcCCCCEEecccccccccccccc
Confidence 99999999999864 3456899999999999999999999998 9999999999999999999999999876332
Q ss_pred ------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhcCCCCccccCCcccccc
Q 004979 586 ------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQ 658 (721)
Q Consensus 586 ------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 658 (721)
.++..|+|||.+....++.++||||+||++|||+| |+.||... ...+.......+.... .+
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~--~~~~~~~~~~~~~~~~----------~~ 229 (269)
T 4hcu_A 162 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR--SNSEVVEDISTGFRLY----------KP 229 (269)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC--CHHHHHHHHHTTCCCC----------CC
T ss_pred ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCC--CHHHHHHHHhcCccCC----------CC
Confidence 12346999999998999999999999999999999 99999633 3334444433321111 11
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 004979 659 ENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAM 696 (721)
Q Consensus 659 ~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~ 696 (721)
...+.++.+++.+||+.||++||++.|+++.|+++.+.
T Consensus 230 ~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 230 RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 22356788999999999999999999999999998764
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=363.28 Aligned_cols=246 Identities=25% Similarity=0.372 Sum_probs=202.2
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
.+.+.+|+|+||+||+|++. ++..||||++.... .....+.|.+|+++|++++|||||++++++...+ ..++|
T Consensus 117 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~--~~~lv 190 (377)
T 3cbl_A 117 VLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL----PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQ--PIYIV 190 (377)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS----CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSS--SCEEE
T ss_pred EEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC----CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCC--CcEEE
Confidence 56788999999999999976 78899999876432 2234467899999999999999999999998776 56999
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCCC--
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTA-- 586 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~~-- 586 (721)
|||+++|+|.++++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 191 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~ 267 (377)
T 3cbl_A 191 MELVQGGDFLTFLRTE-GARLRVKTLLQMVGDAAAGMEYLESKC--CIHRDLAARNCLVTEKNVLKISDFGMSREEADGV 267 (377)
T ss_dssp EECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCGGGCEECTTSE
T ss_pred EEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC--cCCcccCHHHEEEcCCCcEEECcCCCceecCCCc
Confidence 9999999999999643 345899999999999999999999998 99999999999999999999999999864321
Q ss_pred ---------CCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhcCCCCccccCCcccc
Q 004979 587 ---------AKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKS 656 (721)
Q Consensus 587 ---------~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 656 (721)
.+..|+|||.+....++.++|||||||++|||+| |+.||.... ..+.......+. .. .
T Consensus 268 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~--~~~~~~~~~~~~-~~---------~ 335 (377)
T 3cbl_A 268 YAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLS--NQQTREFVEKGG-RL---------P 335 (377)
T ss_dssp EECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSC--HHHHHHHHHTTC-CC---------C
T ss_pred eeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHHHcCC-CC---------C
Confidence 1235999999998899999999999999999999 999996432 222222222221 11 1
Q ss_pred ccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 004979 657 FQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAM 696 (721)
Q Consensus 657 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~ 696 (721)
.+..++.++.++|.+||+.||++|||+.||++.|+++.+.
T Consensus 336 ~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 336 CPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 2234557789999999999999999999999999998764
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=367.62 Aligned_cols=244 Identities=24% Similarity=0.407 Sum_probs=203.4
Q ss_pred hhhCcCCCCceeEEEEEEecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVF 509 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV~ 509 (721)
++++.+|+|+||+||+|++. +..||||+++... ..+.|.+|+++|++++|||||++++++.+.+. ..++||
T Consensus 196 ~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~iv~ 266 (450)
T 1k9a_A 196 KLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-------TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG-GLYIVT 266 (450)
T ss_dssp EEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT-------TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTS-CEEEEE
T ss_pred EEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch-------HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCC-ceEEEE
Confidence 66788999999999999986 6799999886432 23579999999999999999999999876542 469999
Q ss_pred ecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC----
Q 004979 510 EYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT---- 585 (721)
Q Consensus 510 Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~---- 585 (721)
||+++|+|.++++......+++..++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++...
T Consensus 267 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 344 (450)
T 1k9a_A 267 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD 344 (450)
T ss_dssp ECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTSCEEECCCTTCEECC----
T ss_pred EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhhEEECCCCCEEEeeCCCccccccccc
Confidence 9999999999998655556899999999999999999999998 9999999999999999999999999986332
Q ss_pred --CCCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccHHHH
Q 004979 586 --AAKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQENVL 662 (721)
Q Consensus 586 --~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 662 (721)
..+..|+|||.+....++.++|||||||++|||+| |+.||..... .+....+..+.. ...+..++
T Consensus 345 ~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~--~~~~~~i~~~~~----------~~~p~~~~ 412 (450)
T 1k9a_A 345 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--KDVVPRVEKGYK----------MDAPDGCP 412 (450)
T ss_dssp --CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCT--TTHHHHHHTTCC----------CCCCTTCC
T ss_pred CCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHcCCC----------CCCCCcCC
Confidence 23457999999999999999999999999999999 9999964332 222222222211 11234456
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 004979 663 EELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAM 696 (721)
Q Consensus 663 ~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~ 696 (721)
.++.++|.+||+.||++|||+.|+++.|+++...
T Consensus 413 ~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 413 PAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 7899999999999999999999999999998764
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=356.45 Aligned_cols=238 Identities=19% Similarity=0.260 Sum_probs=197.6
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcC-CCCccceEeEEEecCCCceEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKV-NHKNFVNLIGYCEEDEPFTRMM 507 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~~~l 507 (721)
++++.||+|+||+||+|+.. +++.||+|++...... .....+.+.+|.+++..+ +|||||++++++.+.+ ..|+
T Consensus 26 ~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~--~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~--~~~l 101 (353)
T 3txo_A 26 EFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVIL--QDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPD--RLFF 101 (353)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHH--HHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS--EEEE
T ss_pred EEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhc--chhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCC--EEEE
Confidence 77889999999999999965 6889999998653221 122345688999999988 7999999999998877 7899
Q ss_pred EEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC---
Q 004979 508 VFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT--- 584 (721)
Q Consensus 508 V~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~--- 584 (721)
||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 102 v~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~ 177 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKS--RRFDEARARFYAAEIISALMFLHDKG--IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN 177 (353)
T ss_dssp EEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-
T ss_pred EEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCCHHHEEECCCCCEEEccccceeecccC
Confidence 99999999999998643 56999999999999999999999998 999999999999999999999999998642
Q ss_pred ------CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCcccccc
Q 004979 585 ------TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQ 658 (721)
Q Consensus 585 ------~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 658 (721)
..++..|+|||.+.+..++.++|||||||++|||+||+.||... +..+....+..+...+ +
T Consensus 178 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~--~~~~~~~~i~~~~~~~-----------p 244 (353)
T 3txo_A 178 GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAE--NEDDLFEAILNDEVVY-----------P 244 (353)
T ss_dssp --------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHCCCCC-----------C
T ss_pred CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCC--CHHHHHHHHHcCCCCC-----------C
Confidence 23566899999999889999999999999999999999999643 4445555555543222 2
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCH------HHHHH
Q 004979 659 ENVLEELLVVIKNCVHPDPKQRPSM------RGIAA 688 (721)
Q Consensus 659 ~~~~~~l~~li~~Cl~~dP~~RPs~------~evl~ 688 (721)
...+.++.+++.+||+.||++||++ .|+++
T Consensus 245 ~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 245 TWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred CCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 2344678899999999999999998 66654
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=343.80 Aligned_cols=238 Identities=21% Similarity=0.297 Sum_probs=196.3
Q ss_pred hhhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEE
Q 004979 429 SNIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMM 507 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~l 507 (721)
+++++.+|+|+||+||+|+. .+++.||||++....... .+.+.+|+.++++++||||+++++++...+ ..++
T Consensus 22 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--~~~l 94 (297)
T 3fxz_A 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK-----KELIINEILVMRENKNPNIVNYLDSYLVGD--ELWV 94 (297)
T ss_dssp BCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC-----HHHHHHHHHHHHHCCCTTBCCEEEEEEETT--EEEE
T ss_pred eeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH-----HHHHHHHHHHHhcCCCCCCCeEeEEEEECC--EEEE
Confidence 46778899999999999985 578899999886543222 356889999999999999999999998877 6799
Q ss_pred EEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC---
Q 004979 508 VFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT--- 584 (721)
Q Consensus 508 V~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~--- 584 (721)
||||+++|+|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 95 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 169 (297)
T 3fxz_A 95 VMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (297)
T ss_dssp EEECCTTCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EEECCCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEECCCCCEEEeeCCCceecCCc
Confidence 9999999999999864 35899999999999999999999998 999999999999999999999999987532
Q ss_pred ------CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCcccccc
Q 004979 585 ------TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQ 658 (721)
Q Consensus 585 ------~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 658 (721)
..++..|+|||.+.+..++.++|||||||++|||+||+.||.... .............+. . ..+
T Consensus 170 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~--~~~~~~~~~~~~~~~--~------~~~ 239 (297)
T 3fxz_A 170 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN--PLRALYLIATNGTPE--L------QNP 239 (297)
T ss_dssp TCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--HHHHHHHHHHHCSCC--C------SCG
T ss_pred ccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhCCCCC--C------CCc
Confidence 234567999999999999999999999999999999999996432 222222222221110 0 122
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 659 ENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 659 ~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
...+.++.+++.+||+.||++|||+.|+++
T Consensus 240 ~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 240 EKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 345677899999999999999999999976
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=349.24 Aligned_cols=252 Identities=23% Similarity=0.340 Sum_probs=199.9
Q ss_pred hhhhCcCCCCceeEEEEEEe-----cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCc
Q 004979 429 SNIIGSFSDGTVGTVYKGTL-----SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPF 503 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~-----~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 503 (721)
+++++.+|+|+||+||+|++ .++..||||++.... ....+.|.+|++++++++||||+++++++...+..
T Consensus 12 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (295)
T 3ugc_A 12 LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-----EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 86 (295)
T ss_dssp EEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC-----HHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHT
T ss_pred hhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC-----HHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 47888999999999999985 367889999886432 23356799999999999999999999998754332
Q ss_pred eEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCC
Q 004979 504 TRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNN 583 (721)
Q Consensus 504 ~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~ 583 (721)
..++||||+++|+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~ 163 (295)
T 3ugc_A 87 NLKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLTKV 163 (295)
T ss_dssp SCEEEEECCTTCBHHHHHHHC-GGGCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred ceEEEEEeCCCCCHHHHHHhc-ccccCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHhhEEEcCCCeEEEccCccccc
Confidence 569999999999999999643 345899999999999999999999988 99999999999999999999999999864
Q ss_pred CCC------------CCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHH-------------HHHH
Q 004979 584 TTA------------AKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLEN-------------WASE 638 (721)
Q Consensus 584 ~~~------------~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~-------------~~~~ 638 (721)
... ++..|+|||.+.+..++.++|||||||++|||+||..|+......... ....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (295)
T 3ugc_A 164 LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 243 (295)
T ss_dssp ------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred ccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHH
Confidence 321 223489999999999999999999999999999999988522110000 0111
Q ss_pred HhhcCCCCccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcC
Q 004979 639 YLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAME 697 (721)
Q Consensus 639 ~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 697 (721)
.... ......+..++.++.+++.+||+.||++|||+.|+++.|+++.+..
T Consensus 244 ~~~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 244 LLKN---------NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp HHHT---------TCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred HHhc---------cCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 1111 0111223455678999999999999999999999999999987654
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=360.98 Aligned_cols=275 Identities=12% Similarity=0.146 Sum_probs=203.9
Q ss_pred hhhhCcCCCCceeEEEEEEecC------CcEEEEEEeeeccccchh------hHHHHHHHHHHHHHhcCCCCccceEeEE
Q 004979 429 SNIIGSFSDGTVGTVYKGTLSS------GVEIAVTSTSVKSRADWS------KNLESQFRKKIDTLSKVNHKNFVNLIGY 496 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~~------~~~vavk~~~~~~~~~~~------~~~~~~f~~Ei~~l~~l~H~nIv~l~g~ 496 (721)
+++.+.||+|+||+||+|++.. ++.||||++......... ......+.+|+..+..++||||++++++
T Consensus 37 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~ 116 (364)
T 3op5_A 37 WKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGS 116 (364)
T ss_dssp EEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEEE
T ss_pred EEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEee
Confidence 4678899999999999998764 367999987644321100 0011235567778889999999999999
Q ss_pred EecCC--CceEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeC--CCCc
Q 004979 497 CEEDE--PFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLT--EDYA 572 (721)
Q Consensus 497 ~~~~~--~~~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~--~~~~ 572 (721)
+.... ....++||||+ +|+|.+++.. ....+++..++.|+.||+.||+|||+.+ |+||||||+|||++ .++.
T Consensus 117 ~~~~~~~~~~~~lv~e~~-g~~L~~~~~~-~~~~l~~~~~~~i~~qi~~~l~~lH~~~--iiHrDlkp~Nill~~~~~~~ 192 (364)
T 3op5_A 117 GLHDKNGKSYRFMIMDRF-GSDLQKIYEA-NAKRFSRKTVLQLSLRILDILEYIHEHE--YVHGDIKASNLLLNYKNPDQ 192 (364)
T ss_dssp EEEEETTEEEEEEEEECE-EEEHHHHHHH-TTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEESSCTTC
T ss_pred eeeccCCcceEEEEEeCC-CCCHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCC--eEEecCCHHHEEEecCCCCe
Confidence 87642 13579999999 9999999864 3457999999999999999999999998 99999999999999 8899
Q ss_pred EEEeccCCCCCC----------------CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHH-
Q 004979 573 AKISDFSFWNNT----------------TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENW- 635 (721)
Q Consensus 573 ~kL~DFGla~~~----------------~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~- 635 (721)
+||+|||+++.. ..++..|+|||.+.+..++.++|||||||++|||+||+.||.....+....
T Consensus 193 ~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~ 272 (364)
T 3op5_A 193 VYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVR 272 (364)
T ss_dssp EEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHH
T ss_pred EEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHHHH
Confidence 999999998422 115668999999999999999999999999999999999997433322111
Q ss_pred -HHHHhhcCCCCccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCChhHHHHHH
Q 004979 636 -ASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAMEPDGATPKLSPLWWAELE 714 (721)
Q Consensus 636 -~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~~~~p~~~~~~~~~l~ 714 (721)
...... ..+..++++.+. ...++.++.+++..||+.||++||++.+|++.|+++...... +...+++|+..+
T Consensus 273 ~~~~~~~--~~~~~~~~~~~~--~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~---~~~~~~dw~~~~ 345 (364)
T 3op5_A 273 DSKIRYR--ENIASLMDKCFP--AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGS---KDDGKLDLSVVE 345 (364)
T ss_dssp HHHHHHH--HCHHHHHHHHSC--TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTC---CCCCCCCC----
T ss_pred HHHHHhh--hhHHHHHHHhcc--cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCC---CcCCccceEecc
Confidence 111111 111111111110 023357899999999999999999999999999998876543 234566666443
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=355.98 Aligned_cols=253 Identities=18% Similarity=0.292 Sum_probs=202.3
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcC-CCCccceEeEEEecCCCceEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKV-NHKNFVNLIGYCEEDEPFTRMM 507 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~~~l 507 (721)
++++.||+|+||+||+|+.. +++.+|+|++....... ....+.+.+|..++.++ +|||||++++++.+.+ ..++
T Consensus 55 ~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~--~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~--~~~l 130 (396)
T 4dc2_A 55 DLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVND--DEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES--RLFF 130 (396)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC------CCHHHHHHHHHHHHTTCTTBCCEEEEEECSS--EEEE
T ss_pred EEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccC--HHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECC--EEEE
Confidence 67889999999999999965 57789999987543221 22234578899999887 8999999999998877 7899
Q ss_pred EEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC---
Q 004979 508 VFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT--- 584 (721)
Q Consensus 508 V~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~--- 584 (721)
||||+++|+|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 131 V~E~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl~~~g~ikL~DFGla~~~~~~ 206 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQR--QRKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 206 (396)
T ss_dssp EEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEEcCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEECCCCCEEEeecceeeecccC
Confidence 9999999999999864 346999999999999999999999998 999999999999999999999999998642
Q ss_pred ------CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCC------CHHH-HHHHHhhcCCCCccccC
Q 004979 585 ------TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENG------SLEN-WASEYLKGEQPLKDIVD 651 (721)
Q Consensus 585 ------~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~------~~~~-~~~~~~~~~~~~~~~~d 651 (721)
..++..|+|||.+.+..++.++|||||||++|||+||+.||..... ...+ ....+......
T Consensus 207 ~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~------ 280 (396)
T 4dc2_A 207 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR------ 280 (396)
T ss_dssp TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCC------
T ss_pred CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccC------
Confidence 2345679999999999999999999999999999999999963221 1112 22222222211
Q ss_pred CccccccHHHHHHHHHHHHHcccCCCCCCCCH------HHHHHHHHHhhhcCCCCCCCCCChhHHHHHH
Q 004979 652 PTLKSFQENVLEELLVVIKNCVHPDPKQRPSM------RGIAAKLKEITAMEPDGATPKLSPLWWAELE 714 (721)
Q Consensus 652 ~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~------~evl~~L~~i~~~~~~~~~p~~~~~~~~~l~ 714 (721)
++...+.++.+|+.+||+.||++||++ .||++ +|++..++|+.++
T Consensus 281 -----~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~-------------Hpff~~i~w~~l~ 331 (396)
T 4dc2_A 281 -----IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG-------------HPFFRNVDWDMME 331 (396)
T ss_dssp -----CCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHH-------------STTTTTCCHHHHH
T ss_pred -----CCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhc-------------CccccCCCHHHHH
Confidence 223445678999999999999999986 45543 6777777777765
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=342.62 Aligned_cols=254 Identities=20% Similarity=0.345 Sum_probs=206.5
Q ss_pred hhhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEE
Q 004979 429 SNIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMM 507 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~l 507 (721)
+++++.+|+|+||+||+|+.. ++..||+|++....... ....+.|.+|++++++++||||+++++++.+.+ ..++
T Consensus 13 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~--~~~l 88 (294)
T 4eqm_A 13 YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREK--EETLKRFEREVHNSSQLSHQNIVSMIDVDEEDD--CYYL 88 (294)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCC--HHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSS--EEEE
T ss_pred EEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCcccc--HHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCC--eEEE
Confidence 477889999999999999954 68899999886543322 344578999999999999999999999998876 6799
Q ss_pred EEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC--
Q 004979 508 VFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT-- 585 (721)
Q Consensus 508 V~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~-- 585 (721)
||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 89 v~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 164 (294)
T 4eqm_A 89 VMEYIEGPTLSEYIESH--GPLSVDTAINFTNQILDGIKHAHDMR--IVHRDIKPQNILIDSNKTLKIFDFGIAKALSET 164 (294)
T ss_dssp EEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCSSSTTC---
T ss_pred EEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEEeCCCccccccc
Confidence 99999999999998643 46899999999999999999999998 9999999999999999999999999986432
Q ss_pred --------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccc
Q 004979 586 --------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSF 657 (721)
Q Consensus 586 --------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 657 (721)
.++..|+|||.+.+..++.++|||||||++|||+||+.||.... .............+ ......
T Consensus 165 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~--~~~~~~~~~~~~~~------~~~~~~ 236 (294)
T 4eqm_A 165 SLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGET--AVSIAIKHIQDSVP------NVTTDV 236 (294)
T ss_dssp ----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSC--HHHHHHHHHSSCCC------CHHHHS
T ss_pred cccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHhhccCC------Ccchhc
Confidence 24567999999999999999999999999999999999996432 22322233222111 111122
Q ss_pred cHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHHHHhhhcCC
Q 004979 658 QENVLEELLVVIKNCVHPDPKQRP-SMRGIAAKLKEITAMEP 698 (721)
Q Consensus 658 ~~~~~~~l~~li~~Cl~~dP~~RP-s~~evl~~L~~i~~~~~ 698 (721)
...++..+.+++.+||+.||++|| +++++.+.|+.+.....
T Consensus 237 ~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~ 278 (294)
T 4eqm_A 237 RKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENR 278 (294)
T ss_dssp CTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSS
T ss_pred ccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhcc
Confidence 334567889999999999999998 99999999998766543
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=351.50 Aligned_cols=259 Identities=18% Similarity=0.261 Sum_probs=208.7
Q ss_pred hhhhhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccch-hhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCce
Q 004979 427 DFSNIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADW-SKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFT 504 (721)
Q Consensus 427 ~~~~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 504 (721)
+.+++.+.+|+|+||+||+|+.. ++..+|+|++........ .....+.+.+|+++|++++||||+++++++.+.+ .
T Consensus 12 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~--~ 89 (361)
T 2yab_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRT--D 89 (361)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS--E
T ss_pred hceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCC--E
Confidence 44578889999999999999965 688999999876543211 1112467899999999999999999999998876 6
Q ss_pred EEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCC----cEEEeccCC
Q 004979 505 RMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDY----AAKISDFSF 580 (721)
Q Consensus 505 ~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~----~~kL~DFGl 580 (721)
.++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++ .+||+|||+
T Consensus 90 ~~lv~e~~~gg~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~~~~vkl~DFG~ 165 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (361)
T ss_dssp EEEEEECCCSCBHHHHHTT--CSCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCTTSSSCCEEECCCSS
T ss_pred EEEEEEcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEeCCCCCccCEEEEecCC
Confidence 7999999999999999853 456999999999999999999999998 99999999999998877 799999999
Q ss_pred CCCC--------CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCC
Q 004979 581 WNNT--------TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDP 652 (721)
Q Consensus 581 a~~~--------~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 652 (721)
++.. ..++..|+|||.+....++.++|||||||++|||++|+.||... +..+....+.........
T Consensus 166 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~--~~~~~~~~i~~~~~~~~~---- 239 (361)
T 2yab_A 166 AHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD--TKQETLANITAVSYDFDE---- 239 (361)
T ss_dssp CEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS--SHHHHHHHHHTTCCCCCH----
T ss_pred ceEcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHhcCCCCCc----
Confidence 7532 23566799999999999999999999999999999999999643 334444444433221110
Q ss_pred ccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCChhHHHHH
Q 004979 653 TLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAMEPDGATPKLSPLWWAEL 713 (721)
Q Consensus 653 ~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~~~~p~~~~~~~~~l 713 (721)
......+.++.+|+.+||..||++|||+.|+++ +|++.+..|...
T Consensus 240 ---~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~-------------hp~~~~~~~~~~ 284 (361)
T 2yab_A 240 ---EFFSQTSELAKDFIRKLLVKETRKRLTIQEALR-------------HPWITPVDTQQA 284 (361)
T ss_dssp ---HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT-------------STTTSCSSHHHH
T ss_pred ---hhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc-------------CcCcCCCchhhh
Confidence 111234567899999999999999999999875 566666666554
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=345.00 Aligned_cols=238 Identities=20% Similarity=0.271 Sum_probs=198.5
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
++++.+|+|+||+||+|+.. +++.+|+|++....... ....+.+.+|+.+++.++||||+++++++.+.+ ..++|
T Consensus 9 ~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~--~~~lv 84 (318)
T 1fot_A 9 QILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVR--LKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQ--QIFMI 84 (318)
T ss_dssp EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH--TTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSS--EEEEE
T ss_pred EEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh--hhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCC--EEEEE
Confidence 67888999999999999965 68899999986432211 122456889999999999999999999998876 67999
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC----
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT---- 584 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~---- 584 (721)
|||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 85 ~e~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~~ 160 (318)
T 1fot_A 85 MDYIEGGELFSLLRK--SQRFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT 160 (318)
T ss_dssp ECCCCSCBHHHHHHH--TSSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTSCEEECCCSSCEECSSCB
T ss_pred EeCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChheEEEcCCCCEEEeecCcceecCCcc
Confidence 999999999999864 356899999999999999999999998 999999999999999999999999998633
Q ss_pred --CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccHHHH
Q 004979 585 --TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQENVL 662 (721)
Q Consensus 585 --~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 662 (721)
..++..|+|||.+.+..++.++|||||||++|||++|+.||... +..+....+...... ++...+
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~--~~~~~~~~i~~~~~~-----------~p~~~~ 227 (318)
T 1fot_A 161 YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS--NTMKTYEKILNAELR-----------FPPFFN 227 (318)
T ss_dssp CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS--SHHHHHHHHHHCCCC-----------CCTTSC
T ss_pred ccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCC--CHHHHHHHHHhCCCC-----------CCCCCC
Confidence 23566899999999999999999999999999999999999643 344444555444322 122345
Q ss_pred HHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 004979 663 EELLVVIKNCVHPDPKQRP-----SMRGIAA 688 (721)
Q Consensus 663 ~~l~~li~~Cl~~dP~~RP-----s~~evl~ 688 (721)
.++.+++.+||+.||++|| +++|+++
T Consensus 228 ~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 228 EDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp HHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred HHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 6789999999999999999 8888875
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=340.63 Aligned_cols=251 Identities=26% Similarity=0.423 Sum_probs=201.1
Q ss_pred hhhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhH--HHHHHHHHHHHHhcCCCCccceEeEEEecCCCceE
Q 004979 429 SNIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKN--LESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTR 505 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~--~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~ 505 (721)
+++.+.+|+|+||+||+|+. .+++.||+|++........... ..+.+.+|++++++++||||+++++++.+..
T Consensus 21 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---- 96 (287)
T 4f0f_A 21 IEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP---- 96 (287)
T ss_dssp EEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT----
T ss_pred ceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC----
Confidence 36778899999999999996 4788999998865433221111 1167999999999999999999999987644
Q ss_pred EEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCc-----EEEeccCC
Q 004979 506 MMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYA-----AKISDFSF 580 (721)
Q Consensus 506 ~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~-----~kL~DFGl 580 (721)
++||||+++|+|.+++.. ....+++..+..++.|++.||+|||+.+++|+||||||+|||++.++. +||+|||+
T Consensus 97 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~ 175 (287)
T 4f0f_A 97 RMVMEFVPCGDLYHRLLD-KAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGL 175 (287)
T ss_dssp EEEEECCTTCBHHHHHHC-TTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTT
T ss_pred eEEEEecCCCCHHHHHhc-ccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCCCc
Confidence 699999999999998863 345799999999999999999999998877999999999999988776 99999999
Q ss_pred CCCCC------CCCccccchhhc--ccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCC
Q 004979 581 WNNTT------AAKTGSAAMELL--ETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDP 652 (721)
Q Consensus 581 a~~~~------~~~~~~~apE~~--~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 652 (721)
++... .++..|+|||.+ ....++.++|||||||++|||+||+.||....................
T Consensus 176 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~------- 248 (287)
T 4f0f_A 176 SQQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLR------- 248 (287)
T ss_dssp CBCCSSCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCC-------
T ss_pred cccccccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCC-------
Confidence 86432 245678999998 455678999999999999999999999976554444333333322111
Q ss_pred ccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 004979 653 TLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEI 693 (721)
Q Consensus 653 ~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i 693 (721)
...+..++.++.+++.+||+.||++||++.|+++.|+++
T Consensus 249 --~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 249 --PTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred --CCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 112234557899999999999999999999999999864
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=336.52 Aligned_cols=246 Identities=19% Similarity=0.370 Sum_probs=202.1
Q ss_pred hhhhCcCCCCceeEEEEEEecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 429 SNIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
+++++.+|+|+||+||+|+..++..||+|++...... .+++.+|++++.+++||||+++++++.+.+ ..++|
T Consensus 10 y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~~lv 81 (268)
T 3sxs_A 10 ITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS------EDEFFQEAQTMMKLSHPKLVKFYGVCSKEY--PIYIV 81 (268)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBC------HHHHHHHHHHHHHCCCTTBCCEEEEECSSS--SEEEE
T ss_pred eeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCc------HHHHHHHHHHHHhCCCCCEeeEEEEEccCC--ceEEE
Confidence 3677889999999999999998889999988654321 256899999999999999999999998776 57999
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCCC--
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTA-- 586 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~~-- 586 (721)
|||+++|+|.+++... ...+++..+..|+.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 82 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 158 (268)
T 3sxs_A 82 TEYISNGCLLNYLRSH-GKGLEPSQLLEMCYDVCEGMAFLESHQ--FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158 (268)
T ss_dssp EECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred EEccCCCcHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence 9999999999998643 345899999999999999999999998 99999999999999999999999998753221
Q ss_pred --------CCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccc
Q 004979 587 --------AKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSF 657 (721)
Q Consensus 587 --------~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 657 (721)
++..|+|||.+.+..++.++||||||+++|||+| |+.||... ...+.......+.... .
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~--~~~~~~~~~~~~~~~~----------~ 226 (268)
T 3sxs_A 159 YVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLY--TNSEVVLKVSQGHRLY----------R 226 (268)
T ss_dssp EEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTS--CHHHHHHHHHTTCCCC----------C
T ss_pred hhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCcccc--ChHHHHHHHHcCCCCC----------C
Confidence 2235999999998899999999999999999999 99999633 2333333333222111 1
Q ss_pred cHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcC
Q 004979 658 QENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAME 697 (721)
Q Consensus 658 ~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 697 (721)
+...+.++.+++.+||+.||++|||+.|+++.|+.+.+..
T Consensus 227 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~ 266 (268)
T 3sxs_A 227 PHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKD 266 (268)
T ss_dssp CTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC--
T ss_pred CCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhcc
Confidence 1223467889999999999999999999999999887643
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=336.36 Aligned_cols=244 Identities=18% Similarity=0.350 Sum_probs=200.0
Q ss_pred hhhCcCCCCceeEEEEEEecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVF 509 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV~ 509 (721)
++++.+|+|+||+||+|++.++..||+|++...... .+++.+|++++.+++||||+++++++.+.+ ..++||
T Consensus 27 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~ 98 (283)
T 3gen_A 27 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS------EDEFIEEAKVMMNLSHEKLVQLYGVCTKQR--PIFIIT 98 (283)
T ss_dssp EEEEECC---CEEEEEEEETTTEEEEEEEECTTSBC------HHHHHHHHHHHHTCCCTTBCCEEEEECSSS--SEEEEE
T ss_pred HhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCC------HHHHHHHHHHHhcCCCCCEeeEEEEEecCC--CeEEEE
Confidence 678899999999999999998889999988643321 256899999999999999999999998776 579999
Q ss_pred ecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC----
Q 004979 510 EYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT---- 585 (721)
Q Consensus 510 Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~---- 585 (721)
||+++|+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 99 e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 175 (283)
T 3gen_A 99 EYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 175 (283)
T ss_dssp CCCTTCBHHHHHHCG-GGCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH
T ss_pred eccCCCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCccceEEEcCCCCEEEcccccccccccccc
Confidence 999999999998642 346999999999999999999999998 9999999999999999999999999876332
Q ss_pred ------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhcCCCCccccCCcccccc
Q 004979 586 ------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQ 658 (721)
Q Consensus 586 ------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 658 (721)
.++..|+|||.+....++.++|||||||++|||+| |+.||... ...+.......+.... .+
T Consensus 176 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~--~~~~~~~~~~~~~~~~----------~~ 243 (283)
T 3gen_A 176 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF--TNSETAEHIAQGLRLY----------RP 243 (283)
T ss_dssp HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTS--CHHHHHHHHHTTCCCC----------CC
T ss_pred ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCcccc--ChhHHHHHHhcccCCC----------CC
Confidence 22346999999998899999999999999999999 99999633 2333333333221111 11
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 004979 659 ENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAM 696 (721)
Q Consensus 659 ~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~ 696 (721)
...+.++.+++.+||+.||++||++.|+++.|+++...
T Consensus 244 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 244 HLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 22346788999999999999999999999999998764
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=357.39 Aligned_cols=245 Identities=20% Similarity=0.332 Sum_probs=194.6
Q ss_pred hhhCcCCCCceeEEEEEEec----CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceE
Q 004979 430 NIIGSFSDGTVGTVYKGTLS----SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTR 505 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~----~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~ 505 (721)
++.+.+|+|+||+||+|+.. ++..||||++.... .....+.|.+|++++++++|||||++++++.+.+ ..
T Consensus 48 ~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~ 121 (373)
T 2qol_A 48 SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY----TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSK--PV 121 (373)
T ss_dssp CCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC----CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS--SC
T ss_pred eeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc----CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC--ce
Confidence 56678899999999999865 56779999886432 2334578999999999999999999999998776 56
Q ss_pred EEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC
Q 004979 506 MMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT 585 (721)
Q Consensus 506 ~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~ 585 (721)
++||||+++|+|.++++. ....+++..+..|+.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 122 ~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 122 MIVTEYMENGSLDSFLRK-HDAQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp EEEEECCTTCBHHHHHHT-TTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEEEeCCCCCcHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 999999999999999963 3456999999999999999999999988 9999999999999999999999999986432
Q ss_pred C------------CCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhcCCCCccccCC
Q 004979 586 A------------AKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPLKDIVDP 652 (721)
Q Consensus 586 ~------------~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 652 (721)
. ++..|+|||.+....++.++|||||||++|||++ |+.||... ...+....+..+..
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~--~~~~~~~~i~~~~~-------- 268 (373)
T 2qol_A 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM--SNQDVIKAVDEGYR-------- 268 (373)
T ss_dssp ---------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTC--CHHHHHHHHHTTEE--------
T ss_pred cCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHHHcCCC--------
Confidence 1 1235999999999999999999999999999998 99999633 23333333222210
Q ss_pred ccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 004979 653 TLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITA 695 (721)
Q Consensus 653 ~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~ 695 (721)
...+..++.++.+++.+||+.||++||++.||++.|+++..
T Consensus 269 --~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 309 (373)
T 2qol_A 269 --LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309 (373)
T ss_dssp --CCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --CCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHh
Confidence 01122345678999999999999999999999999998754
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=343.36 Aligned_cols=252 Identities=25% Similarity=0.402 Sum_probs=200.6
Q ss_pred hhhCcCCCCceeEEEEEEecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVF 509 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV~ 509 (721)
++.+.+|+|+||+||+|++. ++.||||++... ...+.|.+|++++++++||||+++++++.+ ..++||
T Consensus 11 ~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~-------~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----~~~lv~ 78 (307)
T 2eva_A 11 EVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE-------SERKAFIVELRQLSRVNHPNIVKLYGACLN----PVCLVM 78 (307)
T ss_dssp EEEEEEECCSSSEEEEEEET-TEEEEEEECSST-------THHHHHHHHHHHHHHCCCTTBCCEEEBCTT----TTEEEE
T ss_pred eeeeEeecCCCceEEEEEEC-CeeEEEEEecCh-------hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC----CcEEEE
Confidence 56788899999999999976 678999987532 234679999999999999999999998864 248999
Q ss_pred ecCCCCChhhhhhhccC-CCCCHHHHHHHHHHHHHHHHHHhcCC-CCeEeeCCCCCCeEeCCCCc-EEEeccCCCCCC--
Q 004979 510 EYSPNGSLFEHLHIQEA-EHLDWAMRLRIAMGMAYCLEHMHQLT-PPIAHRNLQSSSIYLTEDYA-AKISDFSFWNNT-- 584 (721)
Q Consensus 510 Ey~~~GsL~~~l~~~~~-~~l~~~~~~~ia~~ia~gL~yLH~~~-~~IvHrDLKp~NILl~~~~~-~kL~DFGla~~~-- 584 (721)
||+++|+|.+++..... ..+++..+..++.|+++||+|||+.+ .+|+||||||+|||++.++. +||+|||++...
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~ 158 (307)
T 2eva_A 79 EYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT 158 (307)
T ss_dssp ECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------
T ss_pred EcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccc
Confidence 99999999999974332 35789999999999999999999832 23999999999999998876 799999997533
Q ss_pred ----CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccHH
Q 004979 585 ----TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQEN 660 (721)
Q Consensus 585 ----~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 660 (721)
..++..|+|||.+.+..++.++|||||||++|||+||+.||................+..+ .....
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~----------~~~~~ 228 (307)
T 2eva_A 159 HMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRP----------PLIKN 228 (307)
T ss_dssp ------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCC----------CCBTT
T ss_pred ccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCC----------Ccccc
Confidence 2356689999999999999999999999999999999999975444433333222222111 11233
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCCCCCCC
Q 004979 661 VLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAMEPDGATP 703 (721)
Q Consensus 661 ~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~~~~p 703 (721)
++.++.+++.+||+.||++|||+.|+++.|+.+.+..+....|
T Consensus 229 ~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~~ 271 (307)
T 2eva_A 229 LPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEP 271 (307)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTTSC
T ss_pred cCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCCCc
Confidence 4567889999999999999999999999999998876654443
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=365.98 Aligned_cols=247 Identities=21% Similarity=0.346 Sum_probs=203.8
Q ss_pred hhhCcCCCCceeEEEEEEecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVF 509 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV~ 509 (721)
++.+.+|+|+||+||+|++..+..||||++..... ..+.|.+|+++|++++|||||++++++.+ + ..++||
T Consensus 187 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~------~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~--~~~iv~ 257 (452)
T 1fmk_A 187 RLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM------SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-E--PIYIVT 257 (452)
T ss_dssp EEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS------CHHHHHHHHHHHHHCCCTTBCCEEEEECS-S--SCEEEE
T ss_pred eeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC------CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-C--ceEEEe
Confidence 56778999999999999998888899998864321 13579999999999999999999999976 3 458999
Q ss_pred ecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCCC---
Q 004979 510 EYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTA--- 586 (721)
Q Consensus 510 Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~~--- 586 (721)
||+++|+|.+++.......+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++....
T Consensus 258 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 335 (452)
T 1fmk_A 258 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 335 (452)
T ss_dssp CCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred hhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhEEECCCCCEEECCCccceecCCCce
Confidence 9999999999997544566999999999999999999999998 99999999999999999999999999864321
Q ss_pred -------CCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhcCCCCccccCCcccccc
Q 004979 587 -------AKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQ 658 (721)
Q Consensus 587 -------~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 658 (721)
++..|+|||.+....++.++|||||||++|||+| |+.||... ...+....+..+.. . ..+
T Consensus 336 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~--~~~~~~~~i~~~~~-~---------~~~ 403 (452)
T 1fmk_A 336 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM--VNREVLDQVERGYR-M---------PCP 403 (452)
T ss_dssp -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC--CHHHHHHHHHTTCC-C---------CCC
T ss_pred ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCC--CHHHHHHHHHcCCC-C---------CCC
Confidence 2246999999998999999999999999999999 99999633 33333333333211 1 122
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCCC
Q 004979 659 ENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAMEPD 699 (721)
Q Consensus 659 ~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~ 699 (721)
..++.++.++|.+||+.||++|||+.+|++.|+++......
T Consensus 404 ~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~ 444 (452)
T 1fmk_A 404 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 444 (452)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCC
T ss_pred CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCc
Confidence 34567889999999999999999999999999998765443
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=355.01 Aligned_cols=254 Identities=19% Similarity=0.311 Sum_probs=204.0
Q ss_pred hhhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEE
Q 004979 429 SNIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMM 507 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~l 507 (721)
+++++.+|+|+||.||+|+.. +++.+|+|++....... ....+.+.+|+++|++++|||||++++++.+.+ ..++
T Consensus 17 y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~--~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~--~~~l 92 (384)
T 4fr4_A 17 FEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVE--RNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEE--DMFM 92 (384)
T ss_dssp EEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHH--TTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS--EEEE
T ss_pred eEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhccc--HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC--EEEE
Confidence 377889999999999999965 57889999886432211 223467889999999999999999999999877 6799
Q ss_pred EEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC---
Q 004979 508 VFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT--- 584 (721)
Q Consensus 508 V~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~--- 584 (721)
||||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 93 v~e~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 168 (384)
T 4fr4_A 93 VVDLLLGGDLRYHLQQ--NVHFKEETVKLFICELVMALDYLQNQR--IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE 168 (384)
T ss_dssp EECCCTTEEHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence 9999999999999863 456999999999999999999999998 999999999999999999999999998632
Q ss_pred -----CCCCccccchhhccc---CCCCCCccHHHHHHHHHHHHhCCCcccCCCC-CHHHHHHHHhhcCCCCccccCCccc
Q 004979 585 -----TAAKTGSAAMELLET---SAVDLESNVYSFGTILFEMITGRISYSIENG-SLENWASEYLKGEQPLKDIVDPTLK 655 (721)
Q Consensus 585 -----~~~~~~~~apE~~~~---~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~-~~~~~~~~~~~~~~~~~~~~d~~l~ 655 (721)
..++..|+|||.+.. ..++.++|||||||++|||+||+.||..... ...+...........
T Consensus 169 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~---------- 238 (384)
T 4fr4_A 169 TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVT---------- 238 (384)
T ss_dssp CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCC----------
T ss_pred CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccC----------
Confidence 235667999999863 4589999999999999999999999975433 333333333322211
Q ss_pred cccHHHHHHHHHHHHHcccCCCCCCCC-HHHHHHHHHHhhhcCCCCCCCCCChhHHHHHH
Q 004979 656 SFQENVLEELLVVIKNCVHPDPKQRPS-MRGIAAKLKEITAMEPDGATPKLSPLWWAELE 714 (721)
Q Consensus 656 ~~~~~~~~~l~~li~~Cl~~dP~~RPs-~~evl~~L~~i~~~~~~~~~p~~~~~~~~~l~ 714 (721)
++...+.++.+|+.+||+.||++||+ +.+|.+ +|++..++|+.+.
T Consensus 239 -~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~-------------hp~f~~~~w~~~~ 284 (384)
T 4fr4_A 239 -YPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN-------------FPYMNDINWDAVF 284 (384)
T ss_dssp -CCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT-------------SGGGTTCCHHHHH
T ss_pred -CCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc-------------ChhhhcCCHHHHH
Confidence 22344578899999999999999998 666543 5666667776664
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=343.04 Aligned_cols=262 Identities=11% Similarity=0.169 Sum_probs=208.7
Q ss_pred hhhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcC-CCCccceEeEEEecCCCceEE
Q 004979 429 SNIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKV-NHKNFVNLIGYCEEDEPFTRM 506 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~~~ 506 (721)
+++.+.+|+|+||+||+|+. .+++.||||++..... .+.+.+|++++.++ +|+||+++++++.+.. ..+
T Consensus 12 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~--~~~ 82 (298)
T 1csn_A 12 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-------APQLRDEYRTYKLLAGCTGIPNVYYFGQEGL--HNV 82 (298)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-------SCCHHHHHHHHHHTTTCTTCCCEEEEEEETT--EEE
T ss_pred eEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc-------cHHHHHHHHHHHHHhcCCCCCeEEeecCCCc--eeE
Confidence 46778899999999999995 5788999998754322 13578899999999 8999999999998776 679
Q ss_pred EEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCc-----EEEeccCCC
Q 004979 507 MVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYA-----AKISDFSFW 581 (721)
Q Consensus 507 lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~-----~kL~DFGla 581 (721)
+||||+ +|+|.+++... ...+++..+..|+.||+.||+|||+++ |+||||||+|||++.++. +||+|||++
T Consensus 83 lv~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~ 158 (298)
T 1csn_A 83 LVIDLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 158 (298)
T ss_dssp EEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred EEEEec-CCCHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEeccCCCCCCCeEEEEECccc
Confidence 999999 99999999643 346999999999999999999999988 999999999999987776 999999987
Q ss_pred CCCC----------------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCC-CHHHHHHHHhhcCC
Q 004979 582 NNTT----------------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENG-SLENWASEYLKGEQ 644 (721)
Q Consensus 582 ~~~~----------------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~-~~~~~~~~~~~~~~ 644 (721)
+... .++..|+|||.+.+..++.++|||||||++|||+||+.||..... ...+..........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 238 (298)
T 1csn_A 159 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ 238 (298)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH
T ss_pred cccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhcc
Confidence 5321 245679999999999999999999999999999999999975432 22222222221100
Q ss_pred CCccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCChhHHHH
Q 004979 645 PLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAMEPDGATPKLSPLWWAE 712 (721)
Q Consensus 645 ~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~~~~p~~~~~~~~~ 712 (721)
. .........++.++.+++.+||+.||++||++.+|++.|+++.+.... ....+++|+.
T Consensus 239 ~------~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~---~~~~~~dw~~ 297 (298)
T 1csn_A 239 S------TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNT---TEDENFDWNL 297 (298)
T ss_dssp H------SCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC---CSCSCCGGGC
T ss_pred C------ccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCC---CCCCccccCC
Confidence 0 001111224467899999999999999999999999999998876543 3456788864
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=347.58 Aligned_cols=235 Identities=18% Similarity=0.277 Sum_probs=192.4
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcC-CCCccceEeEEEecCCCceEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKV-NHKNFVNLIGYCEEDEPFTRMM 507 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~~~l 507 (721)
++++.+|+|+||.||+|+.. +++.+|+|++....... ....+.+.+|+.++.++ +|||||++++++.+.+ ..++
T Consensus 12 ~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~--~~~l 87 (345)
T 3a8x_A 12 DLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVND--DEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES--RLFF 87 (345)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCS--HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS--EEEE
T ss_pred EEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcc--hHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCC--EEEE
Confidence 67788999999999999975 57889999987543222 33456788999999988 8999999999998876 7799
Q ss_pred EEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC---
Q 004979 508 VFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT--- 584 (721)
Q Consensus 508 V~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~--- 584 (721)
||||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 88 v~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~ 163 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 163 (345)
T ss_dssp EECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred EEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence 99999999999998643 46899999999999999999999998 999999999999999999999999998642
Q ss_pred ------CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCC-------CHHHHHHHHhhcCCCCccccC
Q 004979 585 ------TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENG-------SLENWASEYLKGEQPLKDIVD 651 (721)
Q Consensus 585 ------~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~-------~~~~~~~~~~~~~~~~~~~~d 651 (721)
..++..|+|||.+.+..++.++|||||||++|||+||+.||...+. ........+......
T Consensus 164 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~------ 237 (345)
T 3a8x_A 164 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR------ 237 (345)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCC------
T ss_pred CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCC------
Confidence 2345679999999999999999999999999999999999964211 111222222222111
Q ss_pred CccccccHHHHHHHHHHHHHcccCCCCCCCCH
Q 004979 652 PTLKSFQENVLEELLVVIKNCVHPDPKQRPSM 683 (721)
Q Consensus 652 ~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~ 683 (721)
++...+.++.+++.+||+.||++||++
T Consensus 238 -----~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 238 -----IPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp -----CCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred -----CCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 223445678999999999999999996
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=341.17 Aligned_cols=261 Identities=18% Similarity=0.249 Sum_probs=206.5
Q ss_pred hhhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEE
Q 004979 429 SNIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMM 507 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~l 507 (721)
+.+.+.+|+|+||+||+|+.. +++.||||++...... ...+.+.+|++++++++||||+++++++...+....++
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (319)
T 4euu_A 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL----RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (319)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG----SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred EEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccccc----chHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEE
Confidence 467788999999999999965 5889999988643321 12456889999999999999999999998765446799
Q ss_pred EEecCCCCChhhhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEe----CCCCcEEEeccCCCC
Q 004979 508 VFEYSPNGSLFEHLHIQE-AEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYL----TEDYAAKISDFSFWN 582 (721)
Q Consensus 508 V~Ey~~~GsL~~~l~~~~-~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl----~~~~~~kL~DFGla~ 582 (721)
||||+++|+|.+++.... ...+++..+..|+.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 999999999999997543 234999999999999999999999998 9999999999999 888899999999985
Q ss_pred CCC--------CCCccccchhhcc--------cCCCCCCccHHHHHHHHHHHHhCCCcccCCC--CCHHHHHHHHhhcCC
Q 004979 583 NTT--------AAKTGSAAMELLE--------TSAVDLESNVYSFGTILFEMITGRISYSIEN--GSLENWASEYLKGEQ 644 (721)
Q Consensus 583 ~~~--------~~~~~~~apE~~~--------~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~--~~~~~~~~~~~~~~~ 644 (721)
... .++..|+|||.+. ...++.++|||||||++|||+||+.||.... ....+....+..+..
T Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p 244 (319)
T 4euu_A 165 ELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244 (319)
T ss_dssp ECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCC
T ss_pred ecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCC
Confidence 422 2456799999875 5788999999999999999999999996332 223344444443322
Q ss_pred CC--cccc---C---------CccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 004979 645 PL--KDIV---D---------PTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITA 695 (721)
Q Consensus 645 ~~--~~~~---d---------~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~ 695 (721)
.- ..+. . +............+.+++.+||+.||++|||++|+++...+...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~ 309 (319)
T 4euu_A 245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (319)
T ss_dssp TTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC
T ss_pred cccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhh
Confidence 10 0000 0 11113446778899999999999999999999999998876543
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=348.34 Aligned_cols=238 Identities=18% Similarity=0.269 Sum_probs=198.8
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
++++.+|+|+||.||+|+.. ++..||+|++....... ....+.+.+|++++++++||||+++++++.+.+ ..++|
T Consensus 44 ~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--~~~lv 119 (350)
T 1rdq_E 44 DRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVK--LKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS--NLYMV 119 (350)
T ss_dssp EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH--TTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS--EEEEE
T ss_pred EEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhcc--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC--EEEEE
Confidence 67888999999999999965 68899999986432211 122457889999999999999999999998876 67999
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC---
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT--- 585 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~--- 585 (721)
|||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 120 ~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~~ 195 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT 195 (350)
T ss_dssp EECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECSSCB
T ss_pred EcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCccceEEECCCCCEEEcccccceeccCCc
Confidence 9999999999998643 46899999999999999999999998 9999999999999999999999999986432
Q ss_pred ---CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccHHHH
Q 004979 586 ---AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQENVL 662 (721)
Q Consensus 586 ---~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 662 (721)
.++..|+|||.+.+..++.++|||||||++|||+||+.||... +..+....+..+... ++...+
T Consensus 196 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~--~~~~~~~~i~~~~~~-----------~p~~~~ 262 (350)
T 1rdq_E 196 WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD--QPIQIYEKIVSGKVR-----------FPSHFS 262 (350)
T ss_dssp CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHCCCC-----------CCTTCC
T ss_pred ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCC--CHHHHHHHHHcCCCC-----------CCCCCC
Confidence 3456799999999999999999999999999999999999643 344555555544322 123345
Q ss_pred HHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 004979 663 EELLVVIKNCVHPDPKQRPS-----MRGIAA 688 (721)
Q Consensus 663 ~~l~~li~~Cl~~dP~~RPs-----~~evl~ 688 (721)
.++.+++.+||+.||++||+ ++||++
T Consensus 263 ~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 263 SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp HHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred HHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 67899999999999999998 777764
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=353.06 Aligned_cols=254 Identities=20% Similarity=0.269 Sum_probs=195.4
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHH-HhcCCCCccceEeEEEecCCCceEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDT-LSKVNHKNFVNLIGYCEEDEPFTRMM 507 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~-l~~l~H~nIv~l~g~~~~~~~~~~~l 507 (721)
++++.||+|+||+||+|+.. ++..+|+|++....... ......+.+|..+ ++.++|||||++++++.+.+ ..|+
T Consensus 41 ~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~--~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~--~~~l 116 (373)
T 2r5t_A 41 HFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILK--KKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTAD--KLYF 116 (373)
T ss_dssp EEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC---------------CCBCCCCCTTBCCEEEEEECSS--EEEE
T ss_pred EEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhh--hHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCC--EEEE
Confidence 67889999999999999975 57889999987543322 2233556777776 57789999999999999877 7899
Q ss_pred EEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC---
Q 004979 508 VFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT--- 584 (721)
Q Consensus 508 V~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~--- 584 (721)
||||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 117 v~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~ 192 (373)
T 2r5t_A 117 VLDYINGGELFYHLQR--ERCFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLDSQGHIVLTDFGLCKENIEH 192 (373)
T ss_dssp EEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred EEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence 9999999999999864 346889999999999999999999998 999999999999999999999999998631
Q ss_pred ------CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCcccccc
Q 004979 585 ------TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQ 658 (721)
Q Consensus 585 ------~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 658 (721)
..++..|+|||.+.+..++.++|||||||++|||++|+.||... +..+....+......+ +
T Consensus 193 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~--~~~~~~~~i~~~~~~~-----------~ 259 (373)
T 2r5t_A 193 NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR--NTAEMYDNILNKPLQL-----------K 259 (373)
T ss_dssp CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCS--BHHHHHHHHHHSCCCC-----------C
T ss_pred CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCC--CHHHHHHHHHhcccCC-----------C
Confidence 23466799999999999999999999999999999999999643 3445555554432211 1
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCChhHHHHH
Q 004979 659 ENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAMEPDGATPKLSPLWWAEL 713 (721)
Q Consensus 659 ~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~~~~p~~~~~~~~~l 713 (721)
...+.++.+|+.+||+.||++||++.+.+..+.+ +|++..++|+.+
T Consensus 260 ~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~---------h~~f~~~~w~~l 305 (373)
T 2r5t_A 260 PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKS---------HVFFSLINWDDL 305 (373)
T ss_dssp SSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHT---------SGGGTTCCHHHH
T ss_pred CCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhC---------CccccCCCHHHH
Confidence 2345678899999999999999998654444332 445555555554
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=339.27 Aligned_cols=248 Identities=22% Similarity=0.342 Sum_probs=191.7
Q ss_pred hhhhCcCCCCceeEEEEEEecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhc--CCCCccceEeEEEecC--CCce
Q 004979 429 SNIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSK--VNHKNFVNLIGYCEED--EPFT 504 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~--l~H~nIv~l~g~~~~~--~~~~ 504 (721)
+++++.+|+|+||+||+|+. ++..||||++.... ...+.+|.+++.. ++||||+++++++... ....
T Consensus 10 y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--------~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~ 80 (301)
T 3q4u_A 10 ITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRD--------EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQ 80 (301)
T ss_dssp CEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGG--------HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEE
T ss_pred EEEEEeeccCCCcEEEEEEE-CCEEEEEEEecccc--------chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCce
Confidence 46788999999999999988 58899999875321 2345566666665 8999999999987643 2225
Q ss_pred EEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHh--------cCCCCeEeeCCCCCCeEeCCCCcEEEe
Q 004979 505 RMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMH--------QLTPPIAHRNLQSSSIYLTEDYAAKIS 576 (721)
Q Consensus 505 ~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH--------~~~~~IvHrDLKp~NILl~~~~~~kL~ 576 (721)
.++||||+++|+|.++++ ...+++..+..|+.|++.||+||| +.+ |+||||||+|||++.++.+||+
T Consensus 81 ~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dlkp~Nill~~~~~~kl~ 155 (301)
T 3q4u_A 81 LWLITHYHEMGSLYDYLQ---LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA--IAHRDLKSKNILVKKNGQCCIA 155 (301)
T ss_dssp EEEEECCCTTCBHHHHHT---TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE--EECSCCCGGGEEECTTSCEEEC
T ss_pred eEEehhhccCCCHHHHHh---hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC--eecCCCChHhEEEcCCCCEEEe
Confidence 799999999999999995 346999999999999999999999 766 9999999999999999999999
Q ss_pred ccCCCCCC-------------CCCCccccchhhcccC------CCCCCccHHHHHHHHHHHHhC----------CCcccC
Q 004979 577 DFSFWNNT-------------TAAKTGSAAMELLETS------AVDLESNVYSFGTILFEMITG----------RISYSI 627 (721)
Q Consensus 577 DFGla~~~-------------~~~~~~~~apE~~~~~------~~s~ksDVwSfGvvL~ElltG----------~~P~~~ 627 (721)
|||+++.. ..++..|+|||.+... .++.++|||||||++|||+|| +.||..
T Consensus 156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~ 235 (301)
T 3q4u_A 156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD 235 (301)
T ss_dssp CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence 99987421 1456689999998766 455799999999999999999 888853
Q ss_pred CC--CCHHHHHHHHhhcCCCCccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 004979 628 EN--GSLENWASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEI 693 (721)
Q Consensus 628 ~~--~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i 693 (721)
.. .................... .........+.++.+++.+||+.||++|||+.||++.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 236 VVPNDPSFEDMRKVVCVDQQRPNI---PNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TSCSSCCHHHHHHHHTTSCCCCCC---CGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCCCcchhhhhHHHhccCCCCCC---ChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 21 11122222222111111110 00112345778999999999999999999999999999886
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-40 Score=369.85 Aligned_cols=244 Identities=22% Similarity=0.370 Sum_probs=202.4
Q ss_pred hhhCcCCCCceeEEEEEEecC-CcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLSS-GVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~~-~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
++.+.||+|+||.||+|++.. +..||||++..... ..+.|.+|+++|++++|||||+++++|...+ ..++|
T Consensus 223 ~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~--~~~lv 294 (495)
T 1opk_A 223 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM------EVEEFLKEAAVMKEIKHPNLVQLLGVCTREP--PFYII 294 (495)
T ss_dssp EEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS--SCEEE
T ss_pred eeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc------chHHHHHHHHHHHhcCCCCEeeEEEEEecCC--cEEEE
Confidence 567789999999999999764 78899998864321 1367999999999999999999999998876 56999
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCCC--
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTA-- 586 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~~-- 586 (721)
|||+++|+|.++++......+++..++.|+.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++....
T Consensus 295 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 372 (495)
T 1opk_A 295 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT 372 (495)
T ss_dssp EECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECGGGCEEECCTTCEECCTTCC
T ss_pred EEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChhhEEECCCCcEEEeecccceeccCCc
Confidence 99999999999997655667999999999999999999999998 99999999999999999999999999864321
Q ss_pred --------CCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccc
Q 004979 587 --------AKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSF 657 (721)
Q Consensus 587 --------~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 657 (721)
.+..|+|||.+....++.++|||||||++|||+| |+.||.... ..+....+..+ ... ..
T Consensus 373 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~--~~~~~~~~~~~-~~~---------~~ 440 (495)
T 1opk_A 373 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID--LSQVYELLEKD-YRM---------ER 440 (495)
T ss_dssp EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC--GGGHHHHHHTT-CCC---------CC
T ss_pred eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCC--HHHHHHHHHcC-CCC---------CC
Confidence 1236899999998899999999999999999999 999996433 22222222221 111 12
Q ss_pred cHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 004979 658 QENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITA 695 (721)
Q Consensus 658 ~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~ 695 (721)
+..++.++.+||.+||+.||++||++.||++.|+.+..
T Consensus 441 ~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 441 PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred CCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 23456789999999999999999999999999988653
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=348.47 Aligned_cols=249 Identities=23% Similarity=0.353 Sum_probs=202.9
Q ss_pred hhhCcCCCCceeEEEEEEec------CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCc
Q 004979 430 NIIGSFSDGTVGTVYKGTLS------SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPF 503 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~------~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 503 (721)
++++.+|+|+||.||+|+.. ++..||||++.... .....+.|.+|++++++++||||+++++++.+.+
T Consensus 50 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-- 123 (343)
T 1luf_A 50 EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA----SADMQADFQREAALMAEFDNPNIVKLLGVCAVGK-- 123 (343)
T ss_dssp EEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC----CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS--
T ss_pred eeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc----CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCC--
Confidence 67788999999999999974 34789999886432 2334568999999999999999999999998876
Q ss_pred eEEEEEecCCCCChhhhhhhcc----------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCC
Q 004979 504 TRMMVFEYSPNGSLFEHLHIQE----------------------AEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQ 561 (721)
Q Consensus 504 ~~~lV~Ey~~~GsL~~~l~~~~----------------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLK 561 (721)
..++||||+++|+|.+++.... ...+++..++.|+.||+.||+|||+++ |+|||||
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlk 201 (343)
T 1luf_A 124 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHRDLA 201 (343)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCS
T ss_pred ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCC
Confidence 5699999999999999997532 156899999999999999999999998 9999999
Q ss_pred CCCeEeCCCCcEEEeccCCCCCC-----------CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCC
Q 004979 562 SSSIYLTEDYAAKISDFSFWNNT-----------TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIEN 629 (721)
Q Consensus 562 p~NILl~~~~~~kL~DFGla~~~-----------~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~ 629 (721)
|+|||+++++.+||+|||+++.. ..++..|+|||.+.+..++.++|||||||++|||+| |+.||...
T Consensus 202 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~- 280 (343)
T 1luf_A 202 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM- 280 (343)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS-
T ss_pred cceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCC-
Confidence 99999999999999999987421 123446999999998899999999999999999999 99999633
Q ss_pred CCHHHHHHHHhhcCCCCccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCC
Q 004979 630 GSLENWASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAMEP 698 (721)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 698 (721)
...+....+..+.. ...+..++.++.+++.+||+.||++||++.|+++.|+++.+...
T Consensus 281 -~~~~~~~~~~~~~~----------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~ 338 (343)
T 1luf_A 281 -AHEEVIYYVRDGNI----------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAE 338 (343)
T ss_dssp -CHHHHHHHHHTTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC---
T ss_pred -ChHHHHHHHhCCCc----------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhh
Confidence 33343333333211 11223455689999999999999999999999999999876543
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=351.05 Aligned_cols=237 Identities=19% Similarity=0.246 Sum_probs=195.1
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcC-CCCccceEeEEEecCCCceEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKV-NHKNFVNLIGYCEEDEPFTRMM 507 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~~~l 507 (721)
++++.+|+|+||+||+|+.. +++.||+|++....... ......+..|.+++.++ +||||+++++++.+.+ ..++
T Consensus 20 ~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~--~~~l 95 (345)
T 1xjd_A 20 ILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLM--DDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE--NLFF 95 (345)
T ss_dssp EEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHH--TTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS--EEEE
T ss_pred EEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhh--hhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCC--EEEE
Confidence 67788999999999999975 67889999886532111 12235678899999877 9999999999998877 6799
Q ss_pred EEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC---
Q 004979 508 VFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT--- 584 (721)
Q Consensus 508 V~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~--- 584 (721)
||||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 96 v~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 171 (345)
T 1xjd_A 96 VMEYLNGGDLMYHIQS--CHKFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 171 (345)
T ss_dssp EEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCChhhEEECCCCCEEEeEChhhhhcccC
Confidence 9999999999999864 346899999999999999999999998 999999999999999999999999998642
Q ss_pred ------CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCcccccc
Q 004979 585 ------TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQ 658 (721)
Q Consensus 585 ------~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 658 (721)
..++..|+|||.+.+..++.++|||||||++|||+||+.||... +..+....+..+...+ +
T Consensus 172 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~--~~~~~~~~i~~~~~~~-----------p 238 (345)
T 1xjd_A 172 DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ--DEEELFHSIRMDNPFY-----------P 238 (345)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHCCCCC-----------C
T ss_pred CCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCC--CHHHHHHHHHhCCCCC-----------C
Confidence 22456799999999999999999999999999999999999643 3444444444432221 2
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHH-HHH
Q 004979 659 ENVLEELLVVIKNCVHPDPKQRPSMR-GIA 687 (721)
Q Consensus 659 ~~~~~~l~~li~~Cl~~dP~~RPs~~-evl 687 (721)
...+.++.+++.+||+.||++||++. ||.
T Consensus 239 ~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 239 RWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred cccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 23456789999999999999999987 554
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=353.02 Aligned_cols=248 Identities=23% Similarity=0.330 Sum_probs=201.1
Q ss_pred hhhhCcCCCCceeEEEEEEec------CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCC
Q 004979 429 SNIIGSFSDGTVGTVYKGTLS------SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEP 502 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~------~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~ 502 (721)
+++++.+|+|+||+||+|++. ++..||||++.... .......+.+|+.++++++|||||++++++.+.+
T Consensus 73 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~- 147 (367)
T 3l9p_A 73 ITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC----SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL- 147 (367)
T ss_dssp EEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC----CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred eEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc----ChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCC-
Confidence 367889999999999999853 45689999885322 2334467999999999999999999999998876
Q ss_pred ceEEEEEecCCCCChhhhhhhcc-----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCC---cEE
Q 004979 503 FTRMMVFEYSPNGSLFEHLHIQE-----AEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDY---AAK 574 (721)
Q Consensus 503 ~~~~lV~Ey~~~GsL~~~l~~~~-----~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~---~~k 574 (721)
..++||||+++|+|.+++.... ...+++..++.|+.||+.||+|||+++ |+||||||+|||++.++ .+|
T Consensus 148 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~~~~k 224 (367)
T 3l9p_A 148 -PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAK 224 (367)
T ss_dssp -SCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCEE
T ss_pred -CCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhEEEecCCCCceEE
Confidence 5599999999999999997543 245899999999999999999999998 99999999999999554 599
Q ss_pred EeccCCCCCC-----------CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhc
Q 004979 575 ISDFSFWNNT-----------TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKG 642 (721)
Q Consensus 575 L~DFGla~~~-----------~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~ 642 (721)
|+|||+++.. ..++..|+|||.+.+..++.++|||||||++|||+| |+.||... ...+....+..+
T Consensus 225 L~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~--~~~~~~~~i~~~ 302 (367)
T 3l9p_A 225 IGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK--SNQEVLEFVTSG 302 (367)
T ss_dssp ECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC--CHHHHHHHHHTT
T ss_pred ECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHHHcC
Confidence 9999987521 123457999999999999999999999999999998 99999633 333444333332
Q ss_pred CCCCccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 004979 643 EQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAM 696 (721)
Q Consensus 643 ~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~ 696 (721)
... ..+..++.++.+|+.+||+.||++||++.||++.|+.+.+.
T Consensus 303 ~~~----------~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 303 GRM----------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp CCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCC----------CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 211 11233456789999999999999999999999999988764
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=343.31 Aligned_cols=240 Identities=19% Similarity=0.267 Sum_probs=190.6
Q ss_pred hhhhCcCCCCceeEEEEEEe----cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCce
Q 004979 429 SNIIGSFSDGTVGTVYKGTL----SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFT 504 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~----~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 504 (721)
+++++.+|+|+||+||+|+. .+++.+|+|++....... .......+.+|++++++++||||+++++++...+ .
T Consensus 19 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--~ 95 (327)
T 3a62_A 19 FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVR-NAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGG--K 95 (327)
T ss_dssp EEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC---------------HHHHHHHCCCTTBCCEEEEEECSS--C
T ss_pred eEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhh-hhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCC--E
Confidence 37788999999999999986 478899999986543211 1223456889999999999999999999998876 6
Q ss_pred EEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC
Q 004979 505 RMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT 584 (721)
Q Consensus 505 ~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~ 584 (721)
.++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 96 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 171 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLER--EGIFMEDTACFYLAEISMALGHLHQKG--IIYRDLKPENIMLNHQGHVKLTDFGLCKES 171 (327)
T ss_dssp EEEEEECCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred EEEEEeCCCCCcHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCC--EEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence 7999999999999999864 345889999999999999999999998 999999999999999999999999987532
Q ss_pred ---------CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccc
Q 004979 585 ---------TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLK 655 (721)
Q Consensus 585 ---------~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 655 (721)
..++..|+|||.+....++.++|||||||++|||++|+.||... +..+....+......
T Consensus 172 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~--~~~~~~~~i~~~~~~---------- 239 (327)
T 3a62_A 172 IHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGE--NRKKTIDKILKCKLN---------- 239 (327)
T ss_dssp -------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCS--SHHHHHHHHHHTCCC----------
T ss_pred ccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCC--CHHHHHHHHHhCCCC----------
Confidence 23566799999999999999999999999999999999999643 334444444443222
Q ss_pred cccHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 004979 656 SFQENVLEELLVVIKNCVHPDPKQRP-----SMRGIAA 688 (721)
Q Consensus 656 ~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~evl~ 688 (721)
++...+.++.+++.+||+.||++|| ++.|+++
T Consensus 240 -~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 240 -LPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp -CCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred -CCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 1223456789999999999999999 7778765
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-39 Score=341.44 Aligned_cols=247 Identities=18% Similarity=0.267 Sum_probs=199.9
Q ss_pred hhhhhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccch-hhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCce
Q 004979 427 DFSNIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADW-SKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFT 504 (721)
Q Consensus 427 ~~~~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 504 (721)
+.+++.+.+|+|+||.||+|+.. ++..||+|++........ .....+.+.+|++++++++||||+++++++.+.+ .
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--~ 88 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKT--D 88 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS--E
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC--E
Confidence 44578889999999999999965 688999998875432211 1112467999999999999999999999998876 6
Q ss_pred EEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCC----cEEEeccCC
Q 004979 505 RMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDY----AAKISDFSF 580 (721)
Q Consensus 505 ~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~----~~kL~DFGl 580 (721)
.++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||+
T Consensus 89 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~ 164 (326)
T 2y0a_A 89 VILILELVAGGELFDFLAE--KESLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164 (326)
T ss_dssp EEEEEECCCSCBHHHHHTT--SSCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEEEcCCCCCHHHHHHh--cCCcCHHHHHHHHHHHHHHHHHHHHCC--eEcCCCCHHHEEEecCCCCCCCEEEEECCC
Confidence 7999999999999999853 456999999999999999999999998 99999999999999887 899999999
Q ss_pred CCCCC--------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCC
Q 004979 581 WNNTT--------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDP 652 (721)
Q Consensus 581 a~~~~--------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 652 (721)
++... .++..|+|||.+....++.++|||||||++|||+||+.||... ...+....+........
T Consensus 165 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~--~~~~~~~~~~~~~~~~~----- 237 (326)
T 2y0a_A 165 AHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD--TKQETLANVSAVNYEFE----- 237 (326)
T ss_dssp CEECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS--SHHHHHHHHHHTCCCCC-----
T ss_pred CeECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCC--CHHHHHHHHHhcCCCcC-----
Confidence 85432 2456799999999999999999999999999999999999643 23333333332221111
Q ss_pred ccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 653 TLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 653 ~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
.......+.++.+++.+||+.||++|||+.|+++
T Consensus 238 --~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 238 --DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp --HHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred --ccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0111234567889999999999999999999986
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=341.28 Aligned_cols=251 Identities=22% Similarity=0.279 Sum_probs=194.1
Q ss_pred hhhhCcCCCCceeEEEEEEecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 429 SNIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
|++++.+|+|+||+||+|+..+++.||+|++..... .....+.+.+|++++++++|||||++++++.+.+ ..++|
T Consensus 23 y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--~~~lv 97 (311)
T 3niz_A 23 YQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAE---DEGIPSTAIREISLLKELHHPNIVSLIDVIHSER--CLTLV 97 (311)
T ss_dssp EEEEEEEEECSSCEEEEEEETTSCEEEEEEEC---------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSS--CEEEE
T ss_pred hHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccc---cchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCC--EEEEE
Confidence 477889999999999999998899999999865422 1223467899999999999999999999998776 67999
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC---
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT--- 585 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~--- 585 (721)
|||++ |+|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 98 ~e~~~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 173 (311)
T 3niz_A 98 FEFME-KDLKKVLDE-NKTGLQDSQIKIYLYQLLRGVAHCHQHR--ILHRDLKPQNLLINSDGALKLADFGLARAFGIPV 173 (311)
T ss_dssp EECCS-EEHHHHHHT-CTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred EcCCC-CCHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence 99997 588888753 3456999999999999999999999998 9999999999999999999999999985332
Q ss_pred ------CCCccccchhhccc-CCCCCCccHHHHHHHHHHHHhCCCcccCCCC-CHHHHHHHHhhcCCCC--ccc------
Q 004979 586 ------AAKTGSAAMELLET-SAVDLESNVYSFGTILFEMITGRISYSIENG-SLENWASEYLKGEQPL--KDI------ 649 (721)
Q Consensus 586 ------~~~~~~~apE~~~~-~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~-~~~~~~~~~~~~~~~~--~~~------ 649 (721)
.++..|+|||.+.+ ..++.++|||||||++|||+||+.||..... +....+........+. ...
T Consensus 174 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 253 (311)
T 3niz_A 174 RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLW 253 (311)
T ss_dssp C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHH
T ss_pred ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchh
Confidence 24567999999865 5689999999999999999999999975432 2222222222111100 000
Q ss_pred -------cC-CccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 650 -------VD-PTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 650 -------~d-~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
.+ .......+....++.+|+.+||+.||++|||+.|+++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 254 KQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp HSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 00 0001112234568899999999999999999999986
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=347.51 Aligned_cols=245 Identities=20% Similarity=0.335 Sum_probs=192.1
Q ss_pred hhhhCcCCCCceeEEEEEEec-CCcE----EEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCc
Q 004979 429 SNIIGSFSDGTVGTVYKGTLS-SGVE----IAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPF 503 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~-~~~~----vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 503 (721)
+++++.+|+|+||+||+|++. ++.. |++|.+.... .....+.|.+|++++++++|||||+++++|.+..
T Consensus 17 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-- 90 (327)
T 3poz_A 17 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT----SPKANKEILDEAYVMASVDNPHVCRLLGICLTST-- 90 (327)
T ss_dssp EEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-----------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS--
T ss_pred cccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc----CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC--
Confidence 367788999999999999964 4444 4666554221 1223467999999999999999999999998754
Q ss_pred eEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCC
Q 004979 504 TRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNN 583 (721)
Q Consensus 504 ~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~ 583 (721)
.++|+||+++|+|.+++... ...+++..+..|+.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 91 -~~~v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 166 (327)
T 3poz_A 91 -VQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp -EEEEEECCTTCBHHHHHHHS-TTSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEETTEEEECCTTHHHH
T ss_pred -eEEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCChheEEECCCCCEEEccCcceeE
Confidence 57999999999999998643 456999999999999999999999998 99999999999999999999999998742
Q ss_pred CC-----------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhcCCCCccccC
Q 004979 584 TT-----------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPLKDIVD 651 (721)
Q Consensus 584 ~~-----------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d 651 (721)
.. .++..|+|||.+.+..++.++|||||||++|||+| |+.||...... +.......+. ..
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~~~~~~~~-~~----- 238 (327)
T 3poz_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EISSILEKGE-RL----- 238 (327)
T ss_dssp HTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHHHHTTC-CC-----
T ss_pred ccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHH--HHHHHHHcCC-CC-----
Confidence 21 12347999999999999999999999999999999 99999644322 2222221111 11
Q ss_pred CccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 004979 652 PTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITA 695 (721)
Q Consensus 652 ~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~ 695 (721)
..+..++.++.+++.+||+.||++||++.|+++.|+.+..
T Consensus 239 ----~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 239 ----PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp ----CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred ----CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 1123345678899999999999999999999999998764
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=352.38 Aligned_cols=250 Identities=21% Similarity=0.330 Sum_probs=200.5
Q ss_pred hhhhCcCCCCceeEEEEEEe------cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcC-CCCccceEeEEEecCC
Q 004979 429 SNIIGSFSDGTVGTVYKGTL------SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKV-NHKNFVNLIGYCEEDE 501 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~------~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~ 501 (721)
+++.+.+|+|+||.||+|++ .+++.||||++.... .....+.+.+|++++.++ +|||||++++++.+.+
T Consensus 24 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~ 99 (359)
T 3vhe_A 24 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA----THSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 99 (359)
T ss_dssp EEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred eeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC----CHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCC
Confidence 37788999999999999974 245789999886432 123356799999999999 8999999999998755
Q ss_pred CceEEEEEecCCCCChhhhhhhccC-------------------------------------------------------
Q 004979 502 PFTRMMVFEYSPNGSLFEHLHIQEA------------------------------------------------------- 526 (721)
Q Consensus 502 ~~~~~lV~Ey~~~GsL~~~l~~~~~------------------------------------------------------- 526 (721)
. ..++||||+++|+|.++++....
T Consensus 100 ~-~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (359)
T 3vhe_A 100 G-PLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 178 (359)
T ss_dssp S-CCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------------
T ss_pred C-ceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhh
Confidence 3 36899999999999999974321
Q ss_pred ---------CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCCC-----------
Q 004979 527 ---------EHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTA----------- 586 (721)
Q Consensus 527 ---------~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~~----------- 586 (721)
..+++..+..|+.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 179 ~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~--ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 256 (359)
T 3vhe_A 179 EEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 256 (359)
T ss_dssp -----CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CE
T ss_pred cccccchhccccCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccC
Confidence 12889999999999999999999998 99999999999999999999999999864321
Q ss_pred CCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccHHHHHHH
Q 004979 587 AKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQENVLEEL 665 (721)
Q Consensus 587 ~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l 665 (721)
++..|+|||.+.+..++.++|||||||++|||+| |+.||....... . +.......... ..+..++.++
T Consensus 257 ~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-~-~~~~~~~~~~~---------~~~~~~~~~l 325 (359)
T 3vhe_A 257 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-E-FCRRLKEGTRM---------RAPDYTTPEM 325 (359)
T ss_dssp ECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH-H-HHHHHHHTCCC---------CCCTTCCHHH
T ss_pred CCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH-H-HHHHHHcCCCC---------CCCCCCCHHH
Confidence 2335999999999999999999999999999999 999997543322 1 22222211111 1122345678
Q ss_pred HHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 004979 666 LVVIKNCVHPDPKQRPSMRGIAAKLKEITAM 696 (721)
Q Consensus 666 ~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~ 696 (721)
.+++.+||+.||++||++.||++.|+++.+.
T Consensus 326 ~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 326 YQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence 9999999999999999999999999998764
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=347.82 Aligned_cols=238 Identities=17% Similarity=0.230 Sum_probs=196.6
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcC-CCCccceEeEEEecCCCceEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKV-NHKNFVNLIGYCEEDEPFTRMM 507 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~~~l 507 (721)
++++.+|+|+||+||+|+.. +++.||+|++....... ....+.+..|.+++..+ +||||+++++++.+.+ ..|+
T Consensus 23 ~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~--~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~--~~~l 98 (353)
T 2i0e_A 23 NFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQ--DDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD--RLYF 98 (353)
T ss_dssp EEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHH--TTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSS--EEEE
T ss_pred EEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhc--chHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCC--EEEE
Confidence 77888999999999999976 47789999886542211 22345688999999988 8999999999998877 7799
Q ss_pred EEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC---
Q 004979 508 VFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT--- 584 (721)
Q Consensus 508 V~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~--- 584 (721)
||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 99 v~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 174 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 174 (353)
T ss_dssp EEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEEcCCCcEEEEeCCcccccccC
Confidence 99999999999998643 45899999999999999999999998 999999999999999999999999998642
Q ss_pred ------CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCcccccc
Q 004979 585 ------TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQ 658 (721)
Q Consensus 585 ------~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 658 (721)
..++..|+|||.+.+..++.++|||||||++|||++|+.||... +..+....+...... ++
T Consensus 175 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~--~~~~~~~~i~~~~~~-----------~p 241 (353)
T 2i0e_A 175 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE--DEDELFQSIMEHNVA-----------YP 241 (353)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHCCCC-----------CC
T ss_pred CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCC--CHHHHHHHHHhCCCC-----------CC
Confidence 23456799999999999999999999999999999999999643 444555555544322 12
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 004979 659 ENVLEELLVVIKNCVHPDPKQRPS-----MRGIAA 688 (721)
Q Consensus 659 ~~~~~~l~~li~~Cl~~dP~~RPs-----~~evl~ 688 (721)
...+.++.+++.+||+.||++||+ ++||++
T Consensus 242 ~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 242 KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp TTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 344578899999999999999996 466653
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=347.05 Aligned_cols=248 Identities=17% Similarity=0.224 Sum_probs=198.4
Q ss_pred hhhhhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceE
Q 004979 427 DFSNIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTR 505 (721)
Q Consensus 427 ~~~~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~ 505 (721)
+.|++++.+|+|+||+||+|+.. +++.||||++.............+.+.+|++++++++|||||++++++.+.+ ..
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~--~~ 101 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDG--ML 101 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT--EE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC--EE
Confidence 44678889999999999999864 6889999998643221111112467999999999999999999999998877 67
Q ss_pred EEEEecCCCCChhhhhhhc--cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCc---EEEeccCC
Q 004979 506 MMVFEYSPNGSLFEHLHIQ--EAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYA---AKISDFSF 580 (721)
Q Consensus 506 ~lV~Ey~~~GsL~~~l~~~--~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~---~kL~DFGl 580 (721)
++||||+++|+|.+++... ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++. +||+|||+
T Consensus 102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN--IIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 9999999999998887543 2345899999999999999999999998 999999999999986654 99999998
Q ss_pred CCCC---------CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccC
Q 004979 581 WNNT---------TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVD 651 (721)
Q Consensus 581 a~~~---------~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d 651 (721)
++.. ..++..|+|||.+....++.++|||||||++|||+||+.||... ..+....+..+.....
T Consensus 180 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~---~~~~~~~i~~~~~~~~---- 252 (351)
T 3c0i_A 180 AIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT---KERLFEGIIKGKYKMN---- 252 (351)
T ss_dssp CEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS---HHHHHHHHHHTCCCCC----
T ss_pred eeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc---HHHHHHHHHcCCCCCC----
Confidence 7532 23456799999999999999999999999999999999999643 2333333333322111
Q ss_pred CccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 652 PTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 652 ~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
+ ......+.++.+|+.+||+.||++||++.|+++
T Consensus 253 ~---~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 253 P---RQWSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp H---HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred c---cccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0 011234567899999999999999999999986
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=350.21 Aligned_cols=266 Identities=20% Similarity=0.313 Sum_probs=198.2
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcE----EEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCce
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVE----IAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFT 504 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~----vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 504 (721)
++++.+|+|+||+||+|++. ++.. |++|.+...... .....+.+|+.++++++||||+++++++.+. .
T Consensus 16 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---~ 88 (325)
T 3kex_A 16 RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGR----QSFQAVTDHMLAIGSLDHAHIVRLLGLCPGS---S 88 (325)
T ss_dssp EEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSC----SCBCSCCHHHHHHHTCCCTTBCCEEEEECBS---S
T ss_pred eeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccH----HHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC---c
Confidence 67788999999999999964 4444 666665432211 1124578899999999999999999998643 4
Q ss_pred EEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC
Q 004979 505 RMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT 584 (721)
Q Consensus 505 ~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~ 584 (721)
.++||||+++|+|.+++... ...+++..+..|+.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 89 ~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 89 LQLVTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLEEHG--MVHRNLAARNVLLKSPSQVQVADFGVADLL 165 (325)
T ss_dssp EEEEEECCTTCBSHHHHHSS-GGGSCTTHHHHHHHHHHHHHHHHHHTT--CCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred cEEEEEeCCCCCHHHHHHHc-cccCCHHHHHHHHHHHHHHHHHHHhCC--CCCCccchheEEECCCCeEEECCCCccccc
Confidence 68999999999999998643 346889999999999999999999998 999999999999999999999999998643
Q ss_pred CC-----------CCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhcCCCCccccCC
Q 004979 585 TA-----------AKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPLKDIVDP 652 (721)
Q Consensus 585 ~~-----------~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 652 (721)
.. ++..|+|||.+.+..++.++|||||||++|||+| |+.||...... +.......+...
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~~~~~~------- 236 (325)
T 3kex_A 166 PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA--EVPDLLEKGERL------- 236 (325)
T ss_dssp CCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT--HHHHHHHTTCBC-------
T ss_pred CcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHH--HHHHHHHcCCCC-------
Confidence 21 2336999999999999999999999999999999 99999744322 222222222110
Q ss_pred ccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcC------------CCCCCCCCChhHHHHHHhhh
Q 004979 653 TLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAME------------PDGATPKLSPLWWAELEILS 717 (721)
Q Consensus 653 ~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~~------------~~~~~p~~~~~~~~~l~~~~ 717 (721)
..+..++.++.+++.+||+.||++||++.|+++.|+++.... .....|....+.|..++..+
T Consensus 237 ---~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ 310 (325)
T 3kex_A 237 ---AQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDPPRYLVIKRESGPGIAPGPEPHGLTNKKLEEVE 310 (325)
T ss_dssp ---CCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTSHHHHBCCCSSSSCCCBCCCCCCC----------
T ss_pred ---CCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchhhhccccCCCCCCCCCCccccchhhcccccc
Confidence 111223446788999999999999999999999999875421 12234566677887766543
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=345.48 Aligned_cols=248 Identities=13% Similarity=0.170 Sum_probs=200.5
Q ss_pred hhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcC-CCCccceEeEEEecCCCceEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKV-NHKNFVNLIGYCEEDEPFTRMM 507 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~~~l 507 (721)
++++.+|+|+||+||+|+. .+++.||||++...... +.+.+|+++++++ +||||+++++++...+ ..++
T Consensus 12 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~--~~~l 82 (330)
T 2izr_A 12 RVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA-------PQLHLEYRFYKQLGSGDGIPQVYYFGPCGK--YNAM 82 (330)
T ss_dssp EEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS-------CCHHHHHHHHHHHCSCTTSCCEEEEEEETT--EEEE
T ss_pred EEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch-------HHHHHHHHHHHHhhCCCCCCEEEEEEecCC--ccEE
Confidence 6778899999999999995 57889999987644321 3588999999999 9999999999998876 6799
Q ss_pred EEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCc-----EEEeccCCCC
Q 004979 508 VFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYA-----AKISDFSFWN 582 (721)
Q Consensus 508 V~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~-----~kL~DFGla~ 582 (721)
||||+ +|+|.+++... ...+++..+..|+.|++.||+|||+.+ |+||||||+|||++.++. +||+|||+++
T Consensus 83 v~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~--iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~ 158 (330)
T 2izr_A 83 VLELL-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHSKN--LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158 (330)
T ss_dssp EEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECCGGGTCTTSEEECCCTTCE
T ss_pred EEEeC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeeccCCCCCCceEEEEEcccce
Confidence 99999 99999998643 457999999999999999999999998 999999999999998887 9999999875
Q ss_pred CC----------------CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCC-CCHHHHHHHHhhcCCC
Q 004979 583 NT----------------TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIEN-GSLENWASEYLKGEQP 645 (721)
Q Consensus 583 ~~----------------~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~-~~~~~~~~~~~~~~~~ 645 (721)
.. ..++..|+|||.+.+..++.++|||||||++|||+||+.||.... ....+....+.....+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~ 238 (330)
T 2izr_A 159 EYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRA 238 (330)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHH
T ss_pred eeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhcc
Confidence 32 234568999999999999999999999999999999999997543 2333333332211110
Q ss_pred CccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcC
Q 004979 646 LKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAME 697 (721)
Q Consensus 646 ~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 697 (721)
.. ........+ ++.+++..||+.||.+||++.+|.+.|+++.+..
T Consensus 239 ~~------~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~ 283 (330)
T 2izr_A 239 TP------IEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRK 283 (330)
T ss_dssp SC------HHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred CC------HHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHc
Confidence 00 000111233 8999999999999999999999999999887654
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=342.22 Aligned_cols=241 Identities=17% Similarity=0.249 Sum_probs=198.7
Q ss_pred hhhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEE
Q 004979 429 SNIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMM 507 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~l 507 (721)
|++.+.+|+|+||+||+|+.. ++..+|+|.+.... .....+.+|++++++++||||+++++++.+.+ ..++
T Consensus 7 y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~------~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~--~~~l 78 (321)
T 1tki_A 7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG------TDQVLVKKEISILNIARHRNILHLHESFESME--ELVM 78 (321)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT------HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETT--EEEE
T ss_pred eEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc------ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCC--EEEE
Confidence 467788999999999999965 57789999876432 23456889999999999999999999998877 6799
Q ss_pred EEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCC--CCcEEEeccCCCCCCC
Q 004979 508 VFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTE--DYAAKISDFSFWNNTT 585 (721)
Q Consensus 508 V~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~--~~~~kL~DFGla~~~~ 585 (721)
||||+++|+|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||+++...
T Consensus 79 v~e~~~g~~L~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~g--ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~ 155 (321)
T 1tki_A 79 IFEFISGLDIFERINT-SAFELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155 (321)
T ss_dssp EECCCCCCBHHHHHTS-SSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred EEEeCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEEccCCCCCEEEEECCCCeECC
Confidence 9999999999999853 3346999999999999999999999998 999999999999997 7899999999986542
Q ss_pred C--------CCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccc
Q 004979 586 A--------AKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSF 657 (721)
Q Consensus 586 ~--------~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 657 (721)
. ++..|+|||.+.+..++.++|||||||++|||+||+.||... ...+....+..+...... ..
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~--~~~~~~~~i~~~~~~~~~-------~~ 226 (321)
T 1tki_A 156 PGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAE--TNQQIIENIMNAEYTFDE-------EA 226 (321)
T ss_dssp TTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCS--SHHHHHHHHHHTCCCCCH-------HH
T ss_pred CCCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCC--CHHHHHHHHHcCCCCCCh-------hh
Confidence 2 455799999998888999999999999999999999999643 334444444444322110 11
Q ss_pred cHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004979 658 QENVLEELLVVIKNCVHPDPKQRPSMRGIAAK 689 (721)
Q Consensus 658 ~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 689 (721)
....+.++.+++.+||+.||++|||+.|+++.
T Consensus 227 ~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 227 FKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred hccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 12345788999999999999999999999873
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=369.45 Aligned_cols=246 Identities=22% Similarity=0.348 Sum_probs=204.5
Q ss_pred hhhCcCCCCceeEEEEEEecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVF 509 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV~ 509 (721)
++.+.||+|+||+||+|++..+..||||++..... ..+.|.+|+++|++++|||||++++++.+ + ..++||
T Consensus 270 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~------~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~--~~~lv~ 340 (535)
T 2h8h_A 270 RLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM------SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-E--PIYIVT 340 (535)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS------CHHHHHHHHHHHHHCCCTTBCCEEEEECS-S--SCEEEE
T ss_pred hhheecccCCCeEEEEEEECCCceEEEEEeCCCCC------CHHHHHHHHHHHHhCCCCCEeeEEEEEee-c--cceEee
Confidence 66788999999999999998888899998864321 13579999999999999999999999976 3 468999
Q ss_pred ecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCCC---
Q 004979 510 EYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTA--- 586 (721)
Q Consensus 510 Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~~--- 586 (721)
||+++|+|.++++......+++..++.|+.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++....
T Consensus 341 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 418 (535)
T 2h8h_A 341 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 418 (535)
T ss_dssp CCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHH
T ss_pred ehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhhEEEcCCCcEEEcccccceecCCCce
Confidence 9999999999997544566999999999999999999999998 99999999999999999999999999875421
Q ss_pred -------CCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhcCCCCccccCCcccccc
Q 004979 587 -------AKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQ 658 (721)
Q Consensus 587 -------~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 658 (721)
++..|+|||.+....++.++|||||||++|||+| |+.||... ...+....+..+.. . ..+
T Consensus 419 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~--~~~~~~~~i~~~~~-~---------~~~ 486 (535)
T 2h8h_A 419 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM--VNREVLDQVERGYR-M---------PCP 486 (535)
T ss_dssp HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTC--CHHHHHHHHHTTCC-C---------CCC
T ss_pred ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHHHcCCC-C---------CCC
Confidence 2346999999998999999999999999999999 99999633 33333333332211 1 122
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCC
Q 004979 659 ENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAMEP 698 (721)
Q Consensus 659 ~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 698 (721)
..++.++.+||.+||+.||++||++.+|++.|+++.....
T Consensus 487 ~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~ 526 (535)
T 2h8h_A 487 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 526 (535)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCS
T ss_pred CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccC
Confidence 3456788999999999999999999999999998866443
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=365.42 Aligned_cols=248 Identities=19% Similarity=0.269 Sum_probs=196.8
Q ss_pred HhhhhhhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCc
Q 004979 425 CEDFSNIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPF 503 (721)
Q Consensus 425 ~~~~~~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 503 (721)
+++| ++++.||+|+||+||+|+.. +++.||+|++....... ......+.+|+.++..++|||||+++++|.+.+
T Consensus 73 ~~~y-~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~--~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~-- 147 (437)
T 4aw2_A 73 REDF-EILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLK--RAETACFREERDVLVNGDSKWITTLHYAFQDDN-- 147 (437)
T ss_dssp GGGE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHH--TTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSS--
T ss_pred hhhe-EEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhh--HHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCC--
Confidence 3444 67889999999999999976 47789999886432111 111234889999999999999999999999877
Q ss_pred eEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCC
Q 004979 504 TRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNN 583 (721)
Q Consensus 504 ~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~ 583 (721)
..++|||||++|+|.+++.. ....+++..+..++.||+.||+|||+.+ ||||||||+|||++.++.+||+|||+++.
T Consensus 148 ~~~lV~Ey~~gg~L~~~l~~-~~~~l~e~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILl~~~g~vkL~DFGla~~ 224 (437)
T 4aw2_A 148 NLYLVMDYYVGGDLLTLLSK-FEDRLPEEMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMDMNGHIRLADFGSCLK 224 (437)
T ss_dssp EEEEEECCCTTCBHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEEEecCCCCcHHHHHHH-ccCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeeEcCCCCEEEcchhhhhh
Confidence 78999999999999999964 2456999999999999999999999998 99999999999999999999999999853
Q ss_pred C----------CCCCccccchhhcc-----cCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCcc
Q 004979 584 T----------TAAKTGSAAMELLE-----TSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKD 648 (721)
Q Consensus 584 ~----------~~~~~~~~apE~~~-----~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 648 (721)
. ..++..|+|||.+. ...++.++|||||||++|||+||+.||... +..+....++......
T Consensus 225 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~--~~~~~~~~i~~~~~~~-- 300 (437)
T 4aw2_A 225 LMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAE--SLVETYGKIMNHKERF-- 300 (437)
T ss_dssp CCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCS--SHHHHHHHHHTHHHHC--
T ss_pred cccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCC--ChhHHHHhhhhccccc--
Confidence 2 24567899999986 567899999999999999999999999643 3334444433221000
Q ss_pred ccCCccccccHHHHHHHHHHHHHcccCCCCC--CCCHHHHHH
Q 004979 649 IVDPTLKSFQENVLEELLVVIKNCVHPDPKQ--RPSMRGIAA 688 (721)
Q Consensus 649 ~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~--RPs~~evl~ 688 (721)
..+......+.++.+|+.+||..+|++ ||+++|+++
T Consensus 301 ----~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 301 ----QFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp ----CCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred ----cCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 001111234567899999999988888 999999876
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=344.23 Aligned_cols=239 Identities=17% Similarity=0.290 Sum_probs=191.5
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCC------
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEP------ 502 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~------ 502 (721)
++++.+|+|+||+||+|+.. +++.||||++..... ....+.+.+|+++|++++|||||++++++.+...
T Consensus 9 ~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 9 EPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNR----ELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp EEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCST----TTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred ceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCc----hhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 77889999999999999976 789999999875432 2345679999999999999999999999865432
Q ss_pred -------------------------------------------------ceEEEEEecCCCCChhhhhhhcc-CCCCCHH
Q 004979 503 -------------------------------------------------FTRMMVFEYSPNGSLFEHLHIQE-AEHLDWA 532 (721)
Q Consensus 503 -------------------------------------------------~~~~lV~Ey~~~GsL~~~l~~~~-~~~l~~~ 532 (721)
...++||||+++|+|.+++.... .....+.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 12699999999999999997542 2346777
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC---------------------CCCccc
Q 004979 533 MRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT---------------------AAKTGS 591 (721)
Q Consensus 533 ~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~---------------------~~~~~~ 591 (721)
.+..|+.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++... .++..|
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 242 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKG--LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGG
T ss_pred HHHHHHHHHHHHHHHHHhCC--eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCc
Confidence 88999999999999999998 9999999999999999999999999875332 245679
Q ss_pred cchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccHHHHHHHHHHHHH
Q 004979 592 AAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKN 671 (721)
Q Consensus 592 ~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~ 671 (721)
+|||.+.+..++.++|||||||++|||+||..|+.. ........... ...........++.+++.+
T Consensus 243 ~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~----~~~~~~~~~~~----------~~~~~~~~~~~~~~~li~~ 308 (332)
T 3qd2_B 243 MSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME----RVRIITDVRNL----------KFPLLFTQKYPQEHMMVQD 308 (332)
T ss_dssp SCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH----HHHHHHHHHTT----------CCCHHHHHHCHHHHHHHHH
T ss_pred cChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH----HHHHHHHhhcc----------CCCcccccCChhHHHHHHH
Confidence 999999999999999999999999999999776521 11111111111 1112234455678999999
Q ss_pred cccCCCCCCCCHHHHHH
Q 004979 672 CVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 672 Cl~~dP~~RPs~~evl~ 688 (721)
||+.||++||++.|+++
T Consensus 309 ~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 309 MLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHCSSGGGSCCHHHHHH
T ss_pred HccCCCCcCCCHHHHhh
Confidence 99999999999999986
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=359.13 Aligned_cols=239 Identities=20% Similarity=0.252 Sum_probs=190.6
Q ss_pred hhhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEE
Q 004979 429 SNIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMM 507 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~l 507 (721)
+++++.||+|+||.||+|+. .++..||||++...... .......+.+|++++++++||||+++++++.+.+ ..++
T Consensus 150 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~--~~~l 225 (446)
T 4ejn_A 150 FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIV--AKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHD--RLCF 225 (446)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC---------------CCCCCSCTTSCCEEEEEEETT--EEEE
T ss_pred cEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhh--hhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCC--EEEE
Confidence 37788999999999999995 46889999998643211 1223456889999999999999999999999877 6799
Q ss_pred EEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC--
Q 004979 508 VFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQ-LTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT-- 584 (721)
Q Consensus 508 V~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~-~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~-- 584 (721)
||||+++|+|.+++.. ...+++..+..++.||+.||+|||+ .+ |+||||||+|||++.++.+||+|||+++..
T Consensus 226 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~g--iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 301 (446)
T 4ejn_A 226 VMEYANGGELFFHLSR--ERVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIK 301 (446)
T ss_dssp EECCCSSCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHHTC--CCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred EEeeCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhcCC--EEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence 9999999999999864 3468999999999999999999997 87 999999999999999999999999998642
Q ss_pred -------CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccc
Q 004979 585 -------TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSF 657 (721)
Q Consensus 585 -------~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 657 (721)
..++..|+|||.+.+..++.++|||||||++|||+||+.||... +..+....+......+
T Consensus 302 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~--~~~~~~~~i~~~~~~~----------- 368 (446)
T 4ejn_A 302 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ--DHEKLFELILMEEIRF----------- 368 (446)
T ss_dssp -----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHCCCCC-----------
T ss_pred CCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCC--CHHHHHHHHHhCCCCC-----------
Confidence 23466899999999999999999999999999999999999633 3444444444332221
Q ss_pred cHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 004979 658 QENVLEELLVVIKNCVHPDPKQRP-----SMRGIAA 688 (721)
Q Consensus 658 ~~~~~~~l~~li~~Cl~~dP~~RP-----s~~evl~ 688 (721)
+...+.++.+|+.+||+.||++|| ++.|+++
T Consensus 369 p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 369 PRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 223456789999999999999999 9999975
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=335.19 Aligned_cols=250 Identities=22% Similarity=0.360 Sum_probs=202.8
Q ss_pred hhhhCcCCCCceeEEEEEEecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 429 SNIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
+++++.+|+|+||+||+|+..++..|++|++..... ..+.+.+|++++++++||||+++++++.+. ..++|
T Consensus 15 y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~~~v 85 (279)
T 1qpc_A 15 LKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM------SPDAFLAEANLMKQLQHQRLVRLYAVVTQE---PIYII 85 (279)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS---SCEEE
T ss_pred hhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc------cHHHHHHHHHHHHhCCCcCcceEEEEEcCC---CcEEE
Confidence 367788999999999999988888999998864321 135789999999999999999999998754 35899
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCCC--
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTA-- 586 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~~-- 586 (721)
|||+++|+|.+++.......+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 163 (279)
T 1qpc_A 86 TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (279)
T ss_dssp EECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred EecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHhhEEEcCCCCEEECCCcccccccCcc
Confidence 99999999999986443346999999999999999999999998 99999999999999999999999998753321
Q ss_pred --------CCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccc
Q 004979 587 --------AKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSF 657 (721)
Q Consensus 587 --------~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 657 (721)
++..|+|||.+....++.++|||||||++|||+| |+.||... ...+.......+... ..
T Consensus 164 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~--~~~~~~~~~~~~~~~----------~~ 231 (279)
T 1qpc_A 164 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM--TNPEVIQNLERGYRM----------VR 231 (279)
T ss_dssp EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC--CHHHHHHHHHTTCCC----------CC
T ss_pred cccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCccc--CHHHHHHHHhcccCC----------CC
Confidence 2336899999988889999999999999999999 99999633 333333333322111 11
Q ss_pred cHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCCCCC
Q 004979 658 QENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAMEPDGA 701 (721)
Q Consensus 658 ~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~~~ 701 (721)
+..++.++.+++.+||+.||++||++.++++.|+++........
T Consensus 232 ~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~ 275 (279)
T 1qpc_A 232 PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQY 275 (279)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC----
T ss_pred cccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhccCCC
Confidence 23345688999999999999999999999999999877655443
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=347.66 Aligned_cols=239 Identities=22% Similarity=0.333 Sum_probs=194.7
Q ss_pred hhhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEE
Q 004979 429 SNIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMM 507 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~l 507 (721)
|.+.+.+|+|+||+||+|+. .++..||+|++....... ......+.+|+++++.++||||+++++++...+ ..++
T Consensus 11 Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~--~~~l 86 (336)
T 3h4j_B 11 YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKK--SDMHMRVEREISYLKLLRHPHIIKLYDVITTPT--DIVM 86 (336)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHH--TTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSS--EEEE
T ss_pred EEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccc--hhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC--EEEE
Confidence 46778899999999999996 578899999886432111 112357899999999999999999999999877 6799
Q ss_pred EEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC--
Q 004979 508 VFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT-- 585 (721)
Q Consensus 508 V~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~-- 585 (721)
||||+ +|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 87 v~E~~-~g~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~ 161 (336)
T 3h4j_B 87 VIEYA-GGELFDYIVEK--KRMTEDEGRRFFQQIICAIEYCHRHK--IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG 161 (336)
T ss_dssp EECCC-CEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHT--CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred EEECC-CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence 99999 78999988643 46999999999999999999999988 9999999999999999999999999986432
Q ss_pred ------CCCccccchhhcccCCC-CCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCcccccc
Q 004979 586 ------AAKTGSAAMELLETSAV-DLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQ 658 (721)
Q Consensus 586 ------~~~~~~~apE~~~~~~~-s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 658 (721)
.++..|+|||.+.+..+ +.++|||||||++|||+||+.||...... .....+.......+
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~-------------~~~~~i~~~~~~~p 228 (336)
T 3h4j_B 162 NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIP-------------NLFKKVNSCVYVMP 228 (336)
T ss_dssp BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSST-------------TCBCCCCSSCCCCC
T ss_pred cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHH-------------HHHHHHHcCCCCCc
Confidence 34568999999987776 68999999999999999999999643211 11111111122233
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004979 659 ENVLEELLVVIKNCVHPDPKQRPSMRGIAAK 689 (721)
Q Consensus 659 ~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 689 (721)
...+.++.+++.+||+.||.+|||+.|+++.
T Consensus 229 ~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 229 DFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 4456788999999999999999999999863
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=340.97 Aligned_cols=248 Identities=23% Similarity=0.369 Sum_probs=200.9
Q ss_pred hhhhCcCCCCceeEEEEEEe------cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCC
Q 004979 429 SNIIGSFSDGTVGTVYKGTL------SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEP 502 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~------~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~ 502 (721)
+.+.+.+|+|+||.||+|+. .++..||||++.... .....+.+.+|++++++++||||+++++++.+.+
T Consensus 25 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~- 99 (314)
T 2ivs_A 25 LVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA----SPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDG- 99 (314)
T ss_dssp EEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC----CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS-
T ss_pred eeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC----CHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCC-
Confidence 36778899999999999985 234789999886432 2334567999999999999999999999998876
Q ss_pred ceEEEEEecCCCCChhhhhhhccC----------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCC
Q 004979 503 FTRMMVFEYSPNGSLFEHLHIQEA----------------------EHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNL 560 (721)
Q Consensus 503 ~~~~lV~Ey~~~GsL~~~l~~~~~----------------------~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDL 560 (721)
..++||||+++|+|.+++..... ..+++..+..++.||+.||+|||+++ |+||||
T Consensus 100 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~di 176 (314)
T 2ivs_A 100 -PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK--LVHRDL 176 (314)
T ss_dssp -SCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT--EECCCC
T ss_pred -ceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC--Cccccc
Confidence 56999999999999999975322 34889999999999999999999998 999999
Q ss_pred CCCCeEeCCCCcEEEeccCCCCCCC-----------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCC
Q 004979 561 QSSSIYLTEDYAAKISDFSFWNNTT-----------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIE 628 (721)
Q Consensus 561 Kp~NILl~~~~~~kL~DFGla~~~~-----------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~ 628 (721)
||+|||+++++.+||+|||+++... .++..|+|||.+.+..++.++|||||||++|||+| |+.||...
T Consensus 177 kp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 256 (314)
T 2ivs_A 177 AARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 256 (314)
T ss_dssp SGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred chheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999875321 12345899999988889999999999999999999 99999643
Q ss_pred CCCHHHHHHHHhhcCCCCccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 004979 629 NGSLENWASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAM 696 (721)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~ 696 (721)
.. .+.......+.. ...+..++.++.+++.+||+.||++||++.|+++.|+++...
T Consensus 257 ~~--~~~~~~~~~~~~----------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 257 PP--ERLFNLLKTGHR----------MERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp CG--GGHHHHHHTTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CH--HHHHHHhhcCCc----------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 32 222222222111 112234557789999999999999999999999999998764
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=344.43 Aligned_cols=243 Identities=20% Similarity=0.283 Sum_probs=199.5
Q ss_pred hhhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEE
Q 004979 429 SNIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMM 507 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~l 507 (721)
+++++.+|+|+||.||+|+.. ++..||+|++..... .....+.+.+|++++++++|||||++++++.+.+ ..++
T Consensus 31 y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~--~~~l 105 (362)
T 2bdw_A 31 YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL---SARDFQKLEREARICRKLQHPNIVRLHDSIQEES--FHYL 105 (362)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS--EEEE
T ss_pred eEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC--EEEE
Confidence 477889999999999999965 688999999875432 2234567999999999999999999999998877 6799
Q ss_pred EEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCC---CcEEEeccCCCCCC
Q 004979 508 VFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTED---YAAKISDFSFWNNT 584 (721)
Q Consensus 508 V~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~---~~~kL~DFGla~~~ 584 (721)
||||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.+ +.+||+|||+++..
T Consensus 106 v~e~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~ 181 (362)
T 2bdw_A 106 VFDLVTGGELFEDIVA--REFYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 181 (362)
T ss_dssp EECCCCSCBHHHHHTT--CSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCC
T ss_pred EEecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCEEEeecCcceEe
Confidence 9999999999998863 356899999999999999999999998 9999999999999865 45999999998643
Q ss_pred C--------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCcccc
Q 004979 585 T--------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKS 656 (721)
Q Consensus 585 ~--------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 656 (721)
. .++..|+|||.+.+..++.++|||||||++|||+||+.||... +..+....+..+...... +
T Consensus 182 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~--~~~~~~~~i~~~~~~~~~---~---- 252 (362)
T 2bdw_A 182 NDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE--DQHRLYAQIKAGAYDYPS---P---- 252 (362)
T ss_dssp TTCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHTCCCCCT---T----
T ss_pred cCCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCC--CHHHHHHHHHhCCCCCCc---c----
Confidence 2 3456799999999999999999999999999999999999643 334444444443222111 1
Q ss_pred ccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004979 657 FQENVLEELLVVIKNCVHPDPKQRPSMRGIAAK 689 (721)
Q Consensus 657 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 689 (721)
....++.++.+++.+||+.||++||++.|+++.
T Consensus 253 ~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 253 EWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp GGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 112345778999999999999999999999864
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=351.06 Aligned_cols=242 Identities=19% Similarity=0.284 Sum_probs=198.4
Q ss_pred hhhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEE
Q 004979 429 SNIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMM 507 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~l 507 (721)
|++++.||+|+||+||+|+. .++..+|+|++..+.. .....+.+.+|++++++++|||||++++++.+.+ ..++
T Consensus 13 Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~---~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~--~~~l 87 (444)
T 3soa_A 13 YQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL---SARDHQKLEREARICRLLKHPNIVRLHDSISEEG--HHYL 87 (444)
T ss_dssp EEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSC---HHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSS--EEEE
T ss_pred eEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECC--EEEE
Confidence 47888999999999999985 4688899998875432 2334567999999999999999999999998877 6799
Q ss_pred EEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeC---CCCcEEEeccCCCCCC
Q 004979 508 VFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLT---EDYAAKISDFSFWNNT 584 (721)
Q Consensus 508 V~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~---~~~~~kL~DFGla~~~ 584 (721)
||||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++ +++.+||+|||+++..
T Consensus 88 v~E~~~gg~L~~~i~~--~~~~~e~~~~~i~~qil~aL~~lH~~g--ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~ 163 (444)
T 3soa_A 88 IFDLVTGGELFEDIVA--REYYSEADASHCIQQILEAVLHCHQMG--VVHRNLKPENLLLASKLKGAAVKLADFGLAIEV 163 (444)
T ss_dssp EECCCBCCBHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCC
T ss_pred EEEeCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEeccCCCCcEEEccCceeEEe
Confidence 9999999999999864 356999999999999999999999998 99999999999998 5688999999998543
Q ss_pred C---------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccc
Q 004979 585 T---------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLK 655 (721)
Q Consensus 585 ~---------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 655 (721)
. .++..|+|||.+....++.++||||+||++|||++|+.||... +..+....+..+...... +.
T Consensus 164 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~--~~~~~~~~i~~~~~~~~~---~~-- 236 (444)
T 3soa_A 164 EGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDE--DQHRLYQQIKAGAYDFPS---PE-- 236 (444)
T ss_dssp CTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCS--SHHHHHHHHHHTCCCCCT---TT--
T ss_pred cCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCc--cHHHHHHHHHhCCCCCCc---cc--
Confidence 2 3456899999999999999999999999999999999999643 344444444444322111 11
Q ss_pred cccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 656 SFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 656 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
....+.++.+|+.+||+.||++|||+.|+++
T Consensus 237 --~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 237 --WDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp --TTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred --cccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 1234567899999999999999999999987
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=328.98 Aligned_cols=244 Identities=20% Similarity=0.345 Sum_probs=203.0
Q ss_pred hhhCcCCCCceeEEEEEEecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVF 509 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV~ 509 (721)
++++.+|+|+||.||+|+..++..|++|++...... .+.+.+|++++++++||||+++++++.+.+ ..++||
T Consensus 11 ~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~ 82 (267)
T 3t9t_A 11 TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS------EEDFIEEAEVMMKLSHPKLVQLYGVCLEQA--PICLVT 82 (267)
T ss_dssp EEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBC------HHHHHHHHHHHHTCCCTTBCCEEEEECSSS--SCEEEE
T ss_pred eeeeEecCCCceeEEEEEecCCCeEEEEEccccCCC------HHHHHHHHHHHHhCCCCCEeeEEEEEccCC--CeEEEE
Confidence 667889999999999999988889999988653321 257899999999999999999999998876 569999
Q ss_pred ecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC----
Q 004979 510 EYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT---- 585 (721)
Q Consensus 510 Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~---- 585 (721)
||+++|+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 83 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 159 (267)
T 3t9t_A 83 EFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 159 (267)
T ss_dssp CCCTTCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred eCCCCCcHHHHHhhC-cccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEECCCCCEEEcccccccccccccc
Confidence 999999999998643 356899999999999999999999998 9999999999999999999999999876431
Q ss_pred ------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhcCCCCccccCCcccccc
Q 004979 586 ------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQ 658 (721)
Q Consensus 586 ------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 658 (721)
.++..|+|||.+....++.++||||||+++|||+| |+.||... ...+.......+.... .+
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~--~~~~~~~~i~~~~~~~----------~~ 227 (267)
T 3t9t_A 160 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR--SNSEVVEDISTGFRLY----------KP 227 (267)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC--CHHHHHHHHHTTCCCC----------CC
T ss_pred cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCC--CHHHHHHHHhcCCcCC----------CC
Confidence 22346899999998899999999999999999999 89999633 3334444433321110 11
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 004979 659 ENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAM 696 (721)
Q Consensus 659 ~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~ 696 (721)
...+.++.+++.+||+.||++||++.|+++.|+++.+.
T Consensus 228 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 228 RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 23356788999999999999999999999999998763
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=343.22 Aligned_cols=241 Identities=20% Similarity=0.318 Sum_probs=193.5
Q ss_pred hhhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEE
Q 004979 429 SNIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMM 507 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~l 507 (721)
+++++.+|+|+||+||+|+.. +++.||||++..+... ...+.+.+|+.++++++|||||++++++.+.+ ..++
T Consensus 9 y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~--~~~l 82 (323)
T 3tki_A 9 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV----DCPENIKKEICINKMLNHENVVKFYGHRREGN--IQYL 82 (323)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-----------CHHHHHHHHHHCCCTTBCCEEEEEECSS--EEEE
T ss_pred ceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc----chHHHHHHHHHHHHhCCCCCCCeEEEEEecCC--eEEE
Confidence 367888999999999999965 7889999998654322 22356889999999999999999999999877 6799
Q ss_pred EEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCC----
Q 004979 508 VFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNN---- 583 (721)
Q Consensus 508 V~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~---- 583 (721)
||||+++|+|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 83 v~e~~~~~~L~~~l~--~~~~~~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 158 (323)
T 3tki_A 83 FLEYCSGGELFDRIE--PDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (323)
T ss_dssp EEECCTTEEGGGGSB--TTTBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred EEEcCCCCcHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccchHHEEEeCCCCEEEEEeeccceeccC
Confidence 999999999999985 3346999999999999999999999998 99999999999999999999999999852
Q ss_pred -------CCCCCccccchhhcccCCC-CCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccc
Q 004979 584 -------TTAAKTGSAAMELLETSAV-DLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLK 655 (721)
Q Consensus 584 -------~~~~~~~~~apE~~~~~~~-s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 655 (721)
...++..|+|||.+.+..+ +.++|||||||++|||+||+.||.........+.. ........
T Consensus 159 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~-~~~~~~~~--------- 228 (323)
T 3tki_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD-WKEKKTYL--------- 228 (323)
T ss_dssp TEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHH-HHTTCTTS---------
T ss_pred CcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHH-HhcccccC---------
Confidence 2235667999999977765 78899999999999999999999754433222221 11111110
Q ss_pred cccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004979 656 SFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAK 689 (721)
Q Consensus 656 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 689 (721)
......+.++.+|+.+||+.||++|||+.|+++.
T Consensus 229 ~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 229 NPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 0113345678899999999999999999999763
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=349.45 Aligned_cols=250 Identities=17% Similarity=0.253 Sum_probs=196.1
Q ss_pred hhhhCcCCCC--ceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceE
Q 004979 429 SNIIGSFSDG--TVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTR 505 (721)
Q Consensus 429 ~~ii~~lg~G--~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~ 505 (721)
|++++.+|+| +||+||+|+.. +++.||||++..... .....+.+.+|++++++++|||||++++++.+.+ ..
T Consensus 27 y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~ 101 (389)
T 3gni_B 27 YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC---SNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN--EL 101 (389)
T ss_dssp EEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGS---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT--EE
T ss_pred EEEEecccCCcCCceEEEEEEEcCCCCEEEEEEeccccc---ChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECC--EE
Confidence 4778889999 99999999975 689999999875432 2344567899999999999999999999999877 67
Q ss_pred EEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC-
Q 004979 506 MMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT- 584 (721)
Q Consensus 506 ~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~- 584 (721)
++|||||++|+|.+++.......+++..+..|+.||+.||+|||+++ |+||||||+|||++.++.+||+|||.+...
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~ 179 (389)
T 3gni_B 102 WVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILISVDGKVYLSGLRSNLSMI 179 (389)
T ss_dssp EEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred EEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence 99999999999999997655567999999999999999999999998 999999999999999999999999975321
Q ss_pred ---------------CCCCccccchhhccc--CCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCc
Q 004979 585 ---------------TAAKTGSAAMELLET--SAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLK 647 (721)
Q Consensus 585 ---------------~~~~~~~~apE~~~~--~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~ 647 (721)
..++..|+|||.+.+ ..++.++|||||||++|||+||+.||........ ......+.. .
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~--~ 255 (389)
T 3gni_B 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM--LLEKLNGTV--P 255 (389)
T ss_dssp ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTH--HHHC--------
T ss_pred cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHhcCCC--C
Confidence 134456899999977 6799999999999999999999999974332111 111111000 0
Q ss_pred cccC-------------------------------------CccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004979 648 DIVD-------------------------------------PTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAK 689 (721)
Q Consensus 648 ~~~d-------------------------------------~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 689 (721)
.+.+ ..........+.++.+|+.+||+.||++|||+.|+++.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 256 CLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp --------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred ccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 0000 00001223345679999999999999999999999864
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-39 Score=338.71 Aligned_cols=259 Identities=20% Similarity=0.277 Sum_probs=201.8
Q ss_pred hhhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCc--eE
Q 004979 429 SNIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPF--TR 505 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~--~~ 505 (721)
+++.+.+|+|+||+||+|+. .+++.||||++...... .......+.+|++++.+++||||+++++++...... ..
T Consensus 14 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 91 (311)
T 3ork_A 14 YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLAR--DPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 91 (311)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTT--SHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred EEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccC--CHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCccc
Confidence 46788899999999999995 57889999988654322 234456799999999999999999999998764321 34
Q ss_pred EEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC
Q 004979 506 MMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT 585 (721)
Q Consensus 506 ~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~ 585 (721)
++||||+++|+|.++++.. ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 92 ~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 167 (311)
T 3ork_A 92 YIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIARAIA 167 (311)
T ss_dssp EEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEETTSCEEECCCSCC----
T ss_pred EEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEEcCCCCEEEeeccCccccc
Confidence 8999999999999998643 46899999999999999999999998 9999999999999999999999999986321
Q ss_pred ------------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCc
Q 004979 586 ------------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPT 653 (721)
Q Consensus 586 ------------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 653 (721)
.++..|+|||.+.+..++.++|||||||++|||+||+.||... ...+..............
T Consensus 168 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~--~~~~~~~~~~~~~~~~~~----- 240 (311)
T 3ork_A 168 DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD--SPVSVAYQHVREDPIPPS----- 240 (311)
T ss_dssp --------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS--SHHHHHHHHHHCCCCCHH-----
T ss_pred ccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC--ChHHHHHHHhcCCCCCcc-----
Confidence 2466799999999999999999999999999999999999643 333333333332211110
Q ss_pred cccccHHHHHHHHHHHHHcccCCCCCCCCHHH-HHHHHHHhhhcCCCCCC
Q 004979 654 LKSFQENVLEELLVVIKNCVHPDPKQRPSMRG-IAAKLKEITAMEPDGAT 702 (721)
Q Consensus 654 l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~e-vl~~L~~i~~~~~~~~~ 702 (721)
.....++.++.+++.+||+.||++||++.+ +...+.++....+....
T Consensus 241 --~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~~~~~~ 288 (311)
T 3ork_A 241 --ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPEAP 288 (311)
T ss_dssp --HHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTTCCCSSC
T ss_pred --cccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcCCCCCCC
Confidence 111234577899999999999999996554 55667776665544433
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-39 Score=363.06 Aligned_cols=242 Identities=19% Similarity=0.242 Sum_probs=199.1
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
++++.||+|+||.||+|+.. ++..||+|++....... ......+.+|+++|.+++|||||++++++.+.+ ..++|
T Consensus 187 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~--~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~--~l~lV 262 (576)
T 2acx_A 187 RQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK--RKGEAMALNEKQILEKVNSRFVVSLAYAYETKD--ALCLV 262 (576)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHH--TTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS--EEEEE
T ss_pred EEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhh--hHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCC--EEEEE
Confidence 56778999999999999965 78999999986543211 122456889999999999999999999998877 78999
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC----
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT---- 584 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~---- 584 (721)
|||+++|+|.+++.......+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 263 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g--IvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~ 340 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER--IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 340 (576)
T ss_dssp ECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred EEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCchheEEEeCCCCeEEEecccceecccCc
Confidence 99999999999987555556999999999999999999999998 999999999999999999999999998643
Q ss_pred ----CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCC--CHHHHHHHHhhcCCCCccccCCcccccc
Q 004979 585 ----TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENG--SLENWASEYLKGEQPLKDIVDPTLKSFQ 658 (721)
Q Consensus 585 ----~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~--~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 658 (721)
..++..|+|||.+.+..++.++|||||||++|||+||+.||..... ...+....+...... ++
T Consensus 341 ~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~-----------~p 409 (576)
T 2acx_A 341 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEE-----------YS 409 (576)
T ss_dssp CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCC-----------CC
T ss_pred cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhccccc-----------CC
Confidence 2346679999999988999999999999999999999999975432 223333332222111 22
Q ss_pred HHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 004979 659 ENVLEELLVVIKNCVHPDPKQRP-----SMRGIAA 688 (721)
Q Consensus 659 ~~~~~~l~~li~~Cl~~dP~~RP-----s~~evl~ 688 (721)
...+.++.+|+.+||+.||++|| ++.||++
T Consensus 410 ~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 410 ERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred ccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 34457889999999999999999 7788875
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=337.94 Aligned_cols=249 Identities=20% Similarity=0.278 Sum_probs=182.8
Q ss_pred hhhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEE
Q 004979 429 SNIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMM 507 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~l 507 (721)
+++++.+|+|+||+||+|+.. +++.||+|++....... ..+.+.+|++++++++|||||++++++.+.+ ..++
T Consensus 7 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--~~~l 80 (317)
T 2pmi_A 7 FKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEG----TPSTAIREISLMKELKHENIVRLYDVIHTEN--KLTL 80 (317)
T ss_dssp ------------CEEEEEECSSSCCEEEEEEEECCSTTC----SCHHHHHHHHHHTTCCBTTBCCEEEEECCTT--EEEE
T ss_pred eeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccc----cHHHHHHHHHHHHhcCCCCcceEEEEEEECC--eEEE
Confidence 367889999999999999864 68899999887543221 2256889999999999999999999998876 6799
Q ss_pred EEecCCCCChhhhhhhcc----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCC
Q 004979 508 VFEYSPNGSLFEHLHIQE----AEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNN 583 (721)
Q Consensus 508 V~Ey~~~GsL~~~l~~~~----~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~ 583 (721)
||||++ |+|.+++.... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 81 v~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~ 157 (317)
T 2pmi_A 81 VFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK--ILHRDLKPQNLLINKRGQLKLGDFGLARA 157 (317)
T ss_dssp EEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCSSCEE
T ss_pred EEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCChHHeEEcCCCCEEECcCcccee
Confidence 999998 69999886432 245899999999999999999999998 99999999999999999999999998753
Q ss_pred CC---------CCCccccchhhccc-CCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccc----
Q 004979 584 TT---------AAKTGSAAMELLET-SAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDI---- 649 (721)
Q Consensus 584 ~~---------~~~~~~~apE~~~~-~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~---- 649 (721)
.. .++..|+|||.+.+ ..++.++|||||||++|||+||+.||.... ..+....+..........
T Consensus 158 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~ 235 (317)
T 2pmi_A 158 FGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTN--DEEQLKLIFDIMGTPNESLWPS 235 (317)
T ss_dssp TTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHHHCSCCTTTCGG
T ss_pred cCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHHHhCCCChhHhhh
Confidence 21 24567999999875 468999999999999999999999996433 222222222110000000
Q ss_pred ------cCCcc-------------ccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 650 ------VDPTL-------------KSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 650 ------~d~~l-------------~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
..+.. .......+.++.+++.+||+.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 236 VTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp GGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 00000 0011134568999999999999999999999875
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-40 Score=359.84 Aligned_cols=241 Identities=19% Similarity=0.256 Sum_probs=194.3
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
++++.||+|+||+||+|+.. ++..+|+|++....... ....+.+.+|+++++.++|||||++++++.+.+ ..|+|
T Consensus 72 ~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~--~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~--~~~lV 147 (410)
T 3v8s_A 72 EVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIK--RSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR--YLYMV 147 (410)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH--TCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSS--EEEEE
T ss_pred EEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhh--hHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECC--EEEEE
Confidence 77889999999999999975 57889999886432111 111235889999999999999999999999877 78999
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCC-----
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNN----- 583 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~----- 583 (721)
|||+++|+|.++++. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 148 ~E~~~gg~L~~~l~~---~~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~ 222 (410)
T 3v8s_A 148 MEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG 222 (410)
T ss_dssp ECCCTTEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred EeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeeECCCCCEEEeccceeEeeccCC
Confidence 999999999999863 35899999999999999999999998 99999999999999999999999999853
Q ss_pred -----CCCCCccccchhhcccCC----CCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCcc
Q 004979 584 -----TTAAKTGSAAMELLETSA----VDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTL 654 (721)
Q Consensus 584 -----~~~~~~~~~apE~~~~~~----~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 654 (721)
...++..|+|||.+.... ++.++|||||||++|||+||+.||... +..+....+........ -+.
T Consensus 223 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~--~~~~~~~~i~~~~~~~~---~p~- 296 (410)
T 3v8s_A 223 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD--SLVGTYSKIMNHKNSLT---FPD- 296 (410)
T ss_dssp EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCS--SHHHHHHHHHTHHHHCC---CCT-
T ss_pred cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCC--ChhhHHHHHHhcccccc---CCC-
Confidence 233567899999987655 789999999999999999999999643 33444444433211000 000
Q ss_pred ccccHHHHHHHHHHHHHcccCCCCC--CCCHHHHHH
Q 004979 655 KSFQENVLEELLVVIKNCVHPDPKQ--RPSMRGIAA 688 (721)
Q Consensus 655 ~~~~~~~~~~l~~li~~Cl~~dP~~--RPs~~evl~ 688 (721)
....+.++.+|+.+||+.+|.+ ||+++||++
T Consensus 297 ---~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~ 329 (410)
T 3v8s_A 297 ---DNDISKEAKNLICAFLTDREVRLGRNGVEEIKR 329 (410)
T ss_dssp ---TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred ---cccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence 1124567899999999999988 999999986
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=336.25 Aligned_cols=256 Identities=20% Similarity=0.340 Sum_probs=202.3
Q ss_pred hhhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEE
Q 004979 429 SNIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMM 507 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~l 507 (721)
+++.+.+|+|+||.||+|+. .++..||+|++......+ ......+.+|++++++++||||+++++++...+ ..++
T Consensus 34 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~~l 109 (310)
T 2wqm_A 34 FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMD--AKARADCIKEIDLLKQLNHPNVIKYYASFIEDN--ELNI 109 (310)
T ss_dssp EEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCC--HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT--EEEE
T ss_pred eEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccC--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC--cEEE
Confidence 36778899999999999996 578899999886533222 334577999999999999999999999998877 6799
Q ss_pred EEecCCCCChhhhhhhc--cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC
Q 004979 508 VFEYSPNGSLFEHLHIQ--EAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT 585 (721)
Q Consensus 508 V~Ey~~~GsL~~~l~~~--~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~ 585 (721)
||||+++|+|.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 99999999999998642 3456899999999999999999999998 9999999999999999999999999875322
Q ss_pred ---------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCcccc
Q 004979 586 ---------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKS 656 (721)
Q Consensus 586 ---------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 656 (721)
.++..|+|||.+....++.++|||||||++|||+||+.||...................+ ...
T Consensus 188 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~------ 259 (310)
T 2wqm_A 188 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYP--PLP------ 259 (310)
T ss_dssp -----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSC--CCC------
T ss_pred CCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCC--CCc------
Confidence 245578999999999999999999999999999999999976555555554444332211 110
Q ss_pred ccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCCC
Q 004979 657 FQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAMEPD 699 (721)
Q Consensus 657 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~ 699 (721)
....+.++.+++.+||+.||++||++.||++.|+++.+....
T Consensus 260 -~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~ 301 (310)
T 2wqm_A 260 -SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTAS 301 (310)
T ss_dssp -TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred -ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhh
Confidence 123456789999999999999999999999999999876543
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=344.38 Aligned_cols=252 Identities=20% Similarity=0.327 Sum_probs=194.1
Q ss_pred hhhhCcCCCCceeEEEEEEecCCc----EEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCc-
Q 004979 429 SNIIGSFSDGTVGTVYKGTLSSGV----EIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPF- 503 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~~~~----~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~- 503 (721)
+++++.+|+|+||+||+|+..... .||||++...... ....+.+.+|++++++++||||+++++++...+..
T Consensus 25 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (323)
T 3qup_A 25 FTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIA---SSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG 101 (323)
T ss_dssp CEEEEEEEEETTEEEEEEEC-------CEEEEEEC---------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred eEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccC---HHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence 367788999999999999865432 7899988643221 23356899999999999999999999999875421
Q ss_pred ---eEEEEEecCCCCChhhhhhhcc----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEe
Q 004979 504 ---TRMMVFEYSPNGSLFEHLHIQE----AEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKIS 576 (721)
Q Consensus 504 ---~~~lV~Ey~~~GsL~~~l~~~~----~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~ 576 (721)
..++||||+++|+|.+++.... ...+++..+..|+.|++.||+|||+.+ |+||||||+|||+++++.+||+
T Consensus 102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--ivH~Dikp~NIli~~~~~~kl~ 179 (323)
T 3qup_A 102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN--FIHRDLAARNCMLAEDMTVCVA 179 (323)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTSCEEEC
T ss_pred CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC--cccCCCCcceEEEcCCCCEEEe
Confidence 2389999999999999986432 225899999999999999999999998 9999999999999999999999
Q ss_pred ccCCCCCCCC-----------CCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhcCC
Q 004979 577 DFSFWNNTTA-----------AKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQ 644 (721)
Q Consensus 577 DFGla~~~~~-----------~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~ 644 (721)
|||+++.... ++..|+|||.+.+..++.++|||||||++|||+| |+.||.... ..+.......+..
T Consensus 180 Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~--~~~~~~~~~~~~~ 257 (323)
T 3qup_A 180 DFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIE--NAEIYNYLIGGNR 257 (323)
T ss_dssp CCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--GGGHHHHHHTTCC
T ss_pred eccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccC--hHHHHHHHhcCCC
Confidence 9999864321 2336899999999999999999999999999999 999996433 2222233322211
Q ss_pred CCccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcC
Q 004979 645 PLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAME 697 (721)
Q Consensus 645 ~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 697 (721)
...+..++.++.+++.+||+.||++||++.|+++.|+++....
T Consensus 258 ----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~ 300 (323)
T 3qup_A 258 ----------LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300 (323)
T ss_dssp ----------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred ----------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 1112344567899999999999999999999999999987643
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=334.93 Aligned_cols=244 Identities=21% Similarity=0.254 Sum_probs=189.7
Q ss_pred hhhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccch---------------------hhHHHHHHHHHHHHHhcCC
Q 004979 429 SNIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADW---------------------SKNLESQFRKKIDTLSKVN 486 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~---------------------~~~~~~~f~~Ei~~l~~l~ 486 (721)
+++.+.+|+|+||+||+|+.. +++.||||++........ .....+.+.+|++++++++
T Consensus 15 y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 94 (298)
T 2zv2_A 15 YTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLD 94 (298)
T ss_dssp EEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTCC
T ss_pred eEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhCC
Confidence 367788999999999999864 678899999865432110 0112356899999999999
Q ss_pred CCccceEeEEEecCCCceEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeE
Q 004979 487 HKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIY 566 (721)
Q Consensus 487 H~nIv~l~g~~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NIL 566 (721)
||||+++++++.+......++||||+++|+|.+++. ...+++..+..++.||+.||+|||+.+ |+||||||+|||
T Consensus 95 h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil 169 (298)
T 2zv2_A 95 HPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT---LKPLSEDQARFYFQDLIKGIEYLHYQK--IIHRDIKPSNLL 169 (298)
T ss_dssp CTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC---SSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEE
T ss_pred CCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEE
Confidence 999999999998744346899999999999988753 356999999999999999999999998 999999999999
Q ss_pred eCCCCcEEEeccCCCCCC---------CCCCccccchhhcccCC---CCCCccHHHHHHHHHHHHhCCCcccCCCCCHHH
Q 004979 567 LTEDYAAKISDFSFWNNT---------TAAKTGSAAMELLETSA---VDLESNVYSFGTILFEMITGRISYSIENGSLEN 634 (721)
Q Consensus 567 l~~~~~~kL~DFGla~~~---------~~~~~~~~apE~~~~~~---~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~ 634 (721)
++.++.+||+|||+++.. ..++..|+|||.+.... ++.++|||||||++|||+||+.||... ....
T Consensus 170 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~--~~~~ 247 (298)
T 2zv2_A 170 VGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE--RIMC 247 (298)
T ss_dssp ECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS--SHHH
T ss_pred ECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc--cHHH
Confidence 999999999999987532 23456799999987655 378899999999999999999999643 3333
Q ss_pred HHHHHhhcCCCCccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 635 WASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 635 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
+............. ....+.++.+++.+||+.||++||++.|+++
T Consensus 248 ~~~~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 248 LHSKIKSQALEFPD---------QPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp HHHHHHHCCCCCCS---------SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred HHHHHhcccCCCCC---------ccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 33333322211110 1234467899999999999999999999864
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=345.83 Aligned_cols=254 Identities=23% Similarity=0.321 Sum_probs=203.5
Q ss_pred hhhhCcCCCCceeEEEEEEec-----CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCc
Q 004979 429 SNIIGSFSDGTVGTVYKGTLS-----SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPF 503 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~-----~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 503 (721)
+++++.+|+|+||+||++.+. +++.||||++.... .....+.+.+|++++++++||||+++++++.+.+..
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA----GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAA 108 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC----CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTT
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc----ChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCc
Confidence 377889999999999998753 67889999886432 233456799999999999999999999999876444
Q ss_pred eEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCC
Q 004979 504 TRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNN 583 (721)
Q Consensus 504 ~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~ 583 (721)
..++||||+++|+|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~i~~~l~~~l~~LH~~~--ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 183 (318)
T 3lxp_A 109 SLQLVMEYVPLGSLRDYLPR---HSIGLAQLLLFAQQICEGMAYLHAQH--YIHRDLAARNVLLDNDRLVKIGDFGLAKA 183 (318)
T ss_dssp EEEEEECCCTTCBHHHHGGG---SCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred eEEEEEecccCCcHHHHHhh---CCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEEcCCCCEEECCcccccc
Confidence 67999999999999999853 34899999999999999999999998 99999999999999999999999998754
Q ss_pred CCC------------CCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHH------------HHHHH
Q 004979 584 TTA------------AKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLEN------------WASEY 639 (721)
Q Consensus 584 ~~~------------~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~------------~~~~~ 639 (721)
... ++..|+|||.+.+..++.++|||||||++|||+||+.||......... .....
T Consensus 184 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (318)
T 3lxp_A 184 VPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTEL 263 (318)
T ss_dssp CCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHH
T ss_pred ccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHH
Confidence 322 233589999999888999999999999999999999998632111000 01111
Q ss_pred hhcCCCCccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCCCC
Q 004979 640 LKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAMEPDG 700 (721)
Q Consensus 640 ~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~~ 700 (721)
.... .....+..++.++.+++.+||+.||++||++.|+++.|+++.+.....
T Consensus 264 ~~~~---------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~ 315 (318)
T 3lxp_A 264 LERG---------ERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQ 315 (318)
T ss_dssp HHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC-
T ss_pred Hhcc---------cCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccC
Confidence 1110 011123345678999999999999999999999999999988765543
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=358.78 Aligned_cols=246 Identities=19% Similarity=0.267 Sum_probs=194.8
Q ss_pred hhhhhhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCce
Q 004979 426 EDFSNIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFT 504 (721)
Q Consensus 426 ~~~~~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 504 (721)
++| ++++.||+|+||+||+|+.. +++.||+|++....... ....+.+.+|++++.+++|||||++++++.+.+ .
T Consensus 61 ~~f-~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~--~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~--~ 135 (412)
T 2vd5_A 61 DDF-EILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLK--RGEVSCFREERDVLVNGDRRWITQLHFAFQDEN--Y 135 (412)
T ss_dssp GGE-EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH--HGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSS--E
T ss_pred hhE-EEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhh--HHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC--E
Confidence 344 67888999999999999975 68999999986432111 112345889999999999999999999999877 7
Q ss_pred EEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC
Q 004979 505 RMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT 584 (721)
Q Consensus 505 ~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~ 584 (721)
.|+||||+++|+|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 136 ~~lVmE~~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILld~~g~vkL~DFGla~~~ 212 (412)
T 2vd5_A 136 LYLVMEYYVGGDLLTLLSKF-GERIPAEMARFYLAEIVMAIDSVHRLG--YVHRDIKPDNILLDRCGHIRLADFGSCLKL 212 (412)
T ss_dssp EEEEECCCCSCBHHHHHHHH-SSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEEcCCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccCHHHeeecCCCCEEEeechhheec
Confidence 89999999999999999643 346999999999999999999999998 999999999999999999999999997532
Q ss_pred ----------CCCCccccchhhcc-------cCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCc
Q 004979 585 ----------TAAKTGSAAMELLE-------TSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLK 647 (721)
Q Consensus 585 ----------~~~~~~~~apE~~~-------~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~ 647 (721)
..++..|+|||.+. ...|+.++|||||||++|||+||+.||... +..+....+.......
T Consensus 213 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~--~~~~~~~~i~~~~~~~- 289 (412)
T 2vd5_A 213 RADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYAD--STAETYGKIVHYKEHL- 289 (412)
T ss_dssp CTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCS--SHHHHHHHHHTHHHHC-
T ss_pred cCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCC--CHHHHHHHHHhcccCc-
Confidence 24567899999986 467899999999999999999999999643 3333333333211000
Q ss_pred cccCCccccccHHHHHHHHHHHHHcccCCCCCC---CCHHHHHH
Q 004979 648 DIVDPTLKSFQENVLEELLVVIKNCVHPDPKQR---PSMRGIAA 688 (721)
Q Consensus 648 ~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~R---Ps~~evl~ 688 (721)
..+......+.++.+||.+||. +|++| |+++|+++
T Consensus 290 -----~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 290 -----SLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp -----CCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred -----CCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 0011123355789999999999 99998 58988865
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=334.86 Aligned_cols=251 Identities=22% Similarity=0.331 Sum_probs=202.4
Q ss_pred hhhhCcCCCCceeEEEEEEe------cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcC-CCCccceEeEEEecCC
Q 004979 429 SNIIGSFSDGTVGTVYKGTL------SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKV-NHKNFVNLIGYCEEDE 501 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~------~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~ 501 (721)
+++.+.+|+|+||+||+|+. .++..||||++..... ....+.+.+|+++++++ +||||+++++++...+
T Consensus 25 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 100 (313)
T 1t46_A 25 LSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH----LTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (313)
T ss_dssp EEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC----HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred hhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchh----HHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence 36778899999999999985 3467899998864321 23356799999999999 9999999999998877
Q ss_pred CceEEEEEecCCCCChhhhhhhccC----------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCe
Q 004979 502 PFTRMMVFEYSPNGSLFEHLHIQEA----------------EHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSI 565 (721)
Q Consensus 502 ~~~~~lV~Ey~~~GsL~~~l~~~~~----------------~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NI 565 (721)
..++||||+++|+|.+++..... ..+++..+..++.|++.||+|||+.+ |+||||||+||
T Consensus 101 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Ni 176 (313)
T 1t46_A 101 --PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNI 176 (313)
T ss_dssp --SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGE
T ss_pred --CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCccceE
Confidence 56999999999999999975432 24899999999999999999999998 99999999999
Q ss_pred EeCCCCcEEEeccCCCCCCCCC-----------CccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHH
Q 004979 566 YLTEDYAAKISDFSFWNNTTAA-----------KTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLE 633 (721)
Q Consensus 566 Ll~~~~~~kL~DFGla~~~~~~-----------~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~ 633 (721)
|++.++.+||+|||+++..... +..|+|||.+.+..++.++|||||||++|||+| |+.||.......
T Consensus 177 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~- 255 (313)
T 1t46_A 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS- 255 (313)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH-
T ss_pred EEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh-
Confidence 9999999999999988644321 235999999998999999999999999999999 999996443321
Q ss_pred HHHHHHhhcCCCCccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCC
Q 004979 634 NWASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAMEP 698 (721)
Q Consensus 634 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 698 (721)
............ ..+...+.++.+++.+||+.||++||++.|+++.|+++.....
T Consensus 256 -~~~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 310 (313)
T 1t46_A 256 -KFYKMIKEGFRM---------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISEST 310 (313)
T ss_dssp -HHHHHHHHTCCC---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred -HHHHHhccCCCC---------CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhh
Confidence 122222211110 0112345678999999999999999999999999999876543
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-39 Score=331.36 Aligned_cols=246 Identities=24% Similarity=0.388 Sum_probs=191.4
Q ss_pred hhhCcCCCCceeEEEEEEecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVF 509 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV~ 509 (721)
++.+.+|+|+||+||+|+.. +..+|||++........ ....+.+.+|++++++++||||+++++++.+.+ ..++||
T Consensus 10 ~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~ 85 (271)
T 3dtc_A 10 TLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDI-SQTIENVRQEAKLFAMLKHPNIIALRGVCLKEP--NLCLVM 85 (271)
T ss_dssp EEEEEEEEETTEEEEEEEET-TEEEEEEEC-----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC----CEEEE
T ss_pred eeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccH-HHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC--ceEEEE
Confidence 56778899999999999975 78899998865432221 222467899999999999999999999998876 569999
Q ss_pred ecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CeEeeCCCCCCeEeCC--------CCcEEEeccCC
Q 004979 510 EYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTP-PIAHRNLQSSSIYLTE--------DYAAKISDFSF 580 (721)
Q Consensus 510 Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~-~IvHrDLKp~NILl~~--------~~~~kL~DFGl 580 (721)
||+++|+|.+++. ...+++..+..++.|++.||+|||+.+. +|+||||||+|||++. ++.+||+|||+
T Consensus 86 e~~~~~~L~~~~~---~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~ 162 (271)
T 3dtc_A 86 EFARGGPLNRVLS---GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGL 162 (271)
T ss_dssp ECCTTEEHHHHHT---SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC
T ss_pred EcCCCCCHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCc
Confidence 9999999999984 3468999999999999999999999773 4999999999999986 77899999999
Q ss_pred CCCC-------CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCc
Q 004979 581 WNNT-------TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPT 653 (721)
Q Consensus 581 a~~~-------~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 653 (721)
++.. ..++..|+|||.+.+..++.++||||||+++|||+||+.||.... ..............
T Consensus 163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~--~~~~~~~~~~~~~~-------- 232 (271)
T 3dtc_A 163 AREWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGID--GLAVAYGVAMNKLA-------- 232 (271)
T ss_dssp -------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSC--HHHHHHHHHTSCCC--------
T ss_pred ccccccccccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHhhhcCCCC--------
Confidence 8632 234567999999999999999999999999999999999996432 22222222222111
Q ss_pred cccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 004979 654 LKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEI 693 (721)
Q Consensus 654 l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i 693 (721)
...+..++.++.+++.+||+.||++||++.|+++.|+++
T Consensus 233 -~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 233 -LPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp -CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred -CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 112234457789999999999999999999999999864
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=334.37 Aligned_cols=249 Identities=26% Similarity=0.481 Sum_probs=193.8
Q ss_pred hhhhCcCCCCceeEEEEEEecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 429 SNIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
+++.+.+|+|+||+||+|+... .+|+|++..... .....+.|.+|++++++++||||+++++++... ..++|
T Consensus 26 y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~lv 97 (289)
T 3og7_A 26 ITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAP---TPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAP---QLAIV 97 (289)
T ss_dssp CEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS---SCEEE
T ss_pred eeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCC---CHHHHHHHHHHHHHHHhCCCCcEEEEEeeccCC---ccEEE
Confidence 3677889999999999998653 589998865432 233456799999999999999999999977543 35899
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC---
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT--- 585 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~--- 585 (721)
|||+++|+|.+++.. ....+++..+..|+.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 98 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 174 (289)
T 3og7_A 98 TQWCEGSSLYHHLHA-SETKFEMKKLIDIARQTARGMDYLHAKS--IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS 174 (289)
T ss_dssp EECCCEEEHHHHHTT-C---CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEETTTEEEECCCC---------
T ss_pred EEecCCCcHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccccCccceEEECCCCCEEEccceecccccccc
Confidence 999999999999853 3456999999999999999999999998 9999999999999999999999999875322
Q ss_pred --------CCCccccchhhcc---cCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCcc
Q 004979 586 --------AAKTGSAAMELLE---TSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTL 654 (721)
Q Consensus 586 --------~~~~~~~apE~~~---~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 654 (721)
.++..|+|||.+. ...++.++|||||||++|||+||+.||.... ...........+.. .+..
T Consensus 175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-~~~~~~~~~~~~~~------~~~~ 247 (289)
T 3og7_A 175 GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNIN-NRDQIIEMVGRGSL------SPDL 247 (289)
T ss_dssp ---------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCC-CHHHHHHHHHHTSC------CCCT
T ss_pred ccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccc-hHHHHHHHhccccc------Ccch
Confidence 2456799999986 6678889999999999999999999996432 22222222222211 1112
Q ss_pred ccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 004979 655 KSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITA 695 (721)
Q Consensus 655 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~ 695 (721)
......++.++.+++.+||+.||++||++.|+++.|+++.+
T Consensus 248 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 248 SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 22334556789999999999999999999999999998764
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=340.77 Aligned_cols=251 Identities=23% Similarity=0.403 Sum_probs=202.8
Q ss_pred hhhhCcCCCCceeEEEEEEec--------CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcC-CCCccceEeEEEec
Q 004979 429 SNIIGSFSDGTVGTVYKGTLS--------SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKV-NHKNFVNLIGYCEE 499 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~--------~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~ 499 (721)
+.+.+.+|+|+||+||+|+.. ++..||+|++.... .....+.+.+|+++++++ +||||+++++++..
T Consensus 37 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 37 LTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA----TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp EEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred eEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC----cHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 367788999999999999863 46789999886432 233456799999999999 99999999999988
Q ss_pred CCCceEEEEEecCCCCChhhhhhhccC--------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCe
Q 004979 500 DEPFTRMMVFEYSPNGSLFEHLHIQEA--------------EHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSI 565 (721)
Q Consensus 500 ~~~~~~~lV~Ey~~~GsL~~~l~~~~~--------------~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NI 565 (721)
.+ ..++||||+++|+|.+++..... ..+++..+..++.||+.||+|||+.+ |+||||||+||
T Consensus 113 ~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NI 188 (334)
T 2pvf_A 113 DG--PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNV 188 (334)
T ss_dssp SS--CCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGE
T ss_pred CC--ceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCccceE
Confidence 76 56999999999999999974321 34899999999999999999999998 99999999999
Q ss_pred EeCCCCcEEEeccCCCCCCC-----------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHH
Q 004979 566 YLTEDYAAKISDFSFWNNTT-----------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLE 633 (721)
Q Consensus 566 Ll~~~~~~kL~DFGla~~~~-----------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~ 633 (721)
|++.++.+||+|||+++... .++..|+|||.+.+..++.++|||||||++|||+| |+.||... ...
T Consensus 189 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~--~~~ 266 (334)
T 2pvf_A 189 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI--PVE 266 (334)
T ss_dssp EECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC--CHH
T ss_pred EEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcC--CHH
Confidence 99999999999999875322 12345999999988889999999999999999999 99999633 333
Q ss_pred HHHHHHhhcCCCCccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCCC
Q 004979 634 NWASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAMEPD 699 (721)
Q Consensus 634 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~ 699 (721)
+.......+... ..+..++.++.+++.+||+.||++||++.|+++.|+++......
T Consensus 267 ~~~~~~~~~~~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~ 322 (334)
T 2pvf_A 267 ELFKLLKEGHRM----------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 322 (334)
T ss_dssp HHHHHHHHTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred HHHHHHhcCCCC----------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcccc
Confidence 443333332111 11233456789999999999999999999999999999876543
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=349.35 Aligned_cols=264 Identities=14% Similarity=0.166 Sum_probs=204.6
Q ss_pred hhhhCcCCCCceeEEEEEEecC---------CcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccce-------
Q 004979 429 SNIIGSFSDGTVGTVYKGTLSS---------GVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVN------- 492 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~~---------~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~------- 492 (721)
+++.+.+|+|+||+||+|+... +..||+|++... +.+.+|++++++++|||||+
T Consensus 44 y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----------~~~~~E~~~l~~l~h~niv~~~~~~~~ 113 (352)
T 2jii_A 44 WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----------GRLFNEQNFFQRAAKPLQVNKWKKLYS 113 (352)
T ss_dssp EEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT----------STHHHHHHHHHHHCCHHHHHHHHHHTT
T ss_pred EEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----------chHHHHHHHHHHhcccchhhhhhhhcc
Confidence 4677889999999999999764 788999987632 35789999999999999998
Q ss_pred --------EeEEEecCCCceEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCC
Q 004979 493 --------LIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSS 564 (721)
Q Consensus 493 --------l~g~~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~N 564 (721)
+++++...+. ..++||||+ +|+|.+++.......+++..+..|+.||+.||+|||+.+ |+||||||+|
T Consensus 114 ~~~~~i~~~~~~~~~~~~-~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dikp~N 189 (352)
T 2jii_A 114 TPLLAIPTCMGFGVHQDK-YRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE--YVHGNVTAEN 189 (352)
T ss_dssp CTTCSCCCCCEEEEETTT-EEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCCGGG
T ss_pred CCccCccchhhccccCCc-EEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCHHH
Confidence 6777765332 679999999 999999997554567999999999999999999999998 9999999999
Q ss_pred eEeCCCC--cEEEeccCCCCCCC----------------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCccc
Q 004979 565 IYLTEDY--AAKISDFSFWNNTT----------------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYS 626 (721)
Q Consensus 565 ILl~~~~--~~kL~DFGla~~~~----------------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~ 626 (721)
||++.++ .+||+|||+++... .++..|+|||.+.+..++.++|||||||++|||+||+.||.
T Consensus 190 Il~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 269 (352)
T 2jii_A 190 IFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWT 269 (352)
T ss_dssp EEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred EEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 9999998 99999999985321 34557899999999999999999999999999999999997
Q ss_pred CCCCCHHHHHHHHhhcCCCCccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCC
Q 004979 627 IENGSLENWASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAMEPDGATPKLS 706 (721)
Q Consensus 627 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~~~~p~~~ 706 (721)
........................+... .....+.++.+++.+||+.||++||++.||++.|+++.+.... ....
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~---~~~~ 344 (352)
T 2jii_A 270 NCLPNTEDIMKQKQKFVDKPGPFVGPCG--HWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRV---SPYD 344 (352)
T ss_dssp GGTTCHHHHHHHHHHHHHSCCCEECTTS--CEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTC---CTTS
T ss_pred cCCcCHHHHHHHHHhccCChhhhhhhcc--ccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCC---CcCc
Confidence 5443332222111100001111111110 0112357799999999999999999999999999998877643 2344
Q ss_pred hhHHH
Q 004979 707 PLWWA 711 (721)
Q Consensus 707 ~~~~~ 711 (721)
+++|+
T Consensus 345 ~~dw~ 349 (352)
T 2jii_A 345 PIGLP 349 (352)
T ss_dssp CCCCC
T ss_pred cccCc
Confidence 56664
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-39 Score=336.75 Aligned_cols=251 Identities=24% Similarity=0.329 Sum_probs=197.1
Q ss_pred hhhhhCcCCCCceeEEEEEEe-----cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCC
Q 004979 428 FSNIIGSFSDGTVGTVYKGTL-----SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEP 502 (721)
Q Consensus 428 ~~~ii~~lg~G~~g~Vyk~~~-----~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~ 502 (721)
++++++.+|+|+||.||+|++ .++..||+|++..... ....+.+.+|++++++++||||+++++++...+.
T Consensus 22 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 97 (302)
T 4e5w_A 22 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG----GNHIADLKKEIEILRNLYHENIVKYKGICTEDGG 97 (302)
T ss_dssp GEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC---------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---
T ss_pred hhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEeccccc----chhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCC
Confidence 357788999999999999984 3678899998864432 1224678999999999999999999999987644
Q ss_pred ceEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCC
Q 004979 503 FTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWN 582 (721)
Q Consensus 503 ~~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~ 582 (721)
...++||||+++|+|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 98 ~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 98 NGIKLIMEFLPSGSLKEYLPK-NKNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp CCEEEEEECCTTCBHHHHHHH-HTTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred ceEEEEEEeCCCCcHHHHHHh-ccccCCHHHHHHHHHHHHHHHHHhhcCC--cccCCCchheEEEcCCCCEEECcccccc
Confidence 467999999999999999854 3356999999999999999999999998 9999999999999999999999999875
Q ss_pred CCC------------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCC------------CCHHHHHHH
Q 004979 583 NTT------------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIEN------------GSLENWASE 638 (721)
Q Consensus 583 ~~~------------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~------------~~~~~~~~~ 638 (721)
... .++..|+|||.+.+..++.++|||||||++|||+||+.|+.... .........
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (302)
T 4e5w_A 175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVN 254 (302)
T ss_dssp ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHH
T ss_pred cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHH
Confidence 322 22335899999988899999999999999999999998864210 000111111
Q ss_pred HhhcCCCCccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 004979 639 YLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEIT 694 (721)
Q Consensus 639 ~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~ 694 (721)
...... ....+..+++++.+++.+||+.||++|||+.|+++.|+++.
T Consensus 255 ~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 255 TLKEGK---------RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHTTC---------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHhccC---------CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 111111 11123345678999999999999999999999999999875
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=344.16 Aligned_cols=238 Identities=19% Similarity=0.279 Sum_probs=191.1
Q ss_pred hCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEEEe
Q 004979 432 IGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFE 510 (721)
Q Consensus 432 i~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV~E 510 (721)
.+.||+|+||.||+|+. .++..||+|++..... ...+.+.+|+++|++++|||||++++++.+.+ ..++|||
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~--~~~lv~E 166 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM-----KDKEEVKNEISVMNQLDHANLIQLYDAFESKN--DIVLVME 166 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSH-----HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS--EEEEEEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc-----ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECC--EEEEEEe
Confidence 45689999999999986 4688999998875432 23467999999999999999999999998876 6799999
Q ss_pred cCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEe--CCCCcEEEeccCCCCCCC---
Q 004979 511 YSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYL--TEDYAAKISDFSFWNNTT--- 585 (721)
Q Consensus 511 y~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl--~~~~~~kL~DFGla~~~~--- 585 (721)
|+++|+|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||+ ++++.+||+|||+++...
T Consensus 167 ~~~~~~L~~~l~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~ 243 (373)
T 2x4f_A 167 YVDGGELFDRIID-ESYNLTELDTILFMKQICEGIRHMHQMY--ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE 243 (373)
T ss_dssp CCTTCEEHHHHHH-TGGGCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC
T ss_pred CCCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc
Confidence 9999999998864 2346899999999999999999999998 9999999999999 677899999999986322
Q ss_pred -----CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccHH
Q 004979 586 -----AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQEN 660 (721)
Q Consensus 586 -----~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 660 (721)
.++..|+|||.+....++.++|||||||++|||+||+.||... +..+....+......... .....
T Consensus 244 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~--~~~~~~~~i~~~~~~~~~-------~~~~~ 314 (373)
T 2x4f_A 244 KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGD--NDAETLNNILACRWDLED-------EEFQD 314 (373)
T ss_dssp BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCS--SHHHHHHHHHHTCCCSCS-------GGGTT
T ss_pred ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHhccCCCCh-------hhhcc
Confidence 2566799999999889999999999999999999999999643 334444444443222111 11123
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 661 VLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 661 ~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
.+.++.+|+.+||+.||++||++.|+++
T Consensus 315 ~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 315 ISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 4578899999999999999999999987
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=335.12 Aligned_cols=260 Identities=18% Similarity=0.257 Sum_probs=208.6
Q ss_pred hhhhhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccch-hhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCce
Q 004979 427 DFSNIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADW-SKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFT 504 (721)
Q Consensus 427 ~~~~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 504 (721)
+.+++.+.+|+|+||.||+|+.. ++..+|+|++........ .....+.+.+|++++++++||||+++++++.+.+ .
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~ 89 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRT--D 89 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS--E
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCC--E
Confidence 44578889999999999999965 688999999875432211 1112467999999999999999999999998876 6
Q ss_pred EEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCC----cEEEeccCC
Q 004979 505 RMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDY----AAKISDFSF 580 (721)
Q Consensus 505 ~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~----~~kL~DFGl 580 (721)
.++||||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++ .+||+|||+
T Consensus 90 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~--ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~ 165 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (321)
T ss_dssp EEEEECCCCSCBHHHHHHT--CSCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCTTSSSCCEEECCCTT
T ss_pred EEEEEEcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChHHEEEecCCCCcCCEEEccCcc
Confidence 7999999999999999863 456899999999999999999999998 99999999999999887 799999998
Q ss_pred CCCCC--------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCC
Q 004979 581 WNNTT--------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDP 652 (721)
Q Consensus 581 a~~~~--------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 652 (721)
++... .++..|+|||.+.+..++.++|||||||++|||+||+.||... ...+....+........
T Consensus 166 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~--~~~~~~~~i~~~~~~~~----- 238 (321)
T 2a2a_A 166 AHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD--TKQETLANITSVSYDFD----- 238 (321)
T ss_dssp CEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS--SHHHHHHHHHTTCCCCC-----
T ss_pred ceecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCC--CHHHHHHHHHhcccccC-----
Confidence 75322 2456799999999999999999999999999999999999643 33344433333221111
Q ss_pred ccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCChhHHHHHH
Q 004979 653 TLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAMEPDGATPKLSPLWWAELE 714 (721)
Q Consensus 653 ~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~~~~p~~~~~~~~~l~ 714 (721)
.......+.++.+++.+||+.||++|||+.|+++ +|.+.+..|....
T Consensus 239 --~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~-------------hp~~~~~~~~~~~ 285 (321)
T 2a2a_A 239 --EEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR-------------HPWITPVDNQQAM 285 (321)
T ss_dssp --HHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH-------------STTTSCSSHHHHH
T ss_pred --hhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc-------------CccccCCCccccc
Confidence 0111234567899999999999999999999986 5677777776653
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=336.67 Aligned_cols=255 Identities=20% Similarity=0.221 Sum_probs=194.6
Q ss_pred hhhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcC---CCCccceEeEEEecCCC--
Q 004979 429 SNIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKV---NHKNFVNLIGYCEEDEP-- 502 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l---~H~nIv~l~g~~~~~~~-- 502 (721)
+++++.+|+|+||+||+|+. .+++.||+|++...............+.+|+++++++ +||||+++++++.....
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~ 90 (308)
T 3g33_A 11 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDR 90 (308)
T ss_dssp CEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSS
T ss_pred eEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCC
Confidence 47888999999999999995 5788999999875432221111223566777777666 59999999999976442
Q ss_pred -ceEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCC
Q 004979 503 -FTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFW 581 (721)
Q Consensus 503 -~~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla 581 (721)
...++||||+. |+|.+++.......+++..+..|+.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 91 ~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 167 (308)
T 3g33_A 91 EIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSGGTVKLADFGLA 167 (308)
T ss_dssp EEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCTTTEEECTTSCEEECSCSCT
T ss_pred ceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCCCCEEEeeCccc
Confidence 24689999996 69999997655556999999999999999999999998 999999999999999999999999998
Q ss_pred CCCC--------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhc--CCCCccc--
Q 004979 582 NNTT--------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKG--EQPLKDI-- 649 (721)
Q Consensus 582 ~~~~--------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~--~~~~~~~-- 649 (721)
+... .++..|+|||.+.+..++.++|||||||++|||+||+.||.... ..+....+... ..+...+
T Consensus 168 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~ 245 (308)
T 3g33_A 168 RIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNS--EADQLGKIFDLIGLPPEDDWPR 245 (308)
T ss_dssp TTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSS--HHHHHHHHHHHHCCCCTTTSCS
T ss_pred cccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHHhCCCChhhccc
Confidence 6432 23557999999999999999999999999999999999996433 22222222211 0100000
Q ss_pred --------cC----CccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 650 --------VD----PTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 650 --------~d----~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
.. .......++.++++.+++.+||+.||++|||+.|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 246 DVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp SCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 00 0001112345578899999999999999999999985
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=349.53 Aligned_cols=252 Identities=24% Similarity=0.378 Sum_probs=194.2
Q ss_pred hhhCcCCCCceeEEEEEEec--CC--cEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceE
Q 004979 430 NIIGSFSDGTVGTVYKGTLS--SG--VEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTR 505 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~--~~--~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~ 505 (721)
++.+.+|+|+||+||+|++. ++ ..+|||.+.... .....++|.+|+.++++++|||||+++++|...+. ..
T Consensus 92 ~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~-~~ 166 (373)
T 3c1x_A 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT----DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG-SP 166 (373)
T ss_dssp EEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS----CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSS-CC
T ss_pred ecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC----CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCC-Ce
Confidence 45567899999999999864 22 356777764321 12345789999999999999999999999865432 46
Q ss_pred EEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC
Q 004979 506 MMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT 585 (721)
Q Consensus 506 ~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~ 585 (721)
++||||+++|+|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 167 ~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 167 LVVLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp EEEEECCTTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEEEECCCCCCHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHHHCC--EecCccchheEEECCCCCEEEeecccccccc
Confidence 899999999999999963 3456899999999999999999999998 9999999999999999999999999986331
Q ss_pred C-------------CCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhcCCCCccccC
Q 004979 586 A-------------AKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPLKDIVD 651 (721)
Q Consensus 586 ~-------------~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d 651 (721)
. ++..|+|||.+.+..++.++|||||||++|||+| |..||...... +.......+...
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~--~~~~~~~~~~~~------ 315 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITVYLLQGRRL------ 315 (373)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSS--CHHHHHHTTCCC------
T ss_pred ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHH--HHHHHHHcCCCC------
Confidence 1 2235999999999999999999999999999999 67777543321 112222222111
Q ss_pred CccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCCCCC
Q 004979 652 PTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAMEPDGA 701 (721)
Q Consensus 652 ~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~~~ 701 (721)
..+..++.++.+++.+||+.||++||++.|+++.|+++........
T Consensus 316 ----~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~~ 361 (373)
T 3c1x_A 316 ----LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH 361 (373)
T ss_dssp ----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSCC
T ss_pred ----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhccccc
Confidence 1123345678999999999999999999999999999987665443
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=334.19 Aligned_cols=249 Identities=19% Similarity=0.282 Sum_probs=193.6
Q ss_pred hhhhCcCCCCceeEEEEEEecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 429 SNIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
|++++.+|+|+||+||+|+..+++.+|+|++...... ....+.+.+|++++++++||||+++++++.+.+ ..++|
T Consensus 4 y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~lv 78 (288)
T 1ob3_A 4 YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKED---EGIPSTTIREISILKELKHSNIVKLYDVIHTKK--RLVLV 78 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGG---GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSS--CEEEE
T ss_pred chhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccc---cccchhHHHHHHHHHhcCCCCEeeeeeEEccCC--eEEEE
Confidence 3677889999999999999988999999998654322 122356889999999999999999999998876 67999
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC----
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT---- 584 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~---- 584 (721)
|||+++ +|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 79 ~e~~~~-~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (288)
T 1ob3_A 79 FEHLDQ-DLKKLLDV-CEGGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (288)
T ss_dssp EECCSE-EHHHHHHT-STTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred EEecCC-CHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCCEEEeECccccccCccc
Confidence 999975 99888863 3356899999999999999999999998 999999999999999999999999986421
Q ss_pred -----CCCCccccchhhccc-CCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhh--cCCCCcc--------
Q 004979 585 -----TAAKTGSAAMELLET-SAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLK--GEQPLKD-------- 648 (721)
Q Consensus 585 -----~~~~~~~~apE~~~~-~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~--~~~~~~~-------- 648 (721)
..++..|+|||.+.+ ..++.++|||||||++|||+||+.||.... ..+....... +......
T Consensus 155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T 1ob3_A 155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS--EADQLMRIFRILGTPNSKNWPNVTELP 232 (288)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHHHCCCChhhchhhhccc
Confidence 134567999999865 458999999999999999999999996432 2222222221 1000000
Q ss_pred ccCCc--------cccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 649 IVDPT--------LKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 649 ~~d~~--------l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
..++. ........+.++.+++.+||+.||++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00110 01122345678899999999999999999999875
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=339.80 Aligned_cols=247 Identities=15% Similarity=0.207 Sum_probs=193.9
Q ss_pred hhhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEE
Q 004979 429 SNIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMM 507 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~l 507 (721)
+++++.+|+|+||+||+|+. .++..+|+|++.............+.+.+|++++++++|||||++++++.+.+ ..++
T Consensus 28 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~--~~~l 105 (345)
T 3hko_A 28 YHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQ--YICL 105 (345)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS--EEEE
T ss_pred eeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCC--eEEE
Confidence 47888999999999999996 46788999988654322222344578999999999999999999999998876 6799
Q ss_pred EEecCCCCChhhhhhhcc--------------------------------------CCCCCHHHHHHHHHHHHHHHHHHh
Q 004979 508 VFEYSPNGSLFEHLHIQE--------------------------------------AEHLDWAMRLRIAMGMAYCLEHMH 549 (721)
Q Consensus 508 V~Ey~~~GsL~~~l~~~~--------------------------------------~~~l~~~~~~~ia~~ia~gL~yLH 549 (721)
||||+++|+|.+++.... ...+++..+..|+.||+.||+|||
T Consensus 106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH 185 (345)
T 3hko_A 106 VMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH 185 (345)
T ss_dssp EEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH
Confidence 999999999999884210 112356677889999999999999
Q ss_pred cCCCCeEeeCCCCCCeEeCCCC--cEEEeccCCCCCC-------------CCCCccccchhhccc--CCCCCCccHHHHH
Q 004979 550 QLTPPIAHRNLQSSSIYLTEDY--AAKISDFSFWNNT-------------TAAKTGSAAMELLET--SAVDLESNVYSFG 612 (721)
Q Consensus 550 ~~~~~IvHrDLKp~NILl~~~~--~~kL~DFGla~~~-------------~~~~~~~~apE~~~~--~~~s~ksDVwSfG 612 (721)
+.+ |+||||||+|||++.++ .+||+|||+++.. ..++..|+|||.+.. ..++.++||||||
T Consensus 186 ~~~--ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG 263 (345)
T 3hko_A 186 NQG--ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAG 263 (345)
T ss_dssp HTT--EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHH
T ss_pred HCC--ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHH
Confidence 998 99999999999998776 8999999987532 224567999999865 6789999999999
Q ss_pred HHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 613 TILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 613 vvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
|++|||+||+.||... ...+............. .+ .....+.++.+++.+||+.||++||++.|+++
T Consensus 264 ~il~el~~g~~pf~~~--~~~~~~~~~~~~~~~~~---~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 330 (345)
T 3hko_A 264 VLLHLLLMGAVPFPGV--NDADTISQVLNKKLCFE---NP----NYNVLSPLARDLLSNLLNRNVDERFDAMRALQ 330 (345)
T ss_dssp HHHHHHHHSSCSSCCS--SHHHHHHHHHHCCCCTT---SG----GGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHH
T ss_pred HHHHHHHHCCCCCCCC--ChHHHHHHHHhcccccC---Cc----ccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 9999999999999633 33344444443322111 11 11234567899999999999999999999987
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=359.03 Aligned_cols=237 Identities=19% Similarity=0.237 Sum_probs=195.6
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
++++.||+|+||+||+|+.. +++.||+|++....... ......+.+|++++++++|||||++++++.+.+ ..|+|
T Consensus 188 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~--~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~--~l~lV 263 (543)
T 3c4z_A 188 LDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKK--RKGYQGAMVEKKILAKVHSRFIVSLAYAFETKT--DLCLV 263 (543)
T ss_dssp EEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHH--TTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS--EEEEE
T ss_pred EEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhh--hHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCC--EEEEE
Confidence 55677999999999999975 68999999986543211 122457889999999999999999999998876 67999
Q ss_pred EecCCCCChhhhhhhcc--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC--
Q 004979 509 FEYSPNGSLFEHLHIQE--AEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT-- 584 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~--~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~-- 584 (721)
|||+++|+|.+++.... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g--IvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN--IIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC--CcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 99999999999986433 456999999999999999999999998 999999999999999999999999998532
Q ss_pred -------CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCC--CHHHHHHHHhhcCCCCccccCCccc
Q 004979 585 -------TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENG--SLENWASEYLKGEQPLKDIVDPTLK 655 (721)
Q Consensus 585 -------~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~--~~~~~~~~~~~~~~~~~~~~d~~l~ 655 (721)
..++..|+|||.+.+..++.++|||||||++|||+||+.||..... ...+....+......
T Consensus 342 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~---------- 411 (543)
T 3c4z_A 342 GQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVT---------- 411 (543)
T ss_dssp TCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCC----------
T ss_pred CCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccC----------
Confidence 2456689999999999999999999999999999999999975432 334444444433221
Q ss_pred cccHHHHHHHHHHHHHcccCCCCCCCCH
Q 004979 656 SFQENVLEELLVVIKNCVHPDPKQRPSM 683 (721)
Q Consensus 656 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~ 683 (721)
++...+.++.+++.+||+.||++||++
T Consensus 412 -~p~~~s~~~~~li~~lL~~dP~~R~~~ 438 (543)
T 3c4z_A 412 -YPDKFSPASKDFCEALLQKDPEKRLGF 438 (543)
T ss_dssp -CCTTSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred -CCcccCHHHHHHHHHhccCCHhHCCCC
Confidence 223445788999999999999999976
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=341.33 Aligned_cols=251 Identities=21% Similarity=0.332 Sum_probs=197.3
Q ss_pred hhhCcCCCCceeEEEEEEe------cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcC-CCCccceEeEEEecCCC
Q 004979 430 NIIGSFSDGTVGTVYKGTL------SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKV-NHKNFVNLIGYCEEDEP 502 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~------~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~ 502 (721)
++.+.+|+|+||+||+|+. .++..||||++..... ....+.+.+|++++.++ +||||+++++++...+
T Consensus 48 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~- 122 (344)
T 1rjb_A 48 EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD----SSEREALMSELKMMTQLGSHENIVNLLGACTLSG- 122 (344)
T ss_dssp EEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred eeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccC----HHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC-
Confidence 6778899999999999986 2456799998864321 22346799999999999 9999999999998876
Q ss_pred ceEEEEEecCCCCChhhhhhhccC---------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCC
Q 004979 503 FTRMMVFEYSPNGSLFEHLHIQEA---------------------EHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQ 561 (721)
Q Consensus 503 ~~~~lV~Ey~~~GsL~~~l~~~~~---------------------~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLK 561 (721)
..++||||+++|+|.+++..... ..+++..+..++.||+.||+|||+.+ |+|||||
T Consensus 123 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dik 199 (344)
T 1rjb_A 123 -PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CVHRDLA 199 (344)
T ss_dssp -SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--EEETTCS
T ss_pred -ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCC
Confidence 56999999999999999964322 23899999999999999999999988 9999999
Q ss_pred CCCeEeCCCCcEEEeccCCCCCCCC-----------CCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCC
Q 004979 562 SSSIYLTEDYAAKISDFSFWNNTTA-----------AKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIEN 629 (721)
Q Consensus 562 p~NILl~~~~~~kL~DFGla~~~~~-----------~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~ 629 (721)
|+|||++.++.+||+|||+++.... ++..|+|||.+.+..++.++|||||||++|||+| |+.||....
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 279 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence 9999999999999999999864321 1235999999988999999999999999999998 999997543
Q ss_pred CCHHHHHHHHhhcCCCCccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCCC
Q 004979 630 GSLENWASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAMEPD 699 (721)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~ 699 (721)
.. ............. ..+..++.++.+++.+||+.||++||++.|+++.|+.+....+.
T Consensus 280 ~~--~~~~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~ 338 (344)
T 1rjb_A 280 VD--ANFYKLIQNGFKM---------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAEE 338 (344)
T ss_dssp CS--HHHHHHHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-----
T ss_pred cH--HHHHHHHhcCCCC---------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHHH
Confidence 32 1222222221110 11223457789999999999999999999999999998776554
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=366.95 Aligned_cols=242 Identities=19% Similarity=0.300 Sum_probs=198.9
Q ss_pred cCCCCceeEEEEEEec---CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEEEe
Q 004979 434 SFSDGTVGTVYKGTLS---SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFE 510 (721)
Q Consensus 434 ~lg~G~~g~Vyk~~~~---~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV~E 510 (721)
.||+|+||+||+|.+. ++..||||+++.... ....+.|.+|+++|++++|||||+++++|... ..++|||
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~----~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~---~~~lv~E 415 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE----KADTEEMMREAQIMHQLDNPYIVRLIGVCQAE---ALMLVME 415 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCS----STTHHHHHHHHHHHTTCCCTTBCCEEEEEESS---SEEEEEE
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCC----hHHHHHHHHHHHHHHhCCCCCEeeEEEEeccC---CeEEEEE
Confidence 6899999999999864 456799998864321 22346799999999999999999999999763 4699999
Q ss_pred cCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCCC----
Q 004979 511 YSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTA---- 586 (721)
Q Consensus 511 y~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~~---- 586 (721)
|+++|+|.+++.. ....+++..+..|+.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 416 ~~~~g~L~~~l~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 492 (613)
T 2ozo_A 416 MAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSY 492 (613)
T ss_dssp CCTTCBHHHHHTT-CTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCCSTTTTCC-----
T ss_pred eCCCCcHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHCC--EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCce
Confidence 9999999999864 3456999999999999999999999998 99999999999999999999999999875321
Q ss_pred --------CCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccc
Q 004979 587 --------AKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSF 657 (721)
Q Consensus 587 --------~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 657 (721)
++..|+|||.+....++.++|||||||++|||+| |+.||.... ..+....+..+.. ...
T Consensus 493 ~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~--~~~~~~~i~~~~~----------~~~ 560 (613)
T 2ozo_A 493 YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK--GPEVMAFIEQGKR----------MEC 560 (613)
T ss_dssp ---------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--SHHHHHHHHTTCC----------CCC
T ss_pred eeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCC--HHHHHHHHHcCCC----------CCC
Confidence 1246999999999999999999999999999998 999996433 2333333333211 112
Q ss_pred cHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcC
Q 004979 658 QENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAME 697 (721)
Q Consensus 658 ~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 697 (721)
+..++.++.+||.+||+.||++||++.+|++.|+.+....
T Consensus 561 p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~ 600 (613)
T 2ozo_A 561 PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 600 (613)
T ss_dssp CTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 3345678999999999999999999999999999876543
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=343.91 Aligned_cols=242 Identities=17% Similarity=0.293 Sum_probs=197.9
Q ss_pred hhhhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEE
Q 004979 428 FSNIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRM 506 (721)
Q Consensus 428 ~~~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~ 506 (721)
.+++++.+|+|+||+||+|+.. ++..+|+|++.... ......+.+|+++|++++|||||++++++.+.+ ..+
T Consensus 52 ~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-----~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~--~~~ 124 (387)
T 1kob_A 52 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-----PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKY--EMV 124 (387)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-----HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSS--EEE
T ss_pred ceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc-----hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCC--EEE
Confidence 3578889999999999999965 67889998876432 122457899999999999999999999998876 679
Q ss_pred EEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCC--CCcEEEeccCCCCCC
Q 004979 507 MVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTE--DYAAKISDFSFWNNT 584 (721)
Q Consensus 507 lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~--~~~~kL~DFGla~~~ 584 (721)
+||||+++|+|.+++.. ....+++..+..++.||+.||+|||+++ |+||||||+|||++. ++.+||+|||+++..
T Consensus 125 lv~E~~~gg~L~~~l~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~ 201 (387)
T 1kob_A 125 LILEFLSGGELFDRIAA-EDYKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKL 201 (387)
T ss_dssp EEEECCCCCBHHHHTTC-TTCCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred EEEEcCCCCcHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccchHHeEEecCCCCceEEEecccceec
Confidence 99999999999999863 3346899999999999999999999998 999999999999984 578999999998643
Q ss_pred C--------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCcccc
Q 004979 585 T--------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKS 656 (721)
Q Consensus 585 ~--------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 656 (721)
. .++..|+|||.+.+..++.++|||||||++|||+||+.||... +..+....+......... .
T Consensus 202 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~--~~~~~~~~i~~~~~~~~~-------~ 272 (387)
T 1kob_A 202 NPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGE--DDLETLQNVKRCDWEFDE-------D 272 (387)
T ss_dssp CTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS--SHHHHHHHHHHCCCCCCS-------S
T ss_pred CCCcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCC--CHHHHHHHHHhCCCCCCc-------c
Confidence 2 3456799999999999999999999999999999999999643 333444444333221111 1
Q ss_pred ccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 657 FQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 657 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
.....+.++.+++.+||+.||++|||+.|+++
T Consensus 273 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 273 AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 11234567899999999999999999999986
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=335.63 Aligned_cols=246 Identities=20% Similarity=0.337 Sum_probs=193.1
Q ss_pred hhhhCcCCCCceeEEEEEEecC----CcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCce
Q 004979 429 SNIIGSFSDGTVGTVYKGTLSS----GVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFT 504 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~~----~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 504 (721)
+++.+.+|+|+||+||+|+... +..|++|+..... .....+.+.+|+.++++++||||+++++++.+. .
T Consensus 17 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---~ 89 (281)
T 1mp8_A 17 IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT----SDSVREKFLQEALTMRQFDHPHIVKLIGVITEN---P 89 (281)
T ss_dssp EEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT----SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS---S
T ss_pred eEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC----CHHHHHHHHHHHHHHHhCCCCccceEEEEEccC---c
Confidence 4677889999999999998643 3468888765322 233456799999999999999999999998543 4
Q ss_pred EEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC
Q 004979 505 RMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT 584 (721)
Q Consensus 505 ~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~ 584 (721)
.++||||+++|+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (281)
T 1mp8_A 90 VWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRYM 166 (281)
T ss_dssp CEEEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECC-------
T ss_pred cEEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHEEECCCCCEEECcccccccc
Confidence 58999999999999998643 346899999999999999999999998 999999999999999999999999988643
Q ss_pred CC----------CCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhcCCCCccccCCc
Q 004979 585 TA----------AKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPLKDIVDPT 653 (721)
Q Consensus 585 ~~----------~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 653 (721)
.. ++..|+|||.+....++.++|||||||++|||++ |+.||..... .+....+..+..
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~--~~~~~~i~~~~~--------- 235 (281)
T 1mp8_A 167 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN--NDVIGRIENGER--------- 235 (281)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG--GGHHHHHHTTCC---------
T ss_pred CcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCH--HHHHHHHHcCCC---------
Confidence 22 2236999999998999999999999999999997 9999964332 222222222211
Q ss_pred cccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 004979 654 LKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAM 696 (721)
Q Consensus 654 l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~ 696 (721)
...+..++.++.+++.+||+.||++||++.|+++.|+++.+.
T Consensus 236 -~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 277 (281)
T 1mp8_A 236 -LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277 (281)
T ss_dssp -CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 112234557789999999999999999999999999998654
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=341.06 Aligned_cols=242 Identities=19% Similarity=0.245 Sum_probs=196.4
Q ss_pred hhhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEE
Q 004979 429 SNIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMM 507 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~l 507 (721)
+++++.+|+|+||+||+|+. .++..||||++...... .....+.+.+|++++++++|||||++++++...+ ..++
T Consensus 56 y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~--~~~l 131 (348)
T 1u5q_A 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQ--SNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH--TAWL 131 (348)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT--EEEE
T ss_pred eeeeeEEccCCCEEEEEEEEccCCeEEEEEEEcccccc--chHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC--eEEE
Confidence 36678899999999999995 57889999988654322 2334567999999999999999999999998876 6799
Q ss_pred EEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC--
Q 004979 508 VFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT-- 585 (721)
Q Consensus 508 V~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~-- 585 (721)
||||+. |+|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 132 v~e~~~-g~l~~~l~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 207 (348)
T 1u5q_A 132 VMEYCL-GSASDLLEV-HKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 207 (348)
T ss_dssp EEECCS-EEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred EEecCC-CCHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCCCCEEEeeccCceecCCC
Confidence 999997 688888753 3457999999999999999999999998 9999999999999999999999999986433
Q ss_pred ---CCCccccchhhcc---cCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccH
Q 004979 586 ---AAKTGSAAMELLE---TSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQE 659 (721)
Q Consensus 586 ---~~~~~~~apE~~~---~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 659 (721)
.++..|+|||.+. ...++.++|||||||++|||+||+.||... +.............+. . ...
T Consensus 208 ~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~--~~~~~~~~~~~~~~~~--~-------~~~ 276 (348)
T 1u5q_A 208 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM--NAMSALYHIAQNESPA--L-------QSG 276 (348)
T ss_dssp CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS--CHHHHHHHHHHSCCCC--C-------CCT
T ss_pred CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC--ChHHHHHHHHhcCCCC--C-------CCC
Confidence 3566799999984 567899999999999999999999999633 3333333333332211 1 112
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004979 660 NVLEELLVVIKNCVHPDPKQRPSMRGIAAK 689 (721)
Q Consensus 660 ~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 689 (721)
..+.++.+++.+||+.||++|||+.|+++.
T Consensus 277 ~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 277 HWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred CCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 344678899999999999999999999864
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=332.21 Aligned_cols=250 Identities=16% Similarity=0.197 Sum_probs=193.7
Q ss_pred hhhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEE
Q 004979 429 SNIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMM 507 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~l 507 (721)
+++++.+|+|+||+||+|+.. +++.||+|++...... ....+.+.+|++++++++||||+++++++.+.+ ..++
T Consensus 4 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~l 78 (292)
T 3o0g_A 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD---EGVPSSALREICLLKELKHKNIVRLHDVLHSDK--KLTL 78 (292)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSS---TTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT--EEEE
T ss_pred ceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCc---CCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCC--EEEE
Confidence 366788999999999999965 6889999998754322 234467889999999999999999999998877 6799
Q ss_pred EEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC--
Q 004979 508 VFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT-- 585 (721)
Q Consensus 508 V~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~-- 585 (721)
||||+++ ++.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 79 v~e~~~~-~l~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~~--ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 154 (292)
T 3o0g_A 79 VFEFCDQ-DLKKYFDS-CNGDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp EEECCSE-EHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECCSC
T ss_pred EEecCCC-CHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeecccceecCCc
Confidence 9999975 66666543 3456999999999999999999999998 9999999999999999999999999985322
Q ss_pred -------CCCccccchhhcccCC-CCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCC-Ccccc------
Q 004979 586 -------AAKTGSAAMELLETSA-VDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQP-LKDIV------ 650 (721)
Q Consensus 586 -------~~~~~~~apE~~~~~~-~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~-~~~~~------ 650 (721)
.++..|+|||.+.+.. ++.++|||||||++|||+||..||... .+..+....+...... .....
T Consensus 155 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 233 (292)
T 3o0g_A 155 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG-NDVDDQLKRIFRLLGTPTEEQWPSMTKL 233 (292)
T ss_dssp CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCC-SSHHHHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred cccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCC-CCHHHHHHHHHHHhCCCChhhhhhhccc
Confidence 2355799999987665 899999999999999999998886433 2333333333221110 00000
Q ss_pred -----------CCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 651 -----------DPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 651 -----------d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
........+..+.++.+|+.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 00111122345678899999999999999999999975
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=337.71 Aligned_cols=265 Identities=14% Similarity=0.190 Sum_probs=203.8
Q ss_pred hhhhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEE
Q 004979 428 FSNIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRM 506 (721)
Q Consensus 428 ~~~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~ 506 (721)
-+++.+.+|+|+||+||+|+. .+++.||||++...... ..+.+|++++.+++|++++..++++...+. ..+
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~-~~~ 81 (296)
T 4hgt_A 10 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-------PQLHIESKIYKMMQGGVGIPTIRWCGAEGD-YNV 81 (296)
T ss_dssp -CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C-------CCHHHHHHHHHHHTTSTTCCCEEEEEEETT-EEE
T ss_pred ceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc-------hHHHHHHHHHHHhcCCCCCCeeeeecCCCC-ceE
Confidence 347788899999999999996 57888999986543321 357889999999999998888877754332 579
Q ss_pred EEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEe---CCCCcEEEeccCCCCC
Q 004979 507 MVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYL---TEDYAAKISDFSFWNN 583 (721)
Q Consensus 507 lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl---~~~~~~kL~DFGla~~ 583 (721)
+||||+ +|+|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+|||+ ++++.+||+|||+++.
T Consensus 82 lv~e~~-~~~L~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~ 157 (296)
T 4hgt_A 82 MVMELL-GPSLEDLFNF-CSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp EEEECC-CCBHHHHHHH-TTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred EEEEcc-CCCHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeeeeccCCCCeEEEecCcccee
Confidence 999999 9999999863 3456999999999999999999999998 9999999999999 7889999999998753
Q ss_pred C----------------CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCC-HHHHHHHHhhcCCCC
Q 004979 584 T----------------TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGS-LENWASEYLKGEQPL 646 (721)
Q Consensus 584 ~----------------~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~-~~~~~~~~~~~~~~~ 646 (721)
. ..++..|+|||.+.+..++.++|||||||++|||+||+.||...... ..+...........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~- 236 (296)
T 4hgt_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS- 236 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH-
T ss_pred ccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhccccc-
Confidence 2 23456789999999999999999999999999999999999743211 11111111110000
Q ss_pred ccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCChhHHHHH
Q 004979 647 KDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAMEPDGATPKLSPLWWAEL 713 (721)
Q Consensus 647 ~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~~~~p~~~~~~~~~l 713 (721)
.........++.++.+++.+||+.||++||++.||++.|+++...... ....+++|+.+
T Consensus 237 -----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~---~~~~~~dw~~~ 295 (296)
T 4hgt_A 237 -----TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF---SYDYVFDWNML 295 (296)
T ss_dssp -----SCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTC---CTTCCCGGGGC
T ss_pred -----chhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCC---CccCccchhhc
Confidence 000011123357899999999999999999999999999998876543 34557778754
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=334.17 Aligned_cols=253 Identities=22% Similarity=0.397 Sum_probs=196.7
Q ss_pred hhhCcCCCCceeEEEEEEec----CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCc--
Q 004979 430 NIIGSFSDGTVGTVYKGTLS----SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPF-- 503 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~----~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~-- 503 (721)
.+.+.+|+|+||.||+|+.. ++..||+|++..... .....+.+.+|++++++++||||+++++++.+.+..
T Consensus 37 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 113 (313)
T 3brb_A 37 ILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS---SQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGI 113 (313)
T ss_dssp EEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CC---CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC------
T ss_pred eeccceeecCCeEEEEEEEeccCCceeEEEEEEEecccc---chhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCC
Confidence 66778999999999999864 344799998865432 233456799999999999999999999999875422
Q ss_pred -eEEEEEecCCCCChhhhhhhc----cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEecc
Q 004979 504 -TRMMVFEYSPNGSLFEHLHIQ----EAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDF 578 (721)
Q Consensus 504 -~~~lV~Ey~~~GsL~~~l~~~----~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DF 578 (721)
..++||||+++|+|.+++... ....+++..+..|+.|++.||+|||+.+ |+||||||+|||++.++.+||+||
T Consensus 114 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~NIli~~~~~~kl~Df 191 (313)
T 3brb_A 114 PKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN--FLHRDLAARNCMLRDDMTVCVADF 191 (313)
T ss_dssp -CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCSGGGEEECTTSCEEECSC
T ss_pred cccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEcCCCcEEEeec
Confidence 358999999999999998532 3356999999999999999999999988 999999999999999999999999
Q ss_pred CCCCCCCC-----------CCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhcCCCC
Q 004979 579 SFWNNTTA-----------AKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPL 646 (721)
Q Consensus 579 Gla~~~~~-----------~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~ 646 (721)
|+++.... ++..|+|||.+.+..++.++|||||||++|||+| |+.||..... .+.......+..
T Consensus 192 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--~~~~~~~~~~~~-- 267 (313)
T 3brb_A 192 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN--HEMYDYLLHGHR-- 267 (313)
T ss_dssp SCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG--GGHHHHHHTTCC--
T ss_pred CcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCH--HHHHHHHHcCCC--
Confidence 99864321 2346899999999999999999999999999999 8889864332 222223322211
Q ss_pred ccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCCC
Q 004979 647 KDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAMEPD 699 (721)
Q Consensus 647 ~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~ 699 (721)
...+..++.++.+++.+||+.||++||++.|+++.|+++.+..++
T Consensus 268 --------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp~ 312 (313)
T 3brb_A 268 --------LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLPD 312 (313)
T ss_dssp --------CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC--
T ss_pred --------CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCC
Confidence 112234557799999999999999999999999999999876543
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=337.43 Aligned_cols=246 Identities=20% Similarity=0.333 Sum_probs=197.1
Q ss_pred hhhCcCCCCceeEEEEEEecCC-----cEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCce
Q 004979 430 NIIGSFSDGTVGTVYKGTLSSG-----VEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFT 504 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~~~-----~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 504 (721)
.+.+.+|+|+||+||+|+.... ..||||++.... .......+.+|++++++++||||+++++++.+.+ .
T Consensus 47 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~ 120 (333)
T 1mqb_A 47 TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY----TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK--P 120 (333)
T ss_dssp EEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC----CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS--S
T ss_pred hcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC----CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCC--C
Confidence 4557789999999999986532 358888876432 2334567999999999999999999999998766 6
Q ss_pred EEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC
Q 004979 505 RMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT 584 (721)
Q Consensus 505 ~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~ 584 (721)
.++||||+++|+|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 121 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 197 (333)
T 1mqb_A 121 MMIITEYMENGALDKFLRE-KDGEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVNSNLVCKVSDFGLSRVL 197 (333)
T ss_dssp EEEEEECCTTEEHHHHHHH-TTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred cEEEEeCCCCCcHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChheEEECCCCcEEECCCCcchhh
Confidence 7999999999999999864 3456999999999999999999999998 999999999999999999999999997643
Q ss_pred CC------------CCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhcCCCCccccC
Q 004979 585 TA------------AKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPLKDIVD 651 (721)
Q Consensus 585 ~~------------~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d 651 (721)
.. ++..|+|||.+....++.++|||||||++|||+| |+.||... ...+....+..+.. .
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~--~~~~~~~~~~~~~~-~----- 269 (333)
T 1mqb_A 198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL--SNHEVMKAINDGFR-L----- 269 (333)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC--CHHHHHHHHHTTCC-C-----
T ss_pred ccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccC--CHHHHHHHHHCCCc-C-----
Confidence 21 1235999999999999999999999999999999 99999533 23333333332211 1
Q ss_pred CccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 004979 652 PTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAM 696 (721)
Q Consensus 652 ~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~ 696 (721)
..+..++.++.+++.+||+.||++||++.|+++.|+++...
T Consensus 270 ----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 310 (333)
T 1mqb_A 270 ----PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 310 (333)
T ss_dssp ----CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ----CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 11223456789999999999999999999999999987664
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=347.05 Aligned_cols=262 Identities=18% Similarity=0.239 Sum_probs=208.2
Q ss_pred hhhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEE
Q 004979 429 SNIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMM 507 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~l 507 (721)
|.+.+.+|+|+||+||+|+.. +++.||||++...... ...+.+.+|++++++++|||||++++++...+....++
T Consensus 11 y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 86 (396)
T 4eut_A 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL----RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (396)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG----SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred eEEEEEEEcCCCeEEEEEEECCCCcEEEEEEecccccc----chHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEE
Confidence 467788999999999999965 5889999998643221 12456889999999999999999999998765446799
Q ss_pred EEecCCCCChhhhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEe----CCCCcEEEeccCCCC
Q 004979 508 VFEYSPNGSLFEHLHIQE-AEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYL----TEDYAAKISDFSFWN 582 (721)
Q Consensus 508 V~Ey~~~GsL~~~l~~~~-~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl----~~~~~~kL~DFGla~ 582 (721)
||||+++|+|.+++.... ...+++..+..|+.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||+++
T Consensus 87 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp EECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 999999999999997543 234999999999999999999999998 9999999999999 788889999999985
Q ss_pred CC--------CCCCccccchhhccc--------CCCCCCccHHHHHHHHHHHHhCCCcccCCC--CCHHHHHHHHhhcCC
Q 004979 583 NT--------TAAKTGSAAMELLET--------SAVDLESNVYSFGTILFEMITGRISYSIEN--GSLENWASEYLKGEQ 644 (721)
Q Consensus 583 ~~--------~~~~~~~~apE~~~~--------~~~s~ksDVwSfGvvL~ElltG~~P~~~~~--~~~~~~~~~~~~~~~ 644 (721)
.. ..++..|+|||.+.. ..++.++|||||||++|||+||+.||.... ....+.......+..
T Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p 244 (396)
T 4eut_A 165 ELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244 (396)
T ss_dssp ECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCC
T ss_pred EccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCC
Confidence 42 234568999998864 567889999999999999999999997422 233444555554422
Q ss_pred CC--c---cccC---------CccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 004979 645 PL--K---DIVD---------PTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAM 696 (721)
Q Consensus 645 ~~--~---~~~d---------~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~ 696 (721)
.. . ...+ +............+.+++.+||+.||++||++.|+++.++++...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp TTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred cccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 10 0 0000 111134467788899999999999999999999999999987664
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=335.32 Aligned_cols=264 Identities=14% Similarity=0.196 Sum_probs=204.9
Q ss_pred hhhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEE
Q 004979 429 SNIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMM 507 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~l 507 (721)
+++.+.+|+|+||+||+|+. .+++.||||++...... +.+.+|++++++++|++++..++++...+. ..++
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~-~~~l 82 (296)
T 3uzp_A 11 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-------PQLHIESKIYKMMQGGVGIPTIRWCGAEGD-YNVM 82 (296)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC-------CHHHHHHHHHHHHTTSTTCCCEEEEEEETT-EEEE
T ss_pred EEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch-------hHHHHHHHHHHHhhcCCCCCccccccCCCC-ceEE
Confidence 36778899999999999996 57889999987654322 358899999999999998877777654332 5799
Q ss_pred EEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEe---CCCCcEEEeccCCCCCC
Q 004979 508 VFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYL---TEDYAAKISDFSFWNNT 584 (721)
Q Consensus 508 V~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl---~~~~~~kL~DFGla~~~ 584 (721)
||||+ +|+|.+++.. ....+++..+..++.|++.||+|||+++ |+||||||+|||+ ++++.+||+|||+++..
T Consensus 83 v~e~~-~~~L~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 158 (296)
T 3uzp_A 83 VMELL-GPSLEDLFNF-CSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp EEECC-CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred EEEec-CCCHHHHHHh-hccCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence 99999 9999999863 3456999999999999999999999998 9999999999999 48899999999987532
Q ss_pred ----------------CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCC-CHHHHHHHHhhcCCCCc
Q 004979 585 ----------------TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENG-SLENWASEYLKGEQPLK 647 (721)
Q Consensus 585 ----------------~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~-~~~~~~~~~~~~~~~~~ 647 (721)
..++..|+|||.+.+..++.++|||||||++|||+||+.||..... ...+..........
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~--- 235 (296)
T 3uzp_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM--- 235 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH---
T ss_pred cccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhccccc---
Confidence 2345578999999999999999999999999999999999974321 11111111111000
Q ss_pred cccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCChhHHHHH
Q 004979 648 DIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAMEPDGATPKLSPLWWAEL 713 (721)
Q Consensus 648 ~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~~~~p~~~~~~~~~l 713 (721)
..........++.++.+++.+||+.||++||++.||++.|+++...... +...+++|+.+
T Consensus 236 ---~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~---~~~~~~dw~~~ 295 (296)
T 3uzp_A 236 ---STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF---SYDYVFDWNML 295 (296)
T ss_dssp ---HSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTC---CSSCCCGGGGC
T ss_pred ---CCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCC---ccccccccccc
Confidence 0000111123457799999999999999999999999999998876643 34556888754
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=341.59 Aligned_cols=240 Identities=19% Similarity=0.248 Sum_probs=191.5
Q ss_pred hhhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEE
Q 004979 429 SNIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMM 507 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~l 507 (721)
|++++.+|+|+||+||+++.. +++.||||++...... .+.+.+|+.++++++|||||++++++.+.+ ..++
T Consensus 22 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~E~~~l~~l~hpniv~~~~~~~~~~--~~~l 93 (361)
T 3uc3_A 22 YDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI------DENVQREIINHRSLRHPNIVRFKEVILTPT--HLAI 93 (361)
T ss_dssp EEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS------CHHHHHHHHHHHHCCCTTBCCEEEEEECSS--EEEE
T ss_pred EEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc------cHHHHHHHHHHHhCCCCCCCcEEEEEeeCC--EEEE
Confidence 477889999999999999965 7889999988643321 246889999999999999999999999877 6799
Q ss_pred EEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCc--EEEeccCCCCCC-
Q 004979 508 VFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYA--AKISDFSFWNNT- 584 (721)
Q Consensus 508 V~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~--~kL~DFGla~~~- 584 (721)
||||+++|+|.+++.. ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++. +||+|||+++..
T Consensus 94 v~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~ql~~~L~~LH~~~--ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~ 169 (361)
T 3uc3_A 94 IMEYASGGELYERICN--AGRFSEDEARFFFQQLLSGVSYCHSMQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 169 (361)
T ss_dssp EEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTT--CCSCCCCGGGEEECSSSSCCEEECCCCCC----
T ss_pred EEEeCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCCCCceEEEeecCcccccc
Confidence 9999999999999864 346899999999999999999999998 999999999999987765 999999988632
Q ss_pred -------CCCCccccchhhcccCCCCCC-ccHHHHHHHHHHHHhCCCcccCCC--CCHHHHHHHHhhcCCCCccccCCcc
Q 004979 585 -------TAAKTGSAAMELLETSAVDLE-SNVYSFGTILFEMITGRISYSIEN--GSLENWASEYLKGEQPLKDIVDPTL 654 (721)
Q Consensus 585 -------~~~~~~~~apE~~~~~~~s~k-sDVwSfGvvL~ElltG~~P~~~~~--~~~~~~~~~~~~~~~~~~~~~d~~l 654 (721)
..++..|+|||.+.+..++.+ +|||||||++|||+||+.||.... ...................
T Consensus 170 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~------ 243 (361)
T 3uc3_A 170 LHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPD------ 243 (361)
T ss_dssp -----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCT------
T ss_pred ccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCC------
Confidence 235668999999988887665 899999999999999999997432 2333444444332221111
Q ss_pred ccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004979 655 KSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAK 689 (721)
Q Consensus 655 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 689 (721)
....+.++.+|+.+||+.||++|||+.|+++.
T Consensus 244 ---~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 244 ---DIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp ---TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred ---cCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 11234678899999999999999999999864
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-39 Score=341.78 Aligned_cols=245 Identities=20% Similarity=0.348 Sum_probs=193.4
Q ss_pred hhhhCcCCCCceeEEEEEEec-CCcEE----EEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCc
Q 004979 429 SNIIGSFSDGTVGTVYKGTLS-SGVEI----AVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPF 503 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~-~~~~v----avk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 503 (721)
+++++.+|+|+||+||+|+.. ++..+ ++|.+.... .....+.+.+|++++++++||||+++++++....
T Consensus 17 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~----~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-- 90 (327)
T 3lzb_A 17 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT----SPKANKEILDEAYVMASVDNPHVCRLLGICLTST-- 90 (327)
T ss_dssp EEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS----SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS--
T ss_pred ceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc----CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC--
Confidence 367889999999999999954 45444 555443221 1223467999999999999999999999998754
Q ss_pred eEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCC
Q 004979 504 TRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNN 583 (721)
Q Consensus 504 ~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~ 583 (721)
.++|+||+++|+|.+++... ...+++..+..|+.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 91 -~~~v~~~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kL~DfG~a~~ 166 (327)
T 3lzb_A 91 -VQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp -EEEEECCCSSCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEETTEEEECCTTC---
T ss_pred -ceEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhCC--CcCCCCCHHHEEEcCCCCEEEccCcceeE
Confidence 57999999999999998643 456999999999999999999999998 99999999999999999999999999864
Q ss_pred CCC-----------CCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhcCCCCccccC
Q 004979 584 TTA-----------AKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPLKDIVD 651 (721)
Q Consensus 584 ~~~-----------~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d 651 (721)
... ++..|+|||.+.+..++.++|||||||++|||+| |+.||...... +.......+.. .
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~--~~~~~~~~~~~-~----- 238 (327)
T 3lzb_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EISSILEKGER-L----- 238 (327)
T ss_dssp -------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHHHHTTCC-C-----
T ss_pred ccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHH--HHHHHHHcCCC-C-----
Confidence 321 2336999999999999999999999999999999 99999643322 22222222111 0
Q ss_pred CccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 004979 652 PTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITA 695 (721)
Q Consensus 652 ~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~ 695 (721)
..+..++.++.+++.+||+.||++||++.|+++.|+++..
T Consensus 239 ----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 239 ----PQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp ----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred ----CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 1122345678899999999999999999999999999864
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=332.58 Aligned_cols=254 Identities=22% Similarity=0.347 Sum_probs=195.8
Q ss_pred hhhhhhCcCCCCceeEEEEEEecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcC--CCCccceEeEEEecCCC--
Q 004979 427 DFSNIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKV--NHKNFVNLIGYCEEDEP-- 502 (721)
Q Consensus 427 ~~~~ii~~lg~G~~g~Vyk~~~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l--~H~nIv~l~g~~~~~~~-- 502 (721)
+-+++++.+|+|+||+||+|+.. +..||||++.... ...+.+|.+++..+ +||||+++++++.....
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 107 (337)
T 3mdy_A 37 KQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE--------EASWFRETEIYQTVLMRHENILGFIAADIKGTGSW 107 (337)
T ss_dssp HHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG--------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGG
T ss_pred cceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc--------cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCC
Confidence 33478899999999999999976 8899999875321 13345555655554 99999999999987632
Q ss_pred ceEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcC------CCCeEeeCCCCCCeEeCCCCcEEEe
Q 004979 503 FTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQL------TPPIAHRNLQSSSIYLTEDYAAKIS 576 (721)
Q Consensus 503 ~~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~------~~~IvHrDLKp~NILl~~~~~~kL~ 576 (721)
...++||||+++|+|.++++. ..+++..+..++.|++.||+|||+. .++|+||||||+|||++.++.+||+
T Consensus 108 ~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~ 184 (337)
T 3mdy_A 108 TQLYLITDYHENGSLYDYLKS---TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIA 184 (337)
T ss_dssp CEEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEEC
T ss_pred CceEEEEeccCCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEE
Confidence 267999999999999999963 3589999999999999999999987 2239999999999999999999999
Q ss_pred ccCCCCCC-------------CCCCccccchhhcccCCCCCC------ccHHHHHHHHHHHHhC----------CCcccC
Q 004979 577 DFSFWNNT-------------TAAKTGSAAMELLETSAVDLE------SNVYSFGTILFEMITG----------RISYSI 627 (721)
Q Consensus 577 DFGla~~~-------------~~~~~~~~apE~~~~~~~s~k------sDVwSfGvvL~ElltG----------~~P~~~ 627 (721)
|||+++.. ..++..|+|||.+....++.+ +|||||||++|||+|| +.||..
T Consensus 185 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~ 264 (337)
T 3mdy_A 185 DLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHD 264 (337)
T ss_dssp CCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhh
Confidence 99987421 235567999999987777665 9999999999999999 666643
Q ss_pred CC---CCHHHHHHHHhhcCCCCccccCCccc--cccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCC
Q 004979 628 EN---GSLENWASEYLKGEQPLKDIVDPTLK--SFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAMEP 698 (721)
Q Consensus 628 ~~---~~~~~~~~~~~~~~~~~~~~~d~~l~--~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 698 (721)
.. ...... ........ ..+... .....++.++.+++.+||+.||++||++.||++.|+++.+...
T Consensus 265 ~~~~~~~~~~~-~~~~~~~~-----~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 334 (337)
T 3mdy_A 265 LVPSDPSYEDM-REIVCIKK-----LRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQD 334 (337)
T ss_dssp TSCSSCCHHHH-HHHHTTSC-----CCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTTT
T ss_pred hcCCCCchhhh-HHHHhhhc-----cCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhcc
Confidence 21 111222 22111111 111111 1124678899999999999999999999999999999887654
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-38 Score=339.04 Aligned_cols=241 Identities=20% Similarity=0.270 Sum_probs=187.0
Q ss_pred hhhhhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceE
Q 004979 427 DFSNIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTR 505 (721)
Q Consensus 427 ~~~~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~ 505 (721)
+.+++.+.+|+|+||+||+|+.. +++.||||++.... ..+.+.+|++++++++||||+++++++.+.+ ..
T Consensus 53 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~ 123 (349)
T 2w4o_A 53 DFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-------DKKIVRTEIGVLLRLSHPNIIKLKEIFETPT--EI 123 (349)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------------CHHHHHCCCTTBCCEEEEEECSS--EE
T ss_pred CcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-------hHHHHHHHHHHHHhCCCCCCcceeeeEecCC--eE
Confidence 33577788999999999999976 57889999886432 2356889999999999999999999998876 67
Q ss_pred EEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCC---CCcEEEeccCCCC
Q 004979 506 MMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTE---DYAAKISDFSFWN 582 (721)
Q Consensus 506 ~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~---~~~~kL~DFGla~ 582 (721)
++||||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||+++
T Consensus 124 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~ 199 (349)
T 2w4o_A 124 SLVLELVTGGELFDRIVE--KGYYSERDAADAVKQILEAVAYLHENG--IVHRDLKPENLLYATPAPDAPLKIADFGLSK 199 (349)
T ss_dssp EEEECCCCSCBHHHHHTT--CSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEESSSSTTCCEEECCCC---
T ss_pred EEEEEeCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCcccEEEecCCCCCCEEEccCcccc
Confidence 999999999999999863 356899999999999999999999998 999999999999975 8999999999976
Q ss_pred CCC--------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCcc
Q 004979 583 NTT--------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTL 654 (721)
Q Consensus 583 ~~~--------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 654 (721)
... .++..|+|||.+.+..++.++|||||||++|||+||+.||...... ......+....... ..
T Consensus 200 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~~~~~i~~~~~~~---~~--- 272 (349)
T 2w4o_A 200 IVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD-QFMFRRILNCEYYF---IS--- 272 (349)
T ss_dssp -------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH-HHHHHHHHTTCCCC---CT---
T ss_pred ccCcccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc-HHHHHHHHhCCCcc---CC---
Confidence 432 2456799999999999999999999999999999999999644322 22233333322111 11
Q ss_pred ccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 655 KSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 655 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
......+.++.+|+.+||+.||++||++.|+++
T Consensus 273 -~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 273 -PWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp -TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -chhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 112344567899999999999999999999986
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=332.66 Aligned_cols=246 Identities=25% Similarity=0.419 Sum_probs=197.8
Q ss_pred hhhhCcCCCCceeEEEEEEecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 429 SNIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
+++++.+|+|+||+||+|+.. +..|+||++.... ..+.+.+|++++++++||||+++++++.+.+. ..++|
T Consensus 23 y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~-------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~lv 93 (278)
T 1byg_A 23 LKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-------TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG-GLYIV 93 (278)
T ss_dssp EEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC---------HHHHHTHHHHTTCCCTTBCCEEEEECCC---CCEEE
T ss_pred ceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh-------HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCC-ceEEE
Confidence 367788999999999999875 7889999886432 23578999999999999999999999765432 46899
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC---
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT--- 585 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~--- 585 (721)
|||+++|+|.+++.......+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 94 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 171 (278)
T 1byg_A 94 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 171 (278)
T ss_dssp ECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred EecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCcceEEEeCCCcEEEeeccccccccccc
Confidence 99999999999997544445889999999999999999999998 9999999999999999999999999876432
Q ss_pred ---CCCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccHHH
Q 004979 586 ---AAKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQENV 661 (721)
Q Consensus 586 ---~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 661 (721)
.++..|+|||.+.+..++.++||||||+++|||+| |+.||.... ..+.......+.. ...+..+
T Consensus 172 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~--~~~~~~~~~~~~~----------~~~~~~~ 239 (278)
T 1byg_A 172 DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP--LKDVVPRVEKGYK----------MDAPDGC 239 (278)
T ss_dssp ----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC--GGGHHHHHTTTCC----------CCCCTTC
T ss_pred cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHHhcCCC----------CCCcccC
Confidence 23457999999998999999999999999999999 999996432 2222222222211 1122345
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcC
Q 004979 662 LEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAME 697 (721)
Q Consensus 662 ~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 697 (721)
+.++.+++.+||+.||++||++.|+++.|+++....
T Consensus 240 ~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~ 275 (278)
T 1byg_A 240 PPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 275 (278)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred CHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhhh
Confidence 578899999999999999999999999999987654
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=343.15 Aligned_cols=260 Identities=12% Similarity=0.089 Sum_probs=192.2
Q ss_pred hhhhCcCCCCceeEEEEEEec----CCcEEEEEEeeeccccchh------hHHHHHHHHHHHHHhcCCCCccceEeEEEe
Q 004979 429 SNIIGSFSDGTVGTVYKGTLS----SGVEIAVTSTSVKSRADWS------KNLESQFRKKIDTLSKVNHKNFVNLIGYCE 498 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~----~~~~vavk~~~~~~~~~~~------~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~ 498 (721)
+++.+.+|+|+||+||+|+.. ++..+++|+.......... ......+.+|+..+..++||||+++++++.
T Consensus 39 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~~ 118 (345)
T 2v62_A 39 WVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGL 118 (345)
T ss_dssp EEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEEE
T ss_pred EEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecccc
Confidence 467789999999999999975 5678999988654321110 011234778999999999999999999987
Q ss_pred cC--CCceEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCC--cEE
Q 004979 499 ED--EPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDY--AAK 574 (721)
Q Consensus 499 ~~--~~~~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~--~~k 574 (721)
.. +....++||||+ +|+|.+++.... .+++..+..|+.||+.||+|||+.+ |+||||||+|||++.++ .+|
T Consensus 119 ~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~~~k 193 (345)
T 2v62_A 119 TEFKGRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHENE--YVHGDIKAANLLLGYKNPDQVY 193 (345)
T ss_dssp EESSSCEEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEESSSTTSEE
T ss_pred cccCCCcEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCcCHHHEEEccCCCCcEE
Confidence 62 123679999999 999999986433 7999999999999999999999998 99999999999999887 999
Q ss_pred EeccCCCCCC----------------CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHH
Q 004979 575 ISDFSFWNNT----------------TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASE 638 (721)
Q Consensus 575 L~DFGla~~~----------------~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~ 638 (721)
|+|||+++.. ..++..|+|||.+.+..++.++|||||||++|||+||+.||.....+.......
T Consensus 194 L~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~ 273 (345)
T 2v62_A 194 LADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTA 273 (345)
T ss_dssp ECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHH
T ss_pred EEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHHH
Confidence 9999998532 234568999999999999999999999999999999999996433332222111
Q ss_pred HhhcCCCCccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 004979 639 YLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITA 695 (721)
Q Consensus 639 ~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~ 695 (721)
................ ....++.++.+++.+||+.||++||++.+|++.|+++..
T Consensus 274 ~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 274 KTNLLDELPQSVLKWA--PSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp HHHHHHTTTHHHHHHS--CTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred HHhhcccccHHHHhhc--cccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 1100000110000000 001345689999999999999999999999999988654
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=326.74 Aligned_cols=239 Identities=21% Similarity=0.360 Sum_probs=196.5
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
++.+.+|+|+||+||+|+.. ++..||+|++....... ......+.+|++++++++||||+++++++.+.+ ..++|
T Consensus 12 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv 87 (279)
T 3fdn_A 12 EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEK--AGVEHQLRREVEIQSHLRHPNILRLYGYFHDAT--RVYLI 87 (279)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH--HTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS--EEEEE
T ss_pred EEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccch--hhHHHHHHHHHHHHHcCCCCCCcchhheEecCC--EEEEE
Confidence 67788999999999999865 56789999886432211 223467899999999999999999999998876 67999
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC----
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT---- 584 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~---- 584 (721)
|||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 88 ~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~ 163 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 163 (279)
T ss_dssp ECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTT--CEECCCCGGGEEECTTSCEEECSCCEESCC----
T ss_pred EecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHhEEEcCCCCEEEEeccccccCCccc
Confidence 9999999999998643 45899999999999999999999988 999999999999999999999999987532
Q ss_pred ---CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccHHH
Q 004979 585 ---TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQENV 661 (721)
Q Consensus 585 ---~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 661 (721)
..++..|+|||.+.+..++.++||||||+++|||++|+.||... ...+........... .+...
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~--~~~~~~~~~~~~~~~-----------~~~~~ 230 (279)
T 3fdn_A 164 RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN--TYQETYKRISRVEFT-----------FPDFV 230 (279)
T ss_dssp ----CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCS--SHHHHHHHHHHTCCC-----------CCTTS
T ss_pred ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCC--cHHHHHHHHHhCCCC-----------CCCcC
Confidence 23456789999999999999999999999999999999999633 333333333332221 12234
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004979 662 LEELLVVIKNCVHPDPKQRPSMRGIAAK 689 (721)
Q Consensus 662 ~~~l~~li~~Cl~~dP~~RPs~~evl~~ 689 (721)
+.++.+++.+||+.||++||++.|+++.
T Consensus 231 ~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 231 TEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp CHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred CHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 4678899999999999999999999974
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-39 Score=334.99 Aligned_cols=245 Identities=23% Similarity=0.344 Sum_probs=193.3
Q ss_pred hhhhCcCCCCceeEEEEEEecC-C-------cEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecC
Q 004979 429 SNIIGSFSDGTVGTVYKGTLSS-G-------VEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEED 500 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~~-~-------~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~ 500 (721)
+++.+.+|+|+||+||+|+... + ..|++|++.... ....+.+.+|++++++++||||+++++++.+.
T Consensus 10 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~-----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (289)
T 4fvq_A 10 LIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH-----RNYSESFFEAASMMSKLSHKHLVLNYGVCVCG 84 (289)
T ss_dssp EEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG-----GGGHHHHHHHHHHHHTSCCTTBCCEEEEECCT
T ss_pred eeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc-----HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC
Confidence 3677889999999999998653 3 468888875432 22346799999999999999999999999887
Q ss_pred CCceEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCc--------
Q 004979 501 EPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYA-------- 572 (721)
Q Consensus 501 ~~~~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~-------- 572 (721)
+ ..++||||+++|+|.+++... ...+++..+..|+.||+.||+|||+.+ |+||||||+|||++.++.
T Consensus 85 ~--~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~~~~ 159 (289)
T 4fvq_A 85 D--ENILVQEFVKFGSLDTYLKKN-KNCINILWKLEVAKQLAAAMHFLEENT--LIHGNVCAKNILLIREEDRKTGNPPF 159 (289)
T ss_dssp T--CCEEEEECCTTCBHHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEEECCBGGGTBCCE
T ss_pred C--CCEEEEECCCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHhhCC--eECCCcCcceEEEecCCcccccccce
Confidence 6 569999999999999999643 334899999999999999999999998 999999999999998887
Q ss_pred EEEeccCCCCCCCC-----CCccccchhhccc-CCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCC
Q 004979 573 AKISDFSFWNNTTA-----AKTGSAAMELLET-SAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPL 646 (721)
Q Consensus 573 ~kL~DFGla~~~~~-----~~~~~~apE~~~~-~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~ 646 (721)
+||+|||++..... ++..|+|||.+.+ ..++.++|||||||++|||+||..|+.... ....... ........
T Consensus 160 ~kl~Dfg~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~-~~~~~~~-~~~~~~~~ 237 (289)
T 4fvq_A 160 IKLSDPGISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSAL-DSQRKLQ-FYEDRHQL 237 (289)
T ss_dssp EEECCCCSCTTTSCHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTS-CHHHHHH-HHHTTCCC
T ss_pred eeeccCcccccccCccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCcccc-chHHHHH-HhhccCCC
Confidence 99999999865433 3457999999977 779999999999999999999655543222 2222111 11111111
Q ss_pred ccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 004979 647 KDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAM 696 (721)
Q Consensus 647 ~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~ 696 (721)
. ...+.++.+++.+||+.||++|||+.|+++.|+++...
T Consensus 238 ~-----------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p 276 (289)
T 4fvq_A 238 P-----------APKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP 276 (289)
T ss_dssp C-----------CCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred C-----------CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 1 11234578899999999999999999999999987664
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=332.14 Aligned_cols=245 Identities=21% Similarity=0.346 Sum_probs=202.5
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
++.+.+|+|+||+||+|+.. ++..||+|++.... ...+.+.+|++++++++||||+++++++.+.+ ..++|
T Consensus 16 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~~~v 87 (288)
T 3kfa_A 16 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT------MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP--PFYII 87 (288)
T ss_dssp EEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS------THHHHHHHHHHHHHHCCCTTBCCEEEEECSSS--SEEEE
T ss_pred eEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH------HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC--CEEEE
Confidence 67788999999999999976 47789999886432 23467999999999999999999999998776 57999
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCCCC-
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTAA- 587 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~~~- 587 (721)
|||+++|+|.+++.......+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 88 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 165 (288)
T 3kfa_A 88 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165 (288)
T ss_dssp EECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT--CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred EEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC--ccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence 99999999999997656677999999999999999999999988 999999999999999999999999988644321
Q ss_pred ---------CccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccc
Q 004979 588 ---------KTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSF 657 (721)
Q Consensus 588 ---------~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 657 (721)
+..|+|||.+....++.++||||||+++|||++ |+.||..... .......... .. ...
T Consensus 166 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~--~~~~~~~~~~-~~---------~~~ 233 (288)
T 3kfa_A 166 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--SQVYELLEKD-YR---------MER 233 (288)
T ss_dssp SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG--GGHHHHHHTT-CC---------CCC
T ss_pred cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHhcc-CC---------CCC
Confidence 235899999998999999999999999999999 9999964332 2222222211 11 011
Q ss_pred cHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 004979 658 QENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAM 696 (721)
Q Consensus 658 ~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~ 696 (721)
+..++.++.+++.+||+.||++||++.|+++.|+++...
T Consensus 234 ~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~ 272 (288)
T 3kfa_A 234 PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272 (288)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence 234457789999999999999999999999999987654
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=336.82 Aligned_cols=259 Identities=23% Similarity=0.340 Sum_probs=190.1
Q ss_pred hhhCcCCCCceeEEEEEEecCCcEEEEEEeeeccccchhhHHHHHHHHH--HHHHhcCCCCccceEeEEEec---CCCce
Q 004979 430 NIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKK--IDTLSKVNHKNFVNLIGYCEE---DEPFT 504 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~~~~~vavk~~~~~~~~~~~~~~~~~f~~E--i~~l~~l~H~nIv~l~g~~~~---~~~~~ 504 (721)
++++.+|+|+||+||+|+. ++..||||++..... ..+..| +..+..++||||+++++++.. .+...
T Consensus 16 ~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~--------~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 86 (336)
T 3g2f_A 16 KLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR--------QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME 86 (336)
T ss_dssp EEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGH--------HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred heeeecccCCCeEEEEEEE-CCeEEEEEEeeccch--------hhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence 6778899999999999987 578999998864321 233344 444556899999999986542 22235
Q ss_pred EEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcC-------CCCeEeeCCCCCCeEeCCCCcEEEec
Q 004979 505 RMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQL-------TPPIAHRNLQSSSIYLTEDYAAKISD 577 (721)
Q Consensus 505 ~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~-------~~~IvHrDLKp~NILl~~~~~~kL~D 577 (721)
.++||||+++|+|.+++.. ...++..+..|+.||+.||+|||+. .++|+||||||+|||++.++.+||+|
T Consensus 87 ~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~D 163 (336)
T 3g2f_A 87 YLLVMEYYPNGSLXKYLSL---HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISD 163 (336)
T ss_dssp EEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECC
T ss_pred EEEEEecCCCCcHHHHHhh---cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEee
Confidence 6899999999999999964 3358999999999999999999998 11399999999999999999999999
Q ss_pred cCCCCCCC-----------------CCCccccchhhccc-------CCCCCCccHHHHHHHHHHHHhCCCcccCCCCC--
Q 004979 578 FSFWNNTT-----------------AAKTGSAAMELLET-------SAVDLESNVYSFGTILFEMITGRISYSIENGS-- 631 (721)
Q Consensus 578 FGla~~~~-----------------~~~~~~~apE~~~~-------~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~-- 631 (721)
||+++... .++..|+|||.+.+ ..++.++|||||||++|||+||+.||......
T Consensus 164 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~ 243 (336)
T 3g2f_A 164 FGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPE 243 (336)
T ss_dssp CTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCC
T ss_pred ccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhH
Confidence 99985321 25568999999876 45678899999999999999998776422110
Q ss_pred -------------HHHHHHHHhhcCCCCccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCC
Q 004979 632 -------------LENWASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAMEP 698 (721)
Q Consensus 632 -------------~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 698 (721)
..+........... ...+.. .......++.++.+++.+||+.||++|||+.|+++.|+++.....
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~ 321 (336)
T 3g2f_A 244 YQMAFQTEVGNHPTFEDMQVLVSREKQ-RPKFPE-AWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWE 321 (336)
T ss_dssp CCCTTHHHHCSSCCHHHHHHHHTTSCC-CCCCCT-TCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCC
T ss_pred HHHhhhcccCCCchHHHHHhhhccccc-CCCCCc-ccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHH
Confidence 00011111111110 000000 111123467789999999999999999999999999999987665
Q ss_pred CCCC
Q 004979 699 DGAT 702 (721)
Q Consensus 699 ~~~~ 702 (721)
....
T Consensus 322 ~~~~ 325 (336)
T 3g2f_A 322 RNKS 325 (336)
T ss_dssp C---
T ss_pred hccc
Confidence 4443
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=330.08 Aligned_cols=247 Identities=18% Similarity=0.290 Sum_probs=201.1
Q ss_pred hhhC-cCCCCceeEEEEEEec---CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceE
Q 004979 430 NIIG-SFSDGTVGTVYKGTLS---SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTR 505 (721)
Q Consensus 430 ~ii~-~lg~G~~g~Vyk~~~~---~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~ 505 (721)
.+++ .+|+|+||+||+|++. ++..||||++.... .....+.+.+|++++++++||||+++++++.. + ..
T Consensus 12 ~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~--~~ 84 (287)
T 1u59_A 12 LIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT----EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-E--AL 84 (287)
T ss_dssp EEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC----CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-S--SE
T ss_pred hhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc----chhHHHHHHHHHHHHHhCCCCCEeEEEEEecC-C--Cc
Confidence 4555 7899999999999854 57789999886432 23345679999999999999999999999954 3 46
Q ss_pred EEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC
Q 004979 506 MMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT 585 (721)
Q Consensus 506 ~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~ 585 (721)
++||||+++|+|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 85 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 161 (287)
T 1u59_A 85 MLVMEMAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLVNRHYAKISDFGLSKALG 161 (287)
T ss_dssp EEEEECCTTEEHHHHHTT-CTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEEEEeCCCCCHHHHHHh-CCccCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCchheEEEcCCCCEEECcccceeeec
Confidence 999999999999999863 3456999999999999999999999998 9999999999999999999999999875332
Q ss_pred ------------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhcCCCCccccCC
Q 004979 586 ------------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPLKDIVDP 652 (721)
Q Consensus 586 ------------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 652 (721)
.++..|+|||.+....++.++|||||||++|||+| |+.||.... ..+.......+..
T Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~--~~~~~~~i~~~~~-------- 231 (287)
T 1u59_A 162 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK--GPEVMAFIEQGKR-------- 231 (287)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC--THHHHHHHHTTCC--------
T ss_pred cCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC--HHHHHHHHhcCCc--------
Confidence 12346899999988889999999999999999999 999996433 2333333322211
Q ss_pred ccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCC
Q 004979 653 TLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAMEP 698 (721)
Q Consensus 653 ~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 698 (721)
...+..++.++.+++.+||+.||++||++.|+++.|+++.....
T Consensus 232 --~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 275 (287)
T 1u59_A 232 --MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 275 (287)
T ss_dssp --CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred --CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 11223456789999999999999999999999999999876543
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-38 Score=351.24 Aligned_cols=239 Identities=21% Similarity=0.346 Sum_probs=197.8
Q ss_pred hhhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEE
Q 004979 429 SNIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMM 507 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~l 507 (721)
+.+.+.+|+|+||.||+|+.. +++.||||++....... ......+.+|+++++.++||||+++++++...+ ..++
T Consensus 18 Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~--~~~l 93 (476)
T 2y94_A 18 YILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRS--LDVVGKIRREIQNLKLFRHPHIIKLYQVISTPS--DIFM 93 (476)
T ss_dssp EEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHH--TTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSS--EEEE
T ss_pred EEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccC--HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC--EEEE
Confidence 467788999999999999975 78999999986432211 123457899999999999999999999998876 6799
Q ss_pred EEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC---
Q 004979 508 VFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT--- 584 (721)
Q Consensus 508 V~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~--- 584 (721)
||||+++|+|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 94 v~E~~~gg~L~~~l~--~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~ 169 (476)
T 2y94_A 94 VMEYVSGGELFDYIC--KNGRLDEKESRRLFQQILSGVDYCHRHM--VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 169 (476)
T ss_dssp EEECCSSEEHHHHTT--SSSSCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred EEeCCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC--CCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence 999999999999986 3456999999999999999999999998 999999999999999999999999997532
Q ss_pred -----CCCCccccchhhcccCCC-CCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCcccccc
Q 004979 585 -----TAAKTGSAAMELLETSAV-DLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQ 658 (721)
Q Consensus 585 -----~~~~~~~~apE~~~~~~~-s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 658 (721)
..++..|+|||.+.+..+ +.++||||+||++|||++|+.||... +.......+..+.... +
T Consensus 170 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~--~~~~~~~~i~~~~~~~-----------p 236 (476)
T 2y94_A 170 EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDD--HVPTLFKKICDGIFYT-----------P 236 (476)
T ss_dssp CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCS--SSHHHHHHHHTTCCCC-----------C
T ss_pred ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCC--CHHHHHHHHhcCCcCC-----------C
Confidence 234567999999987765 68999999999999999999999643 3334444444332211 1
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 659 ENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 659 ~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
...+.++.+|+.+||+.||++|||+.|+++
T Consensus 237 ~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 237 QYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp TTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 233467889999999999999999999987
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=334.57 Aligned_cols=253 Identities=19% Similarity=0.318 Sum_probs=199.1
Q ss_pred hhhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecC--CCceE
Q 004979 429 SNIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEED--EPFTR 505 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~~ 505 (721)
+++++.+|+|+||.||+++. .+++.||||++.... ....+.+.+|++++++++||||+++++++... .....
T Consensus 31 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 105 (317)
T 2buj_A 31 YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE-----QQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA 105 (317)
T ss_dssp EEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESS-----HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred EEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCC-----HHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence 36778899999999999996 578899999886432 23456789999999999999999999998732 22357
Q ss_pred EEEEecCCCCChhhhhhhc--cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCC
Q 004979 506 MMVFEYSPNGSLFEHLHIQ--EAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNN 583 (721)
Q Consensus 506 ~lV~Ey~~~GsL~~~l~~~--~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~ 583 (721)
++||||+++|+|.+++... ....+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dlkp~NIl~~~~~~~kl~dfg~~~~ 183 (317)
T 2buj_A 106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG--YAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183 (317)
T ss_dssp EEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred EEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence 9999999999999998643 3467999999999999999999999998 99999999999999999999999998764
Q ss_pred CCC------------------CCccccchhhcccCC---CCCCccHHHHHHHHHHHHhCCCcccCC---CCCHHHHHHHH
Q 004979 584 TTA------------------AKTGSAAMELLETSA---VDLESNVYSFGTILFEMITGRISYSIE---NGSLENWASEY 639 (721)
Q Consensus 584 ~~~------------------~~~~~~apE~~~~~~---~s~ksDVwSfGvvL~ElltG~~P~~~~---~~~~~~~~~~~ 639 (721)
... ++..|+|||.+.... ++.++|||||||++|||+||+.||... ........
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~--- 260 (317)
T 2buj_A 184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAV--- 260 (317)
T ss_dssp SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHH---
T ss_pred cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHh---
Confidence 321 255699999986543 689999999999999999999999531 11111111
Q ss_pred hhcCCCCccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCCCCC
Q 004979 640 LKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAMEPDGA 701 (721)
Q Consensus 640 ~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~~~ 701 (721)
...... ......+.++.+++.+||+.||++||++.|+++.|+.+....+.+.
T Consensus 261 -~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~~ 312 (317)
T 2buj_A 261 -QNQLSI---------PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPGQH 312 (317)
T ss_dssp -HCC--C---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCCC--
T ss_pred -hccCCC---------CccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCCCCC
Confidence 111100 0112345678999999999999999999999999999887666543
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=340.28 Aligned_cols=248 Identities=20% Similarity=0.319 Sum_probs=198.8
Q ss_pred hhhCcCCCCceeEEEEEEecC-C-----cEEEEEEeeeccccchhhHHHHHHHHHHHHHhcC-CCCccceEeEEEecCCC
Q 004979 430 NIIGSFSDGTVGTVYKGTLSS-G-----VEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKV-NHKNFVNLIGYCEEDEP 502 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~~-~-----~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~ 502 (721)
++.+.+|+|+||+||+|+... + ..|++|.+.... .....+.+.+|+++++++ +||||+++++++.+.+
T Consensus 49 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~- 123 (333)
T 2i1m_A 49 QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA----HADEKEALMSELKIMSHLGQHENIVNLLGACTHGG- 123 (333)
T ss_dssp EEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred eeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc----ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC-
Confidence 667889999999999998643 2 468998876432 123456799999999999 8999999999998876
Q ss_pred ceEEEEEecCCCCChhhhhhhcc------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCC
Q 004979 503 FTRMMVFEYSPNGSLFEHLHIQE------------AEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTED 570 (721)
Q Consensus 503 ~~~~lV~Ey~~~GsL~~~l~~~~------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~ 570 (721)
..++||||+++|+|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.+
T Consensus 124 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~~~ 200 (333)
T 2i1m_A 124 -PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN--CIHRDVAARNVLLTNG 200 (333)
T ss_dssp -SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGCEEEGG
T ss_pred -ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC--cccCCcccceEEECCC
Confidence 5699999999999999986432 345899999999999999999999988 9999999999999999
Q ss_pred CcEEEeccCCCCCCCC-----------CCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHH
Q 004979 571 YAAKISDFSFWNNTTA-----------AKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASE 638 (721)
Q Consensus 571 ~~~kL~DFGla~~~~~-----------~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~ 638 (721)
+.+||+|||+++.... ++..|+|||.+.+..++.++|||||||++|||+| |+.||....... ....
T Consensus 201 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--~~~~ 278 (333)
T 2i1m_A 201 HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS--KFYK 278 (333)
T ss_dssp GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH--HHHH
T ss_pred CeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH--HHHH
Confidence 9999999999864321 1236999999998999999999999999999999 999996443221 1222
Q ss_pred HhhcCCCCccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 004979 639 YLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAM 696 (721)
Q Consensus 639 ~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~ 696 (721)
........ ..+...+.++.+++.+||+.||++||++.||++.|+++...
T Consensus 279 ~~~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 327 (333)
T 2i1m_A 279 LVKDGYQM---------AQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE 327 (333)
T ss_dssp HHHHTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHhcCCCC---------CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence 22221111 01122346788999999999999999999999999987653
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=337.38 Aligned_cols=253 Identities=21% Similarity=0.283 Sum_probs=199.4
Q ss_pred hhhhCcCCCCceeEEEEEEe-----cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCc
Q 004979 429 SNIIGSFSDGTVGTVYKGTL-----SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPF 503 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~-----~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 503 (721)
+++++.+|+|+||.||+|++ .++..||||++.... ....+.+.+|++++++++||||+++++++...+..
T Consensus 25 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 99 (327)
T 3lxl_A 25 LKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG-----PDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQ 99 (327)
T ss_dssp EEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC-----HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSC
T ss_pred hhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC-----HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCc
Confidence 36788999999999999984 367889999886432 23346799999999999999999999998865444
Q ss_pred eEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCC
Q 004979 504 TRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNN 583 (721)
Q Consensus 504 ~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~ 583 (721)
..++||||+++|+|.+++... ...+++..+..|+.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 176 (327)
T 3lxl_A 100 SLRLVMEYLPSGCLRDFLQRH-RARLDASRLLLYSSQICKGMEYLGSRR--CVHRDLAARNILVESEAHVKIADFGLAKL 176 (327)
T ss_dssp EEEEEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred eEEEEEeecCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChhhEEECCCCCEEEccccccee
Confidence 689999999999999998643 245899999999999999999999988 99999999999999999999999998753
Q ss_pred CC------------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCH------------HHHHHHH
Q 004979 584 TT------------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSL------------ENWASEY 639 (721)
Q Consensus 584 ~~------------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~------------~~~~~~~ 639 (721)
.. .++..|+|||.+.+..++.++|||||||++|||+||+.||....... .......
T Consensus 177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (327)
T 3lxl_A 177 LPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLEL 256 (327)
T ss_dssp CCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHH
T ss_pred cccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 22 12334899999988889999999999999999999999985321100 0011111
Q ss_pred hhcCCCCccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCC
Q 004979 640 LKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAMEP 698 (721)
Q Consensus 640 ~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 698 (721)
..... ....+..++.++.+++.+||+.||++||++.|+++.|+.+.....
T Consensus 257 ~~~~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 306 (327)
T 3lxl_A 257 LEEGQ---------RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSR 306 (327)
T ss_dssp HHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-----
T ss_pred hhccc---------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 11100 111233456789999999999999999999999999999866544
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=329.64 Aligned_cols=252 Identities=17% Similarity=0.214 Sum_probs=197.8
Q ss_pred hhhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEE
Q 004979 429 SNIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMM 507 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~l 507 (721)
+++.+.+|+|+||.||+|+.. +++.|++|++...... .....+.+.+|++++++++||||+++++++...+ ..++
T Consensus 36 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~--~~~l 111 (309)
T 2h34_A 36 YRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSS--DPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDG--QLYV 111 (309)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGG--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT--EEEE
T ss_pred EEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCccccc--CHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCC--eEEE
Confidence 367788999999999999965 6788999988643322 2334578999999999999999999999998876 6799
Q ss_pred EEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC--
Q 004979 508 VFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT-- 585 (721)
Q Consensus 508 V~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~-- 585 (721)
||||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 112 v~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 187 (309)
T 2h34_A 112 DMRLINGVDLAAMLRRQ--GPLAPPRAVAIVRQIGSALDAAHAAG--ATHRDVKPENILVSADDFAYLVDFGIASATTDE 187 (309)
T ss_dssp EEECCCCEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred EEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCc--CCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence 99999999999998643 46899999999999999999999998 9999999999999999999999999875332
Q ss_pred --------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccc
Q 004979 586 --------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSF 657 (721)
Q Consensus 586 --------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 657 (721)
.++..|+|||.+.+..++.++||||||+++|||+||+.||.... ............+.. ...
T Consensus 188 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---~~~~~~~~~~~~~~~-------~~~ 257 (309)
T 2h34_A 188 KLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQ---LSVMGAHINQAIPRP-------STV 257 (309)
T ss_dssp ---------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCH---HHHHHHHHHSCCCCG-------GGT
T ss_pred ccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCch---HHHHHHHhccCCCCc-------ccc
Confidence 23457899999999999999999999999999999999996432 122222222221111 112
Q ss_pred cHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHHHHhhhcCC
Q 004979 658 QENVLEELLVVIKNCVHPDPKQRP-SMRGIAAKLKEITAMEP 698 (721)
Q Consensus 658 ~~~~~~~l~~li~~Cl~~dP~~RP-s~~evl~~L~~i~~~~~ 698 (721)
...++.++.+++.+||+.||++|| +++++++.|+++.....
T Consensus 258 ~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~ 299 (309)
T 2h34_A 258 RPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATAD 299 (309)
T ss_dssp STTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred CCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence 234556788999999999999999 99999999998765543
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=335.80 Aligned_cols=247 Identities=21% Similarity=0.331 Sum_probs=200.8
Q ss_pred hhhhCcCCCCceeEEEEEEec------CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCC
Q 004979 429 SNIIGSFSDGTVGTVYKGTLS------SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEP 502 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~------~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~ 502 (721)
+++.+.+|+|+||.||+|+.. ++..||+|++.... .......+.+|++++++++||||+++++++.+.+
T Consensus 27 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 101 (322)
T 1p4o_A 27 ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA----SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ- 101 (322)
T ss_dssp EEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS----CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS-
T ss_pred eeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc----CHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCC-
Confidence 367788999999999999864 36779999876332 1233467999999999999999999999998776
Q ss_pred ceEEEEEecCCCCChhhhhhhcc--------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEE
Q 004979 503 FTRMMVFEYSPNGSLFEHLHIQE--------AEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAK 574 (721)
Q Consensus 503 ~~~~lV~Ey~~~GsL~~~l~~~~--------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~k 574 (721)
..++||||+++|+|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+|
T Consensus 102 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~NIli~~~~~~k 178 (322)
T 1p4o_A 102 -PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVK 178 (322)
T ss_dssp -SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSGGGEEECTTCCEE
T ss_pred -ccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--CccCCCccceEEEcCCCeEE
Confidence 5699999999999999986432 145799999999999999999999998 99999999999999999999
Q ss_pred EeccCCCCCCCC-----------CCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhc
Q 004979 575 ISDFSFWNNTTA-----------AKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKG 642 (721)
Q Consensus 575 L~DFGla~~~~~-----------~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~ 642 (721)
|+|||+++.... ++..|+|||.+.+..++.++|||||||++|||+| |+.||... ...+.......+
T Consensus 179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~--~~~~~~~~~~~~ 256 (322)
T 1p4o_A 179 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL--SNEQVLRFVMEG 256 (322)
T ss_dssp ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS--CHHHHHHHHHTT
T ss_pred ECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccC--CHHHHHHHHHcC
Confidence 999999864321 2345899999998999999999999999999999 88998533 333333333322
Q ss_pred CCCCccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 004979 643 EQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITA 695 (721)
Q Consensus 643 ~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~ 695 (721)
.. ...+..++.++.+++.+||+.||++||++.|+++.|+++..
T Consensus 257 ~~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 257 GL----------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp CC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred Cc----------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 11 11223455678999999999999999999999999988644
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=328.24 Aligned_cols=243 Identities=17% Similarity=0.292 Sum_probs=197.5
Q ss_pred hhhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecC-------
Q 004979 429 SNIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEED------- 500 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~------- 500 (721)
+++++.+|+|+||.||+|+.. +++.|++|++.... +.+.+|++++++++||||+++++++...
T Consensus 13 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (284)
T 2a19_B 13 FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83 (284)
T ss_dssp EEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS---------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred cceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc---------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence 367788999999999999975 78999999886432 2467899999999999999999988541
Q ss_pred -------CCceEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcE
Q 004979 501 -------EPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAA 573 (721)
Q Consensus 501 -------~~~~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~ 573 (721)
.....++||||+++|+|.+++.......+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~ 161 (284)
T 2a19_B 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK--LINRDLKPSNIFLVDTKQV 161 (284)
T ss_dssp -----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEE
T ss_pred cccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHEEEcCCCCE
Confidence 1224799999999999999997655567999999999999999999999998 9999999999999999999
Q ss_pred EEeccCCCCCC--------CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCC
Q 004979 574 KISDFSFWNNT--------TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQP 645 (721)
Q Consensus 574 kL~DFGla~~~--------~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~ 645 (721)
||+|||+++.. ..++..|+|||.+.+..++.++|||||||++|||+||..|+... .........+ .
T Consensus 162 kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~----~~~~~~~~~~--~ 235 (284)
T 2a19_B 162 KIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET----SKFFTDLRDG--I 235 (284)
T ss_dssp EECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH----HHHHHHHHTT--C
T ss_pred EECcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH----HHHHHHhhcc--c
Confidence 99999987532 22456799999999999999999999999999999999887421 1222222111 1
Q ss_pred CccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCCC
Q 004979 646 LKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAMEPD 699 (721)
Q Consensus 646 ~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~ 699 (721)
. +...+.++.+++.+||+.||++||++.|+++.|..+......
T Consensus 236 ~-----------~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~ 278 (284)
T 2a19_B 236 I-----------SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEK 278 (284)
T ss_dssp C-----------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC----
T ss_pred c-----------cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCc
Confidence 1 122345688999999999999999999999999998775543
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=330.27 Aligned_cols=242 Identities=22% Similarity=0.325 Sum_probs=190.6
Q ss_pred hhhh-CcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcC-CCCccceEeEEEecCCCceE
Q 004979 429 SNII-GSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKV-NHKNFVNLIGYCEEDEPFTR 505 (721)
Q Consensus 429 ~~ii-~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~~ 505 (721)
|+++ +.+|+|+||+||+|+. .+++.||||++..... .....+.+|++++.++ +||||+++++++.+.+ ..
T Consensus 14 y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~--~~ 86 (316)
T 2ac3_A 14 YQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG-----HIRSRVFREVEMLYQCQGHRNVLELIEFFEEED--RF 86 (316)
T ss_dssp CEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS-----CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT--EE
T ss_pred EEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc-----hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC--EE
Confidence 4554 5689999999999995 4788999999865422 1235788999999985 7999999999998877 67
Q ss_pred EEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCc---EEEeccCCCC
Q 004979 506 MMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYA---AKISDFSFWN 582 (721)
Q Consensus 506 ~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~---~kL~DFGla~ 582 (721)
++||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++. +||+|||+++
T Consensus 87 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~ 162 (316)
T 2ac3_A 87 YLVFEKMRGGSILSHIHKR--RHFNELEASVVVQDVASALDFLHNKG--IAHRDLKPENILCEHPNQVSPVKICDFDLGS 162 (316)
T ss_dssp EEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEESCSSSSCSEEECCTTCCC
T ss_pred EEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEEccCCCcCceEEEEccCcc
Confidence 9999999999999998643 46899999999999999999999998 999999999999998776 9999999875
Q ss_pred CCC----------------CCCccccchhhccc-----CCCCCCccHHHHHHHHHHHHhCCCcccCCCCC----------
Q 004979 583 NTT----------------AAKTGSAAMELLET-----SAVDLESNVYSFGTILFEMITGRISYSIENGS---------- 631 (721)
Q Consensus 583 ~~~----------------~~~~~~~apE~~~~-----~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~---------- 631 (721)
... .++..|+|||.+.. ..++.++|||||||++|||+||+.||......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 242 (316)
T 2ac3_A 163 GIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEAC 242 (316)
T ss_dssp -------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CC
T ss_pred ccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccc
Confidence 321 25567999999864 56889999999999999999999999744321
Q ss_pred ---HHHHHHHHhhcCCCCccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 632 ---LENWASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 632 ---~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
.......+..+...... ......+.++.+|+.+||+.||++|||+.|+++
T Consensus 243 ~~~~~~~~~~i~~~~~~~~~-------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 243 PACQNMLFESIQEGKYEFPD-------KDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHHHHHHHHHHHCCCCCCH-------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hhHHHHHHHHHhccCcccCc-------hhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 11122222222111100 001124567899999999999999999999987
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-38 Score=339.20 Aligned_cols=247 Identities=20% Similarity=0.242 Sum_probs=193.3
Q ss_pred hhhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCC-----CCccceEeEEEecCCC
Q 004979 429 SNIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVN-----HKNFVNLIGYCEEDEP 502 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~-----H~nIv~l~g~~~~~~~ 502 (721)
+++++.+|+|+||+||+|+. .++..||||++... ....+.+..|++++.+++ |||||++++++...+
T Consensus 37 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~- 109 (360)
T 3llt_A 37 FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI------KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYD- 109 (360)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC------HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETT-
T ss_pred EEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc------hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECC-
Confidence 47888999999999999996 46888999988532 223456788999999886 999999999998877
Q ss_pred ceEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCC-------------
Q 004979 503 FTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTE------------- 569 (721)
Q Consensus 503 ~~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~------------- 569 (721)
..++||||+ +|+|.+++.......+++..+..|+.||+.||+|||+++ |+||||||+|||++.
T Consensus 110 -~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~~~~~~~~~~ 185 (360)
T 3llt_A 110 -HMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS--LTHTDLKPENILLDDPYFEKSLITVRRV 185 (360)
T ss_dssp -EEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCTTCCEEEEEEECT
T ss_pred -eeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCcccEEEccccccccccchhcc
Confidence 679999999 999999997655567999999999999999999999998 999999999999986
Q ss_pred ------------CCcEEEeccCCCCCC------CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCC
Q 004979 570 ------------DYAAKISDFSFWNNT------TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGS 631 (721)
Q Consensus 570 ------------~~~~kL~DFGla~~~------~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~ 631 (721)
++.+||+|||+++.. ..++..|+|||.+.+..++.++|||||||++|||+||+.||....
T Consensus 186 ~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-- 263 (360)
T 3llt_A 186 TDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHE-- 263 (360)
T ss_dssp TTCCEEEEEEESCCCEEECCCTTCEETTSCCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSS--
T ss_pred cccccccccccCCCCEEEEeccCceecCCCCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCc--
Confidence 789999999998632 234567999999999999999999999999999999999996432
Q ss_pred HHHHHHHHhhcCCCCcc-------------ccC--------Ccc--------------ccccHHHHHHHHHHHHHcccCC
Q 004979 632 LENWASEYLKGEQPLKD-------------IVD--------PTL--------------KSFQENVLEELLVVIKNCVHPD 676 (721)
Q Consensus 632 ~~~~~~~~~~~~~~~~~-------------~~d--------~~l--------------~~~~~~~~~~l~~li~~Cl~~d 676 (721)
..+....+.....+... ..+ +.. ........+.+.+|+.+||+.|
T Consensus 264 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d 343 (360)
T 3llt_A 264 HMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQID 343 (360)
T ss_dssp HHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSS
T ss_pred HHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCC
Confidence 22222211111111100 000 000 0000111256889999999999
Q ss_pred CCCCCCHHHHHH
Q 004979 677 PKQRPSMRGIAA 688 (721)
Q Consensus 677 P~~RPs~~evl~ 688 (721)
|++|||+.|+++
T Consensus 344 P~~Rpta~elL~ 355 (360)
T 3llt_A 344 PTLRPSPAELLK 355 (360)
T ss_dssp GGGSCCHHHHTT
T ss_pred hhhCCCHHHHhc
Confidence 999999999874
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=351.82 Aligned_cols=253 Identities=14% Similarity=0.153 Sum_probs=181.0
Q ss_pred hhhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCC---Cce
Q 004979 429 SNIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDE---PFT 504 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~---~~~ 504 (721)
+++++.||+|+||+||+|+.. ++..||||++..... .....+++.+|+++|++++|||||++++++...+ ...
T Consensus 55 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 55 YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFE---DLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp EEECCC-------CEEEEEECC--CEEEEEEECSTTS---SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred eEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhc---CHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 478889999999999999854 688999998854321 1234567999999999999999999999986432 125
Q ss_pred EEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC
Q 004979 505 RMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT 584 (721)
Q Consensus 505 ~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~ 584 (721)
.|+||||+ +|+|.+++. ....+++..+..|+.||+.||+|||+.+ ||||||||+|||++.++.+||+|||+++..
T Consensus 132 ~~lv~e~~-~~~L~~~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~~--iiHrDlKp~NILl~~~~~~kl~DFGla~~~ 206 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFR--TPVYLTELHIKTLLYNLLVGVKYVHSAG--ILHRDLKPANCLVNQDCSVKVCDFGLARTV 206 (458)
T ss_dssp EEEEECCC-SEEHHHHHH--SSCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTCCEEECCCTTCBCT
T ss_pred EEEEEecc-ccchhhhcc--cCCCCCHHHHHHHHHHHHHHHHHHHhCC--cCCCCCChhhEEECCCCCEeecccccchhc
Confidence 79999998 579999885 3456999999999999999999999998 999999999999999999999999998754
Q ss_pred C------------------------------------CCCccccchhhc-ccCCCCCCccHHHHHHHHHHHHh-------
Q 004979 585 T------------------------------------AAKTGSAAMELL-ETSAVDLESNVYSFGTILFEMIT------- 620 (721)
Q Consensus 585 ~------------------------------------~~~~~~~apE~~-~~~~~s~ksDVwSfGvvL~Ellt------- 620 (721)
. .++..|+|||++ ....|+.++|||||||++|||+|
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~ 286 (458)
T 3rp9_A 207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVA 286 (458)
T ss_dssp TSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCS
T ss_pred cCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccccc
Confidence 2 124569999976 56679999999999999999999
Q ss_pred ----CCCcccCCCCC------------------HHHHHHHHh--hcCCC------------------CccccCCcccccc
Q 004979 621 ----GRISYSIENGS------------------LENWASEYL--KGEQP------------------LKDIVDPTLKSFQ 658 (721)
Q Consensus 621 ----G~~P~~~~~~~------------------~~~~~~~~~--~~~~~------------------~~~~~d~~l~~~~ 658 (721)
|+.+|.+.... ....+..+. .+... +.......+....
T Consensus 287 ~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (458)
T 3rp9_A 287 YHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERF 366 (458)
T ss_dssp SGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGS
T ss_pred ccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHC
Confidence 55555432210 000000000 00000 0000001111122
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004979 659 ENVLEELLVVIKNCVHPDPKQRPSMRGIAAK 689 (721)
Q Consensus 659 ~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 689 (721)
+..+.++.+|+.+||+.||++|||++|+++.
T Consensus 367 ~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~H 397 (458)
T 3rp9_A 367 PASSADAIHLLKRMLVFNPNKRITINECLAH 397 (458)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 3446789999999999999999999999874
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-38 Score=365.72 Aligned_cols=233 Identities=16% Similarity=0.218 Sum_probs=195.2
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcC-CCCccceEeEEEecCCCceEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKV-NHKNFVNLIGYCEEDEPFTRMM 507 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~~~l 507 (721)
+++..||+|+||+||+|+.. +++.||||++....... ....+.+..|.+++..+ +||||+++++++.+.+ ..|+
T Consensus 344 ~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~--~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~--~~~l 419 (674)
T 3pfq_A 344 NFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQ--DDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD--RLYF 419 (674)
T ss_dssp EEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHH--TTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSS--EEEE
T ss_pred EEEEEEccCCCEEEEEEEECCCCcEEEEEEEecccccc--HHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCC--EEEE
Confidence 77889999999999999965 57889999987432211 22235688899999988 7999999999998776 6799
Q ss_pred EEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC---
Q 004979 508 VFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT--- 584 (721)
Q Consensus 508 V~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~--- 584 (721)
||||+++|+|.++++.. ..+++..++.|+.||+.||+|||+.+ ||||||||+||||+.++.+||+|||+++..
T Consensus 420 V~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~g--IiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~ 495 (674)
T 3pfq_A 420 VMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 495 (674)
T ss_dssp EEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTS--EECCCCCSTTEEECSSSCEEECCCTTCEECCCT
T ss_pred EEeCcCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC--eEeccCChhhEEEcCCCcEEEeecceeeccccC
Confidence 99999999999999743 46999999999999999999999998 999999999999999999999999998632
Q ss_pred ------CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCcccccc
Q 004979 585 ------TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQ 658 (721)
Q Consensus 585 ------~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 658 (721)
..++..|+|||++.+..|+.++|||||||++|||+||+.||.. .+..+....+...... ++
T Consensus 496 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~--~~~~~~~~~i~~~~~~-----------~p 562 (674)
T 3pfq_A 496 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG--EDEDELFQSIMEHNVA-----------YP 562 (674)
T ss_dssp TCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCC--SSHHHHHHHHHSSCCC-----------CC
T ss_pred CcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCC--CCHHHHHHHHHhCCCC-----------CC
Confidence 2356689999999999999999999999999999999999964 3445555555544322 22
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCH
Q 004979 659 ENVLEELLVVIKNCVHPDPKQRPSM 683 (721)
Q Consensus 659 ~~~~~~l~~li~~Cl~~dP~~RPs~ 683 (721)
...+.++.+|+.+||+.||++||++
T Consensus 563 ~~~s~~~~~li~~lL~~dP~~R~~~ 587 (674)
T 3pfq_A 563 KSMSKEAVAICKGLMTKHPGKRLGC 587 (674)
T ss_dssp TTSCHHHHHHHHHHSCSSSTTCTTC
T ss_pred ccCCHHHHHHHHHHccCCHHHCCCC
Confidence 3455789999999999999999997
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=365.60 Aligned_cols=240 Identities=21% Similarity=0.334 Sum_probs=196.5
Q ss_pred cCCCCceeEEEEEEec---CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEEEe
Q 004979 434 SFSDGTVGTVYKGTLS---SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFE 510 (721)
Q Consensus 434 ~lg~G~~g~Vyk~~~~---~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV~E 510 (721)
.||+|+||+||+|.+. .+..||||+++.... .....++|.+|+++|++++|||||+++++|... ..++|||
T Consensus 376 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~---~~~lv~E 449 (635)
T 4fl3_A 376 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN---DPALKDELLAEANVMQQLDNPYIVRMIGICEAE---SWMLVME 449 (635)
T ss_dssp EEEECSSEEEEEEEEECSSCEEEEEEEEECGGGG---CGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESS---SEEEEEE
T ss_pred EeccCCCEEEEEEEEcCCCcceEEEEEEeccccC---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC---CEEEEEE
Confidence 6899999999999753 457899998864322 123356799999999999999999999999754 3689999
Q ss_pred cCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCCC----
Q 004979 511 YSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTA---- 586 (721)
Q Consensus 511 y~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~~---- 586 (721)
||++|+|.+++.. ...+++..+..|+.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 450 ~~~~g~L~~~l~~--~~~l~~~~~~~i~~qi~~~L~yLH~~~--iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 525 (635)
T 4fl3_A 450 MAELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 525 (635)
T ss_dssp CCTTEEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC----
T ss_pred ccCCCCHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHHHHCC--EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccc
Confidence 9999999999963 456999999999999999999999998 99999999999999999999999998753211
Q ss_pred --------CCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccc
Q 004979 587 --------AKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSF 657 (721)
Q Consensus 587 --------~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 657 (721)
++..|+|||.+....++.++|||||||++|||+| |+.||... ...+....+..+.. ...
T Consensus 526 ~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~--~~~~~~~~i~~~~~----------~~~ 593 (635)
T 4fl3_A 526 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM--KGSEVTAMLEKGER----------MGC 593 (635)
T ss_dssp ---------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC--CHHHHHHHHHTTCC----------CCC
T ss_pred cccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHHHcCCC----------CCC
Confidence 1245999999999999999999999999999999 99999643 23333333333211 112
Q ss_pred cHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 004979 658 QENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITA 695 (721)
Q Consensus 658 ~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~ 695 (721)
+..++.++.+||.+||+.||++||++.+|++.|+++..
T Consensus 594 p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 631 (635)
T 4fl3_A 594 PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 631 (635)
T ss_dssp CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 23456789999999999999999999999999998754
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=327.17 Aligned_cols=250 Identities=24% Similarity=0.371 Sum_probs=196.3
Q ss_pred hhhCcCCCCceeEEEEEEecCC----cEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceE
Q 004979 430 NIIGSFSDGTVGTVYKGTLSSG----VEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTR 505 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~~~----~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~ 505 (721)
++.+.+|+|+||+||+|+.... ..+++|.+.... .....+.+.+|++++++++||||+++++++...+. ..
T Consensus 28 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~ 102 (298)
T 3f66_A 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT----DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG-SP 102 (298)
T ss_dssp EEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC----SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSS-CC
T ss_pred hhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC----CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCC-ce
Confidence 5677899999999999986432 246777665321 23345679999999999999999999999765443 46
Q ss_pred EEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC
Q 004979 506 MMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT 585 (721)
Q Consensus 506 ~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~ 585 (721)
++||||+++|+|.+++.. ....+++..+..|+.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 103 ~~v~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~ql~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~ 179 (298)
T 3f66_A 103 LVVLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKYLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMY 179 (298)
T ss_dssp EEEEECCTTCBHHHHHHC-TTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTCCEEECSCGGGCCCS
T ss_pred EEEEeCCCCCCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEECCCCCEEECccccccccc
Confidence 899999999999999963 3456899999999999999999999998 9999999999999999999999999986432
Q ss_pred C-------------CCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhcCCCCccccC
Q 004979 586 A-------------AKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPLKDIVD 651 (721)
Q Consensus 586 ~-------------~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d 651 (721)
. ++..|+|||.+.+..++.++|||||||++|||+| |..||..... .+.......+...
T Consensus 180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~--~~~~~~~~~~~~~------ 251 (298)
T 3f66_A 180 DKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--FDITVYLLQGRRL------ 251 (298)
T ss_dssp CGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCT--TTHHHHHHTTCCC------
T ss_pred ccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCH--HHHHHHHhcCCCC------
Confidence 1 2235899999999999999999999999999999 5555543222 1222222222111
Q ss_pred CccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCCC
Q 004979 652 PTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAMEPD 699 (721)
Q Consensus 652 ~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~ 699 (721)
..+..++.++.+++.+||+.||++||++.|+++.|+++......
T Consensus 252 ----~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~ 295 (298)
T 3f66_A 252 ----LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 295 (298)
T ss_dssp ----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSCC
T ss_pred ----CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 11123446789999999999999999999999999998876554
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-38 Score=332.13 Aligned_cols=251 Identities=20% Similarity=0.344 Sum_probs=201.1
Q ss_pred hhhhCcCCCCceeEEEEEEe------cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcC-CCCccceEeEEEecCC
Q 004979 429 SNIIGSFSDGTVGTVYKGTL------SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKV-NHKNFVNLIGYCEEDE 501 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~------~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~ 501 (721)
+++.+.+|+|+||+||+|+. .+++.||||++.... .....+.+.+|++++.++ +||||+++++++...+
T Consensus 29 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 104 (316)
T 2xir_A 29 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA----THSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 104 (316)
T ss_dssp EEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred eeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC----CcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCC
Confidence 47788999999999999984 345789999886432 123446799999999999 7999999999987654
Q ss_pred CceEEEEEecCCCCChhhhhhhccC--------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEe
Q 004979 502 PFTRMMVFEYSPNGSLFEHLHIQEA--------------EHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYL 567 (721)
Q Consensus 502 ~~~~~lV~Ey~~~GsL~~~l~~~~~--------------~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl 567 (721)
. ..++||||+++|+|.+++..... ..+++..+..++.|++.||+|||+.+ |+||||||+|||+
T Consensus 105 ~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dikp~Nil~ 181 (316)
T 2xir_A 105 G-PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILL 181 (316)
T ss_dssp S-CCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEE
T ss_pred C-ceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC--cccccCccceEEE
Confidence 3 36999999999999999974332 12889999999999999999999988 9999999999999
Q ss_pred CCCCcEEEeccCCCCCCCC-----------CCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHH
Q 004979 568 TEDYAAKISDFSFWNNTTA-----------AKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENW 635 (721)
Q Consensus 568 ~~~~~~kL~DFGla~~~~~-----------~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~ 635 (721)
+.++.+||+|||+++.... ++..|+|||.+.+..++.++|||||||++|||+| |+.||....... ..
T Consensus 182 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~-~~ 260 (316)
T 2xir_A 182 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-EF 260 (316)
T ss_dssp CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH-HH
T ss_pred CCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhH-HH
Confidence 9999999999999864322 1235899999999999999999999999999999 999996543322 22
Q ss_pred HHHHhhcCCCCccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcC
Q 004979 636 ASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAME 697 (721)
Q Consensus 636 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 697 (721)
......+.. . ..+...+.++.+++.+||+.||++||++.|+++.|+++.+..
T Consensus 261 ~~~~~~~~~-~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 312 (316)
T 2xir_A 261 CRRLKEGTR-M---------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 312 (316)
T ss_dssp HHHHHHTCC-C---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHhccCcc-C---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 222222211 0 111234567899999999999999999999999999987654
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=325.46 Aligned_cols=252 Identities=21% Similarity=0.309 Sum_probs=198.2
Q ss_pred hhCcCCCCceeEEEEEEecC-C---cEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEE
Q 004979 431 IIGSFSDGTVGTVYKGTLSS-G---VEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRM 506 (721)
Q Consensus 431 ii~~lg~G~~g~Vyk~~~~~-~---~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~ 506 (721)
+.+.+|+|+||+||+|++.+ + ..+|+|++.... .....+.+.+|++++++++||||+++++++.+.+. ..+
T Consensus 25 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~ 99 (298)
T 3pls_A 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT----EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEG-LPH 99 (298)
T ss_dssp EEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC----SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSS-CCE
T ss_pred cCceeccCCCceEEEEEEecCCCceeeeeeeeccccc----cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCC-CcE
Confidence 34678999999999998532 2 268888775322 22345689999999999999999999999986553 348
Q ss_pred EEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC-
Q 004979 507 MVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT- 585 (721)
Q Consensus 507 lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~- 585 (721)
+||||+.+|+|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 100 ~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 176 (298)
T 3pls_A 100 VLLPYMCHGDLLQFIRS-PQRNPTVKDLISFGLQVARGMEYLAEQK--FVHRDLAARNCMLDESFTVKVADFGLARDILD 176 (298)
T ss_dssp EEECCCTTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred EEEecccCCCHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence 99999999999999864 3466899999999999999999999998 9999999999999999999999999986321
Q ss_pred ------------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCc
Q 004979 586 ------------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPT 653 (721)
Q Consensus 586 ------------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 653 (721)
.++..|+|||.+.+..++.++|||||||++|||+||..|+.... +..+.......+...
T Consensus 177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~-~~~~~~~~~~~~~~~-------- 247 (298)
T 3pls_A 177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHI-DPFDLTHFLAQGRRL-------- 247 (298)
T ss_dssp GGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS-CGGGHHHHHHTTCCC--------
T ss_pred CcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccC-CHHHHHHHhhcCCCC--------
Confidence 12346899999999999999999999999999999666553222 222222222222110
Q ss_pred cccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCCCCC
Q 004979 654 LKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAMEPDGA 701 (721)
Q Consensus 654 l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~~~ 701 (721)
..+..++.++.+++.+||+.||++|||+.|+++.|+++........
T Consensus 248 --~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~~ 293 (298)
T 3pls_A 248 --PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGDH 293 (298)
T ss_dssp --CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSCC
T ss_pred --CCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhccc
Confidence 1122345678999999999999999999999999999988765443
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=335.86 Aligned_cols=235 Identities=25% Similarity=0.384 Sum_probs=178.4
Q ss_pred CcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCC-CCccceEeEEEecCCCceEEEEEe
Q 004979 433 GSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVN-HKNFVNLIGYCEEDEPFTRMMVFE 510 (721)
Q Consensus 433 ~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~~~lV~E 510 (721)
+.||+|+||+||+|+.. +++.||||++... ....+.+|++++.+++ |||||++++++.+.+ ..++|||
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~--~~~lv~e 86 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR--------MEANTQKEITALKLCEGHPNIVKLHEVFHDQL--HTFLVME 86 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGG--------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS--EEEEEEC
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChh--------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCC--EEEEEEE
Confidence 57899999999999975 6889999988532 1356788999999997 999999999998876 6799999
Q ss_pred cCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCC---cEEEeccCCCCCCC--
Q 004979 511 YSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDY---AAKISDFSFWNNTT-- 585 (721)
Q Consensus 511 y~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~---~~kL~DFGla~~~~-- 585 (721)
|+++|+|.+++.. ...+++..+..|+.|++.||+|||+++ |+||||||+|||++.++ .+||+|||+++...
T Consensus 87 ~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 162 (325)
T 3kn6_A 87 LLNGGELFERIKK--KKHFSETEASYIMRKLVSAVSHMHDVG--VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD 162 (325)
T ss_dssp CCCSCBHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-
T ss_pred ccCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCHHHEEEecCCCcccEEEeccccceecCCC
Confidence 9999999999864 356999999999999999999999998 99999999999997665 89999999986322
Q ss_pred -------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCC-----CHHHHHHHHhhcCCCCccccCCc
Q 004979 586 -------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENG-----SLENWASEYLKGEQPLKDIVDPT 653 (721)
Q Consensus 586 -------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~-----~~~~~~~~~~~~~~~~~~~~d~~ 653 (721)
.++..|+|||.+....++.++|||||||++|||+||+.||..... ...+....+..+.....
T Consensus 163 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~------ 236 (325)
T 3kn6_A 163 NQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFE------ 236 (325)
T ss_dssp ---------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCC------
T ss_pred CCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCC------
Confidence 235578999999999999999999999999999999999974332 22333333333221111
Q ss_pred cccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 654 LKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 654 l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
......++.++.+|+.+||+.||++||++.|+++
T Consensus 237 -~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 237 -GEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp -SHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred -cccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 0111335678999999999999999999999874
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-38 Score=327.50 Aligned_cols=246 Identities=18% Similarity=0.331 Sum_probs=197.1
Q ss_pred hhhCcCCCCceeEEEEEEecC----CcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceE
Q 004979 430 NIIGSFSDGTVGTVYKGTLSS----GVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTR 505 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~~----~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~ 505 (721)
++.+.+|+|+||+||+|+... +..|++|.+.... .....+.|.+|++++++++||||+++++++.+.. .
T Consensus 15 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---~ 87 (281)
T 3cc6_A 15 VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC----TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEP---T 87 (281)
T ss_dssp EEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS----CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSSS---C
T ss_pred EEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc----CchHHHHHHHHHHHHHhCCCCCcceEEEEEcCCC---C
Confidence 567788999999999998643 2358888876432 2234578999999999999999999999987543 4
Q ss_pred EEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC
Q 004979 506 MMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT 585 (721)
Q Consensus 506 ~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~ 585 (721)
++||||+++|+|.+++.. ....+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 88 ~~v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 164 (281)
T 3cc6_A 88 WIIMELYPYGELGHYLER-NKNSLKVLTLVLYSLQICKAMAYLESIN--CVHRDIAVRNILVASPECVKLGDFGLSRYIE 164 (281)
T ss_dssp EEEEECCTTCBHHHHHHH-HTTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred EEEEecCCCCCHHHHHHh-ccccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEECCCCcEEeCccCCCcccc
Confidence 899999999999999864 3456899999999999999999999998 9999999999999999999999999876432
Q ss_pred ----------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhcCCCCccccCCcc
Q 004979 586 ----------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPLKDIVDPTL 654 (721)
Q Consensus 586 ----------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 654 (721)
.++..|+|||.+....++.++|||||||++|||+| |+.||...... +.......+...
T Consensus 165 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~--~~~~~~~~~~~~--------- 233 (281)
T 3cc6_A 165 DEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK--DVIGVLEKGDRL--------- 233 (281)
T ss_dssp --------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG--GHHHHHHHTCCC---------
T ss_pred cccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChH--HHHHHHhcCCCC---------
Confidence 12346999999998999999999999999999999 99999643221 122222222110
Q ss_pred ccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcC
Q 004979 655 KSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAME 697 (721)
Q Consensus 655 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 697 (721)
..+..+++++.+++.+||+.||++||++.|+++.|+++.+..
T Consensus 234 -~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 275 (281)
T 3cc6_A 234 -PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQME 275 (281)
T ss_dssp -CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhh
Confidence 111234567889999999999999999999999999987643
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=330.23 Aligned_cols=251 Identities=21% Similarity=0.288 Sum_probs=193.4
Q ss_pred hhhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEE
Q 004979 429 SNIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMM 507 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~l 507 (721)
+++++.+|+|+||+||+|+.. ++..||+|++..... .....+.+.+|++++++++||||+++++++.+.+ ..++
T Consensus 5 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~~l 79 (311)
T 4agu_A 5 YEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESED---DPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKR--RLHL 79 (311)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC----HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT--EEEE
T ss_pred ceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeecccc---chHHHHHHHHHHHHHHhCCCCCccchhheeecCC--eEEE
Confidence 367788999999999999975 588999998864432 2334567899999999999999999999998876 6799
Q ss_pred EEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC--
Q 004979 508 VFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT-- 585 (721)
Q Consensus 508 V~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~-- 585 (721)
||||+++++|.+++. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 80 v~e~~~~~~l~~~~~--~~~~~~~~~~~~i~~~l~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 155 (311)
T 4agu_A 80 VFEYCDHTVLHELDR--YQRGVPEHLVKSITWQTLQAVNFCHKHN--CIHRDVKPENILITKHSVIKLCDFGFARLLTGP 155 (311)
T ss_dssp EEECCSEEHHHHHHH--TSSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EEEeCCCchHHHHHh--hhcCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence 999999999998875 3456899999999999999999999998 9999999999999999999999999985432
Q ss_pred -------CCCccccchhhccc-CCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHH-HHHHHHhhc-----------CCC
Q 004979 586 -------AAKTGSAAMELLET-SAVDLESNVYSFGTILFEMITGRISYSIENGSLE-NWASEYLKG-----------EQP 645 (721)
Q Consensus 586 -------~~~~~~~apE~~~~-~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~-~~~~~~~~~-----------~~~ 645 (721)
.++..|+|||.+.+ ..++.++|||||||++|||+||+.||........ ..+...... ...
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (311)
T 4agu_A 156 SDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQY 235 (311)
T ss_dssp ----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGG
T ss_pred ccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccc
Confidence 24556899999865 6789999999999999999999999964332111 111111100 000
Q ss_pred Cc--cccCCcc----ccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 646 LK--DIVDPTL----KSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 646 ~~--~~~d~~l----~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
.. .+.++.. ....+..+.++.+++.+||+.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 236 FSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp GTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred cccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00 0001100 0011235567899999999999999999999986
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=334.72 Aligned_cols=249 Identities=25% Similarity=0.439 Sum_probs=199.2
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEE--EEEEeeeccccchhhHHHHHHHHHHHHHhcC-CCCccceEeEEEecCCCceE
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEI--AVTSTSVKSRADWSKNLESQFRKKIDTLSKV-NHKNFVNLIGYCEEDEPFTR 505 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~v--avk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~~ 505 (721)
++.+.+|+|+||.||+|+.. ++..+ ++|.+.... .....+.+.+|++++.++ +||||+++++++.+.+ ..
T Consensus 28 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~--~~ 101 (327)
T 1fvr_A 28 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA----SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG--YL 101 (327)
T ss_dssp EEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC----------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT--EE
T ss_pred cceeeeecCCCceEEEEEEccCCcccceeeeeecccc----chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCC--ce
Confidence 67788999999999999964 45544 777765322 122346789999999999 9999999999998877 67
Q ss_pred EEEEecCCCCChhhhhhhcc--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCC
Q 004979 506 MMVFEYSPNGSLFEHLHIQE--------------AEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDY 571 (721)
Q Consensus 506 ~lV~Ey~~~GsL~~~l~~~~--------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~ 571 (721)
++||||+++|+|.+++.... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~~~~ 179 (327)
T 1fvr_A 102 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENY 179 (327)
T ss_dssp EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECGGG
T ss_pred EEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCccceEEEcCCC
Confidence 99999999999999986432 246899999999999999999999998 99999999999999999
Q ss_pred cEEEeccCCCCCCC--------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhc
Q 004979 572 AAKISDFSFWNNTT--------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKG 642 (721)
Q Consensus 572 ~~kL~DFGla~~~~--------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~ 642 (721)
.+||+|||+++... .++..|+|||.+....++.++|||||||++|||+| |+.||... ...+.......+
T Consensus 180 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~--~~~~~~~~~~~~ 257 (327)
T 1fvr_A 180 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM--TCAELYEKLPQG 257 (327)
T ss_dssp CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC--CHHHHHHHGGGT
T ss_pred eEEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCC--cHHHHHHHhhcC
Confidence 99999999875321 23446999999988889999999999999999998 99999633 333333333222
Q ss_pred CCCCccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCC
Q 004979 643 EQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAMEP 698 (721)
Q Consensus 643 ~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 698 (721)
... ..+..++.++.+++.+||+.||++||++.|+++.|+++.....
T Consensus 258 ~~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 303 (327)
T 1fvr_A 258 YRL----------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 303 (327)
T ss_dssp CCC----------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred CCC----------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhc
Confidence 110 1122345678999999999999999999999999999877543
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-38 Score=336.73 Aligned_cols=240 Identities=22% Similarity=0.299 Sum_probs=192.0
Q ss_pred hhhhCcCCCCceeEEEEEEecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCC--CccceEeEEEecCCCceEE
Q 004979 429 SNIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNH--KNFVNLIGYCEEDEPFTRM 506 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H--~nIv~l~g~~~~~~~~~~~ 506 (721)
|++++.||+|+||+||+|...++..||||++..... .....+.+.+|+++|.+++| +||+++++++.+.+ ..+
T Consensus 11 y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~--~~~ 85 (343)
T 3dbq_A 11 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA---DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ--YIY 85 (343)
T ss_dssp EEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS--EEE
T ss_pred EEEEEEEecCCCeEEEEEEeCCCCEEEEEEeecccc---chHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCC--EEE
Confidence 477889999999999999988899999999875432 23345679999999999976 99999999999877 779
Q ss_pred EEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC--
Q 004979 507 MVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT-- 584 (721)
Q Consensus 507 lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~-- 584 (721)
+||| +.+|+|.+++.. ...+++..+..|+.||+.||+|||+.+ |+||||||+|||++ ++.+||+|||+++..
T Consensus 86 lv~e-~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH~~~--iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 86 MVME-CGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 159 (343)
T ss_dssp EEEC-CCSEEHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred EEEe-CCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence 9999 568899999864 456899999999999999999999998 99999999999997 578999999998643
Q ss_pred ---------CCCCccccchhhccc-----------CCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCC
Q 004979 585 ---------TAAKTGSAAMELLET-----------SAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQ 644 (721)
Q Consensus 585 ---------~~~~~~~~apE~~~~-----------~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~ 644 (721)
..++..|+|||.+.. ..++.++|||||||++|||+||+.||........ ..........
T Consensus 160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~~~~~~~~ 238 (343)
T 3dbq_A 160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS-KLHAIIDPNH 238 (343)
T ss_dssp ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH-HHHHHHCTTS
T ss_pred ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHH-HHHHHhcCCc
Confidence 235668999999854 6789999999999999999999999964332222 2222221111
Q ss_pred CCccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004979 645 PLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAK 689 (721)
Q Consensus 645 ~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 689 (721)
. ..++.....++.+++.+||+.||++|||+.|+++.
T Consensus 239 ~---------~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 239 E---------IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp C---------CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred c---------cCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 1 01112234578899999999999999999999864
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=327.25 Aligned_cols=239 Identities=19% Similarity=0.311 Sum_probs=178.6
Q ss_pred hhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
++.+.+|+|+||.||+|+. .+++.|++|++...... .....+.+.+|++++++++||||+++++++.+.+ ..++|
T Consensus 14 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv 89 (278)
T 3cok_A 14 KVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMY--KAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSN--YVYLV 89 (278)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH--HTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSS--EEEEE
T ss_pred eeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhh--hhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCC--eEEEE
Confidence 6778899999999999996 57889999988643211 1122467899999999999999999999998876 67999
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC---
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT--- 585 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~--- 585 (721)
|||+++|+|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 90 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 166 (278)
T 3cok_A 90 LEMCHNGEMNRYLKN-RVKPFSENEARHFMHQIITGMLYLHSHG--ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH 166 (278)
T ss_dssp EECCTTEEHHHHHHT-CSSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred EecCCCCcHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCCEEEEeecceeeccCCC
Confidence 999999999999863 3356899999999999999999999998 9999999999999999999999999875432
Q ss_pred ------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccH
Q 004979 586 ------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQE 659 (721)
Q Consensus 586 ------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 659 (721)
.++..|+|||.+....++.++|||||||++|||+||+.||...... +........ . ...+.
T Consensus 167 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~----------~-~~~~~ 233 (278)
T 3cok_A 167 EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVK--NTLNKVVLA----------D-YEMPS 233 (278)
T ss_dssp -------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-------CCSS----------C-CCCCT
T ss_pred CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHH--HHHHHHhhc----------c-cCCcc
Confidence 2355789999999889999999999999999999999999643321 111111100 0 01223
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 660 NVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 660 ~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
..+.++.+++.+||+.||++||++.|+++
T Consensus 234 ~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 234 FLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 34567899999999999999999999975
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=336.14 Aligned_cols=251 Identities=23% Similarity=0.344 Sum_probs=198.5
Q ss_pred hhhhCcCCCCceeEEEEEEe-----cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCc
Q 004979 429 SNIIGSFSDGTVGTVYKGTL-----SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPF 503 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~-----~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 503 (721)
+++++.+|+|+||.||+|++ .++..||||++.... ....+.+.+|++++++++||||+++++++...+..
T Consensus 43 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 117 (326)
T 2w1i_A 43 LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-----EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 117 (326)
T ss_dssp EEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC-----SHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----
T ss_pred ceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC-----HHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCC
Confidence 46788999999999999984 367889999886432 23356799999999999999999999998765433
Q ss_pred eEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCC
Q 004979 504 TRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNN 583 (721)
Q Consensus 504 ~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~ 583 (721)
..++||||+++|+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 118 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 118 NLKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp CCEEEECCCTTCBHHHHHHHS-TTSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred ceEEEEECCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 568999999999999999643 356899999999999999999999988 99999999999999999999999998753
Q ss_pred CCC------------CCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHH-------------HHHHH
Q 004979 584 TTA------------AKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLE-------------NWASE 638 (721)
Q Consensus 584 ~~~------------~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~-------------~~~~~ 638 (721)
... ++..|+|||.+.+..++.++|||||||++|||+||+.||........ .....
T Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (326)
T 2w1i_A 195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 274 (326)
T ss_dssp CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred ccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHH
Confidence 321 22358999999888899999999999999999999998852110000 00111
Q ss_pred HhhcCCCCccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 004979 639 YLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAM 696 (721)
Q Consensus 639 ~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~ 696 (721)
.+.... ....+..++.++.+++.+||+.||++||++.||++.|+++.+.
T Consensus 275 ~~~~~~---------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 275 LLKNNG---------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp HHHTTC---------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HhhcCC---------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 111110 0112234567899999999999999999999999999998753
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=325.26 Aligned_cols=241 Identities=19% Similarity=0.285 Sum_probs=192.9
Q ss_pred hhhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEE
Q 004979 429 SNIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMM 507 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~l 507 (721)
+.+.+.+|+|+||+||+|+.. ++..+++|++...... ...+.+.+|++++++++||||+++++++.+.+ ..++
T Consensus 24 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--~~~l 97 (285)
T 3is5_A 24 FIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ----VPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYH--NMYI 97 (285)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCC----SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS--EEEE
T ss_pred eeecceeccCCCeEEEEEEEccCCceEEEEEeeccccc----hhHHHHHHHHHHHHhCCCchHHhHHHheecCC--eEEE
Confidence 467789999999999999964 6788999988654321 12467899999999999999999999998776 6799
Q ss_pred EEecCCCCChhhhhhhc--cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEe---CCCCcEEEeccCCCC
Q 004979 508 VFEYSPNGSLFEHLHIQ--EAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYL---TEDYAAKISDFSFWN 582 (721)
Q Consensus 508 V~Ey~~~GsL~~~l~~~--~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl---~~~~~~kL~DFGla~ 582 (721)
||||+++|+|.+++... ....+++..+..|+.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 98 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~ 175 (285)
T 3is5_A 98 VMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH--VVHKDLKPENILFQDTSPHSPIKIIDFGLAE 175 (285)
T ss_dssp EECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEESSSSTTCCEEECCCCCCC
T ss_pred EEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCCCHHHEEEecCCCCCCEEEEeeecce
Confidence 99999999999998643 3467999999999999999999999998 9999999999999 456889999999986
Q ss_pred CC--------CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCcc
Q 004979 583 NT--------TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTL 654 (721)
Q Consensus 583 ~~--------~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 654 (721)
.. ..++..|+|||.+. ..++.++|||||||++|||+||+.||... ...+...............
T Consensus 176 ~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~--~~~~~~~~~~~~~~~~~~~----- 247 (285)
T 3is5_A 176 LFKSDEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGT--SLEEVQQKATYKEPNYAVE----- 247 (285)
T ss_dssp C----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHCCCCCCC------
T ss_pred ecCCcccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCC--CHHHHHhhhccCCcccccc-----
Confidence 42 22456789999875 56899999999999999999999999643 3333333333222211110
Q ss_pred ccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 655 KSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 655 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
....++++.+++.+||+.||++||++.|+++
T Consensus 248 ---~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 248 ---CRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp ----CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred ---cCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1113467889999999999999999999975
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=326.03 Aligned_cols=244 Identities=23% Similarity=0.341 Sum_probs=194.7
Q ss_pred hhhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecC--CCceE
Q 004979 429 SNIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEED--EPFTR 505 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~~ 505 (721)
+++...+|+|+||+||+|... ++..|++|++..... .....+.+.+|++++++++||||+++++++... +....
T Consensus 28 ~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (290)
T 1t4h_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL---TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred EEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhh---CHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence 356667999999999999864 677899988764332 233457899999999999999999999998652 22357
Q ss_pred EEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeC-CCCcEEEeccCCCCCC
Q 004979 506 MMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLT-EDYAAKISDFSFWNNT 584 (721)
Q Consensus 506 ~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~-~~~~~kL~DFGla~~~ 584 (721)
++||||+++|+|.+++... ..+++..+..|+.|++.||+|||+.+++|+||||||+|||++ +++.+||+|||++...
T Consensus 105 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~ 182 (290)
T 1t4h_A 105 VLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp EEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EEEEEecCCCCHHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccc
Confidence 9999999999999999643 568999999999999999999999877799999999999998 8899999999987532
Q ss_pred C-------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccc
Q 004979 585 T-------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSF 657 (721)
Q Consensus 585 ~-------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 657 (721)
. .++..|+|||.+. ..++.++|||||||++|||+||+.||.... ...........+..+ ...
T Consensus 183 ~~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~---------~~~ 251 (290)
T 1t4h_A 183 RASFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQ-NAAQIYRRVTSGVKP---------ASF 251 (290)
T ss_dssp CTTSBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCS-SHHHHHHHHTTTCCC---------GGG
T ss_pred cccccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcC-cHHHHHHHHhccCCc---------ccc
Confidence 2 2456799999876 458999999999999999999999996432 333333333322111 011
Q ss_pred cHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 658 QENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 658 ~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
....+.++.+++.+||+.||++||++.|+++
T Consensus 252 ~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 252 DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 2233467899999999999999999999985
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-38 Score=343.49 Aligned_cols=238 Identities=18% Similarity=0.289 Sum_probs=185.5
Q ss_pred CcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHh-cCCCCccceEeEEEec--CCCceEEEE
Q 004979 433 GSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLS-KVNHKNFVNLIGYCEE--DEPFTRMMV 508 (721)
Q Consensus 433 ~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~-~l~H~nIv~l~g~~~~--~~~~~~~lV 508 (721)
+.||+|+||+||+|+.. ++..||||++... ..+.+|++++. ..+||||+++++++.. .+....|+|
T Consensus 68 ~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~----------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv 137 (400)
T 1nxk_A 68 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC----------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIV 137 (400)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECS----------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred ceeeeccCeEEEEEEECCCCCEEEEEEeCcc----------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEE
Confidence 57899999999999965 6888999988521 34677888874 4589999999998864 222267999
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCC---CCcEEEeccCCCCCCC
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTE---DYAAKISDFSFWNNTT 585 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~---~~~~kL~DFGla~~~~ 585 (721)
|||+++|+|.+++.......+++..+..|+.||+.||+|||+++ |+||||||+|||++. ++.+||+|||+++...
T Consensus 138 ~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~ 215 (400)
T 1nxk_A 138 MECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 215 (400)
T ss_dssp EECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred EEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCcceEEEecCCCCccEEEEecccccccC
Confidence 99999999999997554557999999999999999999999988 999999999999997 7899999999986432
Q ss_pred --------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCH--HHHHHHHhhcCCCCccccCCccc
Q 004979 586 --------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSL--ENWASEYLKGEQPLKDIVDPTLK 655 (721)
Q Consensus 586 --------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~--~~~~~~~~~~~~~~~~~~d~~l~ 655 (721)
.++..|+|||++....++.++|||||||++|||+||+.||....... ......+..+..... .+
T Consensus 216 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~---~~--- 289 (400)
T 1nxk_A 216 SHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP---NP--- 289 (400)
T ss_dssp -----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCC---TT---
T ss_pred CCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCC---Cc---
Confidence 23567999999999999999999999999999999999997433210 111122222211111 01
Q ss_pred cccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004979 656 SFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAK 689 (721)
Q Consensus 656 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 689 (721)
....++.++.+|+.+||+.||++|||+.|+++.
T Consensus 290 -~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 290 -EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp -TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 112345778999999999999999999999874
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-38 Score=328.10 Aligned_cols=245 Identities=21% Similarity=0.326 Sum_probs=196.7
Q ss_pred hhhC-cCCCCceeEEEEEEec---CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceE
Q 004979 430 NIIG-SFSDGTVGTVYKGTLS---SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTR 505 (721)
Q Consensus 430 ~ii~-~lg~G~~g~Vyk~~~~---~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~ 505 (721)
++.+ .+|+|+||+||+|.+. ++..|+||++..... .....+.+.+|++++++++||||+++++++.. + ..
T Consensus 19 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~--~~ 92 (291)
T 1xbb_A 19 TLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN---DPALKDELLAEANVMQQLDNPYIVRMIGICEA-E--SW 92 (291)
T ss_dssp EEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC--------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-S--SE
T ss_pred hhccCccccccCeeeEeeeecCCCceeeEEEEeeccccc---CHHHHHHHHHHHHHHHhCCCCCEEEEEEEECC-C--Cc
Confidence 4556 7899999999999642 467899998864322 12345679999999999999999999999943 3 46
Q ss_pred EEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC
Q 004979 506 MMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT 585 (721)
Q Consensus 506 ~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~ 585 (721)
++||||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 93 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 168 (291)
T 1xbb_A 93 MLVMEMAELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALR 168 (291)
T ss_dssp EEEEECCTTEEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEEEeCCCCCHHHHHHh--CcCCCHHHHHHHHHHHHHHHHHHHhCC--eEcCCCCcceEEEeCCCcEEEccCCcceeec
Confidence 899999999999999964 356899999999999999999999998 9999999999999999999999999875332
Q ss_pred C------------CCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhcCCCCccccCC
Q 004979 586 A------------AKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPLKDIVDP 652 (721)
Q Consensus 586 ~------------~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 652 (721)
. ++..|+|||.+.+..++.++||||||+++|||+| |+.||.... ..+.......+..
T Consensus 169 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~--~~~~~~~~~~~~~-------- 238 (291)
T 1xbb_A 169 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK--GSEVTAMLEKGER-------- 238 (291)
T ss_dssp TTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC--HHHHHHHHHTTCC--------
T ss_pred cCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCC--HHHHHHHHHcCCC--------
Confidence 1 1245899999988889999999999999999999 999996432 2333333222211
Q ss_pred ccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 004979 653 TLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAM 696 (721)
Q Consensus 653 ~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~ 696 (721)
...+..++.++.+++.+||+.||++||++.|+++.|+++...
T Consensus 239 --~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 280 (291)
T 1xbb_A 239 --MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 280 (291)
T ss_dssp --CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred --CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 112234557899999999999999999999999999987654
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=321.38 Aligned_cols=240 Identities=18% Similarity=0.270 Sum_probs=194.6
Q ss_pred hhhhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEE
Q 004979 428 FSNIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRM 506 (721)
Q Consensus 428 ~~~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~ 506 (721)
.+.+.+.+|+|+||+||+|+.. ++..+++|++....... .+.+.+|++++++++||||+++++++.+.+ ..+
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~~ 82 (277)
T 3f3z_A 10 YYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED-----VDRFKQEIEIMKSLDHPNIIRLYETFEDNT--DIY 82 (277)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC-----HHHHHHHHHHHHTCCCTTBCCEEEEEECSS--EEE
T ss_pred hEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch-----HHHHHHHHHHHHhCCCCCEeeEEEEEecCC--eEE
Confidence 3577888999999999999965 46789999886543222 357899999999999999999999998876 679
Q ss_pred EEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEe---CCCCcEEEeccCCCCC
Q 004979 507 MVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYL---TEDYAAKISDFSFWNN 583 (721)
Q Consensus 507 lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl---~~~~~~kL~DFGla~~ 583 (721)
+||||+++|+|.+++.. ...+++..+..|+.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||++..
T Consensus 83 lv~e~~~~~~L~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~ 158 (277)
T 3f3z_A 83 LVMELCTGGELFERVVH--KRVFRESDAARIMKDVLSAVAYCHKLN--VAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR 158 (277)
T ss_dssp EEEECCCSCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EEEeccCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEEecCCCCCcEEEEeccccee
Confidence 99999999999998864 345899999999999999999999998 9999999999999 7889999999998753
Q ss_pred C--------CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccc
Q 004979 584 T--------TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLK 655 (721)
Q Consensus 584 ~--------~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 655 (721)
. ..++..|+|||.+.+ .++.++|||||||++|||+||+.||... ...+.......+......
T Consensus 159 ~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~--~~~~~~~~~~~~~~~~~~------- 228 (277)
T 3f3z_A 159 FKPGKMMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAP--TDSEVMLKIREGTFTFPE------- 228 (277)
T ss_dssp CCTTSCBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHCCCCCCH-------
T ss_pred ccCccchhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCC--CHHHHHHHHHhCCCCCCc-------
Confidence 2 234567999998865 4899999999999999999999999643 333334443333221111
Q ss_pred cccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 656 SFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 656 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
......+.++.+++.+||+.||++||++.|+++
T Consensus 229 ~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 229 KDWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred hhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 001134567899999999999999999999986
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=343.37 Aligned_cols=250 Identities=19% Similarity=0.266 Sum_probs=185.9
Q ss_pred hhhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCC-CCccceEeEEEecCCCceEE
Q 004979 429 SNIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVN-HKNFVNLIGYCEEDEPFTRM 506 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~~~ 506 (721)
+++++.+|+|+||+||+|+. .++..||||++..... .....+.+.+|+.++.+++ |||||++++++...+....|
T Consensus 11 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~---~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 87 (388)
T 3oz6_A 11 YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQ---NSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY 87 (388)
T ss_dssp EEEEEC-------CEEEEEETTTCCEEEEEEECC--C---CHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred eEEEEEeeeCCCeEEEEEEECCCCCEEEEEEeccccc---ChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence 47888999999999999985 4688999998854321 1234467889999999997 99999999999865544679
Q ss_pred EEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC--
Q 004979 507 MVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT-- 584 (721)
Q Consensus 507 lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~-- 584 (721)
+|||||+ |+|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 88 lv~e~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 161 (388)
T 3oz6_A 88 LVFDYME-TDLHAVIRA---NILEPVHKQYVVYQLIKVIKYLHSGG--LLHRDMKPSNILLNAECHVKVADFGLSRSFVN 161 (388)
T ss_dssp EEEECCS-EEHHHHHHH---TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEESSS
T ss_pred EEecccC-cCHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHeEEcCCCCEEecCCcccccccc
Confidence 9999997 689988863 46899999999999999999999998 999999999999999999999999998632
Q ss_pred ----------------------------CCCCccccchhhccc-CCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHH
Q 004979 585 ----------------------------TAAKTGSAAMELLET-SAVDLESNVYSFGTILFEMITGRISYSIENGSLENW 635 (721)
Q Consensus 585 ----------------------------~~~~~~~~apE~~~~-~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~ 635 (721)
..++..|+|||.+.+ ..++.++||||+||++|||+||+.||...+ ....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~--~~~~ 239 (388)
T 3oz6_A 162 IRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSS--TMNQ 239 (388)
T ss_dssp CCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHH
T ss_pred cccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC--HHHH
Confidence 134567899999876 678999999999999999999999996432 2222
Q ss_pred HHHHhhcC-CCCcccc----------------------CCcccccc-------------HHHHHHHHHHHHHcccCCCCC
Q 004979 636 ASEYLKGE-QPLKDIV----------------------DPTLKSFQ-------------ENVLEELLVVIKNCVHPDPKQ 679 (721)
Q Consensus 636 ~~~~~~~~-~~~~~~~----------------------d~~l~~~~-------------~~~~~~l~~li~~Cl~~dP~~ 679 (721)
...+.... .+..+.+ ........ ..++.++.+|+.+||+.||++
T Consensus 240 ~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~ 319 (388)
T 3oz6_A 240 LERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNK 319 (388)
T ss_dssp HHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGG
T ss_pred HHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCccc
Confidence 22222110 0000000 00000000 123567899999999999999
Q ss_pred CCCHHHHHHH
Q 004979 680 RPSMRGIAAK 689 (721)
Q Consensus 680 RPs~~evl~~ 689 (721)
|||+.|+++.
T Consensus 320 R~t~~e~l~H 329 (388)
T 3oz6_A 320 RISANDALKH 329 (388)
T ss_dssp SCCHHHHTTS
T ss_pred CCCHHHHhCC
Confidence 9999999875
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=348.80 Aligned_cols=265 Identities=14% Similarity=0.199 Sum_probs=207.2
Q ss_pred hhhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCc-cceEeEEEecCCCceEE
Q 004979 429 SNIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKN-FVNLIGYCEEDEPFTRM 506 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~n-Iv~l~g~~~~~~~~~~~ 506 (721)
+++++.||+|+||.||+|+. .++..||||++...... .++.+|++++..++|++ |..+..++...+ ..+
T Consensus 9 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-------~~~~~E~~il~~L~~~~~i~~i~~~~~~~~--~~~ 79 (483)
T 3sv0_A 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-------PQLLYESKIYRILQGGTGIPNVRWFGVEGD--YNV 79 (483)
T ss_dssp EECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS-------CCHHHHHHHHHHTTTSTTCCCEEEEEEETT--EEE
T ss_pred EEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeeCC--EEE
Confidence 47788999999999999995 57889999987654322 35789999999998754 555555555555 679
Q ss_pred EEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEe---CCCCcEEEeccCCCCC
Q 004979 507 MVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYL---TEDYAAKISDFSFWNN 583 (721)
Q Consensus 507 lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl---~~~~~~kL~DFGla~~ 583 (721)
|||||+ +|+|.+++.. ....+++..++.|+.||+.||+|||+++ ||||||||+|||| +.++.+||+|||+++.
T Consensus 80 lvme~~-g~sL~~ll~~-~~~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 155 (483)
T 3sv0_A 80 LVMDLL-GPSLEDLFNF-CSRKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (483)
T ss_dssp EEEECC-CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred EEEECC-CCCHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCcceEEEecCCCCCeEEEEeCCccee
Confidence 999999 9999999863 3456999999999999999999999998 9999999999999 6889999999999753
Q ss_pred C----------------CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCC-CHHHHHHHHhhcCCCC
Q 004979 584 T----------------TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENG-SLENWASEYLKGEQPL 646 (721)
Q Consensus 584 ~----------------~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~-~~~~~~~~~~~~~~~~ 646 (721)
. ..++..|+|||.+.+..++.++|||||||+||||++|+.||..... ...+.+..+....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~--- 232 (483)
T 3sv0_A 156 YRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK--- 232 (483)
T ss_dssp CBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHH---
T ss_pred ccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcc---
Confidence 2 2345579999999999999999999999999999999999975432 2222222221110
Q ss_pred ccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCChhHHHHHHh
Q 004979 647 KDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAMEPDGATPKLSPLWWAELEI 715 (721)
Q Consensus 647 ~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~~~~p~~~~~~~~~l~~ 715 (721)
....+......++.++.+++..||+.+|++||++.+|++.|+++..... .+.+..++|+.+..
T Consensus 233 ---~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~---~~~~~~~dW~~~~~ 295 (483)
T 3sv0_A 233 ---VATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREG---FQFDYVFDWTILKY 295 (483)
T ss_dssp ---HHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT---CCCSSCCHHHHHTC
T ss_pred ---ccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcC---CCccCCcCchhhcc
Confidence 0011111223345789999999999999999999999999999877553 35677889987743
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=321.58 Aligned_cols=243 Identities=20% Similarity=0.278 Sum_probs=197.4
Q ss_pred hhhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEE
Q 004979 429 SNIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMM 507 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~l 507 (721)
+++.+.+|+|+||.||+|... ++..||+|++..... .....+.+.+|++++++++||||+++++++.+.+ ..++
T Consensus 8 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~~ 82 (284)
T 3kk8_A 8 YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL---SARDFQKLEREARICRKLQHPNIVRLHDSIQEES--FHYL 82 (284)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS--EEEE
T ss_pred hhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccC---CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCC--EEEE
Confidence 467788999999999999965 588999998865432 2334567899999999999999999999998776 6799
Q ss_pred EEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCc---EEEeccCCCCCC
Q 004979 508 VFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYA---AKISDFSFWNNT 584 (721)
Q Consensus 508 V~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~---~kL~DFGla~~~ 584 (721)
||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++. +||+|||++...
T Consensus 83 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~ 158 (284)
T 3kk8_A 83 VFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 158 (284)
T ss_dssp EECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred EEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence 99999999999888643 56899999999999999999999998 999999999999986655 999999987432
Q ss_pred --------CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCcccc
Q 004979 585 --------TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKS 656 (721)
Q Consensus 585 --------~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 656 (721)
..++..|+|||.+.+..++.++||||||+++|||++|+.||... ...........+...... +
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~--~~~~~~~~~~~~~~~~~~---~---- 229 (284)
T 3kk8_A 159 NDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE--DQHRLYAQIKAGAYDYPS---P---- 229 (284)
T ss_dssp CSSCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHTCCCCCT---T----
T ss_pred ccCccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCC--chhHHHHHHHhccccCCc---h----
Confidence 23456789999999999999999999999999999999999643 333334333333221111 1
Q ss_pred ccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004979 657 FQENVLEELLVVIKNCVHPDPKQRPSMRGIAAK 689 (721)
Q Consensus 657 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 689 (721)
.....+.++.+++.+||+.||++||++.|+++.
T Consensus 230 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 230 EWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred hhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 112345678899999999999999999999873
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=329.68 Aligned_cols=236 Identities=22% Similarity=0.272 Sum_probs=187.0
Q ss_pred hhhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcC-CCCccceEeEEEecCCCceEE
Q 004979 429 SNIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKV-NHKNFVNLIGYCEEDEPFTRM 506 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~~~ 506 (721)
+++++.+|+|+||+||+|+.. +++.||||++...... ......+..|+..+.++ +|||||+++++|.+.+ ..+
T Consensus 59 y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~--~~~ 133 (311)
T 3p1a_A 59 FQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRG---PKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGG--ILY 133 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCS---HHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT--EEE
T ss_pred eeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccC---hHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCC--EEE
Confidence 477889999999999999976 7899999987543221 22334556666666555 9999999999998877 779
Q ss_pred EEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC--
Q 004979 507 MVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT-- 584 (721)
Q Consensus 507 lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~-- 584 (721)
+||||+ +|+|.+++... ...++|..+..|+.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 134 lv~e~~-~~~L~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~ 209 (311)
T 3p1a_A 134 LQTELC-GPSLQQHCEAW-GASLPEAQVWGYLRDTLLALAHLHSQG--LVHLDVKPANIFLGPRGRCKLGDFGLLVELGT 209 (311)
T ss_dssp EEEECC-CCBHHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred EEEecc-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence 999999 77999988643 456999999999999999999999988 999999999999999999999999987532
Q ss_pred ------CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCcccccc
Q 004979 585 ------TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQ 658 (721)
Q Consensus 585 ------~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 658 (721)
..++..|+|||.+.+ .++.++|||||||++|||++|..|+... ..+ .....+. .. ....
T Consensus 210 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~----~~~-~~~~~~~------~~---~~~~ 274 (311)
T 3p1a_A 210 AGAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG----EGW-QQLRQGY------LP---PEFT 274 (311)
T ss_dssp -----CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH----HHH-HHHTTTC------CC---HHHH
T ss_pred CCCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc----cHH-HHHhccC------CC---cccc
Confidence 234668999998875 7999999999999999999997766421 111 1111110 00 1122
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 659 ENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 659 ~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
...+.++.+++.+||+.||++|||+.|+++
T Consensus 275 ~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 275 AGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 345678999999999999999999999985
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-38 Score=335.20 Aligned_cols=251 Identities=18% Similarity=0.287 Sum_probs=187.5
Q ss_pred hhhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCC-CCccceEeEEEec------C
Q 004979 429 SNIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVN-HKNFVNLIGYCEE------D 500 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~------~ 500 (721)
+++.+.+|+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++.+++ ||||+++++++.. .
T Consensus 30 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 104 (337)
T 3ll6_A 30 LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE-----EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT 104 (337)
T ss_dssp EEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS-----HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred EEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc-----hHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence 367788999999999999964 78899999885432 233467899999999996 9999999999852 1
Q ss_pred CCceEEEEEecCCCCChhhhhhhc-cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccC
Q 004979 501 EPFTRMMVFEYSPNGSLFEHLHIQ-EAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFS 579 (721)
Q Consensus 501 ~~~~~~lV~Ey~~~GsL~~~l~~~-~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFG 579 (721)
.....++||||+. |+|.+++... ....+++..+..|+.||+.||+|||+.+++|+||||||+|||++.++.+||+|||
T Consensus 105 ~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg 183 (337)
T 3ll6_A 105 GQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFG 183 (337)
T ss_dssp SSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCT
T ss_pred CCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCc
Confidence 2225799999995 7999988642 3456999999999999999999999987789999999999999999999999999
Q ss_pred CCCCCCC---------------------CCccccchhhc---ccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHH
Q 004979 580 FWNNTTA---------------------AKTGSAAMELL---ETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENW 635 (721)
Q Consensus 580 la~~~~~---------------------~~~~~~apE~~---~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~ 635 (721)
+++.... ++..|+|||.+ ....++.++|||||||++|||+||+.||..... ...
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~--~~~ 261 (337)
T 3ll6_A 184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK--LRI 261 (337)
T ss_dssp TCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----------
T ss_pred cceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhH--HHh
Confidence 9864322 45568999998 567789999999999999999999999963221 111
Q ss_pred HHHHhhcCCCCccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCCCC
Q 004979 636 ASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAMEPDG 700 (721)
Q Consensus 636 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~~ 700 (721)
.. ...... .......++.+++.+||+.||++||++.|+++.|+++.+.....
T Consensus 262 ~~----~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~~ 313 (337)
T 3ll6_A 262 VN----GKYSIP---------PHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVN 313 (337)
T ss_dssp --------CCCC---------TTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTCC
T ss_pred hc----CcccCC---------cccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCCC
Confidence 11 100000 01122345778999999999999999999999999998865543
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-38 Score=333.67 Aligned_cols=247 Identities=17% Similarity=0.228 Sum_probs=198.4
Q ss_pred hhhhhhh-CcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcC-CCCccceEeEEEecCCC
Q 004979 426 EDFSNII-GSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKV-NHKNFVNLIGYCEEDEP 502 (721)
Q Consensus 426 ~~~~~ii-~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~ 502 (721)
++++.+. +.+|+|+||+||+|+.. +++.||+|++...... ......+.+|+.++.++ +||||+++++++.+.+
T Consensus 27 ~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~- 102 (327)
T 3lm5_A 27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRG---QDCRAEILHEIAVLELAKSCPRVINLHEVYENTS- 102 (327)
T ss_dssp HHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETT---EECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS-
T ss_pred hhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcc---hHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCC-
Confidence 4455555 67999999999999965 6889999988754322 12246789999999999 5699999999998876
Q ss_pred ceEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCC---CCcEEEeccC
Q 004979 503 FTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTE---DYAAKISDFS 579 (721)
Q Consensus 503 ~~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~---~~~~kL~DFG 579 (721)
..++||||+++|+|.+++.......+++..+..|+.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||
T Consensus 103 -~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g--ivH~Dikp~NIl~~~~~~~~~~kL~Dfg 179 (327)
T 3lm5_A 103 -EIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN--IVHLDLKPQNILLSSIYPLGDIKIVDFG 179 (327)
T ss_dssp -EEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESCBTTBCCEEECCGG
T ss_pred -eEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCChHHEEEecCCCCCcEEEeeCc
Confidence 6799999999999999986555577999999999999999999999998 999999999999998 7899999999
Q ss_pred CCCCCC--------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccC
Q 004979 580 FWNNTT--------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVD 651 (721)
Q Consensus 580 la~~~~--------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d 651 (721)
+++... .++..|+|||.+....++.++|||||||++|||+||+.||.... ..+..............
T Consensus 180 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~--~~~~~~~i~~~~~~~~~--- 254 (327)
T 3lm5_A 180 MSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGED--NQETYLNISQVNVDYSE--- 254 (327)
T ss_dssp GCEEC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHTCCCCCT---
T ss_pred cccccCCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--chHHHHHHHhcccccCc---
Confidence 885332 34567999999999999999999999999999999999996432 23333332222111111
Q ss_pred CccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 652 PTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 652 ~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
.....++.++.+++.+||+.||++|||++|+++
T Consensus 255 ----~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 255 ----ETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp ----TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ----hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 112234567889999999999999999999975
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=322.45 Aligned_cols=254 Identities=18% Similarity=0.254 Sum_probs=202.9
Q ss_pred hhhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccch-hhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEE
Q 004979 429 SNIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADW-SKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRM 506 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~ 506 (721)
+++++.+|+|+||+||+|+.. ++..+++|++........ .....+.+.+|++++++++||||+++++++.+.+ ..+
T Consensus 7 y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~~ 84 (283)
T 3bhy_A 7 YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKT--DVV 84 (283)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS--EEE
T ss_pred hhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCC--eEE
Confidence 477889999999999999976 688999998875432211 1112467999999999999999999999998876 679
Q ss_pred EEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCC----cEEEeccCCCC
Q 004979 507 MVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDY----AAKISDFSFWN 582 (721)
Q Consensus 507 lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~----~~kL~DFGla~ 582 (721)
+||||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++ .+||+|||++.
T Consensus 85 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~ 160 (283)
T 3bhy_A 85 LILELVSGGELFDFLAE--KESLTEDEATQFLKQILDGVHYLHSKR--IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH 160 (283)
T ss_dssp EEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEeecCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChHHEEEecCCCCCCceEEEecccce
Confidence 99999999999999864 346899999999999999999999998 99999999999999877 89999999876
Q ss_pred CCC--------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCcc
Q 004979 583 NTT--------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTL 654 (721)
Q Consensus 583 ~~~--------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 654 (721)
... .++..|+|||.+....++.++||||||+++|||+||+.||... ...+.............
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~--~~~~~~~~~~~~~~~~~------- 231 (283)
T 3bhy_A 161 KIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGE--TKQETLTNISAVNYDFD------- 231 (283)
T ss_dssp ECC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCS--SHHHHHHHHHTTCCCCC-------
T ss_pred eccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCc--chHHHHHHhHhcccCCc-------
Confidence 432 2456799999999899999999999999999999999999643 23333333322211110
Q ss_pred ccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHHhhhcC
Q 004979 655 KSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA--KLKEITAME 697 (721)
Q Consensus 655 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~--~L~~i~~~~ 697 (721)
.......+.++.+++.+||+.||++||++.|+++ .++.+....
T Consensus 232 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~ 276 (283)
T 3bhy_A 232 EEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRN 276 (283)
T ss_dssp HHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHCC
T ss_pred chhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHHh
Confidence 0111234567899999999999999999999997 356655443
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=340.56 Aligned_cols=242 Identities=19% Similarity=0.310 Sum_probs=193.5
Q ss_pred hhhhCcCCCCceeEEEEEEe----cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcC-CCCccceEeEEEecCCCc
Q 004979 429 SNIIGSFSDGTVGTVYKGTL----SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKV-NHKNFVNLIGYCEEDEPF 503 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~----~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~ 503 (721)
+++++.||+|+||+||+|+. .+++.||||++....... .....+.+.+|++++.++ +||||+++++++...+
T Consensus 56 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~-- 132 (355)
T 1vzo_A 56 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQ-KAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET-- 132 (355)
T ss_dssp EEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEE-EESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT--
T ss_pred eEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhh-hhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc--
Confidence 36778899999999999997 478899999986433211 011224577899999999 6999999999998877
Q ss_pred eEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCC
Q 004979 504 TRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNN 583 (721)
Q Consensus 504 ~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~ 583 (721)
..++||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 208 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLSKE 208 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred eEEEEeecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence 679999999999999998643 46899999999999999999999998 99999999999999999999999998753
Q ss_pred C----------CCCCccccchhhccc--CCCCCCccHHHHHHHHHHHHhCCCcccCCC--CCHHHHHHHHhhcCCCCccc
Q 004979 584 T----------TAAKTGSAAMELLET--SAVDLESNVYSFGTILFEMITGRISYSIEN--GSLENWASEYLKGEQPLKDI 649 (721)
Q Consensus 584 ~----------~~~~~~~~apE~~~~--~~~s~ksDVwSfGvvL~ElltG~~P~~~~~--~~~~~~~~~~~~~~~~~~~~ 649 (721)
. ..++..|+|||.+.+ ..++.++|||||||++|||+||+.||.... ...............+
T Consensus 209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~---- 284 (355)
T 1vzo_A 209 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP---- 284 (355)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCC----
T ss_pred cccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCC----
Confidence 2 134667999999875 457899999999999999999999997433 2334444444333221
Q ss_pred cCCccccccHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 004979 650 VDPTLKSFQENVLEELLVVIKNCVHPDPKQRP-----SMRGIAA 688 (721)
Q Consensus 650 ~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~evl~ 688 (721)
.+...+..+.+|+.+||+.||++|| ++.|+++
T Consensus 285 -------~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~ 321 (355)
T 1vzo_A 285 -------YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 321 (355)
T ss_dssp -------CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred -------CCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHc
Confidence 2233456788999999999999999 8999876
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=324.93 Aligned_cols=240 Identities=17% Similarity=0.266 Sum_probs=197.2
Q ss_pred hhhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEE
Q 004979 429 SNIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMM 507 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~l 507 (721)
+.+.+.+|+|+||+||+|+.. ++..+++|++...... .....+.+.+|++++++++||||+++++++.+.+ ..++
T Consensus 17 y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~l 92 (294)
T 2rku_A 17 YVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLL--KPHQREKMSMEISIHRSLAHQHVVGFHGFFEDND--FVFV 92 (294)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCC--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS--EEEE
T ss_pred eEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhcc--CHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCC--EEEE
Confidence 366788899999999999975 5778899987654322 2334567899999999999999999999998876 6799
Q ss_pred EEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC--
Q 004979 508 VFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT-- 585 (721)
Q Consensus 508 V~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~-- 585 (721)
||||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 93 v~e~~~~~~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 168 (294)
T 2rku_A 93 VLELCRRRSLLELHKR--RKALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 168 (294)
T ss_dssp EEECCTTCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEcCCCCEEEEeccCceecccC
Confidence 9999999999998853 346899999999999999999999998 9999999999999999999999999875322
Q ss_pred -------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCcccccc
Q 004979 586 -------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQ 658 (721)
Q Consensus 586 -------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 658 (721)
.++..|+|||.+.+..++.++||||||+++|||+||+.||... ...+........... .+
T Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~--~~~~~~~~~~~~~~~-----------~~ 235 (294)
T 2rku_A 169 GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS--CLKETYLRIKKNEYS-----------IP 235 (294)
T ss_dssp TCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCS--SHHHHHHHHHTTCCC-----------CC
T ss_pred ccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHhhccCC-----------Cc
Confidence 2445699999999889999999999999999999999999643 333333333332211 12
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004979 659 ENVLEELLVVIKNCVHPDPKQRPSMRGIAAK 689 (721)
Q Consensus 659 ~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 689 (721)
.....++.+++.+||+.||++||++.|+++.
T Consensus 236 ~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 236 KHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred cccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 2344678899999999999999999999874
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=332.17 Aligned_cols=240 Identities=17% Similarity=0.269 Sum_probs=197.4
Q ss_pred hhhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEE
Q 004979 429 SNIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMM 507 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~l 507 (721)
+.+.+.+|+|+||.||+++.. ++..+++|++...... .....+.+.+|++++++++||||+++++++.+.+ ..++
T Consensus 43 y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~l 118 (335)
T 2owb_A 43 YVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLL--KPHQREKMSMEISIHRSLAHQHVVGFHGFFEDND--FVFV 118 (335)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCC--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS--EEEE
T ss_pred eEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC--eEEE
Confidence 356778899999999999965 5778899988654322 2334567999999999999999999999999876 6799
Q ss_pred EEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC--
Q 004979 508 VFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT-- 585 (721)
Q Consensus 508 V~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~-- 585 (721)
||||+++++|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 119 v~e~~~~~~L~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 194 (335)
T 2owb_A 119 VLELCRRRSLLELHKR--RKALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 194 (335)
T ss_dssp EECCCTTCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EEecCCCCCHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC--CEecCCCchhEEEcCCCCEEEeeccCceecccC
Confidence 9999999999998864 356899999999999999999999998 9999999999999999999999999975332
Q ss_pred -------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCcccccc
Q 004979 586 -------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQ 658 (721)
Q Consensus 586 -------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 658 (721)
.++..|+|||.+.+..++.++|||||||++|||+||+.||... ...+...........+ +
T Consensus 195 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~--~~~~~~~~~~~~~~~~-----------~ 261 (335)
T 2owb_A 195 GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS--CLKETYLRIKKNEYSI-----------P 261 (335)
T ss_dssp TCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCS--SHHHHHHHHHHTCCCC-----------C
T ss_pred cccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCC--CHHHHHHHHhcCCCCC-----------C
Confidence 2455799999999999999999999999999999999999633 3333333333332211 1
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004979 659 ENVLEELLVVIKNCVHPDPKQRPSMRGIAAK 689 (721)
Q Consensus 659 ~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 689 (721)
.....++.+++.+||+.||++||++.|+++.
T Consensus 262 ~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 262 KHINPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 2334678899999999999999999999873
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-38 Score=327.70 Aligned_cols=238 Identities=17% Similarity=0.257 Sum_probs=191.4
Q ss_pred hhhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcC-CCCccceEeEEEecCCCceEE
Q 004979 429 SNIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKV-NHKNFVNLIGYCEEDEPFTRM 506 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~~~ 506 (721)
+++++.+|+|+||+||+|+.. +++.||+|++...... .....++.+|+..+.++ +||||+++++++.+.+ ..+
T Consensus 13 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~--~~~ 87 (289)
T 1x8b_A 13 FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAG---SVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDD--HML 87 (289)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTT---SHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETT--EEE
T ss_pred hhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccc---cHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCC--eEE
Confidence 377889999999999999975 7899999988754322 22346788999999999 9999999999998877 679
Q ss_pred EEEecCCCCChhhhhhhcc--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCC---------------
Q 004979 507 MVFEYSPNGSLFEHLHIQE--AEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTE--------------- 569 (721)
Q Consensus 507 lV~Ey~~~GsL~~~l~~~~--~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~--------------- 569 (721)
+||||+++|+|.+++.... ...+++..+..|+.||+.||+|||+++ |+||||||+|||++.
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 88 IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS--LVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC----------------
T ss_pred EEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC--EeecCCCHHHEEEcCCCCCccccccccccc
Confidence 9999999999999997532 266899999999999999999999998 999999999999984
Q ss_pred ----CCcEEEeccCCCCCC-----CCCCccccchhhcccC-CCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHH
Q 004979 570 ----DYAAKISDFSFWNNT-----TAAKTGSAAMELLETS-AVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEY 639 (721)
Q Consensus 570 ----~~~~kL~DFGla~~~-----~~~~~~~~apE~~~~~-~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~ 639 (721)
...+||+|||++... ..++..|+|||.+... .++.++|||||||++|||++|+.++... . . ....
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--~--~-~~~~ 240 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG--D--Q-WHEI 240 (289)
T ss_dssp ----CCCEEECCCTTCEETTCSCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS--H--H-HHHH
T ss_pred ccCCceEEEEcccccccccCCccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch--h--H-HHHH
Confidence 448999999987533 2356679999998765 5668999999999999999998776322 1 1 1112
Q ss_pred hhcCCCCccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 640 LKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 640 ~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
..+. ....+..++.++.+++.+||+.||++||++.|+++
T Consensus 241 ~~~~----------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 241 RQGR----------LPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp HTTC----------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HcCC----------CCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 2111 11122334577899999999999999999999975
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-38 Score=326.49 Aligned_cols=247 Identities=18% Similarity=0.268 Sum_probs=197.2
Q ss_pred hhhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEE
Q 004979 429 SNIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMM 507 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~l 507 (721)
+++++.+|+|+||+||+|+.. +++.|++|++..... .....+.+.+|++++++++||||+++++++.+......++
T Consensus 8 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 8 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM---TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTC---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred eeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccC---CHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 367788999999999999965 688899998875432 2334567999999999999999999999886543336799
Q ss_pred EEecCCCCChhhhhhhc--cCCCCCHHHHHHHHHHHHHHHHHHhcCC---CCeEeeCCCCCCeEeCCCCcEEEeccCCCC
Q 004979 508 VFEYSPNGSLFEHLHIQ--EAEHLDWAMRLRIAMGMAYCLEHMHQLT---PPIAHRNLQSSSIYLTEDYAAKISDFSFWN 582 (721)
Q Consensus 508 V~Ey~~~GsL~~~l~~~--~~~~l~~~~~~~ia~~ia~gL~yLH~~~---~~IvHrDLKp~NILl~~~~~~kL~DFGla~ 582 (721)
||||+++|+|.+++... ....+++..+..++.|++.||+|||+.+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 99999999999998643 2345999999999999999999999865 349999999999999999999999999875
Q ss_pred CCC---------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCc
Q 004979 583 NTT---------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPT 653 (721)
Q Consensus 583 ~~~---------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 653 (721)
... .++..|+|||.+.+..++.++||||||+++|||+||+.||... +..+....+..+..+
T Consensus 165 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~--~~~~~~~~i~~~~~~-------- 234 (279)
T 2w5a_A 165 ILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF--SQKELAGKIREGKFR-------- 234 (279)
T ss_dssp HC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHTCCC--------
T ss_pred eeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCccc--CHHHHHHHHhhcccc--------
Confidence 432 2355799999999889999999999999999999999999643 233333333333211
Q ss_pred cccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 004979 654 LKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKL 690 (721)
Q Consensus 654 l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L 690 (721)
..+..++.++.+++.+||+.||++||++.||++.+
T Consensus 235 --~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~ 269 (279)
T 2w5a_A 235 --RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENP 269 (279)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred --cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhCh
Confidence 12234457789999999999999999999998754
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=322.68 Aligned_cols=239 Identities=18% Similarity=0.316 Sum_probs=196.4
Q ss_pred hhhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEE
Q 004979 429 SNIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMM 507 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~l 507 (721)
+++.+.+|+|+||.||+|+.. ++..|++|++....... ......+.+|++++++++||||+++++++.+.+ ..++
T Consensus 16 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~l 91 (284)
T 2vgo_A 16 FDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEK--EGVEHQLRREIEIQSHLRHPNILRMYNYFHDRK--RIYL 91 (284)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHH--TTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS--EEEE
T ss_pred ceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccch--HHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCC--EEEE
Confidence 367788999999999999965 56789999886432111 122467899999999999999999999998876 6799
Q ss_pred EEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC---
Q 004979 508 VFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT--- 584 (721)
Q Consensus 508 V~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~--- 584 (721)
||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++...
T Consensus 92 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 167 (284)
T 2vgo_A 92 MLEFAPRGELYKELQKH--GRFDEQRSATFMEELADALHYCHERK--VIHRDIKPENLLMGYKGELKIADFGWSVHAPSL 167 (284)
T ss_dssp EECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred EEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence 99999999999998643 45899999999999999999999988 999999999999999999999999987432
Q ss_pred ----CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccHH
Q 004979 585 ----TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQEN 660 (721)
Q Consensus 585 ----~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 660 (721)
..++..|+|||.+.+..++.++||||||+++|||++|+.||... ...+........... ++..
T Consensus 168 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~--~~~~~~~~~~~~~~~-----------~~~~ 234 (284)
T 2vgo_A 168 RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSP--SHTETHRRIVNVDLK-----------FPPF 234 (284)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS--SHHHHHHHHHTTCCC-----------CCTT
T ss_pred ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCC--CHhHHHHHHhccccC-----------CCCc
Confidence 23456789999999999999999999999999999999999643 233333333332211 1223
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 661 VLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 661 ~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
.+.++.+++.+||+.||++||++.|+++
T Consensus 235 ~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 235 LSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp SCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 4567889999999999999999999987
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=339.48 Aligned_cols=240 Identities=22% Similarity=0.294 Sum_probs=191.9
Q ss_pred hhhhCcCCCCceeEEEEEEecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCC--CCccceEeEEEecCCCceEE
Q 004979 429 SNIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVN--HKNFVNLIGYCEEDEPFTRM 506 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~--H~nIv~l~g~~~~~~~~~~~ 506 (721)
|++++.||+|+||+||+|...++..||||++..... .....+.+.+|+++|.+++ |||||++++++...+ ..+
T Consensus 58 y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~--~~~ 132 (390)
T 2zmd_A 58 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA---DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ--YIY 132 (390)
T ss_dssp EEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS--EEE
T ss_pred eEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccc---cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCC--EEE
Confidence 467889999999999999988899999999875432 2334578999999999996 599999999998877 679
Q ss_pred EEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC--
Q 004979 507 MVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT-- 584 (721)
Q Consensus 507 lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~-- 584 (721)
+||| +.+|+|.+++.. ...+++..+..|+.||+.||+|||+.+ |+||||||+|||++ ++.+||+|||+++..
T Consensus 133 lv~E-~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~ 206 (390)
T 2zmd_A 133 MVME-CGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 206 (390)
T ss_dssp EEEE-CCSEEHHHHHHH--CSSCCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred EEEe-cCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence 9999 568899999864 346899999999999999999999998 99999999999996 589999999998643
Q ss_pred ---------CCCCccccchhhccc-----------CCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCC
Q 004979 585 ---------TAAKTGSAAMELLET-----------SAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQ 644 (721)
Q Consensus 585 ---------~~~~~~~~apE~~~~-----------~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~ 644 (721)
..++..|+|||.+.. ..++.++|||||||++|||+||+.||..... .............
T Consensus 207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~-~~~~~~~~~~~~~ 285 (390)
T 2zmd_A 207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-QISKLHAIIDPNH 285 (390)
T ss_dssp -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC-HHHHHHHHHCTTS
T ss_pred CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH-HHHHHHHHhCccc
Confidence 235667999999864 4689999999999999999999999964322 2222333332211
Q ss_pred CCccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004979 645 PLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAK 689 (721)
Q Consensus 645 ~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 689 (721)
.. .++...+.++.+|+.+||+.||++||++.|+++.
T Consensus 286 ~~---------~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 286 EI---------EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp CC---------CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cC---------CCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 10 1111224578899999999999999999999864
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=336.82 Aligned_cols=248 Identities=17% Similarity=0.229 Sum_probs=186.3
Q ss_pred hhhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEE
Q 004979 429 SNIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMM 507 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~l 507 (721)
+++++.+|+|+||+||+|+. .+++.||||++..... .....+.+.+|++++++++||||+++++++.+.+ ..++
T Consensus 36 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~l 110 (329)
T 3gbz_A 36 YRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE---EEGVPGTAIREVSLLKELQHRNIIELKSVIHHNH--RLHL 110 (329)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC-----------CHHHHHHGGGCCCTTBCCEEEEEEETT--EEEE
T ss_pred EEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc---ccccchhHHHHHHHHHHcCCCCcceEEEEEecCC--EEEE
Confidence 47788999999999999985 4788899998865432 1233456889999999999999999999999877 6799
Q ss_pred EEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEe-----CCCCcEEEeccCCCC
Q 004979 508 VFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYL-----TEDYAAKISDFSFWN 582 (721)
Q Consensus 508 V~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl-----~~~~~~kL~DFGla~ 582 (721)
||||++ |+|.+++.. ...+++..+..|+.||+.||+|||+++ |+||||||+|||+ ++++.+||+|||+++
T Consensus 111 v~e~~~-~~L~~~~~~--~~~~~~~~~~~i~~ql~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~ 185 (329)
T 3gbz_A 111 IFEYAE-NDLKKYMDK--NPDVSMRVIKSFLYQLINGVNFCHSRR--CLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185 (329)
T ss_dssp EEECCS-EEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEC-----CCEEEECCTTHHH
T ss_pred EEecCC-CCHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCC--EECCCCCHHHEEEecCCCCccceEEECcCCCcc
Confidence 999997 599999864 346899999999999999999999998 9999999999999 455669999999874
Q ss_pred CC---------CCCCccccchhhcccC-CCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCC-CCcc---
Q 004979 583 NT---------TAAKTGSAAMELLETS-AVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQ-PLKD--- 648 (721)
Q Consensus 583 ~~---------~~~~~~~~apE~~~~~-~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~-~~~~--- 648 (721)
.. ..++..|+|||.+.+. .++.++|||||||++|||+||+.||.... ..+.......... +...
T Consensus 186 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~ 263 (329)
T 3gbz_A 186 AFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDS--EIDQLFKIFEVLGLPDDTTWP 263 (329)
T ss_dssp HHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHHHCCCCTTTST
T ss_pred ccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCC--HHHHHHHHHHHhCCCchhhhh
Confidence 22 1235679999998764 58999999999999999999999996432 2222222221100 0000
Q ss_pred --------------ccCCccc-cccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 649 --------------IVDPTLK-SFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 649 --------------~~d~~l~-~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
.....+. ........++.+|+.+||+.||++|||+.|+++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 264 GVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp TGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 0000000 011224578899999999999999999999975
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=337.29 Aligned_cols=235 Identities=18% Similarity=0.277 Sum_probs=191.1
Q ss_pred hhhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccch---hhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCce
Q 004979 429 SNIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADW---SKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFT 504 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 504 (721)
+++++.+|+|+||+||+|+. .++..||||++........ .......+.+|++++++++||||+++++++.+.+ .
T Consensus 26 y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~--~ 103 (335)
T 3dls_A 26 YSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG--F 103 (335)
T ss_dssp EEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS--E
T ss_pred eEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC--E
Confidence 47888999999999999985 4678899998875432110 0112245778999999999999999999998877 6
Q ss_pred EEEEEecCCCC-ChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCC
Q 004979 505 RMMVFEYSPNG-SLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNN 583 (721)
Q Consensus 505 ~~lV~Ey~~~G-sL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~ 583 (721)
.++||||+.+| +|.+++.. ...+++..+..|+.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 104 ~~lv~e~~~~g~~l~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~ 179 (335)
T 3dls_A 104 FQLVMEKHGSGLDLFAFIDR--HPRLDEPLASYIFRQLVSAVGYLRLKD--IIHRDIKDENIVIAEDFTIKLIDFGSAAY 179 (335)
T ss_dssp EEEEEECCTTSCBHHHHHHT--CCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEEEeCCCCccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC--eEEeccCHHHEEEcCCCcEEEeecccceE
Confidence 79999999877 99999863 456999999999999999999999998 99999999999999999999999999864
Q ss_pred CC--------CCCccccchhhcccCCC-CCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCcc
Q 004979 584 TT--------AAKTGSAAMELLETSAV-DLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTL 654 (721)
Q Consensus 584 ~~--------~~~~~~~apE~~~~~~~-s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 654 (721)
.. .++..|+|||.+.+..+ +.++|||||||++|||++|+.||..... .. ....
T Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--------~~------~~~~---- 241 (335)
T 3dls_A 180 LERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE--------TV------EAAI---- 241 (335)
T ss_dssp CCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG--------GT------TTCC----
T ss_pred CCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH--------HH------hhcc----
Confidence 32 24568999999988776 7899999999999999999999953111 00 0000
Q ss_pred ccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 655 KSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 655 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
..+..++.++.+++.+||+.||++||++.|+++
T Consensus 242 -~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~ 274 (335)
T 3dls_A 242 -HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVT 274 (335)
T ss_dssp -CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -CCCcccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 011224567899999999999999999999987
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=331.84 Aligned_cols=248 Identities=22% Similarity=0.331 Sum_probs=197.3
Q ss_pred hhhhCcCCCCceeEEEEEEe------cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCC
Q 004979 429 SNIIGSFSDGTVGTVYKGTL------SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEP 502 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~------~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~ 502 (721)
+++++.+|+|+||.||+|++ .++..||||++.... ......++.+|+.++++++||||+++++++.+.+
T Consensus 32 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 106 (327)
T 2yfx_A 32 ITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC----SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL- 106 (327)
T ss_dssp CEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC----CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred eEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc----chhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC-
Confidence 46788999999999999984 246789999885332 2334567999999999999999999999998876
Q ss_pred ceEEEEEecCCCCChhhhhhhccC-----CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCC---CCcEE
Q 004979 503 FTRMMVFEYSPNGSLFEHLHIQEA-----EHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTE---DYAAK 574 (721)
Q Consensus 503 ~~~~lV~Ey~~~GsL~~~l~~~~~-----~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~---~~~~k 574 (721)
..++||||+++|+|.+++..... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++. +..+|
T Consensus 107 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--i~H~dlkp~NIli~~~~~~~~~k 183 (327)
T 2yfx_A 107 -PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAK 183 (327)
T ss_dssp -SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCEE
T ss_pred -CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eecCcCCHhHEEEecCCCcceEE
Confidence 56999999999999999975432 45899999999999999999999998 999999999999994 45699
Q ss_pred EeccCCCCCC-----------CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhc
Q 004979 575 ISDFSFWNNT-----------TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKG 642 (721)
Q Consensus 575 L~DFGla~~~-----------~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~ 642 (721)
|+|||+++.. ..++..|+|||.+....++.++|||||||++|||+| |+.||... ...+.......+
T Consensus 184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~--~~~~~~~~~~~~ 261 (327)
T 2yfx_A 184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK--SNQEVLEFVTSG 261 (327)
T ss_dssp ECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC--CHHHHHHHHHTT
T ss_pred ECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCc--CHHHHHHHHhcC
Confidence 9999986421 122446999999988999999999999999999999 99999633 333333333322
Q ss_pred CCCCccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 004979 643 EQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAM 696 (721)
Q Consensus 643 ~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~ 696 (721)
... ..+..++.++.+++.+||+.||++||++.|+++.|+.+...
T Consensus 262 ~~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 305 (327)
T 2yfx_A 262 GRM----------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305 (327)
T ss_dssp CCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCC----------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence 111 11233456789999999999999999999999999987664
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=320.05 Aligned_cols=240 Identities=20% Similarity=0.314 Sum_probs=194.6
Q ss_pred hhhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEE
Q 004979 429 SNIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMM 507 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~l 507 (721)
+++++.+|+|+||.||+|+.. ++..|++|++..... ....+.+.+|++++++++||||+++++++.+.+ ..++
T Consensus 9 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~l 82 (276)
T 2yex_A 9 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA----VDCPENIKKEICINKMLNHENVVKFYGHRREGN--IQYL 82 (276)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC----TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT--EEEE
T ss_pred eEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc----hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCC--EEEE
Confidence 377888999999999999965 688999998865432 223467899999999999999999999998876 6799
Q ss_pred EEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC---
Q 004979 508 VFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT--- 584 (721)
Q Consensus 508 V~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~--- 584 (721)
||||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++...
T Consensus 83 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 158 (276)
T 2yex_A 83 FLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (276)
T ss_dssp EEECCTTEEGGGGSBT--TTBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred EEEecCCCcHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence 9999999999999853 356899999999999999999999998 999999999999999999999999987532
Q ss_pred --------CCCCccccchhhcccCCC-CCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccc
Q 004979 585 --------TAAKTGSAAMELLETSAV-DLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLK 655 (721)
Q Consensus 585 --------~~~~~~~~apE~~~~~~~-s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 655 (721)
..++..|+|||.+....+ +.++|||||||++|||+||+.||.........+. .........
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-~~~~~~~~~--------- 228 (276)
T 2yex_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS-DWKEKKTYL--------- 228 (276)
T ss_dssp TEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHH-HHHTTCTTS---------
T ss_pred cchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHH-Hhhhccccc---------
Confidence 224567999999977665 7889999999999999999999975443322221 111111100
Q ss_pred cccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 656 SFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 656 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
......+.++.+++.+||+.||++|||+.|+++
T Consensus 229 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 229 NPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 011234567889999999999999999999875
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=344.58 Aligned_cols=249 Identities=17% Similarity=0.226 Sum_probs=190.2
Q ss_pred hhhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCC----c
Q 004979 429 SNIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEP----F 503 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~----~ 503 (721)
|++++.+|+|+||+||+|+.. +++.||||++..... .....+++.+|+++|+.++|||||++++++...+. .
T Consensus 64 y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 64 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ---NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGG---SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred eEEEEEeecCCCeEEEEEEECCCCCEEEEEEECcccc---ChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 467788999999999999854 688899999864321 23345678999999999999999999999975432 2
Q ss_pred eEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCC
Q 004979 504 TRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNN 583 (721)
Q Consensus 504 ~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~ 583 (721)
..|+||||+++ +|.+.+. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 141 ~~~lv~E~~~~-~l~~~~~----~~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDlkp~NIll~~~~~~kl~DFG~a~~ 213 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLART 213 (464)
T ss_dssp EEEEEEECCSE-EHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCCCC--
T ss_pred eEEEEEeCCCC-CHHHHHh----hcCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChHhEEEeCCCCEEEEEEEeeee
Confidence 57999999976 4666653 34899999999999999999999998 99999999999999999999999999864
Q ss_pred CC--------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcC-CCCcc------
Q 004979 584 TT--------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGE-QPLKD------ 648 (721)
Q Consensus 584 ~~--------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~-~~~~~------ 648 (721)
.. .++..|+|||.+.+..|+.++||||+||++|||++|+.||.+.+ ..+....++... .+..+
T Consensus 214 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~--~~~~~~~i~~~lg~p~~~~~~~~~ 291 (464)
T 3ttj_A 214 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD--YIDQWNKVIEQLGTPCPEFMKKLQ 291 (464)
T ss_dssp ---CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHHHCSCCHHHHTTSC
T ss_pred cCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHhcCCCCHHHHHHcc
Confidence 32 34567999999999999999999999999999999999996432 222222221100 00000
Q ss_pred --------------------ccCCc----cccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004979 649 --------------------IVDPT----LKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAK 689 (721)
Q Consensus 649 --------------------~~d~~----l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 689 (721)
..... ..........++.+|+.+||+.||++|||++|+++.
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 292 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000 001112236789999999999999999999999873
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-38 Score=327.33 Aligned_cols=250 Identities=22% Similarity=0.344 Sum_probs=192.7
Q ss_pred hhhhCcCCCCceeEEEEEEec--CCc--EEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCce
Q 004979 429 SNIIGSFSDGTVGTVYKGTLS--SGV--EIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFT 504 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~--~~~--~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 504 (721)
+++++.+|+|+||+||+|++. ++. .|+||++...... .....+.+.+|++++++++||||+++++++....
T Consensus 20 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--- 94 (291)
T 1u46_A 20 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLS--QPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP--- 94 (291)
T ss_dssp EEEEEECC----CCCEEEEEECTTSCEEEEEEEC----------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS---
T ss_pred eeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccC--CHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC---
Confidence 367889999999999999863 233 5788877543221 1234578999999999999999999999998754
Q ss_pred EEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC
Q 004979 505 RMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT 584 (721)
Q Consensus 505 ~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~ 584 (721)
.++||||+++|+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 95 ~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 171 (291)
T 1u46_A 95 MKMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMRAL 171 (291)
T ss_dssp CEEEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred ceeeEecccCCCHHHHHHhc-cCCcCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEEcCCCCEEEccccccccc
Confidence 58999999999999998643 345899999999999999999999998 999999999999999999999999987543
Q ss_pred CC------------CCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhcCCCCccccC
Q 004979 585 TA------------AKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPLKDIVD 651 (721)
Q Consensus 585 ~~------------~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d 651 (721)
.. ++..|+|||.+....++.++||||||+++|||+| |+.||... +..+............
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~--~~~~~~~~~~~~~~~~----- 244 (291)
T 1u46_A 172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL--NGSQILHKIDKEGERL----- 244 (291)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC--CHHHHHHHHHTSCCCC-----
T ss_pred cccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccC--CHHHHHHHHHccCCCC-----
Confidence 21 2235899999988889999999999999999999 99999633 3344444443322111
Q ss_pred CccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcC
Q 004979 652 PTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAME 697 (721)
Q Consensus 652 ~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 697 (721)
..+..++.++.+++.+||+.||++||++.|+++.|+++....
T Consensus 245 ----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 286 (291)
T 1u46_A 245 ----PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTD 286 (291)
T ss_dssp ----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred ----CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccc
Confidence 112345577999999999999999999999999999876544
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-37 Score=322.89 Aligned_cols=240 Identities=18% Similarity=0.262 Sum_probs=196.1
Q ss_pred hhhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEE
Q 004979 429 SNIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMM 507 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~l 507 (721)
+.+++.+|+|+||+||+|+.. +++.||+|++..... ...+.+.+|++++++++||||+++++++.+.+ ..++
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~l 83 (304)
T 2jam_A 11 FIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA-----FRDSSLENEIAVLKKIKHENIVTLEDIYESTT--HYYL 83 (304)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-----------HHHHHHHHHHHCCCTTBCCEEEEEECSS--EEEE
T ss_pred ceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc-----cchHHHHHHHHHHHhCCCCCeeehhhhcccCC--EEEE
Confidence 467888999999999999965 688999998874321 12356889999999999999999999998876 6799
Q ss_pred EEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEe---CCCCcEEEeccCCCCCC
Q 004979 508 VFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYL---TEDYAAKISDFSFWNNT 584 (721)
Q Consensus 508 V~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl---~~~~~~kL~DFGla~~~ 584 (721)
||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||+ ++++.+||+|||+++..
T Consensus 84 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~ 159 (304)
T 2jam_A 84 VMQLVSGGELFDRILER--GVYTEKDASLVIQQVLSAVKYLHENG--IVHRDLKPENLLYLTPEENSKIMITDFGLSKME 159 (304)
T ss_dssp EECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCC
T ss_pred EEEcCCCccHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEecCCCCCCEEEccCCcceec
Confidence 99999999999998643 46899999999999999999999998 9999999999999 78899999999998654
Q ss_pred CC-------CCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccc
Q 004979 585 TA-------AKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSF 657 (721)
Q Consensus 585 ~~-------~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 657 (721)
.. ++..|+|||.+.+..++.++|||||||++|||+||+.||... ...+....+..+...... ..
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~--~~~~~~~~i~~~~~~~~~-------~~ 230 (304)
T 2jam_A 160 QNGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEE--TESKLFEKIKEGYYEFES-------PF 230 (304)
T ss_dssp CCBTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTS--CHHHHHHHHHHCCCCCCT-------TT
T ss_pred CCCccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCC--CHHHHHHHHHcCCCCCCc-------cc
Confidence 33 456799999999999999999999999999999999999643 333344444333221111 11
Q ss_pred cHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 658 QENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 658 ~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
....+.++.+++.+||+.||++||++.|+++
T Consensus 231 ~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 231 WDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp TTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 2334567899999999999999999999986
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=334.30 Aligned_cols=239 Identities=19% Similarity=0.308 Sum_probs=193.5
Q ss_pred hhhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcC-CCCccceEeEEEecCCCceEE
Q 004979 429 SNIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKV-NHKNFVNLIGYCEEDEPFTRM 506 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~~~ 506 (721)
+++++.+|+|+||+||+|+.. +++.+|+|++..... .+.+|++++.++ +|||||++++++.+.+ ..+
T Consensus 24 y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~---------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~--~~~ 92 (342)
T 2qr7_A 24 YEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR---------DPTEEIEILLRYGQHPNIITLKDVYDDGK--YVY 92 (342)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC---------CCHHHHHHHHHHTTSTTBCCEEEEEECSS--EEE
T ss_pred EEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC---------ChHHHHHHHHHhcCCCCcCeEEEEEEcCC--EEE
Confidence 477889999999999999965 678899998864321 245688888887 7999999999998876 779
Q ss_pred EEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCC----CcEEEeccCCCC
Q 004979 507 MVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTED----YAAKISDFSFWN 582 (721)
Q Consensus 507 lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~----~~~kL~DFGla~ 582 (721)
+||||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+.++ +.+||+|||+++
T Consensus 93 lv~E~~~gg~L~~~i~~--~~~~~~~~~~~~~~qi~~al~~lH~~g--ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~ 168 (342)
T 2qr7_A 93 VVTELMKGGELLDKILR--QKFFSEREASAVLFTITKTVEYLHAQG--VVHRDLKPSNILYVDESGNPESIRICDFGFAK 168 (342)
T ss_dssp EEECCCCSCBHHHHHHT--CTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSSCSGGGEEECCCTTCE
T ss_pred EEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC--cEeccCCHHHEEEecCCCCcCeEEEEECCCcc
Confidence 99999999999999863 356999999999999999999999998 9999999999998543 359999999976
Q ss_pred CC---------CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCC-CCHHHHHHHHhhcCCCCccccCC
Q 004979 583 NT---------TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIEN-GSLENWASEYLKGEQPLKDIVDP 652 (721)
Q Consensus 583 ~~---------~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~-~~~~~~~~~~~~~~~~~~~~~d~ 652 (721)
.. ..++..|+|||.+.+..++.++|||||||++|||++|+.||.... ....+....+..+......
T Consensus 169 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~---- 244 (342)
T 2qr7_A 169 QLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSG---- 244 (342)
T ss_dssp ECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCS----
T ss_pred cCcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCc----
Confidence 32 224567999999988889999999999999999999999997543 3444555554444322111
Q ss_pred ccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004979 653 TLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAK 689 (721)
Q Consensus 653 ~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 689 (721)
......+.++.+|+.+||+.||++||++.|+++.
T Consensus 245 ---~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 245 ---GYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp ---TTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred ---cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 1123345778999999999999999999999863
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=335.83 Aligned_cols=271 Identities=14% Similarity=0.180 Sum_probs=210.0
Q ss_pred hhhhCcCCCCceeEEEEEEecCCcEEEEEEeeeccccchh------------hHHHHHHHHHHHHHhcCCCCccceEeEE
Q 004979 429 SNIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWS------------KNLESQFRKKIDTLSKVNHKNFVNLIGY 496 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~~~~~vavk~~~~~~~~~~~------------~~~~~~f~~Ei~~l~~l~H~nIv~l~g~ 496 (721)
+++++.+|+|+||.||+|+. ++..||+|++......... ....+.+.+|++++++++||||++++++
T Consensus 33 y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 111 (348)
T 2pml_X 33 YRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGI 111 (348)
T ss_dssp EEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSEE
T ss_pred eEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEEE
Confidence 36778899999999999999 8999999998654221100 0112679999999999999999999999
Q ss_pred EecCCCceEEEEEecCCCCChhhh------hhhccCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCeEeeCCCCCCeEeCC
Q 004979 497 CEEDEPFTRMMVFEYSPNGSLFEH------LHIQEAEHLDWAMRLRIAMGMAYCLEHMHQ-LTPPIAHRNLQSSSIYLTE 569 (721)
Q Consensus 497 ~~~~~~~~~~lV~Ey~~~GsL~~~------l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~-~~~~IvHrDLKp~NILl~~ 569 (721)
+.+.+ ..++||||+++|+|.++ +.......+++..+..++.|++.||+|||+ .+ |+||||||+|||++.
T Consensus 112 ~~~~~--~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i~H~dl~p~Nil~~~ 187 (348)
T 2pml_X 112 ITNYD--EVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDK 187 (348)
T ss_dssp EESSS--EEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC--EECCCCCGGGEEECT
T ss_pred EeeCC--eEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC--EeecCCChHhEEEcC
Confidence 99876 67999999999999998 654335779999999999999999999998 88 999999999999999
Q ss_pred CCcEEEeccCCCCCC-------CCCCccccchhhcccC-CCCC-CccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHh
Q 004979 570 DYAAKISDFSFWNNT-------TAAKTGSAAMELLETS-AVDL-ESNVYSFGTILFEMITGRISYSIENGSLENWASEYL 640 (721)
Q Consensus 570 ~~~~kL~DFGla~~~-------~~~~~~~~apE~~~~~-~~s~-ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~ 640 (721)
++.+||+|||++... ..++..|+|||.+.+. .++. ++|||||||++|||+||+.||...... .+....+.
T Consensus 188 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~~i~ 266 (348)
T 2pml_X 188 NGRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL-VELFNNIR 266 (348)
T ss_dssp TSCEEECCCTTCEECBTTEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS-HHHHHHHT
T ss_pred CCcEEEeccccccccccccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHh
Confidence 999999999987642 2345679999999876 6666 999999999999999999999744332 33344433
Q ss_pred hcCCCCccccC----C----ccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCChhHHHH
Q 004979 641 KGEQPLKDIVD----P----TLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAMEPDGATPKLSPLWWAE 712 (721)
Q Consensus 641 ~~~~~~~~~~d----~----~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~~~~p~~~~~~~~~ 712 (721)
.+......... + .........+.++.+++.+||+.||++||++.|+++ +|.+....|++
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~-------------hp~f~~~~~~~ 333 (348)
T 2pml_X 267 TKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK-------------HEWLADTNIED 333 (348)
T ss_dssp SCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT-------------SGGGTTCCHHH
T ss_pred ccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc-------------CccccCCCHHH
Confidence 33222111000 0 000011345678899999999999999999999986 57777777877
Q ss_pred HHhhhc
Q 004979 713 LEILSS 718 (721)
Q Consensus 713 l~~~~~ 718 (721)
++-+..
T Consensus 334 ~~~~~~ 339 (348)
T 2pml_X 334 LREFSK 339 (348)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 765543
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=342.35 Aligned_cols=246 Identities=20% Similarity=0.271 Sum_probs=188.5
Q ss_pred hhhhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccch---hhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCc
Q 004979 428 FSNIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADW---SKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPF 503 (721)
Q Consensus 428 ~~~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 503 (721)
.+.+.+.+|+|+||+||+|+.. ++..||||++..+..... .......+.+|+++|++++|||||++++++...
T Consensus 136 ~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--- 212 (419)
T 3i6u_A 136 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE--- 212 (419)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEESS---
T ss_pred cEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEecC---
Confidence 3477888999999999999864 678999999875432111 111223588999999999999999999998654
Q ss_pred eEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCC---CcEEEeccCC
Q 004979 504 TRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTED---YAAKISDFSF 580 (721)
Q Consensus 504 ~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~---~~~kL~DFGl 580 (721)
..++||||+++|+|.+++. ....+++..+..|+.|++.||+|||+++ |+||||||+|||++.+ +.+||+|||+
T Consensus 213 ~~~lv~e~~~~g~L~~~l~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~NIll~~~~~~~~~kl~DFG~ 288 (419)
T 3i6u_A 213 DYYIVLELMEGGELFDKVV--GNKRLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGH 288 (419)
T ss_dssp EEEEEEECCTTCBGGGGTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSSSCCEEECCSST
T ss_pred ceEEEEEcCCCCcHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEecCCCcceEEEeeccc
Confidence 4689999999999999885 3456999999999999999999999998 9999999999999754 4599999999
Q ss_pred CCCCC--------CCCccccchhhcc---cCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccc
Q 004979 581 WNNTT--------AAKTGSAAMELLE---TSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDI 649 (721)
Q Consensus 581 a~~~~--------~~~~~~~apE~~~---~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (721)
++... .++..|+|||.+. ...++.++|||||||++|||+||+.||....... ........+....
T Consensus 289 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~-~~~~~i~~~~~~~--- 364 (419)
T 3i6u_A 289 SKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV-SLKDQITSGKYNF--- 364 (419)
T ss_dssp TTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC-CHHHHHHTTCCCC---
T ss_pred ceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH-HHHHHHhcCCCCC---
Confidence 87532 2456899999975 4678899999999999999999999997432211 1111111111110
Q ss_pred cCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 650 VDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 650 ~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
........+.++.+++.+||+.||++||++.|+++
T Consensus 365 ----~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 365 ----IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp ----CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ----CchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 01111234578899999999999999999999987
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-37 Score=328.47 Aligned_cols=252 Identities=21% Similarity=0.341 Sum_probs=199.0
Q ss_pred hhhhhhhCcCCCCceeEEEEEEecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhc--CCCCccceEeEEEecCCC-
Q 004979 426 EDFSNIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSK--VNHKNFVNLIGYCEEDEP- 502 (721)
Q Consensus 426 ~~~~~ii~~lg~G~~g~Vyk~~~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~--l~H~nIv~l~g~~~~~~~- 502 (721)
.+.+++.+.+|+|+||+||+|+.. ++.||||++.... ...+.+|++++.. ++||||+++++++...+.
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~--------~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~ 111 (342)
T 1b6c_B 41 ARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE--------ERSWFREAEIYQTVMLRHENILGFIAADNKDNGT 111 (342)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECGGG--------HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSS
T ss_pred cccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCchh--------HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCc
Confidence 344578889999999999999984 8899999875321 2467788888887 799999999999987542
Q ss_pred -ceEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHh--------cCCCCeEeeCCCCCCeEeCCCCcE
Q 004979 503 -FTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMH--------QLTPPIAHRNLQSSSIYLTEDYAA 573 (721)
Q Consensus 503 -~~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH--------~~~~~IvHrDLKp~NILl~~~~~~ 573 (721)
...++||||+++|+|.+++.. ..+++..+..++.|++.||+||| +.+ |+||||||+|||++.++.+
T Consensus 112 ~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dlkp~NIll~~~~~~ 186 (342)
T 1b6c_B 112 WTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA--IAHRDLKSKNILVKKNGTC 186 (342)
T ss_dssp CCCEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE--EECSCCSGGGEEECTTSCE
T ss_pred cceeEEEEeecCCCcHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC--eeeCCCCHHHEEECCCCCE
Confidence 156999999999999999963 35899999999999999999999 666 9999999999999999999
Q ss_pred EEeccCCCCCC-------------CCCCccccchhhcccC------CCCCCccHHHHHHHHHHHHhC----------CCc
Q 004979 574 KISDFSFWNNT-------------TAAKTGSAAMELLETS------AVDLESNVYSFGTILFEMITG----------RIS 624 (721)
Q Consensus 574 kL~DFGla~~~-------------~~~~~~~~apE~~~~~------~~s~ksDVwSfGvvL~ElltG----------~~P 624 (721)
||+|||+++.. ..++..|+|||.+... .++.++|||||||++|||+|| +.|
T Consensus 187 kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p 266 (342)
T 1b6c_B 187 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 266 (342)
T ss_dssp EECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred EEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccC
Confidence 99999987421 1345679999998765 234689999999999999999 778
Q ss_pred ccCCC---CCHHHHHHHHhhcCCCCccccCCcccc--ccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcC
Q 004979 625 YSIEN---GSLENWASEYLKGEQPLKDIVDPTLKS--FQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAME 697 (721)
Q Consensus 625 ~~~~~---~~~~~~~~~~~~~~~~~~~~~d~~l~~--~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 697 (721)
|.... .....+........ ..+.+.. ...++...+.+|+.+||+.||++||++.||++.|+++.+..
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~ 338 (342)
T 1b6c_B 267 YYDLVPSDPSVEEMRKVVCEQK------LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 338 (342)
T ss_dssp TTTTSCSSCCHHHHHHHHTTSC------CCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred ccccCcCcccHHHHHHHHHHHH------hCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHh
Confidence 76432 23333333332211 1111111 12467788999999999999999999999999999987754
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=345.87 Aligned_cols=237 Identities=11% Similarity=0.156 Sum_probs=184.2
Q ss_pred hhhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHH---HHHhcCCCCccceEe-------EEE
Q 004979 429 SNIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKI---DTLSKVNHKNFVNLI-------GYC 497 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei---~~l~~l~H~nIv~l~-------g~~ 497 (721)
+++.+.+|+|+||+||+|+. .+++.||||++....... ....+.|.+|+ +++++++|||||+++ +++
T Consensus 75 y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~ 152 (377)
T 3byv_A 75 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPP--SNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 152 (377)
T ss_dssp EEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CC--TTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEE
T ss_pred EEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccc--hHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhh
Confidence 36678899999999999995 568999999987543222 23456799999 556666899999998 666
Q ss_pred ecCCC---------------ceEEEEEecCCCCChhhhhhhccC-----CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEe
Q 004979 498 EEDEP---------------FTRMMVFEYSPNGSLFEHLHIQEA-----EHLDWAMRLRIAMGMAYCLEHMHQLTPPIAH 557 (721)
Q Consensus 498 ~~~~~---------------~~~~lV~Ey~~~GsL~~~l~~~~~-----~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvH 557 (721)
...+. ...++||||+ +|+|.+++..... ..+++..+..|+.||+.||+|||+++ |+|
T Consensus 153 ~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH 229 (377)
T 3byv_A 153 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LVH 229 (377)
T ss_dssp ECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT--EEC
T ss_pred hccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC--eec
Confidence 54421 0268999999 6899999974321 12446888899999999999999998 999
Q ss_pred eCCCCCCeEeCCCCcEEEeccCCCCCC------CCCCccccchhhcccC-----------CCCCCccHHHHHHHHHHHHh
Q 004979 558 RNLQSSSIYLTEDYAAKISDFSFWNNT------TAAKTGSAAMELLETS-----------AVDLESNVYSFGTILFEMIT 620 (721)
Q Consensus 558 rDLKp~NILl~~~~~~kL~DFGla~~~------~~~~~~~~apE~~~~~-----------~~s~ksDVwSfGvvL~Ellt 620 (721)
|||||+|||++.++.+||+|||+++.. ..+ ..|+|||.+.+. .++.++|||||||++|||+|
T Consensus 230 rDikp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~ellt 308 (377)
T 3byv_A 230 TYLRPVDIVLDQRGGVFLTGFEHLVRDGARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWC 308 (377)
T ss_dssp SCCCGGGEEECTTCCEEECCGGGCEETTCEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCCCHHHEEEcCCCCEEEEechhheecCCcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHH
Confidence 999999999999999999999998642 234 789999999877 89999999999999999999
Q ss_pred CCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 621 GRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 621 G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
|+.||...... .....+.. ....++.++.+++.+||+.||++||++.|+++
T Consensus 309 g~~Pf~~~~~~------------~~~~~~~~-----~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 309 ADLPITKDAAL------------GGSEWIFR-----SCKNIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp SSCCC------------------CCSGGGGS-----SCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred CCCCCcccccc------------cchhhhhh-----hccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 99999532210 11111111 11234567899999999999999999999986
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=333.96 Aligned_cols=255 Identities=19% Similarity=0.245 Sum_probs=192.3
Q ss_pred hhhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCC----c
Q 004979 429 SNIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEP----F 503 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~----~ 503 (721)
|++++.+|+|+||.||+|+. .+++.||||++..... .....+++.+|++++++++||||+++++++...+. .
T Consensus 27 y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 27 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ---SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp EEEEEEC------CEEEEEETTTCCEEEEEECSSTTS---SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred EEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCcccc---CHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 46778899999999999996 4789999998854321 23345678999999999999999999999976531 2
Q ss_pred eEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCC
Q 004979 504 TRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNN 583 (721)
Q Consensus 504 ~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~ 583 (721)
..++||||+ +++|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 177 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLARQ 177 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred eEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCHHHEEEcCCCCEEEEeeecccc
Confidence 459999999 8899999864 46899999999999999999999998 99999999999999999999999999864
Q ss_pred CC------CCCccccchhhccc-CCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCC-CC---------
Q 004979 584 TT------AAKTGSAAMELLET-SAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQ-PL--------- 646 (721)
Q Consensus 584 ~~------~~~~~~~apE~~~~-~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~-~~--------- 646 (721)
.. .++..|+|||.+.+ ..++.++||||+||++|||++|+.||...+ ..+.+..+..... +.
T Consensus 178 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~--~~~~l~~i~~~~g~~~~~~~~~~~~ 255 (367)
T 1cm8_A 178 ADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD--HLDQLKEIMKVTGTPPAEFVQRLQS 255 (367)
T ss_dssp CCSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred cccccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHhcCCCCHHHHHHhhh
Confidence 32 34557899999876 789999999999999999999999996432 2222222221100 00
Q ss_pred ----------ccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHHhh
Q 004979 647 ----------KDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAK--LKEIT 694 (721)
Q Consensus 647 ----------~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~--L~~i~ 694 (721)
...............+.++.+|+.+||+.||++|||+.|+++. ++++.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~ 315 (367)
T 1cm8_A 256 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 315 (367)
T ss_dssp HHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred HHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence 0001111122233456789999999999999999999999873 44443
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=335.41 Aligned_cols=253 Identities=17% Similarity=0.195 Sum_probs=189.9
Q ss_pred hhhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEE
Q 004979 429 SNIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMM 507 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~l 507 (721)
+++++.+|+|+||+||+|+.. +++.||||++.............+.+.+|++++++++||||+++++++.+.+ ..++
T Consensus 12 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~l 89 (346)
T 1ua2_A 12 YEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS--NISL 89 (346)
T ss_dssp -CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT--CCEE
T ss_pred cEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC--ceEE
Confidence 467788999999999999964 6889999998754322222222356889999999999999999999998776 5699
Q ss_pred EEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC--
Q 004979 508 VFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT-- 585 (721)
Q Consensus 508 V~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~-- 585 (721)
||||+++ +|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 90 v~e~~~~-~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 165 (346)
T 1ua2_A 90 VFDFMET-DLEVIIKD-NSLVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP 165 (346)
T ss_dssp EEECCSE-EHHHHHTT-CCSSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC
T ss_pred EEEcCCC-CHHHHHHh-cCcCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCCHHHEEEcCCCCEEEEecccceeccCC
Confidence 9999975 88888753 3346888999999999999999999998 9999999999999999999999999886432
Q ss_pred -------CCCccccchhhccc-CCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhc--CCCCccc------
Q 004979 586 -------AAKTGSAAMELLET-SAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKG--EQPLKDI------ 649 (721)
Q Consensus 586 -------~~~~~~~apE~~~~-~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~--~~~~~~~------ 649 (721)
.++..|+|||.+.+ ..++.++|||||||++|||++|..||.... ..+....+... ......+
T Consensus 166 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~ 243 (346)
T 1ua2_A 166 NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS--DLDQLTRIFETLGTPTEEQWPDMCSL 243 (346)
T ss_dssp CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHHHCCCCTTTSSSTTSS
T ss_pred cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCC--HHHHHHHHHHHcCCCChhhhhhhccC
Confidence 23556899999865 458999999999999999999999986432 22222332221 1100000
Q ss_pred ---cC-Cccc-----cccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004979 650 ---VD-PTLK-----SFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAK 689 (721)
Q Consensus 650 ---~d-~~l~-----~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 689 (721)
+. .... ......+.++.+|+.+||+.||++|||+.|+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 244 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp TTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred cccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 00 0000 1113345789999999999999999999999874
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=340.48 Aligned_cols=251 Identities=16% Similarity=0.202 Sum_probs=179.8
Q ss_pred hhhhhC-cCCCCceeEEEEEEec---CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCc
Q 004979 428 FSNIIG-SFSDGTVGTVYKGTLS---SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPF 503 (721)
Q Consensus 428 ~~~ii~-~lg~G~~g~Vyk~~~~---~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 503 (721)
.+++.| +||+|+||+||+|+.. ++..||+|++..... ...+.+|+++|++++|||||++++++......
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 93 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-------SMSACREIALLRELKHPNVISLQKVFLSHADR 93 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-------CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTT
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-------CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCC
Confidence 345555 6999999999999965 578899998864321 13688999999999999999999999754444
Q ss_pred eEEEEEecCCCCChhhhhhhcc-------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEe----CCCCc
Q 004979 504 TRMMVFEYSPNGSLFEHLHIQE-------AEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYL----TEDYA 572 (721)
Q Consensus 504 ~~~lV~Ey~~~GsL~~~l~~~~-------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl----~~~~~ 572 (721)
..++||||+. |+|.+++.... ...+++..+..|+.||+.||+|||+.+ |+||||||+|||+ +.++.
T Consensus 94 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~ 170 (405)
T 3rgf_A 94 KVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGR 170 (405)
T ss_dssp EEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECCSSTTTTC
T ss_pred eEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--EeCCCcCHHHeEEecCCCCCCc
Confidence 7899999996 58888875321 234899999999999999999999998 9999999999999 77899
Q ss_pred EEEeccCCCCCCC------------CCCccccchhhccc-CCCCCCccHHHHHHHHHHHHhCCCcccCCCCCH-------
Q 004979 573 AKISDFSFWNNTT------------AAKTGSAAMELLET-SAVDLESNVYSFGTILFEMITGRISYSIENGSL------- 632 (721)
Q Consensus 573 ~kL~DFGla~~~~------------~~~~~~~apE~~~~-~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~------- 632 (721)
+||+|||+++... .++..|+|||.+.+ ..++.++|||||||++|||+||+.||.....+.
T Consensus 171 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~ 250 (405)
T 3rgf_A 171 VKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYH 250 (405)
T ss_dssp EEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCC
T ss_pred EEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccch
Confidence 9999999986432 23557999999876 458999999999999999999999996443211
Q ss_pred HHHHHHHhhcCCCCccccCCccccc---------------------------cHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 004979 633 ENWASEYLKGEQPLKDIVDPTLKSF---------------------------QENVLEELLVVIKNCVHPDPKQRPSMRG 685 (721)
Q Consensus 633 ~~~~~~~~~~~~~~~~~~d~~l~~~---------------------------~~~~~~~l~~li~~Cl~~dP~~RPs~~e 685 (721)
.+.+..++.............+... ......++.+|+.+||+.||++|||+.|
T Consensus 251 ~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e 330 (405)
T 3rgf_A 251 HDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQ 330 (405)
T ss_dssp HHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHH
T ss_pred HHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHH
Confidence 1111111111000000000000000 0011457889999999999999999999
Q ss_pred HHH
Q 004979 686 IAA 688 (721)
Q Consensus 686 vl~ 688 (721)
+++
T Consensus 331 ~L~ 333 (405)
T 3rgf_A 331 AMQ 333 (405)
T ss_dssp HHT
T ss_pred Hhc
Confidence 987
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-37 Score=322.04 Aligned_cols=244 Identities=20% Similarity=0.234 Sum_probs=194.7
Q ss_pred hhhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEE
Q 004979 429 SNIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMM 507 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~l 507 (721)
|++.+.+|+|+||.||+|+. .++..+++|++....... .....+.+.+|++++++++||||+++++++...+....++
T Consensus 7 y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (305)
T 2wtk_C 7 YLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRR-IPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYM 85 (305)
T ss_dssp BCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHH-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEE
T ss_pred eeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccc-cchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEE
Confidence 46778899999999999996 467899999886543211 1234567999999999999999999999986544336799
Q ss_pred EEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC---
Q 004979 508 VFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT--- 584 (721)
Q Consensus 508 V~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~--- 584 (721)
||||+++| |.+++.......+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 86 v~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~ 162 (305)
T 2wtk_C 86 VMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG--IVHKDIKPGNLLLTTGGTLKISALGVAEALHPF 162 (305)
T ss_dssp EEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred EehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEEcCCCcEEeeccccccccCcc
Confidence 99999877 777776555667999999999999999999999998 999999999999999999999999987532
Q ss_pred --------CCCCccccchhhcccCC--CCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCcc
Q 004979 585 --------TAAKTGSAAMELLETSA--VDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTL 654 (721)
Q Consensus 585 --------~~~~~~~~apE~~~~~~--~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 654 (721)
..++..|+|||.+.+.. ++.++|||||||++|||+||+.||.. .+..+.......+...
T Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~--~~~~~~~~~i~~~~~~--------- 231 (305)
T 2wtk_C 163 AADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEG--DNIYKLFENIGKGSYA--------- 231 (305)
T ss_dssp CSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCC--SSHHHHHHHHHHCCCC---------
T ss_pred ccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCC--chHHHHHHHHhcCCCC---------
Confidence 22456789999987644 37899999999999999999999963 3344444444333221
Q ss_pred ccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004979 655 KSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAK 689 (721)
Q Consensus 655 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 689 (721)
.+..++.++.+++.+||+.||++||++.|+++.
T Consensus 232 --~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 232 --IPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp --CCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred --CCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 122345678899999999999999999999874
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=323.11 Aligned_cols=247 Identities=19% Similarity=0.291 Sum_probs=192.0
Q ss_pred HHHHHHhhhhhhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEe
Q 004979 420 ELEAACEDFSNIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCE 498 (721)
Q Consensus 420 ~l~~~~~~~~~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~ 498 (721)
++.....+.+++++.+|+|+||.||+|+.. ++..|++|++..... .+.+.+|++++.+++||||+++++++.
T Consensus 22 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~~~e~~~l~~l~h~~i~~~~~~~~ 94 (314)
T 3com_A 22 SLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD-------LQEIIKEISIMQQCDSPHVVKYYGSYF 94 (314)
T ss_dssp --------CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC-------CHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred hhhhcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH-------HHHHHHHHHHHHhCCCCCCccEEEEEE
Confidence 333333444578889999999999999975 588999998864321 246889999999999999999999998
Q ss_pred cCCCceEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEecc
Q 004979 499 EDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDF 578 (721)
Q Consensus 499 ~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DF 578 (721)
..+ ..++||||+++|+|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+||
T Consensus 95 ~~~--~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~df 169 (314)
T 3com_A 95 KNT--DLWIVMEYCGAGSVSDIIRL-RNKTLTEDEIATILQSTLKGLEYLHFMR--KIHRDIKAGNILLNTEGHAKLADF 169 (314)
T ss_dssp ETT--EEEEEEECCTTEEHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCC
T ss_pred eCC--EEEEEeecCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCcCHHHEEECCCCCEEEeec
Confidence 876 67999999999999999863 3457999999999999999999999998 999999999999999999999999
Q ss_pred CCCCCC---------CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccc
Q 004979 579 SFWNNT---------TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDI 649 (721)
Q Consensus 579 Gla~~~---------~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (721)
|++... ..++..|+|||.+....++.++|||||||++|||+||+.||.... .............+ ..
T Consensus 170 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~~~~~--~~ 245 (314)
T 3com_A 170 GVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIH--PMRAIFMIPTNPPP--TF 245 (314)
T ss_dssp TTCEECBTTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSC--HHHHHHHHHHSCCC--CC
T ss_pred ccchhhhhhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHhcCCCc--cc
Confidence 987432 224557899999999899999999999999999999999996332 22222222222111 00
Q ss_pred cCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 650 VDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 650 ~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
..+...+.++.+++.+||+.||++||++.|+++
T Consensus 246 ------~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 246 ------RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp ------SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 112334577899999999999999999999986
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=333.29 Aligned_cols=241 Identities=13% Similarity=0.218 Sum_probs=194.2
Q ss_pred hhhhCcCCCCceeEEEEEE------ecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCC---CCccceEeEEEec
Q 004979 429 SNIIGSFSDGTVGTVYKGT------LSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVN---HKNFVNLIGYCEE 499 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~------~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~---H~nIv~l~g~~~~ 499 (721)
+.+.+.+|+|+||+||+|+ ..+++.||||++.... ..++.+|++++.+++ |+||+++++++..
T Consensus 67 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--------~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~ 138 (365)
T 3e7e_A 67 VYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN--------PWEFYIGTQLMERLKPSMQHMFMKFYSAHLF 138 (365)
T ss_dssp EEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC--------HHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred EEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC--------hhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence 3677889999999999994 4568899999886432 245778888888886 9999999999988
Q ss_pred CCCceEEEEEecCCCCChhhhhhhc---cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCC-------
Q 004979 500 DEPFTRMMVFEYSPNGSLFEHLHIQ---EAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTE------- 569 (721)
Q Consensus 500 ~~~~~~~lV~Ey~~~GsL~~~l~~~---~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~------- 569 (721)
.+ ..++||||+++|+|.+++... ....+++..+..|+.||+.||+|||+++ ||||||||+|||++.
T Consensus 139 ~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~--ivHrDiKp~NIll~~~~~~~~~ 214 (365)
T 3e7e_A 139 QN--GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE--IIHGDIKPDNFILGNGFLEQDD 214 (365)
T ss_dssp SS--CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECGGGTCC--
T ss_pred CC--CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEecccccCccc
Confidence 77 679999999999999999643 2456999999999999999999999988 999999999999998
Q ss_pred ----CCcEEEeccCCCCCC-----------CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHH
Q 004979 570 ----DYAAKISDFSFWNNT-----------TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLEN 634 (721)
Q Consensus 570 ----~~~~kL~DFGla~~~-----------~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~ 634 (721)
++.+||+|||+++.. ..++..|+|||.+.+..++.++|||||||++|||+||+.||.......
T Consensus 215 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-- 292 (365)
T 3e7e_A 215 EDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE-- 292 (365)
T ss_dssp ----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE--
T ss_pred cccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc--
Confidence 899999999998421 235678999999999999999999999999999999999985322110
Q ss_pred HHHHHhhcCCCCccccCCccccccHHHHHHHHHHHHHcccCCCCCC-CCHHHHHHHHHHhhhcCC
Q 004979 635 WASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQR-PSMRGIAAKLKEITAMEP 698 (721)
Q Consensus 635 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~R-Ps~~evl~~L~~i~~~~~ 698 (721)
. ......... ...+.+.+++..|++.+|.+| |++.++.+.|+++.....
T Consensus 293 ---------~----~~~~~~~~~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~~ 342 (365)
T 3e7e_A 293 ---------C----KPEGLFRRL--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHY 342 (365)
T ss_dssp ---------E----EECSCCTTC--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred ---------e----eechhcccc--CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHhh
Confidence 0 011111111 124567789999999999998 689999999998776543
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=324.42 Aligned_cols=239 Identities=19% Similarity=0.292 Sum_probs=196.6
Q ss_pred hhhhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEE
Q 004979 428 FSNIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRM 506 (721)
Q Consensus 428 ~~~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~ 506 (721)
.+++++.+|+|+||.||+|+. .++..|++|++...... ...+.+.+|+.++++++||||+++++++.+.+ ..+
T Consensus 23 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~ 96 (303)
T 3a7i_A 23 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE----DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDT--KLW 96 (303)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS----TTHHHHHHHHHHHHHCCCTTBCCEEEEEEETT--EEE
T ss_pred HHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH----HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC--eEE
Confidence 346788899999999999985 46889999988654322 23467999999999999999999999998876 679
Q ss_pred EEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC--
Q 004979 507 MVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT-- 584 (721)
Q Consensus 507 lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~-- 584 (721)
+||||+++|+|.+++. ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++...
T Consensus 97 lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 171 (303)
T 3a7i_A 97 IIMEYLGGGSALDLLE---PGPLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLLSEHGEVKLADFGVAGQLTD 171 (303)
T ss_dssp EEEECCTTEEHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECBT
T ss_pred EEEEeCCCCcHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChheEEECCCCCEEEeecccceecCc
Confidence 9999999999999985 346899999999999999999999998 999999999999999999999999987432
Q ss_pred -------CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccc
Q 004979 585 -------TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSF 657 (721)
Q Consensus 585 -------~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 657 (721)
..++..|+|||.+....++.++|||||||++|||+||+.||... ...+..........+ ..
T Consensus 172 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~--~~~~~~~~~~~~~~~----------~~ 239 (303)
T 3a7i_A 172 TQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL--HPMKVLFLIPKNNPP----------TL 239 (303)
T ss_dssp TBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS--CHHHHHHHHHHSCCC----------CC
T ss_pred cccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCc--CHHHHHHHhhcCCCC----------CC
Confidence 22455789999999999999999999999999999999999633 222322222222111 11
Q ss_pred cHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004979 658 QENVLEELLVVIKNCVHPDPKQRPSMRGIAAK 689 (721)
Q Consensus 658 ~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 689 (721)
...++.++.+++.+||+.||++||++.|+++.
T Consensus 240 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 240 EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp CSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred ccccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 22345678999999999999999999999875
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-37 Score=327.74 Aligned_cols=244 Identities=16% Similarity=0.210 Sum_probs=189.6
Q ss_pred hhhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCC-CCccceEeEEEecCCCceEE
Q 004979 429 SNIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVN-HKNFVNLIGYCEEDEPFTRM 506 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~~~ 506 (721)
+++++.+|+|+||+||+|+. .+++.||||++.... .+.+.+|++++++++ ||||+++++++.+......+
T Consensus 38 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 109 (330)
T 3nsz_A 38 YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 109 (330)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC--------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEE
T ss_pred eEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc--------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceE
Confidence 46788999999999999985 578899999876321 256889999999997 99999999999875444679
Q ss_pred EEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCC-cEEEeccCCCCCC-
Q 004979 507 MVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDY-AAKISDFSFWNNT- 584 (721)
Q Consensus 507 lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~-~~kL~DFGla~~~- 584 (721)
+||||+++++|.+++. .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++ .+||+|||+++..
T Consensus 110 lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 110 LVFEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp EEEECCCCCCHHHHGG-----GCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EEEeccCchhHHHHHH-----hCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 9999999999999874 3889999999999999999999998 99999999999999776 8999999998532
Q ss_pred -------CCCCccccchhhccc-CCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhh-------------cC
Q 004979 585 -------TAAKTGSAAMELLET-SAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLK-------------GE 643 (721)
Q Consensus 585 -------~~~~~~~~apE~~~~-~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~-------------~~ 643 (721)
..++..|+|||.+.. ..++.++|||||||++|||+||+.||........... .... ..
T Consensus 183 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~-~~~~~~~~~~~~~~~~~~~ 261 (330)
T 3nsz_A 183 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV-RIAKVLGTEDLYDYIDKYN 261 (330)
T ss_dssp TTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHH-HHHHHHCHHHHHHHHHHTT
T ss_pred CCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHH-HHHHhcCCchhhhHHHHhc
Confidence 224557899999876 6789999999999999999999999964332221111 1100 00
Q ss_pred CCCc----cccC----Cc-----cccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 644 QPLK----DIVD----PT-----LKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 644 ~~~~----~~~d----~~-----l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
.... +... .. ........+.++.+|+.+||+.||++|||++|+++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 262 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp CCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred cccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0000 0000 00 00112235678999999999999999999999986
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=332.97 Aligned_cols=250 Identities=19% Similarity=0.290 Sum_probs=194.1
Q ss_pred hhhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEE
Q 004979 429 SNIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMM 507 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~l 507 (721)
+++++.+|+|+||+||+|+.. ++..||+|++.... .....+.+.+|++++++++||||+++++++.+.+ ..++
T Consensus 35 y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~l 108 (360)
T 3eqc_A 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI----KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG--EISI 108 (360)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC----CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETT--EEEE
T ss_pred ceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc----CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECC--EEEE
Confidence 367788999999999999965 68889999886542 2334578999999999999999999999998877 6799
Q ss_pred EEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCeEeeCCCCCCeEeCCCCcEEEeccCCCC----
Q 004979 508 VFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQL-TPPIAHRNLQSSSIYLTEDYAAKISDFSFWN---- 582 (721)
Q Consensus 508 V~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~-~~~IvHrDLKp~NILl~~~~~~kL~DFGla~---- 582 (721)
||||+++|+|.+++... ..+++..+..|+.|++.||+|||+. + |+||||||+|||++.++.+||+|||+++
T Consensus 109 v~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 184 (360)
T 3eqc_A 109 CMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 184 (360)
T ss_dssp EECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred EEECCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHhCC--EEcCCccHHHEEECCCCCEEEEECCCCccccc
Confidence 99999999999998643 4589999999999999999999985 7 9999999999999999999999999874
Q ss_pred ---CCCCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHH-hhcCC------------CC
Q 004979 583 ---NTTAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEY-LKGEQ------------PL 646 (721)
Q Consensus 583 ---~~~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~-~~~~~------------~~ 646 (721)
....++..|+|||.+.+..++.++|||||||++|||+||+.||.............. ..+.. ..
T Consensus 185 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (360)
T 3eqc_A 185 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 264 (360)
T ss_dssp HC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------------------
T ss_pred ccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcc
Confidence 223456789999999999999999999999999999999999964332111110000 00000 00
Q ss_pred c-------------cc----cCCcccc-ccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 647 K-------------DI----VDPTLKS-FQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 647 ~-------------~~----~d~~l~~-~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
. +. ....... ....++.++.+|+.+||+.||++|||+.|+++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 265 NKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp ---------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred cccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 0 00 0000000 01124567899999999999999999999986
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=333.86 Aligned_cols=248 Identities=17% Similarity=0.231 Sum_probs=189.6
Q ss_pred hhhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEE
Q 004979 429 SNIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMM 507 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~l 507 (721)
|.+++.+|+|+||+||+|+.. ++..||+|++...... .....+.+|++++++++||||+++++++...+ ..++
T Consensus 4 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~l 77 (324)
T 3mtl_A 4 YIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE----GAPCTAIREVSLLKDLKHANIVTLHDIIHTEK--SLTL 77 (324)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC----------CCCCCCCHHHHSCCCCTTBCCEEEEEECSS--CEEE
T ss_pred eEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc----ccchhHHHHHHHHHhcCCCCCCeeeeEEeeCC--EEEE
Confidence 356788999999999999975 7889999988643221 11124568999999999999999999998876 6799
Q ss_pred EEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC--
Q 004979 508 VFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT-- 585 (721)
Q Consensus 508 V~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~-- 585 (721)
||||++ |+|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 78 v~e~~~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 153 (324)
T 3mtl_A 78 VFEYLD-KDLKQYLDD-CGNIINMHNVKLFLFQLLRGLAYCHRQK--VLHRDLKPQNLLINERGELKLADFGLARAKSIP 153 (324)
T ss_dssp EEECCS-EEHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCCGGGEEECTTCCEEECSSSEEECC---
T ss_pred Eecccc-cCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCcCHHHEEECCCCCEEEccCcccccccCC
Confidence 999997 699988864 3456899999999999999999999998 9999999999999999999999999875332
Q ss_pred -------CCCccccchhhccc-CCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcC-CCCccccCC----
Q 004979 586 -------AAKTGSAAMELLET-SAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGE-QPLKDIVDP---- 652 (721)
Q Consensus 586 -------~~~~~~~apE~~~~-~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~-~~~~~~~d~---- 652 (721)
.++..|+|||.+.+ ..++.++|||||||++|||+||+.||.... ..+....+.... .+.......
T Consensus 154 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~ 231 (324)
T 3mtl_A 154 TKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGST--VEEQLHFIFRILGTPTEETWPGILSN 231 (324)
T ss_dssp ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHHHCCCCTTTSTTGGGC
T ss_pred ccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHHhCCCChHhchhhhcc
Confidence 23567899999865 678999999999999999999999996433 222222222110 111110000
Q ss_pred --------------ccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 653 --------------TLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 653 --------------~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
......+....++.+|+.+||+.||++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 232 EEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp HHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 000112234567899999999999999999999987
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-37 Score=318.90 Aligned_cols=240 Identities=20% Similarity=0.334 Sum_probs=192.9
Q ss_pred hhhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEE
Q 004979 429 SNIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMM 507 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~l 507 (721)
+.+.+.+|+|+||.||+|+.. +++.|++|++...... .....+.+.+|++++++++||||+++++++...+ ..++
T Consensus 13 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~l 88 (276)
T 2h6d_A 13 YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIR--SLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPT--DFFM 88 (276)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH--HTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS--EEEE
T ss_pred EEEEeeecCCCCeEEEEEEECCCCceEEEEEecccccc--chhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC--eEEE
Confidence 366788999999999999975 7889999988643211 1223457899999999999999999999998876 6799
Q ss_pred EEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCCC-
Q 004979 508 VFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTA- 586 (721)
Q Consensus 508 V~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~~- 586 (721)
||||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 89 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 164 (276)
T 2h6d_A 89 VMEYVSGGELFDYICKH--GRVEEMEARRLFQQILSAVDYCHRHM--VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 164 (276)
T ss_dssp EEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHC--SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred EEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence 99999999999998643 45899999999999999999999988 99999999999999999999999998764322
Q ss_pred -------CCccccchhhcccCCC-CCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCcccccc
Q 004979 587 -------AKTGSAAMELLETSAV-DLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQ 658 (721)
Q Consensus 587 -------~~~~~~apE~~~~~~~-s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 658 (721)
++..|+|||.+.+..+ +.++||||||+++|||++|+.||... ...........+... .+
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~--~~~~~~~~~~~~~~~-----------~~ 231 (276)
T 2h6d_A 165 EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDE--HVPTLFKKIRGGVFY-----------IP 231 (276)
T ss_dssp ------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHCCCC-----------CC
T ss_pred cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCC--cHHHHHHHhhcCccc-----------Cc
Confidence 3457899999987765 68999999999999999999999643 333333333332211 11
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004979 659 ENVLEELLVVIKNCVHPDPKQRPSMRGIAAK 689 (721)
Q Consensus 659 ~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 689 (721)
.....++.+++.+||+.||++||++.|+++.
T Consensus 232 ~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 232 EYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred hhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 2334678899999999999999999999873
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=341.33 Aligned_cols=247 Identities=9% Similarity=0.059 Sum_probs=175.4
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHH---HHHhcCCCCccceEe-------EEEe
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKI---DTLSKVNHKNFVNLI-------GYCE 498 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei---~~l~~l~H~nIv~l~-------g~~~ 498 (721)
++++.+|+|+||+||+|+.. +++.||||++...... .....+.+.+|+ +.|+. +||||++++ +++.
T Consensus 65 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 65 KLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAEN--SRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTT--HHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEEE
T ss_pred eeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccc--cccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehhee
Confidence 56788999999999999965 7889999998765432 233456778885 45555 799988755 4444
Q ss_pred cCCC---------------ceEEEEEecCCCCChhhhhhhccCCCCCHHHH------HHHHHHHHHHHHHHhcCCCCeEe
Q 004979 499 EDEP---------------FTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMR------LRIAMGMAYCLEHMHQLTPPIAH 557 (721)
Q Consensus 499 ~~~~---------------~~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~------~~ia~~ia~gL~yLH~~~~~IvH 557 (721)
..+. ...++||||++ |+|.+++.... ..+.+..+ ..++.||+.||+|||+++ |+|
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~--ivH 217 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD-FVYVFRGDEGILALHILTAQLIRLAANLQSKG--LVH 217 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH-HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT--EEE
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc-cccchhhhhhhhhHHHHHHHHHHHHHHHHHCC--Ccc
Confidence 3221 24799999998 89999997532 23455555 788899999999999998 999
Q ss_pred eCCCCCCeEeCCCCcEEEeccCCCCCCC------CCCccccchhhccc--CCCCCCccHHHHHHHHHHHHhCCCcccCCC
Q 004979 558 RNLQSSSIYLTEDYAAKISDFSFWNNTT------AAKTGSAAMELLET--SAVDLESNVYSFGTILFEMITGRISYSIEN 629 (721)
Q Consensus 558 rDLKp~NILl~~~~~~kL~DFGla~~~~------~~~~~~~apE~~~~--~~~s~ksDVwSfGvvL~ElltG~~P~~~~~ 629 (721)
|||||+|||++.++.+||+|||+++... .++..|+|||.+.+ ..++.++|||||||++|||+||+.||....
T Consensus 218 rDikp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~ 297 (371)
T 3q60_A 218 GHFTPDNLFIMPDGRLMLGDVSALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVT 297 (371)
T ss_dssp TTCSGGGEEECTTSCEEECCGGGEEETTCEEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCC
T ss_pred CcCCHHHEEECCCCCEEEEecceeeecCCCccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcC
Confidence 9999999999999999999999986432 23467999999977 789999999999999999999999997543
Q ss_pred CCHHHHHHHHhhcCCCCccccCCcc-ccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 630 GSLENWASEYLKGEQPLKDIVDPTL-KSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~d~~l-~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
...... ... ........... ......++.++.+|+.+||+.||++||++.|+++
T Consensus 298 ~~~~~~----~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 298 PGIKGS----WKR-PSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp TTCTTC----CCB-CCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred cccccc----hhh-hhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 211000 000 00000000000 0111345678999999999999999999999975
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=327.85 Aligned_cols=245 Identities=20% Similarity=0.305 Sum_probs=195.7
Q ss_pred hhhhCcCCCCceeEEEEEEec-CCcEEEEEEeeecccc---chhhHHHHHHHHHHHHHhcC-CCCccceEeEEEecCCCc
Q 004979 429 SNIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRA---DWSKNLESQFRKKIDTLSKV-NHKNFVNLIGYCEEDEPF 503 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~---~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~ 503 (721)
+++...+|.|+||.||+|+.. +|..||||++...... .......+.+.+|+.++.++ +||||+++++++...+
T Consensus 96 y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~-- 173 (365)
T 2y7j_A 96 YDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS-- 173 (365)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS--
T ss_pred cccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC--
Confidence 367788999999999999975 7899999988654321 11123356789999999999 8999999999998876
Q ss_pred eEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCC
Q 004979 504 TRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNN 583 (721)
Q Consensus 504 ~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~ 583 (721)
..++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++..
T Consensus 174 ~~~lv~e~~~g~~L~~~l~~--~~~l~~~~~~~i~~qi~~~L~~LH~~g--i~H~Dlkp~NIl~~~~~~ikl~DfG~~~~ 249 (365)
T 2y7j_A 174 FMFLVFDLMRKGELFDYLTE--KVALSEKETRSIMRSLLEAVSFLHANN--IVHRDLKPENILLDDNMQIRLSDFGFSCH 249 (365)
T ss_dssp EEEEEECCCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEEEeCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEEEecCcccc
Confidence 67999999999999999864 346899999999999999999999998 99999999999999999999999998753
Q ss_pred C--------CCCCccccchhhccc------CCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccc
Q 004979 584 T--------TAAKTGSAAMELLET------SAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDI 649 (721)
Q Consensus 584 ~--------~~~~~~~~apE~~~~------~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (721)
. ..++..|+|||.+.+ ..++.++|||||||++|||+||+.||... ........+..+......
T Consensus 250 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~--~~~~~~~~i~~~~~~~~~- 326 (365)
T 2y7j_A 250 LEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHR--RQILMLRMIMEGQYQFSS- 326 (365)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHTCCCCCH-
T ss_pred cCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCC--CHHHHHHHHHhCCCCCCC-
Confidence 2 234567999998853 36889999999999999999999999643 233333333333211110
Q ss_pred cCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 650 VDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 650 ~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
+ .....+.++.+++.+||+.||++||++.|+++
T Consensus 327 --~----~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 327 --P----EWDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp --H----HHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred --c----ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0 01123467889999999999999999999986
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-37 Score=323.48 Aligned_cols=241 Identities=20% Similarity=0.286 Sum_probs=193.0
Q ss_pred hhhhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEE
Q 004979 428 FSNIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRM 506 (721)
Q Consensus 428 ~~~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~ 506 (721)
.+++++.+|+|+||+||+|+.. ++..+++|++...... ..+.+.+|++++++++||||+++++++...+ ..+
T Consensus 20 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~ 92 (302)
T 2j7t_A 20 VWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEE-----ELEDYIVEIEILATCDHPYIVKLLGAYYHDG--KLW 92 (302)
T ss_dssp TEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----C-----CHHHHHHHHHHHHHCCCTTBCCEEEEEECC---CEE
T ss_pred ceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHH-----HHHHHHHHHHHHhcCCCCCEeeeeeeeeeCC--eEE
Confidence 3478889999999999999975 5788999987644321 2467899999999999999999999998876 679
Q ss_pred EEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCC----
Q 004979 507 MVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWN---- 582 (721)
Q Consensus 507 lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~---- 582 (721)
+||||+++|+|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 93 lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 169 (302)
T 2j7t_A 93 IMIEFCPGGAVDAIMLE-LDRGLTEPQIQVVCRQMLEALNFLHSKR--IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK 169 (302)
T ss_dssp EEEECCTTEEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTTSCEEECCCHHHHHHHH
T ss_pred EEEEeCCCCcHHHHHHh-hccCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEECCCCCEEEEECCCCccccc
Confidence 99999999999998864 2456999999999999999999999998 9999999999999999999999999753
Q ss_pred -----CCCCCCccccchhhc-----ccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCC
Q 004979 583 -----NTTAAKTGSAAMELL-----ETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDP 652 (721)
Q Consensus 583 -----~~~~~~~~~~apE~~-----~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 652 (721)
....++..|+|||.+ ....++.++|||||||++|||+||+.||... +.............+. .
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~--~~~~~~~~~~~~~~~~--~--- 242 (302)
T 2j7t_A 170 TLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL--NPMRVLLKIAKSDPPT--L--- 242 (302)
T ss_dssp HHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTS--CHHHHHHHHHHSCCCC--C---
T ss_pred cccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccC--CHHHHHHHHhccCCcc--c---
Confidence 223456789999987 4677899999999999999999999999633 3333333333332211 0
Q ss_pred ccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 653 TLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 653 ~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
..+..++.++.+++.+||+.||++|||+.|+++
T Consensus 243 ---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 243 ---LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp ---SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred ---CCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 112344567899999999999999999999875
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=343.12 Aligned_cols=243 Identities=21% Similarity=0.285 Sum_probs=192.7
Q ss_pred hhhhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEE
Q 004979 428 FSNIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRM 506 (721)
Q Consensus 428 ~~~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~ 506 (721)
.|++++.||+|+||+||+|+.. ++..+|+|++....... .....+.+|++++++++|||||++++++.+.+ ..+
T Consensus 38 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~--~~~ 112 (494)
T 3lij_A 38 MYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVST---SSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKR--NYY 112 (494)
T ss_dssp HEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC--------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSS--EEE
T ss_pred CeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCc---hHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC--EEE
Confidence 3578889999999999999965 67889999987543221 12357899999999999999999999998876 679
Q ss_pred EEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCC---CCcEEEeccCCCCC
Q 004979 507 MVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTE---DYAAKISDFSFWNN 583 (721)
Q Consensus 507 lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~---~~~~kL~DFGla~~ 583 (721)
+||||+++|+|.+++... ..+++..+..|+.||+.||+|||+++ |+||||||+|||++. ++.+||+|||+++.
T Consensus 113 lv~e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~ 188 (494)
T 3lij_A 113 LVMECYKGGELFDEIIHR--MKFNEVDAAVIIKQVLSGVTYLHKHN--IVHRDLKPENLLLESKEKDALIKIVDFGLSAV 188 (494)
T ss_dssp EEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence 999999999999988643 46899999999999999999999998 999999999999976 45599999998753
Q ss_pred C--------CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccc
Q 004979 584 T--------TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLK 655 (721)
Q Consensus 584 ~--------~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 655 (721)
. ..++..|+|||.+. ..++.++||||+||++|||++|+.||... ...+....+..+..... .+
T Consensus 189 ~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~--~~~~~~~~i~~~~~~~~---~~--- 259 (494)
T 3lij_A 189 FENQKKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQ--TDQEILRKVEKGKYTFD---SP--- 259 (494)
T ss_dssp CBTTBCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHTCCCCC---SG---
T ss_pred CCCCccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHhCCCCCC---ch---
Confidence 2 23566899999886 56999999999999999999999999643 34445555444432211 11
Q ss_pred cccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004979 656 SFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAK 689 (721)
Q Consensus 656 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 689 (721)
.....+.++.+++.+||+.||++|||+.|+++.
T Consensus 260 -~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 260 -EWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp -GGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred -hcccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 112345678999999999999999999999863
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-37 Score=320.64 Aligned_cols=237 Identities=21% Similarity=0.294 Sum_probs=188.8
Q ss_pred CcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEEEec
Q 004979 433 GSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEY 511 (721)
Q Consensus 433 ~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV~Ey 511 (721)
..+|+|+||.||+|+. .++..|++|.+..... ...+.+.+|+.++++++||||+++++++...+ ..++||||
T Consensus 28 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e~ 100 (295)
T 2clq_A 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS-----RYSQPLHEEIALHKHLKHKNIVQYLGSFSENG--FIKIFMEQ 100 (295)
T ss_dssp CEEEECSSSEEEEEEETTTCCEEEEEEEECCCC--------HHHHHHHHHHHTCCCTTBCCEEEEEEETT--EEEEEEEC
T ss_pred EEEeecCcEEEEEEEECCCCeEEEEEEccCCch-----HHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCC--cEEEEEEe
Confidence 4678999999999995 4678899998865421 23467899999999999999999999998877 67999999
Q ss_pred CCCCChhhhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCC-CCcEEEeccCCCCCC-----
Q 004979 512 SPNGSLFEHLHIQE-AEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTE-DYAAKISDFSFWNNT----- 584 (721)
Q Consensus 512 ~~~GsL~~~l~~~~-~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~-~~~~kL~DFGla~~~----- 584 (721)
+++|+|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++. ++.+||+|||+++..
T Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~ 178 (295)
T 2clq_A 101 VPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP 178 (295)
T ss_dssp CSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred CCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC--EEccCCChhhEEEECCCCCEEEeecccccccCCCCC
Confidence 99999999987542 335678899999999999999999988 999999999999987 899999999987532
Q ss_pred ----CCCCccccchhhcccC--CCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCcccccc
Q 004979 585 ----TAAKTGSAAMELLETS--AVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQ 658 (721)
Q Consensus 585 ----~~~~~~~~apE~~~~~--~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 658 (721)
..++..|+|||.+... .++.++|||||||++|||+||+.||................... + ..+
T Consensus 179 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-------~---~~~ 248 (295)
T 2clq_A 179 CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVH-------P---EIP 248 (295)
T ss_dssp --CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCC-------C---CCC
T ss_pred cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcccccc-------c---ccc
Confidence 2345678999998654 38899999999999999999999996433222222211111110 1 122
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 659 ENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 659 ~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
...+.++.+++.+||+.||++||++.|+++
T Consensus 249 ~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 249 ESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp TTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred ccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 344577899999999999999999999975
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=328.57 Aligned_cols=249 Identities=20% Similarity=0.317 Sum_probs=193.9
Q ss_pred hhhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEE
Q 004979 429 SNIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMM 507 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~l 507 (721)
+++++.+|+|+||.||+|+.. ++..||||++..... .....+.+.+|++++++++||||+++++++.+.+ ..++
T Consensus 27 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~l 101 (331)
T 4aaa_A 27 YENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDD---DKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKK--RWYL 101 (331)
T ss_dssp EEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSS---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT--EEEE
T ss_pred heeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCC---chHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCC--EEEE
Confidence 367889999999999999965 588999998864432 2334567889999999999999999999998877 6799
Q ss_pred EEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC---
Q 004979 508 VFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT--- 584 (721)
Q Consensus 508 V~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~--- 584 (721)
||||+++++|.+++. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 102 v~e~~~~~~l~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 177 (331)
T 4aaa_A 102 VFEFVDHTILDDLEL--FPNGLDYQVVQKYLFQIINGIGFCHSHN--IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 177 (331)
T ss_dssp EEECCSEEHHHHHHH--STTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred EEecCCcchHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHHHCC--EEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence 999999999988764 3456999999999999999999999998 999999999999999999999999988532
Q ss_pred ------CCCCccccchhhcccC-CCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhh--------------cC
Q 004979 585 ------TAAKTGSAAMELLETS-AVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLK--------------GE 643 (721)
Q Consensus 585 ------~~~~~~~~apE~~~~~-~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~--------------~~ 643 (721)
..++..|+|||.+.+. .++.++|||||||++|||+||+.||..... .+....... ..
T Consensus 178 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (331)
T 4aaa_A 178 GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSD--IDQLYHIMMCLGNLIPRHQELFNKN 255 (331)
T ss_dssp ------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHHHCSCCHHHHHHHHHC
T ss_pred ccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCc--HHHHHHHHHHhCCCChhhhhHhhhc
Confidence 2245678999998765 789999999999999999999999964432 111111110 00
Q ss_pred CCCccccCCcc------ccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 644 QPLKDIVDPTL------KSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 644 ~~~~~~~d~~l------~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
........+.. ....+.+++++.+|+.+||+.||++|||+.|+++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 256 PVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp GGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred cccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00000111111 1112245678999999999999999999999886
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-37 Score=345.15 Aligned_cols=244 Identities=21% Similarity=0.256 Sum_probs=198.9
Q ss_pred hhhhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEE
Q 004979 428 FSNIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRM 506 (721)
Q Consensus 428 ~~~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~ 506 (721)
.|++.+.+|+|+||+||+|+.. ++..||||++....... ....+.+.+|++++++++|||||++++++.+.+ ..+
T Consensus 27 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~--~~~ 102 (484)
T 3nyv_A 27 RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQ--KTDKESLLREVQLLKQLDHPNIMKLYEFFEDKG--YFY 102 (484)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCB--SSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS--EEE
T ss_pred ceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhccc--chHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC--EEE
Confidence 3577888999999999999965 78899999986543221 122467999999999999999999999998876 679
Q ss_pred EEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEe---CCCCcEEEeccCCCCC
Q 004979 507 MVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYL---TEDYAAKISDFSFWNN 583 (721)
Q Consensus 507 lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl---~~~~~~kL~DFGla~~ 583 (721)
+||||+.+|+|.+++.. ...+++..+..|+.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++.
T Consensus 103 lv~e~~~~~~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 178 (484)
T 3nyv_A 103 LVGEVYTGGELFDEIIS--RKRFSEVDAARIIRQVLSGITYMHKNK--IVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178 (484)
T ss_dssp EEECCCCSCBHHHHHHT--CSCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred EEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence 99999999999998863 356999999999999999999999998 9999999999999 5678999999998753
Q ss_pred CC--------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccc
Q 004979 584 TT--------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLK 655 (721)
Q Consensus 584 ~~--------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 655 (721)
.. .++..|+|||.+.+ .++.++||||+||++|||+||+.||... +..+....+..+......
T Consensus 179 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~--~~~~~~~~i~~~~~~~~~------- 248 (484)
T 3nyv_A 179 FEASKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGA--NEYDILKKVEKGKYTFEL------- 248 (484)
T ss_dssp BCCCCSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHCCCCCCS-------
T ss_pred cccccccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCC--CHHHHHHHHHcCCCCCCC-------
Confidence 22 24567999999865 6999999999999999999999999643 334444444443222110
Q ss_pred cccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004979 656 SFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAK 689 (721)
Q Consensus 656 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 689 (721)
.....++.++.+++.+||+.||++|||+.|+++.
T Consensus 249 ~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 249 PQWKKVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp GGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred cccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 1113456778999999999999999999999863
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=341.76 Aligned_cols=242 Identities=21% Similarity=0.271 Sum_probs=197.6
Q ss_pred hhhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEE
Q 004979 429 SNIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMM 507 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~l 507 (721)
|++++.||+|+||+||+|+.. ++..||||++....... .....+.+|++++++++|||||++++++.+.+ ..++
T Consensus 24 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~--~~~l 98 (486)
T 3mwu_A 24 YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN---KDTSTILREVELLKKLDHPNIMKLFEILEDSS--SFYI 98 (486)
T ss_dssp EEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBC---SCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS--EEEE
T ss_pred eEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccc---hHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCC--EEEE
Confidence 578899999999999999965 78899999986432211 12467899999999999999999999998876 6799
Q ss_pred EEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeC---CCCcEEEeccCCCCCC
Q 004979 508 VFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLT---EDYAAKISDFSFWNNT 584 (721)
Q Consensus 508 V~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~---~~~~~kL~DFGla~~~ 584 (721)
||||+++|+|.+++... ..+++..+..|+.||+.||+|||+.+ |+||||||+|||++ .++.+||+|||+++..
T Consensus 99 v~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 174 (486)
T 3mwu_A 99 VGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (486)
T ss_dssp EECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred EEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence 99999999999988643 46899999999999999999999998 99999999999995 5668999999998633
Q ss_pred --------CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCcccc
Q 004979 585 --------TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKS 656 (721)
Q Consensus 585 --------~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 656 (721)
..++..|+|||.+.+ .++.++||||+||++|||++|+.||... +..+....+..+...... .
T Consensus 175 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~--~~~~~~~~i~~~~~~~~~-------~ 244 (486)
T 3mwu_A 175 QQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGK--NEYDILKRVETGKYAFDL-------P 244 (486)
T ss_dssp CCC----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHTCCCSCS-------G
T ss_pred CCCCccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHhCCCCCCC-------c
Confidence 235668999999875 5999999999999999999999999643 344444444443222110 1
Q ss_pred ccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004979 657 FQENVLEELLVVIKNCVHPDPKQRPSMRGIAAK 689 (721)
Q Consensus 657 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 689 (721)
....++.++.+++.+||+.||++|||+.|+++.
T Consensus 245 ~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 245 QWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp GGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred ccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 113455778999999999999999999999874
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=329.34 Aligned_cols=249 Identities=18% Similarity=0.224 Sum_probs=190.0
Q ss_pred hhhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCC----c
Q 004979 429 SNIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEP----F 503 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~----~ 503 (721)
+++++.+|+|+||+||+|+.. ++..||||++..... .....+.+.+|++++++++||||+++++++...+. .
T Consensus 27 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 27 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ---NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTS---SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred eeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccC---ChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 367788999999999999854 688899998864321 13345678999999999999999999999976542 2
Q ss_pred eEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCC
Q 004979 504 TRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNN 583 (721)
Q Consensus 504 ~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~ 583 (721)
..++||||++ |+|.+++. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 104 ~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 176 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLART 176 (371)
T ss_dssp EEEEEEECCS-EEHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECCCCC---
T ss_pred ceEEEEEcCC-CCHHHHHh----hccCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEEcCCCCEEEEEeecccc
Confidence 5799999996 57888874 34899999999999999999999998 99999999999999999999999999864
Q ss_pred CC--------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCC-CCcc------
Q 004979 584 TT--------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQ-PLKD------ 648 (721)
Q Consensus 584 ~~--------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~-~~~~------ 648 (721)
.. .++..|+|||.+.+..++.++|||||||++|||+||+.||...+ ..+....+..... +..+
T Consensus 177 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~~ 254 (371)
T 2xrw_A 177 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD--HIDQWNKVIEQLGTPCPEFMKKLQ 254 (371)
T ss_dssp -------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHC-CCCCCHHHHTTSC
T ss_pred cccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHHhCCCCHHHHHHhh
Confidence 32 24557999999999999999999999999999999999996432 2222222221110 0000
Q ss_pred ------------------------ccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004979 649 ------------------------IVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAK 689 (721)
Q Consensus 649 ------------------------~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 689 (721)
..-+...........++.+|+.+||+.||++|||++|+++.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 255 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp HHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred hHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 00000011122346789999999999999999999999874
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=329.94 Aligned_cols=263 Identities=18% Similarity=0.196 Sum_probs=196.1
Q ss_pred HHHHHHhhhhhhhCcCCCCceeEEEEEEecCCcEEEEEEeeeccccc------hhhHHHHHHHHHHHHHhcCCCCccceE
Q 004979 420 ELEAACEDFSNIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRAD------WSKNLESQFRKKIDTLSKVNHKNFVNL 493 (721)
Q Consensus 420 ~l~~~~~~~~~ii~~lg~G~~g~Vyk~~~~~~~~vavk~~~~~~~~~------~~~~~~~~f~~Ei~~l~~l~H~nIv~l 493 (721)
++....+. +.+.+.+|+|+||.||+|+..++..||||++....... ......+.+.+|++++++++||||+++
T Consensus 16 ~~~~~~~~-y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~ 94 (362)
T 3pg1_A 16 ELHAMQSP-YTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGL 94 (362)
T ss_dssp HHHHTTCS-CEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCC
T ss_pred HHHHhccc-eEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccce
Confidence 33333333 37788999999999999998889999999886533211 112334789999999999999999999
Q ss_pred eEEEecCC---CceEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCC
Q 004979 494 IGYCEEDE---PFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTED 570 (721)
Q Consensus 494 ~g~~~~~~---~~~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~ 570 (721)
++++...+ ....++||||+. |+|.+++.. ....+++..+..|+.||+.||+|||+.+ |+||||||+|||++.+
T Consensus 95 ~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~~~ 170 (362)
T 3pg1_A 95 RDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD-QRIVISPQHIQYFMYHILLGLHVLHEAG--VVHRDLHPGNILLADN 170 (362)
T ss_dssp SEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC-TTSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT
T ss_pred eeeEEeccCCCcceEEEEEccCC-CCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCc--CEecCCChHHEEEcCC
Confidence 99986422 225799999997 688888863 3456999999999999999999999998 9999999999999999
Q ss_pred CcEEEeccCCCCCCC--------CCCccccchhhccc-CCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhh
Q 004979 571 YAAKISDFSFWNNTT--------AAKTGSAAMELLET-SAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLK 641 (721)
Q Consensus 571 ~~~kL~DFGla~~~~--------~~~~~~~apE~~~~-~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~ 641 (721)
+.+||+|||+++... .++..|+|||.+.+ ..++.++|||||||++|||+||+.||.... ..+....+..
T Consensus 171 ~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~--~~~~~~~i~~ 248 (362)
T 3pg1_A 171 NDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGST--FYNQLNKIVE 248 (362)
T ss_dssp CCEEECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHH
T ss_pred CCEEEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCC--HHHHHHHHHH
Confidence 999999999986322 23456899999876 778999999999999999999999996432 2222222211
Q ss_pred c--CCC-------------------CccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004979 642 G--EQP-------------------LKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAK 689 (721)
Q Consensus 642 ~--~~~-------------------~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 689 (721)
. ... ...................+.+|+.+||+.||++|||+.|+++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 249 VVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 0 000 00000111111223345678999999999999999999999873
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-37 Score=321.04 Aligned_cols=242 Identities=18% Similarity=0.249 Sum_probs=184.4
Q ss_pred hhhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEE
Q 004979 429 SNIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMM 507 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~l 507 (721)
+++++.+|+|+||+||+|+. .+++.||+|++..... .....+.+.++...++.++||||+++++++.+.+ ..++
T Consensus 9 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~--~~~l 83 (290)
T 3fme_A 9 LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN---SQEQKRLLMDLDISMRTVDCPFTVTFYGALFREG--DVWI 83 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---C---HHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS--SEEE
T ss_pred hhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccC---cHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccC--CEEE
Confidence 36788999999999999996 4788999998864322 1223344556666688899999999999999876 6799
Q ss_pred EEecCCCCChhhhhhhc--cCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC
Q 004979 508 VFEYSPNGSLFEHLHIQ--EAEHLDWAMRLRIAMGMAYCLEHMHQL-TPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT 584 (721)
Q Consensus 508 V~Ey~~~GsL~~~l~~~--~~~~l~~~~~~~ia~~ia~gL~yLH~~-~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~ 584 (721)
||||++ |+|.+++... ....+++..+..|+.|++.||+|||+. + |+||||||+|||++.++.+||+|||+++..
T Consensus 84 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 84 CMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC--CCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred EEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 999997 5888877532 356799999999999999999999986 8 999999999999999999999999987532
Q ss_pred --------CCCCccccchhhc----ccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCC
Q 004979 585 --------TAAKTGSAAMELL----ETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDP 652 (721)
Q Consensus 585 --------~~~~~~~~apE~~----~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 652 (721)
..++..|+|||.+ ....++.++|||||||++|||+||+.||......... .........+. .
T Consensus 161 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~--~--- 234 (290)
T 3fme_A 161 VDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQ-LKQVVEEPSPQ--L--- 234 (290)
T ss_dssp ---------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHH-HHHHHHSCCCC--C---
T ss_pred cccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHH-HHHHhccCCCC--c---
Confidence 2355679999996 5667899999999999999999999999643333322 22222221111 0
Q ss_pred ccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 653 TLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 653 ~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
.....+.++.+++.+||+.||++|||+.|+++
T Consensus 235 ----~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 235 ----PADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp ----CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ----ccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 11234567899999999999999999999987
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=328.50 Aligned_cols=251 Identities=19% Similarity=0.245 Sum_probs=189.5
Q ss_pred hhhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCC------
Q 004979 429 SNIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDE------ 501 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~------ 501 (721)
+++++.+|+|+||+||+|+. .+++.||+|++....... .....+.+|++++++++||||+++++++....
T Consensus 19 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 19 YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE---GFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp EEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSS---SSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred eeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccc---cchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 47788999999999999997 578899999886543222 12346789999999999999999999987643
Q ss_pred CceEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCC
Q 004979 502 PFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFW 581 (721)
Q Consensus 502 ~~~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla 581 (721)
....++||||+++ +|.+.+.. ....+++..+..|+.|++.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 171 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSN-VLVKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFGLA 171 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHC-TTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred CceEEEEEeccCC-CHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEEcCCCCEEEccchhc
Confidence 1257999999974 77777753 3356999999999999999999999998 999999999999999999999999987
Q ss_pred CCCC-------------CCCccccchhhccc-CCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhh--cCCC
Q 004979 582 NNTT-------------AAKTGSAAMELLET-SAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLK--GEQP 645 (721)
Q Consensus 582 ~~~~-------------~~~~~~~apE~~~~-~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~--~~~~ 645 (721)
+... .++..|+|||.+.+ ..++.++|||||||++|||+||+.||..... ......+.. +..+
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--~~~~~~i~~~~~~~~ 249 (351)
T 3mi9_A 172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE--QHQLALISQLCGSIT 249 (351)
T ss_dssp EECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHHHCCCC
T ss_pred ccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHHhCCCC
Confidence 5321 23456899998865 5689999999999999999999999974332 222211111 1111
Q ss_pred Cc---cc-----------cCCccccccHH-----HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 646 LK---DI-----------VDPTLKSFQEN-----VLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 646 ~~---~~-----------~d~~l~~~~~~-----~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
.. .. ........... ...++.+|+.+||+.||++|||+.|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 00 00 00000000111 1356889999999999999999999987
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=319.03 Aligned_cols=245 Identities=20% Similarity=0.290 Sum_probs=196.5
Q ss_pred hhhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccc----hhhHHHHHHHHHHHHHhcCC-CCccceEeEEEecCCC
Q 004979 429 SNIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRAD----WSKNLESQFRKKIDTLSKVN-HKNFVNLIGYCEEDEP 502 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~----~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~ 502 (721)
+++.+.+|+|+||.||+|+.. +++.||||++....... ......+.+.+|++++++++ ||||+++++++...+
T Consensus 19 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~- 97 (298)
T 1phk_A 19 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNT- 97 (298)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS-
T ss_pred cceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCC-
Confidence 367788999999999999975 67889999986543111 11234567899999999995 999999999998776
Q ss_pred ceEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCC
Q 004979 503 FTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWN 582 (721)
Q Consensus 503 ~~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~ 582 (721)
..++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++.
T Consensus 98 -~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 172 (298)
T 1phk_A 98 -FFFLVFDLMKKGELFDYLTE--KVTLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFSC 172 (298)
T ss_dssp -EEEEEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred -eEEEEEeccCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEcCCCcEEEecccchh
Confidence 67999999999999999864 346899999999999999999999998 9999999999999999999999999875
Q ss_pred CCC--------CCCccccchhhcc------cCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCcc
Q 004979 583 NTT--------AAKTGSAAMELLE------TSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKD 648 (721)
Q Consensus 583 ~~~--------~~~~~~~apE~~~------~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 648 (721)
... .++..|+|||.+. ...++.++||||||+++|||++|+.||... ...........+.....
T Consensus 173 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~--~~~~~~~~~~~~~~~~~- 249 (298)
T 1phk_A 173 QLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR--KQMLMLRMIMSGNYQFG- 249 (298)
T ss_dssp ECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHTCCCCC-
T ss_pred hcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCc--cHHHHHHHHhcCCcccC-
Confidence 322 2455789999874 456889999999999999999999999643 33333333333322111
Q ss_pred ccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 649 IVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 649 ~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
.+ ....++.++.+++.+||+.||++||++.|+++
T Consensus 250 --~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 250 --SP----EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp --TT----TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred --cc----cccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 11 11245577899999999999999999999975
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=326.57 Aligned_cols=248 Identities=20% Similarity=0.277 Sum_probs=179.1
Q ss_pred hhhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEE
Q 004979 429 SNIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMM 507 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~l 507 (721)
+++.+.+|+|+||+||+|+. .++..||||++..... ....+.+.+|++++++++||||+++++++...+ ..++
T Consensus 17 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~l 90 (303)
T 2vwi_A 17 YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC----QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKD--ELWL 90 (303)
T ss_dssp CEEEEECC---CCCEEEEEC----CEEEEECCC--------------------CCCCCCCTTBCCEEEEEESSS--CEEE
T ss_pred hhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc----chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecC--CcEE
Confidence 36778899999999999985 4688999998764321 123467889999999999999999999998877 6799
Q ss_pred EEecCCCCChhhhhhhc------cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCC
Q 004979 508 VFEYSPNGSLFEHLHIQ------EAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFW 581 (721)
Q Consensus 508 V~Ey~~~GsL~~~l~~~------~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla 581 (721)
||||+++|+|.+++... ....+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~~ 168 (303)
T 2vwi_A 91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG--QIHRDVKAGNILLGEDGSVQIADFGVS 168 (303)
T ss_dssp EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCCCCChhhEEEcCCCCEEEEeccch
Confidence 99999999999998631 2356899999999999999999999998 999999999999999999999999976
Q ss_pred CCC--------------CCCCccccchhhccc-CCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCC-
Q 004979 582 NNT--------------TAAKTGSAAMELLET-SAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQP- 645 (721)
Q Consensus 582 ~~~--------------~~~~~~~~apE~~~~-~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~- 645 (721)
... ..++..|+|||.+.. ..++.++|||||||++|||+||+.||...... ...........+
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~ 246 (303)
T 2vwi_A 169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPM--KVLMLTLQNDPPS 246 (303)
T ss_dssp HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGG--GHHHHHHTSSCCC
T ss_pred heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchh--hHHHHHhccCCCc
Confidence 422 124557999999865 57899999999999999999999999643321 112222222111
Q ss_pred CccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 646 LKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 646 ~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
..... ........++.++.+++.+||+.||++||++.|+++
T Consensus 247 ~~~~~--~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 247 LETGV--QDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp TTC-------CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ccccc--ccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 10000 001112234567899999999999999999999986
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-37 Score=329.36 Aligned_cols=256 Identities=16% Similarity=0.187 Sum_probs=194.8
Q ss_pred hhhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCC---Cce
Q 004979 429 SNIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDE---PFT 504 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~---~~~ 504 (721)
+++.+.+|+|+||+||+|+.. ++..||||++.... .......+.+|++++++++||||+++++++.... ...
T Consensus 13 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 13 FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD----KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS----SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred eEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc----cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 367788999999999999965 68889999885322 1334567889999999999999999999987541 125
Q ss_pred EEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC
Q 004979 505 RMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT 584 (721)
Q Consensus 505 ~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~ 584 (721)
.++||||+. |+|.+++.. ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 89 ~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVIST---QMLSDDHIQYFIYQTLRAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARII 162 (353)
T ss_dssp EEEEECCCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEeccC-ccHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence 799999996 699998853 46899999999999999999999998 999999999999999999999999987532
Q ss_pred C-------------------CCCccccchhhcc-cCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHh--hc
Q 004979 585 T-------------------AAKTGSAAMELLE-TSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYL--KG 642 (721)
Q Consensus 585 ~-------------------~~~~~~~apE~~~-~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~--~~ 642 (721)
. .++..|+|||.+. ...++.++|||||||++|||++|+.||...+. ......+. .+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~~~~~~~~~~ 240 (353)
T 2b9h_A 163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDY--RHQLLLIFGIIG 240 (353)
T ss_dssp C----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHHHC
T ss_pred ccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCc--HHHHHHHHHHhC
Confidence 2 2355689999875 47789999999999999999999999964432 11111111 11
Q ss_pred CCCCcc----c---------------cCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHHhhhc
Q 004979 643 EQPLKD----I---------------VDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAK--LKEITAM 696 (721)
Q Consensus 643 ~~~~~~----~---------------~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~--L~~i~~~ 696 (721)
...... + ............+.++.+++.+||+.||++|||+.|+++. ++.+...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~ 315 (353)
T 2b9h_A 241 TPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDP 315 (353)
T ss_dssp CCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCT
T ss_pred CCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCc
Confidence 110000 0 0000111123456788999999999999999999999873 5544443
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-37 Score=339.77 Aligned_cols=189 Identities=17% Similarity=0.186 Sum_probs=159.0
Q ss_pred hhhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCC---ce
Q 004979 429 SNIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEP---FT 504 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~---~~ 504 (721)
+++++.+|+|+||+||+|+.. +++.||||++..... .....+++.+|+++|++++|||||++++++...+. ..
T Consensus 28 y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 28 YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFE---DLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTT---SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred EEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhc---ChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 467888999999999999964 578899998864321 23345689999999999999999999999976531 25
Q ss_pred EEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC
Q 004979 505 RMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT 584 (721)
Q Consensus 505 ~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~ 584 (721)
.|+||||+. |+|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 105 ~~lv~e~~~-~~L~~~~~--~~~~l~~~~~~~i~~qil~aL~~LH~~g--ivHrDlkp~NILl~~~~~~kL~DFGla~~~ 179 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFK--TPIFLTEEHIKTILYNLLLGENFIHESG--IIHRDLKPANCLLNQDCSVKVCDFGLARTI 179 (432)
T ss_dssp EEEEEECCS-EEHHHHHH--SSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEecCC-cCHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCHHHeEECCCCCEEEccCCCcccc
Confidence 799999986 69999985 3456999999999999999999999998 999999999999999999999999998632
Q ss_pred C-------------------------------CCCccccchhhc-ccCCCCCCccHHHHHHHHHHHHhCCCcc
Q 004979 585 T-------------------------------AAKTGSAAMELL-ETSAVDLESNVYSFGTILFEMITGRISY 625 (721)
Q Consensus 585 ~-------------------------------~~~~~~~apE~~-~~~~~s~ksDVwSfGvvL~ElltG~~P~ 625 (721)
. .++..|+|||.+ ....++.++||||+||++|||+||..||
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp -------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred cccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 2 235569999986 5667999999999999999999865544
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=324.14 Aligned_cols=245 Identities=21% Similarity=0.288 Sum_probs=189.4
Q ss_pred hhhhhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccc---hhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCC
Q 004979 427 DFSNIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRAD---WSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEP 502 (721)
Q Consensus 427 ~~~~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~---~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~ 502 (721)
+-+++++.+|+|+||.||+|+.. +++.||||++....... ........+.+|++++++++||||+++++++...+
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 88 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED- 88 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence 33578889999999999999965 57889999886543210 11122346889999999999999999999987654
Q ss_pred ceEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCc---EEEeccC
Q 004979 503 FTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYA---AKISDFS 579 (721)
Q Consensus 503 ~~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~---~kL~DFG 579 (721)
.++||||+++|+|.+++. ....+++.....++.||+.||+|||+++ |+||||||+|||++.++. +||+|||
T Consensus 89 --~~lv~e~~~~~~L~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~~~~kl~Dfg 162 (322)
T 2ycf_A 89 --YYIVLELMEGGELFDKVV--GNKRLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFG 162 (322)
T ss_dssp --EEEEEECCTTEETHHHHS--TTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSSSCCEEECCCT
T ss_pred --eEEEEecCCCCcHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEecCCCCCeEEEccCc
Confidence 589999999999999885 3456899999999999999999999998 999999999999987654 9999999
Q ss_pred CCCCCCC--------CCccccchhhcc---cCCCCCCccHHHHHHHHHHHHhCCCcccCCCC--CHHHHHHHHhhcCCCC
Q 004979 580 FWNNTTA--------AKTGSAAMELLE---TSAVDLESNVYSFGTILFEMITGRISYSIENG--SLENWASEYLKGEQPL 646 (721)
Q Consensus 580 la~~~~~--------~~~~~~apE~~~---~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~--~~~~~~~~~~~~~~~~ 646 (721)
+++.... ++..|+|||.+. ...++.++|||||||++|||+||+.||..... .....+ ..+....
T Consensus 163 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~---~~~~~~~ 239 (322)
T 2ycf_A 163 HSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQI---TSGKYNF 239 (322)
T ss_dssp TCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHH---HHTCCCC
T ss_pred cceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHH---HhCcccc
Confidence 9865432 456799999873 56789999999999999999999999974332 222211 1111110
Q ss_pred ccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 647 KDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 647 ~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
........+.++.+++.+||+.||++||++.|+++
T Consensus 240 -------~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 240 -------IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp -------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -------CchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 01111234578899999999999999999999984
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=321.85 Aligned_cols=252 Identities=18% Similarity=0.234 Sum_probs=192.6
Q ss_pred hhhhCcCCCCceeEEEEEEe--cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcC---CCCccceEeEEEec---C
Q 004979 429 SNIIGSFSDGTVGTVYKGTL--SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKV---NHKNFVNLIGYCEE---D 500 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~--~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l---~H~nIv~l~g~~~~---~ 500 (721)
+++++.+|+|+||+||+|+. .+++.||+|++........ ....+.+|+++++++ +||||+++++++.. .
T Consensus 13 y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~ 89 (326)
T 1blx_A 13 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG---MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 89 (326)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTS---CBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred eeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCccccc---CCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccC
Confidence 47788999999999999997 4678899998875432211 112455677666655 89999999999872 1
Q ss_pred CCceEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCC
Q 004979 501 EPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSF 580 (721)
Q Consensus 501 ~~~~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGl 580 (721)
.....++||||+. |+|.+++.......+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 90 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g--i~H~dlkp~Nili~~~~~~kl~Dfg~ 166 (326)
T 1blx_A 90 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGL 166 (326)
T ss_dssp SEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred CCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHHHeEEcCCCCEEEecCcc
Confidence 2236799999997 69999997655566999999999999999999999998 99999999999999999999999999
Q ss_pred CCCCC--------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhc--CCCCccc-
Q 004979 581 WNNTT--------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKG--EQPLKDI- 649 (721)
Q Consensus 581 a~~~~--------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~--~~~~~~~- 649 (721)
++... .++..|+|||.+.+..++.++|||||||++|||+||+.||.... ..+....+... ......+
T Consensus 167 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~ 244 (326)
T 1blx_A 167 ARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS--DVDQLGKILDVIGLPGEEDWP 244 (326)
T ss_dssp CCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHHHCCCCGGGSC
T ss_pred cccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCC--HHHHHHHHHHHcCCCCcccCc
Confidence 86432 24567899999999999999999999999999999999996432 22222222211 0000000
Q ss_pred -------------cCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 650 -------------VDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 650 -------------~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
.......+....+.++.+++.+||+.||++||++.|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 245 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp TTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 001111223345678899999999999999999999985
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=342.21 Aligned_cols=244 Identities=18% Similarity=0.229 Sum_probs=193.7
Q ss_pred hhhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccch--------hhHHHHHHHHHHHHHhcCCCCccceEeEEEec
Q 004979 429 SNIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADW--------SKNLESQFRKKIDTLSKVNHKNFVNLIGYCEE 499 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~--------~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~ 499 (721)
|.+++.||+|+||+||+|+.. ++..+|+|++........ .....+.+.+|++++++++|||||++++++.+
T Consensus 38 Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 117 (504)
T 3q5i_A 38 YFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFED 117 (504)
T ss_dssp EEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred eEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 477889999999999999965 578899999875432110 01234678999999999999999999999988
Q ss_pred CCCceEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCC---cEEEe
Q 004979 500 DEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDY---AAKIS 576 (721)
Q Consensus 500 ~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~---~~kL~ 576 (721)
.+ ..++||||+++|+|.+++... ..+++..+..|+.||+.||+|||+.+ |+||||||+|||++.++ .+||+
T Consensus 118 ~~--~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~ 191 (504)
T 3q5i_A 118 KK--YFYLVTEFYEGGELFEQIINR--HKFDECDAANIMKQILSGICYLHKHN--IVHRDIKPENILLENKNSLLNIKIV 191 (504)
T ss_dssp SS--EEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESSTTCCSSEEEC
T ss_pred CC--EEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCcHHHEEEecCCCCccEEEE
Confidence 76 679999999999999998643 56999999999999999999999998 99999999999999775 69999
Q ss_pred ccCCCCCC--------CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCcc
Q 004979 577 DFSFWNNT--------TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKD 648 (721)
Q Consensus 577 DFGla~~~--------~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 648 (721)
|||+++.. ..++..|+|||.+. ..++.++||||+||++|||++|+.||... +..+....+..+......
T Consensus 192 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~--~~~~~~~~i~~~~~~~~~ 268 (504)
T 3q5i_A 192 DFGLSSFFSKDYKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQ--NDQDIIKKVEKGKYYFDF 268 (504)
T ss_dssp CCTTCEECCTTSCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHCCCCCCH
T ss_pred ECCCCEEcCCCCccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHcCCCCCCc
Confidence 99988532 23566899999986 46899999999999999999999999643 344455554444221110
Q ss_pred ccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 649 IVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 649 ~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
.....++.++.+|+.+||+.||++|||+.|+++
T Consensus 269 -------~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 269 -------NDWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp -------HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -------cccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 011234577999999999999999999999986
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-37 Score=335.01 Aligned_cols=251 Identities=17% Similarity=0.201 Sum_probs=192.6
Q ss_pred hhhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCC--------CCccceEeEEEec
Q 004979 429 SNIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVN--------HKNFVNLIGYCEE 499 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~--------H~nIv~l~g~~~~ 499 (721)
+++++.+|+|+||+||+|+. .+++.||||++... ....+.+.+|++++++++ |+||+++++++..
T Consensus 39 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~ 112 (397)
T 1wak_A 39 YHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA------EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKI 112 (397)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC------HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEE
T ss_pred EEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC------CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceee
Confidence 47788999999999999985 46788999988532 223467889999999985 8889999999873
Q ss_pred C--CCceEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCeEeeCCCCCCeEeCCCC-----
Q 004979 500 D--EPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQL-TPPIAHRNLQSSSIYLTEDY----- 571 (721)
Q Consensus 500 ~--~~~~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~-~~~IvHrDLKp~NILl~~~~----- 571 (721)
. +....++||||+ +|+|.+++.......+++..+..|+.||+.||+|||+. + |+||||||+|||++.++
T Consensus 113 ~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g--ivHrDikp~NIll~~~~~~~~~ 189 (397)
T 1wak_A 113 SGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR--IIHTDIKPENILLSVNEQYIRR 189 (397)
T ss_dssp EETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECCCCSGGGEEECCCHHHHHH
T ss_pred cCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHeeEeccchhhhh
Confidence 2 223679999999 66777777655556799999999999999999999997 7 99999999999999775
Q ss_pred --------------------------------------------cEEEeccCCCCCC------CCCCccccchhhcccCC
Q 004979 572 --------------------------------------------AAKISDFSFWNNT------TAAKTGSAAMELLETSA 601 (721)
Q Consensus 572 --------------------------------------------~~kL~DFGla~~~------~~~~~~~~apE~~~~~~ 601 (721)
.+||+|||+++.. ..++..|+|||.+.+..
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~gt~~y~aPE~~~~~~ 269 (397)
T 1wak_A 190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSG 269 (397)
T ss_dssp HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCSCSCCSCGGGCCHHHHHTSC
T ss_pred hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccCccCCCCCcccCChhhcCCC
Confidence 8999999987532 23466899999999999
Q ss_pred CCCCccHHHHHHHHHHHHhCCCcccCCCCC----HHHHHHHHhh--cCCC-------------------CccccCCc---
Q 004979 602 VDLESNVYSFGTILFEMITGRISYSIENGS----LENWASEYLK--GEQP-------------------LKDIVDPT--- 653 (721)
Q Consensus 602 ~s~ksDVwSfGvvL~ElltG~~P~~~~~~~----~~~~~~~~~~--~~~~-------------------~~~~~d~~--- 653 (721)
++.++|||||||++|||+||+.||...... .......... +..+ ...+.+..
T Consensus 270 ~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (397)
T 1wak_A 270 YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWG 349 (397)
T ss_dssp CCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCC
T ss_pred CCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcc
Confidence 999999999999999999999999743321 1111111110 1000 00000000
Q ss_pred -------cccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 654 -------LKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 654 -------l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
..........++.+|+.+||+.||++|||+.|+++
T Consensus 350 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 350 LFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp HHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred hhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 01234567788999999999999999999999985
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-37 Score=338.12 Aligned_cols=189 Identities=20% Similarity=0.274 Sum_probs=162.5
Q ss_pred hhhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcC------CCCccceEeEEEecCC
Q 004979 429 SNIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKV------NHKNFVNLIGYCEEDE 501 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l------~H~nIv~l~g~~~~~~ 501 (721)
+++++.||+|+||+||+|+.. ++..||||++... ....+.+.+|++++..+ +|+||+++++++...+
T Consensus 99 y~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~------~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 172 (429)
T 3kvw_A 99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE------KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRN 172 (429)
T ss_dssp EEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC------HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETT
T ss_pred EEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc------cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCC
Confidence 477889999999999999865 5788999988642 22335677788877766 6779999999998877
Q ss_pred CceEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCc--EEEeccC
Q 004979 502 PFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYA--AKISDFS 579 (721)
Q Consensus 502 ~~~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~--~kL~DFG 579 (721)
..++||||+. |+|.+++.......+++..+..|+.||+.||+|||+.+ |+||||||+|||++.++. +||+|||
T Consensus 173 --~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NILl~~~~~~~vkL~DFG 247 (429)
T 3kvw_A 173 --HICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR--IIHCDLKPENILLKQQGRSGIKVIDFG 247 (429)
T ss_dssp --EEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHT--EECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred --eEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEccCCCcceEEeecc
Confidence 7799999995 69999987665567999999999999999999999988 999999999999999887 9999999
Q ss_pred CCCCC------CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCC
Q 004979 580 FWNNT------TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIE 628 (721)
Q Consensus 580 la~~~------~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~ 628 (721)
+++.. ..++..|+|||.+.+..++.++|||||||++|||+||+.||...
T Consensus 248 ~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~ 302 (429)
T 3kvw_A 248 SSCYEHQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE 302 (429)
T ss_dssp TCEETTCCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cceecCCcccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence 97532 23456799999999999999999999999999999999999644
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=323.75 Aligned_cols=241 Identities=20% Similarity=0.306 Sum_probs=191.3
Q ss_pred hhhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcC-CCCccceEeEEEecCC----C
Q 004979 429 SNIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKV-NHKNFVNLIGYCEEDE----P 502 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~----~ 502 (721)
+++++.+|+|+||.||+|+. .+++.||+|++..... ..+.+.+|++++.++ +||||+++++++.... .
T Consensus 26 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 99 (326)
T 2x7f_A 26 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD------EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 99 (326)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS------TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCC
T ss_pred EEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc------cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcccc
Confidence 36788899999999999996 4788999998864322 125788999999999 8999999999997632 2
Q ss_pred ceEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCC
Q 004979 503 FTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWN 582 (721)
Q Consensus 503 ~~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~ 582 (721)
...++||||+++|+|.+++.......+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~kl~Dfg~~~ 177 (326)
T 2x7f_A 100 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLTENAEVKLVDFGVSA 177 (326)
T ss_dssp CEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTTCCEEECCCTTTC
T ss_pred ceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCcHHHEEEcCCCCEEEeeCcCce
Confidence 26799999999999999997655567999999999999999999999998 9999999999999999999999999876
Q ss_pred CCC---------CCCccccchhhcc-----cCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCcc
Q 004979 583 NTT---------AAKTGSAAMELLE-----TSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKD 648 (721)
Q Consensus 583 ~~~---------~~~~~~~apE~~~-----~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 648 (721)
... .++..|+|||.+. ...++.++|||||||++|||+||+.||.... ............. ..
T Consensus 178 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~~~~--~~ 253 (326)
T 2x7f_A 178 QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH--PMRALFLIPRNPA--PR 253 (326)
T ss_dssp -------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSC--HHHHHHHHHHSCC--CC
T ss_pred ecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCc--HHHHHHHhhcCcc--cc
Confidence 432 2456799999986 5678999999999999999999999996332 2222222222211 11
Q ss_pred ccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 649 IVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 649 ~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
.. ...++.++.+++.+||+.||++||++.|+++
T Consensus 254 ~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 254 LK-------SKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp CS-------CSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CC-------ccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 11 1223467889999999999999999999986
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=328.11 Aligned_cols=248 Identities=17% Similarity=0.317 Sum_probs=191.6
Q ss_pred hhhCcCCCCceeEEEEEEecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVF 509 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV~ 509 (721)
++.+.+|+|+||.||+|+... .+++|++....... ...+.+.+|++++++++||||+++++++.+.+ ..++||
T Consensus 36 ~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~iv~ 108 (319)
T 2y4i_B 36 EIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNE---DQLKAFKREVMAYRQTRHENVVLFMGACMSPP--HLAIIT 108 (319)
T ss_dssp ECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCC---CCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS--CEEEEC
T ss_pred EEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCH---HHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC--ceEEEe
Confidence 677899999999999999764 48888876543211 11245788999999999999999999999876 679999
Q ss_pred ecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC-----
Q 004979 510 EYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT----- 584 (721)
Q Consensus 510 Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~----- 584 (721)
||+++|+|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++ ++.+||+|||+++..
T Consensus 109 e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~ 184 (319)
T 2y4i_B 109 SLCKGRTLYSVVRD-AKIVLDVNKTRQIAQEIVKGMGYLHAKG--ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQA 184 (319)
T ss_dssp BCCCSEEHHHHTTS-SCCCCCSHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSTTEEEC---CCEECCCSCCC-------
T ss_pred ecccCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChhhEEEe-CCCEEEeecCCccccccccc
Confidence 99999999999863 3346899999999999999999999998 99999999999998 679999999986532
Q ss_pred ---------CCCCccccchhhccc---------CCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCC
Q 004979 585 ---------TAAKTGSAAMELLET---------SAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPL 646 (721)
Q Consensus 585 ---------~~~~~~~~apE~~~~---------~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~ 646 (721)
..++..|+|||.+.. ..++.++|||||||++|||+||+.||... ...........+..+
T Consensus 185 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~--~~~~~~~~~~~~~~~- 261 (319)
T 2y4i_B 185 GRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQ--PAEAIIWQMGTGMKP- 261 (319)
T ss_dssp ---CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSC--CHHHHHHHHHTTCCC-
T ss_pred cccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHhccCCCC-
Confidence 123456899999864 45789999999999999999999999643 333333333332211
Q ss_pred ccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCCC
Q 004979 647 KDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAMEPD 699 (721)
Q Consensus 647 ~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~ 699 (721)
.... ..++.++.+++.+||+.||++||++.|+++.|+++.+....
T Consensus 262 -~~~~-------~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~ 306 (319)
T 2y4i_B 262 -NLSQ-------IGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRR 306 (319)
T ss_dssp -CCCC-------SSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC------
T ss_pred -CCCc-------CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 1111 12345688999999999999999999999999998876543
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=325.29 Aligned_cols=248 Identities=19% Similarity=0.273 Sum_probs=193.4
Q ss_pred hhhhCcCCCCceeEEEEEEe--cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCc------cceEeEEEecC
Q 004979 429 SNIIGSFSDGTVGTVYKGTL--SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKN------FVNLIGYCEED 500 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~--~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~n------Iv~l~g~~~~~ 500 (721)
+++++.+|+|+||+||+|+. .++..||||++... ....+.+.+|++++.+++|+| |+++++++...
T Consensus 16 y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~------~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~ 89 (339)
T 1z57_A 16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV------DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHH 89 (339)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS------HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEET
T ss_pred eEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC------CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccC
Confidence 47788999999999999986 36788999987532 223467888999998887665 99999999887
Q ss_pred CCceEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCC-----------
Q 004979 501 EPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTE----------- 569 (721)
Q Consensus 501 ~~~~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~----------- 569 (721)
+ ..++||||+ +++|.+++.......+++..+..++.|++.||+|||+++ |+||||||+|||++.
T Consensus 90 ~--~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~~~~~ 164 (339)
T 1z57_A 90 G--HICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK--LTHTDLKPENILFVQSDYTEAYNPKI 164 (339)
T ss_dssp T--EEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESCCCEEEEEC---
T ss_pred C--cEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHEEEeccccccccCCcc
Confidence 7 779999999 899999997655567899999999999999999999998 999999999999987
Q ss_pred --------CCcEEEeccCCCCCC------CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCH-HH
Q 004979 570 --------DYAAKISDFSFWNNT------TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSL-EN 634 (721)
Q Consensus 570 --------~~~~kL~DFGla~~~------~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~-~~ 634 (721)
++.+||+|||+++.. ..++..|+|||.+.+..++.++|||||||++|||+||+.||...+... ..
T Consensus 165 ~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 244 (339)
T 1z57_A 165 KRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLA 244 (339)
T ss_dssp -CEEEEESCCCEEECCCSSCEETTSCCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHH
T ss_pred ccccccccCCCceEeeCcccccCccccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 678999999987633 234567999999999999999999999999999999999997443211 11
Q ss_pred HHHHHhhcCCCCc--------cc---------------------cCC--ccccccHHHHHHHHHHHHHcccCCCCCCCCH
Q 004979 635 WASEYLKGEQPLK--------DI---------------------VDP--TLKSFQENVLEELLVVIKNCVHPDPKQRPSM 683 (721)
Q Consensus 635 ~~~~~~~~~~~~~--------~~---------------------~d~--~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~ 683 (721)
.+.... +..+.. .. ..+ ..........+++.+|+.+||+.||++|||+
T Consensus 245 ~~~~~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~ 323 (339)
T 1z57_A 245 MMERIL-GPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITL 323 (339)
T ss_dssp HHHHHH-CSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCH
T ss_pred HHHHHh-CCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCH
Confidence 111111 100000 00 000 0001123457789999999999999999999
Q ss_pred HHHHH
Q 004979 684 RGIAA 688 (721)
Q Consensus 684 ~evl~ 688 (721)
.|+++
T Consensus 324 ~ell~ 328 (339)
T 1z57_A 324 REALK 328 (339)
T ss_dssp HHHTT
T ss_pred HHHhc
Confidence 99975
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=332.75 Aligned_cols=252 Identities=18% Similarity=0.264 Sum_probs=189.3
Q ss_pred hhhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCC------
Q 004979 429 SNIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDE------ 501 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~------ 501 (721)
+++++.+|+|+||+||+|+. .++..||+|++..... ...+|+++|++++|||||++++++....
T Consensus 9 y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~---------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 79 (383)
T 3eb0_A 9 YSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR---------YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP 79 (383)
T ss_dssp EEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT---------SCCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred EEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc---------hHHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence 47788999999999999985 5789999998864321 2347999999999999999999985432
Q ss_pred ------------------------------CceEEEEEecCCCCChhhhhhh--ccCCCCCHHHHHHHHHHHHHHHHHHh
Q 004979 502 ------------------------------PFTRMMVFEYSPNGSLFEHLHI--QEAEHLDWAMRLRIAMGMAYCLEHMH 549 (721)
Q Consensus 502 ------------------------------~~~~~lV~Ey~~~GsL~~~l~~--~~~~~l~~~~~~~ia~~ia~gL~yLH 549 (721)
....++||||++ |+|.+.+.. .....+++..+..++.||+.||+|||
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 158 (383)
T 3eb0_A 80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH 158 (383)
T ss_dssp ------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 113789999998 588877753 24567999999999999999999999
Q ss_pred cCCCCeEeeCCCCCCeEeC-CCCcEEEeccCCCCCC--------CCCCccccchhhcccC-CCCCCccHHHHHHHHHHHH
Q 004979 550 QLTPPIAHRNLQSSSIYLT-EDYAAKISDFSFWNNT--------TAAKTGSAAMELLETS-AVDLESNVYSFGTILFEMI 619 (721)
Q Consensus 550 ~~~~~IvHrDLKp~NILl~-~~~~~kL~DFGla~~~--------~~~~~~~~apE~~~~~-~~s~ksDVwSfGvvL~Ell 619 (721)
+++ |+||||||+|||++ +++.+||+|||+++.. ..++..|+|||.+.+. .++.++||||+||++|||+
T Consensus 159 ~~g--i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell 236 (383)
T 3eb0_A 159 SLG--ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELI 236 (383)
T ss_dssp TTT--EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHH
T ss_pred HCc--CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHH
Confidence 998 99999999999998 6899999999998632 2234568999998764 5899999999999999999
Q ss_pred hCCCcccCCCCCHHHHHHHHhh--cCC----------CCccccCCcc------ccccHHHHHHHHHHHHHcccCCCCCCC
Q 004979 620 TGRISYSIENGSLENWASEYLK--GEQ----------PLKDIVDPTL------KSFQENVLEELLVVIKNCVHPDPKQRP 681 (721)
Q Consensus 620 tG~~P~~~~~~~~~~~~~~~~~--~~~----------~~~~~~d~~l------~~~~~~~~~~l~~li~~Cl~~dP~~RP 681 (721)
+|+.||.... ..+....+.. +.. ...+..-+.. ..++...+.++.+|+.+||+.||++||
T Consensus 237 ~g~~pf~~~~--~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ 314 (383)
T 3eb0_A 237 LGKPLFSGET--SIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRI 314 (383)
T ss_dssp HSSCSSCCSS--HHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSC
T ss_pred hCCCCCCCCC--hHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCC
Confidence 9999997432 2222222211 000 0000000110 012334567899999999999999999
Q ss_pred CHHHHHHH--HHHhh
Q 004979 682 SMRGIAAK--LKEIT 694 (721)
Q Consensus 682 s~~evl~~--L~~i~ 694 (721)
|+.|+++. ++++.
T Consensus 315 t~~e~l~hp~f~~~~ 329 (383)
T 3eb0_A 315 NPYEAMAHPFFDHLR 329 (383)
T ss_dssp CHHHHHTSGGGHHHH
T ss_pred CHHHHhcCHHHHHHH
Confidence 99999853 44443
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=335.33 Aligned_cols=252 Identities=18% Similarity=0.261 Sum_probs=188.2
Q ss_pred hhhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecC----CCc
Q 004979 429 SNIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEED----EPF 503 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~----~~~ 503 (721)
+++++.||+|+||+||+|+.. +++.||||++.... ..+.+|+++|++++|||||++++++... +..
T Consensus 56 y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~---------~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~ 126 (420)
T 1j1b_A 56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK---------RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 126 (420)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT---------TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEE
T ss_pred EEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc---------hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcce
Confidence 356778999999999999975 68999999885432 1234799999999999999999988542 222
Q ss_pred eEEEEEecCCCCChhhhhhh--ccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCC-CcEEEeccCC
Q 004979 504 TRMMVFEYSPNGSLFEHLHI--QEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTED-YAAKISDFSF 580 (721)
Q Consensus 504 ~~~lV~Ey~~~GsL~~~l~~--~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~-~~~kL~DFGl 580 (721)
..++||||+++ +|.+.+.. .....+++..+..++.||+.||+|||+.+ |+||||||+|||++.+ +.+||+|||+
T Consensus 127 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NILl~~~~~~~kl~DFG~ 203 (420)
T 1j1b_A 127 YLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGS 203 (420)
T ss_dssp EEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred eEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChhhEEEeCCCCeEEeccchh
Confidence 46799999975 66666542 23467999999999999999999999988 9999999999999955 6789999999
Q ss_pred CCCC--------CCCCccccchhhcccC-CCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhc---------
Q 004979 581 WNNT--------TAAKTGSAAMELLETS-AVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKG--------- 642 (721)
Q Consensus 581 a~~~--------~~~~~~~~apE~~~~~-~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~--------- 642 (721)
++.. ..++..|+|||.+.+. .++.++|||||||++|||++|+.||.... ..+.+..++..
T Consensus 204 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~--~~~~l~~i~~~lg~p~~~~~ 281 (420)
T 1j1b_A 204 AKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS--GVDQLVEIIKVLGTPTREQI 281 (420)
T ss_dssp CEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHHHCSCCHHHH
T ss_pred hhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHHhCCCCHHHH
Confidence 8632 2245679999998654 79999999999999999999999997443 22222222110
Q ss_pred ---CCCCccccCCccc------cccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHHhh
Q 004979 643 ---EQPLKDIVDPTLK------SFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAK--LKEIT 694 (721)
Q Consensus 643 ---~~~~~~~~d~~l~------~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~--L~~i~ 694 (721)
...+.+..-+.+. .+....+.++.+|+.+||+.||++||++.|+++. ++++.
T Consensus 282 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 344 (420)
T 1j1b_A 282 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 344 (420)
T ss_dssp HHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred HhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccc
Confidence 0001111111111 1123345789999999999999999999999863 44443
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=330.24 Aligned_cols=250 Identities=18% Similarity=0.203 Sum_probs=180.2
Q ss_pred hhhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCC----Cc
Q 004979 429 SNIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDE----PF 503 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~----~~ 503 (721)
+++++.+|+|+||.||+|+. .++..||||++..... .....+.+.+|++++++++||||+++++++.... ..
T Consensus 31 y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 31 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ---SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp EEEEEECC----CCEEEEEETTTTEEEEEEECSSTTS---SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred eEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCcccc---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 46788999999999999985 5688999998864321 1234567899999999999999999999987542 12
Q ss_pred eEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCC
Q 004979 504 TRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNN 583 (721)
Q Consensus 504 ~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~ 583 (721)
..++|+||+ +++|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~~~~kL~DFG~a~~ 181 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH 181 (367)
T ss_dssp CCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECC------
T ss_pred eEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHhhEEECCCCCEEEeecccccc
Confidence 469999999 7899988853 56999999999999999999999998 99999999999999999999999999864
Q ss_pred CC------CCCccccchhhccc-CCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcC-CCCcccc-----
Q 004979 584 TT------AAKTGSAAMELLET-SAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGE-QPLKDIV----- 650 (721)
Q Consensus 584 ~~------~~~~~~~apE~~~~-~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~-~~~~~~~----- 650 (721)
.. .++..|+|||.+.+ ..++.++|||||||++|||+||+.||...+ ....+..+.... .+..+..
T Consensus 182 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~--~~~~l~~i~~~~g~p~~~~~~~~~~ 259 (367)
T 2fst_X 182 TADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD--HIDQLKLILRLVGTPGAELLKKISS 259 (367)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHHHCSCCHHHHTTCCC
T ss_pred ccccCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHHhCCCCHHHHHHhhh
Confidence 32 34567899999876 688999999999999999999999996433 222222221110 0100000
Q ss_pred --------------CCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004979 651 --------------DPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAK 689 (721)
Q Consensus 651 --------------d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 689 (721)
.............++.+|+.+||+.||++|||+.|+++.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 260 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 000111112335678999999999999999999999864
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-36 Score=319.79 Aligned_cols=247 Identities=16% Similarity=0.228 Sum_probs=185.4
Q ss_pred hhhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecC-------
Q 004979 429 SNIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEED------- 500 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~------- 500 (721)
+++++.+|+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++...
T Consensus 13 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 87 (320)
T 2i6l_A 13 YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD-----PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDD 87 (320)
T ss_dssp EEEEEECC-----CEEEEEETTTTEEEEEEEEECCS-----HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC-
T ss_pred eeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC-----hHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccc
Confidence 467788999999999999976 48899999886432 23456789999999999999999999988532
Q ss_pred -----CCceEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeC-CCCcEE
Q 004979 501 -----EPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLT-EDYAAK 574 (721)
Q Consensus 501 -----~~~~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~-~~~~~k 574 (721)
+....++||||++ |+|.+++. ...+++..+..++.|++.||+|||+++ |+||||||+|||++ +++.+|
T Consensus 88 ~~~~~~~~~~~lv~e~~~-~~L~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~k 161 (320)
T 2i6l_A 88 VGSLTELNSVYIVQEYME-TDLANVLE---QGPLLEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANLFINTEDLVLK 161 (320)
T ss_dssp ---CCSCSEEEEEEECCS-EEHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTTTEEE
T ss_pred cccccccCceeEEeeccC-CCHHHHhh---cCCccHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCeEE
Confidence 1126799999997 69999985 346899999999999999999999998 99999999999997 677999
Q ss_pred EeccCCCCCCCC------------CCccccchhhccc-CCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhh
Q 004979 575 ISDFSFWNNTTA------------AKTGSAAMELLET-SAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLK 641 (721)
Q Consensus 575 L~DFGla~~~~~------------~~~~~~apE~~~~-~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~ 641 (721)
|+|||+++.... ++..|+|||.+.. ..++.++|||||||++|||+||+.||.... ..+....+..
T Consensus 162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~--~~~~~~~~~~ 239 (320)
T 2i6l_A 162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAH--ELEQMQLILE 239 (320)
T ss_dssp ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHH
T ss_pred EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCC--HHHHHHHHHH
Confidence 999999864321 2446899998755 778999999999999999999999996432 2222222222
Q ss_pred cCCCCcc-----------------ccCC--ccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 642 GEQPLKD-----------------IVDP--TLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 642 ~~~~~~~-----------------~~d~--~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
....... ...+ ........++.++.+++.+||+.||++||++.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 240 SIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp HSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred hcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 1111000 0000 001112335678999999999999999999999986
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=352.54 Aligned_cols=245 Identities=20% Similarity=0.331 Sum_probs=199.8
Q ss_pred hhhCcCCCCceeEEEEEEecC----CcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceE
Q 004979 430 NIIGSFSDGTVGTVYKGTLSS----GVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTR 505 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~~----~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~ 505 (721)
++.+.+|+|+||+||+|++.. +..||+|+..... .....+.|.+|+.++++++|||||++++++.+. ..
T Consensus 393 ~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~---~~ 465 (656)
T 2j0j_A 393 ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT----SDSVREKFLQEALTMRQFDHPHIVKLIGVITEN---PV 465 (656)
T ss_dssp EEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT----CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS---SC
T ss_pred EEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC----CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC---ce
Confidence 667789999999999998743 4568888765322 233457899999999999999999999998543 45
Q ss_pred EEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC
Q 004979 506 MMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT 585 (721)
Q Consensus 506 ~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~ 585 (721)
++||||+++|+|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 466 ~lv~E~~~~g~L~~~l~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDikp~NILl~~~~~vkL~DFG~a~~~~ 542 (656)
T 2j0j_A 466 WIIMELCTLGELRSFLQV-RKFSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRYME 542 (656)
T ss_dssp EEEEECCTTCBHHHHHHH-TTTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCCCCCCSCC
T ss_pred EEEEEcCCCCcHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchHhEEEeCCCCEEEEecCCCeecC
Confidence 899999999999999964 3346899999999999999999999998 9999999999999999999999999987542
Q ss_pred C----------CCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhcCCCCccccCCcc
Q 004979 586 A----------AKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPLKDIVDPTL 654 (721)
Q Consensus 586 ~----------~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 654 (721)
. ++..|+|||.+....++.++|||||||++|||++ |+.||... ...+....+..+...
T Consensus 543 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~--~~~~~~~~i~~~~~~--------- 611 (656)
T 2j0j_A 543 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV--KNNDVIGRIENGERL--------- 611 (656)
T ss_dssp C----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC--CHHHHHHHHHHTCCC---------
T ss_pred CCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCC--CHHHHHHHHHcCCCC---------
Confidence 2 2246999999998999999999999999999997 99999643 333333333333211
Q ss_pred ccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 004979 655 KSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAM 696 (721)
Q Consensus 655 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~ 696 (721)
..+..++.++.+++.+||+.||++||++.||++.|+++.+.
T Consensus 612 -~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 612 -PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp -CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -CCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 12234557889999999999999999999999999988653
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=312.16 Aligned_cols=239 Identities=23% Similarity=0.328 Sum_probs=187.7
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCC-------
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDE------- 501 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~------- 501 (721)
++++.+|+|+||+||+|+.. +++.||+|++... ....+.+.+|++++++++||||+++++++.+..
T Consensus 9 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 9 EEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT------EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE------HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred hhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc------HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 67788999999999999964 7889999988532 233467999999999999999999999886531
Q ss_pred ----CceEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEec
Q 004979 502 ----PFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISD 577 (721)
Q Consensus 502 ----~~~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~D 577 (721)
....++||||+++|+|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dlkp~Nil~~~~~~~kl~d 159 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHS-ENLNQQRDEYWRLFRQILEALSYIHSQG--IIHRDLKPMNIFIDESRNVKIGD 159 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHH-SCGGGCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECC
T ss_pred ccccCCceEEEEecCCCCCHHHhhhc-cccccchHHHHHHHHHHHHHHHHHHhCC--eecccCCHHhEEEcCCCCEEEee
Confidence 2357999999999999999964 3345788899999999999999999998 99999999999999999999999
Q ss_pred cCCCCCCC-----------------------CCCccccchhhcccC-CCCCCccHHHHHHHHHHHHhCCCcccCCCCCHH
Q 004979 578 FSFWNNTT-----------------------AAKTGSAAMELLETS-AVDLESNVYSFGTILFEMITGRISYSIENGSLE 633 (721)
Q Consensus 578 FGla~~~~-----------------------~~~~~~~apE~~~~~-~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~ 633 (721)
||+++... .++..|+|||.+.+. .++.++|||||||++|||++ ||... .+..
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~-~~~~ 235 (303)
T 1zy4_A 160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG-MERV 235 (303)
T ss_dssp CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH-HHHH
T ss_pred CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc-hhHH
Confidence 99876432 134568999998754 78999999999999999998 44311 1112
Q ss_pred HHHHHHhhcCCCCccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 634 NWASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 634 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
.............. ..+....+..+.+++.+||+.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~-------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 236 NILKKLRSVSIEFP-------PDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp HHHHHHHSTTCCCC-------TTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHhccccccccC-------ccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 22222222111111 1123345567889999999999999999999986
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-36 Score=326.11 Aligned_cols=250 Identities=18% Similarity=0.225 Sum_probs=191.1
Q ss_pred hhhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCC---Cce
Q 004979 429 SNIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDE---PFT 504 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~---~~~ 504 (721)
+++++.+|+|+||+||+|+.. ++..||+|++.... .....+.+.+|++++.+++||||+++++++.... ...
T Consensus 29 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 29 YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE----HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT----CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred EEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc----CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 467889999999999999865 67889999886422 1334467899999999999999999999997543 125
Q ss_pred EEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC
Q 004979 505 RMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT 584 (721)
Q Consensus 505 ~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~ 584 (721)
.++||||+. |+|.+++.. ..+++..+..|+.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 105 ~~iv~e~~~-~~L~~~l~~---~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~ 178 (364)
T 3qyz_A 105 VYIVQDLME-TDLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVA 178 (364)
T ss_dssp EEEEEECCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEcccC-cCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChHhEEECCCCCEEEEeCcceEec
Confidence 799999997 599998853 45899999999999999999999998 999999999999999999999999987532
Q ss_pred C------------CCCccccchhhcc-cCCCCCCccHHHHHHHHHHHHhCCCcccCCCCC-HHHHHHHHhhcCCCCcc--
Q 004979 585 T------------AAKTGSAAMELLE-TSAVDLESNVYSFGTILFEMITGRISYSIENGS-LENWASEYLKGEQPLKD-- 648 (721)
Q Consensus 585 ~------------~~~~~~~apE~~~-~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~-~~~~~~~~~~~~~~~~~-- 648 (721)
. .++..|+|||.+. ...++.++|||||||++|||+||+.||...... ....+.... +......
T Consensus 179 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~ 257 (364)
T 3qyz_A 179 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL-GSPSQEDLN 257 (364)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHH-CSCCHHHHH
T ss_pred CCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHh-CCCCHHHHH
Confidence 2 3456789999865 455899999999999999999999999644321 111111111 1000000
Q ss_pred -------------ccCC---ccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004979 649 -------------IVDP---TLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAK 689 (721)
Q Consensus 649 -------------~~d~---~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 689 (721)
.... .........+.++.+|+.+||+.||++|||+.|+++.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 258 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000 0011123345678999999999999999999999873
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-36 Score=326.32 Aligned_cols=249 Identities=16% Similarity=0.225 Sum_probs=191.8
Q ss_pred hhhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCc----
Q 004979 429 SNIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPF---- 503 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~---- 503 (721)
+.+.+.+|+|+||+||+|+.. ++..||||++..... .....+.+.+|+.++++++||||+++++++...+..
T Consensus 44 y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 44 YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ---SEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTS---SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred EEEEeEEecCCCeEEEEEEECCCCCEEEEEEeccccc---chhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 356778999999999999864 688999998864322 233457889999999999999999999999865521
Q ss_pred eEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCC
Q 004979 504 TRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNN 583 (721)
Q Consensus 504 ~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~ 583 (721)
..++||||+. |+|.+++. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 121 ~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 193 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG----MEFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVNEDCELKILDFGLARH 193 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECSTTCC--
T ss_pred eEEEEEcccc-ccHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCcCHHHeEECCCCCEEEEecCcccc
Confidence 2389999997 68888763 34899999999999999999999998 99999999999999999999999999864
Q ss_pred CC------CCCccccchhhccc-CCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCC-CCcccc-----
Q 004979 584 TT------AAKTGSAAMELLET-SAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQ-PLKDIV----- 650 (721)
Q Consensus 584 ~~------~~~~~~~apE~~~~-~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~-~~~~~~----- 650 (721)
.. .++..|+|||.+.+ ..++.++|||||||++|||+||+.||...+ ..+....+..... +..+..
T Consensus 194 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~ 271 (371)
T 4exu_A 194 ADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD--YLDQLTQILKVTGVPGTEFVQKLND 271 (371)
T ss_dssp ------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHHHCCCCHHHHTTCSC
T ss_pred cccCcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHHHhCCCcHHHHHHhhh
Confidence 32 34567999999876 789999999999999999999999996432 2222222221100 000000
Q ss_pred --------------CCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004979 651 --------------DPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAK 689 (721)
Q Consensus 651 --------------d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 689 (721)
...........+.++.+|+.+||+.||++|||+.|+++.
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 272 KAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 001111223346789999999999999999999999874
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=308.39 Aligned_cols=243 Identities=21% Similarity=0.271 Sum_probs=194.9
Q ss_pred hhhhhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceE
Q 004979 427 DFSNIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTR 505 (721)
Q Consensus 427 ~~~~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~ 505 (721)
+-+++++.+|+|+||+||+|+.. +++.|++|++...... ....+.+.+|++++++++||||+++++++.+.+ ..
T Consensus 22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~ 96 (287)
T 2wei_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK---NKDTSTILREVELLKKLDHPNIMKLFEILEDSS--SF 96 (287)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBS---SSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS--EE
T ss_pred hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccc---hHHHHHHHHHHHHHHhccCCCccEEEEEEeCCC--eE
Confidence 33578899999999999999975 6889999988654322 122467899999999999999999999998876 67
Q ss_pred EEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCC---CcEEEeccCCCC
Q 004979 506 MMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTED---YAAKISDFSFWN 582 (721)
Q Consensus 506 ~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~---~~~kL~DFGla~ 582 (721)
++||||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.+ +.+||+|||++.
T Consensus 97 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~ 172 (287)
T 2wei_A 97 YIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (287)
T ss_dssp EEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred EEEEEccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChhhEEEecCCCcccEEEeccCcce
Confidence 9999999999999988643 46899999999999999999999998 9999999999999754 479999999876
Q ss_pred CCCC--------CCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCcc
Q 004979 583 NTTA--------AKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTL 654 (721)
Q Consensus 583 ~~~~--------~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 654 (721)
.... ++..|+|||.+.+ .++.++||||||+++|||+||+.||... +..+.......+..... .+
T Consensus 173 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~--~~~~~~~~~~~~~~~~~---~~-- 244 (287)
T 2wei_A 173 CFQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGK--NEYDILKRVETGKYAFD---LP-- 244 (287)
T ss_dssp TBCCCSSCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHCCCCCC---SG--
T ss_pred eecCCCccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCC--CHHHHHHHHHcCCCCCC---ch--
Confidence 4332 2346899998865 4899999999999999999999999643 33344444433322111 00
Q ss_pred ccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 655 KSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 655 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
....++.++.+++.+||+.||++|||+.|+++
T Consensus 245 --~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 245 --QWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp --GGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --hhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 11234567899999999999999999999987
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-36 Score=329.44 Aligned_cols=254 Identities=17% Similarity=0.234 Sum_probs=188.6
Q ss_pred hhhhCcCCCCceeEEEEEEecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCC----Cce
Q 004979 429 SNIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDE----PFT 504 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~----~~~ 504 (721)
|.+++.+|+|+||+||+|+...+..+|+|++..... ...+|+++|++++|||||++++++...+ ...
T Consensus 42 Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~---------~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~ 112 (394)
T 4e7w_A 42 YTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR---------FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVF 112 (394)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT---------SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEE
T ss_pred EEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc---------hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceE
Confidence 467788999999999999988777899998754321 1236999999999999999999986533 123
Q ss_pred EEEEEecCCCCChhhhhhh-ccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeC-CCCcEEEeccCCCC
Q 004979 505 RMMVFEYSPNGSLFEHLHI-QEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLT-EDYAAKISDFSFWN 582 (721)
Q Consensus 505 ~~lV~Ey~~~GsL~~~l~~-~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~-~~~~~kL~DFGla~ 582 (721)
.++||||++++.+....+. .....+++..+..++.||+.||+|||+.+ |+||||||+|||++ .++.+||+|||+++
T Consensus 113 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~~kL~DFG~a~ 190 (394)
T 4e7w_A 113 LNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG--ICHRDIKPQNLLLDPPSGVLKLIDFGSAK 190 (394)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEEcCCCCcEEEeeCCCcc
Confidence 6899999987544333221 23467999999999999999999999998 99999999999999 79999999999986
Q ss_pred CC--------CCCCccccchhhcccC-CCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhc--CC-------
Q 004979 583 NT--------TAAKTGSAAMELLETS-AVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKG--EQ------- 644 (721)
Q Consensus 583 ~~--------~~~~~~~~apE~~~~~-~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~--~~------- 644 (721)
.. ..++..|+|||.+.+. .++.++|||||||++|||++|+.||...+ ..+....+... ..
T Consensus 191 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~--~~~~l~~i~~~~g~p~~~~~~~ 268 (394)
T 4e7w_A 191 ILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGES--GIDQLVEIIKVLGTPSREQIKT 268 (394)
T ss_dssp ECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHHHCCCCHHHHHH
T ss_pred cccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHHhCCCCHHHHHh
Confidence 43 2235569999998654 58999999999999999999999997443 22222221110 00
Q ss_pred --------CCccccCCcc-ccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHHhhh
Q 004979 645 --------PLKDIVDPTL-KSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAK--LKEITA 695 (721)
Q Consensus 645 --------~~~~~~d~~l-~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~--L~~i~~ 695 (721)
.+..+..... ..+....+.++.+|+.+||+.||++|||+.|+++. ++++..
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 330 (394)
T 4e7w_A 269 MNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRT 330 (394)
T ss_dssp HCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTS
T ss_pred hChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcc
Confidence 0000000000 01222356789999999999999999999999874 444433
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-36 Score=317.01 Aligned_cols=240 Identities=21% Similarity=0.302 Sum_probs=191.1
Q ss_pred hhhhCcCCCCceeEEEEEEecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCC--CCccceEeEEEecCCCceEE
Q 004979 429 SNIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVN--HKNFVNLIGYCEEDEPFTRM 506 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~--H~nIv~l~g~~~~~~~~~~~ 506 (721)
+++++.+|+|+||.||+|+..++..||||++..... .....+.+.+|++++.+++ |+||+++++++...+ ..+
T Consensus 30 y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~--~~~ 104 (313)
T 3cek_A 30 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA---DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ--YIY 104 (313)
T ss_dssp EEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSC---CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSS--EEE
T ss_pred EEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccc---cccchHHHHHHHHHHHhccccCCceEEEEEEeecCC--EEE
Confidence 367788999999999999988899999999865432 2334567999999999997 599999999998876 679
Q ss_pred EEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC-
Q 004979 507 MVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT- 585 (721)
Q Consensus 507 lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~- 585 (721)
+||| +.+|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||+++ +.+||+|||+++...
T Consensus 105 lv~e-~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~ 178 (313)
T 3cek_A 105 MVME-CGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIVD-GMLKLIDFGIANQMQP 178 (313)
T ss_dssp EEEC-CCSEEHHHHHHH--CSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEET-TEEEECCCSSSCC---
T ss_pred EEEe-cCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEEEC-CeEEEeeccccccccC
Confidence 9999 568899999864 356899999999999999999999998 999999999999975 899999999986432
Q ss_pred ----------CCCccccchhhccc-----------CCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCC
Q 004979 586 ----------AAKTGSAAMELLET-----------SAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQ 644 (721)
Q Consensus 586 ----------~~~~~~~apE~~~~-----------~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~ 644 (721)
.++..|+|||.+.. ..++.++|||||||++|||+||+.||....... ...........
T Consensus 179 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~ 257 (313)
T 3cek_A 179 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-SKLHAIIDPNH 257 (313)
T ss_dssp -----------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH-HHHHHHHCTTS
T ss_pred ccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHH-HHHHHHHhccc
Confidence 24567899999865 478899999999999999999999996433222 22222222111
Q ss_pred CCccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004979 645 PLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAK 689 (721)
Q Consensus 645 ~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 689 (721)
.. .++...+.++.+++.+||+.||++||++.|+++.
T Consensus 258 ~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 258 EI---------EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp CC---------CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cc---------CCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 10 1112234678899999999999999999999863
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=324.33 Aligned_cols=191 Identities=24% Similarity=0.226 Sum_probs=160.5
Q ss_pred hhhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCC-CC-----ccceEeEEEecCC
Q 004979 429 SNIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVN-HK-----NFVNLIGYCEEDE 501 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~-H~-----nIv~l~g~~~~~~ 501 (721)
+++++.||+|+||+||+|+.. +++.||||++... .....++..|++++..++ |+ +|+++++++...+
T Consensus 56 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 129 (382)
T 2vx3_A 56 YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK------KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN 129 (382)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS------HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred EEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc------HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence 367788999999999999865 6788999988632 223456778888888774 55 4999999998877
Q ss_pred CceEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeC--CCCcEEEeccC
Q 004979 502 PFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLT--EDYAAKISDFS 579 (721)
Q Consensus 502 ~~~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~--~~~~~kL~DFG 579 (721)
..++||||+. |+|.+++.......+++..+..++.|++.||+|||....+|+||||||+|||++ .++.+||+|||
T Consensus 130 --~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG 206 (382)
T 2vx3_A 130 --HLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG 206 (382)
T ss_dssp --EEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCT
T ss_pred --ceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEecc
Confidence 7899999995 599999976555679999999999999999999996434599999999999994 57889999999
Q ss_pred CCCCC------CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCC
Q 004979 580 FWNNT------TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIE 628 (721)
Q Consensus 580 la~~~------~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~ 628 (721)
+++.. ..++..|+|||.+.+..++.++|||||||++|||+||+.||...
T Consensus 207 ~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 207 SSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp TCEETTCCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CceecccccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 98543 23456799999999999999999999999999999999999743
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-36 Score=314.11 Aligned_cols=232 Identities=12% Similarity=0.112 Sum_probs=183.2
Q ss_pred hhhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEE
Q 004979 429 SNIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMM 507 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~l 507 (721)
|++++.+|+|+||.||+|+.. +++.||||++....... ....+.|.+|++++.+++||||+++++++.+.+ ..|+
T Consensus 33 y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~--~~~l 108 (286)
T 3uqc_A 33 YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLP--DDVLQETLSRTLRLSRIDKPGVARVLDVVHTRA--GGLV 108 (286)
T ss_dssp EEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSC--HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT--EEEE
T ss_pred EEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccC--HHHHHHHHHHHHHHhcCCCCCcceeeEEEEECC--cEEE
Confidence 467789999999999999975 48899999987543222 334578999999999999999999999998877 6799
Q ss_pred EEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCCCC
Q 004979 508 VFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTAA 587 (721)
Q Consensus 508 V~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~~~ 587 (721)
||||+++++|.+++.. ........+|+.|++.||+|||+++ |+||||||+|||+++++.+||+++|..
T Consensus 109 v~e~~~g~~L~~~l~~----~~~~~~~~~i~~ql~~aL~~lH~~g--ivH~Dikp~NIll~~~g~~kl~~~~~~------ 176 (286)
T 3uqc_A 109 VAEWIRGGSLQEVADT----SPSPVGAIRAMQSLAAAADAAHRAG--VALSIDHPSRVRVSIDGDVVLAYPATM------ 176 (286)
T ss_dssp EEECCCEEEHHHHHTT----CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEETTSCEEECSCCCC------
T ss_pred EEEecCCCCHHHHHhc----CCChHHHHHHHHHHHHHHHHHHHCC--CccCCCCcccEEEcCCCCEEEEecccc------
Confidence 9999999999999852 2355578899999999999999998 999999999999999999999976642
Q ss_pred CccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCcc---ccccHHHHHH
Q 004979 588 KTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTL---KSFQENVLEE 664 (721)
Q Consensus 588 ~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l---~~~~~~~~~~ 664 (721)
..++.++|||||||++|||+||+.||...+.... + ........... ......++.+
T Consensus 177 ------------~~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~------~---~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T 3uqc_A 177 ------------PDANPQDDIRGIGASLYALLVNRWPLPEAGVRSG------L---APAERDTAGQPIEPADIDRDIPFQ 235 (286)
T ss_dssp ------------TTCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCC------S---EECCBCTTSCBCCHHHHCTTSCHH
T ss_pred ------------CCCCchhHHHHHHHHHHHHHHCCCCCCcCCcchh------h---HHHHHHhccCCCChhhcccCCCHH
Confidence 2478899999999999999999999974332100 0 00001111111 1122345678
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCC
Q 004979 665 LLVVIKNCVHPDPKQRPSMRGIAAKLKEITAMEP 698 (721)
Q Consensus 665 l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 698 (721)
+.+++.+||+.||++| |+.|+++.|+++.....
T Consensus 236 l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~ 268 (286)
T 3uqc_A 236 ISAVAARSVQGDGGIR-SASTLLNLMQQATAVAD 268 (286)
T ss_dssp HHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC---
T ss_pred HHHHHHHHcccCCccC-CHHHHHHHHHHHhccCC
Confidence 9999999999999999 99999999999877544
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-36 Score=322.03 Aligned_cols=248 Identities=19% Similarity=0.263 Sum_probs=190.5
Q ss_pred hhhhCcCCCCceeEEEEEEec-CC-cEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCc------cceEeEEEecC
Q 004979 429 SNIIGSFSDGTVGTVYKGTLS-SG-VEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKN------FVNLIGYCEED 500 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~-~~-~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~n------Iv~l~g~~~~~ 500 (721)
+++++.+|+|+||+||+|+.. ++ ..||+|++... ....+.+.+|++++++++|++ ++.+++++...
T Consensus 21 y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~------~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 94 (355)
T 2eu9_A 21 YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV------GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFH 94 (355)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC------HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET
T ss_pred EEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc------ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC
Confidence 477889999999999999964 34 68999987532 223467888999999987766 89999999887
Q ss_pred CCceEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEe-------------
Q 004979 501 EPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYL------------- 567 (721)
Q Consensus 501 ~~~~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl------------- 567 (721)
+ ..++||||+ +|+|.+++.......+++..+..|+.||+.||+|||+++ |+||||||+|||+
T Consensus 95 ~--~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~~~~~ 169 (355)
T 2eu9_A 95 G--HMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ--LTHTDLKPENILFVNSEFETLYNEHK 169 (355)
T ss_dssp T--EEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEESCCCEEEEECCC-
T ss_pred C--eEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEecccccccccccc
Confidence 7 779999999 778888876555567999999999999999999999988 9999999999999
Q ss_pred ------CCCCcEEEeccCCCCCC------CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCH-HH
Q 004979 568 ------TEDYAAKISDFSFWNNT------TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSL-EN 634 (721)
Q Consensus 568 ------~~~~~~kL~DFGla~~~------~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~-~~ 634 (721)
+.++.+||+|||+++.. ..++..|+|||.+.+..++.++|||||||++|||+||+.||....... ..
T Consensus 170 ~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 249 (355)
T 2eu9_A 170 SCEEKSVKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLV 249 (355)
T ss_dssp CCCEEEESCCCEEECCCTTCEETTSCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred cccccccCCCcEEEeecCccccccccccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 56789999999998632 234567999999999999999999999999999999999997433211 11
Q ss_pred HHHHHhhcCCCCc--------cc-cC--------------------C--ccccccHHHHHHHHHHHHHcccCCCCCCCCH
Q 004979 635 WASEYLKGEQPLK--------DI-VD--------------------P--TLKSFQENVLEELLVVIKNCVHPDPKQRPSM 683 (721)
Q Consensus 635 ~~~~~~~~~~~~~--------~~-~d--------------------~--~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~ 683 (721)
.+.... +..+.. .. .. + ...........++.+|+.+||+.||++|||+
T Consensus 250 ~~~~~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~ 328 (355)
T 2eu9_A 250 MMEKIL-GPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITL 328 (355)
T ss_dssp HHHHHH-CCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCH
T ss_pred HHHHHc-CCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCH
Confidence 111111 110000 00 00 0 0000112345689999999999999999999
Q ss_pred HHHHH
Q 004979 684 RGIAA 688 (721)
Q Consensus 684 ~evl~ 688 (721)
.|+++
T Consensus 329 ~e~l~ 333 (355)
T 2eu9_A 329 AEALL 333 (355)
T ss_dssp HHHTT
T ss_pred HHHhc
Confidence 99975
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=320.58 Aligned_cols=249 Identities=16% Similarity=0.223 Sum_probs=192.9
Q ss_pred hhhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCc----
Q 004979 429 SNIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPF---- 503 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~---- 503 (721)
+.+.+.+|+|+||.||+|+.. ++..||||++..... .....+.+.+|+.++++++||||+++++++...+..
T Consensus 26 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 26 YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ---SEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTS---SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred EEEeeeEecCCCeEEEEEEECCCCCEEEEEEeccccc---chHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 356678899999999999964 688999998864321 233456789999999999999999999999865421
Q ss_pred eEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCC
Q 004979 504 TRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNN 583 (721)
Q Consensus 504 ~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~ 583 (721)
..++||||+. |+|.+++. ..+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.
T Consensus 103 ~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~LH~~~--ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~ 175 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG----LKFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVNEDCELKILDFGLARH 175 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT----SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECTTCCEEECSTTCTTC
T ss_pred eEEEEecccc-CCHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEeECCCCcEEEeecccccC
Confidence 3489999997 68888774 34899999999999999999999998 99999999999999999999999999864
Q ss_pred CC------CCCccccchhhccc-CCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCC-C----------
Q 004979 584 TT------AAKTGSAAMELLET-SAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQ-P---------- 645 (721)
Q Consensus 584 ~~------~~~~~~~apE~~~~-~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~-~---------- 645 (721)
.. .++..|+|||.+.+ ..++.++|||||||++|||+||+.||...+ ..+....+..... +
T Consensus 176 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~ 253 (353)
T 3coi_A 176 ADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD--YLDQLTQILKVTGVPGTEFVQKLND 253 (353)
T ss_dssp --------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSC--HHHHHHHHHHHHCBCCHHHHTTCSC
T ss_pred CCCCccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHHhCCCCHHHHHHHhh
Confidence 32 34567999999876 688999999999999999999999996433 2222222211100 0
Q ss_pred ---------CccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004979 646 ---------LKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAK 689 (721)
Q Consensus 646 ---------~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 689 (721)
+...............+.++.+++.+||+.||++|||+.|+++.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 254 KAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp HHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 00000111112223456789999999999999999999999863
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-36 Score=323.17 Aligned_cols=263 Identities=17% Similarity=0.236 Sum_probs=182.9
Q ss_pred HHHHHhhhhhhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEec
Q 004979 421 LEAACEDFSNIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEE 499 (721)
Q Consensus 421 l~~~~~~~~~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~ 499 (721)
.....++| ++.+.+|+|+||+||+|+.. ++..||||++...... ...+.+|++.+..++||||+++++++..
T Consensus 18 ~~~~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~~l~~l~h~niv~~~~~~~~ 90 (360)
T 3e3p_A 18 SRKEMDRF-QVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF------RNRELQIMQDLAVLHHPNIVQLQSYFYT 90 (360)
T ss_dssp HHHHHTTE-EEC----------CEEEEETTTCCEEEEEEEECCTTC------CCHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred chhhccce-EEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc------cHHHHHHHHHHHhcCCCCcccHHHhhhc
Confidence 33444444 77889999999999999974 6889999988543221 1356778888999999999999999865
Q ss_pred CCC-----ceEEEEEecCCCCChhhhhhh--ccCCCCCHHHHHHHHHHHHHHHHHHh--cCCCCeEeeCCCCCCeEeCC-
Q 004979 500 DEP-----FTRMMVFEYSPNGSLFEHLHI--QEAEHLDWAMRLRIAMGMAYCLEHMH--QLTPPIAHRNLQSSSIYLTE- 569 (721)
Q Consensus 500 ~~~-----~~~~lV~Ey~~~GsL~~~l~~--~~~~~l~~~~~~~ia~~ia~gL~yLH--~~~~~IvHrDLKp~NILl~~- 569 (721)
.+. ...++||||+++ +|...+.. .....+++..+..++.|++.||+||| +++ |+||||||+|||++.
T Consensus 91 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~--ivH~Dlkp~NIll~~~ 167 (360)
T 3e3p_A 91 LGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN--VCHRDIKPHNVLVNEA 167 (360)
T ss_dssp ECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC--CBCSCCCGGGEEEETT
T ss_pred cccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC--eecCcCCHHHEEEeCC
Confidence 321 136899999976 55544432 24567899999999999999999999 666 999999999999996
Q ss_pred CCcEEEeccCCCCCCC--------CCCccccchhhcccC-CCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHh
Q 004979 570 DYAAKISDFSFWNNTT--------AAKTGSAAMELLETS-AVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYL 640 (721)
Q Consensus 570 ~~~~kL~DFGla~~~~--------~~~~~~~apE~~~~~-~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~ 640 (721)
++.+||+|||+++... .++..|+|||.+.+. .++.++|||||||++|||+||+.||.... .......+.
T Consensus 168 ~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~--~~~~~~~~~ 245 (360)
T 3e3p_A 168 DGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDN--SAGQLHEIV 245 (360)
T ss_dssp TTEEEECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHH
T ss_pred CCcEEEeeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCC--hHHHHHHHH
Confidence 8999999999986432 245579999998654 48999999999999999999999996433 222222222
Q ss_pred hcC-CCC-------------ccccCCc-------cccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHHhhh
Q 004979 641 KGE-QPL-------------KDIVDPT-------LKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAK--LKEITA 695 (721)
Q Consensus 641 ~~~-~~~-------------~~~~d~~-------l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~--L~~i~~ 695 (721)
... .+. ....+.. ........+.++.+|+.+||+.||++|||+.|+++. ++++..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 323 (360)
T 3e3p_A 246 RVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHD 323 (360)
T ss_dssp HHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGC
T ss_pred HHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCC
Confidence 110 000 0000000 001112256789999999999999999999999874 555544
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=317.01 Aligned_cols=242 Identities=21% Similarity=0.327 Sum_probs=173.6
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHH-HHhcCCCCccceEeEEEecCCCceEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKID-TLSKVNHKNFVNLIGYCEEDEPFTRMM 507 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~-~l~~l~H~nIv~l~g~~~~~~~~~~~l 507 (721)
++++.+|+|+||.||+|+.. +++.||||++..... .....++..|+. +++.++||||+++++++...+ ..++
T Consensus 25 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~--~~~l 98 (327)
T 3aln_A 25 KDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD----EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREG--DCWI 98 (327)
T ss_dssp EC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC----HHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSS--EEEE
T ss_pred hehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC----chHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCC--ceEE
Confidence 56788999999999999975 688999998865422 222345556665 778889999999999998876 6799
Q ss_pred EEecCCCCChhhhhhh---ccCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCeEeeCCCCCCeEeCCCCcEEEeccCCCCC
Q 004979 508 VFEYSPNGSLFEHLHI---QEAEHLDWAMRLRIAMGMAYCLEHMHQL-TPPIAHRNLQSSSIYLTEDYAAKISDFSFWNN 583 (721)
Q Consensus 508 V~Ey~~~GsL~~~l~~---~~~~~l~~~~~~~ia~~ia~gL~yLH~~-~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~ 583 (721)
||||+++ +|.+++.. .....+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+|||+++.
T Consensus 99 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~--ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 175 (327)
T 3aln_A 99 CMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQ 175 (327)
T ss_dssp EECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS--CCCSCCCGGGEEEETTTEEEECCCSSSCC
T ss_pred EEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC--EeECCCCHHHEEEcCCCCEEEccCCCcee
Confidence 9999975 88777652 1246789999999999999999999997 7 99999999999999999999999999864
Q ss_pred CC--------CCCccccchhhc----ccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccC
Q 004979 584 TT--------AAKTGSAAMELL----ETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVD 651 (721)
Q Consensus 584 ~~--------~~~~~~~apE~~----~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d 651 (721)
.. .++..|+|||.+ ....++.++|||||||++|||+||+.||....... +.......+. .
T Consensus 176 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~-------~ 247 (327)
T 3aln_A 176 LVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF-DQLTQVVKGD-------P 247 (327)
T ss_dssp ------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC--------CCCCCSC-------C
T ss_pred cccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH-HHHHHHhcCC-------C
Confidence 32 345578999998 46678999999999999999999999996432111 1111111110 0
Q ss_pred Cccc-cccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 652 PTLK-SFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 652 ~~l~-~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
+.+. .....++.++.+++.+||+.||++||++.|+++
T Consensus 248 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 248 PQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 1111 111234578999999999999999999999976
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-36 Score=326.04 Aligned_cols=251 Identities=18% Similarity=0.283 Sum_probs=192.4
Q ss_pred hhhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCC-----------CCccceEeEE
Q 004979 429 SNIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVN-----------HKNFVNLIGY 496 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~-----------H~nIv~l~g~ 496 (721)
+++++.+|+|+||+||+|+. .+++.||||++... ....+.+.+|++++.+++ |+||++++++
T Consensus 21 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~ 94 (373)
T 1q8y_A 21 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD------KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 94 (373)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC------HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred EEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC------ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHH
Confidence 46788999999999999996 56889999988632 223456889999998886 8999999999
Q ss_pred EecCC--CceEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCeEeeCCCCCCeEeC-----
Q 004979 497 CEEDE--PFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQL-TPPIAHRNLQSSSIYLT----- 568 (721)
Q Consensus 497 ~~~~~--~~~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~-~~~IvHrDLKp~NILl~----- 568 (721)
+...+ ....++||||+ +++|.+++.......+++..+..|+.||+.||+|||+. + |+||||||+|||++
T Consensus 95 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~--ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 95 FNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSGGGEEEEEEETT
T ss_pred hhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCC--EEecCCChHHeEEeccCCC
Confidence 87532 23579999999 99999999765556799999999999999999999997 8 99999999999994
Q ss_pred -CCCcEEEeccCCCCCC------CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCC----HHHHHH
Q 004979 569 -EDYAAKISDFSFWNNT------TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGS----LENWAS 637 (721)
Q Consensus 569 -~~~~~kL~DFGla~~~------~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~----~~~~~~ 637 (721)
..+.+||+|||+++.. ..++..|+|||.+.+..++.++|||||||++|||+||+.||...... ......
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 251 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 251 (373)
T ss_dssp TTEEEEEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHH
T ss_pred cCcceEEEcccccccccCCCCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHH
Confidence 4558999999997532 23456799999999999999999999999999999999999743311 111111
Q ss_pred HHhh--cCCC-------------------CccccCC----------ccccccHHHHHHHHHHHHHcccCCCCCCCCHHHH
Q 004979 638 EYLK--GEQP-------------------LKDIVDP----------TLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGI 686 (721)
Q Consensus 638 ~~~~--~~~~-------------------~~~~~d~----------~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev 686 (721)
.... +..+ ...+... ....++.....++.+|+.+||+.||++|||+.|+
T Consensus 252 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el 331 (373)
T 1q8y_A 252 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL 331 (373)
T ss_dssp HHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHH
T ss_pred HHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHH
Confidence 1111 0000 0000000 0012345678899999999999999999999999
Q ss_pred HH
Q 004979 687 AA 688 (721)
Q Consensus 687 l~ 688 (721)
++
T Consensus 332 l~ 333 (373)
T 1q8y_A 332 VN 333 (373)
T ss_dssp HT
T ss_pred hh
Confidence 87
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=312.61 Aligned_cols=241 Identities=19% Similarity=0.269 Sum_probs=178.2
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
++++.+|+|+||.||+|+.. +++.||||++...... ....+.+.++..+++.++||||+++++++.+.+ ..++|
T Consensus 28 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~--~~~lv 102 (318)
T 2dyl_A 28 ENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNK---EENKRILMDLDVVLKSHDCPYIVQCFGTFITNT--DVFIA 102 (318)
T ss_dssp EEEEEC------CEEEEEETTTCCEEEEEEEETTSCH---HHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS--EEEEE
T ss_pred cccceeeecCCeeEEEEEEecCCeEEEEEEecccccc---hHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC--cEEEE
Confidence 67788999999999999975 6889999988654321 222344555666788899999999999998876 67999
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC---
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQL-TPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT--- 584 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~-~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~--- 584 (721)
|||+ ++.+..+. ......+++..+..++.|++.||+|||+. + |+||||||+|||++.++.+||+|||+++..
T Consensus 103 ~e~~-~~~~~~l~-~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (318)
T 2dyl_A 103 MELM-GTCAEKLK-KRMQGPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRLVDD 178 (318)
T ss_dssp ECCC-SEEHHHHH-HHHTSCCCHHHHHHHHHHHHHHHHHHHHHHC--CCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred Eecc-CCcHHHHH-HHhccCCCHHHHHHHHHHHHHHHHHHHhhCC--EEeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence 9999 45554444 33356799999999999999999999984 7 999999999999999999999999987533
Q ss_pred -----CCCCccccchhhcc-----cCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCcc
Q 004979 585 -----TAAKTGSAAMELLE-----TSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTL 654 (721)
Q Consensus 585 -----~~~~~~~~apE~~~-----~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 654 (721)
..++..|+|||.+. ...++.++|||||||++|||+||+.||..... ..+.......+..+.. +
T Consensus 179 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~----~-- 251 (318)
T 2dyl_A 179 KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT-DFEVLTKVLQEEPPLL----P-- 251 (318)
T ss_dssp --------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCS-HHHHHHHHHHSCCCCC----C--
T ss_pred ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCc-cHHHHHHHhccCCCCC----C--
Confidence 23456799999984 56788999999999999999999999964332 2333344443322111 0
Q ss_pred ccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 655 KSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 655 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
....++.++.+++.+||+.||.+||++.|+++
T Consensus 252 --~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 252 --GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp --SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred --ccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 01124467889999999999999999999986
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=334.47 Aligned_cols=241 Identities=18% Similarity=0.274 Sum_probs=182.3
Q ss_pred hhhhhhCcCCCCceeEEEEEEecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcC-CCCccceEeEEEecCCCceE
Q 004979 427 DFSNIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKV-NHKNFVNLIGYCEEDEPFTR 505 (721)
Q Consensus 427 ~~~~ii~~lg~G~~g~Vyk~~~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~~ 505 (721)
+++.+.+.+|+|+||+||.+...+|+.||||++.... .+.+.+|++++.++ +|||||++++++.+.+ ..
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~--------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~--~~ 84 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF--------CDIALMEIKLLTESDDHPNVIRYYCSETTDR--FL 84 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG--------HHHHHHHHHHHHHHTTSTTBCCEEEEEECSS--EE
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH--------HHHHHHHHHHHHhccCCCCcCeEEEEEecCC--eE
Confidence 3444456789999999987766779999999885421 24578899999876 8999999999998776 67
Q ss_pred EEEEecCCCCChhhhhhhccCCC-----CCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCC-----------
Q 004979 506 MMVFEYSPNGSLFEHLHIQEAEH-----LDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTE----------- 569 (721)
Q Consensus 506 ~lV~Ey~~~GsL~~~l~~~~~~~-----l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~----------- 569 (721)
++||||+. |+|.+++....... ..+..+..|+.||+.||+|||+++ |+||||||+|||++.
T Consensus 85 ~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~~~~~~~~~ 161 (434)
T 2rio_A 85 YIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQTG 161 (434)
T ss_dssp EEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEECCHHHHSCCTTC
T ss_pred EEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEecCcccccccccC
Confidence 99999995 79999996432211 123345789999999999999998 999999999999965
Q ss_pred --CCcEEEeccCCCCCCC-------------CCCccccchhhccc-------CCCCCCccHHHHHHHHHHHHh-CCCccc
Q 004979 570 --DYAAKISDFSFWNNTT-------------AAKTGSAAMELLET-------SAVDLESNVYSFGTILFEMIT-GRISYS 626 (721)
Q Consensus 570 --~~~~kL~DFGla~~~~-------------~~~~~~~apE~~~~-------~~~s~ksDVwSfGvvL~Ellt-G~~P~~ 626 (721)
++.+||+|||+++... .++..|+|||.+.+ ..++.++|||||||++|||+| |+.||.
T Consensus 162 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~ 241 (434)
T 2rio_A 162 AENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG 241 (434)
T ss_dssp CCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTC
T ss_pred CCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCC
Confidence 4589999999876322 34567999999865 678999999999999999999 999996
Q ss_pred CCCCCHHHHHHHHhhcCCCCccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 627 IENGSLENWASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 627 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
....... ....+....... ........+.++.+++.+||+.||++||++.||++
T Consensus 242 ~~~~~~~----~i~~~~~~~~~~----~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 242 DKYSRES----NIIRGIFSLDEM----KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp STTTHHH----HHHHTCCCCCCC----TTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CchhhHH----HHhcCCCCcccc----cccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 4332221 222222111111 01123467788999999999999999999999985
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-36 Score=320.29 Aligned_cols=242 Identities=17% Similarity=0.243 Sum_probs=168.7
Q ss_pred hhhC-cCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecC--CCceE
Q 004979 430 NIIG-SFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEED--EPFTR 505 (721)
Q Consensus 430 ~ii~-~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~~ 505 (721)
.+++ .+|+|+||+||+|+.. +++.||||++.... . ...+....+..++||||+++++++... +....
T Consensus 31 ~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~---~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 31 QLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP------K---ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH------H---HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred EecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH------H---HHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 5555 4899999999999976 68899999885321 1 112222345667999999999998752 12247
Q ss_pred EEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCC---CCcEEEeccCCCC
Q 004979 506 MMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTE---DYAAKISDFSFWN 582 (721)
Q Consensus 506 ~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~---~~~~kL~DFGla~ 582 (721)
++||||+++|+|.+++.......+++..+..|+.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||+++
T Consensus 102 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~--ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~ 179 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN--IAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 179 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEEecCCCceEEEeccccce
Confidence 99999999999999997655567999999999999999999999998 999999999999986 4569999999986
Q ss_pred CCC-------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHH--HHHHHHhhcCCCCccccCCc
Q 004979 583 NTT-------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLE--NWASEYLKGEQPLKDIVDPT 653 (721)
Q Consensus 583 ~~~-------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~--~~~~~~~~~~~~~~~~~d~~ 653 (721)
... .++..|+|||.+....++.++|||||||++|||+||+.||........ ............. ..
T Consensus 180 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---~~-- 254 (336)
T 3fhr_A 180 ETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGF---PN-- 254 (336)
T ss_dssp EC----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CC---CT--
T ss_pred eccccccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhcccccc---Cc--
Confidence 332 235678999999888899999999999999999999999964332111 0000100000000 00
Q ss_pred cccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004979 654 LKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAK 689 (721)
Q Consensus 654 l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 689 (721)
.....++.++.+++.+||+.||++|||+.|+++.
T Consensus 255 --~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 288 (336)
T 3fhr_A 255 --PEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH 288 (336)
T ss_dssp --TTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred --hhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 1112345778999999999999999999999973
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=320.66 Aligned_cols=235 Identities=22% Similarity=0.376 Sum_probs=184.0
Q ss_pred hhhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhh-HHHHHHHHHHHHHhcC----CCCccceEeEEEecCCC
Q 004979 429 SNIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSK-NLESQFRKKIDTLSKV----NHKNFVNLIGYCEEDEP 502 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~-~~~~~f~~Ei~~l~~l----~H~nIv~l~g~~~~~~~ 502 (721)
+++.+.+|+|+||.||+|+. .+++.||||++.......... .....+.+|++++.++ +||||+++++++...+
T Consensus 33 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~~- 111 (312)
T 2iwi_A 33 YRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQE- 111 (312)
T ss_dssp CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-----
T ss_pred eEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecCC-
Confidence 47788899999999999985 468899999986543221110 1223467789999888 8999999999998776
Q ss_pred ceEEEEEec-CCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeC-CCCcEEEeccCC
Q 004979 503 FTRMMVFEY-SPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLT-EDYAAKISDFSF 580 (721)
Q Consensus 503 ~~~~lV~Ey-~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~-~~~~~kL~DFGl 580 (721)
..++|||| +.+++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||+++ +++.+||+|||+
T Consensus 112 -~~~~v~e~~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~kl~dfg~ 186 (312)
T 2iwi_A 112 -GFMLVLERPLPAQDLFDYITE--KGPLGEGPSRCFFGQVVAAIQHCHSRG--VVHRDIKDENILIDLRRGCAKLIDFGS 186 (312)
T ss_dssp --CEEEEECCSSEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHHT--EECCCCSGGGEEEETTTTEEEECCCSS
T ss_pred -eEEEEEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChhhEEEeCCCCeEEEEEcch
Confidence 56899999 789999999864 346899999999999999999999988 99999999999999 889999999998
Q ss_pred CCCCC-------CCCccccchhhcccCCCC-CCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCC
Q 004979 581 WNNTT-------AAKTGSAAMELLETSAVD-LESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDP 652 (721)
Q Consensus 581 a~~~~-------~~~~~~~apE~~~~~~~s-~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 652 (721)
++... .++..|+|||.+....+. .++|||||||++|||+||+.||... .+ .......
T Consensus 187 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~----~~----~~~~~~~------- 251 (312)
T 2iwi_A 187 GALLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD----QE----ILEAELH------- 251 (312)
T ss_dssp CEECCSSCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH----HH----HHHTCCC-------
T ss_pred hhhcccCcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh----HH----HhhhccC-------
Confidence 75332 345679999998776664 5899999999999999999999532 11 1111111
Q ss_pred ccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 653 TLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 653 ~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
++.....++.+++.+||+.||++||++.|+++
T Consensus 252 ----~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 252 ----FPAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp ----CCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ----CcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 12334567889999999999999999999987
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-35 Score=308.39 Aligned_cols=226 Identities=18% Similarity=0.302 Sum_probs=175.8
Q ss_pred hhh-CcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHH-hcCCCCccceEeEEEec--CCCce
Q 004979 430 NII-GSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTL-SKVNHKNFVNLIGYCEE--DEPFT 504 (721)
Q Consensus 430 ~ii-~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l-~~l~H~nIv~l~g~~~~--~~~~~ 504 (721)
.++ +.+|+|+||.||+|+. .+++.||+|++... ..+.+|++++ +..+||||+++++++.. .+...
T Consensus 20 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 89 (299)
T 3m2w_A 20 KVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 89 (299)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred hhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc----------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCce
Confidence 444 5689999999999996 56889999988531 3467888887 56699999999999875 22226
Q ss_pred EEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCC---CCcEEEeccCCC
Q 004979 505 RMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTE---DYAAKISDFSFW 581 (721)
Q Consensus 505 ~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~---~~~~kL~DFGla 581 (721)
.++||||+++|+|.+++.......+++..+..++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||++
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a 167 (299)
T 3m2w_A 90 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFA 167 (299)
T ss_dssp EEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence 799999999999999997655567999999999999999999999998 999999999999998 789999999987
Q ss_pred CCCCCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCcccccc---
Q 004979 582 NNTTAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQ--- 658 (721)
Q Consensus 582 ~~~~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~--- 658 (721)
.... ...++.++|||||||++|||+||+.||....... .. ......+.......+
T Consensus 168 ~~~~-------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~------~~---~~~~~~~~~~~~~~~~~~ 225 (299)
T 3m2w_A 168 KETT-------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA------IS---PGMKTRIRMGQYEFPNPE 225 (299)
T ss_dssp EECT-------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC----------------CCSCCSSCTTCCSSCHHH
T ss_pred cccc-------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchh------hh---HHHHHHHhhccccCCchh
Confidence 5432 3457789999999999999999999996432110 00 000111111111111
Q ss_pred -HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004979 659 -ENVLEELLVVIKNCVHPDPKQRPSMRGIAAK 689 (721)
Q Consensus 659 -~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 689 (721)
..++.++.+++.+||+.||++||++.|+++.
T Consensus 226 ~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 226 WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 2356789999999999999999999999873
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-36 Score=320.30 Aligned_cols=235 Identities=19% Similarity=0.357 Sum_probs=188.8
Q ss_pred hhhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhh-HHHHHHHHHHHHHhcCC--CCccceEeEEEecCCCce
Q 004979 429 SNIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSK-NLESQFRKKIDTLSKVN--HKNFVNLIGYCEEDEPFT 504 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~-~~~~~f~~Ei~~l~~l~--H~nIv~l~g~~~~~~~~~ 504 (721)
+++.+.+|+|+||+||+|+. .+++.||||++.......... ...+.+.+|++++++++ |+||+++++++...+ .
T Consensus 45 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~--~ 122 (320)
T 3a99_A 45 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD--S 122 (320)
T ss_dssp EEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS--E
T ss_pred eEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCC--c
Confidence 47788999999999999985 468889999987543221100 11245778999999996 599999999998877 6
Q ss_pred EEEEEecCCC-CChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeC-CCCcEEEeccCCCC
Q 004979 505 RMMVFEYSPN-GSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLT-EDYAAKISDFSFWN 582 (721)
Q Consensus 505 ~~lV~Ey~~~-GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~-~~~~~kL~DFGla~ 582 (721)
.++||||+.+ ++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++ +++.+||+|||+++
T Consensus 123 ~~lv~e~~~~~~~L~~~l~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~ 198 (320)
T 3a99_A 123 FVLILERPEPVQDLFDFITE--RGALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFGSGA 198 (320)
T ss_dssp EEEEEECCSSEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEEEEcCCCCccHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC--cEeCCCCHHHEEEeCCCCCEEEeeCcccc
Confidence 7999999976 899999864 356899999999999999999999998 99999999999999 78999999999875
Q ss_pred CCC-------CCCccccchhhcccCCC-CCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCcc
Q 004979 583 NTT-------AAKTGSAAMELLETSAV-DLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTL 654 (721)
Q Consensus 583 ~~~-------~~~~~~~apE~~~~~~~-s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 654 (721)
... .++..|+|||.+....+ +.++|||||||++|||+||+.||.... + .......
T Consensus 199 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~----~----~~~~~~~--------- 261 (320)
T 3a99_A 199 LLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----E----IIRGQVF--------- 261 (320)
T ss_dssp ECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----H----HHHCCCC---------
T ss_pred ccccccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh----h----hhccccc---------
Confidence 332 34567999999877665 688999999999999999999995321 1 1111111
Q ss_pred ccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 655 KSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 655 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
.....+.++.+++.+||+.||++||++.||++
T Consensus 262 --~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 262 --FRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp --CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --ccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11233467889999999999999999999976
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-35 Score=323.06 Aligned_cols=235 Identities=19% Similarity=0.256 Sum_probs=178.1
Q ss_pred hhhCcCCCCceeEEEEEEecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcC-CCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKV-NHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
++.+.+|+|+||+||.....+++.||||++..... ..+.+|+++|+++ +|||||++++++.+.+ ..++|
T Consensus 27 ~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~--------~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~--~~~lv 96 (432)
T 3p23_A 27 CPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF--------SFADREVQLLRESDEHPNVIRYFCTEKDRQ--FQYIA 96 (432)
T ss_dssp EEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE--------EECHHHHHHHHHSCCCTTBCCEEEEEEETT--EEEEE
T ss_pred ecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH--------HHHHHHHHHHHhccCCCCcCeEEEEEecCC--EEEEE
Confidence 45667899999996655556789999998864322 1256899999999 8999999999998876 67999
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCC-----CCcEEEeccCCCCC
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTE-----DYAAKISDFSFWNN 583 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~-----~~~~kL~DFGla~~ 583 (721)
|||+. |+|.+++.... ..+.+..+..|+.||+.||+|||+.+ |+||||||+|||++. ...+||+|||+++.
T Consensus 97 ~E~~~-g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~ 172 (432)
T 3p23_A 97 IELCA-ATLQEYVEQKD-FAHLGLEPITLLQQTTSGLAHLHSLN--IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK 172 (432)
T ss_dssp EECCS-EEHHHHHHSSS-CCCCSSCHHHHHHHHHHHHHHHHHTT--CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred EECCC-CCHHHHHHhcC-CCccchhHHHHHHHHHHHHHHHHHCc--CEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence 99996 69999986432 33445556789999999999999998 999999999999953 34688999998754
Q ss_pred CC------------CCCccccchhhcc---cCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhcCCCCc
Q 004979 584 TT------------AAKTGSAAMELLE---TSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPLK 647 (721)
Q Consensus 584 ~~------------~~~~~~~apE~~~---~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~ 647 (721)
.. .++..|+|||.+. ...++.++|||||||++|||+| |+.||....... ... ........
T Consensus 173 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~---~~~-~~~~~~~~ 248 (432)
T 3p23_A 173 LAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ---ANI-LLGACSLD 248 (432)
T ss_dssp C------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH---HHH-HTTCCCCT
T ss_pred ccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH---HHH-HhccCCcc
Confidence 32 2566899999987 4677889999999999999999 999985332211 111 11111111
Q ss_pred cccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 648 DIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 648 ~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
. . .........+.+|+.+||+.||++||++.||++
T Consensus 249 ~-~-----~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 249 C-L-----HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp T-S-----CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred c-c-----CccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 1 1 112344567889999999999999999999984
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=332.39 Aligned_cols=261 Identities=20% Similarity=0.229 Sum_probs=195.1
Q ss_pred hhhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecC----CCc
Q 004979 429 SNIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEED----EPF 503 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~----~~~ 503 (721)
+++.+.+|+|+||+||+|.. .++..||||++.... .....+.+.+|++++++++|||||++++++... ...
T Consensus 16 Y~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~----~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~ 91 (676)
T 3qa8_A 16 WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL----SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND 91 (676)
T ss_dssp -CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC----CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred eEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC----CHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence 47889999999999999986 468899999875432 234457799999999999999999999987651 122
Q ss_pred eEEEEEecCCCCChhhhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCc---EEEeccC
Q 004979 504 TRMMVFEYSPNGSLFEHLHIQE-AEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYA---AKISDFS 579 (721)
Q Consensus 504 ~~~lV~Ey~~~GsL~~~l~~~~-~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~---~kL~DFG 579 (721)
..++||||+++|+|.+++.... ...+++..+..|+.|++.||+|||+.+ |+||||||+|||++.++. +||+|||
T Consensus 92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g--IVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR--IIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT--BCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEeecCCCceeEEEcccc
Confidence 5689999999999999987432 236889999999999999999999988 999999999999997664 9999999
Q ss_pred CCCCCC--------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcC---CCCcc
Q 004979 580 FWNNTT--------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGE---QPLKD 648 (721)
Q Consensus 580 la~~~~--------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~---~~~~~ 648 (721)
+++... .++..|+|||.+.+..++.++|||||||++|||+||+.||.... ....|........ ....+
T Consensus 170 ~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~-~~~~~~~~i~~~~~~~~~~~~ 248 (676)
T 3qa8_A 170 YAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNW-QPVQWHGKVREKSNEHIVVYD 248 (676)
T ss_dssp CCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSC-HHHHSSTTCC------CCSCC
T ss_pred cccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCccc-chhhhhhhhhcccchhhhhhh
Confidence 986432 24567899999999999999999999999999999999996321 1111111000000 00000
Q ss_pred ccC---------CccccccHHHHHHHHHHHHHcccCCCCCCCCHHHH-----HHHHHHhhhc
Q 004979 649 IVD---------PTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGI-----AAKLKEITAM 696 (721)
Q Consensus 649 ~~d---------~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev-----l~~L~~i~~~ 696 (721)
... +.........+.++.+++.+||..||++|||+.|+ .+.++++...
T Consensus 249 ~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~ 310 (676)
T 3qa8_A 249 DLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSL 310 (676)
T ss_dssp CCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCC
T ss_pred hhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhc
Confidence 000 11112345678899999999999999999999884 4555555443
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-34 Score=335.99 Aligned_cols=234 Identities=18% Similarity=0.273 Sum_probs=185.4
Q ss_pred hhhhCcCCCCceeEEEEEEec--CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCC---c
Q 004979 429 SNIIGSFSDGTVGTVYKGTLS--SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEP---F 503 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~--~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~---~ 503 (721)
+++++.+|+|+||+||+|+.. +++.|+||++.... .......|.+|++++++++|||||++++++...+. .
T Consensus 82 y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 157 (681)
T 2pzi_A 82 YEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG----DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP 157 (681)
T ss_dssp EEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC----CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred eEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC----CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence 477889999999999999975 57889999875432 12345678999999999999999999999987542 1
Q ss_pred eEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCC
Q 004979 504 TRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNN 583 (721)
Q Consensus 504 ~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~ 583 (721)
..||||||+++++|.+++. ..++|..++.|+.||+.||+|||+++ |+||||||+|||++++ .+||+|||+++.
T Consensus 158 ~~~lv~E~~~g~~L~~~~~----~~l~~~~~~~~~~qi~~aL~~lH~~g--iiHrDlkp~NIll~~~-~~kl~DFG~a~~ 230 (681)
T 2pzi_A 158 VGYIVMEYVGGQSLKRSKG----QKLPVAEAIAYLLEILPALSYLHSIG--LVYNDLKPENIMLTEE-QLKLIDLGAVSR 230 (681)
T ss_dssp EEEEEEECCCCEECC--------CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred eeEEEEEeCCCCcHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC--CeecccChHHeEEeCC-cEEEEecccchh
Confidence 1599999999999998764 26999999999999999999999998 9999999999999986 899999999864
Q ss_pred CC-----CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCcccccc
Q 004979 584 TT-----AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQ 658 (721)
Q Consensus 584 ~~-----~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 658 (721)
.. .++..|+|||.+.+.. +.++|||||||++|||++|..||..... ..+. . ....
T Consensus 231 ~~~~~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~-------------~~~~----~--~~~~ 290 (681)
T 2pzi_A 231 INSFGYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYV-------------DGLP----E--DDPV 290 (681)
T ss_dssp TTCCSCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEEC-------------SSCC----T--TCHH
T ss_pred cccCCccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccc-------------cccc----c--cccc
Confidence 32 3567899999987654 8999999999999999999988752110 0000 0 0111
Q ss_pred HHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHHHHh
Q 004979 659 ENVLEELLVVIKNCVHPDPKQRP-SMRGIAAKLKEI 693 (721)
Q Consensus 659 ~~~~~~l~~li~~Cl~~dP~~RP-s~~evl~~L~~i 693 (721)
......+.+++.+||+.||++|| +++++...|..+
T Consensus 291 ~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 291 LKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp HHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred cccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 23456788999999999999999 566677766654
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-34 Score=314.40 Aligned_cols=235 Identities=12% Similarity=0.143 Sum_probs=171.0
Q ss_pred hhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCC-CccceE---------e-----
Q 004979 431 IIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNH-KNFVNL---------I----- 494 (721)
Q Consensus 431 ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H-~nIv~l---------~----- 494 (721)
..+.||+|+||+||+|+. .+++.||||++....... ....+.|.+|+.+++.++| +|+..+ .
T Consensus 82 ~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~--~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 159 (413)
T 3dzo_A 82 RGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPP--SNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKD 159 (413)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC------CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEEC
T ss_pred EecccccCCCEEEEEEEecCCCCceEEEEEecCCCcc--HHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhccc
Confidence 345788999999999994 578999999886433222 2224679999999999987 322111 1
Q ss_pred -------EEEecCC---CceEEEEEecCCCCChhhhhhh-----ccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeC
Q 004979 495 -------GYCEEDE---PFTRMMVFEYSPNGSLFEHLHI-----QEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRN 559 (721)
Q Consensus 495 -------g~~~~~~---~~~~~lV~Ey~~~GsL~~~l~~-----~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrD 559 (721)
.++.... ....+++|+++ +|+|.+++.. .....+++..++.|+.||+.||+|||+++ |+|||
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--iiHrD 236 (413)
T 3dzo_A 160 PQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LVHTY 236 (413)
T ss_dssp CC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT--EECSC
T ss_pred CCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCC
Confidence 1111111 12346777765 7899998841 22345788899999999999999999998 99999
Q ss_pred CCCCCeEeCCCCcEEEeccCCCCCC------CCCCccccchhhc----------ccCCCCCCccHHHHHHHHHHHHhCCC
Q 004979 560 LQSSSIYLTEDYAAKISDFSFWNNT------TAAKTGSAAMELL----------ETSAVDLESNVYSFGTILFEMITGRI 623 (721)
Q Consensus 560 LKp~NILl~~~~~~kL~DFGla~~~------~~~~~~~~apE~~----------~~~~~s~ksDVwSfGvvL~ElltG~~ 623 (721)
|||+|||++.++.+||+|||+++.. ..+ ..|+|||.+ ....++.++|||||||++|||+||+.
T Consensus 237 iKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~ 315 (413)
T 3dzo_A 237 LRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADL 315 (413)
T ss_dssp CCGGGEEECTTCCEEECCGGGCEETTEEECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSC
T ss_pred cccceEEEecCCeEEEEeccceeecCCccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCC
Confidence 9999999999999999999997532 234 789999998 55668899999999999999999999
Q ss_pred cccCCCCCHHHHHHHHhhcCCCCccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 624 SYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 624 P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
||...... .....++.. ...+++++.+|+.+||+.||++||++.|+++
T Consensus 316 Pf~~~~~~------------~~~~~~~~~-----~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 316 PNTDDAAL------------GGSEWIFRS-----CKNIPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp CCCTTGGG------------SCSGGGGSS-----CCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCcchh------------hhHHHHHhh-----cccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 99643210 111111110 0123467999999999999999999777643
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-34 Score=306.11 Aligned_cols=242 Identities=13% Similarity=0.133 Sum_probs=179.0
Q ss_pred hhhhCcCCCCceeEEEEEEecCCcEEEEEEeeeccccc---hhhHHHHHHHHHHHHHhcCC---------CCccceEeEE
Q 004979 429 SNIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRAD---WSKNLESQFRKKIDTLSKVN---------HKNFVNLIGY 496 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~~~~~vavk~~~~~~~~~---~~~~~~~~f~~Ei~~l~~l~---------H~nIv~l~g~ 496 (721)
+++++.+|+|+||+||+|+. +++.||||++....... ......+.+.+|++++++++ |||||+++++
T Consensus 22 y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~ 100 (336)
T 2vuw_A 22 LQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSV 100 (336)
T ss_dssp HHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEE
T ss_pred chheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhcce
Confidence 47788999999999999998 68999999997653210 01122356888888888875 7777777776
Q ss_pred EecC----------------------------CCceEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHH
Q 004979 497 CEED----------------------------EPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHM 548 (721)
Q Consensus 497 ~~~~----------------------------~~~~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yL 548 (721)
+... +....++||||+++|++.+.+.. ..+++..+..|+.||+.||+||
T Consensus 101 ~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~aL~~l 177 (336)
T 2vuw_A 101 HCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTASLAVA 177 (336)
T ss_dssp EEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHHHHHH
T ss_pred eEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHHHHHH
Confidence 4310 02267999999999987776632 5689999999999999999999
Q ss_pred h-cCCCCeEeeCCCCCCeEeCCCC--------------------cEEEeccCCCCCCC----CCCccccchhhcccCCCC
Q 004979 549 H-QLTPPIAHRNLQSSSIYLTEDY--------------------AAKISDFSFWNNTT----AAKTGSAAMELLETSAVD 603 (721)
Q Consensus 549 H-~~~~~IvHrDLKp~NILl~~~~--------------------~~kL~DFGla~~~~----~~~~~~~apE~~~~~~~s 603 (721)
| +++ |+||||||+|||++.++ .+||+|||+++... .++..|+|||.+.+.. +
T Consensus 178 H~~~~--ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~~~~gt~~y~aPE~~~g~~-~ 254 (336)
T 2vuw_A 178 EASLR--FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTGDG-D 254 (336)
T ss_dssp HHHHC--CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETTEEECCCCTTCSGGGCCCS-S
T ss_pred HHhCC--EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCCcEEEeecccChhhhcCCC-c
Confidence 9 888 99999999999999887 89999999987543 3567899999998666 8
Q ss_pred CCccHHHHHHH-HHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccHHHHHHHHHHHHHcccCCCCCCCC
Q 004979 604 LESNVYSFGTI-LFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPS 682 (721)
Q Consensus 604 ~ksDVwSfGvv-L~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs 682 (721)
.++||||+|++ .+++++|..||.... ............ .... ...........+.++.+|+.+||+.| |
T Consensus 255 ~~~Diwsl~~~~~~~~~~g~~p~~~~~-~~~~~~~~~~~~-~~~~---~~~~~~~~~~~s~~~~dli~~~L~~d-----s 324 (336)
T 2vuw_A 255 YQFDIYRLMKKENNNRWGEYHPYSNVL-WLHYLTDKMLKQ-MTFK---TKCNTPAMKQIKRKIQEFHRTMLNFS-----S 324 (336)
T ss_dssp HHHHHHHHHHHHHTTCTTSCCTHHHHH-HHHHHHHHHHHT-CCCS---SCCCSHHHHHHHHHHHHHHHHGGGSS-----S
T ss_pred cceehhhhhCCCCcccccccCCCcchh-hhhHHHHhhhhh-hccC---cccchhhhhhcCHHHHHHHHHHhccC-----C
Confidence 99999998777 788889999984210 000111111111 1111 01112234568889999999999976 8
Q ss_pred HHHHH
Q 004979 683 MRGIA 687 (721)
Q Consensus 683 ~~evl 687 (721)
+.|++
T Consensus 325 a~e~l 329 (336)
T 2vuw_A 325 ATDLL 329 (336)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 98887
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.4e-27 Score=269.60 Aligned_cols=180 Identities=13% Similarity=0.089 Sum_probs=125.2
Q ss_pred CCCceeEEEEEE-ecCCcEEEEEEeeecccc-----chhhHHHHHHHHHHHHHhcC-CCCccceEeEEEecCCCceEEEE
Q 004979 436 SDGTVGTVYKGT-LSSGVEIAVTSTSVKSRA-----DWSKNLESQFRKKIDTLSKV-NHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 436 g~G~~g~Vyk~~-~~~~~~vavk~~~~~~~~-----~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
+.|+.|.+++++ .-.|..++||.+...... .......++|.+|+++|+++ .|+||+++++++.+++ ..|||
T Consensus 243 ~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~--~~yLV 320 (569)
T 4azs_A 243 YAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQ--SGWLV 320 (569)
T ss_dssp C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSS--EEEEE
T ss_pred ccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECC--EEEEE
Confidence 345555555544 345788999988654211 12234456799999999999 7999999999999887 78999
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCCC--
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTA-- 586 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~~-- 586 (721)
|||++||+|.++|.. ...++.. +|+.||+.||+|+|+++ ||||||||+||||++++.+||+|||+++....
T Consensus 321 MEyv~G~~L~d~i~~--~~~l~~~---~I~~QIl~AL~ylH~~G--IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~ 393 (569)
T 4azs_A 321 MEKLPGRLLSDMLAA--GEEIDRE---KILGSLLRSLAALEKQG--FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC 393 (569)
T ss_dssp EECCCSEEHHHHHHT--TCCCCHH---HHHHHHHHHHHHHHHTT--CEESCCCGGGEEECTTSCEEECCCTTEESCC---
T ss_pred EecCCCCcHHHHHHh--CCCCCHH---HHHHHHHHHHHHHHHCC--ceeccCchHhEEECCCCCEEEeecccCeeCCCCC
Confidence 999999999999964 3456653 58999999999999999 99999999999999999999999999875432
Q ss_pred -------CCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcc
Q 004979 587 -------AKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISY 625 (721)
Q Consensus 587 -------~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~ 625 (721)
++..|+|||.+.+ .+..++|+||+|++++++.++..++
T Consensus 394 ~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 394 SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp CCSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence 3457899999865 4678899999999999887765443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.1e-24 Score=247.60 Aligned_cols=176 Identities=13% Similarity=0.145 Sum_probs=138.8
Q ss_pred CcCCCCceeEEEEEEecCCcEEEEEEeeeccccch---hhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEEE
Q 004979 433 GSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADW---SKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVF 509 (721)
Q Consensus 433 ~~lg~G~~g~Vyk~~~~~~~~vavk~~~~~~~~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV~ 509 (721)
+.+|+|+||+||+|+. .+..+++|+...+..... .....++|.+|++++++++||||+++..++...+ ..++||
T Consensus 342 ~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~--~~~lVm 418 (540)
T 3en9_A 342 HLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLD--NKRIMM 418 (540)
T ss_dssp ------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETT--TTEEEE
T ss_pred CEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCC--ccEEEE
Confidence 4678999999999954 467888887654432211 1123466899999999999999996665555555 459999
Q ss_pred ecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCCC---
Q 004979 510 EYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTA--- 586 (721)
Q Consensus 510 Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~~--- 586 (721)
||+++|+|.+++.. +..|+.|++.||+|||+++ |+||||||+|||+++ .+||+|||+++....
T Consensus 419 E~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~g--IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~ 484 (540)
T 3en9_A 419 SYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKND--VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDED 484 (540)
T ss_dssp ECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHTT--EECTTCCTTSEEESS--SEEECCCTTCEECCCHHH
T ss_pred ECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHCc--CccCCCCHHHEEECC--eEEEEECccCEECCCccc
Confidence 99999999999863 5689999999999999998 999999999999999 999999999875433
Q ss_pred -------------CCccccchhhccc--CCCCCCccHHHHHHHHHHHHhCCCcc
Q 004979 587 -------------AKTGSAAMELLET--SAVDLESNVYSFGTILFEMITGRISY 625 (721)
Q Consensus 587 -------------~~~~~~apE~~~~--~~~s~ksDVwSfGvvL~ElltG~~P~ 625 (721)
++..|+|||++.. ..|+..+|+|+..+-..|.+.++.+|
T Consensus 485 ~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 485 KAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred cccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 3457899999876 66788899999999999988887776
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.89 E-value=2.6e-23 Score=220.28 Aligned_cols=158 Identities=27% Similarity=0.473 Sum_probs=147.3
Q ss_pred cCChHHHHHHHHHHHhcccCCCCCCCCCCCCCCCCCCCCCCc--eeeEEeCC----CcEEEEEeCCCCCCC--cCchhhc
Q 004979 68 RCLNSEGMALLRFRERVVRDPFGALSKWSDNDGVGDNVNPCS--WFGVECSD----GKVVILNLRDLCLGG--MLAPELG 139 (721)
Q Consensus 68 ~~~~~~~~~ll~~k~~~~~~~~~~l~~W~~~~~~~~~~~~C~--w~gv~C~~----~~v~~l~L~~~~l~G--~ip~~l~ 139 (721)
.|.+.|..||++||+++. ||. .+.+|+.. .+||. |.||+|+. ++|+.|+|+++++.| .+|+.++
T Consensus 2 ~c~~~~~~aL~~~k~~~~-~~~-~l~~W~~~------~~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~l~ 73 (313)
T 1ogq_A 2 LCNPQDKQALLQIKKDLG-NPT-TLSSWLPT------TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLA 73 (313)
T ss_dssp CSCHHHHHHHHHHHHHTT-CCG-GGTTCCTT------SCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGG
T ss_pred CCCHHHHHHHHHHHHhcC-Ccc-cccCCCCC------CCCCcCCCcceEeCCCCCCceEEEEECCCCCccCCcccChhHh
Confidence 377889999999999984 665 78999653 37898 99999974 799999999999999 9999999
Q ss_pred CCCCCCEEEccC-CcccccCchhhcCCCCCCEeEcccCcccccCCccccCCCCCCEEECccCCCCcCCChhccCCCCCCE
Q 004979 140 QLSELKSIILRN-NSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLLDNNQYLGGISPELHVLKVISE 218 (721)
Q Consensus 140 ~l~~L~~L~L~~-n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~~L~~l~l~~N~~~G~iP~~~~~l~~L~~ 218 (721)
++++|++|+|++ |++.|.+|..++++++|++|+|++|+++|.+|..+.++++|++|+|++|.++|.+|..+..+++|++
T Consensus 74 ~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 153 (313)
T 1ogq_A 74 NLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVG 153 (313)
T ss_dssp GCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCE
T ss_pred CCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCe
Confidence 999999999995 9999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred EEccCCCCCCccccc
Q 004979 219 IQVDESWLTNAASRA 233 (721)
Q Consensus 219 l~l~~n~~~g~~p~~ 233 (721)
|+|++|.++|.+|..
T Consensus 154 L~L~~N~l~~~~p~~ 168 (313)
T 1ogq_A 154 ITFDGNRISGAIPDS 168 (313)
T ss_dssp EECCSSCCEEECCGG
T ss_pred EECcCCcccCcCCHH
Confidence 999999999998874
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=4.5e-22 Score=207.39 Aligned_cols=159 Identities=14% Similarity=0.126 Sum_probs=122.1
Q ss_pred hhhCcCCCCceeEEEEEEecCCcEEEEEEeeecccc-------------chhhHHHHHHHHHHHHHhcCCCCccceEeEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRA-------------DWSKNLESQFRKKIDTLSKVNHKNFVNLIGY 496 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~~~~~vavk~~~~~~~~-------------~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~ 496 (721)
.+.+.+|+|+||.||+|+..++..||+|.+...... .|.......+.+|+++|++++ | ++++++
T Consensus 93 ~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~ 169 (282)
T 1zar_A 93 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKV 169 (282)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCE
T ss_pred EecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeE
Confidence 456789999999999999977899999998643211 011124567999999999999 5 666666
Q ss_pred EecCCCceEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEe
Q 004979 497 CEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKIS 576 (721)
Q Consensus 497 ~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~ 576 (721)
+... ..++||||+++|+|.+ +.. .....++.|++.||+|||+++ |+||||||+|||++ ++.+||+
T Consensus 170 ~~~~---~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH~~g--iiHrDlkp~NILl~-~~~vkl~ 234 (282)
T 1zar_A 170 YAWE---GNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLVS-EEGIWII 234 (282)
T ss_dssp EEEE---TTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEE-TTEEEEC
T ss_pred Eecc---ceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHHHCC--CEeCCCCHHHEEEE-CCcEEEE
Confidence 5443 3489999999999988 421 123469999999999999998 99999999999999 9999999
Q ss_pred ccCCCCCCCCCCccccchhhccc----------CCCCCCccHHH
Q 004979 577 DFSFWNNTTAAKTGSAAMELLET----------SAVDLESNVYS 610 (721)
Q Consensus 577 DFGla~~~~~~~~~~~apE~~~~----------~~~s~ksDVwS 610 (721)
|||+++.. ..+.|||.+.. .+|..++|+|.
T Consensus 235 DFG~a~~~----~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~ 274 (282)
T 1zar_A 235 DFPQSVEV----GEEGWREILERDVRNIITYFSRTYRTEKDINS 274 (282)
T ss_dssp CCTTCEET----TSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred ECCCCeEC----CCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence 99998743 34678887642 44556666664
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=1.1e-21 Score=232.92 Aligned_cols=159 Identities=23% Similarity=0.299 Sum_probs=122.7
Q ss_pred hccCChHHHHHHHHHHHhcccCCCCCCCCCCCCCCCCCCCCCCceeeEEeCCCcEEEEEeCCCCCCCc---Cch------
Q 004979 66 LARCLNSEGMALLRFRERVVRDPFGALSKWSDNDGVGDNVNPCSWFGVECSDGKVVILNLRDLCLGGM---LAP------ 136 (721)
Q Consensus 66 ~~~~~~~~~~~ll~~k~~~~~~~~~~l~~W~~~~~~~~~~~~C~w~gv~C~~~~v~~l~L~~~~l~G~---ip~------ 136 (721)
++.+.++|+.||++||+++. ||. .+++|+.. .+||+|.||+|+.++|+.|+|+++++.|. +|+
T Consensus 6 ~~~~~~~~~~all~~k~~~~-~~~-~l~~W~~~------~~~C~w~gv~C~~~~v~~L~L~~~~l~g~~~~l~~~l~~L~ 77 (768)
T 3rgz_A 6 PSQSLYREIHQLISFKDVLP-DKN-LLPDWSSN------KNPCTFDGVTCRDDKVTSIDLSSKPLNVGFSAVSSSLLSLT 77 (768)
T ss_dssp --CCHHHHHHHHHHHHTTCS-CTT-SSTTCCTT------SCGGGSTTEEEETTEEEEEECTTSCCCEEHHHHHHHTTTCT
T ss_pred cccCCHHHHHHHHHHHhhCC-Ccc-cccCCCCC------CCCcCCcceEECCCcEEEEECCCCCcCCccCccChhHhccC
Confidence 34456789999999999986 787 89999743 47999999999989999999999999998 665
Q ss_pred -----------------hhcCCCCCCEEEccCCcccccCch--hhcCCCCCCEeEcccCcccccCCccc-cCCCCCCEEE
Q 004979 137 -----------------ELGQLSELKSIILRNNSFFGTIPK--EIGELKELEILDLGFNNFSGPFPSDF-GNSFSLTTLL 196 (721)
Q Consensus 137 -----------------~l~~l~~L~~L~L~~n~l~G~ip~--~l~~l~~L~~l~ls~N~l~G~iP~~~-~~~~~L~~l~ 196 (721)
.++++++|++|||++|.++|.+|. .+++|++|++|||++|.++|.+|..+ .++++|++|+
T Consensus 78 ~L~~l~~~~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~ 157 (768)
T 3rgz_A 78 GLESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLD 157 (768)
T ss_dssp TCCEEECTTSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEE
T ss_pred cccccCCcCCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEE
Confidence 556667777777777777777777 77777777777777777777777665 6777777777
Q ss_pred CccCCCCcCCChh---ccCCCCCCEEEccCCCCCCcccc
Q 004979 197 LDNNQYLGGISPE---LHVLKVISEIQVDESWLTNAASR 232 (721)
Q Consensus 197 l~~N~~~G~iP~~---~~~l~~L~~l~l~~n~~~g~~p~ 232 (721)
|++|+++|.+|.. +.++++|++|+|++|.++|.+|.
T Consensus 158 Ls~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~ 196 (768)
T 3rgz_A 158 LSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDV 196 (768)
T ss_dssp CCSSCCEEETHHHHHHTTCCTTCCEEECCSSEEESCCBC
T ss_pred CCCCccCCcCChhhhhhccCCCCCEEECCCCcccccCCc
Confidence 7777777777665 56666666666666666665544
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.83 E-value=1.1e-20 Score=224.57 Aligned_cols=157 Identities=21% Similarity=0.267 Sum_probs=140.3
Q ss_pred ChHHHHHHHHHHHhcccCCCCCCCCCCCCCCCCCCCCC--Cce------------eeEEeC-CCcEEEEEeCCCCCCCcC
Q 004979 70 LNSEGMALLRFRERVVRDPFGALSKWSDNDGVGDNVNP--CSW------------FGVECS-DGKVVILNLRDLCLGGML 134 (721)
Q Consensus 70 ~~~~~~~ll~~k~~~~~~~~~~l~~W~~~~~~~~~~~~--C~w------------~gv~C~-~~~v~~l~L~~~~l~G~i 134 (721)
...|..||++||+++. +| +|+.++.+.. .+| |.| .||+|+ .++|+.|+|++++|.|.+
T Consensus 267 ~~~d~~ALl~~k~~l~-~~-----~W~~~~~~~~-~~~~~C~W~~~~~~~~w~~~~GV~C~~~~~V~~L~Ls~~~L~G~i 339 (876)
T 4ecn_A 267 YIKDYKALKAIWEALD-GK-----NWRYYSGTIN-NTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRV 339 (876)
T ss_dssp HHHHHHHHHHHHHHTT-GG-----GCCCCCSSCS-SCCCCCSCCCSSCGGGTTCCTTEEECTTSCEEEEECTTTCCEEEE
T ss_pred chHHHHHHHHHHHHcC-CC-----CCCcCCCccc-ccCCccccccccccccccCcCceEecCCCCEEEEECccCCCCCcC
Confidence 3579999999999984 44 8976542211 345 999 999998 589999999999999999
Q ss_pred chhhcCCCCCCEEEc-cCCccccc--------------------------------------------------------
Q 004979 135 APELGQLSELKSIIL-RNNSFFGT-------------------------------------------------------- 157 (721)
Q Consensus 135 p~~l~~l~~L~~L~L-~~n~l~G~-------------------------------------------------------- 157 (721)
|++|++|++|++|+| ++|.++|.
T Consensus 340 p~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~i~~ 419 (876)
T 4ecn_A 340 PDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKK 419 (876)
T ss_dssp CGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCCCCC
T ss_pred chHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCcccccccc
Confidence 999999999999999 88877766
Q ss_pred --------------------CchhhcCCCCCCEeEcccCcccc-----------------cCCcccc--CCCCCCEEECc
Q 004979 158 --------------------IPKEIGELKELEILDLGFNNFSG-----------------PFPSDFG--NSFSLTTLLLD 198 (721)
Q Consensus 158 --------------------ip~~l~~l~~L~~l~ls~N~l~G-----------------~iP~~~~--~~~~L~~l~l~ 198 (721)
||..++++++|+.|+|++|+|+| .||..++ ++++|++|+|+
T Consensus 420 ~~~l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls 499 (876)
T 4ecn_A 420 DSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELY 499 (876)
T ss_dssp CCCCCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEE
T ss_pred ccccchhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECc
Confidence 89999999999999999999999 5999998 99999999999
Q ss_pred cCCCCcCCChhccCCCCCCEEEccCCC-CCC-ccccc
Q 004979 199 NNQYLGGISPELHVLKVISEIQVDESW-LTN-AASRA 233 (721)
Q Consensus 199 ~N~~~G~iP~~~~~l~~L~~l~l~~n~-~~g-~~p~~ 233 (721)
+|++.|.+|..++++++|+.|+|++|. ++| .+|..
T Consensus 500 ~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~ 536 (876)
T 4ecn_A 500 NCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKAD 536 (876)
T ss_dssp SCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHH
T ss_pred CCCCCccChHHHhCCCCCCEEECcCCCCcccccchHH
Confidence 999999999999999999999999998 999 88863
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.82 E-value=1.3e-20 Score=218.98 Aligned_cols=156 Identities=21% Similarity=0.265 Sum_probs=137.1
Q ss_pred hHHHHHHHHHHHhcccCC-------CCCCCCCCCCCCCCCCCCCCce---eeEEeC-CCcEEEEEeCCCCCCCcCchhhc
Q 004979 71 NSEGMALLRFRERVVRDP-------FGALSKWSDNDGVGDNVNPCSW---FGVECS-DGKVVILNLRDLCLGGMLAPELG 139 (721)
Q Consensus 71 ~~~~~~ll~~k~~~~~~~-------~~~l~~W~~~~~~~~~~~~C~w---~gv~C~-~~~v~~l~L~~~~l~G~ip~~l~ 139 (721)
..|..||.+++.++..+. .....+|+. +.+||.| .||+|+ .++|+.|+|++++++|.+|++++
T Consensus 29 ~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~------~~~~c~w~~~~GV~C~~~~~V~~L~L~~~~l~g~lp~~l~ 102 (636)
T 4eco_A 29 IKDYLALKEIWDALNGKNWSQQGFGTQPGANWNF------NKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIG 102 (636)
T ss_dssp HHHHHHHHHHHHHTTGGGCCCCC------CCCCC------SSCGGGTTCCTTEEECTTCCEEEEECTTSCCEEEECGGGG
T ss_pred HHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCC------CCCcccccCCCCeEEcCCCCEEEEEecCcccCCcCChHHh
Confidence 468999999999875321 111235653 3589999 999997 47999999999999999999999
Q ss_pred CCCCCCEEEccCC-------------------------------------------------------------------
Q 004979 140 QLSELKSIILRNN------------------------------------------------------------------- 152 (721)
Q Consensus 140 ~l~~L~~L~L~~n------------------------------------------------------------------- 152 (721)
+|++|++|+|++|
T Consensus 103 ~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~ 182 (636)
T 4eco_A 103 QLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRIT 182 (636)
T ss_dssp GCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCCCCCC
T ss_pred cCccceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHHHHHHhhcCccccccccccccc
Confidence 9999999999988
Q ss_pred -----------cccccCchhhcCCCCCCEeEcccCccccc-----------------CCcccc--CCCCCCEEECccCCC
Q 004979 153 -----------SFFGTIPKEIGELKELEILDLGFNNFSGP-----------------FPSDFG--NSFSLTTLLLDNNQY 202 (721)
Q Consensus 153 -----------~l~G~ip~~l~~l~~L~~l~ls~N~l~G~-----------------iP~~~~--~~~~L~~l~l~~N~~ 202 (721)
+|+| ||..++++++|++|+|++|+|+|. +|..++ ++++|++|+|++|++
T Consensus 183 l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l 261 (636)
T 4eco_A 183 LKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPN 261 (636)
T ss_dssp CCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTT
T ss_pred hhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcC
Confidence 4556 999999999999999999999997 999999 999999999999999
Q ss_pred CcCCChhccCCCCCCEEEccCCC-CCC-ccccc
Q 004979 203 LGGISPELHVLKVISEIQVDESW-LTN-AASRA 233 (721)
Q Consensus 203 ~G~iP~~~~~l~~L~~l~l~~n~-~~g-~~p~~ 233 (721)
+|.+|..++++++|++|+|++|. ++| .+|..
T Consensus 262 ~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~ 294 (636)
T 4eco_A 262 LTKLPTFLKALPEMQLINVACNRGISGEQLKDD 294 (636)
T ss_dssp CSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHH
T ss_pred CccChHHHhcCCCCCEEECcCCCCCccccchHH
Confidence 99999999999999999999998 999 88863
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.74 E-value=4.4e-19 Score=188.97 Aligned_cols=159 Identities=17% Similarity=0.226 Sum_probs=140.9
Q ss_pred CChHHHHHHHHHHHhcccCCCCCCCCCCCCCCCCCCCCCCceeeEEeC----------CCcEEEEEeCCCCCCCcCchhh
Q 004979 69 CLNSEGMALLRFRERVVRDPFGALSKWSDNDGVGDNVNPCSWFGVECS----------DGKVVILNLRDLCLGGMLAPEL 138 (721)
Q Consensus 69 ~~~~~~~~ll~~k~~~~~~~~~~l~~W~~~~~~~~~~~~C~w~gv~C~----------~~~v~~l~L~~~~l~G~ip~~l 138 (721)
+..++..||++||..+..|+.+.+++|.... ....++|.|.|+.|. ..+|+.|+|++|.+. .+|+.+
T Consensus 24 ~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~--~~~~~~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~~l 100 (328)
T 4fcg_A 24 ALRPYHDVLSQWQRHYNADRNRWHSAWRQAN--SNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQA 100 (328)
T ss_dssp CCCCHHHHHHHHHHHHHHCCTTHHHHHHHHT--TTCTTSCCSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCSCG
T ss_pred cCchHHHHHHHHHHhccCCchhhhhhhcccc--cccccccccCCcchhhhHHHHhcccccceeEEEccCCCch-hcChhh
Confidence 5578999999999988778877778894211 012578999999994 268999999999998 899999
Q ss_pred cCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCccccCCCCCCEEECccCCCCcCCChhccC------
Q 004979 139 GQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLLDNNQYLGGISPELHV------ 212 (721)
Q Consensus 139 ~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~~L~~l~l~~N~~~G~iP~~~~~------ 212 (721)
+++++|++|+|++|.++ .+|..++++++|++|+|++|+++ .||..++++++|++|+|++|++.|.+|..++.
T Consensus 101 ~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~ 178 (328)
T 4fcg_A 101 FRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGE 178 (328)
T ss_dssp GGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCC
T ss_pred hhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccchhh
Confidence 99999999999999999 99999999999999999999999 99999999999999999999999999998765
Q ss_pred ---CCCCCEEEccCCCCCCccccc
Q 004979 213 ---LKVISEIQVDESWLTNAASRA 233 (721)
Q Consensus 213 ---l~~L~~l~l~~n~~~g~~p~~ 233 (721)
+++|++|+|++|.++ .+|..
T Consensus 179 ~~~l~~L~~L~L~~n~l~-~lp~~ 201 (328)
T 4fcg_A 179 HQGLVNLQSLRLEWTGIR-SLPAS 201 (328)
T ss_dssp EEESTTCCEEEEEEECCC-CCCGG
T ss_pred hccCCCCCEEECcCCCcC-cchHh
Confidence 999999999999999 77764
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.74 E-value=2.7e-18 Score=176.43 Aligned_cols=141 Identities=13% Similarity=0.114 Sum_probs=104.8
Q ss_pred hhhhCcCCCCceeEEEEEEe-cCCcE--EEEEEeeeccccch-------------------hhHHHHHHHHHHHHHhcCC
Q 004979 429 SNIIGSFSDGTVGTVYKGTL-SSGVE--IAVTSTSVKSRADW-------------------SKNLESQFRKKIDTLSKVN 486 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~-~~~~~--vavk~~~~~~~~~~-------------------~~~~~~~f~~Ei~~l~~l~ 486 (721)
+++.+.+|+|+||.||+|.. .+|.. ||||+......... .......+.+|+++|.+++
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 35667899999999999997 67888 99998653211100 1122346889999999998
Q ss_pred CCcc--ceEeEEEecCCCceEEEEEecCCC-C----ChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHh-cCCCCeEee
Q 004979 487 HKNF--VNLIGYCEEDEPFTRMMVFEYSPN-G----SLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMH-QLTPPIAHR 558 (721)
Q Consensus 487 H~nI--v~l~g~~~~~~~~~~~lV~Ey~~~-G----sL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH-~~~~~IvHr 558 (721)
|++| ..++++ . ..+|||||+.+ | +|.++... .++.....++.|++.||.||| +++ |+||
T Consensus 129 ~~~i~~p~~~~~--~----~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~g--ivHr 195 (258)
T 1zth_A 129 EAGVSVPQPYTY--M----KNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEAE--LVHA 195 (258)
T ss_dssp HTTCCCCCEEEE--E----TTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTSC--EECS
T ss_pred hCCCCCCeEEEc--C----CCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHCC--EEeC
Confidence 8864 334432 1 34899999942 4 56655421 223456789999999999999 888 9999
Q ss_pred CCCCCCeEeCCCCcEEEeccCCCCCC
Q 004979 559 NLQSSSIYLTEDYAAKISDFSFWNNT 584 (721)
Q Consensus 559 DLKp~NILl~~~~~~kL~DFGla~~~ 584 (721)
||||+|||+++ .++|+|||++...
T Consensus 196 Dlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 196 DLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SCSTTSEEESS--SEEECCCTTCEET
T ss_pred CCCHHHEEEcC--cEEEEECcccccC
Confidence 99999999998 9999999998654
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.60 E-value=2e-15 Score=147.71 Aligned_cols=125 Identities=22% Similarity=0.259 Sum_probs=114.6
Q ss_pred CceeeEEeCC-----------CcEEEEEeCCCCCCCcCch-hhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEccc
Q 004979 108 CSWFGVECSD-----------GKVVILNLRDLCLGGMLAP-ELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGF 175 (721)
Q Consensus 108 C~w~gv~C~~-----------~~v~~l~L~~~~l~G~ip~-~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~ 175 (721)
|.|..+.|.. ..++.|+|++|.+++..+. .++.+++|++|+|++|.+++.+|..+.++++|+.|+|++
T Consensus 8 C~~~~l~~s~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 8 CEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp EETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred ECCCEEEcCCCCcCcCccCCCCCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 7899999963 2678999999999877665 389999999999999999999999999999999999999
Q ss_pred CcccccCCccccCCCCCCEEECccCCCCcCCChhccCCCCCCEEEccCCCCCCcccc
Q 004979 176 NNFSGPFPSDFGNSFSLTTLLLDNNQYLGGISPELHVLKVISEIQVDESWLTNAASR 232 (721)
Q Consensus 176 N~l~G~iP~~~~~~~~L~~l~l~~N~~~G~iP~~~~~l~~L~~l~l~~n~~~g~~p~ 232 (721)
|++++..|..+.++++|++|+|++|+++|.+|..+..+++|++|+|++|.|++..+.
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l 144 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHL 144 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGG
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcc
Confidence 999998888899999999999999999999999999999999999999999987653
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.58 E-value=1.1e-15 Score=163.66 Aligned_cols=141 Identities=9% Similarity=0.071 Sum_probs=99.5
Q ss_pred hhhhhCcCCCCceeEEEEEEecCCcEEEEEEeeecccc--------c---------hhhHHHHHHHHHHHHHhcCCCCcc
Q 004979 428 FSNIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRA--------D---------WSKNLESQFRKKIDTLSKVNHKNF 490 (721)
Q Consensus 428 ~~~ii~~lg~G~~g~Vyk~~~~~~~~vavk~~~~~~~~--------~---------~~~~~~~~f~~Ei~~l~~l~H~nI 490 (721)
.|.+.+.||.|+||.||+|...+|+.||||+++..... + +.........+|...|.++.+.++
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 35778899999999999999989999999987532110 0 000111123456777777755544
Q ss_pred ceEeEEEecCCCceEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCC
Q 004979 491 VNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTED 570 (721)
Q Consensus 491 v~l~g~~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~ 570 (721)
.-..-+... ..+|||||++++.|.++... .....++.|++.+|.|||+++ ||||||||.|||++++
T Consensus 176 ~vp~p~~~~----~~~LVME~i~G~~L~~l~~~--------~~~~~l~~qll~~l~~lH~~g--IVHrDLKp~NILl~~d 241 (397)
T 4gyi_A 176 PVPEPIAQS----RHTIVMSLVDALPMRQVSSV--------PDPASLYADLIALILRLAKHG--LIHGDFNEFNILIREE 241 (397)
T ss_dssp SCCCEEEEE----TTEEEEECCSCEEGGGCCCC--------SCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEEEE
T ss_pred CCCeeeecc----CceEEEEecCCccHhhhccc--------HHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHEEEeCC
Confidence 222112222 12799999999888765421 123568899999999999998 9999999999999887
Q ss_pred C----------cEEEeccCCCC
Q 004979 571 Y----------AAKISDFSFWN 582 (721)
Q Consensus 571 ~----------~~kL~DFGla~ 582 (721)
+ .+.|+||+-+-
T Consensus 242 gd~~d~~~~~~~~~iID~~Q~V 263 (397)
T 4gyi_A 242 KDAEDPSSITLTPIIIXFPQMV 263 (397)
T ss_dssp ECSSCTTSEEEEEEECCCTTCE
T ss_pred CCcccccccccceEEEEeCCcc
Confidence 6 38999999654
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.57 E-value=1e-14 Score=146.74 Aligned_cols=125 Identities=22% Similarity=0.286 Sum_probs=111.4
Q ss_pred CCCCceeeEEeCC-----------CcEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEc
Q 004979 105 VNPCSWFGVECSD-----------GKVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDL 173 (721)
Q Consensus 105 ~~~C~w~gv~C~~-----------~~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~l 173 (721)
...|+|.+|.|.. ..++.|+|++|.+.+..|..+..+++|++|+|++|.+.+..+..+..+++|+.|+|
T Consensus 16 ~~~Cs~~~v~c~~~~l~~ip~~~~~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~L 95 (229)
T 3e6j_A 16 QCSCSGTTVDCRSKRHASVPAGIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDL 95 (229)
T ss_dssp TCEEETTEEECTTSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCEEeCCEeEccCCCcCccCCCCCCCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEEC
Confidence 3679999999963 25789999999999988989999999999999999996544456789999999999
Q ss_pred ccCcccccCCccccCCCCCCEEECccCCCCcCCChhccCCCCCCEEEccCCCCCCcc
Q 004979 174 GFNNFSGPFPSDFGNSFSLTTLLLDNNQYLGGISPELHVLKVISEIQVDESWLTNAA 230 (721)
Q Consensus 174 s~N~l~G~iP~~~~~~~~L~~l~l~~N~~~G~iP~~~~~l~~L~~l~l~~n~~~g~~ 230 (721)
++|++++..+..+..+++|++|+|++|+++ .||..+..+++|++|+|++|.+++-.
T Consensus 96 s~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~ 151 (229)
T 3e6j_A 96 GTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIP 151 (229)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCC
T ss_pred CCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccC
Confidence 999999766666889999999999999999 89999999999999999999999643
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.56 E-value=1.3e-15 Score=180.88 Aligned_cols=111 Identities=29% Similarity=0.472 Sum_probs=105.9
Q ss_pred EEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCccccCCCCCCEEECccCCC
Q 004979 123 LNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLLDNNQY 202 (721)
Q Consensus 123 l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~~L~~l~l~~N~~ 202 (721)
+++..+.+.|.+|+.++++++|+.|||++|.|+|.||.++++++.|+.|||++|+|+|.||..++++++|++|||++|++
T Consensus 613 ~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l 692 (768)
T 3rgz_A 613 CNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKL 692 (768)
T ss_dssp SCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCC
T ss_pred cccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcc
Confidence 35566788899999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CcCCChhccCCCCCCEEEccCCCCCCccccc
Q 004979 203 LGGISPELHVLKVISEIQVDESWLTNAASRA 233 (721)
Q Consensus 203 ~G~iP~~~~~l~~L~~l~l~~n~~~g~~p~~ 233 (721)
+|.||..++.++.|++|+|++|+|+|.||..
T Consensus 693 ~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~ 723 (768)
T 3rgz_A 693 DGRIPQAMSALTMLTEIDLSNNNLSGPIPEM 723 (768)
T ss_dssp EECCCGGGGGCCCCSEEECCSSEEEEECCSS
T ss_pred cCcCChHHhCCCCCCEEECcCCcccccCCCc
Confidence 9999999999999999999999999999963
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.54 E-value=2.5e-14 Score=137.71 Aligned_cols=125 Identities=21% Similarity=0.215 Sum_probs=108.2
Q ss_pred CceeeEEeCC-----------CcEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccC
Q 004979 108 CSWFGVECSD-----------GKVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFN 176 (721)
Q Consensus 108 C~w~gv~C~~-----------~~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N 176 (721)
|+|.++.|.. ..++.|+|++|.+.+..+..+..+++|++|+|++|.+++..+..++.+++|+.|+|++|
T Consensus 7 C~~~~l~~~~~~l~~~p~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N 86 (177)
T 2o6r_A 7 CSGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHEN 86 (177)
T ss_dssp EETTEEECCSSCCSSCCTTCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred eCCCEEEecCCCCccCCCCCCCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCC
Confidence 7899999963 25789999999999766666899999999999999999766666899999999999999
Q ss_pred cccccCCccccCCCCCCEEECccCCCCcCCChhccCCCCCCEEEccCCCCCCcccc
Q 004979 177 NFSGPFPSDFGNSFSLTTLLLDNNQYLGGISPELHVLKVISEIQVDESWLTNAASR 232 (721)
Q Consensus 177 ~l~G~iP~~~~~~~~L~~l~l~~N~~~G~iP~~~~~l~~L~~l~l~~n~~~g~~p~ 232 (721)
++++..|..+..+++|++|+|++|++++-.+..+..+++|+.|+|++|.+++..|.
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~ 142 (177)
T 2o6r_A 87 KLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 142 (177)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHHH
T ss_pred CccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCcc
Confidence 99977667789999999999999999854444468899999999999999987763
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.50 E-value=1.1e-14 Score=153.98 Aligned_cols=116 Identities=21% Similarity=0.399 Sum_probs=110.6
Q ss_pred CcEEEEEeCC-CCCCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCccccCCCCCCEEE
Q 004979 118 GKVVILNLRD-LCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLL 196 (721)
Q Consensus 118 ~~v~~l~L~~-~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~~L~~l~ 196 (721)
.++..|+|++ |.+.|.+|..++++++|++|+|++|.++|.+|..++++++|++|+|++|.++|.+|..++++++|++|+
T Consensus 76 ~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 155 (313)
T 1ogq_A 76 PYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGIT 155 (313)
T ss_dssp TTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEE
T ss_pred CCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEE
Confidence 4678999995 999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CccCCCCcCCChhccCCC-CCCEEEccCCCCCCccccc
Q 004979 197 LDNNQYLGGISPELHVLK-VISEIQVDESWLTNAASRA 233 (721)
Q Consensus 197 l~~N~~~G~iP~~~~~l~-~L~~l~l~~n~~~g~~p~~ 233 (721)
|++|.++|.+|..++.+. +|+.|+|++|.++|.+|..
T Consensus 156 L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~ 193 (313)
T 1ogq_A 156 FDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPT 193 (313)
T ss_dssp CCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGG
T ss_pred CcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChH
Confidence 999999999999999998 9999999999999988864
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.50 E-value=8.6e-14 Score=137.59 Aligned_cols=125 Identities=20% Similarity=0.254 Sum_probs=108.3
Q ss_pred CCceeeEEeCC-----------CcEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEccc
Q 004979 107 PCSWFGVECSD-----------GKVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGF 175 (721)
Q Consensus 107 ~C~w~gv~C~~-----------~~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~ 175 (721)
.|.|.+|.|.. .+++.|+|++|.+.+..+..+..+++|++|+|++|.+++..+..+..+++|++|+|++
T Consensus 6 ~C~~~~v~c~~~~l~~~p~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~ 85 (208)
T 2o6s_A 6 SCSGTTVECYSQGRTSVPTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLST 85 (208)
T ss_dssp EEETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred EECCCEEEecCCCccCCCCCCCCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCC
Confidence 37899999963 2588999999999976666688999999999999999966566678999999999999
Q ss_pred CcccccCCccccCCCCCCEEECccCCCCcCCChhccCCCCCCEEEccCCCCCCccc
Q 004979 176 NNFSGPFPSDFGNSFSLTTLLLDNNQYLGGISPELHVLKVISEIQVDESWLTNAAS 231 (721)
Q Consensus 176 N~l~G~iP~~~~~~~~L~~l~l~~N~~~G~iP~~~~~l~~L~~l~l~~n~~~g~~p 231 (721)
|++++..+..+.++++|++|+|++|++++-.+..+..+++|+.|+|++|.+++..+
T Consensus 86 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 141 (208)
T 2o6s_A 86 NQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPD 141 (208)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCT
T ss_pred CcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCH
Confidence 99997666668999999999999999997666668999999999999999996433
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.49 E-value=6.7e-14 Score=139.92 Aligned_cols=125 Identities=19% Similarity=0.168 Sum_probs=112.0
Q ss_pred CceeeEEeCCC-----------cEEEEEeCCCCCCCcCch-hhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEccc
Q 004979 108 CSWFGVECSDG-----------KVVILNLRDLCLGGMLAP-ELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGF 175 (721)
Q Consensus 108 C~w~gv~C~~~-----------~v~~l~L~~~~l~G~ip~-~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~ 175 (721)
|.|..+.|... .++.|+|++|.+++..+. .+..+++|++|+|++|.+++..|..+..+++|+.|+|++
T Consensus 11 C~~~~l~~s~n~l~~iP~~~~~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 90 (220)
T 2v70_A 11 CEGTTVDCSNQKLNKIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTS 90 (220)
T ss_dssp EETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred ECCCEeEeCCCCcccCccCCCCCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCC
Confidence 78999999632 467899999999988664 478999999999999999988888899999999999999
Q ss_pred CcccccCCccccCCCCCCEEECccCCCCcCCChhccCCCCCCEEEccCCCCCCcccc
Q 004979 176 NNFSGPFPSDFGNSFSLTTLLLDNNQYLGGISPELHVLKVISEIQVDESWLTNAASR 232 (721)
Q Consensus 176 N~l~G~iP~~~~~~~~L~~l~l~~N~~~G~iP~~~~~l~~L~~l~l~~n~~~g~~p~ 232 (721)
|++++..|..+.++++|++|+|++|++++-.|..+..+++|+.|+|++|.+++..|.
T Consensus 91 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 147 (220)
T 2v70_A 91 NRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPG 147 (220)
T ss_dssp SCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTT
T ss_pred CccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHH
Confidence 999988788899999999999999999999999999999999999999999986664
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.48 E-value=1.1e-13 Score=138.39 Aligned_cols=124 Identities=23% Similarity=0.226 Sum_probs=111.2
Q ss_pred CceeeEEeCC-----------CcEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccC
Q 004979 108 CSWFGVECSD-----------GKVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFN 176 (721)
Q Consensus 108 C~w~gv~C~~-----------~~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N 176 (721)
|.|..|.|.. ..++.|+|++|.+.+..+..+..+++|++|+|++|.+++..|..+..+++|++|+|++|
T Consensus 11 C~~~~v~c~~~~l~~iP~~l~~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N 90 (220)
T 2v9t_B 11 CSNNIVDCRGKGLTEIPTNLPETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN 90 (220)
T ss_dssp EETTEEECTTSCCSSCCSSCCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred ECCCEEEcCCCCcCcCCCccCcCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence 7899999963 25789999999999877778999999999999999999999999999999999999999
Q ss_pred cccccCCccccCCCCCCEEECccCCCCcCCChhccCCCCCCEEEccCCCCCCccc
Q 004979 177 NFSGPFPSDFGNSFSLTTLLLDNNQYLGGISPELHVLKVISEIQVDESWLTNAAS 231 (721)
Q Consensus 177 ~l~G~iP~~~~~~~~L~~l~l~~N~~~G~iP~~~~~l~~L~~l~l~~n~~~g~~p 231 (721)
++++-.+..+.++++|++|+|++|++++-.|..+..+++|+.|+|++|.+++..+
T Consensus 91 ~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 145 (220)
T 2v9t_B 91 KITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAK 145 (220)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCT
T ss_pred cCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECH
Confidence 9995434446889999999999999999989999999999999999999997544
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.46 E-value=1.2e-13 Score=146.99 Aligned_cols=114 Identities=17% Similarity=0.142 Sum_probs=86.5
Q ss_pred CcEEEEEeCCCCCCCcCchhhcC---------CCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCccccC
Q 004979 118 GKVVILNLRDLCLGGMLAPELGQ---------LSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGN 188 (721)
Q Consensus 118 ~~v~~l~L~~~~l~G~ip~~l~~---------l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~~ 188 (721)
.++..|+|++|++.|.+|..++. +++|++|+|++|.++ .+|..++++++|+.|+|++|++++ +|+.++.
T Consensus 150 ~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~ 227 (328)
T 4fcg_A 150 NRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHH 227 (328)
T ss_dssp TTCCEEEEEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-CCGGGGG
T ss_pred cCCCEEECCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-Cchhhcc
Confidence 36777788887777777776654 777778888777777 777777777777777777777774 6667777
Q ss_pred CCCCCEEECccCCCCcCCChhccCCCCCCEEEccCCCCCCccccc
Q 004979 189 SFSLTTLLLDNNQYLGGISPELHVLKVISEIQVDESWLTNAASRA 233 (721)
Q Consensus 189 ~~~L~~l~l~~N~~~G~iP~~~~~l~~L~~l~l~~n~~~g~~p~~ 233 (721)
+++|++|+|++|++.|.+|..++.+++|+.|+|++|.+.+.+|..
T Consensus 228 l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~ 272 (328)
T 4fcg_A 228 LPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLD 272 (328)
T ss_dssp CTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTT
T ss_pred CCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchh
Confidence 777777777777777777777777777777777777777777753
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.45 E-value=2.1e-13 Score=139.10 Aligned_cols=109 Identities=21% Similarity=0.203 Sum_probs=72.4
Q ss_pred EEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCccccCCCCCCEEECcc
Q 004979 120 VVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLLDN 199 (721)
Q Consensus 120 v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~~L~~l~l~~ 199 (721)
+..|+|++|.+.+..+..+..+++|++|+|++|.+++..|..+..+++|+.|+|++|++++..|..+..+++|++|+|++
T Consensus 37 l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 116 (251)
T 3m19_A 37 TEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGG 116 (251)
T ss_dssp CCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCC
Confidence 45666666666666666666677777777777777666666666677777777777777655555566667777777777
Q ss_pred CCCCcCCChhccCCCCCCEEEccCCCCCC
Q 004979 200 NQYLGGISPELHVLKVISEIQVDESWLTN 228 (721)
Q Consensus 200 N~~~G~iP~~~~~l~~L~~l~l~~n~~~g 228 (721)
|++++-.+..+..+++|+.|+|++|.+++
T Consensus 117 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 145 (251)
T 3m19_A 117 NQLKSLPSGVFDRLTKLKELRLNTNQLQS 145 (251)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCCC
T ss_pred CcCCCcChhHhccCCcccEEECcCCcCCc
Confidence 77665444445666777777777776664
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.44 E-value=2.5e-13 Score=135.74 Aligned_cols=114 Identities=17% Similarity=0.108 Sum_probs=107.8
Q ss_pred CcEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCccccCCCCCCEEEC
Q 004979 118 GKVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLL 197 (721)
Q Consensus 118 ~~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~~L~~l~l 197 (721)
.++..|+|++|.+++..+..+..+++|++|+|++|.+++..|..+..+++|+.|+|++|++++..|..+.++++|++|+|
T Consensus 57 ~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 136 (220)
T 2v70_A 57 PQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSL 136 (220)
T ss_dssp TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEEC
T ss_pred CCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEEC
Confidence 57899999999999887778999999999999999999888888999999999999999999999999999999999999
Q ss_pred ccCCCCcCCChhccCCCCCCEEEccCCCCCCccc
Q 004979 198 DNNQYLGGISPELHVLKVISEIQVDESWLTNAAS 231 (721)
Q Consensus 198 ~~N~~~G~iP~~~~~l~~L~~l~l~~n~~~g~~p 231 (721)
++|++++-.|..+..+++|+.|+|++|.+++..+
T Consensus 137 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 170 (220)
T 2v70_A 137 YDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY 170 (220)
T ss_dssp TTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred CCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence 9999999999999999999999999999998654
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.44 E-value=3.4e-13 Score=131.88 Aligned_cols=121 Identities=23% Similarity=0.224 Sum_probs=100.9
Q ss_pred CceeeEEeCC-----------CcEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccC
Q 004979 108 CSWFGVECSD-----------GKVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFN 176 (721)
Q Consensus 108 C~w~gv~C~~-----------~~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N 176 (721)
|.|..+.|.. ..++.|+|++|.++ .+|..+.++++|+.|+|++|.+++..|..+..+++|+.|+|++|
T Consensus 10 C~~~~l~~~~~~l~~ip~~~~~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N 88 (193)
T 2wfh_A 10 CLDTVVRCSNKGLKVLPKGIPRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN 88 (193)
T ss_dssp EETTEEECTTSCCSSCCSCCCTTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred eCCCEEEcCCCCCCcCCCCCCCCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence 6788888853 25778899999887 67888888999999999999998877778888999999999999
Q ss_pred cccccCCccccCCCCCCEEECccCCCCcCCChhccCCCCCCEEEccCCCCCCc
Q 004979 177 NFSGPFPSDFGNSFSLTTLLLDNNQYLGGISPELHVLKVISEIQVDESWLTNA 229 (721)
Q Consensus 177 ~l~G~iP~~~~~~~~L~~l~l~~N~~~G~iP~~~~~l~~L~~l~l~~n~~~g~ 229 (721)
++++..|..+.++++|++|+|++|++++-.+..+..+++|+.|+|++|.++..
T Consensus 89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~ 141 (193)
T 2wfh_A 89 RLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCD 141 (193)
T ss_dssp CCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECS
T ss_pred ccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecC
Confidence 99987777888899999999999998865445678889999999999988754
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.43 E-value=8e-14 Score=163.82 Aligned_cols=106 Identities=24% Similarity=0.351 Sum_probs=50.9
Q ss_pred EEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCccccCCCCCCEEECccCC
Q 004979 122 ILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLLDNNQ 201 (721)
Q Consensus 122 ~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~~L~~l~l~~N~ 201 (721)
.|+|++|.+. .||+.++.|++|++|+|++|.|+ .||..+++|++|++|||++|+|+ .||..+++|++|++|+|++|.
T Consensus 228 ~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~ 304 (727)
T 4b8c_D 228 ALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNM 304 (727)
T ss_dssp EEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSC
T ss_pred EEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCC
Confidence 3444444443 34444444444445555544444 44444444445555555555444 444444444445555554444
Q ss_pred CCcCCChhccCCCCCCEEEccCCCCCCccc
Q 004979 202 YLGGISPELHVLKVISEIQVDESWLTNAAS 231 (721)
Q Consensus 202 ~~G~iP~~~~~l~~L~~l~l~~n~~~g~~p 231 (721)
++ .||..++.+++|+.|+|++|.|+|.+|
T Consensus 305 l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p 333 (727)
T 4b8c_D 305 VT-TLPWEFGNLCNLQFLGVEGNPLEKQFL 333 (727)
T ss_dssp CC-CCCSSTTSCTTCCCEECTTSCCCSHHH
T ss_pred CC-ccChhhhcCCCccEEeCCCCccCCCCh
Confidence 43 444444444455555555555444444
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.41 E-value=1.2e-13 Score=128.95 Aligned_cols=112 Identities=21% Similarity=0.183 Sum_probs=102.2
Q ss_pred CcEEEEEeCCCCCC-CcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCccccCCCCCCEEE
Q 004979 118 GKVVILNLRDLCLG-GMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLL 196 (721)
Q Consensus 118 ~~v~~l~L~~~~l~-G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~~L~~l~ 196 (721)
.+++.|+|++|.+. |.+|..+..+++|++|+|++|.+++. ..++.+++|++|+|++|.+++.+|..+..+++|++|+
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence 46889999999999 89999899999999999999999976 7889999999999999999998998888899999999
Q ss_pred CccCCCCc-CCChhccCCCCCCEEEccCCCCCCccc
Q 004979 197 LDNNQYLG-GISPELHVLKVISEIQVDESWLTNAAS 231 (721)
Q Consensus 197 l~~N~~~G-~iP~~~~~l~~L~~l~l~~n~~~g~~p 231 (721)
+++|.+++ ..|..+..+++|+.|++++|.+++..+
T Consensus 95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 130 (149)
T 2je0_A 95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLND 130 (149)
T ss_dssp CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTT
T ss_pred CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHH
Confidence 99999988 456889999999999999999987543
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.40 E-value=2.8e-13 Score=154.22 Aligned_cols=125 Identities=24% Similarity=0.251 Sum_probs=113.8
Q ss_pred CCceeeEEeCC-------------CcEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEc
Q 004979 107 PCSWFGVECSD-------------GKVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDL 173 (721)
Q Consensus 107 ~C~w~gv~C~~-------------~~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~l 173 (721)
.|.|.|+ |+. .+++.|+|++|.+++..|..+.++++|++|+|++|.+++..|..++++++|++|||
T Consensus 3 ~C~~~~~-c~~~~~~l~~ip~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L 81 (549)
T 2z81_A 3 SCDASGV-CDGRSRSFTSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDL 81 (549)
T ss_dssp EECTTSE-EECTTSCCSSCCSCCCTTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred cCCCCce-EECCCCccccccccCCCCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEEC
Confidence 4999998 852 26899999999999988889999999999999999999988899999999999999
Q ss_pred ccCcccccCCccccCCCCCCEEECccCCCCc-CCChhccCCCCCCEEEccCCCCCCcccc
Q 004979 174 GFNNFSGPFPSDFGNSFSLTTLLLDNNQYLG-GISPELHVLKVISEIQVDESWLTNAASR 232 (721)
Q Consensus 174 s~N~l~G~iP~~~~~~~~L~~l~l~~N~~~G-~iP~~~~~l~~L~~l~l~~n~~~g~~p~ 232 (721)
++|++++..|..++++++|++|+|++|.+++ .+|..++++++|++|++++|.+.+.+|.
T Consensus 82 s~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~ 141 (549)
T 2z81_A 82 SDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRR 141 (549)
T ss_dssp TTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECT
T ss_pred CCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCH
Confidence 9999998877779999999999999999997 6788899999999999999997777774
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.38 E-value=6.5e-13 Score=147.40 Aligned_cols=127 Identities=17% Similarity=0.255 Sum_probs=114.5
Q ss_pred CCCceee--EEeCC----------CcEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCc-hhhcCCCCCCEeE
Q 004979 106 NPCSWFG--VECSD----------GKVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIP-KEIGELKELEILD 172 (721)
Q Consensus 106 ~~C~w~g--v~C~~----------~~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip-~~l~~l~~L~~l~ 172 (721)
..|.|.+ |.|.. .+++.|+|++|.+.+..|..++++++|++|+|++|.+.+.+| ..+.++++|++|+
T Consensus 6 ~~c~~~~~~~~c~~~~l~~lp~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~ 85 (455)
T 3v47_A 6 SECSVIGYNAICINRGLHQVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILK 85 (455)
T ss_dssp -CCEEETTEEECCSSCCSSCCCCCTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEE
T ss_pred ceeEEEccccCcCCCCcccCCCCCCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEe
Confidence 4577776 88863 358999999999999889999999999999999999998885 4689999999999
Q ss_pred cccCcccccCCccccCCCCCCEEECccCCCCcCCChh--ccCCCCCCEEEccCCCCCCcccc
Q 004979 173 LGFNNFSGPFPSDFGNSFSLTTLLLDNNQYLGGISPE--LHVLKVISEIQVDESWLTNAASR 232 (721)
Q Consensus 173 ls~N~l~G~iP~~~~~~~~L~~l~l~~N~~~G~iP~~--~~~l~~L~~l~l~~n~~~g~~p~ 232 (721)
|++|++++..|..++++++|++|+|++|+++|.+|.. +..+++|++|+|++|.+++..|.
T Consensus 86 Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 147 (455)
T 3v47_A 86 LDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPA 147 (455)
T ss_dssp CTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCC
T ss_pred CCCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcc
Confidence 9999999999999999999999999999999988776 89999999999999999987665
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.37 E-value=2.4e-12 Score=123.10 Aligned_cols=107 Identities=21% Similarity=0.182 Sum_probs=92.9
Q ss_pred EEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCccccCCCCCCEEECccCC
Q 004979 122 ILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLLDNNQ 201 (721)
Q Consensus 122 ~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~~L~~l~l~~N~ 201 (721)
.|+++++.|.. +|..+. +.|++|+|++|.+++..|..++++++|+.|+|++|+|++-.|..+.++++|++|+|++|+
T Consensus 13 ~l~~s~n~l~~-ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~ 89 (170)
T 3g39_A 13 TVDCSGKSLAS-VPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQ 89 (170)
T ss_dssp EEECTTSCCSS-CCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEEeCCCCcCc-cCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCc
Confidence 45566777765 776653 889999999999999989999999999999999999996655667899999999999999
Q ss_pred CCcCCChhccCCCCCCEEEccCCCCCCccc
Q 004979 202 YLGGISPELHVLKVISEIQVDESWLTNAAS 231 (721)
Q Consensus 202 ~~G~iP~~~~~l~~L~~l~l~~n~~~g~~p 231 (721)
+++-.|..+..+++|+.|+|++|.|++..+
T Consensus 90 l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~ 119 (170)
T 3g39_A 90 LKSIPRGAFDNLKSLTHIWLLNNPWDCACS 119 (170)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCBCTTBG
T ss_pred cCEeCHHHhcCCCCCCEEEeCCCCCCCCch
Confidence 998666679999999999999999997654
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.36 E-value=8e-13 Score=150.72 Aligned_cols=108 Identities=23% Similarity=0.237 Sum_probs=101.7
Q ss_pred cEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCccccCCCCCCEEECc
Q 004979 119 KVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLLD 198 (721)
Q Consensus 119 ~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~~L~~l~l~ 198 (721)
.+..|+|++|.|++ +|. ++.|++|+.|+|++|.|+ .||..++++++|+.|+|++|+|++ || .++++++|++|+|+
T Consensus 442 ~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls 516 (567)
T 1dce_A 442 DVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLC 516 (567)
T ss_dssp TCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECC
T ss_pred CceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECC
Confidence 46789999999998 776 999999999999999999 999999999999999999999998 88 89999999999999
Q ss_pred cCCCCcCC-ChhccCCCCCCEEEccCCCCCCccc
Q 004979 199 NNQYLGGI-SPELHVLKVISEIQVDESWLTNAAS 231 (721)
Q Consensus 199 ~N~~~G~i-P~~~~~l~~L~~l~l~~n~~~g~~p 231 (721)
+|++++.+ |..++.+++|+.|+|++|.|++..|
T Consensus 517 ~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~ 550 (567)
T 1dce_A 517 NNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEG 550 (567)
T ss_dssp SSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSS
T ss_pred CCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCcc
Confidence 99999988 9999999999999999999998655
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.35 E-value=2.5e-12 Score=132.61 Aligned_cols=120 Identities=19% Similarity=0.213 Sum_probs=60.2
Q ss_pred CCCceeeEEeC-CCcEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCc
Q 004979 106 NPCSWFGVECS-DGKVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPS 184 (721)
Q Consensus 106 ~~C~w~gv~C~-~~~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~ 184 (721)
+.|.|.|+.|. .+.++.+++++++|.. ||..+. +.|+.|+|++|.+++..+..++++++|++|+|++|+++.-.+.
T Consensus 3 ~~C~~~~~~C~c~~~~~~l~~~~~~l~~-ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~ 79 (270)
T 2o6q_A 3 ALCKKDGGVCSCNNNKNSVDCSSKKLTA-IPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAG 79 (270)
T ss_dssp CCBGGGTCSBEEETTTTEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTT
T ss_pred ccCCCCCCCCEeCCCCCEEEccCCCCCc-cCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChh
Confidence 56888887774 2233455555555552 443332 3455555555555543333455555555555555555522222
Q ss_pred cccCCCCCCEEECccCCCCcCCChhccCCCCCCEEEccCCCCCC
Q 004979 185 DFGNSFSLTTLLLDNNQYLGGISPELHVLKVISEIQVDESWLTN 228 (721)
Q Consensus 185 ~~~~~~~L~~l~l~~N~~~G~iP~~~~~l~~L~~l~l~~n~~~g 228 (721)
.+.++++|++|+|++|.+++-.+..+..+++|++|+|++|.+++
T Consensus 80 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 123 (270)
T 2o6q_A 80 IFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKS 123 (270)
T ss_dssp TTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCC
T ss_pred hhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCe
Confidence 23445555555555555544333334455555555555555544
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.35 E-value=2.3e-12 Score=125.84 Aligned_cols=109 Identities=15% Similarity=0.187 Sum_probs=99.2
Q ss_pred EEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCch-hhcCCCCCCEeEcccCcccccCCccccCCCCCCEEECcc
Q 004979 121 VILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPK-EIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLLDN 199 (721)
Q Consensus 121 ~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~-~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~~L~~l~l~~ 199 (721)
..+++++++| +.||..+.. +|++|+|++|.+++..|. .++.+++|++|+|++|++++.+|..+.++++|++|+|++
T Consensus 11 ~~l~~s~~~l-~~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 11 TTVDCTGRGL-KEIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCC-SSCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCc-CcCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 4789999999 678876654 899999999999877665 489999999999999999999999999999999999999
Q ss_pred CCCCcCCChhccCCCCCCEEEccCCCCCCcccc
Q 004979 200 NQYLGGISPELHVLKVISEIQVDESWLTNAASR 232 (721)
Q Consensus 200 N~~~G~iP~~~~~l~~L~~l~l~~n~~~g~~p~ 232 (721)
|++++..|..+..+++|++|+|++|.+++.+|.
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 120 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPG 120 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTT
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHH
Confidence 999999888899999999999999999987765
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.35 E-value=3.4e-13 Score=156.47 Aligned_cols=124 Identities=14% Similarity=0.171 Sum_probs=114.1
Q ss_pred CCceeeEEeC---CCcEEEEEeCCCCCCCc-----------------Cchhhc--CCCCCCEEEccCCcccccCchhhcC
Q 004979 107 PCSWFGVECS---DGKVVILNLRDLCLGGM-----------------LAPELG--QLSELKSIILRNNSFFGTIPKEIGE 164 (721)
Q Consensus 107 ~C~w~gv~C~---~~~v~~l~L~~~~l~G~-----------------ip~~l~--~l~~L~~L~L~~n~l~G~ip~~l~~ 164 (721)
++...|+.-. -.++..|+|++|.++|. +|..++ ++++|++|+|++|.+.|.+|..+++
T Consensus 192 ~n~l~~ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~ 271 (636)
T 4eco_A 192 SNNITFVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKA 271 (636)
T ss_dssp SCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTT
T ss_pred cCCCccCCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhc
Confidence 4567774211 35789999999999997 999999 9999999999999999999999999
Q ss_pred CCCCCEeEcccCc-ccc-cCCccccCC------CCCCEEECccCCCCcCCCh--hccCCCCCCEEEccCCCCCCccc
Q 004979 165 LKELEILDLGFNN-FSG-PFPSDFGNS------FSLTTLLLDNNQYLGGISP--ELHVLKVISEIQVDESWLTNAAS 231 (721)
Q Consensus 165 l~~L~~l~ls~N~-l~G-~iP~~~~~~------~~L~~l~l~~N~~~G~iP~--~~~~l~~L~~l~l~~n~~~g~~p 231 (721)
+++|+.|+|++|+ ++| .+|..++++ ++|++|+|++|+++ .||. .++++++|+.|+|++|.++|.+|
T Consensus 272 l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip 347 (636)
T 4eco_A 272 LPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP 347 (636)
T ss_dssp CSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC
T ss_pred CCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchh
Confidence 9999999999998 999 999998887 99999999999999 9999 99999999999999999999998
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.35 E-value=6.8e-13 Score=126.36 Aligned_cols=112 Identities=20% Similarity=0.165 Sum_probs=100.1
Q ss_pred CcEEEEEeCCCCCC-CcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCccccCCCCCCEEE
Q 004979 118 GKVVILNLRDLCLG-GMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLL 196 (721)
Q Consensus 118 ~~v~~l~L~~~~l~-G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~~L~~l~ 196 (721)
.+++.|+|++|.+. |.+|..+..+++|++|+|++|.+++. ..++.+++|+.|+|++|++++.+|..+.++++|++|+
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence 46889999999998 89998889999999999999999876 7889999999999999999998888888899999999
Q ss_pred CccCCCCcC-CChhccCCCCCCEEEccCCCCCCccc
Q 004979 197 LDNNQYLGG-ISPELHVLKVISEIQVDESWLTNAAS 231 (721)
Q Consensus 197 l~~N~~~G~-iP~~~~~l~~L~~l~l~~n~~~g~~p 231 (721)
|++|.+++- .+..+..+++|+.|++++|.+++..+
T Consensus 102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~ 137 (168)
T 2ell_A 102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLND 137 (168)
T ss_dssp CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTT
T ss_pred ccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHH
Confidence 999999873 33788999999999999999986543
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.35 E-value=3.8e-12 Score=122.17 Aligned_cols=107 Identities=18% Similarity=0.193 Sum_probs=93.5
Q ss_pred EEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCccccCCCCCCEEECccC
Q 004979 121 VILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLLDNN 200 (721)
Q Consensus 121 ~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~~L~~l~l~~N 200 (721)
..++++++.| +.||..+. ++|++|+|++|.|.+..|..++++++|+.|+|++|+|++-.+..+.++++|++|+|++|
T Consensus 15 ~~l~~~~n~l-~~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRL-ASVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCC-SSCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCC-CccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 4678889988 57887765 89999999999999999999999999999999999999744445689999999999999
Q ss_pred CCCcCCChhccCCCCCCEEEccCCCCCCcc
Q 004979 201 QYLGGISPELHVLKVISEIQVDESWLTNAA 230 (721)
Q Consensus 201 ~~~G~iP~~~~~l~~L~~l~l~~n~~~g~~ 230 (721)
++++-.+..+..+++|+.|+|++|.|+...
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~c~~ 121 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWDCEC 121 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBCTTB
T ss_pred ccceeCHHHhccccCCCEEEeCCCCccccc
Confidence 999655555999999999999999998653
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.33 E-value=4.3e-12 Score=130.95 Aligned_cols=115 Identities=19% Similarity=0.199 Sum_probs=97.7
Q ss_pred CcEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCccccCCCCCCEEEC
Q 004979 118 GKVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLL 197 (721)
Q Consensus 118 ~~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~~L~~l~l 197 (721)
.++..|+|++|.+++..+..++.+++|++|+|++|.+++..|..++.+++|+.|+|++|++++..|..++++++|++|++
T Consensus 85 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l 164 (272)
T 3rfs_A 85 TNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDL 164 (272)
T ss_dssp TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEEC
Confidence 46888999999998777667888999999999999998777777888999999999999999766666788999999999
Q ss_pred ccCCCCcCCChhccCCCCCCEEEccCCCCCCcccc
Q 004979 198 DNNQYLGGISPELHVLKVISEIQVDESWLTNAASR 232 (721)
Q Consensus 198 ~~N~~~G~iP~~~~~l~~L~~l~l~~n~~~g~~p~ 232 (721)
++|++++-.|..++.+++|+.|+|++|.+++..|.
T Consensus 165 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 199 (272)
T 3rfs_A 165 SYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDG 199 (272)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTT
T ss_pred CCCCcCccCHHHhcCCccCCEEECCCCcCCccCHH
Confidence 99999877666678899999999999999875553
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.33 E-value=4.9e-12 Score=128.86 Aligned_cols=114 Identities=23% Similarity=0.202 Sum_probs=100.3
Q ss_pred CcEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCccccCCCCCCEEEC
Q 004979 118 GKVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLL 197 (721)
Q Consensus 118 ~~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~~L~~l~l 197 (721)
.+++.|+|++|.+++..+..+..+++|++|+|++|.+++..|..+..+++|+.|+|++|++++..|..+.++++|++|+|
T Consensus 59 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 138 (251)
T 3m19_A 59 TKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRL 138 (251)
T ss_dssp TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred ccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEEC
Confidence 47889999999999987778899999999999999999777778899999999999999999666666789999999999
Q ss_pred ccCCCCcCCChhccCCCCCCEEEccCCCCCCccc
Q 004979 198 DNNQYLGGISPELHVLKVISEIQVDESWLTNAAS 231 (721)
Q Consensus 198 ~~N~~~G~iP~~~~~l~~L~~l~l~~n~~~g~~p 231 (721)
++|++++-.|..+..+++|++|+|++|.+++..+
T Consensus 139 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 172 (251)
T 3m19_A 139 NTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPH 172 (251)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCT
T ss_pred cCCcCCccCHHHcCcCcCCCEEECCCCcCCccCH
Confidence 9999987666678999999999999999996544
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.32 E-value=5.2e-12 Score=124.72 Aligned_cols=114 Identities=18% Similarity=0.112 Sum_probs=101.0
Q ss_pred CcEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCccccCCCCCCEEEC
Q 004979 118 GKVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLL 197 (721)
Q Consensus 118 ~~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~~L~~l~l 197 (721)
.++..|+|++|.+.+..+..+..+++|++|+|++|.+++..+..+..+++|+.|+|++|++++..|..+.++++|++|+|
T Consensus 52 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l 131 (208)
T 2o6s_A 52 TSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRL 131 (208)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred ccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEEC
Confidence 47889999999999655556789999999999999999766666899999999999999999766667899999999999
Q ss_pred ccCCCCcCCChhccCCCCCCEEEccCCCCCCccc
Q 004979 198 DNNQYLGGISPELHVLKVISEIQVDESWLTNAAS 231 (721)
Q Consensus 198 ~~N~~~G~iP~~~~~l~~L~~l~l~~n~~~g~~p 231 (721)
++|++++-.+..+..+++|+.|+|++|.+++..|
T Consensus 132 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 165 (208)
T 2o6s_A 132 YQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP 165 (208)
T ss_dssp CSSCCSCCCTTTTTTCTTCCEEECCSCCBCCCTT
T ss_pred CCCccceeCHHHhccCCCccEEEecCCCeecCCC
Confidence 9999997666668999999999999999998765
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.32 E-value=3.4e-12 Score=127.46 Aligned_cols=112 Identities=17% Similarity=0.167 Sum_probs=102.7
Q ss_pred CcEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCccccCCCCCCEEEC
Q 004979 118 GKVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLL 197 (721)
Q Consensus 118 ~~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~~L~~l~l 197 (721)
.++..|+|++|.+++..|..+..+++|++|+|++|.|++-.+..+..+++|+.|+|++|++++..|..+.++++|++|+|
T Consensus 56 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 135 (220)
T 2v9t_B 56 KKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSL 135 (220)
T ss_dssp TTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEEC
Confidence 47899999999999988999999999999999999999544445788999999999999999988999999999999999
Q ss_pred ccCCCCcCCChhccCCCCCCEEEccCCCCCCc
Q 004979 198 DNNQYLGGISPELHVLKVISEIQVDESWLTNA 229 (721)
Q Consensus 198 ~~N~~~G~iP~~~~~l~~L~~l~l~~n~~~g~ 229 (721)
++|++++-.+..+..+++|+.|+|++|.|+..
T Consensus 136 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~ 167 (220)
T 2v9t_B 136 YDNKLQTIAKGTFSPLRAIQTMHLAQNPFICD 167 (220)
T ss_dssp CSSCCSCCCTTTTTTCTTCCEEECCSSCEECS
T ss_pred CCCcCCEECHHHHhCCCCCCEEEeCCCCcCCC
Confidence 99999988877899999999999999998754
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.32 E-value=5.1e-12 Score=126.96 Aligned_cols=113 Identities=19% Similarity=0.126 Sum_probs=101.3
Q ss_pred CcEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCccccCCCCCCEEEC
Q 004979 118 GKVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLL 197 (721)
Q Consensus 118 ~~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~~L~~l~l 197 (721)
..+..|+|++|.+++-.+..+..+++|++|+|++|.|++..+..+..+++|+.|+|++|+++ .||..+..+++|++|+|
T Consensus 64 ~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L 142 (229)
T 3e6j_A 64 INLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLAL 142 (229)
T ss_dssp TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEEC
T ss_pred cCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEEC
Confidence 47899999999996544455789999999999999999776777899999999999999999 89999999999999999
Q ss_pred ccCCCCcCCChhccCCCCCCEEEccCCCCCCccc
Q 004979 198 DNNQYLGGISPELHVLKVISEIQVDESWLTNAAS 231 (721)
Q Consensus 198 ~~N~~~G~iP~~~~~l~~L~~l~l~~n~~~g~~p 231 (721)
++|++++-.+..+..+++|+.|+|++|.+++..+
T Consensus 143 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 176 (229)
T 3e6j_A 143 DQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCECR 176 (229)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTBG
T ss_pred CCCcCCccCHHHHhCCCCCCEEEeeCCCccCCcc
Confidence 9999997666678999999999999999997654
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.31 E-value=4.9e-12 Score=146.00 Aligned_cols=127 Identities=17% Similarity=0.116 Sum_probs=109.3
Q ss_pred CCCcee----eEEeCC-----------CcEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCE
Q 004979 106 NPCSWF----GVECSD-----------GKVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEI 170 (721)
Q Consensus 106 ~~C~w~----gv~C~~-----------~~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~ 170 (721)
.+|.+. .|.|.. ..++.|+|++|.+++-.+..|.+|++|++|||++|.+++-.|..+.+|++|++
T Consensus 25 ~~c~~~~~~~~~~c~~~~l~~vP~~lp~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~ 104 (635)
T 4g8a_A 25 EPCVEVVPNITYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLST 104 (635)
T ss_dssp CCSEEEETTTEEECTTSCCSSCCSSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCE
T ss_pred CCccccCCCCEEECCCCCcCccCCCCCcCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCE
Confidence 467653 477852 25789999999999877778999999999999999999877778999999999
Q ss_pred eEcccCcccccCCccccCCCCCCEEECccCCCCcCCChhccCCCCCCEEEccCCCCCC-cccc
Q 004979 171 LDLGFNNFSGPFPSDFGNSFSLTTLLLDNNQYLGGISPELHVLKVISEIQVDESWLTN-AASR 232 (721)
Q Consensus 171 l~ls~N~l~G~iP~~~~~~~~L~~l~l~~N~~~G~iP~~~~~l~~L~~l~l~~n~~~g-~~p~ 232 (721)
|+|++|++++-.|..+.++++|++|+|++|++++-.+..++++++|++|+|++|.+++ .+|.
T Consensus 105 L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~ 167 (635)
T 4g8a_A 105 LILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPE 167 (635)
T ss_dssp EECTTCCCCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCG
T ss_pred EEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCch
Confidence 9999999997666678999999999999999998666679999999999999999976 3444
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.31 E-value=5.8e-12 Score=134.71 Aligned_cols=109 Identities=18% Similarity=0.145 Sum_probs=94.3
Q ss_pred CceeeEEeCCCcEEEEEeCCC-CCCCcCchhhcCCCCCCEEEccC-CcccccCchhhcCCCCCCEeEcccCcccccCCcc
Q 004979 108 CSWFGVECSDGKVVILNLRDL-CLGGMLAPELGQLSELKSIILRN-NSFFGTIPKEIGELKELEILDLGFNNFSGPFPSD 185 (721)
Q Consensus 108 C~w~gv~C~~~~v~~l~L~~~-~l~G~ip~~l~~l~~L~~L~L~~-n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~ 185 (721)
|.|..|.|. ++ +|.+ ||. |..+++|+.|+|++ |.|.+..|..+++|++|+.|+|++|+|+|..|..
T Consensus 8 C~~~~v~~~----------~~n~l~~-ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~ 75 (347)
T 2ifg_A 8 HGSSGLRCT----------RDGALDS-LHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDA 75 (347)
T ss_dssp SSSSCEECC----------SSCCCTT-TTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTG
T ss_pred ccCCEEEcC----------CCCCCCc-cCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHH
Confidence 888888775 44 6665 888 99999999999996 9999888889999999999999999999998989
Q ss_pred ccCCCCCCEEECccCCCCcCCChhccCCCCCCEEEccCCCCCCc
Q 004979 186 FGNSFSLTTLLLDNNQYLGGISPELHVLKVISEIQVDESWLTNA 229 (721)
Q Consensus 186 ~~~~~~L~~l~l~~N~~~G~iP~~~~~l~~L~~l~l~~n~~~g~ 229 (721)
|+++++|+.|+|++|+|++ +|+.+.....|+.|+|.+|.|...
T Consensus 76 ~~~l~~L~~L~l~~N~l~~-~~~~~~~~~~L~~l~l~~N~~~c~ 118 (347)
T 2ifg_A 76 FHFTPRLSRLNLSFNALES-LSWKTVQGLSLQELVLSGNPLHCS 118 (347)
T ss_dssp GGSCSCCCEEECCSSCCSC-CCSTTTCSCCCCEEECCSSCCCCC
T ss_pred hcCCcCCCEEeCCCCccce-eCHHHcccCCceEEEeeCCCccCC
Confidence 9999999999999999996 555444433499999999999864
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.30 E-value=8.3e-12 Score=128.81 Aligned_cols=112 Identities=22% Similarity=0.176 Sum_probs=100.6
Q ss_pred CcEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCccccCCCCCCEEEC
Q 004979 118 GKVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLL 197 (721)
Q Consensus 118 ~~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~~L~~l~l 197 (721)
..+..|+|++|.+.+ + +.+..+++|++|+|++|.+++..|..++++++|+.|+|++|++++..|..++++++|++|+|
T Consensus 63 ~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 140 (272)
T 3rfs_A 63 PNVRYLALGGNKLHD-I-SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNL 140 (272)
T ss_dssp TTCCEEECTTSCCCC-C-GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCcEEECCCCCCCC-c-hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEEC
Confidence 578899999999988 3 47999999999999999999877777899999999999999999877777899999999999
Q ss_pred ccCCCCcCCChhccCCCCCCEEEccCCCCCCccc
Q 004979 198 DNNQYLGGISPELHVLKVISEIQVDESWLTNAAS 231 (721)
Q Consensus 198 ~~N~~~G~iP~~~~~l~~L~~l~l~~n~~~g~~p 231 (721)
++|++++-.|..++.+++|+.|+|++|.+++..+
T Consensus 141 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 174 (272)
T 3rfs_A 141 AHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPE 174 (272)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCT
T ss_pred CCCccCccCHHHhccCccCCEEECCCCCcCccCH
Confidence 9999997777678999999999999999997544
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.29 E-value=8.7e-12 Score=143.64 Aligned_cols=128 Identities=20% Similarity=0.160 Sum_probs=109.3
Q ss_pred CCCcee----eEEeCC-----------CcEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCE
Q 004979 106 NPCSWF----GVECSD-----------GKVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEI 170 (721)
Q Consensus 106 ~~C~w~----gv~C~~-----------~~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~ 170 (721)
+||.|. .+.|.. .+++.|+|++|.+.+..+..+.++++|++|+|++|.+++..|..++++++|++
T Consensus 5 ~~c~~~~~~~~~~c~~~~l~~ip~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~ 84 (606)
T 3vq2_A 5 NPCIEVVPNITYQCMDQKLSKVPDDIPSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSN 84 (606)
T ss_dssp -CCEEEETTTEEECTTSCCSSCCTTSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCE
T ss_pred CCceecCCCCceEccCCCcccCCCCCCCCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCE
Confidence 567763 577852 36889999999999888888999999999999999999888888999999999
Q ss_pred eEcccCcccccCCccccCCCCCCEEECccCCCCcCCChhccCCCCCCEEEccCCCCCC-ccccc
Q 004979 171 LDLGFNNFSGPFPSDFGNSFSLTTLLLDNNQYLGGISPELHVLKVISEIQVDESWLTN-AASRA 233 (721)
Q Consensus 171 l~ls~N~l~G~iP~~~~~~~~L~~l~l~~N~~~G~iP~~~~~l~~L~~l~l~~n~~~g-~~p~~ 233 (721)
|+|++|.+++..|..++++++|++|+|++|.+++-.|..++++.+|++|+|++|.+++ .+|..
T Consensus 85 L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~ 148 (606)
T 3vq2_A 85 LILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAY 148 (606)
T ss_dssp EECTTCCCCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGG
T ss_pred eECCCCcccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHh
Confidence 9999999998889899999999999999999988777788889999999999998876 56653
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.28 E-value=8.3e-12 Score=134.43 Aligned_cols=124 Identities=19% Similarity=0.207 Sum_probs=109.7
Q ss_pred CceeeEEeCC-----------CcEEEEEeCCCCCCCcCchhhc-CCCCCCEEEccCCcccccCchhhcCCCCCCEeEccc
Q 004979 108 CSWFGVECSD-----------GKVVILNLRDLCLGGMLAPELG-QLSELKSIILRNNSFFGTIPKEIGELKELEILDLGF 175 (721)
Q Consensus 108 C~w~gv~C~~-----------~~v~~l~L~~~~l~G~ip~~l~-~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~ 175 (721)
|.|..+.|.. ..++.|+|++|.+++..+..+. .+++|+.|+|++|.+++..|..+.++++|++|+|++
T Consensus 18 C~~~~l~c~~~~l~~iP~~~~~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 97 (361)
T 2xot_A 18 CASNILSCSKQQLPNVPQSLPSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS 97 (361)
T ss_dssp EETTEEECCSSCCSSCCSSCCTTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred ECCCEEEeCCCCcCccCccCCCCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence 6788899963 2467899999999987776676 999999999999999988788899999999999999
Q ss_pred CcccccCCccccCCCCCCEEECccCCCCcCCChhccCCCCCCEEEccCCCCCCcccc
Q 004979 176 NNFSGPFPSDFGNSFSLTTLLLDNNQYLGGISPELHVLKVISEIQVDESWLTNAASR 232 (721)
Q Consensus 176 N~l~G~iP~~~~~~~~L~~l~l~~N~~~G~iP~~~~~l~~L~~l~l~~n~~~g~~p~ 232 (721)
|+|++..+..+.++++|++|+|++|++++-.|..+..+++|+.|+|++|.+++ +|.
T Consensus 98 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~-l~~ 153 (361)
T 2xot_A 98 NHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISR-FPV 153 (361)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCS-CCG
T ss_pred CcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCe-eCH
Confidence 99997777778999999999999999998888899999999999999999986 444
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.27 E-value=6.2e-12 Score=141.02 Aligned_cols=121 Identities=19% Similarity=0.112 Sum_probs=89.2
Q ss_pred CceeeEEeCC-CcEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhc-CCCCCCEeEcccCcccccCCcc
Q 004979 108 CSWFGVECSD-GKVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIG-ELKELEILDLGFNNFSGPFPSD 185 (721)
Q Consensus 108 C~w~gv~C~~-~~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~-~l~~L~~l~ls~N~l~G~iP~~ 185 (721)
|.+.++.|.. ..+..|+|++|.++|..|..++.+++|++|+|++|.++|.+|..+. .+++|+.|+|++|.|++. | .
T Consensus 109 N~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~-~-~ 186 (487)
T 3oja_A 109 NNISRVSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-K-G 186 (487)
T ss_dssp SCCCCEEECCCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-E-C
T ss_pred CcCCCCCccccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccc-c-c
Confidence 5566666652 4677788888888877777777788888888888888887777765 678888888888888765 2 2
Q ss_pred ccCCCCCCEEECccCCCCcCCChhccCCCCCCEEEccCCCCCCcccc
Q 004979 186 FGNSFSLTTLLLDNNQYLGGISPELHVLKVISEIQVDESWLTNAASR 232 (721)
Q Consensus 186 ~~~~~~L~~l~l~~N~~~G~iP~~~~~l~~L~~l~l~~n~~~g~~p~ 232 (721)
+..+++|+.|+|++|.++| +|+.+..+++|+.|+|++|.+++ +|.
T Consensus 187 ~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~Ls~N~l~~-lp~ 231 (487)
T 3oja_A 187 QVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLVL-IEK 231 (487)
T ss_dssp CCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCCE-ECT
T ss_pred cccCCCCCEEECCCCCCCC-CCHhHcCCCCccEEEecCCcCcc-cch
Confidence 3457788888888888876 45557778888888888888775 443
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.27 E-value=2.2e-11 Score=125.74 Aligned_cols=114 Identities=17% Similarity=0.065 Sum_probs=99.4
Q ss_pred cEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCccccCCCCCCEEECc
Q 004979 119 KVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLLD 198 (721)
Q Consensus 119 ~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~~L~~l~l~ 198 (721)
.++.|+|++|.+.+..+..+.++++|++|+|++|.+.+..+..+.++++|+.|+|++|.+++..|..+.++++|++|+++
T Consensus 29 ~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~ 108 (276)
T 2z62_A 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV 108 (276)
T ss_dssp TCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECT
T ss_pred CccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECC
Confidence 47899999999988777788999999999999999987777788999999999999999998888888999999999999
Q ss_pred cCCCCcCCChhccCCCCCCEEEccCCCCCC-cccc
Q 004979 199 NNQYLGGISPELHVLKVISEIQVDESWLTN-AASR 232 (721)
Q Consensus 199 ~N~~~G~iP~~~~~l~~L~~l~l~~n~~~g-~~p~ 232 (721)
+|++++-.+..++.+++|++|+|++|.+++ .+|.
T Consensus 109 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~ 143 (276)
T 2z62_A 109 ETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPE 143 (276)
T ss_dssp TSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCG
T ss_pred CCCccccCchhcccCCCCCEEECcCCccceecCch
Confidence 999988777678899999999999999886 3454
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.27 E-value=1.1e-11 Score=137.53 Aligned_cols=112 Identities=19% Similarity=0.134 Sum_probs=96.0
Q ss_pred CcEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCccccCCCCCCEEEC
Q 004979 118 GKVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLL 197 (721)
Q Consensus 118 ~~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~~L~~l~l 197 (721)
..+..++|++|.+.+.+|..++.+++|++|+|++|.+.+..|..++.+++|+.|+|++|.+++..|..+.++++|++|+|
T Consensus 275 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 354 (455)
T 3v47_A 275 SGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDL 354 (455)
T ss_dssp SCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEEC
T ss_pred cCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEEC
Confidence 36788888888888888888888888888888888888888888888888888888888888777888888888888888
Q ss_pred ccCCCCcCCChhccCCCCCCEEEccCCCCCCc
Q 004979 198 DNNQYLGGISPELHVLKVISEIQVDESWLTNA 229 (721)
Q Consensus 198 ~~N~~~G~iP~~~~~l~~L~~l~l~~n~~~g~ 229 (721)
++|++++.+|..+..+++|++|+|++|.+++.
T Consensus 355 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 386 (455)
T 3v47_A 355 SYNHIRALGDQSFLGLPNLKELALDTNQLKSV 386 (455)
T ss_dssp CSSCCCEECTTTTTTCTTCCEEECCSSCCSCC
T ss_pred CCCcccccChhhccccccccEEECCCCccccC
Confidence 88888888888888888888888888888863
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.26 E-value=2e-12 Score=153.82 Aligned_cols=122 Identities=15% Similarity=0.165 Sum_probs=110.9
Q ss_pred CceeeEEeC---CCcEEEEEeCCCCCCC-----------------cCchhhc--CCCCCCEEEccCCcccccCchhhcCC
Q 004979 108 CSWFGVECS---DGKVVILNLRDLCLGG-----------------MLAPELG--QLSELKSIILRNNSFFGTIPKEIGEL 165 (721)
Q Consensus 108 C~w~gv~C~---~~~v~~l~L~~~~l~G-----------------~ip~~l~--~l~~L~~L~L~~n~l~G~ip~~l~~l 165 (721)
|...|+.-. -.++..|+|++|.|+| .||+.++ +|++|++|+|++|.+.|.+|..++++
T Consensus 435 N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L 514 (876)
T 4ecn_A 435 NRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDL 514 (876)
T ss_dssp CEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGC
T ss_pred CcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCC
Confidence 566774322 3578999999999999 4999988 99999999999999999999999999
Q ss_pred CCCCEeEcccCc-ccc-cCCccccCCC-------CCCEEECccCCCCcCCCh--hccCCCCCCEEEccCCCCCCccc
Q 004979 166 KELEILDLGFNN-FSG-PFPSDFGNSF-------SLTTLLLDNNQYLGGISP--ELHVLKVISEIQVDESWLTNAAS 231 (721)
Q Consensus 166 ~~L~~l~ls~N~-l~G-~iP~~~~~~~-------~L~~l~l~~N~~~G~iP~--~~~~l~~L~~l~l~~n~~~g~~p 231 (721)
++|+.|+|++|+ |+| .+|..+++++ +|++|+|++|+++ .||. .++++++|+.|+|++|.++ .+|
T Consensus 515 ~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp 589 (876)
T 4ecn_A 515 PELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLE 589 (876)
T ss_dssp SSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCC
T ss_pred CCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cch
Confidence 999999999998 999 9998777665 9999999999999 9999 9999999999999999999 888
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.26 E-value=8.6e-12 Score=122.12 Aligned_cols=108 Identities=12% Similarity=0.181 Sum_probs=93.8
Q ss_pred CcEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCccccCCCCCCEEEC
Q 004979 118 GKVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLL 197 (721)
Q Consensus 118 ~~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~~L~~l~l 197 (721)
.++..|+|++|.+ ..++.+..+++|++|+|++|.+++..|..++.+++|+.|+|++|++++..|..++.+++|++|++
T Consensus 66 ~~L~~L~l~~n~~--~~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L 143 (197)
T 4ezg_A 66 HNIKDLTINNIHA--TNYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDL 143 (197)
T ss_dssp TTCSEEEEESCCC--SCCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEEC
T ss_pred CCCCEEEccCCCC--CcchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEEc
Confidence 4678889988854 34457888999999999999999888888999999999999999999988888999999999999
Q ss_pred ccCCCCcCCChhccCCCCCCEEEccCCCCCC
Q 004979 198 DNNQYLGGISPELHVLKVISEIQVDESWLTN 228 (721)
Q Consensus 198 ~~N~~~G~iP~~~~~l~~L~~l~l~~n~~~g 228 (721)
++|.+.+.+| .+..+++|+.|++++|.+++
T Consensus 144 ~~n~~i~~~~-~l~~l~~L~~L~l~~n~i~~ 173 (197)
T 4ezg_A 144 SYNGAITDIM-PLKTLPELKSLNIQFDGVHD 173 (197)
T ss_dssp CSCTBCCCCG-GGGGCSSCCEEECTTBCCCC
T ss_pred cCCCCccccH-hhcCCCCCCEEECCCCCCcC
Confidence 9998667787 68889999999999999886
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.26 E-value=5.8e-12 Score=150.95 Aligned_cols=123 Identities=20% Similarity=0.186 Sum_probs=78.3
Q ss_pred CceeeEEeCCCcEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccC-chhhcCCCCCCEeEcccCcccccCCccc
Q 004979 108 CSWFGVECSDGKVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTI-PKEIGELKELEILDLGFNNFSGPFPSDF 186 (721)
Q Consensus 108 C~w~gv~C~~~~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~i-p~~l~~l~~L~~l~ls~N~l~G~iP~~~ 186 (721)
|.|..|.+-..+++.|+|++|.+++..|..+.+|++|++|+|++|.+.+.| |..++++++|++|+|++|++++..|..+
T Consensus 14 ~~L~~vP~lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~ 93 (844)
T 3j0a_A 14 CNLTQVPQVLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAF 93 (844)
T ss_dssp CCSSCCCSSCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSS
T ss_pred CCCCCCCCCCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHc
Confidence 445555553346667777777776666666666666666666666666666 4456666666666666666666666666
Q ss_pred cCCCCCCEEECccCCCCcCCChh--ccCCCCCCEEEccCCCCCCcc
Q 004979 187 GNSFSLTTLLLDNNQYLGGISPE--LHVLKVISEIQVDESWLTNAA 230 (721)
Q Consensus 187 ~~~~~L~~l~l~~N~~~G~iP~~--~~~l~~L~~l~l~~n~~~g~~ 230 (721)
+++++|++|+|++|.+++.+|.. ++++++|++|+|++|.+++..
T Consensus 94 ~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~ 139 (844)
T 3j0a_A 94 QGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLY 139 (844)
T ss_dssp CSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCC
T ss_pred cCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccc
Confidence 66666666666666666665554 566666666666666666543
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.25 E-value=1.6e-11 Score=141.32 Aligned_cols=112 Identities=16% Similarity=0.165 Sum_probs=72.1
Q ss_pred EEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCccccCCCCCCEEECcc
Q 004979 120 VVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLLDN 199 (721)
Q Consensus 120 v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~~L~~l~l~~ 199 (721)
+..++|+++.+++-.+..+..+++|++|+|++|.+.+..|..++.+++|+.|+|++|.+++..|..++++++|++|+|++
T Consensus 53 l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 132 (597)
T 3oja_B 53 QKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLER 132 (597)
T ss_dssp CSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred ceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeC
Confidence 34566666665443333356677777777777777766666677777777777777777766666666777777777777
Q ss_pred CCCCcCCChhccCCCCCCEEEccCCCCCCccc
Q 004979 200 NQYLGGISPELHVLKVISEIQVDESWLTNAAS 231 (721)
Q Consensus 200 N~~~G~iP~~~~~l~~L~~l~l~~n~~~g~~p 231 (721)
|.+++-.+..++.+++|++|+|++|.+++..|
T Consensus 133 n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~ 164 (597)
T 3oja_B 133 NDLSSLPRGIFHNTPKLTTLSMSNNNLERIED 164 (597)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCCBCCT
T ss_pred CCCCCCCHHHhccCCCCCEEEeeCCcCCCCCh
Confidence 77663322334667777777777777766544
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.24 E-value=1.6e-11 Score=128.75 Aligned_cols=112 Identities=17% Similarity=0.137 Sum_probs=84.9
Q ss_pred CcEEEEEeCCCCCCCcCc-hhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccc-cCCccccCCCCCCEE
Q 004979 118 GKVVILNLRDLCLGGMLA-PELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSG-PFPSDFGNSFSLTTL 195 (721)
Q Consensus 118 ~~v~~l~L~~~~l~G~ip-~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G-~iP~~~~~~~~L~~l 195 (721)
..+..|+|++|.+.+..+ ..+..+++|++|+|++|.+.+.+|..+..+++|+.|+|++|.+++ .+|..+..+++|++|
T Consensus 101 ~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L 180 (306)
T 2z66_A 101 EQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFL 180 (306)
T ss_dssp TTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEE
T ss_pred CCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEE
Confidence 467777787777776554 457777788888888888777777777777888888888887776 567777777788888
Q ss_pred ECccCCCCcCCChhccCCCCCCEEEccCCCCCCc
Q 004979 196 LLDNNQYLGGISPELHVLKVISEIQVDESWLTNA 229 (721)
Q Consensus 196 ~l~~N~~~G~iP~~~~~l~~L~~l~l~~n~~~g~ 229 (721)
+|++|.+++..|..+..+++|+.|+|++|.+++.
T Consensus 181 ~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 214 (306)
T 2z66_A 181 DLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSL 214 (306)
T ss_dssp ECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBC
T ss_pred ECCCCCcCCcCHHHhcCCCCCCEEECCCCccCcc
Confidence 8888887777777777777888888888877754
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.24 E-value=5e-12 Score=143.69 Aligned_cols=111 Identities=26% Similarity=0.321 Sum_probs=98.9
Q ss_pred CCC-----ceeeE-EeCCCcEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCccc
Q 004979 106 NPC-----SWFGV-ECSDGKVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFS 179 (721)
Q Consensus 106 ~~C-----~w~gv-~C~~~~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~ 179 (721)
.+| .|.|+ .|..++++.|+|++|+|++ ||+.+. ++|++|+|++|.|+ .|| ..+++|+.|+|++|+|+
T Consensus 41 ~~~~~~~~~~~~l~~C~~~~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~ 113 (571)
T 3cvr_A 41 LPGENRNEAVSLLKECLINQFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLS 113 (571)
T ss_dssp CTTCCHHHHHHHHHHHHHTTCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCS
T ss_pred CccccccchhhhccccccCCccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCC
Confidence 567 79999 7877789999999999998 888774 89999999999999 788 56899999999999999
Q ss_pred ccCCccccCCCCCCEEECccCCCCcCCChhccCCCCCCEEEccCCCCCCcccc
Q 004979 180 GPFPSDFGNSFSLTTLLLDNNQYLGGISPELHVLKVISEIQVDESWLTNAASR 232 (721)
Q Consensus 180 G~iP~~~~~~~~L~~l~l~~N~~~G~iP~~~~~l~~L~~l~l~~n~~~g~~p~ 232 (721)
+ ||. +.+ +|++|+|++|++++ ||. .+++|+.|+|++|.+++ +|.
T Consensus 114 ~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~ 157 (571)
T 3cvr_A 114 T-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE 157 (571)
T ss_dssp C-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC
T ss_pred C-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC
Confidence 8 888 665 99999999999998 887 68999999999999997 665
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.24 E-value=1.3e-11 Score=120.84 Aligned_cols=111 Identities=14% Similarity=0.131 Sum_probs=97.8
Q ss_pred CcEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCccccCCCCCCEEEC
Q 004979 118 GKVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLL 197 (721)
Q Consensus 118 ~~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~~L~~l~l 197 (721)
.+++.|+|+++.+. .+| .+..+++|++|+|++|.+. .++.+..+++|+.|+|++|.+++..|..++.+++|++|+|
T Consensus 44 ~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L 119 (197)
T 4ezg_A 44 NSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDI 119 (197)
T ss_dssp HTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEEC
T ss_pred CCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEe
Confidence 36788999999998 666 7899999999999999654 4558899999999999999999989999999999999999
Q ss_pred ccCCCCcCCChhccCCCCCCEEEccCCCCCCcccc
Q 004979 198 DNNQYLGGISPELHVLKVISEIQVDESWLTNAASR 232 (721)
Q Consensus 198 ~~N~~~G~iP~~~~~l~~L~~l~l~~n~~~g~~p~ 232 (721)
++|.+++.+|..++.+++|++|+|++|.+.+.+|.
T Consensus 120 s~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~~~ 154 (197)
T 4ezg_A 120 SHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP 154 (197)
T ss_dssp CSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCCGG
T ss_pred cCCccCcHhHHHHhhCCCCCEEEccCCCCccccHh
Confidence 99999999999999999999999999985455653
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.23 E-value=1.1e-11 Score=132.98 Aligned_cols=124 Identities=23% Similarity=0.257 Sum_probs=99.6
Q ss_pred CCCceeeEEeCC-------------CcEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeE
Q 004979 106 NPCSWFGVECSD-------------GKVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILD 172 (721)
Q Consensus 106 ~~C~w~gv~C~~-------------~~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ 172 (721)
.+|.|.|+ |+. .+++.|+|++|.+.+..+..+.++++|++|+|++|.+++..|..++++++|++|+
T Consensus 28 ~~C~~~~~-c~~~~~~l~~iP~~~~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 106 (353)
T 2z80_A 28 LSCDRNGI-CKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLD 106 (353)
T ss_dssp CEECTTSE-EECCSTTCSSCCTTCCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred CCCCCCeE-eeCCCCCcccccccccccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEE
Confidence 56899987 641 2578899999998876556788999999999999999988788899999999999
Q ss_pred cccCcccccCCccccCCCCCCEEECccCCCCcCCCh--hccCCCCCCEEEccCCCCCCccc
Q 004979 173 LGFNNFSGPFPSDFGNSFSLTTLLLDNNQYLGGISP--ELHVLKVISEIQVDESWLTNAAS 231 (721)
Q Consensus 173 ls~N~l~G~iP~~~~~~~~L~~l~l~~N~~~G~iP~--~~~~l~~L~~l~l~~n~~~g~~p 231 (721)
|++|++++-.+..++++++|++|+|++|.++ .+|. .+..+++|++|++++|...+.++
T Consensus 107 Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~~l~~L~~L~l~~n~~~~~~~ 166 (353)
T 2z80_A 107 LSYNYLSNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQ 166 (353)
T ss_dssp CCSSCCSSCCHHHHTTCTTCSEEECTTCCCS-SSCSSCSCTTCTTCCEEEEEESSSCCEEC
T ss_pred CCCCcCCcCCHhHhCCCccCCEEECCCCCCc-ccCchhhhccCCCCcEEECCCCccccccC
Confidence 9999998533334888999999999999888 4665 67889999999999885333443
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.23 E-value=4.3e-11 Score=116.87 Aligned_cols=104 Identities=22% Similarity=0.302 Sum_probs=94.8
Q ss_pred EEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCccccCCCCCCEEECccC
Q 004979 121 VILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLLDNN 200 (721)
Q Consensus 121 ~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~~L~~l~l~~N 200 (721)
..++++++++. .||..+. +.|++|+|++|.++ .||..+.++++|+.|+|++|++++..|..+.++++|++|+|++|
T Consensus 13 ~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N 88 (193)
T 2wfh_A 13 TVVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN 88 (193)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence 36889999987 5776553 68999999999998 89999999999999999999999887788999999999999999
Q ss_pred CCCcCCChhccCCCCCCEEEccCCCCCC
Q 004979 201 QYLGGISPELHVLKVISEIQVDESWLTN 228 (721)
Q Consensus 201 ~~~G~iP~~~~~l~~L~~l~l~~n~~~g 228 (721)
++++-.|..+..+++|+.|+|++|.+++
T Consensus 89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~~ 116 (193)
T 2wfh_A 89 RLRCIPPRTFDGLKSLRLLSLHGNDISV 116 (193)
T ss_dssp CCCBCCTTTTTTCTTCCEEECCSSCCCB
T ss_pred ccCEeCHHHhCCCCCCCEEECCCCCCCe
Confidence 9999888889999999999999999995
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.23 E-value=5.1e-12 Score=133.15 Aligned_cols=110 Identities=21% Similarity=0.221 Sum_probs=86.3
Q ss_pred CcEEEEEeCCCCCCCcCchhh--cCCCCCCEEEccCCcccccCchhhcCC-----CCCCEeEcccCcccccCCccccCCC
Q 004979 118 GKVVILNLRDLCLGGMLAPEL--GQLSELKSIILRNNSFFGTIPKEIGEL-----KELEILDLGFNNFSGPFPSDFGNSF 190 (721)
Q Consensus 118 ~~v~~l~L~~~~l~G~ip~~l--~~l~~L~~L~L~~n~l~G~ip~~l~~l-----~~L~~l~ls~N~l~G~iP~~~~~~~ 190 (721)
.++..|+|++|.++|.+|..+ +.+++|++|+|++|.+++. |..++.+ ++|++|+|++|++++..|..+++++
T Consensus 95 ~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~ 173 (312)
T 1wwl_A 95 SGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFP 173 (312)
T ss_dssp SCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCS
T ss_pred CCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCC
Confidence 367788888888888888776 7788888888888888876 7767666 7888888888888877777888888
Q ss_pred CCCEEECccCCCCcC--CChhc--cCCCCCCEEEccCCCCCC
Q 004979 191 SLTTLLLDNNQYLGG--ISPEL--HVLKVISEIQVDESWLTN 228 (721)
Q Consensus 191 ~L~~l~l~~N~~~G~--iP~~~--~~l~~L~~l~l~~n~~~g 228 (721)
+|++|+|++|+++|. +|+.+ ..+++|++|+|++|.+++
T Consensus 174 ~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~ 215 (312)
T 1wwl_A 174 ALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMET 215 (312)
T ss_dssp SCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCC
T ss_pred CCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcc
Confidence 888888888888776 34455 778888888888888874
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.22 E-value=2.9e-11 Score=125.45 Aligned_cols=114 Identities=18% Similarity=0.169 Sum_probs=71.3
Q ss_pred cEEEEEeCCCC-CCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCccccCCCCCCEEEC
Q 004979 119 KVVILNLRDLC-LGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLL 197 (721)
Q Consensus 119 ~v~~l~L~~~~-l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~~L~~l~l 197 (721)
.+..|+|++|. +.+..|..+..+++|++|+|++|.+++..|..+.++++|+.|+|++|++++..+..++.+++|++|+|
T Consensus 81 ~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 160 (285)
T 1ozn_A 81 LLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFL 160 (285)
T ss_dssp TCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEEC
Confidence 56666666665 44433555666666666666666666655666666666666666666666544445666666666666
Q ss_pred ccCCCCcCCChhccCCCCCCEEEccCCCCCCcccc
Q 004979 198 DNNQYLGGISPELHVLKVISEIQVDESWLTNAASR 232 (721)
Q Consensus 198 ~~N~~~G~iP~~~~~l~~L~~l~l~~n~~~g~~p~ 232 (721)
++|++++-.+..+..+++|+.|+|++|.+++..|.
T Consensus 161 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 195 (285)
T 1ozn_A 161 HGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPH 195 (285)
T ss_dssp CSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTT
T ss_pred CCCcccccCHHHhcCccccCEEECCCCcccccCHh
Confidence 66666654444466666666666666666655443
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.22 E-value=3.2e-11 Score=124.52 Aligned_cols=114 Identities=15% Similarity=0.137 Sum_probs=105.0
Q ss_pred CcEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCccccCCCCCCEEEC
Q 004979 118 GKVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLL 197 (721)
Q Consensus 118 ~~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~~L~~l~l 197 (721)
.++..|+|++|.+.+..+..+..+++|++|+|++|.+.+..|..+.++++|+.|++++|++++..+..++++++|++|++
T Consensus 52 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 131 (276)
T 2z62_A 52 PELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNV 131 (276)
T ss_dssp TTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEEC
T ss_pred cCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEEC
Confidence 47889999999999877778999999999999999999988889999999999999999999877778999999999999
Q ss_pred ccCCCCc-CCChhccCCCCCCEEEccCCCCCCccc
Q 004979 198 DNNQYLG-GISPELHVLKVISEIQVDESWLTNAAS 231 (721)
Q Consensus 198 ~~N~~~G-~iP~~~~~l~~L~~l~l~~n~~~g~~p 231 (721)
++|.+++ .+|..++.+++|+.|+|++|.+++..+
T Consensus 132 ~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~ 166 (276)
T 2z62_A 132 AHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYC 166 (276)
T ss_dssp CSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECG
T ss_pred cCCccceecCchhhccCCCCCEEECCCCCCCcCCH
Confidence 9999987 689999999999999999999987543
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.21 E-value=3.1e-11 Score=125.23 Aligned_cols=112 Identities=19% Similarity=0.102 Sum_probs=101.3
Q ss_pred cEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCc-ccccCCccccCCCCCCEEEC
Q 004979 119 KVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNN-FSGPFPSDFGNSFSLTTLLL 197 (721)
Q Consensus 119 ~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~-l~G~iP~~~~~~~~L~~l~l 197 (721)
.++.|+|++|.+.+..+..+..+++|++|+|++|.+++..|..+..+++|+.|+|++|. +++..|..+..+++|++|++
T Consensus 33 ~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l 112 (285)
T 1ozn_A 33 ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHL 112 (285)
T ss_dssp TCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEEC
T ss_pred CceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEEC
Confidence 57899999999998777789999999999999999998889999999999999999998 66655788999999999999
Q ss_pred ccCCCCcCCChhccCCCCCCEEEccCCCCCCcc
Q 004979 198 DNNQYLGGISPELHVLKVISEIQVDESWLTNAA 230 (721)
Q Consensus 198 ~~N~~~G~iP~~~~~l~~L~~l~l~~n~~~g~~ 230 (721)
++|.+++..|..+..+++|++|+|++|.+++..
T Consensus 113 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 145 (285)
T 1ozn_A 113 DRCGLQELGPGLFRGLAALQYLYLQDNALQALP 145 (285)
T ss_dssp TTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCC
T ss_pred CCCcCCEECHhHhhCCcCCCEEECCCCcccccC
Confidence 999999888888999999999999999998643
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.21 E-value=2.1e-11 Score=137.79 Aligned_cols=108 Identities=21% Similarity=0.257 Sum_probs=101.6
Q ss_pred CcEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCccccCCCCCCEEEC
Q 004979 118 GKVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLL 197 (721)
Q Consensus 118 ~~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~~L~~l~l 197 (721)
.+++.|+|++|.+.+..|..+.++++|++|+|++|.+++..|..++++++|++|||++|+++ .||.. .+++|++|+|
T Consensus 21 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~L 97 (520)
T 2z7x_B 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KISCH--PTVNLKHLDL 97 (520)
T ss_dssp TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCC-EEECC--CCCCCSEEEC
T ss_pred ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCcee-ecCcc--ccCCccEEec
Confidence 57889999999999988889999999999999999999988999999999999999999999 68877 8999999999
Q ss_pred ccCCCCc-CCChhccCCCCCCEEEccCCCCCC
Q 004979 198 DNNQYLG-GISPELHVLKVISEIQVDESWLTN 228 (721)
Q Consensus 198 ~~N~~~G-~iP~~~~~l~~L~~l~l~~n~~~g 228 (721)
++|.+++ .+|..++++++|++|+|++|.+++
T Consensus 98 ~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~ 129 (520)
T 2z7x_B 98 SFNAFDALPICKEFGNMSQLKFLGLSTTHLEK 129 (520)
T ss_dssp CSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG
T ss_pred cCCccccccchhhhccCCcceEEEecCcccch
Confidence 9999998 799999999999999999999986
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.21 E-value=9.7e-12 Score=115.78 Aligned_cols=103 Identities=17% Similarity=0.147 Sum_probs=94.3
Q ss_pred CcEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccc-cCCccccCCCCCCEEE
Q 004979 118 GKVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSG-PFPSDFGNSFSLTTLL 196 (721)
Q Consensus 118 ~~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G-~iP~~~~~~~~L~~l~ 196 (721)
.++..|+|++|.+.+. ..++.+++|++|+|++|.+++.+|..++.+++|+.|+|++|.+++ +.|..++.+++|++|+
T Consensus 42 ~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~l~~L~~L~ 119 (149)
T 2je0_A 42 EELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLD 119 (149)
T ss_dssp TTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEECTTSCCCSHHHHGGGGGCTTCCEEE
T ss_pred CCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEECCCCcCCChHHHHHHhhCCCCCEEe
Confidence 5789999999999987 779999999999999999999999988899999999999999998 4568899999999999
Q ss_pred CccCCCCcCCC---hhccCCCCCCEEEcc
Q 004979 197 LDNNQYLGGIS---PELHVLKVISEIQVD 222 (721)
Q Consensus 197 l~~N~~~G~iP---~~~~~l~~L~~l~l~ 222 (721)
+++|.+++..+ ..+..+++|+.|+++
T Consensus 120 l~~N~l~~~~~~~~~~~~~l~~L~~L~l~ 148 (149)
T 2je0_A 120 LFNCEVTNLNDYRENVFKLLPQLTYLDGY 148 (149)
T ss_dssp CTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred CcCCcccchHHHHHHHHHHCCCcccccCC
Confidence 99999998766 578999999999886
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.20 E-value=3.2e-11 Score=138.93 Aligned_cols=115 Identities=15% Similarity=0.163 Sum_probs=107.0
Q ss_pred CcEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCccccCCCCCCEEEC
Q 004979 118 GKVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLL 197 (721)
Q Consensus 118 ~~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~~L~~l~l 197 (721)
.+++.|+|++|.+.+..|..++++++|++|+|++|.+.+..|..++++++|++|+|++|.+++..|..++++++|++|+|
T Consensus 56 ~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 135 (606)
T 3vq2_A 56 SELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNV 135 (606)
T ss_dssp TTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEEC
T ss_pred ccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeC
Confidence 47899999999999888888999999999999999999988999999999999999999999877788999999999999
Q ss_pred ccCCCCc-CCChhccCCCCCCEEEccCCCCCCcccc
Q 004979 198 DNNQYLG-GISPELHVLKVISEIQVDESWLTNAASR 232 (721)
Q Consensus 198 ~~N~~~G-~iP~~~~~l~~L~~l~l~~n~~~g~~p~ 232 (721)
++|.+++ .+|..++++++|++|+|++|.+++..|.
T Consensus 136 ~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~ 171 (606)
T 3vq2_A 136 AHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVN 171 (606)
T ss_dssp CSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTT
T ss_pred CCCcccceechHhHhhcCCCCEEEccCCcceecChh
Confidence 9999986 8899999999999999999999986554
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.20 E-value=1.9e-11 Score=116.33 Aligned_cols=108 Identities=19% Similarity=0.158 Sum_probs=97.6
Q ss_pred CcEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCccccc-CCccccCCCCCCEEE
Q 004979 118 GKVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGP-FPSDFGNSFSLTTLL 196 (721)
Q Consensus 118 ~~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~-iP~~~~~~~~L~~l~ 196 (721)
.++..|+|++|.+.+. ..+..+++|++|+|++|.+++.+|..+.++++|++|+|++|++++. .+..+..+++|++|+
T Consensus 49 ~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~l~~l~~L~~L~ 126 (168)
T 2ell_A 49 VNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLD 126 (168)
T ss_dssp GGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEECBSSSCCSSGGGGGGSSCSCCCEEE
T ss_pred CCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEeccCCccCcchhHHHHhcCCCCCEEE
Confidence 4788999999999886 7899999999999999999999998888899999999999999973 337899999999999
Q ss_pred CccCCCCcCCC---hhccCCCCCCEEEccCCCCC
Q 004979 197 LDNNQYLGGIS---PELHVLKVISEIQVDESWLT 227 (721)
Q Consensus 197 l~~N~~~G~iP---~~~~~l~~L~~l~l~~n~~~ 227 (721)
+++|.+++..+ ..+..+++|++|+++.|.+.
T Consensus 127 l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~ 160 (168)
T 2ell_A 127 LFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ 160 (168)
T ss_dssp CCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred eeCCcCcchHHHHHHHHHhCccCcEecCCCCChh
Confidence 99999997655 47899999999999999876
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.20 E-value=4e-11 Score=133.09 Aligned_cols=123 Identities=20% Similarity=0.131 Sum_probs=106.9
Q ss_pred eeeEEeCC-----------CcEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcc
Q 004979 110 WFGVECSD-----------GKVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNF 178 (721)
Q Consensus 110 w~gv~C~~-----------~~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l 178 (721)
|..|.|.. ..++.|+|++|.+.+..|..+.++++|++|+|++|.+++..|..+.++++|+.|+|++|++
T Consensus 56 ~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l 135 (452)
T 3zyi_A 56 FSKVVCTRRGLSEVPQGIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWL 135 (452)
T ss_dssp SCEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred CcEEEECCCCcCccCCCCCCCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcC
Confidence 67888963 2578999999999998888999999999999999999998889999999999999999999
Q ss_pred cccCCccccCCCCCCEEECccCCCCcCCChhccCCCCCCEEEccCCCCCCcccc
Q 004979 179 SGPFPSDFGNSFSLTTLLLDNNQYLGGISPELHVLKVISEIQVDESWLTNAASR 232 (721)
Q Consensus 179 ~G~iP~~~~~~~~L~~l~l~~N~~~G~iP~~~~~l~~L~~l~l~~n~~~g~~p~ 232 (721)
++..+..+.++++|++|+|++|.+++-.+..+.++++|+.|+|++|+.-+.++.
T Consensus 136 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~ 189 (452)
T 3zyi_A 136 TVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISE 189 (452)
T ss_dssp SBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECT
T ss_pred CccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccCh
Confidence 976666789999999999999999865555788888999999988666666654
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.20 E-value=2.3e-11 Score=127.48 Aligned_cols=116 Identities=18% Similarity=0.260 Sum_probs=104.8
Q ss_pred CcEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccc-cCchhhcCCCCCCEeEcccCcccccCCccccCCCCCCEEE
Q 004979 118 GKVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFG-TIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLL 196 (721)
Q Consensus 118 ~~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G-~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~~L~~l~ 196 (721)
.++..|+|++|.+.+.++..+..+++|++|+|++|.+.+ .+|..+..+++|+.|+|++|++++..|..+..+++|+.|+
T Consensus 126 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 205 (306)
T 2z66_A 126 RNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLN 205 (306)
T ss_dssp TTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred cCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEE
Confidence 478899999999998888889999999999999999988 6788899999999999999999988888999999999999
Q ss_pred CccCCCCcCCChhccCCCCCCEEEccCCCCCCccccc
Q 004979 197 LDNNQYLGGISPELHVLKVISEIQVDESWLTNAASRA 233 (721)
Q Consensus 197 l~~N~~~G~iP~~~~~l~~L~~l~l~~n~~~g~~p~~ 233 (721)
|++|.+++..+..+..+++|+.|+|++|.+++..|..
T Consensus 206 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 242 (306)
T 2z66_A 206 MSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQE 242 (306)
T ss_dssp CTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSS
T ss_pred CCCCccCccChhhccCcccCCEeECCCCCCcccCHHH
Confidence 9999999877778889999999999999999877653
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.20 E-value=4.1e-11 Score=133.82 Aligned_cols=124 Identities=19% Similarity=0.165 Sum_probs=110.6
Q ss_pred ceeeEEeCC-----------CcEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCc
Q 004979 109 SWFGVECSD-----------GKVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNN 177 (721)
Q Consensus 109 ~w~gv~C~~-----------~~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~ 177 (721)
.|..|.|.. ..++.|+|++|.+.+..+..+.++++|++|+|++|.+++..|..++++++|++|+|++|+
T Consensus 12 ~~~~v~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~ 91 (477)
T 2id5_A 12 QDRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNR 91 (477)
T ss_dssp TTTEEECCSCCCSSCCSCCCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred CCCEEEeCCCCcCcCCCCCCCCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCc
Confidence 377899963 257899999999999888899999999999999999999989999999999999999999
Q ss_pred ccccCCccccCCCCCCEEECccCCCCcCCChhccCCCCCCEEEccCCCCCCcccc
Q 004979 178 FSGPFPSDFGNSFSLTTLLLDNNQYLGGISPELHVLKVISEIQVDESWLTNAASR 232 (721)
Q Consensus 178 l~G~iP~~~~~~~~L~~l~l~~N~~~G~iP~~~~~l~~L~~l~l~~n~~~g~~p~ 232 (721)
+++..+..+.++++|++|+|++|.+++.+|..+..+++|+.|+|++|.+++..|.
T Consensus 92 l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 146 (477)
T 2id5_A 92 LKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHR 146 (477)
T ss_dssp CCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTT
T ss_pred CCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChh
Confidence 9965555688999999999999999999999999999999999999999875543
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.19 E-value=4.9e-11 Score=128.38 Aligned_cols=110 Identities=20% Similarity=0.154 Sum_probs=100.0
Q ss_pred CcEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCccccCCCCCCEEEC
Q 004979 118 GKVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLL 197 (721)
Q Consensus 118 ~~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~~L~~l~l 197 (721)
.++..|+|++|.+++..+..+..+++|++|+|++|.|.+..+..+..+++|+.|+|++|++++..|..+.++++|+.|+|
T Consensus 64 ~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L 143 (361)
T 2xot_A 64 TNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYL 143 (361)
T ss_dssp TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred cccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEEC
Confidence 57899999999999877778999999999999999999877778999999999999999999888999999999999999
Q ss_pred ccCCCCcCCChhc----cCCCCCCEEEccCCCCCC
Q 004979 198 DNNQYLGGISPEL----HVLKVISEIQVDESWLTN 228 (721)
Q Consensus 198 ~~N~~~G~iP~~~----~~l~~L~~l~l~~n~~~g 228 (721)
++|++++ +|..+ ..+++|+.|+|++|.|++
T Consensus 144 ~~N~l~~-l~~~~~~~~~~l~~L~~L~L~~N~l~~ 177 (361)
T 2xot_A 144 SQNQISR-FPVELIKDGNKLPKLMLLDLSSNKLKK 177 (361)
T ss_dssp CSSCCCS-CCGGGTC----CTTCCEEECCSSCCCC
T ss_pred CCCcCCe-eCHHHhcCcccCCcCCEEECCCCCCCc
Confidence 9999986 67665 579999999999999995
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.18 E-value=3.6e-11 Score=137.20 Aligned_cols=115 Identities=17% Similarity=0.152 Sum_probs=101.1
Q ss_pred CcEEEEEeCCCCCCCcCc-hhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCccc-ccCCccccCCCCCCEE
Q 004979 118 GKVVILNLRDLCLGGMLA-PELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFS-GPFPSDFGNSFSLTTL 195 (721)
Q Consensus 118 ~~v~~l~L~~~~l~G~ip-~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~-G~iP~~~~~~~~L~~l 195 (721)
..+..|+|++|.+.+..| ..+..+++|++|+|++|.+.+.+|..+..+++|+.|+|++|.++ |.+|..+..+++|++|
T Consensus 396 ~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L 475 (570)
T 2z63_A 396 EQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFL 475 (570)
T ss_dssp TTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEE
T ss_pred CCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEE
Confidence 467788999999888776 45788999999999999999999988999999999999999998 6899899999999999
Q ss_pred ECccCCCCcCCChhccCCCCCCEEEccCCCCCCcccc
Q 004979 196 LLDNNQYLGGISPELHVLKVISEIQVDESWLTNAASR 232 (721)
Q Consensus 196 ~l~~N~~~G~iP~~~~~l~~L~~l~l~~n~~~g~~p~ 232 (721)
++++|++++.+|..+..+++|+.|+|++|.+++..|.
T Consensus 476 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 512 (570)
T 2z63_A 476 DLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDG 512 (570)
T ss_dssp ECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTT
T ss_pred ECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHH
Confidence 9999999998898999999999999999999876553
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.18 E-value=7.5e-11 Score=122.88 Aligned_cols=108 Identities=21% Similarity=0.094 Sum_probs=60.1
Q ss_pred cEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCccccCCCCCCEEECc
Q 004979 119 KVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLLD 198 (721)
Q Consensus 119 ~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~~L~~l~l~ 198 (721)
.+..|+|++|.+. .+|..+..+++|++|+|++|.+++..|..+..+++|+.|+|++|++++..|..+..+++|+.|+|+
T Consensus 78 ~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 156 (290)
T 1p9a_G 78 VLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLA 156 (290)
T ss_dssp TCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECT
T ss_pred cCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECC
Confidence 4555556655554 455555556666666666666655444555556666666666666654433444555666666666
Q ss_pred cCCCCcCCChhccCCCCCCEEEccCCCCC
Q 004979 199 NNQYLGGISPELHVLKVISEIQVDESWLT 227 (721)
Q Consensus 199 ~N~~~G~iP~~~~~l~~L~~l~l~~n~~~ 227 (721)
+|++++-.+..+..+++|+.|+|++|.++
T Consensus 157 ~N~l~~l~~~~~~~l~~L~~L~L~~N~l~ 185 (290)
T 1p9a_G 157 NNNLTELPAGLLNGLENLDTLLLQENSLY 185 (290)
T ss_dssp TSCCSCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred CCcCCccCHHHhcCcCCCCEEECCCCcCC
Confidence 66655322223345566666666666655
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.17 E-value=6.7e-11 Score=138.19 Aligned_cols=114 Identities=21% Similarity=0.195 Sum_probs=91.0
Q ss_pred cEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCccccCCCCCCEEECc
Q 004979 119 KVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLLD 198 (721)
Q Consensus 119 ~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~~L~~l~l~ 198 (721)
+++.|+|++|.+.+..+..++++++|++|+|++|.+++..|..++++++|++|+|++|++++-.+..++++++|++|+|+
T Consensus 26 ~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~ 105 (680)
T 1ziw_A 26 NITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLM 105 (680)
T ss_dssp TCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECC
T ss_pred CCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEECC
Confidence 67888888888888777778888888888888888888888888888888888888888885333457888888888888
Q ss_pred cCCCCcCCChhccCCCCCCEEEccCCCCCCcccc
Q 004979 199 NNQYLGGISPELHVLKVISEIQVDESWLTNAASR 232 (721)
Q Consensus 199 ~N~~~G~iP~~~~~l~~L~~l~l~~n~~~g~~p~ 232 (721)
+|++++-.|..++++++|++|+|++|.+++..|.
T Consensus 106 ~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~ 139 (680)
T 1ziw_A 106 SNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLG 139 (680)
T ss_dssp SSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCC
T ss_pred CCccCccChhHccccCCCCEEECCCCcccccCch
Confidence 8888766666788888888888888888776554
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.16 E-value=8.9e-11 Score=124.65 Aligned_cols=118 Identities=22% Similarity=0.308 Sum_probs=106.2
Q ss_pred CceeeEEeCC-----------CcEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccC
Q 004979 108 CSWFGVECSD-----------GKVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFN 176 (721)
Q Consensus 108 C~w~gv~C~~-----------~~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N 176 (721)
|+|..+.|.. ..++.|+|++|.+.+..|..+.++++|++|+|++|.+++..|..++++++|++|+|++|
T Consensus 33 c~l~~l~~~~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n 112 (332)
T 2ft3_A 33 CHLRVVQCSDLGLKAVPKEISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKN 112 (332)
T ss_dssp EETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSS
T ss_pred ccCCEEECCCCCccccCCCCCCCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCC
Confidence 7899999962 25789999999999877778999999999999999999998999999999999999999
Q ss_pred cccccCCccccCCCCCCEEECccCCCCcCCChhccCCCCCCEEEccCCCCCC
Q 004979 177 NFSGPFPSDFGNSFSLTTLLLDNNQYLGGISPELHVLKVISEIQVDESWLTN 228 (721)
Q Consensus 177 ~l~G~iP~~~~~~~~L~~l~l~~N~~~G~iP~~~~~l~~L~~l~l~~n~~~g 228 (721)
+++ .+|..+. ++|++|++++|++++-.+..+..+++|+.|++++|.++.
T Consensus 113 ~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~ 161 (332)
T 2ft3_A 113 HLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLEN 161 (332)
T ss_dssp CCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBG
T ss_pred cCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCcccc
Confidence 998 7888776 899999999999986655668999999999999999973
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.16 E-value=5.1e-11 Score=113.77 Aligned_cols=100 Identities=27% Similarity=0.271 Sum_probs=88.8
Q ss_pred CceeeEEeCC-----------CcEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccC
Q 004979 108 CSWFGVECSD-----------GKVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFN 176 (721)
Q Consensus 108 C~w~gv~C~~-----------~~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N 176 (721)
|+|..+.|.. ..+..|+|++|.+++..|..+..+++|++|+|++|.|++..|..+..+++|++|+|++|
T Consensus 9 C~~~~l~~s~n~l~~ip~~~~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N 88 (170)
T 3g39_A 9 CSGTTVDCSGKSLASVPTGIPTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDN 88 (170)
T ss_dssp EETTEEECTTSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cCCCEEEeCCCCcCccCccCCCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCC
Confidence 7899999963 25778999999999988989999999999999999999766666799999999999999
Q ss_pred cccccCCccccCCCCCCEEECccCCCCcCCC
Q 004979 177 NFSGPFPSDFGNSFSLTTLLLDNNQYLGGIS 207 (721)
Q Consensus 177 ~l~G~iP~~~~~~~~L~~l~l~~N~~~G~iP 207 (721)
+|++..|..+.++++|++|+|++|.+++..+
T Consensus 89 ~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~ 119 (170)
T 3g39_A 89 QLKSIPRGAFDNLKSLTHIWLLNNPWDCACS 119 (170)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCBCTTBG
T ss_pred ccCEeCHHHhcCCCCCCEEEeCCCCCCCCch
Confidence 9997666679999999999999999987654
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.16 E-value=7e-11 Score=134.92 Aligned_cols=108 Identities=19% Similarity=0.191 Sum_probs=100.1
Q ss_pred CcEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCccccCCCCCCEEEC
Q 004979 118 GKVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLL 197 (721)
Q Consensus 118 ~~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~~L~~l~l 197 (721)
.+++.|+|++|.+.+..|..+.++++|++|+|++|.+++..|..++++++|++|||++|+++ .||.. .+++|++|+|
T Consensus 52 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~L 128 (562)
T 3a79_B 52 PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISCC--PMASLRHLDL 128 (562)
T ss_dssp TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCC-EECSC--CCTTCSEEEC
T ss_pred CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCC-ccCcc--ccccCCEEEC
Confidence 47889999999999888889999999999999999999988999999999999999999999 78877 8999999999
Q ss_pred ccCCCCc-CCChhccCCCCCCEEEccCCCCCC
Q 004979 198 DNNQYLG-GISPELHVLKVISEIQVDESWLTN 228 (721)
Q Consensus 198 ~~N~~~G-~iP~~~~~l~~L~~l~l~~n~~~g 228 (721)
++|++++ ++|..++++++|++|+|++|.+++
T Consensus 129 s~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~ 160 (562)
T 3a79_B 129 SFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQ 160 (562)
T ss_dssp CSSCCSBCCCCGGGGGCTTCCEEEEECSBCCT
T ss_pred CCCCccccCchHhhcccCcccEEecCCCcccc
Confidence 9999988 788899999999999999999886
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.16 E-value=8.1e-11 Score=135.74 Aligned_cols=115 Identities=15% Similarity=0.135 Sum_probs=104.3
Q ss_pred CcEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCccccCCCCCCEEEC
Q 004979 118 GKVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLL 197 (721)
Q Consensus 118 ~~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~~L~~l~l 197 (721)
.+++.|+|++|.+++-.|..|.+|++|++|+|++|.|++-.|..+.+|++|++|+|++|++++-.|..++++++|++|+|
T Consensus 76 ~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~L 155 (635)
T 4g8a_A 76 PELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNV 155 (635)
T ss_dssp TTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEEC
T ss_pred CCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeecc
Confidence 47899999999999866777999999999999999999877778999999999999999999766667999999999999
Q ss_pred ccCCCCc-CCChhccCCCCCCEEEccCCCCCCcccc
Q 004979 198 DNNQYLG-GISPELHVLKVISEIQVDESWLTNAASR 232 (721)
Q Consensus 198 ~~N~~~G-~iP~~~~~l~~L~~l~l~~n~~~g~~p~ 232 (721)
++|.+++ .+|..++.+++|++|+|++|.+++-.|.
T Consensus 156 s~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 191 (635)
T 4g8a_A 156 AHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCT 191 (635)
T ss_dssp CSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGG
T ss_pred ccCccccCCCchhhccchhhhhhcccCccccccccc
Confidence 9999976 6889999999999999999999976554
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.15 E-value=6.3e-11 Score=136.42 Aligned_cols=114 Identities=12% Similarity=0.072 Sum_probs=105.0
Q ss_pred cEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCccccCCCCCCEEECc
Q 004979 119 KVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLLD 198 (721)
Q Consensus 119 ~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~~L~~l~l~ 198 (721)
.++.|+|++|.+++..|..++++++|++|+|++|.+.+..|..++++++|++|+|++|++++..|..++++++|++|+|+
T Consensus 34 ~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~ 113 (606)
T 3t6q_A 34 STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFI 113 (606)
T ss_dssp TCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEECT
T ss_pred cCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEeecc
Confidence 68899999999998888899999999999999999999889999999999999999999999999999999999999999
Q ss_pred cCCCCcCCChhccCCCCCCEEEccCCCCCC-cccc
Q 004979 199 NNQYLGGISPELHVLKVISEIQVDESWLTN-AASR 232 (721)
Q Consensus 199 ~N~~~G~iP~~~~~l~~L~~l~l~~n~~~g-~~p~ 232 (721)
+|.+++-.|..++.+++|++|+|++|.+++ .+|.
T Consensus 114 ~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 148 (606)
T 3t6q_A 114 QTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPK 148 (606)
T ss_dssp TSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCT
T ss_pred ccCcccCCcchhccCCcccEEECCCCcccccCccc
Confidence 999998667778999999999999999987 3343
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.15 E-value=1.6e-10 Score=119.03 Aligned_cols=112 Identities=21% Similarity=0.198 Sum_probs=82.0
Q ss_pred CcEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCccccCCCCCCEEEC
Q 004979 118 GKVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLL 197 (721)
Q Consensus 118 ~~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~~L~~l~l 197 (721)
.++..|+|++|.+++-.+..+..+++|++|+|++|.+.+..+..+..+++|+.|+|++|++++..|..+.++++|++|+|
T Consensus 61 ~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L 140 (270)
T 2o6q_A 61 TKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSL 140 (270)
T ss_dssp TTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEEC
Confidence 36777888888777433334567888888888888887655556677888888888888887766666777888888888
Q ss_pred ccCCCCcCCChhccCCCCCCEEEccCCCCCCc
Q 004979 198 DNNQYLGGISPELHVLKVISEIQVDESWLTNA 229 (721)
Q Consensus 198 ~~N~~~G~iP~~~~~l~~L~~l~l~~n~~~g~ 229 (721)
++|.+++-.+..+..+++|+.|+|++|.+++-
T Consensus 141 s~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~ 172 (270)
T 2o6q_A 141 GYNELQSLPKGVFDKLTSLKELRLYNNQLKRV 172 (270)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCSCC
T ss_pred CCCcCCccCHhHccCCcccceeEecCCcCcEe
Confidence 88887764444567788888888888877753
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.14 E-value=8.6e-11 Score=118.55 Aligned_cols=109 Identities=12% Similarity=0.117 Sum_probs=96.6
Q ss_pred CcEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCc-ccccCchhhcCCCCCCEeEccc-CcccccCCccccCCCCCCEE
Q 004979 118 GKVVILNLRDLCLGGMLAPELGQLSELKSIILRNNS-FFGTIPKEIGELKELEILDLGF-NNFSGPFPSDFGNSFSLTTL 195 (721)
Q Consensus 118 ~~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~-l~G~ip~~l~~l~~L~~l~ls~-N~l~G~iP~~~~~~~~L~~l 195 (721)
..++.|+|++|.+.+..+..+..+++|++|+|++|. +++-.+..+.++++|+.|+|++ |++++-.|..+.++++|++|
T Consensus 31 ~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L 110 (239)
T 2xwt_C 31 PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFL 110 (239)
T ss_dssp TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEE
T ss_pred CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEE
Confidence 468899999999998777789999999999999997 7755555889999999999999 99997666788999999999
Q ss_pred ECccCCCCcCCChhccCCCCCC---EEEccCC-CCCC
Q 004979 196 LLDNNQYLGGISPELHVLKVIS---EIQVDES-WLTN 228 (721)
Q Consensus 196 ~l~~N~~~G~iP~~~~~l~~L~---~l~l~~n-~~~g 228 (721)
++++|.+++ +|. +..+.+|+ .|++++| .+++
T Consensus 111 ~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~ 145 (239)
T 2xwt_C 111 GIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTS 145 (239)
T ss_dssp EEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCE
T ss_pred eCCCCCCcc-ccc-cccccccccccEEECCCCcchhh
Confidence 999999998 887 88888888 9999999 8875
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.14 E-value=1e-11 Score=130.90 Aligned_cols=108 Identities=18% Similarity=0.234 Sum_probs=88.5
Q ss_pred EEEeCCCCC-CCcCchhhc-------CCCCCCEEEccCCcccccCchhh--cCCCCCCEeEcccCcccccCCccccCC--
Q 004979 122 ILNLRDLCL-GGMLAPELG-------QLSELKSIILRNNSFFGTIPKEI--GELKELEILDLGFNNFSGPFPSDFGNS-- 189 (721)
Q Consensus 122 ~l~L~~~~l-~G~ip~~l~-------~l~~L~~L~L~~n~l~G~ip~~l--~~l~~L~~l~ls~N~l~G~iP~~~~~~-- 189 (721)
.|+|++|.+ .+.+|..+. ++++|++|+|++|.++|.+|..+ +.+++|++|+|++|++++. |..++.+
T Consensus 67 ~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~ 145 (312)
T 1wwl_A 67 SLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQ 145 (312)
T ss_dssp HCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHT
T ss_pred hcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHH
Confidence 345555555 355666555 78899999999999999998876 8899999999999999887 8777766
Q ss_pred ---CCCCEEECccCCCCcCCChhccCCCCCCEEEccCCCCCCcc
Q 004979 190 ---FSLTTLLLDNNQYLGGISPELHVLKVISEIQVDESWLTNAA 230 (721)
Q Consensus 190 ---~~L~~l~l~~N~~~G~iP~~~~~l~~L~~l~l~~n~~~g~~ 230 (721)
++|++|+|++|++++..|..++.+++|++|+|++|.++|.+
T Consensus 146 ~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 189 (312)
T 1wwl_A 146 WLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGER 189 (312)
T ss_dssp TCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHH
T ss_pred hhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcch
Confidence 88999999999998888888999999999999999988763
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.14 E-value=3.6e-11 Score=136.65 Aligned_cols=116 Identities=22% Similarity=0.248 Sum_probs=107.2
Q ss_pred CcEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccc-cCCccccCCCCCCEEE
Q 004979 118 GKVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSG-PFPSDFGNSFSLTTLL 196 (721)
Q Consensus 118 ~~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G-~iP~~~~~~~~L~~l~ 196 (721)
.+++.|+|++|.+.+..|..++.+++|++|+|++|.+++..|..++++++|++|+|++|.+++ .+|..++++++|++|+
T Consensus 50 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~ 129 (549)
T 2z81_A 50 ANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLR 129 (549)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEE
T ss_pred CcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEE
Confidence 578999999999999888899999999999999999999888889999999999999999997 6788999999999999
Q ss_pred CccCCCCcCCC-hhccCCCCCCEEEccCCCCCCccccc
Q 004979 197 LDNNQYLGGIS-PELHVLKVISEIQVDESWLTNAASRA 233 (721)
Q Consensus 197 l~~N~~~G~iP-~~~~~l~~L~~l~l~~n~~~g~~p~~ 233 (721)
+++|.+.+.+| ..+..+++|++|++++|.+++.+|..
T Consensus 130 L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 167 (549)
T 2z81_A 130 IGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQS 167 (549)
T ss_dssp EEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTT
T ss_pred CCCCccccccCHhhhhcccccCeeeccCCcccccChhh
Confidence 99999888887 47999999999999999999887753
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.14 E-value=1.3e-10 Score=121.16 Aligned_cols=108 Identities=21% Similarity=0.163 Sum_probs=95.8
Q ss_pred cEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCccccCCCCCCEEECc
Q 004979 119 KVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLLD 198 (721)
Q Consensus 119 ~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~~L~~l~l~ 198 (721)
.++.|+|++|.+++..+..+..+++|++|+|++|.+++. |.. +.+++|+.|+|++|+++ .+|..+..+++|++|+|+
T Consensus 32 ~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~-~~~-~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~ 108 (290)
T 1p9a_G 32 DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL-QVD-GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVS 108 (290)
T ss_dssp TCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEE-ECC-SCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECC
T ss_pred CCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcc-cCC-CCCCcCCEEECCCCcCC-cCchhhccCCCCCEEECC
Confidence 578999999999988888899999999999999999864 433 78999999999999998 789888999999999999
Q ss_pred cCCCCcCCChhccCCCCCCEEEccCCCCCCc
Q 004979 199 NNQYLGGISPELHVLKVISEIQVDESWLTNA 229 (721)
Q Consensus 199 ~N~~~G~iP~~~~~l~~L~~l~l~~n~~~g~ 229 (721)
+|++++-.|..+..+++|+.|+|++|.+++-
T Consensus 109 ~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~ 139 (290)
T 1p9a_G 109 FNRLTSLPLGALRGLGELQELYLKGNELKTL 139 (290)
T ss_dssp SSCCCCCCSSTTTTCTTCCEEECTTSCCCCC
T ss_pred CCcCcccCHHHHcCCCCCCEEECCCCCCCcc
Confidence 9999977777889999999999999999854
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.13 E-value=2.6e-10 Score=109.36 Aligned_cols=106 Identities=18% Similarity=0.164 Sum_probs=91.6
Q ss_pred EEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCccccCCCCCCEEECccC
Q 004979 121 VILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLLDNN 200 (721)
Q Consensus 121 ~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~~L~~l~l~~N 200 (721)
..++++++++.. +|..+ .++|+.|+|++|.+.+..+..++.+++|+.|+|++|++++..|..+.++++|++|+|++|
T Consensus 10 ~~l~~~~~~l~~-~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N 86 (177)
T 2o6r_A 10 TEIRCNSKGLTS-VPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHEN 86 (177)
T ss_dssp TEEECCSSCCSS-CCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEecCCCCcc-CCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCC
Confidence 478899998864 55444 479999999999999766667899999999999999999766666899999999999999
Q ss_pred CCCcCCChhccCCCCCCEEEccCCCCCCc
Q 004979 201 QYLGGISPELHVLKVISEIQVDESWLTNA 229 (721)
Q Consensus 201 ~~~G~iP~~~~~l~~L~~l~l~~n~~~g~ 229 (721)
++++-.+..+..+++|+.|+|++|.+++-
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~ 115 (177)
T 2o6r_A 87 KLQSLPNGVFDKLTQLKELALDTNQLKSV 115 (177)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCSCC
T ss_pred CccccCHHHhhCCcccCEEECcCCcceEe
Confidence 99987777789999999999999999953
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.13 E-value=8.5e-11 Score=132.73 Aligned_cols=110 Identities=19% Similarity=0.163 Sum_probs=53.5
Q ss_pred EEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccc--cCCccccCCCCCCEEEC
Q 004979 120 VVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSG--PFPSDFGNSFSLTTLLL 197 (721)
Q Consensus 120 v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G--~iP~~~~~~~~L~~l~l 197 (721)
+..|+|++|.+.+..- ...+++|++|+|++|.+++.+|..++++++|+.|+|++|++++ .+|..++.+++|++|++
T Consensus 304 L~~L~l~~n~l~~~~~--~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~L 381 (520)
T 2z7x_B 304 IKNFTVSGTRMVHMLC--PSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDI 381 (520)
T ss_dssp CSEEEEESSCCCCCCC--CSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEEC
T ss_pred eeEEEcCCCccccccc--hhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEEC
Confidence 4445555554433210 1344455555555555555555555555555555555555554 44444555555555555
Q ss_pred ccCCCCcCCChh-ccCCCCCCEEEccCCCCCCccc
Q 004979 198 DNNQYLGGISPE-LHVLKVISEIQVDESWLTNAAS 231 (721)
Q Consensus 198 ~~N~~~G~iP~~-~~~l~~L~~l~l~~n~~~g~~p 231 (721)
++|.+++.+|.. +..+++|+.|+|++|.+++.+|
T Consensus 382 s~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~ 416 (520)
T 2z7x_B 382 SQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIF 416 (520)
T ss_dssp CSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGG
T ss_pred CCCcCCcccccchhccCccCCEEECcCCCCCcchh
Confidence 555555544443 3444555555555555554444
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.13 E-value=1.4e-10 Score=122.88 Aligned_cols=119 Identities=22% Similarity=0.309 Sum_probs=103.7
Q ss_pred CCceeeEEeCC-----------CcEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEccc
Q 004979 107 PCSWFGVECSD-----------GKVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGF 175 (721)
Q Consensus 107 ~C~w~gv~C~~-----------~~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~ 175 (721)
.|+|..+.|.. ..++.|+|++|.+.+..+..++++++|++|+|++|.+++..|..++++++|++|+|++
T Consensus 30 ~c~l~~l~~~~~~l~~lp~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~ 109 (330)
T 1xku_A 30 QCHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSK 109 (330)
T ss_dssp EEETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred cCCCeEEEecCCCccccCccCCCCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCC
Confidence 37899999962 2578899999999987777899999999999999999998899999999999999999
Q ss_pred CcccccCCccccCCCCCCEEECccCCCCcCCChhccCCCCCCEEEccCCCCCC
Q 004979 176 NNFSGPFPSDFGNSFSLTTLLLDNNQYLGGISPELHVLKVISEIQVDESWLTN 228 (721)
Q Consensus 176 N~l~G~iP~~~~~~~~L~~l~l~~N~~~G~iP~~~~~l~~L~~l~l~~n~~~g 228 (721)
|+++ .+|..+. ++|++|++++|.+++-.+..+..+++|+.|++++|.++.
T Consensus 110 n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 159 (330)
T 1xku_A 110 NQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKS 159 (330)
T ss_dssp SCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCG
T ss_pred CcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCc
Confidence 9998 7887665 689999999998887777778888889999998888863
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.13 E-value=5.5e-11 Score=133.28 Aligned_cols=111 Identities=18% Similarity=0.213 Sum_probs=99.4
Q ss_pred CcEEEEEeCCCCCCCcCchhhc-CCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCccccCCCCCCEEE
Q 004979 118 GKVVILNLRDLCLGGMLAPELG-QLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLL 196 (721)
Q Consensus 118 ~~v~~l~L~~~~l~G~ip~~l~-~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~~L~~l~ 196 (721)
.++..|+|++|.++|.+|..+. .+++|+.|+|++|.|++. | .+..+++|+.|+|++|.++| +|+.+..+++|+.|+
T Consensus 144 ~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~-~-~~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~ 220 (487)
T 3oja_A 144 SRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-K-GQVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWIS 220 (487)
T ss_dssp SSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-E-CCCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEE
T ss_pred CCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccc-c-ccccCCCCCEEECCCCCCCC-CCHhHcCCCCccEEE
Confidence 5799999999999999998886 899999999999999987 3 34579999999999999997 566699999999999
Q ss_pred CccCCCCcCCChhccCCCCCCEEEccCCCCC-Ccccc
Q 004979 197 LDNNQYLGGISPELHVLKVISEIQVDESWLT-NAASR 232 (721)
Q Consensus 197 l~~N~~~G~iP~~~~~l~~L~~l~l~~n~~~-g~~p~ 232 (721)
|++|.+++ ||..++.+++|+.|++++|.++ +.+|.
T Consensus 221 Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~~~~ 256 (487)
T 3oja_A 221 LRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRD 256 (487)
T ss_dssp CTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHHHHHH
T ss_pred ecCCcCcc-cchhhccCCCCCEEEcCCCCCcCcchHH
Confidence 99999996 8999999999999999999998 54443
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.13 E-value=8.3e-11 Score=140.94 Aligned_cols=115 Identities=21% Similarity=0.205 Sum_probs=96.4
Q ss_pred CcEEEEEeCCCCCCCcC-chhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCcc--ccCCCCCCE
Q 004979 118 GKVVILNLRDLCLGGML-APELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSD--FGNSFSLTT 194 (721)
Q Consensus 118 ~~v~~l~L~~~~l~G~i-p~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~--~~~~~~L~~ 194 (721)
..++.|+|++|.+.+.| |..+.+|++|++|+|++|.+.+..|..++++++|++|+|++|.+++.+|.. ++++++|++
T Consensus 48 ~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~ 127 (844)
T 3j0a_A 48 EQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTR 127 (844)
T ss_dssp CSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCE
T ss_pred ccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCE
Confidence 46788888888888888 456888899999999999998888888888999999999999998887765 888889999
Q ss_pred EECccCCCCcCCC-hhccCCCCCCEEEccCCCCCCcccc
Q 004979 195 LLLDNNQYLGGIS-PELHVLKVISEIQVDESWLTNAASR 232 (721)
Q Consensus 195 l~l~~N~~~G~iP-~~~~~l~~L~~l~l~~n~~~g~~p~ 232 (721)
|+|++|.+++..| ..++++++|++|+|++|.+++..+.
T Consensus 128 L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~ 166 (844)
T 3j0a_A 128 LDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEH 166 (844)
T ss_dssp EEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSG
T ss_pred EECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHH
Confidence 9999998887655 5788888999999988888876554
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.12 E-value=3.8e-12 Score=149.56 Aligned_cols=113 Identities=21% Similarity=0.218 Sum_probs=103.0
Q ss_pred CcEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCccccCCCCCCEEEC
Q 004979 118 GKVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLL 197 (721)
Q Consensus 118 ~~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~~L~~l~l 197 (721)
.++..|+|++|.|+ .||..|++|++|++|+|++|.|+ .||..+++|++|++|+|++|.|+ .||..|+++++|++|+|
T Consensus 247 ~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L 323 (727)
T 4b8c_D 247 DFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGV 323 (727)
T ss_dssp CSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEEC
T ss_pred CCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeC
Confidence 46889999999999 89999999999999999999999 89999999999999999999997 89999999999999999
Q ss_pred ccCCCCcCCChhccCCCCC-CEEEccCCCCCCccccc
Q 004979 198 DNNQYLGGISPELHVLKVI-SEIQVDESWLTNAASRA 233 (721)
Q Consensus 198 ~~N~~~G~iP~~~~~l~~L-~~l~l~~n~~~g~~p~~ 233 (721)
++|.|+|.+|..+..+..+ ..|+|++|.++|.+|..
T Consensus 324 ~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~ 360 (727)
T 4b8c_D 324 EGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHE 360 (727)
T ss_dssp TTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC
T ss_pred CCCccCCCChHHHhhcchhhhHHhhccCcccCcCccc
Confidence 9999999999888664322 24789999999999874
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.11 E-value=1e-10 Score=112.14 Aligned_cols=105 Identities=21% Similarity=0.186 Sum_probs=90.2
Q ss_pred CcEEEEEeCCCCCCCcCchhhcCCC-CCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCcc-ccCCCCCCEE
Q 004979 118 GKVVILNLRDLCLGGMLAPELGQLS-ELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSD-FGNSFSLTTL 195 (721)
Q Consensus 118 ~~v~~l~L~~~~l~G~ip~~l~~l~-~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~-~~~~~~L~~l 195 (721)
..++.|+|++|.+.. +| .+..+. +|++|+|++|.+++. ..++.+++|+.|+|++|++++ +|+. +..+++|++|
T Consensus 19 ~~L~~L~l~~n~l~~-i~-~~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L 93 (176)
T 1a9n_A 19 VRDRELDLRGYKIPV-IE-NLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICR-IGEGLDQALPDLTEL 93 (176)
T ss_dssp TSCEEEECTTSCCCS-CC-CGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCE-ECSCHHHHCTTCCEE
T ss_pred CCceEEEeeCCCCch-hH-HhhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccc-cCcchhhcCCCCCEE
Confidence 468899999999984 54 465555 999999999999975 678999999999999999995 5544 4899999999
Q ss_pred ECccCCCCcCCCh--hccCCCCCCEEEccCCCCCC
Q 004979 196 LLDNNQYLGGISP--ELHVLKVISEIQVDESWLTN 228 (721)
Q Consensus 196 ~l~~N~~~G~iP~--~~~~l~~L~~l~l~~n~~~g 228 (721)
+|++|.+ +.+|. .+..+++|+.|+|++|.++.
T Consensus 94 ~L~~N~i-~~~~~~~~l~~l~~L~~L~l~~N~i~~ 127 (176)
T 1a9n_A 94 ILTNNSL-VELGDLDPLASLKSLTYLCILRNPVTN 127 (176)
T ss_dssp ECCSCCC-CCGGGGGGGGGCTTCCEEECCSSGGGG
T ss_pred ECCCCcC-CcchhhHhhhcCCCCCEEEecCCCCCC
Confidence 9999998 56887 88999999999999999873
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.11 E-value=8e-11 Score=134.44 Aligned_cols=94 Identities=20% Similarity=0.123 Sum_probs=60.9
Q ss_pred cCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccc--cCCccccCCCCCCEEECccCCCCcCCChh-ccCCCC
Q 004979 139 GQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSG--PFPSDFGNSFSLTTLLLDNNQYLGGISPE-LHVLKV 215 (721)
Q Consensus 139 ~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G--~iP~~~~~~~~L~~l~l~~N~~~G~iP~~-~~~l~~ 215 (721)
..+++|++|+|++|.+++.+|..++++++|+.|+|++|++++ .+|..+.++++|++|+|++|++++.+|.. +..+++
T Consensus 350 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~ 429 (562)
T 3a79_B 350 PSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAES 429 (562)
T ss_dssp SSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTT
T ss_pred cCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCccc
Confidence 455666666666666666666666666666666666666665 44555666666666666666666666654 555666
Q ss_pred CCEEEccCCCCCCcccc
Q 004979 216 ISEIQVDESWLTNAASR 232 (721)
Q Consensus 216 L~~l~l~~n~~~g~~p~ 232 (721)
|+.|+|++|.+++.+|.
T Consensus 430 L~~L~l~~n~l~~~~~~ 446 (562)
T 3a79_B 430 ILVLNLSSNMLTGSVFR 446 (562)
T ss_dssp CCEEECCSSCCCGGGGS
T ss_pred CCEEECCCCCCCcchhh
Confidence 66666666666665553
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.10 E-value=3.7e-11 Score=126.34 Aligned_cols=113 Identities=14% Similarity=0.047 Sum_probs=55.1
Q ss_pred cEEEEEeCCCCCCCcCc----hhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCccccc--CC--ccccCCC
Q 004979 119 KVVILNLRDLCLGGMLA----PELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGP--FP--SDFGNSF 190 (721)
Q Consensus 119 ~v~~l~L~~~~l~G~ip----~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~--iP--~~~~~~~ 190 (721)
.+..|+|++|.+++.++ ..+..+++|++|+|++|.+.+..|..++.+++|++|||++|++.|. +| ..++.++
T Consensus 118 ~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~ 197 (310)
T 4glp_A 118 ALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFP 197 (310)
T ss_dssp CCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSC
T ss_pred CCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCC
Confidence 34455555555555433 2234455555555555555555555555555555555555555442 22 1124455
Q ss_pred CCCEEECccCCCC--cCCChh-ccCCCCCCEEEccCCCCCCccc
Q 004979 191 SLTTLLLDNNQYL--GGISPE-LHVLKVISEIQVDESWLTNAAS 231 (721)
Q Consensus 191 ~L~~l~l~~N~~~--G~iP~~-~~~l~~L~~l~l~~n~~~g~~p 231 (721)
+|++|+|++|+++ +.++.. +..+++|++|+|++|.+++.+|
T Consensus 198 ~L~~L~Ls~N~l~~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p 241 (310)
T 4glp_A 198 AIQNLALRNTGMETPTGVCAALAAAGVQPHSLDLSHNSLRATVN 241 (310)
T ss_dssp CCCSCBCCSSCCCCHHHHHHHHHHHTCCCSSEECTTSCCCCCCC
T ss_pred CCCEEECCCCCCCchHHHHHHHHhcCCCCCEEECCCCCCCccch
Confidence 5555555555553 111111 2444555555555555555444
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.10 E-value=1.7e-10 Score=125.32 Aligned_cols=111 Identities=16% Similarity=0.221 Sum_probs=91.5
Q ss_pred cEEEEEeCCCCCCCcCchh-hcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCccccCCCCCCEEEC
Q 004979 119 KVVILNLRDLCLGGMLAPE-LGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLL 197 (721)
Q Consensus 119 ~v~~l~L~~~~l~G~ip~~-l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~~L~~l~l 197 (721)
.+..++|+++.+.. +|+. +..+++|++|+|++|.+.+..|..++.+++|+.|+|++|.+++..|..++++++|++|+|
T Consensus 46 ~l~~l~l~~~~l~~-l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 124 (390)
T 3o6n_A 46 NQKIVTFKNSTMRK-LPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVL 124 (390)
T ss_dssp CCSEEEEESCEESE-ECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CceEEEecCCchhh-CChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEEC
Confidence 35677888877654 5544 688999999999999998877778899999999999999999877788889999999999
Q ss_pred ccCCCCcCCChh-ccCCCCCCEEEccCCCCCCccc
Q 004979 198 DNNQYLGGISPE-LHVLKVISEIQVDESWLTNAAS 231 (721)
Q Consensus 198 ~~N~~~G~iP~~-~~~l~~L~~l~l~~n~~~g~~p 231 (721)
++|.++ .+|+. +..+++|++|+|++|.+++..|
T Consensus 125 ~~n~l~-~l~~~~~~~l~~L~~L~L~~n~l~~~~~ 158 (390)
T 3o6n_A 125 ERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIED 158 (390)
T ss_dssp CSSCCC-CCCTTTTTTCTTCCEEECCSSCCCBCCT
T ss_pred CCCccC-cCCHHHhcCCCCCcEEECCCCccCccCh
Confidence 999988 56665 5789999999999999886544
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.09 E-value=2.1e-10 Score=131.95 Aligned_cols=116 Identities=19% Similarity=0.135 Sum_probs=103.1
Q ss_pred CcEEEEEeCCCCCCCcCchh-hcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCccccc---CCccccCCCCCC
Q 004979 118 GKVVILNLRDLCLGGMLAPE-LGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGP---FPSDFGNSFSLT 193 (721)
Q Consensus 118 ~~v~~l~L~~~~l~G~ip~~-l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~---iP~~~~~~~~L~ 193 (721)
..+..|+|++|.+.+.+++. +..+++|+.|+|++|.+.+..|..++.+++|+.|+|++|.+++. .+..+..+++|+
T Consensus 400 ~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~ 479 (606)
T 3t6q_A 400 PQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLE 479 (606)
T ss_dssp TTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCC
T ss_pred ccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCcc
Confidence 46789999999999887765 88999999999999999999999999999999999999999873 335688999999
Q ss_pred EEECccCCCCcCCChhccCCCCCCEEEccCCCCCCccccc
Q 004979 194 TLLLDNNQYLGGISPELHVLKVISEIQVDESWLTNAASRA 233 (721)
Q Consensus 194 ~l~l~~N~~~G~iP~~~~~l~~L~~l~l~~n~~~g~~p~~ 233 (721)
+|++++|++++.+|..+..+++|+.|+|++|.+++.+|..
T Consensus 480 ~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 519 (606)
T 3t6q_A 480 ILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEA 519 (606)
T ss_dssp EEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGG
T ss_pred EEECCCCccCccChhhhccccCCCEEECCCCccCcCChhH
Confidence 9999999999999999999999999999999999877754
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.08 E-value=3.1e-10 Score=125.41 Aligned_cols=123 Identities=19% Similarity=0.128 Sum_probs=107.4
Q ss_pred eeeEEeCC-----------CcEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcc
Q 004979 110 WFGVECSD-----------GKVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNF 178 (721)
Q Consensus 110 w~gv~C~~-----------~~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l 178 (721)
|..|.|.. ..++.|+|++|.+.+..+..+.++++|++|+|++|.+.+..|..+.++++|+.|+|++|++
T Consensus 45 ~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l 124 (440)
T 3zyj_A 45 FSKVICVRKNLREVPDGISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRL 124 (440)
T ss_dssp SCEEECCSCCCSSCCSCCCTTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCC
T ss_pred CCEEEeCCCCcCcCCCCCCCCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcC
Confidence 67899963 2467899999999998888999999999999999999988888999999999999999999
Q ss_pred cccCCccccCCCCCCEEECccCCCCcCCChhccCCCCCCEEEccCCCCCCcccc
Q 004979 179 SGPFPSDFGNSFSLTTLLLDNNQYLGGISPELHVLKVISEIQVDESWLTNAASR 232 (721)
Q Consensus 179 ~G~iP~~~~~~~~L~~l~l~~N~~~G~iP~~~~~l~~L~~l~l~~n~~~g~~p~ 232 (721)
++-.+..+..+++|++|+|++|.+++-.+..+..+++|+.|+|++|+..+.++.
T Consensus 125 ~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~ 178 (440)
T 3zyj_A 125 TTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISE 178 (440)
T ss_dssp SSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECT
T ss_pred CeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCc
Confidence 965556799999999999999999876666788999999999998776666665
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.08 E-value=2.8e-10 Score=129.80 Aligned_cols=110 Identities=17% Similarity=0.070 Sum_probs=55.5
Q ss_pred cEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCccccCCCCCCEEECc
Q 004979 119 KVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLLD 198 (721)
Q Consensus 119 ~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~~L~~l~l~ 198 (721)
+++.|+|++|.+++..+..+.++++|++|+|++|.+++..|..++++++|++|+|++|++++..|..++++++|++|+++
T Consensus 29 ~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 108 (570)
T 2z63_A 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV 108 (570)
T ss_dssp SCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECT
T ss_pred cccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCcccccccccc
Confidence 34455555555555444445555555555555555554444445555555555555555554444445555555555555
Q ss_pred cCCCCcCCChhccCCCCCCEEEccCCCCCC
Q 004979 199 NNQYLGGISPELHVLKVISEIQVDESWLTN 228 (721)
Q Consensus 199 ~N~~~G~iP~~~~~l~~L~~l~l~~n~~~g 228 (721)
+|++++--+..++++++|++|+|++|.+++
T Consensus 109 ~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~ 138 (570)
T 2z63_A 109 ETNLASLENFPIGHLKTLKELNVAHNLIQS 138 (570)
T ss_dssp TSCCCCSTTCSCTTCTTCCEEECCSSCCCC
T ss_pred ccccccCCCccccccccccEEecCCCccce
Confidence 555444322234455555555555554443
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.07 E-value=2.3e-10 Score=133.71 Aligned_cols=115 Identities=17% Similarity=0.096 Sum_probs=88.7
Q ss_pred CcEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCccccCCCCCCEEEC
Q 004979 118 GKVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLL 197 (721)
Q Consensus 118 ~~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~~L~~l~l 197 (721)
.+++.|+|++|.+.+..|..++++++|++|+|++|.+++-.+..++++++|++|+|++|++++..|..++++++|++|+|
T Consensus 49 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 128 (680)
T 1ziw_A 49 SQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDL 128 (680)
T ss_dssp TTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEEC
T ss_pred CcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEEC
Confidence 46778888888888877777888888888888888887533345788888888888888887666667788888888888
Q ss_pred ccCCCCcCCChhccCCCCCCEEEccCCCCCCcccc
Q 004979 198 DNNQYLGGISPELHVLKVISEIQVDESWLTNAASR 232 (721)
Q Consensus 198 ~~N~~~G~iP~~~~~l~~L~~l~l~~n~~~g~~p~ 232 (721)
++|.+++..|..++++++|++|+|++|.+++..+.
T Consensus 129 s~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 163 (680)
T 1ziw_A 129 SHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSE 163 (680)
T ss_dssp CSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHH
T ss_pred CCCcccccCchhhcccccCCEEEccCCcccccCHH
Confidence 88888887777777888888888888888765443
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.07 E-value=8.5e-11 Score=123.62 Aligned_cols=110 Identities=21% Similarity=0.193 Sum_probs=89.3
Q ss_pred cEEEEEeCCCCCCCcCchhh--cCCCCCCEEEccCCcccccCc----hhhcCCCCCCEeEcccCcccccCCccccCCCCC
Q 004979 119 KVVILNLRDLCLGGMLAPEL--GQLSELKSIILRNNSFFGTIP----KEIGELKELEILDLGFNNFSGPFPSDFGNSFSL 192 (721)
Q Consensus 119 ~v~~l~L~~~~l~G~ip~~l--~~l~~L~~L~L~~n~l~G~ip----~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~~L 192 (721)
++..|+|++|.+.|.+|..+ ..+++|++|+|++|.+++.+| ..+..+++|+.|+|++|++++..|..++++++|
T Consensus 92 ~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L 171 (310)
T 4glp_A 92 RLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPAL 171 (310)
T ss_dssp CCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTC
T ss_pred ceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCC
Confidence 47788888999888888887 888889999999999888666 344578889999999999988878888888899
Q ss_pred CEEECccCCCCcC--CChh--ccCCCCCCEEEccCCCCCC
Q 004979 193 TTLLLDNNQYLGG--ISPE--LHVLKVISEIQVDESWLTN 228 (721)
Q Consensus 193 ~~l~l~~N~~~G~--iP~~--~~~l~~L~~l~l~~n~~~g 228 (721)
++|+|++|++.|. ++.. ++.+++|++|+|++|.++.
T Consensus 172 ~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~ 211 (310)
T 4glp_A 172 TSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMET 211 (310)
T ss_dssp CEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCC
T ss_pred CEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCc
Confidence 9999999988764 3322 3678888999999998873
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.07 E-value=3.6e-10 Score=122.70 Aligned_cols=111 Identities=23% Similarity=0.278 Sum_probs=101.0
Q ss_pred CcEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCcc-ccCCCCCCEEE
Q 004979 118 GKVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSD-FGNSFSLTTLL 196 (721)
Q Consensus 118 ~~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~-~~~~~~L~~l~ 196 (721)
.++..|+|++|.+.+..+..+..+++|++|+|++|.+.+..|..++++++|++|+|++|.++ .+|.. +.++++|++|+
T Consensus 69 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~l~~L~~L~ 147 (390)
T 3o6n_A 69 RQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLS 147 (390)
T ss_dssp CCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEE
T ss_pred ccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccC-cCCHHHhcCCCCCcEEE
Confidence 36789999999998877778999999999999999999888888999999999999999999 56665 58999999999
Q ss_pred CccCCCCcCCChhccCCCCCCEEEccCCCCCCc
Q 004979 197 LDNNQYLGGISPELHVLKVISEIQVDESWLTNA 229 (721)
Q Consensus 197 l~~N~~~G~iP~~~~~l~~L~~l~l~~n~~~g~ 229 (721)
+++|.+++-.|..+..+++|+.|++++|.+++.
T Consensus 148 L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 180 (390)
T 3o6n_A 148 MSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV 180 (390)
T ss_dssp CCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC
T ss_pred CCCCccCccChhhccCCCCCCEEECCCCcCCcc
Confidence 999999988888899999999999999999863
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.06 E-value=2.5e-10 Score=127.50 Aligned_cols=112 Identities=17% Similarity=0.180 Sum_probs=88.8
Q ss_pred CcEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCccccCCCCCCEEEC
Q 004979 118 GKVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLL 197 (721)
Q Consensus 118 ~~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~~L~~l~l 197 (721)
.++..|+|++|.+.+..|..+.++++|++|+|++|.+++..+..+.++++|+.|+|++|++++..|..+.++++|+.|+|
T Consensus 56 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l 135 (477)
T 2id5_A 56 PHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEV 135 (477)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEE
T ss_pred CCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEEC
Confidence 46778888888888877777888888888888888887544455678888888888888888877777888888888888
Q ss_pred ccCCCCcCCChhccCCCCCCEEEccCCCCCCc
Q 004979 198 DNNQYLGGISPELHVLKVISEIQVDESWLTNA 229 (721)
Q Consensus 198 ~~N~~~G~iP~~~~~l~~L~~l~l~~n~~~g~ 229 (721)
++|.+++-.|..+..+++|+.|+|++|.+++.
T Consensus 136 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 167 (477)
T 2id5_A 136 GDNDLVYISHRAFSGLNSLEQLTLEKCNLTSI 167 (477)
T ss_dssp CCTTCCEECTTSSTTCTTCCEEEEESCCCSSC
T ss_pred CCCccceeChhhccCCCCCCEEECCCCcCccc
Confidence 88888877777788888888888888887753
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.05 E-value=4.4e-10 Score=114.98 Aligned_cols=137 Identities=12% Similarity=0.136 Sum_probs=101.8
Q ss_pred hhhCcCCCCceeEEEEEEecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCC-CCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVN-HKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~~~lV 508 (721)
.+....+.|+.+.||+.... +..+++|......... ...+.+|+++++.+. |..+.++++++...+ ..++|
T Consensus 17 ~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~--~~~lv 88 (263)
T 3tm0_A 17 RCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGT-----TYDVEREKDMMLWLEGKLPVPKVLHFERHDG--WSNLL 88 (263)
T ss_dssp EEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTS-----TTCHHHHHHHHHHHTTTSCCCCEEEEEEETT--EEEEE
T ss_pred eeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCC-----HHHHHHHHHHHHHHhcCCCCCeEEEEEecCC--ceEEE
Confidence 44455566777899999754 6788998875421111 135888999999884 677889999888765 67999
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCC------------------------------------
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLT------------------------------------ 552 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~------------------------------------ 552 (721)
|||++|.+|.+.+. +......++.+++.+|+.||+..
T Consensus 89 ~e~i~G~~l~~~~~-------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (263)
T 3tm0_A 89 MSEADGVLCSEEYE-------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED 161 (263)
T ss_dssp EECCSSEEHHHHCC-------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTT
T ss_pred EEecCCeehhhccC-------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccc
Confidence 99999999877531 11123468889999999999711
Q ss_pred ---------------------CCeEeeCCCCCCeEeCCCCcEEEeccCCC
Q 004979 553 ---------------------PPIAHRNLQSSSIYLTEDYAAKISDFSFW 581 (721)
Q Consensus 553 ---------------------~~IvHrDLKp~NILl~~~~~~kL~DFGla 581 (721)
+.++|+|+++.|||++++..+.|+||+.+
T Consensus 162 ~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a 211 (263)
T 3tm0_A 162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRS 211 (263)
T ss_dssp CSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTC
T ss_pred ccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhc
Confidence 34899999999999987666779999864
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.05 E-value=2.2e-10 Score=130.47 Aligned_cols=101 Identities=22% Similarity=0.180 Sum_probs=91.9
Q ss_pred CcEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccC-CccccCCCCCCEEE
Q 004979 118 GKVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPF-PSDFGNSFSLTTLL 196 (721)
Q Consensus 118 ~~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~i-P~~~~~~~~L~~l~ 196 (721)
..++.|+|++|.|+ .+|..++.|++|+.|+|++|.|++ || .++.+++|+.|+|++|+|++.+ |..++.+++|+.|+
T Consensus 463 ~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~ 539 (567)
T 1dce_A 463 LLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLN 539 (567)
T ss_dssp TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEE
T ss_pred ccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEE
Confidence 57899999999999 899999999999999999999998 88 8999999999999999999987 99999999999999
Q ss_pred CccCCCCcCCChh---ccCCCCCCEEEc
Q 004979 197 LDNNQYLGGISPE---LHVLKVISEIQV 221 (721)
Q Consensus 197 l~~N~~~G~iP~~---~~~l~~L~~l~l 221 (721)
|++|.++|..|.. +..+++|+.|+|
T Consensus 540 L~~N~l~~~~~~~~~l~~~lp~L~~L~l 567 (567)
T 1dce_A 540 LQGNSLCQEEGIQERLAEMLPSVSSILT 567 (567)
T ss_dssp CTTSGGGGSSSCTTHHHHHCTTCSEEEC
T ss_pred ecCCcCCCCccHHHHHHHHCcccCccCC
Confidence 9999999876632 334889998865
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.04 E-value=1.3e-09 Score=120.53 Aligned_cols=114 Identities=19% Similarity=0.110 Sum_probs=99.2
Q ss_pred CcEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCccccCCCCCCEEEC
Q 004979 118 GKVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLL 197 (721)
Q Consensus 118 ~~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~~L~~l~l 197 (721)
.++..|+|++|.+.+..+..+.++++|++|+|++|.+++..+..+..+++|+.|+|++|.+++-.+..+.++++|+.|+|
T Consensus 88 ~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l 167 (440)
T 3zyj_A 88 RHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDL 167 (440)
T ss_dssp SSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEEC
T ss_pred CCCCEEECCCCcCCccChhhccCCccCCEEECCCCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCC
Confidence 47889999999999887888999999999999999999666667999999999999999999766668889999999999
Q ss_pred ccCCCCcCCCh-hccCCCCCCEEEccCCCCCCcccc
Q 004979 198 DNNQYLGGISP-ELHVLKVISEIQVDESWLTNAASR 232 (721)
Q Consensus 198 ~~N~~~G~iP~-~~~~l~~L~~l~l~~n~~~g~~p~ 232 (721)
++|+..+.+|. .+..+++|++|+|++|.++ .+|.
T Consensus 168 ~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~~ 202 (440)
T 3zyj_A 168 GELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPN 202 (440)
T ss_dssp CCCTTCCEECTTTTTTCSSCCEEECTTSCCS-SCCC
T ss_pred CCCCCcceeCcchhhcccccCeecCCCCcCc-cccc
Confidence 99777777776 5788999999999999988 3553
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.04 E-value=1.2e-10 Score=111.60 Aligned_cols=105 Identities=16% Similarity=0.120 Sum_probs=92.8
Q ss_pred cEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCc--cccCCCCCCEEE
Q 004979 119 KVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPS--DFGNSFSLTTLL 196 (721)
Q Consensus 119 ~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~--~~~~~~~L~~l~ 196 (721)
.+..|+|++|.+++- +.+..+++|++|+|++|.+++..|..++.+++|++|+|++|+++ .+|. .+..+++|+.|+
T Consensus 43 ~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~ 119 (176)
T 1a9n_A 43 QFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYLC 119 (176)
T ss_dssp CCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCEEE
T ss_pred CCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEECCCCcCC-cchhhHhhhcCCCCCEEE
Confidence 788999999999985 67999999999999999999654444589999999999999995 6786 889999999999
Q ss_pred CccCCCCcCCChh----ccCCCCCCEEEccCCCCC
Q 004979 197 LDNNQYLGGISPE----LHVLKVISEIQVDESWLT 227 (721)
Q Consensus 197 l~~N~~~G~iP~~----~~~l~~L~~l~l~~n~~~ 227 (721)
+++|.++ .+|.. +..+++|+.|+++.|...
T Consensus 120 l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 120 ILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp CCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred ecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHH
Confidence 9999997 67775 899999999999998765
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.03 E-value=5.8e-10 Score=118.16 Aligned_cols=111 Identities=16% Similarity=0.172 Sum_probs=92.9
Q ss_pred CcEEEEEeCCCCCC--CcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCccccCCCCCCEE
Q 004979 118 GKVVILNLRDLCLG--GMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTL 195 (721)
Q Consensus 118 ~~v~~l~L~~~~l~--G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~~L~~l 195 (721)
..+..|+|++|.+. |..+..+..+++|++|+|++|.++. +|..+. ++|+.|+|++|.+++..|..+..+++|+.|
T Consensus 145 ~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 221 (330)
T 1xku_A 145 NQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT-IPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKL 221 (330)
T ss_dssp TTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS-CCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEE
T ss_pred ccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCcccc-CCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEE
Confidence 46788999999886 4667778889999999999998874 676554 789999999999988888888889999999
Q ss_pred ECccCCCCcCCChhccCCCCCCEEEccCCCCCCcccc
Q 004979 196 LLDNNQYLGGISPELHVLKVISEIQVDESWLTNAASR 232 (721)
Q Consensus 196 ~l~~N~~~G~iP~~~~~l~~L~~l~l~~n~~~g~~p~ 232 (721)
+|++|.+++..|..+..+++|+.|+|++|.++ .+|.
T Consensus 222 ~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~ 257 (330)
T 1xku_A 222 GLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPG 257 (330)
T ss_dssp ECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCT
T ss_pred ECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCCh
Confidence 99999988877778888899999999999888 5665
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.02 E-value=2.3e-12 Score=126.40 Aligned_cols=105 Identities=25% Similarity=0.316 Sum_probs=68.1
Q ss_pred cEEEEEeCCCCCCCcCch------hhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCccccCCCCC
Q 004979 119 KVVILNLRDLCLGGMLAP------ELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSL 192 (721)
Q Consensus 119 ~v~~l~L~~~~l~G~ip~------~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~~L 192 (721)
+|+.++|+.+.|+|.+|+ .+..+++|++|+|++|.+++ +| .+.++++|+.|+|++|.++ .+|..+..+++|
T Consensus 19 ~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L 95 (198)
T 1ds9_A 19 SVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTL 95 (198)
T ss_dssp CCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHC
T ss_pred cccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcC
Confidence 344555555566666554 66667777777777777665 56 6666677777777777766 566666566667
Q ss_pred CEEECccCCCCcCCChhccCCCCCCEEEccCCCCCC
Q 004979 193 TTLLLDNNQYLGGISPELHVLKVISEIQVDESWLTN 228 (721)
Q Consensus 193 ~~l~l~~N~~~G~iP~~~~~l~~L~~l~l~~n~~~g 228 (721)
++|+|++|++++ +| .+..+++|++|+|++|.+++
T Consensus 96 ~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~ 129 (198)
T 1ds9_A 96 EELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITN 129 (198)
T ss_dssp SEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCC
T ss_pred CEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCc
Confidence 777777776665 44 46666667777777666664
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.01 E-value=6.2e-10 Score=117.39 Aligned_cols=106 Identities=19% Similarity=0.101 Sum_probs=68.9
Q ss_pred cEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhc-CCCCCCEeEcccCcccccCCccccCCCCCCEEEC
Q 004979 119 KVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIG-ELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLL 197 (721)
Q Consensus 119 ~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~-~l~~L~~l~ls~N~l~G~iP~~~~~~~~L~~l~l 197 (721)
.+..|+|++|.+++..+..++.+++|++|+|++|.+.+..|..+. .+++|+.|+|++|.+++. | ....+++|++|+|
T Consensus 121 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~-~~~~l~~L~~L~L 198 (317)
T 3o53_A 121 GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-K-GQVVFAKLKTLDL 198 (317)
T ss_dssp SCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-E-CCCCCTTCCEEEC
T ss_pred CCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-c-cccccccCCEEEC
Confidence 456666666666665555666667777777777777766555553 566777777777776644 2 2334667777777
Q ss_pred ccCCCCcCCChhccCCCCCCEEEccCCCCC
Q 004979 198 DNNQYLGGISPELHVLKVISEIQVDESWLT 227 (721)
Q Consensus 198 ~~N~~~G~iP~~~~~l~~L~~l~l~~n~~~ 227 (721)
++|.+++ +|+.+..+++|+.|+|++|.++
T Consensus 199 s~N~l~~-l~~~~~~l~~L~~L~L~~N~l~ 227 (317)
T 3o53_A 199 SSNKLAF-MGPEFQSAAGVTWISLRNNKLV 227 (317)
T ss_dssp CSSCCCE-ECGGGGGGTTCSEEECTTSCCC
T ss_pred CCCcCCc-chhhhcccCcccEEECcCCccc
Confidence 7777664 4455666777777777777766
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.00 E-value=6.9e-10 Score=123.06 Aligned_cols=112 Identities=21% Similarity=0.203 Sum_probs=98.4
Q ss_pred CcEEEEEeCCCCCCCcCch-hhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCccccCCCCCCEEE
Q 004979 118 GKVVILNLRDLCLGGMLAP-ELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLL 196 (721)
Q Consensus 118 ~~v~~l~L~~~~l~G~ip~-~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~~L~~l~ 196 (721)
..+..|+|++++.-+.+++ .+..+++|++|+|++|.+++ +| .+..+++|+.|+|++|++++..|..+.++++|+.|+
T Consensus 171 ~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 248 (452)
T 3zyi_A 171 PSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD-MP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLW 248 (452)
T ss_dssp TTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSS-CC-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEE
T ss_pred CcccEEeCCCCCCccccChhhccCCCCCCEEECCCCcccc-cc-cccccccccEEECcCCcCcccCcccccCccCCCEEE
Confidence 3678899999777777776 48899999999999999985 45 588999999999999999998899999999999999
Q ss_pred CccCCCCcCCChhccCCCCCCEEEccCCCCCCccc
Q 004979 197 LDNNQYLGGISPELHVLKVISEIQVDESWLTNAAS 231 (721)
Q Consensus 197 l~~N~~~G~iP~~~~~l~~L~~l~l~~n~~~g~~p 231 (721)
|++|++++..|..+..+++|+.|+|++|.+++-.+
T Consensus 249 L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 283 (452)
T 3zyi_A 249 VMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPH 283 (452)
T ss_dssp CTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCT
T ss_pred eCCCcCceECHHHhcCCCCCCEEECCCCcCCccCh
Confidence 99999999889899999999999999999986433
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.00 E-value=3.7e-10 Score=120.93 Aligned_cols=114 Identities=18% Similarity=0.170 Sum_probs=99.8
Q ss_pred CcEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCc--cccCCCCCCEE
Q 004979 118 GKVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPS--DFGNSFSLTTL 195 (721)
Q Consensus 118 ~~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~--~~~~~~~L~~l 195 (721)
.++..|+|++|.+.+..|..+.++++|++|+|++|.+++..+..++++++|++|+|++|+++ .+|. .+.++++|++|
T Consensus 76 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~~l~~L~~L 154 (353)
T 2z80_A 76 VNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQIL 154 (353)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCS-SSCSSCSCTTCTTCCEE
T ss_pred CCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCc-ccCchhhhccCCCCcEE
Confidence 47899999999999888888999999999999999999654555899999999999999999 5665 78899999999
Q ss_pred ECccCC-CCcCCChhccCCCCCCEEEccCCCCCCcccc
Q 004979 196 LLDNNQ-YLGGISPELHVLKVISEIQVDESWLTNAASR 232 (721)
Q Consensus 196 ~l~~N~-~~G~iP~~~~~l~~L~~l~l~~n~~~g~~p~ 232 (721)
++++|+ +.+-.|..+..+++|+.|++++|.+++..|.
T Consensus 155 ~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 192 (353)
T 2z80_A 155 RVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPK 192 (353)
T ss_dssp EEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTT
T ss_pred ECCCCccccccCHHHccCCCCCCEEECCCCCcCccCHH
Confidence 999995 5555567889999999999999999987665
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.00 E-value=5.4e-10 Score=128.56 Aligned_cols=111 Identities=22% Similarity=0.221 Sum_probs=101.9
Q ss_pred cEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCccccCCCCCCEEECc
Q 004979 119 KVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLLD 198 (721)
Q Consensus 119 ~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~~L~~l~l~ 198 (721)
.+..|+|++|.+.+..|..++.+++|++|+|++|.+++..|..++++++|++|+|++|.+++-.|..++++++|++|+|+
T Consensus 76 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls 155 (597)
T 3oja_B 76 QVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMS 155 (597)
T ss_dssp CCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEee
Confidence 57899999999999888899999999999999999999888889999999999999999995444446899999999999
Q ss_pred cCCCCcCCChhccCCCCCCEEEccCCCCCCc
Q 004979 199 NNQYLGGISPELHVLKVISEIQVDESWLTNA 229 (721)
Q Consensus 199 ~N~~~G~iP~~~~~l~~L~~l~l~~n~~~g~ 229 (721)
+|.+++..|..++.+++|+.|+|++|.+++.
T Consensus 156 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 186 (597)
T 3oja_B 156 NNNLERIEDDTFQATTSLQNLQLSSNRLTHV 186 (597)
T ss_dssp SSCCCBCCTTTTTTCTTCCEEECTTSCCSBC
T ss_pred CCcCCCCChhhhhcCCcCcEEECcCCCCCCc
Confidence 9999998888999999999999999999974
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.00 E-value=4.9e-10 Score=118.16 Aligned_cols=111 Identities=18% Similarity=0.213 Sum_probs=97.8
Q ss_pred CcEEEEEeCCCCCCCcCchhhc-CCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCccccCCCCCCEEE
Q 004979 118 GKVVILNLRDLCLGGMLAPELG-QLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLL 196 (721)
Q Consensus 118 ~~v~~l~L~~~~l~G~ip~~l~-~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~~L~~l~ 196 (721)
..+..|+|++|.+.+..+..+. .+++|++|+|++|.+++. | ....+++|+.|+|++|++++ +|+.+..+++|+.|+
T Consensus 144 ~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~-~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~ 220 (317)
T 3o53_A 144 SRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-K-GQVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWIS 220 (317)
T ss_dssp SSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-E-CCCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEE
T ss_pred CCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-c-cccccccCCEEECCCCcCCc-chhhhcccCcccEEE
Confidence 4799999999999998887774 799999999999999865 4 34569999999999999995 666799999999999
Q ss_pred CccCCCCcCCChhccCCCCCCEEEccCCCCC-Ccccc
Q 004979 197 LDNNQYLGGISPELHVLKVISEIQVDESWLT-NAASR 232 (721)
Q Consensus 197 l~~N~~~G~iP~~~~~l~~L~~l~l~~n~~~-g~~p~ 232 (721)
|++|.++ .||..+..+++|+.|+|++|.++ +.+|.
T Consensus 221 L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~ 256 (317)
T 3o53_A 221 LRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRD 256 (317)
T ss_dssp CTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHHHH
T ss_pred CcCCccc-chhhHhhcCCCCCEEEccCCCccCcCHHH
Confidence 9999999 58999999999999999999998 54443
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.00 E-value=4.2e-10 Score=113.45 Aligned_cols=113 Identities=16% Similarity=0.145 Sum_probs=98.8
Q ss_pred CcEEEEEeCCCC-CCCcCchhhcCCCCCCEEEccC-CcccccCchhhcCCCCCCEeEcccCcccccCCccccCCCCCC--
Q 004979 118 GKVVILNLRDLC-LGGMLAPELGQLSELKSIILRN-NSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLT-- 193 (721)
Q Consensus 118 ~~v~~l~L~~~~-l~G~ip~~l~~l~~L~~L~L~~-n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~~L~-- 193 (721)
.++..|+|++|. +++-.+..+..+++|++|+|++ |.+++..|..+..+++|+.|+|++|.+++ +|. +..+++|+
T Consensus 55 ~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~L 132 (239)
T 2xwt_C 55 PNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTDIF 132 (239)
T ss_dssp TTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCCS-CCC-CTTCCBCCSE
T ss_pred CCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc-ccc-cccccccccc
Confidence 478999999997 7655555789999999999999 99997667788999999999999999997 887 88889998
Q ss_pred -EEECccC-CCCcCCChhccCCCCCC-EEEccCCCCCCccccc
Q 004979 194 -TLLLDNN-QYLGGISPELHVLKVIS-EIQVDESWLTNAASRA 233 (721)
Q Consensus 194 -~l~l~~N-~~~G~iP~~~~~l~~L~-~l~l~~n~~~g~~p~~ 233 (721)
+|++++| ++++-.+..+..+++|+ .|++++|.++ .+|..
T Consensus 133 ~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~-~i~~~ 174 (239)
T 2xwt_C 133 FILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGY 174 (239)
T ss_dssp EEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC-EECTT
T ss_pred cEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc-ccCHh
Confidence 9999999 88766556689999999 9999999998 67753
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=98.99 E-value=3.1e-10 Score=120.39 Aligned_cols=110 Identities=21% Similarity=0.234 Sum_probs=80.5
Q ss_pred CcEEEEEeCCCCCC--CcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCccccCCCCCCEE
Q 004979 118 GKVVILNLRDLCLG--GMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTL 195 (721)
Q Consensus 118 ~~v~~l~L~~~~l~--G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~~L~~l 195 (721)
..+..|+|++|.+. |..+..+..+ +|++|++++|.+++ +|..+. ++|+.|+|++|.+++..|..+..+++|+.|
T Consensus 147 ~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L 222 (332)
T 2ft3_A 147 RNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTG-IPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRL 222 (332)
T ss_dssp SSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSS-CCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCC
T ss_pred ccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCc-cCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEE
Confidence 46888999999885 4566667766 77788888777775 665544 677777777777777666777777777777
Q ss_pred ECccCCCCcCCChhccCCCCCCEEEccCCCCCCcccc
Q 004979 196 LLDNNQYLGGISPELHVLKVISEIQVDESWLTNAASR 232 (721)
Q Consensus 196 ~l~~N~~~G~iP~~~~~l~~L~~l~l~~n~~~g~~p~ 232 (721)
+|++|.+++..|..+..+++|+.|+|++|.++ .+|.
T Consensus 223 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~ 258 (332)
T 2ft3_A 223 GLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPA 258 (332)
T ss_dssp BCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCT
T ss_pred ECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecCh
Confidence 77777777766667777777777777777777 5554
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=98.99 E-value=9.4e-10 Score=105.37 Aligned_cols=98 Identities=22% Similarity=0.245 Sum_probs=83.6
Q ss_pred CceeeEEeCC-----------CcEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccC
Q 004979 108 CSWFGVECSD-----------GKVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFN 176 (721)
Q Consensus 108 C~w~gv~C~~-----------~~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N 176 (721)
|...-+.|.+ ..+..|+|++|.+.+..|..+..+++|++|+|++|.|++-.+..+.++++|+.|+|++|
T Consensus 12 C~~~~l~~~~n~l~~iP~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 12 CDQTLVNCQNIRLASVPAGIPTDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp ECSSEEECCSSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred ECCcEEEeCCCCCCccCCCcCCCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 4455667752 25789999999999988989999999999999999999755555789999999999999
Q ss_pred cccccCCccccCCCCCCEEECccCCCCcC
Q 004979 177 NFSGPFPSDFGNSFSLTTLLLDNNQYLGG 205 (721)
Q Consensus 177 ~l~G~iP~~~~~~~~L~~l~l~~N~~~G~ 205 (721)
+|++-.|..+..+++|++|+|++|.+...
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~c~ 120 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWDCE 120 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBCTT
T ss_pred ccceeCHHHhccccCCCEEEeCCCCcccc
Confidence 99965555599999999999999999864
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=98.97 E-value=5.6e-10 Score=126.79 Aligned_cols=98 Identities=20% Similarity=0.178 Sum_probs=80.2
Q ss_pred cEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCccccCCCCCCEEECc
Q 004979 119 KVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLLD 198 (721)
Q Consensus 119 ~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~~L~~l~l~ 198 (721)
.+..|+|++|.|++ ||. .+++|+.|+|++|.|++ ||. .+++|+.|+|++|+|++ ||. +. ++|++|+|+
T Consensus 121 ~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls 188 (571)
T 3cvr_A 121 SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVS 188 (571)
T ss_dssp TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECC
T ss_pred CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECc
Confidence 67778888888877 666 67889999999999987 776 67899999999999998 888 65 899999999
Q ss_pred cCCCCcCCChhccCCCCC-------CEEEccCCCCCCccccc
Q 004979 199 NNQYLGGISPELHVLKVI-------SEIQVDESWLTNAASRA 233 (721)
Q Consensus 199 ~N~~~G~iP~~~~~l~~L-------~~l~l~~n~~~g~~p~~ 233 (721)
+|+++ .||. +.. +| +.|+|++|.++ .+|..
T Consensus 189 ~N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~ 225 (571)
T 3cvr_A 189 TNLLE-SLPA-VPV--RNHHSEETEIFFRCRENRIT-HIPEN 225 (571)
T ss_dssp SSCCS-SCCC-CC----------CCEEEECCSSCCC-CCCGG
T ss_pred CCCCC-chhh-HHH--hhhcccccceEEecCCCcce-ecCHH
Confidence 99998 7887 654 77 99999999998 47764
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=98.97 E-value=1.7e-09 Score=112.64 Aligned_cols=106 Identities=22% Similarity=0.285 Sum_probs=81.8
Q ss_pred CcEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCccccCCCCCCEEEC
Q 004979 118 GKVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLL 197 (721)
Q Consensus 118 ~~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~~L~~l~l 197 (721)
.++..|+|++|.+.+..+ +..+++|++|+|++|.+++ +| .++.+++|+.|+|++|++++ + +.+..+++|+.|++
T Consensus 68 ~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~L~~n~i~~-~-~~l~~l~~L~~L~l 141 (291)
T 1h6t_A 68 PNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYL 141 (291)
T ss_dssp TTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEEC
T ss_pred CCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCEEECCCCcCCC-C-hhhcCCCCCCEEEc
Confidence 467788888888877443 7888888888888888876 33 47888888888888888876 3 45778888888888
Q ss_pred ccCCCCcCCChhccCCCCCCEEEccCCCCCCccc
Q 004979 198 DNNQYLGGISPELHVLKVISEIQVDESWLTNAAS 231 (721)
Q Consensus 198 ~~N~~~G~iP~~~~~l~~L~~l~l~~n~~~g~~p 231 (721)
++|++++- +.+..+++|+.|+|++|.+++..|
T Consensus 142 ~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~ 173 (291)
T 1h6t_A 142 GNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP 173 (291)
T ss_dssp CSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG
T ss_pred cCCcCCcc--hhhccCCCCCEEEccCCccccchh
Confidence 88888764 567888888888888888876544
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=98.97 E-value=1.6e-10 Score=128.28 Aligned_cols=49 Identities=12% Similarity=-0.018 Sum_probs=22.6
Q ss_pred CcEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCC
Q 004979 118 GKVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKE 167 (721)
Q Consensus 118 ~~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~ 167 (721)
.++..++|++|.+ |.||+++++|++|++|+|++|.+.|.+|..++++.+
T Consensus 11 ~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~ 59 (454)
T 1jl5_A 11 TFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQRE 59 (454)
T ss_dssp ------------------------CCHHHHHHHHHHHHHTSCTTSCCCHH
T ss_pred ccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchh
Confidence 4688899999999 899999999999999999999999999988877654
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=98.97 E-value=1.4e-09 Score=120.78 Aligned_cols=100 Identities=16% Similarity=0.228 Sum_probs=70.0
Q ss_pred CcEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCccccCCCCCCEEEC
Q 004979 118 GKVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLL 197 (721)
Q Consensus 118 ~~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~~L~~l~l 197 (721)
.+++.|+|+++.+.|. | .++.+++|++|+|++|.+++ +| ++.+++|++|+|++|++++ +| ++++++|++|++
T Consensus 42 ~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~-~~--~~~l~~L~~L~Ls~N~l~~-~~--~~~l~~L~~L~L 113 (457)
T 3bz5_A 42 ATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITT-LD--LSQNTNLTYLACDSNKLTN-LD--VTPLTKLTYLNC 113 (457)
T ss_dssp TTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSC-CC--CTTCTTCCEEEC
T ss_pred CCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCe-Ec--cccCCCCCEEECcCCCCce-ee--cCCCCcCCEEEC
Confidence 3566777777777763 3 57777777777777777776 33 6777777777777777776 33 667777777777
Q ss_pred ccCCCCcCCChhccCCCCCCEEEccCCCCCC
Q 004979 198 DNNQYLGGISPELHVLKVISEIQVDESWLTN 228 (721)
Q Consensus 198 ~~N~~~G~iP~~~~~l~~L~~l~l~~n~~~g 228 (721)
++|++++ +| ++.+++|++|++++|.+++
T Consensus 114 ~~N~l~~-l~--~~~l~~L~~L~l~~N~l~~ 141 (457)
T 3bz5_A 114 DTNKLTK-LD--VSQNPLLTYLNCARNTLTE 141 (457)
T ss_dssp CSSCCSC-CC--CTTCTTCCEEECTTSCCSC
T ss_pred CCCcCCe-ec--CCCCCcCCEEECCCCccce
Confidence 7777776 44 6677777777777777776
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=98.95 E-value=2.2e-09 Score=109.96 Aligned_cols=102 Identities=18% Similarity=0.158 Sum_probs=59.1
Q ss_pred cEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCccccCCCCCCEEECc
Q 004979 119 KVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLLD 198 (721)
Q Consensus 119 ~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~~L~~l~l~ 198 (721)
++..|+|++|.+++..+ +..+++|+.|+|++|.+++ +|.. .. ++|+.|+|++|++++ +| .+..+++|+.|+|+
T Consensus 64 ~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~~N~l~~-l~~~-~~-~~L~~L~L~~N~l~~-~~-~l~~l~~L~~L~Ls 136 (263)
T 1xeu_A 64 NLKELHLSHNQISDLSP--LKDLTKLEELSVNRNRLKN-LNGI-PS-ACLSRLFLDNNELRD-TD-SLIHLKNLEILSIR 136 (263)
T ss_dssp TCCEEECCSSCCCCCGG--GTTCSSCCEEECCSSCCSC-CTTC-CC-SSCCEEECCSSCCSB-SG-GGTTCTTCCEEECT
T ss_pred CCCEEECCCCccCCChh--hccCCCCCEEECCCCccCC-cCcc-cc-CcccEEEccCCccCC-Ch-hhcCcccccEEECC
Confidence 45566666666655332 6666666666666666654 3332 22 566666666666664 22 45666666666666
Q ss_pred cCCCCcCCChhccCCCCCCEEEccCCCCCCc
Q 004979 199 NNQYLGGISPELHVLKVISEIQVDESWLTNA 229 (721)
Q Consensus 199 ~N~~~G~iP~~~~~l~~L~~l~l~~n~~~g~ 229 (721)
+|++++- | .+..+++|+.|+|++|.+++.
T Consensus 137 ~N~i~~~-~-~l~~l~~L~~L~L~~N~i~~~ 165 (263)
T 1xeu_A 137 NNKLKSI-V-MLGFLSKLEVLDLHGNEITNT 165 (263)
T ss_dssp TSCCCBC-G-GGGGCTTCCEEECTTSCCCBC
T ss_pred CCcCCCC-h-HHccCCCCCEEECCCCcCcch
Confidence 6666552 3 456666666666666666543
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=98.94 E-value=2.1e-09 Score=111.97 Aligned_cols=103 Identities=25% Similarity=0.304 Sum_probs=92.6
Q ss_pred CcEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCccccCCCCCCEEEC
Q 004979 118 GKVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLL 197 (721)
Q Consensus 118 ~~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~~L~~l~l 197 (721)
.++..|+|++|.+.+ + +.+..+++|++|+|++|.+++ + +.+..+++|+.|+|++|++++. +.+..+++|+.|+|
T Consensus 90 ~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~L~~n~i~~-~-~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L 163 (291)
T 1h6t_A 90 KNLGWLFLDENKVKD-L-SSLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSL 163 (291)
T ss_dssp TTCCEEECCSSCCCC-G-GGGTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEEC
T ss_pred CCCCEEECCCCcCCC-C-hhhccCCCCCEEECCCCcCCC-C-hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEc
Confidence 578999999999987 3 459999999999999999987 3 4789999999999999999975 67899999999999
Q ss_pred ccCCCCcCCChhccCCCCCCEEEccCCCCCC
Q 004979 198 DNNQYLGGISPELHVLKVISEIQVDESWLTN 228 (721)
Q Consensus 198 ~~N~~~G~iP~~~~~l~~L~~l~l~~n~~~g 228 (721)
++|.+++..| +..+++|+.|+|++|.+++
T Consensus 164 ~~N~l~~~~~--l~~l~~L~~L~L~~N~i~~ 192 (291)
T 1h6t_A 164 EDNQISDIVP--LAGLTKLQNLYLSKNHISD 192 (291)
T ss_dssp CSSCCCCCGG--GTTCTTCCEEECCSSCCCB
T ss_pred cCCccccchh--hcCCCccCEEECCCCcCCC
Confidence 9999987554 9999999999999999986
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=98.94 E-value=2.3e-09 Score=109.86 Aligned_cols=103 Identities=23% Similarity=0.279 Sum_probs=89.7
Q ss_pred CcEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCccccCCCCCCEEEC
Q 004979 118 GKVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLL 197 (721)
Q Consensus 118 ~~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~~L~~l~l 197 (721)
.++..|+|++|.+.. ++ .+..+++|++|+|++|.+++..| +.++++|+.|+|++|++++ +|... . ++|+.|+|
T Consensus 41 ~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~~N~l~~-l~~~~-~-~~L~~L~L 113 (263)
T 1xeu_A 41 SGVQNFNGDNSNIQS-LA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNRNRLKN-LNGIP-S-ACLSRLFL 113 (263)
T ss_dssp TTCSEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEECCSSCCSC-CTTCC-C-SSCCEEEC
T ss_pred CcCcEEECcCCCccc-ch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEECCCCccCC-cCccc-c-CcccEEEc
Confidence 468899999999874 55 78999999999999999997544 9999999999999999997 66433 3 89999999
Q ss_pred ccCCCCcCCChhccCCCCCCEEEccCCCCCCc
Q 004979 198 DNNQYLGGISPELHVLKVISEIQVDESWLTNA 229 (721)
Q Consensus 198 ~~N~~~G~iP~~~~~l~~L~~l~l~~n~~~g~ 229 (721)
++|++++ + +.+..+++|+.|+|++|.+++-
T Consensus 114 ~~N~l~~-~-~~l~~l~~L~~L~Ls~N~i~~~ 143 (263)
T 1xeu_A 114 DNNELRD-T-DSLIHLKNLEILSIRNNKLKSI 143 (263)
T ss_dssp CSSCCSB-S-GGGTTCTTCCEEECTTSCCCBC
T ss_pred cCCccCC-C-hhhcCcccccEEECCCCcCCCC
Confidence 9999987 4 4699999999999999999874
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.93 E-value=1.7e-09 Score=110.06 Aligned_cols=126 Identities=12% Similarity=0.123 Sum_probs=92.5
Q ss_pred CCceeEEEEEEecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCc--cceEeEEEecCCCceEEEEEecCCC
Q 004979 437 DGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKN--FVNLIGYCEEDEPFTRMMVFEYSPN 514 (721)
Q Consensus 437 ~G~~g~Vyk~~~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~n--Iv~l~g~~~~~~~~~~~lV~Ey~~~ 514 (721)
.|..+.||+....+|..+++|...... ...+.+|+++++.+++.+ +.+++++....+ ..++||||++|
T Consensus 30 gg~~~~v~~~~~~~g~~~vlK~~~~~~--------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~--~~~~v~e~i~G 99 (264)
T 1nd4_A 30 GCSDAAVFRLSAQGRPVLFVKTDLSGA--------LNELQDEAARLSWLATTGVPCAAVLDVVTEAG--RDWLLLGEVPG 99 (264)
T ss_dssp TTSSCEEEEEECTTSCCEEEEEECSCT--------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSS--CEEEEEECCSS
T ss_pred CCCCceEEEEecCCCCeEEEEeCCccc--------chhhhHHHHHHHHHHhCCCCCCeEEEeccCCC--CCEEEEEecCC
Confidence 455689999987777789998764321 134778899998886545 456888877655 56999999999
Q ss_pred CChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCC------------------------------------------
Q 004979 515 GSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLT------------------------------------------ 552 (721)
Q Consensus 515 GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~------------------------------------------ 552 (721)
.+|. ... .+ ...++.+++..|+.||+..
T Consensus 100 ~~l~--~~~-----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (264)
T 1nd4_A 100 QDLL--SSH-----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAE 169 (264)
T ss_dssp EETT--TSC-----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHH
T ss_pred cccC--cCc-----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHH
Confidence 8884 211 11 2356777888888888643
Q ss_pred --------------CCeEeeCCCCCCeEeCCCCcEEEeccCCCC
Q 004979 553 --------------PPIAHRNLQSSSIYLTEDYAAKISDFSFWN 582 (721)
Q Consensus 553 --------------~~IvHrDLKp~NILl~~~~~~kL~DFGla~ 582 (721)
+.++|+|++|.|||++++..++|.||+.+.
T Consensus 170 ~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 170 LFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 129999999999999887667899999753
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=98.92 E-value=2.9e-10 Score=123.38 Aligned_cols=111 Identities=14% Similarity=0.123 Sum_probs=71.0
Q ss_pred CcEEEEEeCCCCCC-CcCc---hhhcCCCCCCEEEccCCccc--c---cCchhhcCCCCCCEeEcccCccc----ccCCc
Q 004979 118 GKVVILNLRDLCLG-GMLA---PELGQLSELKSIILRNNSFF--G---TIPKEIGELKELEILDLGFNNFS----GPFPS 184 (721)
Q Consensus 118 ~~v~~l~L~~~~l~-G~ip---~~l~~l~~L~~L~L~~n~l~--G---~ip~~l~~l~~L~~l~ls~N~l~----G~iP~ 184 (721)
.++..|+|++|.++ +.++ ..+..+++|+.|+|++|.++ | .+|..+..+++|+.|+|++|.++ +.+|.
T Consensus 159 ~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~ 238 (386)
T 2ca6_A 159 PPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAI 238 (386)
T ss_dssp CCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHH
T ss_pred CCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHH
Confidence 35666777777766 4444 35556667777777777666 3 23446666677777777777765 56666
Q ss_pred cccCCCCCCEEECccCCCCcC----CChhc--cCCCCCCEEEccCCCCCC
Q 004979 185 DFGNSFSLTTLLLDNNQYLGG----ISPEL--HVLKVISEIQVDESWLTN 228 (721)
Q Consensus 185 ~~~~~~~L~~l~l~~N~~~G~----iP~~~--~~l~~L~~l~l~~n~~~g 228 (721)
.+..+++|++|+|++|.+++. +|..+ +++++|+.|+|++|.+++
T Consensus 239 ~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~ 288 (386)
T 2ca6_A 239 ALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIEL 288 (386)
T ss_dssp HGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBH
T ss_pred HHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCH
Confidence 666666777777777776654 45555 336667777777777666
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=98.92 E-value=4e-10 Score=119.53 Aligned_cols=111 Identities=14% Similarity=0.110 Sum_probs=91.3
Q ss_pred CcEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCccccc-CchhhcCCCCCCEeEcccCcccccCCccccCCCCCCEEE
Q 004979 118 GKVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGT-IPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLL 196 (721)
Q Consensus 118 ~~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~-ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~~L~~l~ 196 (721)
.++..++|++|.+.+.++. +..+++|++|+|++|.+++. +|..+..+++|+.|+|++|.+++.+|..++.+++|++|+
T Consensus 70 ~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~ 148 (336)
T 2ast_B 70 QGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN 148 (336)
T ss_dssp TTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEE
T ss_pred ccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEE
Confidence 4577888888888776654 66788888999998888876 888888888899999998888888888888888899999
Q ss_pred CccC-CCCc-CCChhccCCCCCCEEEccCC-CCCCc
Q 004979 197 LDNN-QYLG-GISPELHVLKVISEIQVDES-WLTNA 229 (721)
Q Consensus 197 l~~N-~~~G-~iP~~~~~l~~L~~l~l~~n-~~~g~ 229 (721)
|++| .+++ .+|..+..+++|++|+|++| .+++.
T Consensus 149 L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~ 184 (336)
T 2ast_B 149 LSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEK 184 (336)
T ss_dssp CTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHH
T ss_pred CCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChH
Confidence 9888 6776 37777888888888988888 88764
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=98.92 E-value=3e-09 Score=111.68 Aligned_cols=106 Identities=20% Similarity=0.345 Sum_probs=89.3
Q ss_pred CcEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCccccCCCCCCEEEC
Q 004979 118 GKVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLL 197 (721)
Q Consensus 118 ~~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~~L~~l~l 197 (721)
.++..|+|++|.+.+ + +.+..+++|++|+|++|.+++ +|. +..+++|+.|+|++|.+++..+ +..+++|++|+|
T Consensus 85 ~~L~~L~L~~n~l~~-~-~~~~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l 158 (308)
T 1h6u_A 85 TKITELELSGNPLKN-V-SAIAGLQSIKTLDLTSTQITD-VTP-LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSI 158 (308)
T ss_dssp CSCCEEECCSCCCSC-C-GGGTTCTTCCEEECTTSCCCC-CGG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEEC
T ss_pred CCCCEEEccCCcCCC-c-hhhcCCCCCCEEECCCCCCCC-chh-hcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEc
Confidence 478899999999887 3 468899999999999999987 453 8899999999999999986543 888999999999
Q ss_pred ccCCCCcCCChhccCCCCCCEEEccCCCCCCccc
Q 004979 198 DNNQYLGGISPELHVLKVISEIQVDESWLTNAAS 231 (721)
Q Consensus 198 ~~N~~~G~iP~~~~~l~~L~~l~l~~n~~~g~~p 231 (721)
++|.+++ +|+ +..+++|+.|+|++|.+++..+
T Consensus 159 ~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~~~ 190 (308)
T 1h6u_A 159 GNAQVSD-LTP-LANLSKLTTLKADDNKISDISP 190 (308)
T ss_dssp CSSCCCC-CGG-GTTCTTCCEEECCSSCCCCCGG
T ss_pred cCCcCCC-Chh-hcCCCCCCEEECCCCccCcChh
Confidence 9999886 444 8889999999999999987543
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=98.91 E-value=8.6e-12 Score=122.22 Aligned_cols=110 Identities=17% Similarity=0.176 Sum_probs=98.0
Q ss_pred CcEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCccccCCCCCCEEEC
Q 004979 118 GKVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLL 197 (721)
Q Consensus 118 ~~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~~L~~l~l 197 (721)
..+..|+|++|.+.+ +| .+..+++|++|+|++|.++ .+|..+..+++|+.|+|++|++++ +| .+..+++|++|+|
T Consensus 48 ~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l 122 (198)
T 1ds9_A 48 KACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVLYM 122 (198)
T ss_dssp TTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEE
T ss_pred CCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECcCCcCCc-CC-ccccCCCCCEEEC
Confidence 578899999999988 77 8999999999999999998 789888889999999999999997 66 6889999999999
Q ss_pred ccCCCCcCC-ChhccCCCCCCEEEccCCCCCCcccc
Q 004979 198 DNNQYLGGI-SPELHVLKVISEIQVDESWLTNAASR 232 (721)
Q Consensus 198 ~~N~~~G~i-P~~~~~l~~L~~l~l~~n~~~g~~p~ 232 (721)
++|++++-- ...+..+++|++|++++|.+++.+|.
T Consensus 123 ~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~ 158 (198)
T 1ds9_A 123 SNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKE 158 (198)
T ss_dssp SEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHT
T ss_pred CCCcCCchhHHHHHhcCCCCCEEEecCCcccccccc
Confidence 999998622 24789999999999999999887664
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=98.91 E-value=3.8e-09 Score=110.93 Aligned_cols=104 Identities=22% Similarity=0.350 Sum_probs=84.4
Q ss_pred CcEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCccccCCCCCCEEEC
Q 004979 118 GKVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLL 197 (721)
Q Consensus 118 ~~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~~L~~l~l 197 (721)
.++..|+|++|.+.+.. + +..+++|++|+|++|.+.+ +| .+..+++|+.|+|++|++++ +|+ +..+++|++|++
T Consensus 63 ~~L~~L~L~~n~i~~~~-~-~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l 136 (308)
T 1h6u_A 63 NNLIGLELKDNQITDLA-P-LKNLTKITELELSGNPLKN-VS-AIAGLQSIKTLDLTSTQITD-VTP-LAGLSNLQVLYL 136 (308)
T ss_dssp TTCCEEECCSSCCCCCG-G-GTTCCSCCEEECCSCCCSC-CG-GGTTCTTCCEEECTTSCCCC-CGG-GTTCTTCCEEEC
T ss_pred CCCCEEEccCCcCCCCh-h-HccCCCCCEEEccCCcCCC-ch-hhcCCCCCCEEECCCCCCCC-chh-hcCCCCCCEEEC
Confidence 46888899888887643 3 8888999999999998876 34 68888999999999999886 443 888889999999
Q ss_pred ccCCCCcCCChhccCCCCCCEEEccCCCCCCc
Q 004979 198 DNNQYLGGISPELHVLKVISEIQVDESWLTNA 229 (721)
Q Consensus 198 ~~N~~~G~iP~~~~~l~~L~~l~l~~n~~~g~ 229 (721)
++|.+++- |+ +..+++|+.|+|++|.+++.
T Consensus 137 ~~n~l~~~-~~-l~~l~~L~~L~l~~n~l~~~ 166 (308)
T 1h6u_A 137 DLNQITNI-SP-LAGLTNLQYLSIGNAQVSDL 166 (308)
T ss_dssp CSSCCCCC-GG-GGGCTTCCEEECCSSCCCCC
T ss_pred CCCccCcC-cc-ccCCCCccEEEccCCcCCCC
Confidence 99988764 33 88888999999999988863
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=98.91 E-value=2.8e-09 Score=122.18 Aligned_cols=106 Identities=22% Similarity=0.282 Sum_probs=85.3
Q ss_pred CcEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCccccCCCCCCEEEC
Q 004979 118 GKVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLL 197 (721)
Q Consensus 118 ~~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~~L~~l~l 197 (721)
.++..|+|++|.|.+..| +..|++|+.|+|++|.|.+ +| .+..|++|+.|+|++|++++ + +.+..+++|+.|+|
T Consensus 65 ~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~L 138 (605)
T 1m9s_A 65 PNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYL 138 (605)
T ss_dssp TTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCC-CT-TSTTCTTCCEEECTTSCCCC-C-GGGGGCTTCSEEEC
T ss_pred CCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCC-Ch-hhccCCCCCEEEecCCCCCC-C-ccccCCCccCEEEC
Confidence 467888888888887544 8888888888888888876 33 68888888888888888886 3 45788888888888
Q ss_pred ccCCCCcCCChhccCCCCCCEEEccCCCCCCccc
Q 004979 198 DNNQYLGGISPELHVLKVISEIQVDESWLTNAAS 231 (721)
Q Consensus 198 ~~N~~~G~iP~~~~~l~~L~~l~l~~n~~~g~~p 231 (721)
++|.+++- +.+..+++|+.|+|++|.+++..|
T Consensus 139 s~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~ 170 (605)
T 1m9s_A 139 GNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP 170 (605)
T ss_dssp CSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG
T ss_pred CCCccCCc--hhhcccCCCCEEECcCCcCCCchh
Confidence 88888874 568888888888888888887665
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=98.91 E-value=1.4e-10 Score=123.00 Aligned_cols=119 Identities=11% Similarity=0.082 Sum_probs=106.1
Q ss_pred CCceeeEEeCCCcEEEEEeCCCCCCCcCchhhcCC--CCCCEEEccCCcccccCchhhcCCCCCCEeEcccCccccc-CC
Q 004979 107 PCSWFGVECSDGKVVILNLRDLCLGGMLAPELGQL--SELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGP-FP 183 (721)
Q Consensus 107 ~C~w~gv~C~~~~v~~l~L~~~~l~G~ip~~l~~l--~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~-iP 183 (721)
|.+|.++.|+...+..++|+++.+. +..+..+ +.++.|++++|.+.+.+|. +.++++|+.|+|++|.+++. +|
T Consensus 36 c~~W~~~~~~~~~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~ 111 (336)
T 2ast_B 36 CKRWYRLASDESLWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLH 111 (336)
T ss_dssp CHHHHHHHTCSTTSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHH
T ss_pred HHHHHHHhcCchhheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHH
Confidence 4469998887666889999999887 5566777 8999999999999988775 67899999999999999987 99
Q ss_pred ccccCCCCCCEEECccCCCCcCCChhccCCCCCCEEEccCC-CCCCc
Q 004979 184 SDFGNSFSLTTLLLDNNQYLGGISPELHVLKVISEIQVDES-WLTNA 229 (721)
Q Consensus 184 ~~~~~~~~L~~l~l~~N~~~G~iP~~~~~l~~L~~l~l~~n-~~~g~ 229 (721)
..+..+++|++|+|++|.+++.+|..++.+++|++|+|++| .+++.
T Consensus 112 ~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~ 158 (336)
T 2ast_B 112 GILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEF 158 (336)
T ss_dssp HHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHH
T ss_pred HHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHH
Confidence 89999999999999999999999999999999999999999 78863
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=98.90 E-value=2.8e-09 Score=122.16 Aligned_cols=105 Identities=25% Similarity=0.285 Sum_probs=92.5
Q ss_pred CCcEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCccccCCCCCCEEE
Q 004979 117 DGKVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLL 196 (721)
Q Consensus 117 ~~~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~~L~~l~ 196 (721)
..++..|+|++|.|.+ + +.+..|++|+.|+|++|.+.+ + +.+..|++|+.|+|++|.+++. +.+..+++|+.|+
T Consensus 86 l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~ 159 (605)
T 1m9s_A 86 LKNLGWLFLDENKIKD-L-SSLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLS 159 (605)
T ss_dssp CTTCCEEECCSSCCCC-C-TTSTTCTTCCEEECTTSCCCC-C-GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEE
T ss_pred CCCCCEEECcCCCCCC-C-hhhccCCCCCEEEecCCCCCC-C-ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEE
Confidence 3578899999999987 3 478999999999999999987 4 4689999999999999999975 6788999999999
Q ss_pred CccCCCCcCCChhccCCCCCCEEEccCCCCCCc
Q 004979 197 LDNNQYLGGISPELHVLKVISEIQVDESWLTNA 229 (721)
Q Consensus 197 l~~N~~~G~iP~~~~~l~~L~~l~l~~n~~~g~ 229 (721)
|++|.+++..| +..+++|+.|+|++|.+++.
T Consensus 160 Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~l 190 (605)
T 1m9s_A 160 LEDNQISDIVP--LAGLTKLQNLYLSKNHISDL 190 (605)
T ss_dssp CCSSCCCCCGG--GTTCTTCCEEECCSSCCCBC
T ss_pred CcCCcCCCchh--hccCCCCCEEECcCCCCCCC
Confidence 99999998766 89999999999999999873
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.87 E-value=5.2e-09 Score=112.27 Aligned_cols=142 Identities=11% Similarity=0.209 Sum_probs=102.6
Q ss_pred hCcCCCCceeEEEEEEecCCcEEEEEEee--eccccchhhHHHHHHHHHHHHHhcCC--CCccceEeEEEecCCC-ceEE
Q 004979 432 IGSFSDGTVGTVYKGTLSSGVEIAVTSTS--VKSRADWSKNLESQFRKKIDTLSKVN--HKNFVNLIGYCEEDEP-FTRM 506 (721)
Q Consensus 432 i~~lg~G~~g~Vyk~~~~~~~~vavk~~~--~~~~~~~~~~~~~~f~~Ei~~l~~l~--H~nIv~l~g~~~~~~~-~~~~ 506 (721)
+..++.|.++.||+....+ ..+++|+.. .... ......+.+|+++++.++ +..+.++++++.+.+. ...+
T Consensus 43 ~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~----~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~ 117 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKL----LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAF 117 (359)
T ss_dssp EEECCC-CCSCEEEEECSS-CEEEEECCCC--------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCE
T ss_pred EEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCC----CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeE
Confidence 3567789999999998764 567777654 2111 011246788999999886 4567889998876531 1358
Q ss_pred EEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcC-----------------------------------
Q 004979 507 MVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQL----------------------------------- 551 (721)
Q Consensus 507 lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~----------------------------------- 551 (721)
+||||++|..+.+.. ...++...+..++.++++.|+.||..
T Consensus 118 ~vme~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (359)
T 3dxp_A 118 YIMEFVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETES 193 (359)
T ss_dssp EEEECCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSC
T ss_pred EEEEecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcC
Confidence 999999998875421 23477888889999999999999963
Q ss_pred ---------------------CCCeEeeCCCCCCeEeCCCCc--EEEeccCCCC
Q 004979 552 ---------------------TPPIAHRNLQSSSIYLTEDYA--AKISDFSFWN 582 (721)
Q Consensus 552 ---------------------~~~IvHrDLKp~NILl~~~~~--~kL~DFGla~ 582 (721)
.+.++|+|+++.|||+++++. +.|.||+.+.
T Consensus 194 ~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~ 247 (359)
T 3dxp_A 194 IPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELST 247 (359)
T ss_dssp CHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCE
T ss_pred ChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccc
Confidence 145999999999999997753 6899999764
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=98.85 E-value=3.1e-09 Score=113.17 Aligned_cols=109 Identities=21% Similarity=0.286 Sum_probs=97.7
Q ss_pred CcEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCccccCCCCCCEEEC
Q 004979 118 GKVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLL 197 (721)
Q Consensus 118 ~~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~~L~~l~l 197 (721)
.++..|+|++|.+.+..+ +..+++|++|+|++|.+++ + +.+..+++|+.|++++|++++. +.+..+++|+.|++
T Consensus 221 ~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L 294 (347)
T 4fmz_A 221 TRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD-I-NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFL 294 (347)
T ss_dssp TTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-C-GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEEC
T ss_pred CcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCccCC-C-hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEEC
Confidence 478899999999987544 8999999999999999987 3 4689999999999999999974 45889999999999
Q ss_pred ccCCCCcCCChhccCCCCCCEEEccCCCCCCcccc
Q 004979 198 DNNQYLGGISPELHVLKVISEIQVDESWLTNAASR 232 (721)
Q Consensus 198 ~~N~~~G~iP~~~~~l~~L~~l~l~~n~~~g~~p~ 232 (721)
++|.+++..|..++.+++|+.|+|++|.+++..|.
T Consensus 295 ~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~ 329 (347)
T 4fmz_A 295 NNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRPL 329 (347)
T ss_dssp CSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGGG
T ss_pred cCCcCCCcChhHhhccccCCEEEccCCccccccCh
Confidence 99999999999999999999999999999987663
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=98.85 E-value=5.3e-09 Score=111.37 Aligned_cols=107 Identities=18% Similarity=0.240 Sum_probs=94.1
Q ss_pred CcEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCccccCCCCCCEEEC
Q 004979 118 GKVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLL 197 (721)
Q Consensus 118 ~~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~~L~~l~l 197 (721)
..+..+++++|.+.+..+ +..+++|+.|+|++|.+++..+ +..+++|+.|+|++|.+++ + +.+..+++|++|++
T Consensus 199 ~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L~l 272 (347)
T 4fmz_A 199 TSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD-I-NAVKDLTKLKMLNV 272 (347)
T ss_dssp TTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-C-GGGTTCTTCCEEEC
T ss_pred CccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCccCC-C-hhHhcCCCcCEEEc
Confidence 468899999999987655 8899999999999999986544 8999999999999999987 3 46889999999999
Q ss_pred ccCCCCcCCChhccCCCCCCEEEccCCCCCCcccc
Q 004979 198 DNNQYLGGISPELHVLKVISEIQVDESWLTNAASR 232 (721)
Q Consensus 198 ~~N~~~G~iP~~~~~l~~L~~l~l~~n~~~g~~p~ 232 (721)
++|.+++- +.+..+++|+.|++++|.+++..|.
T Consensus 273 ~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~ 305 (347)
T 4fmz_A 273 GSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDME 305 (347)
T ss_dssp CSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHH
T ss_pred cCCccCCC--hhhcCCCCCCEEECcCCcCCCcChh
Confidence 99999874 4689999999999999999987665
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=98.85 E-value=5.8e-09 Score=116.07 Aligned_cols=104 Identities=20% Similarity=0.223 Sum_probs=85.2
Q ss_pred CcEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCccccCCCCCCEEEC
Q 004979 118 GKVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLL 197 (721)
Q Consensus 118 ~~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~~L~~l~l 197 (721)
.++..|+|++|.+.+..+ +..+++|+.|+|++|.+++..| +..+++|+.|+|++|++++..| ++.+++|+.|+|
T Consensus 243 ~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L 316 (466)
T 1o6v_A 243 TNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTL 316 (466)
T ss_dssp TTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEEC
T ss_pred CCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEEC
Confidence 467888999998887654 7888899999999998887544 7888889999999998887544 778888899999
Q ss_pred ccCCCCcCCChhccCCCCCCEEEccCCCCCCc
Q 004979 198 DNNQYLGGISPELHVLKVISEIQVDESWLTNA 229 (721)
Q Consensus 198 ~~N~~~G~iP~~~~~l~~L~~l~l~~n~~~g~ 229 (721)
++|++++..| +..+++|+.|++++|.+++.
T Consensus 317 ~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~ 346 (466)
T 1o6v_A 317 YFNNISDISP--VSSLTKLQRLFFYNNKVSDV 346 (466)
T ss_dssp CSSCCSCCGG--GGGCTTCCEEECCSSCCCCC
T ss_pred cCCcCCCchh--hccCccCCEeECCCCccCCc
Confidence 8888887665 77888888888888888874
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=98.84 E-value=2.3e-09 Score=118.89 Aligned_cols=103 Identities=21% Similarity=0.285 Sum_probs=73.5
Q ss_pred CcEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccc--cCchhhc-------------CC-CCCCEeEcccCccccc
Q 004979 118 GKVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFG--TIPKEIG-------------EL-KELEILDLGFNNFSGP 181 (721)
Q Consensus 118 ~~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G--~ip~~l~-------------~l-~~L~~l~ls~N~l~G~ 181 (721)
..+..|+|++|.+.+ +|.. +++|+.|+|++|.++| .+|+.+. .+ ++|+.|+|++|++++
T Consensus 257 ~~L~~L~l~~N~l~~-l~~~---~~~L~~L~ls~N~l~~l~~~~~~L~~L~l~~N~l~~i~~~~~~L~~L~Ls~N~l~~- 331 (454)
T 1jl5_A 257 PSLEALNVRDNYLTD-LPEL---PQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE- 331 (454)
T ss_dssp TTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSEESCCCTTCCEEECCSSCCSEECCCCTTCCEEECCSSCCSC-
T ss_pred cccCEEECCCCcccc-cCcc---cCcCCEEECcCCccCcccCcCCcCCEEECcCCcCCcccCCcCcCCEEECCCCcccc-
Confidence 356677777777766 4432 3566666666666666 4443332 22 578888888888886
Q ss_pred CCccccCCCCCCEEECccCCCCcCCChhccCCCCCCEEEccCCCCCC--cccc
Q 004979 182 FPSDFGNSFSLTTLLLDNNQYLGGISPELHVLKVISEIQVDESWLTN--AASR 232 (721)
Q Consensus 182 iP~~~~~~~~L~~l~l~~N~~~G~iP~~~~~l~~L~~l~l~~n~~~g--~~p~ 232 (721)
+|.. +++|++|++++|+++ .||. .+++|+.|+|++|.++| .+|.
T Consensus 332 lp~~---~~~L~~L~L~~N~l~-~lp~---~l~~L~~L~L~~N~l~~l~~ip~ 377 (454)
T 1jl5_A 332 LPAL---PPRLERLIASFNHLA-EVPE---LPQNLKQLHVEYNPLREFPDIPE 377 (454)
T ss_dssp CCCC---CTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCSSCCCCCT
T ss_pred cccc---CCcCCEEECCCCccc-cccc---hhhhccEEECCCCCCCcCCCChH
Confidence 7764 578899999999888 5877 47889999999999998 6665
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=98.82 E-value=5.7e-09 Score=119.91 Aligned_cols=58 Identities=17% Similarity=0.184 Sum_probs=31.3
Q ss_pred CCCCEeEcccCcccccCCccccCCCCCCEEECccCCCCcCCChhccCCCCCCEEEccCCCCCCcccc
Q 004979 166 KELEILDLGFNNFSGPFPSDFGNSFSLTTLLLDNNQYLGGISPELHVLKVISEIQVDESWLTNAASR 232 (721)
Q Consensus 166 ~~L~~l~ls~N~l~G~iP~~~~~~~~L~~l~l~~N~~~G~iP~~~~~l~~L~~l~l~~n~~~g~~p~ 232 (721)
++|+.|+|++|++++ +| ..+++|+.|+|++|+++ .||. .+++|+.|+|++|.++ .+|.
T Consensus 221 ~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~ 278 (622)
T 3g06_A 221 SGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPE 278 (622)
T ss_dssp TTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCG
T ss_pred CCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCH
Confidence 455556666665554 44 33455555666655555 3544 4455555666666555 4443
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=98.82 E-value=9.5e-09 Score=114.04 Aligned_cols=99 Identities=17% Similarity=0.183 Sum_probs=55.7
Q ss_pred cEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCccccCCCCCCEEECc
Q 004979 119 KVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLLD 198 (721)
Q Consensus 119 ~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~~L~~l~l~ 198 (721)
++..|+|++|.+++ ++ ++.+++|++|+|++|.+.|.+ .++.+++|+.|+|++|++++ +| ++.+++|+.|+++
T Consensus 128 ~L~~L~l~~N~l~~-l~--l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~-l~--l~~l~~L~~L~l~ 199 (457)
T 3bz5_A 128 LLTYLNCARNTLTE-ID--VSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKITE-LD--VSQNKLLNRLNCD 199 (457)
T ss_dssp TCCEEECTTSCCSC-CC--CTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSSCCCC-CC--CTTCTTCCEEECC
T ss_pred cCCEEECCCCccce-ec--cccCCcCCEEECCCCCccccc--ccccCCcCCEEECCCCccce-ec--cccCCCCCEEECc
Confidence 56666677666666 32 555666666666666555555 25555666666666666555 44 4555555555555
Q ss_pred cCCCCcCCChhccCCCCCCEEEccCCCCCC
Q 004979 199 NNQYLGGISPELHVLKVISEIQVDESWLTN 228 (721)
Q Consensus 199 ~N~~~G~iP~~~~~l~~L~~l~l~~n~~~g 228 (721)
+|++++- .++.+++|+.|+|++|.+++
T Consensus 200 ~N~l~~~---~l~~l~~L~~L~Ls~N~l~~ 226 (457)
T 3bz5_A 200 TNNITKL---DLNQNIQLTFLDCSSNKLTE 226 (457)
T ss_dssp SSCCSCC---CCTTCTTCSEEECCSSCCSC
T ss_pred CCcCCee---ccccCCCCCEEECcCCcccc
Confidence 5555542 24555555555555555554
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=98.81 E-value=1.1e-09 Score=118.81 Aligned_cols=113 Identities=21% Similarity=0.296 Sum_probs=98.7
Q ss_pred CCcEEEEEeCCCCCCC----cCchhhcCC---------CCCCEEEccCCccc-ccCc---hhhcCCCCCCEeEcccCccc
Q 004979 117 DGKVVILNLRDLCLGG----MLAPELGQL---------SELKSIILRNNSFF-GTIP---KEIGELKELEILDLGFNNFS 179 (721)
Q Consensus 117 ~~~v~~l~L~~~~l~G----~ip~~l~~l---------~~L~~L~L~~n~l~-G~ip---~~l~~l~~L~~l~ls~N~l~ 179 (721)
..++..|+|++|.+++ .++..+..+ ++|++|+|++|.++ +.+| ..+..+++|+.|+|++|+++
T Consensus 121 ~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~ 200 (386)
T 2ca6_A 121 HTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIR 200 (386)
T ss_dssp CTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCC
T ss_pred CCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCC
Confidence 3578999999999974 356667777 89999999999998 6677 57788999999999999998
Q ss_pred --c---cCCccccCCCCCCEEECccCCCC----cCCChhccCCCCCCEEEccCCCCCCc
Q 004979 180 --G---PFPSDFGNSFSLTTLLLDNNQYL----GGISPELHVLKVISEIQVDESWLTNA 229 (721)
Q Consensus 180 --G---~iP~~~~~~~~L~~l~l~~N~~~----G~iP~~~~~l~~L~~l~l~~n~~~g~ 229 (721)
| .+|..+..+++|++|+|++|.++ +.+|..+..+++|+.|+|++|.+++.
T Consensus 201 ~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~ 259 (386)
T 2ca6_A 201 PEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSAR 259 (386)
T ss_dssp HHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHH
T ss_pred HhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchh
Confidence 4 45558899999999999999997 78999999999999999999999876
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=98.80 E-value=5.4e-09 Score=116.32 Aligned_cols=107 Identities=25% Similarity=0.294 Sum_probs=95.8
Q ss_pred CcEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCccccCCCCCCEEEC
Q 004979 118 GKVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLL 197 (721)
Q Consensus 118 ~~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~~L~~l~l 197 (721)
..+..|+|++|.+.+..+ +..+++|+.|+|++|.+.+..| ++.+++|+.|+|++|++++..| +..+++|+.|++
T Consensus 265 ~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l 338 (466)
T 1o6v_A 265 TKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFF 338 (466)
T ss_dssp TTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEEC
T ss_pred CCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEeEC
Confidence 468899999999988544 8899999999999999998554 8899999999999999998776 789999999999
Q ss_pred ccCCCCcCCChhccCCCCCCEEEccCCCCCCcccc
Q 004979 198 DNNQYLGGISPELHVLKVISEIQVDESWLTNAASR 232 (721)
Q Consensus 198 ~~N~~~G~iP~~~~~l~~L~~l~l~~n~~~g~~p~ 232 (721)
++|.+++. +.+..+++|+.|++++|.+++.+|.
T Consensus 339 ~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~~ 371 (466)
T 1o6v_A 339 YNNKVSDV--SSLANLTNINWLSAGHNQISDLTPL 371 (466)
T ss_dssp CSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGGG
T ss_pred CCCccCCc--hhhccCCCCCEEeCCCCccCccchh
Confidence 99999985 5799999999999999999998874
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=98.79 E-value=8.7e-09 Score=109.85 Aligned_cols=83 Identities=10% Similarity=0.030 Sum_probs=76.6
Q ss_pred CEEEccCC-cccccCchhhcCCCCCCEeEccc-CcccccCCccccCCCCCCEEECccCCCCcCCChhccCCCCCCEEEcc
Q 004979 145 KSIILRNN-SFFGTIPKEIGELKELEILDLGF-NNFSGPFPSDFGNSFSLTTLLLDNNQYLGGISPELHVLKVISEIQVD 222 (721)
Q Consensus 145 ~~L~L~~n-~l~G~ip~~l~~l~~L~~l~ls~-N~l~G~iP~~~~~~~~L~~l~l~~N~~~G~iP~~~~~l~~L~~l~l~ 222 (721)
..++++++ .|++ ||. ++.+++|+.|+|++ |+|++..|..|+++++|+.|+|++|+|+|-.|..+.++++|+.|+|+
T Consensus 11 ~~v~~~~~n~l~~-ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~ 88 (347)
T 2ifg_A 11 SGLRCTRDGALDS-LHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS 88 (347)
T ss_dssp SCEECCSSCCCTT-TTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred CEEEcCCCCCCCc-cCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCC
Confidence 35789998 8885 999 99999999999996 99998888899999999999999999999999899999999999999
Q ss_pred CCCCCCc
Q 004979 223 ESWLTNA 229 (721)
Q Consensus 223 ~n~~~g~ 229 (721)
+|.|++-
T Consensus 89 ~N~l~~~ 95 (347)
T 2ifg_A 89 FNALESL 95 (347)
T ss_dssp SSCCSCC
T ss_pred CCcccee
Confidence 9999964
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=98.75 E-value=3.2e-08 Score=105.78 Aligned_cols=115 Identities=17% Similarity=0.136 Sum_probs=68.0
Q ss_pred CceeeEEeCCC-----------cEEEEEeCCCCCCCcCch-hhcCCCCCCEEEccCCcccccCchh-hcCCCCCCE-eEc
Q 004979 108 CSWFGVECSDG-----------KVVILNLRDLCLGGMLAP-ELGQLSELKSIILRNNSFFGTIPKE-IGELKELEI-LDL 173 (721)
Q Consensus 108 C~w~gv~C~~~-----------~v~~l~L~~~~l~G~ip~-~l~~l~~L~~L~L~~n~l~G~ip~~-l~~l~~L~~-l~l 173 (721)
|.|..|.|+.. .++.|+|++|.++. ||+ .+.+|++|++|+|++|.+.+.||.. +.++++|.. +++
T Consensus 9 C~~~~v~C~~~~Lt~iP~~l~~~l~~L~Ls~N~i~~-i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~ 87 (350)
T 4ay9_X 9 CSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRV-IQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE 87 (350)
T ss_dssp EETTEEEEESTTCCSCCTTCCTTCSEEEEESCCCSE-ECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEE
T ss_pred eeCCEEEecCCCCCccCcCcCCCCCEEEccCCcCCC-cCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcc
Confidence 78889999632 35566666666653 443 3566666666666666666666543 455555543 445
Q ss_pred ccCcccccCCccccCCCCCCEEECccCCCCcCCChhccCCCCCCEEEccC
Q 004979 174 GFNNFSGPFPSDFGNSFSLTTLLLDNNQYLGGISPELHVLKVISEIQVDE 223 (721)
Q Consensus 174 s~N~l~G~iP~~~~~~~~L~~l~l~~N~~~G~iP~~~~~l~~L~~l~l~~ 223 (721)
+.|++++-.|..+.++++|++|++++|++++..+..+....++..|++.+
T Consensus 88 ~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~ 137 (350)
T 4ay9_X 88 KANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQD 137 (350)
T ss_dssp EETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEES
T ss_pred cCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhcc
Confidence 55666655555566666666666666666554444444444555555544
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.75 E-value=5.1e-10 Score=114.19 Aligned_cols=124 Identities=20% Similarity=0.131 Sum_probs=88.0
Q ss_pred CCceeeEEeCCC--cEEEEEeCC---CCCCCcCchh------------------------hcCCCCCCE--EEccCC---
Q 004979 107 PCSWFGVECSDG--KVVILNLRD---LCLGGMLAPE------------------------LGQLSELKS--IILRNN--- 152 (721)
Q Consensus 107 ~C~w~gv~C~~~--~v~~l~L~~---~~l~G~ip~~------------------------l~~l~~L~~--L~L~~n--- 152 (721)
.|+|.|+.|+.+ +|+.+...+ ..+.|.+.++ +...+.|.. ++++.|
T Consensus 77 l~~~~g~i~~~~~~ki~~~v~~~~~~~~~~~~l~~~~~~~Lk~~l~~ryn~~~~~LdLs~l~~dp~L~~~~l~l~~N~~~ 156 (267)
T 3rw6_A 77 LKAVNYKILDRENRRISIIINSSAPPHTILNELKPEQVEQLKLIMSKRYDGSQQALDLKGLRSDPDLVAQNIDVVLNRRS 156 (267)
T ss_dssp HHHTTSSCBCTTSCBCCCEEEECCCCHHHHTSCCHHHHHHHHHHHHHTEETTTTEEECTTGGGCHHHHHTTCCCCTTSHH
T ss_pred HHhcCcEEECCCCCEEEEEEecCCCcccccccCCHHHHHHHHHHHHhccchhccccCHHHcCCCcchhhcCccccCCHHH
Confidence 488999999743 676665554 3344555431 111222332 455666
Q ss_pred cccccCchhhcCCCCCCEeEcccCcccc--cCCccccCCCCCCEEECccCCCCcCCChhccCCC--CCCEEEccCCCCCC
Q 004979 153 SFFGTIPKEIGELKELEILDLGFNNFSG--PFPSDFGNSFSLTTLLLDNNQYLGGISPELHVLK--VISEIQVDESWLTN 228 (721)
Q Consensus 153 ~l~G~ip~~l~~l~~L~~l~ls~N~l~G--~iP~~~~~~~~L~~l~l~~N~~~G~iP~~~~~l~--~L~~l~l~~n~~~g 228 (721)
.+.+.++-.-.++++|+.|+||+|+|++ .+|..+..+++|+.|+|++|++++- .++..+. +|+.|+|++|.+++
T Consensus 157 ~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~ 234 (267)
T 3rw6_A 157 CMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCD 234 (267)
T ss_dssp HHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGG
T ss_pred HHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCcc
Confidence 3333333333578999999999999999 7888888999999999999999875 4455555 99999999999998
Q ss_pred cccc
Q 004979 229 AASR 232 (721)
Q Consensus 229 ~~p~ 232 (721)
.+|.
T Consensus 235 ~~~~ 238 (267)
T 3rw6_A 235 TFRD 238 (267)
T ss_dssp GCSS
T ss_pred ccCc
Confidence 7763
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=98.75 E-value=3.3e-09 Score=114.03 Aligned_cols=104 Identities=14% Similarity=0.044 Sum_probs=45.8
Q ss_pred EeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCc----hhhcCCC-CCCEeEcccCcccccCCccccCC-----CCCC
Q 004979 124 NLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIP----KEIGELK-ELEILDLGFNNFSGPFPSDFGNS-----FSLT 193 (721)
Q Consensus 124 ~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip----~~l~~l~-~L~~l~ls~N~l~G~iP~~~~~~-----~~L~ 193 (721)
+|+.++++|.+|..+...++|++|+|++|.+++.-+ ..+..++ +|+.|+|++|.+++..+..+..+ ++|+
T Consensus 4 ~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~ 83 (362)
T 3goz_A 4 KLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVT 83 (362)
T ss_dssp ECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCC
T ss_pred ccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCcc
Confidence 344444444444444444444444444444444333 3334444 44444444444444444333332 4444
Q ss_pred EEECccCCCCcCCChhccC----C-CCCCEEEccCCCCC
Q 004979 194 TLLLDNNQYLGGISPELHV----L-KVISEIQVDESWLT 227 (721)
Q Consensus 194 ~l~l~~N~~~G~iP~~~~~----l-~~L~~l~l~~n~~~ 227 (721)
+|+|++|.+++..+..++. + ++|+.|+|++|.++
T Consensus 84 ~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~ 122 (362)
T 3goz_A 84 SLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFS 122 (362)
T ss_dssp EEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGG
T ss_pred EEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCC
Confidence 4444444444444332222 1 44444444444444
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=98.70 E-value=4.6e-09 Score=112.89 Aligned_cols=111 Identities=20% Similarity=0.149 Sum_probs=80.0
Q ss_pred cEEEEEeCCCCCCCcCc----hhhcCCC-CCCEEEccCCcccccCchhhcCC-----CCCCEeEcccCcccccCCcccc-
Q 004979 119 KVVILNLRDLCLGGMLA----PELGQLS-ELKSIILRNNSFFGTIPKEIGEL-----KELEILDLGFNNFSGPFPSDFG- 187 (721)
Q Consensus 119 ~v~~l~L~~~~l~G~ip----~~l~~l~-~L~~L~L~~n~l~G~ip~~l~~l-----~~L~~l~ls~N~l~G~iP~~~~- 187 (721)
.++.|+|++|.+++.-+ ..+..++ +|++|+|++|.+++..+..+..+ ++|+.|+|++|.+++..+..+.
T Consensus 23 ~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~ 102 (362)
T 3goz_A 23 GVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVK 102 (362)
T ss_dssp TCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHH
T ss_pred CceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHHH
Confidence 47788888888777665 5667777 78888888888887777666654 7888888888888776665443
Q ss_pred ---CC-CCCCEEECccCCCCcCCChhccC-----CCCCCEEEccCCCCCCc
Q 004979 188 ---NS-FSLTTLLLDNNQYLGGISPELHV-----LKVISEIQVDESWLTNA 229 (721)
Q Consensus 188 ---~~-~~L~~l~l~~N~~~G~iP~~~~~-----l~~L~~l~l~~n~~~g~ 229 (721)
.+ ++|++|+|++|.+++..+..++. .++|++|+|++|.+++.
T Consensus 103 ~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~ 153 (362)
T 3goz_A 103 TLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIK 153 (362)
T ss_dssp HHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGS
T ss_pred HHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHH
Confidence 33 77888888888877665554432 35788888888877753
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=98.70 E-value=6.6e-09 Score=119.39 Aligned_cols=109 Identities=17% Similarity=0.245 Sum_probs=72.3
Q ss_pred CCCCceeeEE--------eCCCcEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccC
Q 004979 105 VNPCSWFGVE--------CSDGKVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFN 176 (721)
Q Consensus 105 ~~~C~w~gv~--------C~~~~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N 176 (721)
.+||.|.|.. |....++.|+|++++|+ .||..+. ++|+.|+|++|.++ .||. .+++|+.|+|++|
T Consensus 19 ~~~~~~~~r~~~~~~~~~c~~~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N 91 (622)
T 3g06_A 19 APAEESRGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGN 91 (622)
T ss_dssp CCGGGHHHHHHHHHHHHHHHHHCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CCTTCCEEEECSC
T ss_pred CCcchhccccccCcccccccCCCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cCCCCCEEEcCCC
Confidence 3678886643 22345778888888887 7776665 67888888888877 5665 5677888888888
Q ss_pred cccccCCccccCCCCCCEEECccCCCCcCCChhccCCCCCCEEEccCCCCCC
Q 004979 177 NFSGPFPSDFGNSFSLTTLLLDNNQYLGGISPELHVLKVISEIQVDESWLTN 228 (721)
Q Consensus 177 ~l~G~iP~~~~~~~~L~~l~l~~N~~~G~iP~~~~~l~~L~~l~l~~n~~~g 228 (721)
+++ .||. .+++|++|+|++|++++ +|. .+.+|+.|+|++|.+++
T Consensus 92 ~l~-~lp~---~l~~L~~L~Ls~N~l~~-l~~---~l~~L~~L~L~~N~l~~ 135 (622)
T 3g06_A 92 QLT-SLPV---LPPGLLELSIFSNPLTH-LPA---LPSGLCKLWIFGNQLTS 135 (622)
T ss_dssp CCS-CCCC---CCTTCCEEEECSCCCCC-CCC---CCTTCCEEECCSSCCSC
T ss_pred cCC-cCCC---CCCCCCEEECcCCcCCC-CCC---CCCCcCEEECCCCCCCc
Confidence 877 4665 55667777777776665 343 34445555555555543
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.61 E-value=4.1e-08 Score=102.64 Aligned_cols=178 Identities=14% Similarity=0.174 Sum_probs=113.8
Q ss_pred CcCCCCceeEEEEEEecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCC-CCc--cceEeEEEecCCC-ceEEEE
Q 004979 433 GSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVN-HKN--FVNLIGYCEEDEP-FTRMMV 508 (721)
Q Consensus 433 ~~lg~G~~g~Vyk~~~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~-H~n--Iv~l~g~~~~~~~-~~~~lV 508 (721)
..++.|....||+.. ..+++|+... ......+.+|+++|+.+. +.. +.+++......+. ...|+|
T Consensus 26 ~~~~~G~~n~v~~v~----~~~vlR~~~~-------~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~v 94 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN----RDFIFKFPKH-------SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAG 94 (304)
T ss_dssp CEEEECSSEEEEEST----TSEEEEEESS-------HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEE
T ss_pred EecCCCCcceEEEEC----CEEEEEecCC-------cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEE
Confidence 456678888999863 4577776432 123457889999998873 333 3344444433221 134799
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcC-------------------------------------
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQL------------------------------------- 551 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~------------------------------------- 551 (721)
|||++|..|.+... ..++..++..++.+++..++.||+.
T Consensus 95 m~~i~G~~l~~~~~----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (304)
T 3sg8_A 95 FTKIKGVPLTPLLL----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQM 170 (304)
T ss_dssp EECCCCEECCHHHH----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHH
T ss_pred EcccCCeECCcccc----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccH
Confidence 99999988865322 2356667777788888888777751
Q ss_pred -------------------CCCeEeeCCCCCCeEeCC--CCcEEEeccCCCCCCCCC-----Cccc---cchhhc----c
Q 004979 552 -------------------TPPIAHRNLQSSSIYLTE--DYAAKISDFSFWNNTTAA-----KTGS---AAMELL----E 598 (721)
Q Consensus 552 -------------------~~~IvHrDLKp~NILl~~--~~~~kL~DFGla~~~~~~-----~~~~---~apE~~----~ 598 (721)
.+.++|+|+++.||++++ ...+.|.||+.+...... .... ..++.. .
T Consensus 171 ~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~ 250 (304)
T 3sg8_A 171 KKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILN 250 (304)
T ss_dssp HHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHH
T ss_pred HHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHH
Confidence 134899999999999998 556889999976432211 0000 122211 1
Q ss_pred c-CCC---------CCCccHHHHHHHHHHHHhCCCcc
Q 004979 599 T-SAV---------DLESNVYSFGTILFEMITGRISY 625 (721)
Q Consensus 599 ~-~~~---------s~ksDVwSfGvvL~ElltG~~P~ 625 (721)
. ... ....+.|++|.++|++.+|..+|
T Consensus 251 ~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 251 HYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 0 111 11257899999999999998876
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=98.50 E-value=1.2e-08 Score=113.04 Aligned_cols=111 Identities=19% Similarity=0.147 Sum_probs=85.2
Q ss_pred CcEEEEEeCCCCCCCc----CchhhcCCCCCCEEEccCCcccccCchhhcC-----CCCCCEeEcccCccccc----CCc
Q 004979 118 GKVVILNLRDLCLGGM----LAPELGQLSELKSIILRNNSFFGTIPKEIGE-----LKELEILDLGFNNFSGP----FPS 184 (721)
Q Consensus 118 ~~v~~l~L~~~~l~G~----ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~-----l~~L~~l~ls~N~l~G~----iP~ 184 (721)
.++..|+|++|.+++. ++..+..+++|++|+|++|.+++..+..+.. .++|+.|+|++|.+++. +|.
T Consensus 256 ~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~ 335 (461)
T 1z7x_W 256 SRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSS 335 (461)
T ss_dssp CCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHH
T ss_pred CCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHH
Confidence 4788899999988865 6777888889999999999887655444433 26888888888888875 566
Q ss_pred cccCCCCCCEEECccCCCCcCCChhccC-----CCCCCEEEccCCCCCC
Q 004979 185 DFGNSFSLTTLLLDNNQYLGGISPELHV-----LKVISEIQVDESWLTN 228 (721)
Q Consensus 185 ~~~~~~~L~~l~l~~N~~~G~iP~~~~~-----l~~L~~l~l~~n~~~g 228 (721)
.+..+++|+.|+|++|.+++..+..+.. .++|+.|+|++|.+++
T Consensus 336 ~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~ 384 (461)
T 1z7x_W 336 VLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSD 384 (461)
T ss_dssp HHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCH
T ss_pred HHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCCh
Confidence 6777788888888888887665554543 6788888888888875
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=98.48 E-value=2.3e-07 Score=99.04 Aligned_cols=111 Identities=13% Similarity=0.171 Sum_probs=91.2
Q ss_pred EeCCCcEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCch-hhcCCCCCCEeEcccCcccccCCc-cccCCCC
Q 004979 114 ECSDGKVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPK-EIGELKELEILDLGFNNFSGPFPS-DFGNSFS 191 (721)
Q Consensus 114 ~C~~~~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~-~l~~l~~L~~l~ls~N~l~G~iP~-~~~~~~~ 191 (721)
.|.. + .++-++++|+ .||..+ .++|+.|+|++|.++ .||+ .+.++++|+.|+|++|++.+.||. .+.++++
T Consensus 8 ~C~~-~--~v~C~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~-~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~ 80 (350)
T 4ay9_X 8 HCSN-R--VFLCQESKVT-EIPSDL--PRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 80 (350)
T ss_dssp EEET-T--EEEEESTTCC-SCCTTC--CTTCSEEEEESCCCS-EECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTT
T ss_pred EeeC-C--EEEecCCCCC-ccCcCc--CCCCCEEEccCCcCC-CcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchh
Confidence 4643 3 4677888887 678766 468999999999998 5665 689999999999999999999986 4678888
Q ss_pred CCE-EECccCCCCcCCChhccCCCCCCEEEccCCCCCCccc
Q 004979 192 LTT-LLLDNNQYLGGISPELHVLKVISEIQVDESWLTNAAS 231 (721)
Q Consensus 192 L~~-l~l~~N~~~G~iP~~~~~l~~L~~l~l~~n~~~g~~p 231 (721)
|.. +.++.|++++-.|..+..+++|++|++++|.+++..+
T Consensus 81 l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~ 121 (350)
T 4ay9_X 81 LHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPD 121 (350)
T ss_dssp CCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCC
T ss_pred hhhhhcccCCcccccCchhhhhccccccccccccccccCCc
Confidence 765 6677899988778889999999999999999986433
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.42 E-value=5.2e-08 Score=99.29 Aligned_cols=80 Identities=20% Similarity=0.286 Sum_probs=68.3
Q ss_pred cCCCCCCEEEccCCcccc--cCchhhcCCCCCCEeEcccCcccccCCccccCCC--CCCEEECccCCCCcCCCh------
Q 004979 139 GQLSELKSIILRNNSFFG--TIPKEIGELKELEILDLGFNNFSGPFPSDFGNSF--SLTTLLLDNNQYLGGISP------ 208 (721)
Q Consensus 139 ~~l~~L~~L~L~~n~l~G--~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~--~L~~l~l~~N~~~G~iP~------ 208 (721)
.++++|+.|+|++|.|++ .+|..+..+++|+.|+|++|+|++. ..+..+. +|++|+|++|.+++.+|.
T Consensus 167 ~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~ 244 (267)
T 3rw6_A 167 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYIS 244 (267)
T ss_dssp HHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHH
T ss_pred hhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHH
Confidence 468999999999999999 7888889999999999999999975 3344444 999999999999999883
Q ss_pred -hccCCCCCCEEE
Q 004979 209 -ELHVLKVISEIQ 220 (721)
Q Consensus 209 -~~~~l~~L~~l~ 220 (721)
-+..+++|+.||
T Consensus 245 ~il~~~P~L~~LD 257 (267)
T 3rw6_A 245 AIRERFPKLLRLD 257 (267)
T ss_dssp HHHHHCTTCCEES
T ss_pred HHHHHCcccCeEC
Confidence 356788888774
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=98.41 E-value=2.5e-08 Score=110.46 Aligned_cols=115 Identities=19% Similarity=0.245 Sum_probs=94.5
Q ss_pred CcEEEEEeCCCCCCCc----Cchhh-cCCCCCCEEEccCCccccc----CchhhcCCCCCCEeEcccCcccccCCcccc-
Q 004979 118 GKVVILNLRDLCLGGM----LAPEL-GQLSELKSIILRNNSFFGT----IPKEIGELKELEILDLGFNNFSGPFPSDFG- 187 (721)
Q Consensus 118 ~~v~~l~L~~~~l~G~----ip~~l-~~l~~L~~L~L~~n~l~G~----ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~- 187 (721)
..+..|+|++|.+++. +.+.+ ..+++|++|+|++|.+++. ++..+.++++|+.|+|++|.+++..+..+.
T Consensus 227 ~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~ 306 (461)
T 1z7x_W 227 ASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCE 306 (461)
T ss_dssp TTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHH
T ss_pred CCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHH
Confidence 5788999999998764 22333 3689999999999999875 788888999999999999999876554443
Q ss_pred ----CCCCCCEEECccCCCCcC----CChhccCCCCCCEEEccCCCCCCcccc
Q 004979 188 ----NSFSLTTLLLDNNQYLGG----ISPELHVLKVISEIQVDESWLTNAASR 232 (721)
Q Consensus 188 ----~~~~L~~l~l~~N~~~G~----iP~~~~~l~~L~~l~l~~n~~~g~~p~ 232 (721)
..++|+.|+|++|.+++. +|..+..+++|+.|+|++|.+++..+.
T Consensus 307 ~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~ 359 (461)
T 1z7x_W 307 TLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVR 359 (461)
T ss_dssp HHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHH
T ss_pred HhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHH
Confidence 236999999999999876 677788899999999999999875443
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.40 E-value=1.1e-07 Score=102.36 Aligned_cols=111 Identities=16% Similarity=0.095 Sum_probs=71.0
Q ss_pred CcEEEEEeCCCCCCCcCchhh-cCCCCCCEEEccCCcccccCchhh-----cCCCCCCEeEcccCcccc----cCCcccc
Q 004979 118 GKVVILNLRDLCLGGMLAPEL-GQLSELKSIILRNNSFFGTIPKEI-----GELKELEILDLGFNNFSG----PFPSDFG 187 (721)
Q Consensus 118 ~~v~~l~L~~~~l~G~ip~~l-~~l~~L~~L~L~~n~l~G~ip~~l-----~~l~~L~~l~ls~N~l~G----~iP~~~~ 187 (721)
..+..|+|++|.++..-...+ ..+.+|+.|+|++|.++..-...+ ...+.|+.|+|++|.++. .++..+.
T Consensus 101 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~ 180 (372)
T 3un9_A 101 HALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLA 180 (372)
T ss_dssp SCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHH
T ss_pred CCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHh
Confidence 467788888887764322222 234567777888777765433333 245677777887777754 3444556
Q ss_pred CCCCCCEEECccCCCCc----CCChhccCCCCCCEEEccCCCCCC
Q 004979 188 NSFSLTTLLLDNNQYLG----GISPELHVLKVISEIQVDESWLTN 228 (721)
Q Consensus 188 ~~~~L~~l~l~~N~~~G----~iP~~~~~l~~L~~l~l~~n~~~g 228 (721)
.+++|++|+|++|.++. .|+..+...++|+.|+|++|.++.
T Consensus 181 ~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~ 225 (372)
T 3un9_A 181 GNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGD 225 (372)
T ss_dssp TCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCH
T ss_pred cCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCH
Confidence 67777777777777754 234555666777777777777764
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.21 E-value=3e-07 Score=98.98 Aligned_cols=110 Identities=13% Similarity=0.128 Sum_probs=73.4
Q ss_pred cEEEEEeCCCCCCCcCchhh-----cCCCCCCEEEccCCcccc----cCchhhcCCCCCCEeEcccCcccc----cCCcc
Q 004979 119 KVVILNLRDLCLGGMLAPEL-----GQLSELKSIILRNNSFFG----TIPKEIGELKELEILDLGFNNFSG----PFPSD 185 (721)
Q Consensus 119 ~v~~l~L~~~~l~G~ip~~l-----~~l~~L~~L~L~~n~l~G----~ip~~l~~l~~L~~l~ls~N~l~G----~iP~~ 185 (721)
++..|+|++|.++..-...+ ...+.|+.|+|++|.++. .++..+..+++|++|||++|.++. .++..
T Consensus 127 ~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~ 206 (372)
T 3un9_A 127 RARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQ 206 (372)
T ss_dssp TEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHH
T ss_pred hccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHH
Confidence 57778888887764433222 245677888888887754 355556677778888888887764 23455
Q ss_pred ccCCCCCCEEECccCCCCc----CCChhccCCCCCCEEEccCCCCCC
Q 004979 186 FGNSFSLTTLLLDNNQYLG----GISPELHVLKVISEIQVDESWLTN 228 (721)
Q Consensus 186 ~~~~~~L~~l~l~~N~~~G----~iP~~~~~l~~L~~l~l~~n~~~g 228 (721)
+...++|+.|+|++|.++. .++..+..+++|++|+|++|.++.
T Consensus 207 L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~ 253 (372)
T 3un9_A 207 LDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSS 253 (372)
T ss_dssp GGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCH
T ss_pred HhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCH
Confidence 6666778888888887764 244445566778888888777664
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=98.16 E-value=4.1e-07 Score=104.04 Aligned_cols=110 Identities=11% Similarity=0.060 Sum_probs=52.4
Q ss_pred cEEEEEeCCCCCCCcCchhhcC-CCCCCEEEcc----CCccccc-----CchhhcCCCCCCEeEccc--CcccccCCccc
Q 004979 119 KVVILNLRDLCLGGMLAPELGQ-LSELKSIILR----NNSFFGT-----IPKEIGELKELEILDLGF--NNFSGPFPSDF 186 (721)
Q Consensus 119 ~v~~l~L~~~~l~G~ip~~l~~-l~~L~~L~L~----~n~l~G~-----ip~~l~~l~~L~~l~ls~--N~l~G~iP~~~ 186 (721)
++..|+|..+.+++..+..++. +++|+.|+|+ .|.+++. ++..+.++++|+.|+|+. |.+++..+..+
T Consensus 379 ~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~ 458 (592)
T 3ogk_B 379 ELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYI 458 (592)
T ss_dssp TCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHH
T ss_pred cCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHH
Confidence 4455555555555555544443 5555555554 4455442 333344455555555542 22444433333
Q ss_pred cC-CCCCCEEECccCCCCc-CCChhccCCCCCCEEEccCCCCCC
Q 004979 187 GN-SFSLTTLLLDNNQYLG-GISPELHVLKVISEIQVDESWLTN 228 (721)
Q Consensus 187 ~~-~~~L~~l~l~~N~~~G-~iP~~~~~l~~L~~l~l~~n~~~g 228 (721)
+. +++|+.|+|++|++++ .++..+..+++|+.|+|++|.+++
T Consensus 459 ~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~ 502 (592)
T 3ogk_B 459 GQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSE 502 (592)
T ss_dssp HHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBH
T ss_pred HHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcH
Confidence 32 4445555555555544 233333444555555555555443
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.14 E-value=9.7e-06 Score=84.65 Aligned_cols=134 Identities=14% Similarity=0.108 Sum_probs=85.3
Q ss_pred CcCCCCceeEEEEEEecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCC---ccceEeEEEecCCCceEEEEE
Q 004979 433 GSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHK---NFVNLIGYCEEDEPFTRMMVF 509 (721)
Q Consensus 433 ~~lg~G~~g~Vyk~~~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~---nIv~l~g~~~~~~~~~~~lV~ 509 (721)
..++.|....||+. +..+++|+-.. ......+.+|+++|..+++. .|.+++.++..... ..++||
T Consensus 25 ~~l~~G~~n~v~~v----g~~~VlR~~~~-------~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g-~~~~v~ 92 (306)
T 3tdw_A 25 ESLGEGFRNYAILV----NGDWVFRFPKS-------QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDG-NPFVGY 92 (306)
T ss_dssp EEEEECSSEEEEEE----TTTEEEEEESS-------HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTS-CEEEEE
T ss_pred eecCCCcceeEEEE----CCEEEEEecCC-------chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCC-ceEEEE
Confidence 34566777889987 56677776321 12345789999999999653 25566666653222 468999
Q ss_pred ecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhc---------------------------------------
Q 004979 510 EYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQ--------------------------------------- 550 (721)
Q Consensus 510 Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~--------------------------------------- 550 (721)
||++|..+.+... ..++...+..++.++++.|+.||+
T Consensus 93 e~i~G~~l~~~~~----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~ 168 (306)
T 3tdw_A 93 RKVQGQILGEDGM----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESL 168 (306)
T ss_dssp ECCCSEECHHHHH----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHH
T ss_pred eccCCeECchhhh----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhh
Confidence 9999988765211 112333333344444444444432
Q ss_pred -------------------CCCCeEeeCCCCCCeEeCC---CCc-EEEeccCCCC
Q 004979 551 -------------------LTPPIAHRNLQSSSIYLTE---DYA-AKISDFSFWN 582 (721)
Q Consensus 551 -------------------~~~~IvHrDLKp~NILl~~---~~~-~kL~DFGla~ 582 (721)
..+.++|+|+++.|||+++ ++. +.|.||+.+.
T Consensus 169 ~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~ 223 (306)
T 3tdw_A 169 RDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAA 223 (306)
T ss_dssp HHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCE
T ss_pred HHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcC
Confidence 2234799999999999997 455 4899999754
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.07 E-value=9.3e-07 Score=85.23 Aligned_cols=110 Identities=14% Similarity=0.087 Sum_probs=87.3
Q ss_pred CcEEEEEeCCC-CCCCc----CchhhcCCCCCCEEEccCCcccc----cCchhhcCCCCCCEeEcccCccccc----CCc
Q 004979 118 GKVVILNLRDL-CLGGM----LAPELGQLSELKSIILRNNSFFG----TIPKEIGELKELEILDLGFNNFSGP----FPS 184 (721)
Q Consensus 118 ~~v~~l~L~~~-~l~G~----ip~~l~~l~~L~~L~L~~n~l~G----~ip~~l~~l~~L~~l~ls~N~l~G~----iP~ 184 (721)
..++.|+|++| .++.. +...+...+.|++|+|++|.+.. .|...+...+.|+.|+|++|.++.. |..
T Consensus 36 ~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~~ 115 (185)
T 1io0_A 36 PDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVE 115 (185)
T ss_dssp TTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHH
T ss_pred CCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHHH
Confidence 46889999998 88742 45667788999999999999964 2555666778999999999999864 556
Q ss_pred cccCCCCCCEEEC--ccCCCCcC----CChhccCCCCCCEEEccCCCCC
Q 004979 185 DFGNSFSLTTLLL--DNNQYLGG----ISPELHVLKVISEIQVDESWLT 227 (721)
Q Consensus 185 ~~~~~~~L~~l~l--~~N~~~G~----iP~~~~~l~~L~~l~l~~n~~~ 227 (721)
.+...++|++|+| ++|.++.. |-..+...+.|+.|+|+.|.++
T Consensus 116 ~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 116 ALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp GGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 6778889999999 88998754 3445566789999999999875
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.05 E-value=2.3e-05 Score=79.85 Aligned_cols=124 Identities=11% Similarity=0.139 Sum_probs=82.1
Q ss_pred EEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCC-CCccceEeEEEecCCCceEEEEEecCCCCChhh
Q 004979 442 TVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVN-HKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFE 519 (721)
Q Consensus 442 ~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~~~lV~Ey~~~GsL~~ 519 (721)
.||+.... ++..+++|+.... ....+.+|+..|+.+. +--|-++++++.+.+ ..++|||++++.++.+
T Consensus 40 ~v~rl~~~~~~~~~~lk~~~~~--------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~--~~~lvme~l~G~~~~~ 109 (272)
T 4gkh_A 40 TIYRLYGKPNAPELFLKHGKGS--------VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPD--DAWLLTTAIPGKTAFQ 109 (272)
T ss_dssp EEEEEECCTTCCCEEEEEEETH--------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETT--EEEEEEECCCSEEHHH
T ss_pred eEEEEEecCCCeEEEEEECCCC--------CHhHHHHHHHHHHHhccCCCcCeEEEEEEECC--eEEEEEEeeCCccccc
Confidence 68987754 3556777765321 2346788999888773 333667888888766 6799999999987765
Q ss_pred hhhhccCCCCCHHHHHHHHHHHHHHHHHHhcC------------------------------------------------
Q 004979 520 HLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQL------------------------------------------------ 551 (721)
Q Consensus 520 ~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~------------------------------------------------ 551 (721)
..... ......++.+++..|.-||..
T Consensus 110 ~~~~~------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 183 (272)
T 4gkh_A 110 VLEEY------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEM 183 (272)
T ss_dssp HHHHC------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHH
T ss_pred cccCC------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHH
Confidence 43210 011223344444444444421
Q ss_pred --------CCCeEeeCCCCCCeEeCCCCcEEEeccCCC
Q 004979 552 --------TPPIAHRNLQSSSIYLTEDYAAKISDFSFW 581 (721)
Q Consensus 552 --------~~~IvHrDLKp~NILl~~~~~~kL~DFGla 581 (721)
.+.++|+|+.+.|||+++++.+-|.||+.+
T Consensus 184 ~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a 221 (272)
T 4gkh_A 184 HKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRV 221 (272)
T ss_dssp HTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTC
T ss_pred HhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccc
Confidence 113799999999999998877789999865
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.80 E-value=3.7e-05 Score=81.83 Aligned_cols=84 Identities=7% Similarity=-0.024 Sum_probs=51.0
Q ss_pred CcC-CCCceeEEEEEEec-------CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCC-C--CccceEeEEEecCC
Q 004979 433 GSF-SDGTVGTVYKGTLS-------SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVN-H--KNFVNLIGYCEEDE 501 (721)
Q Consensus 433 ~~l-g~G~~g~Vyk~~~~-------~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~-H--~nIv~l~g~~~~~~ 501 (721)
..+ +.|....+|+.... ++..+++|+.......... ....+.+|+.+++.++ + -.+.++++++.+.+
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~--~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~ 103 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVF--PTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGD 103 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSS--SCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSST
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccC--chhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCC
Confidence 344 67888999998754 2556777765432100000 0124667888887774 2 34667888776542
Q ss_pred C-ceEEEEEecCCCCChh
Q 004979 502 P-FTRMMVFEYSPNGSLF 518 (721)
Q Consensus 502 ~-~~~~lV~Ey~~~GsL~ 518 (721)
. ...++||||++|..+.
T Consensus 104 ~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 104 VLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TTSSCEEEEECCCCBCCC
T ss_pred ccCCceEEEEecCCCChh
Confidence 1 1357999999987654
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=97.79 E-value=1.6e-05 Score=90.66 Aligned_cols=109 Identities=12% Similarity=0.058 Sum_probs=59.4
Q ss_pred cEEEEEeCCCCCCCc----CchhhcCCCCCCEEEccCCccc----ccCchhhcCCCCCCEeEcccCcccccCCccccCCC
Q 004979 119 KVVILNLRDLCLGGM----LAPELGQLSELKSIILRNNSFF----GTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSF 190 (721)
Q Consensus 119 ~v~~l~L~~~~l~G~----ip~~l~~l~~L~~L~L~~n~l~----G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~ 190 (721)
++..|+|+++.+++. ++..+..+++|++|+|+.|.++ +.++..+.++++|+.|+|++|.+.+ +|..+.+++
T Consensus 165 ~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~ 243 (592)
T 3ogk_B 165 KIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAAA 243 (592)
T ss_dssp TCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCT
T ss_pred CCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhh
Confidence 455566666655443 3334445556666666666654 3444445555666666666665554 444444444
Q ss_pred C---------------------------CCEEECccCCCCcCCChhccCCCCCCEEEccCCCCCCc
Q 004979 191 S---------------------------LTTLLLDNNQYLGGISPELHVLKVISEIQVDESWLTNA 229 (721)
Q Consensus 191 ~---------------------------L~~l~l~~N~~~G~iP~~~~~l~~L~~l~l~~n~~~g~ 229 (721)
+ |+.|+++++ ..+.+|..+..+++|++|+|++|.+++.
T Consensus 244 ~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~-~~~~l~~~~~~~~~L~~L~Ls~~~l~~~ 308 (592)
T 3ogk_B 244 NLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYM-GPNEMPILFPFAAQIRKLDLLYALLETE 308 (592)
T ss_dssp TCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTC-CTTTGGGGGGGGGGCCEEEETTCCCCHH
T ss_pred HHHhhcccccccccchHHHHHHhhccccccccCcccc-chhHHHHHHhhcCCCcEEecCCCcCCHH
Confidence 4 444444443 2345555556666666666666665543
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=97.66 E-value=5.6e-06 Score=94.50 Aligned_cols=110 Identities=7% Similarity=-0.031 Sum_probs=72.6
Q ss_pred cEEEEEeCCCCCCCcCchhhc-CCCCCCEEEcc--C----Cccc-----ccCchhhcCCCCCCEeEcccCcccccCCccc
Q 004979 119 KVVILNLRDLCLGGMLAPELG-QLSELKSIILR--N----NSFF-----GTIPKEIGELKELEILDLGFNNFSGPFPSDF 186 (721)
Q Consensus 119 ~v~~l~L~~~~l~G~ip~~l~-~l~~L~~L~L~--~----n~l~-----G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~ 186 (721)
++..|.+.++.+++.....+. .+++|+.|+|+ + |.++ ..++.-+..+++|+.|+|++ ++++..+..+
T Consensus 373 ~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l 451 (594)
T 2p1m_B 373 KLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYI 451 (594)
T ss_dssp TCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHH
T ss_pred hHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHH
Confidence 456667777777776665555 47778888887 3 4554 12333456677778888766 6666555555
Q ss_pred cC-CCCCCEEECccCCCCcCCChhc-cCCCCCCEEEccCCCCCCc
Q 004979 187 GN-SFSLTTLLLDNNQYLGGISPEL-HVLKVISEIQVDESWLTNA 229 (721)
Q Consensus 187 ~~-~~~L~~l~l~~N~~~G~iP~~~-~~l~~L~~l~l~~n~~~g~ 229 (721)
+. +++|+.|+|++|.+++..+..+ ..+++|+.|+|++|.+++.
T Consensus 452 ~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~ 496 (594)
T 2p1m_B 452 GTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDK 496 (594)
T ss_dssp HHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHH
T ss_pred HHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHH
Confidence 54 6777777777777766555444 5577777777777777543
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.63 E-value=2.3e-05 Score=75.37 Aligned_cols=96 Identities=14% Similarity=0.130 Sum_probs=77.3
Q ss_pred CchhhcCCCCCCEEEccCC-cccc----cCchhhcCCCCCCEeEcccCccccc----CCccccCCCCCCEEECccCCCCc
Q 004979 134 LAPELGQLSELKSIILRNN-SFFG----TIPKEIGELKELEILDLGFNNFSGP----FPSDFGNSFSLTTLLLDNNQYLG 204 (721)
Q Consensus 134 ip~~l~~l~~L~~L~L~~n-~l~G----~ip~~l~~l~~L~~l~ls~N~l~G~----iP~~~~~~~~L~~l~l~~N~~~G 204 (721)
+...+...+.|++|+|++| .+.. .+...+...+.|+.|+|++|.++.. |...+...++|++|+|++|.++.
T Consensus 28 l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~ 107 (185)
T 1io0_A 28 LKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISG 107 (185)
T ss_dssp HHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCH
T ss_pred HHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCH
Confidence 4556778999999999999 8864 2556677889999999999999752 34455667899999999999975
Q ss_pred C----CChhccCCCCCCEEEc--cCCCCCCc
Q 004979 205 G----ISPELHVLKVISEIQV--DESWLTNA 229 (721)
Q Consensus 205 ~----iP~~~~~l~~L~~l~l--~~n~~~g~ 229 (721)
. |...+...+.|++|+| ++|.++..
T Consensus 108 ~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~ 138 (185)
T 1io0_A 108 SGILALVEALQSNTSLIELRIDNQSQPLGNN 138 (185)
T ss_dssp HHHHHHHHGGGGCSSCCEEECCCCSSCCCHH
T ss_pred HHHHHHHHHHHhCCCceEEEecCCCCCCCHH
Confidence 3 5566778899999999 88988753
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=97.62 E-value=2.6e-05 Score=88.89 Aligned_cols=106 Identities=11% Similarity=0.107 Sum_probs=80.4
Q ss_pred CcEEEEEeCCCCCCCcCchhhc-CCCCCCEEEccCC-ccccc-CchhhcCCCCCCEeEcccCcccccCCccc----cCCC
Q 004979 118 GKVVILNLRDLCLGGMLAPELG-QLSELKSIILRNN-SFFGT-IPKEIGELKELEILDLGFNNFSGPFPSDF----GNSF 190 (721)
Q Consensus 118 ~~v~~l~L~~~~l~G~ip~~l~-~l~~L~~L~L~~n-~l~G~-ip~~l~~l~~L~~l~ls~N~l~G~iP~~~----~~~~ 190 (721)
.+++.|+|+++.+++..+..+. .+++|+.|+|++| .++.. ++..+.++++|+.|+|++|.+++..+..+ ..++
T Consensus 105 ~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~ 184 (594)
T 2p1m_B 105 TWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYT 184 (594)
T ss_dssp TTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCC
T ss_pred CCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCC
Confidence 4788899999988887777776 6899999999998 55543 55555689999999999999887554433 3677
Q ss_pred CCCEEECccCCCCcCCCh-----hccCCCCCCEEEccCCC
Q 004979 191 SLTTLLLDNNQYLGGISP-----ELHVLKVISEIQVDESW 225 (721)
Q Consensus 191 ~L~~l~l~~N~~~G~iP~-----~~~~l~~L~~l~l~~n~ 225 (721)
+|+.|++++|. +.++. -+..+++|+.|+|++|.
T Consensus 185 ~L~~L~l~~~~--~~~~~~~l~~l~~~~~~L~~L~L~~~~ 222 (594)
T 2p1m_B 185 SLVSLNISCLA--SEVSFSALERLVTRCPNLKSLKLNRAV 222 (594)
T ss_dssp CCCEEECTTCC--SCCCHHHHHHHHHHCTTCCEEECCTTS
T ss_pred cCcEEEecccC--CcCCHHHHHHHHHhCCCCcEEecCCCC
Confidence 89999999886 33332 23457899999998883
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.53 E-value=0.00021 Score=77.22 Aligned_cols=80 Identities=10% Similarity=0.028 Sum_probs=46.7
Q ss_pred hCcCCCCceeEEEEEEec-CCcEEEEEEeeeccc-c-chhhHHHHHHHHHHHHHhcCCC--Cc-cceEeEEEecCCCceE
Q 004979 432 IGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSR-A-DWSKNLESQFRKKIDTLSKVNH--KN-FVNLIGYCEEDEPFTR 505 (721)
Q Consensus 432 i~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~-~-~~~~~~~~~f~~Ei~~l~~l~H--~n-Iv~l~g~~~~~~~~~~ 505 (721)
+..+|.|..+.||+++.. ++..++||......+ . ........++..|++++..+.. +. +.+++.+. .+ ..
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~~--~~ 110 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TE--MA 110 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TT--TT
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--CC--cc
Confidence 346788999999999754 467888987643221 0 0000112346778888887632 33 34565543 22 23
Q ss_pred EEEEecCCCC
Q 004979 506 MMVFEYSPNG 515 (721)
Q Consensus 506 ~lV~Ey~~~G 515 (721)
++||||+++.
T Consensus 111 ~lvmE~l~g~ 120 (397)
T 2olc_A 111 VTVMEDLSHL 120 (397)
T ss_dssp EEEECCCTTS
T ss_pred EEEEEeCCCc
Confidence 7999999763
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.45 E-value=0.00069 Score=71.13 Aligned_cols=30 Identities=17% Similarity=0.308 Sum_probs=26.6
Q ss_pred CCCeEeeCCCCCCeEeCCCCcEEEeccCCC
Q 004979 552 TPPIAHRNLQSSSIYLTEDYAAKISDFSFW 581 (721)
Q Consensus 552 ~~~IvHrDLKp~NILl~~~~~~kL~DFGla 581 (721)
.+.++|+|+++.|||++.++.+.|.||+.+
T Consensus 221 ~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a 250 (346)
T 2q83_A 221 SPNLCHQDYGTGNTLLGENEQIWVIDLDTV 250 (346)
T ss_dssp SCCEECSSCSTTSEEECGGGCEEECCCTTC
T ss_pred cCceecCCCCcccEEEeCCCcEEEEehhhc
Confidence 346999999999999988889999999864
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=97.39 E-value=3.2e-05 Score=82.59 Aligned_cols=109 Identities=15% Similarity=0.135 Sum_probs=71.3
Q ss_pred CcEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhc--CCCCCCEeEccc--Cccccc--C---Cccc--
Q 004979 118 GKVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIG--ELKELEILDLGF--NNFSGP--F---PSDF-- 186 (721)
Q Consensus 118 ~~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~--~l~~L~~l~ls~--N~l~G~--i---P~~~-- 186 (721)
.++..|+|+++. .-.+++ + .+++|+.|+|..+.++...-..++ .+++|+.|+|+. |...|. + -..+
T Consensus 172 P~L~~L~L~g~~-~l~l~~-~-~~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~ 248 (362)
T 2ra8_A 172 PLLNNLKIKGTN-NLSIGK-K-PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSK 248 (362)
T ss_dssp TTCCEEEEECCB-TCBCCS-C-BCTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCT
T ss_pred CCCcEEEEeCCC-Cceecc-c-cCCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhc
Confidence 468888887762 113443 3 378888998888887655444554 688888888863 332222 1 1112
Q ss_pred cCCCCCCEEECccCCCCcCCChhcc---CCCCCCEEEccCCCCCCc
Q 004979 187 GNSFSLTTLLLDNNQYLGGISPELH---VLKVISEIQVDESWLTNA 229 (721)
Q Consensus 187 ~~~~~L~~l~l~~N~~~G~iP~~~~---~l~~L~~l~l~~n~~~g~ 229 (721)
..+++|++|+|.+|.+.+..+..+. .+++|+.|+|+.|.+++.
T Consensus 249 ~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~ 294 (362)
T 2ra8_A 249 DRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDE 294 (362)
T ss_dssp TTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHH
T ss_pred CCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChH
Confidence 2478888888888888765444343 467888888888888764
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.33 E-value=0.00033 Score=72.15 Aligned_cols=75 Identities=17% Similarity=0.269 Sum_probs=51.1
Q ss_pred hCcCCCCceeEEEEEEecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCC---ccceEeEEEecCCCceEEEE
Q 004979 432 IGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHK---NFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 432 i~~lg~G~~g~Vyk~~~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~---nIv~l~g~~~~~~~~~~~lV 508 (721)
+..+|.|..+.||+.+..+|+.+.||+....... ....|..|++.|+.+.-. -+.+++++. . .++|
T Consensus 20 v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~-----~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~--~----~~lv 88 (288)
T 3f7w_A 20 VAERGHSHRWHLYRVELADGTPLFVKALPDDAPA-----LDGLFRAEALGLDWLGRSFGSPVPQVAGWD--D----RTLA 88 (288)
T ss_dssp EEEEEEETTEEEEEEEETTSCEEEEEECCTTCCC-----CTTHHHHHHHHHHHHTCSTTCCSCCEEEEE--T----TEEE
T ss_pred EEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcc-----hhhHHHHHHHHHHHHHhhCCCCcceEEecc--C----ceEE
Confidence 4567789999999999999999999975432211 123578899888877422 244554432 2 2789
Q ss_pred EecCCCCCh
Q 004979 509 FEYSPNGSL 517 (721)
Q Consensus 509 ~Ey~~~GsL 517 (721)
|||++.+..
T Consensus 89 ~e~l~~~~~ 97 (288)
T 3f7w_A 89 MEWVDERPP 97 (288)
T ss_dssp EECCCCCCC
T ss_pred EEeecccCC
Confidence 999987654
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.32 E-value=0.00083 Score=69.99 Aligned_cols=135 Identities=17% Similarity=0.229 Sum_probs=87.1
Q ss_pred CcCCCCceeEEEEEEecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCC---CCccceEeEEEecCCCceEEEEE
Q 004979 433 GSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVN---HKNFVNLIGYCEEDEPFTRMMVF 509 (721)
Q Consensus 433 ~~lg~G~~g~Vyk~~~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~---H~nIv~l~g~~~~~~~~~~~lV~ 509 (721)
..++.|....+|+.... +..+++|+.... ....|..|++.|+.+. ...+.++++++...+ ..++||
T Consensus 42 ~~l~gG~~n~~y~v~~~-~~~~vlK~~~~~--------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g--~~~lvm 110 (312)
T 3jr1_A 42 EKLYSGEMNEIWLINDE-VQTVFVKINERS--------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQG--HSFLLL 110 (312)
T ss_dssp EEECCSSSSEEEEEESS-SCEEEEEEEEGG--------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSS--EEEEEE
T ss_pred EEeCCccceeeeEEEEC-CCeEEEEeCCcc--------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCC--ceEEEE
Confidence 45678888999998764 567788765421 1356888988888873 356788888887655 579999
Q ss_pred ecCCCCChhh-----------hhhhccC-C-------------------CCCHHHHH---HHHH----------------
Q 004979 510 EYSPNGSLFE-----------HLHIQEA-E-------------------HLDWAMRL---RIAM---------------- 539 (721)
Q Consensus 510 Ey~~~GsL~~-----------~l~~~~~-~-------------------~l~~~~~~---~ia~---------------- 539 (721)
||+++..+.. .||.... . .-+|.... ++..
T Consensus 111 e~l~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~ 190 (312)
T 3jr1_A 111 EALNKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNID 190 (312)
T ss_dssp ECCCCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHH
T ss_pred EeccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHH
Confidence 9999876521 1232111 0 12464321 1111
Q ss_pred HHH-HHHHHH--hcCCCCeEeeCCCCCCeEeCCCCcEEEeccC
Q 004979 540 GMA-YCLEHM--HQLTPPIAHRNLQSSSIYLTEDYAAKISDFS 579 (721)
Q Consensus 540 ~ia-~gL~yL--H~~~~~IvHrDLKp~NILl~~~~~~kL~DFG 579 (721)
.+. .....| |...+.++|+|+.+.||+++.++ +.|.||.
T Consensus 191 ~l~~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 191 LIVQIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 111 112334 23346799999999999999887 8899974
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=96.93 E-value=0.0016 Score=68.35 Aligned_cols=83 Identities=20% Similarity=0.181 Sum_probs=59.7
Q ss_pred CCCCCCEEEccCCcccccCch-hhcCCCCCCEeEcccCcccccCC-ccccCCCCCC-EEECccCCCCcCCC-hhccCCCC
Q 004979 140 QLSELKSIILRNNSFFGTIPK-EIGELKELEILDLGFNNFSGPFP-SDFGNSFSLT-TLLLDNNQYLGGIS-PELHVLKV 215 (721)
Q Consensus 140 ~l~~L~~L~L~~n~l~G~ip~-~l~~l~~L~~l~ls~N~l~G~iP-~~~~~~~~L~-~l~l~~N~~~G~iP-~~~~~l~~ 215 (721)
.+++|+.|+|++|+++ .||. .+.+|++|+.|+|++| ++ .|+ ..|.+|.+|+ .+++.+ +++ .|+ ..+..|.+
T Consensus 224 ~~~~L~~l~L~~n~i~-~I~~~aF~~~~~L~~l~l~~n-i~-~I~~~aF~~~~~L~~~l~l~~-~l~-~I~~~aF~~c~~ 298 (329)
T 3sb4_A 224 YMPNLVSLDISKTNAT-TIPDFTFAQKKYLLKIKLPHN-LK-TIGQRVFSNCGRLAGTLELPA-SVT-AIEFGAFMGCDN 298 (329)
T ss_dssp HCTTCCEEECTTBCCC-EECTTTTTTCTTCCEEECCTT-CC-EECTTTTTTCTTCCEEEEECT-TCC-EECTTTTTTCTT
T ss_pred hcCCCeEEECCCCCcc-eecHhhhhCCCCCCEEECCcc-cc-eehHHHhhCChhccEEEEEcc-cce-EEchhhhhCCcc
Confidence 3778888888888877 4444 5777888888888887 55 354 4577888888 888876 443 333 45677888
Q ss_pred CCEEEccCCCCC
Q 004979 216 ISEIQVDESWLT 227 (721)
Q Consensus 216 L~~l~l~~n~~~ 227 (721)
|+.++++.|.++
T Consensus 299 L~~l~l~~n~i~ 310 (329)
T 3sb4_A 299 LRYVLATGDKIT 310 (329)
T ss_dssp EEEEEECSSCCC
T ss_pred CCEEEeCCCccC
Confidence 888888888776
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=96.88 E-value=0.00056 Score=72.92 Aligned_cols=110 Identities=15% Similarity=0.124 Sum_probs=67.5
Q ss_pred CcEEEEEeCCCCC---------CCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCcccc-
Q 004979 118 GKVVILNLRDLCL---------GGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFG- 187 (721)
Q Consensus 118 ~~v~~l~L~~~~l---------~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~- 187 (721)
.++..|.+.++.. .+.+.+-+..+++|+.|+|++|.- -.+|+ + .+++|+.|+|..+.++...-..+.
T Consensus 139 ~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~-l~l~~-~-~~~~L~~L~L~~~~l~~~~l~~l~~ 215 (362)
T 2ra8_A 139 AHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNN-LSIGK-K-PRPNLKSLEIISGGLPDSVVEDILG 215 (362)
T ss_dssp TTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBT-CBCCS-C-BCTTCSEEEEECSBCCHHHHHHHHH
T ss_pred chhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCC-ceecc-c-cCCCCcEEEEecCCCChHHHHHHHH
Confidence 3566666655433 234666677788888888887731 13443 3 378888888888776654333343
Q ss_pred -CCCCCCEEECcc--CCCCcC--C---Chhc--cCCCCCCEEEccCCCCCCcc
Q 004979 188 -NSFSLTTLLLDN--NQYLGG--I---SPEL--HVLKVISEIQVDESWLTNAA 230 (721)
Q Consensus 188 -~~~~L~~l~l~~--N~~~G~--i---P~~~--~~l~~L~~l~l~~n~~~g~~ 230 (721)
.+++|+.|+|+. |...|. + -+.+ ..+++|++|+|..|.+++..
T Consensus 216 ~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~ 268 (362)
T 2ra8_A 216 SDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVV 268 (362)
T ss_dssp SBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHH
T ss_pred ccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHH
Confidence 678888888753 332222 1 1112 24678888888888877543
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.68 E-value=0.0025 Score=65.85 Aligned_cols=29 Identities=10% Similarity=0.096 Sum_probs=24.1
Q ss_pred CCeEeeCCCCCCeEeCCCCcEEEeccCCCC
Q 004979 553 PPIAHRNLQSSSIYLTEDYAAKISDFSFWN 582 (721)
Q Consensus 553 ~~IvHrDLKp~NILl~~~~~~kL~DFGla~ 582 (721)
+.++|+|+.+.||+ ..++.+.|.||..+.
T Consensus 173 ~~l~HgDl~~~Nil-~~~~~~~lID~e~a~ 201 (301)
T 3dxq_A 173 LAACHCDPLCENFL-DTGERMWIVDWEYSG 201 (301)
T ss_dssp CEEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred ceeeccCCCcCCEE-ECCCCEEEEeccccc
Confidence 35899999999999 556678999998654
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.61 E-value=0.0069 Score=63.45 Aligned_cols=30 Identities=13% Similarity=0.227 Sum_probs=25.9
Q ss_pred CCeEeeCCCCCCeEeCCC----CcEEEeccCCCC
Q 004979 553 PPIAHRNLQSSSIYLTED----YAAKISDFSFWN 582 (721)
Q Consensus 553 ~~IvHrDLKp~NILl~~~----~~~kL~DFGla~ 582 (721)
+.++|||+.+.|||++.+ ..+.|.||+.+.
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~ 216 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAK 216 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcC
Confidence 359999999999999875 689999998754
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=96.47 E-value=0.008 Score=65.30 Aligned_cols=30 Identities=23% Similarity=0.379 Sum_probs=26.2
Q ss_pred CCeEeeCCCCCCeEeCCCCcEEEeccCCCCC
Q 004979 553 PPIAHRNLQSSSIYLTEDYAAKISDFSFWNN 583 (721)
Q Consensus 553 ~~IvHrDLKp~NILl~~~~~~kL~DFGla~~ 583 (721)
+.++|+|+++.|||+++++ ++|.||+.+..
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~ 261 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFY 261 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence 4599999999999999876 99999987653
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=96.38 E-value=0.0052 Score=64.32 Aligned_cols=83 Identities=13% Similarity=0.135 Sum_probs=56.3
Q ss_pred CCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCc-cccCCCCCCEEECccCCCCcCCCh-hccCCCCCC-
Q 004979 141 LSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPS-DFGNSFSLTTLLLDNNQYLGGISP-ELHVLKVIS- 217 (721)
Q Consensus 141 l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~-~~~~~~~L~~l~l~~N~~~G~iP~-~~~~l~~L~- 217 (721)
+.+++.+.+.++-....+..-...|++|+.|+|++|+++ .||. .+.+|.+|+.|+|++| +. .|+. .+..+.+|+
T Consensus 201 ~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~-~I~~~aF~~~~~L~~l~l~~n-i~-~I~~~aF~~~~~L~~ 277 (329)
T 3sb4_A 201 PRDINFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNAT-TIPDFTFAQKKYLLKIKLPHN-LK-TIGQRVFSNCGRLAG 277 (329)
T ss_dssp GGGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCC-EECTTTTTTCTTCCEEECCTT-CC-EECTTTTTTCTTCCE
T ss_pred ccccceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCcc-eecHhhhhCCCCCCEEECCcc-cc-eehHHHhhCChhccE
Confidence 566777776665332222221223788999999988887 5664 5788889999999887 43 4554 467788898
Q ss_pred EEEccCCCCC
Q 004979 218 EIQVDESWLT 227 (721)
Q Consensus 218 ~l~l~~n~~~ 227 (721)
.+.+.. .++
T Consensus 278 ~l~l~~-~l~ 286 (329)
T 3sb4_A 278 TLELPA-SVT 286 (329)
T ss_dssp EEEECT-TCC
T ss_pred EEEEcc-cce
Confidence 888876 443
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.22 E-value=0.01 Score=61.63 Aligned_cols=157 Identities=10% Similarity=0.151 Sum_probs=82.5
Q ss_pred CCCHHHHHHHHhhhh--h--hhCcCCCCceeEEEEEEecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCc-
Q 004979 415 KLKRSELEAACEDFS--N--IIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKN- 489 (721)
Q Consensus 415 ~~~~~~l~~~~~~~~--~--ii~~lg~G~~g~Vyk~~~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~n- 489 (721)
.++.+++......|. + -+..++.|....+|+....++ .+++|....... ...+..|+.++..++...
T Consensus 6 ~~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~~-------~~~l~~e~~~l~~L~~~g~ 77 (322)
T 2ppq_A 6 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVE-------KNDLPFFLGLMQHLAAKGL 77 (322)
T ss_dssp CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC----------CCHHHHHHHHHHHHHHTTC
T ss_pred cCCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCCC-------HHHHHHHHHHHHHHHHCCC
Confidence 455566666665542 1 123456677789999887655 567776653111 123455666666553212
Q ss_pred -cceEeEE------EecCCCceEEEEEecCCCCChhh--------------hhhhcc----CC---C---CCHHHHHH--
Q 004979 490 -FVNLIGY------CEEDEPFTRMMVFEYSPNGSLFE--------------HLHIQE----AE---H---LDWAMRLR-- 536 (721)
Q Consensus 490 -Iv~l~g~------~~~~~~~~~~lV~Ey~~~GsL~~--------------~l~~~~----~~---~---l~~~~~~~-- 536 (721)
+.+++.. ....+ ..+++|||++|..+.. .+|... .. . ..|.....
T Consensus 78 ~vP~~~~~~~g~~~~~~~g--~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~ 155 (322)
T 2ppq_A 78 SCPLPLPRKDGELLGELSG--RPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKS 155 (322)
T ss_dssp CCCCBCCBTTCCSCEEETT--EEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHH
T ss_pred CCCcccCCCCCCEEEEECC--EEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHH
Confidence 2233321 11112 4589999998865421 122110 00 0 12332110
Q ss_pred ----------HHHHHHHHHHHHhcC-----CCCeEeeCCCCCCeEeCCCCcEEEeccCCC
Q 004979 537 ----------IAMGMAYCLEHMHQL-----TPPIAHRNLQSSSIYLTEDYAAKISDFSFW 581 (721)
Q Consensus 537 ----------ia~~ia~gL~yLH~~-----~~~IvHrDLKp~NILl~~~~~~kL~DFGla 581 (721)
+...+...++++++. ...++|+|+.+.|||++++..+.|.||+.+
T Consensus 156 ~~~~~~~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a 215 (322)
T 2ppq_A 156 EERADEVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFA 215 (322)
T ss_dssp GGGGGGTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTC
T ss_pred HHHHHhhhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhc
Confidence 111244455555421 235999999999999998766689999864
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=95.96 E-value=0.018 Score=61.58 Aligned_cols=136 Identities=14% Similarity=0.150 Sum_probs=75.7
Q ss_pred cCCCCceeEEEEEEecC--------CcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCC-CCccceEeEEEecCCCce
Q 004979 434 SFSDGTVGTVYKGTLSS--------GVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVN-HKNFVNLIGYCEEDEPFT 504 (721)
Q Consensus 434 ~lg~G~~g~Vyk~~~~~--------~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~ 504 (721)
.+..|-...+|+....+ +..+.+++..... . ....+.+|.++++.+. +.-..++++++. +
T Consensus 57 ~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~-~-----~~~~~~rE~~vl~~L~~~gv~P~ll~~~~--~--- 125 (379)
T 3feg_A 57 PVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL-Q-----GVDSLVLESVMFAILAERSLGPQLYGVFP--E--- 125 (379)
T ss_dssp EC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----C-----CHHHHHHHHHHHHHHHHTTSSCCEEEEET--T---
T ss_pred EcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc-c-----hHHHHHHHHHHHHHHHhcCCCCeEEEEcC--C---
Confidence 44457777899988642 4677777642211 0 1234568888887773 222356666653 2
Q ss_pred EEEEEecCCCCChhhh-----------------hhhcc---CCCCC--HHHHHHHHHHHH-------------------H
Q 004979 505 RMMVFEYSPNGSLFEH-----------------LHIQE---AEHLD--WAMRLRIAMGMA-------------------Y 543 (721)
Q Consensus 505 ~~lV~Ey~~~GsL~~~-----------------l~~~~---~~~l~--~~~~~~ia~~ia-------------------~ 543 (721)
.+||||++|..|..- ||... ..... |.+..++..++. .
T Consensus 126 -g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~ 204 (379)
T 3feg_A 126 -GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKD 204 (379)
T ss_dssp -EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHH
T ss_pred -ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHH
Confidence 289999987655311 12111 11122 344444443332 1
Q ss_pred HHHHH----hc--CCCCeEeeCCCCCCeEeCCC----CcEEEeccCCC
Q 004979 544 CLEHM----HQ--LTPPIAHRNLQSSSIYLTED----YAAKISDFSFW 581 (721)
Q Consensus 544 gL~yL----H~--~~~~IvHrDLKp~NILl~~~----~~~kL~DFGla 581 (721)
.++.| .. ....++|+|+.+.|||++++ +.+.|.||..+
T Consensus 205 ~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a 252 (379)
T 3feg_A 205 EMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYS 252 (379)
T ss_dssp HHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTC
T ss_pred HHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccC
Confidence 23333 22 22359999999999999876 78999999865
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=95.96 E-value=0.03 Score=58.25 Aligned_cols=158 Identities=9% Similarity=0.048 Sum_probs=83.8
Q ss_pred CCCCHHHHHHHHhhhh-h---hhCcCCCCceeEEEEEEecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCC-
Q 004979 414 PKLKRSELEAACEDFS-N---IIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHK- 488 (721)
Q Consensus 414 ~~~~~~~l~~~~~~~~-~---ii~~lg~G~~g~Vyk~~~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~- 488 (721)
..++.+++....+.+. . -+..++ |....||+....+|..+++|....... . ...+..|+.++..++..
T Consensus 9 ~~l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~---~---~~~~~~E~~~~~~L~~~g 81 (328)
T 1zyl_A 9 QTLHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPERW---T---ADQILEEHQFALQLVNDE 81 (328)
T ss_dssp CCCCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTTS---C---HHHHHHHHHHHHHHHHTT
T ss_pred CCCCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCCC---C---HHHHHHHHHHHHHHHHcC
Confidence 4455666666655442 0 112344 666799998776677788887652211 1 23456677777666322
Q ss_pred -ccceEeEE-----EecCCCceEEEEEecCCCCChhh-----h---------hhhcc-------CCCCCHHHH----HHH
Q 004979 489 -NFVNLIGY-----CEEDEPFTRMMVFEYSPNGSLFE-----H---------LHIQE-------AEHLDWAMR----LRI 537 (721)
Q Consensus 489 -nIv~l~g~-----~~~~~~~~~~lV~Ey~~~GsL~~-----~---------l~~~~-------~~~l~~~~~----~~i 537 (721)
.+.+++.. ....+ ..++||||++|..+.. . +|... ....++... ..+
T Consensus 82 ~~vp~~~~~~g~~~~~~~g--~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T 1zyl_A 82 VPVAAPVAFNGQTLLNHQG--FYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKL 159 (328)
T ss_dssp CSBCCCCCBTTBSCEEETT--EEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHH
T ss_pred CeecceeecCCcEEEEECC--EEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHH
Confidence 23444433 11122 4578999998754321 0 12110 111232211 001
Q ss_pred ---------------HHHHHHHHHHHhc-----CCCCeEeeCCCCCCeEeCCCCcEEEeccCCCC
Q 004979 538 ---------------AMGMAYCLEHMHQ-----LTPPIAHRNLQSSSIYLTEDYAAKISDFSFWN 582 (721)
Q Consensus 538 ---------------a~~ia~gL~yLH~-----~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~ 582 (721)
...+...++.+.+ ....++|+|+++.|||++ + .+.|.||+.+.
T Consensus 160 l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~ 222 (328)
T 1zyl_A 160 FEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDAR 222 (328)
T ss_dssp HHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred HhhcCcCCHHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence 1111122333321 233589999999999999 4 89999998653
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=95.91 E-value=0.034 Score=60.93 Aligned_cols=73 Identities=11% Similarity=0.059 Sum_probs=43.7
Q ss_pred CcCCCCceeEEEEEEecC-CcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCcc-ceEeEEEecCCCceEEEEEe
Q 004979 433 GSFSDGTVGTVYKGTLSS-GVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNF-VNLIGYCEEDEPFTRMMVFE 510 (721)
Q Consensus 433 ~~lg~G~~g~Vyk~~~~~-~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nI-v~l~g~~~~~~~~~~~lV~E 510 (721)
..++.|-...+|+....+ +..+++|+..... ... -+-.+|..++..+...++ .++++++. + .+|||
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~-~~~-----idR~~E~~vl~~L~~~gl~P~ll~~~~--~----G~v~e 181 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKT-DEI-----INREREKKISCILYNKNIAKKIYVFFT--N----GRIEE 181 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-C-CSC-----SCHHHHHHHHHHHTTSSSBCCEEEEET--T----EEEEE
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCCh-hhh-----cCHHHHHHHHHHHHhcCCCCCEEEEeC--C----eEEEE
Confidence 355667788999998765 4667777653221 110 012477888888754444 46777662 2 35999
Q ss_pred cCCCCCh
Q 004979 511 YSPNGSL 517 (721)
Q Consensus 511 y~~~GsL 517 (721)
|+++..|
T Consensus 182 ~I~G~~l 188 (458)
T 2qg7_A 182 FMDGYAL 188 (458)
T ss_dssp CCCSEEC
T ss_pred eeCCccC
Confidence 9987544
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=95.83 E-value=0.022 Score=62.07 Aligned_cols=72 Identities=15% Similarity=0.202 Sum_probs=45.2
Q ss_pred CcCCCCceeEEEEEEecC--------CcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCcc-ceEeEEEecCCCc
Q 004979 433 GSFSDGTVGTVYKGTLSS--------GVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNF-VNLIGYCEEDEPF 503 (721)
Q Consensus 433 ~~lg~G~~g~Vyk~~~~~--------~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nI-v~l~g~~~~~~~~ 503 (721)
..++.|....||+....+ +..+.+|+..... . ...+.+|..++..+...++ .++++.+. +
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~----~---~~~li~E~~~l~~L~~~g~~P~l~~~~~--~-- 147 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE----T---ESHLVAESVIFTLLSERHLGPKLYGIFS--G-- 147 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC----C---HHHHHHHHHHHHHHHHTTSSSCEEEEET--T--
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC----c---HHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--
Confidence 345667778999998753 4677787663211 1 1234578888887743333 56776553 2
Q ss_pred eEEEEEecCCCCCh
Q 004979 504 TRMMVFEYSPNGSL 517 (721)
Q Consensus 504 ~~~lV~Ey~~~GsL 517 (721)
.+|+||+++..|
T Consensus 148 --g~v~e~l~G~~l 159 (429)
T 1nw1_A 148 --GRLEEYIPSRPL 159 (429)
T ss_dssp --EEEECCCCEEEC
T ss_pred --CEEEEEeCCccc
Confidence 389999986443
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=95.80 E-value=0.0056 Score=57.74 Aligned_cols=33 Identities=9% Similarity=0.046 Sum_probs=15.0
Q ss_pred CCCEEECccCC-CCcCCChhccCCCCCCEEEccC
Q 004979 191 SLTTLLLDNNQ-YLGGISPELHVLKVISEIQVDE 223 (721)
Q Consensus 191 ~L~~l~l~~N~-~~G~iP~~~~~l~~L~~l~l~~ 223 (721)
+|++|+|+++. +|..==..+..+++|+.|+|++
T Consensus 115 ~L~~L~Ls~C~~ITD~Gl~~L~~~~~L~~L~L~~ 148 (176)
T 3e4g_A 115 SMLEMEIISCGNVTDKGIIALHHFRNLKYLFLSD 148 (176)
T ss_dssp HCCEEEEESCTTCCHHHHHHGGGCTTCCEEEEES
T ss_pred CCCEEEcCCCCcCCHHHHHHHhcCCCCCEEECCC
Confidence 45555555542 3321112344555555555554
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=95.69 E-value=0.013 Score=52.29 Aligned_cols=16 Identities=6% Similarity=0.086 Sum_probs=7.3
Q ss_pred cCCCCCCEEEccCCCC
Q 004979 211 HVLKVISEIQVDESWL 226 (721)
Q Consensus 211 ~~l~~L~~l~l~~n~~ 226 (721)
..+++|+.|+|++|.+
T Consensus 52 ~~l~~L~~L~L~~NP~ 67 (130)
T 3rfe_A 52 DALPALRTAHLGANPW 67 (130)
T ss_dssp GGCTTCCEEECCSSCC
T ss_pred hhccccCEEEecCCCe
Confidence 3344444444544444
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=95.65 E-value=0.0045 Score=58.41 Aligned_cols=83 Identities=14% Similarity=0.127 Sum_probs=63.5
Q ss_pred cEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCc-ccccCchhhcCC----CCCCEeEcccC-cccccCCccccCCCCC
Q 004979 119 KVVILNLRDLCLGGMLAPELGQLSELKSIILRNNS-FFGTIPKEIGEL----KELEILDLGFN-NFSGPFPSDFGNSFSL 192 (721)
Q Consensus 119 ~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~-l~G~ip~~l~~l----~~L~~l~ls~N-~l~G~iP~~~~~~~~L 192 (721)
+++.|||+++.++..=-..+..+++|+.|+|+++. ++..-=..++.+ ++|+.|||+++ ++|..==..+.++++|
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L 141 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNL 141 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTC
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCC
Confidence 69999999998764433457899999999999985 665433456664 47999999996 4765333457789999
Q ss_pred CEEECccCC
Q 004979 193 TTLLLDNNQ 201 (721)
Q Consensus 193 ~~l~l~~N~ 201 (721)
+.|+|++..
T Consensus 142 ~~L~L~~c~ 150 (176)
T 3e4g_A 142 KYLFLSDLP 150 (176)
T ss_dssp CEEEEESCT
T ss_pred CEEECCCCC
Confidence 999999874
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=95.61 E-value=0.018 Score=61.25 Aligned_cols=27 Identities=26% Similarity=0.455 Sum_probs=22.9
Q ss_pred CeEeeCCCCCCeEeCCCCcEEEeccCCC
Q 004979 554 PIAHRNLQSSSIYLTEDYAAKISDFSFW 581 (721)
Q Consensus 554 ~IvHrDLKp~NILl~~~~~~kL~DFGla 581 (721)
.++|+|+++.|||++++. +.|+||..+
T Consensus 213 ~l~HgDl~~~Nil~~~~~-~~lID~e~a 239 (369)
T 3c5i_A 213 VFCHNDLQENNIINTNKC-LRLIDFEYS 239 (369)
T ss_dssp EEECSCCCGGGEEECC-C-EEECCCTTC
T ss_pred EEEeCCCCcccEEecCCc-EEEEEecCC
Confidence 589999999999998655 899999864
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=95.25 E-value=0.011 Score=56.89 Aligned_cols=108 Identities=10% Similarity=0.078 Sum_probs=71.5
Q ss_pred CcEEEEEeCCC-CCCC----cCchhhcCCCCCCEEEccCCcccc----cCchhhcCCCCCCEeEcccCccccc----CCc
Q 004979 118 GKVVILNLRDL-CLGG----MLAPELGQLSELKSIILRNNSFFG----TIPKEIGELKELEILDLGFNNFSGP----FPS 184 (721)
Q Consensus 118 ~~v~~l~L~~~-~l~G----~ip~~l~~l~~L~~L~L~~n~l~G----~ip~~l~~l~~L~~l~ls~N~l~G~----iP~ 184 (721)
..++.|+|+++ .++. .|...|..=+.|+.|+|++|.+.- .|-..|..-+.|+.|+|++|+++.. |-.
T Consensus 41 ~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~ 120 (197)
T 1pgv_A 41 TDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLR 120 (197)
T ss_dssp SSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHH
T ss_pred CCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHHH
Confidence 46778888875 6652 244566677889999999998863 2344455567899999999988753 223
Q ss_pred cccCCCCCCEEECccC---CCCc----CCChhccCCCCCCEEEccCCC
Q 004979 185 DFGNSFSLTTLLLDNN---QYLG----GISPELHVLKVISEIQVDESW 225 (721)
Q Consensus 185 ~~~~~~~L~~l~l~~N---~~~G----~iP~~~~~l~~L~~l~l~~n~ 225 (721)
.+..-+.|+.|+|++| .+.. .|-..+..-+.|..|+|+.|.
T Consensus 121 aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~ 168 (197)
T 1pgv_A 121 STLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFAS 168 (197)
T ss_dssp HTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCC
T ss_pred HHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCC
Confidence 3445566889998764 2221 133345566788888887664
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=95.02 E-value=0.045 Score=48.79 Aligned_cols=56 Identities=18% Similarity=0.182 Sum_probs=45.8
Q ss_pred CEEEccCCccc-ccCchhhcCCCCCCEeEcccCcccccCC-ccccCCCCCCEEECccCCCC
Q 004979 145 KSIILRNNSFF-GTIPKEIGELKELEILDLGFNNFSGPFP-SDFGNSFSLTTLLLDNNQYL 203 (721)
Q Consensus 145 ~~L~L~~n~l~-G~ip~~l~~l~~L~~l~ls~N~l~G~iP-~~~~~~~~L~~l~l~~N~~~ 203 (721)
..++.+++.|+ -.||..+. ++|+.|+|++|+|+. || ..+..+++|+.|+|++|.+.
T Consensus 11 ~~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~-l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 11 TLVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTA-LPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp TEEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSS-CCTTTGGGCTTCCEEECCSSCCB
T ss_pred CEEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCc-cChhhhhhccccCEEEecCCCee
Confidence 47899999997 57776543 479999999999995 55 45678999999999999874
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=94.95 E-value=0.091 Score=55.10 Aligned_cols=30 Identities=10% Similarity=0.175 Sum_probs=26.3
Q ss_pred CCeEeeCCCCCCeEeCCCCcEEEeccCCCC
Q 004979 553 PPIAHRNLQSSSIYLTEDYAAKISDFSFWN 582 (721)
Q Consensus 553 ~~IvHrDLKp~NILl~~~~~~kL~DFGla~ 582 (721)
..++|+|+.+.||++++++.+.|.||+.+.
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~ 235 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPM 235 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCe
Confidence 359999999999999988889999997643
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=94.49 E-value=0.14 Score=49.58 Aligned_cols=98 Identities=18% Similarity=0.145 Sum_probs=63.7
Q ss_pred CChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHH-hcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCCCCCccccc
Q 004979 515 GSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHM-HQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTAAKTGSAA 593 (721)
Q Consensus 515 GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yL-H~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~a 593 (721)
-+|.++|.. ...++++.++..++.|.+.+|.-+ +...+ ..+=+-|..|++..+|.+...+ +.+. .......+
T Consensus 33 vSL~eIL~~-~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~--~~~i~~~~~i~l~~dG~V~f~~-~~s~---~~~~~~~~ 105 (229)
T 2yle_A 33 LSLEEILRL-YNQPINEEQAWAVCYQCCGSLRAAARRRQP--RHRVRSAAQIRVWRDGAVTLAP-AADD---AGEPPPVA 105 (229)
T ss_dssp EEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred ccHHHHHHH-cCCCcCHHHHHHHHHHHHHHHHhhhhcccC--CceecCCcceEEecCCceeccc-cccc---ccccCCCC
Confidence 478888864 457899999999999999988776 22111 1222346899999999998875 2211 12234557
Q ss_pred hhhcccCCCCCCccHHHHHHHHHHHHh
Q 004979 594 MELLETSAVDLESNVYSFGTILFEMIT 620 (721)
Q Consensus 594 pE~~~~~~~s~ksDVwSfGvvL~Ellt 620 (721)
||... ...+.+.=|||+|+++|.-+-
T Consensus 106 pe~~~-~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 106 GKLGY-SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp -CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred hhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence 77653 344677789999999998876
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=93.18 E-value=0.18 Score=54.11 Aligned_cols=78 Identities=10% Similarity=0.042 Sum_probs=34.9
Q ss_pred CCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccc----cCC-ccccCCCCCCEEECccCCCCcCCC-hhccCCCC
Q 004979 142 SELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSG----PFP-SDFGNSFSLTTLLLDNNQYLGGIS-PELHVLKV 215 (721)
Q Consensus 142 ~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G----~iP-~~~~~~~~L~~l~l~~N~~~G~iP-~~~~~l~~ 215 (721)
..|+.++|. |++.--=+..+.+|++|+.+++++|.+.. .|+ ..+.+|++|+.++|.+ +++ .|+ ..+..|.+
T Consensus 248 ~~L~~i~lp-~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~~-~i~-~I~~~aF~~c~~ 324 (401)
T 4fdw_A 248 SGITTVKLP-NGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIPE-SIR-ILGQGLLGGNRK 324 (401)
T ss_dssp CCCSEEEEE-TTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCCT-TCC-EECTTTTTTCCS
T ss_pred CCccEEEeC-CCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeCC-ceE-EEhhhhhcCCCC
Confidence 455555552 33331112344555555555555554431 122 2344555555555552 222 222 22344555
Q ss_pred CCEEEcc
Q 004979 216 ISEIQVD 222 (721)
Q Consensus 216 L~~l~l~ 222 (721)
|+.+.|.
T Consensus 325 L~~l~lp 331 (401)
T 4fdw_A 325 VTQLTIP 331 (401)
T ss_dssp CCEEEEC
T ss_pred ccEEEEC
Confidence 5555553
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=93.01 E-value=0.058 Score=51.74 Aligned_cols=89 Identities=18% Similarity=0.138 Sum_probs=64.2
Q ss_pred hhhcCCCCCCEEEccCC-cccc----cCchhhcCCCCCCEeEcccCccccc----CCccccCCCCCCEEECccCCCCcC-
Q 004979 136 PELGQLSELKSIILRNN-SFFG----TIPKEIGELKELEILDLGFNNFSGP----FPSDFGNSFSLTTLLLDNNQYLGG- 205 (721)
Q Consensus 136 ~~l~~l~~L~~L~L~~n-~l~G----~ip~~l~~l~~L~~l~ls~N~l~G~----iP~~~~~~~~L~~l~l~~N~~~G~- 205 (721)
.-+.+-+.|+.|+|++| .+.. .|-..+..-+.|+.|+|++|++... |-..+..-+.|+.|+|++|++...
T Consensus 35 ~ll~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~G 114 (197)
T 1pgv_A 35 RLREDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPEL 114 (197)
T ss_dssp HHHTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHH
T ss_pred HHHhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHH
Confidence 33456688999999986 7642 2445566778999999999999742 223344557899999999998742
Q ss_pred ---CChhccCCCCCCEEEccCC
Q 004979 206 ---ISPELHVLKVISEIQVDES 224 (721)
Q Consensus 206 ---iP~~~~~l~~L~~l~l~~n 224 (721)
|-..+..-..|+.|+|++|
T Consensus 115 a~ala~aL~~N~tL~~L~L~n~ 136 (197)
T 1pgv_A 115 LARLLRSTLVTQSIVEFKADNQ 136 (197)
T ss_dssp HHHHHHHTTTTCCCSEEECCCC
T ss_pred HHHHHHHHhhCCceeEEECCCC
Confidence 3334556678999999865
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=90.43 E-value=0.6 Score=50.01 Aligned_cols=103 Identities=14% Similarity=0.137 Sum_probs=74.1
Q ss_pred cEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccc----cCc-hhhcCCCCCCEeEcccCcccccCC-ccccCCCCC
Q 004979 119 KVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFG----TIP-KEIGELKELEILDLGFNNFSGPFP-SDFGNSFSL 192 (721)
Q Consensus 119 ~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G----~ip-~~l~~l~~L~~l~ls~N~l~G~iP-~~~~~~~~L 192 (721)
.+..|.|. +++.---...+.++++|+.++|.+|.+.. .|+ ..+..|++|+.++|++ +++ .|+ ..+.+|++|
T Consensus 249 ~L~~i~lp-~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~~-~i~-~I~~~aF~~c~~L 325 (401)
T 4fdw_A 249 GITTVKLP-NGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIPE-SIR-ILGQGLLGGNRKV 325 (401)
T ss_dssp CCSEEEEE-TTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCCT-TCC-EECTTTTTTCCSC
T ss_pred CccEEEeC-CCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeCC-ceE-EEhhhhhcCCCCc
Confidence 45666774 33432223457889999999999988751 244 4678899999999994 465 454 467889999
Q ss_pred CEEECccCCCCcCCC-hhccCCCCCCEEEccCCCCC
Q 004979 193 TTLLLDNNQYLGGIS-PELHVLKVISEIQVDESWLT 227 (721)
Q Consensus 193 ~~l~l~~N~~~G~iP-~~~~~l~~L~~l~l~~n~~~ 227 (721)
+.+.|..| ++ .|+ ..+.++ +|+.+.+.+|.+.
T Consensus 326 ~~l~lp~~-l~-~I~~~aF~~~-~L~~l~l~~n~~~ 358 (401)
T 4fdw_A 326 TQLTIPAN-VT-QINFSAFNNT-GIKEVKVEGTTPP 358 (401)
T ss_dssp CEEEECTT-CC-EECTTSSSSS-CCCEEEECCSSCC
T ss_pred cEEEECcc-cc-EEcHHhCCCC-CCCEEEEcCCCCc
Confidence 99999666 33 343 356678 9999999999765
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=90.24 E-value=0.58 Score=50.50 Aligned_cols=27 Identities=19% Similarity=0.434 Sum_probs=24.2
Q ss_pred CeEeeCCCCCCeEeCCCCcEEEeccCCC
Q 004979 554 PIAHRNLQSSSIYLTEDYAAKISDFSFW 581 (721)
Q Consensus 554 ~IvHrDLKp~NILl~~~~~~kL~DFGla 581 (721)
.++|+|+.+.||+ ++++.+.+.||..+
T Consensus 263 ~~~H~D~~~~N~l-~~~~~~~~IDwe~a 289 (424)
T 3mes_A 263 VFAHNDLQENNLL-QTQNNIRMIDYEYS 289 (424)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTC
T ss_pred eEECCCCCcccee-cCCCcEEEEecccC
Confidence 5899999999999 77889999999765
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=87.30 E-value=0.42 Score=33.42 Aligned_cols=28 Identities=29% Similarity=0.599 Sum_probs=15.9
Q ss_pred eeehHHHHHHHHHHHHHHH-HHhhhcccc
Q 004979 364 LVLAGIIGGLSLILISAIG-FFVCRSSKV 391 (721)
Q Consensus 364 ~i~~~~~~~~~~~~~~~~~-~~~~r~~~~ 391 (721)
.|+++++++++++++++++ ++++|+|+.
T Consensus 12 ~IA~gVVgGv~~~~ii~~~~~~~~RRr~~ 40 (44)
T 2ks1_B 12 SIATGMVGALLLLLVVALGIGLFMRRRHI 40 (44)
T ss_dssp SSTHHHHHHHHHHHHHHHHHHHHHHTTTC
T ss_pred eEEeehhHHHHHHHHHHHHHHHHhhhhHh
Confidence 4777887766655444443 455555443
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=87.12 E-value=1.9 Score=45.97 Aligned_cols=28 Identities=25% Similarity=0.444 Sum_probs=23.5
Q ss_pred eEeeCCCCCCeEe------CCCCcEEEeccCCCC
Q 004979 555 IAHRNLQSSSIYL------TEDYAAKISDFSFWN 582 (721)
Q Consensus 555 IvHrDLKp~NILl------~~~~~~kL~DFGla~ 582 (721)
++|+|+.+.|||+ +++..++++||-++.
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 5799999999999 456789999997653
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=86.27 E-value=0.42 Score=33.35 Aligned_cols=29 Identities=31% Similarity=0.596 Sum_probs=16.1
Q ss_pred eeehHHHHHHHHHHHHHHH-HHhhhccccc
Q 004979 364 LVLAGIIGGLSLILISAIG-FFVCRSSKVV 392 (721)
Q Consensus 364 ~i~~~~~~~~~~~~~~~~~-~~~~r~~~~~ 392 (721)
.|++++++++++++++++. ++++|+|+.+
T Consensus 11 aIA~gVVgGv~~v~ii~~~~~~~~RRRr~~ 40 (44)
T 2l2t_A 11 LIAAGVIGGLFILVIVGLTFAVYVRRKSIK 40 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHTTCSS
T ss_pred eEEEeehHHHHHHHHHHHHHHHHhhhhhhh
Confidence 4677777766654444443 5555554443
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=81.63 E-value=0.91 Score=31.62 Aligned_cols=26 Identities=8% Similarity=0.333 Sum_probs=10.9
Q ss_pred eehHHHHHHHHHHHHHHHHHhhhccc
Q 004979 365 VLAGIIGGLSLILISAIGFFVCRSSK 390 (721)
Q Consensus 365 i~~~~~~~~~~~~~~~~~~~~~r~~~ 390 (721)
+++++++.+++++++++.+++.|||+
T Consensus 14 Ia~~vVGvll~vi~~l~~~~~~RRR~ 39 (44)
T 2jwa_A 14 IISAVVGILLVVVLGVVFGILIKRRQ 39 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHC
T ss_pred hHHHHHHHHHHHHHHHHHHhheehhh
Confidence 55555553333333333334444433
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 721 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 5e-50 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-45 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 6e-45 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-43 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 4e-43 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-42 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-42 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-42 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 6e-42 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-41 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-41 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-40 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-40 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-40 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 6e-40 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 9e-39 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-38 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 5e-38 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 9e-38 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-37 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 7e-37 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-36 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-36 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-36 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-35 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-35 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 7e-35 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 8e-35 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-34 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-34 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-34 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-33 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-33 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 9e-33 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-31 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-31 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-31 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 7e-31 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-30 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-30 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-29 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 5e-29 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 6e-29 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 6e-29 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 8e-29 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-28 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-28 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-27 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-27 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-27 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-26 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-26 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-26 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-26 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 4e-25 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 8e-25 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-22 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-21 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-20 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-19 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 6e-18 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-14 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-13 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-11 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-08 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-06 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 0.002 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 7e-10 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-06 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-06 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 0.001 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 0.004 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-04 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 0.003 | |
| d1z9ha1 | 161 | a.45.1.1 (A:213-373) Microsomal prostaglandin E sy | 2e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.001 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.001 | |
| d2ikka1 | 153 | d.190.1.2 (A:86-238) Hypothetical transcriptional | 0.001 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.004 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 5e-50
Identities = 67/285 (23%), Positives = 121/285 (42%), Gaps = 35/285 (12%)
Query: 428 FSNIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNH 487
IGS G+ GTVYKG V + + + + F+ ++ L K H
Sbjct: 12 VGQRIGS---GSFGTVYKGKWHGDVAVKM-----LNVTAPTPQQLQAFKNEVGVLRKTRH 63
Query: 488 KNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEH 547
N + +GY + +V ++ SL+ HLHI E + + IA A +++
Sbjct: 64 VNILLFMGYSTAPQLA---IVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDY 119
Query: 548 MHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSF------WNNTTAAKT-----GSAAMEL 596
+H I HR+L+S++I+L ED KI DF W+ + + A E+
Sbjct: 120 LHA--KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV 177
Query: 597 LET---SAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPT 653
+ + +S+VY+FG +L+E++TG++ YS N + + + P
Sbjct: 178 IRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQII-------FMVGRGYLSPD 230
Query: 654 LKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAMEP 698
L + N + + ++ C+ +RP I A ++ + P
Sbjct: 231 LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 275
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 4e-45
Identities = 62/280 (22%), Positives = 110/280 (39%), Gaps = 33/280 (11%)
Query: 426 EDFS--NIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLS 483
++ IG G G V G G ++AV + F + ++
Sbjct: 7 KELKLLQTIGK---GEFGDVMLGDYR-GNKVAVKCIK-------NDATAQAFLAEASVMT 55
Query: 484 KVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAY 543
++ H N V L+G E++ +V EY GSL ++L + L L+ ++ +
Sbjct: 56 QLRHSNLVQLLGVIVEEKGG-LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCE 114
Query: 544 CLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWN------NTTAAKTGSAAMELL 597
+E++ HR+L + ++ ++ED AK+SDF +T A E L
Sbjct: 115 AMEYLEG--NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEAL 172
Query: 598 ETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSF 657
+S+V+SFG +L+E+ + L++ KG +
Sbjct: 173 REKKFSTKSDVWSFGILLWEIYSFG-RVPYPRIPLKDVVPRVEKGYKM----------DA 221
Query: 658 QENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAME 697
+ + V+KNC H D RPS + +L+ I E
Sbjct: 222 PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 261
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 6e-45
Identities = 57/282 (20%), Positives = 113/282 (40%), Gaps = 38/282 (13%)
Query: 428 FSNIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNH 487
+G+ G G V+ G + ++AV K F + + + ++ H
Sbjct: 17 LVERLGA---GQFGEVWMGYYNGHTKVAV-----K-SLKQGSMSPDAFLAEANLMKQLQH 67
Query: 488 KNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEH 547
+ V L ++ + ++ EY NGSL + L L L +A +A +
Sbjct: 68 QRLVRLYAVVTQEPIY---IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 124
Query: 548 MHQLTPPIAHRNLQSSSIYLTEDYAAKISDF----------SFWNNTTAAKTGSAAMELL 597
+ + HR+L++++I +++ + KI+DF A E +
Sbjct: 125 IEE--RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI 182
Query: 598 ETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKS 656
++S+V+SFG +L E++T GRI Y + ++++
Sbjct: 183 NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT------------NPEVIQNLERGYRMV 230
Query: 657 FQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEI-TAME 697
+N EEL +++ C P+ RP+ + + L++ TA E
Sbjct: 231 RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATE 272
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 3e-43
Identities = 50/278 (17%), Positives = 106/278 (38%), Gaps = 35/278 (12%)
Query: 426 EDFS--NIIGSFSDGTVGTVYKGT-LSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTL 482
ED+ IG+ G+ G K S G + ++ + +++ L
Sbjct: 4 EDYEVLYTIGT---GSYGRCQKIRRKSDGKILVW---KELDYGSMTEAEKQMLVSEVNLL 57
Query: 483 SKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLH--IQEAEHLDWAMRLRIAMG 540
++ H N V + T +V EY G L + +E ++LD LR+
Sbjct: 58 RELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQ 117
Query: 541 MAYCLEHMHQL---TPPIAHRNLQSSSIYLTEDYAAKISDF----SFWNNTTAAKT---- 589
+ L+ H+ + HR+L+ ++++L K+ DF ++T+ AK
Sbjct: 118 LTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGT 177
Query: 590 -GSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKD 648
+ E + + + +S+++S G +L+E+ ++ + ++
Sbjct: 178 PYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS------------QKELAGK 225
Query: 649 IVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGI 686
I + + +EL +I ++ RPS+ I
Sbjct: 226 IREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEI 263
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 4e-43
Identities = 56/303 (18%), Positives = 114/303 (37%), Gaps = 51/303 (16%)
Query: 432 IGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFV 491
IG G G V++G G E+AV S + W +I + H+N +
Sbjct: 11 IGK---GRFGEVWRGKWR-GEEVAVKIFSSREERSW------FREAEIYQTVMLRHENIL 60
Query: 492 NLIGYCEEDEP--FTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMH 549
I +D +V +Y +GSLF++L+ + +++A+ A L H+H
Sbjct: 61 GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN---RYTVTVEGMIKLALSTASGLAHLH 117
Query: 550 QL------TPPIAHRNLQSSSIYLTEDYAAKISDFSFWN-------------NTTAAKTG 590
P IAHR+L+S +I + ++ I+D N
Sbjct: 118 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 177
Query: 591 SAAMELLETSA------VDLESNVYSFGTILFEMITGRISYSIENG--------SLENWA 636
A E+L+ S +++Y+ G + +E+ I + +
Sbjct: 178 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237
Query: 637 SEYLKGEQPLKDIVDPTLKSFQEN--VLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEIT 694
E ++ + + + P + + ++ L + +++ C + + R + I L +++
Sbjct: 238 VEEMR-KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296
Query: 695 AME 697
E
Sbjct: 297 QQE 299
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (391), Expect = 1e-42
Identities = 61/283 (21%), Positives = 112/283 (39%), Gaps = 39/283 (13%)
Query: 428 FSNIIGSFSDGTVGTVYKGTL----SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLS 483
F+ +IG G G VY GTL + AV SQF + +
Sbjct: 31 FNEVIGR---GHFGCVYHGTLLDNDGKKIHCAV----KSLNRITDIGEVSQFLTEGIIMK 83
Query: 484 KVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAY 543
+H N ++L+G C E + ++V Y +G L + E + + + +A
Sbjct: 84 DFSHPNVLSLLGICLRSE-GSPLVVLPYMKHGDLR-NFIRNETHNPTVKDLIGFGLQVAK 141
Query: 544 CLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTAAKTGSA----------- 592
++ + HR+L + + L E + K++DF + + S
Sbjct: 142 GMKFLAS--KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVK 199
Query: 593 --AMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIV 650
A+E L+T +S+V+SFG +L+E++T + + + L+G + L+
Sbjct: 200 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP-YPDVNTFDITVYLLQGRRLLQP-- 256
Query: 651 DPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEI 693
E + L V+ C HP + RPS + +++ I
Sbjct: 257 --------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 291
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (386), Expect = 1e-42
Identities = 62/288 (21%), Positives = 114/288 (39%), Gaps = 40/288 (13%)
Query: 416 LKRSELEAACEDFSNIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQF 475
+ SEL F IGS G G V+ G + ++A+ K E F
Sbjct: 2 IDPSELT-----FVQEIGS---GQFGLVHLGYWLNKDKVAI-----K-TIREGAMSEEDF 47
Query: 476 RKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRL 535
++ + + K++H V L G C E P +VFE+ +G L ++L Q L
Sbjct: 48 IEEAEVMMKLSHPKLVQLYGVCLEQAPI--CLVFEFMEHGCLSDYLRTQRGLF-AAETLL 104
Query: 536 RIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTAAKT------ 589
+ + + + ++ + + HR+L + + + E+ K+SDF +
Sbjct: 105 GMCLDVCEGMAYLEE--ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGT 162
Query: 590 ----GSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQP 645
A+ E+ S +S+V+SFG +++E+ + EN S + G +
Sbjct: 163 KFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIP-YENRSNSEVVEDISTGFRL 221
Query: 646 LKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEI 693
P L S + ++ +C P+ RP+ + +L EI
Sbjct: 222 ----YKPRLAS------THVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 2e-42
Identities = 48/278 (17%), Positives = 105/278 (37%), Gaps = 37/278 (13%)
Query: 427 DFSNIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVN 486
F +G+ G G V G ++A+ K E +F ++ + ++
Sbjct: 7 TFLKELGT---GQFGVVKYGKWRGQYDVAI-----K-MIKEGSMSEDEFIEEAKVMMNLS 57
Query: 487 HKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLE 546
H+ V L G C + P ++ EY NG L +L L + + +E
Sbjct: 58 HEKLVQLYGVCTKQRPI--FIITEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAME 114
Query: 547 HMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTAAKTGS----------AAMEL 596
++ HR+L + + + + K+SDF + S + E+
Sbjct: 115 YLES--KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEV 172
Query: 597 LETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPLKDIVDPTLK 655
L S +S++++FG +++E+ + G++ Y E + + I
Sbjct: 173 LMYSKFSSKSDIWAFGVLMWEIYSLGKMPY------------ERFTNSETAEHIAQGLRL 220
Query: 656 SFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEI 693
E++ ++ +C H +RP+ + + + + ++
Sbjct: 221 YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 152 bits (384), Expect = 6e-42
Identities = 55/290 (18%), Positives = 121/290 (41%), Gaps = 42/290 (14%)
Query: 416 LKRSELEAACEDFSNIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQ 474
++R+++ + +G G G VY+G + +AV K +
Sbjct: 14 MERTDIT-----MKHKLGG---GQYGEVYEGVWKKYSLTVAV-----K-TLKEDTMEVEE 59
Query: 475 FRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMR 534
F K+ + ++ H N V L+G C + PF + E+ G+L ++L + + +
Sbjct: 60 FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT--EFMTYGNLLDYLRECNRQEVSAVVL 117
Query: 535 LRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFW----NNTTAAKTG 590
L +A ++ +E++ + HR+L + + + E++ K++DF +T A G
Sbjct: 118 LYMATQISSAMEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG 175
Query: 591 SA------AMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQ 644
+ A E L + ++S+V++FG +L+E+ T +
Sbjct: 176 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYG------------MSPYPGIDLS 223
Query: 645 PLKDIVDPTLK-SFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEI 693
+ ++++ + E E++ +++ C +P RPS I + +
Sbjct: 224 QVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 2e-41
Identities = 62/270 (22%), Positives = 109/270 (40%), Gaps = 30/270 (11%)
Query: 428 FSNIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVN 486
F IG G+ TVYKG + VE+A +K+ +F+++ + L +
Sbjct: 13 FDIEIGR---GSFKTVYKGLDTETTVEVAW---CELQDRKLTKSERQRFKEEAEMLKGLQ 66
Query: 487 HKNFVNLIGYCEE--DEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYC 544
H N V E ++V E +G+L +L + + + +
Sbjct: 67 HPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK--RFKVMKIKVLRSWCRQILKG 124
Query: 545 LEHMHQLTPPIAHRNLQSSSIYLT-EDYAAKISDFSFWNNTTAAKTGS-------AAMEL 596
L+ +H TPPI HR+L+ +I++T + KI D A+ + A E+
Sbjct: 125 LQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEM 184
Query: 597 LETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKS 656
E D +VY+FG + EM T YS E + G +P S
Sbjct: 185 YEEK-YDESVDVYAFGMCMLEMATSEYPYS-ECQNAAQIYRRVTSGVKPA---------S 233
Query: 657 FQENVLEELLVVIKNCVHPDPKQRPSMRGI 686
F + + E+ +I+ C+ + +R S++ +
Sbjct: 234 FDKVAIPEVKEIIEGCIRQNKDERYSIKDL 263
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 150 bits (380), Expect = 2e-41
Identities = 62/321 (19%), Positives = 119/321 (37%), Gaps = 65/321 (20%)
Query: 414 PKLKRSELEAACEDFS--NIIGSFSDGTVGTVYKGTL------SSGVEIAVTSTSVKSRA 465
PKL LE + IG G G V++ +AV +
Sbjct: 3 PKLL--SLEYPRNNIEYVRDIGE---GAFGRVFQARAPGLLPYEPFTMVAVK----MLKE 53
Query: 466 DWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLH--- 522
+ S ++++ F+++ +++ ++ N V L+G C +P ++FEY G L E L
Sbjct: 54 EASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP--MCLLFEYMAYGDLNEFLRSMS 111
Query: 523 -------------------IQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSS 563
L A +L IA +A + ++ + HR+L +
Sbjct: 112 PHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE--RKFVHRDLATR 169
Query: 564 SIYLTEDYAAKISDFSFW-----------NNTTAAKTGSAAMELLETSAVDLESNVYSFG 612
+ + E+ KI+DF + A E + + ES+V+++G
Sbjct: 170 NCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYG 229
Query: 613 TILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNC 672
+L+E+ + + + E+ + + D + + EN EL +++ C
Sbjct: 230 VVLWEIFSYGLQPY-----------YGMAHEEVIYYVRDGNILACPENCPLELYNLMRLC 278
Query: 673 VHPDPKQRPSMRGIAAKLKEI 693
P RPS I L+ +
Sbjct: 279 WSKLPADRPSFCSIHRILQRM 299
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (373), Expect = 1e-40
Identities = 53/280 (18%), Positives = 107/280 (38%), Gaps = 41/280 (14%)
Query: 430 NIIGSFSDGTVGTVYKGTL---SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVN 486
+GS G GTV KG +AV + L+ + + + + +++
Sbjct: 13 KELGS---GNFGTVKKGYYQMKKVVKTVAV---KILKNEANDPALKDELLAEANVMQQLD 66
Query: 487 HKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLE 546
+ V +IG CE + + M+V E + G L ++L + H+ + + ++ ++
Sbjct: 67 NPYIVRMIGICEAE---SWMLVMEMAELGPLNKYLQ--QNRHVKDKNIIELVHQVSMGMK 121
Query: 547 HMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSF---------WNNTTAAKTGSA---AM 594
++ + HR+L + ++ L + AKISDF + A
Sbjct: 122 YLEE--SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAP 179
Query: 595 ELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPLKDIVDPT 653
E + +S+V+SFG +++E + G+ Y G + KGE+
Sbjct: 180 ECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--SEVTAMLEKGERM-------- 229
Query: 654 LKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEI 693
E+ ++ C D + RP + +L+
Sbjct: 230 --GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (373), Expect = 2e-40
Identities = 55/294 (18%), Positives = 114/294 (38%), Gaps = 32/294 (10%)
Query: 419 SELEAACEDFSNIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKS-RADWSKNLESQFRK 477
+E+ +C +IG+ G G VYKG L + ++K+ +A +++ F
Sbjct: 2 TEIHPSCVTRQKVIGA---GEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLG 58
Query: 478 KIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRI 537
+ + + +H N + L G + +P M++ EY NG+ + ++ + +
Sbjct: 59 EAGIMGQFSHHNIIRLEGVISKYKPM--MIITEYMENGA-LDKFLREKDGEFSVLQLVGM 115
Query: 538 AMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWN---------NTTAAK 588
G+A ++++ HR+L + +I + + K+SDF TT+
Sbjct: 116 LRGIAAGMKYLAN--MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGG 173
Query: 589 TGS---AAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQP 645
A E + S+V+SFG +++E++T E L +
Sbjct: 174 KIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE-----------LSNHEV 222
Query: 646 LKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAMEPD 699
+K I D + + ++ C + +RP I + L ++
Sbjct: 223 MKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDS 276
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 3e-40
Identities = 57/299 (19%), Positives = 110/299 (36%), Gaps = 38/299 (12%)
Query: 414 PKLKRSELEAACEDFS--NIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNL 471
L + E E +G G G V+ GT + +A+ K
Sbjct: 5 QGLAKDAWEIPRESLRLEVKLGQ---GCFGEVWMGTWNGTTRVAI-----K-TLKPGTMS 55
Query: 472 ESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDW 531
F ++ + K+ H+ V L E+ + +V EY GSL + L + ++L
Sbjct: 56 PEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIY---IVTEYMSKGSLLDFLKGETGKYLRL 112
Query: 532 AMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFW---------- 581
+ +A +A + ++ + HR+L++++I + E+ K++DF
Sbjct: 113 PQLVDMAAQIASGMAYVER--MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 170
Query: 582 NNTTAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLK 641
A E ++S+V+SFG +L E+ T +
Sbjct: 171 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP-----------YPGMV 219
Query: 642 GEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKE-ITAMEPD 699
+ L + E L ++ C +P++RP+ + A L++ T+ EP
Sbjct: 220 NREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 278
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 6e-40
Identities = 67/309 (21%), Positives = 124/309 (40%), Gaps = 53/309 (17%)
Query: 411 TGVPKLKRSELEAACEDFSNIIGSFSDGTVGTVYKGTLSSG---VEIAVTSTSVKSRADW 467
T P L ++++ F ++IG G G V K + ++ A+ + +
Sbjct: 2 TIYPVLDWNDIK-----FQDVIGE---GNFGQVLKARIKKDGLRMDAAI----KRMKEYA 49
Query: 468 SKNLESQFRKKIDTLSKV-NHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLH---- 522
SK+ F +++ L K+ +H N +NL+G CE + EY+P+G+L + L
Sbjct: 50 SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY--LYLAIEYAPHGNLLDFLRKSRV 107
Query: 523 ----------IQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYA 572
A L L A +A ++++ Q HR+L + +I + E+Y
Sbjct: 108 LETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ--KQFIHRDLAARNILVGENYV 165
Query: 573 AKISDFSF---WNNTTAAKTGS-----AAMELLETSAVDLESNVYSFGTILFEMITGRIS 624
AKI+DF G A+E L S S+V+S+G +L+E+++ +
Sbjct: 166 AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT 225
Query: 625 YSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMR 684
+ + +G + N +E+ +++ C P +RPS
Sbjct: 226 PY-CGMTCAELYEKLPQGYRL----------EKPLNCDDEVYDLMRQCWREKPYERPSFA 274
Query: 685 GIAAKLKEI 693
I L +
Sbjct: 275 QILVSLNRM 283
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (360), Expect = 9e-39
Identities = 45/278 (16%), Positives = 103/278 (37%), Gaps = 41/278 (14%)
Query: 432 IGSFSDGTVGTVYKGTL---SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHK 488
+G G G+V +G +++A+ + K + ++ + ++++
Sbjct: 17 LGC---GNFGSVRQGVYRMRKKQIDVAI----KVLKQGTEKADTEEMMREAQIMHQLDNP 69
Query: 489 NFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHM 548
V LIG C+ + +V E + G L + L + E + + + ++ ++++
Sbjct: 70 YIVRLIGVCQAEALM---LVMEMAGGGPLHKFLV-GKREEIPVSNVAELLHQVSMGMKYL 125
Query: 549 HQLTPPIAHRNLQSSSIYLTEDYAAKISDFSF---------WNNTTAAKTGSA---AMEL 596
+ HR+L + ++ L + AKISDF + +A A E
Sbjct: 126 EE--KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPEC 183
Query: 597 LETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPLKDIVDPTLK 655
+ S+V+S+G ++E ++ G+ Y G + + I
Sbjct: 184 INFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG------------PEVMAFIEQGKRM 231
Query: 656 SFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEI 693
EL ++ +C + RP + +++
Sbjct: 232 ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 1e-38
Identities = 53/271 (19%), Positives = 104/271 (38%), Gaps = 34/271 (12%)
Query: 426 EDFS--NIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTL 482
EDF +G G G VY S +A+ + +E Q R++++
Sbjct: 6 EDFEIGRPLGK---GKFGNVYLAREKQSKFILALKV--LFKAQLEKAGVEHQLRREVEIQ 60
Query: 483 SKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMA 542
S + H N + L GY + ++ EY+P G+++ L + D +A
Sbjct: 61 SHLRHPNILRLYGYFHDATRV--YLILEYAPLGTVYRELQ--KLSKFDEQRTATYITELA 116
Query: 543 YCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSF----WNNTTAAKTGS---AAME 595
L + H + HR+++ ++ L KI+DF + ++ G+ E
Sbjct: 117 NALSYCHSK--RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPE 174
Query: 596 LLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLK 655
++E D + +++S G + +E + G+ + E + + + E D V +
Sbjct: 175 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPF--EANTYQETYKRISRVEFTFPDFVTEGAR 232
Query: 656 SFQENVLEELLVVIKNCVHPDPKQRPSMRGI 686
I + +P QRP +R +
Sbjct: 233 DL-----------ISRLLKHNPSQRPMLREV 252
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 5e-38
Identities = 53/305 (17%), Positives = 111/305 (36%), Gaps = 53/305 (17%)
Query: 421 LEAACEDFS--NIIGSFSDGTVGTVYKGT-LSSGVEIAVTSTSVKSRADWSKNLESQFRK 477
+E +DF + +G+ G G V+K + SG+ +A + + +Q +
Sbjct: 1 MELKDDDFEKISELGA---GNGGVVFKVSHKPSGLVMARK----LIHLEIKPAIRNQIIR 53
Query: 478 KIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRI 537
++ L + N V G D + E+ GSL + L +A + + ++
Sbjct: 54 ELQVLHECNSPYIVGFYGAFYSDGEI--SICMEHMDGGSLDQVLK--KAGRIPEQILGKV 109
Query: 538 AMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDF----SFWNNTTAAKTGS-- 591
++ + L ++ + I HR+++ S+I + K+ DF ++ + G+
Sbjct: 110 SIAVIKGLTYLREK-HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS 168
Query: 592 -AAMELLETSAVDLESNVYSFGTILFEMITGRISYSIEN--------------------- 629
+ E L+ + ++S+++S G L EM GR +
Sbjct: 169 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPP 228
Query: 630 --GSLENWASEYLKGEQPLKDIVD--------PTLKSFQENVLEELLVVIKNCVHPDPKQ 679
+ S Y +P I + P K E + C+ +P +
Sbjct: 229 RPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAE 288
Query: 680 RPSMR 684
R ++
Sbjct: 289 RADLK 293
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 140 bits (354), Expect = 9e-38
Identities = 51/290 (17%), Positives = 107/290 (36%), Gaps = 35/290 (12%)
Query: 419 SELEAACEDFSNIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKK 478
E++ +C +IG+ G G V G L + + ++ +++ F +
Sbjct: 21 KEIDISCVKIEQVIGA---GEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSE 77
Query: 479 IDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIA 538
+ + +H N ++L G + P M++ E+ NGSL Q + +
Sbjct: 78 ASIMGQFDHPNVIHLEGVVTKSTPV--MIITEFMENGSLD-SFLRQNDGQFTVIQLVGML 134
Query: 539 MGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFW--------NNTTAAKTG 590
G+A ++++ HR+L + +I + + K+SDF + T + G
Sbjct: 135 RGIAAGMKYLAD--MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALG 192
Query: 591 SA------AMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGE 643
A E ++ S+V+S+G +++E+++ G Y +
Sbjct: 193 GKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN------------Q 240
Query: 644 QPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEI 693
+ I + L ++ +C D RP I L ++
Sbjct: 241 DVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 3e-37
Identities = 51/281 (18%), Positives = 103/281 (36%), Gaps = 38/281 (13%)
Query: 427 DFSNIIGSFSDGTVGTVYKGTLSS----GVEIAVTSTSVKSRADWSKNLESQFRKKIDTL 482
+ IG G G V++G S + +A+ + S ++ +F ++ T+
Sbjct: 10 ELGRCIGE---GQFGDVHQGIYMSPENPALAVAI----KTCKNCTSDSVREKFLQEALTM 62
Query: 483 SKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMA 542
+ +H + V LIG E+ + ++ E G L LD A + A ++
Sbjct: 63 RQFDHPHIVKLIGVITENPVW---IIMELCTLGELRSF-LQVRKYSLDLASLILYAYQLS 118
Query: 543 YCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFW---NNTTAAKTGSA------- 592
L ++ HR++ + ++ ++ + K+ DF ++T K
Sbjct: 119 TALAYLES--KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM 176
Query: 593 AMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDP 652
A E + S+V+ FG ++E++ + + + GE+
Sbjct: 177 APESINFRRFTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGRIENGERL------- 228
Query: 653 TLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEI 693
N L ++ C DP +RP + A+L I
Sbjct: 229 ---PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 7e-37
Identities = 59/279 (21%), Positives = 102/279 (36%), Gaps = 39/279 (13%)
Query: 432 IGSFSDGTVGTVYKGTL--SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKN 489
+G G+ G V +G SG ++V +K F ++++ + ++H+N
Sbjct: 16 LGD---GSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 72
Query: 490 FVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMH 549
+ L G MV E +P GSL + + H R A+ +A + ++
Sbjct: 73 LIRLYGVVLTPPMK---MVTELAPLGSLLDR-LRKHQGHFLLGTLSRYAVQVAEGMGYLE 128
Query: 550 QLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTAAKTGS------------AAMELL 597
HR+L + ++ L KI DF A E L
Sbjct: 129 S--KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 186
Query: 598 ETSAVDLESNVYSFGTILFEMIT-GRISYSIENGS--LENWASEYLKGEQPLKDIVDPTL 654
+T S+ + FG L+EM T G+ + NGS L E + +P
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRP--------- 237
Query: 655 KSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEI 693
E+ +++ V+ C P+ RP+ + L E
Sbjct: 238 ----EDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 1e-36
Identities = 60/308 (19%), Positives = 115/308 (37%), Gaps = 54/308 (17%)
Query: 416 LKRSELEAACEDFSNIIGSFSDGTVGTVYKGTL------SSGVEIAVTSTSVKSRADWSK 469
+ R ++ S +G G+ G VY+G +A+ S
Sbjct: 17 VAREKIT-----MSRELGQ---GSFGMVYEGVAKGVVKDEPETRVAIK----TVNEAASM 64
Query: 470 NLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQ----- 524
+F + + + N + V L+G + +P +++ E G L +L
Sbjct: 65 RERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP--TLVIMELMTRGDLKSYLRSLRPAMA 122
Query: 525 ---EAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFW 581
+ +++A +A + +++ HR+L + + + ED+ KI DF
Sbjct: 123 NNPVLAPPSLSKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMT 180
Query: 582 NNTTAAKT-----------GSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENG 630
+ + E L+ S+V+SFG +L+E+ T
Sbjct: 181 RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA-------- 232
Query: 631 SLENWASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKL 690
+ L EQ L+ +++ L +N + L +++ C +PK RPS I + +
Sbjct: 233 ---EQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 289
Query: 691 KEITAMEP 698
KE MEP
Sbjct: 290 KEE--MEP 295
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 1e-36
Identities = 55/276 (19%), Positives = 95/276 (34%), Gaps = 35/276 (12%)
Query: 426 EDFSNIIGSFSDGTVGTVYKGT-LSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSK 484
EDF IIG DG G VYK + V A KS + + +ID L+
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELE-----DYMVEIDILAS 65
Query: 485 VNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYC 544
+H N V L+ + ++ E+ G++ + E L + +
Sbjct: 66 CDHPNIVKLLDAFYYENNL--WILIEFCAGGAVDAVMLELE-RPLTESQIQVVCKQTLDA 122
Query: 545 LEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSF---------WNNTTAAKTGSAAME 595
L ++H I HR+L++ +I T D K++DF ++ A E
Sbjct: 123 LNYLHDN--KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPE 180
Query: 596 LL-----ETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIV 650
++ + D +++V+S G L EM + N + K E P
Sbjct: 181 VVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELN--PMRVLLKIAKSEPPTLA-- 236
Query: 651 DPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGI 686
+K C+ + R + +
Sbjct: 237 ------QPSRWSSNFKDFLKKCLEKNVDARWTTSQL 266
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 2e-36
Identities = 63/312 (20%), Positives = 112/312 (35%), Gaps = 60/312 (19%)
Query: 416 LKRSELEAACEDFSNIIGSFSDGTVGTVYKGTL------SSGVEIAVTSTSVKSRADWSK 469
R+ L F +G+ G G V + T + + +AV +
Sbjct: 20 FPRNRLS-----FGKTLGA---GAFGKVVEATAYGLIKSDAAMTVAVK----MLKPSAHL 67
Query: 470 NLESQFRKKIDTLSKV-NHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLH------ 522
++ LS + NH N VNL+G C P +++ EY G L L
Sbjct: 68 TEREALMSELKVLSYLGNHMNIVNLLGACTIGGP--TLVITEYCCYGDLLNFLRRKRDSF 125
Query: 523 ----------IQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYA 572
+ LD L + +A + + HR+L + +I LT
Sbjct: 126 ICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS--KNCIHRDLAARNILLTHGRI 183
Query: 573 AKISDF----SFWNNTTAAKTGSA-------AMELLETSAVDLESNVYSFGTILFEMITG 621
KI DF N++ G+A A E + ES+V+S+G L+E+ +
Sbjct: 184 TKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSL 243
Query: 622 RISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRP 681
S +++ + +K + E+ E+ ++K C DP +RP
Sbjct: 244 GSSPY-PGMPVDSKFYKMIKEGFRML---------SPEHAPAEMYDIMKTCWDADPLKRP 293
Query: 682 SMRGIAAKLKEI 693
+ + I +++
Sbjct: 294 TFKQIVQLIEKQ 305
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 133 bits (337), Expect = 2e-35
Identities = 48/272 (17%), Positives = 95/272 (34%), Gaps = 33/272 (12%)
Query: 426 EDFSNI--IGSFSDGTVGTVYKGT-LSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTL 482
+ FS++ IG G+ G VY + + +A+ S + K++ L
Sbjct: 15 KLFSDLREIGH---GSFGAVYFARDVRNSEVVAIKKMSYSGKQS--NEKWQDIIKEVRFL 69
Query: 483 SKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMA 542
K+ H N + G + +V EY + L + L + G
Sbjct: 70 QKLRHPNTIQYRGCYLREHTA--WLVMEYCLGSASD--LLEVHKKPLQEVEIAAVTHGAL 125
Query: 543 YCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTAAKT-----GSAAMELL 597
L ++H + HR++++ +I L+E K+ DF + A + A E++
Sbjct: 126 QGLAYLHSH--NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGTPYWMAPEVI 183
Query: 598 ETS---AVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTL 654
D + +V+S G E+ + N + + + E P
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPL--FNMNAMSALYHIAQNESPALQ------ 235
Query: 655 KSFQENVLEELLVVIKNCVHPDPKQRPSMRGI 686
+ E + +C+ P+ RP+ +
Sbjct: 236 ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVL 264
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 3e-35
Identities = 65/311 (20%), Positives = 117/311 (37%), Gaps = 53/311 (17%)
Query: 416 LKRSELEAACEDFSNIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSV----KSRADWSKNL 471
L R L +G G G V + + ++D ++
Sbjct: 10 LPRDRLV-----LGKPLGE---GAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD 61
Query: 472 ESQFRKKIDTLSKV-NHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQ------ 524
S +++ + + HKN +NL+G C +D P ++ EY+ G+L E+L +
Sbjct: 62 LSDLISEMEMMKMIGKHKNIINLLGACTQDGPL--YVIVEYASKGNLREYLQARRPPGLE 119
Query: 525 --------EAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKIS 576
E L + A +A +E++ HR+L + ++ +TED KI+
Sbjct: 120 YSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS--KKCIHRDLAARNVLVTEDNVMKIA 177
Query: 577 DFSFWNNTTAAKT-----------GSAAMELLETSAVDLESNVYSFGTILFEMITGRISY 625
DF + A E L +S+V+SFG +L+E+ T S
Sbjct: 178 DFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 237
Query: 626 SIENGSLENWASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRG 685
+ E+ K + + N EL +++++C H P QRP+ +
Sbjct: 238 Y-----------PGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQ 286
Query: 686 IAAKLKEITAM 696
+ L I A+
Sbjct: 287 LVEDLDRIVAL 297
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (334), Expect = 7e-35
Identities = 48/282 (17%), Positives = 108/282 (38%), Gaps = 34/282 (12%)
Query: 426 EDFS--NIIGSFSDGTVGTVYKGT-LSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTL 482
+F ++GS G GTVYKG + G ++ + + R S + + +
Sbjct: 9 TEFKKIKVLGS---GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 65
Query: 483 SKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMA 542
+ V++ + L+G C ++ + P G L ++ + +++ L + +A
Sbjct: 66 ASVDNPHVCRLLGICLTSTVQ---LITQLMPFGCLLDY-VREHKDNIGSQYLLNWCVQIA 121
Query: 543 YCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSF-----WNNTTAAKTGSA----- 592
+ ++ + HR+L + ++ + KI+DF G
Sbjct: 122 KGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 179
Query: 593 -AMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVD 651
A+E + +S+V+S+G ++E++T S + +S KGE+ +
Sbjct: 180 MALESILHRIYTHQSDVWSYGVTVWELMTFG-SKPYDGIPASEISSILEKGERLPQP--- 235
Query: 652 PTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEI 693
++ +++ C D RP R + + ++
Sbjct: 236 -------PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 8e-35
Identities = 60/303 (19%), Positives = 114/303 (37%), Gaps = 45/303 (14%)
Query: 426 EDFS--NIIGSFSDGTVGTVYKGT-LSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTL 482
EDF I+G G+ TV L++ E A+ ++ R +N ++ D +
Sbjct: 8 EDFKFGKILGE---GSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVM 62
Query: 483 SKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMA 542
S+++H FV L ++DE Y+ NG L +++ + D +
Sbjct: 63 SRLDHPFFVKLYFTFQDDEKL--YFGLSYAKNGELLKYIR--KIGSFDETCTRFYTAEIV 118
Query: 543 YCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWN-----------NTTAAKTGS 591
LE++H I HR+L+ +I L ED +I+DF N+
Sbjct: 119 SALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQY 176
Query: 592 AAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVD 651
+ ELL + S++++ G I+++++ G + G+ + +K E +
Sbjct: 177 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF--RAGNEYLIFQKIIKLEYDFPEKFF 234
Query: 652 PTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAMEPDGATPKLSPLWWA 711
P + ++ + D +R +E+ P A P + W
Sbjct: 235 PKARDL-----------VEKLLVLDATKRLGC-------EEMEGYGPLKAHPFFESVTWE 276
Query: 712 ELE 714
L
Sbjct: 277 NLH 279
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 2e-34
Identities = 53/276 (19%), Positives = 99/276 (35%), Gaps = 38/276 (13%)
Query: 426 EDFS--NIIGSFSDGTVGTVYKGT-LSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTL 482
ED+ +G G G V + +AV +K D + +K+I
Sbjct: 5 EDWDLVQTLGE---GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE----NIKKEICIN 57
Query: 483 SKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMA 542
+NH+N V G+ E + EY G LF+ + + R +
Sbjct: 58 KMLNHENVVKFYGHRREGNIQ--YLFLEYCSGGELFDRIE--PDIGMPEPDAQRFFHQLM 113
Query: 543 YCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSF-----WNNTTAAKTGSA----- 592
+ ++H + I HR+++ ++ L E KISDF +NN
Sbjct: 114 AGVVYLHGI--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 171
Query: 593 -AMELLETSAVD-LESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIV 650
A ELL+ +V+S G +L M+ G + + + S + ++
Sbjct: 172 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS----------DWKE 221
Query: 651 DPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGI 686
T + + + L ++ + +P R ++ I
Sbjct: 222 KKTYLNPWKKIDSAPLALLHKILVENPSARITIPDI 257
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 3e-34
Identities = 55/265 (20%), Positives = 106/265 (40%), Gaps = 35/265 (13%)
Query: 432 IGSFSDGTVGTVYKGT-LSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNF 490
IG G GTVY +++G E+A+ +++ + + +I + + + N
Sbjct: 28 IGQ---GASGTVYTAMDVATGQEVAIRQMNLQQQPK-----KELIINEILVMRENKNPNI 79
Query: 491 VNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQ 550
VN + + +V EY GSL + + +D + LE +H
Sbjct: 80 VNYLDSYLVGDEL--WVVMEYLAGGSLTDVVT---ETCMDEGQIAAVCRECLQALEFLHS 134
Query: 551 LTPPIAHRNLQSSSIYLTEDYAAKISDFSF------WNNTTAAKTGS---AAMELLETSA 601
+ HR+++S +I L D + K++DF F + + G+ A E++ A
Sbjct: 135 N--QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA 192
Query: 602 VDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQENV 661
+ +++S G + EMI G Y EN + YL ++ +P E +
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGEPPYLNEN----PLRALYLIATNGTPELQNP------EKL 242
Query: 662 LEELLVVIKNCVHPDPKQRPSMRGI 686
+ C+ D ++R S + +
Sbjct: 243 SAIFRDFLNRCLDMDVEKRGSAKEL 267
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 3e-34
Identities = 56/306 (18%), Positives = 109/306 (35%), Gaps = 64/306 (20%)
Query: 427 DFSNIIGSFSDGTVGTVYKGTL------SSGVEIAVTSTSVKSRADWSKNLESQFRKKID 480
+F ++GS G G V T +++AV + + ++
Sbjct: 40 EFGKVLGS---GAFGKVMNATAYGISKTGVSIQVAV----KMLKEKADSSEREALMSELK 92
Query: 481 TLSKV-NHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLH----------------- 522
++++ +H+N VNL+G C P ++FEY G L +L
Sbjct: 93 MMTQLGSHENIVNLLGACTLSGPI--YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQK 150
Query: 523 ----IQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDF 578
++ L + L A +A +E + HR+L + ++ +T KI DF
Sbjct: 151 RLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF--KSCVHRDLAARNVLVTHGKVVKICDF 208
Query: 579 SFW-----------NNTTAAKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYS 626
A E L ++S+V+S+G +L+E+ + G Y
Sbjct: 209 GLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 268
Query: 627 IENGSLENWASEYLKGEQPLKDIVDPTLK-SFQENVLEELLVVIKNCVHPDPKQRPSMRG 685
+ ++ K EE+ +++++C D ++RPS
Sbjct: 269 GIPV------------DANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPN 316
Query: 686 IAAKLK 691
+ + L
Sbjct: 317 LTSFLG 322
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 128 bits (322), Expect = 1e-33
Identities = 60/285 (21%), Positives = 105/285 (36%), Gaps = 44/285 (15%)
Query: 426 EDFS--NIIGSFSDGTVGTVYKGT-LSSGVEIAV----TSTSVKSRADWSKNLESQFRKK 478
E++ I+G G V + + E AV + A+ + L K+
Sbjct: 3 ENYEPKEILGR---GVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKE 59
Query: 479 IDTLSKVN-HKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRI 537
+D L KV+ H N + L E + F +VF+ G LF++L E L +I
Sbjct: 60 VDILRKVSGHPNIIQLKDTYETNTFF--FLVFDLMKKGELFDYLT--EKVTLSEKETRKI 115
Query: 538 AMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFW--------NNTTAAKT 589
+ + +H+L I HR+L+ +I L +D K++DF F
Sbjct: 116 MRALLEVICALHKL--NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTP 173
Query: 590 GSAAMELLETSAVDL------ESNVYSFGTILFEMITGRISYSIENGS--LENWASEYLK 641
A E++E S D E +++S G I++ ++ G + L S +
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQ 233
Query: 642 GEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGI 686
P D T+K + + P++R +
Sbjct: 234 FGSPEWDDYSDTVKDL-----------VSRFLVVQPQKRYTAEEA 267
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 129 bits (326), Expect = 2e-33
Identities = 58/273 (21%), Positives = 100/273 (36%), Gaps = 37/273 (13%)
Query: 427 DFSNIIGSFSDGTVGTVYKGT-LSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKV 485
D +G+ G G V++ T ++G A +D + RK+I T+S +
Sbjct: 29 DIHEELGT---GAFGVVHRVTERATGNNFAAKFVMTPHESD-----KETVRKEIQTMSVL 80
Query: 486 NHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCL 545
H VNL E+D +M++E+ G LFE + E + + + L
Sbjct: 81 RHPTLVNLHDAFEDDNEM--VMIYEFMSGGELFEKVA-DEHNKMSEDEAVEYMRQVCKGL 137
Query: 546 EHMHQLTPPIAHRNLQSSSIYLT--EDYAAKISDFSF--------WNNTTAAKTGSAAME 595
HMH+ H +L+ +I T K+ DF T AA E
Sbjct: 138 CHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPE 195
Query: 596 LLETSAVDLESNVYSFGTILFEMITGRISYSIENGS--LENWASEYLKGEQPLKDIVDPT 653
+ E V ++++S G + + +++G + EN L N S + +
Sbjct: 196 VAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISED 255
Query: 654 LKSFQENVLEELLVVIKNCVHPDPKQRPSMRGI 686
K F I+ + DP R ++
Sbjct: 256 GKDF-----------IRKLLLADPNTRMTIHQA 277
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 127 bits (321), Expect = 9e-33
Identities = 48/268 (17%), Positives = 108/268 (40%), Gaps = 37/268 (13%)
Query: 432 IGSFSDGTVGTVYKGT-LSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNF 490
+GS G G V++ ++G + D + + +I +++++H
Sbjct: 37 LGS---GAFGVVHRCVEKATGRVFVAKFINTPYPLD-----KYTVKNEISIMNQLHHPKL 88
Query: 491 VNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQ 550
+NL E+ +++ E+ G LF+ + E + A + L+HMH+
Sbjct: 89 INLHDAFEDKYEM--VLILEFLSGGELFDRIA-AEDYKMSEAEVINYMRQACEGLKHMHE 145
Query: 551 LTPPIAHRNLQSSSIYL--TEDYAAKISDFSF-----WNNTTAAKTGSA---AMELLETS 600
I H +++ +I + + KI DF + T +A A E+++
Sbjct: 146 H--SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDRE 203
Query: 601 AVDLESNVYSFGTILFEMITGRISYSIENGS--LENWASEYLKGEQPLKDIVDPTLKSFQ 658
V +++++ G + + +++G ++ E+ L+N + ++ V P K F
Sbjct: 204 PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDF- 262
Query: 659 ENVLEELLVVIKNCVHPDPKQRPSMRGI 686
IKN + +P++R ++
Sbjct: 263 ----------IKNLLQKEPRKRLTVHDA 280
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (311), Expect = 1e-31
Identities = 44/268 (16%), Positives = 92/268 (34%), Gaps = 38/268 (14%)
Query: 432 IGSFSDGTVGTVYKGT-LSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNF 490
+G G G V++ SS VK + +K+I L+ H+N
Sbjct: 13 LGR---GEFGIVHRCVETSSKKTYMAKFVKVKGTD------QVLVKKEISILNIARHRNI 63
Query: 491 VNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQ 550
++L E E +M+FE+ +FE ++ A L+ + + L+ +H
Sbjct: 64 LHLHESFESMEEL--VMIFEFISGLDIFERIN-TSAFELNEREIVSYVHQVCEALQFLHS 120
Query: 551 LTPPIAHRNLQSSSIYLT--EDYAAKISDFSF--------WNNTTAAKTGSAAMELLETS 600
I H +++ +I KI +F A E+ +
Sbjct: 121 H--NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHD 178
Query: 601 AVDLESNVYSFGTILFEMITGRISYSIENGS--LENWASEYLKGEQPLKDIVDPTLKSFQ 658
V ++++S GT+++ +++G + E +EN + ++ + F
Sbjct: 179 VVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDF- 237
Query: 659 ENVLEELLVVIKNCVHPDPKQRPSMRGI 686
+ + + K R +
Sbjct: 238 ----------VDRLLVKERKSRMTASEA 255
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 122 bits (306), Expect = 1e-31
Identities = 50/279 (17%), Positives = 104/279 (37%), Gaps = 34/279 (12%)
Query: 431 IIGSFSDGTVGTVYKGT-LSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKN 489
I+G G + V+ L ++AV +++ + +FR++ + +NH
Sbjct: 14 ILGF---GGMSEVHLARDLRLHRDVAVKV--LRADLARDPSFYLRFRREAQNAAALNHPA 68
Query: 490 FVNLIGYCEEDEPFTR--MMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEH 547
V + E + P +V EY +L + +H + + + L
Sbjct: 69 IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH--TEGPMTPKRAIEVIADACQALNF 126
Query: 548 MHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWN------------NTTAAKTGSAAME 595
HQ I HR+++ ++I ++ A K+ DF + E
Sbjct: 127 SHQ--NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 184
Query: 596 LLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLK 655
+VD S+VYS G +L+E++TG + S + A ++++ +
Sbjct: 185 QARGDSVDARSDVYSLGCVLYEVLTGEPPF--TGDSPVSVAYQHVREDPIPPSARHE--- 239
Query: 656 SFQENVLEELLVVIKNCVHPDPKQRP-SMRGIAAKLKEI 693
+ +L V+ + +P+ R + + A L +
Sbjct: 240 ----GLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 122 bits (307), Expect = 3e-31
Identities = 48/272 (17%), Positives = 95/272 (34%), Gaps = 34/272 (12%)
Query: 427 DFSNIIGSFSDGTVGTVYKGT-LSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKV 485
DF +++G+ G V + +A+ + E +I L K+
Sbjct: 12 DFRDVLGT---GAFSEVILAEDKRTQKLVAIK----CIAKKALEGKEGSMENEIAVLHKI 64
Query: 486 NHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCL 545
H N V L E ++ + G LF+ + E R+ + +
Sbjct: 65 KHPNIVALDDIYESGGHL--YLIMQLVSGGELFDRIV--EKGFYTERDASRLIFQVLDAV 120
Query: 546 EHMHQLTPPIAHRNLQSSSIYLT---EDYAAKISDFSFW-----NNTTAAKTGS---AAM 594
+++H I HR+L+ ++ ED ISDF + + G+ A
Sbjct: 121 KYLHD--LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAP 178
Query: 595 ELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTL 654
E+L + +S G I + ++ G + EN + LK E
Sbjct: 179 EVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEN--DAKLFEQILKAEYEFD------- 229
Query: 655 KSFQENVLEELLVVIKNCVHPDPKQRPSMRGI 686
+ +++ + I++ + DP++R +
Sbjct: 230 SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQA 261
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 121 bits (304), Expect = 7e-31
Identities = 51/273 (18%), Positives = 95/273 (34%), Gaps = 33/273 (12%)
Query: 426 EDFS--NIIGSFSDGTVGTVYKGT-LSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTL 482
+DF +G+ G+ G V+ +G A+ +K + L
Sbjct: 4 QDFQILRTLGT---GSFGRVHLIRSRHNGRYYAMKV--LKKEIVVRLKQVEHTNDERLML 58
Query: 483 SKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMA 542
S V H + + G ++ + M+ +Y G LF L + + A +
Sbjct: 59 SIVTHPFIIRMWGTFQDAQQI--FMIMDYIEGGELFSLLRKS--QRFPNPVAKFYAAEVC 114
Query: 543 YCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFW------NNTTAAKTGSAAMEL 596
LE++H I +R+L+ +I L ++ KI+DF F T A E+
Sbjct: 115 LALEYLHS--KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPDYIAPEV 172
Query: 597 LETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKS 656
+ T + + +SFG +++EM+ G + N + L E + +K
Sbjct: 173 VSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN--TMKTYEKILNAELRFPPFFNEDVKD 230
Query: 657 FQENVLEELLVVIKNCVHPDPKQRPSMRGIAAK 689
+ + D QR +
Sbjct: 231 L-----------LSRLITRDLSQRLGNLQNGTE 252
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 1e-30
Identities = 52/309 (16%), Positives = 103/309 (33%), Gaps = 55/309 (17%)
Query: 416 LKRSELEAACEDFSNIIGSFSDGTVGTVYKGT------LSSGVEIAVTSTSVKSRADWSK 469
R L+ +G G G V + ++ +AV + +
Sbjct: 10 FPRDRLK-----LGKPLGR---GAFGQVIEADAFGIDKTATCRTVAVK----MLKEGATH 57
Query: 470 NLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAE-- 527
+ ++ L + H V + M++ E+ G+L +L + E
Sbjct: 58 SEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFV 117
Query: 528 ------------HLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKI 575
L + + +A +E + HR+L + +I L+E KI
Sbjct: 118 PYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS--RKCIHRDLAARNILLSEKNVVKI 175
Query: 576 SDFSF----WNNTTAAKTGSA-------AMELLETSAVDLESNVYSFGTILFEMITGRIS 624
DF + + + G A A E + ++S+V+SFG +L+E+ + S
Sbjct: 176 CDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS 235
Query: 625 YSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMR 684
E + +G + + E+ + +C H +P QRP+
Sbjct: 236 PYPGVKIDEEFCRRLKEGTRM----------RAPDYTTPEMYQTMLDCWHGEPSQRPTFS 285
Query: 685 GIAAKLKEI 693
+ L +
Sbjct: 286 ELVEHLGNL 294
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 120 bits (303), Expect = 2e-30
Identities = 55/277 (19%), Positives = 91/277 (32%), Gaps = 33/277 (11%)
Query: 426 EDFS--NIIGSFSDGTVGTVYKGT-LSSGVEIAVTSTSVKS-RADWSKNLESQFRKKIDT 481
DFS IIG G G VY +G A+ K + + L R +
Sbjct: 4 NDFSVHRIIGR---GGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSL 60
Query: 482 LSKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGM 541
+S + V + + + + G L HL A +
Sbjct: 61 VSTGDCPFIVCMSYAFHTPDKL--SFILDLMNGGDLHYHLSQHGVFSEADMR--FYAAEI 116
Query: 542 AYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTAAKTG--------SAA 593
LEHMH + +R+L+ ++I L E +ISD + + K A
Sbjct: 117 ILGLEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAP 174
Query: 594 MELLETSAVDLESNVYSFGTILFEMITGRISYSIENGS-LENWASEYLKGEQPLKDIVDP 652
L + A D ++ +S G +LF+++ G + L L D P
Sbjct: 175 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSP 234
Query: 653 TLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAK 689
L+S ++ + D +R G A+
Sbjct: 235 ELRSL-----------LEGLLQRDVNRRLGCLGRGAQ 260
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 1e-29
Identities = 46/281 (16%), Positives = 99/281 (35%), Gaps = 35/281 (12%)
Query: 430 NIIGSFSDGTVGTVYKGT-LSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHK 488
+ +G G TVYK ++ +A+ + R++ + ++I L +++H
Sbjct: 4 DFLGE---GQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60
Query: 489 NFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHM 548
N + L+ +VF++ + + L + + LE++
Sbjct: 61 NIIGLLDAFGHKSNI--SLVFDFMETDLEV--IIKDNSLVLTPSHIKAYMLMTLQGLEYL 116
Query: 549 HQLTPPIAHRNLQSSSIYLTEDYAAKISDFSF----------WNNTTAAKTGSAAMELLE 598
HQ I HR+L+ +++ L E+ K++DF + + + A L
Sbjct: 117 HQ--HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFG 174
Query: 599 TSAVDLESNVYSFGTILFEMITGR--------------ISYSIENGSLENWASEY-LKGE 643
+ ++++ G IL E++ I ++ + E W L
Sbjct: 175 ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY 234
Query: 644 QPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMR 684
K L ++LL +I+ +P R +
Sbjct: 235 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITAT 275
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (290), Expect = 5e-29
Identities = 53/272 (19%), Positives = 95/272 (34%), Gaps = 35/272 (12%)
Query: 426 EDFS--NIIGSFSDGTVGTVYKGT-LSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTL 482
EDF ++G G+ G V+ + A+ + K ++E +K
Sbjct: 2 EDFILHKMLGK---GSFGKVFLAEFKKTNQFFAIKALK-KDVVLMDDDVECTMVEKRVLS 57
Query: 483 SKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMA 542
H ++ + E +M EY G L H IQ D + A +
Sbjct: 58 LAWEHPFLTHMFCTFQTKENLFFVM--EYLNGGDLMYH--IQSCHKFDLSRATFYAAEII 113
Query: 543 YCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFW---------NNTTAAKTGSAA 593
L+ +H I +R+L+ +I L +D KI+DF NT A
Sbjct: 114 LGLQFLHS--KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIA 171
Query: 594 MELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPT 653
E+L + + +SFG +L+EM+ G+ + ++ E ++
Sbjct: 172 PEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD--EEELFHSIRMDNPFYPRWLEKE 229
Query: 654 LKSFQENVLEELLVVIKNCVHPDPKQRPSMRG 685
K + +P++R +RG
Sbjct: 230 AKDL-----------LVKLFVREPEKRLGVRG 250
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 114 bits (287), Expect = 6e-29
Identities = 50/283 (17%), Positives = 98/283 (34%), Gaps = 38/283 (13%)
Query: 430 NIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKN 489
IG GT G VYK + G A+ ++ + + S ++I L ++ H N
Sbjct: 8 EKIGE---GTYGVVYKAQNNYGETFALKKIRLEKE---DEGIPSTTIREISILKELKHSN 61
Query: 490 FVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMH 549
V L ++VFE+ L L+ + + + + H
Sbjct: 62 IVKLYDVIHTK--KRLVLVFEHLDQDLK--KLLDVCEGGLESVTAKSFLLQLLNGIAYCH 117
Query: 550 QLTPPIAHRNLQSSSIYLTEDYAAKISDFSF----------WNNTTAAKTGSAAMELLET 599
+ HR+L+ ++ + + KI+DF + + A L+ +
Sbjct: 118 D--RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGS 175
Query: 600 SAVDLESNVYSFGTILFEMITGR--------------ISYSIENGSLENWA--SEYLKGE 643
+++S G I EM+ G I + + +NW +E K +
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235
Query: 644 QPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGI 686
+SF + + E + ++ + DP QR + +
Sbjct: 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 115 bits (288), Expect = 6e-29
Identities = 43/282 (15%), Positives = 90/282 (31%), Gaps = 40/282 (14%)
Query: 432 IGSFSDGTVGTVYKGT-LSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNF 490
IGS G+ G +Y GT +++G E+A+ VK++ Q + +
Sbjct: 15 IGS---GSFGDIYLGTDIAAGEEVAIKLECVKTKHP-------QLHIESKIYKMMQGGVG 64
Query: 491 VNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQ 550
+ I +C + + +MV E L + L +A M +E++H
Sbjct: 65 IPTIRWCGAEGDY-NVMVMELLGPSLED--LFNFCSRKFSLKTVLLLADQMISRIEYIHS 121
Query: 551 LTPPIAHRNLQSSSIYLTE---DYAAKISDFSFWNNTTAAKTGS---------------- 591
HR+++ + + I DF A+T
Sbjct: 122 KN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 179
Query: 592 AAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVD 651
A++ ++ S G +L G + + A++ K E+ + +
Sbjct: 180 ASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLK-----AATKRQKYERISEKKMS 234
Query: 652 PTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEI 693
++ + E + C +P + + +
Sbjct: 235 TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (289), Expect = 8e-29
Identities = 46/275 (16%), Positives = 106/275 (38%), Gaps = 43/275 (15%)
Query: 431 IIGSFSDGTVGTVYKGT-LSSGVEIAVTSTSVKSRADWSKNLE--SQFRKKIDTLSKV-N 486
++G G G V + + + A+ K L+ + R++++ +
Sbjct: 19 VLGL---GINGKVLQIFNKRTQEKFAL------------KMLQDCPKARREVELHWRASQ 63
Query: 487 HKNFVNLIGYCEEDEPFTR--MMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYC 544
+ V ++ E + ++V E G LF + + + I +
Sbjct: 64 CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 123
Query: 545 LEHMHQLTPPIAHRNLQSSSIYLT---EDYAAKISDFSFWNNTTAAKTGS--------AA 593
++++H + IAHR+++ ++ T + K++DF F TT+ + + A
Sbjct: 124 IQYLHSI--NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVA 181
Query: 594 MELLETSAVDLESNVYSFGTILFEMITGRISYSIENGS--LENWASEYLKGEQPLKDIVD 651
E+L D +++S G I++ ++ G + +G + G+ +
Sbjct: 182 PEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 241
Query: 652 PTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGI 686
V EE+ ++I+N + +P QR ++
Sbjct: 242 S-------EVSEEVKMLIRNLLKTEPTQRMTITEF 269
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (285), Expect = 1e-28
Identities = 48/283 (16%), Positives = 92/283 (32%), Gaps = 31/283 (10%)
Query: 430 NIIGSFSDGTVGTVYKGT--LSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNH 487
IG G G V+K + G +A+ V++ + + + L H
Sbjct: 13 AEIGE---GAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEH 69
Query: 488 KNFVNLIGYCEEDEP--FTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCL 545
N V L C T++ + + L +L + + + L
Sbjct: 70 PNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGL 129
Query: 546 EHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSF--------WNNTTAAKTGSAAMELL 597
+ +H + HR+L+ +I +T K++DF + A E+L
Sbjct: 130 DFLHSH--RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVL 187
Query: 598 ETSAVDLESNVYSFGTILFEMITGR--------------ISYSIENGSLENWASEYLKGE 643
S+ +++S G I EM + I I E+W +
Sbjct: 188 LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPR 247
Query: 644 QPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGI 686
Q ++ F ++ E ++ C+ +P +R S
Sbjct: 248 QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (284), Expect = 2e-28
Identities = 51/277 (18%), Positives = 103/277 (37%), Gaps = 33/277 (11%)
Query: 426 EDFSNIIGSFSDGTVGTVYKGT-LSSGVEIAVTSTSVKSRADWSKNLESQ-FRKKIDTLS 483
+D+ + G V K S+G++ A + + + + +++ L
Sbjct: 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 68
Query: 484 KVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAY 543
++ H N + L E +++ E G LF+ L E E L +
Sbjct: 69 EIQHPNVITLHEVYENKTDV--ILILELVAGGELFDFLA--EKESLTEEEATEFLKQILN 124
Query: 544 CLEHMHQLTPPIAHRNLQSSSIYLTEDYAA----KISDFSF-----WNNTTAAKTGS--- 591
+ ++H IAH +L+ +I L + KI DF + N G+
Sbjct: 125 GVYYLHS--LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 182
Query: 592 AAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGS--LENWASEYLKGEQPLKDI 649
A E++ + LE++++S G I + +++G + + L N ++ + E
Sbjct: 183 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN 242
Query: 650 VDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGI 686
K F I+ + DPK+R +++
Sbjct: 243 TSALAKDF-----------IRRLLVKDPKKRMTIQDS 268
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (277), Expect = 2e-27
Identities = 51/290 (17%), Positives = 99/290 (34%), Gaps = 40/290 (13%)
Query: 426 EDFS--NIIGSFSDGTVGTVYKGT-LSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTL 482
E+F IG GT G VYK +G +A+ + + ++ + S ++I L
Sbjct: 2 ENFQKVEKIGE---GTYGVVYKARNKLTGEVVALKKIRLDTE---TEGVPSTAIREISLL 55
Query: 483 SKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMA 542
++NH N V L+ + +VFE+ + L + + + + +
Sbjct: 56 KELNHPNIVKLLDVIHTENKL--YLVFEF-LHQDLKKFMDASALTGIPLPLIKSYLFQLL 112
Query: 543 YCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDF----------SFWNNTTAAKTGSA 592
L H + HR+L+ ++ + + A K++DF + + A
Sbjct: 113 QGLAFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRA 170
Query: 593 AMELLETSAVDLESNVYSFGTILFEMITGR--------------ISYSIENGSLENWASE 638
LL +++S G I EM+T R I ++ W
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 230
Query: 639 YLKGE--QPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGI 686
+ + E+ ++ +H DP +R S +
Sbjct: 231 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (280), Expect = 2e-27
Identities = 48/293 (16%), Positives = 100/293 (34%), Gaps = 48/293 (16%)
Query: 427 DFSNIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKV 485
+ +IG+ G+ G VY+ L SG +A+ R +++ + K+
Sbjct: 23 TDTKVIGN---GSFGVVYQAKLCDSGELVAIKKVLQDKR---------FKNRELQIMRKL 70
Query: 486 NHKNFVNLIGYC----EEDEPFTRMMVFEYSPNGSLFEHLH-IQEAEHLDWAMRLRIAMG 540
+H N V L + E+ + +V +Y P H + + L
Sbjct: 71 DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 130
Query: 541 MAYCLEHMHQLTPPIAHRNLQSSSIYLTED-YAAKISDF---------SFWNNTTAAKTG 590
+ L ++H I HR+++ ++ L D K+ DF + ++
Sbjct: 131 LFRSLAYIHS--FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYY 188
Query: 591 SAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENG-----------------SLE 633
A + + +V+S G +L E++ G+ + ++G +
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 248
Query: 634 NWASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGI 686
Y + + P + P K F+ E + + + P R +
Sbjct: 249 EMNPNYTEFKFP-QIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 109 bits (274), Expect = 3e-27
Identities = 35/284 (12%), Positives = 86/284 (30%), Gaps = 42/284 (14%)
Query: 432 IGSFSDGTVGTVYKGT-LSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNF 490
IG G+ G +++GT L + ++A+ +S A Q R + T +
Sbjct: 13 IGE---GSFGVIFEGTNLLNNQQVAIKFEPRRSDAP-------QLRDEYRTYKLLAGCTG 62
Query: 491 VNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQ 550
+ + Y ++ ++V + G E L A M ++ +H+
Sbjct: 63 IPNVYYFGQEGLH-NVLVIDL--LGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE 119
Query: 551 LTPPIAHRNLQSSSIYLTEDYA-----AKISDFSF-------------WNNTTAAKTGSA 592
+ +R+++ + + + + DF +G+A
Sbjct: 120 K--SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 177
Query: 593 ---AMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDI 649
++ ++ + G + + G + + A+ K E+ +
Sbjct: 178 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPW-----QGLKAATNKQKYERIGEKK 232
Query: 650 VDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEI 693
L+ EE + + P + ++
Sbjct: 233 QSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (273), Expect = 1e-26
Identities = 47/291 (16%), Positives = 96/291 (32%), Gaps = 46/291 (15%)
Query: 430 NIIGSFSDGTVGTVYKGT-LSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHK 488
+ IG G G V + V +A+ S + + + ++I L + H+
Sbjct: 14 SYIGE---GAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQ----RTLREIKILLRFRHE 66
Query: 489 NFVNLIGYCEEDEPFTRMMVF--EYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLE 546
N + + V+ + L++ L Q HL + L+
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLK 123
Query: 547 HMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSF------------WNNTTAAKTGSAAM 594
++H + HR+L+ S++ L KI DF + A A
Sbjct: 124 YIHSA--NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 181
Query: 595 ELLETSAVDLES-NVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPT 653
E++ S +S +++S G IL EM++ R + ++ + + G +D+
Sbjct: 182 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 241
Query: 654 ------------------LKSFQENVLEELLVVIKNCVHPDPKQRPSMRGI 686
N + L ++ + +P +R +
Sbjct: 242 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (272), Expect = 2e-26
Identities = 50/283 (17%), Positives = 97/283 (34%), Gaps = 42/283 (14%)
Query: 432 IGSFSDGTVGTVYKGT-LSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNF 490
+GS G G V +G ++A+ R S+ + +++ L + H+N
Sbjct: 26 VGS---GAYGAVCSAVDGRTGAKVAI---KKLYRPFQSELFAKRAYRELRLLKHMRHENV 79
Query: 491 VNLIGYCEEDEPFTR----MMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLE 546
+ L+ DE +V + + + + E L + M L
Sbjct: 80 IGLLDVFTPDETLDDFTDFYLVMPFMGT----DLGKLMKHEKLGEDRIQFLVYQMLKGLR 135
Query: 547 HMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTAAKTGS-------AAMELLET 599
++H HR+L+ ++ + ED KI DF + TG A +L
Sbjct: 136 YIHAAGII--HRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNW 193
Query: 600 SAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQP-------------- 645
+++S G I+ EMITG+ + + + + G P
Sbjct: 194 MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKN 253
Query: 646 ----LKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMR 684
L ++ S N + +++ + D +QR +
Sbjct: 254 YMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAG 296
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (270), Expect = 3e-26
Identities = 55/273 (20%), Positives = 96/273 (35%), Gaps = 34/273 (12%)
Query: 427 DFSNIIGSFSDGTVGTVYKGT-LSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKV 485
D+ ++G GT G V ++G A+ ++ +K+ + + L
Sbjct: 8 DYLKLLGK---GTFGKVILVREKATGRYYAMKI--LRKEVIIAKDEVAHTVTESRVLQNT 62
Query: 486 NHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCL 545
H L + + V EY+ G LF HL + L
Sbjct: 63 RHPFLTALKYAFQTHDRL--CFVMEYANGGELFFHLS--RERVFTEERARFYGAEIVSAL 118
Query: 546 EHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFW------NNTTAAKTGS---AAMEL 596
E++H + +R+++ ++ L +D KI+DF T G+ A E+
Sbjct: 119 EYLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEV 176
Query: 597 LETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKS 656
LE + + + G +++EM+ GR+ + N E L E + P KS
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRLPF--YNQDHERLFELILMEEIRFPRTLSPEAKS 234
Query: 657 FQENVLEELLVVIKNCVHPDPKQRPSMRGIAAK 689
+ + DPKQR AK
Sbjct: 235 L-----------LAGLLKKDPKQRLGGGPSDAK 256
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (266), Expect = 3e-26
Identities = 46/269 (17%), Positives = 96/269 (35%), Gaps = 40/269 (14%)
Query: 431 IIGSFSDGTVGTVYKGT-LSSGVEIAVTSTSVKSRADWSK-NLESQFRKKIDTLSKVN-- 486
++GS G G+VY G +S + +A+ +DW + ++ ++ L KV+
Sbjct: 11 LLGS---GGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 67
Query: 487 HKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLE 546
+ L+ + E + F +++ E I E L + + +
Sbjct: 68 FSGVIRLLDWFERPDSF--VLILERPEPVQDLFDF-ITERGALQEELARSFFWQVLEAVR 124
Query: 547 HMHQLTPPIAHRNLQSSSIYLTED-YAAKISDFSF-------WNNTTAAKTGSAAMELLE 598
H H + HR+++ +I + + K+ DF + E +
Sbjct: 125 HCHNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIR 182
Query: 599 TSAV-DLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSF 657
+ V+S G +L++M+ G I + + E ++G+ + V +
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--------EIIRGQVFFRQRVSSECQHL 234
Query: 658 QENVLEELLVVIKNCVHPDPKQRPSMRGI 686
I+ C+ P RP+ I
Sbjct: 235 -----------IRWCLALRPSDRPTFEEI 252
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (260), Expect = 4e-25
Identities = 54/285 (18%), Positives = 101/285 (35%), Gaps = 42/285 (14%)
Query: 426 EDFS--NIIGSFSDGTVGTVYKGTL----SSGVEIAVTSTSVKSRADWSKNLESQFRKKI 479
E+F ++G+ G G V+ +G A+ + +K E R +
Sbjct: 24 ENFELLKVLGT---GAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTE-HTRTER 79
Query: 480 DTLSKVNHKNF-VNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIA 538
L + F V L + + ++ +Y G LF HL + E
Sbjct: 80 QVLEHIRQSPFLVTLHYAFQTETKLHLIL--DYINGGELFTHLS--QRERFTEHEVQIYV 135
Query: 539 MGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTAAKTG-------- 590
+ LEH+H+L I +R+++ +I L + ++DF A +T
Sbjct: 136 GEIVLALEHLHKL--GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGT 193
Query: 591 ----SAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIEN--GSLENWASEYLKGEQ 644
+ + S D + +S G +++E++TG ++++ S + LK E
Sbjct: 194 IEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP 253
Query: 645 PLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAK 689
P + K I+ + DPK+R A
Sbjct: 254 PYPQEMSALAKDL-----------IQRLLMKDPKKRLGCGPRDAD 287
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (258), Expect = 8e-25
Identities = 52/297 (17%), Positives = 100/297 (33%), Gaps = 50/297 (16%)
Query: 430 NIIGSFSDGTVGTVYKGT-LSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHK 488
IG GT G V+K +G ++A+ +++ + ++I L + H+
Sbjct: 16 AKIGQ---GTFGEVFKARHRKTGQKVALKKVLMENE---KEGFPITALREIKILQLLKHE 69
Query: 489 NFVNLIGYCEEDEPFTRM------MVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMA 542
N VNLI C +VF++ + ++ L R+ +
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEI--KRVMQMLL 127
Query: 543 YCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSF----------WNNTTAAKTGSA 592
L ++H+ I HR+++++++ +T D K++DF N + +
Sbjct: 128 NGLYYIHR--NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTL 185
Query: 593 AM----ELLETSAVDLESNVYSFGTILFEMITGR-----------------ISYSIENGS 631
LL +++ G I+ EM T + SI
Sbjct: 186 WYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 245
Query: 632 LENWASEYLKGEQPLKDIVDPTLKSFQENVL--EELLVVIKNCVHPDPKQRPSMRGI 686
N + L + L +K + + L +I + DP QR
Sbjct: 246 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 96.8 bits (240), Expect = 3e-22
Identities = 44/277 (15%), Positives = 95/277 (34%), Gaps = 34/277 (12%)
Query: 426 EDFSNI--IGSFSDGTVGTVYKGT-LSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTL 482
+ F I +G+ G+ G V SG A+ + + + L
Sbjct: 41 DQFDRIKTLGT---GSFGRVMLVKHKESGNHYAMKI--LDKQKVVKLKQIEHTLNEKRIL 95
Query: 483 SKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMA 542
VN V L + MV EY G +F HL A +
Sbjct: 96 QAVNFPFLVKLEFSF--KDNSNLYMVMEYVAGGEMFSHLR--RIGRFSEPHARFYAAQIV 151
Query: 543 YCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFW------NNTTAAKTGSAAMEL 596
E++H L + +R+L+ ++ + + +++DF F T + A E+
Sbjct: 152 LTFEYLHSL--DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEALAPEI 209
Query: 597 LETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKS 656
+ + + + ++ G +++EM G + + + + +
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ-------------PIQIYEKIVSGKVR 256
Query: 657 FQENVLEELLVVIKNCVHPDPKQR-PSMRGIAAKLKE 692
F + +L +++N + D +R +++ +K
Sbjct: 257 FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.9 bits (232), Expect = 1e-21
Identities = 45/285 (15%), Positives = 87/285 (30%), Gaps = 40/285 (14%)
Query: 430 NIIGSFSDGTVGTVYKGT-LSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHK 488
IG GT GTV+K + +A+ D + + S ++I L ++ HK
Sbjct: 8 EKIGE---GTYGTVFKAKNRETHEIVAL---KRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 489 NFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHM 548
N V L D +VFE+ + + L
Sbjct: 62 NIVRLHDVLHSD--KKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKS--FLFQLLKGLGFC 117
Query: 549 HQLTPPIAHRNLQSSSIYLTEDYAAKISDFSF----------WNNTTAAKTGSAAMELLE 598
H + HR+L+ ++ + + K+++F ++ L
Sbjct: 118 HS--RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG 175
Query: 599 TSAVDLESNVYSFGTILFEMITG---------------RISYSIENGSLENWAS--EYLK 641
+++S G I E+ RI + + E W S +
Sbjct: 176 AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235
Query: 642 GEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGI 686
+ +L + + +++N + +P QR S
Sbjct: 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 91.1 bits (225), Expect = 2e-20
Identities = 44/298 (14%), Positives = 99/298 (33%), Gaps = 57/298 (19%)
Query: 426 EDFS--NIIGSFSDGTVGTVYKGT-LSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTL 482
+D+ +G G V++ +++ ++ V K + + +++I L
Sbjct: 35 DDYQLVRKLGR---GKYSEVFEAINITNNEKVVV-----KI---LKPVKKKKIKREIKIL 83
Query: 483 SKVN-HKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGM 541
+ N + L ++ T +VFE+ N + L +
Sbjct: 84 ENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ-----TLTDYDIRFYMYEI 138
Query: 542 AYCLEHMHQLTPPIAHRNLQSSSIYLT-EDYAAKISDFSF---------WNNTTAAKTGS 591
L++ H + I HR+++ ++ + E ++ D+ +N A++
Sbjct: 139 LKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFK 196
Query: 592 AAMELLETSAVDLESNVYSFGTILFEMITGR---------------ISYSIENGSLENWA 636
L++ D +++S G +L MI + I+ + L ++
Sbjct: 197 GPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYI 256
Query: 637 SEY----------LKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMR 684
+Y + G K Q V E L + + D + R + R
Sbjct: 257 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAR 314
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.0 bits (217), Expect = 2e-19
Identities = 51/303 (16%), Positives = 103/303 (33%), Gaps = 40/303 (13%)
Query: 414 PKLKRSELEAACEDFSN---IIGSFSDGTVGTVYKGT-LSSGVEIAVTSTSVKSRADWSK 469
P R EL + + G G+V +G+ +AV SR S
Sbjct: 2 PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAV---KKLSRPFQSI 58
Query: 470 NLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEP---FTRMMVFEYSPNGSLFEHLHIQEA 526
+ +++ L + H+N + L+ F + + + +I +
Sbjct: 59 IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGAD---LNNIVKC 115
Query: 527 EHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSF-----W 581
+ L + + L+++H I HR+L+ S++ + ED KI DF
Sbjct: 116 QKLTDDHVQFLIYQILRGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 173
Query: 582 NNTTAAKT--GSAAMELLETSAVDLESNVYSFGTILFEMITGR----------------- 622
T T A +L + +++S G I+ E++TGR
Sbjct: 174 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 233
Query: 623 ISYSIENGSLENWASEYLKG-EQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRP 681
+ + L+ +SE + Q L + + + +++ + D +R
Sbjct: 234 LVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI 293
Query: 682 SMR 684
+
Sbjct: 294 TAA 296
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 83.8 bits (206), Expect = 6e-18
Identities = 49/296 (16%), Positives = 95/296 (32%), Gaps = 55/296 (18%)
Query: 431 IIGSFSDGTVGTVYKGT-LSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKN 489
IGS G G V +A+ SR ++ + +++ + VNHKN
Sbjct: 24 PIGS---GAQGIVCAAYDAVLDRNVAI---KKLSRPFQNQTHAKRAYRELVLMKCVNHKN 77
Query: 490 FVNLIGYCEEDEPF----TRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCL 545
++L+ + +V E LD + M +
Sbjct: 78 IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM-----ELDHERMSYLLYQMLCGI 132
Query: 546 EHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSF-----WNNTTAAKTGS---AAMELL 597
+H+H I HR+L+ S+I + D KI DF + + A E++
Sbjct: 133 KHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 190
Query: 598 ETSAVDLESNVYSFGTILFEMITGRISYSIEN--------------------GSLENWAS 637
+++S G I+ EM+ +I + + L+
Sbjct: 191 LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 250
Query: 638 EYLKG---------EQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMR 684
Y++ + D + P + + ++ + DP +R S+
Sbjct: 251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD 306
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 72.8 bits (177), Expect = 3e-14
Identities = 41/313 (13%), Positives = 90/313 (28%), Gaps = 70/313 (22%)
Query: 432 IGSFSDGTVGTVYKGT-LSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNF 490
+G G TV+ + + +A+ K K +I L +VN +
Sbjct: 21 LGW---GHFSTVWLAKDMVNNTHVAM-----K-IVRGDKVYTEAAEDEIKLLQRVNDADN 71
Query: 491 VNLIGYCEEDEPFTRMMVFEYSPNGSLF------------EHLHIQEAEHLDWAMRLRIA 538
PNG + E + +I+
Sbjct: 72 TKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQIS 131
Query: 539 MGMAYCLEHMHQLTPPIAHRNLQSSSIYLT-EDYAAKISDFSFWNNTTAAKTGS------ 591
+ L++MH+ I H +++ ++ + D + + A
Sbjct: 132 KQLLLGLDYMHR-RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI 190
Query: 592 -----AAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLK----- 641
+ E+L + ++++S ++FE+ITG + + G +++
Sbjct: 191 QTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIEL 250
Query: 642 -GEQPLKDI-----------------------------VDPTLKSFQENVLEELLVVIKN 671
GE P + V F ++ +E+ +
Sbjct: 251 LGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSP 310
Query: 672 CVHPDPKQRPSMR 684
+ DP++R
Sbjct: 311 MLQLDPRKRADAG 323
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 66.7 bits (162), Expect = 3e-13
Identities = 22/155 (14%), Positives = 45/155 (29%), Gaps = 18/155 (11%)
Query: 430 NIIGSFSDGTVGTVYKGTLSSGVEIAV-----TSTSVKSRADWSKNLESQFRKKIDTLSK 484
++G G V+ E V TS K + + F ++
Sbjct: 6 KLMGE---GKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSAR 62
Query: 485 VNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYC 544
+ L G V+ + N L E + +E + + +
Sbjct: 63 NEFRALQKLQGLAV-------PKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEE 115
Query: 545 LEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFS 579
+ + I H +L ++ ++ + I DF
Sbjct: 116 VAKFYH--RGIVHGDLSQYNVLVS-EEGIWIIDFP 147
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 63.2 bits (152), Expect = 2e-11
Identities = 22/58 (37%), Positives = 30/58 (51%), Gaps = 1/58 (1%)
Query: 149 LRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLLDNNQYLGGI 206
LRNN +GT+P+ + +LK L L++ FNN G P GN NN+ L G
Sbjct: 251 LRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKCLCGS 307
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 54.4 bits (129), Expect = 2e-08
Identities = 40/166 (24%), Positives = 64/166 (38%), Gaps = 13/166 (7%)
Query: 69 CLNSEGMALLRFRERVVRDPFGALSKWSDNDGVGDNVNPCSWFGVECSD----GKVVILN 124
C + ALL+ ++ + +P LS W + +W GV C +V L+
Sbjct: 3 CNPQDKQALLQIKKDL-GNP-TTLSSWLP----TTDCCNRTWLGVLCDTDTQTYRVNNLD 56
Query: 125 LRDLCLGGM--LAPELGQLSELKSIILRNN-SFFGTIPKEIGELKELEILDLGFNNFSGP 181
L L L + L L L + + + G IP I +L +L L + N SG
Sbjct: 57 LSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGA 116
Query: 182 FPSDFGNSFSLTTLLLDNNQYLGGISPELHVLKVISEIQVDESWLT 227
P +L TL N G + P + L + I D + ++
Sbjct: 117 IPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRIS 162
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 47.8 bits (112), Expect = 2e-06
Identities = 18/63 (28%), Positives = 29/63 (46%), Gaps = 3/63 (4%)
Query: 124 NLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNF--SGP 181
+LR+ + G L L QL L S+ + N+ G IP + G L+ ++ N P
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSP 308
Query: 182 FPS 184
P+
Sbjct: 309 LPA 311
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 38.6 bits (88), Expect = 0.002
Identities = 12/43 (27%), Positives = 16/43 (37%), Gaps = 1/43 (2%)
Query: 172 DLGFNNFSGPFPSDFGNSFSLTTLLLDNNQYLGGISPELHVLK 214
DL N G P L +L + N G I P+ L+
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEI-PQGGNLQ 291
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 59.2 bits (142), Expect = 7e-10
Identities = 33/193 (17%), Positives = 61/193 (31%), Gaps = 21/193 (10%)
Query: 19 SLDPSFNSLETKAFRLAPQTHPCRFHRLRL---------NMAALTLVMLLFLQNLSLARC 69
SL + N + + P L L +A+LT + L L N ++
Sbjct: 201 SLIATNNQISD----ITPLGILTNLDELSLNGNQLKDIGTLASLTNLTDLDLANNQISNL 256
Query: 70 LNSEGMALLRFRERVVRDPFG--ALSKWSDNDGVGDNVNPCSWFGVECSDGKVVILNLRD 127
G+ L + L+ + + N N + + L L
Sbjct: 257 APLSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYF 316
Query: 128 LCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFG 187
+ + + L++L+ + NN + + L + L G N S P
Sbjct: 317 NNISDI--SPVSSLTKLQRLFFANNKV--SDVSSLANLTNINWLSAGHNQISDLTP--LA 370
Query: 188 NSFSLTTLLLDNN 200
N +T L L++
Sbjct: 371 NLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 47.7 bits (112), Expect = 3e-06
Identities = 16/69 (23%), Positives = 27/69 (39%), Gaps = 5/69 (7%)
Query: 140 QLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLLDN 199
L L + L N+ P + L +L+ L N S S N ++ L +
Sbjct: 305 NLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSDV--SSLANLTNINWLSAGH 360
Query: 200 NQYLGGISP 208
NQ + ++P
Sbjct: 361 NQ-ISDLTP 368
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 48.1 bits (113), Expect = 2e-06
Identities = 26/104 (25%), Positives = 36/104 (34%), Gaps = 14/104 (13%)
Query: 108 CSWFGVECSDGKVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKE 167
C V+CSD L L + P+ + + L+NN + LK
Sbjct: 10 CHLRVVQCSD-----LGLEKV-------PK-DLPPDTALLDLQNNKITEIKDGDFKNLKN 56
Query: 168 LEILDLGFNNFSGPFPSDFGNSFSLTTLLLDNNQYLGGISPELH 211
L L L N S P F L L L NQ L + ++
Sbjct: 57 LHTLILINNKISKISPGAFAPLVKLERLYLSKNQ-LKELPEKMP 99
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 39.3 bits (90), Expect = 0.001
Identities = 17/72 (23%), Positives = 31/72 (43%), Gaps = 2/72 (2%)
Query: 157 TIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLLDNNQYLGGISPELHVLKVI 216
+PK++ + +LDL N + DF N +L TL+L NN+ L +
Sbjct: 24 KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81
Query: 217 SEIQVDESWLTN 228
+ + ++ L
Sbjct: 82 ERLYLSKNQLKE 93
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 37.7 bits (86), Expect = 0.004
Identities = 33/230 (14%), Positives = 69/230 (30%), Gaps = 13/230 (5%)
Query: 15 ANPTSLDPSFNSLETKAFRLAPQTHPCRFHRLR-LNMAALTLVMLLFLQNLSLARCLNSE 73
+ LD N + F L+ L+ L + + + A + E
Sbjct: 31 PDTALLDLQNNKITE--------IKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLE 82
Query: 74 GMALLRFRERVVRDPFGALSKWSDNDGVGDNVNPCSWFGVECSDGKVVILNLRDLCLGGM 133
+ L + + + + + + S F + VV L L G+
Sbjct: 83 RLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFN-GLNQMIVVELGTNPLKSSGI 141
Query: 134 LAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLT 193
+ +L I + + + TIP+ + L L L N + + +L
Sbjct: 142 ENGAFQGMKKLSYIRIADTNI-TTIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLA 198
Query: 194 TLLLDNNQYLGGISPELHVLKVISEIQVDESWLTNAASRASCNSGLFTWN 243
L L N + L + E+ ++ + L + + +
Sbjct: 199 KLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVY 248
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.0 bits (97), Expect = 1e-04
Identities = 12/66 (18%), Positives = 24/66 (36%), Gaps = 3/66 (4%)
Query: 137 ELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLL 196
E+ +++ + + +P ++ K+ IL L N + LT L
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 197 LDNNQY 202
LD +
Sbjct: 62 LDRAEL 67
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.8 bits (86), Expect = 0.003
Identities = 13/50 (26%), Positives = 18/50 (36%), Gaps = 1/50 (2%)
Query: 151 NNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLLDNN 200
NN+ + L+ L+ L L N+ P F S L L N
Sbjct: 157 NNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >d1z9ha1 a.45.1.1 (A:213-373) Microsomal prostaglandin E synthase-2 {Crab-eating macaque (Macaca fascicularis) [TaxId: 9541]} Length = 161 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: GST C-terminal domain-like superfamily: GST C-terminal domain-like family: Glutathione S-transferase (GST), C-terminal domain domain: Microsomal prostaglandin E synthase-2 species: Crab-eating macaque (Macaca fascicularis) [TaxId: 9541]
Score = 40.2 bits (94), Expect = 2e-04
Identities = 11/49 (22%), Positives = 18/49 (36%), Gaps = 2/49 (4%)
Query: 546 EHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTAAKTGSAAM 594
+ + L P +R + + DY + F A G+AAM
Sbjct: 28 DWLVHLISPNVYRTPTEA--LASFDYIVREGKFGAVEGAVAKYMGAAAM 74
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (93), Expect = 6e-04
Identities = 15/95 (15%), Positives = 26/95 (27%), Gaps = 15/95 (15%)
Query: 123 LNLRDLCLGGM------LAPELGQLSELKSIILRNNSF----FGTIPKEIGELKELEILD 172
L+++ L + A L L + + + L + I + L L+
Sbjct: 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61
Query: 173 LGFNNFSGPFPSDFG-----NSFSLTTLLLDNNQY 202
L N S + L L N
Sbjct: 62 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCL 96
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.6 bits (90), Expect = 0.001
Identities = 18/132 (13%), Positives = 34/132 (25%), Gaps = 12/132 (9%)
Query: 95 WSDNDGVGDNVNPCSWFGVECSDGKVVILNLRDLCLGGMLAPELGQL---SELKSIILRN 151
+ S + + ++ L G+ G S L+ + L +
Sbjct: 319 VKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLAD 378
Query: 152 NSFFGTIPKEIGE----LKELEILDLGFNNFSGPFPSDFGNSF-----SLTTLLLDNNQY 202
+ + L LDL N S L L+L + +
Sbjct: 379 CDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYW 438
Query: 203 LGGISPELHVLK 214
+ L L+
Sbjct: 439 SEEMEDRLQALE 450
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 39.8 bits (91), Expect = 0.001
Identities = 15/125 (12%), Positives = 32/125 (25%), Gaps = 10/125 (8%)
Query: 93 SKWSDNDGVGDNVNPCSWFGVECSDGKVVILNLRDLCLGGMLAPELGQLSELKSIILRNN 152
+ + ++ + L+ + + NN
Sbjct: 235 YLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNN 294
Query: 153 SFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLLDNNQ--YLGGISPEL 210
+P L+ L FN+ + P N L L ++ N I +
Sbjct: 295 KL-IELPALPPRLERL---IASFNHLAE-VPELPQN---LKQLHVEYNPLREFPDIPESV 346
Query: 211 HVLKV 215
L++
Sbjct: 347 EDLRM 351
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 36.9 bits (84), Expect = 0.004
Identities = 16/64 (25%), Positives = 25/64 (39%), Gaps = 4/64 (6%)
Query: 136 PELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTL 195
L LS+L ++ +N P + L L + L N S P N+ +L +
Sbjct: 167 TPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIV 222
Query: 196 LLDN 199
L N
Sbjct: 223 TLTN 226
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 721 | |||
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.91 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.85 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.44 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.33 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.25 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.19 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.08 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.06 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 98.95 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 98.95 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 98.9 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 98.88 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 98.88 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 98.76 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 98.74 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 98.72 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 98.58 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 98.56 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 98.53 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 98.51 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 98.48 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 98.48 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 98.47 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 98.35 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 98.33 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 98.32 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 98.28 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 98.18 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 98.13 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 97.94 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 97.92 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 97.85 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 97.64 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.58 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 97.58 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 97.53 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 97.51 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 97.49 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 97.36 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.26 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 97.25 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 97.14 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 96.7 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 96.06 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 95.94 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 94.89 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 94.6 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 93.58 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 91.47 |
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.3e-49 Score=416.92 Aligned_cols=260 Identities=18% Similarity=0.315 Sum_probs=205.0
Q ss_pred CCCHHHHHHHHhhhh--------hhhCcCCCCceeEEEEEEecC-C---cEEEEEEeeeccccchhhHHHHHHHHHHHHH
Q 004979 415 KLKRSELEAACEDFS--------NIIGSFSDGTVGTVYKGTLSS-G---VEIAVTSTSVKSRADWSKNLESQFRKKIDTL 482 (721)
Q Consensus 415 ~~~~~~l~~~~~~~~--------~ii~~lg~G~~g~Vyk~~~~~-~---~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l 482 (721)
.++++++.+++.+|. ++.+.||+|+||+||+|+++. + ..||||++.... .....++|.+|+++|
T Consensus 6 ~~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l 81 (299)
T d1jpaa_ 6 PFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY----TEKQRRDFLSEASIM 81 (299)
T ss_dssp GGGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC----CHHHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc----CHHHHHHHHHHHHHH
Confidence 345567777777774 344678999999999999753 2 247777664322 233456899999999
Q ss_pred hcCCCCccceEeEEEecCCCceEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCC
Q 004979 483 SKVNHKNFVNLIGYCEEDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQS 562 (721)
Q Consensus 483 ~~l~H~nIv~l~g~~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp 562 (721)
++++|||||+++|+|.+.+ ..++|||||++|+|.+++.. ....++|.+++.|+.||+.||+|||+++ |+||||||
T Consensus 82 ~~l~HpnIv~l~g~~~~~~--~~~iv~Ey~~~g~L~~~~~~-~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHrDlKp 156 (299)
T d1jpaa_ 82 GQFDHPNVIHLEGVVTKST--PVMIITEFMENGSLDSFLRQ-NDGQFTVIQLVGMLRGIAAGMKYLADMN--YVHRDLAA 156 (299)
T ss_dssp TTCCCTTBCCEEEEECSSS--SCEEEEECCTTEEHHHHHHT-TTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCG
T ss_pred HhCCCCCCccEEEEEeeCC--EEEEEEEecCCCcceeeecc-ccCCCCHHHHHHHHHHHHHHHHHHhhCC--CccCcccc
Confidence 9999999999999998877 56999999999999998863 3456999999999999999999999988 99999999
Q ss_pred CCeEeCCCCcEEEeccCCCCCCC--------------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccC
Q 004979 563 SSIYLTEDYAAKISDFSFWNNTT--------------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSI 627 (721)
Q Consensus 563 ~NILl~~~~~~kL~DFGla~~~~--------------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~ 627 (721)
+||||+.++++||+|||+++... .++..|+|||.+.+..++.++|||||||++|||+| |+.||..
T Consensus 157 ~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~ 236 (299)
T d1jpaa_ 157 RNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD 236 (299)
T ss_dssp GGEEECTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred ceEEECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCC
Confidence 99999999999999999986432 12346999999999999999999999999999998 8999963
Q ss_pred CCCCHHHHHHHHhhcCCCCccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 004979 628 ENGSLENWASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITA 695 (721)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~ 695 (721)
. ...+....+..+... ..+.+++.++.+||.+||+.||++||||.||++.|+++.+
T Consensus 237 ~--~~~~~~~~i~~~~~~----------~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 237 M--TNQDVINAIEQDYRL----------PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp C--CHHHHHHHHHTTCCC----------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred C--CHHHHHHHHHcCCCC----------CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 3 334444444333211 1223456788999999999999999999999999998765
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-49 Score=408.83 Aligned_cols=245 Identities=20% Similarity=0.318 Sum_probs=199.8
Q ss_pred hhhCcCCCCceeEEEEEEecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVF 509 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV~ 509 (721)
++++.||+|+||+||+|++.++..||||++..... ..++|.+|++++++++|||||+++|+|.+.+ ..++||
T Consensus 8 ~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~------~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~--~~~lv~ 79 (263)
T d1sm2a_ 8 TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM------SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA--PICLVF 79 (263)
T ss_dssp EEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSS------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS--SCEEEE
T ss_pred EEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcC------cHHHHHHHHHHHHhcCCCCcccccceeccCC--ceEEEE
Confidence 56788999999999999998888999999864322 1357999999999999999999999998877 569999
Q ss_pred ecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC----
Q 004979 510 EYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT---- 585 (721)
Q Consensus 510 Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~---- 585 (721)
||+++|+|.+++.. ....++|..++.|+.|||.||+|||+++ |+||||||+|||+++++.+||+|||+++...
T Consensus 80 E~~~~g~L~~~l~~-~~~~~~~~~~~~i~~qia~gl~~lH~~~--iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~ 156 (263)
T d1sm2a_ 80 EFMEHGCLSDYLRT-QRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 156 (263)
T ss_dssp ECCTTCBHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCTTCSGGGEEECGGGCEEECSCC----------
T ss_pred EecCCCcHHHHhhc-cccCCCHHHHHHHHHHHHHHHHhhhccc--eeecccchhheeecCCCCeEecccchheeccCCCc
Confidence 99999999999864 3456899999999999999999999988 9999999999999999999999999986332
Q ss_pred ------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccH
Q 004979 586 ------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQE 659 (721)
Q Consensus 586 ------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 659 (721)
.++..|+|||.+.+..|+.++|||||||++|||+|+..|+. ...+..+....+..+.... .+.
T Consensus 157 ~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~-~~~~~~~~~~~i~~~~~~~----------~p~ 225 (263)
T d1sm2a_ 157 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPY-ENRSNSEVVEDISTGFRLY----------KPR 225 (263)
T ss_dssp --------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTT-CSCCHHHHHHHHHHTCCCC----------CCT
T ss_pred eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCC-CCCCHHHHHHHHHhcCCCC----------Ccc
Confidence 23457999999999999999999999999999999544443 2334444444444432211 123
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 004979 660 NVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAM 696 (721)
Q Consensus 660 ~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~ 696 (721)
.+++++.+||.+||+.||++||||+||++.|+++++.
T Consensus 226 ~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 226 LASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 3456789999999999999999999999999998763
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-49 Score=409.62 Aligned_cols=251 Identities=26% Similarity=0.460 Sum_probs=202.4
Q ss_pred hhhCcCCCCceeEEEEEEecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVF 509 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV~ 509 (721)
++.+.||+|+||+||+|+++. .||||++...... ....+.|.+|+++|++++|||||+++|++.++ ..++||
T Consensus 11 ~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~---~~~lv~ 82 (276)
T d1uwha_ 11 TVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPT---PQQLQAFKNEVGVLRKTRHVNILLFMGYSTAP---QLAIVT 82 (276)
T ss_dssp CCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCC---TTHHHHHHHHHHHHTTCCCTTBCCEEEEECSS---SCEEEE
T ss_pred EEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCC---HHHHHHHHHHHHHHHhCCCCCEeeeeEEEecc---EEEEEE
Confidence 567789999999999998753 5999988654322 33457899999999999999999999998654 358999
Q ss_pred ecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC----
Q 004979 510 EYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT---- 585 (721)
Q Consensus 510 Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~---- 585 (721)
|||++|+|.++++. ....++|..++.|+.||+.||+|||+++ ||||||||+|||++.++.+||+|||+++...
T Consensus 83 Ey~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~gl~yLH~~~--ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~ 159 (276)
T d1uwha_ 83 QWCEGSSLYHHLHI-IETKFEMIKLIDIARQTAQGMDYLHAKS--IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG 159 (276)
T ss_dssp ECCCEEEHHHHHHT-SCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEETTSSEEECCCCCSCC------
T ss_pred ecCCCCCHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHhcCC--EeccccCHHHEEEcCCCCEEEccccceeeccccCC
Confidence 99999999999964 3356999999999999999999999988 9999999999999999999999999986432
Q ss_pred -------CCCccccchhhccc---CCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccc
Q 004979 586 -------AAKTGSAAMELLET---SAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLK 655 (721)
Q Consensus 586 -------~~~~~~~apE~~~~---~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 655 (721)
.++..|+|||.+.+ ..|+.++|||||||++|||+||+.||..... ..........+. ..+...
T Consensus 160 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~-~~~~~~~~~~~~------~~p~~~ 232 (276)
T d1uwha_ 160 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN-RDQIIFMVGRGY------LSPDLS 232 (276)
T ss_dssp ------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC-HHHHHHHHHHTS------CCCCGG
T ss_pred cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCCh-HHHHHHHHhcCC------CCCcch
Confidence 34567999999853 4589999999999999999999999964322 222222222221 122233
Q ss_pred cccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCC
Q 004979 656 SFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAMEP 698 (721)
Q Consensus 656 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 698 (721)
.....+++++.+||.+||+.||++||||+||++.|+.+.+..|
T Consensus 233 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~P 275 (276)
T d1uwha_ 233 KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 275 (276)
T ss_dssp GSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred hccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcCC
Confidence 3445567889999999999999999999999999999987544
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-49 Score=408.54 Aligned_cols=244 Identities=21% Similarity=0.330 Sum_probs=201.7
Q ss_pred hhhCcCCCCceeEEEEEEecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVF 509 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV~ 509 (721)
++++.||+|+||+||+|+++++..||||++..... ..+.|.+|+++|++++|||||+++|++.++ ..++||
T Consensus 16 ~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~------~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~---~~~iv~ 86 (272)
T d1qpca_ 16 KLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM------SPDAFLAEANLMKQLQHQRLVRLYAVVTQE---PIYIIT 86 (272)
T ss_dssp EEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS---SCEEEE
T ss_pred EEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcC------CHHHHHHHHHHHHhCCCCCEeEEEeeeccC---CeEEEE
Confidence 67788999999999999999888999998864321 135799999999999999999999988654 358999
Q ss_pred ecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC----
Q 004979 510 EYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT---- 585 (721)
Q Consensus 510 Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~---- 585 (721)
||+++|+|.+++.......++|..++.|+.||++||+|||+++ |+||||||+||||++++.+||+|||+++...
T Consensus 87 Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~--ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~ 164 (272)
T d1qpca_ 87 EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164 (272)
T ss_dssp ECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred EeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCccchhheeeecccceeeccccceEEccCCcc
Confidence 9999999999887555557999999999999999999999988 9999999999999999999999999986432
Q ss_pred ------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccH
Q 004979 586 ------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQE 659 (721)
Q Consensus 586 ------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 659 (721)
.++..|+|||.+....++.++|||||||++|||+||..|+.. .....+....+..+..+ ..+.
T Consensus 165 ~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~-~~~~~~~~~~i~~~~~~----------~~p~ 233 (272)
T d1qpca_ 165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYP-GMTNPEVIQNLERGYRM----------VRPD 233 (272)
T ss_dssp ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSST-TCCHHHHHHHHHTTCCC----------CCCT
T ss_pred ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCC-CCCHHHHHHHHHhcCCC----------CCcc
Confidence 234569999999999999999999999999999997666542 23334444444333211 1123
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 004979 660 NVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITA 695 (721)
Q Consensus 660 ~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~ 695 (721)
.+++++.+|+.+||+.||++||||+||++.|+++-.
T Consensus 234 ~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 234 NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 455778999999999999999999999999988643
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.2e-48 Score=405.07 Aligned_cols=245 Identities=21% Similarity=0.334 Sum_probs=203.2
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
++.+.||+|+||+||+|++. +++.||||++..... ..++|.+|+++|++++|||||+++|+|.+.+ ..++|
T Consensus 20 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~------~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~--~~~iv 91 (287)
T d1opja_ 20 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM------EVEEFLKEAAVMKEIKHPNLVQLLGVCTREP--PFYII 91 (287)
T ss_dssp EEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS--SCEEE
T ss_pred EEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc------hHHHHHHHHHHHHhCCCCCEecCCccEeeCC--eeEEE
Confidence 56788999999999999975 578899998764321 1357999999999999999999999998877 56999
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCCC--
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTA-- 586 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~~-- 586 (721)
||||++|+|.+++.......++|..++.|+.||+.||+|||+++ |+||||||+||||++++.+||+|||+++....
T Consensus 92 ~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~--iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~ 169 (287)
T d1opja_ 92 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 169 (287)
T ss_dssp EECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS
T ss_pred eecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC--cccCccccCeEEECCCCcEEEccccceeecCCCC
Confidence 99999999999997666678999999999999999999999988 99999999999999999999999999875432
Q ss_pred --------CCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCcccccc
Q 004979 587 --------AKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQ 658 (721)
Q Consensus 587 --------~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 658 (721)
++..|+|||.+.+..|+.++|||||||++|||+||..||.. ..+..+....+..+ .. ...+
T Consensus 170 ~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~-~~~~~~~~~~i~~~-~~---------~~~~ 238 (287)
T d1opja_ 170 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP-GIDLSQVYELLEKD-YR---------MERP 238 (287)
T ss_dssp SEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSST-TCCHHHHHHHHHTT-CC---------CCCC
T ss_pred ceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCC-cchHHHHHHHHhcC-CC---------CCCC
Confidence 23468999999999999999999999999999997777642 22333333322222 11 1122
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 004979 659 ENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITA 695 (721)
Q Consensus 659 ~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~ 695 (721)
..+++++.+||.+||+.||++||||.||++.|+.+.+
T Consensus 239 ~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 239 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 3456789999999999999999999999999988754
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-48 Score=396.49 Aligned_cols=241 Identities=18% Similarity=0.355 Sum_probs=202.6
Q ss_pred hhhCcCCCCceeEEEEEEecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVF 509 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV~ 509 (721)
+++++||+|+||+||+|+++++..||||+++..... .++|.+|++++++++|||||+++|+|.+++ ..++||
T Consensus 7 ~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~------~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~--~~~iv~ 78 (258)
T d1k2pa_ 7 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS------EDEFIEEAKVMMNLSHEKLVQLYGVCTKQR--PIFIIT 78 (258)
T ss_dssp CCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSC------HHHHHHHHHHHHTCCCTTBCCEEEEECCSS--SEEEEE
T ss_pred EEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCC------HHHHHHHHHHHHhcCCCceeeEEEEEeeCC--ceEEEE
Confidence 577899999999999999998889999998754322 357999999999999999999999998876 679999
Q ss_pred ecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC----
Q 004979 510 EYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT---- 585 (721)
Q Consensus 510 Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~---- 585 (721)
||+++|+|..++.. ....+++..+.+|+.||++||+|||+++ |+||||||+|||+++++.+||+|||+++...
T Consensus 79 Ey~~~g~l~~~~~~-~~~~~~~~~~~~i~~qi~~gl~~LH~~~--iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 155 (258)
T d1k2pa_ 79 EYMANGCLLNYLRE-MRHRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 155 (258)
T ss_dssp ECCTTEEHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT--BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC
T ss_pred EccCCCcHHHhhhc-cccCCcHHHHHHHHHHHHHHHHHHhhcC--cccccccceeEEEcCCCcEEECcchhheeccCCCc
Confidence 99999999998754 3456899999999999999999999988 9999999999999999999999999986322
Q ss_pred ------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhcCCCCccccCCcccccc
Q 004979 586 ------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQ 658 (721)
Q Consensus 586 ------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 658 (721)
.++..|+|||.+....++.++|||||||++|||+| |+.||... +..+....+..+... ..+
T Consensus 156 ~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~--~~~~~~~~i~~~~~~----------~~p 223 (258)
T d1k2pa_ 156 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF--TNSETAEHIAQGLRL----------YRP 223 (258)
T ss_dssp CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS--CHHHHHHHHHTTCCC----------CCC
T ss_pred eeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCC--CHHHHHHHHHhCCCC----------CCc
Confidence 23446899999999999999999999999999998 89999633 344444444433211 112
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 004979 659 ENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEI 693 (721)
Q Consensus 659 ~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i 693 (721)
..+++++.+||.+||+.||++||||+||++.|.+|
T Consensus 224 ~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 224 HLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred ccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 34457899999999999999999999999998754
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-48 Score=394.89 Aligned_cols=239 Identities=20% Similarity=0.350 Sum_probs=201.6
Q ss_pred hhhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEE
Q 004979 429 SNIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMM 507 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~l 507 (721)
+++++.||+|+||+||+|+.. +++.||+|++......+ ....+.+.+|+++|++++|||||++++++.+.+ ..++
T Consensus 8 y~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~--~~~i 83 (263)
T d2j4za1 8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEK--AGVEHQLRREVEIQSHLRHPNILRLYGYFHDAT--RVYL 83 (263)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH--TTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS--EEEE
T ss_pred eEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccC--hHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECC--EEEE
Confidence 367888999999999999975 68899999886433221 223467899999999999999999999999877 7799
Q ss_pred EEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC--
Q 004979 508 VFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT-- 585 (721)
Q Consensus 508 V~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~-- 585 (721)
|||||++|+|.+++.. ...+++..+..|+.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++...
T Consensus 84 vmEy~~~g~L~~~l~~--~~~l~e~~~~~i~~qi~~al~~lH~~~--ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 84 ILEYAPLGTVYRELQK--LSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp EEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred EEeecCCCcHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeeeeccccceecCCCCEeecccceeeecCCC
Confidence 9999999999999864 346999999999999999999999998 9999999999999999999999999986543
Q ss_pred -----CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccHH
Q 004979 586 -----AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQEN 660 (721)
Q Consensus 586 -----~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 660 (721)
.++..|+|||.+.+..|+.++|||||||++|||+||+.||.. .+..+....+......+ +..
T Consensus 160 ~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~--~~~~~~~~~i~~~~~~~-----------p~~ 226 (263)
T d2j4za1 160 RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA--NTYQETYKRISRVEFTF-----------PDF 226 (263)
T ss_dssp CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCC--SSHHHHHHHHHTTCCCC-----------CTT
T ss_pred cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCC--CCHHHHHHHHHcCCCCC-----------Ccc
Confidence 245689999999999999999999999999999999999963 34445555544433222 233
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 661 VLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 661 ~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
.++++.+|+.+||+.||++|||++|+++
T Consensus 227 ~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 227 VTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 4567899999999999999999999975
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-48 Score=400.14 Aligned_cols=240 Identities=18% Similarity=0.301 Sum_probs=197.7
Q ss_pred cCCCCceeEEEEEEec---CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEEEe
Q 004979 434 SFSDGTVGTVYKGTLS---SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFE 510 (721)
Q Consensus 434 ~lg~G~~g~Vyk~~~~---~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV~E 510 (721)
+||+|+||+||+|.++ ++..||||++.... .....++|.+|+++|++++|||||+++|+|.++ ..++|||
T Consensus 16 ~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~----~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~---~~~lvmE 88 (285)
T d1u59a_ 16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT----EKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE---ALMLVME 88 (285)
T ss_dssp EEECCTTEEEEEEEEC---CCEEEEEEEECSSC----CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS---SEEEEEE
T ss_pred EEecccCeEEEEEEEecCCCcEEEEEEEEChhc----CHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC---eEEEEEE
Confidence 4899999999999864 34579999886432 233457899999999999999999999999754 3689999
Q ss_pred cCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC-----
Q 004979 511 YSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT----- 585 (721)
Q Consensus 511 y~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~----- 585 (721)
||++|+|.+++.. ....+++..++.|+.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 89 ~~~~g~L~~~l~~-~~~~l~~~~~~~i~~qi~~gL~ylH~~~--iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~ 165 (285)
T d1u59a_ 89 MAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY 165 (285)
T ss_dssp CCTTEEHHHHHTT-CTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCE
T ss_pred eCCCCcHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCcCchhheeeccCCceeeccchhhhcccccccc
Confidence 9999999998753 3457999999999999999999999988 9999999999999999999999999986322
Q ss_pred -------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccc
Q 004979 586 -------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSF 657 (721)
Q Consensus 586 -------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 657 (721)
.++..|+|||.+....++.++|||||||++|||+| |+.||.... ..+....+..+..+ ..
T Consensus 166 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~--~~~~~~~i~~~~~~----------~~ 233 (285)
T d1u59a_ 166 YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK--GPEVMAFIEQGKRM----------EC 233 (285)
T ss_dssp ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC--THHHHHHHHTTCCC----------CC
T ss_pred cccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCC--HHHHHHHHHcCCCC----------CC
Confidence 23457999999999999999999999999999998 999996433 33444443333211 12
Q ss_pred cHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 004979 658 QENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITA 695 (721)
Q Consensus 658 ~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~ 695 (721)
++.++.++.+||.+||+.||++||||.+|++.|+.+..
T Consensus 234 p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~ 271 (285)
T d1u59a_ 234 PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271 (285)
T ss_dssp CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 34556789999999999999999999999999987543
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-48 Score=401.02 Aligned_cols=243 Identities=22% Similarity=0.272 Sum_probs=201.7
Q ss_pred hhhhhhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCce
Q 004979 426 EDFSNIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFT 504 (721)
Q Consensus 426 ~~~~~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 504 (721)
+++|++++.||+|+||+||+|+.. ++..||||++...... ..+.|.+|+++|++++|||||++++++.+.+ .
T Consensus 11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-----~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~--~ 83 (288)
T d2jfla1 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEE-----ELEDYMVEIDILASCDHPNIVKLLDAFYYEN--N 83 (288)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSG-----GGGGTHHHHHHHHHCCCTTBCCEEEEEEETT--E
T ss_pred ccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHH-----HHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC--e
Confidence 356788999999999999999964 6889999998754322 2356889999999999999999999999877 6
Q ss_pred EEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCC-
Q 004979 505 RMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNN- 583 (721)
Q Consensus 505 ~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~- 583 (721)
.++|||||++|+|.+++.. ....+++.++..|+.||+.||+|||+++ |+||||||+|||++.++++||+|||+++.
T Consensus 84 ~~lvmEy~~~g~L~~~~~~-~~~~l~e~~~~~i~~qi~~gL~ylH~~~--ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~ 160 (288)
T d2jfla1 84 LWILIEFCAGGAVDAVMLE-LERPLTESQIQVVCKQTLDALNYLHDNK--IIHRDLKAGNILFTLDGDIKLADFGVSAKN 160 (288)
T ss_dssp EEEEEECCTTEEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEEecCCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEEeecChhheeECCCCCEEEEechhhhcc
Confidence 7999999999999998753 3456999999999999999999999998 99999999999999999999999999752
Q ss_pred --------CCCCCccccchhhc-----ccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCcccc
Q 004979 584 --------TTAAKTGSAAMELL-----ETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIV 650 (721)
Q Consensus 584 --------~~~~~~~~~apE~~-----~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (721)
...++..|+|||++ ....|+.++|||||||++|||+||+.||...+ ..+....+..+..+..
T Consensus 161 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~--~~~~~~~i~~~~~~~~--- 235 (288)
T d2jfla1 161 TRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELN--PMRVLLKIAKSEPPTL--- 235 (288)
T ss_dssp HHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSC--GGGHHHHHHHSCCCCC---
T ss_pred CCCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCC--HHHHHHHHHcCCCCCC---
Confidence 34467789999997 35668999999999999999999999996432 3333444444432111
Q ss_pred CCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 651 DPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 651 d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
..+..++.++.+|+.+||+.||++|||+.|+++
T Consensus 236 -----~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 236 -----AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp -----SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -----CccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 122345678999999999999999999999875
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-48 Score=399.10 Aligned_cols=245 Identities=19% Similarity=0.271 Sum_probs=193.9
Q ss_pred hhhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEE
Q 004979 429 SNIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMM 507 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~l 507 (721)
+++++.||+|+||+||+|+. .+|+.||||++...... +...+.|.+|+++|++++|||||++++++.+......|+
T Consensus 6 y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~---~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT---EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSC---HHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred CEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCC---HHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 37888999999999999986 46889999998754332 334567999999999999999999999997654335799
Q ss_pred EEecCCCCChhhhhhhc--cCCCCCHHHHHHHHHHHHHHHHHHhcCC---CCeEeeCCCCCCeEeCCCCcEEEeccCCCC
Q 004979 508 VFEYSPNGSLFEHLHIQ--EAEHLDWAMRLRIAMGMAYCLEHMHQLT---PPIAHRNLQSSSIYLTEDYAAKISDFSFWN 582 (721)
Q Consensus 508 V~Ey~~~GsL~~~l~~~--~~~~l~~~~~~~ia~~ia~gL~yLH~~~---~~IvHrDLKp~NILl~~~~~~kL~DFGla~ 582 (721)
|||||++|+|.+++... ....+++..+..|+.||+.||+|||+.+ .+||||||||+|||++.++.+||+|||+++
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 99999999999998643 3567999999999999999999999754 359999999999999999999999999875
Q ss_pred CC---------CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCc
Q 004979 583 NT---------TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPT 653 (721)
Q Consensus 583 ~~---------~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 653 (721)
.. ..++..|+|||.+.+..|+.++|||||||++|||+||+.||... +..+....+..+..+
T Consensus 163 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~--~~~~~~~~i~~~~~~-------- 232 (269)
T d2java1 163 ILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF--SQKELAGKIREGKFR-------- 232 (269)
T ss_dssp HC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS--SHHHHHHHHHHTCCC--------
T ss_pred ecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCC--CHHHHHHHHHcCCCC--------
Confidence 32 23566899999999999999999999999999999999999643 344444444433211
Q ss_pred cccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 654 LKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 654 l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
..+..+++++.+|+.+||+.||++|||+.|+++
T Consensus 233 --~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 233 --RIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 122345578999999999999999999999975
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-47 Score=396.39 Aligned_cols=238 Identities=21% Similarity=0.336 Sum_probs=194.9
Q ss_pred cCCCCceeEEEEEEecC---CcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEEEe
Q 004979 434 SFSDGTVGTVYKGTLSS---GVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVFE 510 (721)
Q Consensus 434 ~lg~G~~g~Vyk~~~~~---~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV~E 510 (721)
+||+|+||+||+|.++. ++.||||++..... .....++|.+|+++|++++|||||+++|+|..+ ..+||||
T Consensus 14 ~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~---~~~lvmE 87 (277)
T d1xbba_ 14 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN---DPALKDELLAEANVMQQLDNPYIVRMIGICEAE---SWMLVME 87 (277)
T ss_dssp EEEECSSEEEEEEEEECSSSEEEEEEEEEC--------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS---SEEEEEE
T ss_pred CcccCCCeEEEEEEEccCCcCeEEEEEEEChhhC---CHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC---CEEEEEE
Confidence 58999999999998653 45799998864322 233457899999999999999999999999754 3589999
Q ss_pred cCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC-----
Q 004979 511 YSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT----- 585 (721)
Q Consensus 511 y~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~----- 585 (721)
||++|+|.++++. ...++|..++.|+.||+.||+|||+++ ||||||||+|||++.++.+||+|||+++...
T Consensus 88 ~~~~g~L~~~l~~--~~~l~~~~~~~i~~qi~~gl~ylH~~~--iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~ 163 (277)
T d1xbba_ 88 MAELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 163 (277)
T ss_dssp CCTTEEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE
T ss_pred cCCCCcHHHHHhh--ccCCCHHHHHHHHHHHHHHHhhHHhCC--cccCCCcchhhcccccCcccccchhhhhhccccccc
Confidence 9999999999863 456999999999999999999999988 9999999999999999999999999986321
Q ss_pred -------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccc
Q 004979 586 -------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSF 657 (721)
Q Consensus 586 -------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 657 (721)
.++..|+|||.+....++.++|||||||++|||+| |+.||... +..+....+..+..+ ..
T Consensus 164 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~--~~~~~~~~i~~~~~~----------~~ 231 (277)
T d1xbba_ 164 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM--KGSEVTAMLEKGERM----------GC 231 (277)
T ss_dssp EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTC--CHHHHHHHHHTTCCC----------CC
T ss_pred cccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCC--CHHHHHHHHHcCCCC----------CC
Confidence 23457999999999999999999999999999998 89999643 333433333333211 12
Q ss_pred cHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 004979 658 QENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEI 693 (721)
Q Consensus 658 ~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i 693 (721)
+..++.++.+||.+||+.||++||||+||++.|+..
T Consensus 232 p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 232 PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 334567899999999999999999999999988774
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-47 Score=395.71 Aligned_cols=238 Identities=21% Similarity=0.293 Sum_probs=198.8
Q ss_pred hhhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEE
Q 004979 429 SNIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMM 507 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~l 507 (721)
|++++.||+|+||+||+|+. .+|+.||||++....... .+.+.+|+++|++++|||||++++++.+.+ ..|+
T Consensus 22 Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~-----~~~~~~E~~il~~l~HpnIv~~~~~~~~~~--~~~i 94 (293)
T d1yhwa1 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK-----KELIINEILVMRENKNPNIVNYLDSYLVGD--ELWV 94 (293)
T ss_dssp BCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC-----HHHHHHHHHHHHHCCCTTBCCEEEEEEETT--EEEE
T ss_pred cEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH-----HHHHHHHHHHHHhCCCCCEeeEeEEEEECC--EEEE
Confidence 57788999999999999995 578999999987543222 357899999999999999999999999877 6799
Q ss_pred EEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC---
Q 004979 508 VFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT--- 584 (721)
Q Consensus 508 V~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~--- 584 (721)
|||||++|+|.+++.. ..+++.++..|+.||+.||+|||+++ |+||||||+|||++.++++||+|||+++..
T Consensus 95 vmEy~~gg~L~~~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~ 169 (293)
T d1yhwa1 95 VMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (293)
T ss_dssp EEECCTTCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EEEecCCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCcHHHeEECCCCcEeeccchhheeeccc
Confidence 9999999999998753 35899999999999999999999998 999999999999999999999999998632
Q ss_pred ------CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCcccccc
Q 004979 585 ------TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQ 658 (721)
Q Consensus 585 ------~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 658 (721)
..++..|+|||.+.+..|+.++|||||||++|||+||+.||... +..+..........+. . ..+
T Consensus 170 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~--~~~~~~~~~~~~~~~~--~------~~~ 239 (293)
T d1yhwa1 170 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE--NPLRALYLIATNGTPE--L------QNP 239 (293)
T ss_dssp TCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTS--CHHHHHHHHHHHCSCC--C------SSG
T ss_pred cccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCC--CHHHHHHHHHhCCCCC--C------CCc
Confidence 22566799999999999999999999999999999999999643 2333333333322111 0 123
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 659 ENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 659 ~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
..++.++.+|+.+||+.||++|||+.|+++
T Consensus 240 ~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 240 EKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp GGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 445678999999999999999999999875
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-47 Score=395.28 Aligned_cols=240 Identities=19% Similarity=0.312 Sum_probs=194.7
Q ss_pred hhhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEE
Q 004979 429 SNIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMM 507 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~l 507 (721)
+++++.||+|+||+||+|+.. +++.||||++...... ...+++.+|+++|++++|||||++++++.+.+ ..|+
T Consensus 7 y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~----~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~--~~~i 80 (271)
T d1nvra_ 7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV----DCPENIKKEICINKMLNHENVVKFYGHRREGN--IQYL 80 (271)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-----------CHHHHHHHHHTCCCTTBCCEEEEEEETT--EEEE
T ss_pred eEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc----hHHHHHHHHHHHHHhCCCCCEeeEeeeeccCc--eeEE
Confidence 367889999999999999964 6889999998754322 22357899999999999999999999999877 7799
Q ss_pred EEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC---
Q 004979 508 VFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT--- 584 (721)
Q Consensus 508 V~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~--- 584 (721)
||||+++|+|.+++. ....+++..+..|+.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 vmEy~~gg~L~~~l~--~~~~l~e~~~~~i~~qi~~al~ylH~~~--IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~ 156 (271)
T d1nvra_ 81 FLEYCSGGELFDRIE--PDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYN 156 (271)
T ss_dssp EEECCTTEEGGGGSB--TTTBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCCTTCEECEET
T ss_pred EEeccCCCcHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHcC--CccCcccHHHEEECCCCCEEEccchhheeeccC
Confidence 999999999999985 3456999999999999999999999998 999999999999999999999999998632
Q ss_pred --------CCCCccccchhhcccCCC-CCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccc
Q 004979 585 --------TAAKTGSAAMELLETSAV-DLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLK 655 (721)
Q Consensus 585 --------~~~~~~~~apE~~~~~~~-s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 655 (721)
..++..|+|||++.+..+ +.++||||+||++|||+||+.||.........+.. .... ....
T Consensus 157 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~-~~~~-~~~~-------- 226 (271)
T d1nvra_ 157 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD-WKEK-KTYL-------- 226 (271)
T ss_dssp TEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHH-HHTT-CTTS--------
T ss_pred CccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHH-HhcC-CCCC--------
Confidence 235678999999988776 57899999999999999999999754433332221 1111 1110
Q ss_pred cccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 656 SFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 656 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
......+.++.+|+.+||+.||++|||++|+++
T Consensus 227 ~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 227 NPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 112334577889999999999999999999864
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-47 Score=397.34 Aligned_cols=247 Identities=20% Similarity=0.295 Sum_probs=204.1
Q ss_pred hhhCcCCCCceeEEEEEEecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVF 509 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV~ 509 (721)
++.+.||+|+||+||+|+++++..||||++..... ..+.|.+|+.+|++++|||||+++|+|.+. ..++||
T Consensus 20 ~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~------~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~---~~~lv~ 90 (285)
T d1fmka3 20 RLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM------SPEAFLQEAQVMKKLRHEKLVQLYAVVSEE---PIYIVT 90 (285)
T ss_dssp EEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS---SCEEEE
T ss_pred EEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccC------CHHHHHHHHHHHHhcccCCEeEEEEEEecC---CeEEEE
Confidence 67788999999999999998888999999864322 135799999999999999999999998654 358999
Q ss_pred ecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC----
Q 004979 510 EYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT---- 585 (721)
Q Consensus 510 Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~---- 585 (721)
||+++|+|..++.......++|.+++.|+.||+.||+|||+.+ |+||||||+||||++++++||+|||+++...
T Consensus 91 Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~--ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~ 168 (285)
T d1fmka3 91 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 168 (285)
T ss_dssp CCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred EecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh--eecccccceEEEECCCCcEEEcccchhhhccCCCc
Confidence 9999999999987665667999999999999999999999988 9999999999999999999999999986432
Q ss_pred ------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccH
Q 004979 586 ------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQE 659 (721)
Q Consensus 586 ------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 659 (721)
.++..|+|||.+....++.++|||||||++|||+||..|+.. .....+....+..+... +.+.
T Consensus 169 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~-~~~~~~~~~~i~~~~~~----------~~~~ 237 (285)
T d1fmka3 169 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP-GMVNREVLDQVERGYRM----------PCPP 237 (285)
T ss_dssp -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST-TCCHHHHHHHHHTTCCC----------CCCT
T ss_pred eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCC-CCCHHHHHHHHHhcCCC----------CCCc
Confidence 234579999999999999999999999999999997766643 23344444444333211 1223
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCC
Q 004979 660 NVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAMEP 698 (721)
Q Consensus 660 ~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 698 (721)
.+++++.++|.+||+.||++||+|++|++.|++......
T Consensus 238 ~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~ 276 (285)
T d1fmka3 238 ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 276 (285)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred ccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCC
Confidence 456789999999999999999999999999998665443
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-47 Score=391.29 Aligned_cols=243 Identities=23% Similarity=0.342 Sum_probs=196.3
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecC--CCceEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEED--EPFTRM 506 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~~~ 506 (721)
++..+||+|+||+||+|+.. +++.||+|++..... .....+.|.+|+++|++++|||||++++++.+. +....+
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~---~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ 88 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL---TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 88 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEE
Confidence 44457899999999999965 678999998875432 233456799999999999999999999998652 223579
Q ss_pred EEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeC-CCCcEEEeccCCCCCCC
Q 004979 507 MVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLT-EDYAAKISDFSFWNNTT 585 (721)
Q Consensus 507 lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~-~~~~~kL~DFGla~~~~ 585 (721)
+||||+++|+|.+++.. ...+++..+..|+.||+.||+|||+++++|+||||||+|||++ +++.+||+|||+++...
T Consensus 89 ivmE~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 89 LVTELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp EEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEEeCCCCCcHHHHHhc--cccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 99999999999999864 3568999999999999999999999888899999999999996 57899999999986432
Q ss_pred -------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCcccccc
Q 004979 586 -------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQ 658 (721)
Q Consensus 586 -------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 658 (721)
.++..|+|||.+.+ .|+.++|||||||++|||+||+.||... .+..+....+..+..+. .+.
T Consensus 167 ~~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~-~~~~~~~~~i~~~~~~~---------~~~ 235 (270)
T d1t4ha_ 167 ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSEC-QNAAQIYRRVTSGVKPA---------SFD 235 (270)
T ss_dssp TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTC-SSHHHHHHHHTTTCCCG---------GGG
T ss_pred CCccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCc-ccHHHHHHHHHcCCCCc---------ccC
Confidence 35678999999865 6999999999999999999999999633 23344444443332211 122
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 659 ENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 659 ~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
...++++.+|+.+||+.||++|||+.|+++
T Consensus 236 ~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 236 KVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp GCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 334567889999999999999999999975
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-48 Score=400.34 Aligned_cols=258 Identities=19% Similarity=0.272 Sum_probs=212.2
Q ss_pred hhhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEE
Q 004979 429 SNIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMM 507 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~l 507 (721)
+++++.||+|+||+||+|+. .+++.||||++....... ....+.+.+|+++|++++|||||++++++.+.+ ..|+
T Consensus 10 y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~--~~~i 85 (288)
T d1uu3a_ 10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK--ENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDE--KLYF 85 (288)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH--TTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSS--EEEE
T ss_pred CEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccC--HHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECC--EEEE
Confidence 37888999999999999996 468899999986433211 223467999999999999999999999999877 6799
Q ss_pred EEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC---
Q 004979 508 VFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT--- 584 (721)
Q Consensus 508 V~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~--- 584 (721)
|||||++|+|.+++.. ...+++..+..++.|++.||+|||+++ ||||||||+|||+++++.+||+|||+++..
T Consensus 86 vmEy~~gg~L~~~~~~--~~~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 86 GLSYAKNGELLKYIRK--IGSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp EECCCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EEEccCCCCHHHhhhc--cCCCCHHHHHHHHHHHHHHHHhhcccc--EEcCcCCccccccCCCceEEecccccceecccC
Confidence 9999999999998864 356999999999999999999999998 999999999999999999999999998632
Q ss_pred --------CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCcccc
Q 004979 585 --------TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKS 656 (721)
Q Consensus 585 --------~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 656 (721)
..++..|+|||++.+..|+.++||||+||++|||+||+.||... +..+....+..+...
T Consensus 162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~--~~~~~~~~i~~~~~~----------- 228 (288)
T d1uu3a_ 162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG--NEYLIFQKIIKLEYD----------- 228 (288)
T ss_dssp --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHTTCCC-----------
T ss_pred CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCc--CHHHHHHHHHcCCCC-----------
Confidence 23567899999999999999999999999999999999999643 444444555444322
Q ss_pred ccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCChhHHHHHH
Q 004979 657 FQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAMEPDGATPKLSPLWWAELE 714 (721)
Q Consensus 657 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~~~~p~~~~~~~~~l~ 714 (721)
++...++++.+||.+||+.||++|||++|+++.- .++ .+|++..++|+.|+
T Consensus 229 ~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~-~i~------~Hpff~~i~w~~l~ 279 (288)
T d1uu3a_ 229 FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYG-PLK------AHPFFESVTWENLH 279 (288)
T ss_dssp CCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHH-HHH------TSGGGTTCCCTTGG
T ss_pred CCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCH-HHH------cCCccCCCCHHHhh
Confidence 2234456789999999999999999999975421 121 36778888888764
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-47 Score=393.54 Aligned_cols=246 Identities=20% Similarity=0.298 Sum_probs=197.4
Q ss_pred hhCcCCCCceeEEEEEEecCC-----cEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceE
Q 004979 431 IIGSFSDGTVGTVYKGTLSSG-----VEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTR 505 (721)
Q Consensus 431 ii~~lg~G~~g~Vyk~~~~~~-----~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~ 505 (721)
+...||+|+||+||+|+++.. ..||||++.... ......+|.+|+++|++++|||||+++|++.+.+ ..
T Consensus 11 ~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~----~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~--~~ 84 (283)
T d1mqba_ 11 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY----TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK--PM 84 (283)
T ss_dssp EEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC----CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS--SE
T ss_pred eeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc----ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCC--ce
Confidence 445678999999999997643 368999875332 2334567999999999999999999999998877 56
Q ss_pred EEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC
Q 004979 506 MMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT 585 (721)
Q Consensus 506 ~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~ 585 (721)
++|||||.+|++.+++.. ....++|.+++.|+.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++...
T Consensus 85 ~~v~e~~~~~~l~~~~~~-~~~~~~~~~~~~i~~~i~~gl~~lH~~~--iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 85 MIITEYMENGALDKFLRE-KDGEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 161 (283)
T ss_dssp EEEEECCTTEEHHHHHHH-TTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEEEEecccCcchhhhhc-ccccccHHHHHHHHHHHHHhhhhccccc--cccCccccceEEECCCCeEEEcccchhhccc
Confidence 999999999999988753 3457999999999999999999999988 9999999999999999999999999986432
Q ss_pred ------------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCc
Q 004979 586 ------------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPT 653 (721)
Q Consensus 586 ------------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 653 (721)
.++..|+|||.+....++.++|||||||++|||+||..|+... ....+....+..+..
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~-~~~~~~~~~i~~~~~--------- 231 (283)
T d1mqba_ 162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE-LSNHEVMKAINDGFR--------- 231 (283)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHHHTTCC---------
T ss_pred CCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCcccc-CCHHHHHHHHhccCC---------
Confidence 1345699999999999999999999999999999976665432 333444444333211
Q ss_pred cccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 004979 654 LKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAM 696 (721)
Q Consensus 654 l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~ 696 (721)
...+..++.++.+||.+||+.||++||||.||++.|+++.+.
T Consensus 232 -~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 232 -LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp -CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred -CCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 112234557789999999999999999999999999988764
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-47 Score=391.53 Aligned_cols=244 Identities=25% Similarity=0.422 Sum_probs=198.0
Q ss_pred hhhCcCCCCceeEEEEEEecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVF 509 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV~ 509 (721)
++++.||+|+||.||+|+++ |..||||+++... ..++|.+|++++++++|||||+++|+|.+.+. ..++||
T Consensus 10 ~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~-------~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~-~~~lv~ 80 (262)
T d1byga_ 10 KLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-------TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG-GLYIVT 80 (262)
T ss_dssp EEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC---------HHHHHTHHHHTTCCCTTBCCEEEEECCC---CCEEEE
T ss_pred EEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHH-------HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCC-cEEEEE
Confidence 56778999999999999985 7789999985422 23579999999999999999999999965432 459999
Q ss_pred ecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC----
Q 004979 510 EYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT---- 585 (721)
Q Consensus 510 Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~---- 585 (721)
||+++|+|.++++.+....++|..+++|+.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 81 ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~--ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~~ 158 (262)
T d1byga_ 81 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD 158 (262)
T ss_dssp CCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred eccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCc--eeccccchHhheecCCCCEeecccccceecCCCCc
Confidence 9999999999997655556899999999999999999999987 9999999999999999999999999987432
Q ss_pred --CCCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccHHHH
Q 004979 586 --AAKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQENVL 662 (721)
Q Consensus 586 --~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 662 (721)
.++..|+|||.+.+..++.++|||||||++|||+| |+.||... ...+....+..+.. .+.+..++
T Consensus 159 ~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~--~~~~~~~~i~~~~~----------~~~~~~~~ 226 (262)
T d1byga_ 159 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI--PLKDVVPRVEKGYK----------MDAPDGCP 226 (262)
T ss_dssp ---CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS--CGGGHHHHHTTTCC----------CCCCTTCC
T ss_pred cccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCC--CHHHHHHHHHcCCC----------CCCCccCC
Confidence 23457899999999999999999999999999999 67777533 23333333332211 12233455
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 004979 663 EELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAM 696 (721)
Q Consensus 663 ~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~ 696 (721)
.++.+|+.+||+.||++||||.||+++|++++..
T Consensus 227 ~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~ 260 (262)
T d1byga_ 227 PAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260 (262)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence 7889999999999999999999999999998653
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.2e-47 Score=396.84 Aligned_cols=241 Identities=17% Similarity=0.208 Sum_probs=198.7
Q ss_pred hhhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEE
Q 004979 429 SNIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMM 507 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~l 507 (721)
+++++.||+|+||+||+|+. .++..||||++....... ....+.|.+|+++|++++|||||++++++.+.+ ..|+
T Consensus 17 y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~--~~~i 92 (309)
T d1u5ra_ 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQS--NEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH--TAWL 92 (309)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCH--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT--EEEE
T ss_pred cEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccC--HHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECC--EEEE
Confidence 47788999999999999995 468889999987543322 334567999999999999999999999998877 6799
Q ss_pred EEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC--
Q 004979 508 VFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT-- 585 (721)
Q Consensus 508 V~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~-- 585 (721)
|||||++|+|..++. ....+++..+..|+.||+.||+|||+++ ||||||||+|||+++++.+||+|||+++...
T Consensus 93 v~E~~~~g~l~~~~~--~~~~l~e~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~ 168 (309)
T d1u5ra_ 93 VMEYCLGSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (309)
T ss_dssp EEECCSEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred EEEecCCCchHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEECCCCCEEEeecccccccCCC
Confidence 999999999976654 3457999999999999999999999998 9999999999999999999999999986433
Q ss_pred ---CCCccccchhhccc---CCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccH
Q 004979 586 ---AAKTGSAAMELLET---SAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQE 659 (721)
Q Consensus 586 ---~~~~~~~apE~~~~---~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 659 (721)
.++..|+|||++.+ ..|+.++|||||||++|||+||+.||... ...+.......+..+. .. ..
T Consensus 169 ~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~--~~~~~~~~i~~~~~~~--~~-------~~ 237 (309)
T d1u5ra_ 169 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM--NAMSALYHIAQNESPA--LQ-------SG 237 (309)
T ss_dssp CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS--CHHHHHHHHHHSCCCC--CS-------CT
T ss_pred CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCC--CHHHHHHHHHhCCCCC--CC-------CC
Confidence 45678999999853 56899999999999999999999999633 3334444444432221 11 12
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 660 NVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 660 ~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
.+++++.+|+.+||+.||++|||+.|+++
T Consensus 238 ~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 238 HWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 34568999999999999999999999975
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-47 Score=401.60 Aligned_cols=250 Identities=18% Similarity=0.288 Sum_probs=196.8
Q ss_pred hhhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEE
Q 004979 429 SNIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMM 507 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~l 507 (721)
+++++.||+|+||+||+|+.. ++..||+|++..... .....++.+|+++|++++|||||+++++|.+.+ +.++
T Consensus 8 y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~--~~~i 81 (322)
T d1s9ja_ 8 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK----PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG--EISI 81 (322)
T ss_dssp EEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCC----TTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSS--EEEE
T ss_pred CEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhC----HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC--EEEE
Confidence 478899999999999999964 688999999865422 233567999999999999999999999999877 7899
Q ss_pred EEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCC---
Q 004979 508 VFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQ-LTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNN--- 583 (721)
Q Consensus 508 V~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~-~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~--- 583 (721)
|||||++|+|.+++... ..+++..+..++.|++.||.|||+ ++ |+||||||+|||+++++++||+|||+++.
T Consensus 82 VmEy~~gg~L~~~l~~~--~~l~~~~~~~~~~qil~aL~yLH~~~~--IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 82 CMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp EEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred EEEcCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHhCC--EEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence 99999999999999643 469999999999999999999997 47 99999999999999999999999999852
Q ss_pred ----CCCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHH-hhcCCC------------C
Q 004979 584 ----TTAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEY-LKGEQP------------L 646 (721)
Q Consensus 584 ----~~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~-~~~~~~------------~ 646 (721)
...++..|+|||++.+..|+.++||||+||++|||+||+.||...+.......... ..+... .
T Consensus 158 ~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (322)
T d1s9ja_ 158 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 237 (322)
T ss_dssp HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------------------
T ss_pred CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccc
Confidence 33567889999999999999999999999999999999999975543322111000 000000 0
Q ss_pred c-cccC--Ccc--------------ccc-cHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 647 K-DIVD--PTL--------------KSF-QENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 647 ~-~~~d--~~l--------------~~~-~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
. ...+ +.. ... ....+.++.+|+.+||+.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 238 SSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp --------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 0 0000 000 000 0123467899999999999999999999987
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.2e-47 Score=397.37 Aligned_cols=246 Identities=23% Similarity=0.353 Sum_probs=202.9
Q ss_pred hhhCcCCCCceeEEEEEEec------CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCc
Q 004979 430 NIIGSFSDGTVGTVYKGTLS------SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPF 503 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~------~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 503 (721)
++++.||+|+||+||+|++. ++..||||++.... .....++|.+|+++|++++||||++++++|...+
T Consensus 16 ~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~----~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~-- 89 (301)
T d1lufa_ 16 EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA----SADMQADFQREAALMAEFDNPNIVKLLGVCAVGK-- 89 (301)
T ss_dssp EEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC----CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS--
T ss_pred EEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc----ChHHHHHHHHHHHHHHhcCCCCcccceeeeccCC--
Confidence 78899999999999999864 34689999886432 2344678999999999999999999999998876
Q ss_pred eEEEEEecCCCCChhhhhhhcc----------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCC
Q 004979 504 TRMMVFEYSPNGSLFEHLHIQE----------------------AEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQ 561 (721)
Q Consensus 504 ~~~lV~Ey~~~GsL~~~l~~~~----------------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLK 561 (721)
..++||||+++|+|.++++... ...++|..++.|+.|++.||+|||+++ |||||||
T Consensus 90 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~--ivHrDlK 167 (301)
T d1lufa_ 90 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHRDLA 167 (301)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCS
T ss_pred ceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC--eEeeEEc
Confidence 5699999999999999986321 235899999999999999999999988 9999999
Q ss_pred CCCeEeCCCCcEEEeccCCCCCC-----------CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCC-CcccCCC
Q 004979 562 SSSIYLTEDYAAKISDFSFWNNT-----------TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGR-ISYSIEN 629 (721)
Q Consensus 562 p~NILl~~~~~~kL~DFGla~~~-----------~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~-~P~~~~~ 629 (721)
|+|||+|.++++||+|||+++.. ..++..|+|||.+....|+.++|||||||++|||+||. .||. +
T Consensus 168 p~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~--~ 245 (301)
T d1lufa_ 168 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY--G 245 (301)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT--T
T ss_pred ccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCC--C
Confidence 99999999999999999997521 22345799999999999999999999999999999986 5664 2
Q ss_pred CCHHHHHHHHhhcCCCCccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 004979 630 GSLENWASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITA 695 (721)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~ 695 (721)
.+..+....+..+.. ...+..++.++.+|+.+||+.||++||||.||++.|+++++
T Consensus 246 ~~~~e~~~~v~~~~~----------~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~ 301 (301)
T d1lufa_ 246 MAHEEVIYYVRDGNI----------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 301 (301)
T ss_dssp SCHHHHHHHHHTTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred CCHHHHHHHHHcCCC----------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 344444444443321 11233455789999999999999999999999999999864
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-47 Score=401.32 Aligned_cols=243 Identities=21% Similarity=0.346 Sum_probs=194.6
Q ss_pred hhhCcCCCCceeEEEEEEecC-C-----cEEEEEEeeeccccchhhHHHHHHHHHHHHHhcC-CCCccceEeEEEecCCC
Q 004979 430 NIIGSFSDGTVGTVYKGTLSS-G-----VEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKV-NHKNFVNLIGYCEEDEP 502 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~~-~-----~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~ 502 (721)
++.+.||+|+||+||+|++.. + ..||||++..... ......|.+|+.+|.++ +|||||+++|++.+.+
T Consensus 40 ~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~- 114 (325)
T d1rjba_ 40 EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD----SSEREALMSELKMMTQLGSHENIVNLLGACTLSG- 114 (325)
T ss_dssp EEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred EEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccC----HHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC-
Confidence 677889999999999998643 2 2578887654321 22346789999999998 8999999999999877
Q ss_pred ceEEEEEecCCCCChhhhhhhcc---------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCC
Q 004979 503 FTRMMVFEYSPNGSLFEHLHIQE---------------------AEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQ 561 (721)
Q Consensus 503 ~~~~lV~Ey~~~GsL~~~l~~~~---------------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLK 561 (721)
..++|||||++|+|.++|+... ...++|..++.|+.||+.||+|||+++ |||||||
T Consensus 115 -~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~--IiHRDlK 191 (325)
T d1rjba_ 115 -PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CVHRDLA 191 (325)
T ss_dssp -SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--EEETTCS
T ss_pred -eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCc
Confidence 5699999999999999997432 135899999999999999999999988 9999999
Q ss_pred CCCeEeCCCCcEEEeccCCCCCCCC-----------CCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCC
Q 004979 562 SSSIYLTEDYAAKISDFSFWNNTTA-----------AKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIEN 629 (721)
Q Consensus 562 p~NILl~~~~~~kL~DFGla~~~~~-----------~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~ 629 (721)
|+|||++.++.+||+|||+++.... ++..|+|||.+.+..|+.++|||||||++|||+| |+.||....
T Consensus 192 p~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~ 271 (325)
T d1rjba_ 192 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 271 (325)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999864321 2457999999999999999999999999999998 899996443
Q ss_pred CCHHHHHHHHhhcCCCCccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 004979 630 GSLENWASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLK 691 (721)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 691 (721)
.. +.+...+...... +.+..+++++.+||.+||+.||++||||+||++.|.
T Consensus 272 ~~--~~~~~~~~~~~~~---------~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 272 VD--ANFYKLIQNGFKM---------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp CS--HHHHHHHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HH--HHHHHHHhcCCCC---------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 32 2223333332211 123345678999999999999999999999999885
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-46 Score=389.44 Aligned_cols=248 Identities=19% Similarity=0.280 Sum_probs=203.1
Q ss_pred hhhhhhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccch-hhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCc
Q 004979 426 EDFSNIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADW-SKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPF 503 (721)
Q Consensus 426 ~~~~~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 503 (721)
++.|++++.||+|+||+||+|+. .+|+.||||++........ .....+.|.+|+++|++++|||||++++++.+.+
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-- 86 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKT-- 86 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS--
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC--
Confidence 35568889999999999999996 4789999999875432221 1123467999999999999999999999999877
Q ss_pred eEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCC----cEEEeccC
Q 004979 504 TRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDY----AAKISDFS 579 (721)
Q Consensus 504 ~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~----~~kL~DFG 579 (721)
..|||||||++|+|.+++... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++ .+||+|||
T Consensus 87 ~~~iv~E~~~gg~L~~~i~~~--~~l~~~~~~~~~~qi~~al~yLH~~~--ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 87 DVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp EEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEEEcCCCccccchhccc--cccchhHHHHHHHHHHHHHHhhhhcc--eeecccccceEEEecCCCcccceEecchh
Confidence 779999999999999998643 46999999999999999999999998 99999999999999776 49999999
Q ss_pred CCCCC--------CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccC
Q 004979 580 FWNNT--------TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVD 651 (721)
Q Consensus 580 la~~~--------~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d 651 (721)
+++.. ..++..|+|||.+.+..++.++|||||||++|||+||+.||... +..+....+.........
T Consensus 163 ~a~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~--~~~~~~~~i~~~~~~~~~--- 237 (293)
T d1jksa_ 163 LAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD--TKQETLANVSAVNYEFED--- 237 (293)
T ss_dssp TCEECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHTTCCCCCH---
T ss_pred hhhhcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCC--CHHHHHHHHHhcCCCCCc---
Confidence 98533 23455799999999999999999999999999999999999643 344444444433222111
Q ss_pred CccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 652 PTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 652 ~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
......+.++.+|+.+||+.||++|||++|+++
T Consensus 238 ----~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 238 ----EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp ----HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ----hhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 122344577899999999999999999999976
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=8.7e-46 Score=390.44 Aligned_cols=238 Identities=19% Similarity=0.269 Sum_probs=200.6
Q ss_pred hhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
++++.||+|+||+||+|+. .+|+.||||++....... ....+.+.+|+.+|++++|||||++++++.+.+ ..|+|
T Consensus 7 ~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~--~~~iv 82 (316)
T d1fota_ 7 QILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVR--LKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQ--QIFMI 82 (316)
T ss_dssp EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH--TTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSS--EEEEE
T ss_pred EEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccC--HHHHHHHHHHHHHHHhccCcChhheeeeEeeCC--eeeeE
Confidence 7889999999999999996 468999999986432211 223467999999999999999999999999877 78999
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC----
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT---- 584 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~---- 584 (721)
||||++|+|..++. ....+++.....++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 83 mE~~~gg~l~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~ 158 (316)
T d1fota_ 83 MDYIEGGELFSLLR--KSQRFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT 158 (316)
T ss_dssp ECCCCSCBHHHHHH--HTSSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTSCEEECCCSSCEECSSCB
T ss_pred eeecCCcccccccc--ccccccccHHHHHHHHHHHhhhhhccCc--EEccccCchheeEcCCCCEEEecCccceEecccc
Confidence 99999999998886 3456888899999999999999999998 999999999999999999999999998643
Q ss_pred --CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccHHHH
Q 004979 585 --TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQENVL 662 (721)
Q Consensus 585 --~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 662 (721)
..++..|+|||.+.+..|+.++||||+||++|||+||+.||.. .+..+....+..+.... ++..+
T Consensus 159 ~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~--~~~~~~~~~i~~~~~~~-----------p~~~s 225 (316)
T d1fota_ 159 YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD--SNTMKTYEKILNAELRF-----------PPFFN 225 (316)
T ss_dssp CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC--SSHHHHHHHHHHCCCCC-----------CTTSC
T ss_pred ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCC--cCHHHHHHHHHcCCCCC-----------CCCCC
Confidence 3466789999999999999999999999999999999999963 34455555555543322 22345
Q ss_pred HHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 004979 663 EELLVVIKNCVHPDPKQRP-----SMRGIAA 688 (721)
Q Consensus 663 ~~l~~li~~Cl~~dP~~RP-----s~~evl~ 688 (721)
+++.+++.+||+.||.+|+ |++|+++
T Consensus 226 ~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 226 EDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp HHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred HHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 6788999999999999996 8888875
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.4e-46 Score=389.85 Aligned_cols=243 Identities=19% Similarity=0.289 Sum_probs=191.9
Q ss_pred hhhhhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceE
Q 004979 427 DFSNIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTR 505 (721)
Q Consensus 427 ~~~~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~ 505 (721)
+.|++++.||+|+||+||+|+.. +++.||||++...... .....+.+|+++|++++|||||++++++.+.+ ..
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~--~~ 82 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE----GKEGSMENEIAVLHKIKHPNIVALDDIYESGG--HL 82 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC--------------CHHHHHHHTCCCTTBCCEEEEEECSS--EE
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh----hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC--EE
Confidence 44678899999999999999965 6889999998754322 12356889999999999999999999999877 67
Q ss_pred EEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeC---CCCcEEEeccCCCC
Q 004979 506 MMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLT---EDYAAKISDFSFWN 582 (721)
Q Consensus 506 ~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~---~~~~~kL~DFGla~ 582 (721)
|+|||||++|+|.+++.. ...+++..+..|+.||+.||+|||+++ |+||||||+|||+. +++.+||+|||+++
T Consensus 83 ~lvmE~~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~ 158 (307)
T d1a06a_ 83 YLIMQLVSGGELFDRIVE--KGFYTERDASRLIFQVLDAVKYLHDLG--IVHRDLKPENLLYYSLDEDSKIMISDFGLSK 158 (307)
T ss_dssp EEEECCCCSCBHHHHHHT--CSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEECCC----
T ss_pred EEEEeccCCCcHHHhhhc--ccCCCHHHHHHHHHHHHHHHHhhhhce--eeeEEecccceeecccCCCceEEEeccceeE
Confidence 999999999999999963 456999999999999999999999998 99999999999994 57899999999986
Q ss_pred CC--------CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCcc
Q 004979 583 NT--------TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTL 654 (721)
Q Consensus 583 ~~--------~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 654 (721)
.. ..++..|+|||.+.+..|+.++|||||||++|||+||+.||... ...+....+..+......
T Consensus 159 ~~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~--~~~~~~~~i~~~~~~~~~------ 230 (307)
T d1a06a_ 159 MEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDE--NDAKLFEQILKAEYEFDS------ 230 (307)
T ss_dssp --------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS--SHHHHHHHHHTTCCCCCT------
T ss_pred EccCCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCC--CHHHHHHHHhccCCCCCC------
Confidence 33 23567899999999999999999999999999999999999643 334444444444322211
Q ss_pred ccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 655 KSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 655 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
......++++.+|+.+||+.||++|||+.|+++
T Consensus 231 -~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 231 -PYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp -TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -ccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 112345578899999999999999999999976
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-46 Score=386.88 Aligned_cols=245 Identities=23% Similarity=0.355 Sum_probs=192.9
Q ss_pred hhhCcCCCCceeEEEEEEecC--C--cEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceE
Q 004979 430 NIIGSFSDGTVGTVYKGTLSS--G--VEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTR 505 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~~--~--~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~ 505 (721)
++++.||+|+||+||+|++.. + ..||||++...... .....++|.+|+++|++++|||||+++|+|.++ ..
T Consensus 11 ~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~---~~ 85 (273)
T d1u46a_ 11 RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLS--QPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP---PM 85 (273)
T ss_dssp EEEEECC----CCCEEEEEECTTSCEEEEEEEC----------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS---SC
T ss_pred EEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcC--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec---ch
Confidence 778899999999999998642 2 36788877543322 233457899999999999999999999999764 35
Q ss_pred EEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC
Q 004979 506 MMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT 585 (721)
Q Consensus 506 ~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~ 585 (721)
++||||+++|++.+++..+ ...+++..++.++.|||.||+|||+++ |+||||||+|||++.++++||+|||+++...
T Consensus 86 ~lv~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp EEEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred heeeeeecCcchhhhhhcc-cCCCCHHHHHHHHHHHHHHHHHhhhCC--EeeeeecHHHhccccccceeeccchhhhhcc
Confidence 8999999999999987643 346999999999999999999999988 9999999999999999999999999986432
Q ss_pred C------------CCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhcCCCCccccCC
Q 004979 586 A------------AKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPLKDIVDP 652 (721)
Q Consensus 586 ~------------~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 652 (721)
. ++..|+|||.+....++.++|||||||++|||+| |+.||.. .+..+....+.......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~--~~~~~~~~~i~~~~~~~------ 234 (273)
T d1u46a_ 163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIG--LNGSQILHKIDKEGERL------ 234 (273)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTT--CCHHHHHHHHHTSCCCC------
T ss_pred cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCC--cCHHHHHHHHHhCCCCC------
Confidence 1 2346899999999999999999999999999998 8999963 34445445544432211
Q ss_pred ccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 004979 653 TLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEI 693 (721)
Q Consensus 653 ~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i 693 (721)
+.+..++.++.+|+.+||+.||++||||.||.+.|++.
T Consensus 235 ---~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 235 ---PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 11234456789999999999999999999999998875
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-45 Score=390.83 Aligned_cols=238 Identities=20% Similarity=0.266 Sum_probs=200.4
Q ss_pred hhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
++++.||+|+||+||+|+. .+++.||+|++....... ....+.+.+|+++|++++|||||++++++.+.+ ..|+|
T Consensus 8 ~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~--~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~--~~~iv 83 (337)
T d1o6la_ 8 DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIA--KDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD--RLCFV 83 (337)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH--TTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSS--EEEEE
T ss_pred EEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccC--HHHHHHHHHHHHHHHhCCCCCEEEEEeeecccc--ccccc
Confidence 7888999999999999996 578999999987543221 223467899999999999999999999999887 78999
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC---
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT--- 585 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~--- 585 (721)
||||++|+|.+++.. ...+++.....++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++...
T Consensus 84 ~ey~~gg~L~~~~~~--~~~~~e~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~ 159 (337)
T d1o6la_ 84 MEYANGGELFFHLSR--ERVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp EECCTTCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred eeccCCCchhhhhhc--ccCCcHHHHHHHHHHHhhhhhhhhhcC--ccccccCHHHeEecCCCCEEEeecccccccccCC
Confidence 999999999999864 356899999999999999999999998 9999999999999999999999999986432
Q ss_pred ------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccH
Q 004979 586 ------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQE 659 (721)
Q Consensus 586 ------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 659 (721)
.++..|+|||++.+..|+.++||||+||++|||+||+.||... +..+.......+... ++.
T Consensus 160 ~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~--~~~~~~~~i~~~~~~-----------~p~ 226 (337)
T d1o6la_ 160 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ--DHERLFELILMEEIR-----------FPR 226 (337)
T ss_dssp CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHCCCC-----------CCT
T ss_pred cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCc--CHHHHHHHHhcCCCC-----------CCc
Confidence 2456799999999999999999999999999999999999643 444555555544322 223
Q ss_pred HHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 004979 660 NVLEELLVVIKNCVHPDPKQRPS-----MRGIAA 688 (721)
Q Consensus 660 ~~~~~l~~li~~Cl~~dP~~RPs-----~~evl~ 688 (721)
..+.++.+||.+||+.||++||+ +.|+++
T Consensus 227 ~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 227 TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred cCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 45567899999999999999995 777765
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-45 Score=385.90 Aligned_cols=249 Identities=23% Similarity=0.349 Sum_probs=198.7
Q ss_pred CcCCCCceeEEEEEEecCC----cEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 433 GSFSDGTVGTVYKGTLSSG----VEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 433 ~~lg~G~~g~Vyk~~~~~~----~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
+.||+|+||+||+|++..+ ..||||++.... .....++|.+|+++|++++|||||+++|+|.+.+. ..++|
T Consensus 33 ~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~----~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~-~~~lv 107 (311)
T d1r0pa_ 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT----DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG-SPLVV 107 (311)
T ss_dssp EEEEEETTEEEEEEEECC----CEEEEEEEECCCC----CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTT-EEEEE
T ss_pred eEEeecCCeEEEEEEEECCCCEEEEEEEEEECccc----CHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCC-ceEEE
Confidence 3578999999999997532 357888875321 23445789999999999999999999999876443 57999
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC---
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT--- 585 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~--- 585 (721)
||||++|+|.++++. ....+++..+++++.|+++||.|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 108 ~E~~~~g~l~~~~~~-~~~~~~~~~~~~i~~qia~gL~~lH~~~--iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~ 184 (311)
T d1r0pa_ 108 LPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 184 (311)
T ss_dssp EECCTTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred EEEeecCchhhhhcc-ccccchHHHHHHHHHHHHHhhhhhcccC--cccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence 999999999998863 4456889999999999999999999988 9999999999999999999999999986432
Q ss_pred ----------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccc
Q 004979 586 ----------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLK 655 (721)
Q Consensus 586 ----------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 655 (721)
.++..|+|||.+....++.++|||||||++|||+||+.||.... +..++...+..+..+
T Consensus 185 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~-~~~~~~~~i~~g~~~---------- 253 (311)
T d1r0pa_ 185 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-NTFDITVYLLQGRRL---------- 253 (311)
T ss_dssp CCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------CHHHHHTTCCC----------
T ss_pred cccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCC-CHHHHHHHHHcCCCC----------
Confidence 13456899999999999999999999999999999888875332 223333333333221
Q ss_pred cccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCCCC
Q 004979 656 SFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAMEPDG 700 (721)
Q Consensus 656 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~~ 700 (721)
..+..+++++.+||.+||+.||++||+|.||++.|+++......+
T Consensus 254 ~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~~ 298 (311)
T d1r0pa_ 254 LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 298 (311)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhhh
Confidence 112334567899999999999999999999999999998765443
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=3.6e-45 Score=391.12 Aligned_cols=243 Identities=17% Similarity=0.295 Sum_probs=202.1
Q ss_pred hhhhhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceE
Q 004979 427 DFSNIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTR 505 (721)
Q Consensus 427 ~~~~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~ 505 (721)
+.|++++.||+|+||+||+|+. .+|+.||||++..... ...+.+.+|+++|++++|||||++++++.+.+ ..
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~-----~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~--~~ 101 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP-----LDKYTVKNEISIMNQLHHPKLINLHDAFEDKY--EM 101 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH-----HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSS--EE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcch-----hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC--EE
Confidence 3458889999999999999996 4789999998865432 23467889999999999999999999999877 77
Q ss_pred EEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeC--CCCcEEEeccCCCCC
Q 004979 506 MMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLT--EDYAAKISDFSFWNN 583 (721)
Q Consensus 506 ~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~--~~~~~kL~DFGla~~ 583 (721)
|+|||||++|+|.+++.. ....+++..+..|+.||+.||+|||+++ ||||||||+|||++ .++.+||+|||+++.
T Consensus 102 ~ivmE~~~gg~L~~~~~~-~~~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHRDiKp~NILl~~~~~~~vkL~DFGla~~ 178 (352)
T d1koba_ 102 VLILEFLSGGELFDRIAA-EDYKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATK 178 (352)
T ss_dssp EEEEECCCCCBHHHHTTC-TTCCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCCTTCEE
T ss_pred EEEEEcCCCChHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccccccccccccCCCeEEEeeccccee
Confidence 999999999999988753 3456999999999999999999999998 99999999999998 678999999999864
Q ss_pred CC--------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccc
Q 004979 584 TT--------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLK 655 (721)
Q Consensus 584 ~~--------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 655 (721)
.. .++..|+|||++.+..|+.++||||+||++|||+||+.||.. .+..+....+..+......
T Consensus 179 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~--~~~~~~~~~i~~~~~~~~~------- 249 (352)
T d1koba_ 179 LNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAG--EDDLETLQNVKRCDWEFDE------- 249 (352)
T ss_dssp CCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC--SSHHHHHHHHHHCCCCCCS-------
T ss_pred cCCCCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCC--CCHHHHHHHHHhCCCCCCc-------
Confidence 32 345678999999999999999999999999999999999963 3344445555544332211
Q ss_pred cccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 656 SFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 656 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
......+.++.+|+.+||+.||++|||+.|+++
T Consensus 250 ~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 250 DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 112345577899999999999999999999976
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-46 Score=392.46 Aligned_cols=244 Identities=19% Similarity=0.326 Sum_probs=195.5
Q ss_pred hhhCcCCCCceeEEEEEEec-CCc----EEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCce
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGV----EIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFT 504 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~----~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 504 (721)
++++.||+|+||+||+|++. +|+ .||+|++.... .....++|.+|+++|++++|||||+++|+|.+.+
T Consensus 12 ~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~--- 84 (317)
T d1xkka_ 12 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT----SPKANKEILDEAYVMASVDNPHVCRLLGICLTST--- 84 (317)
T ss_dssp EEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC--------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSS---
T ss_pred EEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc----CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC---
Confidence 67889999999999999864 443 47777664322 1223568999999999999999999999998754
Q ss_pred EEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC
Q 004979 505 RMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT 584 (721)
Q Consensus 505 ~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~ 584 (721)
.++++||+.+|+|.+++.. ....+++..++.|+.||+.||+|||+++ ||||||||+|||++.++.+||+|||+++..
T Consensus 85 ~~~v~e~~~~~~l~~~~~~-~~~~~~~~~~~~i~~qi~~gl~yLH~~~--iiHrDlKp~NIll~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 85 VQLITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLL 161 (317)
T ss_dssp EEEEEECCTTCBHHHHHHH-TSSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred eeEEEEeccCCcccccccc-cccCCCHHHHHHHHHHHHHHHHHHHHcC--cccCcchhhcceeCCCCCeEeeccccceec
Confidence 5789999999999998764 4567999999999999999999999988 999999999999999999999999987532
Q ss_pred C-----------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhcCCCCccccCC
Q 004979 585 T-----------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPLKDIVDP 652 (721)
Q Consensus 585 ~-----------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 652 (721)
. .++..|+|||.+.+..|+.++|||||||++|||+| |+.||.... ..+....+..+...
T Consensus 162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~--~~~~~~~i~~~~~~------- 232 (317)
T d1xkka_ 162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP--ASEISSILEKGERL------- 232 (317)
T ss_dssp TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC--GGGHHHHHHHTCCC-------
T ss_pred ccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCC--HHHHHHHHHcCCCC-------
Confidence 1 23567999999999999999999999999999999 788886433 22222223232211
Q ss_pred ccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 004979 653 TLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITA 695 (721)
Q Consensus 653 ~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~ 695 (721)
..++.++.++.+|+.+||+.||++||||.||++.|+.+..
T Consensus 233 ---~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 233 ---PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp ---CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 1223455788999999999999999999999999988753
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-45 Score=382.39 Aligned_cols=246 Identities=20% Similarity=0.330 Sum_probs=194.8
Q ss_pred hhhhCcCCCCceeEEEEEEecC----CcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCce
Q 004979 429 SNIIGSFSDGTVGTVYKGTLSS----GVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFT 504 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~~----~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 504 (721)
+++.+.||+|+||+||+|++.. +..||||++.... .....+.|.+|+++|++++|||||+++|++.+. .
T Consensus 9 ~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~----~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~---~ 81 (273)
T d1mp8a_ 9 IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT----SDSVREKFLQEALTMRQFDHPHIVKLIGVITEN---P 81 (273)
T ss_dssp EEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT----SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS---S
T ss_pred eEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc----CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC---e
Confidence 3677889999999999998653 3456777664322 234457899999999999999999999999643 4
Q ss_pred EEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC
Q 004979 505 RMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT 584 (721)
Q Consensus 505 ~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~ 584 (721)
.++||||+++|+|.+++.. ....+++..++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++..
T Consensus 82 ~~iv~E~~~~g~l~~~~~~-~~~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 82 VWIIMELCTLGELRSFLQV-RKYSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRYM 158 (273)
T ss_dssp CEEEEECCTTEEHHHHHHH-TTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEEEEEeccCCcHHhhhhc-cCCCCCHHHHHHHHHHHHHHhhhhcccC--eeccccchhheeecCCCcEEEccchhheec
Confidence 6899999999999998753 3457999999999999999999999998 999999999999999999999999998643
Q ss_pred C----------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHHHHHHHhhcCCCCccccCCc
Q 004979 585 T----------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLENWASEYLKGEQPLKDIVDPT 653 (721)
Q Consensus 585 ~----------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 653 (721)
. .++..|+|||.+....++.++|||||||++|||+| |+.||.... ..+....+..+...
T Consensus 159 ~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~--~~~~~~~i~~~~~~-------- 228 (273)
T d1mp8a_ 159 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK--NNDVIGRIENGERL-------- 228 (273)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCC--GGGHHHHHHTTCCC--------
T ss_pred cCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCC--HHHHHHHHHcCCCC--------
Confidence 2 23457999999999999999999999999999998 898986433 23333333333211
Q ss_pred cccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 004979 654 LKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAM 696 (721)
Q Consensus 654 l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~ 696 (721)
..+..+++++.+||.+||+.||++|||+.||++.|+.+.+.
T Consensus 229 --~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 229 --PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp --CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 12344567899999999999999999999999999988654
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=3.5e-45 Score=390.93 Aligned_cols=242 Identities=21% Similarity=0.299 Sum_probs=202.1
Q ss_pred hhhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEE
Q 004979 429 SNIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMM 507 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~l 507 (721)
|++++.||+|+||+||+|+. .+|..||||++..... ...+.+.+|+++|++++|||||++++++.+.+ ..|+
T Consensus 28 Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~-----~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~--~~~i 100 (350)
T d1koaa2 28 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE-----SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDN--EMVM 100 (350)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSH-----HHHHHHHHHHHHHHHTCCTTBCCEEEEEEETT--EEEE
T ss_pred eEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccch-----hhHHHHHHHHHHHHhCCCCCCCcEEEEEEECC--EEEE
Confidence 47888999999999999996 4688999999865432 23467899999999999999999999999877 7899
Q ss_pred EEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeC--CCCcEEEeccCCCCCCC
Q 004979 508 VFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLT--EDYAAKISDFSFWNNTT 585 (721)
Q Consensus 508 V~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~--~~~~~kL~DFGla~~~~ 585 (721)
|||||++|+|.+++.. ....+++..+..|+.||+.||+|||+++ ||||||||+|||++ .++.+||+|||+++...
T Consensus 101 vmE~~~gg~L~~~l~~-~~~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~ 177 (350)
T d1koaa2 101 IYEFMSGGELFEKVAD-EHNKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 177 (350)
T ss_dssp EECCCCSCBHHHHHTC-TTSCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTSCCEEECCCTTCEECC
T ss_pred EEEcCCCCCHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHhcC--CeeeeechhHeeeccCCCCeEEEeecchheecc
Confidence 9999999999999853 3456999999999999999999999998 99999999999996 46889999999986432
Q ss_pred --------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccc
Q 004979 586 --------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSF 657 (721)
Q Consensus 586 --------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 657 (721)
.++..|+|||++.+..|+.++||||+||++|||+||+.||.. .+..+....+......... ..
T Consensus 178 ~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~--~~~~~~~~~i~~~~~~~~~-------~~ 248 (350)
T d1koaa2 178 PKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGG--ENDDETLRNVKSCDWNMDD-------SA 248 (350)
T ss_dssp TTSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCC--SSHHHHHHHHHHTCCCSCC-------GG
T ss_pred cccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCC--CCHHHHHHHHHhCCCCCCc-------cc
Confidence 356789999999999999999999999999999999999963 3445555555544322211 11
Q ss_pred cHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004979 658 QENVLEELLVVIKNCVHPDPKQRPSMRGIAAK 689 (721)
Q Consensus 658 ~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 689 (721)
...+++++.+|+.+||+.||++|||++|+++.
T Consensus 249 ~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 249 FSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp GGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred ccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 23455788999999999999999999999873
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-45 Score=386.68 Aligned_cols=249 Identities=24% Similarity=0.417 Sum_probs=199.8
Q ss_pred hhhCcCCCCceeEEEEEEec-CCc--EEEEEEeeeccccchhhHHHHHHHHHHHHHhcC-CCCccceEeEEEecCCCceE
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGV--EIAVTSTSVKSRADWSKNLESQFRKKIDTLSKV-NHKNFVNLIGYCEEDEPFTR 505 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~--~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~~ 505 (721)
++.+.||+|+||+||+|++. ++. .||||++..... ....+.|.+|+++|+++ +|||||+++|+|.+.+ ..
T Consensus 13 ~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~--~~ 86 (309)
T d1fvra_ 13 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS----KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG--YL 86 (309)
T ss_dssp EEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC----------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT--EE
T ss_pred EEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccC----hHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCC--ee
Confidence 45678899999999999975 444 356666543221 22346799999999999 7999999999999877 67
Q ss_pred EEEEecCCCCChhhhhhhc--------------cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCC
Q 004979 506 MMVFEYSPNGSLFEHLHIQ--------------EAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDY 571 (721)
Q Consensus 506 ~lV~Ey~~~GsL~~~l~~~--------------~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~ 571 (721)
++||||+++|+|.++++.. ....++|..+.+++.||+.||.|||+++ |+||||||+|||++.++
T Consensus 87 ~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~--iiHrDlkp~NIL~~~~~ 164 (309)
T d1fvra_ 87 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENY 164 (309)
T ss_dssp EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECGGG
T ss_pred EEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC--ccccccccceEEEcCCC
Confidence 9999999999999998643 2467999999999999999999999988 99999999999999999
Q ss_pred cEEEeccCCCCCC--------CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCC-cccCCCCCHHHHHHHHhhc
Q 004979 572 AAKISDFSFWNNT--------TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRI-SYSIENGSLENWASEYLKG 642 (721)
Q Consensus 572 ~~kL~DFGla~~~--------~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~-P~~~~~~~~~~~~~~~~~~ 642 (721)
.+||+|||+++.. ..++..|+|||.+....++.++|||||||++|||+||.. ||. ..+..+....+..+
T Consensus 165 ~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~--~~~~~~~~~~i~~~ 242 (309)
T d1fvra_ 165 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC--GMTCAELYEKLPQG 242 (309)
T ss_dssp CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTT--TCCHHHHHHHGGGT
T ss_pred ceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCC--CCCHHHHHHHHHhc
Confidence 9999999997532 234567899999999999999999999999999999765 563 33445544444433
Q ss_pred CCCCccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCC
Q 004979 643 EQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAMEP 698 (721)
Q Consensus 643 ~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 698 (721)
..+ ..+..+++++.+||.+||+.||++||||.||++.|+++.+...
T Consensus 243 ~~~----------~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~ 288 (309)
T d1fvra_ 243 YRL----------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 288 (309)
T ss_dssp CCC----------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred CCC----------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCc
Confidence 211 1223456789999999999999999999999999999876543
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=8.6e-45 Score=376.43 Aligned_cols=253 Identities=20% Similarity=0.269 Sum_probs=204.7
Q ss_pred hhhhhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCC--c
Q 004979 427 DFSNIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEP--F 503 (721)
Q Consensus 427 ~~~~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~--~ 503 (721)
+.|++++.||+|+||+||+|+. .+++.||||++......+ ......|.+|+++|++++|||||++++++...+. .
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~--~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~ 84 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARD--PSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 84 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTC--HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSE
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccC--HHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCc
Confidence 3357888999999999999995 578899999987543322 3345679999999999999999999999876442 2
Q ss_pred eEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCC
Q 004979 504 TRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNN 583 (721)
Q Consensus 504 ~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~ 583 (721)
..|+||||+++|+|.+++.. ...+++.+++.|+.||+.||+|||+++ |+||||||+|||++.++..+|+|||.++.
T Consensus 85 ~~~lvmE~~~g~~L~~~~~~--~~~l~~~~~~~i~~qi~~al~~lH~~~--iiHrDiKP~NIll~~~~~~~l~d~~~~~~ 160 (277)
T d1o6ya_ 85 LPYIVMEYVDGVTLRDIVHT--EGPMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIARA 160 (277)
T ss_dssp EEEEEEECCCEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTSCEEECCCTTCEE
T ss_pred eEEEEEECCCCCEehhhhcc--cCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCccccCcccccCccccceeehhhhhhh
Confidence 46899999999999998853 356999999999999999999999988 99999999999999999999999997642
Q ss_pred C------------CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccC
Q 004979 584 T------------TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVD 651 (721)
Q Consensus 584 ~------------~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d 651 (721)
. ..++..|+|||.+.+..++.++|||||||++|||+||+.||... +..+...............
T Consensus 161 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~--~~~~~~~~~~~~~~~~~~~-- 236 (277)
T d1o6ya_ 161 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD--SPVSVAYQHVREDPIPPSA-- 236 (277)
T ss_dssp CC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS--SHHHHHHHHHHCCCCCGGG--
T ss_pred hccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCc--CHHHHHHHHHhcCCCCCch--
Confidence 1 23567899999999999999999999999999999999999633 3444444455443222111
Q ss_pred CccccccHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHHHHhh
Q 004979 652 PTLKSFQENVLEELLVVIKNCVHPDPKQRP-SMRGIAAKLKEIT 694 (721)
Q Consensus 652 ~~l~~~~~~~~~~l~~li~~Cl~~dP~~RP-s~~evl~~L~~i~ 694 (721)
..+.+++++.+++.+||+.||++|| |++|+.+.|.++.
T Consensus 237 -----~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 237 -----RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp -----TSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred -----hccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 1233457889999999999999999 8999999988775
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.1e-45 Score=388.74 Aligned_cols=239 Identities=17% Similarity=0.257 Sum_probs=200.6
Q ss_pred hhhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEE
Q 004979 429 SNIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMM 507 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~l 507 (721)
+++++.||+|+||+||+|+.. +|+.||||++......+ ....+.+.+|+++|++++|||||++++++.+.+ ..++
T Consensus 43 y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~--~~~~ 118 (350)
T d1rdqe_ 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVK--LKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS--NLYM 118 (350)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH--TTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS--EEEE
T ss_pred eEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccC--HHHHHHHHHHHHHHHHcCCCcEeeccccccccc--cccc
Confidence 478899999999999999964 78999999986432211 223467899999999999999999999998877 6799
Q ss_pred EEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC--
Q 004979 508 VFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT-- 585 (721)
Q Consensus 508 V~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~-- 585 (721)
||||+.+|+|..++... ..+++..+..|+.||+.||.|||+++ ||||||||+|||++.++.+||+|||+++...
T Consensus 119 v~e~~~~g~l~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~--iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 119 VMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp EEECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred ccccccccchhhhHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCC--EecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence 99999999999998643 46999999999999999999999998 9999999999999999999999999986433
Q ss_pred ----CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccccHHH
Q 004979 586 ----AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSFQENV 661 (721)
Q Consensus 586 ----~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 661 (721)
.++..|+|||++.+..|+.++|||||||++|||+||+.||... +.......+..+.... +..+
T Consensus 195 ~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~--~~~~~~~~i~~~~~~~-----------p~~~ 261 (350)
T d1rdqe_ 195 TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD--QPIQIYEKIVSGKVRF-----------PSHF 261 (350)
T ss_dssp BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHCCCCC-----------CTTC
T ss_pred cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCc--CHHHHHHHHhcCCCCC-----------CccC
Confidence 3566899999999999999999999999999999999999643 4455555555443221 2334
Q ss_pred HHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 004979 662 LEELLVVIKNCVHPDPKQRP-----SMRGIAA 688 (721)
Q Consensus 662 ~~~l~~li~~Cl~~dP~~RP-----s~~evl~ 688 (721)
+.++.+++.+||+.||++|+ |++|+++
T Consensus 262 s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 262 SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp CHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 56789999999999999994 8888875
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-45 Score=382.82 Aligned_cols=249 Identities=20% Similarity=0.337 Sum_probs=191.1
Q ss_pred hhhhCcCCCCceeEEEEEEec------CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcC-CCCccceEeEEEecCC
Q 004979 429 SNIIGSFSDGTVGTVYKGTLS------SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKV-NHKNFVNLIGYCEEDE 501 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~------~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~ 501 (721)
+++++.||+|+||+||+|++. +++.||||++.... .....+.+.+|+..+.++ +|+|||.+++++...+
T Consensus 15 y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~----~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~ 90 (299)
T d1ywna1 15 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA----THSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 90 (299)
T ss_dssp EEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC--------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred EEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc----CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCC
Confidence 477889999999999999854 23579999876432 223456788888888877 7999999999987654
Q ss_pred CceEEEEEecCCCCChhhhhhhcc--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEe
Q 004979 502 PFTRMMVFEYSPNGSLFEHLHIQE--------------AEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYL 567 (721)
Q Consensus 502 ~~~~~lV~Ey~~~GsL~~~l~~~~--------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl 567 (721)
. ..++|||||++|+|.++++... ...+++.+++.|+.||+.||+|||+++ ||||||||+||||
T Consensus 91 ~-~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--ivHrDlKp~NILl 167 (299)
T d1ywna1 91 G-PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILL 167 (299)
T ss_dssp S-CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEE
T ss_pred C-eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC--CcCCcCCccceeE
Confidence 3 4699999999999999996432 235899999999999999999999988 9999999999999
Q ss_pred CCCCcEEEeccCCCCCC-----------CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCC-CcccCCCCCHHHH
Q 004979 568 TEDYAAKISDFSFWNNT-----------TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGR-ISYSIENGSLENW 635 (721)
Q Consensus 568 ~~~~~~kL~DFGla~~~-----------~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~-~P~~~~~~~~~~~ 635 (721)
++++++||+|||+++.. ..++..|+|||.+.+..++.++|||||||++|||+||. .||...... ...
T Consensus 168 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~-~~~ 246 (299)
T d1ywna1 168 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-EEF 246 (299)
T ss_dssp CGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS-HHH
T ss_pred CCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH-HHH
Confidence 99999999999998532 12455799999999999999999999999999999964 567533322 222
Q ss_pred HHHHhhcCCCCccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 004979 636 ASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITA 695 (721)
Q Consensus 636 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~ 695 (721)
......+.. . ..+..+++++.++|.+||+.||++||||.||++.|+++.+
T Consensus 247 ~~~~~~~~~-~---------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 247 CRRLKEGTR-M---------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp HHHHHHTCC-C---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHhcCCC-C---------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 222222211 1 1223455678999999999999999999999999998865
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=8.2e-45 Score=390.30 Aligned_cols=242 Identities=19% Similarity=0.227 Sum_probs=192.2
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccch-hhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADW-SKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMM 507 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~l 507 (721)
++++.||+|+||+||+|+.. +|+.||||++........ .........+|+++++.++|||||++++++.+.+ ..|+
T Consensus 7 ~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~--~~~i 84 (364)
T d1omwa3 7 SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD--KLSF 84 (364)
T ss_dssp EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS--EEEE
T ss_pred eeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECC--EEEE
Confidence 67889999999999999965 689999999864332111 1111223344577888889999999999999877 6799
Q ss_pred EEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC---
Q 004979 508 VFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT--- 584 (721)
Q Consensus 508 V~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~--- 584 (721)
|||||++|+|.+++.. ...+++..+..|+.||+.||+|||+++ ||||||||+|||+++++.+||+|||+++..
T Consensus 85 vmE~~~gg~L~~~l~~--~~~~~e~~~~~~~~qi~~aL~ylH~~~--iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~ 160 (364)
T d1omwa3 85 ILDLMNGGDLHYHLSQ--HGVFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKK 160 (364)
T ss_dssp EECCCCSCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECSSSCEEECCCTTCEECSSS
T ss_pred EEEecCCCcHHHHHHh--cccccHHHHHHHHHHHHHHHHHHHHCC--ccceeeccceeEEcCCCcEEEeeeceeeecCCC
Confidence 9999999999999864 356889999999999999999999998 999999999999999999999999998633
Q ss_pred ----CCCCccccchhhcc-cCCCCCCccHHHHHHHHHHHHhCCCcccCCCCC-HHHHHHHHhhcCCCCccccCCcccccc
Q 004979 585 ----TAAKTGSAAMELLE-TSAVDLESNVYSFGTILFEMITGRISYSIENGS-LENWASEYLKGEQPLKDIVDPTLKSFQ 658 (721)
Q Consensus 585 ----~~~~~~~~apE~~~-~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~-~~~~~~~~~~~~~~~~~~~d~~l~~~~ 658 (721)
..++..|+|||.+. +..|+.++|||||||++|||+||+.||...... ............. ..+
T Consensus 161 ~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~-----------~~~ 229 (364)
T d1omwa3 161 KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV-----------ELP 229 (364)
T ss_dssp CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCC-----------CCC
T ss_pred cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCC-----------CCC
Confidence 33667899999986 456899999999999999999999999755433 2222222111111 122
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 004979 659 ENVLEELLVVIKNCVHPDPKQRPS-----MRGIAA 688 (721)
Q Consensus 659 ~~~~~~l~~li~~Cl~~dP~~RPs-----~~evl~ 688 (721)
..+++++.+||.+||+.||++||| ++|+++
T Consensus 230 ~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 230 DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp SSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred CCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 345577899999999999999999 677764
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-44 Score=378.57 Aligned_cols=248 Identities=25% Similarity=0.392 Sum_probs=196.5
Q ss_pred hhhhCcCCCCceeEEEEEEecC--------CcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcC-CCCccceEeEEEec
Q 004979 429 SNIIGSFSDGTVGTVYKGTLSS--------GVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKV-NHKNFVNLIGYCEE 499 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~~--------~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~ 499 (721)
+++++.||+|+||.||+|+... +..||||++.... ......++.+|+..+.++ +|||||+++++|.+
T Consensus 15 ~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~----~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~ 90 (299)
T d1fgka_ 15 LVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA----TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 90 (299)
T ss_dssp EEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred eEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc----ChHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence 3677889999999999998532 2468998876432 233456789999999888 89999999999998
Q ss_pred CCCceEEEEEecCCCCChhhhhhhcc--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCe
Q 004979 500 DEPFTRMMVFEYSPNGSLFEHLHIQE--------------AEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSI 565 (721)
Q Consensus 500 ~~~~~~~lV~Ey~~~GsL~~~l~~~~--------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NI 565 (721)
++ ..++|||||++|+|.+++..+. ...+++.++++++.||+.||+|||+++ ||||||||+||
T Consensus 91 ~~--~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~--ivHrDiKp~Ni 166 (299)
T d1fgka_ 91 DG--PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNV 166 (299)
T ss_dssp SS--SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGE
T ss_pred CC--eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC--EEeeeecccce
Confidence 76 5699999999999999996442 245899999999999999999999998 99999999999
Q ss_pred EeCCCCcEEEeccCCCCCC-----------CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHH
Q 004979 566 YLTEDYAAKISDFSFWNNT-----------TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLE 633 (721)
Q Consensus 566 Ll~~~~~~kL~DFGla~~~-----------~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~ 633 (721)
|++.++.+||+|||+++.. ..++..|+|||.+.+..|+.++||||||||+|||+| |..||.. ....
T Consensus 167 Ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~--~~~~ 244 (299)
T d1fgka_ 167 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG--VPVE 244 (299)
T ss_dssp EECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT--CCHH
T ss_pred eecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCC--CCHH
Confidence 9999999999999987633 123457899999999999999999999999999998 6888853 3333
Q ss_pred HHHHHHhhcCCCCccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 004979 634 NWASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAM 696 (721)
Q Consensus 634 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~ 696 (721)
+....+..+..+ ..+..++.++.+||.+||+.||++||||.||++.|+++.+.
T Consensus 245 ~~~~~i~~~~~~----------~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~ 297 (299)
T d1fgka_ 245 ELFKLLKEGHRM----------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297 (299)
T ss_dssp HHHHHHHTTCCC----------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHcCCCC----------CCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence 333333222111 12233456789999999999999999999999999998764
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-44 Score=382.46 Aligned_cols=239 Identities=18% Similarity=0.246 Sum_probs=195.4
Q ss_pred hhhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHh-cCCCCccceEeEEEecCCCceEE
Q 004979 429 SNIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLS-KVNHKNFVNLIGYCEEDEPFTRM 506 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~-~l~H~nIv~l~g~~~~~~~~~~~ 506 (721)
+++++.||+|+||+||+|+.. +++.||||++....... ....+.+..|+.++. .++|||||++++++.+++ ..|
T Consensus 4 y~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~--~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~--~~y 79 (320)
T d1xjda_ 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLM--DDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE--NLF 79 (320)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHH--TTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS--EEE
T ss_pred eEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccC--hHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCC--cee
Confidence 367788999999999999964 68899999986432111 122345667777665 689999999999999887 789
Q ss_pred EEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC--
Q 004979 507 MVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT-- 584 (721)
Q Consensus 507 lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~-- 584 (721)
+|||||++|+|.+++.. ...+++.++..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++..
T Consensus 80 ivmEy~~~g~L~~~i~~--~~~~~e~~~~~~~~qi~~al~ylH~~~--iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 80 FVMEYLNGGDLMYHIQS--CHKFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEeecCCCcHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCcccceeecCCCceeccccchhhhccc
Confidence 99999999999999864 346889999999999999999999998 999999999999999999999999998632
Q ss_pred -------CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccc
Q 004979 585 -------TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSF 657 (721)
Q Consensus 585 -------~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 657 (721)
..++..|+|||.+.+..|+.++|||||||++|||+||+.||.+. +..+....+..+... +
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~--~~~~~~~~i~~~~~~-----------~ 222 (320)
T d1xjda_ 156 GDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ--DEEELFHSIRMDNPF-----------Y 222 (320)
T ss_dssp TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHCCCC-----------C
T ss_pred ccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCC--CHHHHHHHHHcCCCC-----------C
Confidence 23456799999999999999999999999999999999999643 444444444443222 1
Q ss_pred cHHHHHHHHHHHHHcccCCCCCCCCHH-HHHH
Q 004979 658 QENVLEELLVVIKNCVHPDPKQRPSMR-GIAA 688 (721)
Q Consensus 658 ~~~~~~~l~~li~~Cl~~dP~~RPs~~-evl~ 688 (721)
+..++.++.+|+.+||+.||++||++. |+++
T Consensus 223 p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 223 PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred CccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 233457789999999999999999995 6753
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-44 Score=377.02 Aligned_cols=253 Identities=21% Similarity=0.299 Sum_probs=192.2
Q ss_pred hhCcCCCCceeEEEEEEecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCC--ceEEEE
Q 004979 431 IIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEP--FTRMMV 508 (721)
Q Consensus 431 ii~~lg~G~~g~Vyk~~~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~--~~~~lV 508 (721)
+.+.||+|+||+||+|++ +|..||||++.... .....+..|+..+.+++|||||+++|+|.+.+. ...++|
T Consensus 7 l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~------~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 7 LQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE------ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp EEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred EEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc------hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence 345788999999999997 47899999885322 111223345566678899999999999986432 357999
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcC------CCCeEeeCCCCCCeEeCCCCcEEEeccCCCC
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQL------TPPIAHRNLQSSSIYLTEDYAAKISDFSFWN 582 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~------~~~IvHrDLKp~NILl~~~~~~kL~DFGla~ 582 (721)
||||++|+|.++++. ..++|..+.+++.|+|.||+|+|+. .++||||||||+||||++++.+||+|||+++
T Consensus 80 ~Ey~~~g~L~~~l~~---~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~ 156 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp EECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred EecccCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence 999999999999964 3589999999999999999999974 2359999999999999999999999999875
Q ss_pred CC-------------CCCCccccchhhcccC------CCCCCccHHHHHHHHHHHHhCCCcccCCCC------------C
Q 004979 583 NT-------------TAAKTGSAAMELLETS------AVDLESNVYSFGTILFEMITGRISYSIENG------------S 631 (721)
Q Consensus 583 ~~-------------~~~~~~~~apE~~~~~------~~s~ksDVwSfGvvL~ElltG~~P~~~~~~------------~ 631 (721)
.. ..++..|+|||.+... .++.++|||||||+||||+||..||..... .
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T d1vjya_ 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccc
Confidence 22 2346789999998654 257789999999999999999887742111 1
Q ss_pred HHHHHHHHhhcCCCCccccCCcccc--ccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCC
Q 004979 632 LENWASEYLKGEQPLKDIVDPTLKS--FQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAMEP 698 (721)
Q Consensus 632 ~~~~~~~~~~~~~~~~~~~d~~l~~--~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 698 (721)
..+........ ...++.+.. ...+...++.+|+.+||+.||++||||.||++.|+++.+...
T Consensus 237 ~~~~~~~~~~~-----~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~~ 300 (303)
T d1vjya_ 237 SVEEMRKVVCE-----QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 300 (303)
T ss_dssp CHHHHHHHHTT-----SCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred hHHHHHHHHhc-----cccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhcC
Confidence 11122222211 111222221 123466789999999999999999999999999999886543
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-44 Score=380.18 Aligned_cols=250 Identities=17% Similarity=0.193 Sum_probs=188.6
Q ss_pred hhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEEE
Q 004979 431 IIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMVF 509 (721)
Q Consensus 431 ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV~ 509 (721)
.++.||+|+||+||+|+. .+++.||||++.............+.+.+|+++|++++|||||++++++.+.+ ..++||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~--~~~ivm 79 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS--NISLVF 79 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT--CCEEEE
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCC--ceeehh
Confidence 356789999999999996 46899999998755433322233457899999999999999999999999877 679999
Q ss_pred ecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCC----
Q 004979 510 EYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTT---- 585 (721)
Q Consensus 510 Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~---- 585 (721)
||+.+|++..+.. ....+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++...
T Consensus 80 E~~~~~~~~~~~~--~~~~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~ 155 (299)
T d1ua2a_ 80 DFMETDLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 155 (299)
T ss_dssp ECCSEEHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred hhhcchHHhhhhh--cccCCCHHHHHHHHHHHHHHHHHhhccc--eecccCCcceEEecCCCccccccCccccccCCCcc
Confidence 9999887776653 3456888899999999999999999998 9999999999999999999999999986432
Q ss_pred -----CCCccccchhhccc-CCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhc--CCCCccccC------
Q 004979 586 -----AAKTGSAAMELLET-SAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKG--EQPLKDIVD------ 651 (721)
Q Consensus 586 -----~~~~~~~apE~~~~-~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~--~~~~~~~~d------ 651 (721)
.++..|+|||.+.. ..|+.++|||||||++|||+||+.||.... ..+....+... ........+
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~--~~~~l~~i~~~~~~~~~~~~~~~~~~~~ 233 (299)
T d1ua2a_ 156 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS--DLDQLTRIFETLGTPTEEQWPDMCSLPD 233 (299)
T ss_dssp CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHHHCCCCTTTSSSTTSSTT
T ss_pred cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCC--HHHHHHHHHHhcCCCChhhccchhccch
Confidence 24567999999864 567999999999999999999999996432 22222222211 000000000
Q ss_pred ----Ccc-----ccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 652 ----PTL-----KSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 652 ----~~l-----~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
... .......++++.+|+.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 234 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp CCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 000 1111234578999999999999999999999986
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=6.3e-44 Score=369.02 Aligned_cols=245 Identities=20% Similarity=0.291 Sum_probs=199.4
Q ss_pred hhhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccch----hhHHHHHHHHHHHHHhcCC-CCccceEeEEEecCCC
Q 004979 429 SNIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADW----SKNLESQFRKKIDTLSKVN-HKNFVNLIGYCEEDEP 502 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~----~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~ 502 (721)
+++++.||+|+||+||+|+. .+++.+|||++........ .....+.+.+|+.+|++++ |||||++++++.+++
T Consensus 5 y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~- 83 (277)
T d1phka_ 5 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNT- 83 (277)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS-
T ss_pred CEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCc-
Confidence 37788999999999999996 5788999999876543221 1234467899999999997 999999999999877
Q ss_pred ceEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCC
Q 004979 503 FTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWN 582 (721)
Q Consensus 503 ~~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~ 582 (721)
..|||||||++|+|.++++. ...+++.+++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 84 -~~~ivmE~~~~g~L~~~l~~--~~~l~e~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~~~~~~kl~DFG~a~ 158 (277)
T d1phka_ 84 -FFFLVFDLMKKGELFDYLTE--KVTLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFSC 158 (277)
T ss_dssp -EEEEEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred -ceEEEEEcCCCchHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcC--CcccccccceEEEcCCCCeEEccchhee
Confidence 78999999999999999964 346999999999999999999999998 9999999999999999999999999986
Q ss_pred CCC--------CCCccccchhhcc------cCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCcc
Q 004979 583 NTT--------AAKTGSAAMELLE------TSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKD 648 (721)
Q Consensus 583 ~~~--------~~~~~~~apE~~~------~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 648 (721)
... .++..|++||.+. ...++.++||||+||++|||+||+.||... +.......+..+.....
T Consensus 159 ~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~--~~~~~~~~i~~~~~~~~- 235 (277)
T d1phka_ 159 QLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR--KQMLMLRMIMSGNYQFG- 235 (277)
T ss_dssp ECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHTCCCCC-
T ss_pred EccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCC--CHHHHHHHHHhCCCCCC-
Confidence 432 2455789999874 345788999999999999999999999743 33334444444432211
Q ss_pred ccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 649 IVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 649 ~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
. ......++++.+|+.+||+.||++|||+.||++
T Consensus 236 --~----~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 236 --S----PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp --T----TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred --C----cccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 1 112345678999999999999999999999865
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-44 Score=378.96 Aligned_cols=246 Identities=21% Similarity=0.330 Sum_probs=202.2
Q ss_pred hhhCcCCCCceeEEEEEEec------CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCc
Q 004979 430 NIIGSFSDGTVGTVYKGTLS------SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPF 503 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~------~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 503 (721)
++.+.||+|+||+||+|.+. ++..||||++.... .......|.+|++++++++|||||+++|+|...+
T Consensus 23 ~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~----~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~-- 96 (308)
T d1p4oa_ 23 TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA----SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ-- 96 (308)
T ss_dssp EEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS----CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS--
T ss_pred EEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc----ChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCC--
Confidence 57788999999999999864 35689999886322 2334567999999999999999999999998776
Q ss_pred eEEEEEecCCCCChhhhhhhcc--------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEE
Q 004979 504 TRMMVFEYSPNGSLFEHLHIQE--------AEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKI 575 (721)
Q Consensus 504 ~~~lV~Ey~~~GsL~~~l~~~~--------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL 575 (721)
..++|||||++|+|.++++... ...+++..+.+|+.|+|+||.|||+++ |+||||||+|||+++++++||
T Consensus 97 ~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~--ivHrDlk~~NiLld~~~~~Kl 174 (308)
T d1p4oa_ 97 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKI 174 (308)
T ss_dssp SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSGGGEEECTTCCEEE
T ss_pred ceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeeceEcCCceeecCCceEEE
Confidence 5699999999999999986431 235799999999999999999999988 999999999999999999999
Q ss_pred eccCCCCCCC-----------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCC-CcccCCCCCHHHHHHHHhhcC
Q 004979 576 SDFSFWNNTT-----------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGR-ISYSIENGSLENWASEYLKGE 643 (721)
Q Consensus 576 ~DFGla~~~~-----------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~-~P~~~~~~~~~~~~~~~~~~~ 643 (721)
+|||+++... .++..|+|||.+.+..++.++|||||||++|||+||+ .||. +.+..++...+..+.
T Consensus 175 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~--~~~~~~~~~~i~~~~ 252 (308)
T d1p4oa_ 175 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ--GLSNEQVLRFVMEGG 252 (308)
T ss_dssp CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTT--TSCHHHHHHHHHTTC
T ss_pred eecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCC--CCCHHHHHHHHHhCC
Confidence 9999986332 2345789999999999999999999999999999985 5664 345555555554432
Q ss_pred CCCccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhh
Q 004979 644 QPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITA 695 (721)
Q Consensus 644 ~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~ 695 (721)
. ...+..++.++.++|.+||+.+|++||||.||++.|++..+
T Consensus 253 ~----------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 253 L----------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp C----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred C----------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 1 11223455789999999999999999999999999887644
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-44 Score=377.21 Aligned_cols=240 Identities=18% Similarity=0.248 Sum_probs=199.2
Q ss_pred hhhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEE
Q 004979 429 SNIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMM 507 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~l 507 (721)
|++++.||+|+||+||+|+.. +++.||||++..+.. ....+.+|+++|++++|||||++++++.+.+ ..||
T Consensus 7 Y~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~------~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~--~~~l 78 (321)
T d1tkia_ 7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT------DQVLVKKEISILNIARHRNILHLHESFESME--ELVM 78 (321)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH------HHHHHHHHHHHHHHSCCTTBCCEEEEEEETT--EEEE
T ss_pred eEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc------cHHHHHHHHHHHHhCCCCCCCeEEEEEEECC--EEEE
Confidence 477889999999999999965 688899999865431 2356889999999999999999999999877 7899
Q ss_pred EEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCC--CCcEEEeccCCCCCCC
Q 004979 508 VFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTE--DYAAKISDFSFWNNTT 585 (721)
Q Consensus 508 V~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~--~~~~kL~DFGla~~~~ 585 (721)
|||||++|+|.+++.. ....+++.++..|+.||+.||+|||+++ |+||||||+|||++. ...+||+|||+++...
T Consensus 79 vmE~~~gg~L~~~i~~-~~~~l~e~~~~~i~~qi~~al~yLH~~~--iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~ 155 (321)
T d1tkia_ 79 IFEFISGLDIFERINT-SAFELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155 (321)
T ss_dssp EECCCCCCBHHHHHTS-SSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred EEecCCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHcC--CCcccccccceeecCCCceEEEEcccchhhccc
Confidence 9999999999999863 3346999999999999999999999998 999999999999985 4589999999986443
Q ss_pred C--------CCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCccccc
Q 004979 586 A--------AKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTLKSF 657 (721)
Q Consensus 586 ~--------~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 657 (721)
. ++..|+|||...+..|+.++||||+||++|||+||+.||... +..+....+..+...... ..
T Consensus 156 ~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~--~~~~~~~~i~~~~~~~~~-------~~ 226 (321)
T d1tkia_ 156 PGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAE--TNQQIIENIMNAEYTFDE-------EA 226 (321)
T ss_dssp TTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCS--SHHHHHHHHHHTCCCCCH-------HH
T ss_pred cCCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCC--CHHHHHHHHHhCCCCCCh-------hh
Confidence 2 345789999999999999999999999999999999999643 344555555544332211 11
Q ss_pred cHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 658 QENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 658 ~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
...++.++.+|+.+||+.||++|||+.|+++
T Consensus 227 ~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 227 FKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1234567899999999999999999999987
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-44 Score=376.06 Aligned_cols=248 Identities=23% Similarity=0.338 Sum_probs=198.2
Q ss_pred hhhCcCCCCceeEEEEEEec------CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcC-CCCccceEeEEEecCCC
Q 004979 430 NIIGSFSDGTVGTVYKGTLS------SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKV-NHKNFVNLIGYCEEDEP 502 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~------~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~ 502 (721)
++.+.||+|+||.||+|++. +++.||||++..... ......|.+|+.+++++ +|||||+++|+|.+.+
T Consensus 26 ~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~----~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~- 100 (311)
T d1t46a_ 26 SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH----LTEREALMSELKVLSYLGNHMNIVNLLGACTIGG- 100 (311)
T ss_dssp EEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC----HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred EEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccC----HHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCC-
Confidence 56678899999999999862 456899998864322 23456799999999999 7999999999998876
Q ss_pred ceEEEEEecCCCCChhhhhhhcc----------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeE
Q 004979 503 FTRMMVFEYSPNGSLFEHLHIQE----------------AEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIY 566 (721)
Q Consensus 503 ~~~~lV~Ey~~~GsL~~~l~~~~----------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NIL 566 (721)
..++|||||++|+|.++++... ...+++..++.|+.||+.||+|||+++ ||||||||+|||
T Consensus 101 -~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~--ivHrDLKp~NIl 177 (311)
T d1t46a_ 101 -PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNIL 177 (311)
T ss_dssp -SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEE
T ss_pred -EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccccccccc
Confidence 5699999999999999987432 235899999999999999999999998 999999999999
Q ss_pred eCCCCcEEEeccCCCCCCCC-----------CCccccchhhcccCCCCCCccHHHHHHHHHHHHh-CCCcccCCCCCHHH
Q 004979 567 LTEDYAAKISDFSFWNNTTA-----------AKTGSAAMELLETSAVDLESNVYSFGTILFEMIT-GRISYSIENGSLEN 634 (721)
Q Consensus 567 l~~~~~~kL~DFGla~~~~~-----------~~~~~~apE~~~~~~~s~ksDVwSfGvvL~Ellt-G~~P~~~~~~~~~~ 634 (721)
++.++.+|++|||+++.... ++..|+|||.+....++.++|||||||++|||+| |+.||...... +
T Consensus 178 ~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~--~ 255 (311)
T d1t46a_ 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD--S 255 (311)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS--H
T ss_pred ccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH--H
Confidence 99999999999999864322 2446899999999999999999999999999999 55555433222 2
Q ss_pred HHHHHhhcCCCCccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhc
Q 004979 635 WASEYLKGEQPLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAM 696 (721)
Q Consensus 635 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~ 696 (721)
.+...+...... ..+...+.++.+||.+||+.||++||||.||+++|+++...
T Consensus 256 ~~~~~i~~~~~~---------~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 256 KFYKMIKEGFRM---------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp HHHHHHHHTCCC---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHhcCCCC---------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 222222221111 11233457799999999999999999999999999986543
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-44 Score=378.55 Aligned_cols=242 Identities=17% Similarity=0.264 Sum_probs=191.0
Q ss_pred hhhhCc-CCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcC-CCCccceEeEEEec--CCCc
Q 004979 429 SNIIGS-FSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKV-NHKNFVNLIGYCEE--DEPF 503 (721)
Q Consensus 429 ~~ii~~-lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~--~~~~ 503 (721)
|+++++ ||+|+||+||+|+. .+++.||||++... ..+.+|++++.++ +|||||++++++.+ ....
T Consensus 13 y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~----------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~ 82 (335)
T d2ozaa1 13 YKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 82 (335)
T ss_dssp EEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS----------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred EEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc----------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCC
Confidence 367765 89999999999996 57899999987532 3567899987655 89999999999865 2223
Q ss_pred eEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCC---CCcEEEeccCC
Q 004979 504 TRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTE---DYAAKISDFSF 580 (721)
Q Consensus 504 ~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~---~~~~kL~DFGl 580 (721)
..|+|||||++|+|.+++..+....+++.++..|+.||+.||+|||+++ |+||||||+|||+++ ++.+||+|||+
T Consensus 83 ~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~--iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 83 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcC--Cccccccccccccccccccccccccccce
Confidence 6799999999999999997555567999999999999999999999998 999999999999985 56799999999
Q ss_pred CCCC--------CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCH-HHHHHHHhhcCCCCccccC
Q 004979 581 WNNT--------TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSL-ENWASEYLKGEQPLKDIVD 651 (721)
Q Consensus 581 a~~~--------~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~-~~~~~~~~~~~~~~~~~~d 651 (721)
++.. ..++..|+|||++.+..|+.++|||||||++|||+||+.||...+... .......... ..
T Consensus 161 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~----~~--- 233 (335)
T d2ozaa1 161 AKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM----GQ--- 233 (335)
T ss_dssp CEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCS----CS---
T ss_pred eeeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhc----CC---
Confidence 8632 235678999999999999999999999999999999999997543211 1111100000 00
Q ss_pred Cccc-cccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004979 652 PTLK-SFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAK 689 (721)
Q Consensus 652 ~~l~-~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 689 (721)
...+ .....+++++.+|+.+||+.||++|||+.|+++.
T Consensus 234 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 234 YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp SSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 0011 1123456789999999999999999999999873
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-43 Score=368.56 Aligned_cols=250 Identities=19% Similarity=0.290 Sum_probs=191.7
Q ss_pred hhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 430 NIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
++++.+|+|+||+||+|+. .+++.||||++...... ....+++.+|+++|++++|||||++++++.+.+ ..|+|
T Consensus 5 ~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~---~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~--~~~iv 79 (298)
T d1gz8a_ 5 QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET---EGVPSTAIREISLLKELNHPNIVKLLDVIHTEN--KLYLV 79 (298)
T ss_dssp EEEEEEEECSSSEEEEEEETTTCCEEEEEEEC----------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETT--EEEEE
T ss_pred EeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcC---hHHHHHHHHHHHHHHhCCCCcEEEecccccccc--ceeEE
Confidence 6788999999999999996 57899999998643321 122467899999999999999999999999877 78999
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCC-----
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNN----- 583 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~----- 583 (721)
|||+.+ ++.+++.......+++..+..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+++.
T Consensus 80 ~e~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~--IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 80 FEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp EECCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred EeecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC--EEccccCchheeecccCcceeccCCcceeccCCc
Confidence 999965 5555655455667999999999999999999999998 99999999999999999999999998742
Q ss_pred ----CCCCCccccchhhcccCC-CCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCcccc--------
Q 004979 584 ----TTAAKTGSAAMELLETSA-VDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIV-------- 650 (721)
Q Consensus 584 ----~~~~~~~~~apE~~~~~~-~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~-------- 650 (721)
...++..|+|||.+.... ++.++||||+||++|||+||+.||...+ ..+.............+..
T Consensus 157 ~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~~ 234 (298)
T d1gz8a_ 157 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS--EIDQLFRIFRTLGTPDEVVWPGVTSMP 234 (298)
T ss_dssp BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCC--HHHHHHHHHHhcCCCchhhcccccccc
Confidence 124566889999876655 5789999999999999999999997433 2222222221111101000
Q ss_pred ----------CCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004979 651 ----------DPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAK 689 (721)
Q Consensus 651 ----------d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 689 (721)
...........+.++.+|+.+||+.||++|||+.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp TCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 000011112345788999999999999999999999874
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.3e-42 Score=361.68 Aligned_cols=249 Identities=18% Similarity=0.249 Sum_probs=194.1
Q ss_pred hhhhCcCCCCceeEEEEEEecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEEE
Q 004979 429 SNIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMMV 508 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~lV 508 (721)
|++++.||+|+||+||+|+.++++.||||++...... ....+++.+|+.+|++++|||||++++++.+.+ ..+++
T Consensus 4 Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~--~~~i~ 78 (286)
T d1ob3a_ 4 YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKED---EGIPSTTIREISILKELKHSNIVKLYDVIHTKK--RLVLV 78 (286)
T ss_dssp EEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGG---GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSS--CEEEE
T ss_pred ceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcC---hHHHHHHHHHHHHHHhCCCCcEEeeeeecccCC--ceeEE
Confidence 4778899999999999999999999999998654322 223467999999999999999999999999877 67999
Q ss_pred EecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCC-----
Q 004979 509 FEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNN----- 583 (721)
Q Consensus 509 ~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~----- 583 (721)
|||+.++.+..+.. ....+++..+..|+.||+.||+|||+.+ ||||||||+|||++.++.+||+|||++..
T Consensus 79 ~e~~~~~~~~~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~--IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~ 154 (286)
T d1ob3a_ 79 FEHLDQDLKKLLDV--CEGGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (286)
T ss_dssp EECCSEEHHHHHHT--STTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred EEeehhhhHHHHHh--hcCCcchhhhHHHHHHHHHHHHHhccCc--EEecCCCCceeeEcCCCCEEecccccceecccCc
Confidence 99998877766653 3467999999999999999999999988 99999999999999999999999998632
Q ss_pred ----CCCCCccccchhhccc-CCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhh--cCCCCcccc------
Q 004979 584 ----TTAAKTGSAAMELLET-SAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLK--GEQPLKDIV------ 650 (721)
Q Consensus 584 ----~~~~~~~~~apE~~~~-~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~--~~~~~~~~~------ 650 (721)
...++..|++||.+.. ..++.++||||+||++|||+||+.||...+ ..+...++.. +........
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~~ 232 (286)
T d1ob3a_ 155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS--EADQLMRIFRILGTPNSKNWPNVTELP 232 (286)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCC--HHHHHHHHHHhhCCCChhhccchhhhh
Confidence 1234567899999865 457999999999999999999999996432 2222222221 111100000
Q ss_pred --C-------C-ccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 651 --D-------P-TLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 651 --d-------~-~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
+ + .........+.++.+|+.+||+.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 0 001122334578899999999999999999999974
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-42 Score=358.70 Aligned_cols=254 Identities=17% Similarity=0.189 Sum_probs=191.2
Q ss_pred hhhhhhCcCCCCceeEEEEEEe-cC-CcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcC---CCCccceEeEEEecC-
Q 004979 427 DFSNIIGSFSDGTVGTVYKGTL-SS-GVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKV---NHKNFVNLIGYCEED- 500 (721)
Q Consensus 427 ~~~~ii~~lg~G~~g~Vyk~~~-~~-~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l---~H~nIv~l~g~~~~~- 500 (721)
+-|++++.||+|+||+||+|+. .+ ++.||||++......+.. ...+.+|+++|+.+ +|||||+++++|...
T Consensus 7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~---~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~ 83 (305)
T d1blxa_ 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM---PLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 83 (305)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSC---BCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchH---HHHHHHHHHHHHHHhhcCCCCcceeeeeecccc
Confidence 3458899999999999999996 34 566899998754332211 12355667666554 899999999998632
Q ss_pred --CCceEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEecc
Q 004979 501 --EPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDF 578 (721)
Q Consensus 501 --~~~~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DF 578 (721)
.....+++|||+.+|.+.... ......+++.....++.|++.||+|||+++ ||||||||+|||+++++.+||+||
T Consensus 84 ~~~~~~~~~~~e~~~~~~~~~~~-~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~--ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 84 TDRETKLTLVFEHVDQDLTTYLD-KVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp CSSEEEEEEEEECCSCBHHHHHH-HSCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECSC
T ss_pred cccCceEEEEEEeccCCchhhhh-hccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEecCCCccEEEEcCCCCeeecch
Confidence 223579999999887765443 344567899999999999999999999998 999999999999999999999999
Q ss_pred CCCCCC--------CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhc--CCCCc-
Q 004979 579 SFWNNT--------TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKG--EQPLK- 647 (721)
Q Consensus 579 Gla~~~--------~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~--~~~~~- 647 (721)
|+++.. ..++..|+|||.+.+..|+.++||||+||++|||+||+.||...+ ..+....+... .....
T Consensus 161 g~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~--~~~~~~~i~~~~~~~~~~~ 238 (305)
T d1blxa_ 161 GLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS--DVDQLGKILDVIGLPGEED 238 (305)
T ss_dssp CSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHHHCCCCGGG
T ss_pred hhhhhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCC--HHHHHHHHHHhhCCCchhc
Confidence 987643 335678999999999999999999999999999999999996443 22222222211 00000
Q ss_pred -------------cccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 648 -------------DIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 648 -------------~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
.........+....++++.+|+.+||+.||++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp SCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00001111223345678899999999999999999999976
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-42 Score=358.97 Aligned_cols=235 Identities=19% Similarity=0.353 Sum_probs=188.4
Q ss_pred hhhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhh-HHHHHHHHHHHHHhcCC--CCccceEeEEEecCCCce
Q 004979 429 SNIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSK-NLESQFRKKIDTLSKVN--HKNFVNLIGYCEEDEPFT 504 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~-~~~~~f~~Ei~~l~~l~--H~nIv~l~g~~~~~~~~~ 504 (721)
|++.+.||+|+||+||+|+. .+++.||||++......+... ....++.+|+++|++++ |||||++++++.+.+ .
T Consensus 6 Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~--~ 83 (273)
T d1xwsa_ 6 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD--S 83 (273)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS--E
T ss_pred EEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC--e
Confidence 46778899999999999996 478999999987543222111 11234778999999986 999999999999877 6
Q ss_pred EEEEEecCCC-CChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCC-CCcEEEeccCCCC
Q 004979 505 RMMVFEYSPN-GSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTE-DYAAKISDFSFWN 582 (721)
Q Consensus 505 ~~lV~Ey~~~-GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~-~~~~kL~DFGla~ 582 (721)
.++||||+.+ +++.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++. ++.+||+|||+++
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~--~~~l~e~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NIll~~~~~~vkl~DFG~a~ 159 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITE--RGALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFGSGA 159 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEEEEeccCcchHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC--CccccCcccceEEecCCCeEEECccccce
Confidence 7999999976 678777753 356999999999999999999999998 999999999999985 5799999999975
Q ss_pred CC-------CCCCccccchhhcccCCC-CCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCccccCCcc
Q 004979 583 NT-------TAAKTGSAAMELLETSAV-DLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLKDIVDPTL 654 (721)
Q Consensus 583 ~~-------~~~~~~~~apE~~~~~~~-s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 654 (721)
.. ..++..|+|||.+.+..+ +.++||||+||++|||+||+.||.... ....+...
T Consensus 160 ~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--------~i~~~~~~--------- 222 (273)
T d1xwsa_ 160 LLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--------EIIRGQVF--------- 222 (273)
T ss_dssp ECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------HHHHCCCC---------
T ss_pred ecccccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch--------HHhhcccC---------
Confidence 32 235668999999987765 577999999999999999999996321 12222211
Q ss_pred ccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 655 KSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 655 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
++..++.++.+|+.+||+.||++|||++|+++
T Consensus 223 --~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 223 --FRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp --CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --CCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 12234567899999999999999999999975
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-41 Score=361.00 Aligned_cols=257 Identities=19% Similarity=0.260 Sum_probs=191.0
Q ss_pred hhhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCC----c
Q 004979 429 SNIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEP----F 503 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~----~ 503 (721)
|++++.||+|+||+||+|+. .+|+.||||++..... .....+.+.+|+++|++++|||||+++++|...+. .
T Consensus 20 Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~---~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 20 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ---SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp EEEEEEC------CEEEEEETTTCCEEEEEECSSTTS---SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred EEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhc---ChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 57889999999999999996 4689999999864322 23445789999999999999999999999976542 2
Q ss_pred eEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCC
Q 004979 504 TRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNN 583 (721)
Q Consensus 504 ~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~ 583 (721)
+.|+||||+ +++|..+++ ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+|++|||+++.
T Consensus 97 ~~~lv~e~~-~~~l~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~--IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~ 170 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMK---HEKLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLARQ 170 (346)
T ss_dssp CCEEEEECC-SEEHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred eEEEEEecc-cccHHHHHH---hccccHHHHHHHHHHHHHHHHHHHhCC--CcccccCcchhhcccccccccccccceec
Confidence 469999999 667877764 246999999999999999999999998 99999999999999999999999999864
Q ss_pred C------CCCCccccchhhccc-CCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHh--hcCCC---------
Q 004979 584 T------TAAKTGSAAMELLET-SAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYL--KGEQP--------- 645 (721)
Q Consensus 584 ~------~~~~~~~~apE~~~~-~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~--~~~~~--------- 645 (721)
. ..++..|+|||.+.+ ..++.++||||+||++|||++|+.||...+. ........ .+..+
T Consensus 171 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 248 (346)
T d1cm8a_ 171 ADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH--LDQLKEIMKVTGTPPAEFVQRLQS 248 (346)
T ss_dssp CCSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred cCCccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCCh--HHHHHHHHhccCCCcHHHHhhhcc
Confidence 3 335667899999865 4578999999999999999999999964432 11111111 11000
Q ss_pred ---------CccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHHhhhc
Q 004979 646 ---------LKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAK--LKEITAM 696 (721)
Q Consensus 646 ---------~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~--L~~i~~~ 696 (721)
..................++.+|+.+||..||++|||+.|+++. ++++...
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~ 310 (346)
T d1cm8a_ 249 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDT 310 (346)
T ss_dssp HHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC--
T ss_pred hhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCc
Confidence 00111111112223445678899999999999999999999874 5555433
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.3e-41 Score=354.52 Aligned_cols=265 Identities=15% Similarity=0.206 Sum_probs=198.1
Q ss_pred hhhhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEE-ecCCCceE
Q 004979 428 FSNIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYC-EEDEPFTR 505 (721)
Q Consensus 428 ~~~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~-~~~~~~~~ 505 (721)
-|++++.||+|+||+||+|+. .+++.||||++...... .++..|++++++++|+|+|..++.+ .+.+ ..
T Consensus 8 rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-------~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~--~~ 78 (299)
T d1ckia_ 8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-------PQLHIESKIYKMMQGGVGIPTIRWCGAEGD--YN 78 (299)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS-------CCHHHHHHHHHHSTTSTTCCCEEEEEEETT--EE
T ss_pred EEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC-------HHHHHHHHHHHHccCCCcccEEEEEEecCC--EE
Confidence 357888999999999999996 56889999987654322 3578899999999888766665555 4444 57
Q ss_pred EEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeC---CCCcEEEeccCCCC
Q 004979 506 MMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLT---EDYAAKISDFSFWN 582 (721)
Q Consensus 506 ~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~---~~~~~kL~DFGla~ 582 (721)
++||||+ +|+|.+.+.. ....+++..++.++.|++.||+|||+++ ||||||||+|||++ .+..+||+|||+++
T Consensus 79 ~ivme~~-~~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~ 154 (299)
T d1ckia_ 79 VMVMELL-GPSLEDLFNF-CSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 154 (299)
T ss_dssp EEEEECC-CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEECCCSSCE
T ss_pred EEEEEEc-CCchhhhhhh-ccCCCcHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHhhccccccCCCceeeeeccCcce
Confidence 8999999 5667666543 3467999999999999999999999998 99999999999986 45679999999986
Q ss_pred CC----------------CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHH-HHHHHHhhcCCC
Q 004979 583 NT----------------TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLE-NWASEYLKGEQP 645 (721)
Q Consensus 583 ~~----------------~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~-~~~~~~~~~~~~ 645 (721)
.. ..++..|+|||.+.+..++.++|||||||++|||+||+.||........ ..........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~-- 232 (299)
T d1ckia_ 155 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK-- 232 (299)
T ss_dssp ECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHH--
T ss_pred eccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhccc--
Confidence 32 1356689999999999999999999999999999999999974332211 1111111000
Q ss_pred CccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCChhHHHHHH
Q 004979 646 LKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAMEPDGATPKLSPLWWAELE 714 (721)
Q Consensus 646 ~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~~~~p~~~~~~~~~l~ 714 (721)
...........+++++.+++..||+.+|++||++.++.+.|+++..... .....+++|+-+.
T Consensus 233 ----~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~---~~~~~~~Dw~~~~ 294 (299)
T d1ckia_ 233 ----MSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG---FSYDYVFDWNMLK 294 (299)
T ss_dssp ----HHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHT---CCCSCCCHHHHGG
T ss_pred ----CCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcC---CCCCCCcCchhhc
Confidence 0000111223456789999999999999999999999999988754322 1234567897653
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-41 Score=357.62 Aligned_cols=252 Identities=16% Similarity=0.181 Sum_probs=187.7
Q ss_pred hhhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCc--eE
Q 004979 429 SNIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPF--TR 505 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~--~~ 505 (721)
|++++.||+|+||+||+|+. .+++.||||++..... ....+.+.+|+++|++++|||||++++++...... ..
T Consensus 10 Y~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~----~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 10 YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEH----QTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp EEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTC----HHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred eEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcC----hHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 57889999999999999985 5889999999864321 33456789999999999999999999999764311 22
Q ss_pred EEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC-
Q 004979 506 MMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT- 584 (721)
Q Consensus 506 ~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~- 584 (721)
+++++|+.+|+|.+++.. ..+++..++.++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+++..
T Consensus 86 ~~l~~~~~~g~L~~~l~~---~~l~~~~i~~i~~qil~al~yLH~~~--iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~ 160 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVAD 160 (345)
T ss_dssp EEEEEECCCEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEEeecCCchhhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCcceEEECCCCCEEEcccCceeecc
Confidence 455567779999999853 36899999999999999999999998 999999999999999999999999987522
Q ss_pred -----------CCCCccccchhhc-ccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCC------
Q 004979 585 -----------TAAKTGSAAMELL-ETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPL------ 646 (721)
Q Consensus 585 -----------~~~~~~~~apE~~-~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~------ 646 (721)
..++..|+|||.+ ....++.++||||+||++|||+||+.||.........+...........
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (345)
T d1pmea_ 161 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 240 (345)
T ss_dssp GGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTC
T ss_pred CCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhh
Confidence 1245578999998 4556789999999999999999999999754321111111111110000
Q ss_pred ------------ccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004979 647 ------------KDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAK 689 (721)
Q Consensus 647 ------------~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 689 (721)
...............+.++.+|+.+||+.||++|||+.|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 241 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp CCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000000011112334678999999999999999999999874
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-40 Score=351.00 Aligned_cols=251 Identities=17% Similarity=0.196 Sum_probs=187.3
Q ss_pred hhhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCC------
Q 004979 429 SNIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDE------ 501 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~------ 501 (721)
|++++.||+|+||+||+|+. .+|+.||||++...... ....+++.+|+++|++++||||+++++++....
T Consensus 12 Y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~---~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 12 YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK---EGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CT---TSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred EEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc---hHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 47889999999999999996 57899999998654322 223467889999999999999999999986532
Q ss_pred CceEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCC
Q 004979 502 PFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFW 581 (721)
Q Consensus 502 ~~~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla 581 (721)
....++||||+.++.+..+. .....++......|+.|++.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~--~~~~~~~~~~~~~i~~qil~~l~~lH~~~--ivHrDlKp~NILl~~~~~~kl~dfg~~ 164 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLS--NVLVKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFGLA 164 (318)
T ss_dssp --CEEEEEECCCEEHHHHHT--CTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred CceEEEEEeccCCCccchhh--hcccccccHHHHHHHHHHHHHHHHhccCC--EEecCcCchheeecCCCcEEeeeccee
Confidence 12579999999887776544 24456888999999999999999999998 999999999999999999999999997
Q ss_pred CCC-------------CCCCccccchhhcccC-CCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCCc
Q 004979 582 NNT-------------TAAKTGSAAMELLETS-AVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPLK 647 (721)
Q Consensus 582 ~~~-------------~~~~~~~~apE~~~~~-~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~~ 647 (721)
+.. ..++..|+|||.+.+. .|+.++||||+||++|||+||+.||.... .......+........
T Consensus 165 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~--~~~~~~~i~~~~~~~~ 242 (318)
T d3blha1 165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT--EQHQLALISQLCGSIT 242 (318)
T ss_dssp EECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHHHCCCC
T ss_pred eecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCC--HHHHHHHHHHhcCCCC
Confidence 422 2245678999998654 68999999999999999999999996433 2222222211101000
Q ss_pred -cc----cCCc-----------cccccH-----HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 648 -DI----VDPT-----------LKSFQE-----NVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 648 -~~----~d~~-----------l~~~~~-----~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
+. .... .....+ ....++.+|+.+||+.||++|||++|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp TTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 00 0000 000111 11356789999999999999999999986
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-41 Score=355.40 Aligned_cols=256 Identities=18% Similarity=0.304 Sum_probs=201.3
Q ss_pred hhhhCcCCCCceeEEEEEEec----CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCC-CccceEeEEEecCCCc
Q 004979 429 SNIIGSFSDGTVGTVYKGTLS----SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNH-KNFVNLIGYCEEDEPF 503 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~----~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H-~nIv~l~g~~~~~~~~ 503 (721)
+++++.||+|+||+||+|+.. +|+.||||++........ ....+.+.+|+++|++++| |||+++++++.+..
T Consensus 26 y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~-~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~-- 102 (322)
T d1vzoa_ 26 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQK-AKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET-- 102 (322)
T ss_dssp EEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEE-ESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT--
T ss_pred eEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccc-hHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC--
Confidence 478889999999999999852 478999999865432111 1123568899999999976 89999999998877
Q ss_pred eEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCC
Q 004979 504 TRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNN 583 (721)
Q Consensus 504 ~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~ 583 (721)
..++||||+.+|+|.+++... ..+.......++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 103 ~~~~v~e~~~~~~L~~~i~~~--~~~~e~~~~~~~~Qi~~al~~lH~~~--ivHrDiKp~Nill~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 103 KLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLSKE 178 (322)
T ss_dssp EEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred ceeeeeecccccHHHHHHHhc--ccccHHHHHHHHHHHHHHHHHhhcCC--EEeccCCccceeecCCCCEEEeeccchhh
Confidence 779999999999999998643 45678888999999999999999998 99999999999999999999999998753
Q ss_pred C----------CCCCccccchhhcccC--CCCCCccHHHHHHHHHHHHhCCCcccCCC--CCHHHHHHHHhhcCCCCccc
Q 004979 584 T----------TAAKTGSAAMELLETS--AVDLESNVYSFGTILFEMITGRISYSIEN--GSLENWASEYLKGEQPLKDI 649 (721)
Q Consensus 584 ~----------~~~~~~~~apE~~~~~--~~s~ksDVwSfGvvL~ElltG~~P~~~~~--~~~~~~~~~~~~~~~~~~~~ 649 (721)
. ..++..|++||.+... .++.++||||+||+||||+||+.||.... ...............+
T Consensus 179 ~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~---- 254 (322)
T d1vzoa_ 179 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP---- 254 (322)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCC----
T ss_pred hcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCC----
Confidence 2 2245578899998654 46889999999999999999999997543 2223333333222211
Q ss_pred cCCccccccHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHHHHHhhhcCCCCCCCCCChhHHHHHHh
Q 004979 650 VDPTLKSFQENVLEELLVVIKNCVHPDPKQRPS-----MRGIAAKLKEITAMEPDGATPKLSPLWWAELEI 715 (721)
Q Consensus 650 ~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs-----~~evl~~L~~i~~~~~~~~~p~~~~~~~~~l~~ 715 (721)
.+..++.++.+++.+||+.||++||| ++|+++ +|++..++|+.++.
T Consensus 255 -------~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~-------------Hpff~~i~~~~l~~ 305 (322)
T d1vzoa_ 255 -------YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE-------------HLFFQKINWDDLAA 305 (322)
T ss_dssp -------CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT-------------SGGGTTCCHHHHHT
T ss_pred -------CcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc-------------CHhhcCCCHHHHHh
Confidence 22345678999999999999999994 777753 67777888887765
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-40 Score=346.39 Aligned_cols=250 Identities=16% Similarity=0.181 Sum_probs=195.7
Q ss_pred hhhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCCceEEE
Q 004979 429 SNIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEPFTRMM 507 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~l 507 (721)
|++++.||+|+||+||+|+. .+++.||||+++.... ......++.+|+.+|++++|||||++++++.+.+ ..++
T Consensus 4 y~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~---~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~--~~~i 78 (292)
T d1unla_ 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD---DEGVPSSALREICLLKELKHKNIVRLHDVLHSDK--KLTL 78 (292)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS---STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS--EEEE
T ss_pred CEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhC---ChHHHHHHHHHHHHHHhcCcCCEEeecccccccc--ceeE
Confidence 47889999999999999996 5788899999865432 2334578999999999999999999999999877 6799
Q ss_pred EEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCCCC-
Q 004979 508 VFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNTTA- 586 (721)
Q Consensus 508 V~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~~~- 586 (721)
|+||+.+++|..++. ....+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||.++....
T Consensus 79 v~~~~~~~~l~~~~~--~~~~~~~~~~~~~~~q~~~aL~~lH~~~--IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~ 154 (292)
T d1unla_ 79 VFEFCDQDLKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp EEECCSEEHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred Eeeeccccccccccc--cccccchhHHHHHHHHHHHHHHHhhcCC--EeeecccCcccccccCCceeeeecchhhcccCC
Confidence 999999999988765 4467889999999999999999999998 99999999999999999999999999864321
Q ss_pred --------CCccccchhhcccCC-CCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCCCC-ccc-------
Q 004979 587 --------AKTGSAAMELLETSA-VDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQPL-KDI------- 649 (721)
Q Consensus 587 --------~~~~~~apE~~~~~~-~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~~~-~~~------- 649 (721)
+...+++||.+.... ++.++||||+||++|||++|+.||.... +..+....+....... ...
T Consensus 155 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (292)
T d1unla_ 155 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN-DVDDQLKRIFRLLGTPTEEQWPSMTKL 233 (292)
T ss_dssp CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCS-SHHHHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred CccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCC-CHHHHHHHHHhhcCCCChhhhhhhhhc
Confidence 234577899886554 6899999999999999999999975333 3333333322111100 000
Q ss_pred c----------CCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 650 V----------DPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 650 ~----------d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
. .............++.+|+.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 00111223345577899999999999999999999875
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.1e-40 Score=354.01 Aligned_cols=245 Identities=16% Similarity=0.210 Sum_probs=188.7
Q ss_pred hhhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCC-CCccceEeEEEecCCCceEE
Q 004979 429 SNIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVN-HKNFVNLIGYCEEDEPFTRM 506 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~~~ 506 (721)
+++++.||+|+||+||+|+. .+++.||||+++... .+++.+|+++|++++ ||||+++++++........+
T Consensus 37 y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~ 108 (328)
T d3bqca1 37 YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 108 (328)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC--------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEE
T ss_pred eEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH--------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCcee
Confidence 47889999999999999996 578899999885321 256889999999995 99999999999865444689
Q ss_pred EEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCC-CcEEEeccCCCCCCC
Q 004979 507 MVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTED-YAAKISDFSFWNNTT 585 (721)
Q Consensus 507 lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~-~~~kL~DFGla~~~~ 585 (721)
+|||||.+|+|..+. +.+++..++.++.||+.||+|||+++ |+||||||+|||++.+ ..+||+|||+++...
T Consensus 109 ~v~e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~g--IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~ 181 (328)
T d3bqca1 109 LVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 181 (328)
T ss_dssp EEEECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred EEEeecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhcc--cccccccccceEEcCCCCeeeecccccceecc
Confidence 999999999997764 35899999999999999999999998 9999999999999865 469999999985432
Q ss_pred --------CCCccccchhhcccC-CCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHH--HHh---------h-cCC
Q 004979 586 --------AAKTGSAAMELLETS-AVDLESNVYSFGTILFEMITGRISYSIENGSLENWAS--EYL---------K-GEQ 644 (721)
Q Consensus 586 --------~~~~~~~apE~~~~~-~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~--~~~---------~-~~~ 644 (721)
.++..|+|||.+.+. .++.++||||+||++|||++|+.||.........+.. ... . ...
T Consensus 182 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 261 (328)
T d3bqca1 182 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 261 (328)
T ss_dssp TTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred CCCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccc
Confidence 235578999997654 5799999999999999999999999754433221111 000 0 000
Q ss_pred C----CccccCC----cc-----ccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 645 P----LKDIVDP----TL-----KSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 645 ~----~~~~~d~----~l-----~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
. ....... .. .......+.++.+|+.+||+.||++|||++|+++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp CCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 0000000 00 0112334578999999999999999999999975
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.5e-40 Score=345.31 Aligned_cols=261 Identities=11% Similarity=0.171 Sum_probs=204.3
Q ss_pred hhhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCC-CccceEeEEEecCCCceEE
Q 004979 429 SNIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNH-KNFVNLIGYCEEDEPFTRM 506 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H-~nIv~l~g~~~~~~~~~~~ 506 (721)
|++++.||+|+||+||+|+.. +++.||||++...... ..+.+|++.+..++| +||+.+++++.... ..+
T Consensus 7 Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-------~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~--~~~ 77 (293)
T d1csna_ 7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-------PQLRDEYRTYKLLAGCTGIPNVYYFGQEGL--HNV 77 (293)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS-------CCHHHHHHHHHHTTTCTTCCCEEEEEEETT--EEE
T ss_pred eEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc-------HHHHHHHHHHHHhcCCCCCCEEEEEeecCC--ccE
Confidence 467888999999999999964 6889999987543221 347788899999965 89999999998877 679
Q ss_pred EEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCC-----CCcEEEeccCCC
Q 004979 507 MVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTE-----DYAAKISDFSFW 581 (721)
Q Consensus 507 lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~-----~~~~kL~DFGla 581 (721)
+||||+ +|+|.++++. ....+++..+..++.|++.||+|||+++ |+||||||+|||++. ++.+||+|||++
T Consensus 78 ~vme~~-~~~l~~~~~~-~~~~~~~~~~~~i~~q~~~~l~~lH~~g--iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a 153 (293)
T d1csna_ 78 LVIDLL-GPSLEDLLDL-CGRKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 153 (293)
T ss_dssp EEEECC-CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred EEEEec-CCCHHHHHHh-hccchhhHHHHHHHHHHHHHHHHHHHCC--ceeccCCccceeecCcccccCCceEEccccee
Confidence 999999 7899998853 3456999999999999999999999998 999999999999974 578999999998
Q ss_pred CCC----------------CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCC-HHHHHHHHhhcCC
Q 004979 582 NNT----------------TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGS-LENWASEYLKGEQ 644 (721)
Q Consensus 582 ~~~----------------~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~-~~~~~~~~~~~~~ 644 (721)
+.. ..++..|+|||.+.+..++.++|||||||++|||+||+.||...... .......+.....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (293)
T d1csna_ 154 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ 233 (293)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH
T ss_pred EEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccC
Confidence 532 12567899999999999999999999999999999999999754332 2222222211100
Q ss_pred CCccccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhhcCCCCCCCCCChhHHH
Q 004979 645 PLKDIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAKLKEITAMEPDGATPKLSPLWWA 711 (721)
Q Consensus 645 ~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~~~~p~~~~~~~~ 711 (721)
. .........+++++.+++..||+.+|++||+++.+.+.|+++.+.... ....+++|+
T Consensus 234 ~------~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~---~~~~~~Dw~ 291 (293)
T d1csna_ 234 S------TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNT---TEDENFDWN 291 (293)
T ss_dssp H------SCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC---CSCSCCGGG
T ss_pred C------CChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCC---CCCCCCCCC
Confidence 0 001112233457789999999999999999999999999987665432 234577886
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-40 Score=355.64 Aligned_cols=253 Identities=19% Similarity=0.261 Sum_probs=187.8
Q ss_pred hhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecC----CCce
Q 004979 430 NIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEED----EPFT 504 (721)
Q Consensus 430 ~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~----~~~~ 504 (721)
+.++.||+|+||+||+|+.. +++.||||++..... .+.+|+++|++++|||||++++++... +..+
T Consensus 23 ~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~---------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~ 93 (350)
T d1q5ka_ 23 TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 93 (350)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS---------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCE
T ss_pred EeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch---------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceE
Confidence 45677899999999999964 689999999864321 234799999999999999999998643 2235
Q ss_pred EEEEEecCCCCChhhhhhh-ccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCC-cEEEeccCCCC
Q 004979 505 RMMVFEYSPNGSLFEHLHI-QEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDY-AAKISDFSFWN 582 (721)
Q Consensus 505 ~~lV~Ey~~~GsL~~~l~~-~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~-~~kL~DFGla~ 582 (721)
.+||||||++|.+..+.+. .....+++..+..|+.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+++
T Consensus 94 ~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~--IiHrDiKp~NILl~~~~~~~kl~DFG~a~ 171 (350)
T d1q5ka_ 94 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171 (350)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTTCCEEECCCTTCE
T ss_pred EEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC--CcccCCCcceEEEecCCCceeEecccchh
Confidence 7899999987644443322 24557999999999999999999999988 99999999999999765 89999999975
Q ss_pred CC--------CCCCccccchhhcc-cCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhh--cC--------
Q 004979 583 NT--------TAAKTGSAAMELLE-TSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLK--GE-------- 643 (721)
Q Consensus 583 ~~--------~~~~~~~~apE~~~-~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~--~~-------- 643 (721)
.. ..++..|+|||.+. ...|+.++||||+||++|||+||+.||.... ..+....+.. +.
T Consensus 172 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~--~~~~l~~i~~~~g~~~~~~~~~ 249 (350)
T d1q5ka_ 172 QLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS--GVDQLVEIIKVLGTPTREQIRE 249 (350)
T ss_dssp ECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSS--HHHHHHHHHHHHCCCCHHHHHH
T ss_pred hccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCC--HHHHHHHHHHHhCCChHHhhhh
Confidence 32 23456789999875 4578999999999999999999999996433 1222211111 00
Q ss_pred -------CCCccccCCc-cccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHHhhh
Q 004979 644 -------QPLKDIVDPT-LKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAK--LKEITA 695 (721)
Q Consensus 644 -------~~~~~~~d~~-l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~--L~~i~~ 695 (721)
.......... ........++++.+|+.+||+.||++|||+.|+++. ++++..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 311 (350)
T d1q5ka_ 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 311 (350)
T ss_dssp HCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred hccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccC
Confidence 0000000000 011123345678999999999999999999999863 555544
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-39 Score=344.17 Aligned_cols=248 Identities=17% Similarity=0.217 Sum_probs=187.9
Q ss_pred hhhhCcCCCCceeEEEEEEec-CCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCC----c
Q 004979 429 SNIIGSFSDGTVGTVYKGTLS-SGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEP----F 503 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~~-~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~----~ 503 (721)
|++++.||+|+||+||+|+.. +|+.||||++..... ......++.+|+.+|++++|||||++++++...+. .
T Consensus 19 Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~---~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ---NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp EEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS---SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred eEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhc---CHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 478899999999999999965 689999999875432 23344678999999999999999999999975422 3
Q ss_pred eEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCC
Q 004979 504 TRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNN 583 (721)
Q Consensus 504 ~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~ 583 (721)
..|+|||||.++ +.+.+. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+|++|||+++.
T Consensus 96 ~~~iv~Ey~~~~-l~~~~~----~~~~~~~i~~~~~qil~gl~~LH~~g--iiHrDlKP~Nil~~~~~~~kl~df~~~~~ 168 (355)
T d2b1pa1 96 DVYLVMELMDAN-LCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_dssp EEEEEEECCSEE-HHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred eeEEEEeccchH-HHHhhh----cCCCHHHHHHHHHHHHHHHHHhhhcc--cccccCCccccccccccceeeechhhhhc
Confidence 689999999665 444443 45899999999999999999999998 99999999999999999999999998653
Q ss_pred CC--------CCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHH----------------
Q 004979 584 TT--------AAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEY---------------- 639 (721)
Q Consensus 584 ~~--------~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~---------------- 639 (721)
.. .++..|+|||.+.+..++.++||||+||++|||++|+.||...+. ......+
T Consensus 169 ~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~--~~~~~~i~~~~~~~~~~~~~~~~ 246 (355)
T d2b1pa1 169 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY--IDQWNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_dssp ------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHHHCCCCHHHHTTSC
T ss_pred cccccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCH--HHHHHHHHHhccCCCHHHHHHhh
Confidence 32 345688999999999999999999999999999999999964431 1111111
Q ss_pred ------hhcCCCCcc-----cc----CCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004979 640 ------LKGEQPLKD-----IV----DPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAA 688 (721)
Q Consensus 640 ------~~~~~~~~~-----~~----d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 688 (721)
......... .. .+.........+.++.+|+.+||+.||++|||++|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310 (355)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 111110000 00 01111122345778999999999999999999999986
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-39 Score=347.67 Aligned_cols=256 Identities=17% Similarity=0.203 Sum_probs=190.8
Q ss_pred hhhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCccceEeEEEecCCC---ce
Q 004979 429 SNIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEEDEP---FT 504 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~---~~ 504 (721)
|++++.||+|+||+||+|+. .+++.||||++..... .....+++.+|+++|++++|||||++++++..... ..
T Consensus 20 Y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~---~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 20 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ---SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp EEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTS---SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred eEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhc---ChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 57889999999999999995 5789999999874332 22334678999999999999999999999864321 13
Q ss_pred EEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccCCCCCC
Q 004979 505 RMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFSFWNNT 584 (721)
Q Consensus 505 ~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFGla~~~ 584 (721)
.++++||+.+|+|.+++.. ..+++..+..|+.||+.||+|||+++ |+||||||+|||++.++.+|++|||++...
T Consensus 97 ~~~i~~~~~gg~L~~~~~~---~~l~e~~~~~i~~qil~aL~~LH~~g--iiHrDiKp~NILi~~~~~~kl~dfg~a~~~ 171 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHT 171 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECCC----CC
T ss_pred eEEEEEeecCCchhhhccc---ccccHHHHHHHHHHHHHHHHHHHhCC--CcccccCCccccccccccccccccchhccc
Confidence 3667788889999999853 46999999999999999999999998 999999999999999999999999997643
Q ss_pred C------CCCccccchhhcccC-CCCCCccHHHHHHHHHHHHhCCCcccCCCCCHHHHHHHHhhcCC-CCc---------
Q 004979 585 T------AAKTGSAAMELLETS-AVDLESNVYSFGTILFEMITGRISYSIENGSLENWASEYLKGEQ-PLK--------- 647 (721)
Q Consensus 585 ~------~~~~~~~apE~~~~~-~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~~~~~~~~~~~~~~-~~~--------- 647 (721)
. .++..|+|||..... .++.++||||+||++|||++|+.||...+. ......+..... +..
T Consensus 172 ~~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~~ 249 (348)
T d2gfsa1 172 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH--IDQLKLILRLVGTPGAELLKKISSE 249 (348)
T ss_dssp TGGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHHHCCCCHHHHTTCCCH
T ss_pred CcccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCH--HHHHHHHHHhcCCCChHHhhhccch
Confidence 2 234568999986654 568999999999999999999999964432 111111111100 000
Q ss_pred ----------cccCCccccccHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHHhh
Q 004979 648 ----------DIVDPTLKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIAAK--LKEIT 694 (721)
Q Consensus 648 ----------~~~d~~l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~--L~~i~ 694 (721)
..............+.++.+|+.+||+.||++|||+.|+++. ++++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~ 308 (348)
T d2gfsa1 250 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 308 (348)
T ss_dssp HHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred hhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCC
Confidence 000000111112345678999999999999999999999873 54443
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.4e-35 Score=314.15 Aligned_cols=253 Identities=16% Similarity=0.249 Sum_probs=184.6
Q ss_pred hhhhCcCCCCceeEEEEEEe-cCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCC-----------CCccceEeEE
Q 004979 429 SNIIGSFSDGTVGTVYKGTL-SSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVN-----------HKNFVNLIGY 496 (721)
Q Consensus 429 ~~ii~~lg~G~~g~Vyk~~~-~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~-----------H~nIv~l~g~ 496 (721)
|++++.||+|+||+||+|+. .+|+.||||++.... ...+.+.+|++++++++ |+|||+++++
T Consensus 15 Y~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~------~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~ 88 (362)
T d1q8ya_ 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK------VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 88 (362)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH------HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred EEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc------cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEE
Confidence 57899999999999999996 578999999986432 22356778888887775 5789999999
Q ss_pred EecCCCceEEEEEecCCCCChh-hhhhhccCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCeEeeCCCCCCeEeCCCC---
Q 004979 497 CEEDEPFTRMMVFEYSPNGSLF-EHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQ-LTPPIAHRNLQSSSIYLTEDY--- 571 (721)
Q Consensus 497 ~~~~~~~~~~lV~Ey~~~GsL~-~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~-~~~~IvHrDLKp~NILl~~~~--- 571 (721)
+........+++++++..+... ..........+++..+..++.||+.||+|||+ .+ |+||||||+|||++.++
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~--IvHrDlKp~NIll~~~~~~~ 166 (362)
T d1q8ya_ 89 FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPE 166 (362)
T ss_dssp EEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSGGGEEEEEEETTT
T ss_pred eeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC--cccccCChhHeeeeccCccc
Confidence 8765444567777777655433 33333445678899999999999999999997 77 99999999999998654
Q ss_pred ---cEEEeccCCCCCC------CCCCccccchhhcccCCCCCCccHHHHHHHHHHHHhCCCcccCCCCC----HHHHHHH
Q 004979 572 ---AAKISDFSFWNNT------TAAKTGSAAMELLETSAVDLESNVYSFGTILFEMITGRISYSIENGS----LENWASE 638 (721)
Q Consensus 572 ---~~kL~DFGla~~~------~~~~~~~~apE~~~~~~~s~ksDVwSfGvvL~ElltG~~P~~~~~~~----~~~~~~~ 638 (721)
.+|++|||.+... ..++..|+|||.+....++.++||||+||+++||++|+.||...... .......
T Consensus 167 ~~~~~kl~dfg~s~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~ 246 (362)
T d1q8ya_ 167 NLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 246 (362)
T ss_dssp TEEEEEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHH
T ss_pred ccceeeEeecccccccccccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHH
Confidence 3999999987532 33556799999999999999999999999999999999999743221 1111111
Q ss_pred Hhh--cCC-------------------CCccccCCc----------cccccHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 004979 639 YLK--GEQ-------------------PLKDIVDPT----------LKSFQENVLEELLVVIKNCVHPDPKQRPSMRGIA 687 (721)
Q Consensus 639 ~~~--~~~-------------------~~~~~~d~~----------l~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl 687 (721)
... +.. ....+.... ..........++.+|+.+|+..||++|||++|++
T Consensus 247 ~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L 326 (362)
T d1q8ya_ 247 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLV 326 (362)
T ss_dssp HHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHH
T ss_pred HHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 100 000 000000000 0123356778999999999999999999999998
Q ss_pred HH
Q 004979 688 AK 689 (721)
Q Consensus 688 ~~ 689 (721)
+.
T Consensus 327 ~H 328 (362)
T d1q8ya_ 327 NH 328 (362)
T ss_dssp TC
T ss_pred cC
Confidence 73
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.91 E-value=8.5e-25 Score=229.06 Aligned_cols=159 Identities=27% Similarity=0.470 Sum_probs=146.2
Q ss_pred cCChHHHHHHHHHHHhcccCCCCCCCCCCCCCCCCCCCCCC--ceeeEEeCC----CcEEEEEeCCCCCCC--cCchhhc
Q 004979 68 RCLNSEGMALLRFRERVVRDPFGALSKWSDNDGVGDNVNPC--SWFGVECSD----GKVVILNLRDLCLGG--MLAPELG 139 (721)
Q Consensus 68 ~~~~~~~~~ll~~k~~~~~~~~~~l~~W~~~~~~~~~~~~C--~w~gv~C~~----~~v~~l~L~~~~l~G--~ip~~l~ 139 (721)
.|.++|+.||++||+.+. || ..+++|... .||| .|.||+|+. +||+.|+|++++++| .||++|+
T Consensus 2 ~c~~~e~~aLl~~k~~~~-~~-~~l~sW~~~------~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~ 73 (313)
T d1ogqa_ 2 LCNPQDKQALLQIKKDLG-NP-TTLSSWLPT------TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLA 73 (313)
T ss_dssp CSCHHHHHHHHHHHHHTT-CC-GGGTTCCTT------SCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGG
T ss_pred CCCHHHHHHHHHHHHHCC-CC-CcCCCCCCC------CCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHh
Confidence 378899999999999986 45 368999754 4899 499999973 389999999999998 5889999
Q ss_pred CCCCCCEEEccC-CcccccCchhhcCCCCCCEeEcccCcccccCCccccCCCCCCEEECccCCCCcCCChhccCCCCCCE
Q 004979 140 QLSELKSIILRN-NSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLLDNNQYLGGISPELHVLKVISE 218 (721)
Q Consensus 140 ~l~~L~~L~L~~-n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~~L~~l~l~~N~~~G~iP~~~~~l~~L~~ 218 (721)
+|++|++|+|++ |+|+|.||+++++|++|++|+|++|++.|..|..+..+..|+++++++|.+.+.+|..+++++.|+.
T Consensus 74 ~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~ 153 (313)
T d1ogqa_ 74 NLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVG 153 (313)
T ss_dssp GCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCE
T ss_pred cCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccce
Confidence 999999999997 8999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred EEccCCCCCCcccccc
Q 004979 219 IQVDESWLTNAASRAS 234 (721)
Q Consensus 219 l~l~~n~~~g~~p~~~ 234 (721)
+++++|.++|.+|...
T Consensus 154 l~l~~n~l~~~ip~~~ 169 (313)
T d1ogqa_ 154 ITFDGNRISGAIPDSY 169 (313)
T ss_dssp EECCSSCCEEECCGGG
T ss_pred eecccccccccccccc
Confidence 9999999999998753
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.85 E-value=3.7e-22 Score=193.36 Aligned_cols=164 Identities=12% Similarity=0.063 Sum_probs=118.2
Q ss_pred CcCCCCceeEEEEEEecCCcEEEEEEeeecccc-------------chhhHHHHHHHHHHHHHhcCCCCccceEeEEEec
Q 004979 433 GSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRA-------------DWSKNLESQFRKKIDTLSKVNHKNFVNLIGYCEE 499 (721)
Q Consensus 433 ~~lg~G~~g~Vyk~~~~~~~~vavk~~~~~~~~-------------~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~ 499 (721)
.+||+|+||+||+|+..+|+.||||++...... .........+.+|+..+.+++|.+++..+++..
T Consensus 6 ~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~~- 84 (191)
T d1zara2 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWEG- 84 (191)
T ss_dssp EEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEET-
T ss_pred CEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEecC-
Confidence 468899999999999888999999986432110 011222345677899999999999999876531
Q ss_pred CCCceEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCCeEeCCCCcEEEeccC
Q 004979 500 DEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQLTPPIAHRNLQSSSIYLTEDYAAKISDFS 579 (721)
Q Consensus 500 ~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~IvHrDLKp~NILl~~~~~~kL~DFG 579 (721)
.++||||++++.+.++ +......++.|++.+++|||+++ |+||||||+|||++++ .++|+|||
T Consensus 85 -----~~lvme~~~~~~~~~l---------~~~~~~~i~~ql~~~l~~lH~~g--iiHrDiKP~NILv~~~-~~~liDFG 147 (191)
T d1zara2 85 -----NAVLMELIDAKELYRV---------RVENPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLVSEE-GIWIIDFP 147 (191)
T ss_dssp -----TEEEEECCCCEEGGGC---------CCSCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEETT-EEEECCCT
T ss_pred -----CEEEEEeeccccccch---------hhHHHHHHHHHHHHHHHHHhhCC--EEEccCChhheeeeCC-CEEEEECC
Confidence 2799999988665432 23335679999999999999998 9999999999999965 58999999
Q ss_pred CCCCCCCCCccc-cc--hhh---cccCCCCCCccHHHHHHH
Q 004979 580 FWNNTTAAKTGS-AA--MEL---LETSAVDLESNVYSFGTI 614 (721)
Q Consensus 580 la~~~~~~~~~~-~a--pE~---~~~~~~s~ksDVwSfGvv 614 (721)
++.........+ .. .+. .-...|+.++||||..--
T Consensus 148 ~a~~~~~~~~~~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 148 QSVEVGEEGWREILERDVRNIITYFSRTYRTEKDINSAIDR 188 (191)
T ss_dssp TCEETTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHHHHHH
T ss_pred CcccCCCCCcHHHHHHHHHHHHHHHcCCCCCcccHHHHHHH
Confidence 986554322111 11 000 123567899999997543
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.44 E-value=1.4e-13 Score=132.22 Aligned_cols=123 Identities=22% Similarity=0.270 Sum_probs=108.1
Q ss_pred CceeeEEeCC-----------CcEEEEEeCCCCCCCcCch-hhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEccc
Q 004979 108 CSWFGVECSD-----------GKVVILNLRDLCLGGMLAP-ELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGF 175 (721)
Q Consensus 108 C~w~gv~C~~-----------~~v~~l~L~~~~l~G~ip~-~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~ 175 (721)
|+|..|.|+. ..++.|+|++|.+++.++. .+..+++|+.|+|++|.+.+..+..+..+++|+.|+|++
T Consensus 8 C~~~~v~Cs~~~L~~iP~~lp~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~ 87 (192)
T d1w8aa_ 8 CEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp EETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred EcCCEEEEeCCCcCccCCCCCCCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeecc
Confidence 6799999963 2578999999999987754 578899999999999999999999999999999999999
Q ss_pred CcccccCCccccCCCCCCEEECccCCCCcCCChhccCCCCCCEEEccCCCCCCcc
Q 004979 176 NNFSGPFPSDFGNSFSLTTLLLDNNQYLGGISPELHVLKVISEIQVDESWLTNAA 230 (721)
Q Consensus 176 N~l~G~iP~~~~~~~~L~~l~l~~N~~~G~iP~~~~~l~~L~~l~l~~n~~~g~~ 230 (721)
|++++-.|..|.++++|++|+|++|++++-.|..+..+++|++|+|++|.+....
T Consensus 88 N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~ 142 (192)
T d1w8aa_ 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNC 142 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSG
T ss_pred ccccccCHHHHhCCCcccccccCCccccccCHHHhcCCccccccccccccccccc
Confidence 9999766777899999999999999999877777889999999999999887654
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.33 E-value=3.2e-13 Score=139.88 Aligned_cols=116 Identities=21% Similarity=0.394 Sum_probs=109.8
Q ss_pred CcEEEEEeCC-CCCCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCccccCCCCCCEEE
Q 004979 118 GKVVILNLRD-LCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLL 196 (721)
Q Consensus 118 ~~v~~l~L~~-~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~~L~~l~ 196 (721)
..+..|+|++ |++.|.||++|++|++|++|+|++|.+.|..|..+..+..|+.++++.|++.+.+|..+++++.|++++
T Consensus 76 ~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~ 155 (313)
T d1ogqa_ 76 PYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGIT 155 (313)
T ss_dssp TTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEE
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccceee
Confidence 4678999987 899999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CccCCCCcCCChhccCCCCC-CEEEccCCCCCCccccc
Q 004979 197 LDNNQYLGGISPELHVLKVI-SEIQVDESWLTNAASRA 233 (721)
Q Consensus 197 l~~N~~~G~iP~~~~~l~~L-~~l~l~~n~~~g~~p~~ 233 (721)
+++|.++|.+|..++.+..+ +.++++.|.++|..|..
T Consensus 156 l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~ 193 (313)
T d1ogqa_ 156 FDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPT 193 (313)
T ss_dssp CCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGG
T ss_pred cccccccccccccccccccccccccccccccccccccc
Confidence 99999999999999998886 88999999999987764
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.25 E-value=1.1e-11 Score=109.68 Aligned_cols=102 Identities=24% Similarity=0.264 Sum_probs=89.9
Q ss_pred EEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCccccCCCCCCEEECccCC
Q 004979 122 ILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLLDNNQ 201 (721)
Q Consensus 122 ~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~~L~~l~l~~N~ 201 (721)
.|+|++|+++ .++ .+..+++|++|+|++|.++ .+|+.++.+++|+.|++++|.+++ +| .+.++++|+.|++++|.
T Consensus 2 ~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N~ 76 (124)
T d1dcea3 2 VLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNR 76 (124)
T ss_dssp EEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSC
T ss_pred EEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCCc
Confidence 5899999998 444 5899999999999999998 689899999999999999999995 55 58999999999999999
Q ss_pred CCcC-CChhccCCCCCCEEEccCCCCCC
Q 004979 202 YLGG-ISPELHVLKVISEIQVDESWLTN 228 (721)
Q Consensus 202 ~~G~-iP~~~~~l~~L~~l~l~~n~~~g 228 (721)
++.- -+..+..+++|+.|++++|.++.
T Consensus 77 i~~~~~~~~l~~~~~L~~L~l~~N~i~~ 104 (124)
T d1dcea3 77 LQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104 (124)
T ss_dssp CCSSSTTGGGGGCTTCCEEECTTSGGGG
T ss_pred cCCCCCchhhcCCCCCCEEECCCCcCCc
Confidence 9753 23568999999999999999874
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.19 E-value=2.7e-11 Score=115.83 Aligned_cols=114 Identities=15% Similarity=0.201 Sum_probs=98.8
Q ss_pred eEEeCCCcEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCc-hhhcCCCCCCEeEcccCcccccCCccccCCC
Q 004979 112 GVECSDGKVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIP-KEIGELKELEILDLGFNNFSGPFPSDFGNSF 190 (721)
Q Consensus 112 gv~C~~~~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip-~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~ 190 (721)
|-.|.. +.++.++++|+ .||..+. +++++|+|++|.+++.++ ..+.++++|+.|+|++|++.+..+..+..++
T Consensus 5 ~C~C~~---~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~ 78 (192)
T d1w8aa_ 5 MCHCEG---TTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGAS 78 (192)
T ss_dssp TSEEET---TEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCT
T ss_pred CCEEcC---CEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeecccccccccccccccccc
Confidence 445643 36889999998 6887764 689999999999998774 4578999999999999999999999999999
Q ss_pred CCCEEECccCCCCcCCChhccCCCCCCEEEccCCCCCCccc
Q 004979 191 SLTTLLLDNNQYLGGISPELHVLKVISEIQVDESWLTNAAS 231 (721)
Q Consensus 191 ~L~~l~l~~N~~~G~iP~~~~~l~~L~~l~l~~n~~~g~~p 231 (721)
+|++|+|++|++++-.|..+.++++|++|+|++|.+++-.|
T Consensus 79 ~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~ 119 (192)
T d1w8aa_ 79 HIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMP 119 (192)
T ss_dssp TCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECT
T ss_pred ccceeeeccccccccCHHHHhCCCcccccccCCccccccCH
Confidence 99999999999997777778999999999999999996433
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.08 E-value=1.2e-10 Score=118.26 Aligned_cols=112 Identities=20% Similarity=0.214 Sum_probs=84.9
Q ss_pred cEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCccccCCCCCCEEECc
Q 004979 119 KVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLLD 198 (721)
Q Consensus 119 ~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~~L~~l~l~ 198 (721)
.+..+++++|.+++..+..+..+++|+.|+|++|++.+..|..+..+++|+.+++++|++++..|..+.++++|++|+++
T Consensus 130 ~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~ 209 (284)
T d1ozna_ 130 ALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLF 209 (284)
T ss_dssp TCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred ccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhccccccc
Confidence 46677777777776555556777778888888888877666777778888888888888887777777778888888888
Q ss_pred cCCCCcCCChhccCCCCCCEEEccCCCCCCcc
Q 004979 199 NNQYLGGISPELHVLKVISEIQVDESWLTNAA 230 (721)
Q Consensus 199 ~N~~~G~iP~~~~~l~~L~~l~l~~n~~~g~~ 230 (721)
+|.+++..|..+..+.+|++|+|++|.+.+..
T Consensus 210 ~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C 241 (284)
T d1ozna_ 210 ANNLSALPTEALAPLRALQYLRLNDNPWVCDC 241 (284)
T ss_dssp SSCCSCCCHHHHTTCTTCCEEECCSSCEECSG
T ss_pred ccccccccccccccccccCEEEecCCCCCCCc
Confidence 88887766677777788888888888777643
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.06 E-value=3.4e-10 Score=104.15 Aligned_cols=111 Identities=17% Similarity=0.099 Sum_probs=90.2
Q ss_pred CCCCceeeEEeCCCcEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCc-ccccCchhhcCCCCCCEeEcccCcccccCC
Q 004979 105 VNPCSWFGVECSDGKVVILNLRDLCLGGMLAPELGQLSELKSIILRNNS-FFGTIPKEIGELKELEILDLGFNNFSGPFP 183 (721)
Q Consensus 105 ~~~C~w~gv~C~~~~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~-l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP 183 (721)
..|+.+.++.|.. +++. .+|..+..+++|+.|+|++|+ +..--+..+..+++|+.|+|++|+++.--|
T Consensus 5 C~c~~~~~l~c~~----------~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~ 73 (156)
T d2ifga3 5 CCPHGSSGLRCTR----------DGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAP 73 (156)
T ss_dssp SCCSSSSCEECCS----------SCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECT
T ss_pred CCcCCCCeEEecC----------CCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCccc
Confidence 3455678888853 3332 456678889999999998775 765445578999999999999999997667
Q ss_pred ccccCCCCCCEEECccCCCCcCCChhccCCCCCCEEEccCCCCC
Q 004979 184 SDFGNSFSLTTLLLDNNQYLGGISPELHVLKVISEIQVDESWLT 227 (721)
Q Consensus 184 ~~~~~~~~L~~l~l~~N~~~G~iP~~~~~l~~L~~l~l~~n~~~ 227 (721)
..+..+++|++|+|++|+++ .||........|+.|+|++|.|.
T Consensus 74 ~~f~~l~~L~~L~Ls~N~l~-~l~~~~~~~~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 74 DAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116 (156)
T ss_dssp TGGGSCSCCCEEECCSSCCS-CCCSTTTCSCCCCEEECCSSCCC
T ss_pred ccccccccccceeccCCCCc-ccChhhhccccccccccCCCccc
Confidence 77999999999999999998 78877776678999999999886
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.95 E-value=1.2e-09 Score=110.82 Aligned_cols=115 Identities=20% Similarity=0.170 Sum_probs=97.5
Q ss_pred CcEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCccccCCCCCCEEEC
Q 004979 118 GKVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLL 197 (721)
Q Consensus 118 ~~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~~L~~l~l 197 (721)
.++..|+|++|.+.+..+..+..+.+|+.+++++|.+++..+..+..+++|+.|+|++|++++-.|..+.++++|+.+++
T Consensus 105 ~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l 184 (284)
T d1ozna_ 105 GRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLL 184 (284)
T ss_dssp TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred ccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhh
Confidence 46778899998887776777888889999999999998665667788889999999999998777778888999999999
Q ss_pred ccCCCCcCCChhccCCCCCCEEEccCCCCCCcccc
Q 004979 198 DNNQYLGGISPELHVLKVISEIQVDESWLTNAASR 232 (721)
Q Consensus 198 ~~N~~~G~iP~~~~~l~~L~~l~l~~n~~~g~~p~ 232 (721)
++|++++-.|..+..+++|++|+++.|.+++..|.
T Consensus 185 ~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~ 219 (284)
T d1ozna_ 185 HQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTE 219 (284)
T ss_dssp CSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHH
T ss_pred hhccccccChhHhhhhhhccccccccccccccccc
Confidence 99999988888899999999999999999875543
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.95 E-value=1.2e-09 Score=109.66 Aligned_cols=114 Identities=19% Similarity=0.096 Sum_probs=77.5
Q ss_pred CcEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCccccCCCCCCEEEC
Q 004979 118 GKVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLL 197 (721)
Q Consensus 118 ~~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~~L~~l~l 197 (721)
..+..|+|++|.+.+. ++.+..+++|+.|+|++|.+.+..+..+..+.+|+.|++++|.+++-.|..+..+++|+.|++
T Consensus 77 ~~L~~L~Ls~N~l~~~-~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l 155 (266)
T d1p9ag_ 77 PVLGTLDLSHNQLQSL-PLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSL 155 (266)
T ss_dssp TTCCEEECCSSCCSSC-CCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred cccccccccccccccc-ccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhccc
Confidence 3566777777777653 445667777777777777776655666666777777777777777544455566677777777
Q ss_pred ccCCCCcCCChhccCCCCCCEEEccCCCCCCccccc
Q 004979 198 DNNQYLGGISPELHVLKVISEIQVDESWLTNAASRA 233 (721)
Q Consensus 198 ~~N~~~G~iP~~~~~l~~L~~l~l~~n~~~g~~p~~ 233 (721)
++|++++-.|..+..+++|++|+|++|.|+ .+|..
T Consensus 156 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~ 190 (266)
T d1p9ag_ 156 ANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKG 190 (266)
T ss_dssp TTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTT
T ss_pred ccccccccCccccccccccceeecccCCCc-ccChh
Confidence 777777665566667777777777777777 56653
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.90 E-value=3.5e-09 Score=106.24 Aligned_cols=108 Identities=20% Similarity=0.177 Sum_probs=59.7
Q ss_pred cEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCccccCCCCCCEEECc
Q 004979 119 KVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLLD 198 (721)
Q Consensus 119 ~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~~L~~l~l~ 198 (721)
++..++|+++.+.+..+..+..+.+|+.|++++|.+.+-.+..+..++.|+.|++++|++++..|..+..+++|++|+|+
T Consensus 101 ~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls 180 (266)
T d1p9ag_ 101 ALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQ 180 (266)
T ss_dssp TCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECC
T ss_pred ccccccccccccceeeccccccccccccccccccccceeccccccccccchhcccccccccccCccccccccccceeecc
Confidence 44555555555554444445555555555555555554434444455555555555555555444445555555555555
Q ss_pred cCCCCcCCChhccCCCCCCEEEccCCCCC
Q 004979 199 NNQYLGGISPELHVLKVISEIQVDESWLT 227 (721)
Q Consensus 199 ~N~~~G~iP~~~~~l~~L~~l~l~~n~~~ 227 (721)
+|+++ .||+.+..+++|+.|+|++|.+.
T Consensus 181 ~N~L~-~lp~~~~~~~~L~~L~L~~Np~~ 208 (266)
T d1p9ag_ 181 ENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208 (266)
T ss_dssp SSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred cCCCc-ccChhHCCCCCCCEEEecCCCCC
Confidence 55555 55555555555555555555544
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=98.88 E-value=1.8e-09 Score=94.99 Aligned_cols=79 Identities=16% Similarity=0.253 Sum_probs=72.0
Q ss_pred CEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCccccCCCCCCEEECccCCCCcCCChhccCCCCCCEEEccCC
Q 004979 145 KSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLLDNNQYLGGISPELHVLKVISEIQVDES 224 (721)
Q Consensus 145 ~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~~L~~l~l~~N~~~G~iP~~~~~l~~L~~l~l~~n 224 (721)
++|+|++|+++ .+| .+..+++|++|||++|.++ .+|+.++.+++|++|++++|.+++ +| .++.+++|+.|++++|
T Consensus 1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCC
Confidence 58999999998 565 5899999999999999998 689999999999999999999985 55 5999999999999999
Q ss_pred CCCC
Q 004979 225 WLTN 228 (721)
Q Consensus 225 ~~~g 228 (721)
.++.
T Consensus 76 ~i~~ 79 (124)
T d1dcea3 76 RLQQ 79 (124)
T ss_dssp CCCS
T ss_pred ccCC
Confidence 9985
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.88 E-value=1.5e-09 Score=100.31 Aligned_cols=106 Identities=20% Similarity=0.153 Sum_probs=86.7
Q ss_pred cEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCccccCCCCCCEEECc
Q 004979 119 KVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLLD 198 (721)
Q Consensus 119 ~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~~L~~l~l~ 198 (721)
++..|+|++|.++. |+..+..+++|+.|+|++|.++ .++ .+..+++|+.|+|++|+++.--+..+..+++|+.|+++
T Consensus 19 ~lr~L~L~~n~I~~-i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L~ 95 (162)
T d1a9na_ 19 RDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILT 95 (162)
T ss_dssp SCEEEECTTSCCCS-CCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECC
T ss_pred cCcEEECCCCCCCc-cCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCccccccccccccceec
Confidence 57789999999865 5655577999999999999998 554 58889999999999999985444445679999999999
Q ss_pred cCCCCcCCC--hhccCCCCCCEEEccCCCCCC
Q 004979 199 NNQYLGGIS--PELHVLKVISEIQVDESWLTN 228 (721)
Q Consensus 199 ~N~~~G~iP--~~~~~l~~L~~l~l~~n~~~g 228 (721)
+|+++. ++ ..+..+++|++|++++|.++.
T Consensus 96 ~N~i~~-~~~l~~l~~l~~L~~L~l~~N~i~~ 126 (162)
T d1a9na_ 96 NNSLVE-LGDLDPLASLKSLTYLCILRNPVTN 126 (162)
T ss_dssp SCCCCC-GGGGGGGGGCTTCCEEECCSSGGGG
T ss_pred cccccc-cccccccccccccchhhcCCCcccc
Confidence 999864 33 357889999999999998764
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=98.76 E-value=1e-08 Score=104.65 Aligned_cols=110 Identities=19% Similarity=0.233 Sum_probs=94.4
Q ss_pred CcEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCccccCCCCCCEEEC
Q 004979 118 GKVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLL 197 (721)
Q Consensus 118 ~~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~~L~~l~l 197 (721)
..+..++++++.+.- +|.. .+++|+.|++++|...+.++..+.+++.++.|++++|.+++-.|..+.++++|++|+|
T Consensus 150 ~~L~~l~l~~n~l~~-l~~~--~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L 226 (305)
T d1xkua_ 150 KKLSYIRIADTNITT-IPQG--LPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHL 226 (305)
T ss_dssp TTCCEEECCSSCCCS-CCSS--CCTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEEC
T ss_pred cccCccccccCCccc-cCcc--cCCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeec
Confidence 357788898888763 5543 3688999999999999999999999999999999999999888888899999999999
Q ss_pred ccCCCCcCCChhccCCCCCCEEEccCCCCCCcccc
Q 004979 198 DNNQYLGGISPELHVLKVISEIQVDESWLTNAASR 232 (721)
Q Consensus 198 ~~N~~~G~iP~~~~~l~~L~~l~l~~n~~~g~~p~ 232 (721)
++|.++ .||..+..+++|++|+|++|.++. |+.
T Consensus 227 ~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~-i~~ 259 (305)
T d1xkua_ 227 NNNKLV-KVPGGLADHKYIQVVYLHNNNISA-IGS 259 (305)
T ss_dssp CSSCCS-SCCTTTTTCSSCCEEECCSSCCCC-CCT
T ss_pred cccccc-ccccccccccCCCEEECCCCccCc-cCh
Confidence 999987 689899999999999999999883 443
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=98.74 E-value=1.3e-08 Score=103.94 Aligned_cols=109 Identities=17% Similarity=0.166 Sum_probs=81.0
Q ss_pred EEEEEeCCCCC--CCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCccccCCCCCCEEEC
Q 004979 120 VVILNLRDLCL--GGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLL 197 (721)
Q Consensus 120 v~~l~L~~~~l--~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~~L~~l~l 197 (721)
...++...+.. .+..+..+..++.|+.+++++|.+. .+|.. .+++|+.|++++|..++.+|..+.+++.+++|++
T Consensus 126 ~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~-~l~~~--~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~ 202 (305)
T d1xkua_ 126 MIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQG--LPPSLTELHLDGNKITKVDAASLKGLNNLAKLGL 202 (305)
T ss_dssp CCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSS--CCTTCSEEECTTSCCCEECTGGGTTCTTCCEEEC
T ss_pred ccccccccccccccCCCccccccccccCccccccCCcc-ccCcc--cCCccCEEECCCCcCCCCChhHhhcccccccccc
Confidence 44555555543 2334456777888888888888876 45543 3578888888888888888888888888888888
Q ss_pred ccCCCCcCCChhccCCCCCCEEEccCCCCCCcccc
Q 004979 198 DNNQYLGGISPELHVLKVISEIQVDESWLTNAASR 232 (721)
Q Consensus 198 ~~N~~~G~iP~~~~~l~~L~~l~l~~n~~~g~~p~ 232 (721)
++|.+++-.|..+..+++|++|+|++|.++ .+|.
T Consensus 203 s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~ 236 (305)
T d1xkua_ 203 SFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPG 236 (305)
T ss_dssp CSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCT
T ss_pred ccccccccccccccccccceeeeccccccc-cccc
Confidence 888888777777888888888888888887 4554
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.72 E-value=8.2e-09 Score=95.25 Aligned_cols=90 Identities=18% Similarity=0.157 Sum_probs=76.9
Q ss_pred hhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCccccCCCCCCEEECccCCCCcCCChhccCCCC
Q 004979 136 PELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLLDNNQYLGGISPELHVLKV 215 (721)
Q Consensus 136 ~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~~L~~l~l~~N~~~G~iP~~~~~l~~ 215 (721)
+.+.++..|+.|||++|.++ .||.....+++|+.|||++|+++ .++ .+..+++|++|++++|+++.--+..+..+++
T Consensus 12 ~~~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~ 88 (162)
T d1a9na_ 12 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPD 88 (162)
T ss_dssp CEEECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTT
T ss_pred HhccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCccccccccc
Confidence 34678889999999999997 56766678999999999999998 564 5889999999999999998644444567999
Q ss_pred CCEEEccCCCCCC
Q 004979 216 ISEIQVDESWLTN 228 (721)
Q Consensus 216 L~~l~l~~n~~~g 228 (721)
|+.|+|++|.++.
T Consensus 89 L~~L~L~~N~i~~ 101 (162)
T d1a9na_ 89 LTELILTNNSLVE 101 (162)
T ss_dssp CCEEECCSCCCCC
T ss_pred cccceeccccccc
Confidence 9999999999874
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=98.58 E-value=5e-08 Score=102.31 Aligned_cols=106 Identities=25% Similarity=0.283 Sum_probs=88.2
Q ss_pred CcEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCccccCCCCCCEEEC
Q 004979 118 GKVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLL 197 (721)
Q Consensus 118 ~~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~~L~~l~l 197 (721)
..+..++++++.+.+.. .+..+..++.++++.|.+.+ +..+..+++++.|+|++|++++-. .+..+++|+.|++
T Consensus 263 ~~L~~L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~--~~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L 336 (384)
T d2omza2 263 TKLTELKLGANQISNIS--PLAGLTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFF 336 (384)
T ss_dssp TTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCSC--CGGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEEC
T ss_pred ccCCEeeccCcccCCCC--cccccccccccccccccccc--ccccchhcccCeEECCCCCCCCCc--ccccCCCCCEEEC
Confidence 36788999999988644 37788999999999999987 235788899999999999999743 3788999999999
Q ss_pred ccCCCCcCCChhccCCCCCCEEEccCCCCCCccc
Q 004979 198 DNNQYLGGISPELHVLKVISEIQVDESWLTNAAS 231 (721)
Q Consensus 198 ~~N~~~G~iP~~~~~l~~L~~l~l~~n~~~g~~p 231 (721)
++|++++ +| .+..+++|++|+|++|.+++-+|
T Consensus 337 ~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~ 368 (384)
T d2omza2 337 ANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP 368 (384)
T ss_dssp CSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG
T ss_pred CCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh
Confidence 9999875 54 68899999999999999997655
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=98.56 E-value=1.3e-07 Score=90.13 Aligned_cols=103 Identities=21% Similarity=0.273 Sum_probs=72.6
Q ss_pred CcEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCccccCCCCCCEEEC
Q 004979 118 GKVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLL 197 (721)
Q Consensus 118 ~~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~~L~~l~l 197 (721)
.+++.|+|+++++.. + +.+..|++|++|+|++|.+++..| ++++++|+.|++++|.+.. +| .+.+++.|+.|++
T Consensus 40 ~~l~~L~l~~~~i~~-l-~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~~-~~-~l~~l~~L~~L~l 113 (199)
T d2omxa2 40 DQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD-IT-PLANLTNLTGLTL 113 (199)
T ss_dssp TTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCSEEEC
T ss_pred cCCCEEECCCCCCCC-c-cccccCCCcCcCccccccccCccc--ccCCccccccccccccccc-cc-ccccccccccccc
Confidence 356677777777653 3 246777888888888888876432 7778888888888887763 44 3677788888888
Q ss_pred ccCCCCcCCChhccCCCCCCEEEccCCCCCC
Q 004979 198 DNNQYLGGISPELHVLKVISEIQVDESWLTN 228 (721)
Q Consensus 198 ~~N~~~G~iP~~~~~l~~L~~l~l~~n~~~g 228 (721)
++|.+... ..+..+++|+.|++++|.+..
T Consensus 114 ~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~ 142 (199)
T d2omxa2 114 FNNQITDI--DPLKNLTNLNRLELSSNTISD 142 (199)
T ss_dssp CSSCCCCC--GGGTTCTTCSEEECCSSCCCC
T ss_pred cccccccc--cccchhhhhHHhhhhhhhhcc
Confidence 87776653 246777888888888887763
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=98.53 E-value=1e-07 Score=99.84 Aligned_cols=105 Identities=26% Similarity=0.264 Sum_probs=80.9
Q ss_pred CcEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCC--------------
Q 004979 118 GKVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFP-------------- 183 (721)
Q Consensus 118 ~~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP-------------- 183 (721)
.++..++|++|.+.. + +.+..+++|+.|++++|.+++..| ++.+++|+.|++++|.+++..|
T Consensus 219 ~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~~~~~~~~~~~l~~l~~~~ 294 (384)
T d2omza2 219 TNLDELSLNGNQLKD-I-GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNE 294 (384)
T ss_dssp TTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGGGTTCTTCSEEECCS
T ss_pred CCCCEEECCCCCCCC-c-chhhcccccchhccccCccCCCCc--ccccccCCEeeccCcccCCCCccccccccccccccc
Confidence 356778888888765 2 357778888888888888876443 6777888888888877765322
Q ss_pred ------ccccCCCCCCEEECccCCCCcCCChhccCCCCCCEEEccCCCCCC
Q 004979 184 ------SDFGNSFSLTTLLLDNNQYLGGISPELHVLKVISEIQVDESWLTN 228 (721)
Q Consensus 184 ------~~~~~~~~L~~l~l~~N~~~G~iP~~~~~l~~L~~l~l~~n~~~g 228 (721)
..+..+++++.|++++|++++- + .+..+++|+.|+|++|.+++
T Consensus 295 n~l~~~~~~~~~~~l~~L~ls~n~l~~l-~-~l~~l~~L~~L~L~~n~l~~ 343 (384)
T d2omza2 295 NQLEDISPISNLKNLTYLTLYFNNISDI-S-PVSSLTKLQRLFFANNKVSD 343 (384)
T ss_dssp SCCSCCGGGGGCTTCSEEECCSSCCSCC-G-GGGGCTTCCEEECCSSCCCC
T ss_pred cccccccccchhcccCeEECCCCCCCCC-c-ccccCCCCCEEECCCCCCCC
Confidence 2355678899999999999974 3 38899999999999999986
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.51 E-value=9.2e-08 Score=87.36 Aligned_cols=85 Identities=20% Similarity=0.254 Sum_probs=73.4
Q ss_pred CcEEEEEeCCCC-CCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCccccCCCCCCEEE
Q 004979 118 GKVVILNLRDLC-LGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLL 196 (721)
Q Consensus 118 ~~v~~l~L~~~~-l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~~L~~l~ 196 (721)
.+++.|+|.+++ +..--+..|.++++|+.|+|++|.|+.--|..+..+++|+.|+|++|+|+ .+|..+....+|+.|+
T Consensus 31 ~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~-~l~~~~~~~~~l~~L~ 109 (156)
T d2ifga3 31 ENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELV 109 (156)
T ss_dssp SCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCS-CCCSTTTCSCCCCEEE
T ss_pred cccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCCCCc-ccChhhhccccccccc
Confidence 478899998775 66544566899999999999999999777788999999999999999999 7887766666899999
Q ss_pred CccCCCC
Q 004979 197 LDNNQYL 203 (721)
Q Consensus 197 l~~N~~~ 203 (721)
|++|.|.
T Consensus 110 L~~Np~~ 116 (156)
T d2ifga3 110 LSGNPLH 116 (156)
T ss_dssp CCSSCCC
T ss_pred cCCCccc
Confidence 9999885
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=98.48 E-value=2.9e-07 Score=87.57 Aligned_cols=104 Identities=23% Similarity=0.315 Sum_probs=87.6
Q ss_pred CcEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCccccCCCCCCEEEC
Q 004979 118 GKVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLL 197 (721)
Q Consensus 118 ~~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~~L~~l~l 197 (721)
.++..|+|++|.+++.. + ++++++|++|++++|.+.. +| .+.+++.|+.|++++|.+... ..+..+++|+.|++
T Consensus 62 ~nL~~L~Ls~N~l~~~~-~-l~~l~~L~~L~l~~n~~~~-~~-~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l 135 (199)
T d2omxa2 62 NNLTQINFSNNQLTDIT-P-LKNLTKLVDILMNNNQIAD-IT-PLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLEL 135 (199)
T ss_dssp TTCCEEECCSSCCCCCG-G-GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEEC
T ss_pred CCcCcCccccccccCcc-c-ccCCccccccccccccccc-cc-ccccccccccccccccccccc--cccchhhhhHHhhh
Confidence 57889999999998743 3 8999999999999998864 45 488999999999999988763 34788999999999
Q ss_pred ccCCCCcCCChhccCCCCCCEEEccCCCCCCc
Q 004979 198 DNNQYLGGISPELHVLKVISEIQVDESWLTNA 229 (721)
Q Consensus 198 ~~N~~~G~iP~~~~~l~~L~~l~l~~n~~~g~ 229 (721)
++|++.. + +.+..+++|+.|++.+|.+++-
T Consensus 136 ~~n~l~~-~-~~l~~~~~L~~L~l~~n~l~~l 165 (199)
T d2omxa2 136 SSNTISD-I-SALSGLTSLQQLNFSSNQVTDL 165 (199)
T ss_dssp CSSCCCC-C-GGGTTCTTCSEEECCSSCCCCC
T ss_pred hhhhhcc-c-ccccccccccccccccccccCC
Confidence 9999864 4 3588999999999999999863
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=98.48 E-value=2.8e-07 Score=88.42 Aligned_cols=102 Identities=23% Similarity=0.315 Sum_probs=54.5
Q ss_pred cEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCccccCCCCCCEEECc
Q 004979 119 KVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLLD 198 (721)
Q Consensus 119 ~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~~L~~l~l~ 198 (721)
+++.|+|++|.+++ ++ .++.+++|++|+|++|.+++ +| .+..+++|+.|++++|.+.. + ..+..++.|+.++++
T Consensus 69 ~L~~L~L~~n~i~~-l~-~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~l~~~~~~~-~-~~l~~l~~l~~l~~~ 142 (210)
T d1h6ta2 69 NVTKLFLNGNKLTD-IK-PLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLG 142 (210)
T ss_dssp TCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEECC
T ss_pred CCCEEeCCCccccC-cc-ccccCccccccccccccccc-cc-cccccccccccccccccccc-c-ccccccccccccccc
Confidence 45556666665554 22 24556666666666666553 33 35555666666666655542 2 234555555555555
Q ss_pred cCCCCcCCChhccCCCCCCEEEccCCCCCC
Q 004979 199 NNQYLGGISPELHVLKVISEIQVDESWLTN 228 (721)
Q Consensus 199 ~N~~~G~iP~~~~~l~~L~~l~l~~n~~~g 228 (721)
+|.+++ +..+..+++|+.+++++|.+++
T Consensus 143 ~n~l~~--~~~~~~l~~L~~l~l~~n~l~~ 170 (210)
T d1h6ta2 143 NNKITD--ITVLSRLTKLDTLSLEDNQISD 170 (210)
T ss_dssp SSCCCC--CGGGGGCTTCSEEECCSSCCCC
T ss_pred cccccc--cccccccccccccccccccccc
Confidence 555543 2234455555555555555553
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=98.47 E-value=2.3e-07 Score=89.10 Aligned_cols=105 Identities=26% Similarity=0.308 Sum_probs=90.0
Q ss_pred CcEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCccccCCCCCCEEEC
Q 004979 118 GKVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLL 197 (721)
Q Consensus 118 ~~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~~L~~l~l 197 (721)
.++..|+|++|.+++ +| .+..+++|+.|++++|.+.. + +.+..++.|+.++++.|.+++. ..+..+++|+.+++
T Consensus 90 ~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~l~~~~~~~-~-~~l~~l~~l~~l~~~~n~l~~~--~~~~~l~~L~~l~l 163 (210)
T d1h6ta2 90 KNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSL 163 (210)
T ss_dssp TTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEEC
T ss_pred ccccccccccccccc-cc-cccccccccccccccccccc-c-cccccccccccccccccccccc--cccccccccccccc
Confidence 478899999999986 54 58999999999999999863 4 3688999999999999999863 45778999999999
Q ss_pred ccCCCCcCCChhccCCCCCCEEEccCCCCCCccc
Q 004979 198 DNNQYLGGISPELHVLKVISEIQVDESWLTNAAS 231 (721)
Q Consensus 198 ~~N~~~G~iP~~~~~l~~L~~l~l~~n~~~g~~p 231 (721)
++|++++ ++ .+.++++|+.|+|++|.++. +|
T Consensus 164 ~~n~l~~-i~-~l~~l~~L~~L~Ls~N~i~~-l~ 194 (210)
T d1h6ta2 164 EDNQISD-IV-PLAGLTKLQNLYLSKNHISD-LR 194 (210)
T ss_dssp CSSCCCC-CG-GGTTCTTCCEEECCSSCCCB-CG
T ss_pred ccccccc-cc-cccCCCCCCEEECCCCCCCC-Ch
Confidence 9999986 54 38999999999999999984 55
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=98.35 E-value=5.1e-09 Score=100.11 Aligned_cols=103 Identities=17% Similarity=0.214 Sum_probs=51.4
Q ss_pred cEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCccccCCCCCCEEECc
Q 004979 119 KVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLLD 198 (721)
Q Consensus 119 ~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~~L~~l~l~ 198 (721)
++..|+|++|.+. .|+ .+..|++|+.|+|++|.++ .||.....++.|+.|++++|+++. ++ .+..+++|++|+++
T Consensus 49 ~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~L~ 123 (198)
T d1m9la_ 49 ACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMS 123 (198)
T ss_dssp TCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-HH-HHHHHHHSSEEEES
T ss_pred ccceeECcccCCC-Ccc-cccCCccccChhhcccccc-cccccccccccccccccccccccc-cc-cccccccccccccc
Confidence 4455555555554 232 3555555555555555554 344333334455555555555553 22 24455555555555
Q ss_pred cCCCCcCCC--hhccCCCCCCEEEccCCCCC
Q 004979 199 NNQYLGGIS--PELHVLKVISEIQVDESWLT 227 (721)
Q Consensus 199 ~N~~~G~iP--~~~~~l~~L~~l~l~~n~~~ 227 (721)
+|+++. ++ ..+..+++|+.|+|++|.++
T Consensus 124 ~N~i~~-~~~~~~l~~l~~L~~L~L~~N~l~ 153 (198)
T d1m9la_ 124 NNKITN-WGEIDKLAALDKLEDLLLAGNPLY 153 (198)
T ss_dssp EEECCC-HHHHHHHTTTTTCSEEEECSSHHH
T ss_pred cchhcc-ccccccccCCCccceeecCCCccc
Confidence 555542 11 23455555555555555443
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=98.33 E-value=4.8e-07 Score=87.78 Aligned_cols=102 Identities=25% Similarity=0.338 Sum_probs=76.0
Q ss_pred cEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCccccCCCCCCEEECc
Q 004979 119 KVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLLD 198 (721)
Q Consensus 119 ~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~~L~~l~l~ 198 (721)
.+..++++++...+.. .+...+.+..+.++++.+.+..+ +.++++|+.|++++|.+++.. .++++++|+.|+|+
T Consensus 108 ~L~~l~l~~~~~~~~~--~~~~~~~~~~l~~~~~~~~~~~~--~~~~~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~Ls 181 (227)
T d1h6ua2 108 SIKTLDLTSTQITDVT--PLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLT--PLANLSKLTTLKAD 181 (227)
T ss_dssp TCCEEECTTSCCCCCG--GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECC
T ss_pred cccccccccccccccc--hhccccchhhhhchhhhhchhhh--hccccccccccccccccccch--hhcccccceecccC
Confidence 5667778777665533 35667788888888888775443 567788888888888887543 37788888888888
Q ss_pred cCCCCcCCChhccCCCCCCEEEccCCCCCC
Q 004979 199 NNQYLGGISPELHVLKVISEIQVDESWLTN 228 (721)
Q Consensus 199 ~N~~~G~iP~~~~~l~~L~~l~l~~n~~~g 228 (721)
+|++++ +| .+..+++|++|+|++|++++
T Consensus 182 ~n~l~~-l~-~l~~l~~L~~L~Ls~N~lt~ 209 (227)
T d1h6ua2 182 DNKISD-IS-PLASLPNLIEVHLKNNQISD 209 (227)
T ss_dssp SSCCCC-CG-GGGGCTTCCEEECTTSCCCB
T ss_pred CCccCC-Ch-hhcCCCCCCEEECcCCcCCC
Confidence 888875 54 37888888888888888885
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.32 E-value=5.8e-07 Score=87.86 Aligned_cols=108 Identities=12% Similarity=0.136 Sum_probs=76.9
Q ss_pred CceeeEEeCCCcEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCc-cc
Q 004979 108 CSWFGVECSDGKVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPS-DF 186 (721)
Q Consensus 108 C~w~gv~C~~~~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~-~~ 186 (721)
|.+..|.|. +.+|. .+|+.+. +++++|+|++|.++.--+..+.++++|++|+|++|.+...+|+ .+
T Consensus 8 C~~~~i~c~----------~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f 74 (242)
T d1xwdc1 8 CSNRVFLCQ----------ESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVF 74 (242)
T ss_dssp ECSSEEEEE----------SCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSE
T ss_pred CcCCEEEEe----------CCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccc
Confidence 556666664 34444 5665442 4688888888888743334577888888888888888777764 46
Q ss_pred cCCCCCCEEECcc-CCCCcCCChhccCCCCCCEEEccCCCCCC
Q 004979 187 GNSFSLTTLLLDN-NQYLGGISPELHVLKVISEIQVDESWLTN 228 (721)
Q Consensus 187 ~~~~~L~~l~l~~-N~~~G~iP~~~~~l~~L~~l~l~~n~~~g 228 (721)
.+++.++.+++.. |++....+..+..+++|+.|++++|.++.
T Consensus 75 ~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~ 117 (242)
T d1xwdc1 75 SNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKH 117 (242)
T ss_dssp ESCTTCCEEEEECCTTCCEECTTSEECCTTCCEEEEESCCCCS
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhcc
Confidence 6788888887754 66666666677888888888888888764
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=98.28 E-value=1.3e-08 Score=97.14 Aligned_cols=90 Identities=21% Similarity=0.272 Sum_probs=78.2
Q ss_pred CchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCccccCCCCCCEEECccCCCCcCCChhccCC
Q 004979 134 LAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLLDNNQYLGGISPELHVL 213 (721)
Q Consensus 134 ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~~L~~l~l~~N~~~G~iP~~~~~l 213 (721)
++..+..|++|++|+|++|.++ .|+ .+..|++|+.|+|++|.++ .||.....+++|+.|++++|+++. + +.+..+
T Consensus 40 l~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l-~~~~~l 114 (198)
T d1m9la_ 40 MDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-L-SGIEKL 114 (198)
T ss_dssp CHHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-H-HHHHHH
T ss_pred hhhHHhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-cccccccccccccccccccccccc-c-cccccc
Confidence 4567999999999999999998 676 5899999999999999997 677666666789999999999985 4 458889
Q ss_pred CCCCEEEccCCCCCC
Q 004979 214 KVISEIQVDESWLTN 228 (721)
Q Consensus 214 ~~L~~l~l~~n~~~g 228 (721)
++|+.|+|++|.++.
T Consensus 115 ~~L~~L~L~~N~i~~ 129 (198)
T d1m9la_ 115 VNLRVLYMSNNKITN 129 (198)
T ss_dssp HHSSEEEESEEECCC
T ss_pred ccccccccccchhcc
Confidence 999999999999875
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=98.18 E-value=3e-06 Score=81.86 Aligned_cols=102 Identities=20% Similarity=0.285 Sum_probs=74.8
Q ss_pred cEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCccccCCCCCCEEECc
Q 004979 119 KVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLLD 198 (721)
Q Consensus 119 ~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~~L~~l~l~ 198 (721)
++..++++++.++ .++ .+..++.|+.++++.+...+.. .+...+.+..+.++.+.+.+..+ +.++++|+.|+++
T Consensus 86 ~l~~l~~~~n~~~-~i~-~l~~l~~L~~l~l~~~~~~~~~--~~~~~~~~~~l~~~~~~~~~~~~--~~~~~~L~~L~l~ 159 (227)
T d1h6ua2 86 KITELELSGNPLK-NVS-AIAGLQSIKTLDLTSTQITDVT--PLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIG 159 (227)
T ss_dssp SCCEEECCSCCCS-CCG-GGTTCTTCCEEECTTSCCCCCG--GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECC
T ss_pred ccccccccccccc-ccc-cccccccccccccccccccccc--hhccccchhhhhchhhhhchhhh--hcccccccccccc
Confidence 5667777777665 343 4778888888888888776543 35667788888888888775443 5677888888888
Q ss_pred cCCCCcCCChhccCCCCCCEEEccCCCCCC
Q 004979 199 NNQYLGGISPELHVLKVISEIQVDESWLTN 228 (721)
Q Consensus 199 ~N~~~G~iP~~~~~l~~L~~l~l~~n~~~g 228 (721)
+|.+++.. .+.++++|+.|+|++|.+++
T Consensus 160 ~n~~~~~~--~l~~l~~L~~L~Ls~n~l~~ 187 (227)
T d1h6ua2 160 NAQVSDLT--PLANLSKLTTLKADDNKISD 187 (227)
T ss_dssp SSCCCCCG--GGTTCTTCCEEECCSSCCCC
T ss_pred ccccccch--hhcccccceecccCCCccCC
Confidence 88876532 37788888888888888875
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=98.13 E-value=2e-06 Score=88.29 Aligned_cols=97 Identities=25% Similarity=0.269 Sum_probs=79.4
Q ss_pred cEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCccccCCCCCCEEECc
Q 004979 119 KVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLLD 198 (721)
Q Consensus 119 ~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~~L~~l~l~ 198 (721)
+++.|+|++++|+ .+|+. +++|++|+|++|+|+ .||.. +.+|+.|++++|+++ .|+. + .+.|++|+++
T Consensus 39 ~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~l~~n~l~-~l~~-l--p~~L~~L~L~ 106 (353)
T d1jl5a_ 39 QAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPEL---PQSLKSLLVDNNNLK-ALSD-L--PPLLEYLGVS 106 (353)
T ss_dssp TCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCC---CTTCCEEECCSSCCS-CCCS-C--CTTCCEEECC
T ss_pred CCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccc---hhhhhhhhhhhcccc-hhhh-h--cccccccccc
Confidence 4678999999997 58753 578999999999998 88865 457899999999987 4542 1 1469999999
Q ss_pred cCCCCcCCChhccCCCCCCEEEccCCCCCCc
Q 004979 199 NNQYLGGISPELHVLKVISEIQVDESWLTNA 229 (721)
Q Consensus 199 ~N~~~G~iP~~~~~l~~L~~l~l~~n~~~g~ 229 (721)
+|.+. .+|. ++.+++|+.|++++|.++..
T Consensus 107 ~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~~ 135 (353)
T d1jl5a_ 107 NNQLE-KLPE-LQNSSFLKIIDVDNNSLKKL 135 (353)
T ss_dssp SSCCS-SCCC-CTTCTTCCEEECCSSCCSCC
T ss_pred ccccc-cccc-hhhhccceeecccccccccc
Confidence 99987 5774 68899999999999998754
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.94 E-value=6.1e-06 Score=80.26 Aligned_cols=109 Identities=18% Similarity=0.157 Sum_probs=84.6
Q ss_pred cEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCch-hhcCCCCCCEeEccc-CcccccCCccccCCCCCCEEE
Q 004979 119 KVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPK-EIGELKELEILDLGF-NNFSGPFPSDFGNSFSLTTLL 196 (721)
Q Consensus 119 ~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~-~l~~l~~L~~l~ls~-N~l~G~iP~~~~~~~~L~~l~ 196 (721)
.++.|+|++|.+..-.+..+.++++|++|+|++|.+...+|. .+..++.++.|++.. |++....|..+.++++|++|+
T Consensus 30 ~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~ 109 (242)
T d1xwdc1 30 NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLL 109 (242)
T ss_dssp CCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEEE
T ss_pred CCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccccccccccccccccccccccccc
Confidence 578999999999753344688999999999999999887765 578899999999864 788877778889999999999
Q ss_pred CccCCCCcCCC-hhccCCCCCCEEEccCCCCC
Q 004979 197 LDNNQYLGGIS-PELHVLKVISEIQVDESWLT 227 (721)
Q Consensus 197 l~~N~~~G~iP-~~~~~l~~L~~l~l~~n~~~ 227 (721)
+++|.+...-+ ..+..+..+..+..+.+.++
T Consensus 110 l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~ 141 (242)
T d1xwdc1 110 ISNTGIKHLPDVHKIHSLQKVLLDIQDNINIH 141 (242)
T ss_dssp EESCCCCSCCCCTTTCBSSCEEEEEESCTTCC
T ss_pred cchhhhcccccccccccccccccccccccccc
Confidence 99999864322 23444555555555665554
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=97.92 E-value=2.3e-05 Score=76.93 Aligned_cols=146 Identities=13% Similarity=0.155 Sum_probs=86.6
Q ss_pred HHHHHHhhhhhhhCcCCCCceeEEEEEEecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCC-CCccceEeEEEe
Q 004979 420 ELEAACEDFSNIIGSFSDGTVGTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVN-HKNFVNLIGYCE 498 (721)
Q Consensus 420 ~l~~~~~~~~~ii~~lg~G~~g~Vyk~~~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~ 498 (721)
|+.+..+.+ .++...+-++...||+.... +..+++|+........ ...+.+|...+..+. +--+-+++.+..
T Consensus 8 ~l~~~~~~~-~~~~~~~G~s~~~v~rv~~~-~~~~vlk~~~~~~~~~-----~~~~~~E~~~l~~l~~~vpvP~vl~~~~ 80 (263)
T d1j7la_ 8 ELKKLIEKY-RCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGT-----TYDVEREKDMMLWLEGKLPVPKVLHFER 80 (263)
T ss_dssp HHHHHHTTS-EEEECSCCCSSSEEEEEECS-SCEEEEEEECGGGTTS-----TTCHHHHHHHHHHHTTTSCCCCEEEEEE
T ss_pred HHHHhhhce-EEEEcCCCCCCCcEEEEEeC-CCeEEEEEcCCCcccc-----hhhHHHHHHHHHHHhccCCCCcEEEEEe
Confidence 444444444 33333323444689998644 5566777664332211 124567777776663 333567777776
Q ss_pred cCCCceEEEEEecCCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHHhcC---------------------------
Q 004979 499 EDEPFTRMMVFEYSPNGSLFEHLHIQEAEHLDWAMRLRIAMGMAYCLEHMHQL--------------------------- 551 (721)
Q Consensus 499 ~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~--------------------------- 551 (721)
+++ ..++|||++++..+.+.... ... ...++.++++.++.||+.
T Consensus 81 ~~~--~~~lv~~~l~G~~~~~~~~~----~~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 151 (263)
T d1j7la_ 81 HDG--WSNLLMSEADGVLCSEEYED----EQS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLA 151 (263)
T ss_dssp ETT--EEEEEEECCSSEEHHHHTTT----CSC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCS
T ss_pred cCC--ceEEEEEecccccccccccc----ccc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhh
Confidence 665 57999999999877554311 001 122333444444444421
Q ss_pred ------------------------------CCCeEeeCCCCCCeEeCCCCcEEEeccCCC
Q 004979 552 ------------------------------TPPIAHRNLQSSSIYLTEDYAAKISDFSFW 581 (721)
Q Consensus 552 ------------------------------~~~IvHrDLKp~NILl~~~~~~kL~DFGla 581 (721)
.+.++|+|+.+.|||++++..+-|.||+.+
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a 211 (263)
T d1j7la_ 152 DVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRS 211 (263)
T ss_dssp CCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTC
T ss_pred hhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhc
Confidence 113789999999999998776779999864
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.85 E-value=2.7e-06 Score=90.42 Aligned_cols=110 Identities=19% Similarity=0.234 Sum_probs=87.0
Q ss_pred cEEEEEeCCCCCCCc-CchhhcCCCCCCEEEccCCccc----ccCchhhcCCCCCCEeEcccCccccc----CCcccc-C
Q 004979 119 KVVILNLRDLCLGGM-LAPELGQLSELKSIILRNNSFF----GTIPKEIGELKELEILDLGFNNFSGP----FPSDFG-N 188 (721)
Q Consensus 119 ~v~~l~L~~~~l~G~-ip~~l~~l~~L~~L~L~~n~l~----G~ip~~l~~l~~L~~l~ls~N~l~G~----iP~~~~-~ 188 (721)
++..||++++++++. +..-+..+.+|+.|+|++|.++ ..|...+..+++|+.|||++|.++.. +...+. .
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence 588999999999874 2334566788999999999987 35677788999999999999998631 222232 2
Q ss_pred CCCCCEEECccCCCCcC----CChhccCCCCCCEEEccCCCCCC
Q 004979 189 SFSLTTLLLDNNQYLGG----ISPELHVLKVISEIQVDESWLTN 228 (721)
Q Consensus 189 ~~~L~~l~l~~N~~~G~----iP~~~~~l~~L~~l~l~~n~~~g 228 (721)
..+|++|+|++|+++.. ++..+..+++|++|+|++|.++.
T Consensus 83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~ 126 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGD 126 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHH
T ss_pred CCCCCEEECCCCCccccccccccchhhccccccccccccccchh
Confidence 35799999999999754 56667889999999999998864
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.64 E-value=7.5e-06 Score=74.70 Aligned_cols=80 Identities=21% Similarity=0.280 Sum_probs=42.8
Q ss_pred cCCCCCCEEEccCCcccc--cCchhhcCCCCCCEeEcccCcccccCCc-cccCCCCCCEEECccCCCCcCCChh------
Q 004979 139 GQLSELKSIILRNNSFFG--TIPKEIGELKELEILDLGFNNFSGPFPS-DFGNSFSLTTLLLDNNQYLGGISPE------ 209 (721)
Q Consensus 139 ~~l~~L~~L~L~~n~l~G--~ip~~l~~l~~L~~l~ls~N~l~G~iP~-~~~~~~~L~~l~l~~N~~~G~iP~~------ 209 (721)
..++.|++|+|++|.++. .++..+..+++|+.|||++|.++. +++ .......|+.|++++|.+++.....
T Consensus 62 ~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~-l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~ 140 (162)
T d1koha1 62 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKS-ERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISA 140 (162)
T ss_dssp HHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCC-GGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHH
T ss_pred HhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCcccc-chhhhhhhccccceeecCCCCcCcCcccchhHHHH
Confidence 345666666666666653 234445556666666666666653 221 1222335666666666665544322
Q ss_pred -ccCCCCCCEE
Q 004979 210 -LHVLKVISEI 219 (721)
Q Consensus 210 -~~~l~~L~~l 219 (721)
+..+++|+.|
T Consensus 141 i~~~~P~L~~L 151 (162)
T d1koha1 141 IRERFPKLLRL 151 (162)
T ss_dssp HHTTSTTCCEE
T ss_pred HHHHCCCCCEE
Confidence 3345555554
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.58 E-value=8.5e-05 Score=72.35 Aligned_cols=68 Identities=10% Similarity=0.155 Sum_probs=46.2
Q ss_pred eEEEEEEecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCC--CccceEeEEEecCCCceEEEEEecCCCCChh
Q 004979 441 GTVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNH--KNFVNLIGYCEEDEPFTRMMVFEYSPNGSLF 518 (721)
Q Consensus 441 g~Vyk~~~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H--~nIv~l~g~~~~~~~~~~~lV~Ey~~~GsL~ 518 (721)
+.||+...+++..+++|....... ..+..|+..++.+.. -.+.+++++..+.+ ..++||||+++-++.
T Consensus 25 ~~v~r~~~~~~~~~vlK~~~~~~~--------~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~--~~~~v~~~i~G~~~~ 94 (255)
T d1nd4a_ 25 AAVFRLSAQGRPVLFVKTDLSGAL--------NELQDEAARLSWLATTGVPCAAVLDVVTEAG--RDWLLLGEVPGQDLL 94 (255)
T ss_dssp CEEEEEECTTSCCEEEEEECSCTT--------SCHHHHHHHHHHHHTTTCCBCCEEEEEECSS--CEEEEEECCSSEETT
T ss_pred CeEEEEEeCCCCEEEEEeCCccCH--------hHHHHHHHHHHHHHhcCCCCCceeeeccccc--ceEEEEEeeeccccc
Confidence 579999888787788886543221 235667777766632 33566777777665 568999999876653
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.58 E-value=1.5e-05 Score=79.70 Aligned_cols=57 Identities=23% Similarity=0.286 Sum_probs=27.3
Q ss_pred cEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCC-ccccc-CchhhcCCCCCCEeEccc
Q 004979 119 KVVILNLRDLCLGGMLAPELGQLSELKSIILRNN-SFFGT-IPKEIGELKELEILDLGF 175 (721)
Q Consensus 119 ~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n-~l~G~-ip~~l~~l~~L~~l~ls~ 175 (721)
++..|+|+++.+++..+..++.+++|++|+|+++ .++.. +..-..++++|+.|+|++
T Consensus 72 ~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~ 130 (284)
T d2astb2 72 KLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSW 130 (284)
T ss_dssp CCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCC
T ss_pred CcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhcccccccc
Confidence 3445555555555555555555555555555552 33321 222223455555555554
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=97.53 E-value=1.5e-05 Score=81.88 Aligned_cols=109 Identities=17% Similarity=0.167 Sum_probs=51.3
Q ss_pred cEEEEEeCCCCCCCc-----CchhhcCCCCCCEEEccCCccccc----CchhhcCCCCCCEeEcccCcccccCCcc----
Q 004979 119 KVVILNLRDLCLGGM-----LAPELGQLSELKSIILRNNSFFGT----IPKEIGELKELEILDLGFNNFSGPFPSD---- 185 (721)
Q Consensus 119 ~v~~l~L~~~~l~G~-----ip~~l~~l~~L~~L~L~~n~l~G~----ip~~l~~l~~L~~l~ls~N~l~G~iP~~---- 185 (721)
.+..|+|+.|.++.. +...+..+++|+.|+|++|.++.. +...+..+++|+.|+|++|.+++.-...
T Consensus 187 ~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~ 266 (344)
T d2ca6a1 187 LLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDA 266 (344)
T ss_dssp TCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHH
T ss_pred hhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCchhhHHHHHH
Confidence 345555555555421 222344555556666665555421 3344455555666666666554421111
Q ss_pred cc--CCCCCCEEECccCCCCcC----CChhc-cCCCCCCEEEccCCCCC
Q 004979 186 FG--NSFSLTTLLLDNNQYLGG----ISPEL-HVLKVISEIQVDESWLT 227 (721)
Q Consensus 186 ~~--~~~~L~~l~l~~N~~~G~----iP~~~-~~l~~L~~l~l~~n~~~ 227 (721)
+. ....|++|++++|+++.. +...+ .++++|+.|+|++|.|+
T Consensus 267 l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~ 315 (344)
T d2ca6a1 267 FSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 315 (344)
T ss_dssp HHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSC
T ss_pred hhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCC
Confidence 11 123455666666555432 12222 13455556666655554
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.51 E-value=1.6e-05 Score=84.26 Aligned_cols=112 Identities=19% Similarity=0.181 Sum_probs=80.8
Q ss_pred CcEEEEEeCCCCCCCcCchhh----c-CCCCCCEEEccCCcccccCc----hhhcCCCCCCEeEcccCccccc----CCc
Q 004979 118 GKVVILNLRDLCLGGMLAPEL----G-QLSELKSIILRNNSFFGTIP----KEIGELKELEILDLGFNNFSGP----FPS 184 (721)
Q Consensus 118 ~~v~~l~L~~~~l~G~ip~~l----~-~l~~L~~L~L~~n~l~G~ip----~~l~~l~~L~~l~ls~N~l~G~----iP~ 184 (721)
..+..+++++|.++..-...+ . ....|+.+++++|.++..-. ..+..+.+|+.|||++|+++.. ++.
T Consensus 283 ~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~ 362 (460)
T d1z7xw1 283 ESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQ 362 (460)
T ss_dssp TTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHH
T ss_pred ccccccccccccccccccchhhccccccccccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhh
Confidence 467788999988864322222 2 34678999999998876533 3344567899999999998753 444
Q ss_pred ccc-CCCCCCEEECccCCCCc----CCChhccCCCCCCEEEccCCCCCCc
Q 004979 185 DFG-NSFSLTTLLLDNNQYLG----GISPELHVLKVISEIQVDESWLTNA 229 (721)
Q Consensus 185 ~~~-~~~~L~~l~l~~N~~~G----~iP~~~~~l~~L~~l~l~~n~~~g~ 229 (721)
.+. ..+.|++|+|++|+++. .|+..+..+++|++|+|++|.++..
T Consensus 363 ~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~ 412 (460)
T d1z7xw1 363 GLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDA 412 (460)
T ss_dssp HHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHH
T ss_pred hhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCCHH
Confidence 443 46679999999999874 3555667788999999999998854
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=97.49 E-value=0.00016 Score=73.34 Aligned_cols=78 Identities=24% Similarity=0.228 Sum_probs=62.9
Q ss_pred CcEEEEEeCCCCCCCcCchhhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccccCCccccCCCCCCEEEC
Q 004979 118 GKVVILNLRDLCLGGMLAPELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSGPFPSDFGNSFSLTTLLL 197 (721)
Q Consensus 118 ~~v~~l~L~~~~l~G~ip~~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~~L~~l~l 197 (721)
.+++.|+|++|.|+ .+|.. +.+|+.|++++|.++ .|+. + .+.|++|+|++|.++ .+|. ++.+++|+.|++
T Consensus 58 ~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~l~~n~l~-~l~~-l--p~~L~~L~L~~n~l~-~lp~-~~~l~~L~~L~l 127 (353)
T d1jl5a_ 58 PHLESLVASCNSLT-ELPEL---PQSLKSLLVDNNNLK-ALSD-L--PPLLEYLGVSNNQLE-KLPE-LQNSSFLKIIDV 127 (353)
T ss_dssp TTCSEEECCSSCCS-SCCCC---CTTCCEEECCSSCCS-CCCS-C--CTTCCEEECCSSCCS-SCCC-CTTCTTCCEEEC
T ss_pred CCCCEEECCCCCCc-ccccc---hhhhhhhhhhhcccc-hhhh-h--ccccccccccccccc-cccc-hhhhccceeecc
Confidence 36789999999998 77764 457899999999987 4442 1 146999999999998 6775 688999999999
Q ss_pred ccCCCCcC
Q 004979 198 DNNQYLGG 205 (721)
Q Consensus 198 ~~N~~~G~ 205 (721)
++|.+.+.
T Consensus 128 ~~~~~~~~ 135 (353)
T d1jl5a_ 128 DNNSLKKL 135 (353)
T ss_dssp CSSCCSCC
T ss_pred cccccccc
Confidence 99988653
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=97.36 E-value=3.4e-05 Score=79.22 Aligned_cols=108 Identities=13% Similarity=0.075 Sum_probs=51.9
Q ss_pred EEEEEeCCCCCCC----cCchhhcCCCCCCEEEccCCccccc-----CchhhcCCCCCCEeEcccCccccc----CCccc
Q 004979 120 VVILNLRDLCLGG----MLAPELGQLSELKSIILRNNSFFGT-----IPKEIGELKELEILDLGFNNFSGP----FPSDF 186 (721)
Q Consensus 120 v~~l~L~~~~l~G----~ip~~l~~l~~L~~L~L~~n~l~G~-----ip~~l~~l~~L~~l~ls~N~l~G~----iP~~~ 186 (721)
+..++++++.++- .+...+..+..|+.|+|++|.++.. +...+..+++|+.|+|++|.++.. +...+
T Consensus 160 L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l 239 (344)
T d2ca6a1 160 LRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIAL 239 (344)
T ss_dssp CCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHG
T ss_pred cceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccc
Confidence 4455555555431 1223344455566666666655421 223344555566666666655422 33334
Q ss_pred cCCCCCCEEECccCCCCcCCChhc----c--CCCCCCEEEccCCCCC
Q 004979 187 GNSFSLTTLLLDNNQYLGGISPEL----H--VLKVISEIQVDESWLT 227 (721)
Q Consensus 187 ~~~~~L~~l~l~~N~~~G~iP~~~----~--~l~~L~~l~l~~n~~~ 227 (721)
..+++|++|+|++|.+++.-...+ . ....|+.|++++|.++
T Consensus 240 ~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~ 286 (344)
T d2ca6a1 240 KSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIE 286 (344)
T ss_dssp GGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCB
T ss_pred cccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCC
Confidence 455556666666665543211111 1 1244556666666554
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.26 E-value=0.00034 Score=72.98 Aligned_cols=79 Identities=13% Similarity=0.134 Sum_probs=45.4
Q ss_pred CcCCCCceeEEEEEEecC-CcEEEEEEeeecccc---chhhHHHHHHHHHHHHHhcC-CC--CccceEeEEEecCCCceE
Q 004979 433 GSFSDGTVGTVYKGTLSS-GVEIAVTSTSVKSRA---DWSKNLESQFRKKIDTLSKV-NH--KNFVNLIGYCEEDEPFTR 505 (721)
Q Consensus 433 ~~lg~G~~g~Vyk~~~~~-~~~vavk~~~~~~~~---~~~~~~~~~f~~Ei~~l~~l-~H--~nIv~l~g~~~~~~~~~~ 505 (721)
..+|.|....||+....+ ++.++||.-....+. .+.. ...+...|.+.|..+ .+ ..+.+++.+..+ ..
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~-~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d~~----~~ 106 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPL-TIDRARIESSALIRQGEHVPHLVPRVFYSDTE----MA 106 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCC-CTTHHHHHHHHHHHHHTTCGGGSCCEEEEETT----TT
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCC-CHHHHHHHHHHHHHhhhhCCCCcceEEEEcCC----CC
Confidence 467889999999998654 567888865322111 1110 112345677777655 22 345666655432 23
Q ss_pred EEEEecCCCCC
Q 004979 506 MMVFEYSPNGS 516 (721)
Q Consensus 506 ~lV~Ey~~~Gs 516 (721)
++||||+.+..
T Consensus 107 ~lvmE~L~~~~ 117 (392)
T d2pula1 107 VTVMEDLSHLK 117 (392)
T ss_dssp EEEECCCTTSE
T ss_pred EEEEeccCCcc
Confidence 79999997644
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.25 E-value=1.2e-05 Score=73.35 Aligned_cols=92 Identities=17% Similarity=0.083 Sum_probs=65.4
Q ss_pred hhcCCCCCCEEEccCCcccccCchhhcCCCCCCEeEcccCcccc--cCCccccCCCCCCEEECccCCCCcCCCh-hccCC
Q 004979 137 ELGQLSELKSIILRNNSFFGTIPKEIGELKELEILDLGFNNFSG--PFPSDFGNSFSLTTLLLDNNQYLGGISP-ELHVL 213 (721)
Q Consensus 137 ~l~~l~~L~~L~L~~n~l~G~ip~~l~~l~~L~~l~ls~N~l~G--~iP~~~~~~~~L~~l~l~~N~~~G~iP~-~~~~l 213 (721)
.+..+..+..+++.+| +...++.....++.|+.|+||+|+++. .++..+..+++|+.|+|++|.++. +++ .....
T Consensus 37 ~l~~~~~~~~l~~~~~-~~~~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~-l~~l~~l~~ 114 (162)
T d1koha1 37 DLVAQNIDVVLNRRSS-MAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKS-ERELDKIKG 114 (162)
T ss_dssp TTTTTTCCCCTTSHHH-HHHHHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCC-GGGHHHHTT
T ss_pred hhhhccchhhcchhhh-HhhhhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCcccc-chhhhhhhc
Confidence 3445555555555544 334455555679999999999999985 344556789999999999999874 332 33345
Q ss_pred CCCCEEEccCCCCCCcc
Q 004979 214 KVISEIQVDESWLTNAA 230 (721)
Q Consensus 214 ~~L~~l~l~~n~~~g~~ 230 (721)
.+|+.|+|++|.++...
T Consensus 115 ~~L~~L~L~~Npl~~~~ 131 (162)
T d1koha1 115 LKLEELWLDGNSLSDTF 131 (162)
T ss_dssp CCCSSCCCTTSTTSSSS
T ss_pred cccceeecCCCCcCcCc
Confidence 57899999999988643
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.14 E-value=0.00014 Score=72.43 Aligned_cols=107 Identities=15% Similarity=0.084 Sum_probs=81.4
Q ss_pred CcEEEEEeCCC-CCCC-cCchhhcC-CCCCCEEEccCC--cccc-cCchhhcCCCCCCEeEcccC-cccccCCccccCCC
Q 004979 118 GKVVILNLRDL-CLGG-MLAPELGQ-LSELKSIILRNN--SFFG-TIPKEIGELKELEILDLGFN-NFSGPFPSDFGNSF 190 (721)
Q Consensus 118 ~~v~~l~L~~~-~l~G-~ip~~l~~-l~~L~~L~L~~n--~l~G-~ip~~l~~l~~L~~l~ls~N-~l~G~iP~~~~~~~ 190 (721)
.++..|+|++. .++. .+...+.. .+.|+.|++++. .++. .+..-..++++|+.|+|++| .+++..+..+..++
T Consensus 121 ~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~ 200 (284)
T d2astb2 121 SRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLN 200 (284)
T ss_dssp TTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCT
T ss_pred HhccccccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccC
Confidence 36888999874 4442 23333333 478999999864 4543 34444567899999999985 68888888899999
Q ss_pred CCCEEECcc-CCCCcCCChhccCCCCCCEEEccCC
Q 004979 191 SLTTLLLDN-NQYLGGISPELHVLKVISEIQVDES 224 (721)
Q Consensus 191 ~L~~l~l~~-N~~~G~iP~~~~~l~~L~~l~l~~n 224 (721)
+|++|+|++ +.+++.....++++++|+.|++.++
T Consensus 201 ~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~ 235 (284)
T d2astb2 201 YLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI 235 (284)
T ss_dssp TCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred cCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence 999999998 5788777778899999999999877
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=96.70 E-value=0.00053 Score=62.20 Aligned_cols=108 Identities=10% Similarity=0.084 Sum_probs=71.1
Q ss_pred CcEEEEEeCCC-CCCCc----CchhhcCCCCCCEEEccCCccccc----CchhhcCCCCCCEeEcccCccccc----CCc
Q 004979 118 GKVVILNLRDL-CLGGM----LAPELGQLSELKSIILRNNSFFGT----IPKEIGELKELEILDLGFNNFSGP----FPS 184 (721)
Q Consensus 118 ~~v~~l~L~~~-~l~G~----ip~~l~~l~~L~~L~L~~n~l~G~----ip~~l~~l~~L~~l~ls~N~l~G~----iP~ 184 (721)
..++.|+|+++ .++.. +-..+...+.|+.|+|++|.+.-. +-..+...+.|+.|+|++|.++.. +-.
T Consensus 15 ~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~ 94 (167)
T d1pgva_ 15 TDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLR 94 (167)
T ss_dssp SSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHH
T ss_pred CCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHH
Confidence 35778888864 45432 334566778888889988888632 233455678888889988888753 223
Q ss_pred cccCCCCCCEEECccCCCCc-------CCChhccCCCCCCEEEccCCC
Q 004979 185 DFGNSFSLTTLLLDNNQYLG-------GISPELHVLKVISEIQVDESW 225 (721)
Q Consensus 185 ~~~~~~~L~~l~l~~N~~~G-------~iP~~~~~l~~L~~l~l~~n~ 225 (721)
.+...++|+.|+|++|.+.. .|-..+...+.|+.|+++.+.
T Consensus 95 aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~ 142 (167)
T d1pgva_ 95 STLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFAS 142 (167)
T ss_dssp HTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCC
T ss_pred HHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCC
Confidence 45667788888888876432 133344556778888876553
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=96.06 E-value=0.0019 Score=58.39 Aligned_cols=89 Identities=18% Similarity=0.126 Sum_probs=66.3
Q ss_pred cCCCCCCEEEccCC-ccccc----CchhhcCCCCCCEeEcccCcccccC----CccccCCCCCCEEECccCCCCcC----
Q 004979 139 GQLSELKSIILRNN-SFFGT----IPKEIGELKELEILDLGFNNFSGPF----PSDFGNSFSLTTLLLDNNQYLGG---- 205 (721)
Q Consensus 139 ~~l~~L~~L~L~~n-~l~G~----ip~~l~~l~~L~~l~ls~N~l~G~i----P~~~~~~~~L~~l~l~~N~~~G~---- 205 (721)
.+.+.|+.|+|+++ .++-. +-..+...+.|+.|+|++|.+...- -..+...+.|+.|+|++|.++..
T Consensus 12 ~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~ 91 (167)
T d1pgva_ 12 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLAR 91 (167)
T ss_dssp TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHH
T ss_pred hCCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHH
Confidence 45689999999974 56432 3445778899999999999987432 23345678999999999998753
Q ss_pred CChhccCCCCCCEEEccCCCCC
Q 004979 206 ISPELHVLKVISEIQVDESWLT 227 (721)
Q Consensus 206 iP~~~~~l~~L~~l~l~~n~~~ 227 (721)
+-..+...+.|++|+|++|.++
T Consensus 92 l~~aL~~n~sL~~L~l~~n~~~ 113 (167)
T d1pgva_ 92 LLRSTLVTQSIVEFKADNQRQS 113 (167)
T ss_dssp HHHHTTTTCCCSEEECCCCSSC
T ss_pred HHHHHHhCCcCCEEECCCCcCC
Confidence 2234567788999999988655
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=95.94 E-value=0.029 Score=56.07 Aligned_cols=67 Identities=9% Similarity=0.025 Sum_probs=40.4
Q ss_pred EEEEEEecCCcEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCcc--ceEeE-----EEecCCCceEEEEEecCCC
Q 004979 442 TVYKGTLSSGVEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNF--VNLIG-----YCEEDEPFTRMMVFEYSPN 514 (721)
Q Consensus 442 ~Vyk~~~~~~~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nI--v~l~g-----~~~~~~~~~~~lV~Ey~~~ 514 (721)
.||+.+.++|..+++|+...... + .+++.+|...+..|....| +..+. .....+ ..+.+++|++|
T Consensus 37 ~vy~v~~~dg~~~VlK~~rp~~~---s---~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~--~~~~l~~~~~G 108 (325)
T d1zyla1 37 RVYQFQDEDRRRFVVKFYRPERW---T---ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQG--FYFAVFPSVGG 108 (325)
T ss_dssp EEEEECCTTCCCEEEEEECTTTS---C---HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETT--EEEEEEECCCC
T ss_pred eeEEEEcCCCCEEEEEEeCCCCC---C---HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeee--EEEEEEeecCC
Confidence 79999999999999987653211 1 2457778777776642222 11111 111122 46889999976
Q ss_pred CC
Q 004979 515 GS 516 (721)
Q Consensus 515 Gs 516 (721)
..
T Consensus 109 ~~ 110 (325)
T d1zyla1 109 RQ 110 (325)
T ss_dssp EE
T ss_pred cC
Confidence 43
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=94.89 E-value=0.0047 Score=55.48 Aligned_cols=109 Identities=14% Similarity=0.085 Sum_probs=72.7
Q ss_pred CcEEEEEeCC-CCCCCc----CchhhcCCCCCCEEEccCCccccc----CchhhcCCCCCCEeEcccCccccc----CCc
Q 004979 118 GKVVILNLRD-LCLGGM----LAPELGQLSELKSIILRNNSFFGT----IPKEIGELKELEILDLGFNNFSGP----FPS 184 (721)
Q Consensus 118 ~~v~~l~L~~-~~l~G~----ip~~l~~l~~L~~L~L~~n~l~G~----ip~~l~~l~~L~~l~ls~N~l~G~----iP~ 184 (721)
..++.|+|++ +.++.. +-..+...++|+.|+|++|.++.. |-..+...+.|+.|++++|.++.. +-.
T Consensus 17 ~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~ 96 (166)
T d1io0a_ 17 PDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVE 96 (166)
T ss_dssp TTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHH
T ss_pred CCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHH
Confidence 3577788887 445422 344566788899999999988654 233455678899999998888643 224
Q ss_pred cccCCCCCCEEEC--ccCCCCc----CCChhccCCCCCCEEEccCCCC
Q 004979 185 DFGNSFSLTTLLL--DNNQYLG----GISPELHVLKVISEIQVDESWL 226 (721)
Q Consensus 185 ~~~~~~~L~~l~l--~~N~~~G----~iP~~~~~l~~L~~l~l~~n~~ 226 (721)
.+...++|+.++| ++|.+.. .|-..+...++|+.|+++.+..
T Consensus 97 ~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~ 144 (166)
T d1io0a_ 97 ALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ 144 (166)
T ss_dssp GGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred HHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCC
Confidence 5667788887655 4566532 2444556788888888876543
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=94.60 E-value=0.05 Score=55.77 Aligned_cols=73 Identities=16% Similarity=0.222 Sum_probs=44.3
Q ss_pred hCcCCCCceeEEEEEEecCC--------cEEEEEEeeeccccchhhHHHHHHHHHHHHHhcCCCCcc-ceEeEEEecCCC
Q 004979 432 IGSFSDGTVGTVYKGTLSSG--------VEIAVTSTSVKSRADWSKNLESQFRKKIDTLSKVNHKNF-VNLIGYCEEDEP 502 (721)
Q Consensus 432 i~~lg~G~~g~Vyk~~~~~~--------~~vavk~~~~~~~~~~~~~~~~~f~~Ei~~l~~l~H~nI-v~l~g~~~~~~~ 502 (721)
+..++.|-.-.+|+....++ ..|.+++.. ... . .....+|..+++.+.-.++ .++++++. +
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~~-~-----~idr~~E~~i~~~ls~~gl~Pkll~~~~--~- 116 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NPE-T-----ESHLVAESVIFTLLSERHLGPKLYGIFS--G- 116 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SCC-C-----HHHHHHHHHHHHHHHHTTSSSCEEEEET--T-
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Ccc-h-----hhHHHHHHHHHHHHHhCCCCCeEEEEcC--C-
Confidence 34566688889999986543 345555443 211 1 1234577888877743344 47777763 2
Q ss_pred ceEEEEEecCCCCCh
Q 004979 503 FTRMMVFEYSPNGSL 517 (721)
Q Consensus 503 ~~~~lV~Ey~~~GsL 517 (721)
.+|+||+++-.+
T Consensus 117 ---g~I~efi~g~~l 128 (395)
T d1nw1a_ 117 ---GRLEEYIPSRPL 128 (395)
T ss_dssp ---EEEECCCCEEEC
T ss_pred ---ceEEEEeccccC
Confidence 589999987544
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=93.58 E-value=0.064 Score=52.91 Aligned_cols=28 Identities=21% Similarity=0.411 Sum_probs=25.3
Q ss_pred CeEeeCCCCCCeEeCCCCcEEEeccCCC
Q 004979 554 PIAHRNLQSSSIYLTEDYAAKISDFSFW 581 (721)
Q Consensus 554 ~IvHrDLKp~NILl~~~~~~kL~DFGla 581 (721)
++||+|+.+.||+++.+...-|.||+.+
T Consensus 184 giIHgDl~~dNvl~~~~~v~gvIDF~~~ 211 (316)
T d2ppqa1 184 GVIHADLFQDNVFFLGDELSGLIDFYFA 211 (316)
T ss_dssp EEECSCCCGGGEEEETTEEEEECCCTTC
T ss_pred ccccCCcchhhhhcccccceeEeccccc
Confidence 5999999999999998877789999965
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=91.47 E-value=0.052 Score=48.17 Aligned_cols=90 Identities=13% Similarity=0.133 Sum_probs=64.0
Q ss_pred hcCCCCCCEEEccC-Cccccc----CchhhcCCCCCCEeEcccCcccccCC----ccccCCCCCCEEECccCCCCcC---
Q 004979 138 LGQLSELKSIILRN-NSFFGT----IPKEIGELKELEILDLGFNNFSGPFP----SDFGNSFSLTTLLLDNNQYLGG--- 205 (721)
Q Consensus 138 l~~l~~L~~L~L~~-n~l~G~----ip~~l~~l~~L~~l~ls~N~l~G~iP----~~~~~~~~L~~l~l~~N~~~G~--- 205 (721)
..+.+.|+.|+|++ +.++-. +-..+...+.|+.|+|++|.++..-- ..+...++|+.+++++|.++..
T Consensus 13 ~~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~ 92 (166)
T d1io0a_ 13 QNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGIL 92 (166)
T ss_dssp HTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHH
T ss_pred HhcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHH
Confidence 34678999999998 556432 33456678999999999998875422 2345678899999999988643
Q ss_pred -CChhccCCCCCCEEEcc--CCCCC
Q 004979 206 -ISPELHVLKVISEIQVD--ESWLT 227 (721)
Q Consensus 206 -iP~~~~~l~~L~~l~l~--~n~~~ 227 (721)
+-..+...++|+.++|+ .|.++
T Consensus 93 ~l~~~l~~~~~L~~l~L~l~~n~i~ 117 (166)
T d1io0a_ 93 ALVEALQSNTSLIELRIDNQSQPLG 117 (166)
T ss_dssp HHHHGGGGCSSCCEEECCCCSSCCC
T ss_pred HHHHHHHhCccccEEeeccCCCcCc
Confidence 23456778889887664 45554
|